PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, YZ; Dai, MS; Zhang, SJ; Shi, ZB				Wang, Yue-zhi; Dai, Mei-song; Zhang, Shu-jun; Shi, Ze-bin			Exploring Candidate Genes for Pericarp Russet Pigmentation of Sand Pear (Pyrus pyrifolia) via RNA-Seq Data in Two Genotypes Contrasting for Pericarp Color	PLOS ONE			English	Article							TRANSPIRATION BARRIER PROPERTIES; TIME QUANTITATIVE PCR; CELL-WALL FORMATION; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTION FACTOR; LIGNIN BIOSYNTHESIS; XANTHINE DEHYDROGENASE; ARABIDOPSIS-THALIANA; WATER PERMEATION; CUTICULAR WAXES	Sand pear (Pyrus pyrifolia) russet pericarp is an important trait affecting both the quality and stress tolerance of fruits. This trait is controlled by a relative complex genetic process, with some fundamental biological questions such as how many and which genes are involved in the process remaining elusive. In this study, we explored differentially expressed genes between the russet-and green-pericarp offspring from the sand pear (Pyrus pyrifolia) cv. 'Qingxiang' x 'Cuiguan' F1 group by RNA-seq-based bulked segregant analysis (BSA). A total of 29,100 unigenes were identified and 206 of which showed significant differences in expression level (log(2)fold values>1) between the two types of pericarp pools. Gene Ontology (GO) analyses detected 123 unigenes in GO terms related to 'cellular_component' and 'biological_process', suggesting developmental and growth differentiations between the two types. GO categories associated with various aspects of 'lipid metabolic processes', 'transport', 'response to stress', 'oxidation-reduction process' and more were enriched with genes with divergent expressions between the two libraries. Detailed examination of a selected set of these categories revealed repressed expressions of candidate genes for suberin, cutin and wax biosynthesis in the russet pericarps. Genes encoding putative cinnamoyl-CoA reductase (CCR), cinnamyl alcohol dehydrogenase (CAD) and peroxidase (POD) that are involved in the lignin biosynthesis were suggested to be candidates for pigmentation of sand pear russet pericarps. Nine differentially expressed genes were analyzed for their expressions using qRT-PCR and the results were consistent with those obtained from Illumina RNA-sequencing. This study provides a comprehensive molecular biology insight into the sand pear pericarp pigmentation and appearance quality formation.	[Wang, Yue-zhi; Dai, Mei-song; Zhang, Shu-jun; Shi, Ze-bin] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences	Shi, ZB (corresponding author), Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China.	shizb@mail.zaas.ac.cn			Special Funds for China "Twelfth Five-Year" National Science and Technology Project for Pear Molecular Breeding and Germplasm Enhancement [2011AA10020602]; Special Funds for China Agriculture Research System [CARS-29-04]; Doctoral Start-up Research Funds of Zhejiang Academy of Agricultural Sciences	Special Funds for China "Twelfth Five-Year" National Science and Technology Project for Pear Molecular Breeding and Germplasm Enhancement; Special Funds for China Agriculture Research System; Doctoral Start-up Research Funds of Zhejiang Academy of Agricultural Sciences	This study was supported by the Special Funds for China "Twelfth Five-Year" National Science and Technology Project for Pear Molecular Breeding and Germplasm Enhancement (2011AA10020602), the Special Funds for China Agriculture Research System (CARS-29-04), and the Doctoral Start-up Research Funds of Zhejiang Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazzak N, 2006, PLANT PHYSIOL, V140, P30, DOI 10.1104/pp.105.069690; Albouyeh R, 2010, TREE GENET GENOMES, V6, P601, DOI 10.1007/s11295-010-0275-0; Anai T, 2003, PLANT CELL REP, V21, P988, DOI 10.1007/s00299-003-0609-6; Andersson-Gunneras S, 2006, PLANT J, V45, P144, DOI 10.1111/j.1365-313X.2005.02584.x; Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; ATTAURRAHMAN, 1995, PHYTOCHEMISTRY, V40, P427, DOI 10.1016/0031-9422(95)00195-D; Beisson F, 2012, CURR OPIN PLANT BIOL, V15, P329, DOI 10.1016/j.pbi.2012.03.003; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; Bernards MA, 2002, CAN J BOT, V80, P227, DOI [10.1139/B02-017, 10.1139/b02-017]; Bernards MA, 1998, PHYTOCHEMISTRY, V47, P915, DOI 10.1016/S0031-9422(98)80052-6; Bessire M, 2011, PLANT CELL, V23, P1958, DOI 10.1105/tpc.111.083121; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Carlsbecker A, 2005, CURR OPIN PLANT BIOL, V8, P512, DOI 10.1016/j.pbi.2005.07.001; Chen GX, 2011, P NATL ACAD SCI USA, V108, P12354, DOI 10.1073/pnas.1108444108; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Fu Y, 1995, P 13 ANN C FRUIT TRE; Girard AL, 2012, PLANT CELL, V24, P3119, DOI 10.1105/tpc.112.101055; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Gou JY, 2009, P NATL ACAD SCI USA, V106, P18855, DOI 10.1073/pnas.0905555106; Inoue E, 2006, SCI HORTIC-AMSTERDAM, V107, P254, DOI 10.1016/j.scienta.2005.07.009; Ito Y, 2011, PLANT J, V66, P680, DOI 10.1111/j.1365-313X.2011.04530.x; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; Jung JH, 2011, PLANT CELL REP, V30, P1881, DOI 10.1007/s00299-011-1095-x; Kannangara R, 2007, PLANT CELL, V19, P1278, DOI 10.1105/tpc.106.047076; Kaur H, 2012, PLANT PHYSIOL, V159, P1545, DOI 10.1104/pp.112.196717; Kim D, 2005, ACTA HORTIC, P315, DOI 10.17660/ActaHortic.2005.671.45; Kim H, 2002, J BIOL CHEM, V277, P47412, DOI 10.1074/jbc.M208860200; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; Kloosterman B, 2008, FUNCT INTEGR GENOMIC, V8, P329, DOI 10.1007/s10142-008-0083-x; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Koutaniemi S, 2007, PLANT MOL BIOL, V65, P311, DOI 10.1007/s11103-007-9220-5; Kurdyukov S, 2006, PLANTA, V224, P315, DOI 10.1007/s00425-005-0215-7; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lee SB, 2009, PLANT J, V60, P462, DOI 10.1111/j.1365-313X.2009.03973.x; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Legay S, 2010, NEW PHYTOL, V188, P774, DOI 10.1111/j.1469-8137.2010.03432.x; Leide J, 2007, PLANT PHYSIOL, V144, P1667, DOI 10.1104/pp.107.099481; Lemaire-Chamley M, 2005, PLANT PHYSIOL, V139, P750, DOI 10.1104/pp.105.063719; LEYDECKER MT, 1995, PLANT PHYSIOL, V107, P1427, DOI 10.1104/pp.107.4.1427; Li XiaoFeng, 2012, Acta Horticulturae Sinica, V39, P828; Li YH, 2007, PLANT PHYSIOL, V144, P1267, DOI 10.1104/pp.107.099432; Li-Beisson Y, 2009, P NATL ACAD SCI USA, V106, P22008, DOI 10.1073/pnas.0909090106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malnoy M, 2005, PLANT CELL REP, V23, P632, DOI 10.1007/s00299-004-0855-2; MARSTON A, 1995, J NAT PRODUCTS, V58, P128, DOI 10.1021/np50115a019; Matas AJ, 2010, J EXP BOT, V61, P3321, DOI 10.1093/jxb/erq153; McFarlane HE, 2010, PLANT CELL, V22, P3066, DOI 10.1105/tpc.110.077974; Mintz-Oron S, 2008, PLANT PHYSIOL, V147, P823, DOI 10.1104/pp.108.116004; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Panikashvili D, 2011, NEW PHYTOL, V190, P113, DOI 10.1111/j.1469-8137.2010.03608.x; Panikashvili D, 2010, MOL PLANT, V3, P563, DOI 10.1093/mp/ssp103; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; PEREIRA H, 1988, WOOD SCI TECHNOL, V22, P211, DOI 10.1007/BF00386015; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Reina JJ, 2007, J EXP BOT, V58, P2717, DOI 10.1093/jxb/erm136; Saballos A, 2009, GENETICS, V181, P783, DOI 10.1534/genetics.108.098996; Sagi M, 1999, PLANT PHYSIOL, V120, P571, DOI 10.1104/pp.120.2.571; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Sartorelli P, 1998, PHYTOCHEMISTRY, V47, P1003, DOI 10.1016/S0031-9422(97)00605-5; Schreiber L, 2010, TRENDS PLANT SCI, V15, P546, DOI 10.1016/j.tplants.2010.06.004; Serra O, 2009, J EXP BOT, V60, P697, DOI 10.1093/jxb/ern314; Shani Z, 2006, PLANT CELL REP, V25, P1067, DOI 10.1007/s00299-006-0167-9; Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x; Shi JX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001388; Sibout R, 2012, CURR BIOL, V22, pR533, DOI 10.1016/j.cub.2012.05.005; Siefritz F, 2002, PLANT CELL, V14, P869, DOI 10.1105/tpc.000901; Soler M, 2007, PLANT PHYSIOL, V144, P419, DOI 10.1104/pp.106.094227; Soler M, 2011, PLANTA, V233, P933, DOI 10.1007/s00425-011-1350-y; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Szepesi A, 2009, J PLANT PHYSIOL, V166, P914, DOI 10.1016/j.jplph.2008.11.012; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vogg G, 2004, J EXP BOT, V55, P1401, DOI 10.1093/jxb/erh149; Wagner A, 2009, PLANT PHYSIOL, V149, P370, DOI 10.1104/pp.108.125765; Wagner A, 2013, PLANT MOL BIOL, V81, P105, DOI 10.1007/s11103-012-9985-z; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Yan W, 2009, J SHANXI AGR U NAT S, V29, P32; Yeats TH, 2010, J EXP BOT, V61, P3759, DOI 10.1093/jxb/erq194; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang HuaYun, 1996, Acta Horticulturae Sinica, V23, P23; Zhang SJ, 2011, J HORTIC SCI BIOTECH, V86, P595, DOI 10.1080/14620316.2011.11512809; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong RQ, 2010, PLANT PHYSIOL, V152, P1044, DOI 10.1104/pp.109.148270	92	33	37	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83675	10.1371/journal.pone.0083675	http://dx.doi.org/10.1371/journal.pone.0083675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400075	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700009
J	Sattar, Z; Saberi, MR; Chamani, J				Sattar, Zohreh; Saberi, Mohammad Reza; Chamani, Jamshidkhan			Determination of LMF Binding Site on a HSA-PPIX Complex in the Presence of Human Holo Transferrin from the Viewpoint of Drug Loading on Proteins	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; PROTOPORPHYRIN-IX; 4TH-DERIVATIVE SPECTROPHOTOMETRY; 3-DIMENSIONAL EXCITATION; FLUORESCENCE; RECEPTOR; LOMEFLOXACIN; BEHAVIOR; CELLS; ACID	Holo transferrin (TF) and the natural complex of human serum albumin and protoporphyrin IX (HSA-PPIX) are two serum carrier proteins that can interact with each other. Such an interaction may alter their binding sites. In this study, fluorescence spectroscopy, as well as zeta potential and molecular modeling techniques, have been used to compare the complexes (HSA-PPIX)-LMF and [(HSA-PPIX)-TF]-LMF. The K-a1, K-a2, values of (HSA-PPIX)-LMF and [(HSA-PPIX)-TF]-LMF were 1.1x10(5) M-1, 9.7x10(6) M-1, and 2.0x10(4) M-1, 1.8x10(5) M-1, respectively, and the n(1), n(2) values were respectively 1.19, 1.53 and 1.17, 1.65. The second derivative of the Trp emission scan of (HSA-PPIX)-LMF exhibited one negative band at 310 nm, whereas for the [(HSA-PPIX)-TF]-LMF system, we observed one negative band at 316 nm indicating an increase in polarity around Trp. The effect of TF on the conformation of (HSA-PPIX)-TF was analyzed using three-dimensional fluorescence spectroscopy. The phase diagram indicated that the presence of a second binding site on HSA and TF was due to the existence of intermediate structures. Zeta potential analysis showed that the presence of TF increased the positive charges of the HSA-PPIX system. Site marker experiments revealed that the binding site of LMF to HSA-PPIX changed from Sudlow's site IIA to Sudlow's site IIIB in the presence of TF. Moreover, molecular modeling studies suggested the sub-domain IIIB in HSA as the candidate place for the formation of the binding site of LMF on the (HSA-PPIX)-TF complex.	[Sattar, Zohreh; Chamani, Jamshidkhan] Islamic Azad Univ, Mashhad Branch, Dept Biochem & Biophys, Fac Sci, Mashhad, Iran; [Saberi, Mohammad Reza] Mashhad Univ Med Sci, Sch Pharm, Dept Med Chem, Mashhad, Iran	Islamic Azad University; Mashhad University Medical Science	Chamani, J (corresponding author), Islamic Azad Univ, Mashhad Branch, Dept Biochem & Biophys, Fac Sci, Mashhad, Iran.	chamani@ibb.ut.ac.ir	Chamani, Jamshidkhan/AAC-7481-2019	Chamani, Jamshidkhan/0000-0003-2562-2458	Research Council of the Islamic Azad University Mashhad Branch	Research Council of the Islamic Azad University Mashhad Branch(Islamic Azad University)	The financial support of the Research Council of the Islamic Azad University Mashhad Branch is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhosale SV, 2011, SUPRAMOL CHEM, V23, P263, DOI 10.1080/10610278.2010.523115; Bi SY, 2004, J MOL STRUCT, V703, P37, DOI 10.1016/j.molstruc.2004.05.026; Brancaleon L, 2002, BIOPHYS CHEM, V96, P77, DOI 10.1016/S0301-4622(02)00035-2; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; De Luca G, 2006, J PHYS CHEM B, V110, P7309, DOI 10.1021/jp0530348; De Luca G, 2005, J PHYS CHEM B, V109, P7149, DOI 10.1021/jp0448797; Ding F, 2010, J LUMIN, V130, P2013, DOI 10.1016/j.jlumin.2010.05.019; DUNACH M, 1983, EUR J BIOCHEM, V134, P123, DOI 10.1111/j.1432-1033.1983.tb07540.x; Gallegos ER, 1999, ARCH MED RES, V30, P163, DOI 10.1016/S0188-0128(99)00013-5; Gardner SF, 2003, ANN PHARMACOTHER, V37, P99; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Kuznetsova IM, 2004, BIOCHEMISTRY-US, V41, P13127; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4161, DOI 10.1021/bi00745a020; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li HY, 2002, MED RES REV, V22, P225, DOI 10.1002/med.10008; Liu T, 2011, WATER RES, V45, P2111, DOI 10.1016/j.watres.2010.12.023; Malhotra A, 2004, FOOD HYDROCOLLOID, V18, P101, DOI 10.1016/S0268-005X(03)00047-X; Nanda RK, 2007, J PHOTOCH PHOTOBIO A, V192, P152, DOI 10.1016/j.jphotochem.2007.05.018; Natarajan P, 2004, EUR POLYM J, V40, P2291, DOI 10.1016/j.eurpolymj.2004.06.003; Neault JF, 1998, BBA-PROTEIN STRUCT M, V1384, P153, DOI 10.1016/S0167-4838(98)00011-9; Oliveira AC, 2009, ACTA BIOMATER, V5, P2142, DOI 10.1016/j.actbio.2009.02.019; Ouameur AA, 2004, BIOPOLYMERS, V73, P503, DOI 10.1002/bip.10557; PADROS E, 1984, TRENDS BIOCHEM SCI, V9, P508, DOI 10.1016/0968-0004(84)90272-X; Peng LC, 2010, COLLOID SURFACE A, V370, P136, DOI 10.1016/j.colsurfa.2010.08.060; Purcell M, 2000, BBA-PROTEIN STRUCT M, V1478, P61, DOI 10.1016/S0167-4838(99)00251-4; Quamer AA, 2005, BIOPOLYMERS, V77, P129; Ragi C, 2005, BIOPOLYMERS, V78, P231, DOI 10.1002/bip.20281; Ruilope L, 1997, J HYPERTENS, V15, pS15; Sattar Z, 2012, SPECTROCHIM ACTA A, V97, P1089, DOI 10.1016/j.saa.2012.07.034; Shaw AK, 2008, J PHOTOCH PHOTOBIO B, V90, P187, DOI 10.1016/j.jphotobiol.2008.01.001; Sheng GP, 2006, WATER RES, V40, P1233, DOI 10.1016/j.watres.2006.01.023; SJOHOLM I, 1979, MOL PHARMACOL, V16, P767; Subramanian B, 2008, INT IMMUNOPHARMACOL, V8, P1533, DOI 10.1016/j.intimp.2008.06.009; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Vahedian-Movahed H, 2011, J BIOMOL STRUCT DYN, V28, P483, DOI 10.1080/07391102.2011.10508590; Visser CC, 2004, J DRUG TARGET, V12, P145, DOI 10.1080/10611860410001701706; Wang J, 2008, SPECTROCHIM ACTA A, V69, P956, DOI 10.1016/j.saa.2007.05.057; Wang YQ, 2008, J MOL STRUCT, V886, P77, DOI 10.1016/j.molstruc.2007.10.039; Wang ZW, 2009, WATER RES, V43, P1533, DOI 10.1016/j.watres.2008.12.033; Yuan JL, 2007, J PHOTOCH PHOTOBIO A, V191, P104, DOI 10.1016/j.jphotochem.2007.04.010; Zhang DY, 2010, J HAZARD MATER, V175, P359, DOI 10.1016/j.jhazmat.2009.10.011; Zhang GW, 2008, J MOL STRUCT, V881, P132, DOI 10.1016/j.molstruc.2007.09.002; Zhang MX, 2004, J AM SOC MASS SPECTR, V15, P1658, DOI 10.1016/j.jasms.2004.08.009; Zhang Y, 2005, J PHYS CHEM A, V109, P7442, DOI 10.1021/jp050516a; Zhao Y, 2009, J COLLOID INTERF SCI, V332, P345, DOI 10.1016/j.jcis.2008.12.048	47	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84045	10.1371/journal.pone.0084045	http://dx.doi.org/10.1371/journal.pone.0084045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392106	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100030
J	Hammer, A; Arah, OA; DerSarkissian, M; Thompson, CA; Mannion, R; Wagner, C; Ommen, O; Sunol, R; Pfaff, H				Hammer, Antje; Arah, Onyebuchi A.; DerSarkissian, Maral; Thompson, Caroline A.; Mannion, Russell; Wagner, Cordula; Ommen, Oliver; Sunol, Rosa; Pfaff, Holger		DUQuE Project Consortium	The Relationship between Social Capital and Quality Management Systems in European Hospitals: A Quantitative Study	PLOS ONE			English	Article							TRANSFORMATIONAL LEADERSHIP; SAFETY CULTURE; HEALTH-CARE; DIRECTORS; PERFORMANCE; IMPROVEMENT; CLIMATE; IMPACT	Background: Strategic leadership is an important organizational capability and is essential for quality improvement in hospital settings. Furthermore, the quality of leadership depends mutual trust between hospital management board members. According to the concept of social capital, these are essential requirements for successful cooperation and coordination within groups. Objectives: We assume that social capital within hospital management boards is an important factor in the development of effective organizational systems for overseeing health care quality. We hypothesized that the degree of social capital within the hospital management board is associated with the effectiveness and maturity of the quality management system in European hospitals. Methods: We used a mixed-method approach to data collection and measurement in 188 hospitals in 7 European countries. For this analysis, we used responses from hospital managers. To test our hypothesis, we conducted a multilevel linear regression analysis of the association between social capital and the quality management system score at the hospital level, controlling for hospital ownership, teaching status, number of beds, number of board members, organizational culture, and country clustering. Results: The average social capital score within a hospital management board was 3.3 (standard deviation: 0.5; range: 1-4) and the average hospital score for the quality management index was 19.2 (standard deviation: 4.5; range: 0-27). Higher social capital was associated with higher quality management system scores (regression coefficient: 1.41; standard error: 0.64, p=0.029). Conclusion: The results suggest that a higher degree of social capital exists in hospitals that exhibit higher maturity in their quality management systems. Although uncontrolled confounding and reverse causation cannot be completely ruled out, our new findings, along with the results of previous research, could have important implications for the work of hospital managers and the design and evaluation of hospital quality management systems.	[Hammer, Antje; Ommen, Oliver; Pfaff, Holger] Univ Cologne, Fac Human Sci, Inst Med Sociol Hlth Serv Res & Rehabil Sci, D-50931 Cologne, Germany; [Hammer, Antje; Ommen, Oliver; Pfaff, Holger] Univ Cologne, Fac Med, D-50931 Cologne, Germany; [Arah, Onyebuchi A.; DerSarkissian, Maral; Thompson, Caroline A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA; [Arah, Onyebuchi A.] Univ Calif Los Angeles, Ctr Hlth Policy Res, Los Angeles, CA USA; [Mannion, Russell] Univ Birmingham, Sch Social Policy, HSMC, Birmingham, W Midlands, England; [Wagner, Cordula] Nederlands Inst Onderzoek Gezondheidszorg, NIVEL, Utrecht, Netherlands; [Wagner, Cordula] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Sunol, Rosa] Univ Autonoma Barcelona, Avedis Donabedian Res Inst FAD, E-08193 Barcelona, Spain	University of Cologne; University of Cologne; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Birmingham; Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam; Autonomous University of Barcelona	Hammer, A (corresponding author), Univ Cologne, Fac Human Sci, Inst Med Sociol Hlth Serv Res & Rehabil Sci, D-50931 Cologne, Germany.	antje.hammer@uk-koeln.de	Sunol, Rosa/AAS-7276-2021; Pfaff, Holger/D-2630-2009; Car, Mate/F-2184-2017; Pfaff, Holger/AAT-6014-2020	Sunol, Rosa/0000-0003-1902-833X; Pfaff, Holger/0000-0001-9154-6575; Car, Mate/0000-0002-7005-0500; Pfaff, Holger/0000-0001-9154-6575; Arah, Onyebuchi/0000-0002-9067-1697; Eiras, Margarida/0000-0001-5759-7336; Thompson, Caroline/0000-0001-9990-9756; Mannion, Russell/0000-0002-0680-8049; Groene, Oliver/0000-0002-1099-2950	European Commission [24188]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This project has been funded by the European Commission's Seventh Framework Programme FP7/2007-2013 under grant agreement number 24188. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, DISTINCTION SOCIAL C; Coleman J.S., 1990, FDN SOCIAL THEORY, P300, DOI [DOI 10.2307/2579680, 10.2307/2579680]; Connell N A D, 2006, J Health Organ Manag, V20, P417, DOI 10.1108/14777260610701795; Dalton CM, 2005, BRIT J MANAGE, V16, pS91, DOI 10.1111/j.1467-8551.2005.00450.x; Dalton DR, 1999, ACAD MANAGE J, V42, P674, DOI 10.2307/256988; Devereaux PJ, 2004, CAN MED ASSOC J, V170, P1817, DOI 10.1503/cmaj.1040722; Ernstmann N, 2012, INT J HEALTHCARE MAN, V5, P98, DOI 10.1179/2047971912Y.0000000007; Ernstmann N, 2009, J NURS CARE QUAL, V24, P340, DOI 10.1097/NCQ.0b013e3181b14ba5; Farsi Mehdi, 2004, Int J Health Care Finance Econ, V4, P211, DOI 10.1023/B:IHFE.0000036047.66483.46; Flin R, 2000, SAFETY SCI, V34, P177, DOI 10.1016/S0925-7535(00)00012-6; Flin R, 2007, SAFETY SCI, V45, P653, DOI 10.1016/j.ssci.2007.04.003; Fukuyama F, 2001, THIRD WORLD Q, V22, P7; Glickman SW, 2007, INT J QUAL HEALTH C, V19, P341, DOI 10.1093/intqhc/mzm047; Gloede TD, 2013, J INTERPROF CARE, V27, P171, DOI 10.3109/13561820.2012.724125; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Groene O, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-281; Guest PM, 2009, EUR J FINANC, V15, P385, DOI 10.1080/13518470802466121; Hammer A, 2012, J PUBLIC HEALTH MAN, V18, P175, DOI 10.1097/PHH.0b013e31823dea94; JENSEN MC, 1993, J FINANC, V48, P831, DOI 10.2307/2329018; LIPTON M, 1992, BUS LAWYER, V48, P59; Mannion Russell, 2005, J Health Serv Res Policy, V10, P129, DOI 10.1258/1355819054339013; McFadden KL, 2009, J OPER MANAG, V27, P390, DOI 10.1016/j.jom.2009.01.001; Pfaff H., 2005, FEHLZEITEN REPORT 20, P81; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Putnam R., 2001, CANADIAN J POLICY RE, V2, P41; PUTNAM RD, 1995, J DEMOCRACY, V0006; QUINN RE, 1983, MANAGE SCI, V29, P33, DOI 10.1287/mnsc.29.1.33; Rousseau D.M., 1990, ORG CLIMATE CULTURE, P153; SHORTELL SM, 1995, HEALTH SERV RES, V30, P377; Sloan FA, 2003, MED CARE, V41, P1193, DOI 10.1097/01.MLR.0000088569.50763.15; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Wagner C, 1999, INT J QUAL HEALTH C, V11, P119, DOI 10.1093/intqhc/11.2.119; Zammuto R.F., 1991, RES ORGANISATIONAL C, V5, P83; Zohar D, 2008, J APPL PSYCHOL, V93, P744, DOI 10.1037/0021-9010.93.4.744	34	26	27	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85662	10.1371/journal.pone.0085662	http://dx.doi.org/10.1371/journal.pone.0085662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24392027	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900171
J	Innes-Brown, H; Barutchu, A; Crewther, DP				Innes-Brown, Hamish; Barutchu, Ayla; Crewther, David P.			Neural Responses in Parietal and Occipital Areas in Response to Visual Events Are Modulated by Prior Multisensory Stimuli	PLOS ONE			English	Article							ELECTROMAGNETIC TOMOGRAPHY; MULTIMODAL INTEGRATION; HUMAN V1; SOUND; CORTEX; BRAIN; REPRESENTATION; PROJECTION; PRIMATE; HUMANS	The effect of multi-modal vs uni-modal prior stimuli on the subsequent processing of a simple flash stimulus was studied in the context of the audio-visual 'flash-beep' illusion, in which the number of flashes a person sees is influenced by accompanying beep stimuli. EEG recordings were made while combinations of simple visual and audio-visual stimuli were presented. The experiments found that the electric field strength related to a flash stimulus was stronger when it was preceded by a multi-modal flash/beep stimulus, compared to when it was preceded by another uni-modal flash stimulus. This difference was found to be significant in two distinct timeframes - an early timeframe, from 130-160 ms, and a late timeframe, from 300-320 ms. Source localisation analysis found that the increased activity in the early interval was localised to an area centred on the inferior and superior parietal lobes, whereas the later increase was associated with stronger activity in an area centred on primary and secondary visual cortex, in the occipital lobe. The results suggest that processing of a visual stimulus can be affected by the presence of an immediately prior multisensory event. Relatively long-lasting interactions generated by the initial auditory and visual stimuli altered the processing of a subsequent visual stimulus.	[Innes-Brown, Hamish] Bion Inst, Melbourne, Vic, Australia; [Innes-Brown, Hamish] Swinburne Univ Technol, Melbourne, Vic, Australia; [Barutchu, Ayla] Deakin Univ, Melbourne, Vic, Australia; [Barutchu, Ayla] Florey Inst Neurosci & Mental Hlth Melbourne, Melbourne, Vic, Australia; [Crewther, David P.] Swinburne Univ Technol, Ctr Human Psychopharmacol, Melbourne, Vic, Australia	Bionics Institute; Swinburne University of Technology; Deakin University; Florey Institute of Neuroscience & Mental Health; Swinburne University of Technology	Innes-Brown, H (corresponding author), Bion Inst, Melbourne, Vic, Australia.	hinnes-brown@bionicsinstitute.org	Innes-Brown, Hamish/H-3298-2019; Crewther, Sheila G/A-2165-2008	Innes-Brown, Hamish/0000-0002-1512-2823; 	Victorian Government; Swinburne University Postgraduate Award	Victorian Government; Swinburne University Postgraduate Award	The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. HIB was supported by a Swinburne University Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JC, 2007, J NEUROSCI, V27, P12775, DOI 10.1523/JNEUROSCI.3524-07.2007; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benjamini Y, 2001, ANN STAT, V29, P1165; Bhattacharya J, 2002, NEUROREPORT, V13, P1727, DOI 10.1097/00001756-200210070-00007; Bolognini N, 2011, NEUROPSYCHOLOGIA, V49, P231, DOI 10.1016/j.neuropsychologia.2010.11.015; Butler JS, 2012, J NEUROSCI, V32, P15338, DOI 10.1523/JNEUROSCI.1796-12.2012; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; Cappe C, 2010, J NEUROSCI, V30, P12572, DOI 10.1523/JNEUROSCI.1099-10.2010; Cappe C, 2009, CEREB CORTEX, V19, P2025, DOI 10.1093/cercor/bhn228; Chen YC, 2009, EXP BRAIN RES, V198, P209, DOI 10.1007/s00221-009-1831-4; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; de Haas B, 2012, P ROY SOC B-BIOL SCI, V279, P4955, DOI 10.1098/rspb.2012.2132; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2006, ENCYCL MED DEVICES I, DOI [10.1002/0471732877.emd318, DOI 10.1002/0471732877.EMD318]; Falchier A, 2002, J NEUROSCI, V22, P5749; Falchier A, 2010, CEREB CORTEX, V20, P1529, DOI 10.1093/cercor/bhp213; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Howell D., 2009, STAT METHODS PSYCHOL, V7th; Innes-Brown H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006450; Jones EG, 1980, BRAIN, V93, P793; Kamke MR, 2012, NEUROIMAGE, V62, P1334, DOI 10.1016/j.neuroimage.2012.05.063; Lakatos P, 2005, NEUROREPORT, V16, P933, DOI 10.1097/00001756-200506210-00011; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Meylan RV, 2007, NEUROIMAGE, V35, P244, DOI 10.1016/j.neuroimage.2006.11.033; Mishra J, 2007, J NEUROSCI, V27, P4120, DOI 10.1523/JNEUROSCI.4912-06.2007; Mognon A, 2010, PSYCHOPHYSIOLOGY; Molholm S, 2006, J NEUROPHYSIOL, V96, P721, DOI 10.1152/jn.00285.2006; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Musacchia G, 2009, HEARING RES, V258, P72, DOI 10.1016/j.heares.2009.06.018; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Rosenthal O, 2009, BRAIN TOPOGR, V21, P185, DOI 10.1007/s10548-009-0090-9; Schroeder C. E., 2004, COGN PROCESS, V5, P140; Senkowski D, 2011, NEUROIMAGE, V56, P2200, DOI 10.1016/j.neuroimage.2011.03.075; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shams L, 2005, NEUROSCI LETT, V378, P76, DOI 10.1016/j.neulet.2004.12.035; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shams L, 2001, NEUROREPORT, V12, P3849, DOI 10.1097/00001756-200112040-00049; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Valdes-Hernandez PA, 2009, J NEUROSCI METH, V185, P125, DOI 10.1016/j.jneumeth.2009.09.005; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Watkins S, 2007, NEUROIMAGE, V37, P572, DOI 10.1016/j.neuroimage.2007.05.027; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016	50	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84331	10.1371/journal.pone.0084331	http://dx.doi.org/10.1371/journal.pone.0084331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391939	gold, Green Published			2022-12-27	WOS:000329323900082
J	Kaushik, K; Leonard, VE; Shamsudheen, KV; Lalwani, MK; Jalali, S; Patowary, A; Joshi, A; Scaria, V; Sivasubbu, S				Kaushik, Kriti; Leonard, Vincent Elvin; Shamsudheen, K., V; Lalwani, Mukesh Kumar; Jalali, Saakshi; Patowary, Ashok; Joshi, Adita; Scaria, Vinod; Sivasubbu, Sridhar			Dynamic Expression of Long Non-Coding RNAs (lncRNAs) in Adult Zebrafish	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; HUMAN GENOME; XIST GENE; MOUSE; MICRORNAS; IDENTIFICATION; ANNOTATION; EVOLUTION; DEPLETION; SEQUENCE	Long non-coding RNAs (lncRNA) represent an assorted class of transcripts having little or no protein coding capacity and have recently gained importance for their function as regulators of gene expression. Molecular studies on lncRNA have uncovered multifaceted interactions with protein coding genes. It has been suggested that lncRNAs are an additional layer of regulatory switches involved in gene regulation during development and disease. LncRNAs expressing in specific tissues or cell types during adult stages can have potential roles in form, function, maintenance and repair of tissues and organs. We used RNA sequencing followed by computational analysis to identify tissue restricted lncRNA transcript signatures from five different tissues of adult zebrafish. The present study reports 442 predicted lncRNA transcripts from adult zebrafish tissues out of which 419 were novel lncRNA transcripts. Of these, 77 lncRNAs show predominant tissue restricted expression across the five major tissues investigated. Adult zebrafish brain expressed the largest number of tissue restricted lncRNA transcripts followed by cardiovascular tissue. We also validated the tissue restricted expression of a subset of lncRNAs using independent methods. Our data constitute a useful genomic resource towards understanding the expression of lncRNAs in various tissues in adult zebrafish. Our study is thus a starting point and opens a way towards discovering new molecular interactions of gene expression within the specific adult tissues in the context of maintenance of organ form and function.	[Kaushik, Kriti; Leonard, Vincent Elvin; Shamsudheen, K., V; Lalwani, Mukesh Kumar; Patowary, Ashok; Joshi, Adita; Sivasubbu, Sridhar] CSIR, Inst Genom & Integrat Biol, Delhi, India; [Jalali, Saakshi; Scaria, Vinod] CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India; [Kaushik, Kriti; Jalali, Saakshi; Scaria, Vinod; Sivasubbu, Sridhar] Acad Sci & Innovat Res AcSIR, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR)	Scaria, V (corresponding author), CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India.	vinods@igib.res.in; s.sivasubbu@igib.res.in	Scaria, Vinod/AAS-3151-2021; Patowary, Ashok/AAT-5305-2020; Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022	Patowary, Ashok/0000-0001-7507-3907; Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Scaria, Vinod/0000-0001-7644-7181	Council of Scientific and Industrial Research (CSIR), India [BSC0123]; CSIR [MLP1202]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge funding from the Council of Scientific and Industrial Research (CSIR), India through the BSC0123 Grant. KK acknowledges junior research fellowship (JRF) from CSIR. AJ acknowledges fellowship funding from MLP1202 grant of CSIR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bhartiya D, 2012, EXPERT OPIN DRUG DIS, V7, P503, DOI 10.1517/17460441.2012.682055; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen ZY, 2008, CARDIOVASC RES, V79, P97, DOI 10.1093/cvr/cvn073; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khaitovich P, 2006, PLOS GENET, V2, P1590, DOI 10.1371/journal.pgen.0020171; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lalwani MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052588; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li KG, 2010, BLOOD, V115, P133, DOI 10.1182/blood-2009-09-242180; Li MX, 2012, NUCLEIC ACIDS RES, V40, P11714, DOI 10.1093/nar/gks943; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Olson Sue A, 2002, Brief Bioinform, V3, P87, DOI 10.1093/bib/3.1.87; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pennisi E, 2012, SCIENCE, V337, P1159, DOI 10.1126/science.337.6099.1159; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Sleep E, 2010, J CARDIOVASC MED, V11, P369, DOI 10.2459/JCM.0b013e3283375900; Sone M, 2007, J CELL SCI, V120, P2498, DOI 10.1242/jcs.009357; Soni K, 2013, NUCLEIC ACIDS RES, V41, P4470, DOI 10.1093/nar/gkt139; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Winkler C, 2003, GENOME RES, V13, P1067, DOI 10.1101/gr.1097503; Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044; Yin VP, 2008, GENE DEV, V22, P728, DOI 10.1101/gad.1641808; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018; Zheng D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-548	64	76	80	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83616	10.1371/journal.pone.0083616	http://dx.doi.org/10.1371/journal.pone.0083616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391796	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200093
J	Kim, J; Frey, WD; He, HZ; Kim, H; Ekram, MB; Bakshi, A; Faisal, M; Perera, BPU; Ye, A; Teruyama, R				Kim, Joomyeong; Frey, Wesley D.; He, Hongzhi; Kim, Hana; Ekram, Muhammad B.; Bakshi, Arundhati; Faisal, Mohammad; Perera, Bambarendage P. U.; Ye, An; Teruyama, Ryoichi			Peg3 Mutational Effects on Reproduction and Placenta-Specific Gene Families	PLOS ONE			English	Article							EXPRESSED IMPRINTED GENE; TUMOR-SUPPRESSOR GENES; METHYLATION; YY1; PROGENITOR; EVOLUTION; PW1/PEG3; BINDING; GROWTH; STEM	Peg3 (paternally expressed gene 3) is an imprinted gene encoding a DNA-binding protein. This gene plays important roles in controlling fetal growth rates and nurturing behaviors. In the current study, a new mutant mouse model has been generated to further characterize the functions of this DNA-binding protein. Besides known phenotypes, this new mutant model also revealed potential roles of Peg3 in mammalian reproduction. Female heterozygotes produce a much smaller number of mature oocytes than the wild-type littermates, resulting in reduced litter sizes. According to genome-wide expression analyses, several placenta-specific gene families are de-repressed in the brain of Peg3 heterozygous embryos, including prolactin, cathepsin and carcinoembryonic antigen cell adhesion molecule (Ceacam) families. The observed derepression is more pronounced in females than in males. The de-repression of several members of these gene families is observed even in the adult brain, suggesting potential defects in epigenetic setting of the placenta-specific gene families in the Peg3 mutants. Overall, these results indicate that Peg3 likely controls the transcription of several placenta-specific gene families, and further suggest that this predicted transcriptional control by Peg3 might be mediated through unknown epigenetic mechanisms.	[Kim, Joomyeong; Frey, Wesley D.; He, Hongzhi; Kim, Hana; Ekram, Muhammad B.; Bakshi, Arundhati; Faisal, Mohammad; Perera, Bambarendage P. U.; Ye, An; Teruyama, Ryoichi] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Frey, Wesley/0000-0003-0392-5714; Bakshi, Arundhati/0000-0001-8483-1597; Teruyama, Ryoichi/0000-0002-9356-8310	National Institutes of Health [R01-GM066225, R01-GM097974, R15-ES019118]; COBRE [NIH P20 GM103528]; NORC [NIH 2P30DK072476]; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103528, R01GM066225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRE; NORC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225, R01-GM097974, and R15-ES019118). The Pennington Biomedical Genomics Core Facility is supported in part by COBRE (NIH P20 GM103528) and NORC (NIH 2P30DK072476) center grants from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Besson V, 2011, P NATL ACAD SCI USA, V108, P11470, DOI 10.1073/pnas.1103873108; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen MY, 2011, CANCER-AM CANCER SOC, V117, P4424, DOI 10.1002/cncr.26073; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Curley JP, 2004, P ROY SOC B-BIOL SCI, V271, P1303, DOI 10.1098/rspb.2004.2725; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Ivanova E, 2011, J MOL ENDOCRINOL, V47, pR67, DOI 10.1530/JME-11-0065; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; Kim J, 2008, HUM MOL GENET, V17, P391, DOI 10.1093/hmg/ddm316; Kim J, 2007, GENOMICS, V90, P85, DOI 10.1016/j.ygeno.2007.03.012; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Swaney WT, 2008, BEHAV NEUROSCI, V122, P963, DOI 10.1037/a0012706; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Yamaguchi A, 2002, J BIOL CHEM, V277, P623, DOI 10.1074/jbc.M107435200	37	46	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83359	10.1371/journal.pone.0083359	http://dx.doi.org/10.1371/journal.pone.0083359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391757	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200054
J	Koetsier, A; van Asten, L; Dijkstra, F; van der Hoek, W; Snijders, BE; van den Wijngaard, CC; Boshuizen, HC; Donker, GA; de Lange, DW; de Keizer, NF; Peek, N				Koetsier, Antonie; van Asten, Liselotte; Dijkstra, Frederika; van der Hoek, Wim; Snijders, Bianca E.; van den Wijngaard, Cees C.; Boshuizen, Hendriek C.; Donker, Ge A.; de Lange, Dylan W.; de Keizer, Nicolette F.; Peek, Niels			Do Intensive Care Data on Respiratory Infections Reflect Influenza Epidemics?	PLOS ONE			English	Article							REGRESSION; SEVERITY; MODELS	Objectives: Severe influenza can lead to Intensive Care Unit (ICU) admission. We explored whether ICU data reflect influenza like illness (ILI) activity in the general population, and whether ICU respiratory infections can predict influenza epidemics. Methods: We calculated the time lag and correlation between ILI incidence (from ILI sentinel surveillance, based on general practitioners (GP) consultations) and percentages of ICU admissions with a respiratory infection (from the Dutch National Intensive Care Registry) over the years 2003-2011. In addition, ICU data of the first three years was used to build three regression models to predict the start and end of influenza epidemics in the years thereafter, one to three weeks ahead. The predicted start and end of influenza epidemics were compared with observed start and end of such epidemics according to the incidence of ILI. Results: Peaks in respiratory ICU admissions lasted longer than peaks in ILI incidence rates. Increases in ICU admissions occurred on average two days earlier compared to ILI. Predicting influenza epidemics one, two, or three weeks ahead yielded positive predictive values ranging from 0.52 to 0.78, and sensitivities from 0.34 to 0.51. Conclusions: ICU data was associated with ILI activity, with increases in ICU data often occurring earlier and for a longer time period. However, in the Netherlands, predicting influenza epidemics in the general population using ICU data was imprecise, with low positive predictive values and sensitivities.	[Koetsier, Antonie; de Keizer, Nicolette F.; Peek, Niels] Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; [van Asten, Liselotte; Dijkstra, Frederika; van der Hoek, Wim; Snijders, Bianca E.; van den Wijngaard, Cees C.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Boshuizen, Hendriek C.] Natl Inst Publ Hlth & Environm, Dept Stat Math Modeling & Data Logist, NL-3720 BA Bilthoven, Netherlands; [Donker, Ge A.] Dutch Sentinel Gen Practice Network, Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [de Lange, Dylan W.] Univ Med Ctr, Dept Intens Care, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Netherlands Institute for Health Services Research; Utrecht University; Utrecht University Medical Center	Koetsier, A (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Informat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.koetsier@amc.uva.nl	Donker, Gé/AAX-8564-2021; Peek, Niels/AAD-9334-2019; Boshuizen, Hendriek/M-3415-2014; Dijkstra, Frederika/ABF-3865-2021; Boshuizen, Hendriek C/B-3718-2014; De Lange, Dylan W/ABB-8172-2020	Peek, Niels/0000-0002-6393-9969; Boshuizen, Hendriek/0000-0002-3916-9095; Dijkstra, Frederika/0000-0003-0012-740X; De Lange, Dylan W/0000-0002-0191-7270; Donker, Ge/0000-0001-6314-9249				Alonso TV, 2004, INT CONGR SER, V1263, P281, DOI 10.1016/j.ics.2004.02.121; Amato-Gauci A, 2011, EURO SURVEILL, V16, P19903; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; Boshuizen Hendriek C, 2010, Epidemiol Perspect Innov, V7, P4, DOI 10.1186/1742-5573-7-4; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Closas P, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-112; Donker GA, 2013, CONTINUOUS MORBIDITY; EFRON B, 1986, J AM STAT ASSOC, V81, P461, DOI 10.2307/2289236; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Nationale Intensive Care Evaluatie, STICHT NICE; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pel JZS, 1965, HUIS WETEN, V8, P321; Steiner SH, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-37; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Thomson G, 2010, EURO SURVEILL, V15; van den Wijngaard CC, 2010, AM J PUBLIC HEALTH, V100, P2248, DOI 10.2105/AJPH.2009.168245; Wijngaard CC, 2012, PLOS ONE, V7	19	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83854	10.1371/journal.pone.0083854	http://dx.doi.org/10.1371/journal.pone.0083854			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284NF	24391837	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200135
J	McLure, KG; Gesner, EM; Tsujikawa, L; Kharenko, OA; Attwell, S; Campeau, E; Wasiak, S; Stein, A; White, A; Fontano, E; Suto, RK; Wong, NCW; Wagner, GS; Hansen, HC; Young, PR				McLure, Kevin G.; Gesner, Emily M.; Tsujikawa, Laura; Kharenko, Olesya A.; Attwell, Sarah; Campeau, Eric; Wasiak, Sylwia; Stein, Adam; White, Andre; Fontano, Eric; Suto, Robert K.; Wong, Norman C. W.; Wagner, Gregory S.; Hansen, Henrik C.; Young, Peter R.			RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-A-I; SMALL-MOLECULE INHIBITORS; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR RISK; LDL CHOLESTEROL; CYCLOSPORINE-A; SAFETY; EFFICACY; PARTICIPANTS	Increased synthesis of Apolipoprotein A-I (ApoA-I) and HDL is believed to provide a new approach to treating atherosclerosis through the stimulation of reverse cholesterol transport. RVX-208 increases the production of ApoA-I in hepatocytes in vitro, and in vivo in monkeys and humans, which results in increased HDL-C, but the molecular target was not previously reported. Using binding assays and X-ray crystallography, we now show that RVX-208 selectively binds to bromodomains of the BET (Bromodomain and Extra Terminal) family, competing for a site bound by the endogenous ligand, acetylated lysine, and that this accounts for its pharmacological activity. siRNA experiments further suggest that induction of ApoA-I mRNA is mediated by BET family member BRD4. These data indicate that RVX-208 increases ApoA-I production through an epigenetic mechanism and suggests that BET inhibition may be a promising new approach to the treatment of atherosclerosis.	[McLure, Kevin G.; Gesner, Emily M.; Tsujikawa, Laura; Kharenko, Olesya A.; Attwell, Sarah; Campeau, Eric; Wasiak, Sylwia; Wong, Norman C. W.; Wagner, Gregory S.; Hansen, Henrik C.; Young, Peter R.] Resverlogix Corp, Calgary, AB, Canada; [Stein, Adam; White, Andre; Fontano, Eric; Suto, Robert K.] Xtal BioStruct Inc, Natick, MD USA		McLure, KG (corresponding author), Resverlogix Corp, Calgary, AB, Canada.	kevin@resverlogix.com	Kharenko, Olesya A./AAC-5873-2019	Kharenko, Olesya A./0000-0003-4710-3886	Resverlogix Corp; Alberta Innovates	Resverlogix Corp; Alberta Innovates	This work was funded by Resverlogix Corp, www.resverlogix.com. EMG received salary support from Alberta Innovates www.albertatechfutures.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bailey D, 2010, J AM COLL CARDIOL, V55, P2580, DOI 10.1016/j.jacc.2010.02.035; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Cheng C, 2009, CIRCULATION, V119, P3017, DOI 10.1161/CIRCULATIONAHA.108.808618; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Collaboration IRGCERF, 2012, LANCET; Consortium I-RMRAIRM, 2012, LANCET; Creider JC, 2012, NATURE REV ENDOCRINO; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Gutstein DE, 2012, CLIN PHARMACOL THER, V91, P109, DOI 10.1038/clpt.2011.271; Hansen H. C., 2012, US Patent, Patent No. [8,114,995, 8114995]; Hansen H. C., 2011, US Patent, Patent No. [8,053,440, 8053440]; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Kamanna VS, 2008, AM J CARDIOL, V101, p20B, DOI 10.1016/j.amjcard.2008.02.029; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Luscher TF, 2012, EUROPEAN HEART J; Mirguet O, 2012, BIOORGANIC MED CHEM; Mrowietz U, 2005, TRENDS MOL MED, V11, P43, DOI 10.1016/j.molmed.2004.11.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholls SJ, 2012, APOA 1 INDUCTION POT; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Nicholls SJ, 2011, J AM COLL CARDIOL, V57, P1111, DOI 10.1016/j.jacc.2010.11.015; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Stahelin HF, 1996, EXPERIENTIA, V52, P5, DOI 10.1007/BF01922409; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Vaisar T, 2012, CURRENT VASCULAR PHA; van der Steeg WA, 2008, J AM COLL CARDIOL, V51, P634, DOI 10.1016/j.jacc.2007.09.060; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Vidler LR, 2012, J MED CHEM, V55, P7346, DOI 10.1021/jm300346w; Waksman R, 2010, J AM COLL CARDIOL, V55, P2727, DOI 10.1016/j.jacc.2009.12.067; WALSH CT, 1992, J BIOL CHEM, V267, P13115; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhu Y., 2012, LEUKEMIA LYMPHOMA	50	141	176	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83190	10.1371/journal.pone.0083190	http://dx.doi.org/10.1371/journal.pone.0083190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391744	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200041
J	Nakimuli, A; Elliott, AM; Kaleebu, P; Moffett, A; Mirembe, F				Nakimuli, Annettee; Elliott, Alison M.; Kaleebu, Pontiano; Moffett, Ashley; Mirembe, Florence			Hypertension Persisting after Pre-Eclampsia: A Prospective Cohort Study at Mulago Hospital, Uganda	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; FETAL HLA-C; RISK-FACTORS; CARDIOVASCULAR SEQUELAE; MATERNAL KIR; PREGNANCY; WOMEN; MORTALITY; MOTHERS; POPULATION	Background: Pre-eclampsia/eclampsia usually resolves after delivery but sometimes hypertension persists and cardiovascular disease develops later. Our objective was to determine the incidence and maternal socio-demographic and obstetric risk factors for persistence of hypertension in women with pre-eclampsia/eclampsia. Methods: This was a prospective cohort study conducted from July 2009 to June 2011 at Mulago Hospital labour ward and postnatal clinics. We followed up 188 women admitted with pre-eclampsia/eclampsia until 3 months after delivery. Data was collected using interviewer-administered questionnaires, examination of participants and review of medical records. Stata (version12) software was used for data analysis. Univariable analysis was used to compute the relative risk of persistent hypertension at the 95% confidence level. This was followed by multivariable logistic regression analysis to determine factors independently associated with persistence of hypertension. Results: 64 (34%) out of the 188 women analysed had persistent hypertension three months after delivery. Maternal age, gestational age at delivery and parity were predictors of persistent hypertension. Conclusion: The proportion of women with pre-eclampsia/eclampsia at risk of persistent hypertension at three months after delivery was high, with nearly one of three mothers remaining hypertensive. Follow up of mothers who develop pre-eclampsia is important so that early diagnosis and management of chronic hypertension can be made to avoid long term morbidity and mortality.	[Nakimuli, Annettee; Mirembe, Florence] Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynaecol, Kampala, Uganda; [Elliott, Alison M.; Kaleebu, Pontiano] MRC, Uganda Virus Res Inst, Uganda Res Unit AIDS, Entebbe, Uganda; [Elliott, Alison M.] London Sch Hyg & Trop Med, London WC1, England; [Moffett, Ashley] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Moffett, Ashley] Ctr Trophoblast Res, Cambridge, England	Makerere University; Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of Cambridge	Nakimuli, A (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynaecol, Kampala, Uganda.	annettee.nakimuli@gmail.com		Elliott, Alison/0000-0003-2818-9549	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity; Wellcome Trust Strategic Award [084344]; Centre for Trophoblast Research at the University of Cambridge	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity; Wellcome Trust Strategic Award(Wellcome Trust); Centre for Trophoblast Research at the University of Cambridge	This work was funded by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by Annettee Nakimuli, funded by a Wellcome Trust Strategic Award, grant number 084344 and by the Centre for Trophoblast Research at the University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett M, 2000, AM J EPIDEMIOL, V151, P315, DOI 10.1093/oxfordjournals.aje.a010208; Berg CJ, 2003, OBSTET GYNECOL, V101, P289, DOI 10.1016/S0029-7844(02)02587-5; Brown DW, 2006, STROKE, V37, P1055, DOI 10.1161/01.STR.0000206284.96739.ee; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Carr DB, 2009, HYPERTENS PREGNANCY, V28, P435, DOI 10.3109/10641950802629675; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cunningham G.F., 2005, WILLIAMS OBSTET, V22nd ed., DOI [10.1097/00001888-193609000-00027, DOI 10.1097/00001888-193609000-00027]; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; Drost JT, 2010, MATURITAS, V67, P321, DOI 10.1016/j.maturitas.2010.08.002; ESKENAZI B, 1991, JAMA-J AM MED ASSOC, V266, P237; Euser AG, 2009, STROKE, V40, P1169, DOI 10.1161/STROKEAHA.108.527788; FRIEDMAN SA, 1995, AM J OBSTET GYNECOL, V172, P1785, DOI 10.1016/0002-9378(95)91412-9; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Haapanen N, 1997, AM J EPIDEMIOL, V145, P762, DOI 10.1093/aje/145.8.762; Hannaford P, 1997, HEART, V77, P154, DOI 10.1136/hrt.77.2.154; Harskamp RE, 2007, AM J MED SCI, V334, P291, DOI 10.1097/MAJ.0b013e3180a6f094; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; IRWIN DE, 1994, AM J PUBLIC HEALTH, V84, P1508, DOI 10.2105/AJPH.84.9.1508; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; Kaye D, 2003, East Afr Med J, V80, P144; Kelsey JL., 1996, METHODS OBSERVATIONA; Kestenbaum B, 2003, AM J KIDNEY DIS, V42, P982, DOI 10.1016/j.ajkd.2003.07.001; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Klungsoyr K, 2012, PAEDIATR PERINAT EP, V26, P190, DOI 10.1111/j.1365-3016.2012.01260.x; Knuist M, 1998, OBSTET GYNECOL, V92, P174, DOI 10.1016/S0029-7844(98)00143-4; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lazzarin N, 2012, PREGNANCY HYPERTENS, V2, P393, DOI 10.1016/j.preghy.2012.02.002; Libby G, 2007, DIABETOLOGIA, V50, P523, DOI 10.1007/s00125-006-0558-z; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042; McDonald SD, 2010, AM J KIDNEY DIS, V55, P1026, DOI 10.1053/j.ajkd.2009.12.036; Mittendorf R, 1996, J REPROD MED, V41, P491; Moffett A, 2007, PLACENTA, V28, pS51, DOI 10.1016/j.placenta.2006.11.008; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moffett A, 2007, PRE-ECLAMPSIA: ETIOLOGY AND CLINICAL PRACTICE, P92; Mostello D, 2002, AM J OBSTET GYNECOL, V187, P425, DOI 10.1067/mob.2002.123608; Mufunda J, 2006, ETHNIC DIS, V16, P521; Nakimuli A, 2013, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2013.10.879, DOI 10.1016/J.AJ0G.2013.10.879]; Ndayambagye EB, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-12; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P114, DOI [10.1038/ncpneph0035, DOI 10.1038/NCPNEPH0035.PUBMED:16932375]; North RA, 2007, PRE-ECLAMPSIA: ETIOLOGY AND CLINICAL PRACTICE, P243; Norwitz ER, 1999, CLIN OBSTET GYNECOL, V42, P436, DOI 10.1097/00003081-199909000-00003; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Pipkin FB, 2001, NEW ENGL J MED, V344, P925, DOI 10.1056/NEJM200103223441209; Podymow T, 2008, HYPERTENSION, V51, P960, DOI 10.1161/HYPERTENSIONAHA.106.075895; Redman C, 2007, PREECLAMPSIA, P114; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SIBAI BM, 1991, AM J OBSTET GYNECOL, V165, P1408; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2000, LANCET, V356, P2066, DOI 10.1016/S0140-6736(00)03406-1; Tranquilli AL, 2012, PREGNANCY HYPERTENS, V2, P350, DOI [10.1016/j.preghy.2012.05.006, 10.1016/j.preghy.2012.04.146]; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Williams B, 2010, OXFORD TXB MED; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; World Health Organization, 2005, WORLD HLTH REP 2005	59	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85273	10.1371/journal.pone.0085273	http://dx.doi.org/10.1371/journal.pone.0085273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392003	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000329323900146
J	Rossi, S; Bozzali, M; Bari, M; Mori, F; Studer, V; Motta, C; Buttari, F; Cercignani, M; Gravina, P; Mastrangelo, N; Castelli, M; Mancino, R; Nucci, C; Sottile, F; Bernardini, S; Maccarrone, M; Centonze, D				Rossi, Silvia; Bozzali, Marco; Bari, Monica; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Cercignani, Mara; Gravina, Paolo; Mastrangelo, Nicolina; Castelli, Maura; Mancino, Raffaele; Nucci, Carlo; Sottile, Fabrizio; Bernardini, Sergio; Maccarrone, Mauro; Centonze, Diego			Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OPTICAL COHERENCE TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; NERVE-FIBER LAYER; COGNITIVE IMPAIRMENT; ENDOCANNABINOID SYSTEM; CB2 RECEPTORS; DISEASE; ATROPHY; ABNORMALITIES	Genetic ablation of type-1 cannabinoid receptors (CB(1)Rs) exacerbates the neurodegenerative damage of experimental autoimmune encephalomyelitis, the rodent model of multiple sclerosis (MS). To address the role on CB(1)Rs in the pathophysiology of human MS, we first investigated the impact of AAT trinucleotide short tandem repeat polymorphism of CNR1 gene on CB1R cell expression, and secondly on the inflammatory neurodegeneration process responsible for irreversible disability in MS patients. We found that MS patients with long AAT repeats within the CNR1 gene (>= 12 in both alleles) had more pronounced neuronal degeneration in response to inflammatory white matter damage both in the optic nerve and in the cortex. Optical Coherence Tomography (OCT), in fact, showed more severe alterations of the retinal nerve fiber layer (RNFL) thickness and of the macular volume (MV) after an episode of optic neuritis in MS patients carrying the long AAT genotype of CNR1. MS patients with long AAT repeats also had magnetic resonance imaging (MRI) evidence of increased gray matter damage in response to inflammatory lesions of the white matter, especially in areas with a major role in cognition. In parallel, visual abilities evaluated at the low contrast acuity test, and cognitive performances were negatively influenced by the long AAT CNR1 genotype in our sample of MS patients. Our results demonstrate the biological relevance of the (AAT)(n) CNR1 repeats in the inflammatory neurodegenerative damage of MS.	[Rossi, Silvia; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Castelli, Maura; Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy; [Rossi, Silvia; Bozzali, Marco; Mori, Francesco; Studer, Valeria; Motta, Caterina; Buttari, Fabio; Cercignani, Mara; Castelli, Maura; Maccarrone, Mauro; Centonze, Diego] Fdn Santa Lucia, CERC, Rome, Italy; [Bari, Monica; Mastrangelo, Nicolina] Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Chirurg, Rome, Italy; [Cercignani, Mara] Univ Sussex, Clin Imaging Sci Ctr, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Gravina, Paolo; Bernardini, Sergio] Policlin Tor Vergata, Dipartimento Med Lab, Rome, Italy; [Mancino, Raffaele; Nucci, Carlo] Univ Roma Tor Vergata, Dipartimento Biopatol, Clin Oculist, Rome, Italy; [Sottile, Fabrizio] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Bernardini, Sergio] Univ Roma Tor Vergata, Dipartimento Med Interna, Rome, Italy; [Maccarrone, Mauro] Campus Biomed Univ Rome, Sch Med, Ctr Integrated Res, Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Brighton; University of Sussex; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; IRCCS Bonino Pulejo; University of Rome Tor Vergata; University Campus Bio-Medico - Rome Italy	Centonze, D (corresponding author), Univ Roma Tor Vergata, Dipartimento Med Sistemi, Clin Neurol, Rome, Italy.	centonze@uniroma2.it	Maccarrone, Mauro/K-5398-2012; Motta, Caterina/L-1513-2018; Centonze, Diego/J-7767-2016; Mori, Francesco/AGX-1659-2022; Bozzali, Marco/AAC-1031-2022	Maccarrone, Mauro/0000-0002-3990-2963; Centonze, Diego/0000-0002-8390-8545; Mori, Francesco/0000-0002-4761-6174; studer, valeria/0000-0003-2529-7640; Bozzali, Marco/0000-0002-0568-2026; Rossi, Silvia/0000-0003-3257-8248; MANCINO, Raffaele/0000-0001-9968-9714; Cercignani, Mara/0000-0002-4550-2456	Fondazione Italiana Sclerosi Multipla (FISM Special Project); Italian National Ministero dell'Universita	Fondazione Italiana Sclerosi Multipla (FISM Special Project); Italian National Ministero dell'Universita	This investigation was supported by Fondazione Italiana Sclerosi Multipla (FISM Special Project to DC), and by the Italian National Ministero dell'Universita to DC and MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar N, 2010, CAN J NEUROL SCI, V37, P608, DOI 10.1017/S0317167100010775; Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Amato MP, 2007, ARCH NEUROL-CHICAGO, V64, P1157, DOI 10.1001/archneur.64.8.1157; Amato MP, 2006, J NEUROL, V253, P1054, DOI 10.1007/s00415-006-0161-8; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Arevalo-Martin A, 2012, NEUROPHARMACOLOGY, V63, P385, DOI 10.1016/j.neuropharm.2012.04.012; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Baier ML, 2005, NEUROLOGY, V64, P992, DOI 10.1212/01.WNL.0000154521.40686.63; Bamdad MJ, 2003, BRAIN INJURY, V17, P1011, DOI 10.1080/0269905031000110553; Barbarotto R, 1998, ITAL J NEUROL SCI, V19, P161, DOI 10.1007/BF00831566; Barkhof F, 2009, NAT REV NEUROL, V5, P256, DOI 10.1038/nrneurol.2009.41; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Burkholder BM, 2009, ARCH NEUROL-CHICAGO, V66, P1366, DOI 10.1001/archneurol.2009.230; Camp SJ, 1999, BRAIN, V122, P1341, DOI 10.1093/brain/122.7.1341; Catani MV, 2010, CURR NEUROVASC RES, V7, P311; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; Centonze D, 2007, BRAIN, V130, P2543, DOI 10.1093/brain/awm160; Costello F, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/148394; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Fine EM, 2009, J CLIN EXP NEUROPSYC, V31, P624, DOI 10.1080/13803390802419017; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; Forn C, 2007, HUM BRAIN MAPP, V28, P424, DOI 10.1002/hbm.20284; Frohman EM, 2008, NAT CLIN PRACT NEURO, V4, P664, DOI 10.1038/ncpneuro0950; Gordon-Lipkin E, 2007, NEUROLOGY, V69, P1603, DOI 10.1212/01.wnl.0000295995.46586.ae; Horakova D, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-10; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Huey ED, 2009, NEUROLOGY, V72, P453, DOI 10.1212/01.wnl.0000341781.39164.26; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2009, CURR TOP BEHAV NEURO, V1, P65, DOI 10.1007/978-3-540-88955-7_3; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanz M, 2007, J NEUROL, V254, P43, DOI 10.1007/s00415-007-2011-8; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lidster K, 2012, CNS NEUROL DISORD-DR, V11, P518, DOI 10.2174/187152712801661185; Lou ZY, 2012, J NEUROSCI RES, V90, P84, DOI 10.1002/jnr.22721; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Moll NM, 2011, ANN NEUROL, V70, P764, DOI 10.1002/ana.22521; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Patti F, 2009, MULT SCLER J, V15, P779, DOI 10.1177/1352458509105544; Patti F, 2009, MULT SCLER J, V15, P2, DOI 10.1177/1352458508096684; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; Ramil E, 2010, MULT SCLER J, V16, P139, DOI 10.1177/1352458509355071; Rao S, 1990, MANUAL BRIEF REPEATA; Reguero L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026167; Rossi S, 2012, J NEUROSCI, V32, P13896, DOI 10.1523/JNEUROSCI.1515-12.2012; Rossi S, 2012, ANN NEUROL, V71, P76, DOI 10.1002/ana.22512; Rossi S, 2011, BRAIN BEHAV IMMUN, V25, P1242, DOI 10.1016/j.bbi.2011.03.017; Rossi S, 2011, MULT SCLER J, V17, P281, DOI 10.1177/1352458510388680; Rypma B, 2005, CORTEX, V41, P582, DOI 10.1016/S0010-9452(08)70198-9; Saito VM, 2012, CURR NEUROPHARMACOL, V10, P159, DOI 10.2174/157015912800604515; Scotter EL, 2010, BRIT J PHARMACOL, V160, P480, DOI 10.1111/j.1476-5381.2010.00735.x; Sepulcre J, 2007, NEUROLOGY, V68, P1488, DOI 10.1212/01.wnl.0000260612.51849.ed; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163; Trip SA, 2006, NEUROIMAGE, V31, P286, DOI 10.1016/j.neuroimage.2005.11.051; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560	58	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82848	10.1371/journal.pone.0082848	http://dx.doi.org/10.1371/journal.pone.0082848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391723	Green Accepted, gold, Green Published			2022-12-27	WOS:000329325200020
J	Underkoffler, LA; Carr, E; Nelson, A; Ryan, MJ; Schultz, R; Loomes, KM				Underkoffler, Lara A.; Carr, Erikka; Nelson, Anthony; Ryan, Matthew J.; Schultz, Reiner; Loomes, Kathleen M.			Microarray Data Reveal Relationship between Jag1 and Ddr1 in Mouse Liver	PLOS ONE			English	Article							BILE-DUCT PROLIFERATION; EXTRACELLULAR-MATRIX; ALAGILLE SYNDROME; MICE LACKING; RECEPTOR; JAGGED1; MUTATIONS; DEFECTS	Alagille syndrome is an autosomal dominant disorder involving bile duct paucity and cholestasis in addition to cardiac, skeletal, ophthalmologic, renal and vascular manifestations. Mutations in JAG1, encoding a ligand in the Notch signaling pathway, are found in 95% of patients meeting clinical criteria for Alagille syndrome. In order to define the role of Jag1 in the bile duct developmental abnormalities seen in ALGS, we previously created a Jag1 conditional knockout mouse model. Mice heterozygous for the Jag1 conditional and null alleles demonstrate abnormalities in postnatal bile duct growth and remodeling, with portal expansion and increased numbers of malformed bile ducts. In this study we report the results of microarray analysis and identify genes and pathways differentially expressed in the Jag1 conditional/ null livers as compared with littermate controls. In the initial microarray analysis, we found that many of the genes up-regulated in the Jag1 conditional/ null mutant livers were related to extracellular matrix (ECM) interactions, cell adhesion and cell migration. One of the most highly up-regulated genes was Ddr1, encoding a receptor tyrosine kinase (RTK) belonging to a large RTK family. We have found extensive co-localization of Jag1 and Ddr1 in bile ducts and blood vessels in postnatal liver. In addition, coimmunoprecipitation data provide evidence for a novel protein interaction between Jag1 and Ddr1. Further studies will be required to define the nature of this interaction and its functional consequences, which may have significant implications for bile duct remodeling and repair of liver injury.	[Underkoffler, Lara A.; Carr, Erikka; Nelson, Anthony; Ryan, Matthew J.; Loomes, Kathleen M.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Ryan, Matthew J.; Loomes, Kathleen M.] Univ Penn, Dept Pediat, Raymond & Ruth Perelman Sch Med, Philadelphia, PA 19104 USA; [Schultz, Reiner] Kings Coll London, Dept Med Genet, London WC2R 2LS, England	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of London; King's College London	Loomes, KM (corresponding author), Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.	loomes@email.chop.edu	Schulz, Reiner/A-5940-2011	Schulz, Reiner/0000-0001-5047-7921	NIH [R01 DK071841]; Engineering and Physical Sciences Research Council [836374] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071841] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH R01 DK071841 to KML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho S, 2004, J CELL BIOCHEM, V92, P1271, DOI 10.1002/jcb.20125; Albig AR, 2008, MICROVASC RES, V76, P7, DOI 10.1016/j.mvr.2008.01.001; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Eswaramoorthy R, 2010, J CELL PHYSIOL, V224, P387, DOI 10.1002/jcp.22134; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Hou GP, 2002, CIRC RES, V90, P1147, DOI 10.1161/01.RES.0000022166.74073.F8; Jian ZX, 2012, MED ONCOL, V29, P3077, DOI 10.1007/s12032-012-0277-x; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Loomes KM, 2007, HEPATOLOGY, V45, P323, DOI 10.1002/hep.21460; Lu FM, 2003, AM J HUM GENET, V72, P1065, DOI 10.1086/374386; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Nehring LC, 2005, J BIOL CHEM, V280, P20349, DOI 10.1074/jbc.M500273200; Nielsen JS, 2008, J CELL SCI, V121, P4145, DOI 10.1242/jcs.03504; Roberts ME, 2011, EUR RESPIR J, V37, P1482, DOI 10.1183/09031936.00039710; Ryan MJ, 2008, HEPATOLOGY, V48, P1989, DOI 10.1002/hep.22538; Song SM, 2011, AM J PATHOL, V178, P1134, DOI 10.1016/j.ajpath.2010.11.068; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Wang CZ, 2005, J CELL PHYSIOL, V203, P295, DOI 10.1002/jcp.20227; Warthen DM, 2006, HUM MUTAT, V27, P436, DOI 10.1002/humu.20310; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yovchev MI, 2007, HEPATOLOGY, V45, P139, DOI 10.1002/hep.21448; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002; Zhang XJ, 2013, INT J BIOCHEM CELL B, V45, P1274, DOI 10.1016/j.biocel.2013.03.020; zum Gottesberge AMM, 2008, LAB INVEST, V88, P27, DOI 10.1038/labinvest.3700692	30	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84383	10.1371/journal.pone.0084383	http://dx.doi.org/10.1371/journal.pone.0084383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391948	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900091
J	Vaswani, K; Hum, MWC; Chan, HW; Ryan, J; Wood-Bradley, RJ; Nitert, MD; Mitchell, MD; Armitage, JA; Rice, GE				Vaswani, Kanchan; Hum, Melissa Wen-Ching; Chan, Hsiu-Wen; Ryan, Jennifer; Wood-Bradley, Ryan J.; Nitert, Marloes Dekker; Mitchell, Murray D.; Armitage, James A.; Rice, Gregory E.			The Effect of Gestational Age on Angiogenic Gene Expression in the Rat Placenta	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-OVINE COTYLEDONS; SIGNALING PATHWAY; HUMAN LABOR; PROMOTES; CELLS; TROPHOBLAST; ACTIVATION; INDUCTION; CD36	The placenta plays a central role in determining the outcome of pregnancy. It undergoes changes during gestation as the fetus develops and as demands for energy substrate transfer and gas exchange increase. The molecular mechanisms that coordinate these changes have yet to be fully elucidated. The study performed a large scale screen of the transcriptome of the rat placenta throughout mid-late gestation (E14.25-E20) with emphasis on characterizing gestational age associated changes in the expression of genes invoved in angiogenic pathways. Sprague Dawley dams were sacrificed at E14.25, E15.25, E17.25 and E20 (n = 6 per group) and RNA was isolated from one placenta per dam. Changes in placental gene expression were identifed using Illumina Rat Ref-12 Expression BeadChip Microarrays. Differentially expressed genes (>2 fold change, <1% false discovery rate, FDR) were functionally categorised by gene ontology pathway analysis. A subset of differentially expressed genes identified by microarrays were confirmed using Real-Time qPCR. The expression of thirty one genes involved in the angiogenic pathway was shown to change over time, using microarray analysis (22 genes displayed increased and 9 gene decreased expression). Five genes (4 up regulated: Cd36, Mmp14, Rhob and Angpt4 and 1 down regulated: Foxm1) involved in angiogenesis and blood vessel morphogenesis were subjected to further validation. qPCR confirmed late gestational increased expression of Cd36, Mmp14, Rhob and Angpt4 and a decrease in expression of Foxm1 before labour onset (P<0.0001). The observed acute, pre-labour changes in the expression of the 31 genes during gestation warrant further investigation to elucidate their role in pregnancy.	[Vaswani, Kanchan; Hum, Melissa Wen-Ching; Chan, Hsiu-Wen; Ryan, Jennifer; Nitert, Marloes Dekker; Mitchell, Murray D.; Rice, Gregory E.] Univ Queensland, Clin Res Ctr, Herston, Qld, Australia; [Wood-Bradley, Ryan J.; Armitage, James A.] Deakin Univ, Sch Med Optometry, Waurn Ponds, Vic, Australia; [Armitage, James A.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	University of Queensland; Deakin University; Monash University	Vaswani, K (corresponding author), Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp Campus, Herston, Qld, Australia.	k.vaswani@uq.edu.au	Armitage, James/AAX-1294-2021; RICE, GREGORY E/F-2412-2010; Mitchell, Murray/A-8639-2010; Nitert, Marloes D/A-8822-2011	RICE, GREGORY E/0000-0001-7177-0246; Mitchell, Murray/0000-0002-6167-7176; Nitert, Marloes D/0000-0002-1909-8920; Armitage, James/0000-0002-3762-0911	NHMRC; Royal Brisbane and Women's Hospital Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Royal Brisbane and Women's Hospital Foundation	GER was in receipt of an NHMRC Principal Research Fellowship. MDN received support from the Royal Brisbane and Women's Hospital Foundation. JAA was a Monash Fellow and Heart Foundation Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2011, ADV ENZYME REGULATIO; Aplin J, 2000, SEMIN CELL DEV BIOL, V11, P115, DOI 10.1006/scdb.2000.0157; APLIN JD, 1993, PLACENTA, V14, P203, DOI 10.1016/S0143-4004(05)80261-9; Belkacemi L, 2010, BIOL REPROD, V83, P325, DOI 10.1095/biolreprod.110.084517; BENNETT PR, 1992, AM J OBSTET GYNECOL, V167, P212, DOI 10.1016/S0002-9378(11)91660-3; Borowicz PP, 2007, BIOL REPROD, V76, P259, DOI 10.1095/biolreprod.106.054684; Brunckhorst MK, 2010, CANCER RES, V70, P7283, DOI 10.1158/0008-5472.CAN-09-4125; Buffat C, 2007, J PATHOL, V213, P337, DOI 10.1002/path.2233; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Cobellis L, 2007, CELL TISSUE RES, V330, P527, DOI 10.1007/s00441-007-0511-6; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; De Falco M, 2007, PLACENTA, V28, P118, DOI 10.1016/j.placenta.2006.03.010; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; Farina MG, 2007, REPRODUCTION, V134, P355, DOI 10.1530/REP-07-0078; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng L, 2012, J CELL PHYSIOL, V227, P2480, DOI 10.1002/jcp.22984; Funahashi Y, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-2; GAFFNEY RC, 1990, REPROD FERT DEVELOP, V2, P603, DOI 10.1071/RD9900603; Godfrey K M, 2001, Public Health Nutr, V4, P611; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Goyal R, 2010, PLACENTA, V31, P568, DOI 10.1016/j.placenta.2010.05.004; Howe GA, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-1; Huang C, 2012, CANCER RES, V72, P655, DOI 10.1158/0008-5472.CAN-11-3102; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; KURUVILLA AG, 1994, J CLIN INVEST, V94, P689, DOI 10.1172/JCI117386; Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com; Lim R, 2012, PLACENTA, V33, P52, DOI 10.1016/j.placenta.2011.10.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizutani T, 2004, ENDOCR J, V51, P569, DOI 10.1507/endocrj.51.569; Pfarrer C, 2003, PLACENTA, V24, P588, DOI 10.1016/S0143-4004(03)00059-6; Reynolds LP, 2005, PLACENTA, V26, P689, DOI 10.1016/j.placenta.2004.11.010; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; RICE GE, 1990, EICOSANOIDS, V3, P231; RICE GE, 1992, PLACENTA, V13, P429, DOI 10.1016/0143-4004(92)90050-4; Santulli P, 2012, FERTIL STERIL, V97, P904, DOI 10.1016/j.fertnstert.2011.12.051; Serrano-Sanchez M, 2008, ENDOCRINOLOGY, V149, P4669, DOI 10.1210/en.2008-1756; Shankar K, 2012, ENDOCRINOLOGY, V153, P1999, DOI 10.1210/en.2011-1833; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Sonveaux P, 2004, CIRC RES, V95, P154, DOI 10.1161/01.RES.0000136344.27825.72; Suzuki T, 2009, J VET MED SCI, V71, P495, DOI 10.1292/jvms.71.495; Szabova L, 2010, BLOOD, V116, P5752, DOI 10.1182/blood-2009-10-249847; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Torry DS, 1997, AM J REPROD IMMUNOL, V37, P21; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Withington SL, 2006, DEV BIOL, V294, P67, DOI 10.1016/j.ydbio.2006.02.025; Xie H, 2011, PLACENTA, V32, P546, DOI 10.1016/j.placenta.2011.04.003; Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968; Zhao WX, 2012, INT J MED SCI, V9, P447, DOI 10.7150/ijms.4593	50	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83762	10.1371/journal.pone.0083762	http://dx.doi.org/10.1371/journal.pone.0083762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391823	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200121
J	Wang, CC; Held, RG; Hall, BJ				Wang, Chih-Chieh; Held, Richard G.; Hall, Benjamin J.			SynGAP Regulates Protein Synthesis and Homeostatic Synaptic Plasticity in Developing Cortical Networks	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; LONG-TERM POTENTIATION; GLUN2B-CONTAINING NMDA RECEPTORS; KINASE-II; IN-VIVO; DEVELOPMENTAL SWITCH; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; ERK ACTIVATION; UP-REGULATION	Disrupting the balance between excitatory and inhibitory neurotransmission in the developing brain has been causally linked with intellectual disability (ID) and autism spectrum disorders (ASD). Excitatory synapse strength is regulated in the central nervous system by controlling the number of postsynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs). De novo genetic mutations of the synaptic GTPase-activating protein (SynGAP) are associated with ID and ASD. SynGAP is enriched at excitatory synapses and genetic suppression of SynGAP increases excitatory synaptic strength. However, exactly how SynGAP acts to maintain synaptic AMPAR content is unclear. We show here that SynGAP limits excitatory synaptic strength, in part, by suppressing protein synthesis in cortical neurons. The data presented here from in vitro, rat and mouse cortical networks, demonstrate that regulation of translation by SynGAP involves ERK, mTOR, and the small GTP-binding protein Rheb. Furthermore, these data show that GluN2B-containing NMDARs and the cognitive kinase CaMKII act upstream of SynGAP and that this signaling cascade is required for proper translation-dependent homeostatic synaptic plasticity of excitatory synapses in developing cortical networks.	[Wang, Chih-Chieh; Hall, Benjamin J.] Tulane Univ, Sch Sci & Engn, Neurosci Program, New Orleans, LA 70118 USA; [Held, Richard G.; Hall, Benjamin J.] Tulane Univ, Sch Sci & Engn, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Tulane University; Tulane University	Hall, BJ (corresponding author), Tulane Univ, Sch Sci & Engn, Neurosci Program, New Orleans, LA 70118 USA.	benhall@tulane.edu		Held, Richard/0000-0001-8231-0341	National Institute for Mental Health [MH099378-01]; National Science Foundation CAREER award [NS065374]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065374] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0952455] Funding Source: National Science Foundation	National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation CAREER award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Institute for Mental Health (MH099378-01 to BJH) and a National Science Foundation CAREER award (NS065374 to BJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2008, P NATL ACAD SCI USA, V105, P5597, DOI 10.1073/pnas.0800946105; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Berglund K, 2002, J NEUROSCI, V22, P4776, DOI 10.1523/JNEUROSCI.22-12-04776.2002; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Blackman MP, 2012, J NEUROSCI, V32, P13529, DOI 10.1523/JNEUROSCI.3077-12.2012; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Carroll RC, 1998, J NEUROPHYSIOL, V80, P2797, DOI 10.1152/jn.1998.80.5.2797; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Chen HX, 2003, J NEUROPHYSIOL, V89, P2482, DOI 10.1152/jn.01031.2002; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; El Gaamouch F, 2012, J NEUROSCI, V32, P10767, DOI 10.1523/JNEUROSCI.5622-11.2012; Fonseca BD, 2011, J BIOL CHEM, V286, P27111, DOI 10.1074/jbc.M111.260794; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gelinas JN, 2007, J BIOL CHEM, V282, P27527, DOI 10.1074/jbc.M701077200; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Gobert D, 2008, J NEUROCHEM, V106, P1160, DOI 10.1111/j.1471-4159.2008.05470.x; Gray JA, 2011, NEURON, V71, P1085, DOI 10.1016/j.neuron.2011.08.007; Guo XC, 2009, NEUROPSYCHOPHARMACOL, V34, P1659, DOI 10.1038/npp.2008.223; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hall BJ, 2008, TRENDS NEUROSCI, V31, P82, DOI 10.1016/j.tins.2007.11.010; Hall BJ, 2007, J NEUROSCI, V27, P13446, DOI 10.1523/JNEUROSCI.3793-07.2007; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hamdan FF, 2011, BIOL PSYCHIAT, V69, P898, DOI 10.1016/j.biopsych.2010.11.015; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Henry FE, 2012, J NEUROSCI, V32, P17128, DOI 10.1523/JNEUROSCI.2149-12.2012; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kim JH, 2003, J NEUROSCI, V23, P1119; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Krepischi ACV, 2010, AM J MED GENET A, V152A, P2376, DOI 10.1002/ajmg.a.33554; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Luikart BW, 2011, J NEUROSCI, V31, P4345, DOI 10.1523/JNEUROSCI.0061-11.2011; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma T, 2011, J NEUROSCI, V31, P17537, DOI 10.1523/JNEUROSCI.4761-11.2011; McMahon AC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1900; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vazquez LE, 2004, J NEUROSCI, V24, P8862, DOI 10.1523/JNEUROSCI.3213-04.2004; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wu XS, 2001, J NEUROSCI, V21, P7928, DOI 10.1523/JNEUROSCI.21-20-07928.2001; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yang Y, 2011, NEUROSCIENCE, V192, P132, DOI 10.1016/j.neuroscience.2011.06.061; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	86	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83941	10.1371/journal.pone.0083941	http://dx.doi.org/10.1371/journal.pone.0083941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391850	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200148
J	Won, YJ; Park, JW; Han, SH; Cho, HG; Kang, LH; Lee, SG; Ryu, SR; Paik, SY				Won, Yu-Jung; Park, Jeong-Woong; han, Sang-ha; Cho, Han-Gil; Kang, Lae-Hyung; Lee, Sung-Geun; Ryu, Sang-Ryeol; Paik, Soon-Young			Full-Genomic Analysis of a Human Norovirus Recombinant GII.12/13 Novel Strain Isolated from South Korea	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; RT-PCR; OUTBREAKS; CHILDREN; EMERGENCE; SEQUENCE; VARIANT; INFECTIONS	Norovirus (NoV) genogroups I and II are frequently recognized as the main causes of acute gastroenteritis and outbreaks of non-bacterial foodborne diseases. Furthermore, variants and recombinant strains of this virus are continuously emerging worldwide. The aim of this study was to identify NoV strains and to investigate and characterize rare genotypes. Stool samples (n = 500) were collected from patients with symptoms of acute gastroenteritis in Korea between December 2004 and November 2007. For analysis of the samples, rapid genotype screening was performed using reverse transcriptase-polymerase chain reaction. Full sequencing, using a newly designed set of 12 primers, revealed GII-12/13 strain. The partial sequence of GII-12/13 strain was compared with published NoV (GII-1 - 14) sequences targeting RdRp and capsid regions using phylogenetic analysis with the SimPlot program, which could evaluate recombination breakpoints. SimPlot analysis was also performed with the strain GII-12/Gifu-96/JPN (AB045603) for the RdRp region and with GII-13/G5175B-83/AUS(DQ379714) for the capsid region. NoV was detected in 19 of the 500 stool samples (3.8%). Genogroup GII-4 was found most frequently (n = 9, 1.8%), followed by GII-3 (n = 4, 0.8%), GII-6 (n = 3, 0.6%), GI-6 (n = 2, 0.4%), and GII-12/13 (n = 1, 0.2%). Importantly, we identified a novel NoV recombinant strain, C9-439 (KF289337), indicating potential risks, which suggested that, recombination occurred in the region between open reading frames 1 and 2 of the GII-12/13 strain and that breakpoints occurred in the polymerase region.	[Won, Yu-Jung; han, Sang-ha; Kang, Lae-Hyung; Paik, Soon-Young] Catholic Univ Korea, Dept Microbiol, Coll Med, Seoul, South Korea; [Park, Jeong-Woong; Ryu, Sang-Ryeol] Seoul Natl Univ, Dept Food & Biotechnol, Dept Agr Biotechnol, Ctr Agr Biomat, Seoul, South Korea; [Park, Jeong-Woong; Ryu, Sang-Ryeol] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Cho, Han-Gil] Gyeonggi Prov Res Inst Publ Hlth & Environm, Div Virol, Suwon, South Korea; [Lee, Sung-Geun] Chonbuk Natl Univ, Korea Zoonosis Res Inst, Jeonju, South Korea	Catholic University of Korea; Seoul National University (SNU); Seoul National University (SNU); Jeonbuk National University	Paik, SY (corresponding author), Catholic Univ Korea, Dept Microbiol, Coll Med, Seoul, South Korea.	paik@catholic.ac.kr			Mid-career Researcher Program from the Environmental Industry & Technology Institute [2012R1A2A2A01045078]; GAIA project from the Environmental Industry & Technology Institute [2013000550009]	Mid-career Researcher Program from the Environmental Industry & Technology Institute; GAIA project from the Environmental Industry & Technology Institute	This work was supported by the Mid-career Researcher Program (2012R1A2A2A01045078) and GAIA project (2013000550009) from the Environmental Industry & Technology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Buesa J, 2002, J CLIN MICROBIOL, V40, P2854, DOI 10.1128/JCM.40.8.2854-2859.2002; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Chhabra P, 2010, INFECT GENET EVOL, V10, P1101, DOI 10.1016/j.meegid.2010.07.007; Chung JY, 2010, J MED VIROL, V82, P146, DOI 10.1002/jmv.21650; Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12; Fretz R, 2005, EPIDEMIOL INFECT, V133, P429, DOI 10.1017/S0950268804003619; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Han TH, 2011, ARCH VIROL, V156, P323, DOI 10.1007/s00705-010-0844-4; Hohne M, 2004, J MED VIROL, V72, P312, DOI 10.1002/jmv.10573; Huang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054976; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Katayama K, 2002, VIROLOGY, V299, P225, DOI 10.1006/viro.2002.1568; Kim SH, 2005, J CLIN MICROBIOL, V43, P4836, DOI 10.1128/JCM.43.9.4836-4839.2005; Koopmans M, 2008, CURR OPIN INFECT DIS, V21, P544, DOI 10.1097/QCO.0b013e3283108965; Kostela J, 2008, J VIROL METHODS, V149, P226, DOI 10.1016/j.jviromet.2008.02.001; Le VP, 2010, J MED VIROL, V82, P1065, DOI 10.1002/jmv.21761; Lee JH, 2011, J GEN VIROL, V92, P1607, DOI 10.1099/vir.0.031104-0; Lee SG, 2011, APPL ENVIRON MICROB, V77, P1466, DOI 10.1128/AEM.01996-10; Mahar JE, 2011, J MED VIROL, V83, P2213, DOI 10.1002/jmv.22215; Mathijs E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-310; Nataraju SM, 2011, INT J MOL EPIDEMIOL, V2, P130; Park JW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-167; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Symes SJ, 2007, ARCH VIROL, V152, P1075, DOI 10.1007/s00705-007-0938-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; van Maarseveen NM, 2010, J CLIN VIROL, V49, P205, DOI 10.1016/j.jcv.2010.07.019; Verhoef L, 2008, EMERG INFECT DIS, V14, P238, DOI 10.3201/eid1402.061567; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Yoda T, 2003, J CLIN MICROBIOL, V41, P2367, DOI 10.1128/JCM.41.6.2367-2371.2003; Yoon JS, 2008, J CLIN MICROBIOL, V46, P1474, DOI 10.1128/JCM.02282-07; Yun SI, 2010, VIRUS RES, V152, P137, DOI 10.1016/j.virusres.2010.06.018; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; 함희진, 2012, [JOURNAL OF ENVIRONMENTAL HEALTH SCIENCES, 한국환경보건학회지], V38, P57	37	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85063	10.1371/journal.pone.0085063	http://dx.doi.org/10.1371/journal.pone.0085063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391985	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900128
J	Bartlett, TE; Olhede, SC; Zaikin, A				Bartlett, Thomas E.; Olhede, Sofia C.; Zaikin, Alexey			A DNA Methylation Network Interaction Measure, and Detection of Network Oncomarkers	PLOS ONE			English	Article							GENOME; CELL; CANCER; LOCALIZATION; LANDSCAPE; SUBUNITS; RECEPTOR; BIOLOGY	Epigenetic processes-including DNA methylation-are increasingly seen as having a fundamental role in chronic diseases like cancer. DNA methylation patterns offer a route to develop prognostic measures based directly on DNA measurements, rather than less-stable RNA measurements. A novel DNA methylation-based measure of the co-ordinated interactive behaviour of genes is developed, in a network context. It is shown that this measure reflects well the co-regulatory behaviour linked to gene expression (at the mRNA level) over the same network interactions. This measure, defined for pairs of genes in a single patient/sample, associates with overall survival outcome independent of known prognostic clinical features, in several independent data sets relating to different cancer types. In total, more than half a billion CpGs in over 1600 samples, taken from nine different cancer entities, are analysed. It is found that groups of gene-pair interactions which associate significantly with survival identify statistically significant subnetwork modules. Many of these subnetwork modules are shown to be biologically relevant by strong correlation with pre-defined gene sets, such as immune function, wound healing, mitochondrial function and MAP-kinase signalling. In particular, the wound healing module corresponds to an increase in co-ordinated interactive behaviour between genes for worse prognosis, and the immune module corresponds to a decrease in co-ordinated interactive behaviour between genes for worse prognosis. This measure has great potential for defining DNA-based cancer biomarkers. Such biomarkers could naturally be developed further, by drawing on the rapidly expanding knowledge base of network science.	[Bartlett, Thomas E.; Zaikin, Alexey] UCL, Dept Math, London, England; [Olhede, Sofia C.] UCL, Dept Stat Sci, London, England; [Bartlett, Thomas E.; Olhede, Sofia C.] UCL, CoMPLEX, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Bartlett, TE (corresponding author), UCL, Dept Math, London, England.	thomas.bartlett.10@ucl.ac.uk	Zaikin, Alexey/T-7171-2019; Zaikin, Alexey/K-6581-2017	Zaikin, Alexey/0000-0001-7540-1130; Zaikin, Alexey/0000-0001-7540-1130; Olhede, Sofia/0000-0003-0061-227X; Bartlett, Thomas/0000-0003-0831-9713	UCL CoMPLEX; Medical Research Council; Engineering and Physical Sciences Research Council (ESPRC); EPSRC [EP/I005250/1]; CR-UK; Eve Appeal [PROMISE-2016]; Engineering and Physical Sciences Research Council [EP/I005250/1] Funding Source: researchfish; Medical Research Council [1297534] Funding Source: researchfish	UCL CoMPLEX; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (ESPRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); CR-UK(Cancer Research UK); Eve Appeal; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded via UCL CoMPLEX, by the Medical Research Council and the Engineering and Physical Sciences Research Council (ESPRC). SCO acknowledges funding from EPSRC grant no. EP/I005250/1. AZ acknowledges financial support from CR-UK and Eve Appeal (PROMISE-2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; BAHRAM S, 1991, P NATL ACAD SCI USA, V88, P10094, DOI 10.1073/pnas.88.22.10094; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartlett TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068285; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonetta L, 2006, NAT METHODS, V3, P141, DOI 10.1038/nmeth0206-141; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Cooney CA, 2007, DIS MARKERS, V23, P121, DOI 10.1155/2007/394034; COUGHLIN SR, 1992, J CLIN INVEST, V89, P351, DOI 10.1172/JCI115592; Cox P R, 2001, BMC Genomics, V2, P7, DOI 10.1186/1471-2164-2-7; Davies PCW, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015001; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; LOVEJOY B, 1993, J MOL BIOL, V234, P640, DOI 10.1006/jmbi.1993.1617; McLane LM, 2013, J IMMUNOL, V190, P3207, DOI 10.4049/jimmunol.1201556; Mimuro J, 1991, Rinsho Ketsueki, V32, P487; OWREN PA, 1947, LANCET, V252, P446; R Core Team, 2021, R LANGUAGE ENV STAT; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Sabater-Lleal M, 2012, ARTERIOSCL THROM VAS, V32, P2008, DOI 10.1161/ATVBAHA.112.248492; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; TRAGARDH L, 1980, P NATL ACAD SCI-BIOL, V77, P1129, DOI 10.1073/pnas.77.2.1129; WEISSMAN AM, 1988, P NATL ACAD SCI USA, V85, P9709, DOI 10.1073/pnas.85.24.9709; Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6	36	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84573	10.1371/journal.pone.0084573	http://dx.doi.org/10.1371/journal.pone.0084573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400102	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700036
J	Dhamdhere, GR; Fang, MY; Jiang, J; Lee, K; Cheng, D; Olveda, RC; Liu, B; Mulligan, KA; Carlson, JC; Ransom, RC; Weis, WI; Helms, JA				Dhamdhere, Girija R.; Fang, Mark Y.; Jiang, Jie; Lee, Katherine; Cheng, Du; Olveda, Rebecca C.; Liu, Bo; Mulligan, Kimberley A.; Carlson, Jeffery C.; Ransom, Ryan C.; Weis, William I.; Helms, Jill A.			Drugging a Stem Cell Compartment Using Wnt3a Protein as a Therapeutic	PLOS ONE			English	Article							DIFFERENTIATION; PROLIFERATION; IDENTIFICATION; SIGNALS; GROWTH	The therapeutic potential of Wnt proteins has long been recognized but challenges associated with in vivo stability and delivery have hindered their development as drug candidates. By exploiting the hydrophobic nature of the protein we provide evidence that exogenous Wnt3a can be delivered in vivo if it is associated with a lipid vesicle. Recombinant Wnt3a associates with the external surface of the lipid membrane; this association stabilizes the protein and leads to prolonged activation of the Wnt pathway in primary cells. We demonstrate the consequences of Wnt pathway activation in vivo using a bone marrow engraftment assay. These data provide validation for the development of WNT3A as a therapeutic protein.	[Dhamdhere, Girija R.; Fang, Mark Y.; Jiang, Jie; Lee, Katherine; Cheng, Du; Olveda, Rebecca C.; Liu, Bo; Carlson, Jeffery C.; Ransom, Ryan C.; Helms, Jill A.] Stanford Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; [Mulligan, Kimberley A.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, HHMI,Dept Dev Biol, Stanford, CA 94305 USA; [Weis, William I.] Stanford Sch Med, Dept Biol Struct, Stanford, CA USA; [Weis, William I.] Stanford Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Helms, JA (corresponding author), Stanford Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.	jhelms@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Jiang, Jie/0000-0001-6619-1936; Cheng, Du/0000-0002-7851-1244; Helms, Jill/0000-0002-0463-396X; Ransom, Ryan/0000-0001-6696-1793	California Institute of Regenerative Medicine [TR1-01249]; National Institutes of Health (NIH) [AG39420]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR059033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039420] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by California Institute of Regenerative Medicine grant TR1-01249 (to J.A.H.) and National Institutes of Health (NIH) AG39420 grant (to W.I.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme F, 2010, J BONE MINER RES, V25, P2412, DOI 10.1002/jbmr.135; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Cladera J, 1997, EUR J BIOCHEM, V243, P798, DOI 10.1111/j.1432-1033.1997.00798.x; Das Soumyashree, 2012, Front Biol (Beijing), V7, P587; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Dell'Accio F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2029; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Fu JA, 2011, DEV DYNAM, V240, P365, DOI 10.1002/dvdy.22541; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giacomelli CE, 2000, LANGMUIR, V16, P4853, DOI 10.1021/la9913708; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Gross JC, 2012, NAT CELL BIOL; Iatropoulos MJ, 1996, EXP TOXICOL PATHOL, V48, P175, DOI 10.1016/S0940-2993(96)80039-X; Immordino ML, 2006, INT J NANOMED, V1, P297; Janda CY, 2012, SCIENCE; Jia LW, 2008, BIOCHEM BIOPH RES CO, V368, P483, DOI 10.1016/j.bbrc.2008.01.097; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kunisaki Y, 2012, NAT MED, V18, P864, DOI 10.1038/nm.2825; Lee Y, 2011, J BIOL CHEM, V286, P7033, DOI 10.1074/jbc.M110.207217; Lewis RNAH, 2004, STRUCTURE BIOL MEMBR; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Manjila SB, 2013, INT J PHARM INVESTIG, V3, P1, DOI 10.4103/2230-973X.108958; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morrell NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002930; Neumann S, 2009, TRAFFIC, V10, P334, DOI 10.1111/j.1600-0854.2008.00872.x; Norkin M, 2012, BONE MARROW TRANSPLA; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Polakis P, 2000, GENE DEV, V14, P1837; Popelut A, 2010, BIOMATERIALS, V31, P9173, DOI 10.1016/j.biomaterials.2010.08.045; Qin XG, 2011, J PHYS CHEM B, V115, P1991, DOI 10.1021/jp108694v; Roarty K, 2007, DEVELOPMENT, V134, P3929, DOI 10.1242/dev.008250; Schuijers J, 2012, EMBO J, V31, P2685, DOI 10.1038/emboj.2012.149; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tokumasu F, 2002, J ELECTRON MICROSC, V51, P1, DOI 10.1093/jmicro/51.1.1; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; Whyte JL, 2012, COLD SPRING HARB PER; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; Zhao JS, 2007, GASTROENTEROLOGY, V132, P1331, DOI 10.1053/j.gastro.2007.02.001; Zhao L, 2009, METHOD ENZYMOL, V465, P331, DOI 10.1016/S0076-6879(09)65017-5; Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]	54	41	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83650	10.1371/journal.pone.0083650	http://dx.doi.org/10.1371/journal.pone.0083650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400074	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700008
J	Delobel, P; Tesniere, C				Delobel, Pierre; Tesniere, Catherine			A Simple FCM Method to Avoid Misinterpretation in Saccharomyces cerevisiae Cell Cycle Assessment between G0 and Sub-G1	PLOS ONE			English	Article							YEAST; BIOCONDUCTOR; APOPTOSIS	Extensively developed for medical and clinical applications, flow cytometry is now being used for diverse applications in food microbiology. Most uses of flow cytometry for yeast cells are derived from methods for mammalian cells, but yeast cells can present specificities that must be taken into account for rigorous analysis of the data output to avoid any misinterpretation. We report an analysis of Saccharomyces cerevisiae cell cycle progression that highlights possible errors. The cell cycle was analyzed using an intercalating fluorochrome to assess cell DNA content. In analyses of yeast cultures, the presence of a sub-G1 peak in the fluorescent signal is often interpreted as a loss of DNA due to its fragmentation associated with apoptosis. However, the cell wall and its stucture may interfere with the fluorescent signal recorded. These observations indicate that misinterpretation of yeast DNA profiles is possible in analyses based on some of the most common probes: cells in G0 appeared to have a lower DNA content and may have been mistaken as a sub-G1 population. However, careful selection of the fluorochrome for DNA quantification allowed a direct discrimination between G0 and G1 yeast cell cycle steps, without additional labeling. We present and discuss results obtained with five current fluorochromes. These observations led us to recommend to use SYTOX Green for cycle analysis of living cells and SYBR Green I for the identification of the apoptosis sub-G1 population identification or the DNA ploidy application.	[Delobel, Pierre; Tesniere, Catherine] INRA, UMR1083, F-34060 Montpellier, France; [Delobel, Pierre; Tesniere, Catherine] SupAgro Montpellier, UMR1083, Montpellier, France; [Delobel, Pierre; Tesniere, Catherine] Univ Montpellier I, UMR1083, Montpellier, France	INRAE; Universite de Montpellier; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Universite de Montpellier	Tesniere, C (corresponding author), INRA, UMR1083, F-34060 Montpellier, France.	tesniere@supagro.inra.fr	Tesnière, Catherine/L-8771-2018	Tesnière, Catherine/0000-0003-4865-9229; Delobel, pierre/0000-0002-8770-3192				Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Brachmann CB, 1998, YEAST, V14, P115; Darzynkiewicz Z, 2001, METHOD CELL BIOL, V63, P527; Ellis B, OWCORE BASIC STRUCTU; Ellis B, OWVIZ VISUALIZATION; Gagneur J, 2012, CELLGROWTH FITTING C; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Malka Y, 2011, CYTOM PART A, V79A, P243, DOI 10.1002/cyto.a.21051; Martani F, 2013, YEAST, V30, P365, DOI 10.1002/yea.2969; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nunez R, 2001, Curr Issues Mol Biol, V3, P39; R Core Team, 2021, R LANGUAGE ENV STAT; SLATER ML, 1977, P NATL ACAD SCI USA, V74, P3850, DOI 10.1073/pnas.74.9.3850; Suzuki T, 1997, J HISTOCHEM CYTOCHEM, V45, P49, DOI 10.1177/002215549704500107	17	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84645	10.1371/journal.pone.0084645	http://dx.doi.org/10.1371/journal.pone.0084645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392149	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100072
J	Herr, L; Friedrich, T; Durante, M; Scholz, M				Herr, Lisa; Friedrich, Thomas; Durante, Marco; Scholz, Michael			A Model of Photon Cell Killing Based on the Spatio-Temporal Clustering of DNA Damage in Higher Order Chromatin Structures	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; STRUCTURE-DEPENDENT REPAIR; HUMAN-TUMOR-CELLS; LOW-DOSE-RATE; IONIZING-RADIATION; H2AX PHOSPHORYLATION; GAMMA-RADIATION; HISTONE H2AX; CHO-CELLS; LINES	We present a new approach to model dose rate effects on cell killing after photon radiation based on the spatio-temporal clustering of DNA double strand breaks (DSBs) within higher order chromatin structures of approximately 1-2 Mbp size, so called giant loops. The main concept of this approach consists of a distinction of two classes of lesions, isolated and clustered DSBs, characterized by the number of double strand breaks induced in a giant loop. We assume a low lethality and fast component of repair for isolated DSBs and a high lethality and slow component of repair for clustered DSBs. With appropriate rates, the temporal transition between the different lesion classes is expressed in terms of five differential equations. These allow formulating the dynamics involved in the competition of damage induction and repair for arbitrary dose rates and fractionation schemes. Final cell survival probabilities are computable with a cell line specific set of three parameters: The lethality for isolated DSBs, the lethality for clustered DSBs and the half-life time of isolated DSBs. By comparison with larger sets of published experimental data it is demonstrated that the model describes the cell line dependent response to treatments using either continuous irradiation at a constant dose rate or to split dose irradiation well. Furthermore, an analytic investigation of the formulation concerning single fraction treatments with constant dose rates in the limiting cases of extremely high or low dose rates is presented. The approach is consistent with the Linear-Quadratic model extended by the Lea-Catcheside factor up to the second moment in dose. Finally, it is shown that the model correctly predicts empirical findings about the dose rate dependence of incidence probabilities for deterministic radiation effects like pneumonitis and the bone marrow syndrome. These findings further support the general concepts on which the approach is based.	[Herr, Lisa; Friedrich, Thomas; Durante, Marco; Scholz, Michael] GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, Darmstadt, Germany; [Herr, Lisa; Durante, Marco] Tech Univ Darmstadt, Inst Festkorperphys, Darmstadt, Germany	Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Technical University of Darmstadt	Scholz, M (corresponding author), GSI Helmholtzzentrum Schwerionenforsch, Dept Biophys, Darmstadt, Germany.	m.scholz@gsi.de	Friedrich, Thomas/K-6748-2013; Durante, Marco/L-4795-2017; Durante, Marco/K-1315-2014	Friedrich, Thomas/0000-0003-0074-6390; Durante, Marco/0000-0002-4615-553X; Durante, Marco/0000-0002-4615-553X; Scholz, Michael/0000-0002-6382-6737	GSI; Studienstiftung des deutschen Volkes; HGS-HIRe	GSI(Helmholtz Association); Studienstiftung des deutschen Volkes; HGS-HIRe	Funding was provided by GSI (http://www.gsi.de/), Studienstiftung des deutschen Volkes (http://www.studienstiftung.de/), and HGS-HIRe (http://hgs-hire.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Bentzen SM, 2000, INT J RADIAT BIOL, V76, P453, DOI 10.1080/095530000138448; Catcheside DG, 1946, J GENET, V47, P137, DOI 10.1007/BF02986783; CURTIS SB, 1986, RADIAT RES, V106, P252, DOI 10.2307/3576798; DahmDaphi J, 1996, INT J RADIAT BIOL, V69, P615, DOI 10.1080/095530096145625; DEALMODOVAR JMR, 1994, RADIAT RES, V138, pS93, DOI 10.2307/3578771; Edwards A. A., 1998, Journal of Radiological Protection, V18, P175, DOI 10.1088/0952-4746/18/3/004; EGUCHIKASAI K, 1991, INT J RADIAT BIOL, V59, P97, DOI 10.1080/09553009114550091; Elsasser T, 2010, INT J RADIAT ONCOL, V78, P1177, DOI 10.1016/j.ijrobp.2010.05.014; Fowler JF, 2004, INT J RADIAT ONCOL, V59, P242, DOI 10.1016/j.ijrobp.2004.01.004; Friedland W, 2006, RADIAT PROT DOSIM, V122, P116, DOI 10.1093/rpd/ncl451; Friedrich T, 2012, RADIAT RES, V178, P385, DOI 10.1667/RR2964.1; Friedrich T, 2012, INT J RADIAT BIOL, V88, P103, DOI 10.3109/09553002.2011.611213; Fry RJM, 2001, HEALTH PHYS, V80, P338, DOI 10.1097/00004032-200104000-00009; Gauter B, 2002, RADIAT RES, V157, P721, DOI 10.1667/0033-7587(2002)157[0721:RORIDD]2.0.CO;2; HOLMES A, 1990, BRIT J CANCER, V62, P791, DOI 10.1038/bjc.1990.381; Johnston PJ, 1997, RADIAT RES, V148, P561, DOI 10.2307/3579731; Johnston PJ, 1998, RADIAT RES, V149, P533, DOI 10.2307/3579899; JOHNSTON PJ, 1994, INT J RADIAT BIOL, V66, P531, DOI 10.1080/09553009414551571; Johnston PJ, 1998, RADIAT RES, V149, P455, DOI 10.2307/3579785; KELLAND LR, 1986, RADIOTHER ONCOL, V7, P259, DOI 10.1016/S0167-8140(86)80037-8; Lea DA, 1946, ACTIONS RAD LIVING C; Ling CC, 2010, RADIOTHER ONCOL, V95, P261, DOI 10.1016/j.radonc.2010.03.014; Little MP, 2003, BRIT MED BULL, V68, P259, DOI 10.1093/bmb/ldg031; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Menegakis A, 2009, INT J RADIAT BIOL, V85, P1032, DOI 10.3109/09553000903242149; NAGASAWA H, 1989, RADIAT RES, V118, P559, DOI 10.2307/3577413; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; NUNEZ MI, 1995, BRIT J CANCER, V71, P311, DOI 10.1038/bjc.1995.62; OLIVER R, 1964, INT J RADIAT BIOL RE, V8, P475, DOI 10.1080/09553006414550581; Orton CG, 2001, INT J RADIAT ONCOL, V49, P183, DOI 10.1016/S0360-3016(00)00810-5; Ostashevsky J, 1998, MOL BIOL CELL, V9, P3031, DOI 10.1091/mbc.9.11.3031; OTTOLENGHI A, 1995, RADIAT ENVIRON BIOPH, V34, P239, DOI 10.1007/BF01209749; PEACOCK JH, 1988, INT J RADIAT BIOL, V54, P945, DOI 10.1080/09553008814552341; Pop LAM, 2000, RADIOTHER ONCOL, V55, P301, DOI 10.1016/S0167-8140(00)00205-X; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Solovjeva L, 1998, CHROMOSOME RES, V6, P595, DOI 10.1023/A:1009293108736; STACKHOUSE MA, 1993, RADIAT RES, V136, P250, DOI 10.2307/3578618; STEEL GG, 1987, RADIOTHER ONCOL, V9, P299; STEPHENS TC, 1987, INT J RADIAT BIOL, V52, P157, DOI 10.1080/09553008714551581; Stisova V, 2011, RADIAT RES, V176, P217, DOI 10.1667/RR2490.1; Stuben G, 1997, RADIOTHER ONCOL, V42, P189, DOI 10.1016/S0167-8140(96)01869-5; Supe Sanjay S, 2006, J Cancer Res Ther, V2, P105; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; THAMES HD, 1982, INT J RADIAT ONCOL, V8, P219, DOI 10.1016/0360-3016(82)90517-X; Tommasino F, 2013, RADIAT RES, V180, P524, DOI 10.1667/RR13389.1; VANDYK J, 1989, RADIOTHER ONCOL, V14, P55, DOI 10.1016/0167-8140(89)90009-1; VANOS R, 1993, RADIAT RES, V136, P118, DOI 10.2307/3578648; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; WELLS RL, 1983, RADIAT RES, V94, P105, DOI 10.2307/3575868; YANG X, 1990, RADIOTHER ONCOL, V19, P49, DOI 10.1016/0167-8140(90)90165-S; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239	55	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83923	10.1371/journal.pone.0083923	http://dx.doi.org/10.1371/journal.pone.0083923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392100	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100024
J	Margevicius, KJ; Generous, N; Taylor-McCabe, KJ; Brown, M; Daniel, WB; Castro, L; Hengartner, A; Deshpande, A				Margevicius, Kristen J.; Generous, Nicholas; Taylor-McCabe, Kirsten J.; Brown, Mac; Daniel, W. Brent; Castro, Lauren; Hengartner, Andrea; Deshpande, Alina			Advancing a Framework to Enable Characterization and Evaluation of Data Streams Useful for Biosurveillance	PLOS ONE			English	Article							PUBLIC-HEALTH SURVEILLANCE; SYNDROMIC SURVEILLANCE; SYSTEMS	In recent years, biosurveillance has become the buzzword under which a diverse set of ideas and activities regarding detecting and mitigating biological threats are incorporated depending on context and perspective. Increasingly, biosurveillance practice has become global and interdisciplinary, requiring information and resources across public health, One Health, and biothreat domains. Even within the scope of infectious disease surveillance, multiple systems, data sources, and tools are used with varying and often unknown effectiveness. Evaluating the impact and utility of state-of-the-art biosurveillance is, in part, confounded by the complexity of the systems and the information derived from them. We present a novel approach conceptualizing biosurveillance from the perspective of the fundamental data streams that have been or could be used for biosurveillance and to systematically structure a framework that can be universally applicable for use in evaluating and understanding a wide range of biosurveillance activities. Moreover, the Biosurveillance Data Stream Framework and associated definitions are proposed as a starting point to facilitate the development of a standardized lexicon for biosurveillance and characterization of currently used and newly emerging data streams. Criteria for building the data stream framework were developed from an examination of the literature, analysis of information on operational infectious disease biosurveillance systems, and consultation with experts in the area of biosurveillance. To demonstrate utility, the framework and definitions were used as the basis for a schema of a relational database for biosurveillance resources and in the development and use of a decision support tool for data stream evaluation.	[Margevicius, Kristen J.; Generous, Nicholas; Brown, Mac; Daniel, W. Brent; Castro, Lauren; Hengartner, Andrea; Deshpande, Alina] Los Alamos Natl Lab, Def Syst & Anal Div, Los Alamos, NM 87545 USA; [Taylor-McCabe, Kirsten J.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Margevicius, KJ (corresponding author), Los Alamos Natl Lab, Def Syst & Anal Div, Los Alamos, NM 87545 USA.	kmargevicius@lanl.gov; deshpande_a@lanl.gov		Generous, Nicholas/0000-0003-2238-428X; Margevicius, Kristen/0000-0002-4116-8307; Deshpande, Alina/0000-0003-4541-4410	Defense Threat Reduction Agency, Joint Science and Technology Office for Chemical and Biological Defense; U.S. Department of Energy [B114525l]; Los Alamos National Laboratory [B114525l]	Defense Threat Reduction Agency, Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency); U.S. Department of Energy(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	The Defense Threat Reduction Agency, Joint Science and Technology Office for Chemical and Biological Defense is acknowledged as the sponsor of this work, under a "work for others" arrangement, issued under the prime contract for research, development, test, and evaluation services between the U.S. Department of Energy and Los Alamos National Laboratory (#B114525l). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NAT BIOS INT CTR STI; [Anonymous], 2011, NACCHO POS; [Anonymous], 2010, CONC PLAN IMPL NAT B; [Anonymous], DICT; Bradley Colleen A, 2005, MMWR Suppl, V54, P11; Bravata DM, 2004, ANN INTERN MED, V140, P910, DOI 10.7326/0003-4819-140-11-200406010-00013; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Buckeridge DL, 2007, J BIOMED INFORM, V40, P370, DOI 10.1016/j.jbi.2006.09.003; Buehler JW, 2003, EMERG INFECT DIS, V9, P1197, DOI 10.3201/eid0910.030231; Chute CG, 2008, J AM MED INFORM ASSN, V15, P172, DOI 10.1197/jamia.M2693; Corley CD, 2012, BIOSECUR BIOTERROR, V10, P131, DOI 10.1089/bsp.2011.0096; DECLICH S, 1994, B WORLD HEALTH ORGAN, V72, P285; Deshpande A, 2013, SYSTEMATIC EVALUATIO; Deshpande A, 2014, ONLINE J PU IN PRESS; Dixon Brian E, 2011, AMIA Annu Symp Proc, V2011, P322; Drewe JA, 2012, EPIDEMIOL INFECT, V140, P575, DOI 10.1017/S0950268811002160; ENDSLEY MR, 1995, HUM FACTORS, V37, P32, DOI 10.1518/001872095779049543; Fricker RD, 2011, STAT MED, V30, P403, DOI 10.1002/sim.3880; Generous EN, 2013, ONLINE J PUBLIC HEAL, V5, DOI [10.5210/ojphi.v5i1.4508, DOI 10.5210/0JPHI.V5I1.4508]; German R R, 2001, MMWR Recomm Rep, V50, P1; Hall H Irene, 2012, MMWR Suppl, V61, P10; Hardiman MC, 2012, EMERG INFECT DIS, V18, P1041, DOI 10.3201/eid1807.120395; Hartley Dm, 2010, Emerg Health Threats J, V3, pe3, DOI 10.3134/ehtj.10.003; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Hitchcock P, 2007, BIOSECUR BIOTERROR, V5, P206, DOI 10.1089/bsp.2007.0041; Holtry R, 2010, ONLINE J PUBLIC HEAL, V2; Hulth A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-252; ICAHS, 2011, AN HLTH SUR IN PRESS; Johnson DL, 1997, J ENVIRON QUAL, V26, P581, DOI 10.2134/jeq1997.00472425002600030002x; Kaydos-Daniels SC, 2013, BIOSECUR BIOTERROR, V11, P20, DOI 10.1089/bsp.2011.0109; Khan K, 2010, CAN MED ASSOC J, V182, P579, DOI 10.1503/cmaj.100093; Kloeze H, 2010, TRANSBOUND EMERG DIS, V57, P414, DOI 10.1111/j.1865-1682.2010.01166.x; Kman Nicholas E, 2012, Adv Prev Med, V2012, P301408, DOI 10.1155/2012/301408; Lee LM, 2011, AM J PREV MED, V41, P636, DOI 10.1016/j.amepre.2011.08.015; Lucero CA, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-56; Lyon A, 2012, TRANSBOUND EMERG DIS, V59, P223, DOI 10.1111/j.1865-1682.2011.01258.x; Malecki KC, 2008, J PUBLIC HEALTH MAN, V14, P543, DOI 10.1097/01.PHH.0000338366.74327.c9; McCabe K, 2013, ONLINE J PUBLIC HEAL, V5, DOI [10.5210/ojphi.v5i1.4404, DOI 10.5210/0JPHI.V5I1.4404]; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Mostashari F, 2003, J URBAN HEALTH, V80, pI43; Parry B, 2012, HEALTH PLACE, V18, P718, DOI 10.1016/j.healthplace.2011.10.010; Rolka H, 2011, INTEGR SER INFORM SY, V27, P3, DOI 10.1007/978-1-4419-6892-0_1; Russell KL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S2-S2; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Scott AE, 2012, PREV VET MED, V105, P265, DOI 10.1016/j.prevetmed.2012.01.007; Seiders B, 2002, P SOC PHOTO-OPT INS, V4745, P13, DOI 10.1117/12.475867; Sosin DM, 2003, J URBAN HEALTH, V80, pI8; Taboy CH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-S1-S6; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Thacker SB, 1992, PUBLIC HLTH SURVEILL; Thacker Stephen B, 2012, MMWR Suppl, V61, P3; U.S. Department of Homeland Security, 2007, HSPD 21 PUBL HLTH ME; Wagner ML, 2011, HUMAN PUBLIC HLTH SU; Wagner MM., 2006, HDB BIOSURVEILLANCE; Walters RA, 2010, WILEY HDB SCI TECHNO, V4, P2431, DOI DOI 10.1002/9780470087923.HHS151; Weber TE, 2001, WALL STR J E ED, V1; White House (United States), 2012, NAT STRAT BIOS	59	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83730	10.1371/journal.pone.0083730	http://dx.doi.org/10.1371/journal.pone.0083730			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392093	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100017
J	Zhou, Q; Yin, WJ; Du, YY; Lu, JS				Zhou, Qiong; Yin, Wenjin; Du, Yueyao; Lu, Jinsong			For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures	PLOS ONE			English	Article							SMALL LESS-THAN-OR-EQUAL-TO-1 CM; SURVIVAL; CHEMOTHERAPY; RECURRENCE; WOMEN; RISK; T1AB	Background: Although the prognosis of patients with small (<= 1cm) tumors is generally favorable, emerging data suggests that biological behavior varies between intrinsic subtypes in such patients. Furthermore, it still remains unclear whether HER2-positive pT1a-bN0M0 patients could benefit from adjuvant trastuzumab. For further evaluation, we sought to conduct a meta-analysis so as to get a better understanding of the prognosis for HER2-positive pT1a-bN0M0 patients and their survival benefit from adjuvant trastuzumab, accordingly, offering the implications for current practice. Methods: The PubMed database, the online proceedings of the American Society of Clinical Oncology (ASCO) Annual Meetings, the online proceedings of the San Antonio Breast Cancer Symposium, and the CD proceedings of the International St. Gallen Breast Cancer Conference were searched for all relevant studies published before September 2012. Relative risks (RRs) were used to compare the prognosis of different intrinsic subtypes for pT1a-bN0M0 breast cancer. Analyses were also performed to estimate the association between adjuvant trastuzumab and various survival outcomes. Results: With eight eligible studies identified, this meta-analysis demonstrated a deleterious effect of HER2+ phenotype on disease-free survival (DFS; RR = 3.677, 95% CI 2.606-5.189, p<0.001) and distant disease-free survival (DDFS; RR = 3.824, 95% CI 2.249-6.501, p<0.001) as compared to HR+/HER2- subgroup. However, significant difference failed to be achieved in terms of any endpoint between HER2+ and triple negative breast cancer (TNBC). Besides, a marked improvement in DFS was observed with the addition of trastuzumab for HER2-positive pT1a-bN0M0 patients (RR = 0.323, 95% CI 0.191-0.547, p<0.001). Conclusion: This meta-analysis clarifies that intrinsic subtypes might be a reliable marker to predict the prognosis in pT1a-bN0M0 breast cancer. Besides, even for such early stage HER2-positive patients, adjuvant trastuzumab might bring significant survival benefit.	[Zhou, Qiong; Yin, Wenjin; Du, Yueyao; Lu, Jinsong] Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Zhou, Qiong; Yin, Wenjin; Du, Yueyao; Lu, Jinsong] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Lu, Jinsong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Breast Surg, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Yin, WJ (corresponding author), Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	followroadyin@yahoo.com; lujjss@163.com	Yin, Wenjin/L-6020-2019	Yin, Wenjin/0000-0002-2129-7443				Aebi S, 2011, ANN ONCOL, V22, pvi12, DOI 10.1093/annonc/mdr371; Albert JM, 2010, INT J RADIAT ONCOL, V77, P1296, DOI 10.1016/j.ijrobp.2009.12.011; Amar S, 2010, ONCOLOGIST, V15, P1043, DOI 10.1634/theoncologist.2010-0036; Cancello G, 2011, BREAST CANCER RES TR, V127, P713, DOI 10.1007/s10549-011-1465-7; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Curigliano G, 2009, J CLIN ONCOL, V27, P5693, DOI 10.1200/JCO.2009.22.0962; Frenel JS, 2012, J CLIN ONCOL S, V30; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gonzalez-Angulo AM, 2009, J CLIN ONCOL, V27, P5700, DOI 10.1200/JCO.2009.23.2025; Heitz F, 2009, EUR J CANCER, V45, P2792, DOI 10.1016/j.ejca.2009.06.027; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horio A, 2012, INT J CLIN ONCOL, V17, P131, DOI 10.1007/s10147-011-0269-4; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Livi L, 2012, CANCER-AM CANCER SOC, V118, P3236, DOI 10.1002/cncr.26647; McArthur HL, 2011, CANCER-AM CANCER SOC, V117, P5461, DOI 10.1002/cncr.26171; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Niwinska A, 2010, ANN ONCOL, V21, P942, DOI 10.1093/annonc/mdp407; Park YH, 2010, BREAST CANCER RES TR, V119, P653, DOI 10.1007/s10549-009-0665-x; Petrelli F, 2012, MED ONCOL, V29, P2586, DOI 10.1007/s12032-012-0201-4; Rodrigues MJ, 2010, J CLIN ONCOL, V28, pE541, DOI 10.1200/JCO.2010.29.7952; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sanpaolo P, 2012, MED ONCOL, V29, P459, DOI 10.1007/s12032-011-9869-0; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Spielmann M, 2009, J CLIN ONCOL, V27, P6129, DOI 10.1200/JCO.2009.23.0946; Theriault RL, 2011, CLIN BREAST CANCER, V11, P325, DOI 10.1016/j.clbc.2011.05.002; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yin WJ, 2009, BREAST CANCER RES TR, V115, P325, DOI 10.1007/s10549-008-0096-0; Yin WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021030	29	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83646	10.1371/journal.pone.0083646	http://dx.doi.org/10.1371/journal.pone.0083646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392090	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100014
J	Arenas, CD; Lehman, N				Arenas, Carolina Diaz; Lehman, Niles			Partitioning the Fitness Components of RNA Populations Evolving In Vitro	PLOS ONE			English	Article							CATALYTIC RNA; TEST-TUBE; EVOLUTION; SELECTION; MUTATION; RIBOZYMES; SURVIVAL; FLATTEST; ENZYMES	All individuals in an evolving population compete for resources, and their performance is measured by a fitness metric. The performance of the individuals is relative to their abilities and to the biotic surroundings -the conditions under which they are competing -and involves many components. Molecules evolving in a test tube can also face complex environments and dynamics, and their fitness measurements should reflect the complexity of various contributing factors as well. Here, the fitnesses of a set of ligase ribozymes evolved by the continuous in vitro evolution system were measured. During these evolution cycles there are three different catalytic steps, ligation, reverse transcription, and forward transcription, each with a potential differential influence on the total fitness of each ligase. For six distinct ligase ribozyme genotypes that resulted from continuous evolution experiments, the rates of reaction were measured for each catalytic step by tracking the kinetics of enzymes reacting with their substrates. The reaction products were analyzed for the amount of product formed per time. Each catalytic step of the evolution cycle was found to have a differential incidence in the total fitness of the ligases, and therefore the total fitness of any ligase cannot be inferred from only one catalytic step of the evolution cycle. Generally, the ribozyme-directed ligation step tends to impart the largest effect on overall fitness. Yet it was found that the ligase genotypes have different absolute fitness values, and that they exploit different stages of the overall cycle to gain a net advantage. This is a new example of molecular niche partitioning that may allow for coexistence of more than one species in a population. The dissection of molecular events into multiple components of fitness provides new insights into molecular evolutionary studies in the laboratory, and has the potential to explain heretofore counterintuitive findings.	[Arenas, Carolina Diaz; Lehman, Niles] Portland State Univ, Dept Chem, Portland, OR 97207 USA	Portland State University	Lehman, N (corresponding author), Portland State Univ, Dept Chem, Portland, OR 97207 USA.	niles@pdx.edu	Lehman, Niles/ABF-7609-2021; DiazArenas, Carolina/H-2396-2015	Lehman, Niles/0000-0002-9056-6600; DiazArenas, Carolina/0000-0002-2308-8717	National Science Foundation [DEB-0315286]; National Aeronautics and Space Administration [NNX07-AU05G]	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	This work was funded by the National Science Foundation (grant DEB-0315286 to NL) and the National Aeronautics and Space Administration (grant NNX07-AU05G to NL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas CD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-80; Arenas CD, 2009, INT J BIOCHEM CELL B, V41, P266, DOI 10.1016/j.biocel.2008.08.034; ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI [10.2307/2408383, 10.1111/j.1558-5646.1984.tb00344.x]; Bergman NH, 2000, BIOCHEMISTRY-US, V39, P3115, DOI 10.1021/bi992654u; Bisswanger H., 2008, ENZYME KINETICS PRIN; Burton AS, 2009, ANAL BIOCHEM, V388, P351, DOI 10.1016/j.ab.2009.02.010; Codoner FM, 2006, PLOS PATHOG, V2, P1187, DOI 10.1371/journal.ppat.0020136; Conner J. K., 2004, PRIMER ECOLOGICAL GE; Diaz Arenas C, 2010, CURRENT PROTOCOLS NU; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; ELDEIRY WS, 1984, P NATL ACAD SCI-BIOL, V81, P7378, DOI 10.1073/pnas.81.23.7378; Falconer D. S., 1981, INTRO QUANTITATIVE G; JI JP, 1992, BIOCHEMISTRY-US, V31, P954, DOI 10.1021/bi00119a002; Joyce GF, 2007, ANGEW CHEM INT EDIT, V46, P6420, DOI 10.1002/anie.200701369; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LAZCANO A, 1992, J MOL EVOL, V35, P524, DOI 10.1007/BF00160213; Lehman N, 2004, ARTIF LIFE, V10, P1, DOI 10.1162/106454604322875887; Lehman N, 2000, J MOL EVOL, V50, P481, DOI 10.1007/s002390010051; Meluzzi D, 2012, RNA, V18, P590, DOI 10.1261/rna.029884.111; Ordoukhanian P, 1999, CHEM BIOL, V6, P881, DOI 10.1016/S1074-5521(00)80007-1; Pearson K, 1903, PHILOS T R SOC LOND, V200, P1, DOI 10.1098/rsta.1903.0001; Preston BD, 1996, P NATL ACAD SCI USA, V93, P7427, DOI 10.1073/pnas.93.15.7427; Sardanyes J, 2008, J THEOR BIOL, V250, P560, DOI 10.1016/j.jtbi.2007.10.027; Schmitt T, 1999, CHEM BIOL, V6, P857, DOI 10.1016/S1074-5521(00)80005-8; Soll SJ, 2007, GENETICS, V175, P267, DOI 10.1534/genetics.106.066142; Takeuchi N, 2012, PHYS LIFE REV, V9, P219, DOI 10.1016/j.plrev.2012.06.001; Vartanian JP, 1999, J GEN VIROL, V80, P1983, DOI 10.1099/0022-1317-80-8-1983; Voytek SB, 2009, P NATL ACAD SCI USA, V106, P7780, DOI 10.1073/pnas.0903397106; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wright MC, 1997, SCIENCE, V276, P614, DOI 10.1126/science.276.5312.614	34	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84454	10.1371/journal.pone.0084454	http://dx.doi.org/10.1371/journal.pone.0084454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391957	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900100
J	Chen, XL; Wee, NLJE; Hiong, KC; Ong, JLY; Chng, YR; Ching, BY; Wong, WP; Chew, SF; Ip, YK				Chen, Xiu L.; Wee, Nicklaus L. J. E.; Hiong, Kum C.; Ong, Jasmine L. Y.; Chng, You R.; Ching, Biyun; Wong, Wai P.; Chew, Shit F.; Ip, Yuen K.			Properties and Expression of Na+/K+-ATPase alpha-Subunit Isoforms in the Brain of the Swamp Eel, Monopterus albus, Which Has Unusually High Brain Ammonia Tolerance	PLOS ONE			English	Article							NA,K-ATPASE ALPHA; OXIDATIVE STRESS; PERIOPHTHALMODON-SCHLOSSERI; ENVIRONMENTAL AMMONIA; SEAWATER ACCLIMATION; NITROGEN-METABOLISM; MOLECULAR-CLONING; GIANT MUDSKIPPER; CLIMBING PERCH; BINDING SITES	The swamp eel, Monopterus albus, can survive in high concentrations of ammonia (>75 mmol l(-1)) and accumulate ammonia to high concentrations in its brain (similar to 4.5 mu mol g(-1)). Na+/K+-ATPase (Nka) is an essential transporter in brain cells, and since NH4+ can substitute for K+ to activate Nka, we hypothesized that the brain of M. albus expressed multiple forms of Nka alpha-subunits, some of which might have high K+ specificity. Thus, this study aimed to clone and sequence the nka alpha-subunits from the brain of M. albus, and to determine the effects of ammonia exposure on their mRNA expression and overall protein abundance. The effectiveness of NH4+ to activate brain Nka from M. albus and Mus musculus was also examined by comparing their Na+/K+-ATPase and Na+/NH4+-ATPase activities over a range of K+/NH4+ concentrations. The full length cDNA coding sequences of three nka alpha (nka alpha 1, nka alpha 3a and nka alpha 3b) were identified in the brain of M. albus, but nka alpha 2 expression was undetectable. Exposure to 50 mmol l(-1) NH4Cl for 1 day or 6 days resulted in significant decreases in the mRNA expression of nka alpha 1, nka alpha 3a and nka alpha 3b. The overall Nka protein abundance also decreased significantly after 6 days of ammonia exposure. For M. albus, brain Na+/NH4+-ATPase activities were significantly lower than the Na+/K+-ATPase activities assayed at various NH4+/K+ concentrations. Furthermore, the effectiveness of NH4+ to activate Nka from the brain of M. albus was significantly lower than that from the brain of M. musculus, which is ammonia-sensitive. Hence, the (1) lack of nka alpha 2 expression, (2) high K+ specificity of K+ binding sites of Nka alpha 1, Nka alpha 3a and Nka alpha 3b, and (3) down-regulation of mRNA expression of all three nka alpha isoforms and the overall Nka protein abundance in response to ammonia exposure might be some of the contributing factors to the high brain ammonia tolerance in M. albus.	[Chen, Xiu L.; Wee, Nicklaus L. J. E.; Hiong, Kum C.; Ong, Jasmine L. Y.; Chng, You R.; Ching, Biyun; Wong, Wai P.; Ip, Yuen K.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Chew, Shit F.] Nanyang Technol Univ, Natl Inst Educ, Singapore 639798, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	Ip, YK (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsipyk@nus.edu.sg	Ip, Yuen Kwong/H-8041-2012; Chew, Shit Fun/I-2248-2012	Ip, Yuen Kwong/0000-0001-9124-7911; Chew, Shit Fun/0000-0003-4599-5817	Singapore Ministry of Education [R154-000-470-112]; National Research Foundation Singapore (NRF) under NRF Environmental and Water Technologies (EWT)	Singapore Ministry of Education(Ministry of Education, Singapore); National Research Foundation Singapore (NRF) under NRF Environmental and Water Technologies (EWT)	This study was supported by the Singapore Ministry of Education through a grant (R154-000-470-112) to Yuen K. Ip. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Xiu L. Chen is supported by the National Research Foundation Singapore (NRF) under its NRF Environmental and Water Technologies (EWT) PhD Scholarship Programme administered by the Environment and Water Industry Programme Office (EWI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALABASTER JS, 1980, AMMONIA WATER QUALIT; APERIA A, 1994, FASEB J, V8, P436, DOI 10.1096/fasebj.8.6.8168694; Balshaw DM, 2000, BIOPHYS J, V79, P853, DOI 10.1016/S0006-3495(00)76341-7; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; Bergmeyer HU., 1985, METHOD ENZYMAT AN, V8, P454; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BLEI AT, 1994, HEPATOLOGY, V19, P1437, DOI 10.1002/hep.1840190619; Bosoi CR, 2012, METAB BRAIN DIS, P1; Bosoi CR, 2012, FREE RADICAL BIO MED, V52, P1228, DOI 10.1016/j.freeradbiomed.2012.01.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brusilow SW, 2002, MEDICINE, V81, P240, DOI 10.1097/00005792-200205000-00007; Chew SF, 2005, PHYSIOL BIOCHEM ZOOL, V78, P620, DOI 10.1086/430233; Chew SF, 2013, J FISH BIOL IN PRESS; Chew SF, 2007, J EXP ZOOL PART A, V307A, P357, DOI 10.1002/jez.385; Chew Shit F., 2006, Fish Physiology, V21, P307; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Davidson A, 1975, FISH FISH DISHES LAO, P1; Dostanic-Larson I, 2005, P NATL ACAD SCI USA, V102, P15845, DOI 10.1073/pnas.0507358102; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feschenko MS, 1997, J BIOL CHEM, V272, P17726, DOI 10.1074/jbc.272.28.17726; FRENEY JR, 1981, AUST J AGR RES, V32, P37, DOI 10.1071/AR9810037; Gerwick L, 2007, FISH SHELLFISH IMMUN, V22, P157, DOI 10.1016/j.fsi.2006.04.003; GLYNN IM, 1984, J PHYSIOL-LONDON, V351, P531, DOI 10.1113/jphysiol.1984.sp015261; Graham JB, 1997, AIR BREATHING FISHES, P234; Guynn SR, 2002, J EXP MAR BIOL ECOL, V273, P15, DOI 10.1016/S0022-0981(02)00136-3; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hermenegildo C, 1996, NEUROCHEM RES, V21, P1237, DOI 10.1007/BF02532401; Horisberger JD, 2002, J PHYSIOL-LONDON, V539, P669, DOI 10.1113/jphysiol.2001.013201; Hosoi R, 1997, J NEUROCHEM, V69, P2189; Illarionova NB, 2010, NEUROSCIENCE, V168, P915, DOI 10.1016/j.neuroscience.2009.11.062; Ip Y.K., 2001, Fish Physiology, V20, P109; Ip YK, 2004, J EXP BIOL, V207, P3015, DOI 10.1242/jeb.01137; Ip YK, 2004, PHYSIOL BIOCHEM ZOOL, V77, P390, DOI 10.1086/383510; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; Ip YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069512; Ip YK, 2012, J COMP PHYSIOL B, V182, P793, DOI 10.1007/s00360-012-0664-9; Ip YK, 2012, AM J PHYSIOL-REG I, V303, pR112, DOI 10.1152/ajpregu.00618.2011; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; JORGENSEN PL, 1980, BIOCHIM BIOPHYS ACTA, V597, P305, DOI 10.1016/0005-2736(80)90108-X; Kala G, 2000, NEUROCHEM INT, V36, P203, DOI 10.1016/S0197-0186(99)00117-5; Kosenko E, 1999, FREE RADICAL BIO MED, V26, P1369, DOI 10.1016/S0891-5849(98)00339-6; KOSENKO E, 1994, J NEUROCHEM, V63, P2172; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; Lingrel JB, 1998, ACTA PHYSIOL SCAND, V163, P69; Loong AM, 2012, J COMP PHYSIOL B, V182, P367, DOI 10.1007/s00360-011-0626-7; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McLean WJ, 2008, JARO-J ASSOC RES OTO, V10, P37; Minana MD, 1996, J PHARMACOL EXP THER, V279, P194; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Nishi A, 1999, EUR J NEUROSCI, V11, P2589, DOI 10.1046/j.1460-9568.1999.00724.x; Norenberg MD, 2009, METAB BRAIN DIS, V24, P103, DOI 10.1007/s11011-008-9113-6; NORENBERG MD, 1987, NEUROCHEM PATHOL, V6, P13, DOI 10.1007/BF02833599; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Ott P, 2004, NEUROCHEM INT, V44, P185, DOI 10.1016/S0197-0186(03)00153-0; Pasantes-Morales H, 2012, NEUROCHEM RES, V37, P2379, DOI 10.1007/s11064-012-0777-2; Peng KW, 1998, FISH PHYSIOL BIOCHEM, V19, P59, DOI 10.1023/A:1007745003948; Peng L, 1997, J NEUROSCI, V17, P3488; Peng L, 2010, NEURON GLIA BIOL, V26, P1; Rainboth WJ, 1996, FISHES CAMBODIAN MEK, P177; Semple JW, 2002, MAR BIOTECHNOL, V4, P512, DOI 10.1007/s10126-002-0031-z; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; Taguchi K, 2007, NEUROSCI LETT, V413, P42, DOI 10.1016/j.neulet.2006.11.061; Tay ASL, 2003, J EXP BIOL, V206, P2473, DOI 10.1242/jeb.00464; Tay YL, 2006, J EXP BIOL, V209, P4475, DOI 10.1242/jeb.02557; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Tng YYM, 2009, J EXP ZOOL PART A, V311A, P676, DOI 10.1002/jez.555; Wilkie MP, 2002, J EXP ZOOL, V293, P284, DOI 10.1002/jez.10123; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Xue ZX, 2010, NEUROCHEM INT, V57, P395, DOI 10.1016/j.neuint.2010.04.014; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201; ZAUGG WS, 1982, CAN J FISH AQUAT SCI, V39, P215, DOI 10.1139/f82-027	76	3	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84298	10.1371/journal.pone.0084298	http://dx.doi.org/10.1371/journal.pone.0084298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391932	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900075
J	Chevallier, M; Ego, A; Cans, C; Debillon, T				Chevallier, Marie; Ego, Anne; Cans, Christine; Debillon, Thierry		French Soc Neonatology	Adherence to Hypothermia Guidelines: A French Multicenter Study of Fullterm Neonates	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; AMPLITUDE-INTEGRATED EEG; WHOLE-BODY HYPOTHERMIA; MODERATE HYPOTHERMIA; SYSTEMIC HYPOTHERMIA; PERINATAL ASPHYXIA; NEWBORNS; OUTCOMES; INFANTS; RISK	Aim: The objective of this study was to describe the French practice of hypothermia treatment (HT) in full-term newborns with hypoxic-ischemic encephalopathy (HIE) and to analyze the deviations from the guidelines of the French Society of Neonatology. Materials and Methods: From May 2010 to March 2012 we recorded all cases of HIE treated by HT in a French national database. The population was divided into three groups, "optimal HT" (OHT), "late HT" (LHT) and "non-indicated" HT (NIHT), according to the guidelines. Results: Of the 311 newborns registered in the database and having HT, 65% were classified in the OHT group, 22% and 13% in the LHT and NIHT groups respectively. The severity of asphyxia and HIE were comparable between newborns with OHT and LHT, apart from EEG. HT was initiated at a mean time of 12 hours of life in the LHT group. An acute obstetrical event was more likely to be identified among newborns with LHT (46%), compared to OHT (34%) and NIHT (22%). There was a gradation in the rate of complications from the NIHT group (29%) to the LHT (38%) group and the OHT group (52%). Despite an insignificant difference in the rates of death or abnormal neurological examination at discharge, nearly 60% of newborns in the OHT group had an MRI showing abnormalities, compared to 44% and 49% in the LHT and NIHT groups respectively. Conclusion: The conduct of the HT for HIE newborns is not consistent with French guidelines for 35% of newborns, 22% being explained by an excessive delay in the start of HT, 13% by the lack of adherence to the clinical indications. This first report illustrates the difficulties in implementing guidelines for HT and should argue for an optimization of perinatal care for HIE.	[Chevallier, Marie; Debillon, Thierry] Grenoble Univ Hosp, Neonatol & Pediat Intens Care Unit, Grenoble, France; [Ego, Anne] Grenoble Univ Hosp, Clin Res Ctr CICO3, Grenoble, France; [Cans, Christine] Univ Grenoble 1, THEMAS Tech Evaluat & Modelisat Act Sante, Grenoble, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Debillon, T (corresponding author), Grenoble Univ Hosp, Neonatol & Pediat Intens Care Unit, Grenoble, France.	TDebillon@chu-grenoble.fr	EGO, Anne/G-7071-2011; Cans, Christine/M-6153-2014; Debillon, Thierry/M-6929-2014	EGO, Anne/0000-0002-1025-910X; Cans, Christine/0000-0003-3071-9959; Beuchee, Alain/0000-0003-0064-7085; Marret, Stephane/0000-0002-2858-148X; CAMBONIE, GILLES/0000-0002-1360-7915; Meau-Petit, Virginie/0000-0002-2725-7522				Amiel-Tison C, 2002, PEDIATR NEUROL, V27, P196, DOI 10.1016/S0887-8994(02)00436-8; Austin T, 2012, COOL NOT COOL HYPOTH, DOI DOI 10.1136/ARCHDISCHILD-2012-302069.ACCESSED; Azzopardi D, 2009, ARCH DIS CHILD-FETAL, V94, pF260, DOI 10.1136/adc.2008.146977; Azzopardi D, 2013, ARCH DIS CHILD FETAL; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; BERGAMASCO B, 1984, EPILEPSIA, V25, P131, DOI 10.1111/j.1528-1157.1984.tb04168.x; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Glass HC, 2011, PEDIATR RES, V70, P535, DOI 10.1203/PDR.0b013e31822f24c7; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Groenendaal F, 2013, NEONATOLOGY, V104, P15, DOI 10.1159/000348823; Inder TE, 2004, J PEDIATR-US, V145, P835, DOI 10.1016/j.jpeds.2004.07.034; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Laptook A, 2013, LATE HYPOTHERMIA HYP; Lin ZL, 2006, J PERINATOL, V26, P180, DOI 10.1038/sj.jp.7211412; O'Reilly D, 2013, J PERINATOL, V33, P435, DOI 10.1038/jp.2012.138; Pfister RH, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-84; Pierrat V, 2005, ARCH DIS CHILD-FETAL, V90, P257, DOI 10.1136/adc.2003.047985; Pin TW, 2009, EUR J PAEDIATR NEURO, V13, P224, DOI 10.1016/j.ejpn.2008.05.001; Saliba E, 2010, ARCH PEDIATRIE, V17, pS67, DOI 10.1016/S0929-693X(10)70904-0; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shah PS, 2010, SEMIN FETAL NEONAT M, V15, P238, DOI 10.1016/j.siny.2010.02.003; Shankaran S, 2002, PEDIATRICS, V110, P377, DOI 10.1542/peds.110.2.377; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shellhaas RA, 2007, PEDIATRICS, V120, P770, DOI 10.1542/peds.2007-0514; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Spitzmiller RE, 2007, J CHILD NEUROL, V22, P1069, DOI 10.1177/0883073807306258; Strohm B, 2011, PEDIATRICS, V128, pE450, DOI 10.1542/peds.2010-3508; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Tao JD, 2010, J PERINATOL, V30, pS73, DOI 10.1038/jp.2010.93; THORNBERG E, 1995, ACTA PAEDIATR, V84, P927, DOI 10.1111/j.1651-2227.1995.tb13794.x; Walsh W, 2013, PILOT STUDY HEAD COO; Yates HL, 2012, ARCH DIS CHILD-FETAL, V97, DOI 10.1136/adc.2011.301240	34	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83742	10.1371/journal.pone.0083742	http://dx.doi.org/10.1371/journal.pone.0083742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391817	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200115
J	Fan, J; Xie, JB; Wang, JL; Qu, JS				Fan Jing; Xie Jianbin; Wang Jinlong; Qu Jinshuai			Uncovering and Testing the Fuzzy Clusters Based on Lumped Markov Chain in Complex Network	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GAUSSIAN MIXTURE	Identifying clusters, namely groups of nodes with comparatively strong internal connectivity, is a fundamental task for deeply understanding the structure and function of a network. By means of a lumped Markov chain model of a random walker, we propose two novel ways of inferring the lumped markov transition matrix. Furthermore, some useful results are proposed based on the analysis of the properties of the lumped Markov process. To find the best partition of complex networks, a novel framework including two algorithms for network partition based on the optimal lumped Markovian dynamics is derived to solve this problem. The algorithms are constructed to minimize the objective function under this framework. It is demonstrated by the simulation experiments that our algorithms can efficiently determine the probabilities with which a node belongs to different clusters during the learning process and naturally supports the fuzzy partition. Moreover, they are successfully applied to real-world network, including the social interactions between members of a karate club.	[Fan Jing; Wang Jinlong; Qu Jinshuai] Yunnan Univ Nationalities, Univ Key Lab Wireless Sensor Networks Yunnan Prov, Kunming, Peoples R China; [Xie Jianbin] Yunnan Univ, Sch Urban Construct & Management, Kunming, Peoples R China	Yunnan Minzu University; Yunnan University	Fan, J (corresponding author), Yunnan Univ Nationalities, Univ Key Lab Wireless Sensor Networks Yunnan Prov, Kunming, Peoples R China.	fanjing9476@163.com			National Natural Science Foundation of China [60963026, 61163061]; Application Basic Research Fund of Yunnan Province [2011FZ174]; National Natural Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Application Basic Research Fund of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant No. 60963026, No. 61163061), and the Application Basic Research Fund of Yunnan Province (grant No. 2011FZ174). Tthe National Natural Science Foundation of China: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Borner K, 2007, ANNU REV INFORM SCI, V41, P537, DOI 10.1002/aris.2007.1440410119; Chorin AJ, 1999, COMMUN PUR APPL MATH, V52, P1231, DOI 10.1002/(SICI)1097-0312(199910)52:10<1231::AID-CPA3>3.0.CO;2-C; Chorin AJ, 2003, MULTISCALE MODEL SIM, V1, P105, DOI 10.1137/S1540345902405556; Chung, 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Devijver P, 1982, PATTERN RECOGNITION; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hofman JM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258701; Lafon S, 2006, IEEE T PATTERN ANAL, V28, P1393, DOI 10.1109/TPAMI.2006.184; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Li TJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026106; Lovasz L, 1993, BOLYAI MATH STUD, V1, P9; Ma JW, 2006, NEURAL PROCESS LETT, V24, P19, DOI 10.1007/s11063-006-9008-7; Ma JW, 2005, INT J PATTERN RECOGN, V19, P701, DOI 10.1142/S0218001405004228; Ma JW, 2004, NEUROCOMPUTING, V56, P481, DOI 10.1016/j.neucom.2003.10.009; Meila M, 2001, RANDOM WALKS VIEW SP; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Qian N, 1999, NEURAL NETWORKS, V12, P145, DOI 10.1016/S0893-6080(98)00116-6; Schilders WHA, 2008, EUR CONSORT MATH IND, P1, DOI 10.1007/978-3-540-78841-6; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Weinan E, 2008, P NATL ACAD SCI USA, V105, P7907, DOI 10.1073/pnas.0707563105; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	27	0	0	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82964	10.1371/journal.pone.0082964	http://dx.doi.org/10.1371/journal.pone.0082964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391729	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200026
J	Huffman, MD; Baldridge, A; Bloomfield, GS; Colantonio, LD; Prabhakaran, P; Ajay, VS; Suh, S; Lewison, G; Prabhakaran, D				Huffman, Mark D.; Baldridge, Abigail; Bloomfield, Gerald S.; Colantonio, Lisandro D.; Prabhakaran, Poornima; Ajay, Vamadevan S.; Suh, Sarah; Lewison, Grant; Prabhakaran, Dorairaj			Global Cardiovascular Research Output, Citations, and Collaborations: A Time-Trend, Bibliometric Analysis (1999-2008)	PLOS ONE			English	Article							PUBLICATION; DISEASE	Introduction: Health research is one mechanism to improve population-level health and should generally match the health needs of populations. However, there have been limited data to assess the trends in national-level cardiovascular research output, even as cardiovascular disease [CVD] has become the leading cause of morbidity and mortality worldwide. Materials and Methods: We performed a time trends analysis of cardiovascular research publications (1999-2008) downloaded from Web of Knowledge using a iteratively-tested cardiovascular bibliometric filter with >90% precision and recall. We evaluated cardiovascular research publications, five-year running actual citation indices [ACIs], and degree of international collaboration measured through the ratio of the fractional count of addresses from one country against all addresses for each publication. Results and Discussion: Global cardiovascular publication volume increased from 40 661 publications in 1999 to 55 284 publications in 2008, which represents a 36% increase. The proportion of cardiovascular publications from high-income, Organization for Economic Cooperation and Development [OECD] countries declined from 93% to 84% of the total share over the study period. High-income, OECD countries generally had higher fractional counts, which suggest less international collaboration, than lower income countries from 1999-2008. There was an inverse relationship between cardiovascular publications and age-standardized CVD morbidity and mortality rates, but a direct, curvilinear relationship between cardiovascular publications and Human Development Index from 1999-2008. Conclusions: Cardiovascular health research output has increased substantially in the past decade, with a greater share of citations being published from low-and middle-income countries. However, low-and middle-income countries with the higher burdens of cardiovascular disease continue to have lower research output than high-income countries, and thus require targeted research investments to improve cardiovascular health.	[Huffman, Mark D.; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Huffman, Mark D.; Baldridge, Abigail; Suh, Sarah] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bloomfield, Gerald S.] Duke Univ, Med Ctr, Durham, NC USA; [Colantonio, Lisandro D.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Prabhakaran, Poornima; Ajay, Vamadevan S.] Publ Hlth Fdn India, New Delhi, India; [Lewison, Grant] Kings Coll London, London WC2R 2LS, England	Northwestern University; Feinberg School of Medicine; Duke University; University of Alabama System; University of Alabama Birmingham; Public Health Foundation of India; University of London; King's College London	Huffman, MD (corresponding author), Ctr Chron Dis Control, New Delhi, India.	m-huffman@northwestern.edu	Prabhakaran, Dorairaj/B-4147-2011	Prabhakaran, Dorairaj/0000-0002-3172-834X; Ajay, Vamadevan S/0000-0002-4102-0505; Colantonio, Lisandro/0000-0001-8742-1788; Huffman, Mark/0000-0001-7412-2519; Bloomfield, Gerald/0000-0002-7176-1611	Global Forum for Health Research; Fogarty International Center; National Heart, Lung, and Blood Institute (NHLBI) [1K99HL107749-01A1]; Fogarty International Center of the National Institutes of Health [K01TW008407]; Wellcome Trust Capacity Strengthening Strategic Award; NHLBI [HHS N268200900026C]; National Institute of Child Health and Human Development [1D43HD065249]; FOGARTY INTERNATIONAL CENTER [K01TW008407] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL107749] Funding Source: NIH RePORTER	Global Forum for Health Research; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust Capacity Strengthening Strategic Award(Wellcome Trust); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Global Forum for Health Research and the Fogarty International Center. Neither participated in the study design, analysis, writing, or decision to publish. MDH is supported by a National Heart, Lung, and Blood Institute (NHLBI) Pathway to Independence award [1K99HL107749-01A1]. GSB is supported by the Fogarty International Center of the National Institutes of Health [K01TW008407]. PP and VSA are supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of United Kingdom universities. DP receives partial salary support from a contract award [HHS N268200900026C] from NHLBI and a grant award [1D43HD065249] from National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2012, PLOS MED, V9; Baussano I, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-16; Bonita R, 2013, LANCET, V381, P575, DOI 10.1016/S0140-6736(12)61993-X; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Clarke A, 2007, EUR J PUBLIC HEALTH, V17, P43, DOI 10.1093/eurpub/ckm063; deJong JW, 1996, EUR HEART J, V17, P35; Durieux V, 2010, RADIOLOGY, V255, P342, DOI 10.1148/radiol.09090626; Falagas ME, 2008, FASEB J, V22, P2623, DOI 10.1096/fj.08-107938; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z; Lewison G, 1996, RES EVALUAT, V6, P25; Lewison G, 2011, DESIDOC J LIB INF TE, V31, P333, DOI 10.14429/djlit.31.5.1189; Lewison G, 2010, EUR J CANCER, V46, P912, DOI 10.1016/j.ejca.2009.12.020; McKee MD, 2012, PEDIATRIC BONE: BIOLOGY & DISEASES, 2ND EDITION, P9, DOI 10.1016/B978-0-12-382040-2.10002-4; McVeigh ME, 2009, JAMA-J AM MED ASSOC, V302, P1107, DOI 10.1001/jama.2009.1301; Mendis S, 2003, LANCET, V361, P2246, DOI 10.1016/S0140-6736(03)13753-1; Mori H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057371; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00902; Prabhakaran P, 2007, J AM COLL CARDIOL, V50, P2322, DOI 10.1016/j.jacc.2007.08.040; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ	20	46	46	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83440	10.1371/journal.pone.0083440	http://dx.doi.org/10.1371/journal.pone.0083440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391769	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200066
J	Humily, F; Partensky, F; Six, C; Farrant, GK; Ratin, M; Marie, D; Garczarek, L				Humily, Florian; Partensky, Frederic; Six, Christophe; Farrant, Gregory K.; Ratin, Morgane; Marie, Dominique; Garczarek, Laurence			A Gene Island with Two Possible Configurations Is Involved in Chromatic Acclimation in Marine Synechococcus	PLOS ONE			English	Article							PHOTOSYNTHESIS GENES; UNICELLULAR CYANOBACTERIA; WATER COLUMN; PROCHLOROCOCCUS; PHYCOERYTHRIN; PROTEIN; SEQUENCE; PHYCOBILISOME; ADAPTATION; ECOTYPES	Synechococcus, the second most abundant oxygenic phototroph in the marine environment, harbors the largest pigment diversity known within a single genus of cyanobacteria, allowing it to exploit a wide range of light niches. Some strains are capable of Type IV chromatic acclimation (CA4), a process by which cells can match the phycobilin content of their phycobilisomes to the ambient light quality. Here, we performed extensive genomic comparisons to explore the diversity of this process within the marine Synechococcus radiation. A specific gene island was identified in all CA4-performing strains, containing two genes (fciA/b) coding for possible transcriptional regulators and one gene coding for a phycobilin lyase. However, two distinct configurations of this cluster were observed, depending on the lineage. CA4-A islands contain the mpeZ gene, encoding a recently characterized phycoerythrobilin lyase-isomerase, and a third, small, possible regulator called fciC. In CA4-B islands, the lyase gene encodes an uncharacterized relative of MpeZ, called MpeW. While mpeZ is expressed more in blue light than green light, this is the reverse for mpeW, although only small phenotypic differences were found among chromatic acclimaters possessing either CA4 island type. This study provides novel insights into understanding both diversity and evolution of the CA4 process.	[Humily, Florian; Partensky, Frederic; Six, Christophe; Farrant, Gregory K.; Ratin, Morgane; Marie, Dominique; Garczarek, Laurence] Univ Paris 06, Stn Biol, Roscoff, France; [Humily, Florian; Partensky, Frederic; Six, Christophe; Farrant, Gregory K.; Ratin, Morgane; Marie, Dominique; Garczarek, Laurence] CNRS, UMR 7144, Ocean Plankton Grp, Marine Phototroph Prokaryotes Team, Roscoff, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Garczarek, L (corresponding author), Univ Paris 06, Stn Biol, Roscoff, France.	laurence.garczarek@sb-roscoff.fr	Farrant, Gregory/K-3394-2015; Partensky, Frédéric/AAH-1170-2021; Partensky, Frédéric/B-9194-2018	Farrant, Gregory/0000-0002-3774-3743; Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Six, Christophe/0000-0002-8506-1149; Garczarek, Laurence/0000-0002-8191-8395	French "Agence Nationale de la Recherche" Microbial Genomics Programme (PELICAN) [ANR-09-GENM-030]; European Union [287589]; MaCumba [311975]	French "Agence Nationale de la Recherche" Microbial Genomics Programme (PELICAN)(French National Research Agency (ANR)); European Union(European Commission); MaCumba	This work was supported by the French "Agence Nationale de la Recherche" Microbial Genomics Programme (PELICAN, ANR-09-GENM-030), the European Union's Seventh Framework Programmes FP7 MicroB3 (grant agreement 287589, http://www.microb3.eu) and MaCumba (grant agreement 311975, http://www.macumbaproject.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Ahlgren NA, 2006, APPL ENVIRON MICROB, V72, P7193, DOI 10.1128/AEM.00358-06; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Biswas A, 2011, J BIOL CHEM, V286, P35509, DOI 10.1074/jbc.M111.284281; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bretaudeau A, 2013, NUCLEIC ACIDS RES, V41, pD396, DOI 10.1093/nar/gks1091; Buitenhuis ET, 2012, EARTH SYST SCI DATA, V4, P37, DOI 10.5194/essd-4-37-2012; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Coste F, 2005, LECT NOTES ARTIF INT, V3720, P522, DOI 10.1007/11564096_50; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; DEMARSAC NT, 1977, J BACTERIOL, V130, P82, DOI 10.1128/JB.130.1.82-91.1977; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; EGAN SM, 1993, J MOL BIOL, V234, P87, DOI 10.1006/jmbi.1993.1565; Everroad C, 2006, J BACTERIOL, V188, P3345, DOI 10.1128/JB.188.9.3345-3356.2006; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fuller NJ, 2003, APPL ENVIRON MICROB, V69, P2430, DOI 10.1128/AEM.69.5.2430-2443.2003; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Garczarek L, 2008, ISME J, V2, P937, DOI 10.1038/ismej.2008.46; Guindon S, 2009, INFECT GENET EVOL, V9, P384; Gutu A, 2012, MOL PLANT, V5, P1, DOI 10.1093/mp/ssr054; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haverkamp T, 2008, ENVIRON MICROBIOL, V10, P174, DOI 10.1111/j.1462-2920.2007.01442.x; Huang SJ, 2012, ISME J, V6, P285, DOI 10.1038/ismej.2011.106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kolowrat C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-204; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Liu H, 1998, DEEP-SEA RES PT II, V45, P2327, DOI 10.1016/S0967-0645(98)00073-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; MARIE D, 1999, CURRENT PROTOCOLS CY, V10; Mazard S, 2012, ENVIRON MICROBIOL, V14, P372, DOI 10.1111/j.1462-2920.2011.02514.x; Mella-Flores D, 2011, BIOGEOSCIENCES, V8, P2785, DOI 10.5194/bg-8-2785-2011; Morel A, 2007, LIMNOL OCEANOGR, V52, P217, DOI 10.4319/lo.2007.52.1.0217; Morimoto K, 2003, J BIOCHEM, V134, P211, DOI 10.1093/jb/mvg131; OLSON RJ, 1990, LIMNOL OCEANOGR, V35, P45, DOI 10.4319/lo.1990.35.1.0045; ONG LJ, 1991, J BIOL CHEM, V266, P9515; ONG LJ, 1984, SCIENCE, V224, P80, DOI 10.1126/science.224.4644.80; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rodgers ME, 2009, PROTEINS, V77, P202, DOI 10.1002/prot.22431; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schleif R, 2003, BIOESSAYS, V25, P274, DOI 10.1002/bies.10237; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shukla A, 2012, P NATL ACAD SCI USA, V109, P20136, DOI 10.1073/pnas.1211777109; SIDLER WA, 1994, MOL BIOL CYANOBACTER, P1999; Six C, 2005, J BACTERIOL, V187, P1685, DOI 10.1128/JB.187.5.1685-1694.2005; Six C, 2004, AQUAT MICROB ECOL, V35, P17, DOI 10.3354/ame035017; Six C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r259; Six C, 2007, PHOTOSYNTH RES, V92, P75, DOI 10.1007/s11120-007-9170-4; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; SWANSON RV, 1991, J BIOL CHEM, V266, P9528; Vaulot D, 2004, NOVA HEDWIGIA, V79, P49, DOI 10.1127/0029-5035/2004/0079-0049; Wickstrum JR, 2010, J BACTERIOL, V192, P225, DOI 10.1128/JB.00829-08; WILBANKS SM, 1993, J BIOL CHEM, V268, P1226; Wood AM, 1998, MAR ECOL PROG SER, V162, P25, DOI 10.3354/meps162025	73	35	36	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84459	10.1371/journal.pone.0084459	http://dx.doi.org/10.1371/journal.pone.0084459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391958	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900101
J	Lemoh, C; Ryan, CE; Sekawi, Z; Hearps, AC; Aleksic, E; Chibo, D; Grierson, J; Baho, S; Street, A; Hellard, M; Biggs, BA; Crowe, SM				Lemoh, Chris; Ryan, Claire E.; Sekawi, Zamberi; Hearps, Anna C.; Aleksic, Eman; Chibo, Doris; Grierson, Jeffrey; Baho, Samia; Street, Alan; Hellard, Margaret; Biggs, Beverley-Ann; Crowe, Suzanne M.			Acquisition of HIV by African-Born Residents of Victoria, Australia: Insights from Molecular Epidemiology	PLOS ONE			English	Article							VIRUS TYPE-1 SUBTYPES; INJECTING DRUG-USERS; GLOBAL EPIDEMIOLOGY; GENETIC DIVERSITY; TRANSMISSION; INFECTION; RISK; SEX; MEN; SURVEILLANCE	African-born Australians are a recognised "priority population" in Australia's Sixth National HIV/AIDS Strategy. We compared exposure location and route for African-born people living with HIV (PLHIV) in Victoria, Australia, with HIV-1 pol subtype from drug resistance assays and geographical origin suggested by phylogenetic analysis of env gene. Twenty adult HIV positive African-born Victorian residents were recruited via treating doctors. HIV exposure details were obtained from interviews and case notes. Viral RNA was extracted from participant stored plasma or whole blood. The env V3 region was sequenced and compared to globally representative reference HIV-1 sequences in the Los Alamos National Library HIV Database. Twelve participants reported exposure via heterosexual sex and two via iatrogenic blood exposures; four were men having sex with men (MSM); two were exposed via unknown routes. Eight participants reported exposure in their countries of birth, seven in Australia, three in other countries and two in unknown locations. Genotype results (pol) were available for ten participants. HIV env amplification was successful in eighteen cases. HIV-1 subtype was identified in all participants: eight both pol and env; ten env alone and two pol alone. Twelve were subtype C, four subtype B, three subtype A and one subtype CRF02_AG. Reported exposure location was consistent with the phylogenetic clustering of env sequences. African Australians are members of multiple transnational social and sexual networks influencing their exposure to HIV. Phylogenetic analysis may complement traditional surveillance to discern patterns of HIV exposure, providing focus for HIV prevention programs in mobile populations.	[Lemoh, Chris; Hellard, Margaret] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Lemoh, Chris; Baho, Samia; Biggs, Beverley-Ann] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Lemoh, Chris; Street, Alan; Biggs, Beverley-Ann] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Ryan, Claire E.; Sekawi, Zamberi; Hearps, Anna C.; Aleksic, Eman; Crowe, Suzanne M.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Sekawi, Zamberi] Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang 43400, Selangor, Malaysia; [Chibo, Doris] Victorian Infect Dis Reference Lab, HIV State Reference Lab, Melbourne, Australia; [Grierson, Jeffrey] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Hellard, Margaret; Crowe, Suzanne M.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia	Burnet Institute; University of Melbourne; Royal Melbourne Hospital; Burnet Institute; Universiti Putra Malaysia; Victorian Infectious Diseases Reference Laboratory; La Trobe University; Florey Institute of Neuroscience & Mental Health	Lemoh, C (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.	chris.lemoh@gmail.com	Nightingale, Claire Elizabeth/K-1667-2019; Sekawi, Zamberi/I-1755-2013	Nightingale, Claire Elizabeth/0000-0002-4103-6240; Sekawi, Zamberi/0000-0002-5387-9640; Chibo, Doris/0000-0002-6950-6910; Biggs, Beverley-Ann/0000-0002-2961-9793; Grierson, Jeffrey/0000-0003-1619-2054; Lemoh, Christopher/0000-0002-8383-9471	Centre for Clinical Research Excellence in Infectious Diseases; Department of Medicine; Victorian Government Department of Human Services; Victor Hurley Research Fund; Australasian Society for Infectious Diseases; Victorian Department of Innovation and Industry; Australian National Health and Medical Research Council; National Health and Medical Research Council	Centre for Clinical Research Excellence in Infectious Diseases; Department of Medicine; Victorian Government Department of Human Services; Victor Hurley Research Fund; Australasian Society for Infectious Diseases; Victorian Department of Innovation and Industry; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors are grateful for the financial and material support provided by the Centre for Clinical Research Excellence in Infectious Diseases and the Department of Medicine; the financial support received from the Victorian Government Department of Human Services, the Victor Hurley Research Fund and the Australasian Society for Infectious Diseases; and the material support provided by the Burnet Institute, the Victorian Infectious Diseases Laboratories and the Victorian Infectious Diseases Service. The authors acknowledge the funding for institutional infrastructure provided by the Victorian Department of Innovation and Industry and the Australian National Health and Medical Research Council. Suzanne Crowe holds a Principal Research Fellowship from the National Health and Medical Research Council. Margaret Hellard holds a Senior Research Fellowship from the National Health and Medical Research Council. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program.	Aggarwal I, 2006, JAIDS-J ACQ IMM DEF, V41, P201, DOI 10.1097/01.qai.0000179430.34660.11; Akouamba BS, 2005, EMERG INFECT DIS, V11, P1230, DOI 10.3201/eid1108.040877; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Australian Bureau of Statistics, 2007, 2006 CENS POP HOUS; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Caridha R, 2012, AIDS RES HUM RETROV, V28, P852, DOI [10.1089/AID.2011.0033, 10.1089/aid.2011.0033]; Carr JK, 1999, AIDS, V13, P1819, DOI 10.1097/00002030-199910010-00003; Chibo D, 2012, AIDS RES HUM RETROV, V28, P578, DOI [10.1089/aid.2011.0200, 10.1089/AID.2011.0200]; Chibo D, 2012, AIDS RES HUM RETROV, V28, P460, DOI [10.1089/AID.2011.0137, 10.1089/aid.2011.0137]; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; de Coul ELMO, 2001, AIDS, V15, P2277, DOI 10.1097/00002030-200111230-00009; Dept Health and Ageing, 2010, 6 NAT HIV STRAT 2010; Dore GJ, 2001, J ACQ IMMUN DEF SYND, V26, P283, DOI 10.1097/00126334-200103010-00012; Dubois-Arber F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-528; EuroHIV, 2007, HIV AIDS SURV EUR EN; Gifford RJ, 2007, J VIROL, V81, P13050, DOI 10.1128/JVI.00889-07; Graw F, 2012, EPIDEMICS-NETH, V4, P104, DOI 10.1016/j.epidem.2012.04.002; Hayman A, 2001, AIDS RES HUM RETROV, V17, P689, DOI 10.1089/088922201750236960; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Herring BL, 2003, J CLIN MICROBIOL, V41, P4600, DOI 10.1128/JCM.41.10.4600-4604.2003; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Jennes W, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037402, DOI 10.1371/J0URNAL.P0NE.0037402]; Kaldor J, 2003, JAIDS-J ACQ IMM DEF, V32, pS18, DOI 10.1097/00126334-200302011-00004; Kandathil AJ, 2005, INDIAN J MED RES, V121, P333; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Lemoh C, 2006, REDUCING RISK TRAND; Lemoh C, 2009, SEX HEALTH, V6, P117, DOI 10.1071/SH08028; Lemoh CN, 2010, SEX HEALTH, V7, P142, DOI 10.1071/SH09120; Liitsola K, 2000, SCAND J INFECT DIS, V32, P475, DOI 10.1080/003655400458721; Lospitao E, 2005, HIV MED, V6, P313, DOI 10.1111/j.1468-1293.2005.00313.x; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; McMichael C, 2010, CULT HEALTH SEX, V12, P263, DOI 10.1080/13691050903359265; Medew J, 2007, AGE             0428; Metlikovec J, 2007, HERALD SUN      0414; Monno L, 2005, J MED VIROL, V75, P483, DOI 10.1002/jmv.20300; Op de Coul ELM, 1998, AIDS, V12, P1253, DOI 10.1097/00002030-199810000-00024; Palmer R., 2009, DIVERSITY HLTH CARE, V6, P109; Papathanasopoulos MA, 2003, VIRUS GENES, V26, P151, DOI 10.1023/A:1023435429841; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Ramsey PG, 1998, AM J MED, V104, P152, DOI 10.1016/S0002-9343(97)00310-0; Ryan CE, 2004, AIDS RES HUM RETROV, V20, P1364, DOI 10.1089/aid.2004.20.1364; Ryan CE, 2007, AIDS RES HUM RETROV, V23, P941, DOI 10.1089/aid.2007.0043; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2650, DOI 10.1001/jama.267.19.2650; Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The Kirby Institute, 2012, HIV VIR HEP SEX TRAN; von Wyl V, 2011, J INFECT DIS, V204, P1095, DOI 10.1093/infdis/jir491; Yebra G, 2009, AIDS RES HUM RETROV, V25, P37, DOI 10.1089/aid.2008.0134; Yirrell DL, 1999, SEX TRANSM INFECT, V75, P392, DOI 10.1136/sti.75.6.392	53	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84008	10.1371/journal.pone.0084008	http://dx.doi.org/10.1371/journal.pone.0084008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391866	Green Published, gold, Green Accepted			2022-12-27	WOS:000329323900009
J	Liang, J; Zhou, MQ; Zhou, X; Jin, YJ; Xu, M; Lin, J				Liang, Jing; Zhou, Mingqi; Zhou, Xin; Jin, Yuanjie; Xu, Ming; Lin, Juan			JcLEA, a Novel LEA-Like Protein from Jatropha curcas, Confers a High Level of Tolerance to Dehydration and Salinity in Arabidopsis thaliana	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; PLANT CRATEROSTIGMA-PLANTAGINEUM; FUNCTIONAL-CHARACTERIZATION; MOLECULAR RESPONSES; DESICCATION STRESS; DROUGHT TOLERANCE; GENE-EXPRESSION; WATER-DEFICIT; STABILIZATION; NEMATODE	Jatropha curcas L. is a highly drought and salt tolerant plant species that is typically used as a traditional folk medicine and biofuel crop in many countries. Understanding the molecular mechanisms that underlie the response to various abiotic environmental stimuli, especially to drought and salt stresses, in J. curcas could be important to crop improvement efforts. In this study, we cloned and characterized the gene for a late embryogenesis abundant (LEA) protein from J. curcas that we designated JcLEA. Sequence analyses showed that the JcLEA protein belongs to group 5, a subgroup of the LEA protein family. In young seedlings, expression of JcLEA is significantly induced by abscisic acid (ABA), dehydration, and salt stress. Subcellular localization analysis shows that that JcLEA protein is distributed in both the nucleus and cytoplasm. Moreover, based on growth status and physiological indices, the overexpression of JcLEA in transgenic Arabidopsis plants conferred increased resistance to both drought and salt stresses compared to the WT. Our data suggests that the group 5 JcLEA protein contributes to drought and salt stress tolerance in plants. Thus, JcLEA is a potential candidate gene for plant genetic modification.	[Liang, Jing; Zhou, Mingqi; Zhou, Xin; Jin, Yuanjie; Xu, Ming; Lin, Juan] Fudan Univ, Sch Life Sci, Inst Plant Biol, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University	Lin, J (corresponding author), Fudan Univ, Sch Life Sci, Inst Plant Biol, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	linjuan@fudan.edu.cn	Zhou, Mingqi/P-1305-2019; Zhou, Xin/B-9779-2012; Zhou, Mingqi/C-4693-2015	Zhou, Mingqi/0000-0002-4605-5467; Zhou, Xin/0000-0001-8089-4507; Zhou, Mingqi/0000-0002-4605-5467; Lin, Juan/0000-0002-8608-9370	Natural Science Foundation of China [31170287]; Major Program for the Fundamental Research of Shanghai, China [09JC1401700]; National High Technology Research and Development Program of China [2008AA10Z105]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program for the Fundamental Research of Shanghai, China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The authors are grateful for the financial support from the Natural Science Foundation of China (31170287)((sic)560000), the Major Program for the Fundamental Research of Shanghai, China (09JC1401700)((sic)300000) and the National High Technology Research and Development Program of China (2008AA10Z105) ((sic)500000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba' S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-39; Arenas-Mena C, 1999, PLANT MOL BIOL, V40, P355, DOI 10.1023/A:1006219315562; BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Bolen D W, 2001, Methods Mol Biol, V168, P17; Borovskii Genadii B, 2002, BMC Plant Biol, V2, P5, DOI 10.1186/1471-2229-2-5; Boudet J, 2006, PLANT PHYSIOL, V140, P1418, DOI 10.1104/pp.105.074039; BRAY EA, 1993, PLANT PHYSIOL, V103, P1035, DOI 10.1104/pp.103.4.1035; Bray EA, 1994, STRESS INDUCED GENE, P1; Browne JA, 2004, EUKARYOT CELL, V3, P966, DOI 10.1128/EC.3.4.966-975.2004; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Checker VG, 2012, TRANSGENIC RES, V21, P939, DOI 10.1007/s11248-011-9577-8; Cheng ZQ, 2002, MOL BREEDING, V10, P71, DOI 10.1023/A:1020329401191; CLOSE TJ, 1993, PLANT PHYSIOL, V101, P773, DOI 10.1104/pp.101.3.773; CUMING AC, 1979, EUR J BIOCHEM, V99, P217, DOI 10.1111/j.1432-1033.1979.tb13248.x; Diaz-Lopez L, 2012, PLANT PHYSIOL BIOCH, V54, P34, DOI 10.1016/j.plaphy.2012.02.005; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; Ghars MA, 2008, J PLANT PHYSIOL, V165, P588, DOI 10.1016/j.jplph.2007.05.014; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Haegeman A, 2009, MOL BIOCHEM PARASIT, V167, P32, DOI 10.1016/j.molbiopara.2009.04.004; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He S, 2012, MOL GENET GENOMICS, V287, P39, DOI 10.1007/s00438-011-0660-x; Huang Jing, 2009, Sichuan Daxue Xuebao (Ziran Kexueban), V46, P223; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; ITURRIAGA G, 1992, PLANT MOL BIOL, V20, P555, DOI 10.1007/BF00040614; Jiao JY, 2011, ACTA ECOLOGICA SINIC, V30, P4460; Karakas B, 1997, PLANT CELL ENVIRON, V20, P609, DOI 10.1111/j.1365-3040.1997.00132.x; Kaye C, 1998, PLANT PHYSIOL, V116, P1367, DOI 10.1104/pp.116.4.1367; Kim HS, 2005, GENE, V344, P115, DOI 10.1016/j.gene.2004.09.012; KIYOSUE T, 1992, PLANT MOL BIOL, V19, P239, DOI 10.1007/BF00027345; Lin Sha, 2008, Chinese Journal of Applied and Environmental Biology, V14, P692, DOI 10.3724/SP.J.1145.2008.00692; LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021; Mastan SG, 2012, GENE, V508, P125, DOI 10.1016/j.gene.2012.07.063; Park SC, 2011, PLANTA, V233, P621, DOI 10.1007/s00425-010-1326-3; PIATKOWSKI D, 1990, PLANT PHYSIOL, V94, P1682, DOI 10.1104/pp.94.4.1682; PLA M, 1991, MOL GEN GENET, V230, P394, DOI 10.1007/BF00280296; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Shih MD, 2008, ADV BOT RES, V48, P211, DOI 10.1016/S0065-2296(08)00404-7; Silva EN, 2010, ENVIRON EXP BOT, V69, P279, DOI 10.1016/j.envexpbot.2010.05.001; Sivamani E, 2000, PLANT SCI, V155, P1, DOI 10.1016/S0168-9452(99)00247-2; Solomon A, 2000, PARASITOLOGY, V121, P409, DOI 10.1017/S0031182099006563; Staden R, 2001, METHOD BIOCHEM ANAL, V43, P302; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Tyson T, 2007, INT J PARASITOL, V37, P763, DOI 10.1016/j.ijpara.2006.12.015; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Warner AH, 2010, J BIOCHEM, V148, P581, DOI 10.1093/jb/mvq091; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Wu LH, 2012, J PLANT PHYSIOL, V169, P1408, DOI 10.1016/j.jplph.2012.05.016; Xie GF, 1997, BIOPHYS CHEM, V64, P25, DOI 10.1016/S0301-4622(96)02222-3; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Yang HP, 1996, PHYSIOL PLANTARUM, V98, P661, DOI 10.1111/j.1399-3054.1996.tb05724.x; Yin ZM, 2006, PLANT SCI, V170, P1164, DOI 10.1016/j.plantsci.2006.02.002; Zegzouti H, 1997, PLANT MOL BIOL, V35, P847, DOI 10.1023/A:1005860302313; Zhou MQ, 2012, MOL BREEDING, V30, P1611, DOI 10.1007/s11032-012-9744-5; Zhou MQ, 2012, MOL BIOL REP, V39, P5169, DOI 10.1007/s11033-011-1313-1; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2	61	30	31	0	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83056	10.1371/journal.pone.0083056	http://dx.doi.org/10.1371/journal.pone.0083056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391737	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200034
J	Mattsson, N; Insel, P; Tosun, D; Zhang, J; Jack, CR; Galasko, D; Weiner, M				Mattsson, Niklas; Insel, Philip; Tosun, Duygu; Zhang, Jing; Jack, Clifford R., Jr.; Galasko, Douglas; Weiner, Michael		Alzheimer's Dis Neuroimaging	Effects of Baseline CSF alpha-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							LEWY BODIES; CEREBROSPINAL-FLUID; FOCAL ATROPHY; DEMENTIA; MRI; BIOMARKERS; PATTERNS; ADNI; TAU	Background: Cerebrospinal fluid (CSF) alpha-synuclein is reduced in synucleinopathies, including dementia with Lewy bodies, and some studies have found increased CSF alpha-synuclein in Alzheimer's disease (AD). No study has explored effects of CSF alpha-synuclein on brain atrophy. Here we tested if baseline CSF alpha-synuclein affects brain atrophy rates and if these effects vary across brain regions, and across the cognitive spectrum from healthy elders (NL), to patients with mild cognitive impairment (MCI) and AD. Methods: Baseline CSF alpha-synuclein measurements and longitudinal structural brain magnetic resonance imaging was performed in 74 NL, 118 MCI patients and 55 AD patients. Effects of baseline CSF alpha-synuclein on regional atrophy rates were tested in 1) four pre-hoc defined regions possibly associated with Lewy body and/or AD pathology (amygdala, caudate, hippocampus, brainstem), and 2) all available regions of interest. Differences across diagnoses were tested by assessing the interaction of CSF alpha-synuclein and diagnosis (testing NL versus MCI, and NL versus AD). Results: The effects of CSF alpha-synuclein on longitudinal atrophy rates were not significant after correction for multiple comparisons. There were tendencies for effects in AD in caudate (higher atrophy rates in subjects with higher CSF alpha-synuclein, P=0.046) and brainstem (higher atrophy rates in subjects with lower CSF alpha-synuclein, P=0.063). CSF alpha-synuclein had significantly different effects on atrophy rates in NL and AD in brainstem (P=0.037) and caudate (P=0.006). Discussion: With the possible exception of caudate and brainstem, the overall weak effects of CSF alpha-synuclein on atrophy rates in NL, MCI and AD argues against CSF alpha-synuclein as a biomarker related to longitudinal brain atrophy in these diagnostic groups. Any effects of CSF alpha-synuclein may be attenuated by possible simultaneous occurrence of AD-related neuronal injury and concomitant Lewy body pathology, which may elevate and reduce CSF alpha-synuclein levels, respectively.	[Mattsson, Niklas; Insel, Philip; Tosun, Duygu; Weiner, Michael] Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Mattsson, Niklas] Univ Gothenburg, Clin Neurochem Lab, Inst Neurosci & Physiol, Sahlgrenska Acad, Molndal, Sweden; [Mattsson, Niklas; Tosun, Duygu; Weiner, Michael] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Zhang, Jing] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Galasko, Douglas] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of Gothenburg; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Mayo Clinic; University of California System; University of California San Diego	Mattsson, N (corresponding author), Ctr Imaging Neurodegenerat Dis, Dept Vet Affairs Med Ctr, San Francisco, CA USA.	niklas.mattsson@neuro.gu.se	Hsiung, Robin/AAT-1661-2021; Levey, Allan/F-2104-2011; Preda, Adrian/K-8889-2013; Jack, Clifford R/F-2508-2010; Mattsson-Carlgren, Niklas/H-7597-2019	Hsiung, Robin/0000-0002-8017-0856; Levey, Allan/0000-0002-3153-502X; Preda, Adrian/0000-0003-3373-2438; Jack, Clifford R/0000-0001-7916-622X; Mattsson-Carlgren, Niklas/0000-0002-8885-7724; Ponto, Laura/0000-0003-1197-6714; Tosun, Duygu/0000-0001-8644-7724	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Northern California Institute for Research and Education; National Institutes of Health (NIH) [P30 AG010129, K01 AG030514]; NIH [R01-AG011378, RO1-AG041851, RO1-AG037551, U01-HL096917, U01-AG032438, U01-AG024904, PO1 AGO5131, U01 AG1048, P01AG020206]; Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation; Michael J. Fox Foundation; Alzheimer's Drug Discovery Foundation; Swedish Research Council; Goteborgs Lakaresallskap; Svenska Lakaresallskapet; Sahlgrenska Universitetssjukhuset; Carl-Bertil Laurells fond; Klinisk Biokemi i Norden; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL096917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004696, P30ES007033, R01ES016873, R01ES019277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS062684, R01NS057567, U01NS082137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020206, P50AG005131, U24AG021886, R01AG041851, R01AG037551, R01AG011378, P30AG013846, R01AG033398, P30AG010129, U01AG024904, P50AG008702, K01AG030514] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Northern California Institute for Research and Education; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation; Michael J. Fox Foundation; Alzheimer's Drug Discovery Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Goteborgs Lakaresallskap; Svenska Lakaresallskapet; Sahlgrenska Universitetssjukhuset; Carl-Bertil Laurells fond; Klinisk Biokemi i Norden; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by National Institutes of Health (NIH) grants P30 AG010129 and K01 AG030514. MW receives research funding from the NIH (R01-AG011378, RO1-AG041851, RO1-AG037551, U01-HL096917, U01-AG032438, U01-AG024904), and the Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation. DG receives research funding from Michael J. Fox Foundation, Alzheimer's Drug Discovery Foundation, and the NIH (PO1 AGO5131; U01 AG1048; P01AG020206). JZ receives research funding from Michael J. Fox Foundation as well as NIH grants (ES004696-5897, ES007033-6364, AG033398, ES016873, ES019277, NS057567, NS062684-6221 and NS082137). NM receives research funding from the Swedish Research Council, Goteborgs Lakaresallskap, Svenska Lakaresallskapet, Sahlgrenska Universitetssjukhuset, Carl-Bertil Laurells fond, and Klinisk Biokemi i Norden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2001, BRAIN RES, V888, P287, DOI 10.1016/S0006-8993(00)03082-1; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bozzali M, 2005, BRAIN, V128, P1595, DOI 10.1093/brain/awh493; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Hall S, 2012, ARCH NEUROL-CHICAGO, V69, P1445, DOI 10.1001/archneurol.2012.1654; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Kantarci K, 2012, NEUROLOGY, V79, P553, DOI 10.1212/WNL.0b013e31826357a5; Korff A, 2013, J ALZHEIMERS DIS, V36, P679, DOI 10.3233/JAD-130458; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Mattsson N, 2014, NEUROBIOL AGING, V35, P614, DOI 10.1016/j.neurobiolaging.2013.08.027; Mollenhauer B, 2008, EXP NEUROL; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Olichney JM, 1998, NEUROLOGY, V51, P351, DOI 10.1212/WNL.51.2.351; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Reesink FE, 2010, J ALZHEIMERS DIS, V22, P87, DOI 10.3233/JAD-2010-100186; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Tateno F, 2012, ALZ DIS ASSOC DIS, V26, P213, DOI 10.1097/WAD.0b013e31823899cc; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Toledo JB, 2013, ACTA NEUROPATHOL, V126, P683, DOI 10.1007/s00401-013-1148-z; Tosun D, 2011, J ALZHEIMERS DIS, V26, P77, DOI 10.3233/JAD-2011-0006; Watson R, 2012, INT PSYCHOGERIATR, V24, P532, DOI 10.1017/S1041610211002171; Wennstrom M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053250, 10.1371/journal.pone.0109387]; Whitwell JL, 2007, BRAIN, V130, P708, DOI 10.1093/brain/awl388; Zaccai J, 2008, NEUROLOGY, V70, P1042, DOI 10.1212/01.wnl.0000306697.48738.b6	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85443	10.1371/journal.pone.0085443	http://dx.doi.org/10.1371/journal.pone.0085443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392009	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900153
J	Ogmen, H; Ekiz, O; Huynh, D; Bedell, HE; Tripathy, SP				Oegmen, Haluk; Ekiz, Onur; Huynh, Duong; Bedell, Harold E.; Tripathy, Srimant P.			Bottlenecks of Motion Processing during a Visual Glance: The Leaky Flask Model	PLOS ONE			English	Article							SHORT-TERM-MEMORY; MULTIPLE OBJECT TRACKING; WORKING-MEMORY; ICONIC MEMORY; ARTICULATORY SUPPRESSION; POSITIONAL INFORMATION; SELECTIVE ATTENTION; CAPACITY LIMITS; DIRECTION; DISTRACTION	Where do the bottlenecks for information and attention lie when our visual system processes incoming stimuli? The human visual system encodes the incoming stimulus and transfers its contents into three major memory systems with increasing time scales, viz., sensory (or iconic) memory, visual short-term memory (VSTM), and long-term memory (LTM). It is commonly believed that the major bottleneck of information processing resides in VSTM. In contrast to this view, we show major bottlenecks for motion processing prior to VSTM. In the first experiment, we examined bottlenecks at the stimulus encoding stage through a partial-report technique by delivering the cue immediately at the end of the stimulus presentation. In the second experiment, we varied the cue delay to investigate sensory memory and VSTM. Performance decayed exponentially as a function of cue delay and we used the time-constant of the exponential-decay to demarcate sensory memory from VSTM. We then decomposed performance in terms of quality and quantity measures to analyze bottlenecks along these dimensions. In terms of the quality of information, two thirds to three quarters of the motion-processing bottleneck occurs in stimulus encoding rather than memory stages. In terms of the quantity of information, the motion-processing bottleneck is distributed, with the stimulus-encoding stage accounting for one third of the bottleneck. The bottleneck for the stimulus-encoding stage is dominated by the selection compared to the filtering function of attention. We also found that the filtering function of attention is operating mainly at the sensory memory stage in a specific manner, i.e., influencing only quantity and sparing quality. These results provide a novel and more complete understanding of information processing and storage bottlenecks for motion processing.	[Oegmen, Haluk; Ekiz, Onur; Huynh, Duong] Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA; [Oegmen, Haluk; Bedell, Harold E.] Univ Houston, Ctr Neuroengn & Cognit Sci, Houston, TX USA; [Bedell, Harold E.] Univ Houston, Coll Optometry, Houston, TX USA; [Tripathy, Srimant P.] Univ Bradford, Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Bradford	Ogmen, H (corresponding author), Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA.	ogmen@uh.edu	Ogmen, Haluk/C-4739-2018	Ogmen, Haluk/0000-0002-5369-1752; Tripathy, Srimant/0000-0002-2988-6840	National Institutes of Health (NIH) [R01 EY018165, P30 EY007551]; NATIONAL EYE INSTITUTE [R01EY018165, P30EY007551] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by R01 EY018165 and P30 EY007551 from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Alvarez GA, 2007, J VISION, V7, DOI 10.1167/7.13.14; Averbach E, 1961, INFORMATION THEORY, P196; Baddeley A., WORKING MEMORY THOUG, DOI [10.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Blake R, 1997, J EXP PSYCHOL HUMAN, V23, P353, DOI 10.1037/0096-1523.23.2.353; Bradley C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00355; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; COLTHEART M, 1983, PHILOS T ROY SOC B, V302, P283, DOI 10.1098/rstb.1983.0055; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Cowan N., 2005, WORKING MEMORY CAPAC, DOI [10.4324/9780203342398, DOI 10.4324/9780203342398]; Cowan N, 2010, CURR DIR PSYCHOL SCI, V19, P51, DOI 10.1177/0963721409359277; d'Avossa G, 2006, VISION RES, V46, P3403, DOI 10.1016/j.visres.2006.04.018; DEMKIW P, 1976, ACTA PSYCHOL, V40, P257, DOI 10.1016/0001-6918(76)90029-9; Dolcos F, 2007, BRAIN RES, V1152, P171, DOI 10.1016/j.brainres.2007.03.059; Fehd HM, 2008, COGNITION, V108, P201, DOI 10.1016/j.cognition.2007.11.008; Fehd HM, 2010, J VISION, V10, DOI 10.1167/10.4.19; Fencsik DE, 2007, PERCEPT PSYCHOPHYS, V69, P567, DOI 10.3758/BF03193914; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; GEGENFURTNER KR, 1993, J EXP PSYCHOL HUMAN, V19, P845, DOI 10.1037/0096-1523.19.4.845; Graziano M, 2008, J VISION, V8, DOI 10.1167/8.5.9; HABER RN, 1983, BEHAV BRAIN SCI, V6, P1, DOI 10.1017/S0140525X0001428X; HABER RN, 1969, Q J EXP PSYCHOL, V21, P43, DOI 10.1080/14640746908400193; HABER RN, 1970, CAN J PSYCHOLOGY, V24, P216, DOI 10.1037/h0082858; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Holcombe AO, 2013, J VISION, V13, DOI 10.1167/13.1.12; Hollingworth A, 2009, COGNITION, V113, P150, DOI 10.1016/j.cognition.2009.08.004; Horowitz TS, 2010, ATTEN PERCEPT PSYCHO, V72, P1765, DOI 10.3758/APP.72.7.1765; Howe PDL, 2012, J VISION, V12, DOI 10.1167/12.13.10; Huang J, 2010, J NEUROSCI, V30, P13461, DOI 10.1523/JNEUROSCI.2560-10.2010; Larsen JD, 2003, Q J EXP PSYCHOL-A, V56, P1249, DOI 10.1080/02724980244000765; Lu ZL, 2005, P NATL ACAD SCI USA, V102, P1797, DOI 10.1073/pnas.0408402102; MAGNUSSEN S, 1992, J EXP PSYCHOL LEARN, V18, P151, DOI 10.1037/0278-7393.18.1.151; Makovski T, 2007, PSYCHON B REV, V14, P1072, DOI 10.3758/BF03193093; Makovski T, 2012, PSYCHON B REV, V19, P470, DOI 10.3758/s13423-012-0235-9; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Matsukura M, 2011, PSYCHON B REV, V18, P1098, DOI 10.3758/s13423-011-0153-2; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; Narasimhan S, 2009, VISION RES, V49, P10, DOI 10.1016/j.visres.2008.09.023; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; PALMER J, 1990, J EXP PSYCHOL HUMAN, V16, P332, DOI 10.1037/0096-1523.16.2.332; Pasternak T, 2005, NAT REV NEUROSCI, V6, P97, DOI [10.1038/nrn1603, 10.1038/nrn1637]; Pasternak T, 2003, J NEUROPHYSIOL, V90, P2757, DOI 10.1152/jn.00422.2003; Persuh M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00126; Polk TA, 2008, J NEUROSCI, V28, P13786, DOI 10.1523/JNEUROSCI.1026-08.2008; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; RICHARDSON JTE, 1975, J VERB LEARN VERB BE, V14, P623, DOI 10.1016/S0022-5371(75)80049-1; Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Shooner C, 2010, J VISION, V10, DOI 10.1167/10.6.8; Sligte IG, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00175; Sligte IG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001699; Smith WS, 2011, Q J EXP PSYCHOL, V64, P767, DOI 10.1080/17470218.2010.511237; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Sreenivasan KK, 2007, J COGNITIVE NEUROSCI, V19, P32, DOI 10.1162/jocn.2007.19.1.32; Tombu MN, 2011, P NATL ACAD SCI USA, V108, P13426, DOI 10.1073/pnas.1103583108; TREISMAN A, 1975, ATTENTION PERFORM, V5, P699; Tripathy S. P., 2011, ATTENTION PHILOS PSY, P117; Tripathy S. P., 2012, SCHOLARPEDIA, V7, P11287, DOI DOI 10.4249/SCHOLARPEDIA.11287; Tripathy SP, 2004, J VISION, V4, P1020, DOI 10.1167/4.12.4; Tripathy SP, 2007, J VISION, V7, DOI 10.1167/7.6.2; Tsubomi H, 2013, J NEUROSCI, V33, P8257, DOI 10.1523/JNEUROSCI.5348-12.2013; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y; Yoon JH, 2006, NEUROIMAGE, V29, P1117, DOI 10.1016/j.neuroimage.2005.08.024; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zhang WW, 2009, PSYCHOL SCI, V20, P423, DOI 10.1111/j.1467-9280.2009.02322.x	77	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83671	10.1371/journal.pone.0083671	http://dx.doi.org/10.1371/journal.pone.0083671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391806	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200104
J	Qi, LN; Li, LQ; Chen, YY; Chen, ZH; Bai, T; Xiang, BD; Qin, X; Xiao, KY; Peng, MH; Liu, ZM; Liu, TW; Qin, X; Li, S; Han, ZG; Mo, ZN; Santella, RM; Winkler, CA; O'Brien, SJ; Peng, T				Qi, Lu-Nan; Li, Le-Qun; Chen, Yuan-Yuan; Chen, Zhao-Hong; Bai, Tao; Xiang, Bang-De; Qin, Xiao; Xiao, Kai-Yin; Peng, Min-Hao; Liu, Zhi-Ming; Liu, Tang-Wei; Qin, Xue; Li, Shan; Han, Ze-Guang; Mo, Zeng-Nan; Santella, Regina M.; Winkler, Cheryl A.; O'Brien, Stephen J.; Peng, Tao			Genome-Wide and Differential Proteomic Analysis of Hepatitis B Virus and Aflatoxin B1 Related Hepatocellular Carcinoma in Guangxi, China	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; RISK-FACTORS; DNA DOMAIN; AKR1B10; EXPRESSION; OVEREXPRESSION; HYBRIDIZATION; ABERRATIONS; TP53; MUTATIONS	Both hepatitis B virus (HBV) and aflatoxin B1 (AFB1) exposure can cause liver damage as well as increase the probability of hepatocellular carcinoma (HCC). To investigate the underlying genetic changes that may influence development of HCC associated with HBV infection and AFB1 exposure, HCC patients were subdivided into 4 groups depending upon HBV and AFB1 exposure status: (HBV(+)/AFB1(+), HBV(+)/AFB1(-), HBV(-)/AFB1(+), HBV(-)/AFB1(-)). Genetic abnormalities and protein expression profiles were analyzed by array-based comparative genomic hybridization and isobaric tagging for quantitation. A total of 573 chromosomal aberrations (CNAs) including 184 increased and 389 decreased were detected in our study population. Twenty-five recurrently altered regions (RARs; chromosomal alterations observed in >= 10 patients) in chromosomes were identified. Loss of 4q13.3-q35.2, 13q12.1-q21.2 and gain of 7q11.2-q35 were observed with a higher frequency in the HBV(+)/AFB1(+), HBV(+)/AFB1(-) and HBV(-)/AFB1(+) groups compared to the HBV(-)/AFB(-) group. Loss of 8p12-p23.2 was associated with high TNM stage tumors (P = 0.038) and was an unfavorable prognostic factor for tumor-free survival (P =0.045). A total of 133 differentially expressed proteins were identified in iTRAQ proteomics analysis, 69 (51.8%) of which mapped within identified RARs. The most common biological processes affected by HBV and AFB1 status in HCC tumorigenesis were detoxification and drug metabolism pathways, antigen processing and anti-apoptosis pathways. Expression of AKR1B10 was increased significantly in the HBV(+)/AFB1(+) and HBV(-)/AFB1(+) groups. A significant correlation between the expression of AKR1B10 mRNA and protein levels as well as AKR1B10 copy number was observered, which suggest that AKR1B10 may play a role in AFB1-related hepatocarcinogenesis. In summary, a number of genetic and gene expression alterations were found to be associated with HBV and AFB1- related HCC. The possible synergistic effects of HBV and AFB1 in hepatocarcinogenesis warrant further investigations.	[Qi, Lu-Nan; Li, Le-Qun; Chen, Zhao-Hong; Bai, Tao; Xiang, Bang-De] Guangxi Med Univ, Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Guangxi Provinc, Peoples R China; [Chen, Yuan-Yuan] Guangxi Med Univ, Affiliated Hosp 1, Dept Ultrasound, Nanning, Guangxi Provinc, Peoples R China; [Qin, Xiao; Xiao, Kai-Yin; Peng, Min-Hao; Liu, Zhi-Ming; Liu, Tang-Wei; Peng, Tao] Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Guangxi Provinc, Peoples R China; [Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi Provinc, Peoples R China; [Han, Ze-Guang] China Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China; [Mo, Zeng-Nan] Guangxi Med Univ, Affiliated Hosp 1, Dept Urol & Nephrol Surg, Nanning, Guangxi Provinc, Peoples R China; [Santella, Regina M.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Winkler, Cheryl A.; O'Brien, Stephen J.; Peng, Tao] NCI, Lab Genom Divers, NIH, Frederick, MD 21701 USA	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peng, T (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Guangxi Provinc, Peoples R China.	pengtaocn@hotmail.com	LI, LI QING/GRR-8855-2022; li, li/HII-4157-2022; Chen, Yuanyuan/GXG-2130-2022; Li, Li/AEM-3636-2022; OBRIEN, STEPHEN/ABD-1346-2020; LI, LI/GVS-5344-2022	Han, Ze-Guang/0000-0002-1018-1752; O'Brien, Stephen J./0000-0001-7353-8301; mo, zengnan/0000-0002-3047-3138; OBRIEN, STEPHEN/0000-0001-7857-0757	National Nature Science Foundation of China [NSFC 81072321, 30960021, 30460143, 30560133]; Program for New Century Excellent Talents in University (NCET, Chinese Ministry of Educationministry of educationministry of education); Guangxi Nature Sciences [GKJ 0236030, 0632007-1E, 0640101, GKG 0592007-1A]; Guangxi Health Ministry Medicine [Z2010108]; USA National Institutes of Health [ES05116, ES09089]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005116, P30ES009089] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET, Chinese Ministry of Educationministry of educationministry of education); Guangxi Nature Sciences; Guangxi Health Ministry Medicine; USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the National Nature Science Foundation of China (NSFC 81072321, 30960021, 30460143, and 30560133), Program for New Century Excellent Talents in University (NCET, 2009 Chinese Ministry of Educationministry of educationministry of education), Guangxi Nature Sciences Grant (GKJ 0236030,0632007-1E, 0640101, GKG 0592007-1A), Guangxi Health Ministry Medicine Grant (Z2010108), and the USA National Institutes of Health Grants (ES05116 and ES09089). The authors thank Ms. Li Guan and Yu-Chun Zhou (Laboratory of Genomic Diversity, National Cancer Institute at Frederick, USA) and Mr. Li Jia Quan (Laboratory Center, GMU, China) for their laboratory assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bedard LL, 2006, CANCER LETT, V241, P174, DOI 10.1016/j.canlet.2005.11.018; Besaratinia A, 2009, GASTROENTEROLOGY, V137, P1127, DOI 10.1053/j.gastro.2009.06.002; Blagosklonny MV, 2001, J NATL CANCER I, V93, P239, DOI 10.1093/jnci/93.3.239-a; BLANQUET V, 1988, HUM GENET, V80, P274, DOI 10.1007/BF01790096; BUETOW KH, 1989, P NATL ACAD SCI USA, V86, P8852, DOI 10.1073/pnas.86.22.8852; Cabibbo G, 2010, EUR REV MED PHARMACO, V14, P352; Chung YT, 2012, MODERN PATHOL, V25, P758, DOI 10.1038/modpathol.2011.191; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Gao J, 2012, ASIAN PAC J CANCER P, V13, P743, DOI 10.7314/APJCP.2012.13.3.743; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Gouas D, 2009, CANCER LETT, V286, P29, DOI 10.1016/j.canlet.2009.02.057; Gupta S.D., 2010, CHEM-BIOL INTERACT, V183, P293, DOI DOI 10.1016/J.CBI.2009.11.006.PUBMED:19913524; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Helmbrecht K, 2000, CELL PROLIFERAT, V33, P341, DOI 10.1046/j.1365-2184.2000.00189.x; Hu JM, 1996, P NATL ACAD SCI USA, V93, P1060, DOI 10.1073/pnas.93.3.1060; Iizuka N, 2002, CANCER RES, V62, P3939; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Jackson PE, 1999, BEST PRACT RES CL GA, V13, P545, DOI 10.1053/bega.1999.0047; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang MW, 2011, J INT MED RES, V39, P78, DOI 10.1177/147323001103900110; Katiyar S, 2000, CANCER, V88, P1565, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1565::AID-CNCR10>3.0.CO;2-9; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; Kim W, 2003, CLIN CANCER RES, V9, P5493; Lebret T, 2003, CANCER, V98, P970, DOI 10.1002/cncr.11594; Li CP, 2008, PATHOL RES PRACT, V204, P295, DOI 10.1016/j.prp.2006.12.012; Liu ZM, 2008, CANCER LETT, V263, P212, DOI 10.1016/j.canlet.2008.01.006; MCGLYNN KA, 1995, P NATL ACAD SCI USA, V92, P2384, DOI 10.1073/pnas.92.6.2384; Moinzadeh P, 2005, BRIT J CANCER, V92, P935, DOI 10.1038/sj.bjc.6602448; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; PASQUINELLI C, 1988, J VIROL, V62, P629, DOI 10.1128/JVI.62.2.629-632.1988; Patil MA, 2005, CARCINOGENESIS, V26, P2050, DOI 10.1093/carcin/bgi178; Paul C, 2010, EXP CELL RES, V316, P1535, DOI 10.1016/j.yexcr.2010.03.006; Pomara G, 2003, J UROLOGY, V170, P927, DOI 10.1097/01.ju.0000080564.23671.32; Qin LX, 2001, J CANCER RES CLIN, V127, P482, DOI 10.1007/s004320100236; Shirabe K, 2011, LIVER INT, V31, P1366, DOI 10.1111/j.1478-3231.2011.02572.x; Staib F, 2003, HUM MUTAT, V21, P201, DOI 10.1002/humu.10176; Su Q, 2000, MUTAT RES-REV MUTAT, V462, P365, DOI 10.1016/S1383-5742(00)00026-0; Sun W, 2007, MOL CELL PROTEOMICS, V6, P1798, DOI 10.1074/mcp.M600449-MCP200; Taniguchi K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-530; van Noort JM, 2012, INT J BIOCHEM CELL B, V44, P1670, DOI 10.1016/j.biocel.2011.12.010; Varma G, 2005, BRIT J CANCER, V93, P699, DOI 10.1038/sj.bjc.6602784; Wang C, 2009, J BIOL CHEM, V284, P26742, DOI 10.1074/jbc.M109.022897; Wild CP, 2002, MUTAGENESIS, V17, P471, DOI 10.1093/mutage/17.6.471; Wong N, 2000, CLIN CANCER RES, V6, P4000; Xue Kai-Xian, 2005, Ai Zheng, V24, P757; YEH FS, 1989, CANCER RES, V49, P2506; Zhong LL, 2011, TOXICOL APPL PHARM, V255, P40, DOI 10.1016/j.taap.2011.05.014; Zhou TL, 1997, CANCER RES, V57, P2749	49	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83465	10.1371/journal.pone.0083465	http://dx.doi.org/10.1371/journal.pone.0083465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391771	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200068
J	Qualls, DA; Crosby, K; Brown, H; Borchelt, DR				Qualls, David A.; Crosby, Keith; Brown, Hilda; Borchelt, David R.			An Analysis of Interactions between Fluorescently-Tagged Mutant and Wild-Type SOD1 in Intracellular Inclusions	PLOS ONE			English	Article							AGGREGATION; COPPER	Background: By mechanisms yet to be discerned, the co-expression of high levels of wild-type human superoxide dismutase 1 (hSOD1) with variants of hSOD1 encoding mutations linked familial amyotrophic lateral sclerosis (fALS) hastens the onset of motor neuron degeneration in transgenic mice. Although it is known that spinal cords of paralyzed mice accumulate detergent insoluble forms of WT hSOD1 along with mutant hSOD1, it has been difficult to determine whether there is co-deposition of the proteins in inclusion structures. Methodology/Principal Findings: In the present study, we use cell culture models of mutant SOD1 aggregation, focusing on the A4V, G37R, and G85R variants, to examine interactions between WT-hSOD1 and misfolded mutant SOD1. In these studies, we fuse WT and mutant proteins to either yellow or red fluorescent protein so that the two proteins can be distinguished within inclusions structures. Conclusions/Significance: Although the interpretation of the data is not entirely straightforward because we have strong evidence that the nature of the fused fluorophores affects the organization of the inclusions that form, our data are most consistent with the idea that normal dimeric WT-hSOD1 does not readily interact with misfolded forms of mutant hSOD1. We also demonstrate the monomerization of WT-hSOD1 by experimental mutation does induce the protein to aggregate, although such monomerization may enable interactions with misfolded mutant SOD1. Our data suggest that WT-hSOD1 is not prone to become intimately associated with misfolded mutant hSOD1 within intracellular inclusions that can be generated in cultured cells.	[Qualls, David A.; Crosby, Keith; Brown, Hilda; Borchelt, David R.] Univ Florida, Coll Med, Dept Neurosci,SantaFe HealthCare Alzheimers Dis R, Ctr Translat Res Neurodegenerat Dis,McKnight Brai, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Coll Med, Dept Neurosci,SantaFe HealthCare Alzheimers Dis R, Ctr Translat Res Neurodegenerat Dis,McKnight Brai, Gainesville, FL 32610 USA.	drb1@ufl.edu	Qualls, David/GWZ-9672-2022		National Institutes of Neurological Disease and Stroke [P01 NS049134-08]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institutes of Neurological Disease and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by the National Institutes of Neurological Disease and Stroke (P01 NS049134-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; BERTINI I, 1994, EUR BIOPHYS J BIOPHY, V23, P167, DOI 10.1007/BF01007608; BORCHELT DR, 1995, J BIOL CHEM, V270, P3234, DOI 10.1074/jbc.270.7.3234; Callahan J, 2009, BIOMACROMOLECULES, V10, P1704, DOI 10.1021/bm801514x; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2010, ARCH BIOCHEM BIOPHYS, V503, P175, DOI 10.1016/j.abb.2010.07.027; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Prudencio M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-77; Prudencio M, 2010, HUM MOL GENET, V19, P4774, DOI 10.1093/hmg/ddq408; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Stevens JC, 2010, PLOS ONE, V5, pA8, DOI 10.1371/journal.pone.0009541; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503	15	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83981	10.1371/journal.pone.0083981	http://dx.doi.org/10.1371/journal.pone.0083981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391857	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200155
J	Terra, R; Wang, XH; Hu, Y; Charpentier, T; Lamarre, A; Zhong, M; Sun, H; Mao, JN; Qi, SJ; Luo, HY; Wu, JP				Terra, Rafik; Wang, Xuehai; Hu, Yan; Charpentier, Tania; Lamarre, Alain; Zhong, Ming; Sun, Hui; Mao, Jianning; Qi, Shijie; Luo, Hongyu; Wu, Jiangping			To Investigate the Necessity of STRA6 Upregulation in T Cells during T Cell Immune Responses	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; VITAMIN-A-DEFICIENCY; MATTHEW-WOOD-SYNDROME; MICROPHTHALMIA MAPS; MICE LACKING; RECEPTOR; ACID; MUTATIONS; DIFFERENTIATION; ANOPHTHALMIA	Our earlier study revealed that STRA6 (stimulated by retinoic acid gene 6) was up-regulated within 3 h of TCR stimulation. STRA6 is the high-affinity receptor for plasma retinol-binding protein (RBP) and mediates cellular vitamin A uptake. We generated STRA6 knockout (KO) mice to assess whether such up-regulation was critical for T-cell activation, differentiation and function. STRA6 KO mice under vitamin A sufficient conditions were fertile without apparent anomalies upon visual inspection. The size, cellularity and lymphocyte subpopulations of STRA6 KO thymus and spleen were comparable to those of their wild type (WT) controls. KO and WT T cells were similar in terms of TCR-stimulated proliferation in vitro and homeostatic expansion in vivo. Naive KO CD4 cells differentiated in vitro into Th1, Th2, Th17 as well as regulatory T cells in an analogous manner as their WT counterparts. In vivo experiments revealed that anti-viral immune responses to lymphocytic choriomeningitis virus in KO mice were comparable to those of WT controls. We also demonstrated that STRA6 KO and WT mice had similar glucose tolerance. Total vitamin A levels are dramatically lower in the eyes of KO mice as compared to those of WT mice, but the levels in other organs were not significantly affected after STRA6 deletion under vitamin A sufficient conditions, indicating that the eye is the mouse organ most sensitive to the loss of STRA6. Our results demonstrate that 1) in vitamin A sufficiency, the deletion of STRA6 in T cells does no affect the T-cell immune responses so-far tested, including those depend on STAT5 signaling; 2) STRA6-independent vitamin A uptake compensated the lack of STRA6 in lymphoid organs under vitamin A sufficient conditions in mice; 3) STRA6 is critical for vitamin A uptake in the eyes even in vitamin A sufficiency.	[Terra, Rafik; Wang, Xuehai; Hu, Yan; Mao, Jianning; Qi, Shijie; Luo, Hongyu; Wu, Jiangping] Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Lab Immunol, Montreal, PQ H2L 4K8, Canada; [Wu, Jiangping] Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Serv Nephrol, Montreal, PQ H2L 4K8, Canada; [Charpentier, Tania; Lamarre, Alain] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada; [Zhong, Ming; Sun, Hui] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Physiol, Los Angeles, CA 90095 USA	Universite de Montreal; Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Wu, JP (corresponding author), Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Lab Immunol, Montreal, PQ H2L 4K8, Canada.	jianping.wu@umontreal.ca			Canadian Institutes of Health Research [MOP69089, MOP123389, MOP97829, MOP89797]; Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada [203906-2012]; Juvenile Diabetes Research Foundation [17-2013-440]; Fonds de Recherche Quebec-Sante/National Sciences Foundation of China [AG-6]; Jean-Louis Levesque Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Fonds de Recherche Quebec-Sante/National Sciences Foundation of China; Jean-Louis Levesque Foundation	This work was supported by grants from the Canadian Institutes of Health Research to J.W. (MOP69089 and MOP123389), H. L. (MOP97829) and A. L. (MOP89797). It was also made possible by grants from the Heart and Stroke Foundation of Quebec, the Natural Sciences and Engineering Research Council of Canada (203906-2012), Juvenile Diabetes Research Foundation (17-2013-440) and Fonds de Recherche Quebec-Sante/National Sciences Foundation of China to J.W. (AG-6), and the Jean-Louis Levesque Foundation to J.W. and A.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Bavik C, 1996, P NATL ACAD SCI USA, V93, P3110, DOI 10.1073/pnas.93.7.3110; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bessant DAR, 1998, AM J HUM GENET, V62, P1113, DOI 10.1086/301843; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; Casey J, 2011, HUM MUTAT, V32, P1417, DOI 10.1002/humu.21590; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Dong S, 2002, BLOOD, V99, P2637, DOI 10.1182/blood.V99.8.2637; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; GRAHAM CA, 1991, OPHTHALMIC PAED GEN, V12, P43, DOI 10.3109/13816819109023084; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Han B, 2007, ARTHRITIS RHEUM-US, V56, P3748, DOI 10.1002/art.22978; Hmani-Aifa M, 2009, HUM GENET, V126, P575, DOI 10.1007/s00439-009-0688-8; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Luo HY, 2011, J BIOL CHEM, V286, P44976, DOI 10.1074/jbc.M111.316414; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Mao JN, 2006, J BIOL CHEM, V281, P12587, DOI 10.1074/jbc.M600497200; Morle L, 2000, AM J HUM GENET, V67, P1592, DOI 10.1086/316894; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naylor HM, 1999, BIOCHEMISTRY-US, V38, P2647, DOI 10.1021/bi982291i; Ng WY, 2013, CLIN GENET, V83, P162, DOI 10.1111/j.1399-0004.2012.01851.x; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; Quadro L, 2000, J INFECT DIS, V182, pS97, DOI 10.1086/315920; Quadro L, 2003, MOL ASPECTS MED, V24, P421, DOI 10.1016/S0098-2997(03)00038-4; RACKE MK, 1995, J IMMUNOL, V154, P450; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Sommer A, 2008, J NUTR, V138, P1835, DOI 10.1093/jn/138.10.1835; Stephensen CB, 2002, J IMMUNOL, V168, P4495, DOI 10.4049/jimmunol.168.9.4495; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200; Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645	49	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82808	10.1371/journal.pone.0082808	http://dx.doi.org/10.1371/journal.pone.0082808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391722	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000329325200019
J	Zhao, HF; Li, M; Li, LH; Yang, XM; Lan, GB; Zhang, Y				Zhao, Huafu; Li, Mei; Li, Lihua; Yang, Xiaoming; Lan, Guobo; Zhang, Yu			MiR-133b Is Down-Regulated in Human Osteosarcoma and Inhibits Osteosarcoma Cells Proliferation, Migration and Invasion, and Promotes Apoptosis	PLOS ONE			English	Article							COLORECTAL-CANCER; BCL-W; MICRORNA; EXPRESSION; METASTASIS; GROWTH; IDENTIFICATION; SIGNATURES; RECEPTOR; PATHWAY	MicroRNAs (miRNAs) decrease the expression of specific target oncogenes or tumor suppressor genes and thereby play crucial roles in tumorigenesis and tumor growth. To date, the potential miRNAs regulating osteosarcoma growth and progression are not fully identified yet. In this study, the miRNA microarray assay and hierarchical clustering analysis were performed in human osteosarcoma samples. In comparison with normal human skeletal muscle, 43 miRNAs were significantly differentially expressed in human osteosarcomas (fold change >= 2 and p <= 0.05). Among these miRNAs, miR-133a and miR-133b expression was decreased by 135 folds and 47 folds respectively and the decreased expression was confirmed in both frozen and paraffin-embedded osteosarcoma samples. The miR-133b precursor expression vector was then transfected into osteosarcoma cell lines U2-OS and MG-63, and the stable transfectants were selected by puromycin. We found that stable over-expression of miR-133b in osteosarcoma cell lines U2-OS and MG-63 inhibited cell proliferation, invasion and migration, and induced apoptosis. Further, over-expression of miR-133b decreased the expression of predicted target genes BCL2L2, MCL-1, IGF1R and MET, as well as the expression of phospho-Akt and FAK. This study provides a new insight into miRNAs dysregulation in osteosarcoma, and indicates that miR-133b may play as a tumor suppressor gene in osteosarcoma.	[Zhao, Huafu] Liu Hua Qiao Hosp, Dept Med Res, Guangzhou, Guangdong, Peoples R China; [Li, Mei; Li, Lihua; Yang, Xiaoming; Lan, Guobo; Zhang, Yu] Liu Hua Qiao Hosp, Dept Orthoped Surg, Guangzhou, Guangdong, Peoples R China		Zhang, Y (corresponding author), Liu Hua Qiao Hosp, Dept Orthoped Surg, Guangzhou, Guangdong, Peoples R China.	luck_2001@126.com			Guangdong Key Lab of Orthopaedic Technology and Implant Materials Construction [2011233-32]	Guangdong Key Lab of Orthopaedic Technology and Implant Materials Construction	This study is supported by Guangdong Key Lab of Orthopaedic Technology and Implant Materials Construction Grant (No. 2011233-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif M, 2010, CIRC RES, V106, P16, DOI 10.1161/CIRCRESAHA.109.212183; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Boguslawska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024541; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duan ZF, 2011, MOL CANCER THER, V10, P1337, DOI 10.1158/1535-7163.MCT-11-0096; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Holmgreen SP, 1999, CELL DEATH DIFFER, V6, P525, DOI 10.1038/sj.cdd.4400519; Hu G, 2010, CANCER BIOL THER, V10, P190, DOI 10.4161/cbt.10.2.12186; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Ji F, 2013, BONE, V56, P220, DOI 10.1016/j.bone.2013.05.020; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Lulla Rishi R., 2011, Sarcoma, V2011, P732690, DOI 10.1155/2011/732690; MacEwen EG, 2004, J CELL BIOCHEM, V92, P77, DOI 10.1002/jcb.20046; Maire G, 2011, CANCER GENET-NY, V204, P138, DOI 10.1016/j.cancergen.2010.12.012; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Ning HX, 2009, DIFFERENTIATION, V78, P253, DOI 10.1016/j.diff.2009.07.009; Nohata N, 2012, ONCOTARGET, V3, P9; Novello C, 2013, INT J ONCOL, V42, P667, DOI 10.3892/ijo.2012.1717; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Reid JF, 2012, MOL CANCER RES, V10, P504, DOI 10.1158/1541-7786.MCR-11-0342; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Skaftnesmo KO, 2007, CURR PHARM BIOTECHNO, V8, P320, DOI 10.2174/138920107783018390; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Takaya T, 2009, CIRC J, V73, P1492, DOI 10.1253/circj.CJ-08-1032; Tan ML, 2009, CANCER BIOL THER, V8, P106, DOI 10.4161/cbt.8.2.7385; Tao J, 2012, ONCOL REP, V27, P1967, DOI 10.3892/or.2012.1711; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang YH, 2012, J SURG ONCOL, V105, P235, DOI 10.1002/jso.22077; Wang YH, 2010, MOL CELL BIOCHEM, V341, P225, DOI 10.1007/s11010-010-0453-2; Wang YH, 2009, MOL CELL BIOCHEM, V327, P257, DOI 10.1007/s11010-009-0064-y; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wu ZY, 2011, MED ONCOL, V28, P1469, DOI 10.1007/s12032-010-9563-7; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yan W, 2000, MOL ENDOCRINOL, V14, P682, DOI 10.1210/me.14.5.682; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Zhu H, 2009, AUTOPHAGY, V5, P816, DOI 10.4161/auto.9064	46	88	93	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83571	10.1371/journal.pone.0083571	http://dx.doi.org/10.1371/journal.pone.0083571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391788	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200085
J	Baussano, I; Elfstrom, KM; Lazzarato, F; Gillio-Tos, A; De Marco, L; Carozzi, F; Del Mistro, A; Dillner, J; Franceschi, S; Ronco, G				Baussano, Iacopo; Elfstrom, K. Miriam; Lazzarato, Fulvio; Gillio-Tos, Anna; De Marco, Laura; Carozzi, Francesca; Del Mistro, Annarosa; Dillner, Joakim; Franceschi, Silvia; Ronco, Guglielmo			Type-Specific Human Papillomavirus Biological Features: Validated Model-Based Estimates	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; CERVICAL-CANCER; GLOBAL BURDEN; HPV TYPES; VACCINATION; IMPACT; WOMEN; INFECTIONS; TRANSMISSION; RISK	Infection with high-risk (hr) human papillomavirus (HPV) is considered the necessary cause of cervical cancer. Vaccination against HPV16 and 18 types, which are responsible of about 75% of cervical cancer worldwide, is expected to have a major global impact on cervical cancer occurrence. Valid estimates of the parameters that regulate the natural history of hrHPV infections are crucial to draw reliable projections of the impact of vaccination. We devised a mathematical model to estimate the probability of infection transmission, the rate of clearance, and the patterns of immune response following the clearance of infection of 13 hrHPV types. To test the validity of our estimates, we fitted the same transmission model to two large independent datasets from Italy and Sweden and assessed finding consistency. The two populations, both unvaccinated, differed substantially by sexual behaviour, age distribution, and study setting (screening for cervical cancer or Chlamydia trachomatis infection). Estimated transmission probability of hrHPV types (80% for HPV16, 73%-82% for HPV18, and above 50% for most other types); clearance rates decreasing as a function of time since infection; and partial protection against re-infection with the same hrHPV type (approximately 20% for HPV16 and 50% for the other types) were similar in the two countries. The model could accurately predict the HPV16 prevalence observed in Italy among women who were not infected three years before. In conclusion, our models inform on biological parameters that cannot at the moment be measured directly from any empirical data but are essential to forecast the impact of HPV vaccination programmes.	[Baussano, Iacopo; Franceschi, Silvia] Int Agcy Res Canc, F-69372 Lyon, France; [Elfstrom, K. Miriam; Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lazzarato, Fulvio; Gillio-Tos, Anna; De Marco, Laura] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Turin, Italy; [Carozzi, Francesca] Inst Canc Study & Prevent ISPO, Florence, Italy; [Del Mistro, Annarosa] Venetian Oncol Inst IOV, Padua, Italy; [Ronco, Guglielmo] Ctr Canc Prevent, Canc Epidemiol Unit, Turin, Italy	World Health Organization; International Agency for Research on Cancer (IARC); Karolinska Institutet; University of Turin; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; IRCCS Istituto Oncologico Veneto (IOV)	Baussano, I (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	baussanoi@iarc.fr	franceschi, silvia/M-2452-2014; Carozzi, Francesca Maria/K-4739-2016; DEL MISTRO, ANNAROSA/E-9352-2014; De Marco, Laura/J-7254-2016; Carozzi, Francesca/AAB-4985-2019; SANI, CRISTINA/J-8722-2016	franceschi, silvia/0000-0003-4181-8071; Carozzi, Francesca Maria/0000-0002-7162-8781; DEL MISTRO, ANNAROSA/0000-0001-7201-9374; De Marco, Laura/0000-0003-2167-9270; Carozzi, Francesca/0000-0002-6980-8011; SANI, CRISTINA/0000-0001-8955-8913; Gillio-Tos, Anna/0000-0001-6553-5362	European Community [242061]; Bill & Melinda Gates Foundation [OPP1053353]	European Community(European Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by the European Community's Seventh Framework programme (FP7/2007-2013) under grant agreement No. 242061 (acronym PREHDICT) and by the Bill & Melinda Gates Foundation (grant number OPP1053353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baussano I, 2011, VACCINE, V29, P1270, DOI 10.1016/j.vaccine.2010.11.082; Baussano I, 2010, EPIDEMICS-NETH, V2, P21, DOI 10.1016/j.epidem.2010.02.002; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Burchell AN, 2011, J INFECT DIS, V204, P1723, DOI 10.1093/infdis/jir644; Burchell AN, 2010, EPIDEMIOLOGY, V21, P31, DOI 10.1097/EDE.0b013e3181c1e70b; Carozzi F, 2012, EUR J CANCER, V48, P1633, DOI 10.1016/j.ejca.2011.10.010; Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Dasbach EJ, 2006, EPIDEMIOL REV, V28, P88, DOI 10.1093/epirev/mxj006; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; de Velde NV, 2007, AM J EPIDEMIOL, V165, P762, DOI 10.1093/aje/kwk059; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; Garnett GP, 2005, J INFECT DIS, V191, pS97, DOI 10.1086/425271; Garnett GP, 2002, SEX TRANSM INFECT, V78, pI14, DOI 10.1136/sti.78.suppl_1.i14; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Johnson HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049614; Kim JJ, 2007, BRIT J CANCER, V97, P1322, DOI 10.1038/sj.bjc.6604023; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; LEWIN B, 2000, SEX SWEDEN SWEDISH S; Maucort-Boulch D, 2010, INT J CANCER, V126, P684, DOI 10.1002/ijc.24752; Newall AT, 2007, LANCET INFECT DIS, V7, P289, DOI 10.1016/S1473-3099(07)70083-X; Olsen J, 2010, INT J TECHNOL ASSESS, V26, P183, DOI 10.1017/S0266462310000085; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Ronco Guglielmo, 2012, Epidemiol Prev, V36, P39; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Ryding J, 2008, VACCINE, V26, P5263, DOI 10.1016/j.vaccine.2008.07.041; Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1653, DOI 10.1093/jnci/djq384; SERGEEV R, 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003815; Signorelli C, 2006, EUR J PUBLIC HEALTH, V16, P498, DOI 10.1093/eurpub/ckl024; Soderlund-Strand A, 2013, CANCER EPIDEM BIOMAR, V22, P242, DOI 10.1158/1055-9965.EPI-12-1003; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Szarewski A, 2012, INT J CANCER, V131, P106, DOI 10.1002/ijc.26362; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; Vaccarella S, 2011, J INFECT DIS, V204, P385, DOI 10.1093/infdis/jir286; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; Vanni T, 2012, VACCINE, V30, P4866, DOI 10.1016/j.vaccine.2012.04.087; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309; Zechmeister I, 2009, VACCINE, V27, P5133, DOI 10.1016/j.vaccine.2009.06.039	49	21	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81171	10.1371/journal.pone.0081171	http://dx.doi.org/10.1371/journal.pone.0081171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24400036	Green Published, Green Submitted, gold			2022-12-27	WOS:000327670300027
J	Benabdellah, K; Gutierrez-Guerrero, A; Cobo, M; Munoz, P; Martin, F				Benabdellah, Karim; Gutierrez-Guerrero, Alejandra; Cobo, Marien; Munoz, Pilar; Martin, Francisco			A Chimeric HS4-SAR Insulator (IS2) That Prevents Silencing and Enhances Expression of Lentiviral Vectors in Pluripotent Stem Cells	PLOS ONE			English	Article							SCAFFOLD ATTACHMENT REGION; TRANSGENE EXPRESSION; GENE-THERAPY; CHROMATIN INSULATOR; CHS4 INSULATOR; RETROVIRAL VECTORS; METHYLATION; DIFFERENTIATION; SEQUENCES; DESIGN	Chromatin insulators, such as the chicken beta-globin locus control region hypersensitive site 4 (HS4), and scaffold/matrix attachment regions (SARs/MARs) have been incorporated separately or in combination into retroviral vectors (RVs) in order to increase transgene expression levels, avoid silencing and reduce expression variability. However, their incorporation into RVs either produces a reduction on titer and/or expression levels or do not have sufficient effect on stem cells. In order to develop an improved insulator we decided to combine SAR elements with HS4 insulators. We designed several synthetic shorter SAR elements containing 4 or 5 MAR/SARs recognition signatures (MRS) and studied their effects on a lentiviral vector (LV) expressing eGFP through the SFFV promoter (SE). A 388 bp SAR element containing 5 MRS, named SAR2, was as efficient or superior to the other SARs analyzed. SAR2 enhanced transgene expression and reduced silencing and variability on human embryonic stem cells (hESCs). We next compared the effect of different HS4-based insulators, the HS4-Core (250 bp), the HS4-Ext (400 bp) and the HS4-650 (650 bp). All HS4 elements reduced silencing and expression variability but they also had a negative effect on transgene expression levels and titer. In general, the HS4-650 element had a better overall effect. Based on these data we developed a chimeric insulator, IS2, combining the SAR2 and the HS4-650. When incorporated into the 3' LTR of the SE LV, the IS2 element was able to enhance expression, avoid silencing and reduce variability of expression on hESCs. Importantly, these effects were maintained after differentiation of the transduced hESCs toward the hematopoietic linage. Neither the HS4-650 nor the SAR2 elements had these effects. The IS2 element is therefore a novel insulator that confers expression stability and enhances expression of LVs on stem cells.	[Benabdellah, Karim; Gutierrez-Guerrero, Alejandra; Cobo, Marien; Munoz, Pilar; Martin, Francisco] Univ Granada, PTS Granada, Pfizer, GENYO Ctr Genom & Oncol Res,Human DNA Variabil De, Granada, Spain	Pfizer; University of Granada	Benabdellah, K (corresponding author), Univ Granada, PTS Granada, Pfizer, GENYO Ctr Genom & Oncol Res,Human DNA Variabil De, Granada, Spain.	Karim.benabdel@genyo.es; francisco.martin@genyo.es	Munoz, Pilar/N-2277-2016; Martin, Francisco/K-8763-2014; Benabdellah, karim/F-4209-2016; Benabdellah, karim/L-4569-2014	Munoz, Pilar/0000-0002-7985-9859; Martin, Francisco/0000-0003-1961-8612; Benabdellah, karim/0000-0003-2790-562X; Benabdellah, karim/0000-0003-4673-2111	Fondo de Investigaciones Sanitarias ISCIII (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [PS09/00340]; Consejeria de Innovacion Ciencia y Empresa [P09-CTS-04532, PAIDI-Bio-326]; Consejeria de Salud from the Junta de Andalucia [PI0001/2009]; FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia; Fundacion Progreso y Salud (Consejeria de Salud, Junta de Andalucia); Fondo de Investigaciones Sanitarias (FIS) - ISCIII	Fondo de Investigaciones Sanitarias ISCIII (Spain); Fondo Europeo de Desarrollo Regional (FEDER) from the European Union; Consejeria de Innovacion Ciencia y Empresa; Consejeria de Salud from the Junta de Andalucia(Junta de Andalucia); FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia; Fundacion Progreso y Salud (Consejeria de Salud, Junta de Andalucia)(Junta de Andalucia); Fondo de Investigaciones Sanitarias (FIS) - ISCIII(Instituto de Salud Carlos III)	This work has been financed by Fondo de Investigaciones Sanitarias ISCIII (Spain) and Fondo Europeo de Desarrollo Regional (FEDER) from the European Union [grant number PS09/00340], by the Consejeria de Innovacion Ciencia y Empresa [grant numbers P09-CTS-04532 and PAIDI-Bio-326] and by the Consejeria de Salud [grant number PI0001/2009] from the Junta de Andalucia and FEDER/Fondo de Cohesion Europeo (FSE) de Andalucia 2007-2013 to F.M., M.C. and F.M. are funded by Fundacion Progreso y Salud (Consejeria de Salud, Junta de Andalucia). K.B. is financed by the Consejeria de Innovacion Ciencia y Empresa [grant number P09-CTS-04532]. P.M. has a Sara Borrell contract from the Fondo de Investigaciones Sanitarias (FIS) - ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 1998, J VIROL, V72, P3720, DOI 10.1128/JVI.72.5.3720-3728.1998; Aker M, 2007, HUM GENE THER, V18, P333, DOI 10.1089/hum.2007.021; Arumugam PI, 2007, MOL THER, V15, P1863, DOI 10.1038/sj.mt.6300259; Arumugam PI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006995; Barkess G, 2012, EPIGENOMICS-UK, V4, P67, DOI [10.2217/EPI.11.112, 10.2217/epi.11.112]; Benabdellah K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023734; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; Cortes JL, 2009, HUM REPROD, V24, P1844, DOI 10.1093/humrep/dep107; Dang Q, 2000, J VIROL, V74, P2671, DOI 10.1128/JVI.74.6.2671-2678.2000; Dravid G, 2011, MOL THER, V19, P768, DOI 10.1038/mt.2010.281; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Emery DW, 2011, HUM GENE THER, V22, P761, DOI 10.1089/hum.2010.233; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Giannakopoulos A, 2009, J MOL BIOL, V387, P1239, DOI 10.1016/j.jmb.2009.02.043; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hawley Robert G., 2001, Current Gene Therapy, V1, P1, DOI 10.2174/1566523013348904; Herbst F, 2012, MOL THER, V20, P1014, DOI 10.1038/mt.2012.46; Ji JF, 2008, STEM CELLS, V26, P2485, DOI 10.1634/stemcells.2008-0642; KLEHR D, 1992, BIOCHEMISTRY-US, V31, P3222, DOI 10.1021/bi00127a025; Li CL, 2009, MOL THER, V17, P716, DOI 10.1038/mt.2009.7; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Mok HP, 2007, GENE THER, V14, P741, DOI 10.1038/sj.gt.3302923; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Munoz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039091; Neff T, 1997, STEM CELLS, V15, P265; Norrman K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012413; Park F, 2001, MOL THER, V4, P164, DOI 10.1006/mthe.2001.0450; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Ramezani A, 2003, BLOOD, V101, P4717, DOI 10.1182/blood-2002-09-2991; Rincon-Arano H, 2007, P NATL ACAD SCI USA, V104, P14044, DOI 10.1073/pnas.0704999104; Rivella S, 2000, J VIROL, V74, P4679, DOI 10.1128/JVI.74.10.4679-4687.2000; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Santilli G, 2011, MOL THER, V19, P122, DOI 10.1038/mt.2010.226; Senigl F, 2012, NUCLEIC ACIDS RES, V40, P5298, DOI 10.1093/nar/gks197; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Stein S, 2008, HUM GENE THER, V19, P1097; Toscano MG, 2008, HUM GENE THER, V19, P179, DOI 10.1089/hum.2007.098; Uchida N, 2011, MOL THER, V19, P133, DOI 10.1038/mt.2010.218; Urbinati F, 2009, MOL THER, V17, P1527, DOI 10.1038/mt.2009.89; van Drunen CM, 1999, NUCLEIC ACIDS RES, V27, P2924, DOI 10.1093/nar/27.14.2924; Wei GH, 2005, CELL RES, V15, P292, DOI 10.1038/sj.cr.7290298; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582	44	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84268	10.1371/journal.pone.0084268	http://dx.doi.org/10.1371/journal.pone.0084268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400083	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700017
J	Cheron, G; Leroy, A; Palmero-Soler, E; De Saedeleer, C; Bengoetxea, A; Cebolla, AM; Vidal, M; Dan, B; Berthoz, A; McIntyre, J				Cheron, Guy; Leroy, Axelle; Palmero-Soler, Ernesto; De Saedeleer, Caty; Bengoetxea, Ana; Cebolla, Ana-Maria; Vidal, Manuel; Dan, Bernard; Berthoz, Alain; McIntyre, Joseph			Gravity Influences Top-Down Signals in Visual Processing	PLOS ONE			English	Article							REFERENCE FRAMES; PARIETAL CORTEX; WORKING-MEMORY; PERCEPTION; MOTION; OSCILLATIONS; MODULATION; ATTENTION; ALPHA; SYNCHRONIZATION	Visual perception is not only based on incoming visual signals but also on information about a multimodal reference frame that incorporates vestibulo-proprioceptive input and motor signals. In addition, top-down modulation of visual processing has previously been demonstrated during cognitive operations including selective attention and working memory tasks. In the absence of a stable gravitational reference, the updating of salient stimuli becomes crucial for successful visuo-spatial behavior by humans in weightlessness. Here we found that visually-evoked potentials triggered by the image of a tunnel just prior to an impending 3D movement in a virtual navigation task were altered in weightlessness aboard the International Space Station, while those evoked by a classical 2D-checkerboard were not. Specifically, the analysis of event-related spectral perturbations and inter-trial phase coherency of these EEG signals recorded in the frontal and occipital areas showed that phase-locking of theta-alpha oscillations was suppressed in weightlessness, but only for the 3D tunnel image. Moreover, analysis of the phase of the coherency demonstrated the existence on Earth of a directional flux in the EEG signals from the frontal to the occipital areas mediating a top-down modulation during the presentation of the image of the 3D tunnel. In weightlessness, this fronto-occipital, top-down control was transformed into a diverging flux from the central areas toward the frontal and occipital areas. These results demonstrate that gravity-related sensory inputs modulate primary visual areas depending on the affordances of the visual scene.	[Cheron, Guy; Leroy, Axelle; Palmero-Soler, Ernesto; De Saedeleer, Caty; Bengoetxea, Ana; Cebolla, Ana-Maria; Dan, Bernard] Univ Libre Bruxelles, ULB Neurosci Inst, Lab Neurophysiol & Biomech Movement, Brussels, Belgium; [Cheron, Guy; De Saedeleer, Caty] Univ Mons, Lab Electrophysiol, B-7000 Mons, Belgium; [Vidal, Manuel; Berthoz, Alain] CNRS, Coll France, Lab Physiol Percept & Act, Paris, France; [McIntyre, Joseph] Univ Paris 05, CNRS, Inst Neurosci & Cognit, Ctr Etude Sensorimotricite,UMR 8194, Paris, France	Universite Libre de Bruxelles; University of Mons; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Cheron, G (corresponding author), Univ Libre Bruxelles, ULB Neurosci Inst, Lab Neurophysiol & Biomech Movement, Brussels, Belgium.	gcheron@ulb.ac.be	McIntyre, Joseph/K-6395-2015	McIntyre, Joseph/0000-0003-4974-4257; Dan, Bernard/0000-0002-2051-9876; , Ana/0000-0002-8885-796X; Vidal, Manuel/0000-0002-8504-1500	Belgian Federal Science Policy Office; European Space Agency [AO-2004,118]; Belgian National Fund for Scientific Research (FNRS); Universite Libre de Bruxelles; Universite de Mons (Belgium); Centre National d'Etudes Spatiales (CNES)	Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); European Space Agency(European Space AgencyEuropean Commission); Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles; Universite de Mons (Belgium); Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales)	This work was funded by the Belgian Federal Science Policy Office, the European Space Agency, (AO-2004,118), the Belgian National Fund for Scientific Research (FNRS), the research funds of the Universite Libre de Bruxelles and of the Universite de Mons (Belgium) and the Centre National d'Etudes Spatiales (CNES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Bartsch T, 2010, SCIENCE, V328, P1412, DOI 10.1126/science.1188160; Berthoz A, 1991, BRAIN SPACE, P82; Bledowski C, 2009, J NEUROSCI, V29, P13735, DOI 10.1523/JNEUROSCI.2547-09.2009; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Cardin V, 2011, CEREB CORTEX, V21, P550, DOI 10.1093/cercor/bhq122; Cheron G, 2006, BRAIN RES, V1121, P104, DOI 10.1016/j.brainres.2006.08.098; Cheron G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-75; Christensen A, 2011, J NEUROSCI, V31, P3493, DOI 10.1523/JNEUROSCI.4277-10.2011; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Curtis CE, 2010, TRENDS COGN SCI, V14, P216, DOI 10.1016/j.tics.2010.03.006; De Saedeleer C, 2013, EXP BRAIN RES, V226, P95, DOI 10.1007/s00221-013-3414-7; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deutschlander A, 2008, BRAIN, V131, P1025, DOI 10.1093/brain/awn035; Duhamel JR, 1998, J NEUROPHYSIOL, V79, P126, DOI 10.1152/jn.1998.79.1.126; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Freunberger R, 2008, EUR J NEUROSCI, V27, P2330, DOI 10.1111/j.1460-9568.2008.06190.x; Gramann K, 2010, J COGNITIVE NEUROSCI, V22, P2836, DOI 10.1162/jocn.2009.21369; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Harris LR, 2010, J VESTIBUL RES-EQUIL, V20, P25, DOI 10.3233/VES-2010-0352; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; Kim YJ, 2007, NAT NEUROSCI, V10, P117, DOI 10.1038/nn1821; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Kovacs G, 2010, NEUROIMAGE, V51, P329, DOI 10.1016/j.neuroimage.2010.02.011; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lipshits M, 2005, PERCEPTION, V34, P545, DOI 10.1068/p5358; Lobel E, 1998, J NEUROPHYSIOL, V80, P2699, DOI 10.1152/jn.1998.80.5.2699; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Michel Christoph M, 2004, Suppl Clin Neurophysiol, V57, P617; MOCKS J, 1984, ELECTROEN CLIN NEURO, V57, P571, DOI 10.1016/0013-4694(84)90093-2; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Patai EZ, 2012, J COGNITIVE NEUROSCI, V24, P2281, DOI 10.1162/jocn_a_00294; PAVARD B, 1977, PERCEPTION, V6, P529, DOI 10.1068/p060529; Peyrin C, 2010, J COGNITIVE NEUROSCI, V22, P2768, DOI 10.1162/jocn.2010.21424; Pollen DA, 2011, CEREB CORTEX, V21, P1941, DOI 10.1093/cercor/bhq285; Ramalingam N, 2013, J NEUROSCI, V33, P1773, DOI 10.1523/JNEUROSCI.3825-12.2013; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Roelfsema PR, 2007, NEURON, V56, P785, DOI 10.1016/j.neuron.2007.10.006; Steve Luck, 2005, INTRO EVENT RELATED; Stokes MG, 2012, P NATL ACAD SCI USA, V109, pE360, DOI 10.1073/pnas.1108555108; Summerfield JJ, 2011, J NEUROSCI, V31, P14952, DOI 10.1523/JNEUROSCI.5541-10.2011; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TURETSKY BI, 1988, ELECTROEN CLIN NEURO, V71, P310, DOI 10.1016/0168-5597(88)90032-9; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vidal M, 2006, PERCEPT PSYCHOPHYS, V68, P1338, DOI 10.3758/BF03193732; Wibral M, 2009, CEREB CORTEX, V19, P1567, DOI 10.1093/cercor/bhn192; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773	58	44	51	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e82371	10.1371/journal.pone.0082371	http://dx.doi.org/10.1371/journal.pone.0082371			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400069	Green Published, gold, Green Submitted			2022-12-27	WOS:000329462700003
J	Chong, PM; Lynch, T; McCorrister, S; Kibsey, P; Miller, M; Gravel, D; Westmacott, GR; Mulvey, MR				Chong, Patrick M.; Lynch, Tarah; McCorrister, Stuart; Kibsey, Pamela; Miller, Mark; Gravel, Denise; Westmacott, Garrett R.; Mulvey, Michael R.		CNISP	Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole	PLOS ONE			English	Article							UPTAKE REGULATOR FUR; HELICOBACTER-PYLORI; 5-NITROIMIDAZOLE RESISTANCE; REDUCED SUSCEPTIBILITY; ESCHERICHIA-COLI; RECA PROTEIN; NIM GENES; STRAINS; OXIDOREDUCTASE; INVOLVEMENT	Background: Clostridium difficile is an anaerobic, Gram-positive bacterium that has been implicated as the leading cause of antibiotic-associated diarrhea. Metronidazole is currently the first-line treatment for mild to moderate C. difficile infections. Our laboratory isolated a strain of C. difficile with a stable resistance phenotype to metronidazole. A shotgun proteomics approach was used to compare differences in the proteomes of metronidazole-resistant and -susceptible isolates. Methodology/Principal Findings: NAP1 C. difficile strains CD26A54_R (Met-resistant), CD26A54_S (reduced-susceptibility), and VLOO13 (Met-susceptible) were grown to mid-log phase, and spiked with metronidazole at concentrations 2 doubling dilutions below the MIC. Peptides from each sample were labeled with iTRAQ and subjected to 2D-LC-MS/MS analysis. In the absence of metronidazole, higher expression was observed of some proteins in C. difficile strains CD26A54_S and CD26A54_R that may be involved with reduced susceptibility or resistance to metronidazole, including DNA repair proteins, putative nitroreductases, and the ferric uptake regulator (Fur). After treatment with metronidazole, moderate increases were seen in the expression of stress-related proteins in all strains. A moderate increase was also observed in the expression of the DNA repair protein RecA in CD26A54_R. Conclusions/Significance: This study provided an in-depth proteomic analysis of a stable, metronidazole-resistant C. difficile isolate. The results suggested that a multi-factorial response may be associated with high level metronidazole-resistance in C. difficile, including the possible roles of altered iron metabolism and/or DNA repair.	[Chong, Patrick M.; Lynch, Tarah; McCorrister, Stuart; Gravel, Denise; Westmacott, Garrett R.; Mulvey, Michael R.] Publ Hlth Agcy Canada, Winnipeg, MB, Canada; [Kibsey, Pamela] Victoria Gen Hosp, Victoria, BC, Canada; [Miller, Mark] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada	Public Health Agency of Canada; University of Victoria; McGill University	Mulvey, MR (corresponding author), Publ Hlth Agcy Canada, Winnipeg, MB, Canada.	Michael_mulvey@phac-aspc.gc.ca	Quach, Caroline/AAT-6987-2021; Evans, Gerald/J-9229-2019; McGeer, Allison/AAB-6885-2020	Quach, Caroline/0000-0002-1170-9475; Evans, Gerald/0000-0003-2557-0897; McGeer, Allison/0000-0001-5647-6137; Forgie, Sarah/0000-0001-8073-5389; Langley, Joanne/0000-0003-3270-7345				Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Alauzet C, 2010, ANTIMICROB AGENTS CH, V54, P60, DOI 10.1128/AAC.01003-09; Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Baines SD, 2008, J ANTIMICROB CHEMOTH, V62, P1046, DOI 10.1093/jac/dkn313; Barbut F, 1999, ANTIMICROB AGENTS CH, V43, P2607, DOI 10.1128/AAC.43.11.2607; Bartlett JG, 2010, ANN NY ACAD SCI, V1213, P62, DOI 10.1111/j.1749-6632.2010.05863.x; Brazier JS, 2001, J ANTIMICROB CHEMOTH, V48, P741, DOI 10.1093/jac/48.5.741; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; Carlier JP, 1997, ANTIMICROB AGENTS CH, V41, P1495, DOI 10.1128/AAC.41.7.1495; Carpenter BM, 2010, J BACTERIOL, V192, P5037, DOI 10.1128/JB.00198-10; Carpenter BM, 2009, INFECT IMMUN, V77, P2590, DOI 10.1128/IAI.00116-09; Carter GP, 2007, J BACTERIOL, V189, P7290, DOI 10.1128/JB.00731-07; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Chang KC, 1997, BIOCHEM BIOPH RES CO, V236, P785, DOI 10.1006/bbrc.1997.7050; Choi SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018236; Delaney JAC, 2007, EMERG INFECT DIS, V13, P761, DOI 10.3201/eid1305.061124; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Diniz CG, 2004, J ANTIMICROB CHEMOTH, V54, P100, DOI 10.1093/jac/dkh256; EDWARDS DI, 1993, J ANTIMICROB CHEMOTH, V31, P9, DOI 10.1093/jac/31.1.9; Emerson JE, 2008, J MED MICROBIOL, V57, P757, DOI 10.1099/jmm.0.47657-0; Ernst FD, 2005, J BACTERIOL, V187, P3687, DOI 10.1128/JB.187.11.3687-3692.2005; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Freeman J, 2005, J ANTIMICROB CHEMOTH, V56, P988, DOI 10.1093/jac/dki357; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gal M, 2004, J ANTIMICROB CHEMOTH, V54, P109, DOI 10.1093/jac/dkh296; Gancz H, 2006, INFECT IMMUN, V74, P602, DOI 10.1128/IAI.74.1.602-614.2006; Gancz H, 2011, J MICROBIOL, V49, P294, DOI 10.1007/s12275-011-0396-7; Goldstein EJC, 2010, ANAEROBE, V16, P220, DOI 10.1016/j.anaerobe.2009.12.002; HAGGOUD A, 1994, ANTIMICROB AGENTS CH, V38, P1047, DOI 10.1128/AAC.38.5.1047; Hoffman PS, 1996, J BACTERIOL, V178, P4822, DOI 10.1128/jb.178.16.4822-4829.1996; Huang HH, 2010, ANAEROBE, V16, P633, DOI 10.1016/j.anaerobe.2010.09.002; Jeong JY, 2000, J BACTERIOL, V182, P5082, DOI 10.1128/JB.182.18.5082-5090.2000; Johnson S, 2000, CLIN INFECT DIS, V31, P625, DOI 10.1086/313955; Jorgensen MA, 2001, ARCH BIOCHEM BIOPHYS, V392, P180, DOI 10.1006/abbi.2001.2427; Kaakoush NO, 2009, ANTIMICROB AGENTS CH, V53, P1884, DOI 10.1128/AAC.01449-08; Kaihovaara P, 1998, J ANTIMICROB CHEMOTH, V41, P171, DOI 10.1093/jac/41.2.171; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kwon DH, 2000, FEMS MICROBIOL LETT, V188, P197, DOI 10.1111/j.1574-6968.2000.tb09193.x; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Land KM, 1999, DRUG RESIST UPDATE, V2, P289, DOI 10.1054/drup.1999.0104; Leffler DA, 2009, GASTROENTEROLOGY, V136, P1899, DOI 10.1053/j.gastro.2008.12.070; Leitsch D, 2011, J ANTIMICROB CHEMOTH, V66, P1756, DOI 10.1093/jac/dkr192; Lofmark S, 2005, ANTIMICROB AGENTS CH, V49, P1253, DOI 10.1128/AAC.49.3.1253-1256.2005; Lofmark S, 2010, CLIN INFECT DIS, V50, pS16, DOI 10.1086/647939; Lynch T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053757; Maul RW, 2005, J BACTERIOL, V187, P7607, DOI 10.1128/JB.187.22.7607-7618.2005; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Moura I, 2013, J ANTIMICROB CHEMOTH, V68, P362, DOI 10.1093/jac/dks420; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Nair S, 1998, AM J GASTROENTEROL, V93, P1873; O'Connor J, 2009, GEOJOURNAL LIB, V98, P1, DOI 10.1007/978-1-4020-9949-6_1; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Pelaez T, 2002, ANTIMICROB AGENTS CH, V46, P1647, DOI 10.1128/AAC.46.6.1647-1650.2002; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Proctor RA, 1998, DRUG RESIST UPDATE, V1, P227, DOI 10.1016/S1368-7646(98)80003-4; Reysset G, 1996, ANAEROBE, V2, P59, DOI 10.1006/anae.1996.0008; REYSSET G, 1993, CLIN INFECT DIS, V16, pS401, DOI 10.1093/clinids/16.Supplement_4.S401; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; Roggenkamp A, 2004, INFECT IMMUN, V72, P2254, DOI 10.1128/IAI.72.4.2254-2262.2004; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Schapiro JM, 2004, J CLIN MICROBIOL, V42, P4127, DOI 10.1128/JCM.42.9.4127-4129.2004; Schaumann R, 2005, INFECTION, V33, P368, DOI 10.1007/s15010-005-5061-9; Sisson G, 2000, J BACTERIOL, V182, P5091, DOI 10.1128/JB.182.18.5091-5096.2000; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; THOMPSON SA, 1995, INFECT IMMUN, V63, P2185, DOI 10.1128/IAI.63.6.2185-2193.1995; TOCHER JH, 1994, BIOCHEM PHARMACOL, V48, P1089, DOI 10.1016/0006-2952(94)90144-9; Tsugawa H, 2011, BIOCHEM BIOPH RES CO, V404, P656, DOI 10.1016/j.bbrc.2010.12.034; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wong SSY, 1999, DIAGN MICR INFEC DIS, V34, P1, DOI 10.1016/S0732-8893(98)00139-4	72	46	48	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e82622	10.1371/journal.pone.0082622	http://dx.doi.org/10.1371/journal.pone.0082622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400070	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700004
J	Bai, L; Kiyama, T; Li, HY; Wang, SW				Bai, Ling; Kiyama, Takae; Li, Hongyan; Wang, Steven W.			Birth of Cone Bipolar Cells, but Not Rod Bipolar Cells, Is Associated with Existing RGCs	PLOS ONE			English	Article							RETINAL GANGLION-CELL; DOMAIN FACTOR BRN-3B; HOMEOBOX GENE VSX1; FATE SPECIFICATION; PROGENITOR CELLS; MOUSE RETINA; MATH5; DIFFERENTIATION; PROLIFERATION; COMPETENCE	Retinal ganglion cells (RGCs) play important roles in retinogenesis. They are required for normal retinal histogenesis and retinal cell number balance. Developmental RGC loss is typically characterized by initial retinal neuronal number imbalance and subsequent loss of retinal neurons. However, it is not clear whether loss of a specific non-RGC cell type in the RGC-depleted retina is due to reduced cell production or subsequent degeneration. Taking advantage of three knockout mice with varying degrees of RGC depletion, we re-examined bipolar cell production in these retinas from various aspects. Results show that generation of the cone bipolar cells is correlated with the existing number of RGCs. However, generation of the rod bipolar cells is unaffected by RGC shortage. Results report the first observation that RGCs selectively influence the genesis of subsequent retinal cell types.	[Kiyama, Takae; Li, Hongyan; Wang, Steven W.] Univ Texas Hlth Sci Ctr Houston, Dept Ophthalmol & Visual Sci, Sch Med, Houston, TX 77030 USA; [Bai, Ling] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Ophthalmol, Xian, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Xi'an Jiaotong University	Wang, SW (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Ophthalmol & Visual Sci, Sch Med, Houston, TX 77030 USA.	Steven.Wang@uth.tmc.edu			National Institutes of Health National Eye Institute (NEI) [EY018352]; NEI [P30EY10608]; E. Matilda Ziegler Foundation for the Blind; Research to Prevent Blindness; Hermann Eye Fund; Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, China; NATIONAL EYE INSTITUTE [R01EY018352, P30EY010608] Funding Source: NIH RePORTER	National Institutes of Health National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); E. Matilda Ziegler Foundation for the Blind; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Hermann Eye Fund; Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, China; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding sources: National Institutes of Health National Eye Institute (NEI) EY018352 to SWW, NEI core grant P30EY10608, E. Matilda Ziegler Foundation for the Blind (http://emzfoundation.com) to SWW, Research to Prevent Blindness (http://www.rpbusa.org), and the Hermann Eye Fund (http://www.cizikeye.org/hermann_eye_fund.htm). Dr. Ling Bai's visiting scholar position was partially supported by the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, China. All mentioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Brown NL, 2001, DEVELOPMENT, V128, P2497; Brzezinski JA, 2005, INVEST OPHTH VIS SCI, V46, P2540, DOI 10.1167/iovs.04-1123; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Cheng CW, 2005, DEV BIOL, V287, P48, DOI 10.1016/j.ydbio.2005.08.029; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; Chow RL, 2001, MECH DEVELOP, V109, P315, DOI 10.1016/S0925-4773(01)00585-8; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; Fu XY, 2009, DEV DYNAM, V238, P2309, DOI 10.1002/dvdy.21974; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Hafler BP, 2012, P NATL ACAD SCI USA, V109, P7882, DOI 10.1073/pnas.1203138109; Hassan BA, 2000, GENE DEV, V14, P1852; Inoue T, 2002, DEVELOPMENT, V129, P831; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Kiyama T, 2011, VISION RES, V51, P251, DOI 10.1016/j.visres.2010.10.016; Le TT, 2006, DEV BIOL, V295, P764, DOI 10.1016/j.ydbio.2006.03.055; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Morrow EM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-2; Moshiri A, 2004, J NEUROSCI, V24, P229, DOI 10.1523/JNEUROSCI.2980-03.2004; Moshiri A, 2008, DEV BIOL, V316, P214, DOI 10.1016/j.ydbio.2008.01.015; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2005, CURR BIOL, V15, P525, DOI 10.1016/j.cub.2005.01.043; Ohtoshi A, 2004, CURR BIOL, V14, P530, DOI 10.1016/j.cub.2004.02.027; Qiu F, 2008, J NEUROSCI, V28, P3392, DOI 10.1523/JNEUROSCI.0043-08.2008; WAID DK, 1995, NEURON, V14, P117, DOI 10.1016/0896-6273(95)90245-7; Waid DK, 1998, DEVELOPMENT, V125, P1059; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Wang YP, 2002, NAT NEUROSCI, V5, P831, DOI 10.1038/nn911; Xiang M, 1997, COLD SPRING HARB SYM, V62, P325; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83686	10.1371/journal.pone.0083686	http://dx.doi.org/10.1371/journal.pone.0083686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392091	gold, Green Submitted, Green Published			2022-12-27	WOS:000329460100015
J	Dafna, E; Tarasiuk, A; Zigel, Y				Dafna, Eliran; Tarasiuk, Ariel; Zigel, Yaniv			Automatic Detection of Whole Night Snoring Events Using Non-Contact Microphone	PLOS ONE			English	Article							SLEEP-APNEA SYNDROME; LOW SOCIOECONOMIC-STATUS; CARDIOVASCULAR-DISEASE; DAYTIME SLEEPINESS; ACOUSTIC ANALYSIS; RISK-FACTOR; HEART-RATE; SOUND; CLASSIFICATION; PREVALENCE	Objective: Although awareness of sleep disorders is increasing, limited information is available on whole night detection of snoring. Our study aimed to develop and validate a robust, high performance, and sensitive whole-night snore detector based on non-contact technology. Design: Sounds during polysomnography (PSG) were recorded using a directional condenser microphone placed 1 m above the bed. An AdaBoost classifier was trained and validated on manually labeled snoring and non-snoring acoustic events. Patients: Sixty-seven subjects (age 52.5 +/- 13.5 years, BMI 30.8 +/- 4.7 kg/m(2), m/f 40/27) referred for PSG for obstructive sleep apnea diagnoses were prospectively and consecutively recruited. Twenty-five subjects were used for the design study; the validation study was blindly performed on the remaining forty-two subjects. Measurements and Results: To train the proposed sound detector, >76,600 acoustic episodes collected in the design study were manually classified by three scorers into snore and non-snore episodes (e. g., bedding noise, coughing, environmental). A feature selection process was applied to select the most discriminative features extracted from time and spectral domains. The average snore/non-snore detection rate (accuracy) for the design group was 98.4% based on a ten-fold cross-validation technique. When tested on the validation group, the average detection rate was 98.2% with sensitivity of 98.0% (snore as a snore) and specificity of 98.3% (noise as noise). Conclusions: Audio-based features extracted from time and spectral domains can accurately discriminate between snore and non-snore acoustic events. This audio analysis approach enables detection and analysis of snoring sounds from a full night in order to produce quantified measures for objective follow-up of patients.	[Dafna, Eliran; Zigel, Yaniv] Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel; [Tarasiuk, Ariel] Ben Gurion Univ Negev, Sleep Wake Disorders Unit, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel; [Tarasiuk, Ariel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Zigel, Y (corresponding author), Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel.	yaniv@bgu.ac.il		Zigel, Yaniv/0000-0002-1994-4242	Israel Ministry of Industry, Trade and Labor - the Kamin Program [46168]	Israel Ministry of Industry, Trade and Labor - the Kamin Program	This work was supported by the Israel Ministry of Industry, Trade and Labor - the Kamin Program, award no. 46168 to YZ and AT. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaer H, 2013, J CLIN MONIT COMPUT; Fiz JA, 2010, LARYNGOSCOPE, V120, P854, DOI 10.1002/lary.20815; Azarbarzin A., 2012, MED ENG PHYS; Azarbarzin A, 2011, IEEE T BIO-MED ENG, V58, P1156, DOI 10.1109/TBME.2010.2061846; Ben-Israel N, 2012, SLEEP, V35, P1299, DOI 10.5665/sleep.2092; BLIWISE DL, 1991, CHEST, V99, P600, DOI 10.1378/chest.99.3.600; Cavusoglu M, 2007, PHYSIOL MEAS, V28, P841, DOI 10.1088/0967-3334/28/8/007; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Counter P, 2004, SLEEP MED REV, V8, P433, DOI 10.1016/j.smrv.2004.03.007; Dafna E., 2011, P 7 INT WORKSH MOD A, P17; Deller J. R., 2000, DISCRETE TIME PROCES; Duckitt WD, 2006, PHYSIOL MEAS, V27, P1047, DOI 10.1088/0967-3334/27/10/010; Fiz JA, 1996, EUR RESPIR J, V9, P2365, DOI 10.1183/09031936.96.09112365; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Greenberg-Dotan S, 2007, SLEEP, V30, P1173, DOI 10.1093/sleep/30.9.1173; GUILLEMINAULT C, 1991, CHEST, V99, P40, DOI 10.1378/chest.99.1.40; Hasan MK, 2004, IEEE SIGNAL PROC LET, V11, P450, DOI 10.1109/LSP.2004.824017; Hoffstein V, 1996, CHEST, V109, P201, DOI 10.1378/chest.109.1.201; HOFFSTEIN V, 1994, SLEEP, V17, P522, DOI 10.1093/sleep/17.6.522; HOFFSTEIN V, 1993, SLEEP, V16, P118; Iber C., 2007, AASM MANUAL SCORING, P1, DOI DOI 10.1016/J.SLEEP.2004.06.007; ISSA FG, 1993, AM REV RESPIR DIS, V148, P1023, DOI 10.1164/ajrccm/148.4_Pt_1.1023; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jane R, 2011, IEEE ENG MED BIO, P8331, DOI 10.1109/IEMBS.2011.6092054; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones TM, 2005, EUR RESPIR J, V25, P1044, DOI 10.1183/09031936.05.00101703; Karunajeewa AS, 2008, PHYSIOL MEAS, V29, P227, DOI 10.1088/0967-3334/29/2/006; KUMP K, 1994, AM J RESP CRIT CARE, V150, P735, DOI 10.1164/ajrccm.150.3.8087345; Lee HK, 2013, PHYSIOL MEAS, V34, pN41, DOI 10.1088/0967-3334/34/5/N41; Lee LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053481; LEIBERMAN A, 1986, INT J PEDIATR OTORHI, V12, P173, DOI 10.1016/S0165-5876(86)80074-X; Marin JM, 1997, INT J EPIDEMIOL, V26, P381, DOI 10.1093/ije/26.2.381; PEREZPADILLA JR, 1987, SLEEP, V10, P249, DOI 10.1093/sleep/10.3.249; PEREZPADILLA JR, 1993, AM REV RESPIR DIS, V147, P635, DOI 10.1164/ajrccm/147.3.635; Pevernagie D, 2010, SLEEP MED REV, V14, P131, DOI 10.1016/j.smrv.2009.06.002; Rabiner L. R., 1978, DIGITAL PROCESSING S; RAUSCHER H, 1991, EUR RESPIR J, V4, P655; Reuveni H, 2004, SLEEP, V27, P1518, DOI 10.1093/sleep/27.8.1518; Rotem AY, 2003, SLEEP, V26, P747, DOI 10.1093/sleep/26.6.747; Sands M, 2013, AM J CARDIOL, V111, P540, DOI 10.1016/j.amjcard.2012.10.039; Scalart P, 1996, INT CONF ACOUST SPEE, P629, DOI 10.1109/ICASSP.1996.543199; SERIES F, 1993, CHEST, V103, P1769, DOI 10.1378/chest.103.6.1769; Simon-Tuval T, 2009, SLEEP, V32, P545, DOI 10.1093/sleep/32.4.545; SKATVEDT O, 1993, ACTA OTO-LARYNGOL, V113, P206, DOI 10.3109/00016489309135794; STOOHS R, 1991, RESP PHYSIOL, V85, P151, DOI 10.1016/0034-5687(91)90058-Q; Stoohs RA, 1998, EUR RESPIR J, V11, P451, DOI 10.1183/09031936.98.11020451; Tarasiuk A, 2006, CHEST, V130, P766, DOI 10.1378/chest.130.3.766; Tarasiuk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033178; WIGGINS CL, 1990, SLEEP, V13, P245, DOI 10.1093/sleep/13.3.245; Wilson K, 1999, CHEST, V115, P762, DOI 10.1378/chest.115.3.762; WILSON K, 1985, LARYNGOSCOPE, V95, P1174; Yadollahi A, 2010, MED ENG PHYS, V32, P985, DOI 10.1016/j.medengphy.2010.06.013	52	73	78	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84139	10.1371/journal.pone.0084139	http://dx.doi.org/10.1371/journal.pone.0084139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391903	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900046
J	Irwin, CR; Favis, NA; Agopsowicz, KC; Hitt, MM; Evans, DH				Irwin, Chad R.; Favis, Nicole A.; Agopsowicz, Kate C.; Hitt, Mary M.; Evans, David H.			Myxoma Virus Oncolytic Efficiency Can Be Enhanced Through Chemical or Genetic Disruption of the Actin Cytoskeleton	PLOS ONE			English	Article							ENVELOPED VACCINIA VIRUS; F11L-MEDIATED INHIBITION; FIBROMA VIRUSES; RABBIT MYXOMA; CELL MOTILITY; LIM KINASES; RHOA; INFECTION; SPREAD; PROTEIN	Myxoma virus (MYXV) is one of many animal viruses that exhibit oncolytic properties in transformed human cells. Compared to orthopoxviruses like vaccinia (VACV), MYXV spreads inefficiently, which could compromise its use in treating tumors and their associated metastases. The VACV F11 protein promotes virus exit and rapid spread by inhibiting Rho signalling, which results in a disruption of cortical actin. We have previously shown that although MYXV lacks an F11 homolog, the F11L gene can be introduced into MYXV promoting the spread of this Leporipoxvirus in natural host cells. Here we show that the F11-encoding (F11L(+)) MYXV strain replicates to higher levels in a number of human cancer cells. We also show that F11L(+) MYXV induces better tumor control and prolonged survival of mice bearing MDA-MB-231 cancer cells. Furthermore, we show that this virus also spreads more efficiently from the site of growth in one injected tumor, to a second untreated tumor. While we focused mostly on the use of a modified MYXV we were able to show that the effects of F11 on MYXV growth in cancer cells could be mimicked through the use of pharmacological inhibition or siRNA-mediated silencing of key regulators of cortical actin (RhoA, RhoC, mDia1, or LIMK2). These data suggest that it may be possible to increase the oncolytic efficacy of wild-type MYXV using chemical inhibitors of RhoA/C or their downstream targets. Furthermore, since all viruses must overcome barriers to exit posed by structures like cortical actin, these findings suggest that the oncolytic activity of other viruses may be enhanced through similar strategies.	[Irwin, Chad R.; Favis, Nicole A.; Evans, David H.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Agopsowicz, Kate C.; Hitt, Mary M.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Hitt, Mary M.; Evans, David H.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Evans, DH (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.	devans@ualberta.ca	Evans, David H/M-1912-2016	Evans, David H/0000-0001-5871-299X	Alberta Cancer Board Legacy program; Alberta Cancer Foundation; Canadian Institutes of Health Research; Li Ka Shing Institute for Virology; Canada Foundation for Innovation; Alberta Cancer Research Institute; Queen Elisabeth II Doctoral Award	Alberta Cancer Board Legacy program; Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Li Ka Shing Institute for Virology; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Cancer Research Institute; Queen Elisabeth II Doctoral Award	This work was funded by operating grants from the Alberta Cancer Board Legacy program, Alberta Cancer Foundation, Canadian Institutes of Health Research, and the Li Ka Shing Institute for Virology. The authors also thank the Canada Foundation for Innovation and its partners for infrastructure support. CRI has been supported by a graduate studentship from the Alberta Cancer Research Institute, a Walter Johns 75th Anniversary Award, and a Queen Elisabeth II Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWES CH, 1957, VIROLOGY, V4, P346, DOI 10.1016/0042-6822(57)90068-5; Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Arakawa Y, 2007, CELL HOST MICROBE, V1, P213, DOI 10.1016/j.chom.2007.04.007; Barry M, 1997, VIROLOGY, V239, P360, DOI 10.1006/viro.1997.8894; Bennett CJ, 2003, VIROLOGY, V315, P10, DOI 10.1016/S0042-6822(03)00512-9; BLASCO R, 1993, J VIROL, V67, P3319, DOI 10.1128/JVI.67.6.3319-3325.1993; CHAPRONIERE DM, 1957, VIROLOGY, V4, P351, DOI 10.1016/0042-6822(57)90069-7; Cordeiro JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008506; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Duteyrat JL, 2006, ARCH VIROL, V151, P2161, DOI 10.1007/s00705-006-0791-2; Gauvin TJ, 2009, BIOCHEMISTRY-US, V48, P9327, DOI 10.1021/bi901354z; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Handa Y, 2013, CELL HOST MICROBE, V14, P51, DOI 10.1016/j.chom.2013.06.006; Harrison BA, 2009, J MED CHEM, V52, P6515, DOI 10.1021/jm901226j; Horsington J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003239; Ichihashi Y, 1996, VIROLOGY, V217, P478, DOI 10.1006/viro.1996.0142; Irwin CR, 2012, J VIROL, V86, P7167, DOI 10.1128/JVI.06936-11; Johnston JB, 2005, VIROLOGY, V332, P235, DOI 10.1016/j.virol.2004.11.030; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Kato SEM, 2004, J VIROL METHODS, V115, P31, DOI 10.1016/j.jviromet.2003.09.011; Kirn DH, 2008, CANCER RES, V68, P2071, DOI 10.1158/0008-5472.CAN-07-6515; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Mardilovich K, 2012, FUTURE ONCOL, V8, P165, DOI [10.2217/fon.11.143, 10.2217/FON.11.143]; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; McHenry PR, 2010, CURR DRUG TARGETS, V11, P1043, DOI 10.2174/138945010792006852; Morales I, 2008, TRAFFIC, V9, P1283, DOI 10.1111/j.1600-0854.2008.00762.x; OPGENORTH A, 1992, J VIROL, V66, P4720, DOI 10.1128/JVI.66.8.4720-4731.1992; PAYNE LG, 1982, ARCH VIROL, V74, P11, DOI 10.1007/BF01320778; Ridley AJ, 2013, J MICROSC; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Roberts KL, 2008, TRENDS MICROBIOL; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Shmulevitz M, 2012, J VIROL, V86, P7403, DOI 10.1128/JVI.00304-12; Smallwood Sherin E, 2010, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14a01s17; Smith GL, 1998, ADV EXP MED BIOL, V440, P395; Smith GL, 2003, ANNU REV MICROBIOL, V57, P323, DOI 10.1146/annurev.micro.57.030502.091037; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Sypula J., 2004, GENE THER MOL BIOL, V8, P103; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Teferi WM, 2013, J VIROL; Thirunavukarasu P, 2013, MOL THER, V21, P1024, DOI 10.1038/mt.2013.27; Valderrama F, 2006, SCIENCE, V311, P377, DOI 10.1126/science.1122411; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Wang FA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000099; Wang F, 2009, VIROLOGY, V387, P136, DOI 10.1016/j.virol.2009.02.013; Wang G, 2006, P NATL ACAD SCI USA, V103, P4640, DOI 10.1073/pnas.0509341103; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Zwilling J, 2010, VIROLOGY, V404, P231, DOI 10.1016/j.virol.2010.05.008	52	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84134	10.1371/journal.pone.0084134	http://dx.doi.org/10.1371/journal.pone.0084134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391902	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900045
J	Methner, C; Buonincontri, G; Hu, CH; Vujic, A; Kretschmer, A; Sawiak, S; Carpenter, A; Stasch, JP; Krieg, T				Methner, Carmen; Buonincontri, Guido; Hu, Chou-Hui; Vujic, Ana; Kretschmer, Axel; Sawiak, Stephen; Carpenter, Adrian; Stasch, Johannes-Peter; Krieg, Thomas			Riociguat Reduces Infarct Size and Post-Infarct Heart Failure in Mouse Hearts: Insights from MRI/PET Imaging	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; TARGETED S-NITROSOTHIOL; NITRIC-OXIDE; PULMONARY-HYPERTENSION; MYOCARDIAL-INFARCTION; RAT HEARTS; REPERFUSION; MICE; VARDENAFIL; ISCHEMIA	Aim: Stimulation of the nitric oxide (NO) - soluble guanylate (sGC) - protein kinase G (PKG) pathway confers protection against acute ischaemia/reperfusion injury, but more chronic effects in reducing post-myocardial infarction (MI) heart failure are less defined. The aim of this study was to not only determine whether the sGC stimulator riociguat reduces infarct size but also whether it protects against the development of post-MI heart failure. Methods and Results: Mice were subjected to 30 min ischaemia via ligation of the left main coronary artery to induce MI and either placebo or riociguat (1.2 mu mol/l) were given as a bolus 5 min before and 5 min after onset of reperfusion. After 24 hours, both, late gadolinium-enhanced magnetic resonance imaging (LGE-MRI) and F-18-FDG-positron emission tomography (PET) were performed to determine infarct size. In the riociguat-treated mice, the resulting infarct size was smaller (8.5 +/- 2.5% of total LV mass vs. 21.8%+/- 1.7%. in controls, p = 0.005) and LV systolic function analysed by MRI was better preserved (60.1%+/- 3.4% of preischaemic vs. 44.2% +/- 3.1% in controls, p = 0.005). After 28 days, LV systolic function by echocardiography treated group was still better preserved (63.5% +/- 3.2% vs. 48.2% +/- 2.2% in control, p = 0.004). Conclusion: Taken together, mice treated acutely at the onset of reperfusion with the sGC stimulator riociguat have smaller infarct size and better long-term preservation of LV systolic function. These findings suggest that sGC stimulation during reperfusion therapy may be a powerful therapeutic treatment strategy for preventing post-MI heart failure.	[Methner, Carmen; Hu, Chou-Hui; Vujic, Ana; Krieg, Thomas] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Buonincontri, Guido; Kretschmer, Axel; Sawiak, Stephen; Carpenter, Adrian] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Stasch, Johannes-Peter] Bayer HealthCare, Wuppertal, Germany	University of Cambridge; University of Cambridge; Bayer AG; Bayer Healthcare Pharmaceuticals	Krieg, T (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	tk382@medschl.cam.ac.uk	Vujic, Ana/AAQ-8417-2020; Sawiak, Stephen J/I-8944-2012; Vujic, Ana/GYJ-6199-2022; Buonincontri, Guido/L-5207-2017	Vujic, Ana/0000-0002-0559-5299; Sawiak, Stephen J/0000-0003-4210-9816; Buonincontri, Guido/0000-0002-8386-639X; Krieg, Thomas/0000-0002-5192-580X	Bayer HealthCare	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	This study supported by funding from Bayer HealthCare. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buonincontri G, 2013, J MAGN RESON IMAGING, V38, P468, DOI 10.1002/jmri.24001; Burley DS, 2007, BASIC RES CARDIOL, V102, P529, DOI 10.1007/s00395-007-0672-1; Epstein FH, 2004, MAGN RESON MED, V52, P774, DOI 10.1002/mrm.20232; Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011; Flynn TJ, 1997, J OPT SOC AM A, V14, P2692, DOI 10.1364/JOSAA.14.002692; Geschka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021853; Ghofrani HA, 2013, NEW ENGL J MED, V369, P330, DOI 10.1056/NEJMoa1209655; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Gilson WD, 2005, AM J PHYSIOL-HEART C, V288, pH1491, DOI 10.1152/ajpheart.00632.2004; Hawkes RC, 2010, TECHNOL CANCER RES T, V9, P53, DOI 10.1177/153303461000900106; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Hung CL, 2010, J AM COLL CARDIOL, V56, P1812, DOI 10.1016/j.jacc.2010.06.044; Krieg T, 2009, EUR HEART J, V30, P1607, DOI 10.1093/eurheartj/ehp143; Maas O, 2008, BRIT J PHARMACOL, V154, P25, DOI 10.1038/bjp.2008.71; MAROKO PR, 1971, CIRCULATION, V43, P67, DOI 10.1161/01.CIR.43.1.67; MAROKO PR, 1976, CIRCULATION, V53, P162; Methner C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0337-1; Ott IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042623; Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106; Salloum FN, 2007, J MOL CELL CARDIOL, V42, P453, DOI 10.1016/j.yjmcc.2006.10.015; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Schmidt K, 2010, EUR HEART J, V31, P1655, DOI 10.1093/eurheartj/ehp555; Sharkovska Y, 2010, J HYPERTENS, V28, P1666, DOI 10.1097/HJH.0b013e32833b558c; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stegger L, 2006, J NUCL MED, V47, P1837; Sun JH, 2013, FREE RADICAL BIO MED, V54, P105, DOI 10.1016/j.freeradbiomed.2012.09.005; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452; Tse MT, 2012, NAT REV DRUG DISCOV, V11, P896, DOI 10.1038/nrd3906	28	30	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83910	10.1371/journal.pone.0083910	http://dx.doi.org/10.1371/journal.pone.0083910			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391843	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200141
J	Pasha, DN; Davis, JT; Rao, FW; Chen, YQ; Wen, G; Fung, MM; Mahata, M; Zhang, KX; Trzebinska, D; Mustapic, M; Hightower, CM; Lipkowitz, MS; Ji, M; Ziegler, MG; Nievergelt, CM; O'Connor, DT				Pasha, Dalal N.; Davis, Jason T.; Rao, Fangwen; Chen, Yuqing; Wen, Gen; Fung, Maple M.; Mahata, Manjula; Zhang, Kuixing; Trzebinska, Danuta; Mustapic, Maja; Hightower, C. Makena; Lipkowitz, Michael S.; Ji, Ming; Ziegler, Michael G.; Nievergelt, Caroline M.; O'Connor, Daniel T.			Heritable Influence of DBH on Adrenergic and Renal Function: Twin and Disease Studies	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; DOPAMINE-BETA-HYDROXYLASE; SYMPATHETIC-NERVOUS-SYSTEM; GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; HYPERTENSIVE NEPHROSCLEROSIS; TYROSINE-HYDROXYLASE; POLYMORPHISM; FAILURE; CATECHOLAMINES	Background: Elevated sympathetic activity is associated with kidney dysfunction. Here we used twin pairs to probe heritability of GFR and its genetic covariance with other traits. Methods: We evaluated renal and adrenergic phenotypes in twins. GFR was estimated by CKD-EPI algorithm. Heritability and genetic covariance of eGFR and associated risk traits were estimated by variance-components. Meta-analysis probed reproducibility of DBH genetic effects. Effect of DBH genetic variation on renal disease was tested in the NIDDK-AASK cohort. Results: Norepinephrine secretion rose across eGFR tertiles while eGFR fell (p < 0.0001). eGFR was heritable, at h(2) = 67.3 +/- 4.7% (p = 3.0E-18), as were secretion of norepinephrine (h(2) = 66.5 +/- 5.0%, p = 3.2E-16) and dopamine (h(2) = 56.5 +/- 5.6%, p = 1.8E-13), and eGFR displayed genetic co-determination (covariance) with norepinephrine (rho(G) = -0.557 +/- 0.088, p = 1.11E-08) as well as dopamine (rho(G) = -0.223 +/- 0.101, p = 2.3E-02). Since dopamine beta-hydroxylase (DBH) catalyzes conversion of dopamine to norepinephrine, we studied functional variation at DBH; DBH promoter haplotypes predicted transcriptional activity (p < 0.001), plasma DBH (p < 0.0001) and norepinephrine (p = 0.0297) secretion; transcriptional activity was inversely (p < 0.0001) associated with basal eGFR. Meta-analysis validated DBH haplotype effects on eGFR across 3 samples. In NIDDK-AASK, we established a role for DBH promoter variation in long-term renal decline rate (GFR slope, p = 0.003). Conclusions: The heritable GFR trait shares genetic determination with catecholamines, suggesting new pathophysiologic, diagnostic and therapeutic approaches towards disorders of GFR as well as CKD. Adrenergic activity may play a role in progressive renal decline, and genetic variation at DBH may assist in profiling subjects for rational preventive treatment.	[Pasha, Dalal N.; Davis, Jason T.; Rao, Fangwen; Chen, Yuqing; Wen, Gen; Fung, Maple M.; Mahata, Manjula; Zhang, Kuixing; Trzebinska, Danuta; Mustapic, Maja; Hightower, C. Makena; Ziegler, Michael G.; O'Connor, Daniel T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [O'Connor, Daniel T.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Nievergelt, Caroline M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Ji, Ming] San Diego State Univ, Grad Sch Publ Hlth, Div Epidemiol & Biostat, San Diego, CA 92182 USA; [O'Connor, Daniel T.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA; [Lipkowitz, Michael S.] Georgetown Univ, Dept Med, Washington, DC USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; San Diego State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Georgetown University	O'Connor, DT (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	doconnor@ucsd.edu	Ziegler, Michael/L-4728-2019; Mustapic, Maja/AAV-3212-2020	Nievergelt, Caroline/0000-0001-5766-8923; Mustapic, Maja/0000-0003-0511-2047	National Institutes of Health (NIH) [DK094894, HL58120, UL1 TR000100]; UCSD Comprehensive Research Center in Health Disparities [MD000220]; Department of Veterans Affairs; NIH (O'Brien AKI center) [DK079337]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000220] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093500] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Comprehensive Research Center in Health Disparities; Department of Veterans Affairs(US Department of Veterans Affairs); NIH (O'Brien AKI center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support provided by National Institutes of Health (NIH) [DK094894; HL58120; UL1 TR000100 (University of California San Diego (UCSD) Clinical and Translational Research Institute); MD000220 (UCSD Comprehensive Research Center in Health Disparities]; Department of Veterans Affairs and NIH DK079337 (O'Brien AKI center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Amann K, 2000, J AM SOC NEPHROL, V11, P1469, DOI 10.1681/ASN.V1181469; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; CAMPESE VM, 1995, HYPERTENSION, V25, P878, DOI 10.1161/01.HYP.25.4.878; Chen YQ, 2011, AM J HYPERTENS, V24, P24, DOI 10.1038/ajh.2010.186; Chen YQ, 2010, AM J NEPHROL, V32, P23, DOI 10.1159/000313927; Chen YQ, 2010, J HYPERTENS, V28, P76, DOI 10.1097/HJH.0b013e328332bc87; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Do KA, 2000, STAT MED, V19, P1217; Eknoyan G, 2008, NEPHROL DIAL TRANSPL, V23, P47, DOI 10.1093/ndt/gfm517; Fung MM, 2009, NEPHROL DIAL TRANSPL, V24, P3677, DOI 10.1093/ndt/gfp471; Grassi G, 2012, CURR OPIN NEPHROL HY, V21, P46, DOI 10.1097/MNH.0b013e32834db45d; Grassi G, 2011, HYPERTENSION, V57, P846, DOI 10.1161/HYPERTENSIONAHA.110.164780; Grassi G, 2009, J HYPERTENS, V27, P562, DOI 10.1097/HJH.0b013e32831fb371; Grisk O, 2004, CARDIOVASC RES, V61, P238, DOI 10.1016/j.cardiores.2003.11.024; Hausberg M, 2002, CIRCULATION, V106, P1974, DOI 10.1161/01.CIR.0000034043.16664.96; Heron M. P., 2008, DEATHS PRELIMINARY D; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; KENNEDY B, 1990, LIFE SCI, V47, P2143, DOI 10.1016/0024-3205(90)90314-H; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Masuo K, 2010, HYPERTENS RES, V33, P521, DOI 10.1038/hr.2010.35; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; NAGATSU T, 1972, CLIN CHEM, V18, P980; NEURINGER JR, 1993, AM J KIDNEY DIS, V22, P98, DOI 10.1016/S0272-6386(12)70174-9; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connor D T, 1983, J Hypertens, V1, P227, DOI 10.1097/00004872-198310000-00006; Peake Michael, 2006, Clin Biochem Rev, V27, P173; Purcell S, 2009, WHOLE GENOME ASS ANA; Rana BK, 2007, HYPERTENSION, V49, P96, DOI 10.1161/01.HYP.0000252029.35106.67; Rao FW, 2007, HYPERTENSION, V49, P1015, DOI 10.1161/HYPERTENSIONAHA.106.081679; Rao F, 2007, CIRCULATION, V116, P993, DOI 10.1161/CIRCULATIONAHA.106.682302; Schlaich MP, 2009, J AM SOC NEPHROL, V20, P933, DOI 10.1681/ASN.2008040402; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Wright JT, 1996, CONTROL CLIN TRIALS, V17, pS3, DOI 10.1016/S0197-2456(96)00081-5; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zhang L, 2004, PHYSIOL GENOMICS, V19, P277, DOI 10.1152/physiolgenomics.00151.2004; ZIEGLER MG, 1990, KIDNEY INT, V37, P1357, DOI 10.1038/ki.1990.122	40	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82956	10.1371/journal.pone.0082956	http://dx.doi.org/10.1371/journal.pone.0082956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391727	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200024
J	Suteu, D; Bacila, I; Has, V; Has, I; Miclaus, M				Suteu, Dana; Bacila, Ioan; Has, Voichita; Has, Ioan; Miclaus, Mihai			Romanian Maize (Zea mays) Inbred Lines as a Source of Genetic Diversity in SE Europe, and Their Potential in Future Breeding Efforts	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; BALSAS RIVER VALLEY; POPULATIONS; INFERENCE; TRAITS; INTROGRESSION; INDIVIDUALS; METHIONINE; NUMBER; GENOME	Maize has always been under constant human selection ever since it had been domesticated. Intensive breeding programs that resulted in the massive use of hybrids nowadays have started in the 60s. That brought significant yield increases but reduced the genetic diversity at the same time. Consequently, breeders and researchers alike turned their attention to national germplasm collections established decades ago in many countries, as they may hold allelic variations that could prove useful for future improvements. These collections are mainly composed of inbred lines originating from well-adapted local open pollinated varieties. However, there is an overall lack of data in the literature about the genetic diversity of maize in SE Europe, and its potential for future breeding efforts. There are no data, whatsoever, on the nutritional quality of the grain, primarily dictated by the zein proteins. We therefore sought to use the Romanian maize germplasm as an entry point in understanding the molecular make-up of maize in this part of Europe. By using 80 SSR markers, evenly spread throughout the genome, on 82 inbred lines from various parts of the country, we were able to decipher population structure and the existing relationships between those and the eight international standards used, including the reference sequenced genome B73. Corroborating molecular data with a standardized morphological, physiological, and biochemical characterization of all 90 inbred lines, this is the first comprehensive such study on the existing SE European maize germplasm. The inbred lines we present here are an important addition to the ever-shrinking gene pool that the breeding programs are faced-with, because of the allelic richness they hold. They may serve as parental lines in crosses that will lead to new hybrids, characterized by a high level of heterosis, nationwide and beyond, due to their existing relationship with the international germplasm.	[Suteu, Dana; Bacila, Ioan; Miclaus, Mihai] Natl Inst Res & Dev Biol Sci, Cluj Napoca, Romania; [Has, Voichita; Has, Ioan] Agr Res & Dev Stn, Turda, Romania; [Has, Ioan] Univ Agr Sci & Vet Med, Cluj Napoca, Romania	University of Agricultural Sciences & Veterinary Medicine Cluj Napoca	Miclaus, M (corresponding author), Natl Inst Res & Dev Biol Sci, Cluj Napoca, Romania.	mihai.miclaus@icbcluj.ro	Miclăuș, Mihai/L-1340-2019; Suteu, Dana/A-1719-2017; Miclaus, Mihai/G-5571-2011; Bacila, Ioan/B-8867-2012	Miclăuș, Mihai/0000-0001-7969-2393; Miclaus, Mihai/0000-0001-7969-2393; 	Romanian National Authority for Scientific Research, CNDI-UEFISCDI [PN-II-PT-PCCA-2011-3.1-0511-103/2012]	Romanian National Authority for Scientific Research, CNDI-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))	This work was supported by a grant of the Romanian National Authority for Scientific Research, CNDI-UEFISCDI (http://uefiscdi.gov.ro/), project number PN-II-PT-PCCA-2011-3.1-0511-103/2012 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bioversity International, 2007, BIOV TECHN B SER; Bitocchi E, 2009, MOL ECOL, V18, P603, DOI 10.1111/j.1365-294X.2008.04064.x; BRANDOLINI A., 1970, Maydica, V15, P5; Cristea M, 1977, ROMANIAN MAIZE RACES; Dubreuil P, 2006, MAYDICA, V51, P281; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hartings H, 2008, THEOR APPL GENET, V117, P831, DOI 10.1007/s00122-008-0823-2; Holding D, 2013, SEED GENOMICS; Holding David R., 2009, V63, P269; Ionescu-Sisesti G, 1955, MAIZE CULTURE; Krishnan HB, 2010, J AGR FOOD CHEM, V58, P7323, DOI 10.1021/jf100927u; LENG ER, 1962, EUPHYTICA, V11, P263; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Madgearu V, 1931, OFFICIAL PUBLICATION, V2, P18; Nuss ET, 2011, ADV NUTR, V2, P217, DOI 10.3945/an.110.000182; Pascovschi V, 1957, MAIZE MONOGRAPH ROMA, P19; PHILLIPS RL, 1985, CEREAL CHEM, V62, P213; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Pritchard JK, 2000, GENETICS, V155, P945; Ranere AJ, 2009, P NATL ACAD SCI USA, V106, P5014, DOI 10.1073/pnas.0812590106; Rebourg C, 2001, HEREDITY, V86, P574, DOI 10.1046/j.1365-2540.2001.00869.x; Reif JC, 2005, THEOR APPL GENET, V111, P838, DOI 10.1007/s00122-005-0004-5; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Scott MP, 2006, MAYDICA, V51, P417; Stupar RM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-33; SWARUP S, 1995, PLANT J, V8, P359, DOI 10.1046/j.1365-313X.1995.08030359.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Troyer AF, 1999, CROP SCI, V39, P601, DOI 10.2135/cropsci1999.0011183X003900020001x; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Wang LZ, 2008, J CEREAL SCI, V48, P387, DOI 10.1016/j.jcs.2007.09.014; Wu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032850; Wu YR, 2009, THEOR APPL GENET, V119, P721, DOI 10.1007/s00122-009-1083-5; Xu JH, 2008, P NATL ACAD SCI USA, V105, P14330, DOI 10.1073/pnas.0807026105; Xu JH, 2012, MOL BIOL EVOL, V29, P861, DOI 10.1093/molbev/msr261; Yang XH, 2011, GENETICA, V139, P1045, DOI 10.1007/s10709-011-9606-9; Zhang PF, 2003, PLANT MOL BIOL, V52, P1, DOI 10.1023/A:1023942819106	43	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85501	10.1371/journal.pone.0085501	http://dx.doi.org/10.1371/journal.pone.0085501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392016	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900160
J	Yang, M; Zhang, W; Dong, HX; Zhang, YY; Lv, K; Wang, DJ; Lian, XM				Yang, Meng; Zhang, Wan; Dong, Huaxia; Zhang, Yuanyuan; Lv, Kai; Wang, Dujun; Lian, Xingming			OsNRAMP3 Is a Vascular Bundles-Specific Manganese Transporter That Is Responsible for Manganese Distribution in Rice	PLOS ONE			English	Article							METAL-NICOTIANAMINE TRANSPORTER; CATION TRANSPORTERS; CA2+/MN2+ PUMP; ZIP FAMILY; T-DNA; ARABIDOPSIS; IRON; TOLERANCE; CADMIUM; PHLOEM	Manganese (Mn) is an essential trace element for plants. Recently, the genes responsible for uptake of Mn in plants were identified in Arabidopsis and rice. However, the mechanism of Mn distribution in plants has not been clarified. In the present study we identified a natural resistance-associated macrophage protein (NRAMP) family gene in rice, OsNRAMP3, involved in Mn distribution. OsNRAMP3 encodes a plasma membrane-localized protein and was specifically expressed in vascular bundles, especially in phloem cells. Yeast complementation assay showed that OsNRAMP3 is a functional Mn-influx transporter. When OsNRAMP3 was absent, rice plants showed high sensitivity to Mn deficiency. Serious necrosis appeared on young leaves and root tips of the OsNRAMP3 knockout line cultivated under low Mn conditions, and high Mn supplies could rescue this phenotype. However, the necrotic young leaves of the knockout line possessed similar levels of Mn to the wild type, suggesting that the necrotic appearance was caused by disturbed distribution of Mn but not a general Mn shortage. Additionally, compared with wild type, leaf Mn content in osnramp3 plants was mostly in older leaves. We conclude that OsNRAMP3 is a vascular bundle-localized Mn-influx transporter involved in Mn distribution and contributes to remobilization of Mn from old to young leaves.	[Yang, Meng; Zhang, Wan; Dong, Huaxia; Zhang, Yuanyuan; Lv, Kai; Wang, Dujun; Lian, Xingming] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Yang, Meng; Zhang, Wan; Dong, Huaxia; Zhang, Yuanyuan; Lv, Kai; Wang, Dujun; Lian, Xingming] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Lian, XM (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	xmlian@mail.hzau.edu.cn	zhang, yuanyuan/GYA-4428-2022	Yang, Meng/0000-0001-8882-1417; Lian, Xingming/0000-0002-5307-2839	National High Technology Research and Development Program of China [2012AA10A303, 2012AA10A304]; National Basic Research Program of China [2011CB100304]; National Natural Science Foundation of China [31172017]; transgenic project [2013ZX08001005]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); transgenic project	This work was supported by grants from the National High Technology Research and Development Program of China (2012AA10A303 and 2012AA10A304), the National Basic Research Program of China (2011CB100304), the National Natural Science Foundation of China (31172017) and transgenic project 2013ZX08001005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereczky Z, 2003, J BIOL CHEM, V278, P24697, DOI 10.1074/jbc.M301365200; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Delhaize E, 2003, PLANT CELL, V15, P1131, DOI 10.1105/tpc.009134; Delhaize E, 2007, PLANT J, V51, P198, DOI 10.1111/j.1365-313X.2007.03138.x; Eckhardt U, 2001, PLANT MOL BIOL, V45, P437, DOI 10.1023/A:1010620012803; Edmond C, 2009, BIOCHEM J, V418, P145, DOI 10.1042/BJ20081814; Hebbern CA, 2005, PLANT SOIL, V272, P233, DOI 10.1007/s11104-004-5048-9; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirschi KD, 2000, PLANT PHYSIOL, V124, P125, DOI 10.1104/pp.124.1.125; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; Ishimaru Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00286; Ishimaru Y, 2010, PLANT J, V62, P379, DOI 10.1111/j.1365-313X.2010.04158.x; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Kamiya T, 2005, PLANT CELL PHYSIOL, V46, P1735, DOI 10.1093/pcp/pci173; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Li XY, 2008, PLANT PHYSIOL, V147, P1675, DOI 10.1104/pp.108.119909; Lopez-Millan AF, 2004, PLANT MOL BIOL, V54, P583, DOI 10.1023/B:PLAN.0000038271.96019.aa; Lu LL, 2013, NEW PHYTOL, V198, P721, DOI 10.1111/nph.12168; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Oomen RJFJ, 2009, NEW PHYTOL, V181, P637, DOI 10.1111/j.1469-8137.2008.02694.x; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Pittman JK, 2005, NEW PHYTOL, V167, P733, DOI 10.1111/j.1469-8137.2005.01453.x; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Sasaki A, 2011, PLANT PHYSIOL, V157, P1832, DOI 10.1104/pp.111.186031; Schaaf G, 2002, PLANT BIOLOGY, V4, P612, DOI 10.1055/s-2002-35432; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Tsukamoto T, 2006, SOIL SCI PLANT NUTR, V52, P717, DOI 10.1111/j.1747-0765.2006.00096.x; Wu ZY, 2002, PLANT PHYSIOL, V130, P128, DOI 10.1104/pp.004440; Yamaguchi N, 2012, J EXP BOT, V63, P2729, DOI 10.1093/jxb/err455; Yamaji N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3442; Ye RJ, 2012, PLANT CELL REP, V31, P1159, DOI 10.1007/s00299-012-1238-8; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zheng LQ, 2012, PLANT CELL, V24, P3767, DOI 10.1105/tpc.112.103820	43	33	36	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83990	10.1371/journal.pone.0083990	http://dx.doi.org/10.1371/journal.pone.0083990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391861	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900004
J	Colon-Lopez, V; Ortiz, AP; Del Toro-Mejias, L; Clatts, MC; Palefsky, JM				Colon-Lopez, Vivian; Ortiz, Ana Patricia; Del Toro-Mejias, Lizbeth; Clatts, Michael Craig; Palefsky, Joel M.			Epidemiology of Anal HPV Infection in High-Risk Men Attending a Sexually Transmitted Infection Clinic in Puerto Rico	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; PREVALENCE; CANCER; WOMEN; SEX	Purpose: Recent studies in Puerto Rico have reported an increasing incidence of anal cancer in Puerto Rican men. The objective of this study was to determine the prevalence, genotype distribution and risk factors associated with anal HPV infection among men attending an STI clinic in Puerto Rico. Methods: We conducted a cross-sectional study among 205 men 18 years and older. A comprehensive survey was administered that included a demographic and a behavioral assessment. Separate logistic regression models were performed to determine factors associated with any, high-risk (HR), and multiple anal HPV infection. Results: The mean age of the study sample was 38.0+/-13.5 years. The most common HR types were 58, 51 and 31. Overall, HR anal HPV infection was found in 53.5% of the participants. Multiple HPV types in the anal canal were found in 47.6% of the sample. A third (29.8%) of participants reported being men who had sex with men (MSM). MSM had a significantly higher prevalence of any, HR and multiple HPV infection (p-value<0.05). Separate multivariate logistic regression analyses showed that being MSM was associated with any (OR = 4.5; [95%CI: 1.9-10.7]), HR (OR = 3.4; [95%CI: 1.1-10.3) and multiple anal HPV infection (OR = 3.6; [95%CI: 1.5-9.1). HIV was marginally associated with multiple anal HPV infection in multivariate analysis (OR = 3.3; 95%CI = 1.0-11.0). Conclusions: Anal HPV is common among sexually active men attending this STI clinic, with higher likelihood of anal HPV infection among MSM.	[Colon-Lopez, Vivian; Ortiz, Ana Patricia] Univ Puerto Rico, Ctr Comprehens Canc, Canc Control & Populat Sci Program, San Juan, PR 00936 USA; [Colon-Lopez, Vivian] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Hlth Serv Adm, San Juan, PR 00936 USA; [Ortiz, Ana Patricia; Del Toro-Mejias, Lizbeth] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Biostat & Epidemiol, San Juan, PR 00936 USA; [Clatts, Michael Craig] Univ Puerto Rico, Grad Sch Publ Hlth, Ctr Res Global Hlth, San Juan, PR 00936 USA; [Palefsky, Joel M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of California System; University of California San Francisco	Colon-Lopez, V (corresponding author), Univ Puerto Rico, Ctr Comprehens Canc, Canc Control & Populat Sci Program, San Juan, PR 00936 USA.	vivian.colon@upr.edu			National Institutes of Health [R03 DA027939-01]; AIDS-Science Track Award for Research Transition A-START from NIDA [1R03DA031590-01]; National Center for Research Resources [U54 RR026139]; National Institute on Minority Health and Health Disparities [8U54MD 007587-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027939, R03DA031590] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS-Science Track Award for Research Transition A-START from NIDA; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was fully supported by National Institutes of Health R03 DA027939-01, and AIDS-Science Track Award for Research Transition A-START 1R03DA031590-01 from NIDA. The project was also partially supported by Award Number U54 RR026139 from the National Center for Research Resources, and the Award Number 8U54MD 007587-03 from the National Institute on Minority Health and Health Disparities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the PR Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2012, INT J CANCER, V131, P1969, DOI 10.1002/ijc.27650; Clatts MC, 2011, P R HEALTH SCI J, V30, P101; Colon-Lopez V, 2013, P R HEALTH SCI J, V32, P76; Colon-Lopez V, 2013, P R HEALTH SCI J, V32, P8; Colon-Lopez V, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-346; Colon-Lopez V, 2012, P R HEALTH SCI J, V31, P227; Colon-Lopez V, 2011, P R HEALTH SCI J, V30, P65; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Alvarez-Arguelles ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054375; Giuliano AR, 2010, GYNECOL ONCOL, V117, pS15, DOI 10.1016/j.ygyno.2010.01.026; IARC, 2012, IARC MON EV CARC R B, V100B; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Machalek DA, 2012, SEX HEALTH, V9, P527, DOI 10.1071/SH12043; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Orlando G, 2008, JAIDS-J ACQ IMM DEF, V47, P129, DOI 10.1097/QAI.0b013e318156ec7b; Piketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008; Ramirez-Marrero FA, 2010, P R HEALTH SCI J, V29, P256; STRAND A, 1993, GENITOURIN MED, V69, P446; Svare EI, 2002, SEX TRANSM INFECT, V78, P215, DOI 10.1136/sti.78.3.215; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035983	21	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83209	10.1371/journal.pone.0083209	http://dx.doi.org/10.1371/journal.pone.0083209			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400071	gold, Green Published, Green Submitted			2022-12-27	WOS:000329462700005
J	Sekiguchi, A; Sugiura, M; Taki, Y; Kotozaki, Y; Nouchi, R; Takeuchi, H; Araki, T; Hanawa, S; Nakagawa, S; Miyauchi, CM; Sakuma, A; Kawashima, R				Sekiguchi, Atsushi; Sugiura, Motoaki; Taki, Yasuyuki; Kotozaki, Yuka; Nouchi, Rui; Takeuchi, Hikaru; Araki, Tsuyoshi; Hanawa, Sugiko; Nakagawa, Seishu; Miyauchi, Carlos Makoto; Sakuma, Atsushi; Kawashima, Ryuta			White Matter Microstructural Changes as Vulnerability Factors and Acquired Signs of Post-Earthquake Distress	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANTERIOR CINGULATE CORTEX; MRI REVEALS; INTEGRITY; BRAIN; AMYGDALA; ANXIETY; VOLUME; ACTIVATIONS; EARTHQUAKE	Many survivors of severe disasters need psychological support, even those not suffering post-traumatic stress disorder (PTSD). The critical issue in understanding the psychological response after experiencing severe disasters is to distinguish neurological microstructural underpinnings as vulnerability factors from signs of emotional distress acquired soon after the stressful life event. We collected diffusion-tensor magnetic resonance imaging (DTI) data from a group of healthy adolescents before the Great East Japan Earthquake and re-examined the DTIs and anxiety levels of 30 non-PTSD subjects from this group 3-4 months after the earthquake using voxel-based analyses in a longitudinal DTI study before and after the earthquake. We found that the state anxiety level after the earthquake was negatively associated with fractional anisotropy (FA) in the right anterior cingulum (Cg) before the earthquake (r = -0.61, voxel level p<0.0025, cluster level p<0.05 corrected), and positively associated with increased FA changes from before to after the earthquake in the left anterior Cg (r = 0.70, voxel level p<0.0025, cluster level p<0.05 corrected) and uncinate fasciculus (Uf) (r = 0.65, voxel level p<0.0025, cluster level p<0.05 corrected). The results demonstrated that lower FA in the right anterior Cg was a vulnerability factor and increased FA in the left anterior Cg and Uf was an acquired sign of state anxiety after the earthquake. We postulate that subjects with dysfunctions in processing fear and anxiety before the disaster were likely to have higher anxiety levels requiring frequent emotional regulation after the disaster. These findings provide new evidence of psychophysiological responses at the neural network level soon after a stressful life event and might contribute to the development of effective methods to prevent PTSD.	[Sekiguchi, Atsushi; Taki, Yasuyuki] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimage Anal, Sendai, Miyagi 980, Japan; [Sekiguchi, Atsushi; Sugiura, Motoaki; Hanawa, Sugiko; Nakagawa, Seishu; Miyauchi, Carlos Makoto; Sakuma, Atsushi; Kawashima, Ryuta] Tohoku Univ, IDAC, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Sugiura, Motoaki; Nouchi, Rui] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki; Takeuchi, Hikaru] Tohoku Univ, IDAC, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan; [Taki, Yasuyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Nucl Med & Radiol, Sendai, Miyagi 980, Japan; [Kotozaki, Yuka; Nouchi, Rui; Araki, Tsuyoshi; Kawashima, Ryuta] Tohoku Univ, IDAC, Smart Ageing Int Res Ctr, Dept Adv Brain Sci, Sendai, Miyagi 980, Japan; [Nouchi, Rui] Japanese Soc Promot Sci, Tokyo, Japan; [Miyauchi, Carlos Makoto] Univ Tokyo, Grad Schools Law & Polit, Tokyo, Japan; [Sakuma, Atsushi] Tohoku Univ, Grad Sch Med, Dept Psychiat, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Japan Society for the Promotion of Science; University of Tokyo; Tohoku University	Sekiguchi, A (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimage Anal, Sendai, Miyagi 980, Japan.	asekiguchi@idac.tohoku.ac.jp	Nouchi, Rui/GQH-1608-2022; Kotozaki, Yuka/ABA-2267-2020; Kotozaki, Yuka/ABA-2922-2020; Takeuchi, Hikaru/D-1057-2011	Kotozaki, Yuka/0000-0002-4659-1200; Sakuma, Atsushi/0000-0002-9290-5311; xing zhi, shi zhi/0000-0003-3289-5681; Nouchi, Rui/0000-0002-2078-9518; Takeuchi, Hikaru/0000-0002-8022-9694	International Research Institute of Disaster Science; Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 24790653]; Ministry of Health, Labor and Welfare in Japan [H24-seishin-wakate014]	International Research Institute of Disaster Science; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	A.S. was supported by a Grant for Special Project Research from the International Research Institute of Disaster Science, a Grant-in-Aid for Young Scientists (B) (KAKENHI 24790653) from the Ministry of Education, Culture, Sports, Science and Technology, and Grants-in-Aid for Scientific Research (H24-seishin-wakate014) from the Ministry of Health, Labor and Welfare in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Albrecht J, 2007, J NEUROL NEUROSUR PS, V78, P964, DOI 10.1136/jnnp.2006.112987; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Baur V, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-4; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Carrion VG, 2010, BIOL PSYCHIAT, V68, P491, DOI 10.1016/j.biopsych.2010.05.010; Chen L, 2013, HUM BRAIN MAPP, V34, P367, DOI 10.1002/hbm.21438; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; EBELING U, 1992, ACTA NEUROCHIR, V115, P143, DOI 10.1007/BF01406373; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Furukawa K, 2011, LANCET, V377, P1652, DOI 10.1016/S0140-6736(11)60671-5; Ganzel BL, 2008, NEUROIMAGE, V40, P788, DOI 10.1016/j.neuroimage.2007.12.010; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Hamner M B, 1999, Depress Anxiety, V9, P1; Hettema JM, 2012, DEPRESS ANXIETY, V29, P202, DOI 10.1002/da.20901; *JAP I HLTH PSYCH, 1996, LAZ TYP STRESS COP I; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Lanius RA, 2004, AM J PSYCHIAT, V161, P36, DOI 10.1176/appi.ajp.161.1.36; Lazarus R.S., 1984, EMOTION ADAPTATION; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; McCurry J, 2011, LANCET, V378, P1061, DOI 10.1016/S0140-6736(11)61466-9; Nakazato K, 1982, USE STAI; Nishizono-Maher A., 1998, JAPANESE VERSION CLI; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Papagni SA, 2011, STRESS, V14, P227, DOI 10.3109/10253890.2010.522279; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shima S, 1985, SEISHIN IGAKU, V27, P717; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tabachnick G.B., 1996, USING MULTIVARIATE S; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	52	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83967	10.1371/journal.pone.0083967	http://dx.doi.org/10.1371/journal.pone.0083967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400079	gold, Green Published, Green Submitted			2022-12-27	WOS:000329462700013
J	Zhao, GD; Guo, S; Somel, M; Khaitovich, P				Zhao, Guodong; Guo, Song; Somel, Mehmet; Khaitovich, Philipp			Evolution of Human Longevity Uncoupled from Caloric Restriction Mechanisms	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; GENE-EXPRESSION; DIETARY RESTRICTION; OXIDATIVE STRESS; INCREASE LONGEVITY; RHESUS-MONKEYS; HUMAN-BEINGS; RESVERATROL; DISEASE; METABOLISM	Caloric restriction (CR) and chemical agents, such as resveratrol and rapamycin that partially mimic the CR effect, can delay morbidity and mortality across a broad range of species. In humans, however, the effects of CR or other life-extending agents have not yet been investigated systematically. Human maximal lifespan is already substantially greater compared to that of closely related primate species. It is therefore possible that humans have acquired genetic mutations that mimic the CR effect. Here, we tested this notion by comparing transcriptome differences between humans and other primates, with the transcriptome changes observed in mice subjected to CR. We show that the human transcriptome state, relative to other primate transcriptomes, does not match that of the CR mice or mice treated with resveratrol, but resembles the transcriptome state of ad libitum fed mice. At the same time, the transcriptome changes induced by CR in mice are enriched among genes showing age-related changes in primates, concentrated in specific expression patterns, and can be linked with specific functional pathways, including insulin signalling, cancer, and the immune response. These findings indicate that the evolution of human longevity was likely independent of CR-induced lifespan extension mechanisms. Consequently, application of CR or CR-mimicking agents may yet offer a promising direction for the extension of healthy human lifespan.	[Zhao, Guodong; Guo, Song; Somel, Mehmet; Khaitovich, Philipp] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Zhao, Guodong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Khaitovich, Philipp] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Somel, Mehmet] Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Max Planck Society; Middle East Technical University	Somel, M (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	somel.mehmet@gmail.com; khaitovich@eva.mpg.de	Guo, Song/F-7572-2016; Khaitovich, Philipp/HGC-8520-2022; Somel, Mehmet/B-1471-2016	Guo, Song/0000-0002-7150-8528; Somel, Mehmet/0000-0002-3138-1307	Ministry of Science and Technology of the People's Republic of China [2012DFG31940]; National Natural Science Fund of China [31171232, 31050110128]; Max Planck-Society; Bundesministerum fuer Bildung und Forschung; 1000 Plan for Foreign Experts; Chinese Academy of Sciences [2009Y2BS12]; European Molecular Biology Organization [EMBO ALTF 1475-2010]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Max Planck-Society(Max Planck SocietyFoundation CELLEX); Bundesministerum fuer Bildung und Forschung; 1000 Plan for Foreign Experts; Chinese Academy of Sciences(Chinese Academy of Sciences); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the Ministry of Science and Technology of the People's Republic of China (grant no. 2012DFG31940), National Natural Science Fund of China (grants no. 31171232 and 31050110128), the Max Planck-Society, and the Bundesministerum fuer Bildung und Forschung for financial support. PK was supported by 1000 Plan for Foreign Experts; MS was supported by fellowships from the Chinese Academy of Sciences (2009Y2BS12) and the European Molecular Biology Organization (EMBO ALTF 1475-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2005, AM J HUM BIOL, V17, P673, DOI 10.1002/ajhb.20439; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; BARRETTCONNOR E, 1986, NEW ENGL J MED, V315, P1519, DOI 10.1056/NEJM198612113152405; Barzilai N, 2009, J GERONTOL A-BIOL, V64, P187, DOI 10.1093/gerona/gln061; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Chouliaras L, 2011, BRAIN BEHAV IMMUN, V25, P616, DOI 10.1016/j.bbi.2010.11.016; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; CUTLER RG, 1979, MECH AGEING DEV, V9, P337, DOI 10.1016/0047-6374(79)90110-6; de Candia P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001670; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; de Magalhaes JP, 2002, EXP GERONTOL, V37, P769, DOI 10.1016/S0531-5565(02)00008-6; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Finch CE, 2004, Q REV BIOL, V79, P3, DOI 10.1086/381662; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hawkes K, 2003, AM J HUM BIOL, V15, P380, DOI 10.1002/ajhb.10156; Hawkes K, 2009, AM J HUM BIOL, V21, P578, DOI 10.1002/ajhb.20890; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JONES M L, 1992, In Vivo (Attiki), V6, P363; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaplan HS, 2002, P NATL ACAD SCI USA, V99, P10221, DOI 10.1073/pnas.152502899; Kemnitz JW, 2011, ILAR J, V52, P66, DOI 10.1093/ilar.52.1.66; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; KRITCHEVSKY D, 1979, FED PROC, V38, P2001; Kuningas M, 2007, EUR J HUM GENET, V15, P294, DOI 10.1038/sj.ejhg.5201766; Lane MA, 2000, MECH AGEING DEV, V112, P185, DOI 10.1016/S0047-6374(99)00087-1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Bourg E, 2006, BIOGERONTOLOGY, V7, P149, DOI 10.1007/s10522-006-9014-1; Le Bourg E, 2006, BIOGERONTOLOGY, V7, P123, DOI 10.1007/s10522-006-9010-5; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lefevre M, 2009, ATHEROSCLEROSIS, V203, P206, DOI 10.1016/j.atherosclerosis.2008.05.036; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; MCCAY CM, 1989, NUTRITION, V5, P155; Merry BJ, 2004, AGING CELL, V3, P7, DOI 10.1046/j.1474-9728.2003.00074.x; Newton IG, 2008, NEUROBIOL AGING, V29, P1308, DOI 10.1016/j.neurobiolaging.2007.03.009; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Phelan JP, 2006, BIOGERONTOLOGY, V7, P161, DOI 10.1007/s10522-006-9005-2; Plank M, 2012, MOL BIOSYST, V8, P1339, DOI 10.1039/c2mb05255e; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qin WP, 2006, J ALZHEIMERS DIS, V10, P417; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; ROBERTST.IC, 1974, LANCET, V2, P368; Rohrbach S, 2008, BIOGERONTOLOGY, V9, P169, DOI 10.1007/s10522-008-9126-x; Shanley DP, 2006, BIOGERONTOLOGY, V7, P165, DOI 10.1007/s10522-006-9006-1; Smith DL, 2010, EUR J CLIN INVEST, V40, P440, DOI 10.1111/j.1365-2362.2010.02276.x; Somel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001504; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Team. RDC, 2007, R LANG ENV STAT COMP; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Tokunaga C, 2004, BIOCHEM BIOPH RES CO, V313, P443, DOI 10.1016/j.bbrc.2003.07.019; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Videan EN, 2009, COMPARATIVE MED, V59, P287; Walker ARP, 2003, NUTRITION, V19, P169, DOI 10.1016/S0899-9007(02)00948-6; Walker R, 2006, AM J HUM BIOL, V18, P295, DOI 10.1002/ajhb.20510; Walker R, 2006, J HUM EVOL, V51, P480, DOI 10.1016/j.jhevol.2006.06.002; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Willcox DC, 2006, BIOGERONTOLOGY, V7, P173, DOI 10.1007/s10522-006-9008-z; Wrangham R, 2003, COMP BIOCHEM PHYS A, V136, P35, DOI 10.1016/S1095-6433(03)00020-5; Wu X, 2009, BIOINFORMATICS, V25, P832, DOI 10.1093/bioinformatics/btp059; Yuan Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-347	82	9	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84117	10.1371/journal.pone.0084117	http://dx.doi.org/10.1371/journal.pone.0084117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400080	Green Published, gold			2022-12-27	WOS:000329462700014
J	Adler, C; Corbalan, NS; Peralta, DR; Pomares, MF; de Cristobal, RE; Vincent, PA				Adler, Conrado; Corbalan, Natalia S.; Peralta, Daiana R.; Fernanda Pomares, Maria; de Cristobal, Ricardo E.; Vincent, Paula A.			The Alternative Role of Enterobactin as an Oxidative Stress Protector Allows Escherichia coli Colony Development	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; NONCULTURABLE STATE; DESFERRIOXAMINE-E; OUTER-MEMBRANE; IRON-TRANSPORT; SIDEROPHORES; BACTERIA; SYSTEM; GROWTH; PROTEINS	Numerous bacteria have evolved different iron uptake systems with the ability to make use of their own and heterologous siderophores. However, there is growing evidence attributing alternative roles for siderophores that might explain the potential adaptive advantages of microorganisms having multiple siderophore systems. In this work, we show the requirement of the siderophore enterobactin for Escherichia coli colony development in minimal media. We observed that a strain impaired in enterobactin production (entE mutant) was unable to form colonies on M9 agar medium meanwhile its growth was normal on LB agar medium. Given that, neither iron nor citrate supplementation restored colony growth, the role of enterobactin as an iron uptake-facilitator would not explain its requirement for colony development. The absence of colony development was reverted either by addition of enterobactin, the reducing agent ascorbic acid or by incubating in anaerobic culture conditions with no additives. Then, we associated the enterobactin requirement for colony development with its ability to reduce oxidative stress, which we found to be higher in media where the colony development was impaired (M9) compared with media where the strain was able to form colonies (LB). Since oxyR and soxS mutants (two major stress response regulators) formed colonies in M9 agar medium, we hypothesize that enterobactin could be an important piece in the oxidative stress response repertoire, particularly required in the context of colony formation. In addition, we show that enterobactin has to be hydrolyzed after reaching the cell cytoplasm in order to enable colony development. By favoring iron release, hydrolysis of the enterobactin-iron complex, not only would assure covering iron needs, but would also provide the cell with a molecule with exposed hydroxyl groups (hydrolyzed enterobactin). This molecule would be able to scavenge radicals and therefore reduce oxidative stress.	[Adler, Conrado; Corbalan, Natalia S.; Peralta, Daiana R.; Fernanda Pomares, Maria; de Cristobal, Ricardo E.; Vincent, Paula A.] INSIBIO Consejo Nacl Invest Cient & Tecn Univ Nac, Dept Bioquim Nutr, San Miguel De Tucuman, Argentina		Vincent, PA (corresponding author), INSIBIO Consejo Nacl Invest Cient & Tecn Univ Nac, Dept Bioquim Nutr, San Miguel De Tucuman, Argentina.	pvincent@fbqf.unt.edu.ar		Corbalan, Natalia/0000-0002-3588-3099	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2107, 1939]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 112]; Consejo de Investigaciones de la U.N.T. [CIUNT 26/D439]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo de Investigaciones de la U.N.T.; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by grants PICT 2107 and 1939 from the Agencia Nacional de Promocion Cientifica y Tecnologica, PIP 112 from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, CIUNT 26/D439 from the Consejo de Investigaciones de la U.N.T. Conrado Adler, Daiana R. Peralta and Natalia S. Corbalan were recipients of a fellowship from CONICET. Ricardo de Cristobal, Maria Fernanda Pomares and Paula Andrea Vincent are Career Investigators from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; Achard ME, 2013, BIOCH J; Adler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046754; Al-Azemi A, 2011, J APPL MICROBIOL, V110, P1307, DOI 10.1111/j.1365-2672.2011.04983.x; Albrecht-Gary AM, 1998, MET IONS BIOL SYST, V35, P239; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Bleuel C, 2005, J BACTERIOL, V187, P6701, DOI 10.1128/JB.187.19.6701-6707.2005; Braud A, 2009, J BACTERIOL, V191, P3517, DOI 10.1128/JB.00010-09; Braun V, 2007, BIOMETALS, V20, P219, DOI 10.1007/s10534-006-9072-5; Brooks BE, 2008, BBA-BIOMEMBRANES, V1778, P1930, DOI 10.1016/j.bbamem.2007.06.005; CARRANO CJ, 1979, J AM CHEM SOC, V101, P5401, DOI 10.1021/ja00512a047; CHENAULT SS, 1991, MOL MICROBIOL, V5, P1405, DOI 10.1111/j.1365-2958.1991.tb00787.x; Chi Z, 2011, BIOMETALS; Clarke Teresa E., 2001, Current Topics in Medicinal Chemistry, V1, P7, DOI 10.2174/1568026013395623; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Hogan D, 2002, CURR OPIN MICROBIOL, V5, P472, DOI 10.1016/S1369-5274(02)00357-0; Ishida S, 2011, BIOL PHARM BULL, V34, P917, DOI 10.1248/bpb.34.917; Jeong JM, 2007, J PHARM PHARM SCI, V10, P537, DOI 10.18433/J3KW2Z; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020777; Ma L, 2012, J BACTERIOL, V194, P6748, DOI 10.1128/JB.01574-12; MA M, 1992, P NATL ACAD SCI USA, V89, P7924, DOI 10.1073/pnas.89.17.7924; Markel E, 2011, J BACTERIOL, V193, P5775, DOI 10.1128/JB.05114-11; Narten M, 2011, CURR MICROBIOL; Negre VL, 2004, INFECT IMMUN, V72, P1216, DOI 10.1128/IAI.72.2.1216-1220.2004; NEILANDS JB, 1992, CAN J MICROBIOL, V38, P728, DOI 10.1139/m92-119; NEILANDS JB, 1982, ANNU REV MICROBIOL, V36, P285, DOI 10.1146/annurev.mi.36.100182.001441; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; OZENBERGER BA, 1987, J BACTERIOL, V169, P3638, DOI 10.1128/jb.169.8.3638-3646.1987; Pazos M, 2006, J AGR FOOD CHEM, V54, P10215, DOI 10.1021/jf062134n; Povie G, CHEM COMMUN CAMB, V46, P803; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Schalk IJ, 2011, ENVIRON MICROBIOL, V13, P2844, DOI 10.1111/j.1462-2920.2011.02556.x; Sorsa LJ, 2003, INFECT IMMUN, V71, P3285, DOI 10.1128/IAI.71.6.3285-3293.2003; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; Tindale AE, 2000, MICROBIOL-SGM, V146, P1617, DOI 10.1099/00221287-146-7-1617; Torres AG, 1997, MOL MICROBIOL, V23, P825, DOI 10.1046/j.1365-2958.1997.2641628.x; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wang WL, 2009, BIORESOURCE TECHNOL, V100, P2639, DOI 10.1016/j.biortech.2008.12.010; Yamanaka K, 2005, MICROBIOL-SGM, V151, P2899, DOI 10.1099/mic.0.28139-0; Zhou YN, 1998, J BACTERIOL, V180, P1154, DOI 10.1128/JB.180.5.1154-1158.1998	48	47	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84734	10.1371/journal.pone.0084734	http://dx.doi.org/10.1371/journal.pone.0084734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392154	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100077
J	Axpe, E; Lopez-Euba, T; Castellanos-Rubio, A; Merida, D; Garcia, JA; Plaza-Izurieta, L; Fernandez-Jimenez, N; Plazaola, F; Bilbao, JR				Axpe, Eneko; Lopez-Euba, Tamara; Castellanos-Rubio, Ainara; Merida, David; Angel Garcia, Jose; Plaza-Izurieta, Leticia; Fernandez-Jimenez, Nora; Plazaola, Fernando; Ramon Bilbao, Jose			Detection of Atomic Scale Changes in the Free Volume Void Size of Three-Dimensional Colorectal Cancer Cell Culture Using Positron Annihilation Lifetime Spectroscopy	PLOS ONE			English	Article							SKIN	Positron annihilation lifetime spectroscopy (PALS) provides a direct measurement of the free volume void sizes in polymers and biological systems. This free volume is critical in explaining and understanding physical and mechanical properties of polymers. Moreover, PALS has been recently proposed as a potential tool in detecting cancer at early stages, probing the differences in the subnanometer scale free volume voids between cancerous/healthy skin samples of the same patient. Despite several investigations on free volume in complex cancerous tissues, no positron annihilation studies of living cancer cell cultures have been reported. We demonstrate that PALS can be applied to the study in human living 3D cell cultures. The technique is also capable to detect atomic scale changes in the size of the free volume voids due to the biological responses to TGF-beta. PALS may be developed to characterize the effect of different culture conditions in the free volume voids of cells grown in vitro.	[Axpe, Eneko; Plazaola, Fernando] Univ Basque Country UPV EHU, Dept Elect & Elect, Leioa, Basque Country, Spain; [Lopez-Euba, Tamara; Castellanos-Rubio, Ainara; Plaza-Izurieta, Leticia; Fernandez-Jimenez, Nora; Ramon Bilbao, Jose] BioCruces Res Inst, Immunogenet Res Lab, Baracaldo, Basque Country, Spain; [Castellanos-Rubio, Ainara; Plaza-Izurieta, Leticia; Fernandez-Jimenez, Nora; Ramon Bilbao, Jose] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Basque Country, Spain; [Merida, David; Angel Garcia, Jose] Univ Basque Country UPV EHU, Dept Appl Phys 2, Leioa, Basque Country, Spain	University of Basque Country; University of Basque Country; University of Basque Country	Axpe, E (corresponding author), Univ Basque Country UPV EHU, Dept Elect & Elect, Leioa, Basque Country, Spain.	eneko.axpe@ehu.es	Castellanos-Rubio, Ainara/AAB-9700-2022; Bilbao, Jose Ramon/A-9177-2008; Fernandez-Jimenez, Nora/T-1535-2019	Bilbao, Jose Ramon/0000-0002-3176-501X; Plazaola Muguruza, Fernando/0000-0002-0081-8131; Castellanos Rubio, Ainara/0000-0003-3192-9544; Axpe, Eneko/0000-0002-9114-5306; Fernandez-Jimenez, Nora/0000-0001-6307-0880	Basque Department of Industry [SAI11/263 - PRODETEC]; Basque Department of Education, Universities and Research [IT/443/10]	Basque Department of Industry; Basque Department of Education, Universities and Research	Basque Department of Industry grant no. SAI11/263 - PRODETEC and Basque Department of Education, Universities and Research grant no. IT/443/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HM, 2012, DEFECT DIFFUS FORUM, V331, P275, DOI 10.4028/www.scientific.net/DDF.331.275; ELDRUP M, 1981, CHEM PHYS, V63, P51, DOI 10.1016/0301-0104(81)80307-2; Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; JEAN YC, 1990, MICROCHEM J, V42, P72, DOI 10.1016/0026-265X(90)90027-3; Juuti-Uusitalo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022967; Kansy J, 1996, NUCL INSTRUM METH A, V374, P235, DOI 10.1016/0168-9002(96)00075-7; Liu G, 2008, APPL SURF SCI, V255, P115, DOI 10.1016/j.apsusc.2008.05.241; Liu G, 2007, PHYS STATUS SOLIDI C, V4, P3912, DOI 10.1002/pssc.200675736; Nakanishi H., 1988, POSITRON ANNIHILATIO; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; Sane P, 2010, BBA-BIOMEMBRANES, V1798, P958, DOI 10.1016/j.bbamem.2010.01.011; Sane P, 2009, J PHYS CHEM B, V113, P1810, DOI 10.1021/jp809308j; Siles S, 1999, J RADIOANAL NUCL CH, V240, P529, DOI 10.1007/BF02349408; TAO SJ, 1972, J CHEM PHYS, V56, P5499, DOI 10.1063/1.1677067; Yang S, 2009, AIP CONF PROC, V1099, P948, DOI 10.1063/1.3120199	15	27	27	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83838	10.1371/journal.pone.0083838	http://dx.doi.org/10.1371/journal.pone.0083838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392097	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100021
J	Jones, DE; Igo, S; Hurdle, J; Facelli, JC				Jones, David E.; Igo, Sean; Hurdle, John; Facelli, Julio C.			Automatic Extraction of Nanoparticle Properties Using Natural Language Processing: NanoSifter an Application to Acquire PAMAM Dendrimer Properties	PLOS ONE			English	Article							KNOWLEDGE	In this study, we demonstrate the use of natural language processing methods to extract, from nanomedicine literature, numeric values of biomedical property terms of poly(amidoamine) dendrimers. We have developed a method for extracting these values for properties taken from the NanoParticle Ontology, using the General Architecture for Text Engineering and a Nearly-New Information Extraction System. We also created a method for associating the identified numeric values with their corresponding dendrimer properties, called NanoSifter. We demonstrate that our system can correctly extract numeric values of dendrimer properties reported in the cancer treatment literature with high recall, precision, and f-measure. The micro-averaged recall was 0.99, precision was 0.84, and f-measure was 0.91. Similarly, the macro-averaged recall was 0.99, precision was 0.87, and f-measure was 0.92. To our knowledge, these results are the first application of text mining to extract and associate dendrimer property terms and their corresponding numeric values.	[Jones, David E.; Igo, Sean; Hurdle, John; Facelli, Julio C.] Univ Utah, Dept Biomed Informat, Salt Lake City, UT 84112 USA; [Igo, Sean; Facelli, Julio C.] Univ Utah, Ctr High Performance Comp, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Jones, DE (corresponding author), Univ Utah, Dept Biomed Informat, Salt Lake City, UT 84112 USA.	davide.jones@utah.edu		Hurdle, John/0000-0002-1188-7685; facelli, julio/0000-0003-1449-477X; Jones, David/0000-0002-6521-3213	National Library of Medicine [T15LM007124, R01-LM010981]; NATIONAL LIBRARY OF MEDICINE [R01LM010981, T15LM007124] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The project described was supported by Grant Numbers T15LM007124 and R01-LM010981 from the National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaussabel Damien, 2004, Am J Pharmacogenomics, V4, P383, DOI 10.2165/00129785-200404060-00005; Cunningham H., 2011, TEXT PROCESSING GATE; de la Iglesia D, 2011, METHOD INFORM MED, V50, P84, DOI 10.3414/ME10-02-0012; du Toit Lisa Claire, 2007, Recent Pat Drug Deliv Formul, V1, P131; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Garcia-Remesal M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/410294; Garten Y, 2010, PHARMACOGENOMICS, V11, P1467, DOI [10.2217/pgs.10.136, 10.2217/PGS.10.136]; Hunter L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-78; Institute ANS, 2013, ANSI NSP LAUNCH NAN; Jain KK, 2008, HDB NANOMEDICINE; Kolhe P, 2003, INT J PHARM, V259, P143, DOI 10.1016/S0378-5173(03)00225-4; Liu KH, 2011, J BIOMED INFORM, V44, P163, DOI 10.1016/j.jbi.2010.07.006; National Cancer Institute, 2011, WELC CANC NAN LAB CA; Staggers N, 2008, NURS OUTLOOK, V56, P268, DOI 10.1016/j.outlook.2008.06.004; Thomas DG, 2011, J BIOMED INFORM, V44, P59, DOI 10.1016/j.jbi.2010.03.001; Wood KC, 2005, ANGEW CHEM INT EDIT, V44, P6704, DOI 10.1002/anie.200502152; Yiming Yang, 1999, Information Retrieval, V1, P69, DOI 10.1023/A:1009982220290; Zaremba S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-177	18	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83932	10.1371/journal.pone.0083932	http://dx.doi.org/10.1371/journal.pone.0083932			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392101	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100025
J	Su, YC; Guo, JL; Ling, H; Chen, SS; Wang, SS; Xu, LP; Allan, AC; Que, YX				Su, Yachun; Guo, Jinlong; Ling, Hui; Chen, Shanshan; Wang, Shanshan; Xu, Liping; Allan, Andrew C.; Que, Youxiong			Isolation of a Novel Peroxisomal Catalase Gene from Sugarcane, Which Is Responsive to Biotic and Abiotic Stresses	PLOS ONE			English	Article							MOLECULAR-CLONING; CELL-DEATH; EXPRESSION ANALYSIS; RESISTANCE; SALT; DISEASE; PROTEIN; SMUT; H2O2; IDENTIFICATION	Catalase is an iron porphyrin enzyme, which serves as an efficient scavenger of reactive oxygen species (ROS) to avoid oxidative damage. In sugarcane, the enzymatic activity of catalase in a variety (Yacheng05-179) resistant to the smut pathogen Sporisorium scitamineum was always higher than that of the susceptible variety (Liucheng03-182), suggesting that catalase activity may have a positive correlation with smut resistance in sugarcane. To understand the function of catalase at the molecular level, a cDNA sequence of ScCAT1 (GenBank Accession No. KF664183), was isolated from sugarcane infected by S. scitamineum. ScCAT1 was predicted to encode 492 amino acid residues, and its deduced amino acid sequence shared a high degree of homology with other plant catalases. Enhanced growth of ScCAT1 in recombinant Escherichia coli Rosetta cells under the stresses of CuCl2, CdCl2 and NaCl indicated its high tolerance. Q-PCR results showed that ScCAT1 was expressed at relatively high levels in the bud, whereas expression was moderate in stem epidermis and stem pith. Different kinds of stresses, including S. scitamineum challenge, plant hormones (SA, MeJA and ABA) treatments, oxidative (H2O2) stress, heavy metal (CuCl2) and hyper-osmotic (PEG and NaCl) stresses, triggered a significant induction of ScCAT1. The ScCAT1 protein appeared to localize in plasma membrane and cytoplasm. Furthermore, histochemical assays using DAB and trypan blue staining, as well as conductivity measurement, indicated that ScCAT1 may confer the sugarcane immunity. In conclusion, the positive response of ScCAT1 to biotic and abiotic stresses suggests that ScCAT1 is involved in protection of sugarcane against reactive oxidant-related environmental stimuli.	[Su, Yachun; Guo, Jinlong; Ling, Hui; Chen, Shanshan; Wang, Shanshan; Xu, Liping; Que, Youxiong] Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Fujian, Peoples R China; [Allan, Andrew C.] New Zealand Inst Plant & Food Res, Auckland, New Zealand	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; New Zealand Institute for Plant & Food Research Ltd	Xu, LP (corresponding author), Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou, Fujian, Peoples R China.	xlpmail@126.com; queyouxiong@hotmail.com	Allan, Andrew C/L-3253-2016	Allan, Andrew C/0000-0003-1944-7067; Que, Youxiong/0000-0003-1111-5834; Su, Yachun/0000-0002-3893-2909; Guo, Jin long/0000-0001-5537-3152	National Natural Science Foundation of China [31101196]; earmarked fund for the Modern Agriculture Technology of China (CARS-20); Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University [xjq201202]; National High Technology Research and Development Program of China (863 Program) Project [2013AA102604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agriculture Technology of China (CARS-20); Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University; National High Technology Research and Development Program of China (863 Program) Project(National High Technology Research and Development Program of China)	This research was supported by National Natural Science Foundation of China (No. 31101196), the earmarked fund for the Modern Agriculture Technology of China (CARS-20), Research Funds for Distinguished Young Scientists in Fujian Agriculture and Forestry University (xjq201202), National High Technology Research and Development Program of China (863 Program) Project (2013AA102604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri VP, 1990, DIS SUGARCANE SUGARB, P72; Alexander K.C., 1980, P INT SOC SUGARCANE, V17, P1452; Casu RE, 2004, PLANT MOL BIOL, V54, P503, DOI 10.1023/B:PLAN.0000038255.96128.41; Chaurasia N, 2008, BIOCHEM BIOPH RES CO, V376, P225, DOI 10.1016/j.bbrc.2008.08.129; Chen HJ, 2012, J PLANT PHYSIOL, V169, P86, DOI 10.1016/j.jplph.2011.08.002; Choi DS, 2012, PLANT CELL, V24, P1675, DOI 10.1105/tpc.112.095869; Choi HW, 2011, MOL PLANT MICROBE IN, V24, P68, DOI 10.1094/MPMI-02-10-0030; DRORY A, 1992, PLANT PHYSIOL, V100, P1605, DOI 10.1104/pp.100.3.1605; Du YY, 2008, J INTEGR PLANT BIOL, V50, P1318, DOI 10.1111/j.1744-7909.2008.00741.x; Dussle CM, 2003, THEOR APPL GENET, V106, P485, DOI 10.1007/s00122-002-1107-x; Fawcett GL, 1942, CIRCULAR ESTACION EX, P114; Frugoli JA, 1996, PLANT PHYSIOL, V112, P327, DOI 10.1104/pp.112.1.327; Guan LM, 2000, FREE RADICAL BIO MED, V28, P1182, DOI 10.1016/S0891-5849(00)00212-4; GUAN LQ, 1995, P NATL ACAD SCI USA, V92, P5930, DOI 10.1073/pnas.92.13.5930; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Guan ZQ, 2009, CHEMOSPHERE, V76, P623, DOI 10.1016/j.chemosphere.2009.04.047; Guo JL, 2012, PLANT CELL REP, V31, P1801, DOI 10.1007/s00299-012-1293-1; Guo JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/904769; Gupta K, 2010, PLANT CELL REP, V29, P1131, DOI 10.1007/s00299-010-0896-7; Hao JJ, 2001, PLANT PHYSL EXPT TEC, P53; HOY JW, 1986, PLANT DIS, V70, P59, DOI 10.1094/PD-70-59; Huckelhoven R, 2000, PLANTA, V212, P16, DOI 10.1007/s004250000385; Hwang IS, 2011, PLANT PHYSIOL, V155, P447, DOI 10.1104/pp.110.164848; Jithesh MN, 2006, PLANT CELL REP, V25, P865, DOI 10.1007/s00299-006-0127-4; Kwon SI, 2001, PLANT SCI, V160, P961, DOI 10.1016/S0168-9452(01)00332-6; Lakshmanan P, 2005, IN VITRO CELL DEV-PL, V41, P345, DOI 10.1079/IVP2005643; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li YZ, 2010, PLANT PHYSIOL, V153, P1425, DOI 10.1104/pp.110.156240; Lin YanQuan, 1996, Journal of Fujian Agricultural University, V25, P271; Liu Y, 2005, BIOCHEM BIOPH RES CO, V331, P325, DOI 10.1016/j.bbrc.2005.03.165; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi L, 2005, PLANT SCI, V168, P797, DOI 10.1016/j.plantsci.2004.10.012; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Moosawi-Jorf S. A., 2007, Journal of Applied Sciences, V7, P3768; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Purev M, 2010, PLANT PHYSIOL BIOCH, V48, P451, DOI 10.1016/j.plaphy.2010.02.005; [阙友雄 Que Youxiong], 2009, [热带作物学报, Chinese Journal of Tropical Crops], V30, P274; Rezaee F, 2013, S AFR J BOT, V84, P13, DOI 10.1016/j.sajb.2012.09.006; SANDMANN G, 1980, PLANT PHYSIOL, V66, P797, DOI 10.1104/pp.66.5.797; Scandalios JG, 2000, PLANT SCI, V156, P103, DOI 10.1016/S0168-9452(00)00235-1; Singh N, 2004, PLANT SCI, V167, P987, DOI 10.1016/j.plantsci.2004.05.006; Skadsen RW, 1995, PLANT MOL BIOL, V29, P1005, DOI 10.1007/BF00014973; Solas M. T., 1999, Sugar Cane, P14; [宋新华 SONG Xinhua], 2007, [安徽农业科学, Journal of Anhui Agricultural Sciences], V35, P9824; Su YC, 2013, PLANT CELL REP, V32, P1503, DOI 10.1007/s00299-013-1463-9; Sundar A.R., 2012, BOTANY, DOI [10.5772/34116, DOI 10.5772/34116]; Takken FLW, 2000, EUR J PLANT PATHOL, V106, P699, DOI 10.1023/A:1026571130477; WALLER JM, 1970, T BRIT MYCOL SOC, V54, P405, DOI 10.1016/S0007-1536(70)80155-3; Wan LL, 2011, PLANTA, V233, P309, DOI 10.1007/s00425-010-1301-z; Wang C, 2013, FISH SHELLFISH IMMUN, V34, P91, DOI 10.1016/j.fsi.2012.10.013; WILLEKENS H, 1994, FEBS LETT, V352, P79, DOI 10.1016/0014-5793(94)00923-6; WILLIAMSON JD, 1992, PLANT J, V2, P351; Xu L. P., 1994, SUGARCANE, V3, P13; [Xu Liping 徐莉萍], 2004, [热带作物学报, Chinese Journal of Tropical Crops], V25, P33	55	69	79	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84426	10.1371/journal.pone.0084426	http://dx.doi.org/10.1371/journal.pone.0084426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392135	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100058
J	Xu, QM; Yuan, FF; Shen, XM; Wen, H; Li, W; Cheng, B; Wu, J				Xu, Qiumei; Yuan, Fangfen; Shen, Xuemei; Wen, Hui; Li, Wei; Cheng, Bei; Wu, Jing			Polymorphisms of C242T and A640G in CYBA Gene and the Risk of Coronary Artery Disease: A Meta-Analysis	PLOS ONE			English	Review							CHRONIC GRANULOMATOUS-DISEASE; OXIDASE P22PHOX GENE; NAD(P)H OXIDASE; HEART-DISEASE; NADPH OXIDASE; P22(PHOX) POLYMORPHISMS; CIGARETTE-SMOKING; LIGHT-CHAIN; POPULATION; P22-PHOX	Background: Coronary artery disease (CAD) is a leading cause of mortality in many countries. Considerable studies have been carried out to investigate the relationship between the C242T and A640G polymorphisms of CYBA gene and CAD, but the results were still inconsistent. Hence we conducted a meta-analysis to clarify the association. Methods and Results: A total of 21 eligible literatures were included in the meta-analysis. We observed a significant decreased risk of CAD for C242T polymorphism in Asian population under an allelic model (OR 0.75; 95% CI 0.67-0.84) and a dominant model (OR 0.69; 95% CI 0.61-0.79), however, in overall population and other population no significant association was revealed. We also found A640G polymorphism may contribute to reducing CAD risk under an allelic model (OR 0.84; 95% CI 0.75-0.93), dominant model (OR0.77; 95% CI 0.64-0.92) and recessive model (OR0.82; 95% CI 0.69-0.97). No publication bias was found. Conclusion: Our meta-analysis confirmed a protective effect of C242Tpolymorphism on CAD in Asian population and indicated that A640G polymorphism was significantly associated with decreased risk of CAD.	[Yuan, Fangfen; Shen, Xuemei; Wu, Jing] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Yuan, Fangfen; Shen, Xuemei; Wu, Jing] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xu, Qiumei; Wen, Hui; Li, Wei; Cheng, Bei] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gerontol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wu, J (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Key Lab Environm & Hlth, Wuhan 430074, Peoples R China.	wujingrlh@163.com			fundamental research funds for the central universities (HUST) [2012QN228]	fundamental research funds for the central universities (HUST)(Fundamental Research Funds for the Central Universities)	This work was supported by the fundamental research funds for the central universities (HUST: NO.2012QN228) granted to Qiumei Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azumi H, 1999, CIRCULATION, V100, P1494, DOI 10.1161/01.CIR.100.14.1494; Bedard K, 2009, HUM MUTAT, V30, P1123, DOI 10.1002/humu.21029; Cai H, 1999, EUR J CLIN INVEST, V29, P744; DEBOER M, 1992, AM J HUM GENET, V51, P1127; Di Castelnuovo A, 2008, THROMB HAEMOSTASIS, V99, P594, DOI 10.1160/TH07-08-0480; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fan M, 2006, AM HEART J, V152, P538, DOI 10.1016/j.ahj.2006.02.018; Fang SX, 2010, THROMB RES, V125, pE197, DOI 10.1016/j.thromres.2010.01.001; Fortuno A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098; Gardemann A, 1999, ATHEROSCLEROSIS, V145, P315, DOI 10.1016/S0021-9150(99)00083-0; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Goliasch G, 2011, THROMB HAEMOSTASIS, V105, P529, DOI 10.1160/TH10-08-0529; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Guzik TJ, 2000, CIRCULATION, V102, P1744; He MA, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.002; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Inoue N, 1998, CIRCULATION, V97, P135, DOI 10.1161/01.CIR.97.2.135; Jose GS, 2008, CLIN SCI, V114, P173, DOI 10.1042/CS20070130; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee WH, 2001, VASC MED, V6, P103, DOI 10.1191/135886301680223635; Li A, 1999, AM J MED GENET, V86, P57, DOI 10.1002/(SICI)1096-8628(19990903)86:1<57::AID-AJMG11>3.0.CO;2-R; Macias-Reyes A, 2008, FREE RADICAL RES, V42, P82, DOI 10.1080/10715760701796918; Mata-Balaguer T, 2004, INT J CARDIOL, V95, P145, DOI 10.1016/j.ijcard.2003.05.017; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McKay J., 2004, ATLAS HEART DIS STRO; MOHAZZABH KM, 1994, AM J PHYSIOL, V266, pH2568, DOI 10.1152/ajpheart.1994.266.6.H2568; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Murase Y, 2004, EUR HEART J, V25, P970, DOI 10.1016/j.ehj.2004.02.020; Najafi M, 2012, GENE, V499, P213, DOI 10.1016/j.gene.2012.02.032; Nasti S, 2006, DIS MARKERS, V22, P167, DOI 10.1155/2006/458587; Niemiec P, 2007, CORONARY ARTERY DIS, V18, P339, DOI 10.1097/MCA.0b013e328241d97a; Niemiec P, 2011, BIOMARKERS, V16, P405, DOI 10.3109/1354750X.2011.580368; Nikitin AG, 2010, HEART VESSELS, V25, P229, DOI 10.1007/s00380-009-1159-9; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Saha N, 1999, EUR J CLIN INVEST, V29, P999; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Stanger O, 2001, CLIN PHYSIOL, V21, P718, DOI 10.1046/j.1365-2281.2001.00381.x; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Vormfelde SV, 2007, PHARMACOGENOMICS J, V7, P200, DOI 10.1038/sj.tpj.6500410; Whitehead AS, 2001, CIRCULATION, V103, P7; Wyche KE, 2004, HYPERTENSION, V43, P1246, DOI 10.1161/01.HYP.0000126579.50711.62; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Zafari AM, 2002, ANTIOXID REDOX SIGN, V4, P675, DOI 10.1089/15230860260220184	50	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84251	10.1371/journal.pone.0084251	http://dx.doi.org/10.1371/journal.pone.0084251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392120	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100043
J	Barth, VC; Rodrigues, BA; Bonatto, GD; Gallo, SW; Pagnussatti, VE; Ferreira, CAS; de Oliveira, SD				Barth, Valdir Cristovao, Jr.; Rodrigues, Belisa Avila; Bonatto, Grasiela Daiane; Gallo, Stephanie Wagner; Pagnussatti, Vany Elisa; Sanchez Ferreira, Carlos Alexandre; de Oliveira, Silvia Dias			Heterogeneous Persister Cells Formation in Acinetobacter baumannii	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; ESCHERICHIA-COLI; BACTERICIDAL ANTIBIOTICS; MULTIDRUG TOLERANCE; DORMANCY; DEATH; INFECTIONS; MECHANISMS	Bacterial persistence is a feature that allows susceptible bacteria to survive extreme concentrations of antibiotics and it has been verified in a number of species, such as Escherichia coli, Pseudomonas aeruginosa, Staphylococcus spp., Mycobacterium spp. However, even though Acinetobacter baumannii is an important nosocomial pathogen, data regarding its persistence phenotype are still lacking. Therefore, the aim of this study was to evaluate the persistence phenotype in A. baumannii strains, as well as its variation among strains after treatment with polymyxin B and tobramycin. Stationary cultures of 37 polymyxin B-susceptible clinical strains of A. baumannii were analyzed for surviving cells after exposure to 15 mu g/mL of polymyxin B for 6 h, by serial dilutions and colony counting. Among these, the 30 tobramycin-susceptible isolates also underwent tobramycin treatment at a concentration of 160 mu g/mL and persister cells occurrence was evaluated equally. A high heterogeneity of persister cells formation patterns among isolates was observed. Polymyxin B-treated cultures presented persister cells corresponding from 0.0007% to 10.1% of the initial population and two isolates failed to produce detectable persister cells under this condition. A high variability could also be observed when cells were treated with tobramycin: the persister fraction corresponded to 0.0003%-11.84% of the pre-treatment population. Moreover, no correlation was found between persister subpopulations comparing both antibiotics among isolates, indicating that different mechanisms underlie the internal control of this phenotype. This is the first report of persister cells occurrence in A. baumannii. Our data suggest that distinct factors regulate the tolerance for unrelated antibiotics in this species, contrasting the multi-drug tolerance observed in other species (eg. dormancy-mediated tolerance). Supporting this observation, polymyxin B -an antibiotic that is believed to act on non-dividing cells as well-failed to eradicate persister cells in the majority of the isolates, possibly reflecting a disconnection between persistence and dormancy.	[Barth, Valdir Cristovao, Jr.; Rodrigues, Belisa Avila; Bonatto, Grasiela Daiane; Gallo, Stephanie Wagner; Sanchez Ferreira, Carlos Alexandre; de Oliveira, Silvia Dias] Pontificia Univ Rio Grande Sul, Fac Biociencias, Lab Imunol & Microbiol, Porto Alegre, RS, Brazil; [Pagnussatti, Vany Elisa] Pontificia Univ Rio Grande Sul, Hosp Sao Lucas, Lab Patol Clin, Dept Microbiol, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	de Oliveira, SD (corresponding author), Pontificia Univ Rio Grande Sul, Fac Biociencias, Lab Imunol & Microbiol, Porto Alegre, RS, Brazil.	silviadias@pucrs.br	Oliveira, Sílvia D/G-3436-2012; Ferreira, Carlos A S/J-3672-2015; Junior, Valdir Cristovao Barth/G-9353-2011	Oliveira, Sílvia D/0000-0002-7296-5085; Ferreira, Carlos A S/0000-0002-3727-5097; Junior, Valdir Cristovao Barth/0000-0002-7410-1598	CAPES, Brazil	CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Valdir C. Barth Jr. received a scholarship from CAPES, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier SP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003144; Bigger JW, 1944, LANCET, V2, P497; Clinical and Laboratory Standards Institute, 2012, APPROV STAND 9 EDITI, V32, P3; CLSI, 2012, PERFORMANCE STANDARD, V7th; Correia FF, 2006, J BACTERIOL, V188, P8360, DOI 10.1128/JB.01237-06; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Fasani RA, 2013, P NATL ACAD SCI USA, V110, pE2528, DOI 10.1073/pnas.1301023110; Fauvart M, 2011, J MED MICROBIOL, V60, P699, DOI 10.1099/jmm.0.030932-0; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Hofsteenge N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-25; Jurenaite M, 2013, J BACTERIOL, V195, P3165, DOI 10.1128/JB.00237-13; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Knudsen GM, 2013, APPL ENVIRON MICROB, V79, P7390, DOI 10.1128/AEM.02184-13; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Moffatt JH, 2010, ANTIMICROB AGENTS CH, V54, P4971, DOI 10.1128/AAC.00834-10; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; Renggli S, 2013, J BACTERIOL, V195, P4067, DOI 10.1128/JB.00393-13; Sampson TR, 2012, ANTIMICROB AGENTS CH, V56, P5642, DOI 10.1128/AAC.00756-12; Stewart B, 2012, EVOLUTION, V66, P933, DOI 10.1111/j.1558-5646.2011.01467.x; Tashiro Y, 2012, J BACTERIOL, V194, P1169, DOI 10.1128/JB.06628-11; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Wu YX, 2012, ANTIMICROB AGENTS CH, V56, P4922, DOI 10.1128/AAC.00921-12	27	37	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84361	10.1371/journal.pone.0084361	http://dx.doi.org/10.1371/journal.pone.0084361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391945	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900088
J	Chen, Y; Molnar, M; Li, L; Friberg, P; Gan, LM; Brismar, H; Fu, Y				Chen, Yun; Molnar, Matyas; Li, Li; Friberg, Peter; Gan, Li-Ming; Brismar, Hjalmar; Fu, Ying			Characterization of VCAM-1-Binding Peptide-Functionalized Quantum Dots for Molecular Imaging of Inflamed Endothelium	PLOS ONE			English	Article							IN-VIVO; GOLD NANOPARTICLES; E-SELECTIN; VCAM-1; CELLS; ATHEROSCLEROSIS; EXPRESSION; ICAM-1; ACTIVATION; PECAM	Inflammation-induced activation of endothelium constitutes one of the earliest changes during atherogenesis. New imaging techniques that allow detecting activated endothelial cells can improve the identification of persons at high cardiovascular risk in early stages. Quantum dots (QDs) have attractive optical properties such as bright fluorescence and high photostability, and have been increasingly studied and developed for bio-imaging and bio-targeting applications. We report here the development of vascular cell adhesion molecule-1 binding peptide (VCAM-1 binding peptide) functionalized QDs (VQDs) from amino QDs. It was found that the QD fluorescence signal in tumor necrosis factor alpha (TNF-alpha) treated endothelial cells in vitro was significantly higher when these cells were labeled with VQDs than amino QDs. The VQD labeling of TNF-alpha-treated endothelial cells was VCAM-1 specific since pre-incubation with recombinant VCAM-1 blocked cells' uptake of VQDs. Our ex vivo and in vivo experiments showed that in the inflamed endothelium, QD fluorescence signal from VQDs was also much stronger than that of amino QDs. Moreover, we observed that the QD fluorescence peak was significantly blue-shifted after VQDs interacted with aortic endothelial cells in vivo and in vitro. A similar blue-shift was observed after VQDs were incubated with recombinant VCAM-1 in tube. We anticipate that the specific interaction between VQDs and VCAM-1 and the blue-shift of the QD fluorescence peak can be very useful for VCAM-1 detection in vivo.	[Chen, Yun; Friberg, Peter; Gan, Li-Ming] Univ Gothenburg, Dept Mol & Clin Med Clin Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Chen, Yun; Friberg, Peter; Gan, Li-Ming] Univ Gothenburg, Univ Hosp, Gothenburg, Sweden; [Molnar, Matyas; Li, Li; Brismar, Hjalmar; Fu, Ying] Royal Inst Technol, Dept Appl Phys, Sci Life Lab, Stockholm, Sweden; [Gan, Li-Ming] AstraZeneca R&D, Molndal, Sweden	University of Gothenburg; University of Gothenburg; Royal Institute of Technology; AstraZeneca	Fu, Y (corresponding author), Royal Inst Technol, Dept Appl Phys, Sci Life Lab, Stockholm, Sweden.	fu@kth.se	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003; Chen, Yun/0000-0002-3746-594X	Swedish Vinnova [P35914-1]; Swedish Foundation for Strategic Research; Swedish Research Council [621-2011-4381]	Swedish Vinnova(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by Swedish Vinnova (project number P35914-1), the Swedish Foundation for Strategic Research (Strategic Mobility 2010), and the Swedish Research Council (grant number 621-2011-4381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012800; Arosio D, 2011, BIOCONJUGATE CHEM, V22, P664, DOI 10.1021/bc100448r; Bernardin A, 2010, BIOCONJUGATE CHEM, V21, P583, DOI 10.1021/bc900564w; Chen YH, 2001, J CELL BIOCHEM, V82, P512, DOI 10.1002/jcb.1176; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Daou TJ, 2009, LANGMUIR, V25, P3040, DOI 10.1021/la8035083; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; Derfus AM, 2007, BIOCONJUGATE CHEM, V18, P1391, DOI 10.1021/bc060367e; Drbohlavova J, 2009, INT J MOL SCI, V10, P656, DOI 10.3390/ijms10020656; Fitzpatrick JAJ, 2009, NANO LETT, V9, P2736, DOI 10.1021/nl901534q; FRIES JWU, 1993, AM J PATHOL, V143, P725; FU Y, 1994, J APPL PHYS, V76, P4225, DOI 10.1063/1.357330; Gao XH, 2003, TRENDS BIOTECHNOL, V21, P371, DOI 10.1016/S0167-7799(03)00209-9; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003; Gregg AJ, 2008, VET IMMUNOL IMMUNOP, V122, P295, DOI 10.1016/j.vetimm.2007.11.008; HASHIDA S, 1984, Journal of Applied Biochemistry, V6, P56; Idowu M, 2008, J PHOTOCH PHOTOBIO A, V198, P7, DOI 10.1016/j.jphotochem.2008.02.008; Jaiswal JK, 2004, NAT METHODS, V1, P73, DOI 10.1038/nmeth1004-73; Jiang W, 2004, TRENDS BIOTECHNOL, V22, P607, DOI 10.1016/j.tibtech.2004.10.012; Kim JH, 2004, SENSOR ACTUAT B-CHEM, V102, P315, DOI 10.1016/j.snb.2004.04.107; Li L, 2013, J PHYS CHEM C, V117, P4844, DOI 10.1021/jp311975h; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Molnar M, 2011, SENSOR ACTUAT B-CHEM, V155, P823, DOI 10.1016/j.snb.2011.01.055; Molnar M, 2010, CELL MED, V1, P105, DOI 10.3727/215517910X451603; Molnar Matyas, 2010, Journal of Nanobiotechnology, V8, P2, DOI 10.1186/1477-3155-8-2; Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380; Ning ZJ, 2011, PHYS CHEM CHEM PHYS, V13, P5848, DOI 10.1039/c0cp02688c; Patel KG, 2011, BIOCONJUGATE CHEM, V22, P376, DOI 10.1021/bc100367u; Ricard I, 1998, EUR J IMMUNOL, V28, P1708, DOI 10.1002/(SICI)1521-4141(199805)28:05<1708::AID-IMMU1708>3.0.CO;2-Y; Riegler Juergen, 2008, Journal of Nanobiotechnology, V6, P7, DOI 10.1186/1477-3155-6-7; Smith AM, 2006, ANN BIOMED ENG, V34, P3, DOI 10.1007/s10439-005-9000-9; Stringer RC, 2008, SENSOR ACTUAT B-CHEM, V134, P427, DOI 10.1016/j.snb.2008.05.018; Tsourkas A, 2005, BIOCONJUGATE CHEM, V16, P576, DOI 10.1021/bc050002e; Wang QB, 2007, J AM CHEM SOC, V129, P6380, DOI 10.1021/ja071434y; Xing Y, 2007, NAT PROTOC, V2, P1152, DOI 10.1038/nprot.2007.107	38	14	14	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83805	10.1371/journal.pone.0083805	http://dx.doi.org/10.1371/journal.pone.0083805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391829	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200127
J	Christensen, AS; Linnet, TE; Borg, M; Boomsma, W; Lindorff-Larsen, K; Hamelryck, T; Jensen, JH				Christensen, Anders S.; Linnet, Troels E.; Borg, Mikael; Boomsma, Wouter; Lindorff-Larsen, Kresten; Hamelryck, Thomas; Jensen, Jan H.			Protein Structure Validation and Refinement Using Amide Proton Chemical Shifts Derived from Quantum Mechanics	PLOS ONE			English	Article							DENSITY-FUNCTIONAL METHODS; HYDROGEN-BONDS; UBIQUITIN; PREDICTION; C-13(ALPHA); (3H)J(NC'); DATABASE; PDB2PQR; N-15; H-1	We present the ProCS method for the rapid and accurate prediction of protein backbone amide proton chemical shifts sensitive probes of the geometry of key hydrogen bonds that determine protein structure. ProCS is parameterized against quantum mechanical (QM) calculations and reproduces high level QM results obtained for a small protein with an RMSD of 0.25 ppm (r = 0.94). ProCS is interfaced with the PHAISTOS protein simulation program and is used to infer statistical protein ensembles that reflect experimentally measured amide proton chemical shift values. Such chemical shift-based structural refinements, starting from high-resolution X-ray structures of Protein G, ubiquitin, and SMN Tudor Domain, result in average chemical shifts, hydrogen bond geometries, and trans-hydrogen bond ((h3)J(NC')) spin-spin coupling constants that are in excellent agreement with experiment. We show that the structural sensitivity of the QM-based amide proton chemical shift predictions is needed to obtain this agreement. The ProCS method thus offers a powerful new tool for refining the structures of hydrogen bonding networks to high accuracy with many potential applications such as protein flexibility in ligand binding.	[Christensen, Anders S.; Jensen, Jan H.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Linnet, Troels E.; Boomsma, Wouter; Lindorff-Larsen, Kresten] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, Copenhagen, Denmark; [Borg, Mikael; Hamelryck, Thomas] Univ Copenhagen, Dept Biol, Sect Computat & RNA Biol, Struct Bioinformat Grp, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Christensen, AS (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	andersx@nano.ku.dk	Jensen, Jan Halborg/G-4338-2010; Lindorff-Larsen, Kresten/K-6469-2014; Linnet, Troels Emtekær/B-4929-2015; Boomsma, Wouter/K-2903-2014; Hamelryck, Thomas/A-3923-2012	Jensen, Jan Halborg/0000-0002-1465-1010; Lindorff-Larsen, Kresten/0000-0002-4750-6039; Linnet, Troels Emtekær/0000-0003-4684-2361; Boomsma, Wouter/0000-0002-8257-3827; Borg, Mikael/0000-0002-0646-4231; Hamelryck, Thomas/0000-0003-2917-3602	Novo Nordisk STAR PhD program; Danish Council for Independent Research (FTP) [09-066546]; Novo Nordisk Foundation; Novo Nordisk Fonden [NNF11OC1014446] Funding Source: researchfish	Novo Nordisk STAR PhD program(Novo Nordisk); Danish Council for Independent Research (FTP)(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	ASC is funded by the Novo Nordisk STAR PhD program. MB is funded by the Danish Council for Independent Research (FTP, 09-066546). WB and KL-L are supported by a Hallas-Moller stipend (to KL-L) from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev D, 2003, CHEMBIOCHEM, V4, P894, DOI 10.1002/cbic.200300699; Barfield M, 2002, J AM CHEM SOC, V124, P4158, DOI 10.1021/ja012674v; Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boomsma W, 2013, J COMPUT CHEM, V34, P1697, DOI 10.1002/jcc.23292; Bottaro S, 2012, J CHEM THEORY COMPUT, V8, P695, DOI 10.1021/ct200641m; Fenwick RB, 2011, J AM CHEM SOC, V133, P10336, DOI 10.1021/ja200461n; Case DA, 2013, CURR OPIN STRUC BIOL, V23, P172, DOI 10.1016/j.sbi.2013.01.007; Christensen AS, 2011, J CHEM THEORY COMPUT, V7, P2078, DOI 10.1021/ct2002607; Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d; Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; Czinki E, 2004, J MOL STRUC-THEOCHEM, V675, P107, DOI 10.1016/j.theochem.2003.12.034; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Frisch M.J., 2016, GAUSSIAN16 REV B01; Hamelryck T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013714; Jain R, 2009, J ORG CHEM, V74, P4017, DOI 10.1021/jo900482q; Jin L, 2000, J BIOL CHEM, V275, P27238; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kohlhoff KJ, 2009, J AM CHEM SOC, V131, P13894, DOI 10.1021/ja903772t; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Markwick PRL, 2003, J AM CHEM SOC, V125, P644, DOI 10.1021/ja028875w; Meiler J, 2003, J BIOMOL NMR, V26, P25, DOI 10.1023/A:1023060720156; Moon S, 2007, J BIOMOL NMR, V38, P139, DOI 10.1007/s10858-007-9156-8; Mulder FAA, 2010, CHEM SOC REV, V39, P578, DOI 10.1039/b811366c; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Parker LL, 2006, J AM CHEM SOC, V128, P9863, DOI 10.1021/ja0617901; POPLE JA, 1956, J CHEM PHYS, V24, P1111, DOI 10.1063/1.1742701; POPLE JA, 1958, MOL PHYS, V1, P175, DOI 10.1080/00268975800100211; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Rablen PR, 1999, J PHYS CHEM A, V103, P7357, DOI 10.1021/jp9916889; RAMAGE R, 1994, BIOCHEM J, V299, P151, DOI 10.1042/bj2990151; Richter B, 2007, J BIOMOL NMR, V37, P117, DOI 10.1007/s10858-006-9117-7; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Vila JA, 2009, P NATL ACAD SCI USA, V106, P16972, DOI 10.1073/pnas.0908833106; Vila JA, 2009, ACCOUNTS CHEM RES, V42, P1545, DOI 10.1021/ar900068s; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Xu XP, 2001, J BIOMOL NMR, V21, P321, DOI 10.1023/A:1013324104681; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	47	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84123	10.1371/journal.pone.0084123	http://dx.doi.org/10.1371/journal.pone.0084123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391900	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900043
J	de Luis, M; Cufar, K; Di Filippo, A; Novak, K; Papadopoulos, A; Piovesan, G; Rathgeber, CBK; Raventos, J; Saz, MA; Smith, KT				de Luis, Martin; Cufar, Katarina; Di Filippo, Alfredo; Novak, Klemen; Papadopoulos, Andreas; Piovesan, Gianluca; Rathgeber, Cyrille B. K.; Raventos, Jose; Angel Saz, Miguel; Smith, Kevin T.			Plasticity in Dendroclimatic Response across the Distribution Range of Aleppo Pine (Pinus halepensis)	PLOS ONE			English	Article							INTRAANNUAL DENSITY-FLUCTUATIONS; CLIMATE-GROWTH RELATIONSHIPS; TREE-RING WIDTHS; PHENOTYPIC PLASTICITY; GLOBAL CHANGE; GENETIC DIVERSITY; WOOD STRUCTURE; CO2 INCREASE; LARGE-SCALE; ABIES-ALBA	We investigated the variability of the climate-growth relationship of Aleppo pine across its distribution range in the Mediterranean Basin. We constructed a network of tree-ring index chronologies from 63 sites across the region. Correlation function analysis identified the relationships of tree-ring index to climate factors for each site. We also estimated the dominant climatic gradients of the region using principal component analysis of monthly, seasonal, and annual mean temperature and total precipitation from 1,068 climatic gridpoints. Variation in ring width index was primarily related to precipitation and secondarily to temperature. However, we found that the dendroclimatic relationship depended on the position of the site along the climatic gradient. In the southern part of the distribution range, where temperature was generally higher and precipitation lower than the regional average, reduced growth was also associated with warm and dry conditions. In the northern part, where the average temperature was lower and the precipitation more abundant than the regional average, reduced growth was associated with cool conditions. Thus, our study highlights the substantial plasticity of Aleppo pine in response to different climatic conditions. These results do not resolve the source of response variability as being due to either genetic variation in provenance, to phenotypic plasticity, or a combination of factors. However, as current growth responses to inter-annual climate variability vary spatially across existing climate gradients, future climate-growth relationships will also likely be determined by differential adaptation and/or acclimation responses to spatial climatic variation. The contribution of local adaptation and/or phenotypic plasticity across populations to the persistence of species under global warming could be decisive for prediction of climate change impacts across populations. In this sense, a more complex forest dynamics modeling approach that includes the contribution of genetic variation and phenotypic plasticity can improve the reliability of the ecological inferences derived from the climate-growth relationships.	[de Luis, Martin; Novak, Klemen; Angel Saz, Miguel] Univ Zaragoza, Dept Geog & Ordenac Terr, Zaragoza, Spain; [de Luis, Martin; Novak, Klemen; Angel Saz, Miguel] Univ Zaragoza, Inst Invest Ciencias Ambientales IUCA, Zaragoza, Spain; [Cufar, Katarina] Univ Ljubljana, Dept Wood Sci & Technol, Ljubljana, Slovenia; [Di Filippo, Alfredo; Piovesan, Gianluca] Univ Tuscia, DendrologyLab DAFNE, Viterbo, Italy; [Papadopoulos, Andreas] Technol Educ Inst Lamia, Dept Forestry & Nat Environm Management, Karpenissi, Greece; [Rathgeber, Cyrille B. K.] Ctr INRA Nancy, Lab Etud Ressources Foret Bois LERFoB, Champenoux, France; [Raventos, Jose] Univ Alicante, Dept Ecol, San Vicente Del Raspeig, Spain; [Smith, Kevin T.] US Forest Serv, No Res Stn, USDA, Durham, NC USA	University of Zaragoza; University of Zaragoza; University of Ljubljana; Tuscia University; INRAE; Universitat d'Alacant; United States Department of Agriculture (USDA); United States Forest Service	de Luis, M (corresponding author), Univ Zaragoza, Dept Geog & Ordenac Terr, Zaragoza, Spain.	mdla@unizar.es	Di Filippo, Alfredo/G-1794-2010; CABAL, ANDREA AHC HEVIA/M-1361-2014; Piovesan, Gianluca/C-2720-2008; Novak, Klemen/K-1008-2017; Cufar, Katarina/AAE-6288-2020; de Luis, Martin/F-2559-2010; RATHGEBER, Cyrille/A-6510-2009	Di Filippo, Alfredo/0000-0001-5863-8339; CABAL, ANDREA AHC HEVIA/0000-0001-6352-1442; Piovesan, Gianluca/0000-0002-3214-0839; Novak, Klemen/0000-0003-0993-5286; Cufar, Katarina/0000-0002-7403-3994; de Luis, Martin/0000-0002-7585-3636; RATHGEBER, Cyrille/0000-0001-7359-8320; Bistinas, Ioannis/0000-0002-4221-6817; Papadopoulos, Andreas/0000-0003-0050-9053; Raventos, Jose/0000-0002-5693-510X; /0000-0001-8979-0253	Spanish Ministry of Education and Science; FEDER program [CGL2012-31668]; European Union; National Ministry of Education and Religion of Greece (EPEAEK- Environment - Archimedes); Slovenian Research Agency [P4-0015]; USDA Forest Service; COST Action [FP1106]	Spanish Ministry of Education and Science(Spanish Government); FEDER program(European Commission); European Union(European Commission); National Ministry of Education and Religion of Greece (EPEAEK- Environment - Archimedes); Slovenian Research Agency(Slovenian Research Agency - Slovenia); USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); COST Action(European Cooperation in Science and Technology (COST))	This work was partially supported by Spanish Ministry of Education and Science co-funded by FEDER program (CGL2012-31668), the European Union and the National Ministry of Education and Religion of Greece (EPEAEK- Environment - Archimedes), the Slovenian Research Agency (program P4-0015), and the USDA Forest Service. The cooperation among international partners was supported by the COST Action FP1106, STREeSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P541; Andreu L, 2007, GLOBAL CHANGE BIOL, V13, P804, DOI 10.1111/j.1365-2486.2007.01322.x; ATTOLINI MR, 1990, THEOR APPL CLIMATOL, V41, P121, DOI 10.1007/BF00866435; Babst F, 2013, GLOBAL ECOL BIOGEOGR, V22, P706, DOI 10.1111/geb.12023; Baquedano FJ, 2008, EUR J FOREST RES, V127, P495, DOI 10.1007/s10342-008-0232-8; Barbero Marcel, 1998, P153; Garzon MB, 2011, GLOBAL ECOL BIOGEOGR, V20, P766, DOI 10.1111/j.1466-8238.2010.00646.x; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Briffa KR, 1998, NATURE, V391, P678, DOI 10.1038/35596; Buntgen U, 2008, GLOBAL CHANGE BIOL, V14, P2443, DOI 10.1111/j.1365-2486.2008.01640.x; Buntgen U, 2010, TREES-STRUCT FUNCT, V24, P261, DOI 10.1007/s00468-009-0396-y; Gonzalez-Hidalgo JC, 2011, INT J CLIMATOL, V31, P715, DOI 10.1002/joc.2115; Carrer M, 2004, ECOLOGY, V85, P730, DOI 10.1890/02-0478; Carrer M, 2007, J ECOL, V95, P1072, DOI 10.1111/j.1365-2745.2007.01281.x; Carrer M, 2010, OIKOS, V119, P1515, DOI 10.1111/j.1600-0706.2010.18293.x; Chambel MR, 2007, ANN FOREST SCI, V64, P87, DOI 10.1051/forest:2006092; Chen PY, 2010, GLOBAL CHANGE BIOL, V16, P3374, DOI 10.1111/j.1365-2486.2010.02166.x; Cherubini P, 2003, BIOL REV, V78, P119, DOI 10.1017/S1464793102006000; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Climent JM, 2006, FOREST ECOL MANAG, V231, P164, DOI 10.1016/j.foreco.2006.05.042; Climent J, 2008, AM J BOT, V95, P833, DOI 10.3732/ajb.2007354; Cook E.R., 2013, METHODS DENDROCHRONO; Cook E.R., 1985, TIME SERIES ANAL APP, P175; Critchfield WB, 1966, USDA FOR SERV MISC P, V991; Cuesta B, 2010, FOREST ECOL MANAG, V260, P71, DOI 10.1016/j.foreco.2010.04.002; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; De Luis M, 2007, IAWA J, V28, P389, DOI 10.1163/22941932-90001651; de Luis M, 2011, FOREST ECOL MANAG, V262, P1630, DOI 10.1016/j.foreco.2011.07.013; de Luis M, 2011, DENDROCHRONOLOGIA, V29, P163, DOI 10.1016/j.dendro.2011.01.005; De Luis M, 2009, TREES-STRUCT FUNCT, V23, P1065, DOI 10.1007/s00468-009-0349-5; Di Filippo A, 2007, J BIOGEOGR, V34, P1873, DOI 10.1111/j.1365-2699.2007.01747.x; Esper J, 2010, GLOBAL CHANGE BIOL, V16, P386, DOI 10.1111/j.1365-2486.2009.01913.x; Fritts H. C., 1976, TREE RINGS CLIMATE; Froux F, 2004, ANN FOREST SCI, V61, P235, DOI 10.1051/forest:2004016; Esteban LG, 2010, TREES-STRUCT FUNCT, V24, P19, DOI 10.1007/s00468-009-0375-3; Gindel I., 1967, Proceedings 14th Congress International Union Forestry Research Organ., Munich Pt. IV, Section 23, 1967, P188; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gomez A, 2001, ANN FOR SCI, V58, P869, DOI 10.1051/forest:2001170; Hamann A, 2005, AGR FOREST METEOROL, V128, P211, DOI 10.1016/j.agrformet.2004.10.004; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Jolliffe I.T., 1986, PRINCIPAL COMPONENT, P487, DOI [DOI 10.1007/B98835, 10.1007/978-1-4757-1904-8_8]; Camarero JJ, 2010, NEW PHYTOL, V185, P471, DOI 10.1111/j.1469-8137.2009.03073.x; KAISER HF, 1992, PERCEPT MOTOR SKILL, V74, P595, DOI 10.2466/PMS.74.2.595-598; Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x; Lebourgeois F, 2010, J VEG SCI, V21, P364, DOI 10.1111/j.1654-1103.2009.01148.x; Lev-Yadun S, 2000, ECOLOGY, BIOGEOGRAPHY AND MANAGEMENT OF PINUS HALEPENSIS AND P BRUTIA FOREST ECOSYSTEMS IN THE MEDITERRANEAN BASIN, P67; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; LIPHSCHITZ N, 1984, IAWA BULL, V5, P263, DOI 10.1163/22941932-90000413; Maiorano L, 2013, GLOBAL ECOL BIOGEOGR, V22, P302, DOI 10.1111/j.1466-8238.2012.00767.x; Matesanz S, 2014, ENVIRON EXP BOT, V103, P53, DOI 10.1016/j.envexpbot.2013.09.004; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Merian P, 2011, FOREST ECOL MANAG, V261, P1382, DOI 10.1016/j.foreco.2011.01.019; Michelozzi M, 2011, PHOTOSYNTHETICA, V49, P564, DOI 10.1007/s11099-011-0068-1; Mitchell T., 2004, WORKING PAPER; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Monnier Y, 2013, EUR J FOREST RES, V132, P325, DOI 10.1007/s10342-012-0677-7; Monnier Y, 2011, TREES-STRUCT FUNCT, V25, P497, DOI 10.1007/s00468-010-0525-7; Montoya D, 2009, GLOBAL ECOL BIOGEOGR, V18, P662, DOI 10.1111/j.1466-8238.2009.00478.x; Ne'eman G, 2004, PLANT ECOL, V171, P69, DOI 10.1023/B:VEGE.0000029380.04821.99; Ne'eman G., 2000, BIOGEOGRAPHY MANAGEM; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Novak K, 2013, IAWA J, V34, P459, DOI 10.1163/22941932-00000037; Novak K, 2013, TREES-STRUCT FUNCT, V27, P927, DOI 10.1007/s00468-013-0845-5; Olivar J, 2012, DENDROCHRONOLOGIA, V30, P35, DOI 10.1016/j.dendro.2011.06.001; Papadopoulos A., 2001, Ecologia Mediterranea, V27, P89; Pardos M, 2003, TREES-STRUCT FUNCT, V17, P442, DOI 10.1007/s00468-003-0259-x; Pasho E, 2011, AGR FOREST METEOROL, V151, P1106, DOI 10.1016/j.agrformet.2011.03.016; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Quezel P, 2000, ECOLOGY, BIOGEOGRAPHY AND MANAGEMENT OF PINUS HALEPENSIS AND P BRUTIA FOREST ECOSYSTEMS IN THE MEDITERRANEAN BASIN, P1; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Rathgeber C, 2003, ECOL MODEL, V166, P239, DOI 10.1016/S0304-3800(03)00161-3; Rathgeber C, 2000, GLOBAL PLANET CHANGE, V26, P405, DOI 10.1016/S0921-8181(00)00053-9; Richardson David M., 1998, P3; RICHMAN MB, 1986, J CLIMATOL, V6, P293, DOI 10.1002/joc.3370060305; Roberts DR, 2012, GLOBAL ECOL BIOGEOGR, V21, P121, DOI 10.1111/j.1466-8238.2011.00657.x; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Santos-del-Blanco L, 2013, J EVOLUTION BIOL, V26, P1912, DOI 10.1111/jeb.12187; Santos-del-Blanco L, 2010, FOREST SYST, V19, P381; Sardans J, 2004, PLANT ECOL, V174, P305, DOI 10.1023/B:VEGE.0000049110.88127.a0; Sarris D, 2007, GLOBAL CHANGE BIOL, V13, P1187, DOI 10.1111/j.1365-2486.2007.01348.x; SCHILLER G, 1986, SILVAE GENET, V35, P11; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Serra-Diaz JM, 2013, J BIOGEOGR, V40, P1928, DOI 10.1111/jbi.12142; Singh J., 2008, CLIMATE DISCUSSIONS, V4, P741, DOI DOI 10.5194/CPD-4-741-2008; Soto A, 2010, MOL ECOL, V19, P1396, DOI 10.1111/j.1365-294X.2010.04571.x; Speer JH, 2010, FUNDAMENTALS TREE RI; Thuiller W, 2006, DIVERS DISTRIB, V12, P49, DOI 10.1111/j.1366-9516.2006.00216.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Touchan R, 2005, CLIM DYNAM, V25, P75, DOI 10.1007/s00382-005-0016-5; Touchan R, 1999, J ARID ENVIRON, V42, P291, DOI 10.1006/jare.1999.0507; Voltas J, 2008, TREES-STRUCT FUNCT, V22, P759, DOI 10.1007/s00468-008-0236-5; Wagner F, 1996, P NATL ACAD SCI USA, V93, P11705, DOI 10.1073/pnas.93.21.11705; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Willson M.F., 1983, PLANT REPROD ECOLOGY; Zavala MA, 2011, CAN J FOREST RES, V41, P1432, DOI [10.1139/X11-050, 10.1139/x11-050]	98	92	92	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83550	10.1371/journal.pone.0083550	http://dx.doi.org/10.1371/journal.pone.0083550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391786	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200083
J	Donaszi-Ivanov, A; Mohorianu, I; Dalmay, T; Powell, PP				Donaszi-Ivanov, Andras; Mohorianu, Irina; Dalmay, Tamas; Powell, Penny P.			Small RNA Analysis in Sindbis Virus Infected Human HEK293 Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; ANTIVIRAL IMMUNITY; PROTEIN EXPRESSION; MICRORNA; INTERFERENCE; INNATE; IDENTIFICATION; PATHOGENESIS; REPLICATION; TRANSLATION	Introduction: In contrast to the defence mechanism of RNA interference (RNAi) in plants and invertebrates, its role in the innate response to virus infection of mammals is a matter of debate. Since RNAi has a well-established role in controlling infection of the alphavirus Sindbis virus (SINV) in insects, we have used this virus to investigate the role of RNAi in SINV infection of human cells. Results: SINV AR339 and TR339-GFP were adapted to grow in HEK293 cells. Deep sequencing of small RNAs (sRNAs) early in SINV infection (4 and 6 hpi) showed low abundance (0.8%) of viral sRNAs (vsRNAs), with no size, sequence or location specific patterns characteristic of Dicer products nor did they possess any discernible pattern to ascribe to a specific RNAi biogenesis pathway. This was supported by multiple variants for each sequence, and lack of hot spots along the viral genome sequence. The abundance of the best defined vsRNAs was below the limit of Northern blot detection. The adaptation of the virus to HEK293 cells showed little sequence changes compared to the reference; however, a SNP in E1 gene with a preference from G to C was found. Deep sequencing results showed little variation of expression of cellular microRNAs (miRNAs) at 4 and 6 hpi compared to uninfected cells. Twelve miRNAs exhibiting some minor differential expression by sequencing, showed no difference in expression by Northern blot analysis. Conclusions: We show that, unlike SINV infection of invertebrates, generation of Dicer-dependent svRNAs and change in expression of cellular miRNAs were not detected as part of the Human response to SINV.	[Donaszi-Ivanov, Andras; Powell, Penny P.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Mohorianu, Irina; Dalmay, Tamas] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Powell, PP (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	p.powell@uea.ac.uk	Mohorianu, Irina/J-2549-2019; Dalmay, Tamas/E-1377-2011	Powell, Penny/0000-0002-5347-0490; Mohorianu, Irina/0000-0003-4863-761X; Dalmay, Tamas/0000-0003-1492-5429	Biotechnology and Biological Sciences Research Council [BBS/B/00689, BB/J021601/1]; BBSRC [BB/J021601/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council grant BBS/B/00689 to PPP and BB/J021601/1 to TD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend JR, 2010, J VIROL, V84, P12139, DOI 10.1128/JVI.00884-10; Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Burke CW, 2009, VIROLOGY, V395, P121, DOI 10.1016/j.virol.2009.08.039; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Greene IP, 2005, J VIROL, V79, P14253, DOI 10.1128/JVI.79.22.14253-14260.2005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002577; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Klimstra WB, 1998, J VIROL, V72, P7357, DOI 10.1128/JVI.72.9.7357-7366.1998; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Leung JYS, 2011, ADV VIROL, V2011, DOI 10.1155/2011/249640; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; McKnight KL, 1996, J VIROL, V70, P1981, DOI 10.1128/JVI.70.3.1981-1989.1996; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mohorianu I, 2013, RNA BIOL, V10, P1221, DOI 10.4161/rna.25538; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pilcher RLR, 2007, PLANTA, V226, P709, DOI 10.1007/s00425-007-0518-y; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Saumet A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-3; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; STOLLAR V, 1972, VIROLOGY, V47, P122, DOI 10.1016/0042-6822(72)90245-0; STRAUSS EG, 1984, VIROLOGY, V133, P92, DOI 10.1016/0042-6822(84)90428-8; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971; Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988	58	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84070	10.1371/journal.pone.0084070	http://dx.doi.org/10.1371/journal.pone.0084070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391886	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900029
J	Kim, H; Kwon, B; Sin, JI				Kim, Ha; Kwon, Byungsuk; Sin, Jeong-Im			Combined Stimulation of IL-2 and 4-1BB Receptors Augments the Antitumor Activity of E7 DNA Vaccines by Increasing Ag-Specific CTL Responses	PLOS ONE			English	Article							ANIMAL TUMOR-MODEL; HUMAN-PAPILLOMAVIRUS VACCINES; T-CELL PROLIFERATION; IN-VIVO; IMMUNE-RESPONSES; CERVICAL-CANCER; RECOMBINANT INTERLEUKIN-2; INCREASED SENSITIVITY; PROTECTIVE IMMUNITY; DOSE INTERLEUKIN-2	Human papillomavirus (HPV) infection is a major cause of cervical cancer. Here, we investigate whether concurrent therapy using HPV E7 DNA vaccines (pE7) plus IL-2 vs. IL-15 cDNA and anti-4-1BB Abs might augment antitumor activity against established tumors. IL-2 cDNA was slightly better than IL-15 cDNA as a pE7 adjuvant. Co-delivery of pE7+IL-2 cDNA increased tumor cure rates from 7% to 27%, whereas co-delivery of pE7+IL-2 cDNA with anti-4-1BB Abs increased tumor cure rates from 27% to 67% and elicited long-term memory responses. This increased activity was concomitant with increased induction of Ag-specific CTL activity and IFN-gamma responses, but not with Ag-specific IgG production. Moreover, the combined stimulation of IL-2 and 4-1BB receptors with rIL-2 and anti-4-1BB Abs resulted in enhanced production of IFN-gamma from Ag-specific CD8+ T cells. However, this effect was abolished by treatment with anti-IL-2 Abs and 4-1BB-Fc, suggesting that the observed effect was IL-2- and anti-4-1BB Ab-specific. A similar result was also obtained for Ag-specific CTL activity. Thus, these studies demonstrate that combined stimulation through the IL-2 and 4-1BB receptors augments the Ag-specific CD8+ CTL responses induced by pE7, increasing tumor cure rates and long-term antitumor immune memory. These findings may have implications for the design of DNA-based therapeutic vaccines against cancer.	[Sin, Jeong-Im] Kangwon Natl Univ, Dept Microbiol, Sch Med, Chunchon, Gangwon Do, South Korea; [Kwon, Byungsuk] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea	Kangwon National University; University of Ulsan	Sin, JI (corresponding author), Kangwon Natl Univ, Dept Microbiol, Sch Med, Chunchon, Gangwon Do, South Korea.	jsin1964@hanmail.net			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A2038430]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2038430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen G, 2007, J IMMUNOL, V179, P4741, DOI 10.4049/jimmunol.179.7.4741; Bae SH, 2007, CLIN CANCER RES, V13, P341, DOI 10.1158/1078-0432.CCR-06-1838; Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; Cannons JL, 2000, J IMMUNOL, V165, P6193, DOI 10.4049/jimmunol.165.11.6193; Capitini Christian M, 2009, Am J Immunol, V5, P65; Cheng WF, 2002, HUM GENE THER, V13, P553, DOI 10.1089/10430340252809847; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; Chianese-Bullock KA, 2005, J IMMUNOTHER, V28, P412, DOI 10.1097/01.cji.0000171314.00924.2b; Colpitts SL, 2012, J IMMUNOL, V188, P2483, DOI 10.4049/jimmunol.1103609; Fehniger TA, 2002, CYTOKINE GROWTH F R, V13, P169, DOI 10.1016/S1359-6101(01)00021-1; Fisher RI, 2000, CANCER J SCI AM, V6, pS55; HURTADO JC, 1995, J IMMUNOL, V155, P3360; Jang IK, 1998, BIOCHEM BIOPH RES CO, V242, P613, DOI 10.1006/bbrc.1997.8016; JOHNSTON JA, 1995, P NATL ACAD SCI USA, V92, P8705, DOI 10.1073/pnas.92.19.8705; Kim HJ, 2012, P NATL ACAD SCI USA, V109, pE13, DOI 10.1073/pnas.1112256109; Kim JJ, 1998, EUR J IMMUNOL, V28, P1089, DOI 10.1002/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L; Kim MS, 2005, IMMUNOLOGY, V116, P255, DOI 10.1111/j.1365-2567.2005.02219.x; Kim TG, 2004, IMMUNOLOGY, V112, P117, DOI 10.1111/j.1365-2567.2004.01851.x; Kim TW, 2005, HUM GENE THER, V16, P26, DOI 10.1089/hum.2005.16.26; Kim TW, 2004, CANCER RES, V64, P400, DOI 10.1158/0008-5472.CAN-03-1475; Kim TY, 2002, CANCER RES, V62, P7234; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Kobayashi H, 2000, CANCER RES, V60, P3577; Kocak E, 2006, CANCER RES, V66, P7276, DOI 10.1158/0008-5472.CAN-05-2128; Lee IH, 2011, DNA CELL BIOL, V30, P975, DOI 10.1089/dna.2011.1266; Li B, 2007, CLIN IMMUNOL, V125, P76, DOI 10.1016/j.clim.2007.07.005; LIN JX, 1995, IMMUNITY, V2, P331, DOI 10.1016/1074-7613(95)90141-8; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Nam KO, 2005, J IMMUNOL, V174, P1898, DOI 10.4049/jimmunol.174.4.1898; Noh KH, 2012, J CLIN INVEST, V122, P4077, DOI 10.1172/JCI64057; POLLOK KE, 1993, J IMMUNOL, V150, P771; Powell DJ, 2006, J IMMUNOL, V177, P6527, DOI 10.4049/jimmunol.177.9.6527; Rosenberg SA, 1998, ANN SURG, V228, P307, DOI 10.1097/00000658-199809000-00004; Shimizu K, 2000, CANCER J SCI AM, V6, pS67; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; Simon AJ, 2008, VACCINE, V26, P5202, DOI 10.1016/j.vaccine.2008.03.058; Sin JI, 2006, EXPERT REV VACCINES, V5, P783, DOI 10.1586/14760584.5.6.783; Sin JI, 2013, CANCER LETT, V330, P190, DOI 10.1016/j.canlet.2012.11.045; Sin JI, 2009, EXPERT REV ANTICANC, V9, P1, DOI 10.1586/14737140.9.1.1; Sin JI, 1999, J VIROL, V73, P501, DOI 10.1128/JVI.73.1.501-509.1999; Smith SE, 2011, CANCER IMMUNOL IMMUN, V60, P1775, DOI 10.1007/s00262-011-1075-6; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Taraban VY, 2002, EUR J IMMUNOL, V32, P3617, DOI 10.1002/1521-4141(200212)32:12<3617::AID-IMMU3617>3.0.CO;2-M; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Waldmann TA, 2002, J CLIN IMMUNOL, V22, P51, DOI 10.1023/A:1014416616687; Waldmann TA, 2001, IMMUNITY, V14, P105, DOI 10.1016/S1074-7613(01)00093-0; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Ye GW, 2007, MOL THER, V15, P1564, DOI 10.1038/sj.mt.6300149; Zhang LX, 2003, P NATL ACAD SCI USA, V100, P15101, DOI 10.1073/pnas.2135379100	50	18	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83765	10.1371/journal.pone.0083765	http://dx.doi.org/10.1371/journal.pone.0083765			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391824	Green Submitted, gold, Green Published			2022-12-27	WOS:000329325200122
J	Panigrahi, R; Adina-Zada, A; Whelan, J; Vrielink, A				Panigrahi, Rashmi; Adina-Zada, Abdussalam; Whelan, James; Vrielink, Alice			Ligand Recognition by the TPR Domain of the Import Factor Toc64 from Arabidopsis thaliana	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; MOLECULAR-DYNAMICS; STRUCTURAL INSIGHTS; REPEAT PROTEINS; OUTER-MEMBRANE; CHLOROPLASTS; PREDICTION; COMPLEXES; RECEPTOR	The specific targeting of protein to organelles is achieved by targeting signals being recognised by their cognate receptors. Cytosolic chaperones, bound to precursor proteins, are recognized by specific receptors of the import machinery enabling transport into the specific organelle. The aim of this study was to gain greater insight into the mode of recognition of the C-termini of Hsp70 and Hsp90 chaperones by the Tetratricopeptide Repeat (TPR) domain of the chloroplast import receptor Toc64 from Arabidopsis thaliana (At). The monomeric TPR domain binds with 1:1 stoichiometry in similar micromolar affinity to both Hsp70 and Hsp90 as determined by isothermal titration calorimetry (ITC). Mutations of the terminal EEVD motif caused a profound decrease in affinity. Additionally, this study considered the contributions of residues upstream as alanine scanning experiments of these residues showed reduced binding affinity. Molecular dynamics simulations of the TPR domain helices upon peptide binding predicted that two helices within the TPR domain move backwards, exposing the cradle surface for interaction with the peptide. Our findings from ITC and molecular dynamics studies suggest that AtToc64_TPR does not discriminate between C-termini peptides of Hsp70 and Hsp90.	[Panigrahi, Rashmi; Adina-Zada, Abdussalam; Vrielink, Alice] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia; [Whelan, James] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA, Australia; [Whelan, James] La Trobe Univ, Sch Life Sci, Dept Bot, Bundoora, Vic, Australia	University of Western Australia; University of Western Australia; La Trobe University	Vrielink, A (corresponding author), Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia.	alice.vrielink@uwa.edu.au	Whelan, James/F-6402-2011; Panigrahi, Rashmi/AAK-2432-2020; Vrielink, Alice/D-3652-2013	Whelan, James/0000-0001-5754-025X; Panigrahi, Rashmi/0000-0002-1727-9269; Vrielink, Alice/0000-0001-8197-3725				Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Case D. A., 2012, AMBER 12; Cheng CY, 2006, BIOCHEMISTRY-US, V45, P12175, DOI 10.1021/bi060819a; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Hainzl O, 2004, J BIOL CHEM, V279, P23267, DOI 10.1074/jbc.M402189200; HARTE WE, 1990, P NATL ACAD SCI USA, V87, P8864, DOI 10.1073/pnas.87.22.8864; Hinnah SC, 2002, BIOPHYS J, V83, P899, DOI 10.1016/S0006-3495(02)75216-8; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Hubbard S. J., 1993, NACCESS; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kajander T, 2005, J AM CHEM SOC, V127, P10188, DOI 10.1021/ja0524494; Koenig P, 2008, STRUCTURE, V16, P585, DOI 10.1016/j.str.2008.01.008; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mirus O, 2009, J MOL MODEL, V15, P971, DOI 10.1007/s00894-008-0449-y; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Qbadou S, 2007, J MOL BIOL, V367, P1330, DOI 10.1016/j.jmb.2007.01.047; Qbadou S, 2006, EMBO J, V25, P1836, DOI 10.1038/sj.emboj.7601091; Ralston G, INTRO ANAL ULTRACENT, P1; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2012, J CHEM THEORY UNPUB; Sampathkumar P, 2008, J MOL BIOL, V381, P867, DOI 10.1016/j.jmb.2008.05.089; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SCHULTZ J, 1990, MOL CELL BIOL, V10, P4744, DOI 10.1128/MCB.10.9.4744; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Smith MD, 2004, J CELL BIOL, V165, P323, DOI 10.1083/jcb.200311074; Sohrt K, 2000, J CELL BIOL, V148, P1213, DOI 10.1083/jcb.148.6.1213; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; Velazquez-Campoy A, 2006, NAT PROTOC, V1, P186, DOI 10.1038/nprot.2006.28; Venclovas C, 2005, PROTEINS, V61, P99, DOI 10.1002/prot.20725; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, pE480, DOI 10.1073/pnas.1103367108; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247	68	10	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83461	10.1371/journal.pone.0083461	http://dx.doi.org/10.1371/journal.pone.0083461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391770	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200067
J	Polston, JE; Pritchett, CE; Tomasko, JM; Rogers, AM; Leggio, L; Thanos, PK; Volkow, ND; Hajnal, A				Polston, James E.; Pritchett, Carolyn E.; Tomasko, Jonathan M.; Rogers, Ann M.; Leggio, Lorenzo; Thanos, Panayotis K.; Volkow, Nora D.; Hajnal, Andras			Roux-en-Y Gastric Bypass Increases Intravenous Ethanol Self-Administration in Dietary Obese Rats	PLOS ONE			English	Article							STIMULATES LOCOMOTOR-ACTIVITY; BARIATRIC SURGERY; NUCLEUS-ACCUMBENS; ALCOHOL METABOLISM; ENERGY-EXPENDITURE; GHRELIN LEVELS; FOOD REWARD; SWEET TASTE; DOPAMINE; CONSUMPTION	Roux-en-Y gastric bypass surgery (RYGB) is an effective treatment for severe obesity. Clinical studies however have reported susceptibility to increased alcohol use after RYGB, and preclinical studies have shown increased alcohol intake in obese rats after RYGB. This could reflect a direct enhancement of alcohol's rewarding effects in the brain or an indirect effect due to increased alcohol absorption after RGYB. To rule out the contribution that changes in alcohol absorption have on its rewarding effects, here we assessed the effects of RYGB on intravenously (IV) administered ethanol (1%). For this purpose, high fat (60% kcal from fat) diet-induced obese male Sprague Dawley rats were tested similar to 2 months after RYGB or sham surgery (SHAM) using both fixed and progressive ratio schedules of reinforcement to evaluate if RGYB modified the reinforcing effects of IV ethanol. Compared to SHAM, RYGB rats made significantly more active spout responses to earn IV ethanol during the fixed ratio schedule, and achieved higher breakpoints during the progressive ratio schedule. Although additional studies are needed, our results provide preliminary evidence that RYGB increases the rewarding effects of alcohol independent of its effects on alcohol absorption.	[Polston, James E.; Pritchett, Carolyn E.; Hajnal, Andras] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA; [Tomasko, Jonathan M.; Rogers, Ann M.; Hajnal, Andras] Penn State Univ, Dept Surg, Coll Med, Hershey, PA USA; [Leggio, Lorenzo] NIAAA, Sect Clin Psychoneuroendocrinol & Neuropsychophar, Lab Clin & Translat Studies, NIH, Bethesda, MD USA; [Leggio, Lorenzo] NIDA, Intramural Res Program, NIH, Baltimore, MD USA; [Leggio, Lorenzo] Brown Univ, Dept Behav & Social Sci, Providence, RI 02912 USA; [Thanos, Panayotis K.] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Volkow, Nora D.] NIAAA Intramural Program, Lab Neuroimaging, NIH, Bethesda, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Brown University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hajnal, A (corresponding author), Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA.	ahajnal@psu.edu	Leggio, Lorenzo/M-2972-2016	Pritchett, Carolyn/0000-0002-3880-6603; Hajnal, Andras/0000-0001-7297-7134	National Institute of Diabetes and Digestive and Kidney Diseases [DK080899]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK080899 (to AH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2011, NEUROSCIENCE, V192, P500, DOI 10.1016/j.neuroscience.2011.06.001; Abizaid A, 2009, J NEUROENDOCRINOL, V21, P787, DOI 10.1111/j.1365-2826.2009.01896.x; Beckman LM, 2011, JPEN-PARENTER ENTER, V35, P169, DOI 10.1177/0148607110381403; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; BROWN EK, 1982, J AM DIET ASSOC, V80, P437; CARROLL ME, 1979, SCIENCE, V205, P319, DOI 10.1126/science.36665; Cummings DE, 2004, AM J PHYSIOL-ENDOC M, V287, pE297, DOI 10.1152/ajpendo.00582.2003; Davis JF, 2013, OBES SURG, V23, P920, DOI 10.1007/s11695-013-0884-4; Davis JF, 2012, BIOL PSYCHIAT, V72, P354, DOI 10.1016/j.biopsych.2012.01.035; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; de Vaca SC, 1998, J NEUROSCI, V18, P7502; Dunn JP, 2012, DIABETES CARE, V35, P1105, DOI 10.2337/dc11-2250; Dunn JP, 2010, BRAIN RES, V1350, P123, DOI 10.1016/j.brainres.2010.03.064; Ertelt TW, 2008, SURG OBES RELAT DIS, V4, P647, DOI 10.1016/j.soard.2008.01.004; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Geraedts MCP, 2012, AM J PHYSIOL-ENDOC M, V303, pE464, DOI 10.1152/ajpendo.00163.2012; Grigson PS, 2002, BEHAV NEUROSCI, V116, P321, DOI 10.1037/0735-7044.116.2.321; Hagedorn JC, 2007, SURG OBES RELAT DIS, V3, P543, DOI 10.1016/j.soard.2007.07.003; Hajnal A, 2010, AM J PHYSIOL-GASTR L, V299, pG967, DOI 10.1152/ajpgi.00070.2010; HALMI KA, 1981, INT J OBESITY, V5, P457; Holt PR, 2011, LANCET, V378, P767, DOI 10.1016/S0140-6736(11)61372-X; Howard EC, 2008, NEUROSCIENCE, V154, P1042, DOI 10.1016/j.neuroscience.2008.04.014; Hsu LKG, 1998, PSYCHOSOM MED, V60, P338, DOI 10.1097/00006842-199805000-00021; Hyytia P, 1996, PSYCHOPHARMACOLOGY, V125, P248, DOI 10.1007/BF02247335; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; JULKUNEN RJK, 1985, ALCOHOL, V2, P437, DOI 10.1016/0741-8329(85)90111-9; Kenna GA, 2012, NEUROPSYCHOL REV, V22, P211, DOI 10.1007/s11065-012-9209-y; King WC, 2012, JAMA-J AM MED ASSOC, V307, P2516, DOI 10.1001/jama.2012.6147; Klockhoff H, 2002, BRIT J CLIN PHARMACO, V54, P587, DOI 10.1046/j.1365-2125.2002.01698.x; Korner J, 2009, INT J OBESITY, V33, P786, DOI 10.1038/ijo.2009.79; Kumar R, 2011, SURGERY, V149, P654, DOI 10.1016/j.surg.2010.11.015; Kuzmin A, 1999, EUR NEUROPSYCHOPHARM, V9, P197, DOI 10.1016/S0924-977X(98)00025-X; le Roux CW, 2011, AM J PHYSIOL-REG I, V301, pR1057, DOI 10.1152/ajpregu.00139.2011; Maluenda F, 2010, OBES SURG, V20, P744, DOI 10.1007/s11695-010-0136-9; Miras AD, 2013, NAT REV GASTROENTERO; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Saules KK, 2010, SURG OBES RELAT DIS, V6, P615, DOI 10.1016/j.soard.2009.12.008; Shin AC, 2011, INT J OBESITY, V35, P642, DOI 10.1038/ijo.2010.174; Shin AC, 2010, ENDOCRINOLOGY, V151, P1588, DOI 10.1210/en.2009-1332; Steele KE, 2010, OBES SURG, V20, P369, DOI 10.1007/s11695-009-0015-4; Stylopoulos N, 2009, OBESITY, V17, P1839, DOI 10.1038/oby.2009.207; Suzuki J, 2012, OBES SURG, V22, P201, DOI 10.1007/s11695-010-0346-1; Tam CS, 2011, OBES REV, V12, P984, DOI 10.1111/j.1467-789X.2011.00902.x; Thanos PK, 2012, OBES SURG, V22, P1884, DOI 10.1007/s11695-012-0749-2; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Werling M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060280; Woodard GA, 2011, J AM COLL SURGEONS, V212, P209, DOI 10.1016/j.jamcollsurg.2010.09.020	52	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83741	10.1371/journal.pone.0083741	http://dx.doi.org/10.1371/journal.pone.0083741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391816	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200114
J	Hohna, S				Hohna, Sebastian			Likelihood Inference of Non-Constant Diversification Rates with Incomplete Taxon Sampling	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; MOLECULAR PHYLOGENIES; EXTINCTION RATES; MODEL; SPECIATION; RADIATIONS; DIVERSITY; INSIGHTS; ORIGINS; CHOICE	Large-scale phylogenies provide a valuable source to study background diversification rates and investigate if the rates have changed over time. Unfortunately most large-scale, dated phylogenies are sparsely sampled (fewer than 5% of the described species) and taxon sampling is not uniform. Instead, taxa are frequently sampled to obtain at least one representative per subgroup (e. g. family) and thus to maximize diversity (diversified sampling). So far, such complications have been ignored, potentially biasing the conclusions that have been reached. In this study I derive the likelihood of a birth-death process with non-constant (time-dependent) diversification rates and diversified taxon sampling. Using simulations I test if the true parameters and the sampling method can be recovered when the trees are small or medium sized (fewer than 200 taxa). The results show that the diversification rates can be inferred and the estimates are unbiased for large trees but are biased for small trees (fewer than 50 taxa). Furthermore, model selection by means of Akaike's Information Criterion favors the true model if the true rates differ sufficiently from alternative models (e. g. the birth-death model is recovered if the extinction rate is large and compared to a pure-birth model). Finally, I applied six different diversification rate models - ranging from a constant-rate pure birth process to a decreasing speciation rate birth-death process but excluding any rate shift models - on three large-scale empirical phylogenies (ants, mammals and snakes with respectively 149, 164 and 41 sampled species). All three phylogenies were constructed by diversified taxon sampling, as stated by the authors. However only the snake phylogeny supported diversified taxon sampling. Moreover, a parametric bootstrap test revealed that none of the tested models provided a good fit to the observed data. The model assumptions, such as homogeneous rates across species or no rate shifts, appear to be violated.	Stockholm Univ, Dept Math, S-10691 Stockholm, Sweden	Stockholm University	Hohna, S (corresponding author), Stockholm Univ, Dept Math, S-10691 Stockholm, Sweden.	Sebastian.Hoehna@gmail.com	Höhna, Sebastian/ABE-9933-2020	Höhna, Sebastian/0000-0001-6519-6292				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Bollback JP, 2002, MOL BIOL EVOL, V19, P1171, DOI 10.1093/oxfordjournals.molbev.a004175; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Condamine FL, 2013, ECOLOGY LETT; Cusimano N, 2012, SYST BIOL, V61, P785, DOI 10.1093/sysbio/sys031; Cusimano N, 2010, SYST BIOL, V59, P458, DOI 10.1093/sysbio/syq032; Davis RB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-109; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Etienne RS, 2012, P ROY SOC B-BIOL SCI, V279, P1300, DOI 10.1098/rspb.2011.1439; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Heath TA, 2012, SYST BIOL, V61, P793, DOI 10.1093/sysbio/sys032; Heath TA, 2012, MOL BIOL EVOL, V29, P939, DOI 10.1093/molbev/msr255; Hohna S, 2013, BIOINFORMATICS, V29, P1367, DOI 10.1093/bioinformatics/btt153; Hohna S, 2011, MOL BIOL EVOL, V28, P2577, DOI 10.1093/molbev/msr095; Huelsenbeck John P., 1996, P19; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Lambert A, 2010, ANN PROBAB, V38, P348, DOI 10.1214/09-AOP485; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Morlon H, 2011, P NATL ACAD SCI USA, V108, P16327, DOI 10.1073/pnas.1102543108; Morlon H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000493; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Pennell MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043348; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Pyron RA, 2012, EVOLUTION, V66, P163, DOI 10.1111/j.1558-5646.2011.01437.x; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stadler T, 2013, SYST BIOL, V62, P220, DOI 10.1093/sysbio/sys087; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Thompson E.A., 1975, HUMAN EVOLUTIONARY T; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	42	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84184	10.1371/journal.pone.0084184	http://dx.doi.org/10.1371/journal.pone.0084184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400082	Green Published, gold, Green Submitted			2022-12-27	WOS:000329462700016
J	Zhao, Z; Zhong, LL; Elrod, E; Struble, E; Ma, L; Yan, HL; Harman, C; Deng, L; Virata-Theimer, ML; Liu, P; Alter, H; Grakoui, A; Zhang, P				Zhao, Zhong; Zhong, Lilin; Elrod, Elizabeth; Struble, Evi; Ma, Li; Yan, Hailing; Harman, Christine; Deng, Lu; Virata-Theimer, Maria Luisa; Liu, Peter; Alter, Harvey; Grakoui, Arash; Zhang, Pei			A Neutralization Epitope in the Hepatitis C Virus E2 Glycoprotein Interacts with Host Entry Factor CD81	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN; VIRAL ENTRY; ANTIBODIES; BINDING; PARTICLES; INFECTION; PLASMA; GENOTYPES; RECEPTOR; PROGRESS	The identification of a specific immunogenic candidate that will effectively activate the appropriate pathway for neutralizing antibody production is fundamental for vaccine design. By using a monoclonal antibody (1H8) that neutralizes HCV in vitro, we have demonstrated here that 1H8 recognized an epitope mapped between residues A524 and W529 of the E2 protein. We also found that the epitope residues A524, P525, Y527 and W529 were crucial for antibody binding, while the residues T526, Y527 and W529 within the same epitope engaged in the interaction with the host entry factor CD81. Furthermore, we detected "1H8-like" antibodies, defined as those with amino acid-specificity similar to 1H8, in the plasma of patients with chronic HCV infection. The time course study of plasma samples from Patient H, a well-characterized case of post-transfusion hepatitis C, showed that "1H8-like" antibodies could be detected in a sample collected almost two years after the initial infection, thus confirming the immunogenicity of this epitope in vivo. The characterization of this neutralization epitope with a function in host entry factor CD81 interaction should enhance our understanding of antibody-mediated neutralization of HCV infections.	[Zhao, Zhong; Zhong, Lilin; Struble, Evi; Ma, Li; Yan, Hailing; Harman, Christine; Deng, Lu; Virata-Theimer, Maria Luisa; Liu, Peter; Zhang, Pei] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Off Blood Res & Review, Bethesda, MD 20892 USA; [Elrod, Elizabeth; Grakoui, Arash] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Alter, Harvey] NIH, Warren Grant Magnuson Clin Ctr, Dept Transfus Med, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Emory University; National Institutes of Health (NIH) - USA	Zhang, P (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Hematol, Off Blood Res & Review, Bethesda, MD 20892 USA.	pei.zhang@fda.hhs.gov	Deng, Lu/AAE-1635-2021		Modernizing Science Funds of the Food and Drug Administration; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083356] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002078, ZIACL002068] Funding Source: NIH RePORTER	Modernizing Science Funds of the Food and Drug Administration; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CLINICAL CENTER	This study was supported by the Modernizing Science Funds of the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter HJ, 2012, ANN INTERN MED, V156, P317, DOI 10.7326/0003-4819-156-4-201202210-00014; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Centers for Disease Control and Prevention, 2012, CDC HLTH INF INT TRA; Clayton RF, 2002, J VIROL, V76, P7672, DOI 10.1128/JVI.76.15.7672-7682.2002; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Drummer HE, 2006, J VIROL, V80, P7844, DOI 10.1128/JVI.00029-06; Fafi-Kremer S, 2010, J EXP MED, V207, P2019, DOI 10.1084/jem.20090766; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Halliday J, 2011, EXPERT REV VACCINES, V10, P659, DOI [10.1586/erv.11.55, 10.1586/ERV.11.55]; Heile JM, 2000, J VIROL, V74, P6885, DOI 10.1128/JVI.74.15.6885-6892.2000; Johansson DX, 2007, P NATL ACAD SCI USA, V104, P16269, DOI 10.1073/pnas.0705522104; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Meyer K, 2002, J VIROL, V76, P2150, DOI 10.1128/JVI.76.5.2150-2158.2002; Owsianka A, 2001, J GEN VIROL, V82, P1877, DOI 10.1099/0022-1317-82-8-1877; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Stoll-Keller F, 2009, EXPERT REV VACCINES, V8, P333, DOI 10.1586/14760584.8.3.333; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; YEI S, 1992, TRANSFUSION, V32, P824, DOI 10.1046/j.1537-2995.1992.32993110753.x; Yu MYW, 2004, P NATL ACAD SCI USA, V101, P7705, DOI 10.1073/pnas.0402458101; Zhang P, 2006, P NATL ACAD SCI USA, V103, P9214, DOI 10.1073/pnas.0603316103; Zhang P, 2007, P NATL ACAD SCI USA, V104, P8449, DOI 10.1073/pnas.0703039104; Zhong L, 2009, BIOCHEM BIOPH RES CO, V390, P1056, DOI 10.1016/j.bbrc.2009.10.115	35	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84346	10.1371/journal.pone.0084346	http://dx.doi.org/10.1371/journal.pone.0084346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400084	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700018
J	Biagi, F; Schiepatti, A; Malamut, G; Marchese, A; Cellier, C; Bakker, SF; Mulder, CJJ; Volta, U; Zingone, F; Ciacci, C; D'Odorico, A; Andrealli, A; Astegiano, M; Klersy, C; Corazza, GR				Biagi, Federico; Schiepatti, Annalisa; Malamut, Georgia; Marchese, Alessandra; Cellier, Christophe; Bakker, Sjoerd F.; Mulder, Chris J. J.; Volta, Umberto; Zingone, Fabiana; Ciacci, Carolina; D'Odorico, Anna; Andrealli, Alida; Astegiano, Marco; Klersy, Catherine; Corazza, Gino R.			PROgnosticating COeliac patieNts SUrvivaL: The PROCONSUL Score	PLOS ONE			English	Article							T-CELL LYMPHOMA; SINGLE-CENTER EXPERIENCE; DISEASE; COMPLICATIONS; MORTALITY; SEVERITY; COHORT; RISK	Introduction: It has been shown that mortality rates of coeliac patients correlate with age at diagnosis of coeliac disease, diagnostic delay for coeliac disease, pattern of clinical presentation and HLA typing. Our aim was to create a tool that identifies coeliac patients at higher risk of developing complications. Methods: To identify predictors of complications in patients with coeliac disease, we organised an observational multicenter case-control study based on a retrospective collection of clinical data. Clinical data from 116 cases (patients with complicated coeliac disease) and 181 controls (coeliac patients without any complications) were collected from seven European centres. For each case, one or two controls, matched to cases according to the year of assessment, gender and age, were selected. Diagnostic delay, pattern of clinical presentation, HLA typing and age at diagnosis were used as predictors. Results: Differences between cases and controls were detected for diagnostic delay and classical presentation. Conditional logistic models based on these statistically different predictors allowed the development of a score system. Tertiles analysis showed a relationship between score and risk of developing complications. Discussion: A score that shows the risk of a newly diagnosed coeliac patient developing complications was devised for the first time. This will make it possible to set up the follow-up of coeliac patients with great benefits not only for their health but also for management of economic resources. Conclusions: We think that our results are very encouraging and represent the first attempt to build a prognostic score for coeliac patients.	[Biagi, Federico; Schiepatti, Annalisa; Marchese, Alessandra; Corazza, Gino R.] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Internal Med 1, Coeliac Ctr, I-27100 Pavia, Italy; [Malamut, Georgia; Cellier, Christophe] Univ Paris 05, Hop Europeen Georges Pompidou, Dept Gastroenterol, Paris, France; [Bakker, Sjoerd F.; Mulder, Chris J. J.] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Volta, Umberto] St Orsola Malpighi Univ Hosp, Dept Clin Med, Coeliac Ctr, Bologna, Italy; [Zingone, Fabiana; Ciacci, Carolina] Univ Salerno, Gastrointestinal Unit, Dept Med & Surg, I-84100 Salerno, Italy; [D'Odorico, Anna] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy; [Andrealli, Alida; Astegiano, Marco] Univ Turin, AOU San Giovanni Battista Molinette, Dept Gastrohepatol, Turin, Italy; [Klersy, Catherine] Fdn IRCCS Policlin San Matteo, Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Vrije Universiteit Amsterdam; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Salerno; University of Padua; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; IRCCS Fondazione San Matteo	Biagi, F (corresponding author), Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Internal Med 1, Coeliac Ctr, Via Palestro 3, I-27100 Pavia, Italy.	f.biagi@smatteo.pv.it	Biagi, Federico/G-2812-2011; carolina, ciacci/A-2594-2012; Schiepatti, Annalisa/R-3802-2018; Corazza, Gino Roberto/K-8500-2016; Schiepatti, Annalisa/ABD-5938-2021; klersy, catherine/AAA-3003-2019; Zingone, Fabiana/O-5361-2018	Biagi, Federico/0000-0002-2227-4622; carolina, ciacci/0000-0002-7426-1145; Schiepatti, Annalisa/0000-0002-8493-7698; Corazza, Gino Roberto/0000-0001-9532-0573; Schiepatti, Annalisa/0000-0002-8493-7698; klersy, catherine/0000-0003-0314-8548; Volta, Umberto/0000-0003-3405-3808; christophe, Cellier/0000-0003-0784-2318; Malamut, Georgia/0000-0003-4030-3025; Zingone, Fabiana/0000-0003-1133-1502	Fondazione Celiachia	Fondazione Celiachia	This work was supported by a grant from the Fondazione Celiachia "Studio di possibili fattori ambientali e sviluppo di nuove strategie terapeutiche nelle complicanze della malattia celiaca". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Toma A, 2007, GUT, V56, P1373, DOI 10.1136/gut.2006.114512; Al-Toma A, 2006, CLIN GASTROENTEROL H, V4, P315, DOI 10.1016/j.cgh.2005.12.011; Biagi F, 2000, SCAND J GASTROENTERO, V35, P785; Biagi F, 2014, DIGEST LIVER DIS, V46, P227, DOI 10.1016/j.dld.2013.10.010; Biagi F, 2012, J CLIN GASTROENTEROL, V46, P46, DOI 10.1097/MCG.0b013e318221077e; Biagi F, 2010, NAT REV GASTRO HEPAT, V7, P158, DOI 10.1038/nrgastro.2010.2; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Daum S, 2009, EUR J GASTROEN HEPAT, V21, P66, DOI 10.1097/MEG.0b013e328307c20c; Di Sabatino A, 2012, BLOOD, V119, P2458, DOI 10.1182/blood-2011-10-385559; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Gale J, 2000, J CLIN ONCOL, V18, P795, DOI 10.1200/JCO.2000.18.4.795; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Malamut G, 2011, AM J GASTROENTEROL, V106, P929, DOI 10.1038/ajg.2011.105; Malamut G, 2009, GASTROENTEROLOGY, V136, P81, DOI 10.1053/j.gastro.2008.09.069; Mearin ML, 2006, EUR J GASTROEN HEPAT, V18, P187; Murray JA, 2007, CLIN GASTROENTEROL H, V5, P1406, DOI 10.1016/j.cgh.2007.08.013; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Roshan B, 2011, AM J GASTROENTEROL, V106, P923, DOI 10.1038/ajg.2011.104; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V136, P99, DOI 10.1053/j.gastro.2008.10.013; West J, 2009, GASTROENTEROLOGY, V136, P32, DOI 10.1053/j.gastro.2008.11.026	22	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84163	10.1371/journal.pone.0084163	http://dx.doi.org/10.1371/journal.pone.0084163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392112	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100036
J	Mallet, D; Wantiez, L; Lemouellic, S; Vigliola, L; Pelletier, D				Mallet, Delphine; Wantiez, Laurent; Lemouellic, Soazig; Vigliola, Laurent; Pelletier, Dominique			Complementarity of Rotating Video and Underwater Visual Census for Assessing Species Richness, Frequency and Density of Reef Fish on Coral Reef Slopes	PLOS ONE			English	Article							ARTIFICIAL REEFS; RELATIVE DENSITY; SIZE STRUCTURE; DIVERS; COMMUNITIES; ABUNDANCE; TRANSECT; ACCURACY; SYSTEM; CAMERA	Estimating diversity and abundance of fish species is fundamental for understanding community structure and dynamics of coral reefs. When designing a sampling protocol, one crucial step is the choice of the most suitable sampling technique which is a compromise between the questions addressed, the available means and the precision required. The objective of this study is to compare the ability to sample reef fish communities at the same locations using two techniques based on the same stationary point count method: one using Underwater Visual Census (UVC) and the other rotating video (STAVIRO). UVC and STAVIRO observations were carried out on the exact same 26 points on the reef slope of an intermediate reef and the associated inner barrier reefs. STAVIRO systems were always deployed 30 min to 1 hour after UVC and set exactly at the same place. Our study shows that; (i) fish community observations by UVC and STAVIRO differed significantly; (ii) species richness and density of large species were not significantly different between techniques; (iii) species richness and density of small species were higher for UVC; (iv) density of fished species was higher for STAVIRO and (v) only UVC detected significant differences in fish assemblage structure across reef type at the spatial scale studied. We recommend that the two techniques should be used in a complementary way to survey a large area within a short period of time. UVC may census reef fish within complex habitats or in very shallow areas such as reef flat whereas STAVIRO would enable carrying out a large number of stations focused on large and diver-averse species, particularly in the areas not covered by UVC due to time and depth constraints. This methodology would considerably increase the spatial coverage and replication level of fish monitoring surveys.	[Mallet, Delphine; Pelletier, Dominique] IFREMER, Unite Rech Lagons Ecosyst & Aquaculture Durable N, Noumea, New Caledonia; [Mallet, Delphine; Wantiez, Laurent; Lemouellic, Soazig] Univ Nouvelle Caledonie, EA LIVE 4243, Noumea, New Caledonia; [Vigliola, Laurent] IRD, UMR CoReUS 227, Lab Excellence LABEX Corail, Noumea, New Caledonia	Ifremer; Universite Nouvelle Caledonie; Institut de Recherche pour le Developpement (IRD)	Mallet, D (corresponding author), IFREMER, Unite Rech Lagons Ecosyst & Aquaculture Durable N, Noumea, New Caledonia.	Delphine.Mallet@ifremer.fr	Wantiez, Laurent/L-3343-2013; Vigliola, Laurent/J-7107-2016; Pelletier, Dominique/A-1649-2011	Wantiez, Laurent/0000-0001-5024-2057; Vigliola, Laurent/0000-0003-4715-7470; Mallet, Delphine/0000-0002-7636-6450; Pelletier, Dominique/0000-0003-2420-1942	French Institute for the Exploitation of the Sea (IFREMER); Agence des Aires Marines Protegees; Environment Department of the South Province of New Caledonia; University of New Caledonia	French Institute for the Exploitation of the Sea (IFREMER); Agence des Aires Marines Protegees; Environment Department of the South Province of New Caledonia; University of New Caledonia	This work is part of a PhD Thesis jointly funded by the French Institute for the Exploitation of the Sea (IFREMER) and the Agence des Aires Marines Protegees. This survey was also funded by the Environment Department of the South Province of New Caledonia and the University of New Caledonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEVIZON WS, 1975, B MAR SCI, V25, P482; Assis J., 2007, Journal of Coastal Conservation, V11, P153, DOI 10.1007/s11852-008-0015-x; BARNES H., 1953, DEUTSCHE HYDROGR ZEITSCHR, V6, P123, DOI 10.1007/BF02020044; Barnes H., 1952, Nature London, V169, P477, DOI 10.1038/169477a0; BELL JD, 1985, CORAL REEFS, V4, P41, DOI 10.1007/BF00302203; Bohnsack J.A., 1986, NOAA Technical Report NMFS, V41, P1; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Burge EJ, 2012, B MAR SCI, V88, P15, DOI 10.5343/bms.2010.1079; Burke L., 2011, REEFS RISK REVISITED; Cappo M, 2003, AQUATIC PROTECTED AR, P455; Chabanet P, 2012, J EXP MAR BIOL ECOL, V430, P10, DOI 10.1016/j.jembe.2012.06.024; CHAPMAN CJ, 1974, MAR BIOL, V27, P357, DOI 10.1007/BF00394372; Chateau O, 2005, CYBIUM, V29, P159; COLE RG, 1994, BIOL CONSERV, V70, P93, DOI 10.1016/0006-3207(94)90276-3; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cooke SJ, 2002, ENVIRON MONIT ASSESS, V73, P109, DOI 10.1023/A:1013099430900; CROSSLAND J, 1976, New Zealand Journal of Marine and Freshwater Research, V10, P511; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Drelon J., 2010, EVALUATION VIDEO ROT; Dumas P, 2009, J EXP MAR BIOL ECOL, V368, P161, DOI 10.1016/j.jembe.2008.10.002; ELLIS DM, 1995, FISH B-NOAA, V93, P67; FEDRA K, 1979, MAR BIOL, V55, P239, DOI 10.1007/BF00396824; FRANCOUR P, 1999, NAT SICIL, V23, P155; GREENE LE, 1989, B MAR SCI, V44, P899; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Harvey E, 2002, MAR TECHNOL SOC J, V36, P38, DOI 10.4031/002533202787914106; Harvey E, 2001, FISH B-NOAA, V99, P72; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey E, 2001, FISH B-NOAA, V99, P63; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; JOHNSTON CS, 1969, J ECOL, V57, P453, DOI 10.2307/2258391; JONES RS, 1978, B MAR SCI, V28, P159; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M, 1988, CORRELATION CATCH DA, P305; Lam K, 2006, J EXP MAR BIOL ECOL, V333, P115, DOI 10.1016/j.jembe.2005.12.009; Langlois T., 2006, FISH NEWSL S PAC COM, P53; Le Grand Y, 1968, LIGHT COLOUR VISION; LEBART L, 1997, STAT EXPLORATOIRE MU; Legendre P., 2012, NUMERICAL ECOLOGY; LEONARD GH, 1993, MAR ECOL PROG SER, V101, P203, DOI 10.3354/meps101203; Lessios HA, 1996, DIVING SCI 1996 METH, P9; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Longo GO, 2012, J FISH BIOL, V81, P1773, DOI 10.1111/j.1095-8649.2012.03441.x; Lowry M, 2012, J EXP MAR BIOL ECOL, V416, P243, DOI 10.1016/j.jembe.2012.01.013; MACHAN R, 1975, MAR BIOL, V33, P75, DOI 10.1007/BF00395004; MICHALOPOULOS C, 1992, MAR TECHNOL SOC J, V26, P27; MILLER RJ, 1987, B MAR SCI, V40, P484; Morrison M, 2006, FISH RES, V82, P150, DOI 10.1016/j.fishres.2006.06.024; Pelletier D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030536; Pelletier D, 2011, FISH RES, V107, P84, DOI 10.1016/j.fishres.2010.10.011; RICHARD JD, 1968, J FISH RES BOARD CAN, V25, P1441, DOI 10.1139/f68-125; Rogers CS, 2001, B MAR SCI, V69, P459; Rotherham D, 2007, ICES J MAR SCI, V64, P1512, DOI 10.1093/icesjms/fsm096; Sarramegna S, 2000, THESIS U NEW CALEDON; Sigler MF, 2000, CAN J FISH AQUAT SCI, V57, P1270, DOI 10.1139/cjfas-57-6-1270; SMITH MPL, 1988, MAR ECOL PROG SER, V43, P223, DOI 10.3354/meps043223; Sokal R. R, 1981, BIOMETRY; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; Tessier A, 2013, AQUAT BIOL, V18, P229, DOI 10.3354/ab00506; Tessier E, 2005, J EXP MAR BIOL ECOL, V315, P17, DOI 10.1016/j.jembe.2004.08.027; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Tillett BJ, 2012, FISH RES, V127, P109, DOI 10.1016/j.fishres.2012.04.007; Trenkel VM, 2011, MAR ECOL PROG SER, V442, P285, DOI 10.3354/meps09425; WALLACE JH, 1984, S AFR J ZOOL, V19, P164; Wantiez L, 1997, CORAL REEFS, V16, P215, DOI 10.1007/s003380050077; Wantiez L, 2006, J MAR BIOL ASSOC UK, V86, P1229, DOI 10.1017/S0025315406014238; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; WILLIAMS DM, 1983, MAR ECOL PROG SER, V10, P239, DOI 10.3354/meps010239; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Winhold L, 2008, NORTHEAST NAT, V15, P263, DOI 10.1656/1092-6194(2008)15[263:NSFBIT]2.0.CO;2; [No title captured]	75	24	24	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84344	10.1371/journal.pone.0084344	http://dx.doi.org/10.1371/journal.pone.0084344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392126	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100049
J	Saha, A; Tan, AC; Kang, J				Saha, Ashis; Tan, Aik Choon; Kang, Jaewoo			Automatic Context-Specific Subnetwork Discovery from Large Interaction Networks	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; EXPRESSION; CANCER; GENE; CLASSIFICATION; MARKERS; PREDICTION; ALGORITHM; TARGETS	Genes act in concert via specific networks to drive various biological processes, including progression of diseases such as cancer. Under different phenotypes, different subsets of the gene members of a network participate in a biological process. Single gene analyses are less effective in identifying such core gene members (subnetworks) within a gene set/network, as compared to gene set/network-based analyses. Hence, it is useful to identify a discriminative classifier by focusing on the subnetworks that correspond to different phenotypes. Here we present a novel algorithm to automatically discover the important subnetworks of closely interacting molecules to differentiate between two phenotypes (context) using gene expression profiles. We name it COSSY (COntext-Specific Subnetwork discoverY). It is a non-greedy algorithm and thus unlikely to have local optima problems. COSSY works for any interaction network regardless of the network topology. One added benefit of COSSY is that it can also be used as a highly accurate classification platform which can produce a set of interpretable features.	[Saha, Ashis; Kang, Jaewoo] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Tan, Aik Choon] Univ Colorado, Dept Med Med Oncol, Aurora, CO USA; [Kang, Jaewoo] Korea Univ, Interdisciplinary Grad Program Bioinformat, Seoul, South Korea	Korea University; University of Colorado System; University of Colorado Anschutz Medical Campus; Korea University	Kang, J (corresponding author), Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea.	kangj@korea.ac.kr	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369	National Research Foundation of Korea (NRF); Korean government (MSIP) [2012R1A2A2A01014729]; Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning [2012M3C4A7033341]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MSIP); Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2012R1A2A2A01014729); and Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3C4A7033341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Chowdhury SA, 2010, BIOCOMPUT-PAC SYM, P133; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Dao P, 2010, BIOINFORMATICS, V26, pi625, DOI 10.1093/bioinformatics/btq393; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Eddy JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000792; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Geman D., 2004, STAT APPL GENETICS M, V3; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Lin X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-256; Magis AT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-227; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Oellerich T, 2013, BLOOD, V121, P3889, DOI 10.1182/blood-2012-09-457887; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Shipp MA, 2002, 1 HARV MED SCH DAN F; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Stalteri MA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-13; Su J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S8; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukhai MA, 2013, J CLIN INVEST, V123, P315, DOI 10.1172/JCI64180; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Wang HY, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S3; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Welsh JB, 2001, CANCER RES, V61, P5974	35	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2014	9	1							e84227	10.1371/journal.pone.0084227	http://dx.doi.org/10.1371/journal.pone.0084227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	285EK	24392115	Green Published, Green Submitted, gold			2022-12-27	WOS:000329375900001
J	Alanazi, M; Pathan, AAK; Arifeen, Z; Shaik, JP; Alabdulkarim, HA; Semlali, A; Bazzi, MD; Parine, NR				Alanazi, Mohammad; Pathan, Akbar Ali Khan; Arifeen, Zainul; Shaik, Jilani P.; Alabdulkarim, Huda A.; Semlali, Abdelhabib; Bazzi, Mohammad D.; Parine, Narasimha Reddy			Association between PARP-1 V762A Polymorphism and Breast Cancer Susceptibility in Saudi Population	PLOS ONE			English	Article							EXCISION-REPAIR PATHWAY; POLY(ADP-RIBOSE) POLYMERASE; DNA-REPAIR; WEB SERVER; RISK; SEQUENCE; TUMORIGENESIS; EXPRESSION; MUTATIONS; BINDING	Genetic aberrations of DNA repair enzymes are known to be common events and to be associated with different cancer entities. Aim of the following study was to analyze the genetic association of rs1136410 (Val762Ala) in PARP1 gene with the risk of breast cancer using genotypic assays and insilico structural predictions. Genotypic analysis of individual locus showed statistically significant association of Val762Ala with increased susceptibility to breast cancer. Protein structural analysis was performed with Val762Ala variant allele and compared with the predicted native protein structure. Protein prediction analysis showed that this nsSNP may cause changes in the protein structure and it is associated with the disease. In addition to the native and mutant 3D structures of PARP1 were also analyzed using solvent accessibility models for further protein stability confirmation. Taken together, this the first study that confirmed Val762Ala variant has functional effect and structural impact on the PARP1 and may play an important role in breast cancer progression in Saudi population.	[Alanazi, Mohammad; Pathan, Akbar Ali Khan; Arifeen, Zainul; Shaik, Jilani P.; Semlali, Abdelhabib; Bazzi, Mohammad D.; Parine, Narasimha Reddy] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia; [Arifeen, Zainul] Umm Al Qura Univ, Dept Med Genet, Sci & Technol Unit, Mecca, Saudi Arabia; [Alabdulkarim, Huda A.] Comprehens Canc Ctr King Fahad Med City, Riyadh, Saudi Arabia	King Saud University; Umm Al Qura University; King Fahad Medical City	Parine, NR (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia.	reddyparine@gmail.com	Semlali, Abdelhabib/AAP-7043-2020; Parine, Narasimha Reddy/B-7975-2011; PATHAN, AKBAR ALI KHAN/ABC-8189-2021	Semlali, Abdelhabib/0000-0002-1643-0377; Parine, Narasimha Reddy/0000-0002-0765-9022; PATHAN, AKBAR ALI KHAN/0000-0002-6516-7587	National Science, Technology, and Innovation Plan strategic technologies program in the Kingdom [10-BIO897-2]	National Science, Technology, and Innovation Plan strategic technologies program in the Kingdom	This study was financially supported by a grant from National Science, Technology, and Innovation Plan strategic technologies program number 10-BIO897-2 in the Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanazi MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059555; Alanazi M, 2013, ASIAN PAC J CANCER P, V14, P3051, DOI 10.7314/APJCP.2013.14.5.3051; [Anonymous], [No title captured]; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bi FF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-90; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101; Ferlay J, 2010, IARC CANCERBASE, V2; Figueroa JD, 2007, HUM GENET, V121, P233, DOI 10.1007/s00439-006-0294-y; Goncalves A, 2011, BREAST CANCER RES TR, V127, P273, DOI 10.1007/s10549-010-1199-y; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; Heinen CD, 2002, CANCER BIOL THER, V1, P477, DOI 10.4161/cbt.1.5.160; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Iwashita A, 2005, FEBS LETT, V579, P1389, DOI 10.1016/j.febslet.2005.01.036; Jo S, 2013, J CHEM INF MODEL, V53, P267, DOI 10.1021/ci300505n; Johnson-Thompson MC, 2000, CANCER, V88, P1224, DOI 10.1002/(SICI)1097-0142(20000301)88:5+<1224::AID-CNCR8>3.0.CO;2-H; Khan W, 2013, GENE, V522, P75, DOI 10.1016/j.gene.2013.03.037; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kumari SR, 1998, CANCER RES, V58, P5075; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Lockett KL, 2004, CANCER RES, V64, P6344, DOI 10.1158/0008-5472.CAN-04-0338; Masutani M, 2003, GENE CHROMOSOME CANC, V38, P339, DOI 10.1002/gcc.10250; Milani L, 2007, EUR J CLIN INVEST, V37, P80; PERO RW, 1990, CANCER DETECT PREV, V14, P555; Prlic A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-333; Rajaee-Behbahani N, 2002, INT J CANCER, V98, P780, DOI 10.1002/ijc.10234; Rodrigues JPGLM, 2012, NUCLEIC ACIDS RES, V40, pW323, DOI 10.1093/nar/gks376; Saudi National Cancer Registry, 2011, CANC INC SURV REP SA; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shiokawa M, 2005, JPN J CLIN ONCOL, V35, P97, DOI 10.1093/jjco/hyi028; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Tong WM, 2007, ONCOGENE, V26, P3857, DOI 10.1038/sj.onc.1210156; Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X; Tong WM, 2002, CANCER RES, V62, P6990; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; van der Spoel D, 2012, BIOINFORMATICS, V28, P752, DOI 10.1093/bioinformatics/bts020; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang XG, 2007, BIOCHEM BIOPH RES CO, V354, P122, DOI 10.1016/j.bbrc.2006.12.162; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037446; Yu HP, 2012, GENET EPIDEMIOL, V36, P56, DOI 10.1002/gepi.20663; Zhang XM, 2005, CANCER RES, V65, P722	43	42	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85541	10.1371/journal.pone.0085541	http://dx.doi.org/10.1371/journal.pone.0085541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392019	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900163
J	Falcone, R; Bevacqua, S; Cerasti, E; Brunamonti, E; Cervelloni, M; Genovesio, A				Falcone, Rossella; Bevacqua, Sara; Cerasti, Erika; Brunamonti, Emiliano; Cervelloni, Milena; Genovesio, Aldo			Transfer of the Nonmatch-to-Goal rule in Monkeys across Cognitive Domains	PLOS ONE			English	Article							PRIMATE PREFRONTAL CORTEX; REVERSE-REWARD CONTINGENCY; CROSS-MODAL TRANSFER; CHIMPANZEES PAN-TROGLODYTES; BABOONS PAPIO-PAPIO; NEURONAL-ACTIVITY; MACACA-MULATTA; RHESUS-MONKEYS; CEBUS-APELLA; EULEMUR-FULVUS	To solve novel problems, it is advantageous to abstract relevant information from past experience to transfer on related problems. To study whether macaque monkeys were able to transfer an abstract rule across cognitive domains, we trained two monkeys on a nonmatch-to-goal (NMTG) task. In the object version of the task (O-NMTG), the monkeys were required to choose between two object-like stimuli, which differed either only in shape or in shape and color. For each choice, they were required to switch from their previously chosen object-goal to a different one. After they reached a performance level of over 90% correct on the O-NMTG task, the monkeys were tested for rule transfer on a spatial version of the task (S-NMTG). To receive a reward, the monkeys had to switch from their previously chosen location to a different one. In both the O-NMTG and S-NMTG tasks, there were four potential choices, presented in pairs from trial-to-trial. We found that both monkeys transferred successfully the NMTG rule within the first testing session, showing effective transfer of the learned rule between two cognitive domains.	[Falcone, Rossella; Bevacqua, Sara; Cerasti, Erika; Brunamonti, Emiliano; Cervelloni, Milena; Genovesio, Aldo] Univ Roma La Sapienza, Dept Physiol & Pharmacol, I-00185 Rome, Italy	Sapienza University Rome	Genovesio, A (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	aldo.genovesio@uniroma1.it		Brunamonti, Emiliano/0000-0002-5119-6950; Genovesio, Aldo/0000-0003-2521-143X; FALCONE, ROSSELLA/0000-0001-5068-2984	Italian Ministry of Research, "Fondo per gli investimenti della ricerca di base" FIRB [RBFR10G5W9_001]	Italian Ministry of Research, "Fondo per gli investimenti della ricerca di base" FIRB(Ministry of Education, Universities and Research (MIUR))	The work was supported by the Italian Ministry of Research, "Fondo per gli investimenti della ricerca di base" FIRB 2010 (Protocol number: RBFR10G5W9_001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2008, J COMP PSYCHOL, V122, P445, DOI 10.1037/a0012624; Blakemore CB, 1966, NATURE, V210, P117; BLAKESLEE P, 1966, BEHAVIOUR, V26, P76, DOI 10.1163/156853966X00029; Bodily KD, 2008, J EXP PSYCHOL ANIM B, V34, P178, DOI 10.1037/0097-7403.34.1.178; Bongard S, 2010, P NATL ACAD SCI USA, V107, P2277, DOI 10.1073/pnas.0909180107; Cole MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00142; Cook RG, 2007, PSYCHON B REV, V14, P1107, DOI 10.3758/BF03193099; Cromer JA, 2010, NEURON, V66, P796, DOI 10.1016/j.neuron.2010.05.005; D'Amato MR, 1984, COGNITIVE PROCESSES; ETTLINGER G, 1976, NATURE, V259, P44, DOI 10.1038/259044b0; Fagot J, 2011, PSYCHOL SCI, V22, P1304, DOI 10.1177/0956797611422916; Fagot J, 2010, J EXP PSYCHOL-ANIM B, V36, P184, DOI 10.1037/a0017169; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040283; Falcone R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032209; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Flemming TM, 2008, J COMP PSYCHOL, V122, P176, DOI 10.1037/0735-7036.122.2.176; Flemming TM, 2013, ANIM COGN, V16, P519, DOI 10.1007/s10071-013-0596-0; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Genovesio A., 2008, NEUROSCIENCE RULE GU, P81; Genovesio A, 2007, J NEUROSCI METH, V165, P38, DOI 10.1016/j.jneumeth.2007.05.026; Genovesio A, 2012, NEURON, V74, P656, DOI 10.1016/j.neuron.2012.02.023; Genovesio A, 2011, J NEUROSCI, V31, P3968, DOI 10.1523/JNEUROSCI.5373-10.2011; Genty E, 2004, ANIM BEHAV, V67, P925, DOI 10.1016/j.anbehav.2003.09.007; Genty E, 2007, J COMP PSYCHOL, V121, P354, DOI 10.1037/0735-7036.121.4.354; Glady Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048378; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Hauser MD, 1999, ANIM BEHAV, V57, P565, DOI 10.1006/anbe.1998.1032; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; JACKSON WJ, 1970, PSYCHOL REP, V27, P839, DOI 10.2466/pr0.1970.27.3.839; Jordan KE, 2008, COGNITION, V108, P617, DOI 10.1016/j.cognition.2008.05.006; KOJIMA T, 1982, JPN PSYCHOL RES, V24, P155, DOI 10.4992/psycholres1954.24.155; Kornell N, 2007, PSYCHOL SCI, V18, P64, DOI 10.1111/j.1467-9280.2007.01850.x; Kralik JD, 2012, J COMP PSYCHOL, V126, P255, DOI 10.1037/a0026019; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Martin-Ordas G, 2008, ANIM COGN, V11, P423, DOI 10.1007/s10071-007-0132-1; Murphy RA, 2008, SCIENCE, V319, P1849, DOI 10.1126/science.1151564; Mushiake H, 2009, INT REV NEUROBIOL, V85, P1, DOI 10.1016/S0074-7742(09)85001-0; NISSEN HW, 1948, J COMP PHYSIOL PSYCH, V41, P62, DOI 10.1037/h0061040; ODEN DL, 1988, J EXP PSYCHOL ANIM B, V14, P140, DOI 10.1037/0097-7403.14.2.140; PAN XC, 2012, J NEUROSCI, V35, P1083; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Procyk E, 2000, COGNITIVE BRAIN RES, V9, P239, DOI 10.1016/S0926-6410(00)00002-1; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Rougier NP, 2005, P NATL ACAD SCI USA, V102, P7338, DOI 10.1073/pnas.0502455102; Rumbaugh D.M., 1984, P569; Rumbaugh D.M., 1984, P221; Saga Y, 2011, J NEUROSCI, V31, P10648, DOI 10.1523/JNEUROSCI.0988-11.2011; Spinozzi G, 2004, J COMP PSYCHOL, V118, P403, DOI 10.1037/0735-7036.118.4.403; Tanji J, 2007, TRENDS COGN SCI, V11, P528, DOI 10.1016/j.tics.2007.09.007; Truppa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023809; Tsujimoto S, 2012, J NEUROSCI, V32, P11017, DOI 10.1523/JNEUROSCI.1230-12.2012; Tsujimoto S, 2011, J NEUROSCI, V31, P4583, DOI 10.1523/JNEUROSCI.5816-10.2011; VISALBERGHI E, 1994, J COMP PSYCHOL, V108, P15, DOI 10.1037/0735-7036.108.1.15; Vonk J, 2003, ANIM COGN, V6, P77, DOI 10.1007/s10071-003-0159-x; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Washburn DA, 2006, J EXP PSYCHOL ANIM B, V32, P185, DOI 10.1037/0097-7403.32.2.185; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Wright A.A., 1984, QUANTITATIVE ANAL BE, V4, P295; WRIGHT AA, 1984, J EXP PSYCHOL ANIM B, V10, P513; Wright AA, 2006, BEHAV PROCESS, V72, P234, DOI 10.1016/j.beproc.2006.03.009; Yamazaki Y, 2012, ANIM COGN, V15, P369, DOI 10.1007/s10071-011-0462-x	64	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84100	10.1371/journal.pone.0084100	http://dx.doi.org/10.1371/journal.pone.0084100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391894	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900037
J	Gupta, P; Jairajpuri, MA; Durani, S				Gupta, Pooja; Jairajpuri, Mohamad Aman; Durani, Susheel			Redox Specificity of 2-Hydroxyacid-Coupled NAD(+)/NADH Dehydrogenases: A Study Exploiting "Reactive" Arginine as a Reporter of Protein Electrostatics	PLOS ONE			English	Article							L-LACTATE DEHYDROGENASE; ANION-BINDING-SITES; AMINO-ACID-SEQUENCE; MALATE-DEHYDROGENASE; BACILLUS-STEAROTHERMOPHILUS; IONIC-STRENGTH; ACTIVE-SITE; RESIDUES; CHARGE; HEART	With "reactive" arginine as a kinetic reporter, 2-hydroxyacid dehydrogenases are assessed in basis of their specialization as NAD(+)-reducing or NADH-oxidizing enzymes. Specifically, M4 and H4 lactate dehydrogenases (LDHs) and cytoplasmic and mitochondrial malate dehydrogenases (MDHs) are compared to assess if their coenzyme specificity may involve electrostatics of cationic or neutral nicotinamide structure as the basis. The enzymes from diverse eukaryote and prokaryote sources thus are assessed in "reactivity" of functionally-critical arginine as a function of salt concentration and pH. Electrostatic calculations were performed on "reactive" arginines and found good correspondence with experiment. The reductive and oxidative LDHs and MDHs are assessed in their count over ionizable residues and in placement details of the residues in their structures as proteins. The variants found to be high or low in Delta pKa of "reactive" arginine are found to be also strong or weak cations that preferentially oxidize NADH (neutral nicotinamide structure) or reduce NAD(+) (cationic nicotinamide structure). The ionized groups of protein structure may thus be important to redox specificity of the enzyme on basis of electrostatic preference for the oxidized (cationic nicotinamide) or reduced (neutral nicotinamide) coenzyme. Detailed comparisons of isozymes establish that the residues contributing in their redox specificity are scrambled in structure of the reductive enzyme.	[Gupta, Pooja; Durani, Susheel] Indian Inst Biotechnol Bombay, Dept Chem, Bombay, Maharashtra, India; [Jairajpuri, Mohamad Aman] Indian Inst Biotechnol Bombay, Dept Biosci & Bioengn, Bombay, Maharashtra, India; [Jairajpuri, Mohamad Aman] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Jamia Millia Islamia	Durani, S (corresponding author), Indian Inst Biotechnol Bombay, Dept Chem, Bombay, Maharashtra, India.	sdurani@iitb.ac.in	Jairajpuri, Mohamad/AAS-2556-2020		Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was funded by the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABURAJ K, 1991, BIOORG CHEM, V19, P229, DOI 10.1016/0045-2068(91)90049-U; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BIRKTOFT JJ, 1982, P NATL ACAD SCI-BIOL, V79, P6166, DOI 10.1073/pnas.79.20.6166; BIRKTOFT JJ, 1983, J BIOL CHEM, V258, P472; Buck H, 2005, INT J QUANTUM CHEM, V101, P389, DOI 10.1002/qua.20282; Buck HM, 2003, NUCLEOS NUCLEOT NUCL, V22, P1545, DOI 10.1081/NCN-120023030; CHAKRABARTI P, 1993, J MOL BIOL, V234, P463, DOI 10.1006/jmbi.1993.1599; EVENTOFF W, 1977, P NATL ACAD SCI USA, V74, P2677, DOI 10.1073/pnas.74.7.2677; GIETL C, 1992, BIOCHIM BIOPHYS ACTA, V1100, P217, DOI 10.1016/0167-4838(92)90476-T; GLEASON WB, 1994, BIOCHEMISTRY-US, V33, P2078, DOI 10.1021/bi00174a014; Glomb MA, 2001, J AGR FOOD CHEM, V49, P1493, DOI 10.1021/jf001082d; GOWARD CR, 1994, PROTEIN SCI, V3, P1883, DOI 10.1002/pro.5560031027; Gulotta M, 2002, BIOCHEMISTRY-US, V41, P3353, DOI 10.1021/bi016009a; Gupta P, 2011, INT J BIOL MACROMOL, V49, P999, DOI 10.1016/j.ijbiomac.2011.08.025; HART KW, 1987, BIOCHEM BIOPH RES CO, V146, P346, DOI 10.1016/0006-291X(87)90731-5; Holmes RS, 2009, COMPUT BIOL CHEM, V33, P379, DOI 10.1016/j.compbiolchem.2009.07.006; HONES J, 1985, BIOL CHEM H-S, V366, P561, DOI 10.1515/bchm3.1985.366.1.561; Jairajpuri MA, 1998, BIOCHEMISTRY-US, V37, P10780, DOI 10.1021/bi980058e; KALLWASS HKW, 1992, J AM CHEM SOC, V114, P10704, DOI 10.1021/ja00053a004; LI SSL, 1983, J BIOL CHEM, V258, P7029; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lsek M.A., 1995, CURR OPIN CHEM BIOL, V5, P775; Madern D, 2002, J MOL EVOL, V54, P825, DOI 10.1007/s00239-001-0088-8; MEDINA M, 1992, ARCH BIOCHEM BIOPHYS, V299, P281, DOI 10.1016/0003-9861(92)90276-3; MITCHELL JBO, 1992, J MOL BIOL, V226, P251, DOI 10.1016/0022-2836(92)90137-9; Mosbach K, 1974, Methods Enzymol, V34, P595; Musrati RA, 1998, GEN PHYSIOL BIOPHYS, V17, P193; NAIK VR, 1968, ARCH BIOCHEM BIOPHYS, V123, P431, DOI 10.1016/0003-9861(68)90163-X; NANDI CL, 1993, PROTEIN ENG, V6, P247, DOI 10.1093/protein/6.3.247; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; QUATTRO JM, 1993, P NATL ACAD SCI USA, V90, P242, DOI 10.1073/pnas.90.1.242; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; RIORDAN JF, 1979, MOL CELL BIOCHEM, V26, P71; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; Swiderek K, 2011, J PHYS CHEM B, V115, P6366, DOI 10.1021/jp201626k; Swiderek K, 2011, ARCH BIOCHEM BIOPHYS, V505, P33, DOI 10.1016/j.abb.2010.10.010; Swiderek K, 2010, J PHYS CHEM B, V114, P3393, DOI 10.1021/jp100026z; TURGEON SL, 1992, J FOOD SCI, V57, P601, DOI 10.1111/j.1365-2621.1992.tb08052.x; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Voet D., 2010, BIOCHEMISTRY; WARWICKER J, 1992, J MOL BIOL, V223, P247, DOI 10.1016/0022-2836(92)90729-4; WILCHEK M, 1984, METHOD ENZYMOL, V104, P3; WILKS HM, 1988, SCIENCE, V242, P1541, DOI 10.1126/science.3201242	47	1	1	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83505	10.1371/journal.pone.0083505	http://dx.doi.org/10.1371/journal.pone.0083505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391777	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200074
J	Halberg, KA; Jorgensen, A; Mobjerg, N				Halberg, Kenneth Agerlin; Jorgensen, Aslak; Mobjerg, Nadja			Desiccation Tolerance in the Tardigrade Richtersius coronifer Relies on Muscle Mediated Structural Reorganization	PLOS ONE			English	Article							HALOBIOTUS-CRISPAE EUTARDIGRADA; BDELLOID ROTIFER; ANHYDROBIOSIS; CYCLOMORPHOSIS; DEHYDRATION; TREHALOSE; ANABIOSIS; LIFE	Life unfolds within a framework of constraining abiotic factors, yet some organisms are adapted to handle large fluctuations in physical and chemical parameters. Tardigrades are microscopic ecdysozoans well known for their ability to endure hostile conditions, such as complete desiccation - a phenomenon called anhydrobiosis. During dehydration, anhydrobiotic animals undergo a series of anatomical changes. Whether this reorganization is an essential regulated event mediated by active controlled processes, or merely a passive result of the dehydration process, has not been clearly determined. Here, we investigate parameters pivotal to the formation of the so-called "tun", a state that in tardigrades and rotifers marks the entrance into anhydrobiosis. Estimation of body volume in the eutardigrade Richtersius coronifer reveals an 87 % reduction in volume from the hydrated active state to the dehydrated tun state, underlining the structural stress associated with entering anhydrobiosis. Survival experiments with pharmacological inhibitors of mitochondrial energy production and muscle contractions show that i) mitochondrial energy production is a prerequisite for surviving desiccation, ii) uncoupling the mitochondria abolishes tun formation, and iii) inhibiting the musculature impairs the ability to form viable tuns. We moreover provide a comparative analysis of the structural changes involved in tun formation, using a combination of cytochemistry, confocal laser scanning microscopy and 3D reconstructions as well as scanning electron microscopy. Our data reveal that the musculature mediates a structural reorganization vital for anhydrobiotic survival, and furthermore that maintaining structural integrity is essential for resumption of life following rehydration.	[Halberg, Kenneth Agerlin; Jorgensen, Aslak; Mobjerg, Nadja] Univ Copenhagen, August Krogh Ctr, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Mobjerg, N (corresponding author), Univ Copenhagen, August Krogh Ctr, Dept Biol, Copenhagen, Denmark.	nmobjerg@bio.ku.dk	Møbjerg, Nadja/AAT-4788-2021; Møbjerg, Nadja/M-2646-2014	Møbjerg, Nadja/0000-0002-5845-9047; Møbjerg, Nadja/0000-0002-5845-9047; Halberg, Kenneth/0000-0002-5903-7196; Jorgensen, Aslak/0000-0001-7191-3796	Carlsberg Foundation; Freja-Programme at Faculty of Science, University of Copenhagen	Carlsberg Foundation(Carlsberg Foundation); Freja-Programme at Faculty of Science, University of Copenhagen	The study was funded by the Carlsberg Foundation (www.carlsbergfondet.dk/) and the Freja-Programme at Faculty of Science, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDEN JA, 1987, EUR J BIOCHEM, V162, P583, DOI 10.1111/j.1432-1033.1987.tb10679.x; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Clegg JS, 2001, COMP BIOCHEM PHYS B, V128, P613, DOI 10.1016/S1096-4959(01)00300-1; CROWE J H, 1975, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V32, P37; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; CROWE JH, 1974, T AM MICROSC SOC, V93, P513, DOI 10.2307/3225155; Crowe LM, 2002, COMP BIOCHEM PHYS A, V131, P505, DOI 10.1016/S1095-6433(01)00503-7; Goldstein B, 2002, CURR BIOL, V12, pR475, DOI 10.1016/S0960-9822(02)00959-4; Guidetti R, 2011, J INSECT PHYSIOL, V57, P567, DOI 10.1016/j.jinsphys.2011.03.003; Halberg KA, 2013, J EXP BIOL, V216, P1235, DOI 10.1242/jeb.075531; Halberg KA, 2012, J EXP BIOL, V215, P497, DOI 10.1242/jeb.065987; Halberg KA, 2009, J EXP BIOL, V212, P2803, DOI 10.1242/jeb.029413; Halberg KA, 2009, J MORPHOL, V270, P996, DOI 10.1002/jmor.10734; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jorgensen A, 2007, J LIMNOL, V66, P77, DOI 10.4081/jlimnol.2007.s1.77; KEILIN D, 1959, PROC R SOC SER B-BIO, V150, P149, DOI 10.1098/rspb.1959.0013; LOOMIS WF, 1948, J BIOL CHEM, V173, P807; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Mobjerg N, 2007, J LIMNOL, V66, P132, DOI 10.4081/jlimnol.2007.s1.132; Nelson DR, 2002, INTEGR COMP BIOL, V42, P652, DOI 10.1093/icb/42.3.652; Persson D, 2011, J ZOOL SYST EVOL RES, V49, P90, DOI 10.1111/j.1439-0469.2010.00605.x; Persson DK, 2012, J MORPHOL, V273, P1227, DOI 10.1002/jmor.20054; Ramazzotti G., 1983, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V41, P1; Reuner A, 2010, CELL STRESS CHAPERON, V15, P423, DOI 10.1007/s12192-009-0158-1; Ricci C, 2003, J MORPHOL, V257, P246, DOI 10.1002/jmor.10120; Ricci C, 2008, J MORPHOL, V269, P233, DOI 10.1002/jmor.10579; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Schmidt-Rhaesa A, 2007, ZOOMORPHOLOGY, V126, P265, DOI 10.1007/s00435-007-0046-0; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Watanabe M, 2002, J EXP BIOL, V205, P2799; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; WHARTON DA, 1985, TISSUE CELL, V17, P79, DOI 10.1016/0040-8166(85)90017-5; WRIGHT JC, 1989, TISSUE CELL, V21, P263, DOI 10.1016/0040-8166(89)90071-2; WRIGHT JC, 1989, J EXP BIOL, V142, P267	37	40	40	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85091	10.1371/journal.pone.0085091	http://dx.doi.org/10.1371/journal.pone.0085091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391987	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900130
J	Marangon, J; Correia, HD; Brondino, CD; Moura, JJG; Romao, MJ; Gonzalez, PJ; Santos-Silva, T				Marangon, Jacopo; Correia, Hugo D.; Brondino, Carlos D.; Moura, Jose J. G.; Romao, Maria J.; Gonzalez, Pablo J.; Santos-Silva, Teresa			Kinetic and Structural Studies of Aldehyde Oxidoreductase from Desulfovibrio gigas Reveal a Dithiolene-Based Chemistry for Enzyme Activation and Inhibition by H2O2	PLOS ONE			English	Article							XANTHINE-OXIDASE; RADIATION-DAMAGE; MOLYBDENUM ENZYMES; RADICAL FORMATION; CRYSTAL-STRUCTURE; PROTEIN; PYRANOPTERIN; TUNGSTEN; DEHYDROGENASE; VALIDATION	Mononuclear Mo-containing enzymes of the xanthine oxidase (XO) family catalyze the oxidative hydroxylation of aldehydes and heterocyclic compounds. The molybdenum active site shows a distorted square-pyramidal geometry in which two ligands, a hydroxyl/water molecule (the catalytic labile site) and a sulfido ligand, have been shown to be essential for catalysis. The XO family member aldehyde oxidoreductase from Desulfovibrio gigas (DgAOR) is an exception as presents in its catalytically competent form an equatorial oxo ligand instead of the sulfido ligand. Despite this structural difference, inactive samples of DgAOR can be activated upon incubation with dithionite plus sulfide, a procedure similar to that used for activation of desulfo-XO. The fact that DgAOR does not need a sulfido ligand for catalysis indicates that the process leading to the activation of inactive DgAOR samples is different to that of desulfo-XO. We now report a combined kinetic and X-ray crystallographic study to unveil the enzyme modification responsible for the inactivation and the chemistry that occurs at the Mo site when DgAOR is activated. In contrast to XO, which is activated by resulfuration of the Mo site, DgAOR activation/inactivation is governed by the oxidation state of the dithiolene moiety of the pyranopterin cofactor, which demonstrates the non-innocent behavior of the pyranopterin in enzyme activity. We also showed that DgAOR incubation with dithionite plus sulfide in the presence of dioxygen produces hydrogen peroxide not associated with the enzyme activation. The peroxide molecule coordinates to molybdenum in a eta(2) fashion inhibiting the enzyme activity.	[Marangon, Jacopo; Correia, Hugo D.; Moura, Jose J. G.; Romao, Maria J.; Gonzalez, Pablo J.; Santos-Silva, Teresa] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE CQFB, Caparica, Setubal, Portugal; [Brondino, Carlos D.; Gonzalez, Pablo J.] Univ Nacl Litoral, Fac Bioquim & Ciencias Biol, Dept Fis, Santa Fe, Argentina	Universidade Nova de Lisboa; National University of the Littoral	Gonzalez, PJ (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, REQUIMTE CQFB, Caparica, Setubal, Portugal.	p.gonzalez@fct.unl.pt; tsss@fct.unl.pt	FCT/UNL, REQUIMTE Biological Chemistry at/V-8183-2017; Moura, José J G/D-6426-2013; Santos-Silva, Teresa/AAE-1795-2019; Santos-Silva, Teresa/D-2050-2013; Romao, Maria J/A-4115-2013; UCIBIO, U Cienc Biom Apl/F-7948-2017	Moura, José J G/0000-0002-4726-2388; Santos-Silva, Teresa/0000-0003-3060-8378; Santos-Silva, Teresa/0000-0003-3060-8378; Romao, Maria J/0000-0002-3004-0543; UCIBIO, U Cienc Biom Apl/0000-0002-3004-0543; Brondino, Carlos D./0000-0002-9468-062X; Gonzalez, Pablo Javier/0000-0001-5430-8981	Fundacao para a Ciencia e a Tecnologia [PTDC/BIA-PRO/118377/2010, PEst-C/EQB/LA0006/2011]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work has been supported by Fundacao para a Ciencia e a Tecnologia through the project PTDC/BIA-PRO/118377/2010 and grant number PEst-C/EQB/LA0006/2011. Funder website: www.fct.mctes.pt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SLA, 2003, BIOCHEM BIOPH RES CO, V308, P73, DOI 10.1016/S0006-291X(03)01337-8; ARCHER SL, 1995, CIRC RES, V77, P174, DOI 10.1161/01.RES.77.1.174; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barata B, 1992, ESTUDO BIOQUIMICO ES; BARATA BAS, 1993, BIOCHEMISTRY-US, V32, P11559, DOI 10.1021/bi00094a012; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BETCHERLANGE SL, 1979, J BIOL CHEM, V254, P8825; Biradar AV, 2009, TETRAHEDRON LETT, V50, P2885, DOI 10.1016/j.tetlet.2009.03.178; Brondino CD, 2006, ACCOUNTS CHEM RES, V39, P788, DOI 10.1021/ar050104k; Brondino CD, 2006, CURR OPIN CHEM BIOL, V10, P109, DOI 10.1016/j.cbpa.2006.01.034; CAMPESTRINI S, 1993, J MOL CATAL, V83, P95, DOI 10.1016/0304-5102(93)87010-6; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coelho C, 2011, J MOL BIOL, V408, P932, DOI 10.1016/j.jmb.2011.03.016; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; CRUTZEN PJ, 1981, ATMOSPHERIC CHEM PRO; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; Hille R, 2002, MET IONS BIOL SYST, V39, P187; Hille R, 2006, EUR J INORG CHEM, P1913, DOI 10.1002/ejic.200600087; Homer C, 2011, J SYNCHROTRON RADIAT, V18, P338, DOI 10.1107/S0909049511005504; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; Johnson MK, 1996, CHEM REV, V96, P2817, DOI 10.1021/cr950063d; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Krippahl L, 2006, EUR J INORG CHEM, P3835, DOI 10.1002/ejic.200600418; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matz KG, 2011, INORG CHEM, V50, P9804, DOI 10.1021/ic200783a; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MOTTLEY C, 1988, ARCH BIOCHEM BIOPHYS, V267, P681, DOI 10.1016/0003-9861(88)90077-X; MOURA JJG, 1976, BIOCHEM BIOPH RES CO, V72, P782, DOI 10.1016/S0006-291X(76)80201-X; MOURA JJG, 1978, BIOCHEM J, V173, P419, DOI 10.1042/bj1730419; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Ravelli RBG, 2003, STRUCTURE, V11, P217, DOI 10.1016/S0969-2126(03)00006-6; Rebelo JM, 2001, J BIOL INORG CHEM, V6, P791, DOI 10.1007/s007750100255; Romao MJ, 2009, DALTON T, P4053, DOI 10.1039/b821108f; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Rothery RA, 2012, P NATL ACAD SCI USA, V109, P14773, DOI 10.1073/pnas.1200671109; Santos-Silva T, 2009, J AM CHEM SOC, V131, P7990, DOI 10.1021/ja809448r; Schiltz M, 2007, J SYNCHROTRON RADIAT, V14, P34, DOI 10.1107/S0909049506038970; Tarini M, 2006, IEEE T VIS COMPUT GR, V12, P1237, DOI 10.1109/TVCG.2006.115; WAHL RC, 1982, J BIOL CHEM, V257, P1354; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Zhao HT, 2001, FREE RADICAL BIO MED, V31, P599, DOI 10.1016/S0891-5849(01)00619-0	47	6	6	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83234	10.1371/journal.pone.0083234	http://dx.doi.org/10.1371/journal.pone.0083234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391748	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200045
J	Seu, L; Ortiz, GM; Epling, L; Sinclair, E; Swainson, LA; Bajpai, UD; Huang, Y; Deeks, SG; Hunt, PW; Martin, JN; McCune, JM				Seu, Lillian; Ortiz, Gabriel M.; Epling, Lorrie; Sinclair, Elizabeth; Swainson, Louise A.; Bajpai, Urmila D.; Huang, Yong; Deeks, Steven G.; Hunt, Peter W.; Martin, Jeffrey N.; McCune, Joseph M.			Higher CD27(+)CD8(+) T Cells Percentages during Suppressive Antiretroviral Therapy Predict Greater Subsequent CD4(+) T Cell Recovery in Treated HIV Infection	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; REPLICATIVE SENESCENCE; LYMPHOCYTE-ACTIVATION; EXPRESSION; CD27; SURVIVAL; MEMORY	HIV-mediated immune dysfunction may influence CD4(+) T cell recovery during suppressive antiretroviral therapy (ART). We analyzed cellular biomarkers of immunological inflammation, maturation, and senescence in HIV-infected subjects on early suppressive ART. We performed longitudinal analyses of peripheral immunological biomarkers of subjects on suppressive ART (n = 24) from early treatment (median 6.4 months, interquartile range [IQR] 4.8-13.9 months) to 1-2 years of follow-up (median 19.8 months, IQR 18.3-24.6 months). We performed multivariate regression to determine which biomarkers were associated with and/or predictive of CD4(+) T cell recovery. After adjusting for the pre-ART CD4(+) T cell count, age, proximal CD4(+) T cell count, and length of ART medication, the percentage of CD27(+)CD8(+) T cells remained significantly associated with the CD4(+) T cell recovery rate (beta = 0.092 cells/ul/month, P = 0.028). In HIV-infected subjects starting suppressive ART, patients with the highest percentage of CD8(+) T cells expressing CD27 had the greatest rate of CD4(+) T cell recovery.	[Seu, Lillian; Huang, Yong] Univ Calif San Francisco, Dept Pharm, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Seu, Lillian; Ortiz, Gabriel M.; Epling, Lorrie; Sinclair, Elizabeth; Swainson, Louise A.; Bajpai, Urmila D.; McCune, Joseph M.] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA 94143 USA; [Ortiz, Gabriel M.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Epling, Lorrie; Sinclair, Elizabeth] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Core Immunol Lab, San Francisco, CA USA; [Bajpai, Urmila D.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Rheumatol, Dept Med, San Francisco, CA USA; [Deeks, Steven G.; Hunt, Peter W.; Martin, Jeffrey N.] Univ Calif San Francisco, San Francisco Gen Hosp, Posit Hlth Program, Dept Med, San Francisco, CA USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McCune, JM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, Div Expt Med, San Francisco, CA 94143 USA.	mike.mccune@ucsf.edu	Hunt, Peter W./P-2976-2017; S., Lillian/D-1165-2011	Hunt, Peter W./0000-0002-4571-4870; S., Lillian/0000-0002-8456-019X	California HIV Research Program grant [D09-SF-313]; National Institutes of Health (NIH) [T32 AI060530, 2T32AI007641]; Gates Foundation [OPP1024421]; NIH [U01 AI43641, R37 AI40312]; Human Frontier Science Program; National Institute of Arthritis and Musculoskeletal and Skin Diseases Academic Rheumatology Training Grant; Rosalind Russell Arthritis Center; National Institutes of Health Director's Pioneer Award as part of the National Institutes of Health Roadmap for Medical Research [DPI OD00329]; Centers for AIDS Research at UCSF [PO AI27763]; CFAR Network of Integrated Systems [R24 AI067039]; UCSF CTSI [UL1 RR024131]; National Institute of Allergy and Infectious Diseases [R01 AI087145, K24AI069994, AI-76174]; AIDS Research Institute at UCSF; Harvey V. Berneking Living Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040312, K24AI069994, P01AI076174, T32AI007641, T32AI060530, R24AI067039, R01AI087145, P30AI027763] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	California HIV Research Program grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); National Institute of Arthritis and Musculoskeletal and Skin Diseases Academic Rheumatology Training Grant; Rosalind Russell Arthritis Center; National Institutes of Health Director's Pioneer Award as part of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for AIDS Research at UCSF; CFAR Network of Integrated Systems; UCSF CTSI; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS Research Institute at UCSF; Harvey V. Berneking Living Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	LS was supported by a pre-doctoral dissertation California HIV Research Program grant (# D09-SF-313). GMO was supported by National Institutes of Health (NIH) Training Grants T32 AI060530 and 2T32AI007641 as well as the Gates Foundation Award # OPP1024421 and the NIH Loan Repayment Program. LAS is supported by the Human Frontier Science Program. UDB is a University of California at San Francisco (UCSF) Rheumatology Fellow and is funded by a National Institute of Arthritis and Musculoskeletal and Skin Diseases Academic Rheumatology Training Grant and the Rosalind Russell Arthritis Center. JMM was supported by NIH Awards U01 AI43641 and R37 AI40312, and is a recipient of the National Institutes of Health Director's Pioneer Award as part of the National Institutes of Health Roadmap for Medical Research (DPI OD00329). The SCOPE cohort was supported by the Centers for AIDS Research at UCSF (PO AI27763), CFAR Network of Integrated Systems (R24 AI067039), the UCSF CTSI (UL1 RR024131), and National Institute of Allergy and Infectious Diseases (R01 AI087145, K24AI069994, AI-76174). This work was also supported by the AIDS Research Institute at UCSF and the Harvey V. Berneking Living Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Cameron PU, 2007, J VIROL, V81, P2297, DOI 10.1128/JVI.01795-06; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Heimbeck I, 2010, CYTOM PART A, V77A, P823, DOI 10.1002/cyto.a.20942; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; KOBATA T, 1994, J IMMUNOL, V153, P5422; Massanella M, 2013, ANTIVIR RES, V100, P420, DOI 10.1016/j.antiviral.2013.07.017; McFarland RD, 2000, P NATL ACAD SCI USA, V97, P4215, DOI 10.1073/pnas.070061597; Mojumdar K, 2012, CYTOM PART B-CLIN CY, V82B, P43, DOI 10.1002/cyto.b.20610; Ochsenbein AF, 2004, J EXP MED, V200, P1407, DOI 10.1084/jem.20040717; Rajasuriar R, 2013, AIDS; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Swainson LA, 2010, J IMMUNOL, V184, P3639, DOI 10.4049/jimmunol.0903943; Vollbrecht T, 2010, J MED VIROL, V82, P358, DOI 10.1002/jmv.21723; Young J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001194	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84091	10.1371/journal.pone.0084091	http://dx.doi.org/10.1371/journal.pone.0084091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391889	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900032
J	Simeon, RL; Chen, ZL				Simeon, Rudo L.; Chen, Zhilei			A Screen for Genetic Suppressor Elements of Hepatitis C Virus Identifies a Supercharged Protein Inhibitor of Viral Replication	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; RNA REPLICATION; EXPRESSION SELECTION; INITIAL TREATMENT; RESISTANCE; COMBINATION; COMPLEX; INTERFERON-ALPHA-2B; ALPHA-DEFENSIN-1; BOCEPREVIR	Genetic suppressor elements (GSEs) are biomolecules derived from a gene or genome of interest that act as transdominant inhibitors of biological functions presumably by disruption of critical biological interfaces. We exploited a cell death reporter cell line for hepatitis C virus (HCV) infection, n4mBid, to develop an iterative selection/enrichment strategy for the identification of anti-HCV GSEs. Using this approach, a library of fragments of an HCV genome was screened for sequences that suppress HCV infection. A 244 amino acid gene fragment, B1, was strongly enriched after 5 rounds of selection. B1 derives from a single-base frameshift of the enhanced green fluorescent protein (eGFP) which was used as a filler during fragment cloning. B1 has a very high net positive charge of 43 at neutral pH and a high charge-to-mass (kDa) ratio of 1.5. We show that B1 expression specifically inhibits HCV replication. In addition, five highly positively charged B1 fragments produced from progressive truncation at the C-terminus all retain the ability to inhibit HCV, suggesting that a high positive charge, rather than a particular motif in B1, likely accounts for B1's anti-HCV activity. Another supercharged protein, +36GFP, was also found to strongly inhibit HCV replication when added to cells at the time of infection. This study reports a new methodology for HCV inhibitor screening and points to the anti-HCV potential of positively charged proteins/peptides.	[Simeon, Rudo L.; Chen, Zhilei] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA; [Chen, Zhilei] Texas A&M Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Chen, ZL (corresponding author), Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX 77843 USA.	zchen4@tamu.edu			National Institutes of Health [R21A1083965-01]; Artie McFerrin Department of Chemical Engineering, Texas AM University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Artie McFerrin Department of Chemical Engineering, Texas AM University	Funding for this study is provided by the National Institutes of Health (R21A1083965-01) and the Artie McFerrin Department of Chemical Engineering, Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Buck CB, 2006, P NATL ACAD SCI USA, V103, P1516, DOI 10.1073/pnas.0508033103; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; Chamoun AM, 2012, ANTIMICROB AGENTS CH, V56, P672, DOI 10.1128/AAC.05722-11; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chen ZL, 2010, ANTIVIR RES, V86, P220, DOI 10.1016/j.antiviral.2010.02.321; Chockalingam K, 2010, P NATL ACAD SCI USA, V107, P3764, DOI 10.1073/pnas.0915117107; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; DAHER KA, 1986, J VIROL, V60, P1068, DOI 10.1128/JVI.60.3.1068-1074.1986; Dunn SJ, 2004, VIROLOGY, V321, P260, DOI 10.1016/j.virol.2004.01.010; Dunn SJ, 1999, GENE THER, V6, P130, DOI 10.1038/sj.gt.3300791; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; GANZ T, 1995, PHARMACOL THERAPEUT, V66, P191, DOI 10.1016/0163-7258(94)00076-F; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gastaminza P, 2011, J VIROL, V85, P5513, DOI 10.1128/JVI.02116-10; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hahn B, 1998, J VIROL, V72, P8782, DOI 10.1128/JVI.72.11.8782-8788.1998; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; HOLZMAYER TA, 1992, NUCLEIC ACIDS RES, V20, P711, DOI 10.1093/nar/20.4.711; Honda M, 2000, GASTROENTEROLOGY, V118, P152, DOI 10.1016/S0016-5085(00)70424-0; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Levenson VV, 1999, SOMAT CELL MOLEC GEN, V25, P9; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Maqbool MA, 2013, J VIROL, V87, P5523, DOI 10.1128/JVI.00585-12; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Newcomer BW, 2013, CAN J VET RES, V77, P170; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pharma T, US Patent Number, Patent No. [6,797,462, 6797462]; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Primiano T, 2003, CANCER CELL, V4, P41, DOI 10.1016/S1535-6108(03)00169-7; REED L. J., 1938, AMER JOUR HYG, V27, P493; RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987; RONINSON IB, 1995, CANCER RES, V55, P4023; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; SELSTED ME, 1985, INFECT IMMUN, V49, P202, DOI 10.1128/IAI.49.1.202-206.1985; SELSTED ME, 1984, INFECT IMMUN, V45, P150, DOI 10.1128/IAI.45.1.150-154.1984; Simeon RL, 2013, ACS CHEM BIOL; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Thompson AJ, 2011, CURR OPIN VIROL, V1, P599, DOI 10.1016/j.coviro.2011.10.001; Tscherne DM, 2008, J VIROL, V82, P2427, DOI 10.1128/JVI.02158-07; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; World Health Organization, 2012, GUID PREV VIR HEP B; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003; Zhang LR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00293; Zhang LQ, 2002, SCIENCE, V298, P995, DOI 10.1126/science.1076185	64	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84022	10.1371/journal.pone.0084022	http://dx.doi.org/10.1371/journal.pone.0084022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391867	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900010
J	Timucin, E; Sezerman, OU				Timucin, Emel; Sezerman, O. Ugur			The Conserved Lid Tryptophan, W211, Potentiates Thermostability and Thermoactivity in Bacterial Thermoalkalophilic Lipases	PLOS ONE			English	Article							BACILLUS-STEAROTHERMOPHILUS L1; MOLECULAR-DYNAMICS SIMULATIONS; HUMICOLA-LANUGINOSA LIPASE; THERMAL-STABILITY; CRYSTAL-STRUCTURE; TRIOSEPHOSPHATE ISOMERASE; EXTREME THERMOPHILE; LIGHT-SCATTERING; FORCE-FIELD; AGGREGATION	We hypothesize that aggregation of thermoalkalophilic lipases could be a thermostability mechanism. The conserved tryptophans (W211, W234) in the lid are of particular interest owing to their previous involvements in aggregation and thermostability mechanisms in many other proteins. The thermoalkalophilic lipase from Bacillus thermocatenulatus (BTL2) and its mutants (W211A, W234A) were expressed and purified to homogeneity. We found that, when aggregated, BTL2 is more thermostable than its non-aggregating form, showing that aggregation potentiates thermostability in the thermoalkalophilic lipase. Among the two lid mutants, the W211A lowered aggregation tendency drastically and resulted in a much less thermostable variant of BTL2, which indicated that W211 stabilizes the intermolecular interactions in BTL2 aggregates. Further thermoactivity and CD spectroscopy analyses showed that W211A also led to a strong decrease in the optimal and the melting temperature of BTL2, implying stabilization by W211 also to the intramolecular interactions. The other lid mutant W234A had no effects on these properties. Finally, we analyzed the molecular basis of these experimental findings in-silico using the dimer (PDB ID: 1KU0) and the monomer (PDB ID: 2W22) lipase structures. The computational analyses confirmed that W211 stabilized the intermolecular interactions in the dimer lipase and it is critical to the stability of the monomer lipase. Explicitly W211 confers stability to the dimer and the monomer lipase through distinct aromatic interactions with Y273-Y282 and H87-P232 respectively. The insights revealed by this work shed light not only on the mechanism of thermostability and its relation to aggregation but also on the particular role of the conserved lid tryptophan in the thermoalkalophilic lipases.	[Timucin, Emel; Sezerman, O. Ugur] Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey	Sabanci University	Timucin, E (corresponding author), Sabanci Univ, Fac Engn & Nat Sci, Istanbul, Turkey.	emeld@sabanciuniv.edu	Timucin, Emel/N-7446-2017; Timucin, Emel/AHE-5258-2022; SEZERMAN, OSMAN U/X-6441-2018	Timucin, Emel/0000-0003-0048-0668; Timucin, Emel/0000-0003-0048-0668; Sezerman, Osman Ugur/0000-0003-0905-6783	State Planning Organization of Turkey [EACF-06-00422]	State Planning Organization of Turkey(Turkiye Cumhuriyeti Kalkinma Bakanligi)	This work was supported by the State Planning Organization of Turkey [EACF-06-00422]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott MA, 2000, J MOL BIOL, V304, P657, DOI 10.1006/jmbi.2000.4240; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Attanasio F, 2013, CHEMBIOCHEM, V14, P583, DOI 10.1002/cbic.201200704; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CAFLISCH A, 1995, J MOL BIOL, V252, P672, DOI 10.1006/jmbi.1995.0528; Carrasco-Lopez C, 2009, J BIOL CHEM, V284, P4365, DOI 10.1074/jbc.M808268200; Castro-Ochoa LD, 2005, ENZYME MICROB TECH, V37, P648, DOI 10.1016/j.enzmictec.2005.06.003; Cecchini P, 2012, PROTEIN ENG DES SEL, V25, P199, DOI 10.1093/protein/gzs005; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Cho AR, 2000, FEMS MICROBIOL LETT, V186, P235, DOI 10.1016/S0378-1097(00)00150-6; Choi WC, 2005, FEBS LETT, V579, P3461, DOI 10.1016/j.febslet.2005.05.016; Cygler M, 1997, METHOD ENZYMOL, V284, P3; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; DEREWENDA U, 1994, J LIPID RES, V35, P524; Ding F, 2002, J MOL BIOL, V324, P851, DOI 10.1016/S0022-2836(02)01112-9; DUNHAUPT A, 1992, BIOTECHNOL LETT, V14, P953, DOI 10.1007/BF01020636; Durmaz E, 2013, PROTEIN ENG DES SEL, V26, P325, DOI 10.1093/protein/gzt004; Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y; Hayakawa IK J, 1992, J FOOD SCI, V57; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jeong ST, 2002, J BIOL CHEM, V277, P17041, DOI 10.1074/jbc.M200640200; Jeong ST, 2001, ACTA CRYSTALLOGR D, V57, P1300, DOI 10.1107/S0907444901010332; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Kayser V, 2011, MABS-AUSTIN, V3, P408, DOI 10.4161/mabs.3.4.15677; Kim SJ, 2001, NAT STRUCT BIOL, V8, P459, DOI 10.1038/87639; KIRINO H, 1994, EUR J BIOCHEM, V220, P275, DOI 10.1111/j.1432-1033.1994.tb18623.x; Kumari A, 2012, BIOTECHNOL LETT, V34, P1733, DOI 10.1007/s10529-012-0958-8; Littlechild JA, 2007, BIOCHEM SOC T, V35, P1558, DOI 10.1042/BST0351558; Lookene A, 1997, J BIOL CHEM, V272, P766, DOI 10.1074/jbc.272.2.766; Lorber B, 2012, BIOCHEM MOL BIOL EDU, V40, P372, DOI 10.1002/bmb.20644; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maithal K, 2002, PROTEIN ENG, V15, P575, DOI 10.1093/protein/15.7.575; Martinelle M, 1996, PROTEIN ENG, V9, P519, DOI 10.1093/protein/9.6.519; Matsumura H, 2008, PROTEINS, V70, P592, DOI 10.1002/prot.21799; MERKLER DJ, 1988, BIOCHIM BIOPHYS ACTA, V952, P101, DOI 10.1016/0167-4838(88)90106-9; Pedersen S, 2006, BIOPOLYMERS, V83, P619, DOI 10.1002/bip.20598; Peters GH, 1996, BIOPHYS J, V71, P119, DOI 10.1016/S0006-3495(96)79207-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Quyen DT, 2003, PROTEIN EXPRES PURIF, V28, P102, DOI 10.1016/S1046-5928(02)00679-4; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Robb FT, 2008, THERMOPHILES BIOL TE, pxiii; Rua ML, 1997, J BIOTECHNOL, V56, P89, DOI 10.1016/S0168-1656(97)00079-5; Ruslan R, 2012, INT J MOL SCI, V13, P943, DOI 10.3390/ijms13010943; Salameh Moh'd A, 2010, Open Biochem J, V4, P22, DOI 10.2174/1874091X01004010022; Schlieben NH, 2004, PROTEIN EXPRES PURIF, V34, P103, DOI 10.1016/j.pep.2003.11.014; Schmid RD, 1998, ANGEW CHEM INT EDIT, V37, P1609; SCHMIDTDANNERT C, 1994, BBA-LIPID LIPID MET, V1214, P43, DOI 10.1016/0005-2760(94)90008-6; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; TAKAGI H, 1990, J BIOL CHEM, V265, P6874; TANAKA S, 2005, BMC BIOCH, V6, DOI DOI 10.1186/1471-2091-6-1; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Taylor DM, 2007, J BIOL CHEM, V282, P16329, DOI 10.1074/jbc.M610119200; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tyndall JDA, 2002, J MOL BIOL, V323, P859, DOI 10.1016/S0022-2836(02)01004-5; Walden H, 2001, J MOL BIOL, V306, P745, DOI 10.1006/jmbi.2000.4433; Zhu K, 2001, BBA-PROTEIN STRUCT M, V1547, P329, DOI 10.1016/S0167-4838(01)00198-4	62	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85186	10.1371/journal.pone.0085186	http://dx.doi.org/10.1371/journal.pone.0085186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391996	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900139
J	Chen, SH; Chan, SC; Chao, YK; Yen, TC				Chen, Shih-Hsin; Chan, Sheng-Chieh; Chao, Yin-Kai; Yen, Tzu-Chen			Detection of Synchronous Cancers by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography during Primary Staging Workup for Esophageal Squamous Cell Carcinoma in Taiwan	PLOS ONE			English	Article							MULTIPLE PRIMARY CANCERS; ALDEHYDE DEHYDROGENASE-2; PRIMARY NEOPLASMS; ALCOHOL-DRINKING; F-18-FDG PET; RISK; IMPACT; MANAGEMENT; POLYMORPHISMS; EPIDEMIOLOGY	Aim: The aim of this retrospective study was to investigate the ability of fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in the detection of synchronous cancers during staging workup for esophageal squamous cell carcinoma. Materials and Methods: We performed a retrospective chart review of 426 Taiwanese patients with esophageal cancer who received FDG-PET/CT during their primary staging workup between December 2006 and December 2011. We defined synchronous cancers as those occurring within 6 months of the FDG-PET/CT scan. All of the synchronous lesions were confirmed by histology or imaging follow-up. The study patients were followed for at least 18 months or were censored on the date of last follow-up. Results: Fifty patients were excluded from analysis because of the presence of distant metastases. Of the remaining 376 patients, 359 were diagnosed with squamous cell carcinoma (SCC). We identified 17 patients with synchronous cancers, and all of them had a diagnosis of SCC. Synchronous head and neck cancers were the most frequent (n=13, 76.4%), followed by gastrointestinal cancers (colon cancer, n=2; hepatocellular carcinoma, n=1), and renal cell carcinoma (n=1). FDG-PET/CT successfully detected 15 synchronous cancers (12 head and neck cancers, 2 colon cancers, and 1 renal cell carcinoma). In contrast, conventional workup detected only 9 synchronous cancers (7 head and neck cancers, 1 hepatocellular carcinoma and 1 renal cell carcinoma). The sensitivity of FDG-PET/CT and conventional workup in detecting synchronous cancers were 88.2% and 52.9% respectively. Conclusion: The most frequent synchronous lesions in patients with esophageal SCC were head and neck cancers in Taiwan. Our data indicate that FDG-PET/CT is superior to conventional workup in the detection of synchronous tumors during primary staging for esophageal squamous cell carcinoma.	[Chen, Shih-Hsin; Chan, Sheng-Chieh; Yen, Tzu-Chen] Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan; [Chao, Yin-Kai] Chang Gung Mem Hosp, Dept Thorac Surg, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yen, TC (corresponding author), Chang Gung Mem Hosp, Dept Nucl Med, Tao Yuan, Taiwan.	yentc1110@gmail.com	Chao, YinKai/ABE-7827-2020; Chan, Sheng Chieh/AAF-9127-2019; Stefanadis, Christodoulos/ABH-2232-2020	Chan, Sheng Chieh/0000-0003-3236-395X; Stefanadis, Christodoulos/0000-0001-5974-6454; Huang, Yan-Ping/0000-0002-3301-2847				[Anonymous], 2012, TAIW CANC REG ANN RE; Barber TW, 2012, J NUCL MED, V53, P864, DOI 10.2967/jnumed.111.101568; Bhargava P, 2011, CLIN NUCL MED, V36, pE20, DOI 10.1097/RLU.0b013e318212c872; Cheng NM, 2009, EUR J NUCL MED MOL I, V36, P607, DOI 10.1007/s00259-008-0995-7; Choi JY, 2005, J CLIN ONCOL, V23, P7654, DOI 10.1200/JCO.2005.01.4340; Ding JH, 2010, J HUM GENET, V55, P97, DOI 10.1038/jhg.2009.129; Ferlay J, 2010, IARC CANCERBASE, V10; Gao CM, 2008, WORLD J GASTROENTERO, V14, P5078, DOI 10.3748/wjg.14.5078; Heusner TA, 2009, EUR RADIOL, V19, P2171, DOI 10.1007/s00330-009-1405-7; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Howlader N., 2016, SEER CANC STAT REV; Kagei K, 2002, JPN J CLIN ONCOL, V32, P120, DOI 10.1093/jjco/hyf028; Kumagai Y, 2001, SURG TODAY, V31, P872, DOI 10.1007/s005950170025; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Little SG, 2007, EUR J CARDIO-THORAC, V31, P791, DOI 10.1016/j.ejcts.2007.01.037; Malik V, 2012, CLIN NUCL MED, V37, P1152, DOI 10.1097/RLU.0b013e31827083ba; Matsuo K, 2013, CARCINOGENESIS, V34, P1510, DOI 10.1093/carcin/bgt080; Miyata H, 2008, DIS ESOPHAGUS, V21, P144, DOI 10.1111/j.1442-2050.2007.00743.x; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Natsugoe S, 2005, WORLD J SURG, V29, P46, DOI 10.1007/s00268-004-7525-y; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Poon RTP, 1998, ANN THORAC SURG, V65, P1529, DOI 10.1016/S0003-4975(98)00177-5; Seitz HK, 2010, GENES NUTR, V5, P121, DOI 10.1007/s12263-009-0154-1; van Westreenen HL, 2005, J NUCL MED, V46, P1321; Vyas S, 2011, J GASTROINTEST SURG, V15, P2127, DOI 10.1007/s11605-011-1686-4; Wu IC, 2006, EUR J CLIN INVEST, V36, P236, DOI 10.1111/j.1365-2362.2006.01621.x	26	25	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82812	10.1371/journal.pone.0082812	http://dx.doi.org/10.1371/journal.pone.0082812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24391852	Green Submitted, gold, Green Published			2022-12-27	WOS:000327670300086
J	Wrede, KH; Dammann, P; Monninghoff, C; Johst, S; Maderwald, S; Sandalcioglu, IE; Muller, O; Ozkan, N; Ladd, ME; Forsting, M; Schlamann, MU; Sure, U; Umutlu, L				Wrede, Karsten H.; Dammann, Philipp; Moenninghoff, Christoph; Johst, Soeren; Maderwald, Stefan; Sandalcioglu, I. Erol; Mueller, Oliver; Oezkan, Neriman; Ladd, Mark E.; Forsting, Michael; Schlamann, Marc U.; Sure, Ulrich; Umutlu, Lale			Non-Enhanced MR Imaging of Cerebral Aneurysms: 7 Tesla versus 1.5 Tesla	PLOS ONE			English	Article							TIME-OF-FLIGHT; DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; INITIAL-EXPERIENCE; FOLLOW-UP; COMPLICATIONS; AGREEMENT; COILS; 3.0-T	Purpose: To prospectively evaluate 7 Tesla time-of-flight (TOF) magnetic resonance angiography (MRA) in comparison to 1.5 Tesla TOF MRA and 7 Tesla non-contrast enhanced magnetization-prepared rapid acquisition gradient-echo (MPRAGE) for delineation of unruptured intracranial aneurysms (UIA). Material and Methods: Sixteen neurosurgical patients (male n = 5, female n = 11) with single or multiple UIA were enrolled in this trial. All patients were accordingly examined at 7 Tesla and 1.5 Tesla MRI utilizing dedicated head coils. The following sequences were obtained: 7 Tesla TOF MRA, 1.5 Tesla TOF MRA and 7 Tesla non-contrast enhanced MPRAGE. Image analysis was performed by two radiologists with regard to delineation of aneurysm features (dome, neck, parent vessel), presence of artifacts, vessel-tissue-contrast and overall image quality. Interobserver accordance and intermethod comparisons were calculated by kappa coefficient and Lin's concordance correlation coefficient. Results: A total of 20 intracranial aneurysms were detected in 16 patients, with two patients showing multiple aneurysms (n = 2, n = 4). Out of 20 intracranial aneurysms, 14 aneurysms were located in the anterior circulation and 6 aneurysms in the posterior circulation. 7 Tesla MPRAGE imaging was superior over 1.5 and 7 Tesla TOF MRA in the assessment of all considered aneurysm and image quality features (e. g. image quality: mean MPRAGE7T: 5.0; mean TOF7T: 4.3; mean TOF1.5T: 4.3). Ratings for 7 Tesla TOF MRA were equal or higher over 1.5 Tesla TOF MRA for all assessed features except for artifact delineation (mean TOF7T: 4.3; mean TOF1.5T 4.4). Interobserver accordance was good to excellent for most ratings. Conclusion: 7 Tesla MPRAGE imaging demonstrated its superiority in the detection and assessment of UIA as well as overall imaging features, offering excellent interobserver accordance and highest scores for all ratings. Hence, it may bear the potential to serve as a high-quality diagnostic tool for pretherapeutic assessment and follow-up of untreated UIA.	[Wrede, Karsten H.; Dammann, Philipp; Johst, Soeren; Maderwald, Stefan; Ladd, Mark E.; Umutlu, Lale] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Wrede, Karsten H.; Dammann, Philipp; Sandalcioglu, I. Erol; Mueller, Oliver; Oezkan, Neriman; Sure, Ulrich] Univ Hosp Essen, Dept Neurosurg, Essen, Germany; [Moenninghoff, Christoph; Johst, Soeren; Maderwald, Stefan; Ladd, Mark E.; Forsting, Michael; Schlamann, Marc U.; Umutlu, Lale] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Wrede, KH (corresponding author), Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	karsten.wrede@uk-essen.de	Wrede, Karsten/AAZ-2154-2020; Maderwald, Stefan/B-4241-2011; Ladd, Mark E./B-3285-2011; Mueller, Oliver Marcus/E-3419-2014; Müller, Oliver/GQZ-2967-2022	Wrede, Karsten/0000-0001-7076-3503; Mueller, Oliver Marcus/0000-0003-4690-370X; Ladd, Mark/0000-0002-4128-9440	IFORES grant from the University Duisburg-Essen	IFORES grant from the University Duisburg-Essen	An IFORES grant to KHW from the University Duisburg-Essen supported the research [http://www.uni-due.de/med/forschung/forschungsfoerderung/ifores.shtml]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2000, AM J NEURORADIOL, V21, P1618; Chung TS, 1999, AM J NEURORADIOL, V20, P229; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; EDELSTEIN WA, 1986, MAGNET RESON MED, V3, P604, DOI 10.1002/mrm.1910030413; Ferre JC, 2009, EUR J RADIOL, V72, P365, DOI 10.1016/j.ejrad.2008.08.005; Fischer A, 2013, INVEST RADIOL, V48, P525, DOI 10.1097/RLI.0b013e3182839c2b; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; Gaa J, 2004, ACTA RADIOL, V45, P327, DOI 10.1080/02841850410004229; Gibbs GF, 2004, AM J NEURORADIOL, V25, P84; Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c; Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q; Johst S, 2012, INVEST RADIOL, V47, P445, DOI 10.1097/RLI.0b013e31824ef21f; Kashiwazaki D, 2013, STROKE; Kaufmann TJ, 2007, RADIOLOGY, V243, P812, DOI 10.1148/radiol.2433060536; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawson MF, 2013, WORLD NEUROSURG, V79, P472, DOI 10.1016/j.wneu.2012.01.038; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; LIN L I K, 1989, BIOMETRICS, V43, P255; Maderwald S, 2008, MAGN RESON MATER PHY, V21, P159, DOI 10.1007/s10334-007-0096-9; Majoie CBLM, 2005, AM J NEURORADIOL, V26, P1349; Monninghoff C, 2009, ROFO-FORTSCHR RONTG, V181, P16, DOI 10.1055/s-2008-1027863; Nakiri GS, 2011, CLINICS, V66, P641, DOI 10.1590/S1807-59322011000400020; Nowinski WL, 2013, J NEUROIMAGING, V23, P86, DOI 10.1111/j.1552-6569.2011.00597.x; Okahara M, 2002, STROKE, V33, P1803, DOI 10.1161/01.STR.0000019510.32145.A9; Schar M, 2004, MAGN RESON MED, V51, P799, DOI 10.1002/mrm.20024; Shahzad R, 2011, JCPSP-J COLL PHYSICI, V21, P325, DOI 07.2011/JCPSP.325329; Steinberg GK, 2013, STROKE, V44, pS97, DOI 10.1161/STROKEAHA.113.001786; Umutlu L, 2013, EUR RADIOL; Umutlu L, 2012, J MAGN RESON IMAGING; Umutlu L, 2013, ACAD RADIOL; White PM, 2001, RADIOLOGY, V219, P739, DOI 10.1148/radiology.219.3.r01ma16739; White PM, 2001, J NEUROL NEUROSUR PS, V71, P322, DOI 10.1136/jnnp.71.3.322; Willinek WA, 2003, RADIOLOGY, V229, P913, DOI 10.1148/radiol.2293020782; Willinsky RA, 2003, RADIOLOGY, V227, P522, DOI 10.1148/radiol.2272012071; Wrede KH, 2012, ACAD RADIOL, V19, P172, DOI 10.1016/j.acra.2011.10.004; Zwanenburg JJM, 2008, J MAGN RESON IMAGING, V28, P1519, DOI 10.1002/jmri.21591	36	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84562	10.1371/journal.pone.0084562	http://dx.doi.org/10.1371/journal.pone.0084562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400100	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700034
J	Yin, SY; Kim, HJ; Kim, HJ				Yin, Sun Young; Kim, Hyoung Jin; Kim, Hong-Jin			Protective Effect of Dietary Xylitol on Influenza A Virus Infection	PLOS ONE			English	Article							KOREAN RED GINSENG; POLYSACCHARIDE; VACCINATION; OSELTAMIVIR; CHILDREN	Xylitol has been used as a substitute for sugar to prevent cavity-causing bacteria, and most studies have focused on its benefits in dental care. Meanwhile, the constituents of red ginseng (RG) are known to be effective in ameliorating the symptoms of influenza virus infection when they are administered orally for 14 days. In this study, we investigated the effect of dietary xylitol on influenza A virus infection (H1N1). We designed regimens containing various fractions of RG (RGs: whole extract, water soluble fraction, saponin and polysaccharide) and xylitol, and combination of xylitol with the RG fractions. Mice received the various combinations orally for 5 days prior to lethal influenza A virus infection. Almost all the mice died post challenge when xylitol or RGs were administered separately. Survival was markedly enhanced when xylitol was administered along with RGs, pointing to a synergistic effect. The effect of xylitol plus RG fractions increased with increasing dose of xylitol. Moreover, dietary xylitol along with the RG water soluble fraction significantly reduced lung virus titers after infection. Therefore, we suggest that dietary xylitol is effective in ameliorating influenza-induced symptoms when it is administered with RG fractions, and this protective effect of xylitol should be considered in relation to other diseases.	[Yin, Sun Young; Kim, Hyoung Jin; Kim, Hong-Jin] Chung Ang Univ, Coll Pharm, Virol Lab, Seoul 156756, South Korea	Chung Ang University	Kim, HJ (corresponding author), Chung Ang Univ, Coll Pharm, Virol Lab, Seoul 156756, South Korea.	hongjink@cau.ac.kr			Chung-Ang University grant	Chung-Ang University grant	Chung-Ang University grant supported the authors' work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bardsley-Elliot A, 1999, DRUGS, V58, P851, DOI 10.2165/00003495-199958050-00007; Byeon SE, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/732860; Converti A, 1999, APPL BIOCHEM BIOTECH, V82, P141, DOI 10.1385/ABAB:82:2:141; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Frejnagel Slawomir S., 2003, Polish Journal of Food and Nutrition Sciences, V12, P32; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Kaverin NV, 2000, VIRUS RES, V66, P123, DOI 10.1016/S0168-1702(99)00131-8; Kim JY, 2011, J GINSENG RES, V35, P104, DOI 10.5142/jgr.2011.35.1.104; KIM Y S, 1990, Archives of Pharmacal Research (Seoul), V13, P330, DOI 10.1007/BF02858168; Kwak YS, 2010, BIOL PHARM BULL, V33, P468, DOI 10.1248/bpb.33.468; Li C, 2012, INT J BIOL MACROMOL, V51, P968, DOI 10.1016/j.ijbiomac.2012.06.031; Makinen K K, 1978, Experientia Suppl, P1; MAKINEN KK, 1989, CARIES RES, V23, P261; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Murphy Frederick A., 1996, P15; NEVINS DJ, 1967, PLANT PHYSIOL, V42, P900, DOI 10.1104/pp.42.7.900; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renko M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-45; Rumschlag-Booms E, 2013, ADV VIROL, V2013, DOI 10.1155/2013/121924; Sato H, 2011, ODONTOLOGY, V99, P28, DOI 10.1007/s10266-010-0143-2; Stephenson I, 2009, CLIN INFECT DIS, V48, P389, DOI 10.1086/596311; Website of Centers for Disease Control and Prevention, 1976, MORBIDITY MORTALITY; Website of Centers for Disease Control and Prevention, 2012, SEAS FLU ANT DRUG RE; Wee JJ, 2011, HERBAL MED BIOMOLECU; Wikipedia the free encyclopedia, XYL; Wikipedia the free encyclopedia, 2013, INFL PAND; Wina E, 2005, J AGR FOOD CHEM, V53, P8093, DOI 10.1021/jf048053d; Yin SY, 2013, BIOL PHARM BULL, V36, P1002, DOI 10.1248/bpb.b13-00123; Yoo DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033678	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84633	10.1371/journal.pone.0084633	http://dx.doi.org/10.1371/journal.pone.0084633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392148	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100071
J	Abu El-Asrar, AM; Mohammad, G; Nawaz, MI; Siddiquei, MM; Van den Eynde, K; Mousa, A; De Hertogh, G; Opdenakker, G				Abu El-Asrar, Ahmed M.; Mohammad, Ghulam; Nawaz, Mohd Imtiaz; Siddiquei, Mohammad Mairaj; Van den Eynde, Kathleen; Mousa, Ahmed; De Hertogh, Gert; Opdenakker, Ghislain			Relationship between Vitreous Levels of Matrix Metalloproteinases and Vascular Endothelial Growth Factor in Proliferative Diabetic Retinopathy	PLOS ONE			English	Article							TIMP-FREE MMP-9; GELATINASE B; VEGF-A; ANGIOGENESIS; CELLS; EXPRESSION; MATRIX-METALLOPROTEINASE-9; RECEPTOR-1; NEUTROPHILS; METASTASIS	To investigate which matrix metalloproteinases (MMPs) are more likely to be involved in the angiogenic process in proliferative diabetic retinopathy (PDR), we measured the levels of MMPs in the vitreous fluid from patients with PDR and controls and correlated these levels with the levels of vascular endothelial growth factor (VEGF). Vitreous samples from 32 PDR and 24 nondiabetic patients were studied by mosaic multiplex MMPs enzyme-linked immunosorbent assay (ELISA), single ELISA, Western blot and zymography analysis. Epiretinal membranes from 11 patients with PDR were studied by immunohistochemistry. MMP-8 and MMP-13 were not detected. ELISA, Western blot and gelatin ymography assays revealed significant increases in the expression levels of MMP-1, MMP-7, MMP-9 and VEGF in vitreous samples from PDR patients compared to nondiabetic controls, whereas MMP-2 and MMP-3 were not upregulated in vitreous samples from PDR patients. Significant correlations existed between ELISA and zymography assays for the quantitation of MMP-2 (r=0.407; p=0.039) and MMP-9 (r=0.711; p < 0.001). Significant correlations were observed between levels of VEGF and levels of MMP-1 (r=0.845; P < 0.001) and MMP-9 (r=0.775; p < 0.001), and between levels of MMP-1 and MMP-9 (r=0.857; p < 0.001). In epiretinal membranes, cytoplasmic immunoreactivity for MMP-9 was present in vascular endothelial cells and stromal monocytes/macrophages and neutrophils. Our findings suggest that among the MMPs measured, MMP-1 and MMP-9 may contribute to the angiogenic switch in PDR.	[Abu El-Asrar, Ahmed M.; Mohammad, Ghulam; Nawaz, Mohd Imtiaz; Siddiquei, Mohammad Mairaj; Mousa, Ahmed] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia; [Van den Eynde, Kathleen; De Hertogh, Gert] Katholieke Univ Leuven, Univ Leuven, Lab Histochem & Cytochem, Louvain, Belgium; [Opdenakker, Ghislain] Katholieke Univ Leuven, Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium	King Saud University; KU Leuven; KU Leuven	Abu El-Asrar, AM (corresponding author), King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia.	abuasrar@KSU.edu.sa	Abu El-Asrar, Ahmed/AAX-5055-2021; Mousa, Ahmed Amin/AAH-2827-2019; NAWAZ, MOHD IMTIAZ/G-5193-2011; Opdenakker, Ghislain/Q-3130-2017; Mohammad, Ghulam/F-5623-2011; Opdenakker, Ghislain/V-8562-2019	NAWAZ, MOHD IMTIAZ/0000-0002-7040-9405; Opdenakker, Ghislain/0000-0003-1714-2294; Mohammad, Ghulam/0000-0002-6418-4772; Opdenakker, Ghislain/0000-0003-1714-2294	Dr. Nasser Al-Rasheed Research Chair in Ophthalmology (AMA); Geconcerteerde OnderzoeksActies [GOA 2013-2017]; Fund For Scientific Research of Flanders (FWO-Vlaanderen)	Dr. Nasser Al-Rasheed Research Chair in Ophthalmology (AMA); Geconcerteerde OnderzoeksActies; Fund For Scientific Research of Flanders (FWO-Vlaanderen)(FWO)	This work was supported by Dr. Nasser Al-Rasheed Research Chair in Ophthalmology (AMA). Research in Leuven was supported by the Geconcerteerde OnderzoeksActies (GOA 2013-2017) and the Fund For Scientific Research of Flanders (FWO-Vlaanderen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/863036; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Alexandrakis MG, 2007, CLIN CHIM ACTA, V379, P31, DOI 10.1016/j.cca.2006.11.024; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Ardi VC, 2009, J BIOL CHEM, V284, P25854, DOI 10.1074/jbc.M109.033472; Bekes EM, 2011, AM J PATHOL, V179, P1455, DOI 10.1016/j.ajpath.2011.05.031; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Blackburn JS, 2008, AM J PATHOL, V173, P1736, DOI 10.2353/ajpath.2008.080512; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Descamps FJ, 2006, EXP EYE RES, V83, P401, DOI 10.1016/j.exer.2006.01.017; Ebrahem Q, 2010, AM J PATHOL, V176, P496, DOI 10.2353/ajpath.2010.080642; Eck SM, 2009, BREAST CANCER RES TR, V116, P79, DOI 10.1007/s10549-008-0085-3; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hollborn M, 2007, INVEST OPHTH VIS SCI, V48, P4360, DOI 10.1167/iovs.06-1234; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huo N, 2002, CANCER LETT, V177, P95, DOI 10.1016/S0304-3835(01)00772-8; Ito TK, 2009, BLOOD, V113, P2363, DOI 10.1182/blood-2008-08-172742; Jin M, 2001, RETINA-J RET VIT DIS, V21, P28, DOI 10.1097/00006982-200102000-00005; Kim KS, 2011, RHEUMATOL INT, V31, P543, DOI 10.1007/s00296-010-1592-1; Kosano H, 1999, LIFE SCI, V64, P2307, DOI 10.1016/S0024-3205(99)00184-8; Noda K, 2003, INVEST OPHTH VIS SCI, V44, P2163, DOI 10.1167/iovs.02-0662; Paemen L, 1995, EUR J BIOCHEM, V234, P759, DOI 10.1111/j.1432-1033.1995.759_a.x; Pufe T, 2004, J PATHOL, V202, P367, DOI 10.1002/path.1527; Pulukuri SMK, 2008, INT J ONCOL, V32, P757; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Shirasawa M, 2011, GRAEF ARCH CLIN EXP, V249, P1805, DOI 10.1007/s00417-011-1795-5; Sier CFM, 2008, MATRIX BIOL, V27, P267, DOI 10.1016/j.matbio.2007.10.006; Spranger J, 2001, EXP CLIN ENDOCR DIAB, V109, pS438, DOI 10.1055/s-2001-18601; Steenport M, 2009, J IMMUNOL, V183, P8119, DOI 10.4049/jimmunol.0901925; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Zaman K, 2006, INT J CANCER, V118, P755, DOI 10.1002/ijc.21408	34	60	60	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85857	10.1371/journal.pone.0085857	http://dx.doi.org/10.1371/journal.pone.0085857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392031	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900175
J	Ferrario, C; Ricci, G; Milani, C; Lugli, GA; Ventura, M; Eraclio, G; Borgo, F; Fortina, MG				Ferrario, Chiara; Ricci, Giovanni; Milani, Christian; Lugli, Gabriele Andrea; Ventura, Marco; Eraclio, Giovanni; Borgo, Francesca; Fortina, Maria Grazia			Lactococcus garvieae: Where Is It From? A First Approach to Explore the Evolutionary History of This Emerging Pathogen	PLOS ONE			English	Article							GENOME SEQUENCE; RAINBOW-TROUT; ITALIAN CHEESE; STRAINS; FISH; IDENTIFICATION; REVEALS; LACTOSE; DISEASE; DAIRY	The population structure and diversity of Lactococcus garvieae, an emerging pathogen of increasing clinical significance, was determined at both gene and genome level. Selected lactococcal isolates of various origins were analyzed by a multi locus sequence typing (MLST). This gene-based analysis was compared to genomic characteristics, estimated through the complete genome sequences available in database. The MLST identified two branches containing the majority of the strains and two branches bearing one strain each. One strain was particularly differentiated from the other L. garvieae strains, showing a significant genetic distance. The genomic characteristics, correlated to the MLST-based phylogeny, indicated that this "separated strain" appeared first and could be considered the evolutionary intermediate between Lactococcus lactis and L. garvieae main clusters. A preliminary genome analysis of L. garvieae indicated a pan-genome constituted of about 4100 genes, which included 1341 core genes and 2760 genes belonging to the dispensable genome. A total of 1491 Clusters of Orthologous Genes (COGs) were found to be specific to the 11 L. garvieae genomes, with the genome of the `` separated strain'' showing the highest presence of unique genes.	[Ferrario, Chiara; Ricci, Giovanni; Eraclio, Giovanni; Borgo, Francesca; Fortina, Maria Grazia] Univ Milan, Dept Food Environm & Nutr Sci DeFENS, Div Food Microbiol & Bioproc, Milan, Italy; [Milani, Christian; Lugli, Gabriele Andrea; Ventura, Marco] Univ Parma, Dept Life Sci, Lab Probiogen, I-43100 Parma, Italy	University of Milan; University of Parma	Fortina, MG (corresponding author), Univ Milan, Dept Food Environm & Nutr Sci DeFENS, Div Food Microbiol & Bioproc, Milan, Italy.	grazia.fortina@unimi.it	Lugli, Gabriele Andrea/AAV-5150-2021; Milani, Christian/ABA-8160-2020; BORGO, FRANCESCA CLAUDIA/AAM-7200-2020; ventura, marco/M-8230-2015; Lugli, Gabriele Andrea/GRX-2617-2022	Lugli, Gabriele Andrea/0000-0002-3024-0537; BORGO, FRANCESCA CLAUDIA/0000-0001-9685-1069; Lugli, Gabriele Andrea/0000-0002-3024-0537; Milani, Christian/0000-0002-5062-3164; FORTINA, MARIA GRAZIA/0000-0002-3275-6000; Ventura, Marco/0000-0002-4875-4560	Lombardy Region, Italy; Project "Post genomica batterica per la qualita' e la sicurezza degli alimenti"	Lombardy Region, Italy(Regione Lombardia); Project "Post genomica batterica per la qualita' e la sicurezza degli alimenti"	This work was carried out with the financial support of the Lombardy Region, Italy, under the Project "Post genomica batterica per la qualita' e la sicurezza degli alimenti." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Urda M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040119; Aguado-Urda M, 2011, J BACTERIOL, V193, P4263, DOI 10.1128/JB.05326-11; Aguado-Urda M, 2011, J BACTERIOL, V193, P4033, DOI 10.1128/JB.05090-11; Aguado-Urda M, 2010, INT MICROBIOL, V13, P189, DOI 10.2436/20.1501.01.125; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aubin GG, 2011, J CLIN MICROBIOL, V49, P2074, DOI 10.1128/JCM.00065-11; Baeck GW, 2006, J VET SCI, V7, P53, DOI 10.4142/jvs.2006.7.1.53; Baker GC, 2006, J MICROBIOL METH, V55, P541; Barnes AC, 2002, FISH SHELLFISH IMMUN, V12, P155, DOI 10.1006/fsim.2001.0361; Florez AB, 2012, J BACTERIOL, V194, P5118, DOI 10.1128/JB.00975-12; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Chen SC, 2001, DIS AQUAT ORGAN, V45, P45, DOI 10.3354/dao045045; Devriese LA, 1999, VET MICROBIOL, V70, P87, DOI 10.1016/S0378-1135(99)00124-8; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Donkor ES, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-569; Eldar A, 1999, APPL ENVIRON MICROB, V65, P1005; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Evans JJ, 2009, J FISH DIS, V32, P943, DOI 10.1111/j.1365-2761.2009.01075.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez E, 2010, INT DAIRY J, V20, P142, DOI 10.1016/j.idairyj.2009.11.004; Ferrario C, 2012, FEMS MICROBIOL LETT, V332, P153, DOI 10.1111/j.1574-6968.2012.02591.x; Fihman V, 2006, J INFECTION, V52, P3; Fortina MG, 2009, J FOOD PROTECT, V72, P1248, DOI 10.4315/0362-028X-72.6.1248; Fortina MG, 2003, FOOD MICROBIOL, V20, P397, DOI 10.1016/S0740-0020(02)00149-1; Gabrielsen C, 2012, J BACTERIOL, V194, P6976, DOI 10.1128/JB.01864-12; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McQuiston JR, 2008, J BACTERIOL, V190, P7060, DOI 10.1128/JB.01552-07; Milani C, 2013, APPL ENVIRON MICROB, V79, P4304, DOI 10.1128/AEM.00984-13; Mira A, 2010, INT MICROBIOL, V13, P45, DOI 10.2436/20.1501.01.110; Miyauchi Eiji, 2012, Int J Microbiol, V2012, P728276, DOI 10.1155/2012/728276; Morita H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023184; Passerini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015306; Pearson W R, 2000, Methods Mol Biol, V132, P185; Perez-Losada M, 2013, INFECT GENET EVOL, V16, P38, DOI 10.1016/j.meegid.2013.01.009; Ravelo C, 2003, J CLIN MICROBIOL, V41, P751, DOI 10.1128/JCM.41.2.751-756.2003; Reimundo P, 2011, MICROBIOL-SGM, V157, P2106, DOI 10.1099/mic.0.047969-0; Reimundo P, 2011, J BACTERIOL, V193, P3684, DOI 10.1128/JB.05210-11; Ricci G, 2013, GENOME ANNOUNC, V1; Ricci G, 2012, J BACTERIOL, V194, P1249, DOI 10.1128/JB.06655-11; Russo G, 2012, NEW MICROBIOL, V35, P495; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmidtke LM, 2003, B EUR ASSOC FISH PAT, V23, P206; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Stabler RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031559; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; van Dongen S. M., 2000, GRAPH CLUSTERING FLO; Vendrell D, 2006, COMP IMMUNOL MICROB, V29, P177, DOI 10.1016/j.cimid.2006.06.003; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	59	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84796	10.1371/journal.pone.0084796	http://dx.doi.org/10.1371/journal.pone.0084796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391975	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900118
J	Kwon, M; Kim, DJ; Cho, H; Yang, S				Kwon, Min; Kim, Dai-Jin; Cho, Hyun; Yang, Soo			The Smartphone Addiction Scale: Development and Validation of a Short Version for Adolescents	PLOS ONE			English	Article							SOCIAL NETWORKING	Objective: This study was designed to investigate the revised and short version of the smartphone addiction scale and the proof of its validity in adolescents. In addition, it suggested cutting off the values by gender in order to determine smartphone addiction and elaborate the characteristics of smartphone usage in adolescents. Method: A set of questionnaires were provided to a total of 540 selected participants from April to May of 2013. The participants consisted of 343 boys and 197 girls, and their average age was 14.5 years old. The content validity was performed on a selection of shortened items, while an internal-consistency test was conducted for the verification of its reliability. The concurrent validity was confirmed using SAS, SAPS and KS-scale. Receiver operating characteristics analysis was conducted to suggest cut-off. Results: The 10 final questions were selected using content validity. The internal consistency and concurrent validity of SAS were verified with a Cronbach's alpha of 0.911. The SAS-SV was significantly correlated with the SAS, SAPS and KS-scale. The SAS-SV scores of gender (p<.001) and self-evaluation of smartphone addiction (p<.001) showed significant difference. The ROC analysis results showed an area under a curve (AUC) value of 0.963(0.888-1.000), a cut-off value of 31, sensitivity value of 0.867 and specificity value of 0.893 in boys while an AUC value of 0.947(0.887-1.000), a cut-off value of 33, sensitivity value of 0.875, and a specificity value of 0.886 in girls. Conclusions: The SAS-SV showed good reliability and validity for the assessment of smartphone addiction. The smartphone addiction scale short version, which was developed and validated in this study, could be used efficiently for the evaluation of smartphone addiction in community and research areas.	[Kwon, Min; Cho, Hyun] Catholic Univ Korea, Seoul St Marys Hosp, Res Inst Addict, Dept Psychiat, Seoul, South Korea; [Kim, Dai-Jin] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Psychiat, Seoul, South Korea; [Yang, Soo] Catholic Univ Korea, Coll Nursing, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Yang, S (corresponding author), Catholic Univ Korea, Coll Nursing, Seoul, South Korea.	sooy@catholic.ac.kr		Kwon, Min/0000-0003-0947-5830				Billieux J, 2007, APPL COGNITIVE PSYCH, V21, P527, DOI 10.1002/acp.1289; Choi Hyunseok, 2012, [Journal of the Korean Data And Information Science Sociaty, 한국데이터정보과학회지], V23, P1005; Cohen P., 2014, APPL MULTIPLE REGRES, DOI [10.4324/9781410606266, DOI 10.4324/9780203774441]; Dong-il Kim, 2012, [The Korea Journal of Youth Counseling, 청소년상담연구], V20, P71; Dong-il Kim, 2008, [Korea Journal of Counseling, 상담학연구], V9, P1703; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Kim Namsun, 2012, [Journal of Health Informatics and Statistics, 보건정보통계학회지], V37, P72; Kuss DJ, 2011, INT J ENV RES PUB HE, V8, P3528, DOI 10.3390/ijerph8093528; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056936; Lee YS, 2006, J KOREAN MED ASSOC, V49, P209, DOI 10.5124/jkma.2006.49.3.209; National Information Society Agency, 2011, IVRER11051 NIA, P85; National Information Society Agency, 2012, INT ADD SURV 2011, P118; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; OSTROV E, 1989, J AM ACAD CHILD PSY, V28, P394, DOI 10.1097/00004583-198905000-00016; Park N, 2012, CYBERPSYCH BEH SOC N, V15, P491, DOI 10.1089/cyber.2011.0580; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Takao M, 2009, CYBERPSYCHOL BEHAV, V12, P501, DOI 10.1089/cpb.2009.0022; Wu AMS, 2013, J BEHAV ADDICT, V2, P160, DOI 10.1556/JBA.2.2013.006	18	414	426	28	221	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83558	10.1371/journal.pone.0083558	http://dx.doi.org/10.1371/journal.pone.0083558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284NF	24391787	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200084
J	Paczkowska, E; Kaczynska, K; Pius-Sadowska, E; Roginska, D; Kawa, M; Ustianowski, P; Safranow, K; Celewicz, Z; Machalinski, B				Paczkowska, Edyta; Kaczynska, Katarzyna; Pius-Sadowska, Ewa; Roginska, Dorota; Kawa, Milosz; Ustianowski, Przemyslaw; Safranow, Krzysztof; Celewicz, Zbigniew; Machalinski, Boguslaw			Humoral Activity of Cord Blood-Derived Stem/Progenitor Cells: Implications for Stem Cell-Based Adjuvant Therapy of Neurodegenerative Disorders	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; HYPOXIA IN-VITRO; RAT SPINAL-CORD; UMBILICAL-CORD; NEUROTROPHIC FACTORS; BONE-MARROW; CEREBRAL-ISCHEMIA; GROWTH-FACTOR; CD133(+) CELLS; CD34(+) CELLS	Background: Stem/progenitor cells (SPCs) demonstrate neuro-regenerative potential that is dependent upon their humoral activity by producing various trophic factors regulating cell migration, growth, and differentiation. Herein, we compared the expression of neurotrophins (NTs) and their receptors in specific umbilical cord blood (UCB) SPC populations, including lineage-negative, CD34(+), and CD133(+) cells, with that in unsorted, nucleated cells (NCs). Methods and Results: The expression of NTs and their receptors was detected by QRT-PCR, western blotting, and immunofluorescent staining in UCB-derived SPC populations (i.e., NCs vs. lineage-negative, CD34(+), and CD133(+) cells). To better characterize, global gene expression profiles of SPCs were determined using genome-wide RNA microarray technology. Furthermore, the intracellular production of crucial neuro-regenerative NTs (i.e., BDNF and NT-3) was assessed in NCs and lineage-negative cells after incubation for 24, 48, and 72 h in both serum and serum-free conditions. We discovered significantly higher expression of NTs and NT receptors at both the mRNA and protein level in lineage-negative, CD34(+), and CD133(+) cells than in NCs. Global gene expression analysis revealed considerably higher expression of genes associated with the production and secretion of proteins, migration, proliferation, and differentiation in lineage-negative cells than in CD34(+) or CD133(+) cell populations. Notably, after short-term incubation under serum-free conditions, lineage-negative cells and NCs produced significantly higher amounts of BDNF and NT-3 than under steady-state conditions. Finally, conditioned medium (CM) from lineage-negative SPCs exerted a beneficial impact on neural cell survival and proliferation. Conclusions: Collectively, our findings demonstrate that UCB-derived SPCs highly express NTs and their relevant receptors under steady-state conditions, NT expression is greater under stress-related conditions and that CM from SPCs favorable influence neural cell proliferation and survival. Understanding the mechanisms governing the characterization and humoral activity of subsets of SPCs may yield new therapeutic strategies that might be more effective in treating neurodegenerative disorders.	[Paczkowska, Edyta; Kaczynska, Katarzyna; Pius-Sadowska, Ewa; Roginska, Dorota; Kawa, Milosz; Safranow, Krzysztof; Machalinski, Boguslaw] Pomeranian Med Univ, Dept Gen Pathol, Szczecin, Poland; [Ustianowski, Przemyslaw; Celewicz, Zbigniew] Pomeranian Med Univ, Dept Obstet & Gynecol, Szczecin, Poland	Pomeranian Medical University; Pomeranian Medical University	Machalinski, B (corresponding author), Pomeranian Med Univ, Dept Gen Pathol, Szczecin, Poland.	machalin@pum.edu.pl	Ustianowski, Przemysław/I-2405-2014; Rogińska, Dorota/B-4424-2016; Pius-Sadowska, Ewa/O-8254-2014; Kawa, Milosz/O-7715-2014; Kosińska-Kaczyńska, Katarzyna/ABH-5914-2020; Machaliński, Bogusław/P-3025-2014; Safranow, Krzysztof/B-5127-2015; Paczkowska, Edyta/N-1209-2014; Paczkowska, Edyta/AAX-2347-2021	Ustianowski, Przemysław/0000-0002-0563-143X; Rogińska, Dorota/0000-0001-8884-837X; Pius-Sadowska, Ewa/0000-0003-3106-8705; Safranow, Krzysztof/0000-0001-9415-2758; Paczkowska, Edyta/0000-0001-7052-9741; Celewicz, Zbigniew/0000-0002-6571-0404; Machalinski, Boguslaw/0000-0002-6013-0419	National Science Center [N 401 613 740]	National Science Center(National Science Centre, Poland)	This work was supported by the National Science Center grant No. N 401 613 740 (to EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Arien-Zakay H, 2009, EXP NEUROL, V216, P83, DOI 10.1016/j.expneurol.2008.11.006; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bakondi B, 2009, MOL THER, V17, P1938, DOI 10.1038/mt.2009.185; Boltze J, 2012, CELL TRANSPLANT, V21, P723, DOI 10.3727/096368911X586783; Bracci-Laudiero L, 2003, J NEUROIMMUNOL, V136, P130, DOI 10.1016/S0165-5728(03)00007-9; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Cantinieaux D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069515; Chen SH, 2006, EXP NEUROL, V199, P67, DOI 10.1016/j.expneurol.2005.11.015; Dao MA, 2003, BLOOD, V101, P112, DOI 10.1182/blood-2002-01-0025; Douglas-Escobar M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051706; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Fan CG, 2005, NEUROSCI LETT, V380, P322, DOI 10.1016/j.neulet.2005.01.070; Flores-Guzman P, 2013, TRANSFUSION, V53, P668, DOI 10.1111/j.1537-2995.2012.03799.x; Forraz N, 2004, STEM CELLS, V22, P100, DOI 10.1634/stemcells.22-1-100; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P8, DOI 10.1038/sj.tpj.6500337; Goldenberg-Cohen N, 2012, STEM CELLS DEV, V21, P1488, DOI 10.1089/scd.2011.0366; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Guillin O, 2003, EUR J PHARMACOL, V480, P89, DOI 10.1016/j.ejphar.2003.08.096; Guo JS, 2007, SPINAL CORD, V45, P15, DOI 10.1038/sj.sc.3101943; Habich A, 2006, EXP HEMATOL, V34, P914, DOI 10.1016/j.exphem.2006.03.010; Harris DT, 2008, STEM CELL REV, V4, P269, DOI 10.1007/s12015-008-9039-8; Hau S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-30; Hemmoranta H, 2006, STEM CELLS DEV, V15, P839, DOI 10.1089/scd.2006.15.839; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iso Y, 2013, STEM CELLS, DOI [10.1002/stem.1546, DOI 10.1002/STEM.1546.[]; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Jiang LX, 2010, STEM CELLS DEV, V19, P221, DOI 10.1089/scd.2009.0170; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Leonardo CC, 2010, J NEUROSCI RES, V88, P1213, DOI 10.1002/jnr.22306; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lonne M, 2013, CELL TISSUE RES, V353, P117, DOI 10.1007/s00441-013-1597-7; MAJDIC O, 1994, BLOOD, V83, P1226; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; Ng YY, 2004, J LEUKOCYTE BIOL, V75, P314, DOI 10.1189/jlb.0603287; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Pelagiadis I, 2012, CYTOTHERAPY, V14, P701, DOI 10.3109/14653249.2012.663487; Rao M, 2012, STEM CELLS, V30, P55, DOI 10.1002/stem.770; Reich DM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-91; Romero MI, 2001, J NEUROSCI, V21, P8408, DOI 10.1523/JNEUROSCI.21-21-08408.2001; Saarma M, 1999, MICROSC RES TECHNIQ, V45, P292, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<292::AID-JEMT13>3.0.CO;2-8; Salgado AJ, 2010, STEM CELLS DEV, V19, P1067, DOI 10.1089/scd.2009.0279; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Servida F, 1996, STEM CELLS, V14, P430, DOI 10.1002/stem.140430; Simone MD, 1999, HEMATOL ONCOL, V17, P1; Sohn J, 2012, J NEUROSCI, V32, P12152, DOI 10.1523/JNEUROSCI.0628-12.2012; Stroh A, 2009, MOL IMAGING, V8, P166, DOI 10.2310/7290.2009.00017; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba	61	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83833	10.1371/journal.pone.0083833	http://dx.doi.org/10.1371/journal.pone.0083833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391835	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200133
J	Upadhyay, SK; Dixit, S; Sharma, S; Singh, H; Kumar, J; Verma, PC; Chandrashekar, K				Upadhyay, Santosh Kumar; Dixit, Sameer; Sharma, Shailesh; Singh, Harpal; Kumar, Jitesh; Verma, Praveen C.; Chandrashekar, K.			siRNA Machinery in Whitefly (Bemisia tabaci)	PLOS ONE			English	Article							RNA INTERFERENCE; SYSTEMIC RNAI; MICRORNA MATURATION; HEMIPTERAN INSECT; DISTINCT ROLES; GENE; INITIATION; ARGONAUTE; TRANSCRIPTOME; REQUIRES	Background: RNA interference has been emerged as an utmost tool for the control of sap sucking insect pests. Systemic response is necessary to control them in field condition. Whitefly is observed to be more prone to siRNA in recent studies, however the siRNA machinery and mechanism is not well established. Methodology/Principal Findings: To identify the core siRNA machinery, we curated transcriptome data of whitefly from NCBI database. Partial mRNA sequences encoding Dicer2, R2D2, Argonaute2 and Sid1 were identified by tblastn search of homologous sequences from Aphis glycines and Tribolium castaneum. Complete encoding sequences were obtained by RACE, protein sequences derived by Expasy translate tool and confirmed by blastp analysis. Conserved domain search and Prosite-Scan showed similar domain architecture as reported in homologs from related insects. We found helicase, PAZ, RNaseIIIa, RNaseIIIb and double-stranded RNA-binding fold (DSRBF) in Dicer2; DsRBD in R2D2; and PAZ and PIWI domains in Argonaute2. Eleven transmembrane domains were detected in Sid1. Sequence homology and phylogenetic analysis revealed that RNAi machinery of whitefly is close to Aphids. Real-time PCR analysis showed similar expression of these genes in different developmental stages as reported in A. glycines and T. castaneum. Further, the expression level of above genes was quite similar to the housekeeping gene actin. Conclusions/Significance: Availability of core siRNA machinery including the Sid1 and their universal expression in reasonable quantity indicated significant response of whitefly towards siRNA. Present report opens the way for controlling whitefly, one of the most destructive crop insect pest.	[Upadhyay, Santosh Kumar; Sharma, Shailesh; Kumar, Jitesh] Govt India, Natl Agri Food Biotechnol Inst, Dept Biotechnol, Mohali, Punjab, India; [Dixit, Sameer; Singh, Harpal; Verma, Praveen C.; Chandrashekar, K.] CSIR, CSIR Natl Bot Res Inst, Lucknow, Uttar Pradesh, India; [Chandrashekar, K.] Indian Agr Res Inst Reg Stn, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Upadhyay, SK (corresponding author), Govt India, Natl Agri Food Biotechnol Inst, Dept Biotechnol, Mohali, Punjab, India.	santoshnbri@hotmail.com; praveencverma@yahoo.com; kc_shekar2001@yahoo.com	Kumar, Jitesh/ABB-5150-2021; Verma, Praveen C/F-9709-2010; Upadhyay, Santosh/ABD-2302-2020; Chadrashekar, K/AAX-4996-2021	Kumar, Jitesh/0000-0003-1606-3420; Verma, Praveen C/0000-0002-3732-0564; Upadhyay, Santosh/0000-0001-6991-0502; Sharma, Shailesh/0000-0001-8832-8956	CSIR; DST-INSPIRE	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST-INSPIRE(Department of Science & Technology (India))	This work is supported by CSIR-Empower project grant and DST-INSPIRE Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Bansal R, 2013, INT J MOL SCI, V14, P3786, DOI 10.3390/ijms14023786; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Dutt U, 2007, ENV NEWS SERVIC 0821; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Faria CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000600; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Gu LQ, 2013, CROP PROT, V45, P36, DOI 10.1016/j.cropro.2012.10.004; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jaubert-Possamai S, 2010, MOL BIOL EVOL, V27, P979, DOI 10.1093/molbev/msp256; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Luo Y, 2012, RNA BIOL, V9, P663, DOI 10.4161/rna.19986; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Marcus JM, 2005, EVOL DEV, V7, P108, DOI 10.1111/j.1525-142X.2005.05012.x; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Xu WN, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3001; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x	53	27	28	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83692	10.1371/journal.pone.0083692	http://dx.doi.org/10.1371/journal.pone.0083692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391810	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200108
J	Wu, WH; Kuo, TC; Lin, YT; Huang, SW; Liu, HF; Wang, J; Chen, YMA				Wu, Wen-Hao; Kuo, Ta-Cheng; Lin, Yu-Ting; Huang, Szu-Wei; Liu, Hsin-Fu; Wang, John; Chen, Yi-Ming Arthur			Molecular Epidemiology of Enterovirus 71 Infection in the Central Region of Taiwan from 2002 to 2012	PLOS ONE			English	Article							EVOLUTION; RECOMBINATION; EMERGENCE; OUTBREAKS; GENOTYPE	Enterovirus 71 (EV71), a causative agent of hand, foot, and mouth disease can be classified into three genotypes and many subtypes. The objectives of this study were to conduct a molecular epidemiological study of EV71 in the central region of Taiwan from 2002-2012 and to test the hypothesis that whether the alternative appearance of different EV71 subtypes in Taiwan is due to transmission from neighboring countries or from re-emergence of pre-existing local strains. We selected 174 EV71 isolates and used reverse transcription-polymerase chain reaction to amplify their VP1 region for DNA sequencing. Phylogenetic analyses were conducted using Neighbor-Joining, Maximum Likelihood and Bayesian methods. We found that the major subtypes of EV71 in Taiwan were B4 for 2002 epidemic, C4 for 2004-2005 epidemic, B5 for 2008-2009 epidemic, C4 for 2010 epidemic and B5 for 2011-2012 epidemic. Phylogenetic analysis demonstrated that the 2002 and 2008 epidemics were associated with EV71 from Malaysia and Singapore; while both 2010 and 2011-2012 epidemics originated from different regions of mainland China including Shanghai, Henan, Xiamen and Gong-Dong. Furthermore, minor strains have been identified in each epidemic and some of them were correlated with the subsequent outbreaks. Therefore, the EV71 infection in Taiwan may originate from pre-existing minor strains or from other regions in Asia including mainland China. In addition, 101 EV71 isolates were selected for the detection of new recombinant strains using the nucleotide sequences spanning the VP1-2A-2B region. No new recombinant strain was found. Analysis of clinical manifestations showed that patients infected with C4 had significantly higher rates of pharyngeal vesicles or ulcers than patients infected with B5. This is the first study demonstrating that different EV 71 genotypes may have different clinical manifestations and the association of EV71 infections between Taiwan and mainland China.	[Wu, Wen-Hao; Liu, Hsin-Fu] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wu, Wen-Hao] Wan Fang Hosp, Dept Pediat, Taipei, Taiwan; [Wu, Wen-Hao; Kuo, Ta-Cheng; Lin, Yu-Ting; Huang, Szu-Wei; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Kuo, Ta-Cheng; Huang, Szu-Wei; Chen, Yi-Ming Arthur] Natl Yang Ming Univ, Inst Microbiol & Immunol, Sch Life Sci, Taipei 112, Taiwan; [Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Wang, John] Taichung Vet Gen Hosp, Dept Pathol, Taichung, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Dept Microbiol, Coll Med, Kaohsiung, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Inst Med Res, Coll Med, Kaohsiung, Taiwan	National Yang Ming Chiao Tung University; Taipei Municipal WanFang Hospital; Kaohsiung Medical University; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Taichung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chen, YMA (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.	arthur@kmu.edu.tw	Huang, Szu-Wei/AAT-1998-2020; Liu, Hsin-Fu/AAR-5960-2020; HUANG, SZU-WEI/AAT-5153-2021	Huang, Szu-Wei/0000-0002-3813-7737; Liu, Hsin-Fu/0000-0003-0082-2269; 	National Science Council of Taiwan [NSC102-2325-B-037-009]; Centers for Disease Control of Taiwan [HZ101060]; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Centers for Disease Control of Taiwan; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan	This study were partially supported by National Science Council of Taiwan (grant No. NSC102-2325-B-037-009), Centers for Disease Control of Taiwan (grant No. HZ101060) and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046845; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Knipe DM, 2007, FIELDS VIROLOGY; Lan YC, 2011, SCAND J INFECT DIS, V43, P354, DOI 10.3109/00365548.2010.545995; Lee MH, 2011, J MICROBIOL IMMUNOL, V44, P178, DOI 10.1016/j.jmii.2011.01.018; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74	20	23	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83711	10.1371/journal.pone.0083711	http://dx.doi.org/10.1371/journal.pone.0083711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391812	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200110
J	Wuyts, V; Mattheus, W; de Bex, GD; Wildemauwe, C; Roosens, NHC; Marchal, K; De Keersmaecker, SCJ; Bertrand, S				Wuyts, Veronique; Mattheus, Wesley; de Bex, Guillaume De Laminne; Wildemauwe, Christa; Roosens, Nancy H. C.; Marchal, Kathleen; De Keersmaecker, Sigrid C. J.; Bertrand, Sophie			MLVA as a Tool for Public Health Surveillance of Human Salmonella Typhimurium: Prospective Study in Belgium and Evaluation of MLVA Loci Stability	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; TANDEM-REPEAT ANALYSIS; VARIABLE-NUMBER; ANTIMICROBIAL RESISTANCE; SEROTYPE TYPHIMURIUM; PHAGE TYPE; OUTBREAK	Surveillance of Salmonella enterica subsp. enterica serovar Typhimurium (S. Typhimurium) is generally considered to benefit from molecular techniques like multiple-locus variable-number of tandem repeats analysis (MLVA), which allow earlier detection and confinement of outbreaks. Here, a surveillance study, including phage typing, antimicrobial susceptibility testing and the in Europe most commonly used 5-loci MLVA on 1,420 S. Typhimurium isolates collected between 2010 and 2012 in Belgium, was used to evaluate the added value of MLVA for public health surveillance. Phage types DT193, DT195, DT120, DT104, DT12 and U302 dominate the Belgian S. Typhimurium population. A combined resistance to ampicillin, streptomycin, sulphonamides and tetracycline (ASSuT) with or without additional resistances was observed for 42.5% of the isolates. 414 different MLVA profiles were detected, of which 14 frequent profiles included 44.4% of the S. Typhimurium population. During a serial passage experiment on selected isolates to investigate the in vitro stability of the 5 MLVA loci, variations over time were observed for loci STTR6, STTR10, STTR5 and STTR9. This study demonstrates that MLVA improves public health surveillance of S. Typhimurium. However, the 5-loci MLVA should be complemented with other subtyping methods for investigation of possible outbreaks with frequent MLVA profiles. Also, variability in these MLVA loci should be taken into account when investigating extended outbreaks and studying dynamics over longer periods.	[Wuyts, Veronique; Marchal, Kathleen] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Louvain, Belgium; [Wuyts, Veronique; Roosens, Nancy H. C.; De Keersmaecker, Sigrid C. J.] Sci Inst Publ Hlth WIV ISP, Brussels, Belgium; [Mattheus, Wesley; de Bex, Guillaume De Laminne; Wildemauwe, Christa; Bertrand, Sophie] Sci Inst Publ Hlth WIV ISP, Div Bacterial Dis, Natl Reference Ctr Salmonella & Shigella, Brussels, Belgium; [Marchal, Kathleen] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9000 Ghent, Belgium; [Marchal, Kathleen] Univ Ghent, IMinds, Dept Informat Technol, B-9000 Ghent, Belgium	KU Leuven; Ghent University; Ghent University; IMEC	Bertrand, S (corresponding author), Sci Inst Publ Hlth WIV ISP, Div Bacterial Dis, Natl Reference Ctr Salmonella & Shigella, Brussels, Belgium.	sophie.bertrand@wiv-isp.be	Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017; De Keersmaecker, Sigrid/ABB-5332-2021	Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; De Keersmaecker, Sigrid/0000-0003-4198-4133; Wuyts, Veronique/0000-0002-0795-1840; Roosens, Nancy H C J/0000-0001-9218-078X	RP/PJ WIV-ISP (SalMolType), the Federal Public Service of Health, Food Chain Safety and Environment; Belgian Ministry of Social Affairs through the Health Insurance System	RP/PJ WIV-ISP (SalMolType), the Federal Public Service of Health, Food Chain Safety and Environment; Belgian Ministry of Social Affairs through the Health Insurance System	This work was supported by: RP/PJ WIV-ISP (SalMolType), the Federal Public Service of Health, Food Chain Safety and Environment. The National Reference Centre for Salmonella and Shigella is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua H, 2013, VET MICROBIOL, V166, P607, DOI 10.1016/j.vetmic.2013.06.035; Bertrand S, 2012, D2012250530; Boxrud D, 2007, J CLIN MICROBIOL, V45, P536, DOI 10.1128/JCM.01595-06; Chiou CS, 2010, INT J FOOD MICROBIOL, V142, P67, DOI 10.1016/j.ijfoodmicro.2010.06.001; Dionisi AM, 2009, FOODBORNE PATHOG DIS, V6, P711, DOI 10.1089/fpd.2008.0240; Dyet KH, 2011, EPIDEMIOL INFECT, V139, P1050, DOI 10.1017/S0950268810002025; Ethelberg S, 2004, CLIN MICROBIOL INFEC, V10, P904, DOI 10.1111/j.1469-0691.2004.00990.x; European Centre for Disease Prevention and Control, 2011, LAB STAND OP PROC ML; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Friesema IHM, 2012, FOODBORNE PATHOG DIS, V9, P102, DOI 10.1089/fpd.2011.0978; Garvey P, 2013, EURO SURVEILL, V18; Gossner CM, 2012, EUROSURVEILLANCE, V17; Graziani C, 2008, VET MICROBIOL, V128, P414, DOI 10.1016/j.vetmic.2007.10.017; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Guigon G, 2008, Euro Surveill, V13; HAMPTON MD, 1995, J APPL BACTERIOL, V78, P402, DOI 10.1111/j.1365-2672.1995.tb03425.x; Hauser E, 2010, APPL ENVIRON MICROB, V76, P4601, DOI 10.1128/AEM.02991-09; Heck M, 2009, EURO SURVEILL, V14; Hopkins KL, 2007, J CLIN MICROBIOL, V45, P3058, DOI 10.1128/JCM.00715-07; Hopkins KL, 2010, EUROSURVEILLANCE, V15, P2; Hopkins KL, 2012, EURO SURVEILL, V17; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; James Danoff-Burg, 2003, MEASURING BIOL DIVER; Kuhn KG, 2013, EPIDEMIOL INFECT, V141, P260, DOI 10.1017/S0950268812000702; Larsson JT, 2009, EUROSURVEILLANCE, V14, P6; Larsson JT, 2013, EURO SURVEILL, V18; Le Fleche P, 2001, BMC Microbiol, V1, P2; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; Lindstedt BA, 2003, J CLIN MICROBIOL, V41, P1469, DOI 10.1128/JCM.41.4.1469-1479.2003; Lindstedt BA, 2013, EURO SURVEILL, V18; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Mossong J, 2007, EURO SURVEILL, V12; Paranthaman K, 2013, FOODBORNE PATHOG DIS; Petersen RF, 2011, FOODBORNE PATHOG DIS, V8, P655, DOI 10.1089/fpd.2010.0683; Prendergast DM, 2011, FOOD MICROBIOL, V28, P1087, DOI 10.1016/j.fm.2011.02.013; PulseNet USA, 2013, PNL24; Ramisse V, 2004, J CLIN MICROBIOL, V42, P5722, DOI 10.1128/JCM.42.12.5722-5730.2004; Ross IL, 2011, CURR MICROBIOL, V62, P1034, DOI 10.1007/s00284-010-9820-1; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sintchenko V, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-78; Soler P, 2006, J ANTIMICROB CHEMOTH, V58, P310, DOI 10.1093/jac/dkl223; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; The European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MIC; The European Committee on Antimicrobial Susceptibility Testing, 2013, ANT SUSC EUCAST; THRELFALL EJ, 1990, J APPL BACTERIOL, V68, P5, DOI 10.1111/j.1365-2672.1990.tb02542.x; Torpdahl M, 2007, EMERG INFECT DIS, V13, P388, DOI 10.3201/eid1303.060460; Wattiau P, 2011, APPL ENVIRON MICROB, V77, P7877, DOI 10.1128/AEM.05527-11; Weill FX, 2006, J CLIN MICROBIOL, V44, P700, DOI 10.1128/JCM.44.3.700-708.2006; Witonski D, 2006, J CLIN MICROBIOL, V44, P3849, DOI 10.1128/JCM.00469-06	49	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84055	10.1371/journal.pone.0084055	http://dx.doi.org/10.1371/journal.pone.0084055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391880	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900023
J	Zhu, QH; Fan, LJ; Liu, Y; Xu, H; Llewellyn, D; Wilson, I				Zhu, Qian-Hao; Fan, Longjiang; Liu, Yang; Xu, Hao; Llewellyn, Danny; Wilson, Iain			miR482 Regulation of NBS-LRR Defense Genes during Fungal Pathogen Infection in Cotton	PLOS ONE			English	Article							GOSSYPIUM-HIRSUTUM L.; GENOME-WIDE ANALYSIS; SMALL RNAS; FIBER DEVELOPMENT; SIRNA BIOGENESIS; STRESS RESPONSES; MICRORNAS; RESISTANCE; MIRNA; ARABIDOPSIS	In this study, we characterized the miR482 family in cotton using existing small RNA datasets and the recently released draft genome sequence of Gossypium raimondii, a diploid cotton species whose progenitor is the putative contributor of the Dt (representing the D genome of tetraploid) genome of the cultivated tetraploid cotton species G. hirsutum and G. barbadense. Of the three ghr-miR482 members reported in G. hirsutum, ghr-miR482a has no homolog in G. raimondii, ghrmiR482b and ghr-miR482c each has a single homolog in G. raimondii. Gra-miR482d has five homologous loci (gra-miR482d, f-i) in G. raimondii and also exists in G. hirsutum (ghr-miR482d). A variant, miR482.2 that is a homolog of miR2118 in other species, is produced from several GHR-MIR482 loci in G. hirsutum. Approximately 12% of the G. raimondii NBS-LRR genes were predicted targets of various members of the gra-miR482 family. Based on the rationale that the regulatory relationship between miR482 and NBS-LRR genes will be conserved in G. raimondii and G. hirsutum, we investigated this relationship using G. hirsutum miR482 and G. raimondii NBS-LRR genes, which are not currently available in G. hirsutum. Ghr-miR482/miR482.2-mediated cleavage was confirmed for three of the four NBS-LRR genes analysed. As in tomato, miR482-mediated cleavage of NBS-LRR genes triggered production of phased secondary small RNAs in cotton. In seedlings of the susceptible cultivar Sicot71 (G. hirsutum) infected with the fungal pathogen Verticillium dahliae, the expression levels of ghr-miR482b/miR482b. 2, ghr-miR482c and ghr-miR482d. 2 were down-regulated, and several NBS-LRR targets of ghr-miR482c and ghrmiR482d were up-regulated. These results imply that, like tomato plants infected with viruses or bacteria, cotton plants are able to induce expression of NBS-LRR defence genes by suppression of the miRNA-mediated gene silencing pathway upon fungal pathogen attack.	[Zhu, Qian-Hao; Llewellyn, Danny; Wilson, Iain] CSIRO Plant Ind, Canberra, ACT, Australia; [Fan, Longjiang; Liu, Yang; Xu, Hao] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Zhejiang University	Zhu, QH (corresponding author), CSIRO Plant Ind, Canberra, ACT, Australia.	Qianhao.Zhu@csiro.au; Iain.Wilson@csiro.au	wei, jiang/GRX-7907-2022; Llewellyn, Danny J/D-5230-2009; Zhu, Qian-Hao/A-1298-2010; yang, liu/GVU-8760-2022; Wilson, Iain/D-4839-2009	Llewellyn, Danny J/0000-0001-9535-8707; Zhu, Qian-Hao/0000-0002-6505-7417; Wilson, Iain/0000-0002-4626-8059; Fan, Longjiang/0000-0003-4846-0500	Cotton Breeding Australia	Cotton Breeding Australia	This work was supported by Cotton Breeding Australia, a joint venture between CSIRO and Cotton Seed Distributors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar MT, 2011, EUPHYTICA, V178, P351, DOI 10.1007/s10681-010-0310-0; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dai X, 2011, PLOS ONE, V39, pw155; Gao YL, 2006, SCI CHINA SER C, V49, P530, DOI 10.1007/s11427-006-2017-y; He LM, 2004, MOL PLANT MICROBE IN, V17, P1234, DOI 10.1094/MPMI.2004.17.11.1234; He XF, 2008, FEBS LETT, V582, P2445, DOI 10.1016/j.febslet.2008.06.011; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Liu Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25079; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yin ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035765; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295; Zhu QH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-149	39	114	125	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84390	10.1371/journal.pone.0084390	http://dx.doi.org/10.1371/journal.pone.0084390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391949	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900092
J	Jain, HV; Richardson, A; Meyer-Hermann, M; Byrne, HM				Jain, Harsh Vardhan; Richardson, Alan; Meyer-Hermann, Michael; Byrne, Helen M.			Exploiting the Synergy between Carboplatin and ABT-737 in the Treatment of Ovarian Carcinomas	PLOS ONE			English	Article							BCL-X-L; PERIODIC CHEMOTHERAPY; MATHEMATICAL-MODEL; DRUG-RESISTANCE; LOGISTIC MODEL; CANCER CELLS; CISPLATIN; BCL-X(L); THERAPY; CHEMORESISTANCE	Platinum drug-resistance in ovarian cancers mediated by anti-apoptotic proteins such as Bcl-xL is a major factor contributing to the chemotherapeutic resistance of recurrent disease. Consequently, concurrent inhibition of Bcl-xL in combination with chemotherapy may improve treatment outcomes for patients. Here, we develop a mathematical model to investigate the potential of combination therapy with ABT-737, a small molecule inhibitor of Bcl-xL, and carboplatin, a platinum-based drug, on a simulated tumor xenograft. The model is calibrated against in vivo experimental data, wherein xenografts established in mice were treated with ABT-737 and/or carboplatin on a fixed periodic schedule. The validated model is used to predict the minimum drug load that will achieve a predetermined level of tumor growth inhibition, thereby maximizing the synergy between the two drugs. Our simulations suggest that the infusion-duration of each carboplatin dose is a critical parameter, with an 8-hour infusion of carboplatin given weekly combined with a daily bolus dose of ABT-737 predicted to minimize residual disease. The potential of combination therapy to prevent or delay the onset of carboplatin-resistance is also investigated. When resistance is acquired as a result of aberrant DNA-damage repair in cells treated with carboplatin, drug delivery schedules that induce tumor remission with even low doses of combination therapy can be identified. Intrinsic resistance due to pre-existing cohorts of resistant cells precludes tumor regression, but dosing strategies that extend disease-free survival periods can still be identified. These results highlight the potential of our model to accelerate the development of novel therapeutics such as BH3 mimetics.	[Jain, Harsh Vardhan] Florida State Univ, Dept Math, Tallahassee, FL 32306 USA; [Richardson, Alan] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England; [Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol, Braunschweig, Germany; [Meyer-Hermann, Michael] Braunschweig Univ Technol, Bio Ctr Life Sci, Braunschweig, Germany; [Byrne, Helen M.] Univ Oxford, Inst Math, Oxford Ctr Collaborat & Appl Math, Oxford OX1 3LB, England; [Byrne, Helen M.] Univ Oxford, Dept Comp Sci, Oxford OX1 3LB, England	State University System of Florida; Florida State University; Keele University; Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology; University of Oxford; University of Oxford	Jain, HV (corresponding author), Florida State Univ, Dept Math, Tallahassee, FL 32306 USA.	hjain@fsu.edu	Richardson, Alan/I-4631-2015	Richardson, Alan/0000-0003-1825-3375; Byrne, Helen/0000-0003-1771-5910	National Science Foundation [DMS 0931642]; King Abdullah University of Science and Technology (KAUST) [KUK-C1-013-04]	National Science Foundation(National Science Foundation (NSF)); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	Funding came from a National Science Foundation grant DMS 0931642 and Award No. KUK-C1-013-04 made by the King Abdullah University of Science and Technology (KAUST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bajaj G, 2010, PHARM RES-DORDR, V27, P735, DOI 10.1007/s11095-009-0031-z; Bonate PL, 2011, PHARMACOKINETICS IN DRUG DEVELOPMENT, VOL 3: ADVANCES AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-7937-7_1; Bookman MA, 2010, ANN ONCOL, V21, P211, DOI 10.1093/annonc/mdq368; Brotin E, 2010, INT J CANCER, V126, P885, DOI 10.1002/ijc.24787; Bukowski RM, 2007, SEMIN ONCOL, V34, pS1, DOI 10.1053/j.seminoncol.2007.03.012; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748, DOI 10.1200/JCO.1989.7.11.1748; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Despierre E, 2010, GYNECOL ONCOL, V117, P358, DOI 10.1016/j.ygyno.2010.02.012; El-Kareh AW, 2008, AAPS J, V10, P15, DOI 10.1208/s12248-007-9003-6; El-Kareh AW, 2003, NEOPLASIA, V5, P161, DOI 10.1016/S1476-5586(03)80008-8; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Jain HV, 2008, B MATH BIOL, V70, P89, DOI 10.1007/s11538-007-9242-9; Jain HV, 2012, APPL MATH LETT, V25, P2132, DOI 10.1016/j.aml.2012.04.024; Jain HV, 2011, CANCER RES, V71, P705, DOI 10.1158/0008-5472.CAN-10-3174; Jain HV, 2009, MOL CANCER THER, V8, P2926, DOI 10.1158/1535-7163.MCT-08-1223; Keyfitz BL, 1997, MATH COMPUT MODEL, V26, P1, DOI 10.1016/S0895-7177(97)00165-9; Liu JR, 1998, GYNECOL ONCOL, V70, P398, DOI 10.1006/gyno.1998.5125; LUKAS G, 1971, J PHARMACOL EXP THER, V178, P562; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; PANETTA JC, 1995, APPL MATH LETT, V8, P83, DOI 10.1016/0893-9659(95)00053-S; Panetta JC, 1997, APPL MATH LETT, V10, P123, DOI 10.1016/S0893-9659(96)00123-1; PANETTA JC, 1995, MATH COMPUT MODEL, V22, P67, DOI 10.1016/0895-7177(95)00112-F; Roett MA, 2009, AM FAM PHYSICIAN, V80, P609; SIDDIK ZH, 1987, BIOCHEM PHARMACOL, V36, P1925, DOI 10.1016/0006-2952(87)90490-4; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Stamelos VA, 2013, GYNECOL ONCOL, V128, P377, DOI 10.1016/j.ygyno.2012.11.019; Tan DSP, 2008, ADV EXP MED BIOL, V622, P153, DOI 10.1007/978-0-387-68969-2_13; Vasey PA, 2003, BRIT J CANCER, V89, pS23, DOI 10.1038/sj.bjc.6601497; Villedieu M, 2007, GYNECOL ONCOL, V105, P31, DOI 10.1016/j.ygyno.2006.12.011; Whitecross KF, 2009, BLOOD, V113, P1982, DOI 10.1182/blood-2008-05-156851; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Witham J, 2007, CLIN CANCER RES, V13, P7191, DOI 10.1158/1078-0432.CCR-07-0362	35	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e81582	10.1371/journal.pone.0081582	http://dx.doi.org/10.1371/journal.pone.0081582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400068	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000329462700002
J	Morishita, S; Oku, H; Horie, T; Tonari, M; Kida, T; Okubo, A; Sugiyama, T; Takai, S; Hara, H; Ikeda, T				Morishita, Seita; Oku, Hidehiro; Horie, Taeko; Tonari, Masahiro; Kida, Teruyo; Okubo, Akiko; Sugiyama, Tetsuya; Takai, Shinji; Hara, Hideaki; Ikeda, Tsunehiko			Systemic Simvastatin Rescues Retinal Ganglion Cells from Optic Nerve Injury Possibly through Suppression of Astroglial NF-kappa B Activation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TRAUMATIC BRAIN-INJURY; RAT RETINA; REACTIVE ASTROCYTES; MULTIPLE-SCLEROSIS; ADULT-RATS; IN-VIVO; EXPRESSION; NEURONS	Neuroinflammation is involved in the death of retinal ganglion cells (RGCs) after optic nerve injury. The purpose of this study was to determine whether systemic simvastatin can suppress neuroinflammation in the optic nerve and rescue RGCs after the optic nerve is crushed. Simvastatin or its vehicle was given through an osmotic minipump beginning one week prior to the crushing. Immunohistochemistry and real-time PCR were used to determine the degree of neuroinflammation on day 3 after the crushing. The density of RGCs was determined in Tuj-1 stained retinal flat mounts on day 7. The effect of simvastain on the TNF-alpha-induced NF-kappa B activation was determined in cultured optic nerve astrocytes. On day 3, CD68-positive cells, most likely microglia/macrophages, were accumulated at the crushed site. Phosphorylated NF-kB was detected in some astrocytes at the border of the lesion where the immunoreactivity to MCP-1 was intensified. There was an increase in the mRNA levels of the CD68 (11.4-fold), MCP-1 (22.6-fold), ET-1 (2.3-fold), GFAP (1.6-fold), TNF-alpha (7.0-fold), and iNOS (14.8-fold) genes on day 3. Systemic simvastatin significantly reduced these changes. The mean +/- SD number of RGCs was 1816.3 +/- 232.6/mm(2) (n = 6) in the sham controls which was significantly reduced to 831.4 +/- 202.5/mm(2) (n = 9) on day 7 after the optic nerve was crushed. This reduction was significantly suppressed to 1169.2 +/- 201.3/mm(2) (P = 0.01, Scheffe; n = 9) after systemic simvastatin. Simvastatin (1.0 mu M) significantly reduced the TNF-a-induced NF-kB activation in cultured optic nerve astrocytes. We conclude that systemic simvastatin can reduce the death of RGCs induced by crushing the optic nerve possibly by suppressing astroglial NF-kappa B activation.	[Morishita, Seita; Oku, Hidehiro; Horie, Taeko; Tonari, Masahiro; Kida, Teruyo; Okubo, Akiko; Sugiyama, Tetsuya; Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, Osaka, Japan; [Takai, Shinji] Osaka Med Coll, Dept Pharmacol, Osaka, Japan; [Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan	Osaka Medical College; Osaka Medical College; Gifu Pharmaceutical University	Oku, H (corresponding author), Osaka Med Coll, Dept Ophthalmol, Osaka, Japan.	hidehirooku@aol.com	Oku, Hidehiro/AAD-5029-2019	Oku, Hidehiro/0000-0003-4359-4219; Hara, Hideaki/0000-0003-2046-9001	Japanese Ministry of Education Grant [225919739]; Osaka Community Foundation grant	Japanese Ministry of Education Grant; Osaka Community Foundation grant	This study was supported by Japanese Ministry of Education Grant 225919739 (HO) and Osaka Community Foundation grant ( HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bian ZM, 2001, EXP EYE RES, V73, P111, DOI 10.1006/exer.2001.1019; Brambilla R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-213; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Kawaji T, 2007, CURR EYE RES, V32, P991, DOI 10.1080/02713680701649603; KIKUCHI A, 1994, J BIOL CHEM, V269, P20054; Kitaoka Y, 2006, INVEST OPHTH VIS SCI, V47, P1448, DOI 10.1167/iovs.05-0299; Ko ML, 2011, EXP EYE RES, V93, P580, DOI 10.1016/j.exer.2011.07.003; Krempler K, 2011, INVEST OPHTH VIS SCI, V52, P2606, DOI 10.1167/iovs.10-6005; Kretz A, 2006, NEUROBIOL DIS, V21, P421, DOI 10.1016/j.nbd.2005.08.003; Kurimoto T, 2006, NEUROREPORT, V17, P1525, DOI 10.1097/01.wnr.0000234749.80936.54; LI SF, 1993, P NATL ACAD SCI USA, V90, P9247, DOI 10.1073/pnas.90.20.9247; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Pahan K, 1997, J CLIN INVEST, V100, P2671, DOI 10.1172/JCI119812; Panagis L, 2005, EUR J NEUROSCI, V21, P2305, DOI 10.1111/j.1460-9568.2005.04046.x; Pazman C, 2000, DEVELOPMENT, V127, P1715; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Rattan R, 2003, FREE RADICAL BIO MED, V35, P1037, DOI 10.1016/S0891-5849(03)00459-3; ROSENMAN SJ, 1995, J IMMUNOL, V154, P1888; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; Schmeer C, 2008, INVEST OPHTH VIS SCI, V49, P4971, DOI 10.1167/iovs.07-1597; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; SNOW RL, 1995, EXP NEUROL, V134, P13, DOI 10.1006/exnr.1995.1032; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Tonari M, 2012, INVEST OPHTH VIS SCI, V53, P3490, DOI 10.1167/iovs.11-9415; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; WINKLER BS, 1972, VISION RES, V12, P1183, DOI 10.1016/0042-6989(72)90106-X; Wu HT, 2010, J NEUROSURG, V113, P591, DOI 10.3171/2009.9.JNS09859	39	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84387	10.1371/journal.pone.0084387	http://dx.doi.org/10.1371/journal.pone.0084387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392131	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100054
J	Shi, XQ; Fu, YJ; Liao, DQ; Chen, YF; Liu, J				Shi, Xianqing; Fu, Yongjian; Liao, Daqing; Chen, Yanfang; Liu, Jin			Alterations of Voltage-Dependent Calcium Channel Currents in Basilar Artery Smooth Muscle Cells at Early Stage of Subarachnoid Hemorrhage in a Rabbit Model	PLOS ONE			English	Article							CEREBRAL VASOSPASM; CA2+ CHANNELS; ION CHANNELS; INJECTION; MYOCYTES; DISEASE; TONE	Objective: To investigate the changes in the currents of voltage-dependent calcium channels (VDCCs) in smooth muscle cells of basilar artery in a rabbit model of subarachnoid hemorrhage (SAH). Methods: New Zealand white rabbits were randomly divided into five groups: sham (C), normal (N), 24 hours (S1), 48 hours (S2) and 72 hours (S3) after SAH. Non-heparinized autologous arterial blood (1ml/kg) was injected into the cisterna magna to create SAH after intravenous anesthesia, and 1 ml/kg of saline was injected into cisterna magna in the sham group. Rabbits in group N received no injections. Basilar artery in S1, S2, S3 group were isolated at 24, 48, 72 hours after SAH. Basilar artery in group C was isolated at 72 hours after physiological saline injection. Basilar artery smooth muscle cells were isolated for all groups. Whole-cell patch-clamp technique was utilized to record cell membrane capacitance and VDCCs currents. The VDCCs antagonist nifedipine was added to the bath solution to block the Ca++ channels currents. Results: There were no significant differences in the number of cells isolated, the cell size and membrane capacitance among all the five groups. VDCC currents in the S1-S3 groups had higher amplitudes than those in control and sham groups. The significant change of current amplitude was observed at 72 hours after SAH, which was higher than those of 24 and 48 hours. The VDCCs were shown to expression in human artery smooth muscle cells. Conclusions: The changes of activation characteristics and voltage-current relationship at 72 hours after SAH might be an important event which leads to a series of molecular events in the microenvironment of the basilar artery smooth muscle cells. This may be the key time point for potential therapeutic intervention against subarachnoid hemorrhage.	[Shi, Xianqing; Fu, Yongjian] Guizhou Prov Peoples Hosp, Intens Care Unit, Guiyang, Peoples R China; [Liao, Daqing; Chen, Yanfang; Liu, Jin] Sichuan Univ, West China Hosp, Lab Anesthesia & Crit Med, Chengdu, Peoples R China	Sichuan University	Liu, J (corresponding author), Sichuan Univ, West China Hosp, Lab Anesthesia & Crit Med, Chengdu, Peoples R China.	sculiujin@gmail.com		Liu, Jin/0000-0002-2026-2513	Department of Science and Technology of Guizhou province [J20072118]	Department of Science and Technology of Guizhou province	This study was supported by a grant from the Department of Science and Technology of Guizhou province (Grant No. J20072118). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBORCH E, 1995, PHARMACOL THERAPEUT, V68, P1, DOI 10.1016/0163-7258(95)00025-9; Bevan JA, 1997, INT J MICROCIRC, V17, P248, DOI 10.1159/000179237; CLOZEL M, 1993, LIFE SCI, V52, P825, DOI 10.1016/0024-3205(93)90081-D; Duchen MR, 2012, PFLUG ARCH EUR J PHY, V464, P111, DOI 10.1007/s00424-012-1112-0; Fu ZJ, 2005, SHENG LI XUE BAO, V57, P27; Fukumori R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069718; Furutani H, 2002, J CARDIOVASC PHARM, V40, P265, DOI 10.1097/00005344-200208000-00012; He J, 1998, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V20, P95; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Ishiguro M, 2008, ACTA NEUROCHIR SUPPL, V104, P99; Ishiguro M, 2005, CIRC RES, V96, P419, DOI 10.1161/01.RES.0000157670.49936.da; Kang S, 2013, J MED CHEM, V56, P4786, DOI 10.1021/jm4005048; Koide M, 2011, J CEREBR BLOOD F MET, V31, P3, DOI 10.1038/jcbfm.2010.143; Koide M, 2011, ACTA NEUROCHIR SUPPL, V110, P145, DOI 10.1007/978-3-7091-0353-1_25; Kovacic S, 2006, AUTON NEUROSCI-BASIC, V130, P28, DOI 10.1016/j.autneu.2006.05.002; Kuo IYT, 2011, J PHYSIOL-LONDON, V589, P783, DOI 10.1113/jphysiol.2010.199497; Lin CL, 2003, J NEUROSCI METH, V123, P89, DOI 10.1016/S0165-0270(02)00344-8; Mizuno T, 2003, AM J NEURORADIOL, V24, P608; NAKAYAMA S, 1993, J PHYSIOL-LONDON, V471, P107, DOI 10.1113/jphysiol.1993.sp019893; Navarro-Gonzalez MF, 2009, CLIN EXP PHARMACOL P, V36, P55, DOI 10.1111/j.1440-1681.2008.05035.x; Nikitina E, 2010, J NEUROSURG, V113, P870, DOI 10.3171/2010.2.JNS091038; Pratt PF, 2002, HYPERTENSION, V40, P214, DOI 10.1161/01.HYP.0000025877.23309.36; Quignard JF, 1997, J CLIN INVEST, V99, P185, DOI 10.1172/JCI119146; Satoh M, 2001, STROKE, V32, P225, DOI 10.1161/01.STR.32.1.225; Shi HC, 2006, THESIS SICHUAN U; Simard JM, 1998, CIRC RES, V82, P1330, DOI 10.1161/01.RES.82.12.1330; STORNELLI SA, 1964, J NEUROSURG, V21, P769, DOI 10.3171/jns.1964.21.9.0769; Sviri GE, 2004, STROKE, V35, P1867, DOI 10.1161/01.STR.0000133397.44528.f8; Tani Eiichi, 2004, Current Vascular Pharmacology, V2, P13, DOI 10.2174/1570161043476492; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Wellman GC, 2002, STROKE, V33, P802, DOI 10.1161/hs0302.104089; Wellman GC, 2006, NEUROL RES, V28, P690, DOI 10.1179/016164106X151972; WILDE DW, 1994, HYPERTENSION, V24, P739, DOI 10.1161/01.HYP.24.6.739; Xie A, 2007, J CEREBR BLOOD F MET, V27, P1692, DOI 10.1038/sj.jcbfm.9600471	34	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84129	10.1371/journal.pone.0084129	http://dx.doi.org/10.1371/journal.pone.0084129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392110	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100034
J	Stone, MD; Harvey, SB; Nelsestuen, GL; Reilly, C; Hertz, MI; Wendt, CH				Stone, Matthew D.; Harvey, Stephen B.; Nelsestuen, Gary L.; Reilly, Cavan; Hertz, Marshall I.; Wendt, Chris H.			Elevated Peptides in Lung Lavage Fluid Associated with Bronchiolitis Obliterans Syndrome	PLOS ONE			English	Article							UNOPPOSED NEUTROPHIL ELASTASE; BRONCHOALVEOLAR LAVAGE; TRANSPLANT RECIPIENTS; DATABASE	Objective: The objective of this discovery-level investigation was to use mass spectrometry to identify low mass compounds in bronchoalveolar lavage fluid from lung transplant recipients that associate with bronchiolitis obliterans syndrome. Experimental Design: Bronchoalveolar lavage fluid samples from lung transplant recipients were evaluated for small molecules using ESI-TOF mass spectrometry and correlated to the development of bronchiolitis obliterans syndrome. Peptides associated with samples from persons with bronchiolitis obliterans syndrome and controls were identified separately by MS/MS analysis. Results: The average bronchoalveolar lavage fluid MS spectrum profile of individuals that developed bronchiolitis obliterans syndrome differed greatly compared to controls. Controls demonstrated close inter-sample correlation (R = 0.97+/-0.02, average+/-SD) while bronchiolitis obliterans syndrome showed greater heterogeneity (R = 0.86+/-0.09, average+/-SD). We identified 89 features that were predictive of developing BOS grade 1 and 66 features predictive of developing BOS grade 2 or higher. Fractions from MS analysis were pooled and evaluated for peptide content. Nearly 10-fold more peptides were found in bronchiolitis obliterans syndrome relative to controls. C-terminal residues suggested trypsin-like specificity among controls compared to elastase-type enzymes among those with bronchiolitis obliterans syndrome. Conclusions: Bronchoalveolar lavage fluid from individuals with bronchiolitis obliterans syndrome has an increase in low mass components detected by mass spectrometry. Many of these features were peptides that likely result from elevated neutrophil elastase activity.	[Stone, Matthew D.] Waters Corp, Milford, MA USA; [Stone, Matthew D.; Harvey, Stephen B.; Nelsestuen, Gary L.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Reilly, Cavan] Univ Minnesota, Dept Biostat, Minneapolis, MN USA; [Hertz, Marshall I.; Wendt, Chris H.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Wendt, Chris H.] Univ Minnesota, Dept Med, Vet Adm Med Ctr, Minneapolis, MN 55455 USA	Waters Corporation; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Wendt, CH (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	wendt005@umn.edu			National Institutes of Health [HL080041]; NIH; NSF; Hatch funds; College of Biological Sciences, Academic Health Center, Medical School, College of Food, Agriculture and Natural Resource Sciences; Office of the Vice President for Research, University of Minnesota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007741, R01HL080041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Hatch funds; College of Biological Sciences, Academic Health Center, Medical School, College of Food, Agriculture and Natural Resource Sciences; Office of the Vice President for Research, University of Minnesota(University of Minnesota System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant HL080041 from the National Institutes of Health. Instruments used for metabolome and peptide analysis were in the Center for Mass Spectrometry and Proteomics (CMSP), University of Minnesota and were purchased with partial support from the NIH, NSF and from Hatch funds and the CMSP receives operational support from the College of Biological Sciences, Academic Health Center, Medical School, College of Food, Agriculture and Natural Resource Sciences and from the Office of the Vice President for Research, University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; Boehler A, 1998, CHEST, V114, P1411, DOI 10.1378/chest.114.5.1411; DiGiovine B, 1996, J IMMUNOL, V157, P4194; Elssner A, 2001, Transpl Infect Dis, V3, P168, DOI 10.1034/j.1399-3062.2001.003003168.x; Estenne M, 2002, AM J RESP CRIT CARE, V166, P440, DOI 10.1164/rccm.200201-003PP; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Henke JA, 1999, CHEST, V115, P403, DOI 10.1378/chest.115.2.403; Hubner RH, 2005, EUR RESPIR J, V25, P494, DOI 10.1183/09031936.05.00091804; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Meyer KC, 2001, AM J RESP CRIT CARE, V164, P97, DOI 10.1164/ajrccm.164.1.2006096; Nelsestuen GL, 2005, PROTEOMICS, V5, P1705, DOI 10.1002/pmic.200401036; Nunley D, 1999, AM J RESP CRIT CARE, V159, P258, DOI 10.1164/ajrccm.159.1.9712068; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Riise GC, 1999, EUR RESPIR J, V14, P1123, DOI 10.1183/09031936.99.14511239; Riise GC, 1998, EUR RESPIR J, V12, P82, DOI 10.1183/09031936.98.12010082; Smith GN, 2007, AM J TRANSPLANT, V7, P1856, DOI 10.1111/j.1600-6143.2007.01850.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Zhang Y, 2005, PROTEOMIS IN PRESS; Zheng L, 2000, THORAX, V55, P53, DOI 10.1136/thorax.55.1.53	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84471	10.1371/journal.pone.0084471	http://dx.doi.org/10.1371/journal.pone.0084471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392140	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100063
J	Wang, BW; Wu, GJ; Cheng, WP; Shyu, KG				Wang, Bao-Wei; Wu, Gong-Jhe; Cheng, Wen-Ping; Shyu, Kou-Gi			MicroRNA-208a Increases Myocardial Fibrosis via Endoglin in Volume Overloading Heart	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; CARDIAC-HYPERTROPHY; MECHANICAL STRETCH; EXPRESSION; ATORVASTATIN; SURVIVAL; FIBROBLASTS; INFARCTION; PRESSURE; FAILURE	MicroRNA-208a (mir-208a) is essential for cardiac hypertrophy and fibrosis. Endoglin, a co-receptor of transforming growth factor-beta is also essential for cardiac fibrosis. Endoglin has been shown to be a target of mir-208a in the in vitro mechanical stress model. Volume overload can lead to heart failure and cardiac fibrosis. The role of mir-208a and endoglin in volume overload heart failure is well known. We sought to investigate the mechanism of regulation of mir-208a and endoglin in volume overload-induced heart failure. Aorta-caval (AV) shunt was performed in adult Sprague-Dawley rats to induce volume overload. Heart weight and heart weight/body weight ratio significantly increased in AV shunt animals. AV shunt significantly increased left ventricular end-diastolic dimension as compared to sham group. Mir-208a was significantly induced by AV shunt from 3 to 14 days. Endoglin, myosin heavy chain-beta and brain natriuretic peptide were significantly induced by AV shunt from 3 to 14 days. Overexpression of mir-208a in the sham group without AV shunt significantly increased endoglin expression similar to the AV shunt group. Antagomir-208a attenuated the endoglin expression induced by AV shunt. Pretreatment with atorvastatin also attenuated the endoglin expression induced by AV shunt. AV shunt significantly increased myocardial fibrosis as compared to sham group. Overexpression of mir-208a in the sham group significantly increased myocardial fibrosis. Antagomir-208a and atorvastatin significantly attenuated the myocardial fibrosis induced by AV shunt. In conclusion, mir-208a increased endoglin expression to induce myocardial fibrosis in volume overloaded heart failure. Treatment with atorvastatin can attenuate the myocardial fibrosis induced by volume overload through inhibition of endoglin expression.	[Wang, Bao-Wei] Fu Jen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Wang, Bao-Wei; Cheng, Wen-Ping; Shyu, Kou-Gi] Shin Kong Wu Ho Mem Hosp, Div Cardiol, Taipei, Taiwan; [Wu, Gong-Jhe] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Wu, Gong-Jhe] Shin Kong Wu Ho Mem Hosp, Dept Anesthesiol, Taipei, Taiwan; [Shyu, Kou-Gi] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan	Fu Jen Catholic University; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University; Shin Kong Wu Ho Su Memorial Hospital; Taipei Medical University	Shyu, KG (corresponding author), Shin Kong Wu Ho Mem Hosp, Div Cardiol, Taipei, Taiwan.	shyukg@ms12.hinet.net			National Science Council, Executive Yuan, Taiwan; Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan	This study was sponsored in part from National Science Council, Executive Yuan, Taiwan and Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benjamin IJ, 2012, CIRCULATION, V125, P2689, DOI 10.1161/CIRCULATIONAHA.112.108282; Broberg CS, 2010, CIRC-CARDIOVASC IMAG, V3, P727, DOI 10.1161/CIRCIMAGING.108.842096; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen J, 2006, AM J PHYSIOL-HEART C, V291, pH1738, DOI 10.1152/ajpheart.00341.2006; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Chiu CZ, 2012, ACTA CARDIOL SIN, V28, P286; Dubey G, 2013, J APPL PHARM SCI, V3, P52; Fonsatti E, 2003, CURR DRUG TARGETS, V4, P291, DOI 10.2174/1389450033491073; Horwich TB, 2004, J AM COLL CARDIOL, V43, P642, DOI 10.1016/j.jacc.2003.07.049; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Kapur NK, 2012, CIRCULATION, V125, P2728, DOI 10.1161/CIRCULATIONAHA.111.080002; Kapur NK, 2010, AM J CARDIOL, V106, P1770, DOI 10.1016/j.amjcard.2010.08.018; Khush KK, 2007, CIRCULATION, V115, P576, DOI 10.1161/CIRCULATIONAHA.106.625574; Kurata T, 2011, BRAIN RES, V1371, P161, DOI 10.1016/j.brainres.2010.11.067; Lambert V, 2010, J THORAC CARDIOV SUR, V139, P1197, DOI 10.1016/j.jtcvs.2009.11.028; Landmesser U, 2004, CIRCULATION, V110, P1933, DOI 10.1161/01.CIR.0000143232.67642.7A; Nachtigal P, 2007, CAN J PHYSIOL PHARM, V85, P767, DOI 10.1139/Y07-068; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Pospisilova N, 2006, J PHARM PHARM SCI, V9, P388; Rodriguez-Barbero A, 2006, CELL PHYSIOL BIOCHEM, V18, P135, DOI 10.1159/000095181; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shyu KG, 2005, CARDIOVASC RES, V68, P405, DOI 10.1016/j.cardiores.2005.06.028; Shyu KG, 2005, J CARD FAIL, V11, P152, DOI 10.1016/j.cardfail.2004.06.433; Shyu KG, 2013, EUR J HEART FAIL, V15, P36, DOI 10.1093/eurjhf/hfs143; Shyu KG, 2010, EUR J HEART FAIL, V12, P219, DOI 10.1093/eurjhf/hfq011; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang BW, 2013, J FORMOS MED ASSOC, V112, P635, DOI 10.1016/j.jfma.2013.01.002; Yanavitski Marat, 2011, Curr Heart Fail Rep, V8, P206, DOI 10.1007/s11897-011-0065-5	33	45	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84188	10.1371/journal.pone.0084188	http://dx.doi.org/10.1371/journal.pone.0084188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392114	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100038
J	Alshalalfa, M; Bader, GD; Bismar, TA; Alhajj, R				Alshalalfa, Mohammed; Bader, Gary D.; Bismar, Tarek A.; Alhajj, Reda			Coordinate MicroRNA-Mediated Regulation of Protein Complexes in Prostate Cancer	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; EXPRESSION; NETWORK; RESOURCE; MIRNAS	MicroRNAs are a class of small non-coding regulatory RNA molecules that regulate mRNAs post-transcriptionally. Recent evidence has shown that miRNAs target entire functionally related proteins such as protein complexes and biological pathways. However, characterizing the influence of miRNAs on genes whose encoded proteins are part of protein complexes has not been studied in the context of disease. We propose an entropy-based framework to identify miRNA-mediated dysregulation of functionally related proteins during prostate cancer progression. The proposed framework uses experimentally verified miRNA-target interactions, functionally related proteins and expression data to identify miRNA-influenced protein complexes in prostate cancer, and identify genes that are dysregulated as a result. The framework constructs correlation matrixes between functionally related proteins and miRNAs that have targets in the complex, and assesses the changes in the Shannon entropy of the modules across different stages of prostate cancer. Results reveal that SMAD4 and HDAC containing protein complexes are highly affected and disrupted by miRNAs, particularly miRNA-1 and miRNA-16. Using biological pathways to define functionally related proteins reveals that NF-kB-, RAS-, and Syndecan-mediated pathways are dysregulated due to miRNA-1- and miRNA-16-mediated regulation. These results suggest that miRNA-1 and miRNA-16 are important master regulators of miRNA-mediated regulation in prostate cancer. Moreover, results reveal that miRNAs with high-influence on the disrupted protein complexes are diagnostic and prognostic biomarker candidates for prostate cancer progression. The observation of miRNA-mediated protein complex regulation and miRNA-mediated pathway regulation, with partial experimental verification from previous studies, demonstrates that our framework is a promising approach for the identification of novel miRNAs and protein complexes related to disease progression.	[Alshalalfa, Mohammed; Alhajj, Reda] Univ Calgary, Dept Comp Sci, Calgary, AB T2N 1N4, Canada; [Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Bader, Gary D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Bismar, Tarek A.] Univ Calgary, Dept Pathol, Fac Med, Calgary, AB, Canada; [Bismar, Tarek A.] Univ Calgary, Dept Oncol, Fac Med, Calgary, AB, Canada; [Bismar, Tarek A.] Univ Calgary, Dept Mol Biol & Biochem, Fac Med, Calgary, AB, Canada; [Alshalalfa, Mohammed] Palestine Polytech Univ, Biotechnol Res Ctr, Hebron, Israel	University of Calgary; University of Toronto; University of Toronto; University of Calgary; University of Calgary; University of Calgary	Alshalalfa, M (corresponding author), Univ Calgary, Dept Comp Sci, Calgary, AB T2N 1N4, Canada.	mohamed.alshalalfa@gmail.com	Bismar, Tarek/ABH-6129-2020; Bader, Gary/C-1176-2009	Bader, Gary/0000-0003-0185-8861	NRNB (U.S. National Institutes of Health, National Center for Research Resources) [P41 GM103504]; NSERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	NRNB (U.S. National Institutes of Health, National Center for Research Resources); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504). This work was funded by NSERC scholarship for Phd students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2008, EPIGENETICS-US, V3, P300, DOI 10.4161/epi.3.6.7273; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Bin Goh WW, 2012, BIOINFORMATICS, V28, P453, DOI 10.1093/bioinformatics/btr693; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Chen JL, 2012, CLIN CANCER RES, V18, P4291, DOI 10.1158/1078-0432.CCR-12-0373; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J. C., 2009, NATURE METHODS, V4, P1045; Hudson R, 2011, NUCLEIC ACIDS RES, P1; Kiviniemi J, 2004, APMIS, V112, P89, DOI 10.1111/j.1600-0463.2004.apm1120202.x; Liang H, 2007, RNA, V13, P1402, DOI 10.1261/rna.634607; Lin KT, 2012, CLIN CANCER RES, V18, P4691, DOI 10.1158/1078-0432.CCR-12-0633; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; MOON YI, 1995, PHYS REV E, V52, P2318, DOI 10.1103/PhysRevE.52.2318; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Priness I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-111; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schmeier S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-183; Srivastava Anvesha, 2011, Mol Cell Pharmacol, V3, P115; Sualp M, 2011, BIOSYSTEMS, V105, P201, DOI 10.1016/j.biosystems.2011.04.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varshavsky R, 2006, BIOINFORMATICS, V22, pE507, DOI 10.1093/bioinformatics/btl214; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu J, 2011, MOL CANCER THER, V10, P1857, DOI 10.1158/1535-7163.MCT-11-0055; Yang G, 2010, INT J BIOL SCI, V6, P1; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040130; Zhang WS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-338	47	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84261	10.1371/journal.pone.0084261	http://dx.doi.org/10.1371/journal.pone.0084261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391925	Green Published, gold			2022-12-27	WOS:000329323900068
J	Bertille, N; Fournier-Charriere, E; Pons, G; Chalumeau, M				Bertille, Nathalie; Fournier-Charriere, Elisabeth; Pons, Gerard; Chalumeau, Martin			Managing Fever in Children: A National Survey of Parents' Knowledge and Practices in France	PLOS ONE			English	Article							CROSS-SECTIONAL SURVEY; CHILDHOOD FEVER; FEBRILE CHILDREN; MANAGEMENT; MOTHERS; CARE; PERCEPTIONS; ATTITUDES; BELIEFS	Introduction: Identifying targets to improve parental practices for managing fever in children is the first step to reducing the overloaded healthcare system related to this common symptom. We aimed to study parents' knowledge and practices and their determinants in managing fever symptoms in children in France as compared with current recommendations. Methods: We conducted an observational national study between 2007 and 2008 of French general practitioners, primary care pediatricians and pharmacists. These healthcare professionals (HPs) were asked to include 5 consecutive patients from 1 month to 12 years old with fever for up to 48 hr who were accompanied by a family member. Parents completed a questionnaire about their knowledge of fever in children and their attitudes about the current fever episode. We used a multilevel logistic regression model to assess the joint effects of patient- and HP-level variables. Results: In all, 1,534 HPs (participation rate 13%) included 6,596 children. Parental concordance with current recommendations for temperature measurement methods, the threshold for defining fever, and physical (oral hydration, undressing, room temperature) and drug treatment was 89%, 61%, 15%, and 23%, respectively. Multivariate multi-level analyses revealed a significant HP effect. In general, high concordance with recommendations was associated with high educational level of parents and the HP consulted being a pediatrician. Conclusions: In France, parents' knowledge and practices related to managing fever symptoms in children frequently differ from recommendations. Targeted health education interventions are needed to effectively manage fever symptoms in children.	[Bertille, Nathalie; Chalumeau, Martin] INSERM, U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France; [Bertille, Nathalie; Pons, Gerard; Chalumeau, Martin] Paris Descartes Univ, Paris, France; [Bertille, Nathalie; Chalumeau, Martin] Hop Necker Enfants Malad, AP HP, Dept Paediat, Paris, France; [Fournier-Charriere, Elisabeth] Hop Bicetre, AP HP, Pain Unit, Le Kremlin Bicetre, France; [Pons, Gerard] Grp Hosp Cochin Broca Hotel Dieu, AP HP, Paris, France; [Pons, Gerard] INSERM, Pediat Epilepsies & Brain Plast U663, Paris, Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chalumeau, M (corresponding author), INSERM, U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France.	martin.chalumeau@nck.aphp.fr	Chalumeau, Martin/F-4293-2017	Chalumeau, Martin/0000-0001-8175-3706; Bertille, Nathalie/0000-0001-7159-2646	Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie; Sanofi Aventis	Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie; Sanofi Aventis(Sanofi-Aventis)	NB is supported by an educational grant from Laboratoires Guigoz - Societe Francaise de Pediatrie - Groupe de Pediatrie Generale - Groupe de Recherches Epidemiologiques en Pediatrie. The work was also funded by Sanofi Aventis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence nationale de securite du medicament et des produits de sante, 2005, INF TRAIT FIEVR CHEZ; Al-Eissa YA, 2000, ANN SAUDI MED, V20, P202, DOI 10.5144/0256-4947.2000.202; American Academy of Pediatrics, 2002, FEV MAK YOUR CHILD C; BELIN J, 1992, ANN PEDIATR-PARIS, V39, P588; Bilenko N, 2006, CLIN THER, V28, P783, DOI 10.1016/j.clinthera.2006.05.010; Blondel B, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P373; Blumenthal I, 1998, FAM PRACT, V15, P513, DOI 10.1093/fampra/15.6.513; Bocquet A, 2005, ARCH PEDIATRIE, V12, P1688, DOI 10.1016/j.arcped.2005.06.014; Boivin JM, 2007, ARCH PEDIATRIE, V14, P322, DOI 10.1016/j.arcped.2006.12.018; Cegedim Group, 2012, HEALTHC PROF DAT; Charkaluk ML, 2005, ARCH PEDIATRIE, V12, P1209, DOI 10.1016/j.arcped.2005.02.024; Chiappini E, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-97; Chiappini E, 2012, CLIN THER, V34, P1648, DOI 10.1016/j.clinthera.2012.06.011; Chiappini E, 2009, CLIN THER, V31, P1826, DOI 10.1016/j.clinthera.2009.08.006; Cohee LMS, 2010, CLIN PEDIATR, V49, P221, DOI 10.1177/0009922809336209; Community Paediatrics Committee, 2008, FEV TEMP TAK; Crocetti M, 2001, PEDIATRICS, V107, P1241, DOI 10.1542/peds.107.6.1241; Enarson MC, 2012, PEDIATRICS, V130, pE905, DOI 10.1542/peds.2011-2140; Grass L, 2005, REV PRAT MED GEN, V686-87, P381; Impicciatore P, 1998, PREV MED, V27, P268, DOI 10.1006/pmed.1998.0262; Karwowska Anna, 2002, CJEM, V4, P394; Langer T, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-41; Launay E, 2010, PEDIATR CRIT CARE ME, V11, P469, DOI 10.1097/PCC.0b013e3181ce752e; Matziou V, 2008, INT J NURS STUD, V45, P829, DOI 10.1016/j.ijnurstu.2006.04.021; *NAT I HLTH CLIN E, 2007, FEV ILLN CHILDR ASS; Nijman RG, 2010, PEDIATR EMERG CARE, V26, P339, DOI 10.1097/PEC.0b013e3181db1dce; Paula JS, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-6; Pruvost I, 2012, ARCH PEDIATRIE, V19, P248, DOI 10.1016/j.arcped.2011.12.013; Stagnara J, 2005, PRESSE MED, V34, P1129, DOI 10.1016/S0755-4982(05)84136-3; Stagnara J, 2004, ARCH PEDIATRIE, V11, P108, DOI 10.1016/j.arcped.2003.11.006; Taveras EM, 2004, PEDIATR EMERG CARE, V20, P579, DOI 10.1097/01.pec.0000139739.46591.dd; Walsh A, 2008, J ADV NURS, V63, P376, DOI 10.1111/j.1365-2648.2008.04721.x	32	36	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83469	10.1371/journal.pone.0083469	http://dx.doi.org/10.1371/journal.pone.0083469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391772	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200069
J	Griffin, AS; Guez, D; Lermite, F; Patience, M				Griffin, Andrea S.; Guez, David; Lermite, Francoise; Patience, Madeleine			Tracking Changing Environments: Innovators Are Fast, but Not Flexible Learners	PLOS ONE			English	Article							PROBLEM-SOLVING PERFORMANCE; BEHAVIORAL FLEXIBILITY; BRAIN SIZE; SERIAL DISCRIMINATION; ACRIDOTHERES-TRISTIS; INDIVIDUAL VARIATION; INVASION SUCCESS; INDIAN MYNAHS; BIRDS; EVOLUTION	Behavioural innovations are increasingly thought to provide a rich source of phenotypic plasticity and evolutionary change. Innovation propensity shows substantial variation across avian taxa and provides an adaptive mechanism by which behaviour is flexibly adjusted to changing environmental conditions. Here, we tested for the first time the prediction that inter-individual variation in innovation propensity is equally a measure of behavioural flexibility. We used Indian mynas, Sturnus tristis, a highly successful worldwide invader. Results revealed that mynas that solved an extractive foraging task more quickly learnt to discriminate between a cue that predicted food, and one that did not more quickly. However, fast innovators were slower to change their behaviour when the significance of the food cues changed. This unexpected finding appears at odds with the well-established view that avian taxa with larger brains relative to their body size, and therefore greater neural processing power, are both faster, and more flexible learners. We speculate that the existence of this relationship across taxa can be reconciled with its absence within species by assuming that fast, innovative learners and non innovative, slow, flexible learners constitute two separate individual strategies, which are both underpinned by enhanced neural processing power. This idea is consistent with the recent proposal that individuals may differ consistently in 'cognitive style', differentially trading off speed against accuracy in cognitive tasks.	[Griffin, Andrea S.; Guez, David; Lermite, Francoise; Patience, Madeleine] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia	University of Newcastle	Griffin, AS (corresponding author), Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia.	andrea.griffin@newcastle.edu.au	Guez, David/B-6502-2009; Galef, Bennett G/A-5678-2008; Griffin, Andrea S/GWM-8557-2022; Guez, David/O-2740-2015	Guez, David/0000-0002-6322-5237; Griffin, Andrea S/0000-0003-4624-9904; Guez, David/0000-0002-6322-5237	University of Newcastle, Faculty of Science and Information Technology Strategic Research Grants	University of Newcastle, Faculty of Science and Information Technology Strategic Research Grants	The research was supported by two University of Newcastle, Faculty of Science and Information Technology Strategic Research Grants (2011, Griffin & Dayas; 2012, Griffin, Dayas and Guez). Internal grants are not attributed grant numbers. The University of Newcastle, Faculty of Science and Information Technology had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; Bouchard J, 2007, ANIM COGN, V10, P259, DOI 10.1007/s10071-006-0064-1; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Brust V, 2013, ETHOLOGY, V119, P559, DOI 10.1111/eth.12095; Byrne R., 1995, THINKING APE EVOLUTI; Cauchard L, 2013, ANIM BEHAV, V85, P19, DOI 10.1016/j.anbehav.2012.10.005; Christidis L, 2008, SYSTEMATICS TAXONOMY; Cole EF, 2012, CURR BIOL, V22, P1808, DOI 10.1016/j.cub.2012.07.051; Cole EF, 2011, ANIM BEHAV, V81, P491, DOI 10.1016/j.anbehav.2010.11.025; Diquelou M., 2010, THESIS U PARIS, P13; Feare C.J., 2010, CONSERV EVIDENCE, V7, P52; GOSSETTE RL, 1969, PERCEPT MOTOR SKILL, V29, P803, DOI 10.2466/pms.1969.29.3.803; Gould JL, 2004, CURR BIOL, V14, pR372, DOI 10.1016/j.cub.2004.05.008; Griffin AS, 2008, ANIM BEHAV, V75, P79, DOI 10.1016/j.anbehav.2007.04.008; Griffin AS, 2011, ANIM BEHAV, V81, P1163, DOI 10.1016/j.anbehav.2011.02.022; Griffin AS, 2009, ANIM BEHAV, V78, P79, DOI 10.1016/j.anbehav.2009.03.012; Guillette LM, 2011, P ROY SOC B-BIOL SCI, V278, P767, DOI 10.1098/rspb.2010.1669; Soler JJ, 2012, NATURWISSENSCHAFTEN, V99, P111, DOI 10.1007/s00114-011-0875-z; Kamil A C, 1987, Nebr Symp Motiv, V35, P257; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Keagy J, 2012, BEHAV ECOL, V23, P448, DOI 10.1093/beheco/arr211; Keagy J, 2009, ANIM BEHAV, V78, P809, DOI 10.1016/j.anbehav.2009.07.011; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; Laland KN, 1999, ANIM BEHAV, V57, P331, DOI 10.1006/anbe.1998.0967; Lefebvre L, 2011, BIOL LETTERS, V7, P631, DOI 10.1098/rsbl.2010.0556; Lermite F., 2012, THESIS U PARIS 13, P13; LEVINE BA, 1974, J COMP PHYSIOL PSYCH, V86, P730, DOI 10.1037/h0036163; Macphail EM, 2001, BIOL REV, V76, P341; Morand-Ferron J, 2011, BEHAV ECOL, V22, P1241, DOI 10.1093/beheco/arr120; Nicolakakis N, 2003, ANIM BEHAV, V65, P445, DOI 10.1006/anbe.2003.2085; Overington SE, 2011, BEHAV PROCESS, V87, P274, DOI 10.1016/j.beproc.2011.06.002; RAJALAKSHMI R, 1965, ANIM BEHAV, V13, P203, DOI 10.1016/0003-3472(65)90035-7; Reader SM, 2007, BEHAV BRAIN SCI, V30, P420, DOI 10.1017/S0140525X07002518; Reader SM, 2003, ANIM BIOL, V53, P147, DOI 10.1163/157075603769700340; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; SCHUSTER.RJ, 1966, J EXP ANAL BEHAV, V9, P593, DOI 10.1901/jeab.1966.9-593; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Sol D, 2000, OIKOS, V90, P599, DOI 10.1034/j.1600-0706.2000.900317.x; Sol D, 2005, EVOLUTION, V59, P2669, DOI 10.1111/j.0014-3820.2005.tb00978.x; Sol D, 2005, P ROY SOC B-BIOL SCI, V272, P1433, DOI 10.1098/rspb.2005.3099; Sol D, 2005, P NATL ACAD SCI USA, V102, P5460, DOI 10.1073/pnas.0408145102; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sol D, 2012, OECOLOGIA, V169, P553, DOI 10.1007/s00442-011-2203-x; Sol D, 2012, ANIM BEHAV, V83, P179, DOI 10.1016/j.anbehav.2011.10.024; Sol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019535; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344	50	58	58	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84907	10.1371/journal.pone.0084907	http://dx.doi.org/10.1371/journal.pone.0084907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391981	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000329323900124
J	Guymer, RH; Baird, PN; Varsamidis, M; Busija, L; Dimitrov, PN; Aung, KZ; Makeyeva, GA; Richardson, AJ; Lim, L; Robman, LD				Guymer, Robyn H.; Baird, Paul N.; Varsamidis, Mary; Busija, Lucy; Dimitrov, Peter N.; Aung, Khin Zaw; Makeyeva, Galina A.; Richardson, Andrea J.; Lim, Lyndell; Robman, Liubov D.			Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration	PLOS ONE			English	Article							REDUCTASE INHIBITORS STATINS; SEVERITY SCALE; A REDUCTASE; MACULOPATHY; PROGRESSION; GENE; RISK; CLASSIFICATION; PREVENTION	Background: HMG Co-A reductase inhibitors are ubiquitous in our community yet their potential role in age-related macular degeneration (AMD) remains to be determined. Methodology/Principal Findings: Objectives: To evaluate the effect of simvastatin on AMD progression and the effect modification by polymorphism in apolipoprotein E (ApoE) and complement factor H (CFH) genes. Design: A proof of concept double-masked randomized controlled study. Participants: 114 participants aged 53 to 91 years, with either bilateral intermediate AMD or unilateral non-advanced AMD (with advanced AMD in fellow eye), BCVA >= 20/60 in at least one eye, and a normal lipid profile. Intervention: Simvastatin 40 mg/day or placebo, allocated 1:1. Main outcome measures: Progression of AMD either to advanced AMD or in severity of non-advanced AMD. Results. The cumulative AMD progression rates were 70% in the placebo and 54% in the simvastatin group. Intent to treat multivariable logistic regression analysis, adjusted for age, sex, smoking and baseline AMD severity, showed a significant 2-fold decrease in the risk of progression in the simvastatin group: OR 0.43 (0.18-0.99), p = 0.047. Post-hoc analysis stratified by baseline AMD severity showed no benefit from treatment in those who had advanced AMD in the fellow eye before enrolment: OR 0.97 (0.27-3.52), p = 0.96, after adjusting for age, sex and smoking. However, there was a significant reduction in the risk of progression in the bilateral intermediate AMD group compared to placebo [adjusted OR 0.23 (0.07-0.75), p = 0.015]. The most prominent effect was observed amongst those who had the CC (Y402H) at risk genotype of the CFH gene [OR 0.08 (0.02-0.45), p = 0.004]. No evidence of harm from simvastatin intervention was detected. Conclusion/Significance: Simvastatin may slow progression of non-advanced AMD, especially for those with the at risk CFH genotype CC (Y402H). Further exploration of the potential use of statins for AMD, with emphasis on genetic subgroups, is warranted.	[Guymer, Robyn H.; Baird, Paul N.; Varsamidis, Mary; Busija, Lucy; Dimitrov, Peter N.; Aung, Khin Zaw; Makeyeva, Galina A.; Richardson, Andrea J.; Lim, Lyndell; Robman, Liubov D.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia; [Busija, Lucy] Deakin Univ, Biostat Unit, Fac Hlth, Burwood, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Deakin University	Robman, LD (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Vic, Australia.	liubov@unimelb.edu.au	Busija, Lucy/Y-6064-2019	Busija, Lucy/0000-0001-7464-9089; Baird, Paul/0000-0002-1305-3502; Lim, Lyndell/0000-0003-2491-685X; Guymer, Robyn/0000-0002-9441-4356	Ian Potter Foundation; John Reid Charitable Trust; Royal Victorian Eye and Ear Hospital; National Health and Medical Research Council (NHMRC) through a Centre for Clinical Research Excellence award [529923, 529905, 1028444]; Wagstaff Fellowship; NHMRC award "Centre for Clinical Research Excellence" [529923]	Ian Potter Foundation; John Reid Charitable Trust; Royal Victorian Eye and Ear Hospital; National Health and Medical Research Council (NHMRC) through a Centre for Clinical Research Excellence award; Wagstaff Fellowship; NHMRC award "Centre for Clinical Research Excellence"	This work was supported by grants from the Ian Potter Foundation, John Reid Charitable Trust and Royal Victorian Eye and Ear Hospital. Merck Sharp and Dohme supplied the active simvastatin and placebo medication. The National Health and Medical Research Council (NHMRC) supported the study through a Centre for Clinical Research Excellence award to CERA(#529923), a Practitioner Fellowship (#529905) to RHG and a Senior Research Fellowship (#1028444) to PNB. LDR was supported by the Wagstaff Fellowship. CERA receives operational infrastructure from the Victorian Government. CERA is a recepient of the NHMRC award "Centre for Clinical Research Excellence" #529923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MKM, 2012, AM J EPIDEMIOL, V175, P511, DOI 10.1093/aje/kwr329; ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; ALBERTS AW, 1988, AM J CARDIOL, V62, pJ10, DOI 10.1016/0002-9149(88)90002-1; Aung KZ, 2009, OPHTHAL EPIDEMIOL, V16, P254, DOI [10.3109/09286580902864419, 10.1080/09286580902864419]; *AUSTR GOV, 2008, MOST COMM US DRUGS A; Baird PN, 2006, INVEST OPHTH VIS SCI, V47, P4194, DOI 10.1167/iovs.05-1285; Baird PN, 2006, HUM MUTAT, V27, P337, DOI 10.1002/humu.20288; Baird PN, 2004, INVEST OPHTH VIS SCI, V45, P1311, DOI 10.1167/iovs.03-1121; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; Chuo JY, 2007, OPHTHAL EPIDEMIOL, V14, P367, DOI 10.1080/09286580701421684; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Dupont W. D., 2009, PS POWER SAMPLE SIZE; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Fong DS, 2010, AM J OPHTHALMOL, V149, P955, DOI 10.1016/j.ajo.2009.12.037; Gehlbach P, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006927.pub2; Guymer RH, 2005, SURV OPHTHALMOL, V50, P194, DOI 10.1016/j.survophthal.2004.12.002; Guymer RH, 2008, CLIN INTERV AGING, V3, P581; Hall NF, 2001, BRIT MED J, V323, P375, DOI 10.1136/bmj.323.7309.375; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein R, 2008, OPHTHALMOLOGY, V115, P1460, DOI 10.1016/j.ophtha.2008.01.026; Klein R, 2007, AM J OPHTHALMOL, V144, P1, DOI 10.1016/j.ajo.2007.02.047; Maguire MG, 2009, OPHTHALMOLOGY, V116, P2381, DOI 10.1016/j.ophtha.2009.06.055; Mant A, 2007, BRIT J CLIN PHARMACO, V63, P125, DOI 10.1111/j.1365-2125.2006.02735.x; MARTINI E, 1991, Annali di Ottalmologia e Clinica Oculistica, V117, P1121; McCarty CA, 2001, MJA, V175, P17; McGwin G, 2003, BRIT J OPHTHALMOL, V87, P1121, DOI 10.1136/bjo.87.9.1121; National Heart Foundation of Australia, 2001, MED J AUST S, V175, pS57; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Robman L, 2010, OPHTHALMOLOGY, V117, P1982, DOI 10.1016/j.ophtha.2010.02.003; Seipp Michael T, 2009, J Biomol Tech, V20, P160; Shalev V, 2011, OPHTHAL EPIDEMIOL, V18, P83, DOI 10.3109/09286586.2011.560746; Smeeth L, 2005, BRIT J OPHTHALMOL, V89, P1171, DOI 10.1136/bjo.2004.064477; Tan JSL, 2007, AM J OPHTHALMOL, V143, P685, DOI 10.1016/j.ajo.2006.11.021; Taylor HR, 2002, BMJ-BRIT MED J, V325, P11, DOI 10.1136/bmj.325.7354.11; Tsao SW, 2013, DRUG AGING, V30, P205, DOI 10.1007/s40266-013-0061-4; Van Leeuwen R, 2004, OPHTHALMOLOGY, V111, P1169, DOI 10.1016/j.ophtha.2003.10.024; van Leeuwen R, 2003, OPHTHALMOLOGY, V110, P1540, DOI 10.1016/S0161-6420(03)00501-3; VanderBeek BL, 2013, RETINA-J RET VIT DIS, V33, P414, DOI 10.1097/IAE.0b013e318276e0cf; Wilson HL, 2004, AM J OPHTHALMOL, V137, P615, DOI 10.1016/j.ajo.2003.10.025; Zhou Q, 2010, CIRC J, V74, P818, DOI 10.1253/circj.CJ-10-0110	45	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83759	10.1371/journal.pone.0083759	http://dx.doi.org/10.1371/journal.pone.0083759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391822	Green Published, gold			2022-12-27	WOS:000329325200120
J	Jager, M; Dayraud, C; Mialot, A; Queinnec, E; le Guyader, H; Manuel, M				Jager, Muriel; Dayraud, Cyrielle; Mialot, Antoine; Queinnec, Eric; le Guyader, Herve; Manuel, Michael			Evidence for Involvement of Wnt Signalling in Body Polarities, Cell Proliferation, and the Neuro-Sensory System in an Adult Ctenophore	PLOS ONE			English	Article							SYNTHASE KINASE 3; STEM-CELLS; MNEMIOPSIS-LEIDYI; SELF-RENEWAL; AMPHIMEDON-QUEENSLANDICA; HOMEOBOX GENES; EVOLUTION; EXPRESSION; PATHWAY; CATENIN	Signalling through the Wnt family of secreted proteins originated in a common metazoan ancestor and greatly influenced the evolution of animal body plans. In bilaterians, Wnt signalling plays multiple fundamental roles during embryonic development and in adult tissues, notably in axial patterning, neural development and stem cell regulation. Studies in various cnidarian species have particularly highlighted the evolutionarily conserved role of the Wnt/b-catenin pathway in specification and patterning of the primary embryonic axis. However in another key non-bilaterian phylum, Ctenophora, Wnts are not involved in early establishment of the body axis during embryogenesis. We analysed the expression in the adult of the ctenophore Pleurobrachia pileus of 11 orthologues of Wnt signalling genes including all ctenophore Wnt ligands and Fz receptors and several members of the intracellular b-catenin pathway machinery. All genes are strongly expressed around the mouth margin at the oral pole, evoking the Wnt oral centre of cnidarians. This observation is consistent with primary axis polarisation by the Wnts being a universal metazoan feature, secondarily lost in ctenophores during early development but retained in the adult. In addition, local expression of Wnt signalling genes was seen in various anatomical structures of the body including in the locomotory comb rows, where their complex deployment suggests control by the Wnts of local comb polarity. Other important contexts of Wnt involvement which probably evolved before the ctenophore/ cnidarian/bilaterian split include proliferating stem cells and progenitors irrespective of cell types, and developing as well as differentiated neuro-sensory structures.	[Jager, Muriel; Dayraud, Cyrielle; Mialot, Antoine; Queinnec, Eric; le Guyader, Herve; Manuel, Michael] Univ Paris 06, CNRS, UMR 7138, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Manuel, M (corresponding author), Univ Paris 06, CNRS, UMR 7138, Paris, France.	michael.manuel@snv.jussieu.fr			"Agence Nationale de la Recherche'' ANR [ANR-09-BLAN-0236 DiploDevo]; Institut Universitaire de France (IUF)	"Agence Nationale de la Recherche'' ANR(French National Research Agency (ANR)); Institut Universitaire de France (IUF)	This work was supported by grants from the "Agence Nationale de la Recherche'' ANR "programme blanc'' ANR-09-BLAN-0236 DiploDevo and from the Institut Universitaire de France (IUF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Adamska M, 2011, ZOOLOGY, V114, P1, DOI 10.1016/j.zool.2010.10.003; Adamska M, 2010, EVOL DEV, V12, P494, DOI 10.1111/j.1525-142X.2010.00435.x; Alie A, 2011, DEV BIOL, V350, P183, DOI 10.1016/j.ydbio.2010.10.019; Augustin R, 2006, DEV BIOL, V296, P62, DOI 10.1016/j.ydbio.2006.04.003; Bode HR, 2012, INT J DEV BIOL, V56, P473, DOI 10.1387/ijdb.113448hb; Chang CH, 2004, MECH DEVELOP, V121, P157, DOI 10.1016/j.mod.2003.12.004; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cho SJ, 2010, MOL BIOL EVOL, V27, P1645, DOI 10.1093/molbev/msq052; Dayraud C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-107; Demilly A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2915; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; Deves M, 2012, SEMIN CELL DEV BIOL, V23, P290, DOI 10.1016/j.semcdb.2012.03.003; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Galliot B, 2010, TRENDS CELL BIOL, V20, P514, DOI 10.1016/j.tcb.2010.05.006; Gee L, 2010, DEV BIOL, V340, P116, DOI 10.1016/j.ydbio.2009.12.036; Gilbert S.F., 2010, DEV BIOL; Guder C, 2006, ONCOGENE, V25, P7450, DOI 10.1038/sj.onc.1210052; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hemmrich G, 2012, MOL BIOL EVOL, V29, P3267, DOI 10.1093/molbev/mss134; Hernandez-Nicaise M.-L., 1991, P359; Hernandez-Nicaise ML, 1994, TRAITE ZOOL, P943; Holstein Thomas W., 2008, V469, P47, DOI 10.1007/978-1-60327-469-5; Jager M, 2011, J EXP ZOOL PART B, V316B, P171, DOI 10.1002/jez.b.21386; Jager M, 2008, J EXP ZOOL PART B, V310B, P650, DOI 10.1002/jez.b.21244; Khalturin K, 2007, DEV BIOL, V309, P32, DOI 10.1016/j.ydbio.2007.06.013; Kuhl SJ, 2013, BBA-GEN SUBJECTS, V1830, P2297, DOI 10.1016/j.bbagen.2012.08.010; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lapebie P, 2011, BIOESSAYS, V33, P759, DOI 10.1002/bies.201100023; Le Dreau G, 2012, DEV NEUROBIOL, V72, P1471, DOI 10.1002/dneu.22015; Lee PN, 2006, SEMIN CELL DEV BIOL, V17, P157, DOI 10.1016/j.semcdb.2006.05.002; Liu F, 2008, DEV BIOL, V313, P210, DOI 10.1016/j.ydbio.2007.10.016; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Manuel M, 2009, CR BIOL, V332, P184, DOI 10.1016/j.crvi.2008.07.009; Marlow H, 2013, DEV BIOL, V380, P324, DOI 10.1016/j.ydbio.2013.05.022; Martin BL, 2009, CURR BIOL, V19, pR215, DOI 10.1016/j.cub.2009.01.052; Martindale Mark Q., 1997, P87; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Momose T, 2007, PLOS BIOL, V5, P889, DOI 10.1371/journal.pbio.0050070; Mulligan KA, 2012, J NEUROIMMUNE PHARM, V7, P774, DOI 10.1007/s11481-012-9404-x; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Oliva CA, 2013, AGEING RES REV; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Pang K, 2008, DEV GENES EVOL, V218, P307, DOI 10.1007/s00427-008-0222-3; Pang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024152; Pang K, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-10; Pang K, 2008, CURR BIOL, V18, pR1119, DOI 10.1016/j.cub.2008.10.004; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Plickert G, 2006, DEV BIOL, V298, P368, DOI 10.1016/j.ydbio.2006.06.043; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rottinger E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003164; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Schnitzler CE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-107; Simmons DK, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-2; Slavik MA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-9; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Tamm S.L., 1982, P266; Tamm SL, 2012, J MORPHOL, V273, P109, DOI 10.1002/jmor.11016; TAMM SL, 1973, J EXP BIOL, V59, P231; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	70	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84363	10.1371/journal.pone.0084363	http://dx.doi.org/10.1371/journal.pone.0084363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391946	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900089
J	Jiang, JY; Li, JY; Zhang, YX; Zhu, H; Liu, JJ; Pumill, C				Jiang, Junyi; Li, Jinyi; Zhang, Yunxia; Zhu, Hong; Liu, Junjiang; Pumill, Chris			The Role of Prostatitis in Prostate Cancer: Meta-Analysis	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; RISK-FACTORS; CHRONIC INFLAMMATION; SELF-REPORT; CONSUMPTION; INFECTIONS; VASECTOMY; CYTOKINE; BEHAVIOR; STAT3	Objective: Use systematic review methods to quantify the association between prostatitis and prostate cancer, under both fixed and random effects model. Evidence Acquisition: Case control studies of prostate cancer with information on prostatitis history. All studies published between 1990-2012, were collected to calculate a pooled odds ratio. Selection criteria: the selection criteria are as follows: human case control studies; published from May 1990 to July 2012; containing number of prostatitis, and prostate cancer cases. Evidence Synthesis: In total, 20 case control studies were included. A significant association between prostatitis and prostate cancer was found, under both fixed effect model (pooled OR=1.50, 95%CI: 1.39-1.62), and random effects model (OR=1.64, 95%CI: 1.36-1.98). Personal interview based case control studies showed a high level of association (fixed effect model: pooled OR=1.59, 95%CI: 1.47-1.73, random effects model: pooled OR=1.87, 95%CI: 1.52-2.29), compared with clinical based studies (fixed effect model: pooled OR=1.05, 95%CI: 0.86-1.28, random effects model: pooled OR=0.98, 95%CI: 0.67-1.45). Additionally, pooled ORs, were calculated for each decade. In a fixed effect model: 1990's: OR=1.58, 95%CI: 1.35-1.84; 2000's: OR=1.59, 95%CI: 1.40-1.79; 2010's: OR=1.37, 95%CI: 1.22-1.56. In a random effects model: 1990's: OR=1.98, 95%CI: 1.08-3.62; 2000's: OR=1.64, 95%CI: 1.23-2.19; 2010's: OR=1.34, 95%CI: 1.03-1.73. Finally a meta-analysis stratified by each country was conducted. In fixed effect models, U. S: pooled OR =1.45, 95%CI: 1.34-1.57; China: pooled OR =4.67, 95%CI: 3.08-7.07; Cuba: pooled OR =1.43, 95%CI: 1.00-2.04; Italy: pooled OR =0.61, 95%CI: 0.13-2.90. In random effects model, U. S: pooled OR=1.50, 95%CI: 1.25-1.80; China: pooled OR =4.67, 95%CI: 3.08-7.07; Cuba: pooled OR =1.43, 95%CI: 1.00-2.04; Italy: pooled OR =0.61, 95%CI: 0.13-2.90. CONCLUSIONS: the present meta-analysis provides the statistical evidence that the association between prostatitis and prostate cancer is significant.	[Jiang, Junyi; Zhu, Hong] Ohio State Univ, Inst Publ Hlth, Columbus, OH 43210 USA; [Li, Jinyi] Weill Cornell Med Coll, Dept Urol, New York, NY USA; [Zhang, Yunxia; Liu, Junjiang] Hebei Gen Hosp, Dept Urol, Shijiazhuang, Peoples R China; [Pumill, Chris] Rutgers State Univ, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA	University System of Ohio; Ohio State University; Cornell University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Liu, JJ (corresponding author), Hebei Gen Hosp, Dept Urol, Shijiazhuang, Peoples R China.	junjiangliu67@gmail.com	jiang, jun/GWC-9329-2022					Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Chao C, 2010, INT J CANCER, V126, P171, DOI 10.1002/ijc.24637; Daniels Nicholas A, 2009, BMC Res Notes, V2, P57, DOI 10.1186/1756-0500-2-57; Delongchamps NB, 2008, J UROLOGY, V179, P1736, DOI 10.1016/j.juro.2008.01.034; Demaria M, 2012, ONCOTARGET, V3, P359; Dennis LK, 2002, UROLOGY, V60, P78, DOI 10.1016/S0090-4295(02)01637-0; Dite P, 2012, DIGEST DIS, V30, P277, DOI 10.1159/000336991; Evans S, 2008, INT J CANCER, V123, P430, DOI 10.1002/ijc.23500; Fernandez L, 2005, INT J EPIDEMIOL, V34, P193, DOI 10.1093/ije/dyh332; Forte V, 2012, CARDIORENAL MED, V2, P143, DOI 10.1159/000337314; Gregorio David I, 2006, Int J Health Geogr, V5, P8, DOI 10.1186/1476-072X-5-8; HIATT RA, 1994, CANCER CAUSE CONTROL, V5, P66, DOI 10.1007/BF01830728; HSING AW, 1994, CANCER EPIDEM BIOMAR, V3, P285; Huang WY, 2008, CANCER EPIDEM BIOMAR, V17, P2374, DOI 10.1158/1055-9965.EPI-08-0173; JOHN EM, 1995, J NATL CANCER I, V87, P662, DOI 10.1093/jnci/87.9.662; Ku JH, 2005, INT J ANDROL, V28, P317, DOI 10.1111/j.1365-2605.2005.00560.x; Lee MM, 1998, CANCER CAUSE CONTROL, V9, P545, DOI 10.1023/A:1008840105531; Lonkar P, 2011, INT J CANCER, V128, P1999, DOI 10.1002/ijc.25815; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Macarthur M, 2004, AM J PHYSIOL-GASTR L, V286, pG515, DOI 10.1152/ajpgi.00475.2003; Magri Vittorio, 2010, Arch Ital Urol Androl, V82, P75; Matysiak-Budnik T, 2006, EUR J CANCER, V42, P708, DOI 10.1016/j.ejca.2006.01.020; Nickel JC, 1999, UROLOGY, V54, P229, DOI 10.1016/S0090-4295(99)00205-8; OHSHIMA H, 1994, MUTAT RES, V305, P253, DOI 10.1016/0027-5107(94)90245-3; Patel DA, 2005, CANCER CAUSE CONTROL, V16, P263, DOI 10.1007/s10552-004-3486-6; Pelucchi C, 2006, EUR J CANCER PREV, V15, P254, DOI 10.1097/01.cej.0000198897.40303.d4; Ritchie JM, 2003, J OCCUP ENVIRON MED, V45, P692, DOI 10.1097/01.jom.0000071510.96740.0b; Roberts RO, 2004, EPIDEMIOLOGY, V15, P93, DOI 10.1097/01.ede.0000101022.38330.7c; Rosenblatt KA, 2001, AM J EPIDEMIOL, V153, P1152, DOI 10.1093/aje/153.12.1152; Rothman I, 2004, UROLOGY, V64, P876, DOI 10.1016/j.urology.2004.06.071; Sarma AV, 2006, J UROLOGY, V176, P1108, DOI 10.1016/j.juro.2006.04.075; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Schiller DS, 2011, AM J GERIATR PHARMAC, V9, P37, DOI 10.1016/j.amjopharm.2011.02.005; Sharp VJ, 2010, AM FAM PHYSICIAN, V82, P397; Silverberg MJ, 2011, CANCER EPIDEM BIOMAR, V20, P2551, DOI 10.1158/1055-9965.EPI-11-0777; Sutcliffe S, 2007, CANCER EPIDEM BIOMAR, V16, P1573, DOI 10.1158/1055-9965.EPI-07-0134; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tunuguntla HSGR, 2002, PROSTATE CANCER P D, V5, P172, DOI 10.1038/sj.pcan.4500604; Weinmann S, 2010, CANCER CAUSE CONTROL, V21, P117, DOI 10.1007/s10552-009-9441-9; Wright JL, 2012, CANCER-AM CANCER SOC, V118, P4437, DOI 10.1002/cncr.26653; Zhu KM, 1999, INT J EPIDEMIOL, V28, P409, DOI 10.1093/ije/28.3.409	41	48	51	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85179	10.1371/journal.pone.0085179	http://dx.doi.org/10.1371/journal.pone.0085179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391995	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900138
J	Kurrle, N; Vollner, F; Eming, R; Hertl, M; Banning, A; Tikkanen, R				Kurrle, Nina; Voellner, Frauke; Eming, Ruediger; Hertl, Michael; Banning, Antje; Tikkanen, Ritva			Flotillins Directly Interact with gamma-Catenin and Regulate Epithelial Cell-Cell Adhesion	PLOS ONE			English	Article							LIPID RAFTS; E-CADHERIN; ALPHA-CATENIN; N-CADHERIN; DESMOSOMAL CADHERINS; PLAKOGLOBIN DOMAINS; BINDING-SITES; BETA-CATENIN; ASSOCIATION; MEMBRANE	Flotillin-1 and flotillin-2 are two homologous, membrane raft associated proteins. Although it has been reported that flotillins are involved in cell adhesion processes and play a role during breast cancer progression, thus making them interesting future therapeutic targets, their precise function has not been well elucidated. The present study investigates the function of these proteins in cell-cell adhesion in non-malignant cells. We have used the non-malignant epithelial MCF10A cells to study the interaction network of flotillins within cell-cell adhesion complexes. RNA interference was used to examine the effect of flotillins on the structure of adherens junctions and on the association of core proteins, such as Ecadherin, with membrane rafts. We here show that the cadherin proteins of the adherens junction associate with flotillin-2 in MCF10A cells and in various human cell lines. In vitro, flotillin-1 and flotillin-2 directly interact with c-catenin which is so far the only protein known to be present both in the adherens junction and the desmosome. Mapping of the interaction domain within the c-catenin sequence identified the Armadillo domains 6-8, especially ARM domain 7, to be important for the association with flotillins. Furthermore, depletion of flotillins significantly influenced the morphology of the adherens junction in human epithelial MCF10A cells and altered the association of E-cadherin and c-catenin with membrane rafts. Taken together, these observations suggest a functional role for flotillins, especially flotillin-2, in cell-cell adhesion in nonmalignant epithelial cells.	[Kurrle, Nina; Voellner, Frauke; Banning, Antje; Tikkanen, Ritva] Univ Giessen, Inst Biochem, Fac Med, D-35390 Giessen, Germany; [Eming, Ruediger; Hertl, Michael] Univ Marburg, Dept Dermatol & Allergol, Marburg, Germany	Justus Liebig University Giessen; Philipps University Marburg	Tikkanen, R (corresponding author), Univ Giessen, Inst Biochem, Fac Med, D-35390 Giessen, Germany.	Ritva.Tikkanen@biochemie.med.uni-giessen.de		Tikkanen, Ritva/0000-0002-8393-1825	Behring-Rontgen Foundation [59-0012]; Deutsche Forschungsgemeinschaft (DFG) [Ti291/6-2]	Behring-Rontgen Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study has been financially supported by a grant from the von Behring-Rontgen Foundation to RT (Grant 59-0012) and by the Deutsche Forschungsgemeinschaft (DFG) grant Ti291/6-2 to RT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Banning A, 2014, CELL SIGNAL, V26, P198, DOI 10.1016/j.cellsig.2013.11.001; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Berger T, 2012, ONCOGENE; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bodrikov V, 2011, J NEUROSCI, V31, P18013, DOI 10.1523/JNEUROSCI.4729-11.2011; BOUKAMP P, 1982, JNCI-J NATL CANCER I, V68, P415; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chartier NT, 2011, EXP CELL RES, V317, P1422, DOI 10.1016/j.yexcr.2011.03.009; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chitaev NA, 1996, J CELL BIOL, V133, P359, DOI 10.1083/jcb.133.2.359; Chitaev NA, 1998, J CELL SCI, V111, P1941; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; Deininger SO, 2003, MOL CELL NEUROSCI, V22, P544, DOI 10.1016/S1044-7431(03)00028-9; Delva E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002543; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; FRANKE WW, 1983, EMBO J, V2, P2211, DOI 10.1002/j.1460-2075.1983.tb01725.x; Giehl K, 2008, FRONT BIOSCI-LANDMRK, V13, P3975, DOI 10.2741/2985; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Guillaume E, 2013, J CELL SCI; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Hazarika P, 1999, J CELL BIOCHEM, V75, P147, DOI 10.1002/(SICI)1097-4644(19991001)75:1<147::AID-JCB15>3.0.CO;2-D; Hoehne M, 2005, MOL CELL NEUROSCI, V30, P326, DOI 10.1016/j.mcn.2005.07.007; KNUDSEN KA, 1992, J CELL BIOL, V118, P671, DOI 10.1083/jcb.118.3.671; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; Misra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049766; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Obama H, 1997, J BIOL CHEM, V272, P11017; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; Pust S, 2013, ONCOGENE, V32, P3443, DOI 10.1038/onc.2012.357; Raemaekers T, 2012, EMBO J, V31, P3252, DOI 10.1038/emboj.2012.182; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; SACCO PA, 1995, J BIOL CHEM, V270, P20201, DOI 10.1074/jbc.270.34.20201; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; SCHROEDER WT, 1994, J BIOL CHEM, V269, P19983; Schulte T, 1997, DEVELOPMENT, V124, P577; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Sorkina T, 2013, TRAFFIC, V14, P709, DOI 10.1111/tra.12059; SOULE HD, 1990, CANCER RES, V50, P6075; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Taulet N, 2009, J BIOL CHEM, V284, P23137, DOI 10.1074/jbc.M109.017665; Tomasovic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029739; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; Wahl JK, 1996, J CELL SCI, V109, P1143; Witcher LL, 1996, J BIOL CHEM, V271, P10904, DOI 10.1074/jbc.271.18.10904; Yang J, 2001, EMBO J, V20, P3645, DOI 10.1093/emboj/20.14.3645; Yap AS, 1998, CANCER INVEST, V16, P252, DOI 10.3109/07357909809039774; Yaswen P, 2002, INT J BIOCHEM CELL B, V34, P1382, DOI 10.1016/S1357-2725(02)00047-X; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	71	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84393	10.1371/journal.pone.0084393	http://dx.doi.org/10.1371/journal.pone.0084393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391950	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900093
J	Napuri, J; Pilakka-Kanthikeel, S; Raymond, A; Agudelo, M; Yndart-Arias, A; Saxena, SK; Nair, M				Napuri, Jessica; Pilakka-Kanthikeel, Sudheesh; Raymond, Andrea; Agudelo, Marisela; Yndart-Arias, Adriana; Saxena, Shailendra K.; Nair, Madhavan			Cocaine Enhances HIV-1 Infectivity in Monocyte Derived Dendritic Cells by Suppressing microRNA-155	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD-BRAIN-BARRIER; TRANSCRIPTION FACTOR PU.1; DC-SIGN; T-CELLS; GENE-EXPRESSION; GM-CSF; REPLICATION; LYMPHOCYTES; IDENTIFICATION	Cocaine and other drugs of abuse increase HIV-induced immunopathogenesis; and neurobiological mechanisms of cocaine addiction implicate a key role for microRNAs (miRNAs), single-stranded non-coding RNAs that regulate gene expression and defend against viruses. In fact, HIV defends against miRNAs by actively suppressing the expression of polycistronic miRNA cluster miRNA-17/92, which encodes miRNAs including miR-20a. IFN-g production by natural killer cells is regulated by miR-155 and this miRNA is also critical to dendritic cell (DC) maturation. However, the impact of cocaine on miR-155 expression and subsequent HIV replication is unknown. We examined the impact of cocaine on two miRNAs, miR-20a and miR-155, which are integral to HIV replication, and immune activation. Using miRNA isolation and analysis, RNA interference, quantitative real time PCR, and reporter assays we explored the effects of cocaine on miR-155 and miR-20 in the context of HIV infection. Here we demonstrate using monocyte-derived dendritic cells (MDCCs) that cocaine significantly inhibited miR-155 and miR-20a expression in a dose dependent manner. Cocaine and HIV synergized to lower miR-155 and miR-20a in MDDCs by 90%. Cocaine treatment elevated LTR-mediated transcription and PU.1 levels in MDCCs. But in context of HIV infection, PU.1 was reduced in MDDCs regardless of cocaine presence. Cocaine increased DC-SIGN and and decreased CD83 expression in MDDC, respectively. Overall, we show that cocaine inhibited miR-155 and prevented maturation of MDDCs; potentially, resulting in increased susceptibility to HIV-1. Our findings could lead to the development of novel miRNA-based therapeutic strategies targeting HIV infected cocaine abusers.	[Napuri, Jessica; Pilakka-Kanthikeel, Sudheesh; Raymond, Andrea; Agudelo, Marisela; Yndart-Arias, Adriana; Nair, Madhavan] Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Pilakka-Kanthikeel, Sudheesh; Raymond, Andrea; Agudelo, Marisela; Yndart-Arias, Adriana; Nair, Madhavan] Florida Int Univ, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Pilakka-Kanthikeel, Sudheesh; Yndart-Arias, Adriana; Nair, Madhavan] Florida Int Univ, Ctr Personalized Nanomed, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Saxena, Shailendra K.] CSIR Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Nair, M (corresponding author), Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.	nairm@fiu.edu	Saxena, Shailendra K/ABK-6489-2022; Saxena, Shailendra K/X-4252-2019	Saxena, Shailendra K/0000-0003-2856-4185; Saxena, Shailendra K/0000-0003-2856-4185	National Institute of Drug Abuse [R37-DA025576]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA025576] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grant from National Institute of Drug Abuse (R37-DA025576). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; Dakic A, 2007, TRENDS IMMUNOL, V28, P108, DOI 10.1016/j.it.2007.01.006; Dominguez-Soto A, 2005, J BIOL CHEM, V280, P33123, DOI 10.1074/jbc.M503401200; Dunand-Sauthier I, 2011, BLOOD, V117, P4490, DOI 10.1182/blood-2010-09-308064; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Fiala AM, 1996, ADV EXP MED BIOL, V402, P145; Fiala M, 2005, J NEUROVIROL, V11, P281, DOI 10.1080/13550280590952835; Fiala M, 1998, ADV EXP MED BIOL, V437, P199; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fisher RC, 1998, STEM CELLS, V16, P25, DOI 10.1002/stem.160025; Ganesh L, 2004, J VIROL, V78, P11980, DOI 10.1128/JVI.78.21.11980-11987.2004; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Kiertscher SM, 1996, J LEUKOCYTE BIOL, V59, P208, DOI 10.1002/jlb.59.2.208; Kim YT, 2003, AM J REPROD IMMUNOL, V49, P230, DOI 10.1034/j.1600-0897.2003.01200.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LANGHOFF E, 1991, P NATL ACAD SCI USA, V88, P7998, DOI 10.1073/pnas.88.18.7998; LARRAT EP, 1993, J PSYCHOACTIVE DRUGS, V25, P207, DOI 10.1080/02791072.1993.10472272; Lee CL, 2009, J BIOL CHEM, V284, P15084, DOI 10.1074/jbc.M807960200; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Lodie TA, 1998, J IMMUNOL, V161, P268; MARTINEZ F, 1990, LIFE SCI, V47, pPL59, DOI 10.1016/0024-3205(90)90205-6; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; Nair MPN, 2005, J IMMUNOL, V174, P6617, DOI 10.4049/jimmunol.174.11.6617; Nair MPN, 2004, J NEUROIMMUNOL, V157, P56, DOI 10.1016/j.jneuroim.2004.08.040; Nath A, 2002, JAIDS-J ACQ IMM DEF, V31, pS62, DOI 10.1097/00126334-200210012-00006; Nishiyama C, 2004, FEBS LETT, V561, P63, DOI 10.1016/S0014-5793(04)00116-4; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Roth MD, 2002, J INFECT DIS, V185, P701, DOI 10.1086/339012; Ryo A, 2000, AIDS RES HUM RETROV, V16, P995, DOI 10.1089/08892220050058416; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schmidtmayerova H, 1998, J VIROL, V72, P4633, DOI 10.1128/JVI.72.6.4633-4642.1998; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Swaminathan G, PLOS PATHOG, V8; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Turkistany SA, 2011, ARCH IMMUNOL THER EX, V59, P431, DOI 10.1007/s00005-011-0147-9; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Vahey MT, 2002, AIDS RES HUM RETROV, V18, P179, DOI 10.1089/08892220252781239; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Yao HH, 2011, BLOOD, V117, P2538, DOI 10.1182/blood-2010-10-313593; Yeung ML, 2005, CELL RES, V15, P935, DOI 10.1038/sj.cr.7290371; Zhang L, 1998, J NEUROVIROL, V4, P619, DOI 10.3109/13550289809114228	51	36	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83682	10.1371/journal.pone.0083682	http://dx.doi.org/10.1371/journal.pone.0083682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391808	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200106
J	Nedrud, JG; Bagheri, N; Schon, K; Xin, W; Bergroth, H; Eliasson, DG; Lycke, NY				Nedrud, John G.; Bagheri, Nayer; Schon, Karin; Xin, Wei; Bergroth, Hilda; Eliasson, Dubravka Grdic; Lycke, Nils Y.			Subcomponent Vaccine Based on CTA1-DD Adjuvant with Incorporated UreB Class II Peptides Stimulates Protective Helicobacter pylori Immunity	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; UREASE-B-SUBUNIT; CHOLERA-TOXIN; MUCOSAL IMMUNIZATION; ORAL IMMUNIZATION; INDUCED REDUCTION; BALB/C MICE; MOUSE MODEL; INFECTION; IDENTIFICATION	A mucosal vaccine against Helicobacter pylori infection could help prevent gastric cancers and peptic ulcers. While previous attempts to develop such a vaccine have largely failed because of the requirement for safe and effective adjuvants or large amounts of well defined antigens, we have taken a unique approach to combining our strong mucosal CTA1-DD adjuvant with selected peptides from urease B (UreB). The protective efficacy of the selected peptides together with cholera toxin (CT) was first confirmed. However, CT is a strong adjuvant that unfortunately is precluded from clinical use because of its toxicity. To circumvent this problem we have developed a derivative of CT, the CTA1-DD adjuvant, that has been found safe in non-human primates and equally effective compared to CT when used intranasally. We genetically fused the selected peptides into the CTA1-DD plasmid and found after intranasal immunizations of Balb/c mice using purified CTA1-DD with 3 copies of an H. pylori urease T cell epitope (CTA1-UreB3T-DD) that significant protection was stimulated against a live challenge infection. Protection was, however, weaker than with the gold standard, bacterial lysate+CT, but considering that we only used a single epitope in nanomolar amounts the results convey optimism. Protection was associated with enhanced Th1 and Th17 immunity, but immunizations in IL-17A-deficient mice revealed that IL-17 may not be essential for protection. Taken together, we have provided evidence for the rational design of an effective mucosal subcomponent vaccine against H. pylori infection based on well selected protective epitopes from relevant antigens incorporated into the CTA1-DD adjuvant platform.	[Nedrud, John G.; Bagheri, Nayer; Xin, Wei] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Schon, Karin; Bergroth, Hilda; Eliasson, Dubravka Grdic; Lycke, Nils Y.] Univ Gothenburg, Mucosal Immunobiol & Vaccine Res Ctr MIVAC, Gothenburg, Sweden; [Schon, Karin; Bergroth, Hilda; Eliasson, Dubravka Grdic; Lycke, Nils Y.] Univ Gothenburg, Inst Biomed, Dept Microbiolgy & Immunol, Gothenburg, Sweden	Case Western Reserve University; University of Gothenburg; University of Gothenburg	Lycke, NY (corresponding author), Univ Gothenburg, Mucosal Immunobiol & Vaccine Res Ctr MIVAC, Gothenburg, Sweden.	nils.lycke@microbio.gu.se			US National Institutes of Health [AI 083694]; Swedish Research Council; Swedish Cancer Foundation [4992-B10 06-03XCC]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083694] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by US National Institutes of Health grant AI 083694 to JGN and NYL and Swedish Research Council, the Swedish Cancer Foundation grant 4992-B10 06-03XCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren LC, 1999, J IMMUNOL, V162, P2432; Agren LC, 1997, J IMMUNOL, V158, P3936; Akhiani AA, 2006, SCAND J IMMUNOL, V63, P97, DOI 10.1111/j.1365-3083.2005.01713.x; Akhiani AA, 2004, J IMMUNOL, V172, P5024, DOI 10.4049/jimmunol.172.8.5024; Blanchard TG, 2010, ADV M C M, P167, DOI 10.1079/9781845935948.0167; Blanchard TG, 1999, CELL IMMUNOL, V191, P74, DOI 10.1006/cimm.1998.1421; Blanchard TG, 2012, CURRENT PROTOCOLS MI, V24; CORTHESYTHEULAZ I, 1995, GASTROENTEROLOGY, V109, P115, DOI 10.1016/0016-5085(95)90275-9; Czinn SJ, 2011, NAT REV GASTRO HEPAT, V8, P133, DOI 10.1038/nrgastro.2011.1; DeLyria ES, 2011, HELICOBACTER, V16, P169, DOI 10.1111/j.1523-5378.2011.00839.x; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; Ding H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069384; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Eliasson DG, 2011, VACCINE, V29, P3951, DOI 10.1016/j.vaccine.2011.03.090; Eriksson AM, 2004, J IMMUNOL, V173, P3310, DOI 10.4049/jimmunol.173.5.3310; Ermak TH, 1998, 3 INT WORKSH PATH HO; Every AL, 2013, TRENDS MICROBIOL; Flach CF, 2011, VACCINE, V29, P1235, DOI 10.1016/j.vaccine.2010.11.088; Flach CF, 2011, INFECT IMMUN, V79, P879, DOI 10.1128/IAI.00756-10; Garhart CA, 2003, INFECT IMMUN, V71, P910, DOI 10.1128/IAI.71.2.910-921.2003; Garhart CA, 2002, INFECT IMMUN, V70, P3529, DOI 10.1128/IAI.70.7.3529-3538.2002; Gomez-Duarte OG, 1998, VACCINE, V16, P460, DOI 10.1016/S0264-410X(97)00247-8; Hirota K, 2001, INFECT IMMUN, V69, P6597, DOI 10.1128/IAI.69.11.6597-6603.2001; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lycke N, 2010, MUCOSAL IMMUNOL; Malfertheiner P, 2008, GASTROENTEROLOGY, V135, P787, DOI 10.1053/j.gastro.2008.05.054; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Marchetti M, 1998, VACCINE, V16, P33, DOI 10.1016/S0264-410X(97)00153-9; Michetti P, 1999, GASTROENTEROLOGY, V116, P804, DOI 10.1016/S0016-5085(99)70063-6; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Pappo J, 1999, INFECT IMMUN, V67, P337, DOI 10.1128/IAI.67.1.337-341.1999; Raghavan S, 2010, INFECT IMMUN, V78, P4251, DOI 10.1128/IAI.00536-10; Ruggiero P, 2003, MICROBES INFECT, V5, P749, DOI 10.1016/S1286-4579(03)00125-4; Shi Y, 2007, VACCINE, V25, P2583, DOI 10.1016/j.vaccine.2006.12.024; Smythies LE, 2005, VACCINE, V23, P901, DOI 10.1016/j.vaccine.2004.07.037; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Summerton NA, 2010, VACCINE, V28, P1404, DOI 10.1016/j.vaccine.2009.10.147; Sundling C, 2008, J GEN VIROL, V89, P2954, DOI 10.1099/vir.0.2008/005470-0; Sutton P, 2000, IMMUNOL CELL BIOL, V78, P28, DOI 10.1046/j.1440-1711.2000.00881.x; Sutton P, 2013, EXPERT REV VACCINES, V12, P433, DOI [10.1586/erv.13.20, 10.1586/ERV.13.20]; Tepes B, 2012, HELICOBACTER, V17, P36, DOI 10.1111/j.1523-5378.2012.00981.x; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; *WHO INT AG RES CA, 1994, IARC MON EV CARC RIS, P177; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yang WC, 2013, VACCINE, V31, P1204, DOI 10.1016/j.vaccine.2012.12.058; Zhao WF, 2007, VACCINE, V25, P7664, DOI 10.1016/j.vaccine.2007.08.034; Zhou WY, 2009, VACCINE, V27, P5013, DOI 10.1016/j.vaccine.2009.05.009	47	16	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83321	10.1371/journal.pone.0083321	http://dx.doi.org/10.1371/journal.pone.0083321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391754	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200051
J	Potiron, VA; Abderrahmani, R; Clement-Colmou, K; Marionneau-Lambot, S; Oullier, T; Paris, F; Supiot, S				Potiron, Vincent A.; Abderrahmani, Rym; Clement-Colmou, Karen; Marionneau-Lambot, Severine; Oullier, Thibauld; Paris, Francois; Supiot, Stephane			Improved Functionality of the Vasculature during Conventionally Fractionated Radiation Therapy of Prostate Cancer	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; TUMOR RESPONSE; HYPOFRACTIONATED RADIOTHERAPY; INDUCED APOPTOSIS; OXYGEN-TENSION; HYPOXIA; IRRADIATION; DENSITY; DAMAGE; MICE	Although endothelial cell apoptosis participates in the tumor shrinkage after single high-dose radiotherapy, little is known regarding the vascular response after conventionally fractionated radiation therapy. Therefore, we evaluated hypoxia, perfusion and vascular microenvironment changes in an orthotopic prostate cancer model of conventionally fractionated radiation therapy at clinically relevant doses (2 Gy fractions, 5 fractions/week). First, conventionally fractionated radiation therapy decreased tumor cell proliferation and increased cell death with kinetics comparable to human prostate cancer radiotherapy. Secondly, the injection of Hoechst 33342 or fluorescent-dextrans showed an increased tumor perfusion within 14 days in irradiated tumors, which was correlated with a clear reduction of hypoxia. Improved perfusion and decreased hypoxia were not explained by increased blood vessel density, size or network morphology. However, a tumor vascular maturation defined by perivascular desmin+/SMA+ cells coverage was clearly observed along with an increase in endothelial, zonula occludens (ZO)-1 positive, intercellular junctions. Our results show that, in addition to tumor cell killing, vascular maturation plays an uncovered role in tumor reoxygenation during fractionated radiation therapy.	[Potiron, Vincent A.; Abderrahmani, Rym; Clement-Colmou, Karen; Paris, Francois; Supiot, Stephane] INSERM, UMR892, Nantes, France; [Potiron, Vincent A.; Abderrahmani, Rym; Clement-Colmou, Karen; Paris, Francois; Supiot, Stephane] Univ Nantes, Nantes, France; [Potiron, Vincent A.; Abderrahmani, Rym; Clement-Colmou, Karen; Paris, Francois; Supiot, Stephane] CNRS, UMR6299, Nantes, France; [Clement-Colmou, Karen; Paris, Francois; Supiot, Stephane] Inst Cancerol Ouest, Dept Radiat Oncol, St Herblain, France; [Marionneau-Lambot, Severine; Oullier, Thibauld] Canceropole Grand Ouest, Plate Forme Vivo, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Supiot, S (corresponding author), INSERM, UMR892, Nantes, France.	stephane.supiot@ico.unicancer.fr	Marionneau-Lambot, Séverine/AAY-1452-2020; Supiot, Stéphane/M-1586-2015; Potiron, Vincent/L-6873-2015; Paris, francois E/L-4915-2015	Marionneau-Lambot, Séverine/0000-0002-5041-8531; Supiot, Stéphane/0000-0003-2094-1708; Potiron, Vincent/0000-0002-3693-6578; Paris, francois E/0000-0002-0176-7348; Clement-Colmou, Karen/0000-0003-0986-2718	Institut National du Cancer (INCA PAIR-prostate); Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer; Region Pays de Loire	Institut National du Cancer (INCA PAIR-prostate)(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Pays de Loire(Region Pays de la Loire)	This work was supported by the Institut National du Cancer (INCA PAIR-prostate 2010), the Association pour la Recherche sur le Cancer, the Ligue Nationale Contre le Cancer and the Region Pays de Loire. The funding source was not involved in the collection, analysis and interpretation of data, preparation of the manuscript and decision to publish.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Baumann M, 2001, ACTA ONCOL, V40, P519, DOI 10.1080/028418601750288262; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bonnaud S, 2007, CANCER RES, V67, P1803, DOI 10.1158/0008-5472.CAN-06-2802; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brizel DM, 1999, RADIOTHER ONCOL, V53, P113, DOI 10.1016/S0167-8140(99)00102-4; Bromfield GP, 2003, PROSTATE CANCER P D, V6, P73, DOI 10.1038/sj.pcan.4500628; Brurberg KG, 2005, RADIOTHER ONCOL, V77, P220, DOI 10.1016/j.radonc.2005.09.009; Burrell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038366; Carlson DJ, 2011, INT J RADIAT ONCOL, V79, P1188, DOI 10.1016/j.ijrobp.2010.10.007; Chen FH, 2009, CLIN CANCER RES, V15, P1721, DOI 10.1158/1078-0432.CCR-08-1471; Chen FH, 2013, INT J RAD ONCOL BIOL; Corre I, 2010, MUTAT RES-REV MUTAT, V704, P61, DOI 10.1016/j.mrrev.2010.01.014; De Bock K, 2011, CURR OPIN GENET DEV, V21, P73, DOI 10.1016/j.gde.2010.10.008; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Gabrys D, 2007, INT J RADIAT ONCOL, V69, P1553, DOI 10.1016/j.ijrobp.2007.08.039; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Imaizumi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011084; Killingsworth MC, 2011, PATHOBIOLOGY, V78, P24, DOI 10.1159/000322739; Kwak HJ, 2000, CIRCULATION, V101, P2317, DOI 10.1161/01.CIR.101.19.2317; Lan J, 2013, RADIAT RES, V179, P458, DOI 10.1667/RR3116.1; Laughlin KM, 1996, J PHARMACOL EXP THER, V277, P1049; LORD EM, 1993, CANCER RES, V53, P5721; Lyng H, 2000, INT J RADIAT ONCOL, V46, P935, DOI 10.1016/S0360-3016(99)00497-6; Maeda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042133; Martin JM, 2011, DRUGS, V71, P1019, DOI 10.2165/11591500-000000000-00000; Milosevic M, 2012, CLIN CANCER RES, V18, P2108, DOI 10.1158/1078-0432.CCR-11-2711; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Park HJ, 2012, RADIAT RES, V177, P311, DOI 10.1667/RR2773.1; Penet MF, 2009, CANCER RES, V69, P8822, DOI 10.1158/0008-5472.CAN-09-1782; Potiron VA, 2013, RADIOTHER ONCOL, V106, P138, DOI 10.1016/j.radonc.2012.11.014; Roe K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-75; Stewart GD, 2010, BJU INT, V105, P8, DOI 10.1111/j.1464-410X.2009.08921.x; Supiot S, 2013, CANCER RADIOTHER, V17, P349, DOI 10.1016/j.canrad.2013.05.005; Supiot S, 2012, CANCER RADIOTHER, V16, P11, DOI 10.1016/j.canrad.2011.10.006; Supiot S, 2008, RADIOTHER ONCOL, V88, P53, DOI 10.1016/j.radonc.2008.03.019; VANPUTTE.LM, 1968, J NATL CANCER I, V40, P441; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yaromina A, 2011, INT J RADIAT ONCOL, V80, P1205, DOI 10.1016/j.ijrobp.2011.02.015; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006; ZYWIETZ F, 1995, INT J RADIAT ONCOL, V32, P1391, DOI 10.1016/0360-3016(94)00653-3	45	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84076	10.1371/journal.pone.0084076	http://dx.doi.org/10.1371/journal.pone.0084076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391887	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900030
J	Renner, LD; Eswaramoorthy, P; Ramamurthi, KS; Weibel, DB				Renner, Lars D.; Eswaramoorthy, Prahathees; Ramamurthi, Kumaran S.; Weibel, Douglas B.			Studying Biomolecule Localization by Engineering Bacterial Cell Wall Curvature	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN LOCALIZATION; MEMBRANE CURVATURE; SHAPE; CARDIOLIPIN; DIVISION; DIVIVA; MICRODOMAINS; ORGANIZATION; CYTOSKELETON	In this article we describe two techniques for exploring the relationship between bacterial cell shape and the intracellular organization of proteins. First, we created microchannels in a layer of agarose to reshape live bacterial cells and predictably control their mean cell wall curvature, and quantified the influence of curvature on the localization and distribution of proteins in vivo. Second, we used agarose microchambers to reshape bacteria whose cell wall had been chemically and enzymatically removed. By combining microstructures with different geometries and fluorescence microscopy, we determined the relationship between bacterial shape and the localization for two different membrane-associated proteins: i) the cell-shape related protein MreB of Escherichia coli, which is positioned along the long axis of the rod-shaped cell; and ii) the negative curvature-sensing cell division protein DivIVA of Bacillus subtilis, which is positioned primarily at cell division sites. Our studies of intracellular organization in live cells of E. coli and B. subtilis demonstrate that MreB is largely excluded from areas of high negative curvature, whereas DivIVA localizes preferentially to regions of high negative curvature. These studies highlight a unique approach for studying the relationship between cell shape and intracellular organization in intact, live bacteria.	[Renner, Lars D.; Weibel, Douglas B.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Renner, Lars D.] Tech Univ Dresden, D-01062 Dresden, Germany; [Renner, Lars D.] Max Bergmann Ctr Biomat, Dresden, Germany; [Eswaramoorthy, Prahathees; Ramamurthi, Kumaran S.] NCI, NIH, Bethesda, MD 20892 USA; [Weibel, Douglas B.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Technische Universitat Dresden; Technische Universitat Dresden; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Wisconsin System; University of Wisconsin Madison	Weibel, DB (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	weibel@biochem.wisc.edu	Renner, Lars D/D-6291-2012; Eswara, Prahathees/J-2353-2019; Renner, Lars David/AAQ-2732-2021; Ramamurthi, Kumaran/P-3516-2015	Renner, Lars D/0000-0003-0178-1788; Eswara, Prahathees/0000-0003-4430-261X; 	National Science Foundation [DMR-1121288]; National Institutes of Health [1DP2OD008735-01]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; University of Wisconsin Materials Research Science and Engineering Center [DMR-1121288]; DFG; Alfred P. Sloan Foundation; NATIONAL CANCER INSTITUTE [ZIABC011211] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008735] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Wisconsin Materials Research Science and Engineering Center(National Science Foundation (NSF)); DFG(German Research Foundation (DFG)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the National Science Foundation (DMR-1121288; L. D. R., D. B. W., http://www.nsf.gov/mps/dmr/highlights.jsp), the National Institutes of Health (1DP2OD008735-01; L. D. R., D. B. W., http://www.nih.gov/), and the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (K. S. R. and P. E., http://www.nih.gov/). The authors gratefully acknowledge use of facilities and instrumentation supported by the University of Wisconsin Materials Research Science and Engineering Center (DMR-1121288, http://mrsec.wisc.edu/), and acknowledge support from a DFG Postdoctoral Fellowship (to L. D. R., http://www.dfg.de/) and an Alfred P. Sloan Foundation Fellowship (to D. B. W., http://www.sloan.org/sloan-research-fellowships/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Cartin R, 2011, P NATL ACAD SCI USA, V108, P7781, DOI 10.1073/pnas.1010427108; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Brake JM, 2003, SCIENCE, V302, P2094, DOI 10.1126/science.1091749; Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; Eswaramoorthy P, 2011, MBIO, V2, DOI 10.1128/mBio.00257-11; Foss MH, 2011, BIOCHEMISTRY-US, V50, P7719, DOI 10.1021/bi200940d; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gold VAM, 2010, P NATL ACAD SCI USA, V107, P10044, DOI 10.1073/pnas.0914680107; Handler AA, 2008, MOL MICROBIOL, V68, P588, DOI 10.1111/j.1365-2958.2008.06173.x; Heinrich M, 2010, P NATL ACAD SCI USA, V107, P7208, DOI 10.1073/pnas.0913997107; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Huang KC, 2010, MOL MICROBIOL, V76, P822, DOI 10.1111/j.1365-2958.2010.07168.x; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Landgraf D, 2012, NAT METHODS, V9, P480, DOI [10.1038/NMETH.1955, 10.1038/nmeth.1955]; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lin IH, 2011, SCIENCE, V332, P1297, DOI 10.1126/science.1195639; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; MADDOCK JR, 1993, SCIENCE, V259, P1717; Matias VRF, 2008, J BACTERIOL, V190, P7414, DOI 10.1128/JB.00581-08; Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Miller DS, 2013, SOFT MATTER, V9, P374, DOI 10.1039/c2sm26811f; Mukhopadhyay R, 2008, BIOPHYS J, V95, P1034, DOI 10.1529/biophysj.107.126920; Muralimohan A, 2009, TRENDS MICROBIOL, V17, P100, DOI 10.1016/j.tim.2008.11.007; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; SCHAEFFER P, 1976, P NATL ACAD SCI USA, V73, P2151, DOI 10.1073/pnas.73.6.2151; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sliusarenko O, 2010, P NATL ACAD SCI USA, V107, P10086, DOI 10.1073/pnas.1000737107; Strahl H, 2012, CURR OPIN MICROBIOL, V15, P731, DOI 10.1016/j.mib.2012.10.006; Swulius MT, 2012, J BACTERIOL, V194, P6382, DOI 10.1128/JB.00505-12; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; Tuson HH, 2012, MOL MICROBIOL, V84, P874, DOI 10.1111/j.1365-2958.2012.08063.x; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Wang S, 2012, P NATL ACAD SCI USA, V109, pE595, DOI 10.1073/pnas.1117132109; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; White CL, 2012, TRENDS MICROBIOL, V20, P74, DOI 10.1016/j.tim.2011.11.004; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	55	26	26	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84143	10.1371/journal.pone.0084143	http://dx.doi.org/10.1371/journal.pone.0084143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391905	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900048
J	Toth, R; Meszaros, I; Stefancsik, R; Bartha, D; Balint, A; Zadori, Z				Toth, Renata; Meszaros, Istvan; Stefancsik, Rajmund; Bartha, Daniel; Balint, Adam; Zadori, Zoltan			CpG Distribution and Methylation Pattern in Porcine Parvovirus	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; DNA METHYLATION; MUTATION-RATE; CYTOSINE METHYLATION; VIRAL PERSISTENCE; VIRUS-INFECTION; BINDING-SITES; PROTEIN; FREQUENCY; CHROMATIN	Based on GC content and the observed/expected CpG ratio (oCpGr), we found three major groups among the members of subfamily Parvovirinae: Group I parvoviruses with low GC content and low oCpGr values, Group II with low GC content and high oCpGr values and Group III with high GC content and high oCpGr values. Porcine parvovirus belongs to Group I and it features an ascendant CpG distribution by position in its coding regions similarly to the majority of the parvoviruses. The entire PPV genome remains hypomethylated during the viral lifecycle independently from the tissue of origin. In vitro CpG methylation of the genome has a modest inhibitory effect on PPV replication. The in vitro hypermethylation disappears from the replicating PPV genome suggesting that beside the maintenance DNMT1 the de novo DNMT3a and DNMT3b DNA methyltransferases can't methylate replicating PPV DNA effectively either, despite that the PPV infection does not seem to influence the expression, translation or localization of the DNA methylases. SNP analysis revealed high mutability of the CpG sites in the PPV genome, while introduction of 29 extra CpG sites into the genome has no significant biological effects on PPV replication in vitro. These experiments raise the possibility that beyond natural selection mutational pressure may also significantly contribute to the low level of the CpG sites in the PPV genome.	[Toth, Renata; Meszaros, Istvan; Bartha, Daniel; Zadori, Zoltan] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary; [Stefancsik, Rajmund] Univ Cambridge, Div Genet, FlyBase, Cambridge, England; [Balint, Adam] Vet Diagnost Directorate, Natl Food Chain Safety Off, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; University of Cambridge	Toth, R (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary.	tothrenata@vmri.hu		Stefancsik, Ray/0000-0001-8314-2140	OTKA; NKTH [Mobilitas 08-C OTKA 81187]; Hungarian Academy of Sciences [BO/00414/10]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NKTH(National Office for Research and Technology); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by OTKA and NKTH (Mobilitas 08-C OTKA 81187), the Janos Bolyai Fellowship from the Hungarian Academy of Sciences (BO/00414/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambinder RF, 1999, SEMIN CANCER BIOL, V9, P369, DOI 10.1006/scbi.1999.0137; Ballestar E, 2011, ADV EXP MED BIOL, V711, P1; BERGERON J, 1993, VIROLOGY, V197, P86, DOI 10.1006/viro.1993.1569; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bonvicini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033316; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; BURNETT TS, 1984, NUCLEIC ACIDS RES, V12, P8847, DOI 10.1093/nar/12.23.8847; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Caiafa P, 2005, J CELL BIOCHEM, V94, P257, DOI 10.1002/jcb.20325; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; CHORBA T, 1986, J INFECT DIS, V154, P383, DOI 10.1093/infdis/154.3.383; COOPER DN, 1985, CELL DIFFER DEV, V17, P199, DOI 10.1016/0045-6039(85)90488-9; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; DANOS O, 1980, EUR J BIOCHEM, V109, P457, DOI 10.1111/j.1432-1033.1980.tb04815.x; Davison AJ, 2006, J GEN VIROL, V87, P3509, DOI 10.1099/vir.0.82291-0; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; DUNNE HW, 1965, AM J VET RES, V26, P1284; EHRLICH M, 1986, BIOSCIENCE REP, V6, P387, DOI 10.1007/BF01116426; Filipovska-Naumovska E, 2010, J AM ASSOC LAB ANIM, V49, P443; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; FORD JP, 1980, J BIOL CHEM, V255, P7544; Foulongne V, 2006, EMERG INFECT DIS, V12, P862, DOI 10.3201/eid1205.051523; Gagnon CA, 2007, CAN VET J, V48, P811; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRADIL CM, 1990, J VET MED B, V37, P309, DOI 10.1111/j.1439-0450.1990.tb01063.x; GUNTHERT U, 1976, P NATL ACAD SCI USA, V73, P3923, DOI 10.1073/pnas.73.11.3923; Harte RA, 2012, TRACKING COORDINATIN; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jung JK, 2007, CANCER RES, V67, P5771, DOI 10.1158/0008-5472.CAN-07-0529; KISARY J, 1978, AVIAN PATHOL, V7, P397, DOI 10.1080/03079457808418293; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Leger A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020881; Leonard S, 2011, J VIROL, V85, P9568, DOI 10.1128/JVI.00468-11; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Linden RM, 1996, P NATL ACAD SCI USA, V93, P11288, DOI 10.1073/pnas.93.21.11288; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; Luo Juan, 2012, Frontiers in Genetics, V3, P20, DOI 10.3389/fgene.2012.00020; Lyko F, 2001, TRENDS GENET, V17, P169, DOI 10.1016/S0168-9525(01)02234-X; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Mattei LM, 2013, J VIROL, V87, P3605, DOI 10.1128/JVI.03155-12; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MOLITOR TW, 1984, VIROLOGY, V137, P241, DOI 10.1016/0042-6822(84)90216-2; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Nachman MW, 2000, GENETICS, V156, P297; Penaud-Budloo M, 2008, J VIROL, V82, P7875, DOI 10.1128/JVI.00649-08; Pringle IA, 2005, GENE THER, V12, P1206, DOI 10.1038/sj.gt.3302518; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Rothenfusser S, 2001, EUR J IMMUNOL, V31, P3525, DOI 10.1002/1521-4141(200112)31:12<3525::AID-IMMU3525>3.0.CO;2-5; Schildgen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068020; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Shao G, 2013, IN VITRO CELL DEV-AN, V49, P386, DOI 10.1007/s11626-013-9619-z; Simmons R, 2011, J INFECT DIS, V203, P1378, DOI 10.1093/infdis/jir036; Stucker KM, 2012, J VIROL, V86, P1514, DOI 10.1128/JVI.06222-11; Takahashi M, 2013, BIOCHEM BIOPH RES CO, V434, P873, DOI 10.1016/j.bbrc.2013.04.041; Tao Q, 2003, CLIN IMMUNOL, V109, P53, DOI 10.1016/S1521-6616(03)00198-0; Tattersall P., 2006, PARVOVIRUSES, P5; VANLEENGOED LA, 1983, VET QUART, V5, P131, DOI 10.1080/01652176.1983.9693887; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WIENHUES U, 1985, J VIROL, V56, P320, DOI 10.1128/JVI.56.1.320-324.1985; WINOCOUR E, 1965, VIROLOGY, V27, P156, DOI 10.1016/0042-6822(65)90155-8; Xia JF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S7; Zadori Z, 2005, J VIROL, V79, P13129, DOI 10.1128/JVI.79.20.13129-13138.2005; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; Zeisberg EM, 2013, J PATHOL, V229, P264, DOI 10.1002/path.4120	76	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85986	10.1371/journal.pone.0085986	http://dx.doi.org/10.1371/journal.pone.0085986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392033	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900177
J	Naya, L; Paul, S; Valdes-Lopez, O; Mendoza-Soto, AB; Nova-Franco, B; Sosa-Valencia, G; Reyes, JL; Hernandez, G				Naya, Loreto; Paul, Sujay; Valdes-Lopez, Oswaldo; Mendoza-Soto, Ana B.; Nova-Franco, Barbara; Sosa-Valencia, Guadalupe; Reyes, Jose L.; Hernandez, Georgina			Regulation of Copper Homeostasis and Biotic Interactions by MicroRNA 398b in Common Bean	PLOS ONE			English	Article							FERRIC-CHELATE REDUCTASE; PHASEOLUS-VULGARIS; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; SCLEROTINIA-SCLEROTIORUM; DIFFERENTIAL REGULATION; PLANT MICRORNAS; DOWN-REGULATION; ARABIDOPSIS; IDENTIFICATION	MicroRNAs are recognized as important post-transcriptional regulators in plants. Information about the roles of miRNAs in common bean (Phaseolus vulgaris L.), an agronomically important legume, is yet scant. The objective of this work was to functionally characterize the conserved miRNA: miR398b and its target Cu/Zn Superoxide Dismutase 1 (CSD1) in common bean. We experimentally validated a novel miR398 target: the stress up-regulated Nodulin 19 (Nod19). Expression analysis of miR398b and target genes -CSD1 and Nod19- in bean roots, nodules and leaves, indicated their role in copper (Cu) homeostasis. In bean plants under Cu toxicity miR398b was decreased and Nod19 and CSD1, that participates in reactive oxygen species (ROS) detoxification, were up-regulated. The opposite regulation was observed in Cu deficient bean plants; lower levels of CSD1 would allow Cu delivery to essential Cu-containing proteins. Composite common bean plants with transgenic roots over-expressing miR398 showed ca. 20-fold higher mature miR398b and almost negligible target transcript levels as well as increased anthocyanin content and expression of Cu-stress responsive genes, when subjected to Cu deficiency. The down-regulation of miR398b with the consequent up-regulation of its targets was observed in common bean roots during the oxidative burst resulting from short-time exposure to high Cu. A similar response occurred at early stage of bean roots inoculated with Rhizobium tropici, where an increase in ROS was observed. In addition, the miR398b down-regulation and an increase in CSD1 and Nod19 were observed in bean leaves challenged with Sclerotinia scleortiorum fungal pathogen. Transient over-expression of miR398b in Nicotiana benthamiana leaves infected with S. sclerotiorum resulted in enhanced fungal lesions. We conclude that the miR398b-mediated up-regulation of CSD and Nod19 is relevant for common bean plants to cope with oxidative stress generated in abiotic and biotic stresses.	[Naya, Loreto; Paul, Sujay; Valdes-Lopez, Oswaldo; Mendoza-Soto, Ana B.; Nova-Franco, Barbara; Hernandez, Georgina] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico; [Valdes-Lopez, Oswaldo] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Lab Bioquim, Tlalnepantla, Estado Mexico, Mexico; [Sosa-Valencia, Guadalupe; Reyes, Jose L.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Hernandez, G (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico.	gina@ccg.unam.mx	Paul, Sujay/R-7572-2019; Reyes, Jose/D-7331-2013; Valdés-López, Oswaldo/K-8695-2019; SOSA-VALENCIA, GUADALUPE/F-8071-2019	Valdés-López, Oswaldo/0000-0002-4760-048X; Mendoza Soto, Ana Belen/0000-0002-9184-1424; Reyes, Jose L./0000-0001-5129-9741; Paul, Sujay/0000-0001-5024-7261; SOSA-VALENCIA, GUADALUPE/0000-0002-7178-3271	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM [PAPIIT IN202213]	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM. Grant no. PAPIIT IN202213 and Postdoctoral Scholarships to LN and SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aparicio-Fabre R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-26; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Baron C, 1995, ANNU REV GENET, V29, P107, DOI 10.1146/annurev.ge.29.120195.000543; Beauclair L, 2010, PLANT J, V62, P454, DOI 10.1111/j.1365-313X.2010.04162.x; BONGUEBARTELSMAN M, 1995, PLANT PHYSIOL BIOCH, V33, P539; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Bouazizi H, 2010, ECOTOX ENVIRON SAFE, V73, P1304, DOI 10.1016/j.ecoenv.2010.05.014; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Cardenas L, 2008, PLANT J, V56, P802, DOI 10.1111/j.1365-313X.2008.03644.x; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cuypers A, 2005, J PLANT PHYSIOL, V162, P383, DOI 10.1016/j.jplph.2004.07.018; Cuypers A, 2000, PHYSIOL PLANTARUM, V110, P512, DOI 10.1111/j.1399-3054.2000.1100413.x; De Luis A, 2012, PLANT PHYSIOL, V160, P2137, DOI 10.1104/pp.112.204883; Doss RP, 2005, PLANT PHYSIOL BIOCH, V43, P225, DOI 10.1016/j.plaphy.2005.01.016; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; ELNENNAH M, 1982, PLANT SOIL, V65, P289, DOI 10.1007/BF02374660; Estrada-Navarrete G, 2007, NAT PROTOC, V2, P1819, DOI 10.1038/nprot.2007.259; FERNANDES JC, 1991, BOT REV, V57, P246, DOI 10.1007/BF02858564; FRANCO AA, 1982, PLANT SOIL, V66, P149, DOI 10.1007/BF02183974; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; Ganesan V, 2001, PLANT SCI, V160, P1095, DOI 10.1016/S0168-9452(01)00327-2; Giusti M. M., 2001, CURR PROTOC FOOD ANA, V00, DOI DOI 10.1002/0471142913.FAF0102S00; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guan QM, 2013, PLANT J, V74, P840, DOI 10.1111/tpj.12169; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim HJ, 2011, APPL ENVIRON MICROB, V77, P7721, DOI 10.1128/AEM.05472-11; Kimura M, 2003, PHOTOCHEM PHOTOBIOL, V77, P226, DOI 10.1562/0031-8655(2003)077&lt;0226:IOAGRB&gt;2.0.CO;2; Kuo HF, 2011, PLANT PHYSIOL, V156, P1016, DOI 10.1104/pp.111.175265; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Liang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048951; Mandon K, 2009, SIGNAL COMMUN PLANTS, P135, DOI 10.1007/978-3-642-00390-5_8; Marschner H., 2002, MINERAL NUTR HIGHER; Moreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016463; Mukherjee I, 2006, PLANTA, V223, P1178, DOI 10.1007/s00425-005-0165-0; OLDENKAM.L, 1966, PLANT SOIL, V25, P150, DOI 10.1007/BF01347969; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; Paul S, 2014, J INTEGR PLANT BIOL, V56, P15, DOI 10.1111/jipb.12115; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Perea-Garcia A, 2013, PLANT PHYSIOL, V162, P180, DOI 10.1104/pp.112.212407; Puig S, 2007, PLANT CELL ENVIRON, V30, P271, DOI 10.1111/j.1365-3040.2007.01642.x; PURDY LH, 1979, PHYTOPATHOLOGY, V69, P875, DOI 10.1094/Phyto-69-875; Ramu SK, 2002, MOL PLANT MICROBE IN, V15, P522, DOI 10.1094/MPMI.2002.15.6.522; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Santos R, 2001, MOL PLANT MICROBE IN, V14, P86, DOI 10.1094/MPMI.2001.14.1.86; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Sgherri C, 2007, J PLANT PHYSIOL, V164, P1152, DOI 10.1016/j.jplph.2006.05.020; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Valdes Lopez O, 2011, PLANT PHYSIOL, V157, P1975; Valdes-Lopez O, 2008, PLANT CELL ENVIRON, V31, P1834, DOI 10.1111/j.1365-3040.2008.01883.x; Valdes-Lopez O, 2010, NEW PHYTOL, V187, P805, DOI 10.1111/j.1469-8137.2010.03320.x; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Zhang WX, 2011, PLANT MOL BIOL, V75, P93, DOI 10.1007/s11103-010-9710-8; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhou J, 2013, J EXP BOT, V64, P3261, DOI 10.1093/jxb/ert166; Zhou ZS, 2008, CHEMOSPHERE, V70, P1500, DOI 10.1016/j.chemosphere.2007.08.028; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x	79	81	86	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84416	10.1371/journal.pone.0084416	http://dx.doi.org/10.1371/journal.pone.0084416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400089	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700023
J	Kemp, A; Preen, DB; Saunders, C; Boyle, F; Bulsara, M; Holman, CDJ; Malacova, E; Roughead, EE				Kemp, Anna; Preen, David B.; Saunders, Christobel; Boyle, Frances; Bulsara, Max; Holman, C. D'Arcy J.; Malacova, Eva; Roughead, Elizabeth E.			Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice	PLOS ONE			English	Article								Background: Australian clinical guidelines recommend endocrine therapy for all women with hormone-dependent early breast cancer. Guidelines specify tamoxifen as first-line therapy for pre-menopausal women, and tamoxifen or an aromatase inhibitor (AI) for post-menopausal women depending on the risk of recurrence based on tumour characteristics including size. Therapies have different side effect profiles; therefore comorbidity may also influence choice. We examined comorbidity, and the clinical and demographic characteristics of women commencing different therapies. Patients and Methods: We identified the first dispensing of tamoxifen, anastrozole or letrozole for women diagnosed with invasive breast cancer in the 45 and Up Study from 2004-2009 (N=1266). Unit-level pharmacy and medical service claims, hospital, Cancer Registry, and self-reported data were linked to determine menopause status at diagnosis, tumour size, age, comorbidities, and change in subsidy restrictions. Chi-square tests and generalised regression models were used to compare the characteristics of women commencing different therapies. Results: Most pre-menopausal women commenced therapy with tamoxifen (91%). Anastrozole was the predominant therapy for post-menopausal women (57%), followed by tamoxifen (28%). Women with osteoporosis were less likely to commence anastrozole compared with tamoxifen (anastrozole RR=0.7, 95% CI=0.5-0.9). Women with arthritis were 1.6-times more likely to commence letrozole than anastrozole (95% CI=1.1-2.1). Tamoxifen was more often initiated in women with tumours >1 cm, who were also >= 75 years. Subsidy restriction changes were associated with substantial increases in the proportion of women commencing AIs (anastrozole RR=4.3, letrozole RR=8.3). Conclusions: The findings indicate interplay of comorbidity and therapy choice for women with invasive breast cancer. Most post-menopausal women commenced therapy with anastrozole; however, letrozole and tamoxifen were more often initiated for women with comorbid arthritis and osteoporosis, respectively. Tamoxifen was also more common for women with tumours >1 cm and aged >= 75 years. Subsidy restrictions appear to have strongly influenced therapy choice.	[Kemp, Anna; Preen, David B.; Holman, C. D'Arcy J.; Malacova, Eva] Univ Western Australia, Ctr Hlth Serv Res, Perth, WA 6009, Australia; [Saunders, Christobel] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Boyle, Frances] Mater Hosp, Patricia Richie Ctr Canc Care & Res, Sydney, NSW, Australia; [Bulsara, Max] Univ Notre Dame, Inst Hlth Res, Perth, WA, Australia; [Holman, C. D'Arcy J.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	University of Western Australia; University of Western Australia; University of Notre Dame Australia; University of South Australia	Kemp, A (corresponding author), Univ Western Australia, Ctr Hlth Serv Res, Perth, WA 6009, Australia.	anna.kemp@uwa.edu.au	Kemp-Casey, Anna/AAU-7292-2021; Preen, David B/H-5663-2014; Saunders, Christobel M/H-5779-2014; Kemp-Casey, Anna/F-1283-2013; Roughead, Elizabeth E/G-4431-2010	Kemp-Casey, Anna/0000-0002-0018-962X; Preen, David B/0000-0002-2982-2169; Saunders, Christobel M/0000-0003-2281-9829; Kemp-Casey, Anna/0000-0002-0018-962X; Roughead, Elizabeth E/0000-0002-6811-8991	Cancer Australia; National Breast Cancer Foundation [Priority-driven Collaborative Cancer Research Scheme] [1011488]; Medical Research Council [MR/K006525/1] Funding Source: researchfish; MRC [MR/K006525/1] Funding Source: UKRI	Cancer Australia; National Breast Cancer Foundation [Priority-driven Collaborative Cancer Research Scheme]; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was jointly-funded by Cancer Australia and the National Breast Cancer Foundation [Priority-driven Collaborative Cancer Research Scheme 1011488 to AK, DBP, CS, MB, CDJH, and EER]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro M, 2006, BREAST, V15, pS30, DOI 10.1016/j.breast.2006.01.005; ALBAIN K, 2002, LANCET, V359, P1925; Amir E, 2011, JNCI-J NATL CANCER I, V103, P1299, DOI 10.1093/jnci/djr242; *AUSTR GOB DEP HLT, 2006, GOV FUNDS NEW BREAST; *AUSTR GOV DEP HLT, 2013, AB PBS; *AUSTR GOV DEP HLT, 2013, FEES PAT CONTR SAF N; *AUSTR GOV DEP HLT, 2005, PUBL SUMM DOC AN TAB; *AUSTR POP MIGR RE, 2013, ACC REM IND AUSTR AR; Australian Bureau of Statistics, 2003, INF PAP CENS POP HOU; Australian Government Department of Health and Ageing, 2013, SCHED PHARM BEN; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Boccardo F, 2005, J CLIN ONCOL, V23, P5138, DOI 10.1200/JCO.2005.04.120; Briot K, 2010, BREAST CANCER RES TR, V120, P127, DOI 10.1007/s10549-009-0692-7; *CANC I NEW S WAL, 2013, LAT PUBL; Cancer Institute New South Wales, 2013, NSW CENTR CANC REG D; *CHEREL, 2009, INF RES; Cheung KL, 2007, BREAST, V16, P327, DOI 10.1016/j.breast.2007.03.004; Chlebowski RT, 2008, BREAST, V17, pS9, DOI 10.1016/j.breast.2007.12.003; Clarke M, 1998, LANCET, V351, P1451; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; DEVOS FYF, CRIT REV ONCOL HEMAT, V84, P252; Hernandez RK, 2008, CANCER EPIDEM BIOMAR, V17, P2509, DOI 10.1158/1055-9965.EPI-08-0570; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; KEMP A, 2013, BMC MED RES METHODOL, V13, DOI DOI 10.1186/1471-2288-1113-1117; National Breast Cancer Centre (NBCC), 2001, CLIN PRACT GUID MAN; *NBCC, 2006, REC AR INH ADJ END T; Niravath P, 2013, ANN ONCOL, V24, P1443, DOI 10.1093/annonc/mdt037; *SAX I, 2013, RES TOOLK; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; World Health Organization, 2001, INT CLASS DIS ONC; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	32	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84835	10.1371/journal.pone.0084835	http://dx.doi.org/10.1371/journal.pone.0084835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392158	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000329460100081
J	Johnson, CM; Fisher, DJ				Johnson, Cayla M.; Fisher, Derek J.			Site-Specific, Insertional Inactivation of incA in Chlamydia trachomatis Using a Group II Intron	PLOS ONE			English	Article							PROTEIN; GENOME; TRANSFORMATION; INFECTIONS; INCLUSIONS; MUTANTS	Chlamydia trachomatis is an obligate, intracellular bacterial pathogen that has until more recently remained recalcitrant to genetic manipulation. However, the field still remains hindered by the absence of tools to create selectable, targeted chromosomal mutations. Previous work with mobile group II introns demonstrated that they can be retargeted by altering DNA sequences within the intron's substrate recognition region to create site-specific gene insertions. This platform (marketed as TargeTron (TM), Sigma) has been successfully employed in a variety of bacteria. We subsequently modified TargeTron (TM) for use in C. trachomatis and as proof of principle used our system to insertionally inactivate incA, a chromosomal gene encoding a protein required for homotypic fusion of chlamydial inclusions. C. trachomatis incA::GII(bla) mutants were selected with ampicillin and plaque purified clones were then isolated for genotypic and phenotypic analysis. PCR, Southern blotting, and DNA sequencing verified proper GII(bla) insertion, while continuous passaging in the absence of selection demonstrated that the insertion was stable. As seen with naturally occurring IncA(-) mutants, light and immunofluorescence microscopy confirmed the presence of non-fusogenic inclusions in cells infected with the incA::GII(bla) mutants at a multiplicity of infection greater than one. Lack of IncA production by mutant clones was further confirmed by Western blotting. Ultimately, the ease of retargeting the intron, ability to select for mutants, and intron stability in the absence of selection makes this method a powerful addition to the growing chlamydial molecular toolbox.	[Johnson, Cayla M.; Fisher, Derek J.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Fisher, DJ (corresponding author), So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA.	fisher@micro.siu.edu		Fisher, Derek/0000-0002-1663-8389	SIU	SIU	Research was supported by internal funds to DJF and an SIU Master's Fellowship to CMJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Akhtar P, 2012, PLASMID, V67, P111, DOI 10.1016/j.plasmid.2011.12.012; Banks J, 1970, INFECT IMMUN, V1, P259; Binet R, 2009, P NATL ACAD SCI USA, V106, P292, DOI 10.1073/pnas.0806768106; Cheng CM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003171; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Cui XX, 2007, FRONT BIOSCI-LANDMRK, V12, P4972, DOI 10.2741/2442; Darville T, 2013, ADV EXP MED BIOL, V764, P109, DOI 10.1007/978-1-4614-4726-9_8; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Enyeart PJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.41; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Fields KA, 2002, INFECT IMMUN, V70, P3816, DOI 10.1128/IAI.70.7.3816-3823.2002; Fisher DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046052; Gerard HC, 2013, NANOMEDICINE; Gong S, 2013, J BACTERIOL; Gupta Phaguni, 2008, V435, P217, DOI 10.1007/978-1-59745-232-8_16; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Kannan RM, 2013, MICROB PATHOGENESIS, V65, P29, DOI 10.1016/j.micpath.2013.08.003; Kari L, 2011, P NATL ACAD SCI USA, V108, P7189, DOI 10.1073/pnas.1102229108; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Longbottom D, 2006, VET J, V171, P263, DOI 10.1016/j.tvjl.2004.09.006; Mueller KE, 2013, INFECT IMMUN; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Pannekoek Y, 2005, J CLIN MICROBIOL, V43, P2441, DOI 10.1128/JCM.43.5.2441-2443.2005; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Rodriguez SA, 2009, METHODS, V49, P270, DOI 10.1016/j.ymeth.2009.04.011; Ronzone E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069769; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Suchland RJ, 2000, INFECT IMMUN, V68, P360, DOI 10.1128/IAI.68.1.360-367.2000; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Wickstrum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076743; Xu Shuang, 2013, BMC Res Notes, V6, P377, DOI 10.1186/1756-0500-6-377; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706	42	80	83	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83989	10.1371/journal.pone.0083989	http://dx.doi.org/10.1371/journal.pone.0083989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391860	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900003
J	Muthumani, K; Wise, MC; Broderick, KE; Hutnick, N; Goodman, J; Flingai, S; Yan, J; Bian, CB; Mendoza, J; Tingey, C; Wilson, C; Wojtak, K; Sardesai, NY; Weiner, DB				Muthumani, Kar; Wise, Megan C.; Broderick, Kate E.; Hutnick, Natalie; Goodman, Jonathan; Flingai, Seleeke; Yan, Jian; Bian, Chaoran B.; Mendoza, Janess; Tingey, Colleen; Wilson, Christine; Wojtak, Krzysztof; Sardesai, Niranjan Y.; Weiner, David B.			HIV-1 Env DNA Vaccine plus Protein Boost Delivered by EP Expands B- and T-Cell Responses and Neutralizing Phenotype In Vivo	PLOS ONE			English	Article							IMMUNE-RESPONSES; NONHUMAN-PRIMATES; ANTIBODY-RESPONSE; RHESUS MACAQUES; SUBTYPE-B; ENVELOPE; IMMUNOGENICITY; VIRUS; ELECTROPORATION; PROTECTION	An effective HIV vaccine will most likely require the induction of strong T-cell responses, broadly neutralizing antibodies (bNAbs), and the elicitation of antibody-dependent cellular cytotoxicity (ADCC). Previously, we demonstrated the induction of strong HIV/SIV cellular immune responses in macaques and humans using synthetic consensus DNA immunogens delivered via adaptive electroporation (EP). However, the ability of this improved DNA approach to prime for relevant antibody responses has not been previously studied. Here, we investigate the immunogenicity of consensus DNA constructs encoding gp140 sequences from HIV-1 subtypes A, B, C and D in a DNA prime-protein boost vaccine regimen. Mice and guinea pigs were primed with single-and multi-clade DNA via EP and boosted with recombinant gp120 protein. Sera were analyzed for gp120 binding and induction of neutralizing antibody activity. Immunization with recombinant Env protein alone induced low-titer binding antibodies with limited neutralization breath. In contrast, the synthetic DNA prime-protein boost protocol induced significantly higher antibody binding titers. Furthermore, sera from DNA prime-protein boost groups were able to neutralize a broader range of viruses in a panel of tier 1 clade B viruses as well as multiple tier 1 clade A and clade C viruses. Further investigation of synthetic DNA prime plus adaptive EP plus protein boost appears warranted.	[Muthumani, Kar; Wise, Megan C.; Hutnick, Natalie; Goodman, Jonathan; Flingai, Seleeke; Bian, Chaoran B.; Tingey, Colleen; Wilson, Christine; Wojtak, Krzysztof; Weiner, David B.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Broderick, Kate E.; Yan, Jian; Mendoza, Janess; Sardesai, Niranjan Y.] Inovio Pharmaceut Inc, Blue Bell, PA USA	University of Pennsylvania	Muthumani, K (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA.	muthuman@mail.med.upenn.edu	Muthumani, Kar/C-8252-2017; Weiner, David B/H-8579-2014; Muthumani, Karuppiah/D-1092-2009; Muthumani, Kar/AAQ-4939-2020	Muthumani, Kar/0000-0002-6807-2065; Muthumani, Kar/0000-0002-6807-2065; Sardesai, Niranjan/0000-0001-6920-1167; WOJTAK, KRZYSZTOF/0000-0002-7834-2946	National Institutes of Health including NIH-CFAR, NIAIDS-HVDDT [HHSN272200800063C]; NIH-NIAID-HIVRAD; National Institutes of Health-Center For Aids Research [-5-P30-AI-045008-13]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	National Institutes of Health including NIH-CFAR, NIAIDS-HVDDT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIAID-HIVRAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health-Center For Aids Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants funded through the National Institutes of Health including NIH-CFAR, NIAIDS-HVDDT (HHSN272200800063C to Inovio Pharmaceuticals, Inc.) and NIH-NIAID-HIVRAD. KM was supported by the National Institutes of Health-Center For Aids Research training supplemental Grant -5-P30-AI-045008-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagarazzi ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004414; Boyer JD, 2007, P NATL ACAD SCI USA, V104, P18648, DOI 10.1073/pnas.0709198104; Broderick KE, 2011, GENE THER, V18, P258, DOI 10.1038/gt.2010.137; Brown SA, 2003, J IMMUNOL, V171, P4140, DOI 10.4049/jimmunol.171.8.4140; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; Donnelly JJ, 2002, SCIENCE, V297, P1277, DOI 10.1126/science.297.5585.1277; Fagone P, 2011, GENE THER, V18, P1070, DOI 10.1038/gt.2011.59; Hirao LA, 2011, J INFECT DIS, V203, P95, DOI 10.1093/infdis/jiq017; Hirao LA, 2010, MOL THER, V18, P1568, DOI 10.1038/mt.2010.112; HORAL P, 1991, J VIROL, V65, P2718, DOI 10.1128/JVI.65.5.2718-2723.1991; Hutnick NA, 2012, HUM GENE THER; Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kent SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000331; Korber B, 2011, SCIENCE, V333, P1589, DOI 10.1126/science.1211919; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Kuhs KAL, 2012, MOL THER, V20, P669, DOI 10.1038/mt.2011.188; Kumar S, 2006, DNA CELL BIOL, V25, P383, DOI 10.1089/dna.2006.25.383; Kutzler MA, 2010, GENE THER, V17, P72, DOI 10.1038/gt.2009.112; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Laddy DJ, 2009, J VIROL, V83, P4624, DOI 10.1128/JVI.02335-08; Letvin NL, 2007, J VIROL, V81, P12368, DOI 10.1128/JVI.00822-07; Mallilankaraman K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000928; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2006, NATURE, V441, P161, DOI 10.1038/441161a; Moir S, 2011, NAT STRUCT MOL BIOL, V18, P1317, DOI 10.1038/nsmb.2194; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Morrow MP, 2010, MOL THER, V18, P1714, DOI 10.1038/mt.2010.118; Muthumani K, 2005, BLOOD, V106, P2059, DOI 10.1182/blood-2005-03-0932; Muthumani K, 2003, VIROLOGY, V314, P134, DOI 10.1016/S0042-6822(03)00459-8; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; Muthumani K, 2011, J IMMUNOL, V187, P2932, DOI 10.4049/jimmunol.1100594; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shedlock DJ, 2011, VACCINE, V29, P6755, DOI 10.1016/j.vaccine.2010.12.064; Shedlock DJ, 2009, NAT REV IMMUNOL, V9, P717, DOI 10.1038/nri2636; Spearman P, 2011, J INFECT DIS, V203, P1165, DOI 10.1093/infdis/jiq175; Wang SX, 2006, VIROLOGY, V350, P34, DOI 10.1016/j.virol.2006.02.032; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yan J, 2008, VACCINE, V26, P5210, DOI 10.1016/j.vaccine.2008.03.069; Yan J, 2007, MOL THER, V15, P411, DOI 10.1038/sj.mt.6300036; Yan J, 2011, VACCINE, V29, P7173, DOI 10.1016/j.vaccine.2011.05.076; Yan J, 2009, VACCINE, V27, P3260, DOI 10.1016/j.vaccine.2009.01.065; Yin JM, 2011, VACCINE, V29, P6763, DOI 10.1016/j.vaccine.2010.12.055; Yin JM, 2009, VIROLOGY, V393, P49, DOI 10.1016/j.virol.2009.07.017; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	50	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84234	10.1371/journal.pone.0084234	http://dx.doi.org/10.1371/journal.pone.0084234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391921	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900064
J	Nelson-Mora, J; Prieto-Sagredo, J; Loredo-Ranjel, R; Fanjul-Moles, ML				Nelson-Mora, Janikua; Prieto-Sagredo, Julio; Loredo-Ranjel, Rosaura; Luisa Fanjul-Moles, Maria			Putative Pacemakers in the Eyestalk and Brain of the Crayfish Procambarus clarkii Show Circadian Oscillations in Levels of mRNA for Crustacean Hyperglycemic Hormone	PLOS ONE			English	Article							SINUS GLAND COMPLEX; ABSOLUTE QUANTIFICATION; ASTACUS-LEPTODACTYLUS; NERVOUS-SYSTEM; CHH; ISOFORMS; LOCALIZATION; CELLS; OSMOREGULATION; MODULATION	Crustacean hyperglycemic hormone (CHH) synthesizing cells in the optic lobe, one of the pacemakers of the circadian system, have been shown to be present in crayfish. However, the presence of CHH in the central brain, another putative pacemaker of the multi-oscillatory circadian system, of this decapod and its circadian transcription in the optic lobe and brain have yet to be explored. Therefore, using qualitative and quantitative PCR, we isolated and cloned a CHH mRNA fragment from two putative pacemakers of the multi-oscillatory circadian system of Procambarus clarkii, the optic lobe and the central brain. This CHH transcript synchronized to daily light-dark cycles and oscillated under dark, constant conditions demonstrating statistically significant daily and circadian rhythms in both structures. Furthermore, to investigate the presence of the peptide in the central brain of this decapod, we used immunohistochemical methods. Confocal microscopy revealed the presence of CHH-IR in fibers and cells of the protocerebral and tritocerebal clusters and neuropiles, particularly in some neurons located in clusters 6, 14, 15 and 17. The presence of CHH positive neurons in structures of P. clarkii where clock proteins have been reported suggests a relationship between the circadian clockwork and CHH. This work provides new insights into the circadian regulation of CHH, a pleiotropic hormone that regulates many physiological processes such as glucose metabolism and osmoregulatory responses to stress.	[Nelson-Mora, Janikua; Prieto-Sagredo, Julio; Loredo-Ranjel, Rosaura; Luisa Fanjul-Moles, Maria] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Lab Neurofisiol Comparada, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Fanjul-Moles, ML (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Lab Neurofisiol Comparada, Mexico City 04510, DF, Mexico.	mfajul@gmail.com		fanjul-Moles, maria Luisa/0000-0003-2927-0154	PAPIIT,UNAM [IN218811]; Conacyt [178526]	PAPIIT,UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support was provided by PAPIIT,UNAM IN218811 and Conacyt 178526 to ML Fanjul-Moles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouna A, 2003, GEN COMP ENDOCR, V131, P134, DOI 10.1016/S0016-6480(02)00645-7; Bocking D, 2002, CRUSTACEAN NERVOUS SYSTEM, P84; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang ES, 1999, J COMP NEUROL, V414, P50; Chen SH, 2004, MAR BIOTECHNOL, V6, P83, DOI 10.1007/s10126-003-0014-8; Chen SH, 2005, MAR BIOTECHNOL, V7, P193, DOI 10.1007/s10126-004-0020-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEKLEIJN DPV, 1995, BBA-GENE STRUCT EXPR, V1260, P62, DOI 10.1016/0167-4781(94)00173-Z; Dircksen H, 2001, BIOCHEM J, V356, P159, DOI 10.1042/0264-6021:3560159; Escamilla-Chimal EG, 2002, GEN COMP ENDOCR, V125, P283, DOI 10.1006/gcen.2001.7752; Escamilla-Chimal EG, 2010, J EXP BIOL, V213, P3723, DOI 10.1242/jeb.047548; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Fanjul-Moles ML, 2003, MICROSC RES TECHNIQ, V60, P291, DOI 10.1002/jemt.10268; Giulianini PG, 2002, CELL TISSUE RES, V307, P243, DOI 10.1007/s00441-001-0484-9; GORGELSKALLEN JL, 1985, CELL TISSUE RES, V241, P361, DOI 10.1007/BF00217181; GORGELSKALLEN JL, 1981, J MORPHOL, V170, P347, DOI 10.1002/jmor.1051700306; KALLEN JL, 1990, BIOL BULL-US, V179, P351, DOI 10.2307/1542327; Kallen JL, 1988, ASPECTS RECENTS BIOL, V8, P105; KELLER R, 1985, AM ZOOL, V25, P207; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Fanjul-Moles ML, 2010, CHRONOBIOL INT, V27, P34, DOI 10.3109/07420520903398526; MARTIN G, 1984, GEN COMP ENDOCR, V55, P217, DOI 10.1016/0016-6480(84)90104-7; Martin G., 1988, Society for Experimental Biology Seminar Series, P79; NUSSBAUM T, 1995, PHILOS T R SOC B, V347, P139, DOI 10.1098/rstb.1995.0018; Ollivaux C, 2000, EUR J BIOCHEM, V267, P5106, DOI 10.1046/j.1432-1327.2000.01574.x; SANDEMAN D, 1992, BIOL BULL, V183, P304, DOI 10.2307/1542217; Sellars MJ, 2007, J BIOTECHNOL, V129, P391, DOI 10.1016/j.jbiotec.2007.01.029; Serrano L, 2004, J HISTOCHEM CYTOCHEM, V52, P1129, DOI 10.1369/jhc.4A6292.2004; Serrano L, 2003, J EXP BIOL, V206, P979, DOI 10.1242/jeb.00178; Soyez D, 1997, ANN NY ACAD SCI, V814, P319, DOI 10.1111/j.1749-6632.1997.tb46174.x; Strauss J, 2010, FRONT BIOSCI-LANDMRK, V15, P1040, DOI 10.2741/3661; TENSEN CP, 1991, NEUROSCI LETT, V124, P178, DOI 10.1016/0304-3940(91)90088-B; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138	35	12	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83937	10.1371/journal.pone.0083937	http://dx.doi.org/10.1371/journal.pone.0083937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391849	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200147
J	Pasin, L; Greco, T; Feltracco, P; Vittorio, A; Neto, CN; Cabrini, L; Landoni, G; Finco, G; Zangrillo, A				Pasin, Laura; Greco, Teresa; Feltracco, Paolo; Vittorio, Annalisa; Neto, Caetano Nigro; Cabrini, Luca; Landoni, Giovanni; Finco, Gabriele; Zangrillo, Alberto			Dexmedetomidine as a Sedative Agent in Critically Ill Patients: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							INTENSIVE-CARE; POSTOPERATIVE SEDATION; INFLAMMATORY RESPONSES; CARDIAC-SURGERY; PROPOFOL; MIDAZOLAM; INFUSION; DELIRIUM	Introduction: The effect of dexmedetomidine on length of intensive care unit (ICU) stay and time to extubation is still unclear. Materials and Methods: Pertinent studies were independently searched in BioMedCentral, PubMed, Embase, and the Cochrane Central Register of clinical trials (updated February first 2013). Randomized studies (dexmedetomidine versus any comparator) were included if including patients mechanically ventilated in an intensive care unit (ICU). Co-primary endpoints were the length of ICU stay (days) and time to extubation (hours). Secondary endpoint was mortality rate at the longest follow-up available. Results: The 27 included manuscripts (28 trials) randomized 3,648 patients (1,870 to dexmedetomidine and 1,778 to control). Overall analysis showed that the use of dexmedetomidine was associated with a significant reduction in length of ICU stay (weighted mean difference (WMD) = -0.79 [-1.17 to -0.40] days, p for effect <0.001) and of time to extubation (WMD = -2.74 [-3.80 to -1.65] hours, p for effect <0.001). Mortality was not different between dexmedetomidine and controls (risk ratio = 1.00 [0.84 to 1.21], p for effect = 0.9). High heterogeneity between included studies was found. Conclusions: This meta-analysis of randomized controlled studies suggests that dexmedetomidine could help to reduce ICU stay and time to extubation, in critically ill patients even if high heterogeneity between studies might confound the interpretation of these results.	[Pasin, Laura; Greco, Teresa; Vittorio, Annalisa; Neto, Caetano Nigro; Cabrini, Luca; Landoni, Giovanni; Zangrillo, Alberto] Ist Sci San Raffaele, Anesthesia & Intens Care Dept, I-20132 Milan, Italy; [Feltracco, Paolo] Univ Hosp Padua, Dept Pharmacol & Anesthesiol, Padua, Italy; [Landoni, Giovanni] Outcomes Res Consortium, Cleveland, OH USA; [Finco, Gabriele] Univ Cagliari, Dept Med Sci M Aresu, Cagliari, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Cagliari	Landoni, G (corresponding author), Ist Sci San Raffaele, Anesthesia & Intens Care Dept, I-20132 Milan, Italy.	landoni.giovanni@hsr.it	Giovanni, Landoni/AAH-1881-2019; Neto, Caetano Nigro/M-4649-2016; Finco, Gabriele/AAH-1697-2022; Zangrillo, Alberto/AAH-2037-2019; Finco, Gabriele/AFL-9587-2022; Pasin, Laura/AAA-8188-2020	Giovanni, Landoni/0000-0002-8594-5980; Neto, Caetano Nigro/0000-0001-8134-3440; Finco, Gabriele/0000-0002-3059-9865; Zangrillo, Alberto/0000-0002-7687-7648; Finco, Gabriele/0000-0002-3059-9865; Pasin, Laura/0000-0001-5757-4791				Abd Aziz N, 2011, INT J CLIN PHARM-NET, V33, P150, DOI 10.1007/s11096-011-9480-7; AHO M, 1993, J CLIN ANESTH, V5, P194, DOI 10.1016/0952-8180(93)90014-6; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Biondi-Zoccai G, 2011, HEART LUNG VESSEL, V3, P161; Chorney SR, 2013, HEART LUNG VESSEL, V5, P17; Corbett SM, 2005, CRIT CARE MED, V33, P940, DOI 10.1097/01.CCM.0000162565.18193.E5; Elbaradie Samia, 2004, J Egypt Natl Canc Inst, V16, P153; Esmaolglu A, 2009, J CRIT CARE, V24, P551, DOI 10.1016/j.jcrc.2009.02.001; Gertler R, 2001, Proc (Bayl Univ Med Cent), V14, P13; Guo TZ, 1996, ANESTHESIOLOGY, V84, P873, DOI 10.1097/00000542-199604000-00015; Herr DL, 2003, J CARDIOTHOR VASC AN, V17, P576, DOI 10.1016/S1053-0770(03)00200-3; Huupponen E, 2008, ACTA ANAESTH SCAND, V52, P289, DOI 10.1111/j.1399-6576.2007.01537.x; Iirola T, 2011, CRIT CARE, V15, DOI 10.1186/cc10518; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Khalil MA, 2013, SEMIN CARDIOTHORAC V, V17, P66, DOI 10.1177/1089253212463969; Leino K, 2011, BMC ANESTHESIOL, V11, DOI 10.1186/1471-2253-11-9; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maldonado JR, 2009, PSYCHOSOMATICS, V50, P206, DOI 10.1176/appi.psy.50.3.206; Martin Eike, 2003, J Intensive Care Med, V18, P29, DOI 10.1177/0885066602239122; Memis D, 2007, BRIT J ANAESTH, V98, P550, DOI 10.1093/bja/aem017; Memis D, 2006, EUR J ANAESTH, V23, P700, DOI 10.1017/S0265021506000512; Memis D, 2009, J CRIT CARE, V24, P603, DOI 10.1016/j.jcrc.2008.10.005; Menda F, 2010, ANN CARD ANAESTH, V13, P16, DOI 10.4103/0971-9784.58829; Morsch RD, 2005, CRITICAL CARE, V9, pP111; Ozkan N, 2007, GOGUS KALP DAMAR ANE, V13, P161; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Paris A, 2005, CURR OPIN ANESTHESIO, V18, P412, DOI 10.1097/01.aco.0000174958.05383.d5; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Reade MC, 2009, CRIT CARE, V13, DOI 10.1186/cc7890; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Ruokonen E, 2009, INTENS CARE MED, V35, P282, DOI 10.1007/s00134-008-1296-0; Sahin N, 2005, EUR J ANAESTH, V22, P40; Shehabi Y, 2009, ANESTHESIOLOGY, V111, P1075, DOI 10.1097/ALN.0b013e3181b6a783; TALKE P, 1995, ANESTHESIOLOGY, V82, P620, DOI 10.1097/00000542-199503000-00003; Tan JA, 2010, INTENS CARE MED, V36, P926, DOI 10.1007/s00134-010-1877-6; Tasdogan M, 2009, J CLIN ANESTH, V21, P394, DOI 10.1016/j.jclinane.2008.10.010; Terao Y, 2012, J ANESTH, V26, P179, DOI 10.1007/s00540-011-1300-7; Triltsch AE, 2002, CRIT CARE MED, V30, P1007, DOI 10.1097/00003246-200205000-00009; Venn RM, 2001, BRIT J ANAESTH, V87, P684, DOI 10.1093/bja/87.5.684; Wan Lin-jun, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P543; Yao Li, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P632; Yazbek-Karam Vanda G., 2006, Middle East Journal of Anesthesiology, V18, P1043	43	35	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82913	10.1371/journal.pone.0082913	http://dx.doi.org/10.1371/journal.pone.0082913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391726	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200023
J	Schilcher, G; Schlagenhauf, A; Schneditz, D; Scharnagl, H; Ribitsch, W; Krause, R; Rosenkranz, AR; Stojakovic, T; Horina, JH				Schilcher, Gernot; Schlagenhauf, Axel; Schneditz, Daniel; Scharnagl, Hubert; Ribitsch, Werner; Krause, Robert; Rosenkranz, Alexander R.; Stojakovic, Tatjana; Horina, Joerg H.			Ethanol Causes Protein Precipitation-New Safety Issues for Catheter Locking Techniques	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HOME PARENTERAL-NUTRITION; CENTRAL VENOUS CATHETERS; HEPARIN LOCK; THERAPY; PREVENTION; CITRATE; COMPLICATIONS; COMPATIBILITY; ERADICATION	Objective: The ethanol lock technique has shown great potential to eradicate organisms in biofilms and to treat or prevent central venous catheter related infections. Following instillation of ethanol lock solution, however, the inherent density gradient between blood and ethanol causes gravity induced seepage of ethanol out of the catheter and blood influx into the catheter. Plasma proteins so are exposed to highly concentrated ethanol, which is a classic agent for protein precipitation. We aimed to investigate the precipitating effect of ethanol locks on plasma proteins as a possible cause for reported catheter occlusions. Methods: Plasma samples were exposed in-vitro to ethanol (concentrations ranging from 7 to 70 v/v%) and heparin lock solutions. In catheter studies designed to mimic different in-vivo situations, the catheter tip was placed in a plasma reservoir and the material contained within the catheter was analyzed after ethanol lock instillation. The samples underwent standardized investigation for protein precipitation. Results: Protein precipitation was observed in plasma samples containing ethanol solutions above a concentration of 28%, as well as in material retrieved from vertically positioned femoral catheters and jugular (subclavian) catheters simulating recumbent or head down tilt body positions. Precipitates could not be re-dissolved by dilution with plasma, urokinase or alteplase. Plasma samples containing heparin lock solutions showed no signs of precipitation. Conclusions: Our in-vitro results demonstrate that ethanol locks may be associated with plasma protein precipitation in central venous catheters. This phenomenon could be related to occlusion of vascular access devices locked with ethanol, as has been reported. Concerns should be raised regarding possible complications upon injection or spontaneous gravity induced leakage of such irreversibly precipitated protein particles into the systemic circulation. We suggest limiting the maximum advisable concentration of ethanol to 28 v/v% in catheter lock solutions.	[Schilcher, Gernot; Ribitsch, Werner; Rosenkranz, Alexander R.; Horina, Joerg H.] Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Graz, Austria; [Schlagenhauf, Axel] Med Univ Graz, Dept Gen Pediat & Adolescent Med, Graz, Austria; [Schneditz, Daniel] Med Univ Graz, Inst Physiol, Graz, Austria; [Scharnagl, Hubert; Stojakovic, Tatjana] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Krause, Robert] Med Univ Graz, Dept Internal Med, Sect Infect Dis & Trop Med, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Schilcher, G (corresponding author), Med Univ Graz, Dept Internal Med, Clin Div Nephrol, Graz, Austria.	gernot.schilcher@medunigraz.at	Schlagenhauf, Axel/AAK-9598-2021; Schneditz, Daniel/E-6580-2010	Schlagenhauf, Axel/0000-0003-3408-6415; Schneditz, Daniel/0000-0002-0124-1012				Agharazii M, 2005, NEPHROL DIAL TRANSPL, V20, P1238, DOI 10.1093/ndt/gfh841; ARONSON JK, 1981, BRIT MED J, V282, P288, DOI 10.1136/bmj.282.6260.288; Balestrino D, 2009, NEPHROL DIAL TRANSPL, V24, P3204, DOI 10.1093/ndt/gfp187; Blackwood RA, 2011, PEDIATR INFECT DIS J, V30, P1105, DOI 10.1097/INF.0b013e31822c84a4; Broom J, 2008, SCAND J INFECT DIS, V40, P399, DOI 10.1080/00365540701756953; Burrows PE, 2004, J VASC INTERV RADIOL, V15, P431, DOI 10.1097/01.RVI.0000124949.24134.CF; Chambers ST, 2007, J ANTIMICROB CHEMOTH, V59, P779, DOI 10.1093/jac/dkl542; CHI LM, 1991, BIOCHIM BIOPHYS ACTA, V1062, P46, DOI 10.1016/0005-2736(91)90333-4; Cober MP, 2011, JPEN-PARENTER ENTER, V35, P67, DOI 10.1177/0148607110362758; COHN EJ, 1947, J AM CHEM SOC, V69, P1753, DOI 10.1021/ja01199a051; Dannenberg C, 2003, J PEDIAT HEMATOL ONC, V25, P616, DOI 10.1097/00043426-200308000-00006; Davenport A, 2012, NEPHROL DIAL TRANSPL, V27, P2621, DOI 10.1093/ndt/gfs274; Doorenbos CJ, 2006, NEPHROL DIAL TRANSPL, V21, P543, DOI 10.1093/ndt/gfi331; Dotson B, 2010, AM J HEALTH-SYST PH, V67, P1195, DOI 10.2146/ajhp090505; Droste JC, 2003, J ANTIMICROB CHEMOTH, V51, P849, DOI 10.1093/jac/dkg179; HINGHOFERSZALKAY H, 1980, BIOMED TECH, V25, P151, DOI 10.1515/bmte.1980.25.6.151; Hoang V, 2008, PEDIATRICS, V121, pE1152, DOI 10.1542/peds.2007-1962; Huang EY, 2011, J PEDIATR SURG, V46, P2000, DOI 10.1016/j.jpedsurg.2011.06.017; JOHNSTON DA, 1992, CLIN NUTR, V11, P97, DOI 10.1016/0261-5614(92)90018-L; Kanji S, 2010, CRIT CARE MED, V38, P1890, DOI 10.1097/CCM.0b013e3181e8adcc; Karaaslan H, 2001, NEPHROL DIAL TRANSPL, V16, P2072, DOI 10.1093/ndt/16.10.2072; Kayton ML, 2010, J PEDIATR SURG, V45, P1961, DOI 10.1016/j.jpedsurg.2010.05.014; Laird J, 2005, J INFECTION, V51, P338, DOI 10.1016/j.jinf.2005.02.009; Maiefski M, 2009, INFECT CONT HOSP EP, V30, P1096, DOI 10.1086/606162; Mellanby J, 1907, J PHYSIOL-LONDON, V36, P288; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Metcalf SCL, 2004, J INFECTION, V49, P20, DOI 10.1016/j.jinf.2003.08.010; Mouw E, 2008, J PEDIATR SURG, V43, P1025, DOI 10.1016/j.jpedsurg.2008.02.026; Niyyar VD, 2012, SEMIN DIALYSIS, V25, P693, DOI 10.1111/j.1525-139X.2011.00991.x; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Oliveira C, 2012, PEDIATRICS, V129, P318, DOI 10.1542/peds.2011-1602; Opilla MT, 2007, JPEN-PARENTER ENTER, V31, P302, DOI 10.1177/0148607107031004302; ORourke MF., 1990, MCDONALDS BLOOD FLOW, P12; PENNINGTON CR, 1987, JPEN-PARENTER ENTER, V11, P507, DOI 10.1177/0148607187011005507; Polaschegg HD, 2008, BLOOD PURIFICAT, V26, P255, DOI 10.1159/000123706; Polaschegg HD, 2012, ARTIF ORGANS, V36, P824, DOI 10.1111/j.1525-1594.2012.01466.x; Polaschegg HD, 2005, ASAIO J, V51, P230, DOI 10.1097/01.MAT.0000159742.15560.93; Qu Y, 2009, J MED MICROBIOL, V58, P442, DOI 10.1099/jmm.0.006387-0; Rajpurkar M, 2009, HAEMOPHILIA, V15, P1267, DOI 10.1111/j.1365-2516.2009.02075.x; Rasmussen RL, 2010, SEMIN DIALYSIS, V23, P648, DOI 10.1111/j.1525-139X.2010.00802.x; Rayner HC, 2010, SEMIN DIALYSIS, V23, P6, DOI 10.1111/j.1525-139X.2009.00675.x; Rimon U, 2004, EUR J RADIOL, V52, P283, DOI 10.1016/j.ejrad.2003.09.010; Rosenblatt J, 2013, ANTIMICROB AGENTS CH; Saad TF, 1999, AM J KIDNEY DIS, V34, P1114, DOI 10.1016/S0272-6386(99)70018-1; Sanders J, 2008, J ANTIMICROB CHEMOTH, V62, P809, DOI 10.1093/jac/dkn284; Schilcher G, 2012, NEPHROL DIAL TRANSPL, V27, P2953, DOI 10.1093/ndt/gfs048; Scopes RK, 1994, PROTEIN PURIFICATION, P85; Sherertz RJ, 2006, ANTIMICROB AGENTS CH, V50, P1865, DOI 10.1128/AAC.50.5.1865-1868.2006; Slobbe L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010840; Sovinz P, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e104; Thomson PC, 2011, CLIN NEPHROL, V75, P212, DOI 10.5414/CN106460; Wales PW, 2011, J PEDIATR SURG, V46, P951, DOI 10.1016/j.jpedsurg.2011.02.036; Weast R.C, 1974, HDB CHEM PHYS, V55; Willicombe MK, 2010, AM J KIDNEY DIS, V55, P348, DOI 10.1053/j.ajkd.2009.06.037; Wolf J, 2013, PEDIATR BLOOD CANCER, V60, P18, DOI 10.1002/pbc.24249; Wong T, 2012, JPEN-PARENTER ENTER, V36, P358, DOI 10.1177/0148607111414713; Yevzlin AS, 2007, SEMIN DIALYSIS, V20, P351, DOI 10.1111/j.1525-139X.2007.00294.x	57	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84869	10.1371/journal.pone.0084869	http://dx.doi.org/10.1371/journal.pone.0084869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391979	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900122
J	Sere, MG; Tortosa, P; Chabanet, P; Turquet, J; Quod, JP; Schleyer, MH				Sere, Mathieu G.; Tortosa, Pablo; Chabanet, Pascale; Turquet, Jean; Quod, Jean-Pascal; Schleyer, Michael H.			Bacterial Communities Associated with Porites White Patch Syndrome (PWPS) on Three Western Indian Ocean (WIO) Coral Reefs	PLOS ONE			English	Article							BLACK BAND DISEASE; SP NOV.; BUILDING CORALS; STONY CORALS; PACIFIC; HEALTHY; VIBRIOS	The scleractinian coral Porites lutea, an important reef-building coral on western Indian Ocean reefs (WIO), is affected by a newly-reported white syndrome (WS) the Porites white patch syndrome (PWPS). Histopathology and culture-independent molecular techniques were used to characterise the microbial communities associated with this emerging disease. Microscopy showed extensive tissue fragmentation generally associated with ovoid basophilic bodies resembling bacterial aggregates. Results of 16S rRNA sequence analysis revealed a high variability between bacterial communities associated with PWPS-infected and healthy tissues in P. lutea, a pattern previously reported in other coral diseases such as black band disease (BBD), white band disease (WBD) and white plague diseases (WPD). Furthermore, substantial variations in bacterial communities were observed at the different sampling locations, suggesting that there is no strong bacterial association in Porites lutea on WIO reefs. Several sequences affiliated with potential pathogens belonging to the Vibrionaceae and Rhodobacteraceae were identified, mainly in PWPS-infected coral tissues. Among them, only two ribotypes affiliated to Shimia marina (NR043300.1) and Vibrio hepatarius (NR025575.1) were consistently found in diseased tissues from the three geographically distant sampling localities. The role of these bacterial species in PWPS needs to be tested experimentally.	[Sere, Mathieu G.; Turquet, Jean; Quod, Jean-Pascal] Agence Rech & Valorisat Marines ARVAM, Ste Clotilde, Reunion, France; [Sere, Mathieu G.; Schleyer, Michael H.] Oceanog Res Inst ORI, Durban, Kwazulu Natal, South Africa; [Sere, Mathieu G.; Chabanet, Pascale] Inst Rech Dev IRD, Ste Clotilde, Reunion, France; [Tortosa, Pablo] Ctr Rech & Veille Malad Emergentes Ocean Indien C, Ste Clotilde, Reunion, France; [Tortosa, Pablo] Univ Reunion Isl, Ste Clotilde, Reunion, France	Institut de Recherche pour le Developpement (IRD); University of La Reunion	Sere, MG (corresponding author), Agence Rech & Valorisat Marines ARVAM, Ste Clotilde, Reunion, France.	mathieu.sere@gmail.com	Chabanet, Pascale/L-9470-2017; Séré, Geoffroy/ABA-7697-2021	Séré, Geoffroy/0000-0003-4310-6115; Chabanet, Pascale/0000-0001-7600-943X; Tortosa, Pablo/0000-0002-7928-7264; Schleyer, Michael/0000-0002-7578-8168	European Union (EU, FEDER); Regional Council of Reunion; French Ministry of Higher Education and Research (DRRT); French Department of Ecology, Sustainable Development, Transportation and Housing (DEAL); South African Association for Marine Biological research (SAAMBR); French Ministry of Overseas (MOM); Western Indian Ocean Marine Science Association(WIOMSA)	European Union (EU, FEDER); Regional Council of Reunion; French Ministry of Higher Education and Research (DRRT); French Department of Ecology, Sustainable Development, Transportation and Housing (DEAL); South African Association for Marine Biological research (SAAMBR); French Ministry of Overseas (MOM); Western Indian Ocean Marine Science Association(WIOMSA)	This work was co-funded by the European Union (EU, FEDER), the Regional Council of Reunion, the French Ministry of Higher Education and Research (DRRT), the French Department of Ecology, Sustainable Development, Transportation and Housing (DEAL), the South African Association for Marine Biological research (SAAMBR), the French Ministry of Overseas (MOM) and the Western Indian Ocean Marine Science Association(WIOMSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda MDM, 2010, DIS AQUAT ORGAN, V90, P93, DOI 10.3354/dao02222; Austin B, 2005, ENVIRON MICROBIOL, V7, P1488, DOI 10.1111/j.1462-2920.2005.00847.x; Austin B, 2010, VET MICROBIOL, V140, P310, DOI 10.1016/j.vetmic.2009.03.015; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Bayer T, 2013, MAR ECOL PROG SER, V479, P75, DOI 10.3354/meps10197; Benzoni F, 2010, CORAL REEFS, V29, P153, DOI 10.1007/s00338-009-0571-z; Boyett H. V, 2006, THESIS; Bythell J, 2004, CORAL HEALTH AND DISEASE, P351; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cho SH, 2008, J MICROBIOL, V46, P325, DOI 10.1007/s12275-008-0015-4; Cole AJ, 2009, CORAL REEFS, V28, P207, DOI 10.1007/s00338-008-0415-2; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Cunning J, 2009, P 11 INT COR REEF S, V7, P206; Daneshvar MI, 2003, J CLIN MICROBIOL, V41, P1289, DOI 10.1128/JCM.41.3.1289-1294.2003; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Galloway S.B., 2007, COR DIS HLTH WORKSH; Gil-Agudelo DL, 2007, CAN J MICROBIOL, V53, P465, DOI 10.1139/W07-002; Godwin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044243; Jensen S, 2010, FEMS MICROBIOL ECOL, V74, P523, DOI 10.1111/j.1574-6941.2010.00981.x; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Luna GM, 2010, ENV MICROBIOL REP, V2, P120, DOI 10.1111/j.1758-2229.2009.00114.x; Miyazaki M, 2008, INT J SYST EVOL MICR, V58, P2815, DOI 10.1099/ijs.0.65826-0; Mohamed A.R., 2012, PROC 12 INT CORAL RE; Myers JL, 2007, APPL ENVIRON MICROB, V73, P5173, DOI 10.1128/AEM.00900-07; Nishijima M, 2013, INT J SYST EVOL MICR, V63, P709, DOI 10.1099/ijs.0.042077-0; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Ravindran J, 1999, CURR SCI INDIA, V76, P233; Roder C., 2013, INT SOC MICROBIAL EC, V1751-7362, P1; Sere MG, 2012, CORAL REEFS, P1; Shafir S, 2008, CORAL REEFS, V27, P379, DOI 10.1007/s00338-008-0353-z; Sudek M, 2012, J INVERTEBRATE PATHO; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweet MJ, 2011, CORAL REEFS, V30, P39, DOI 10.1007/s00338-010-0695-1; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Thompson FL, 2003, INT J SYST EVOL MICR, V53, P1495, DOI 10.1099/ijs.0.02658-0; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; Veron J.E.N., 2000, CORALS WORLD, V1-3; Voss JD, 2007, MICROB ECOL, V54, P730, DOI 10.1007/s00248-007-9234-1; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Wilkinson CR, 2004, GLOBAL CORAL REEF MO, V1, P7; Wilson B, 2012, FEMS MICROBIOL ECOL, V80, P509, DOI 10.1111/j.1574-6941.2012.01319.x; Work TM, 2011, J INVERTEBR PATHOL, V107, P127, DOI 10.1016/j.jip.2011.03.009	50	52	54	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83746	10.1371/journal.pone.0083746	http://dx.doi.org/10.1371/journal.pone.0083746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391819	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200117
J	Sturdivant, SK; Brush, MJ; Diaz, RJ				Sturdivant, Samuel Kersey; Brush, Mark J.; Diaz, Robert J.			Modeling the Effect of Hypoxia on Macrobenthos Production in the Lower Rappahannock River, Chesapeake Bay, USA	PLOS ONE			English	Article							CLAM MACOMA-BALTHICA; BEHAVIORAL-RESPONSES; OXYGEN DEPLETION; DISSOLVED-OXYGEN; EUTROPHICATION; POPULATION; DYNAMICS; WATER; CONSEQUENCES; POLYCHAETE	Hypoxia in Chesapeake Bay has substantially increased in recent decades, with detrimental effects on macrobenthic production; the production of these fauna link energy transfer from primary consumers to epibenthic and demersal predators. As such, the development of accurate predictive models that determine the impact of hypoxia on macrobenthic production is important. A continuous-time, biomass-based model was developed for the lower Rappahannock River, a Bay tributary prone to seasonal hypoxia. Phytoplankton, zooplankton, and macrobenthic state variables were modeled, with a focus on quantitatively constraining the effect of hypoxia on macrobenthic biomass. This was accomplished through regression with Z': a sigmoidal function between macrobenthic biomass and dissolved oxygen concentration, derived using macrobenthic data collected from the Rappahannock River during the summers of 2007 and 2008, and applied to compute hypoxia-induced mortality as a rate process. The model was verified using independent monitoring data collected by the Chesapeake Bay Program. Simulations showed that macrobenthic biomass was strongly linked to dissolved oxygen concentrations, with fluctuations in biomass related to the duration and severity of hypoxia. Our model demonstrated that hypoxia negatively affected macrobenthic biomass, as longer durations of hypoxia and greater hypoxic severity resulted in an increasing loss in biomass. This exercise represents an important contribution to modeling anthropogenically impacted coastal ecosystems, by providing an empirically constrained relationship between hypoxia and macrobenthic biomass, and applying that empirical relationship in a mechanistic model to quantify the effect of the severity, duration, and frequency of hypoxia on benthic biomass dynamics.	[Sturdivant, Samuel Kersey] Duke Univ, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC USA; [Brush, Mark J.; Diaz, Robert J.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	Duke University; William & Mary; Virginia Institute of Marine Science	Sturdivant, SK (corresponding author), Duke Univ, Div Marine Sci & Conservat, Nicholas Sch Environm, Beaufort, NC USA.	kersey.sturdivant@duke.edu			Virginia DEQ; National Oceanic and Atmospheric Administration [NA05NOS4781202]; National Science Foundation; Directorate For Geosciences [0914525] Funding Source: National Science Foundation	Virginia DEQ; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Virginia DEQ funded the benthic monitoring program in the lower Bay. Support for this work was provided by National Oceanic and Atmospheric Administration grant NA05NOS4781202, a National Science Foundation funded Hall-Bonner Fellowship, and a National Oceanic and Atmospheric Administration Graduate Sciences Program fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bonnet MP, 2001, ECOL MODEL, V141, P19, DOI 10.1016/S0304-3800(00)00434-8; Brante A, 2001, MAR ECOL PROG SER, V209, P301, DOI 10.3354/meps209301; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brush MJ, 2010, ECOL MODEL, V221, P1065, DOI 10.1016/j.ecolmodel.2009.11.002; Calvo LMR, 2001, J SHELLFISH RES, V20, P231; Cerco C.F., 2004, 90304004 US EPA CHES; Cerco CF, 2007, ESTUAR COAST, V30, P331, DOI 10.1007/BF02700175; CERCO CF, 1993, J ENVIRON ENG-ASCE, V119, P1006, DOI 10.1061/(ASCE)0733-9372(1993)119:6(1006); Chesapeake Bay Program, 2010, CHES BAY PROGR CHES; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Dauer DM, 2003, ENVIRON MONIT ASSESS, V81, P175, DOI 10.1023/A:1021329108568; DAUER DM, 1992, ESTUARIES, V15, P384, DOI 10.2307/1352785; Day J.W., 1989, ESTUARINE ECOLOGY; De Robertis A, 2001, MAR ECOL PROG SER, V219, P221, DOI 10.3354/meps219221; Diaz, 1990, PERSPECTIVES CHESAPE, V1990, P25; Diaz R.J., 1992, SCI TOTAL ENVIRON, V1992, P1055; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; FONG PP, 1991, J EXP MAR BIOL ECOL, V149, P177, DOI 10.1016/0022-0981(91)90044-W; FRITHSEN JB, 1986, OPHELIA, V25, P169, DOI 10.1080/00785326.1986.10429748; Fulford RS, 2007, MAR ECOL PROG SER, V336, P43, DOI 10.3354/meps336043; Garber JH, 1987, PERSPECTIVES CHESAPE; Hagy JD, 2004, ESTUARIES, V27, P634, DOI 10.1007/BF02907650; HARDEGE JD, 1990, MAR BIOL, V104, P291, DOI 10.1007/BF01313270; Haven DS., 1972, GEOL SOC AM MEM, V133, P121, DOI [10.1130/MEM133-p121, DOI 10.1130/MEM133-P121]; HydroQual, 2000, DEV SUSP FEED DEP FE; JORGENSEN BB, 1980, OIKOS, V34, P68, DOI 10.2307/3544551; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kremer J.N., 1978, COASTAL MARINE ECOSY; KUO AY, 1987, ESTUARIES, V10, P277, DOI 10.2307/1351884; KUO AY, 1991, ESTUARIES, V14, P113, DOI 10.2307/1351684; Laidler J.K., 1987, CHEM KINETICS, V3; LEVIN LA, 1994, AM ZOOL, V34, P323; LEVIN LA, 1990, ECOLOGY, V71, P2191, DOI 10.2307/1938632; LLANSO RJ, 1992, ESTUAR COAST SHELF S, V35, P491, DOI 10.1016/S0272-7714(05)80027-7; Long WC, 2008, MAR ECOL PROG SER, V362, P59, DOI 10.3354/meps07395; Luo JG, 2001, ESTUARIES, V24, P545, DOI 10.2307/1353256; Marcus NH, 2004, J EXP MAR BIOL ECOL, V301, P111, DOI 10.1016/j.jembe.2003.09.016; Mayfield SM, 1988, THESIS TEXAS A M U C; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Nestlerode JA, 1998, MAR ECOL PROG SER, V172, P185, DOI 10.3354/meps172185; Neubauer JR, 1993, THESIS COLL WILLIAM; Newcombe CL, 1939, J MAR RES, V2, P87, DOI 10.1357/002224039806673855; Nilsen M, 2006, MAR ECOL PROG SER, V321, P67, DOI 10.3354/meps321067; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; OFFICER CB, 1984, SCIENCE, V223, P22, DOI 10.1126/science.223.4631.22; Park KO, 1996, ESTUAR COAST SHELF S, V42, P563, DOI 10.1006/ecss.1996.0037; PIHL L, 1991, MAR BIOL, V108, P349, DOI 10.1007/BF01313644; Powers SP, 2001, COAST EST S, V58, P185; PRYOR WA, 1975, GEOL SOC AM BULL, V86, P1244, DOI 10.1130/0016-7606(1975)86<1244:BSAAOA>2.0.CO;2; Rabalais NN., 2004, SEA IDEAOBSERVATIO, P819; Rhodes D., 1982, ANIMAL SEDIMENT RELA, P3, DOI DOI 10.1007/978-1-4757-1317-6; Riedel B, 2008, J EXP MAR BIOL ECOL, V367, P17, DOI 10.1016/j.jembe.2008.08.007; Roden EE, 1996, LIMNOL OCEANOGR, V41, P1733, DOI 10.4319/lo.1996.41.8.1733; ROSENBERG R, 1991, MAR ECOL PROG SER, V79, P127, DOI 10.3354/meps079127; Rosenberg R, 2002, MAR ECOL PROG SER, V234, P43, DOI 10.3354/meps234043; Sale JW, 1917, J FRANKL INST, V184, P0837, DOI 10.1016/S0016-0032(17)90519-8; Schaffner LC, 2002, REV BENTHIC PROCESSE, P1; Seitz RD, 2003, MAR ECOL PROG SER, V257, P179, DOI 10.3354/meps257179; Seitz RD, 2009, J EXP MAR BIOL ECOL, V381, pS4, DOI 10.1016/j.jembe.2009.07.004; Steinberg DK, 1998, MAR ECOL PROG SER, V164, P157, DOI 10.3354/meps164157; Sturdivant SK, 2013, MAR ECOL PROG SER, V490, P53, DOI 10.3354/meps10470; Tallqvist M, 2001, MAR ECOL PROG SER, V212, P183, DOI 10.3354/meps212183; Tiffany MA, 2002, HYDROBIOLOGIA, V473, P103, DOI 10.1023/A:1016529617757; Tyson R.V., 1991, Geological Society Special Publication, V58, P1; Van Colen C, 2010, MAR POLLUT BULL, V60, P178, DOI 10.1016/j.marpolbul.2009.09.028; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vaquer-Sunyer R, 2010, LIMNOL OCEANOGR, V55, P1075, DOI 10.4319/lo.2010.55.3.1075; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WARREN LM, 1976, MAR BIOL, V38, P209, DOI 10.1007/BF00388934; WETZEL RL, 1986, AQUAT BOT, V26, P307, DOI 10.1016/0304-3770(86)90029-X	71	11	12	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84140	10.1371/journal.pone.0084140	http://dx.doi.org/10.1371/journal.pone.0084140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391904	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900047
J	Tanahashi, T; Yamamoto, T; Endo, T; Fujimura, H; Yokoe, M; Mochizuki, H; Nomura, T; Sakoda, S				Tanahashi, Takao; Yamamoto, Tomohisa; Endo, Takuyuki; Fujimura, Harutoshi; Yokoe, Masaru; Mochizuki, Hideki; Nomura, Taishin; Sakoda, Saburo			Noisy Interlimb Coordination Can Be a Main Cause of Freezing of Gait in Patients with Little to No Parkinsonism	PLOS ONE			English	Article							BILATERAL COORDINATION; HUMAN WALKING; CURVED PATH; DISEASE; LENGTH; BODY; ABNORMALITIES; FESTINATION; DYNAMICS; SYSTEM	Freezing of gait in patients with Parkinson's disease is associated with several factors, including interlimb incoordination and impaired gait cycle regulation. Gait analysis in patients with Parkinson's disease is confounded by parkinsonian symptoms such as rigidity. To understand the mechanisms underlying freezing of gait, we compared gait patterns during straight walking between 9 patients with freezing of gait but little to no parkinsonism (freezing patients) and 11 patients with Parkinson's disease (non-freezing patients). Wireless sensors were used to detect foot contact and toe-off events, and the step phase of each foot contact was calculated by defining one stride cycle of the other leg as 360 degrees. Phase-resetting analysis was performed, whereby the relation between the step phase of one leg and the subsequent phase change in the following step of the other leg was quantified using regression analysis. A small slope of the regression line indicates a forceful correction (phase reset) at every step of the deviation of step phase from the equilibrium phase, usually at around 180 degrees. The slope of this relation was smaller in freezing patients than in non-freezing patients, but the slope exhibited larger step-to-step variability. This indicates that freezing patients executed a forceful but noisy correction of the deviation of step phase, whereas non-freezing patients made a gradual correction of the deviation. Moreover, freezing patients tended to show more variable step phase and stride time than non-freezing patients. Dynamics of a model of two coupled oscillators interacting through a phase resetting mechanism were examined, and indicated that the deterioration of phase reset by noise provoked variability in step phase and stride time. That is, interlimb coordination can affect regulation of the gait cycle. These results suggest that noisy interlimb coordination, which probably caused forceful corrections of step phase deviation, can be a cause of freezing of gait.	[Tanahashi, Takao; Yokoe, Masaru; Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Yamamoto, Tomohisa; Nomura, Taishin] Osaka Univ, Grad Sch Engn Sci, Osaka, Japan; [Endo, Takuyuki; Fujimura, Harutoshi; Sakoda, Saburo] Toneyama Natl Hosp, Dept Neurol, Osaka, Japan	Osaka University; Osaka University	Sakoda, S (corresponding author), Toneyama Natl Hosp, Dept Neurol, Osaka, Japan.	sakoda@toneyama.go.jp	Nomura, Taishin/J-8408-2012	Nomura, Taishin/0000-0002-6545-2097	global COE (center of excellence) program from Center of Advanced Medical Engineering and Informatics, Osaka University [Pj-M-22]	global COE (center of excellence) program from Center of Advanced Medical Engineering and Informatics, Osaka University	Financial support for this study was provided by a grant for Research Fellows of the global COE (center of excellence) program (Pj-M-22, 2010) from the Center of Advanced Medical Engineering and Informatics, Osaka University (http://www.mei.osaka-u.ac.jp/gCOE/english/index. html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2003, BRAIN RES BULL, V61, P219, DOI 10.1016/S0361-9230(03)00119-9; Alice N, 2007, J NEUROL, V254, P1268, DOI 10.1007/s00415-006-0514-3; Asai Y, 2003, BIOL CYBERN, V88, P152, DOI 10.1007/s00422-002-0371-9; Asai Y, 2003, BIOSYSTEMS, V71, P11, DOI 10.1016/S0303-2647(03)00105-9; Bhatt H, 2013, PARKINSONISM RELAT D, V19, P181, DOI 10.1016/j.parkreldis.2012.09.006; Browner N, 2010, CURR NEUROL NEUROSCI, V10, P345, DOI 10.1007/s11910-010-0127-1; Chee R, 2009, BRAIN, V132, P2151, DOI 10.1093/brain/awp053; Courtine G, 2003, EUR J NEUROSCI, V18, P191, DOI 10.1046/j.1460-9568.2003.02737.x; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Danoudis M, 2012, PARKINSONISM RELAT D, V18, P543, DOI 10.1016/j.parkreldis.2012.02.005; Factor SA, 2006, NEUROLOGY, V66, P411, DOI 10.1212/01.wnl.0000196469.52995.ab; Factor SA, 2002, ARCH NEUROL-CHICAGO, V59, P1778, DOI 10.1001/archneur.59.11.1778; Factor SA, 2008, MOVEMENT DISORD, V23, pS431, DOI 10.1002/mds.21849; FAHN S, 1995, ADV NEUROL, V67, P53; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fasano A, 2011, MOVEMENT DISORD, V26, P844, DOI 10.1002/mds.23583; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; GILADI N, 1992, NEUROLOGY, V42, P333, DOI 10.1212/WNL.42.2.333; Grillner S, 2000, BRAIN RES, V886, P224, DOI 10.1016/S0006-8993(00)03088-2; Guertin PA, 2009, BRAIN RES REV, V62, P45, DOI 10.1016/j.brainresrev.2009.08.002; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Heremans E, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0350-7; Iansek R, 2006, MOVEMENT DISORD, V21, P1419, DOI 10.1002/mds.20998; Imai H, 1987, Adv Neurol, V45, P207; LOGIGIAN E, 1991, ANN NEUROL, V30, P172, DOI 10.1002/ana.410300208; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Moore ST, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-19; Moreau C, 2007, MOVEMENT DISORD, V22, P1503, DOI 10.1002/mds.21549; Morris M, 1998, MOVEMENT DISORD, V13, P61, DOI 10.1002/mds.870130115; Morris ME, 2008, MOVEMENT DISORD, V23, pS451, DOI 10.1002/mds.21974; NAKAMURA R, 1976, ADV PARKINSONISM, P258; Narabayashi H, 1987, Adv Neurol, V45, P593; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Peterson DS, 2012, PARKINSONISM RELAT D, V18, P1022, DOI 10.1016/j.parkreldis.2012.05.019; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Salarian A, 2004, IEEE T BIO-MED ENG, V51, P1434, DOI 10.1109/TBME.2004.827933; Schaafsma JD, 2003, EUR J NEUROL, V10, P391, DOI 10.1046/j.1468-1331.2003.00611.x; Spildooren J, 2012, NEUROSCIENCE, V207, P298, DOI 10.1016/j.neuroscience.2012.01.024; Spildooren J, 2010, MOVEMENT DISORD, V25, P2563, DOI 10.1002/mds.23327; Vercruysse S, 2012, MOVEMENT DISORD, V27, P254, DOI 10.1002/mds.24015; Williams AJ, 2013, GAIT POSTURE, V38, P340, DOI 10.1016/j.gaitpost.2012.12.009; Yamasaki T, 2003, BIOSYSTEMS, V71, P221, DOI 10.1016/S0303-2647(03)00118-7; Yamasaki T, 2003, BIOL CYBERN, V88, P468, DOI 10.1007/s00422-003-0402-1; Yoneyama M, 2013, IEEE T NEUR IN PRESS	51	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84423	10.1371/journal.pone.0084423	http://dx.doi.org/10.1371/journal.pone.0084423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391953	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900096
J	Tsai, HJ; Wu, CC; Tsai, CR; Lin, SF; Chen, LT; Chang, JS				Tsai, Hui-Jen; Wu, Chun-Chieh; Tsai, Chia-Rung; Lin, Sheng-Fung; Chen, Li-Tzong; Chang, Jeffrey. S.			Second Cancers in Patients with Neuroendocrine Tumors	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; CARCINOID-TUMORS; RISK; GROWTH; CHEMOTHERAPY; MORTALITY; RADIOTHERAPY; EXPRESSION; MALIGNANCY; RECEPTORS	Background: Second cancers have been reported to occur in 10-20% of patients with neuroendocrine tumors (NETs). However, most published studies used data from a single institution or focused only on specific sites of NETs. In addition, most of these studies included second cancers diagnosed concurrently with NETs, making it difficult to assess the temporality and determine the exact incidence of second cancers. In this nationwide population-based study, we used data recorded by the Taiwan Cancer Registry (TCR) to analyze the incidence and distribution of second cancers after the diagnosis of NETs. Methods: NET cases diagnosed from January 1, 1996 to December 31, 2006 were identified from the TCR. The data on the occurrence of second cancers were ascertained up to December 31, 2008. Standardized incidence ratios (SIRs) of second cancers were calculated based on the cancer incidence rates of the general population. Cox-proportional hazards regression analysis was performed to estimate the hazard ratio (HR) and 95% confidence interval (CI) for the risk of second cancers associated with sex, age, and primary NET sites. Results: A total of 1,350 newly diagnosed NET cases were identified according to the selection criteria. Among the 1,350 NET patients, 49 (3.63%) developed a second cancer >3 months after the diagnosis of NET. The risk of second cancer following NETs was increased compared to the general population (SIR = 1.48, 95% CI: 1.09-1.96), especially among those diagnosed at age 70 or older (HR = 5.08, 95% CI = 1.69-15.22). There appeared to be no preference of second cancer type according to the primary sites of NETs. Conclusions: Our study showed that the risk of second cancer following NETs is increased, especially among those diagnosed at age 70 or older. Close monitoring for the occurrence of second cancers after the diagnosis of NETs is warranted.	[Tsai, Hui-Jen; Tsai, Chia-Rung; Chen, Li-Tzong; Chang, Jeffrey. S.] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Tsai, Hui-Jen; Chen, Li-Tzong] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Tsai, Hui-Jen; Lin, Sheng-Fung; Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Hui-Jen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wu, Chun-Chieh] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chen, Li-Tzong] Natl Cheng Kung Univ, Inst Mol Med, Tainan 70101, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University	Lin, SF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.	shlin@cc.kmu.edu.tw; leochen@nhri.org.tw; jeffreychang@nhri.org.tw	Tsai, Hui-Jen/G-9361-2011; Chang, Jeffrey Shu-Ming/B-1092-2010; Chen, Li-Tzong/D-2071-2010; Chang, Jeffrey Shu-Ming/AAR-4161-2020	Chang, Jeffrey Shu-Ming/0000-0002-3236-6205	Department of Health, Executive Yuan, Taiwan [DOH102-TD-C-111-004]; National Health Research Institutes [CA-102-PP-07, CA-102-PP-17]	Department of Health, Executive Yuan, Taiwan; National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by the Establishment of Cancer Research System Excellence Program [DOH102-TD-C-111-004], Department of Health, Executive Yuan, Taiwan. In addition, HJT and JSC were supported by the National Health Research Institutes (CA-102-PP-07 and CA-102-PP-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin S, 2012, ENDOCR-RELAT CANCER, V19, P381, DOI 10.1530/ERC-11-0392; Bold RJ, 1998, ANTICANCER RES, V18, P4051; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; CHAUDHRY A, 1993, ACTA ONCOL, V32, P107, DOI 10.3109/02841869309083898; Cote ML, 2006, LUNG CANCER, V52, P273, DOI 10.1016/j.lungcan.2006.02.004; Curtis RE, 2004, JNCI-J NATL CANCER I, V96, P70, DOI 10.1093/jnci/djh007; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Ferme C, 2006, BLOOD, V107, P4636, DOI 10.1182/blood-2005-11-4429; Flannery J T, 1985, Natl Cancer Inst Monogr, V68, P13; Habal N, 2000, J SURG ONCOL, V75, P301; Hemminki K, 2001, INT J CANCER, V94, P444, DOI 10.1002/ijc.1473; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; KOBAYASHI Y, 1991, JPN J CLIN ONCOL, V21, P233; Krausch M, 2013, ENDOCRINE, V44, P510, DOI 10.1007/s12020-013-9911-4; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lee DH, 2013, OTOLARYNG HEAD NECK, V149, P579, DOI 10.1177/0194599813496373; Li H, 2003, ONCOGENE, V22, P1501, DOI 10.1038/sj.onc.1206223; Lo J, 2002, CELL BIOL INT, V26, P319, DOI 10.1006/cbir.2001.0858; MOERTEL CG, 1961, CANCER, V14, P901, DOI 10.1002/1097-0142(196109/10)14:5<901::AID-CNCR2820140502>3.0.CO;2-Q; Momota H, 2010, PEDIATR BLOOD CANCER, V55, P577, DOI 10.1002/pbc.22542; Moser EC, 2006, HAEMATOLOGICA, V91, P1481; Neyns B, 2008, J CLIN ONCOL, V26, P4518, DOI 10.1200/JCO.2008.18.8177; Niederle MB, 2011, ONCOLOGIST, V16, P602, DOI 10.1634/theoncologist.2011-0002; Perez EA, 2007, WORLD J SURG, V31, P1022, DOI 10.1007/s00268-005-0774-6; Prommegger R, 2004, ANTICANCER RES, V24, P1049; Sharma A, 2009, PEDIATR BLOOD CANCER, V53, P661, DOI 10.1002/pbc.22090; Shin Hai-Rim, 2008, J Prev Med Public Health, V41, P84; Taeger D, 2000, EPIDEMIOLOGY, V11, P607, DOI 10.1097/00001648-200009000-00019; TAJIKA M, 2013, J GASTROENTEROL, P93380; Tichansky DS, 2002, DIS COLON RECTUM, V45, P91, DOI 10.1007/s10350-004-6119-y; Travis LB, 2003, JAMA-J AM MED ASSOC, V290, P465, DOI 10.1001/jama.290.4.465; Travis LB, 1997, JNCI-J NATL CANCER I, V89, P1429, DOI 10.1093/jnci/89.19.1429; Travis LB, 1999, NEW ENGL J MED, V340, P351, DOI 10.1056/NEJM199902043400504; Travis LB, 2002, JNCI-J NATL CANCER I, V94, P182, DOI 10.1093/jnci/94.3.182; Travis LB, 2013, NAT REV CLIN ONCOL, V10, P289, DOI 10.1038/nrclinonc.2013.41; Tsai HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062487; Wang QMJ, 1996, INT J CANCER, V68, P528, DOI 10.1002/(SICI)1097-0215(19961115)68:4<528::AID-IJC20>3.3.CO;2-Q; Wolanska M, 2006, BIOCHIMIE, V88, P141, DOI 10.1016/j.biochi.2005.07.014; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e86414	10.1371/journal.pone.0086414	http://dx.doi.org/10.1371/journal.pone.0086414			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392036	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900180
J	Williams, LV; Veliceasa, D; Vinokour, E; Volpert, OV				Williams, LaTanya V.; Veliceasa, Dorina; Vinokour, Elena; Volpert, Olga V.			miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA EXPRESSION; ANDROGEN RECEPTOR; GASTRIC-CARCINOMA; CELL CARCINOMA; LUNG-CANCER; FAMILY; BIOGENESIS; INVASION; PATHWAY	miRNA regulate gene expression at post-transcriptional level and fine-tune the key biological processes, including cancer progression. Here, we demonstrate the involvement of miR-200b in the metastatic spread of prostate cancer. We identified miR-200b as a downstream target of androgen receptor and linked its expression to decreased tumorigenicity and metastatic capacity of the prostate cancer cells. Overexpression of miR-200b in PC-3 cells significantly inhibited their proliferation and the formation of subcutaneous tumors. Moreover, in an orthotopic model, miR-200b blocked spontaneous metastasis and angiogenesis by PC-3 cells. This decreased metastatic potential was likely due to the reversal of the epithelial-to-mesenchymal transition, as was evidenced by increased pan-epithelial marker E-cadherin and specific markers of prostate epithelium, cytokeratins 8 and 18. In contrast, mesenchymal markers, fibronectin and vimentin, were significantly downregulated by miR-200b. Our results suggest an important role for miR-200b in prostate cancer progression and indicate its potential utility for prostate cancer therapy.	[Williams, LaTanya V.; Veliceasa, Dorina; Vinokour, Elena; Volpert, Olga V.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Volpert, OV (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	olgavolp@northwestern.edu			Herman L. Kretschmer Fund, via Northwestern University Urology Department; SPORE in Prostate Cancer Pilot Award [P50 CA090386]; Diversifying Higher Education Faculty in Illinois Fellowship Grant; NATIONAL CANCER INSTITUTE [P50CA090386] Funding Source: NIH RePORTER	Herman L. Kretschmer Fund, via Northwestern University Urology Department; SPORE in Prostate Cancer Pilot Award; Diversifying Higher Education Faculty in Illinois Fellowship Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Herman L. Kretschmer Fund, via Northwestern University Urology Department (OV), the SPORE in Prostate Cancer Pilot Award P50 CA090386 (OV), Diversifying Higher Education Faculty in Illinois Fellowship Grant (LVW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Blahna MT, 2013, CURR OPIN CELL BIOL, V25, P233, DOI 10.1016/j.ceb.2012.12.005; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He MY, 2013, PROSTATE, V73, P1048, DOI 10.1002/pros.22652; Heisler LE, 1997, MOL CELL ENDOCRINOL, V126, P59, DOI 10.1016/S0303-7207(96)03970-6; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Kurashige J, 2012, ANN SURG ONCOL, V19, pS656, DOI 10.1245/s10434-012-2217-6; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Liu Y, 2013, LEUKEMIA RES, V37, P349, DOI 10.1016/j.leukres.2012.12.003; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Manavalan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062334; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; Mirochnik Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031052; Mitchell S, 2000, BJU INT, V85, P932, DOI 10.1046/j.1464-410x.2000.00606.x; Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768; Nelius T, 2007, INT J CANCER, V121, P999, DOI 10.1002/ijc.22802; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Panda H, 2012, REPROD SCI, V19, P786, DOI 10.1177/1933719112438448; Park Serk In, 2010, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1415s51; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Slabakova E, 2011, PROSTATE, V71, P1332, DOI 10.1002/pros.21350; Su S.F., 2012, ONCOGENE; Susuki D, 2011, CANCER SCI, V102, P2164, DOI 10.1111/j.1349-7006.2011.02096.x; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Vallejo DM, 2011, EMBO J, V30, P756, DOI 10.1038/emboj.2010.358; Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wu CL, 2013, CELL SIGNAL, V25, P1212, DOI 10.1016/j.cellsig.2013.01.028; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Yoshino H, 2013, J HUM GENET; Yu Z, 2013, J MOL HISTOL	46	114	121	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83991	10.1371/journal.pone.0083991	http://dx.doi.org/10.1371/journal.pone.0083991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391862	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900005
J	Lu, LM; Zou, GY; Zeng, Z; Han, L; Guo, Y; Ling, L				Lu, Liming; Zou, Guanyang; Zeng, Zhi; Han, Lu; Guo, Yan; Ling, Li			Health-Related Quality of Life and Its Correlates among Chinese Migrants in Small- and Medium-Sized Enterprises in Two Cities of Guangdong	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; BEHAVIORAL-MODEL; OCCUPATIONAL-HEALTH; WORKERS; SF-12; SERVICES; VALIDITY; POPULATION; VALIDATION; CHALLENGES	Objectives: To explore the relationship between health-related quality of life (HRQOL) status and associated factors among rural-to-urban migrants in China. Methods: A cross-sectional survey was conducted with 856 rural-to-urban migrants working at small- and medium-size enterprises (SMEs) in Shenzhen and Zhongshan City in 2012. Andersen's behavioral model was used as a theoretical framework to exam the relationships among factors affecting HRQOL. Analysis was performed using structural equation modeling (SEM). Results: Workers with statutory working hours, higher wages and less migrant experience had higher HRQOL scores. Need (contracting a disease in the past two weeks and perception of needing health service) had the greatest total effect on HRQOL (beta = -0.78), followed by enabling (labor contract, insurance purchase, income, physical examination during work and training) (beta = 0.40), predisposing (age, family separation, education) (beta = 0.22) and health practices and use of health service (physical exercise weekly, health check-up and use of protective equipments) (beta = -0.20). Conclusions: Priority should be given to satisfy the needs of migrant workers, and improve the enabling resources.	[Lu, Liming; Zeng, Zhi; Han, Lu; Guo, Yan; Ling, Li] Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Liming; Zou, Guanyang; Zeng, Zhi; Han, Lu; Guo, Yan; Ling, Li] Sun Yat Sen Univ, Sun Yat Sen Ctr Migrant Hlth Policy, Guangzhou 510275, Guangdong, Peoples R China; [Zou, Guanyang] Queen Margaret Univ, Inst Int Hlth & Dev, Edinburgh, Midlothian, Scotland	Sun Yat Sen University; Sun Yat Sen University; Queen Margaret University	Ling, L (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	lingli@mail.sysu.edu.cn	Han, Lu/K-4614-2015		China Medical Board [09-984, 12-111]	China Medical Board	This research was funded by the China Medical Board (Grant No. 09-984 and No. 12-111). The funder had no further role in the study design, data collection, analysis and interpretation of data, writing of the report, or decision to submit the paper for publication.	amCham-China, 2011, SMALL MED SIZ ENT; Andersen R, 1996, CHANGING US HLTH CAR; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andrews G, 2002, AUST NZ J PUBL HEAL, V26, P508, DOI 10.1111/j.1467-842X.2002.tb00357.x; [Anonymous], 2011, COMM MAJ DAT 6 NAT C; Babitsch Birgit, 2012, Psychosoc Med, V9, pDoc11, DOI 10.3205/psm000089; Baker SR, 2009, COMMUNITY DENT ORAL, V37, P485, DOI 10.1111/j.1600-0528.2009.00495.x; Brown Timothy A, 2006, CONFIRMATORY FACTOR; Chen YS, 2007, QUAL LIFE RES, V16, P1289, DOI 10.1007/s11136-007-9248-7; Chen YW, 2010, J OCCUP HEALTH, V52, P82, DOI 10.1539/joh.O9005; Comer JS, 2011, J CLIN PSYCHIAT, V72, P43, DOI 10.4088/JCP.09m05094blu; Conner NE, 2012, AM J HOSP PALLIAT ME, V29, P368, DOI 10.1177/1049909111425227; Downey RG, 1998, J GEN PSYCHOL, V125, P175, DOI 10.1080/00221309809595542; Finlayson TL, 2010, J PUBLIC HEALTH DENT, V70, P292, DOI 10.1111/j.1752-7325.2010.00184.x; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Guangdong Statistical Bureau, 2012, GUANGD STAT YB 2012; Guo Q, 2004, HDB SAMPLING RES; Hobart JC, 2002, STROKE, V33, P1348, DOI 10.1161/01.STR.0000015030.59594.B3; Huang Y.X, 2003, CHINA W CEREALS OILS, V5, P13; Kontodimopoulos N, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-55; Li L, 2007, SOC PSYCH PSYCH EPID, V42, P716, DOI 10.1007/s00127-007-0221-0; Li Y, 2010, ELECTRICAL CONDUCTIVE ADHESIVES WITH NANOTECHNOLOGIES, P25, DOI 10.1007/978-0-387-88783-8_2; Liang YX, 2004, TOXICOLOGY, V198, P45, DOI 10.1016/j.tox.2004.01.018; Liu S, 2011, PUBLIC HEALTH, V125, P669, DOI 10.1016/j.puhe.2011.08.004; Ma CH, 2012, J N CHINA I AEROSP E, V22, P61; Michalos AC, 2000, SOC INDIC RES, V51, P245, DOI 10.1023/A:1007010401301; Montazeri A, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-12; Montazeri A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-341; Mou J, 2011, J COMMUNITY PSYCHOL, V39, P212, DOI 10.1002/jcop.20428; Nordin NM., 2010, GLOBAL J HLTH SCI, V2, P104, DOI [10.5539/gjhs.v2n2p104, DOI 10.5539/GJHS.V2N2P104]; People's Government of Guangdong Province, 2011, COMM MAJ DAT 6 NAT C; Phillips KA, 1998, HEALTH SERV RES, V33, P571; Qian S, 2008, CHINA J HLTH PSYCHOL, V16, P459; Researching Group of National Bureau of Statistics (RGNBS), 2007, STAT RES, V24, P3; Schnurr PP, 2006, J CONSULT CLIN PSYCH, V74, P707, DOI 10.1037/0022-006X.74.4.707; Service Management Division of the National Population and Family Planning Commission for the Migrant Population, 2012, REP CHIN MIGR POP DE; Service Management Division of the National Population and Family Planning Commission for the Migrant Population, 2011, REP CHIN MIGR POP DE; Smith DR, 2004, J OCCUP HLTH SAF, V20, P441; Stein JA, 2007, J HEALTH PSYCHOL, V12, P791, DOI 10.1177/1359105307080612; The People's Republic of China Ministry of Industry, 2012, NOT ISS SME PROGR ST; Wang W, 2010, CHIN J PUBLIC HLTH, V26, P317; Wang XR, 2011, ARCH ENVIRON OCCUP H, V66, P3, DOI 10.1080/19338244.2010.486424; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; Wu M., 2010, 3 INT I STAT MAN ENG, V2; XIAO Y, 2008, J OCCUP HLTH SAF AUS, V24, P455; Yan Z, 2010, CHIN J PUBLIC HLTH, V3, P317; Yu W., 2012, OCCUPATIONAL HLTH SA; Zhang JT, 2009, QUAL LIFE RES, V18, P291, DOI 10.1007/s11136-009-9454-6; Zhu CY, 2012, QUAL LIFE RES, V21, P495, DOI 10.1007/s11136-011-9950-3	49	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83315	10.1371/journal.pone.0083315	http://dx.doi.org/10.1371/journal.pone.0083315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286ID	24392084	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100008
J	Luksys, G; Ackermann, S; Coynel, D; Fastenrath, M; Gschwind, L; Heck, A; Rasch, B; Spalek, K; Vogler, C; Papassotiropoulos, A; de Quervain, D				Luksys, Gediminas; Ackermann, Sandra; Coynel, David; Fastenrath, Matthias; Gschwind, Leo; Heck, Angela; Rasch, Bjoern; Spalek, Klara; Vogler, Christian; Papassotiropoulos, Andreas; de Quervain, Dominique			BAIAP2 Is Related to Emotional Modulation of Human Memory Strength	PLOS ONE			English	Article							EPISODIC MEMORY; COGNITIVE NEUROSCIENCE; DECISION-MAKING; ASSOCIATION; GENES; METAANALYSIS; EXPERIENCE; PREDICTS; IRSP53; STRESS	Memory performance is the result of many distinct mental processes, such as memory encoding, forgetting, and modulation of memory strength by emotional arousal. These processes, which are subserved by partly distinct molecular profiles, are not always amenable to direct observation. Therefore, computational models can be used to make inferences about specific mental processes and to study their genetic underpinnings. Here we combined a computational model-based analysis of memory-related processes with high density genetic information derived from a genome-wide study in healthy young adults. After identifying the best-fitting model for a verbal memory task and estimating the best-fitting individual cognitive parameters, we found a common variant in the gene encoding the brain-specific angiogenesis inhibitor 1-associated protein 2 (BAIAP2) that was related to the model parameter reflecting modulation of verbal memory strength by negative valence. We also observed an association between the same genetic variant and a similar emotional modulation phenotype in a different population performing a picture memory task. Furthermore, using functional neuroimaging we found robust genotype-dependent differences in activity of the parahippocampal cortex that were specifically related to successful memory encoding of negative versus neutral information. Finally, we analyzed cortical gene expression data of 193 deceased subjects and detected significant BAIAP2 genotype-dependent differences in BAIAP2 mRNA levels. Our findings suggest that model-based dissociation of specific cognitive parameters can improve the understanding of genetic underpinnings of human learning and memory.	[Luksys, Gediminas; Ackermann, Sandra; Coynel, David; Gschwind, Leo; Heck, Angela; Rasch, Bjoern; Vogler, Christian; Papassotiropoulos, Andreas] Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland; [Luksys, Gediminas; Coynel, David; Fastenrath, Matthias; Rasch, Bjoern; Spalek, Klara; de Quervain, Dominique] Univ Basel, Div Cognit Neurosci, Dept Psychol, Basel, Switzerland; [Ackermann, Sandra; Rasch, Bjoern] Univ Zurich, Dept Psychol, Dept Psychol, Zurich, Switzerland; [Papassotiropoulos, Andreas; de Quervain, Dominique] Univ Basel, Psychiat Univ Clin, Basel, Switzerland; [Papassotiropoulos, Andreas] Univ Basel, Life Sci Training Facil, Dept Biozentrum, Basel, Switzerland	University of Basel; University of Basel; University of Zurich; University of Basel; University of Basel	Luksys, G (corresponding author), Univ Basel, Div Mol Neurosci, Dept Psychol, Basel, Switzerland.	gedi.luksys@unibas.ch; andreas.papas@unibas.ch; dominique.dequervain@unibas.ch	Coynel, David/H-9189-2019; Rasch, Björn/A-3119-2015	Coynel, David/0000-0001-5028-5807; Rasch, Björn/0000-0001-7607-3415; Papassotiropoulos, Andreas/0000-0002-2210-9651; Heck, Angela/0000-0002-1543-3197; Vogler, Christian/0000-0003-3922-109X; de Quervain, Dominique/0000-0001-7131-2464; Spalek, Klara/0000-0002-4244-6495	Swiss National Science Foundation [CRSIK0_122691, CRSI33_130080, CRSII1_136227]; 7th framework programme of the European Union (ADAMS project) [HEALTH-F4-2009-242257]; National Center for Competence in Research SYNAPSY	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 7th framework programme of the European Union (ADAMS project); National Center for Competence in Research SYNAPSY	This work was funded by the Swiss National Science Foundation (Sinergia grants CRSIK0_122691, CRSI33_130080, CRSII1_136227 to DQ and AP), by the 7th framework programme of the European Union (ADAMS project, HEALTH-F4-2009-242257) and by the National Center for Competence in Research SYNAPSY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Corrado G, 2007, J NEUROSCI, V27, P8178, DOI 10.1523/JNEUROSCI.1590-07.2007; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146; de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2009, NAT NEUROSCI, V12, P1062, DOI 10.1038/nn.2342; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Hager W, 1994, HDB DEUTSCHSPRACHIGE; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim MH, 2009, J NEUROSCI, V29, P1586, DOI 10.1523/JNEUROSCI.4306-08.2009; Kolsch H, 2009, J NEURAL TRANSM, V116, P897, DOI 10.1007/s00702-009-0238-5; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lang PJ, 2008, INT AFFECTIVE PICTUR; Luksys G, 2011, CURR OPIN NEUROBIOL, V21, P502, DOI 10.1016/j.conb.2011.03.003; Luksys G, 2009, NAT NEUROSCI, V12, P1180, DOI 10.1038/nn.2374; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milnik A, 2012, AM J MED GENET B, V159B, P958, DOI 10.1002/ajmg.b.32101; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nassar MR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003015; Oda K, 1999, CYTOGENET CELL GENET, V84, P75, DOI 10.1159/000015219; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Panizzon MS, 2011, NEUROPSYCHOLOGY, V25, P488, DOI 10.1037/a0022569; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005; Press W. H., 1992, ART SCI COMPUTING; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ribases M, 2009, BIOL PSYCHIAT, V66, P926, DOI 10.1016/j.biopsych.2009.06.024; Schweighofer N, 2008, J NEUROSCI, V28, P4528, DOI 10.1523/JNEUROSCI.4982-07.2008; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Toma C, 2011, J PSYCHIATR RES, V45, P280, DOI 10.1016/j.jpsychires.2010.09.001; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257	41	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83707	10.1371/journal.pone.0083707	http://dx.doi.org/10.1371/journal.pone.0083707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392092	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000329460100016
J	Stauffer, ME; Fan, T				Stauffer, Melissa E.; Fan, Tao			Prevalence of Anemia in Chronic Kidney Disease in the United States	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; GLOMERULAR-FILTRATION-RATE; CKD; EPIDEMIOLOGY; POPULATION; DIALYSIS; ILLNESS; BURDEN; ADULTS	Anemia is one of the many complications of chronic kidney disease (CKD). However, the current prevalence of anemia in CKD patients in the United States is not known. Data from the National Health and Nutrition Examination Survey (NHANES) in 2007-2008 and 2009-2010 were used to determine the prevalence of anemia in subjects with CKD. The analysis was limited to adults aged >18 who participated in both the interview and exam components of the survey. Three outcomes were assessed: the prevalence of CKD, the prevalence of anemia in subjects with CKD, and the self-reported treatment of anemia. CKD was classified into 5 stages based on the glomerular filtration rate and evidence of kidney damage, in accordance with the guidelines of the National Kidney Foundation. Anemia was defined as serum hemoglobin levels <= 12 g/dL in women and <= 13 g/dL in men. We found that an estimated 14.0% of the US adult population had CKD in 2007-2010. Anemia was twice as prevalent in people with CKD (15.4%) as in the general population (7.6%). The prevalence of anemia increased with stage of CKD, from 8.4% at stage 1 to 53.4% at stage 5. A total of 22.8% of CKD patients with anemia reported being treated for anemia within the previous 3 months-14.6% of patients at CKD stages 1-2 and 26.4% of patients at stages 3-4. These results update our knowledge of the prevalence and treatment of anemia in CKD in the United States.	[Stauffer, Melissa E.] SCRIBCO, Effort, PA 18330 USA; [Fan, Tao] Merck & Co Inc, Whitehouse Stn, NJ USA	Merck & Company	Stauffer, ME (corresponding author), SCRIBCO, Effort, PA 18330 USA.	melstauff@charter.net			Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	This study was funded by Merck & Co., Inc. Web site: http://www.merck.com/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2006, J AM MED DIR ASSOC, V7, pS7, DOI 10.1016/j.jamda.2006.09.005; Bowling CB, 2011, CLIN J AM SOC NEPHRO, V6, P2822, DOI 10.2215/CJN.06770711; Brown WW, 2003, AM J KIDNEY DIS, V42, P22, DOI 10.1016/S0272-6386(03)00405-0; *CDCP, 2007, MMWR-MORBID MORTAL W, V58, P161, DOI DOI 10.1053/AJKD.2003.50007; Centers for Disease Control and Prevention National Center for Health Statistics, 2012, NAT HLTH NUTR EX SUR; Clase CM, 2007, NEPHRON CLIN PRACT, V105, pC178, DOI 10.1159/000100489; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fishbane S, 2009, CLIN J AM SOC NEPHRO, V4, P57, DOI 10.2215/CJN.01670408; Herzog CA, 2004, J CARD FAIL, V10, P467, DOI 10.1016/j.cardfail.2004.03.003; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; Lawler EV, 2010, NEPHROL DIAL TRANSPL, V25, P2237, DOI 10.1093/ndt/gfp758; Lenz O, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-30; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Mehdi U, 2009, DIABETES CARE, V32, P1320, DOI 10.2337/dc08-0779; Moossavi S, 2009, ARCH INTERN MED, V169, P1100, DOI 10.1001/archinternmed.2009.159; National Anemia Action Council, AN KIDN DIS; National Kidney Foundation, FREQ ASK QUEST GFR E; Nissenson Allen R, 2005, J Manag Care Pharm, V11, P565; Rasu RS, 2007, CLIN THER, V29, P1524, DOI 10.1016/j.clinthera.2007.07.016; Robinson B, 2007, J AM GERIATR SOC, V55, P1566, DOI 10.1111/j.1532-5415.2007.01389.x; Smith RE, 2010, AM J MANAG CARE, V16, pS59; Snyder JJ, 2009, AM J KIDNEY DIS, V53, P218, DOI 10.1053/j.ajkd.2008.07.034; Stevens LA, 2011, AM J KIDNEY DIS, V57, pS9, DOI 10.1053/j.ajkd.2010.11.007; Stevens LA, 2010, AM J KIDNEY DIS, V55, pS23, DOI 10.1053/j.ajkd.2009.09.035; van Nooten Floortje E, 2010, J Med Econ, V13, P241, DOI 10.3111/13696998.2010.484307; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	29	280	292	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84943	10.1371/journal.pone.0084943	http://dx.doi.org/10.1371/journal.pone.0084943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392162	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100085
J	Vilardi, F; Stephan, M; Clancy, A; Janshoff, A; Schwappach, B				Vilardi, Fabio; Stephan, Milena; Clancy, Anne; Janshoff, Andreas; Schwappach, Blanche			WRB and CAML Are Necessary and Sufficient to Mediate Tail-Anchored Protein Targeting to the ER Membrane	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; INSERTION; BINDING; IDENTIFICATION; EXPRESSION; PATHWAYS; RECEPTOR; COMPLEX; SITES; CELLS	Tail-Anchored (TA) proteins are inserted into the endoplasmic reticulum (ER) membrane of yeast cells via the posttranslational Guided Entry of Tail-Anchored protein (GET) pathway. The key component of this targeting machinery is the ATPase Get3 that docks to the ER membrane by interacting with a receptor complex formed by the proteins Get1 and Get2. A conserved pathway is present in higher eukaryotes and is mediated by TRC40, homolog of Get3, and the recently identified membrane receptors WRB and CAML. Here, we used yeast lacking the GET1 and GET2 genes and substituted them with WRB and CAML. This rescued the growth phenotypes of the GET receptor mutant. We demonstrate that WRB and CAML efficiently recruit Get3 to the ER membrane and promote the targeting of the TA proteins in vivo. Our results show that the membrane spanning segments of CAML are essential to create a functional receptor with WRB and to ensure TA protein membrane insertion. Finally, we determined the binding parameters of TRC40 to the WRB/CAML receptor. We conclude that together, WRB and CAML are not only necessary but also sufficient to create a functional membrane receptor complex for TRC40. The yeast complementation assay can be used to further dissect the structure-function relationship of the WRB/CAML heteromultimer in the absence of endogenous receptor proteins.	[Vilardi, Fabio; Clancy, Anne; Schwappach, Blanche] Univ Gottingen, Inst Mol Biol, D-37073 Gottingen, Germany; [Stephan, Milena; Janshoff, Andreas] Univ Gottingen, Inst Phys Chem, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen	Schwappach, B (corresponding author), Univ Gottingen, Inst Mol Biol, D-37073 Gottingen, Germany.	blanche.schwappach@med.uni-goettingen.de	Janshoff, Andreas/B-8711-2009	Clancy, Anne/0000-0001-8873-0849; Janshoff, Andreas/0000-0002-0773-2963; Schwappach, Blanche/0000-0003-0225-6432	University Medicine Gottingen	University Medicine Gottingen	The project was funded by core support to BS and FV provided by University Medicine Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; Bryda EC, 2012, MAMM GENOME, V23, P270, DOI 10.1007/s00335-011-9381-z; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Dodd CE, 2008, BIOINTERPHASES, V3, pFA59, DOI 10.1116/1.2896113; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; Hassdenteufel S, 2011, FEBS LETT, V585, P3485, DOI 10.1016/j.febslet.2011.10.008; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kohl C, 2011, BIOL CHEM, V392, P601, DOI 10.1515/BC.2011.066; Krick R, 2012, P NATL ACAD SCI USA, V109, pE2042, DOI 10.1073/pnas.1205128109; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Maniatis T., 1982, MOL CLONING; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Powis K, 2013, J CELL SCI, V126, P473, DOI 10.1242/jcs.112151; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Tram DD, 2005, IMMUNITY, V23, P139, DOI 10.1016/j.immuni.2005.06.006; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002; Zane NA, 2012, J IMMUNOL, V188, P3009, DOI 10.4049/jimmunol.1101641	31	45	45	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e85033	10.1371/journal.pone.0085033	http://dx.doi.org/10.1371/journal.pone.0085033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392163	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100086
J	Wang, Y; Liu, L; Chen, LN; Chen, T; Sun, FZ				Wang, Ying; Liu, Lin; Chen, Lina; Chen, Ting; Sun, Fengzhu			Comparison of Metatranscriptomic Samples Based on k-Tuple Frequencies	PLOS ONE			English	Article							STATISTICAL MEASURES; SEQUENCE; ALIGNMENT	Background: The comparison of samples, or beta diversity, is one of the essential problems in ecological studies. Next generation sequencing (NGS) technologies make it possible to obtain large amounts of metagenomic and metatranscriptomic short read sequences across many microbial communities. De novo assembly of the short reads can be especially challenging because the number of genomes and their sequences are generally unknown and the coverage of each genome can be very low, where the traditional alignment-based sequence comparison methods cannot be used. Alignment-free approaches based on k-tuple frequencies, on the other hand, have yielded promising results for the comparison of metagenomic samples. However, it is not known if these approaches can be used for the comparison of metatranscriptome datasets and which dissimilarity measures perform the best. Results: We applied several beta diversity measures based on k-tuple frequencies to real metatranscriptomic datasets from pyrosequencing 454 and Illumina sequencing platforms to evaluate their effectiveness for the clustering of metatranscriptomic samples, including three d(2) - type dissimilarity measures, one dissimilarity measure in CVTree, one relative entropy based measure S2 and three classical l(p) - norm distances. Results showed that the measure d(2)(S) can achieve superior performance on clustering metatranscriptomic samples into different groups under different sequencing depths for both 454 and Illumina datasets, recovering environmental gradients affecting microbial samples, classifying coexisting metagenomic and metatranscriptomic datasets, and being robust to sequencing errors. We also investigated the effects of tuple size and order of the background Markov model. A software pipeline to implement all the steps of analysis is built and is available at http://code.google.com/p/d2-tools/. Conclusions: The k-tuple based sequence signature measures can effectively reveal major groups and gradient variation among metatranscriptomic samples from NGS reads. The d(2)(S) dissimilarity measure performs well in all application scenarios and its performance is robust with respect to tuple size and order of the Markov model.	[Wang, Ying; Liu, Lin; Chen, Lina] Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China; [Chen, Ting; Sun, Fengzhu] Univ So Calif, Los Angeles, CA USA	Xiamen University; University of Southern California	Wang, Y (corresponding author), Xiamen Univ, Sch Informat Sci & Technol, Xiamen, Fujian, Peoples R China.	wangying@xmu.edu.cn; fsun@usc.edu	Sun, Fengzhu/G-4373-2010	Sun, Fengzhu/0000-0002-8552-043X	National Natural Science Foundation of China [61203282, 61202144]; US NIH [R21HG006199]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006199] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The research is supported by: 1. National Natural Science Foundation of China (61203282, 61202144) http://www.nsfc.gov.cn/Portal0/default166.htm. 2. US NIH (R21HG006199) http://www.nih.gov/. 3. NSF [DMS-1043075, OCE 1136818] http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson M. J., 2003, PCO FORTRAN COMPUTER; Balzer S, 2010, BIOINFORMATICS, V26, pi420, DOI 10.1093/bioinformatics/btq365; BLAISDELL BE, 1986, P NATL ACAD SCI USA, V83, P5155, DOI 10.1073/pnas.83.14.5155; Dai Q, 2008, BIOINFORMATICS, V24, P2296, DOI 10.1093/bioinformatics/btn436; Dai Q, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-394; Dalevi D, 2006, BIOINFORMATICS, V22, P517, DOI 10.1093/bioinformatics/btk029; Dick GJ, 2010, ENVIRON MICROBIOL, V12, P1334, DOI 10.1111/j.1462-2920.2010.02177.x; Dick GJ, 2009, GEOCHIM COSMOCHIM AC, V73, P6517, DOI 10.1016/j.gca.2009.07.039; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Ghosh TS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S9; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P183, DOI 10.4056/sigs.1202536; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Hide W, 1994, J Comput Biol, V1, P199, DOI 10.1089/cmb.1994.1.199; Jiang B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-730; Kantorovitz MR, 2007, BIOINFORMATICS, V23, pI249, DOI 10.1093/bioinformatics/btm211; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Miller RT, 1999, GENOME RES, V9, P1143, DOI 10.1101/gr.9.11.1143; Mou XZ, 2011, ENV MICROBIOL REP, V3, P798, DOI 10.1111/j.1758-2229.2011.00289.x; Murtagh F, 1984, COMPUT STAT Q, V1, P101; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Reinert G, 2009, J COMPUT BIOL, V16, P1615, DOI 10.1089/cmb.2009.0198; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P2379, DOI 10.1128/AEM.72.4.2379-2384.2006; Shi YM, 2011, ISME J, V5, P999, DOI 10.1038/ismej.2010.189; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; Song K, 2013, J COMPUT BIOL, V20, P64, DOI 10.1089/cmb.2012.0228; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Wan L, 2010, J COMPUT BIOL, V17, P1467, DOI 10.1089/cmb.2010.0056; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Xiong XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036009; Zeng F, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt372	37	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84348	10.1371/journal.pone.0084348	http://dx.doi.org/10.1371/journal.pone.0084348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392128	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100051
J	Devendra, A; Makawa, A; Kazembe, PN; Calles, NR; Kuper, H				Devendra, Akash; Makawa, Atupele; Kazembe, Peter N.; Calles, Nancy R.; Kuper, Hannah			HIV and Childhood Disability: A Case-Controlled Study at a Paediatric Antiretroviral Therapy Centre in Lilongwe, Malawi	PLOS ONE			English	Article							INTERNATIONAL CLASSIFICATION; HEALTH ICF; REHABILITATION; COMPONENT; HIV/AIDS; CARE	Background: As paediatric antiretroviral therapy (ART) is rapidly scaled up in Southern Africa, Human Immunodeficiency Virus (HIV) infection is becoming a chronic illness. Children growing up with HIV may begin to encounter disabilities. The relationship between HIV, disability and the need for rehabilitation has added an additional element that needs to be addressed by paediatric HIV treatment programmes. Study Objectives: 1) Estimate the prevalence of disabilities in HIV-infected and HIV-uninfected children in Lilongwe, Malawi. 2) Examine types of disability and associated clinical and socio-demographic factors. 3) Identify needs, opportunities and barriers for rehabilitation in Malawi. Methods: A case-controlled study of 296 HIV-infected children aged 2-9 years attending an ART centre in Lilongwe (cases) and their uninfected siblings (controls) was conducted. Disability was assessed using the WHO Ten Question Screen (TQS). Socio-demographic and clinical data were collected using a parent-proxy questionnaire and medical records. Results: Of 296 case and control pairs recruited, 33% (98) versus 7% (20) screened positive for a disability (OR 8.4, 4.4-15.7) respectively. Of these 98 HIV-infected cases, 6%, 36%, 33%, 53%, 46% and 6% had a vision, hearing; physical, learning/comprehension, speech or seizure-related disability respectively and 51% had multiple coexisting disabilities. HIV-infected cases with a disability were more likely to be WHO stage III or IV at enrolment (71% vs. 52%, OR 2.7, 1.5-4.2), to have had TB (58% vs. 39%, OR 2.3, 1.4-3.8) and to have below-average school grades (18% vs. 2%, OR 11.1, 2.2-54.6) than those without. Sixty-seven percent of cases with a disability had never attended any rehabilitative service. Twenty-nine percent of caregivers reported facing stigma and discrimination because of the child's disability. Conclusion: This study reveals the magnitude of disability among HIV-infected children and the large unmet need for rehabilitation services. This expanding issue demands further investigation to provide an evidence base for holistic care for disabled children living with HIV.	[Devendra, Akash; Makawa, Atupele; Kazembe, Peter N.] Baylor Coll Med, Childrens Clin Ctr Excellence BCOE, Lilongwe, Malawi; [Calles, Nancy R.] Baylor Coll Med, Houston, TX 77030 USA; [Calles, Nancy R.] Texas Childrens Hosp Int Paediat AIDS Initiat BIP, Houston, TX USA; [Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London WC1, England	Baylor College of Medicine; Baylor College of Medicine; University of London; London School of Hygiene & Tropical Medicine	Devendra, A (corresponding author), Baylor Coll Med, Childrens Clin Ctr Excellence BCOE, Lilongwe, Malawi.	akashdevendra@hotmail.com						Baylor College of Medicine Children's Clinical Centre of Excellence - Malawi, 2012, ANN REPORT; Couper J, 2002, SAMJ S AFR MED J, V92, P549; Crystal S, 2000, MED CARE, V38, P1210, DOI 10.1097/00005650-200012000-00008; DURKIN MS, 1994, EPIDEMIOLOGY, V5, P283, DOI 10.1097/00001648-199405000-00005; Gaidhane AM, 2008, AIDS CARE, V20, P1098, DOI 10.1080/09540120701808820; Hanass-Hancock J, 2010, NATL RESPONSE DISABI; Hanass-Hancock J., 2009, J INT AIDS SOC, V2, P9, DOI [10.1186/1758-2652-2-9, DOI 10.1186/1758-2652-2-9]; Hanass-Hancock J, 2010, HIV DISABILITY REHAB; Hanass-Hancock J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-28; Hanass-Hancock J, 2011, DISABIL REHABIL, V33, P2389, DOI 10.3109/09638288.2011.573055; Heidari S, 2009, J INT AIDS SOC, V12, DOI [10.1186/1758-2652-12-26, 10.1186/1758-2652-2-1]; Malawi Ministry of Health, 2012, Q HIV PROGR REP; Mont D, 2007, SP DISCUSSION PAPER; Myezwa H, 2009, AJAR-AFR J AIDS RES, V8, P93, DOI 10.2989/AJAR.2009.8.1.10.723; Nixon S, 2011, S AFR J HIV MED, P12; Nixon SA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-41; O'Brien K, 2010, AIDS BEHAV, V14, P448, DOI 10.1007/s10461-009-9528-z; O'Brien KK, 2013, DISABIL REHABIL, V35, P566, DOI 10.3109/09638288.2012.702848; O'Brien KK, 2009, J INT AIDS SOC, V12, DOI [10.1186/1758-2652-12-30, 10.1186/1758-2652-2-5]; O'Brien KK, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-76; Paramesparan Y, 2010, JAIDS-J ACQ IMM DEF, V55, P134, DOI 10.1097/QAI.0b013e3181d90e8c; Rankin W, 2005, PLOS MED, V2; Rohleder P, 2009, DISABIL REHABIL, V31, P51, DOI 10.1080/09638280802280585; Ruel TD, 2012, CLIN INFECT DIS, V54, P1001, DOI 10.1093/cid/cir1037; Rusch M, 2004, HLTH QOL OUTCOMES, V2, P22; Russell S, 2010, SOC SCI MED, V70, P375, DOI 10.1016/j.socscimed.2009.10.039; UNAIDS, 2012, REP GLOB AIDS EP 201; UNAIDS, 2010, MAL COUNTR PROGR REP; UNAIDS WHO and Office of the High Commissioner for Human Rights (OHCHR), 2009, DIS HIV POL BRIEF; UNICEF University of Wisconsin, 2008, MON CHILD DIS DEV CO; United Nations, 2011, POL DECL HIV AIDS IN; United Nations, 2008, UN CONV RIGHTS PERS; Varni JW, 2013, PEDSQL MEASUREMENT M; Vidrine DJ, 2003, AIDS PATIENT CARE ST, V17, P187, DOI 10.1089/108729103321619791; WHO, 2011, WORLD REPORT ON DISABILITY, P1; [World Health Organization (WHO) UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; Worthington C, 2005, AIDS PATIENT CARE ST, V19, P258, DOI 10.1089/apc.2005.19.258; Wu LA, 2012, CHILD CARE HLTH DEV, V38, P332, DOI 10.1111/j.1365-2214.2011.01221.x; Zonta Marise Bueno, 2005, Braz J Infect Dis, V9, P479, DOI 10.1590/S1413-86702005000600005	39	26	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84024	10.1371/journal.pone.0084024	http://dx.doi.org/10.1371/journal.pone.0084024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391869	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000329323900012
J	Jin, X; Zhao, WK; Shi, KY; Ho, WTT; Zhao, ZZJ				Jin, Xi; Zhao, Wanke; Shi, Kaiyao; Ho, Wanting T.; Zhao, Zhizhuang J.			Generation of a New Congenic Mouse Strain with Enhanced Chymase Expression in Mast Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE POLYMORPHISMS; NEUTRAL PROTEASES; CONVERTING-ENZYME; SERINE-PROTEASE; MICE; ATHEROSCLEROSIS; ASSOCIATION; ANGIOTENSIN; GENOTYPE	Mast cells are effector cells best known for their roles in IgE-associated allergy, but they also play a protective role in defense against pathogens. These cells express high levels of proteases including chymase, tryptase and carboxypeptidase. In the present study, we identified a congenic strain of C57BL/6 mice expressing an extraordinarily high level of chymases Mcp-2 and Mcp-4 in mast cells. The overexpression was associated with variant Mcp-2 and Mcp-4 genes originated from DBA/2 mice that also expressed high levels of the two enzymes. Real time PCR analysis revealed that Mcp-2 and Mcp-4 were selectively overexpressed as tryptases, Cpa3 and several other chymases were kept at normal levels. Reporter gene assays demonstrated that single-nucleotide polymorphisms (SNPs) in the promoter region of Mcp-2 gene may be partly responsible for the increased gene transcription. Our study provides a new model system to study the function of mast cell chymases. The data also suggest that expression of chymases differs considerably in different strains of mice and the increased chymase activity may be responsible for some unique phenotypes observed in DBA/2 mice.	[Jin, Xi; Zhao, Wanke; Shi, Kaiyao; Ho, Wanting T.; Zhao, Zhizhuang J.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73190 USA; [Shi, Kaiyao] Jilin Univ, China Japan Union Hosp, Dept Cardiol, Changchun 130023, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; Jilin University	Zhao, ZZJ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73190 USA.	joe-zhao@ouhsc.edu			National Institutes of Health [HL076309, HL079441]; Oklahoma Center for the Advancement of Science Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079441, R01HL076309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported in part by grants HL076309 and HL079441 from the National Institutes of Health and a grant from Oklahoma Center for the Advancement of Science & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 2008, GENET MED, V10, P593, DOI [10.1097/GIM.0b013e3181804b9c, 10.1097GIM.0b013e3181804b9c]; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Bot I, 2007, CIRCULATION, V115, P2516, DOI 10.1161/CIRCULATIONAHA.106.660472; Bot I, 2011, CARDIOVASC RES, V89, P244, DOI 10.1093/cvr/cvq260; Fukuda M, 2002, HYPERTENS RES, V25, P179, DOI 10.1291/hypres.25.179; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Ge Y, 2001, AM J PATHOL, V158, P281, DOI 10.1016/S0002-9440(10)63967-3; Gumprecht Janusz, 2002, Med Sci Monit, V8, pCR603; He AN, 2013, CURR PHARM DESIGN, V19, P1114; Heikkilae HM, 2008, ARTERIOSCL THROM VAS, V28, P309, DOI 10.1161/ATVBAHA.107.151340; Ihara M, 1999, HYPERTENSION, V33, P1399, DOI 10.1161/01.HYP.33.6.1399; Jippo T, 1999, BLOOD, V93, P1942, DOI 10.1182/blood.V93.6.1942.406k08_1942_1950; Kerley-Hamilton JS, 2012, TOXICOL SCI, V126, P391, DOI 10.1093/toxsci/kfs002; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; Leskinen M, 2001, ARTERIOSCL THROM VAS, V21, P516, DOI 10.1161/01.ATV.21.4.516; LIAO L, 1995, J EXP MED, V181, P1123, DOI 10.1084/jem.181.3.1123; Magnusson SE, 2009, FASEB J, V23, P875, DOI 10.1096/fj.08-120394; Mao XQ, 1996, LANCET, V348, P581, DOI 10.1016/S0140-6736(95)10244-2; Mirghomizadeh F, 2009, J BIOL CHEM, V284, P32635, DOI 10.1074/jbc.M109.015446; Morii E, 1996, BLOOD, V88, P2488, DOI 10.1182/blood.V88.7.2488.bloodjournal8872488; Morii E, 1997, BLOOD, V90, P3057, DOI 10.1182/blood.V90.8.3057; NEBERT DW, 1989, CRIT REV TOXICOL, V20, P153, DOI 10.3109/10408448909017908; NEU N, 1987, J IMMUNOL, V139, P3630; Orinska Z, 2007, NAT MED, V13, P927, DOI 10.1038/nm1615; Ortlepp JR, 2001, CORONARY ARTERY DIS, V12, P493, DOI 10.1097/00019501-200109000-00008; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pemberton AD, 2003, CLIN EXP ALLERGY, V33, P1005, DOI 10.1046/j.1365-2222.2003.01720.x; Pfeufer A, 1996, AM J CARDIOL, V78, P362, DOI 10.1016/S0002-9149(96)00296-2; Piliponsky AM, 2012, AM J PATHOL, V181, P875, DOI 10.1016/j.ajpath.2012.05.013; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Tanaka K, 1999, CLIN EXP ALLERGY, V29, P800; Tani K, 2000, J LEUKOCYTE BIOL, V67, P585, DOI 10.1002/jlb.67.4.585; Waern I, 2013, MUCOSAL IMMUNOL, V6, P911, DOI 10.1038/mi.2012.129; Waern I, 2009, J IMMUNOL, V183, P6369, DOI 10.4049/jimmunol.0900180; Weidinger S, 2005, ALLERGY, V60, P1256, DOI 10.1111/j.1398-9995.2005.00879.x; Xia ZN, 1996, J BIOL CHEM, V271, P8747, DOI 10.1074/jbc.271.15.8747; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84340	10.1371/journal.pone.0084340	http://dx.doi.org/10.1371/journal.pone.0084340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391943	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900086
J	Li, SJ; Qin, XB; Guo, X; Cui, AR; He, YZ; Wei, S; Wang, XL; Shan, BE				Li, Shujun; Qin, Xuebo; Guo, Xin; Cui, Airong; He, Yuzheng; Wei, Sen; Wang, Xiaolu; Shan, Baoen			Dickkopf-1 Is Oncogenic and Involved in Invasive Growth in Non Small Cell Lung Cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; BETA-CATENIN/TCF; STEM-CELLS; WNT; DKK1; PATHWAY; CHINA; PROLIFERATION; ANTAGONIST; EXPRESSION	Dickkopf-1 (DKK1) is an inhibitor of the Wnt/beta-catenin signaling pathway. However, the role of DKK1 in the progression of non small cell lung cancer (NSCLC) is not fully understood. In this study, RT-PCR and Western blot were used to examine the expression of DKK1 in a panel of ten human NSCLC cell lines and NSCLC tissues. DKK1 expression was highly transactivated in the great majority of these cancer lines. The expression of DKK1 was upregulated on both mRNA and protein levels in NSCLC tissues compared with the adjacent normal lung tissues. Immunohistochemistry and immunofluoresence revealed that DKK1 was mainly distributed in the cytoplasm in both carcinoma tissues and cell lines. DKK1 protein expression was also evaluated in paraffin sections from 102 patients with NSCLC by immunohistochemistry, and 65(63.73%) tumors were DKK1 positive. Relative analysis showed a significant relationship between DKK1 positive expression and lymph node metastasis(P< 0.05). Patients with DKK1positive tumors had poorer DFS than those with negative ESCC (5-year DFS; 15.4% versus 27%, P = 0.007). To further explore the biological effects of DKK1 in NSCLC cells, we over-expressed DKK1 in NSCLC 95C cell using eukaryotic expression vector pCMV-Tab-2b and performed a knockdown of DKK1 in LTEP-a-2 cell using a short hairpin RNA expression vector pSilencer 5.1. DKK1 did not have any effect on proliferation, but seemed to play a role in migration and invasion capability. Overexpression of DKK1 promotes migratory and invasive activity of 95C, while DKK1 knockdown resulted in the suppression of migration and invasion potentials of LTEP-a-2 cell. Taken together, these results indicate that DKK1 may be a crucial regulator in the progression of NSCLC. DKK1 might be a potential therapeutic target in NSCLC.	[Li, Shujun; Guo, Xin; Cui, Airong; He, Yuzheng; Wang, Xiaolu] Hebei Med Univ, Hosp 2, Shijiazhuang, Peoples R China; [Qin, Xuebo] Hebei Chest Hosp, Shijiazhuang, Peoples R China; [Wei, Sen] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin, Peoples R China; [Shan, Baoen] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China	Hebei Medical University; Tianjin Medical University; Hebei Medical University	Wang, XL (corresponding author), Hebei Med Univ, Hosp 2, Shijiazhuang, Peoples R China.	thoracic20081069@126.com; shanbaoen_1962@163.com		, Shujun/0000-0001-5959-3160				Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chen WQ, 2011, THORAC CANCER, V2, P149, DOI 10.1111/j.1759-7714.2011.00062.x; Chen WQ, 2013, THORAC CANCER, V4, P102, DOI 10.1111/1759-7714.12025; Darlavoix T, 2009, VIRCHOWS ARCH, V454, P629, DOI 10.1007/s00428-009-0769-z; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Hall CL, 2008, PROSTATE, V68, P1396, DOI 10.1002/pros.20805; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017; Makino T, 2009, ANN SURG ONCOL, V16, P2058, DOI 10.1245/s10434-009-0476-7; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mikheev AM, 2004, CARCINOGENESIS, V25, P47, DOI 10.1093/carcin/bgg190; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Osada H, 2008, CANCER RES, V68, P1647, DOI 10.1158/0008-5472.CAN-07-5039; Patil MA, 2005, ONCOGENE, V24, P3737, DOI 10.1038/sj.onc.1208479; Qin XR, 2007, TRANSL RES, V150, P281, DOI 10.1016/j.trsl.2007.06.005; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sheng SL, 2009, CLIN CHEM, V55, P1656, DOI 10.1373/clinchem.2009.125641; Subramanian J, 2010, J THORAC ONCOL, V5, P1116, DOI 10.1097/JTO.0b013e3181e76159; Takahashi N, 2010, INT J CANCER, V126, P1611, DOI 10.1002/ijc.24865; Wirths O, 2003, LAB INVEST, V83, P429, DOI 10.1097/01.LAB.0000059926.66359.BD; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Yao XA, 2010, BIOMARKERS, V15, P128, DOI 10.3109/13547500903325662; You L, 2004, CANCER RES, V64, P3474, DOI 10.1158/0008-5472.CAN-04-0115; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Zeng HM, 2013, THORAC CANCER, V4, P53, DOI 10.1111/j.1759-7714.2012.00160.x; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	30	11	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84944	10.1371/journal.pone.0084944	http://dx.doi.org/10.1371/journal.pone.0084944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391982	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900125
J	Niimi, R; Watanabe, K				Niimi, Ryosuke; Watanabe, Katsumi			Contextual Effects of Scene on the Visual Perception of Object Orientation in Depth	PLOS ONE			English	Article							PICTURE PERCEPTION; REFERENCE FRAMES; SPATIAL MEMORY; SPACE; COMPENSATION; PERSPECTIVE; SURFACES; SLANT; SHAPE	We investigated the effect of background scene on the human visual perception of depth orientation (i.e., azimuth angle) of three-dimensional common objects. Participants evaluated the depth orientation of objects. The objects were surrounded by scenes with an apparent axis of the global reference frame, such as a sidewalk scene. When a scene axis was slightly misaligned with the gaze line, object orientation perception was biased, as if the gaze line had been assimilated into the scene axis (Experiment 1). When the scene axis was slightly misaligned with the object, evaluated object orientation was biased, as if it had been assimilated into the scene axis (Experiment 2). This assimilation may be due to confusion between the orientation of the scene and object axes (Experiment 3). Thus, the global reference frame may influence object orientation perception when its orientation is similar to that of the gaze-line or object.	[Niimi, Ryosuke] Univ Tokyo, Grad Sch Humanities & Sociol, Tokyo, Japan; [Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan	University of Tokyo; University of Tokyo	Niimi, R (corresponding author), Univ Tokyo, Grad Sch Humanities & Sociol, Tokyo, Japan.	niimi@L.u-tokyo.ac.jp	Niimi, Ryosuke/F-1535-2014	Niimi, Ryosuke/0000-0003-1916-9853; Watanabe, Katsumi/0000-0003-1282-9994	Japan Society for the Promotion of Science Fellows	Japan Society for the Promotion of Science Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grant-in-Aid for Japan Society for the Promotion of Science Fellows, awarded to RN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Barnett-Cowan M, 2008, BRAIN RES, V1242, P231, DOI 10.1016/j.brainres.2008.07.075; Biederman I., 1981, PERCEPTUAL ORG, P213, DOI 10.4324/9781315512372-8; Cuijpers RH, 2001, ACTA PSYCHOL, V108, P283, DOI 10.1016/S0001-6918(01)00046-4; CUTTING JE, 1987, J EXP PSYCHOL HUMAN, V13, P323, DOI 10.1037/0096-1523.13.3.323; CUTTING JE, 1988, J EXP PSYCHOL HUMAN, V14, P305, DOI 10.1037/0096-1523.14.2.305; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Doumen MJA, 2007, PERCEPTION, V36, P75, DOI 10.1068/p5550; Dyde RT, 2006, EXP BRAIN RES, V173, P612, DOI 10.1007/s00221-006-0405-y; EBY DW, 1995, PERCEPTION, V24, P981, DOI 10.1068/p240981; Feresin C, 2007, PERCEPTION, V36, P258, DOI 10.1068/p5528; Gillam B, 2007, PERCEPTION, V36, P596, DOI 10.1068/p5535; Haji-Khamneh B, 2010, VISION RES, V50, P1720, DOI 10.1016/j.visres.2010.05.027; Hermens F, 2003, PERCEPTION, V32, P235, DOI 10.1068/p3386; Juricevic I, 2006, J EXP PSYCHOL GEN, V135, P448, DOI 10.1037/0096-3445.135.3.448; Lawson R, 2000, J EXP PSYCHOL HUMAN, V26, P568, DOI 10.1037/0096-1523.26.2.568; Marchette SA, 2010, SPAT COGN COMPUT, V10, P1, DOI 10.1080/13875860903509406; MCBEATH MK, 1992, PSYCHOL SCI, V3, P362, DOI 10.1111/j.1467-9280.1992.tb00048.x; McNamara TP, 2003, PSYCHON B REV, V10, P589, DOI 10.3758/BF03196519; Mitsumatsu H, 2002, PERCEPTION, V31, P1289, DOI 10.1068/p3421; Mou WM, 2009, J EXP PSYCHOL HUMAN, V35, P83, DOI 10.1037/0096-1523.35.1.83; Niimi R, 2008, PSYCHON B REV, V15, P208, DOI 10.3758/PBR.15.1.208; Niimi R, 2009, PSYCHON B REV, V16, P289, DOI 10.3758/PBR.16.2.289; Nundy S, 2000, P NATL ACAD SCI USA, V97, P5592, DOI 10.1073/pnas.97.10.5592; Oomes AHJ, 2002, PERCEPT PSYCHOPHYS, V64, P507, DOI 10.3758/BF03194722; PALMER SE, 1980, COGNITIVE PSYCHOL, V12, P285, DOI 10.1016/0010-0285(80)90012-2; Reinhardt-Rutland AH, 1999, PERCEPTION, V28, P1361, DOI 10.1068/p2950; ROSINSKI RR, 1980, PERCEPT PSYCHOPHYS, V28, P521, DOI 10.3758/BF03198820; Sekuler AB, 1996, CAN J EXP PSYCHOL, V50, P270, DOI 10.1037/1196-1961.50.3.270; van der Kooij K, 2009, J VISION, V9, DOI 10.1167/9.3.15; Wilson HR, 2000, VISION RES, V40, P459, DOI 10.1016/S0042-6989(99)00195-9; Yang T, 1999, PERCEPT PSYCHOPHYS, V61, P456, DOI 10.3758/BF03211966	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84371	10.1371/journal.pone.0084371	http://dx.doi.org/10.1371/journal.pone.0084371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391947	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900090
J	Perisse, ARS; Smeaton, L; Chen, Y; La Rosa, A; Walawander, A; Nair, A; Grinsztejn, B; Santos, B; Kanyama, C; Hakim, J; Nyirenda, M; Kumarasamy, N; Lalloo, UG; Flanigan, T; Campbell, TB; Hughes, MD				Perisse, Andre R. S.; Smeaton, Laura; Chen, Yun; La Rosa, Alberto; Walawander, Ann; Nair, Apsara; Grinsztejn, Beatriz; Santos, Breno; Kanyama, Cecilia; Hakim, James; Nyirenda, Mulinda; Kumarasamy, Nagalingeswaran; Lalloo, Umesh G.; Flanigan, Timothy; Campbell, Thomas B.; Hughes, Michael D.		ACTG	Outcomes among HIV-1 Infected Individuals First Starting Antiretroviral Therapy with Concurrent Active TB or Other AIDS-Defining Disease	PLOS ONE			English	Article							IMMUNE RESTORATION DISEASE; HIV-INFECTED PATIENTS; OPPORTUNISTIC INFECTIONS; TREATMENT RESPONSE; TUBERCULOSIS; HAART; MORTALITY; SURVIVAL; INITIATION; DIAGNOSIS	Background: Tuberculosis (TB) is common among HIV-infected individuals in many resource-limited countries and has been associated with poor survival. We evaluated morbidity and mortality among individuals first starting antiretroviral therapy (ART) with concurrent active TB or other AIDS-defining disease using data from the "Prospective Evaluation of Antiretrovirals in Resource-Limited Settings" (PEARLS) study. Methods: Participants were categorized retrospectively into three groups according to presence of active confirmed or presumptive disease at ART initiation: those with pulmonary and/or extrapulmonary TB ("TB" group), those with other non-TB AIDS-defining disease ("other disease"), or those without concurrent TB or other AIDS-defining disease ("no disease"). Primary outcome was time to the first of virologic failure, HIV disease progression or death. Since the groups differed in characteristics, proportional hazard models were used to compare the hazard of the primary outcome among study groups, adjusting for age, sex, country, screening CD4 count, baseline viral load and ART regimen. Results: 31 of 102 participants (30%) in the "TB" group, 11 of 56 (20%) in the "other disease'' group, and 287 of 1413 (20%) in the "no disease'' group experienced a primary outcome event (p = 0.042). This difference reflected higher mortality in the TB group: 15 (15%), 0 (0%) and 41 (3%) participants died, respectively (p<0.001). The adjusted hazard ratio comparing the "TB" and "no disease'' groups was 1.39 (95% confidence interval: 0.93-2.10; p = 0.11) for the primary outcome and 3.41 (1.72-6.75; p<0.001) for death. Conclusions: Active TB at ART initiation was associated with increased risk of mortality in HIV-1 infected patients.	[Perisse, Andre R. S.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Ciencias Biol, Rio De Janeiro, Brazil; [Smeaton, Laura; Chen, Yun] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [La Rosa, Alberto] Asociac Civil Impacta Salud & Educ Barranco, Lima, Peru; [Walawander, Ann; Nair, Apsara] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA; [Grinsztejn, Beatriz] Fiocruz MS, Evandro Chagas Clin Res Inst, BR-21045900 Rio De Janeiro, Brazil; [Santos, Breno] Hosp Nossa Senhora Conceicao, Porto Alegre, RS, Brazil; [Kanyama, Cecilia] Kamuzu Cent Hosp, Lilongwe, Malawi; [Hakim, James] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Nyirenda, Mulinda] Univ Malawi, Coll Med, Blantyre, Malawi; [Kumarasamy, Nagalingeswaran] YRG Ctr AIDS Res & Educ, Madras, Tamil Nadu, India; [Lalloo, Umesh G.] Nelson R Mandela Sch Med, Durban, South Africa; [Flanigan, Timothy] Brown Med Sch, Providence, RI USA; [Campbell, Thomas B.] Univ Colorado, Sch Med, Dept Med, Div Infect Dis, Aurora, CO USA; [Hughes, Michael D.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Fundacao Oswaldo Cruz; Harvard University; Harvard T.H. Chan School of Public Health; Frontier Science Foundation; Fundacao Oswaldo Cruz; University of Zimbabwe; University of Malawi; University of Kwazulu Natal; Brown University; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard T.H. Chan School of Public Health	Perisse, ARS (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Ciencias Biol, Rio De Janeiro, Brazil.	aperisse@ensp.fiocruz.br	Kumarasasmy, Nagalingeswaran/AAB-7348-2021	LA ROSA, ALBERTO MARTIN/0000-0002-8005-0598; Nyirenda, Mulinda/0000-0003-2037-7449	National Institute of Allergy and Infectious Diseases [UMAI068634, UMAI068636]; National Institute of Mental Health (NIMH), National Institute of Dental and Craniofacial Research (NIDCR); Gilead Sciences, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069412, UM1AI069518] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH), National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH National Institute of Dental & Craniofacial Research (NIDCR)); Gilead Sciences, Inc.(Gilead Sciences); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Numbers UMAI068634 and UMAI068636 from the National Institute of Allergy and Infectious Diseases and supported by National Institute of Mental Health (NIMH), National Institute of Dental and Craniofacial Research (NIDCR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. Bristol Myers Squibb provided atazanavir, didanosine-EC and efavirenz (with consent of Merck); Gilead Sciences, Inc. provided emtricitabine, tenofovir-DF, emtricitabine/tenofovir-DF and financial support for purchase of other study drugs; GlaxoSmithKline provided lamivudine, zidovudine and lamivudine/zidovudine; and Boehringer Ingelheim Pharmaceuticals, Inc. provided nevirapine. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Employees of the NIAID participated as study team members and authors of this manuscript. The NIAID provided recommendations on the study design and approved the final study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript. Bristol Myers Squibb, Gilead Sciences Inc., GlaxoSmithKline and Boehringer Ingelheim Pharmaceuticals, Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Representatives of the pharmaceutical company sponsors participated as study team members and authors of this manuscript, but did not participate in data collection, data analyses or interpretation.	Aiuti F, 2006, AIDS REV, V8, P88; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Degu WA, 2012, 19 C RETR OPP INF 5; Dronda F, 2011, CURR HIV RES, V9, P229, DOI 10.2174/157016211796320324; Esposito A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-341; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Jevtovic D, 2005, HIV MED, V6, P140, DOI 10.1111/j.1468-1293.2005.00277.x; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2011, CURR OPIN INFECT DIS, V24, P34, DOI 10.1097/QCO.0b013e3283420f76; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2009, CLIN INFECT DIS, V48, P1138, DOI 10.1086/597468; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Perez-Molina JA, 2012, J ANTIMICROB CHEMOTH, V67, P312, DOI 10.1093/jac/dkr478; Sabin CA, 2002, AIDS, V16, pS61, DOI 10.1097/00002030-200216004-00009; Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241; Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Westreich D, 2012, AIDS, V26, P770, DOI 10.1097/QAD.0b013e328351f6b8; WHO, 2010, ANT THER HIV INF AD; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	24	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83643	10.1371/journal.pone.0083643	http://dx.doi.org/10.1371/journal.pone.0083643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391801	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200099
J	Seidlitz, A; Kotzan, N; Nagel, S; Reske, T; Grabow, N; Harder, C; Petersen, S; Sternberg, K; Weitschies, W				Seidlitz, Anne; Kotzan, Nadine; Nagel, Stefan; Reske, Thomas; Grabow, Niels; Harder, Claus; Petersen, Svea; Sternberg, Katrin; Weitschies, Werner			In Vitro Determination of Drug Transfer from Drug-Coated Balloons	PLOS ONE			English	Article							ELUTING BALLOON; PACLITAXEL; RESTENOSIS; MODEL; ANGIOPLASTY; ABSORPTION; TRANSPORT; CATHETER; DELIVERY; CELL	Drug-coated balloons are medical devices designed to locally deliver drug to diseased segments of the vessel wall. For these dosage forms, drug transfer to the vessel wall needs to be examined in detail, since drug released into the blood is cleared from the site. In order to examine drug transfer, a new in vitro setup was developed combining the estimation of drug loss during advancement to the site of application in a model coronary artery pathway with a hydrogel compartment representing, as a very simplified model, the vessel wall. The transfer of fluorescent model substances as well as the drug paclitaxel from coated balloons to the simulated vessel wall was evaluated using this method. The model was suitable to quantify the fractions transferred to the hydrogel and also to qualitatively assess distribution patterns in the hydrogel film. In the case of fluorescein sodium, rhodamin b and paclitaxel, vast amounts of the coated substance were lost during the simulated passage and only very small fractions of about 1% of the total load were transferred to the gel. This must be attributed to good water solubility of the fluorescent substances and the mechanical instability of the paclitaxel coating. Transfer of the hydrophobic model substance triamterene was however nearly unaffected by the preliminary tracking procedure with transferred fractions ranging from 8% to 14%. Analysis of model substance distribution yielded inhomogeneous distributions indicating that the coating was not evenly distributed on the balloon surface and that a great fraction of the coating liquid did not penetrate the folds of the balloon. This finding is contradictory to the generally accepted assumption of a drug depot inside the folds and emphasizes the necessity to thoroughly characterize in vitro performance of drug-coated balloons to support the very promising clinical data.	[Seidlitz, Anne; Kotzan, Nadine; Nagel, Stefan; Weitschies, Werner] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Ctr Drug Absorpt & Transport, Greifswald, Germany; [Reske, Thomas; Grabow, Niels; Petersen, Svea; Sternberg, Katrin] Univ Rostock, Inst Biomed Engn, D-18055 Rostock, Germany; [Harder, Claus] Biotron SE & Co KG, Erlangen, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Rostock	Seidlitz, A (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Ctr Drug Absorpt & Transport, Greifswald, Germany.	anne.seidlitz@uni-greifswald.de	Weitschies, Werner/AAT-7148-2021	Seidlitz, Anne/0000-0003-4493-545X	German Federal Ministry of Education and Research [03IS2081]; German state government of Mecklenburg-Vorpommern from the European social fund; regional development fund [V-630-S-087-210/266, V-630-S-087-210/267]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German state government of Mecklenburg-Vorpommern from the European social fund; regional development fund	Funding was provided by the German Federal Ministry of Education and Research (grant 03IS2081), German state government of Mecklenburg-Vorpommern from the European social fund and regional development fund (grant V-630-S-087-210/266 and/267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afari M, 2012, ENDOVASCULAR TODAY, P53; ARIAS MJ, 1994, J DRUG TARGET, V2, P45, DOI 10.3109/10611869409015892; ASTM International, 2007, F239407 ASTM INT COM; Cortese B, 2013, INT J CARDIOL, V164, P1, DOI 10.1016/j.ijcard.2012.05.037; Cortese B, 2012, INT J CARDIOL, V161, P4, DOI 10.1016/j.ijcard.2011.08.855; Council of Europe, 2010, EUR PHARM ED 7 0 SUP; Forrest ML, 2008, PHARM RES, V25, P194, DOI 10.1007/s11095-007-9451-9; Heilmann T, 2010, EUR CARDIOL REV, DOI [10.15420/ecr.2010.8.2.40, DOI 10.15420/ECR.2010.8.2.40]; Hwang CW, 2001, CIRCULATION, V104, P600, DOI 10.1161/hc3101.092214; Kelsch B, 2011, INVEST RADIOL, V46, P255, DOI 10.1097/RLI.0b013e31820577df; Levin AD, 2004, P NATL ACAD SCI USA, V101, P9463, DOI 10.1073/pnas.0400918101; Liggins RT, 1997, J PHARM SCI, V86, P1458, DOI 10.1021/js9605226; Moes J, 2013, EUR J PHARM BIOPHARM, V83, P87, DOI 10.1016/j.ejpb.2012.09.016; Petersen S, 2013, MAT SCI ENG C-MATER, V33, P4244, DOI 10.1016/j.msec.2013.06.021; Radke PW, 2011, EUROINTERVENTION, V7, P730, DOI 10.4244/EIJV7I6A116; Ruebben A., 2011, INTERVENTIONAL CARDI, V6, P56, DOI 10.15420/ICR.2011.6.1.56; Sakai M, 1997, J PHARM SCI, V86, P779, DOI 10.1021/js960529n; Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Schnorr B, 2010, MINERVA CARDIOANGIOL, V58, P567; Seidlitz A, 2012, BIOMED ENG-BIOMED TE, V57, P403, DOI 10.1515/bmt-2012-4120; Seidlitz A, 2011, EUR J PHARM BIOPHARM, V78, P36, DOI 10.1016/j.ejpb.2010.12.021; Semmling B, 2013, AAPS PHARMSCITECH, V14, P1209, DOI 10.1208/s12249-013-0011-9; SHARMA US, 1995, J PHARM SCI, V84, P1223, DOI 10.1002/jps.2600841015; Surapaneni Madhu S, 2012, ISRN Pharmacol, V2012, P623139, DOI 10.5402/2012/623139; Tepe G, 2008, NEW ENGL J MED, V358, P689, DOI 10.1056/NEJMoa0706356; Toropainen E, 2001, INVEST OPHTH VIS SCI, V42, P2942; Waksman R, 2009, CIRC-CARDIOVASC INTE, V2, P352, DOI 10.1161/CIRCINTERVENTIONS.109.873703; Watanabe E, 2004, EUR J PHARM BIOPHARM, V58, P659, DOI 10.1016/j.ejpb.2004.03.029; Werk M, 2008, CIRCULATION, V118, P1358, DOI 10.1161/CIRCULATIONAHA.107.735985; Wohrle J, 2012, CURR CARDIOL REP, V14, P635, DOI 10.1007/s11886-012-0290-x; Yazdani SK, 2014, CATHETER CARDIO INTE, V83, P132, DOI 10.1002/ccd.24995; Zhao YN, 2002, RAPID COMMUN MASS SP, V16, P1548, DOI 10.1002/rcm.749	33	36	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83992	10.1371/journal.pone.0083992	http://dx.doi.org/10.1371/journal.pone.0083992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391863	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900006
J	Sowa, Y; Imura, T; Numajiri, T; Takeda, K; Mabuchi, Y; Matsuzaki, Y; Nishino, K				Sowa, Yoshihiro; Imura, Tetsuya; Numajiri, Toshiaki; Takeda, Kosuke; Mabuchi, Yo; Matsuzaki, Yumi; Nishino, Kenichi			Adipose Stromal Cells Contain Phenotypically Distinct Adipogenic Progenitors Derived from Neural Crest	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SCHWANN-CELLS; SELF-RENEWAL; IN-VITRO; ORIGIN; LINEAGE; PREADIPOCYTES; MULTIPOTENCY; GENERATION; ADIPOCYTES	Recent studies have shown that adipose-derived stromal/stem cells (ASCs) contain phenotypically and functionally heterogeneous subpopulations of cells, but their developmental origin and their relative differentiation potential remain elusive. In the present study, we aimed at investigating how and to what extent the neural crest contributes to ASCs using Cre-loxP-mediated fate mapping. ASCs harvested from subcutaneous fat depots of either adult P0-Cre/or Wnt1-Cre/Floxed-reporter mice contained a few neural crest-derived ASCs (NCDASCs). This subpopulation of cells was successfully expanded in vitro under standard culture conditions and their growth rate was comparable to non-neural crest derivatives. Although NCDASCs were positive for several mesenchymal stem cell markers as non-neural crest derivatives, they exhibited a unique bipolar or multipolar morphology with higher expression of markers for both neural crest progenitors (p75NTR, Nestin, and Sox2) and preadipocytes (CD24, CD34, S100, Pref-1, GATA2, and C/EBP-delta). NCDASCs were able to differentiate into adipocytes with high efficiency but their osteogenic and chondrogenic potential was markedly attenuated, indicating their commitment to adipogenesis. In vivo, a very small proportion of adipocytes were originated from the neural crest. In addition, p75NTR-positive neural crest-derived cells were identified along the vessels within the subcutaneous adipose tissue, but they were negative for mural and endothelial markers. These results demonstrate that ASCs contain neural crest-derived adipocyte-restricted progenitors whose phenotype is distinct from that of non-neural crest derivatives.	[Sowa, Yoshihiro; Numajiri, Toshiaki; Takeda, Kosuke; Nishino, Kenichi] Kyoto Prefectural Univ Med, Dept Plast & Reconstruct Surg, Kyoto, Japan; [Imura, Tetsuya] Kyoto Prefectural Univ Med, Dept Pathol & Appl Neurobiol, Kyoto, Japan; [Imura, Tetsuya] Fukushima Med Univ, Sch Med, Dept Basic Pathol, Fukushima, Japan; [Mabuchi, Yo; Matsuzaki, Yumi] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Mabuchi, Yo] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Biochem & Biophys, Tokyo, Japan; [Matsuzaki, Yumi] Tokyo Med Univ, Inst Med Sci, Tokyo 1608402, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Fukushima Medical University; Keio University; Tokyo Medical & Dental University (TMDU); Tokyo Medical University	Imura, T (corresponding author), Kyoto Prefectural Univ Med, Dept Pathol & Appl Neurobiol, Kyoto, Japan.	timura@fmu.ac.jp	Mabuchi, Yo/L-1535-2013	Mabuchi, Yo/0000-0001-8008-3966; Matsuzaki, Yumi/0000-0002-3729-2997; Numajiri, Toshiaki/0000-0002-5390-9723	Ministry of Education, Culture, Sports, Science and Technology of Japan [24791913]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#24791913; http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; CINTI S, 1989, ANAT REC, V224, P466, DOI 10.1002/ar.1092240403; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dupin E, 2013, CYTOM PART A, V83A, P38, DOI 10.1002/cyto.a.22098; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Giovannini M, 2000, GENE DEV, V14, P1617; Jeong JY, 2012, J MATER SCI-MATER M, V23, P2773, DOI 10.1007/s10856-012-4718-z; Jiang T, 2010, BIOMATERIALS, V31, P3564, DOI 10.1016/j.biomaterials.2010.01.050; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lemos DR, 2012, STEM CELLS, V30, P1152, DOI 10.1002/stem.1082; Li H, 2011, PLAST RECONSTR SURG, V128, P663, DOI 10.1097/PRS.0b013e318221db33; Liu HX, 2012, DEV BIOL, V368, P294, DOI 10.1016/j.ydbio.2012.05.028; Mabuchi Y, 2013, STEM CELL REP, V1, P152, DOI 10.1016/j.stemcr.2013.06.001; Majka SM, 2010, P NATL ACAD SCI USA, V107, P14781, DOI 10.1073/pnas.1003512107; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Satija NK, 2009, J CELL MOL MED, V13, P4385, DOI 10.1111/j.1582-4934.2009.00857.x; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; Slukvin II, 2011, CELL CYCLE, V10, P1370, DOI 10.4161/cc.10.9.15345; Sowa Y, 2012, STEM CELLS DEV, V21, P1852, DOI 10.1089/scd.2011.0403; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Vinatier C, 2007, J BIOMED MATER RES A, V80A, P66, DOI 10.1002/jbm.a.30867; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Wrage PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001453; Yamamoto N, 2007, J DERMATOL SCI, V48, P43, DOI 10.1016/j.jdermsci.2007.05.015; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Zheng B, 2006, TISSUE ENG, V12, P1891, DOI 10.1089/ten.2006.12.1891	48	38	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84206	10.1371/journal.pone.0084206	http://dx.doi.org/10.1371/journal.pone.0084206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391913	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900056
J	Sun, YBY; Qu, XL; Li, XL; Nikolic-Paterson, DJ; Li, JH				Sun, Yu Bo Yang; Qu, Xinli; Li, Xueling; Nikolic-Paterson, David J.; Li, Jinhua			Endothelial Dysfunction Exacerbates Renal Interstitial Fibrosis through Enhancing Fibroblast Smad3 Linker Phosphorylation in the Mouse Obstructed Kidney	PLOS ONE			English	Article							ENOS DEFICIENCY PREDISPOSES; NITRIC-OXIDE; ANGIOTENSIN-II; TUBULOINTERSTITIAL FIBROSIS; DIABETIC-NEPHROPATHY; PROTECTS; INFLAMMATION; MICE; BLOCKADE; MEDIATOR	Endothelial dysfunction and enhanced transforming growth factor-beta (TGF-beta)/Smad3 signalling are common features of progressive renal fibrosis. This study investigated a potential link between these mechanisms. In unilateral ureteric obstruction (UUO) we observed an acute (6 hr) down-regulation of nitric oxide synthase 3 (NOS3/eNOS) levels and increased phosphorylation of the linker region of Smad3 at T179 and S208 in Smad3/JNK complexes. These events preceded Smad3 C-terminal domain phosphorylation and the induction of myofibroblast proliferation at 48 hrs. Mice deficient in NOS3 showed enhanced myofibroblast proliferation and collagen accumulation compared to wild type mice in a 7 day UUO model. This was associated with enhanced phosphorylation of Smad3 T179 and S208 by 92% and 88%, respectively, whereas Smad3-C-terminal phosphorylation was not affected. Resolvin D1 (RvD1) can suppress renal fibrosis in the UUO model, and further analysis herein showed that RvD1 protected against endothelial dysfunction and suppressed Smad3/JNK complex formation with a consequent reduction in phosphorylation of Smad3 T179 and S208 by 78% and 65%, respectively, while Smad3 C-terminal phosphorylation was unaltered. In vitro, conditioned media from mouse microvascular endothelial cells (MMEC) treated with a general inhibitor of nitric oxide synthase (L-NAME) augmented the proliferation and collagen production of renal fibroblasts (NRK49F cells) compared to control MMEC media and this was associated with increased phosphorylation of JNK and Smad3 T179 and S208, whereas Smad3-C-terminal domain phosphorylation was unaffected. The addition of RvD1 to L-NAME treated MMEC abrogated these effects of the conditioned media on renal fibroblasts. Finally, Smad3 T179/V and S208/A mutations significantly inhibit TGF-beta 1 induced up-regulation collagen I promoter. In conclusion, these data suggest that endothelial dysfunction can exacerbate renal interstitial fibrosis through increased fibroblast proliferation and collagen production via enhanced Smad3 linker phosphorylation.	[Sun, Yu Bo Yang; Qu, Xinli; Li, Jinhua] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Li, Xueling] Inner Mongolia Univ, Minist Mammalian Reprod Biol & Biotechnol, Key Lab Natl Educ, Hohhot, Inner Mongolia, Peoples R China; [Nikolic-Paterson, David J.] Monash Hlth, Dept Nephrol, Clayton, Vic, Australia; [Nikolic-Paterson, David J.] Monash Univ, Dept Med, Clayton, Vic, Australia	Monash University; Inner Mongolia University; Monash University	Li, JH (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.	jinhua.li@monash.edu	Li, Jinhua/I-2741-2014; Li, Jian/I-5538-2016	Li, Jian/0000-0001-7953-8230; Sun, Yu Bo Yang/0000-0003-0863-2769; Nikolic-Paterson, David/0000-0001-5734-2931; Li, Jinhua/0000-0003-4039-5759	Monash University; National Health and Medical Research Council (NHMRC) of Australia; NHMRC	Monash University(Monash University); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by Monash University Accelerating Programme and the National Health and Medical Research Council (NHMRC) of Australia. JL is the recipient of a NHMRC Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Campanholle G, 2013, AM J PHYSIOL-CELL PH, V304, pC591, DOI 10.1152/ajpcell.00414.2012; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Heeringa P, 2000, AM J PATHOL, V156, P879, DOI 10.1016/S0002-9440(10)64957-7; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; ISHIDOYA S, 1995, KIDNEY INT, V47, P1285, DOI 10.1038/ki.1995.183; Ito K, 2005, KIDNEY INT, V68, P515, DOI 10.1111/j.1523-1755.2005.00429.x; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; KATZBERG RW, 1988, LIFE SCI, V42, P1963, DOI 10.1016/0024-3205(88)90495-X; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Li F, 2012, J AM SOC NEPHROL, V23, P652, DOI 10.1681/ASN.2011040369; Li JH, 2006, J AM SOC NEPHROL, V17, P2799, DOI 10.1681/ASN.2006020130; Li JH, 2010, DIABETES, V59, P2612, DOI 10.2337/db09-1631; Li YJ, 2013, LIFE SCI, V92, P547, DOI 10.1016/j.lfs.2013.01.018; Lim AKH, 2011, AM J NEPHROL, V34, P337, DOI 10.1159/000331058; Liu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032009; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Liu Z, 2012, AM J PHYSIOL-RENAL, V302, pF986, DOI 10.1152/ajprenal.00595.2011; Ma FY, 2011, AM J PHYSIOL-RENAL, V300, pF1410, DOI 10.1152/ajprenal.00018.2011; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Matsuzaki K, 2012, CELL TISSUE RES, V347, P225, DOI 10.1007/s00441-011-1178-6; MATTANA J, 1995, CELL PHYSIOL BIOCHEM, V5, P176, DOI 10.1159/000154752; McGaha TL, 2002, ARTHRITIS RHEUM, V46, P2748, DOI 10.1002/art.10549; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Morrissey JJ, 1996, J AM SOC NEPHROL, V7, P2202; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Nakayama T, 2010, AM J PATHOL, V176, P2198, DOI 10.2353/ajpath.2010.090316; Nakayama T, 2009, AM J PHYSIOL-RENAL, V296, pF317, DOI 10.1152/ajprenal.90450.2008; Patzak A, 2008, AM J PHYSIOL-REG I, V294, pR429, DOI 10.1152/ajpregu.00482.2007; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Qu XL, 2012, J PATHOL, V228, P506, DOI 10.1002/path.4050; Rezaei HB, 2012, CLIN EXP PHARMACOL P, V39, P661, DOI 10.1111/j.1440-1681.2011.05592.x; Satchell SC, 2012, KIDNEY INT, V82, P949, DOI 10.1038/ki.2012.258; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Saura M, 2005, CIRC RES, V97, P1115, DOI 10.1161/01.RES.0000191538.76771.66; Savard S, 2012, NEPHROL DIAL TRANSPL, V27, P2182, DOI 10.1093/ndt/gfr641; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Serhan CN, 2008, PROSTAG OTH LIPID M, V73, P155; Smith RS, 2005, LIFE SCI, V76, P2457, DOI 10.1016/j.lfs.2004.11.028; Sun D, 2012, LIFE SCI, V90, P900, DOI 10.1016/j.lfs.2012.04.018; Sun YBY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055027; Velden J L AJ, 2011, AM J RESP CELL MOL B, V44, P571, DOI DOI 10.1165/RCMB.2009-02820C; Wang A, 2007, AM J PHYSIOL-RENAL, V293, pF1657, DOI 10.1152/ajprenal.00274.2007; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Yagi S, 2008, CIRC RES, V102, P68, DOI 10.1161/CIRCRESAHA.107.163493; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zimmerman CM, 2000, GENE, V249, P17, DOI 10.1016/S0378-1119(00)00162-1	61	26	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84063	10.1371/journal.pone.0084063	http://dx.doi.org/10.1371/journal.pone.0084063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391884	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900027
J	Asztalos, A; Sreenivasan, S; Szymanski, BK; Korniss, G				Asztalos, Andrea; Sreenivasan, Sameet; Szymanski, Boleslaw K.; Korniss, Gyorgy			Cascading Failures in Spatially-Embedded Random Networks	PLOS ONE			English	Article							COMPLEX; SYNCHRONIZATION	Cascading failures constitute an important vulnerability of interconnected systems. Here we focus on the study of such failures on networks in which the connectivity of nodes is constrained by geographical distance. Specifically, we use random geometric graphs as representative examples of such spatial networks, and study the properties of cascading failures on them in the presence of distributed flow. The key finding of this study is that the process of cascading failures is non-self-averaging on spatial networks, and thus, aggregate inferences made from analyzing an ensemble of such networks lead to incorrect conclusions when applied to a single network, no matter how large the network is. We demonstrate that this lack of self-averaging disappears with the introduction of a small fraction of long-range links into the network. We simulate the well studied preemptive node removal strategy for cascade mitigation and show that it is largely ineffective in the case of spatial networks. We introduce an altruistic strategy designed to limit the loss of network nodes in the event of a cascade triggering failure and show that it performs better than the preemptive strategy. Finally, we consider a real-world spatial network viz. a European power transmission network and validate that our findings from the study of random geometric graphs are also borne out by simulations of cascading failures on the empirical network.	[Asztalos, Andrea; Sreenivasan, Sameet; Szymanski, Boleslaw K.; Korniss, Gyorgy] Rensselaer Polytech Inst, Acad Res Ctr, Social Network, Troy, NY 12180 USA; [Asztalos, Andrea; Sreenivasan, Sameet; Szymanski, Boleslaw K.; Korniss, Gyorgy] Rensselaer Polytech Inst, Acad Res Ctr, Cognit Network, Troy, NY USA; [Asztalos, Andrea; Sreenivasan, Sameet; Szymanski, Boleslaw K.] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Asztalos, Andrea; Sreenivasan, Sameet; Korniss, Gyorgy] Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Sreenivasan, S (corresponding author), Rensselaer Polytech Inst, Acad Res Ctr, Social Network, Troy, NY 12180 USA.	sreens@rpi.edu	Szymanski, Boleslaw Karol/O-1374-2017; Szymanski, Boleslaw K/A-9121-2009; Korniss, Gyorgy/A-7360-2011	Szymanski, Boleslaw Karol/0000-0002-0307-6743; Szymanski, Boleslaw K/0000-0002-0307-6743; 	DTRA [HDTRA1-09-1-0049]; Army Research Laboratory [W911NF-09-2-0053]; NSF [DMR-1246958]; Direct For Mathematical & Physical Scien [1246958] Funding Source: National Science Foundation	DTRA(United States Department of DefenseDefense Threat Reduction Agency); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by DTRA Award No. HDTRA1-09-1-0049, by the Army Research Laboratory under Cooperative Agreement Number W911NF-09-2-0053 and by NSF Grant No. DMR-1246958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UPDATED UCTE DATA; Asztalos A, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30122-3; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bernstein A, 2011, 20110506 COL U EL EN; BOLLOBAS B., 2001, RANDOM GRAPHS, V73, DOI 10.1017/CBO9780511814068.008; Brandes U, 2005, LECT NOTES COMPUT SC, V3404, P533; Colak S, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/11/113037; Diaz J, 2001, PARALLEL PROCESSING, V10, P2000; Diaz-Guilera A, 2009, INT J BIFURCAT CHAOS, V19, P687, DOI 10.1142/S0218127409023044; Dobson I, 2007, CHAOS, V17, DOI 10.1063/1.2737822; Dorfler F, 2013, P NATL ACAD SCI USA, V110, P2005, DOI 10.1073/pnas.1212134110; Ercsey-Ravasz M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.038701; Hernandez V, 2005, ACM T MATH SOFTWARE, V31, P351, DOI 10.1145/1089014.1089019; Herrmann C, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026128; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; Kong ZN, 2010, IEEE T INFORM THEORY, V56, P5533, DOI 10.1109/TIT.2010.2068910; Korniss G, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051121; Korniss G, 2006, PHYS LETT A, V350, P324, DOI 10.1016/j.physleta.2005.09.081; Korniss G, 2012, SPRINGER SER OPTIM A, V58, P61, DOI 10.1007/978-1-4614-0857-4_3; Krapivsky PL, 2000, PHYS REV E, V61, pR993, DOI 10.1103/PhysRevE.61.R993; Li W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228702; Lopez E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.248701; Lu Q, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016111; Mendes GA, 2012, PHYSICA A, V391, P362, DOI 10.1016/j.physa.2011.07.046; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Penrose M, 2003, OXFORD STUDIES PROBA, V5; Rahnamay-Naeini M, 2013, IEEE T POWE IN PRESS; Rosas-Casals M, 2007, INT J BIFURCAT CHAOS, V17, P2465, DOI 10.1142/S0218127407018531; Sachs JD., 2009, SCI AM, V300, P34; Scala A, 2012, ARXIV12093733V2; Simonsen I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218701; Sreenivasan S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036105; Verma T, 2013, ARXIV13045402PHYSICS; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zaslavsky A, 2013, ARXIV13010159CSCY; Zhou Q, 2005, IEEE T POWER SYST, V20, P782, DOI 10.1109/TPWRS.2005.846178; Zhou Q, 2013, IEEE POWERT IN PRESS; Zimmerman RD, 2011, IEEE T POWER SYST, V26, P12, DOI 10.1109/TPWRS.2010.2051168	45	23	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84563	10.1371/journal.pone.0084563	http://dx.doi.org/10.1371/journal.pone.0084563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400101	gold, Green Published, Green Submitted			2022-12-27	WOS:000329462700035
J	Chi, YK; Han, JW; Jeong, H; Park, JY; Kim, TH; Lee, JJ; Lee, SB; Park, JH; Yoon, JC; Kim, JL; Ryu, SH; Jhoo, JH; Lee, DY; Kim, KW				Chi, Yeon Kyung; Han, Ji Won; Jeong, Hyeon; Park, Jae Young; Kim, Tae Hui; Lee, Jung Jae; Lee, Seok Bum; Park, Joon Hyuk; Yoon, Jong Chul; Kim, Jeong Lan; Ryu, Seung-Ho; Jhoo, Jin Hyeong; Lee, Dong Young; Kim, Ki Woong			Development of a Screening Algorithm for Alzheimer's Disease Using Categorical Verbal Fluency	PLOS ONE			English	Article							MENTAL STATUS EXAMINATION; KOREAN VERSION; PERFORMANCE; DEMENTIA; TIME; DISSOCIATION; REGRESSION; RETRIEVAL; MEMORY; SCALE	We developed a weighted composite score of the categorical verbal fluency test (CVFT) that can more easily and widely screen Alzheimer's disease (AD) than the mini-mental status examination (MMSE). We administered the CVFT using animal category and MMSE to 423 community-dwelling mild probable AD patients and their age-and gender-matched cognitively normal controls. To enhance the diagnostic accuracy for AD of the CVFT, we obtained a weighted composite score from subindex scores of the CVFT using a logistic regression model: logit (case) = 1.160+0.4746 x gender + 0.003 x age + 0.226 x education level -0.089 x first-half score -0.516 x switching score -0.303 x clustering score + 0.534 x perseveration score. The area under the receiver operating curve (AUC) for AD of this composite score AD was 0.903 (95% CI = 0.883 - 0.923), and was larger than that of the age-, gender-and education-adjusted total score of the CVFT (p < 0.001). In 100 bootstrapped resamples, the composite score consistently showed better diagnostic accuracy, sensitivity and specificity for AD than the total score. Although AUC for AD of the CVFT composite score was slightly smaller than that of the MMSE (0.930, p = 0.006), the CVFT composite score may be a good alternative to the MMSE for screening AD since it is much briefer, cheaper, and more easily applicable over phone or internet than the MMSE.	[Chi, Yeon Kyung; Han, Ji Won; Jeong, Hyeon; Park, Jae Young; Kim, Tae Hui; Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea; [Lee, Jung Jae] Kyungbook Natl Univ Hosp, Dept Psychiat, Taegu, South Korea; [Lee, Seok Bum] Dankook Univ Hosp, Dept Psychiat, Cheonan, South Korea; [Park, Joon Hyuk] Jeju Natl Univ Hosp, Dept Neuropsychiat, Cheju, South Korea; [Yoon, Jong Chul] Kyunggi Prov Hosp Elderly, Dept Neuropsychiat, Yongin, South Korea; [Kim, Jeong Lan] Chungnam Natl Univ Hosp, Dept Psychiat, Taejon, South Korea; [Ryu, Seung-Ho] Konkuk Univ Hosp, Dept Neuropsychiat, Seoul, South Korea; [Jhoo, Jin Hyeong] Kangwon Natl Univ Hosp, Dept Neuropsychiat, Chunchon, South Korea; [Lee, Dong Young] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea; [Lee, Dong Young; Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea	Seoul National University (SNU); Kyungpook National University; Kyungpook National University Hospital; Dankook University; Dankook University Hospital; Jeju National University; Chungnam National University; Chungnam National University Hospital; Konkuk University; Konkuk University Medical Center; Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, KW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea.	kwkimmd@snu.ac.kr	Kim, Tae Hui/AAR-9213-2020; Kim, Ki Woong/D-5801-2012	Kim, Ki Woong/0000-0002-1103-3858; PARK, JOON HYUK/0000-0002-0396-5284; Kim, Tae Hui/0000-0003-0133-5227; Kim, Jeong Lan/0000-0002-6554-4637	Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea [A092077]; National Research Foundation of Korea (NRF); Korean government (MEST) [2011-0018262]	Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by the grant of the Korean Health Technology R&D Project, Ministry for Health, Welfare, & Family Affairs, Republic of Korea (Grant No. A092077), and by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST; Grant No. 2011-0018262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Fagundo AB, 2008, INT J GERIATR PSYCH, V23, P1007, DOI 10.1002/gps.2025; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Haugrud N, 2011, J INT NEUROPSYCH SOC, V17, P1153, DOI 10.1017/S1355617711001196; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kim KW, 2011, J ALZHEIMERS DIS, V23, P279, DOI 10.3233/JAD-2010-101221; Kim KW, 2005, DEMENT GERIATR COGN, V19, P324, DOI 10.1159/000084558; Kim KW, 2011, NATIONWIDE SURVEY DE, P347; Kim KW, 2009, NATIONWIDE SURVEY EP, P131; Kim TH, 2010, PSYCHIAT INVEST, V7, P102, DOI 10.4306/pi.2010.7.2.102; Lacruz M, 2012, INT J GERIATR PSYCHI; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; Li CP, 2012, CHINESE MED J-PEKING, V125, P851, DOI 10.3760/cma.j.issn.0366-6999.2012.05.022; March EG, 2006, J CLIN EXP NEUROPSYC, V28, P549, DOI 10.1080/13803390590949502; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Park J, 2006, COMMUNICATION SCI DI, V11, P99; Park J. H., 2007, PSYCHIAT INVEST, V4, P84; Raboutet C, 2010, J CLIN EXP NEUROPSYC, V32, P268, DOI 10.1080/13803390902984464; Reckess GZ, 2013, J ALZHEIMERS DIS; Rosen VM, 1997, J EXP PSYCHOL GEN, V126, P211, DOI 10.1037/0096-3445.126.3.211; Scott AJ, 1997, BIOMETRIKA, V84, P57, DOI 10.1093/biomet/84.1.57; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8	28	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84111	10.1371/journal.pone.0084111	http://dx.doi.org/10.1371/journal.pone.0084111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286ID	24392109	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100033
J	George, AA; Hayden, S; Holzhausen, LC; Ma, EY; Suzuki, SC; Brockerhoff, SE				George, Ashley A.; Hayden, Sara; Holzhausen, Lars C.; Ma, Eva Y.; Suzuki, Sachihiro C.; Brockerhoff, Susan E.			Synaptojanin 1 Is Required for Endolysosomal Trafficking of Synaptic Proteins in Cone Photoreceptor Inner Segments	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT; IN-VIVO; ZEBRAFISH; RAB7; ROD; NEURODEGENERATION; TRANSMISSION; LIGHT; CONSTRUCTION; MATURATION	Highly polarized cells such as photoreceptors require precise and efficient strategies for establishing and maintaining the proper subcellular distribution of proteins. The signals and molecular machinery that regulate trafficking and sorting of synaptic proteins within cone inner segments is mostly unknown. In this study, we show that the polyphosphoinositide phosphatase Synaptojanin 1 (SynJ1) is critical for this process. We used transgenic markers for trafficking pathways, electron microscopy, and immunocytochemistry to characterize trafficking defects in cones of the zebrafish mutant, nrc(a14), which is deficient in phosphoinositide phosphatase, SynJ1. The outer segments and connecting cilia of nrc(a14) cone photoreceptors are normal, but RibeyeB and VAMP2/synaptobrevin, which normally localize to the synapse, accumulate in the nrc(a14) inner segment. The structure of the Endoplasmic Reticulum in nrc(a14) mutant cones is normal. Golgi develop normally, but later become disordered. Large vesicular structures accumulate within nrc(a14) cone photoreceptor inner segments, particularly after prolonged incubation in darkness. Cone inner segments of nrc(a14) mutants also have enlarged acidic vesicles, abnormal late endosomes, and a disruption in autophagy. This last pathway also appears exacerbated by darkness. Taken altogether, these findings show that SynJ1 is required in cones for normal endolysosomal trafficking of synaptic proteins.	[George, Ashley A.; Hayden, Sara; Holzhausen, Lars C.; Ma, Eva Y.; Brockerhoff, Susan E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Suzuki, Sachihiro C.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Brockerhoff, SE (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	sbrocker@uw.edu	Suzuki, Sachihiro/G-5898-2015		NIH [EY015165, RO1 EY14358]; NEI [EY001730]; UW Vision Core; NATIONAL EYE INSTITUTE [P30EY001730, R01EY015165, R01EY014358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); UW Vision Core; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by NIH grant EY015165 (SEB), RO1 EY14358 (SS) and NEI grant EY001730, which supports the UW Vision Core. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allwardt BA, 2001, J NEUROSCI, V21, P2330, DOI 10.1523/JNEUROSCI.21-07-02330.2001; Arshavsky Vadim Y, 2003, Sci STKE, V2003, pPE43, DOI 10.1126/stke.2003.204.pe43; Bensen ES, 2000, GENETICS, V154, P83; Bottger G, 1996, J BIOL CHEM, V271, P29191, DOI 10.1074/jbc.271.46.29191; BRANCHEK T, 1984, J COMP NEUROL, V224, P116, DOI 10.1002/cne.902240110; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; BROCKERHOFF SE, 1997, J NEUROSCI, V20, P1; Brockerhoff SE, 2006, NAT PROTOC, V1, P2448, DOI 10.1038/nprot.2006.255; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chinchore Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000377; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Cook C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009423; Cossec JC, 2012, HUM MOL GENET, V21, P3156, DOI 10.1093/hmg/dds142; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dehay B, 2013, MOVEMENT DISORD, V28, P725, DOI 10.1002/mds.25462; DERETIC D, 1991, J CELL BIOL, V113, P1281, DOI 10.1083/jcb.113.6.1281; Dermaut B, 2005, J CELL BIOL, V170, P127, DOI 10.1083/jcb.200412001; Easter SS, 1996, DEV BIOL, V180, P646; Ferguson CJ, 2012, HUM MOL GENET, V21, P3525, DOI 10.1093/hmg/dds179; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Ganley IG, 2006, J BIOL CHEM, V281, P17890, DOI 10.1074/jbc.M601679200; Gong LW, 2008, P NATL ACAD SCI USA, V105, P17561, DOI 10.1073/pnas.0809221105; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Holzhausen LC, 2009, J COMP NEUROL, V517, P633, DOI 10.1002/cne.22176; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Insinna C, 2008, DEV DYNAM, V237, P1982, DOI 10.1002/dvdy.21554; Insinna C, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-12; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Kennedy BN, 2007, INVEST OPHTH VIS SCI, V48, P522, DOI 10.1167/iovs.06-0975; Kikuta Hiroshi, 2009, V546, P69, DOI 10.1007/978-1-60327-977-2_5; Kirkbride KC, 2012, CYTOSKELETON, V69, P625, DOI 10.1002/cm.21051; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kolb H, 2003, AM SCI, V91, P28, DOI 10.1511/2003.11.841; Krebs CE, 2013, HUM MUTAT, V34, P1200, DOI 10.1002/humu.22372; Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Linton JD, 2010, P NATL ACAD SCI USA, V107, P8599, DOI 10.1073/pnas.1002471107; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Quadri M, 2013, HUM MUTAT, V34, P1208, DOI 10.1002/humu.22373; Rajala A, 2009, BIOCHEMISTRY-US, V48, P5563, DOI 10.1021/bi9000062; Ramamurthy V, 2009, CLIN GENET, V76, P137, DOI 10.1111/j.1399-0004.2009.01240.x; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; SCHMIED R, 1989, J NEUROBIOL, V20, P115, DOI 10.1002/neu.480200303; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Singer-Kruger B, 1998, J CELL SCI, V111, P3347; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Suzuki SC, 2013, P NATL ACAD SCI USA, V110, P15109, DOI 10.1073/pnas.1303551110; Tofaris GK, 2012, MOVEMENT DISORD, V27, P1364, DOI 10.1002/mds.25136; Trapani JG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000480; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Van Epps HA, 2004, J NEUROSCI, V24, P8641, DOI 10.1523/JNEUROSCI.2892-04.2004; Van Epps HA, 2001, INVEST OPHTH VIS SCI, V42, P868; Vergne I, 2010, FEBS LETT, V584, P1313, DOI 10.1016/j.febslet.2010.02.054; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Wan L, 2005, J NEUROSCI, V25, P941, DOI 10.1523/JNEUROSCI.4657-04.2005; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	77	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84394	10.1371/journal.pone.0084394	http://dx.doi.org/10.1371/journal.pone.0084394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392132	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100055
J	Sigvardt, ZMS; Olesen, J				Sigvardt, Zandra M. S.; Olesen, Jorgen			Mating Behaviour in Laevicaudatan Clam Shrimp (Crustacea, Branchiopoda) and Functional Morphology of Male Claspers in a Phylogenetic Context: A Video-Based Analysis	PLOS ONE			English	Article							EULIMNADIA-TEXANA CRUSTACEA; MATE-GUARDING BEHAVIOR; CONCHOSTRACA; CLADOCERA; CLASSIFICATION; EVOLUTION; PACKARD	Clam shrimps are freshwater branchiopod crustaceans which often present complicated breeding systems including asexual reproduction (parthenogenesis) and mixed mating systems (in androdioecious species both selfing and outcrossing occurs due to the co-presence of hermaphrodites and males). Reproductive patterns of Spinicaudata, which contains most clam shrimp species, have received much attention. Another group of clam shrimps, Laevicaudata, which holds a key position in branchiopod phylogeny, has practically not been studied. As a part of the mating process, males clasp to the carapace margin of the females with a pair (or two pairs) of anterior trunk limbs modified as claspers. Previous studies have shown that clasper morphology is important in a phylogenetic context, and that some parts of the claspers in Spinicaudata and Laevicaudata may have undergone a remarkable parallel evolution. Here we have used video microscopy to study aspects of the mating behaviour, egg extrusion, and fertilization in Lynceus brachyurus (Laevicaudata). It is shown that fertilization is likely to be external and that the peculiar tri-lobed lateral lamellae of female's hind body assist in guiding the egg mass to the exopodal egg carriers where they are collected by their distal setation. The functional morphology of the male claspers was studied in detail by close-up video recordings. The movable "finger'' of the clasper bends around the female's carapace edge and serves to hold the female during mating. The larger palp grasps around the female carapace margin in a way very similar to the movable "finger'', possibly indirectly providing sensory input on the "finger'' position. A brief comparative study of the claspers of a spinicaudatan clam shrimp showed both similarities and differences to the laevicaudatan claspers. The presence of two pairs of claspers in Spinicaudata seems to give males a better hold of the female which may play a role during extended mate guarding.	[Sigvardt, Zandra M. S.; Olesen, Jorgen] Nat Hist Museum Denmark, Copenhagen, Denmark		Olesen, J (corresponding author), Nat Hist Museum Denmark, Copenhagen, Denmark.	jolesen@snm.ku.dk	Olesen, Jørgen/A-3353-2013	Olesen, Jørgen/0000-0001-9582-7083; Sigvardt, Zandra/0000-0003-0760-7457; Olesen, Jes/0000-0002-6712-2702				Benvenuto C, 2009, CURR SCI INDIA, V96, P130; Benvenuto C, 2012, BEHAV ECOL, V23, P218, DOI 10.1093/beheco/arr178; Benvenuto C, 2011, BEHAV ECOL SOCIOBIOL, V65, P1899, DOI 10.1007/s00265-011-1199-x; Benvenuto C, 2009, BEHAV ECOL, V20, P1125, DOI 10.1093/beheco/arp106; Botnariuc N, 1947, NOTATIONES BIOL, V5, P68; Brendonck L, 2008, HYDROBIOLOGIA, V595, P167, DOI 10.1007/s10750-007-9119-9; Damgaard J, 1998, HYDROBIOLOGIA, V377, P9, DOI 10.1023/A:1003256906580; Eder E, 2000, J CRUSTACEAN BIOL, V20, P657, DOI 10.1651/0278-0372(2000)020[0657:FROLLM]2.0.CO;2; Elmoor-Loureiro Lourdes M.A., 2006, Nauplius, V14, P19; Ferrari FD, 2012, CRUSTACEANA, V85, P359, DOI 10.1163/156854012X624655; Fox CW, 2003, EVOL ECOL RES, V5, P273; Fritsch M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-35; FRYER G, 1987, ZOOL J LINN SOC-LOND, V91, P357, DOI 10.1111/j.1096-3642.1987.tb01420.x; Fryer G, 2009, ZOOL J LINN SOC-LOND, V155, P513, DOI 10.1111/j.1096-3642.2008.00455.x; Garm A, 2004, ZOOL J LINN SOC-LOND, V142, P233, DOI 10.1111/j.1096-3642.2004.00132.x; KNOLL L, 1995, HYDROBIOLOGIA, V298, P73, DOI 10.1007/BF00033801; KNOLL L, 1995, HYDROBIOLOGIA, V298, P67, DOI 10.1007/BF00033800; Linder Folke, 1945, ARKIV ZOOL, V37A, P1; MARTIN JW, 1986, ZOOL SCR, V15, P221, DOI 10.1111/j.1463-6409.1986.tb00224.x; Medland VL, 2000, ETHOLOGY, V106, P839, DOI 10.1046/j.1439-0310.2000.00603.x; Olesen J, 1996, ZOOL SCR, V25, P291, DOI 10.1111/j.1463-6409.1996.tb00168.x; Olesen J, 1998, ZOOL J LINN SOC-LOND, V122, P491, DOI 10.1111/j.1096-3642.1998.tb02161.x; Olesen J, 2000, CRUSTACEANA, V73, P869, DOI 10.1163/156854000504877; Olesen J, 2014, ATLAS CRUST IN PRESS; Olesen J, 2007, J CRUSTACEAN BIOL, V27, P165, DOI 10.1651/S-2727.1; Olesen J, 2013, J CRUSTACEAN BIOL, V33, P62, DOI 10.1163/1937240X-00002121; Olesen Jorgen, 2009, Arthropod Systematics & Phylogeny, V67, P3; Perez-Bote JL, 2010, CRUSTACEANA, V83, P1327, DOI 10.1163/001121610X535690; Richter S, 2007, CLADISTICS, V23, P301, DOI 10.1111/j.1096-0031.2007.00148.x; ROEN U, 1995, DANMARKS FAUNA, V85; Rogers DC, 2012, J CRUSTACEAN BIOL, V32, P827, DOI 10.1163/193724012X637212; Rogers DC, 2002, HYDROBIOLOGIA, V486, P1, DOI 10.1023/A:1021332610805; Schwentner M, 2011, BIOL J LINN SOC, V104, P575, DOI 10.1111/j.1095-8312.2011.01746.x; Scourfield DJ, 1926, PHILOS T R SOC LON B, V214, P153, DOI 10.1098/rstb.1926.0005; Sichlau MH, 2013, ASLO 2013 AQ SCI M 1; STRENTH N E, 1977, Southwestern Naturalist, V22, P205, DOI 10.2307/3669811; Titelman J, 2007, J PLANKTON RES, V29, P1023, DOI 10.1093/plankt/fbm076; Weeks SC, 2004, INVERTEBR BIOL, V123, P146; Weeks SC, 2002, HYDROBIOLOGIA, V486, P289, DOI 10.1023/A:1021379608504; Weeks SC, 2008, ETHOLOGY, V114, P64, DOI 10.1111/j.1439-0310.2007.01446.x; WINGSTRAND K G, 1978, Kongelige Danske Videnskabernes Selskab Biologiske Skrifter, V22, P1; Yasui Y, 2001, ECOL RES, V16, P605, DOI 10.1046/j.1440-1703.2001.00423.x; Zucker N, 2002, INVERTEBR BIOL, V121, P66	43	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84021	10.1371/journal.pone.0084021	http://dx.doi.org/10.1371/journal.pone.0084021			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392104	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100028
J	Cescon, A; Patterson, S; Chan, K; Palmer, AK; Margolese, S; Burchell, AN; Cooper, C; Klein, MB; Machouf, N; Montaner, JSG; Tsoukas, C; Hogg, RS; Raboud, JM; Loutfy, MR				Cescon, Angela; Patterson, Sophie; Chan, Keith; Palmer, Alexis K.; Margolese, Shari; Burchell, Ann N.; Cooper, Curtis; Klein, Marina B.; Machouf, Nima; Montaner, Julio S. G.; Tsoukas, Chris; Hogg, Robert S.; Raboud, Janet M.; Loutfy, Mona R.		CANOC Collaboration	Gender Differences in Clinical Outcomes among HIV-Positive Individuals on Antiretroviral Therapy in Canada: A Multisite Cohort Study	PLOS ONE			English	Article							DISEASE PROGRESSION; SEX-DIFFERENCES; RNA LEVELS; DRUG-USE; MORTALITY; HIV/AIDS; RACE	Background: Cohort data examining differences by gender in clinical responses to combination antiretroviral therapy (ART) remain inconsistent and have yet to be explored in a multi-province Canadian setting. This study investigates gender differences by injection drug use (IDU) history in virologic responses to ART and mortality. Methods: Data from the Canadian Observational Cohort (CANOC) collaboration, a multisite cohort study of HIV-positive individuals initiating ART after January 1, 2000, were included. This analysis was restricted to participants with a follow-up HIV-RNA plasma viral load measure and known IDU history. Weibull hazard regression evaluated time to virologic suppression (2 consecutive measures <50 copies/mL), rebound (>1000 copies/mL after suppression), and all-cause mortality. Sensitivity analyses explored the impact of presumed ART use in pregnancy on virologic outcomes. Results: At baseline, women (1120 of 5442 participants) were younger (median 36 vs. 41 years) and more frequently reported IDU history (43.5% vs. 28.8%) (both p<0.001). Irrespective of IDU history, in adjusted multivariable analyses women were significantly less likely to virologically suppress after ART initiation and were at increased risk of viral load rebound. In adjusted time to death analysis, no differences by gender were noted. After adjusting for presumed ART use in pregnancy, observed gender differences in time to virologic suppression for non-IDU, and time to virologic rebound for IDU, became insignificant. Conclusions: HIV-positive women in CANOC are at heightened risk for poor clinical outcomes. Further understanding of the intersections between gender and other factors augmenting risk is needed to maximize the benefits of ART.	[Cescon, Angela; Patterson, Sophie; Chan, Keith; Palmer, Alexis K.; Montaner, Julio S. G.; Hogg, Robert S.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Patterson, Sophie; Palmer, Alexis K.; Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Margolese, Shari] Canadian Observat Cohort CANOC Collaborat, Toronto, ON, Canada; [Burchell, Ann N.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Cooper, Curtis] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Klein, Marina B.; Tsoukas, Chris] McGill Univ, Dept Med, Montreal, PQ, Canada; [Klein, Marina B.] McGill Univ, Ctr Hlth, Montreal Chest Inst, Montreal, PQ, Canada; [Machouf, Nima] Clin Med Actuel, Montreal, PQ, Canada; [Montaner, Julio S. G.] Univ British Columbia, Dept Med, Div Aids, Vancouver, BC, Canada; [Raboud, Janet M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Raboud, Janet M.] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada; [Loutfy, Mona R.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Loutfy, Mona R.] Maple Leaf Med Clin, Toronto, ON, Canada; [Loutfy, Mona R.] Univ Toronto, Dept Med, Toronto, ON, Canada	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of Ottawa; Ottawa Hospital Research Institute; McGill University; McGill University; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto	Loutfy, MR (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	mona.loutfy@wchospital.ca	Cooper, Curtis/M-9320-2019	Patterson, Sophie/0000-0002-5503-7447; Cairney, John/0000-0003-2856-3967; Hogg, Robert/0000-0003-3463-5488; Walmsley, Sharon/0000-0002-3959-5692; Klein, Marina/0000-0002-3063-8430	Emerging Team Grant from the Canadian Institutes of Health Research (CIHR); CIHR Canadian HIV Trials Network [CTN 242]; CIHR; OHTN; Fonds de recherche en sante du Quebec (FRSQ); National Institute on Drug Abuse, National Institutes of Health	Emerging Team Grant from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); OHTN; Fonds de recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	CANOC is funded through an Emerging Team Grant from the Canadian Institutes of Health Research (CIHR) (www.cihr-irsc.gc.ca/e/193.html) and is supported by the CIHR Canadian HIV Trials Network (CTN 242) (www.hivnet.ubc.ca/home/). ANB is supported by a CIHR New Investigator Award. CC and JR are supported by Career Scientist Awards from the OHTN. MBK is supported by a Chercheur-Boursier Clinicien Senior Career Award from the Fonds de recherche en sante du Quebec (FRSQ). MRL receives salary support from CIHR. JSGM is supported by an Avant-Garde Award from the National Institute on Drug Abuse, National Institutes of Health. AKP is supported by a CIHR Doctoral Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belvedere LM, 2012, CAN J PUBLIC HEALTH, V103, P202, DOI 10.1007/BF03403813; Canada S., 2011, DEATHS ESTIMATES PRO; Carter AJ, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17433; Collazos J, 2007, AIDS, V21, P835, DOI 10.1097/QAD.0b013e3280b0774a; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Geretti AM, ANTIVIRAL THER, V13, P927; Hankins C, 2008, CURR OPIN HIV AIDS, V3, P514, DOI 10.1097/COH.0b013e32830136b4; Hanna DB, 2013, CLIN INFECT DIS, V56, P1174; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Kuyper LM, 2004, JAIDS-J ACQ IMM DEF, V37, P1470, DOI 10.1097/01.qai.0000138379.39317.62; Lemly DC, 2009, J INFECT DIS, V199, P991, DOI 10.1086/597124; Lucas GM, 2001, J ACQ IMMUN DEF SYND, V27, P251, DOI 10.1097/00126334-200107010-00006; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Mocroft A, 2000, J ACQ IMMUN DEF SYND, V24, P475, DOI 10.1097/00126334-200008150-00013; Moore AL, 2003, JAIDS-J ACQ IMM DEF, V32, P452, DOI 10.1097/00126334-200304010-00017; Moore AL, 2002, J ACQ IMMUN DEF SYND, V29, P197, DOI 10.1097/00042560-200202010-00015; Moore AL, 2001, J ACQ IMMUN DEF SYND, V26, P159, DOI 10.1097/00126334-200102010-00008; NAIDS, 2012 REP GLOB AIDS E; Napravnik S, 2002, JAIDS-J ACQ IMM DEF, V31, P11, DOI 10.1097/00126334-200209010-00002; Nicastri E, 2005, AIDS, V19, P577, DOI 10.1097/01.aids.0000163934.22273.06; Nicastri E, 2007, J ANTIMICROB CHEMOTH, V60, P724, DOI 10.1093/jac/dkm302; Palmer AK, 2011, INT J EPIDEMIOL, V40, P25, DOI 10.1093/ije/dyp393; Poundstone KE, 2001, AIDS, V15, P1115, DOI 10.1097/00002030-200106150-00006; Raboud J, 2010, HIV CLIN TRIALS, V11, P340, DOI 10.1310/hct1106-340; Touloumi G, 2004, AIDS, V18, P1697, DOI 10.1097/01.aids.0000131395.14339.f5; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed	26	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83649	10.1371/journal.pone.0083649	http://dx.doi.org/10.1371/journal.pone.0083649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391803	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200101
J	Chen, Q; Wang, JW; Tian, J; Tang, X; Yu, CQ; Marshall, RJ; Chen, DF; Cao, WH; Zhan, SY; Lv, J; Lee, LM; Hu, YH				Chen, Qing; Wang, Jinwei; Tian, Jun; Tang, Xun; Yu, Canqing; Marshall, Roger J.; Chen, Dafang; Cao, Weihua; Zhan, Siyan; Lv, Jun; Lee, Liming; Hu, Yonghua			Association between Ambient Temperature and Blood Pressure and Blood Pressure Regulators: 1831 Hypertensive Patients Followed Up for Three Years	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; OUTDOOR TEMPERATURE; ALCOHOL-CONSUMPTION; VARIABILITY; COLD; SENSITIVITY; REACTIVITY; PREDICTOR; INHIBITOR; MORTALITY	Several studies have suggested an association between ambient air temperature and blood pressure. However, this has not been reliably confirmed by longitudinal studies. Also, whether the reaction to temperature stimulation is modified by other factors such as antihypertensive medication is rarely investigated. The present study explores the relationship between ambient temperature and blood pressure, without and with antihypertensive medication, in a study of 1,831 hypertensive patients followed up for three years, in two or four weekly check ups, accumulating 62,452 follow-up records. Both baseline and follow-up blood pressure showed an inverse association with ambient temperature, which explained 32.4% and 65.6% of variation of systolic blood pressure and diastolic blood pressure (P < 0.05) respectively. The amplitude of individual blood pressure fluctuation with temperature throughout a year (a 29 degrees centigrade range) was 9.4/7.3 mmHg. Medication with angiotensin converting enzyme inhibitor benazepril attenuated the blood pressure fluctuation by 2.4/1.3 mmHg each year, though the inverse association of temperature and blood pressure remained. Gender, drinking behavior and body mass index were also found to modify the association between temperature and diastolic blood pressure. The results indicate that ambient temperature may negatively regulate blood pressure. Hypertensive patients should monitor and treat blood pressure more carefully in cold days, and it could be especially important for the males, thinner people and drinkers.	[Chen, Qing] Third Mil Med Univ, Coll Prevent Med, Dept Hygien Toxicol, Chongqing, Peoples R China; [Chen, Qing; Wang, Jinwei; Tian, Jun; Tang, Xun; Yu, Canqing; Chen, Dafang; Cao, Weihua; Zhan, Siyan; Lv, Jun; Lee, Liming; Hu, Yonghua] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Marshall, Roger J.] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland 1, New Zealand	Army Medical University; Peking University; University of Auckland	Hu, YH (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	yhhu@bjmu.edu.cn	陈, 卿/Q-5601-2019; Lv, Jun/O-4746-2019; TANG, Xun/L-8375-2013; Chen, Qing/B-5310-2015	陈, 卿/0000-0003-4108-7977; Lv, Jun/0000-0001-7916-3870; TANG, Xun/0000-0002-6990-0168; Chen, Qing/0000-0003-4108-7977; Marshall, Roger/0000-0001-8278-167X	National Key Technologies R&D Program of China for the 9th Five-Year Plan [96-906-02-05]; National Key Technologies R&D Program of China for the 10th Five-Year Plan [2001BAF03B02]; Mega-projects of Science Research for the 11th Five-Year Plan [2006BAI01A03- ( 16)]	National Key Technologies R&D Program of China for the 9th Five-Year Plan; National Key Technologies R&D Program of China for the 10th Five-Year Plan; Mega-projects of Science Research for the 11th Five-Year Plan(National Key Technology R&D Program)	This study has been supported by grants from the National Key Technologies R&D Program of China for the 9th Five-Year Plan (96-906-02-05), National Key Technologies R&D Program of China for the 10th Five-Year Plan (2001BAF03B02), Mega-projects of Science Research for the 11th Five-Year Plan (2006BAI01A03- ( 16)). Website of the funders:http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperovitch A, 2009, ARCH INTERN MED, V169, P75, DOI 10.1001/archinternmed.2008.512; Aubiniere-Robb L, 2013, HYPERTENSION, V62, P190, DOI 10.1161/HYPERTENSIONAHA.111.00686; Bailey SR, 2005, AM J PHYSIOL-HEART C, V289, pH243, DOI 10.1152/ajpheart.01305.2004; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bortkiewicz Alicja, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P123, DOI 10.2478/v10001-006-0020-y; Dyson KS, 2006, AM J PHYSIOL-HEART C, V290, pH1446, DOI 10.1152/ajpheart.00771.2005; Fiordaliso F, 2006, LIFE SCI, V79, P121, DOI 10.1016/j.lfs.2005.12.036; Flaa A, 2008, HYPERTENSION, V52, P336, DOI 10.1161/HYPERTENSIONAHA.108.111625; Fuchs FD, 2007, ALCOHOL, V41, P399, DOI 10.1016/j.alcohol.2007.05.004; Goodwin J, 2001, AGE AGEING, V30, P311, DOI 10.1093/ageing/30.4.311; Guo YM, 2013, EPIDEMIOLOGY, V24, P471, DOI 10.1097/EDE.0b013e31828c4a5d; Hozawa A, 2011, CLIN EXP HYPERTENS, V33, P153, DOI 10.3109/10641963.2010.531841; Hu Y, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P177; Isezuo S A, 2003, Int J Circumpolar Health, V62, P397; Kent ST, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-7; Kingma BRM, 2011, ACTA PHYSIOL, V203, P419, DOI 10.1111/j.1748-1716.2011.02336.x; Kovacs I, 2006, EUR J HEART FAIL, V8, P451, DOI 10.1016/j.ejheart.2005.10.011; Madsen C, 2006, EUR J EPIDEMIOL, V21, P485, DOI 10.1007/s10654-006-9025-x; Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708; MARSHALL RJ, 1988, INT J EPIDEMIOL, V17, P325, DOI 10.1093/ije/17.2.325; MCADOO WG, 1990, J HYPERTENS, V8, P961, DOI 10.1097/00004872-199010000-00012; Metoki H, 2008, J HYPERTENS, V26, P2406, DOI 10.1097/HJH.0b013e32831364a7; Modesti PA, 2006, HYPERTENSION, V47, P155, DOI 10.1161/01.HYP.0000199192.17126.d4; Munakata M, 2003, CLIN EXP HYPERTENS, V25, P169, DOI 10.1081/CEH-120019149; Murakami S, 2011, HYPERTENS RES, V34, P70, DOI 10.1038/hr.2010.176; Onat A, 2008, ALCOHOL, V42, P593, DOI 10.1016/j.alcohol.2008.06.007; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/00004872-200312000-00012; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Sander D, 1996, NEUROLOGY, V47, P500, DOI 10.1212/WNL.47.2.500; Srivastava R D, 2010, Indian J Physiol Pharmacol, V54, P174; Su XW, 2007, CIRCULATION, V115, P725, DOI 10.1161/CIRCULATIONAHA.106.642058; Tatasciore A, 2007, HYPERTENSION, V50, P325, DOI 10.1161/HYPERTENSIONAHA.107.090084; Treiber FA, 2003, PSYCHOSOM MED, V65, P46, DOI 10.1097/00006842-200301000-00007; WAGNER JA, 1985, J APPL PHYSIOL, V58, P187, DOI 10.1152/jappl.1985.58.1.187; Welsh AJL, 2008, INT ARCH OCC ENV HEA, V81, P625, DOI 10.1007/s00420-007-0257-1; Xie X, 2012, EUR J PREV CARDIOL, V19, P314, DOI 10.1177/1741826711404501; Zheng Z, 2009, DIABETES, V58, P954, DOI 10.2337/db07-1524	37	26	29	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84522	10.1371/journal.pone.0084522	http://dx.doi.org/10.1371/journal.pone.0084522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391962	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900105
J	Fisman, DN; Hauck, TS; Tuite, AR; Greer, AL				Fisman, David N.; Hauck, Tanya S.; Tuite, Ashleigh R.; Greer, Amy L.			An IDEA for Short Term Outbreak Projection: Nearcasting Using the Basic Reproduction Number	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; EPIDEMIC; SPREAD; INFLUENZA; H1N1	Background: Communicable disease outbreaks of novel or existing pathogens threaten human health around the globe. It would be desirable to rapidly characterize such outbreaks and develop accurate projections of their duration and cumulative size even when limited preliminary data are available. Here we develop a mathematical model to aid public health authorities in tracking the expansion and contraction of outbreaks with explicit representation of factors (other than population immunity) that may slow epidemic growth. Methodology: The Incidence Decay and Exponential Adjustment (IDEA) model is a parsimonious function that uses the basic reproduction number R-0, along with a discounting factor to project the growth of outbreaks using only basic epidemiological information (e. g., daily incidence counts). Principal Findings: Compared to simulated data, IDEA provides highly accurate estimates of total size and duration for a given outbreak when R-0 is low or moderate, and also identifies turning points or new waves. When tested with an outbreak of pandemic influenza A (H1N1), the model generates estimated incidence at the i+1th serial interval using data from the ith serial interval within an average of 20% of actual incidence. Conclusions and Significance: This model for communicable disease outbreaks provides rapid assessments of outbreak growth and public health interventions. Further evaluation in the context of real-world outbreaks will establish the utility of IDEA as a tool for front-line epidemiologists.	[Fisman, David N.; Tuite, Ashleigh R.; Greer, Amy L.] Univ Toronto, Fac Med, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Fisman, David N.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; [Hauck, Tanya S.] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Fisman, David N.; Tuite, Ashleigh R.; Greer, Amy L.] Decis Ctr Infect Dis Epidemiol DeCIDE, Toronto, ON, Canada; [Greer, Amy L.] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Modeling & Project Sect,Profess Guidelines, Toronto, ON, Canada; [Greer, Amy L.] Publ Hlth Agcy Canada, Ctr Communicable Dis & Infect Control, Publ Hlth Practice Div, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Public Health Agency of Canada; Public Health Agency of Canada	Fisman, DN (corresponding author), Univ Toronto, Fac Med, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	david.fisman@utoronto.ca						Arguin PM, 2009, EMERG INFECT DIS, V15, P1713, DOI 10.3201/eid1511.091426; Bautista E, 2010, NEW ENGLAND J MED, V362; Breban R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000282; Chang LY, 2009, J FORMOS MED ASSOC, V108, P526, DOI 10.1016/S0929-6646(09)60369-7; Davis J. R., 2001, EMERGING INFECT DIS; Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Government of Ontario, 2004, GUID CONTR RESP INF; Hadler SC, 2011, AM J EPIDEMIOL, V174, pS36, DOI 10.1093/aje/kwr309; Haymann DL, 2004, CONTROL COMMUNICABLE; He DH, 2011, THEOR ECOL-NETH, V4, P283, DOI 10.1007/s12080-011-0123-3; Hilborn Ray, 1997, V28; Hsieh YH, 2010, BMC RES NOTES, V3; Hsieh YH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-332; Kenah E, 2008, MATH BIOSCI, V213, P71, DOI 10.1016/j.mbs.2008.02.007; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Loscher T, 2010, STAT BIOL HEALTH, P39, DOI 10.1007/978-0-387-93835-6_3; Peiris JSM, 2004, NATURE MED, V10; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Schanzer DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021471; Schanzer DL, 2010, INFLUENZA OTHER RESP, V4, P295, DOI 10.1111/j.1750-2659.2010.00154.x; StatisticsCanada, 2012, POP DWELL COUNTS CAN; Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010; Svoboda T, 2004, NEW ENGL J MED, V350, P2352, DOI 10.1056/NEJMoa032111; Tuite AR, 2011, ANN INTERNAL MED, V155; Tuite AR, 2011, ANN INTERN MED, V154, P593, DOI 10.7326/0003-4819-154-9-201105030-00334; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wang Lin-Fa, 2011, N S W Public Health Bull, V22, P113, DOI 10.1071/NB10078; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104	31	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83622	10.1371/journal.pone.0083622	http://dx.doi.org/10.1371/journal.pone.0083622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391797	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200094
J	Fornander, L; Graff, P; Wahlen, K; Ydreborg, K; Flodin, U; Leanderson, P; Lindahl, M; Ghafouri, B				Fornander, Louise; Graff, Pal; Wahlen, Karin; Ydreborg, Kjell; Flodin, Ulf; Leanderson, Per; Lindahl, Mats; Ghafouri, Bijar			Airway Symptoms and Biological Markers in Nasal Lavage Fluid in Subjects Exposed to Metalworking Fluids	PLOS ONE			English	Article							LASER-DESORPTION/IONIZATION-TIME; S100 PROTEINS; AEROSOLS; PLUNC; ELECTROPHORESIS; IRRITATION; WORKERS; ASTHMA; MATRIX; BPI	Backgrounds: Occurrence of airway irritation among industrial metal workers was investigated. The aims were to study the association between exposures from water-based metal working fluids (MWF) and the health outcome among the personnel, to assess potential effects on the proteome in nasal mucous membranes, and evaluate preventive actions. Methods: The prevalence of airway symptoms related to work were examined among 271 metalworkers exposed to MWF and 24 metal workers not exposed to MWF at the same factory. At the same time, air levels of potentially harmful substances (oil mist, morpholine, monoethanolamine, formaldehyde) generated from MWF was measured. Nasal lavage fluid was collected from 13 workers and 15 controls and protein profiles were determined by a proteomic approach. Results: Airway symptoms were reported in 39% of the workers exposed to MWF although the measured levels of MWF substances in the work place air were low. Highest prevalence was found among workers handling the MWF machines but also those working in the same hall were affected. Improvement of the ventilation to reduce MWF exposure lowered the prevalence of airway problems. Protein profiling showed significantly higher levels of S100-A9 and lower levels of SPLUNC1, cystatin SN, Ig J and beta 2-microglobulin among workers with airway symptoms. Conclusions: This study confirms that upper airway symptoms among metal workers are a common problem and despite low levels of MWF-generated substances, effects on airway immune proteins are found. Further studies to clarify the role of specific MWF components in connection to airway inflammation and the identified biological markers are warranted.	[Fornander, Louise; Graff, Pal; Wahlen, Karin; Flodin, Ulf; Leanderson, Per; Lindahl, Mats; Ghafouri, Bijar] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden; [Graff, Pal; Flodin, Ulf; Leanderson, Per; Ghafouri, Bijar] Cty Council Ostergotland, Ctr Occupat & Environm Med, Linkoping, Sweden; [Ydreborg, Kjell] Cty Hosp Ryhov, Otorhinolaryngol Clin, Jonkoping, Sweden; [Ghafouri, Bijar] Linkoping Univ, Pain & Rehabil Ctr, Cty Council Ostergotland, Dept Med & Hlth Sci,Fac Hlth Sci, Linkoping, Sweden	Linkoping University; City Council Ostergotland; City Council Ostergotland; Linkoping University	Ghafouri, B (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden.	bijar.ghafouri@liu.se	Ghafouri, Bijar/H-8257-2014; Graff, PÃl/E-1881-2017	Graff, PÃl/0000-0003-4928-617X; Leanderson, Per/0000-0001-6724-7305; Wahlen, Karin/0000-0001-5034-9110	Research Council of South East Sweden [FORSS-37321]; Cancer and Allergy Foundation [149765]	Research Council of South East Sweden; Cancer and Allergy Foundation	This study was supported by the Research Council of South East Sweden (FORSS-37321) and the Cancer and Allergy Foundation (Ref No. 149765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson M, 1997, J CLIN PATHOL-MOL PA, V50, P291, DOI 10.1136/mp.50.6.291; Andersson K, 1998, INDOOR AIR, P32; Bingle CD, 2004, TRENDS IMMUNOL, V25, P53, DOI 10.1016/j.it.2003.11.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canny G, 2008, TRENDS IMMUNOL, V29, P541, DOI 10.1016/j.it.2008.07.012; Champaiboon C, 2009, J BIOL CHEM, V284, P7078, DOI 10.1074/jbc.M806605200; Chang PY, 2006, CLIN CHIM ACTA, V373, P158, DOI 10.1016/j.cca.2006.05.030; Chen MR, 2007, J HAZARD MATER, V146, P393, DOI 10.1016/j.jhazmat.2006.12.036; DeLorme MP, 2003, J TOXICOL ENV HEAL A, V66, P7, DOI 10.1080/15287390306458; Di YP, 2013, AM J RESP CELL MOL B; Fietta AM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2067; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fornander L, 2013, INT ARCH OCC ENV HEA, V86, P571, DOI 10.1007/s00420-012-0790-4; Frosch M, 2005, EXP DERMATOL, V14, P259, DOI 10.1111/j.0906-6705.2005.00271.x; FRUTIGER S, 1992, BIOCHEMISTRY-US, V31, P12643, DOI 10.1021/bi00165a014; Gakhar L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009098; Garland AL, 2013, P NATL ACAD SCI USA, V110, P15973, DOI 10.1073/pnas.1311999110; Ghafouri B, 2004, BBA-PROTEINS PROTEOM, V1699, P57, DOI 10.1016/j.bbapap.2004.01.001; Ghafouri B, 2002, PROTEOMICS, V2, P112, DOI 10.1002/1615-9861(200201)2:1<112::AID-PROT112>3.0.CO;2-N; Ghafouri B, 2007, ANAL BIOCHEM, V371, P121, DOI 10.1016/j.ab.2007.07.002; Gordon T, 2004, J TOXICOL ENV HEAL A, V67, P209, DOI 10.1080/15287390490266864; GOYETTE J, 2010, AMINO ACIDS; Graff P, 2008, SCAND J WORK ENV HEA, V34, P403, DOI 10.5271/sjweh.1276; Greaves IA, 1997, AM J IND MED, V32, P450, DOI 10.1002/(SICI)1097-0274(199711)32:5<450::AID-AJIM4>3.0.CO;2-W; Gruvberger B, 2003, CONTACT DERMATITIS, V48, P80, DOI 10.1034/j.1600-0536.2003.480205.x; Halayko AJ, 2009, CAN J PHYSIOL PHARM, V87, P743, DOI 10.1139/Y09-054; Henriks-Eckerman ML, 2007, ANN OCCUP HYG, V51, P153, DOI 10.1093/annhyg/mel079; ISEMURA S, 1986, FEBS LETT, V198, P145, DOI 10.1016/0014-5793(86)81201-7; Jaakkola MS, 2009, SCAND J WORK ENV HEA, V35, P64, DOI 10.5271/sjweh.1299; Jayawardena U, 2009, J PHYS C SER, V151; Lillienberg L, 2008, ANN OCCUP HYG, V52, P597, DOI 10.1093/annhyg/men043; Lindahl M, 2001, ELECTROPHORESIS, V22, P1795, DOI 10.1002/1522-2683(200105)22:9<1795::AID-ELPS1795>3.0.CO;2-J; Lukinskiene L, 2011, J IMMUNOL, V187, P382, DOI 10.4049/jimmunol.1001769; Marchand G, 2010, J OCCUP ENVIRON HYG, V7, P358, DOI 10.1080/15459621003741631; Murat JB, 2012, APPL ENV MICROBIOL; OSHA, 1999, MET FLUIDS SAF HLTH; Rosano C, 2005, BBA-PROTEINS PROTEOM, V1753, P85, DOI 10.1016/j.bbapap.2005.07.010; Rosenman KD, 2009, CURR OPIN ALLERGY CL, V9, P97, DOI 10.1097/ACI.0b013e3283229f96; Sollenberg J, 1998, OCCUP HYG, V4, P281; Suuronen K, 2008, ANN OCCUP HYG, V52, P607, DOI 10.1093/annhyg/men048; Taylor DR, 2006, THORAX, V61, P817, DOI 10.1136/thx.2005.056093; Trafny EA, 2013, INT J OCCUP MED ENV, V26, P4, DOI 10.2478/S13382-013-0075-5; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]	47	16	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83089	10.1371/journal.pone.0083089	http://dx.doi.org/10.1371/journal.pone.0083089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391738	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200035
J	Galar, A; Kulldorff, M; Rudnick, W; O'Brien, TF; Stelling, J				Galar, Alicia; Kulldorff, Martin; Rudnick, Wallis; O'Brien, Thomas F.; Stelling, John			Biochemical Phenotypes to Discriminate Microbial Subpopulations and Improve Outbreak Detection	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; KLEBSIELLA-PNEUMONIAE; SURVEILLANCE; WHONET; IDENTIFICATION; EPIDEMIOLOGY; SYSTEM	Background: Clinical microbiology laboratories worldwide constitute an invaluable resource for monitoring emerging threats and the spread of antimicrobial resistance. We studied the growing number of biochemical tests routinely performed on clinical isolates to explore their value as epidemiological markers. Methodology/Principal Findings: Microbiology laboratory results from January 2009 through December 2011 from a 793 bed hospital stored in WHONET were examined. Variables included patient location, collection date, organism, and 47 biochemical and 17 antimicrobial susceptibility test results reported by Vitek 2. To identify biochemical tests that were particularly valuable (stable with repeat testing, but good variability across the species) or problematic (inconsistent results with repeat testing), three types of variance analyses were performed on isolates of K. pneumonia: descriptive analysis of discordant biochemical results in same-day isolates, an average within-patient variance index, and generalized linear mixed model variance component analysis. Results: 4,200 isolates of K. pneumoniae were identified from 2,485 patients, 32% of whom had multiple isolates. The first two variance analyses highlighted SUCT, TyrA, GlyA, and GGT as "nuisance'' biochemicals for which discordant within-patient test results impacted a high proportion of patient results, while dTAG had relatively good within-patient stability with good heterogeneity across the species. Variance component analyses confirmed the relative stability of dTAG, and identified additional biochemicals such as PHOS with a large between patient to within patient variance ratio. A reduced subset of biochemicals improved the robustness of strain definition for carbapenemresistant K. pneumoniae. Surveillance analyses suggest that the reduced biochemical profile could improve the timeliness and specificity of outbreak detection algorithms. Conclusions: The statistical approaches explored can improve the robust recognition of microbial subpopulations with routinely available biochemical test results, of value in the timely detection of outbreak clones and evolutionarily important genetic events.	[Galar, Alicia; O'Brien, Thomas F.; Stelling, John] Harvard Univ, Brigham & Womens Hosp, WHO Collaborating Ctr Surveillance Antimicrobial, Sch Med,Dept Med, Boston, MA 02115 USA; [Kulldorff, Martin] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Kulldorff, Martin] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Rudnick, Wallis] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Galar, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, WHO Collaborating Ctr Surveillance Antimicrobial, Sch Med,Dept Med, Boston, MA 02115 USA.	agalar@partners.org		Galar, Alicia/0000-0002-9310-8752; Kulldorff, Martin/0000-0002-5284-2993; Rudnick, Wallis/0000-0003-3457-4216	National Institute of General Medical Science of the National Institutes of Health [R01GM103525]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103525] Funding Source: NIH RePORTER	National Institute of General Medical Science of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Science of the National Institutes of Health under award number R01GM103525. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	bioMerieux, 2010, VIT 2 SYST PROD INF; Braykov NP, 2013, INFECT CONT HOSP EP, V34, P259, DOI 10.1086/669523; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Burke JP, 2003, INFECT CONT HOSP EP, V24, P10, DOI 10.1086/502108; Corporation S, 2011, GLIMMIX PROC; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Hansen DS, 2004, J CLIN MICROBIOL, V42, P3665, DOI 10.1128/jcm.42.8.3665-3669.2004; Huang SS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000238; Hussein K, 2013, J HOSP INFECT; Johnson AP, 2013, J MED MICROBIOL; Levert M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001125; Magiorakos AP, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-6; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; O'Brien TF, 2011, CLIN MICROBIOL REV, V24, P281, DOI 10.1128/CMR.00021-10; OBrien TF, 1996, DIAGN MICR INFEC DIS, V25, P163, DOI 10.1016/S0732-8893(96)00139-3; OBRIEN TF, 1995, EMERG INFECT DIS, V1, P66, DOI 10.3201/eid0102.950209; OBRIEN TF, 1980, ANTIMICROB AGENTS CH, V17, P537, DOI 10.1128/AAC.17.4.537; Sharma A, 2004, Indian J Med Microbiol, V22, P115; Alves MS, 2006, J CLIN MICROBIOL, V44, P3640, DOI 10.1128/JCM.00940-06; Stelling J, 2010, EPIDEMIOL INFECT, V138, P873, DOI 10.1017/S0950268809990884; Stelling JM, 1997, CLIN INFECT DIS, V24, pS157, DOI 10.1093/clinids/24.Supplement_1.S157; Tanne JH, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1646; TOLMASKY ME, 1988, ANTIMICROB AGENTS CH, V32, P1416, DOI 10.1128/AAC.32.9.1416; Vinas MR, 2013, PLOS NEGL T IN PRESS; Werber D, 2011, LANCET, V377, P298, DOI 10.1016/S0140-6736(11)60090-1; Witte JS, 2000, EPIDEMIOLOGY, V11, P684, DOI 10.1097/00001648-200011000-00012; Wright MO, 2004, INFECT CONT HOSP EP, V25, P325, DOI 10.1086/502400	29	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84313	10.1371/journal.pone.0084313	http://dx.doi.org/10.1371/journal.pone.0084313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391936	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900079
J	Heilmann, A; Schinke, T; Bindl, R; Wehner, T; Rapp, A; Haffner-Luntzer, M; Nemitz, C; Liedert, A; Amling, M; Ignatius, A				Heilmann, Aline; Schinke, Thorsten; Bindl, Ronny; Wehner, Tim; Rapp, Anna; Haffner-Luntzer, Melanie; Nemitz, Claudia; Liedert, Astrid; Amling, Michael; Ignatius, Anita			The Wnt Serpentine Receptor Frizzled-9 Regulates New Bone Formation in Fracture Healing	PLOS ONE			English	Article							REGENERATION; OSTEOPOROSIS; DENSITY; MUTATIONS; TARGETS; MICE	Wnt signaling is a key regulator of bone metabolism and fracture healing. The canonical Wnt/beta-catenin pathway is regarded as the dominant mechanism, and targeting this pathway has emerged as a promising strategy for the treatment of osteoporosis and poorly healing fractures. In contrast, little is known about the role of non-canonical Wnt signaling in bone. Recently, it was demonstrated that the serpentine receptor Fzd9, a Wnt receptor of the Frizzled family, is essential for osteoblast function and positively regulates bone remodeling via the non-canonical Wnt pathway without involving beta-catenin-dependent signaling. Here we investigated whether the Fzd9 receptor is essential for fracture healing using a femur osteotomy model in Fzd9(-/-) mice. After 10, 24 and 32 days the fracture calli were analyzed using biomechanical testing, histomorphometry, immunohistochemistry, and micro-computed tomography. Our results demonstrated significantly reduced amounts of newly formed bone at all investigated healing time points in the absence of Fzd9 and, accordingly, a decreased mechanical competence of the callus tissue in the late phase of fracture healing. In contrast, cartilage formation and numbers of osteoclasts degrading mineralized matrix were unaltered. beta-Catenin immunolocalization showed that canonical Wnt-signaling was not affected in the absence of Fzd9 in osteoblasts as well as in proliferating and mature chondrocytes within the fracture callus. The expression of established differentiation markers was not altered in the absence of Fzd9, whereas chemokines Ccl2 and Cxcl5 seemed to be reduced. Collectively, our results suggest that non-canonical signaling via the Fzd9 receptor positively regulates intramembranous and endochondral bone formation during fracture healing, whereas it does not participate in the formation of cartilage or in the osteoclastic degradation of mineralized matrix. The finding that Fzd9, in addition to its role in physiological bone remodeling, regulates bone repair may have implications for the development of treatments for poorly or non-healing fractures.	[Heilmann, Aline; Bindl, Ronny; Wehner, Tim; Rapp, Anna; Haffner-Luntzer, Melanie; Nemitz, Claudia; Liedert, Astrid; Ignatius, Anita] Univ Ulm, Ctr Musculoskeletal Res, Inst Orthopaed Res & Biomech, D-89069 Ulm, Germany; [Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Ignatius, A (corresponding author), Univ Ulm, Ctr Musculoskeletal Res, Inst Orthopaed Res & Biomech, D-89069 Ulm, Germany.	anita.ignatius@uni-ulm.de	Ignatius, Anita/M-6012-2013; Haffner-Luntzer, Melanie/L-3562-2019; Rapp, Anna/L-8807-2016	Ignatius, Anita/0000-0002-4782-1979; Haffner-Luntzer, Melanie/0000-0002-3333-2613; Rapp, Anna/0000-0001-5122-765X	German Research Foundation (DFG) (Research Unit) [FOR793, IG18/7 2, SCHI 5004/5 2]	German Research Foundation (DFG) (Research Unit)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG) (Research Unit FOR793, IG18/7 2 and SCHI 5004/5 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme F, 2011, ACTA ORTHOP, V82, P125, DOI [10.3109/17453674.2011.625539, 10.3109/17453674.2011.572252]; Agholme F, 2010, J BONE MINER RES, V25, P2412, DOI 10.1002/jbmr.135; Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Alblowi J, 2013, BONE, V53, P294, DOI 10.1016/j.bone.2012.12.006; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Caetano-Lopes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016947; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Cherniske EM, 2004, AM J MED GENET A, V131A, P255, DOI 10.1002/ajmg.a.30400; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Claes L, 2011, J ORTHOP TRAUMA, V25, P169, DOI 10.1097/BOT.0b013e3181e3d994; Dean DB, 2010, J ANAT, V216, P625, DOI 10.1111/j.1469-7580.2010.01214.x; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Heilmann A, 2013, J ORTHOP RES, V31, P1845, DOI 10.1002/jor.22426; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Huang Y, 2012, J ORTHOP RES, V30, P304, DOI 10.1002/jor.21505; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jawad MU, 2013, J ORTHOP RES, V31, P155, DOI 10.1002/jor.22186; Kakar S, 2007, J BONE MINER RES, V22, P1903, DOI 10.1359/JBMR.070724; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Schubert C, 2009, CELL MOL LIFE SCI, V66, P1178, DOI 10.1007/s00018-008-8401-y; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Wintges K, 2013, J BONE MINER RES, V28, P2070, DOI 10.1002/jbmr.1937; Yates KE, 2005, DNA CELL BIOL, V24, P446, DOI 10.1089/dna.2005.24.446; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008	46	36	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84232	10.1371/journal.pone.0084232	http://dx.doi.org/10.1371/journal.pone.0084232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391920	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900063
J	Kiragga, AN; Castelnuovo, B; Musomba, R; Levin, J; Kambugu, A; Manabe, YC; Yiannoutsos, CT; Kiwanuka, N				Kiragga, Agnes N.; Castelnuovo, Barbara; Musomba, Rachel; Levin, Jonathan; Kambugu, Andrew; Manabe, Yukari C.; Yiannoutsos, Constantin T.; Kiwanuka, Noah			Comparison of Methods for Correction of Mortality Estimates for Loss to Follow-Up after ART Initiation: A Case of the Infectious Diseases Institute, Uganda	PLOS ONE			English	Article							SAMPLING-BASED APPROACH; ANTIRETROVIRAL THERAPY; 1ST YEAR; PROGRAM; PEPFAR; SURVIVAL; OUTCOMES; AFRICA	Background: In sub-Saharan Africa, a large proportion of HIV positive patients on antiretroviral therapy (ART) are lost to follow-up, some of whom are dead. The objective of this study was to validate methods used to correct mortality estimates for loss-to-follow-up using a cohort with complete death ascertainment. Methods: Routinely collected data from HIV patients initiating first line antiretroviral therapy (ART) at the Infectious Diseases Institute (IDI) (Routine Cohort) was used. Three methods to estimate mortality after initiation were: 1) standard Kaplan-Meier estimation (uncorrected method) that uses passively observed data; 2) double-sampling methods by Frangakis and Rubin (F&R) where deaths obtained from patient tracing studies are given a higher weight than those passively ascertained; 3) Nomogram proposed by Egger et al. Corrected mortality estimates in the Routine Cohort, were compared with the estimates from the IDI research observational cohort (Research Cohort), which was used as the "gold-standard". Results: We included 5,633 patients from the Routine Cohort and 559 from the Research Cohort. Uncorrected mortality estimates (95% confidence interval [1]) in the Routine Cohort at 1, 2 and 3 years were 5.5% (4.9%-6.3%), 6.6% (5.9%-7.5%) and 7.4% (6.5%-8.5%), respectively. The F&R corrected estimates at 1, 2 and 3 years were 11.2% (5.8%-21.2%), 15.8% (9.9%-24.8%) and 18.5% (12.3%-27.2%) respectively. The estimates obtained from the Research Cohort were 15.6% (12.8%-18.9%), 17.5% (14.6%-21.0%) and 19.0% (15.3%-21.9%) at 1, 2 and 3 years respectively. Using the nomogram method in the Routine Cohort, the corrected programme-level mortality estimate in year 1 was 11.9% (8.0%-15.7%). Conclusion: Mortality adjustments provided by the F&R and nomogram methods are adequate and should be employed to correct mortality for loss-to-follow-up in large HIV care centres in Sub-Saharan Africa.	[Kiragga, Agnes N.; Castelnuovo, Barbara; Musomba, Rachel; Kambugu, Andrew] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Levin, Jonathan] MRC, Uganda Virus Res Inst Uganda Res Unit AIDS, Entebbe, Uganda; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Yiannoutsos, Constantin T.] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN 46204 USA; [Kiwanuka, Noah] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda	Makerere University; Johns Hopkins University; Indiana University System; Indiana University-Purdue University Indianapolis; Makerere University	Kiragga, AN (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	akiragga@idi.co.ug			Wellcome Trust Uganda PhD Fellowship in Infection and Immunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102710] Funding Source: NIH RePORTER	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by ANK. The IeDEA-Eastern Africa provided support for data assurance and quality services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MW, 2009, BIOMETRICS, V65, P301, DOI 10.1111/j.1541-0420.2008.01043.x; Bass E, 2005, LANCET, V365, P2077, DOI 10.1016/S0140-6736(05)66717-7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; BRINKHOF MW, 2008, B WHO, V26; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Frangakis CE, 2001, BIOMETRICS, V57, P333, DOI 10.1111/j.0006-341X.2001.00333.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Henriques J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031706; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; *IDI, 2012, INF DIS I ANN REP 20; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Schomaker M, 2013, STAT MED; Somi G, 2012, TROP MED INT HEALTH, V17, P497, DOI 10.1111/j.1365-3156.2011.02952.x; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	20	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83524	10.1371/journal.pone.0083524	http://dx.doi.org/10.1371/journal.pone.0083524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391780	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200077
J	Lane, DR; Ready, RC; Buddemeier, RW; Martinich, JA; Shouse, KC; Wobus, CW				Lane, Diana R.; Ready, Richard C.; Buddemeier, Robert W.; Martinich, Jeremy A.; Shouse, Kate Cardamone; Wobus, Cameron W.			Quantifying and Valuing Potential Climate Change Impacts on Coral Reefs in the United States: Comparison of Two Scenarios	PLOS ONE			English	Article							BENEFIT TRANSFER; FLORIDA-KEYS; FUTURE; MODEL; METAANALYSIS	The biological and economic values of coral reefs are highly vulnerable to increasing atmospheric and ocean carbon dioxide concentrations. We applied the COMBO simulation model (COral Mortality and Bleaching Output) to three major U.S. locations for shallow water reefs: South Florida, Puerto Rico, and Hawaii. We compared estimates of future coral cover from 2000 to 2100 for a "business as usual" (BAU) greenhouse gas (GHG) emissions scenario with a GHG mitigation policy scenario involving full international participation in reducing GHG emissions. We also calculated the economic value of changes in coral cover using a benefit transfer approach based on published studies of consumers' recreational values for snorkeling and diving on coral reefs as well as existence values for coral reefs. Our results suggest that a reduced emissions scenario would provide a large benefit to shallow water reefs in Hawaii by delaying or avoiding potential future bleaching events. For Hawaii, reducing emissions is projected to result in an estimated "avoided loss" from 2000 to 2100 of approximately $10.6 billion in recreational use values compared to a BAU scenario. However, reducing emissions is projected to provide only a minor economic benefit in Puerto Rico and South Florida, where sea-surface temperatures are already close to bleaching thresholds and coral cover is projected to drop well below 5% cover under both scenarios by 2050, and below 1% cover under both scenarios by 2100.	[Lane, Diana R.; Wobus, Cameron W.] Stratus Consulting Inc, Boulder, CO 80302 USA; [Ready, Richard C.] Penn State Univ, Dept Agr Econ & Rural Sociol, University Pk, PA 16802 USA; [Buddemeier, Robert W.] Kansas Geol Survey, Lawrence, KS 66044 USA; [Martinich, Jeremy A.; Shouse, Kate Cardamone] US EPA, Climate Change Div 6207J, Washington, DC 20460 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Environmental Protection Agency	Lane, DR (corresponding author), Stratus Consulting Inc, Boulder, CO 80302 USA.	dlane@stratusconsulting.com		Wobus, Cameron/0000-0002-9654-1738	U.S. Environmental Protection Agency's (EPA's) Office of Air and Radiation [EP-W-07-072]	U.S. Environmental Protection Agency's (EPA's) Office of Air and Radiation	This work was supported by the U.S. Environmental Protection Agency's (EPA's) Office of Air and Radiation, under contract EP-W-07-072 (http://www.epa.gov/climatechange). The EPA co-authors provided substantial contributions to this work, including technical oversight of the project conception and design, analysis of the data, drafting and critical review of the manuscript, and support of the decision to submit the paper to this journal. The views expressed in this document are solely those of the authors, and do not necessarily reflect those of the Agency.	Bhat MG, 2003, J ENVIRON MANAGE, V67, P315, DOI 10.1016/S0301-4797(02)00207-4; Birkeland C, 2004, BIOSCIENCE, V54, P1021, DOI 10.1641/0006-3568(2004)054[1021:RDTCR]2.0.CO;2; Bishop RC, 2011, TOTAL EC VALUE PROTE; Brander L, 2009, 282 ESRI; Buddemeier RW, 2011, CLIMATIC CHANGE, V109, P375, DOI 10.1007/s10584-011-0022-z; Buddemeier RW, 2008, LIMNOL OCEANOGR-METH, V6, P395, DOI 10.4319/lom.2008.6.395; Burke L., 2004, REEFS RISK CARIBBEAN; Burke L., 2008, COASTAL CAPITAL EC V; Burke L., 2011, REEFS RISK REVISITED; Calvin K, 2009, ENERG ECON, V31, pS107, DOI 10.1016/j.eneco.2009.06.006; Carbone JC, 2013, J ENVIRON ECON MANAG, V66, P72, DOI 10.1016/j.jeem.2012.12.007; Caribbean Tourism Organization, 2011, LAT STAT 2010; CESAR H, 2002, EC VALUATION CORAL R; Cesar H., 2003, EC WORLDWIDE CORAL R; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Crowards T, 1997, ENVIRON VALUE, V6, P143, DOI 10.3197/096327197776679167; Cummings R. G., 1995, Environmental and Resource Economics, V5, P225, DOI 10.1007/BF00691518; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Estudios Tecnicos, 2007, VAL EC ARR COR AMB A; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Harriott VJ, 2002, CORAL REEFS, V21, P83, DOI 10.1007/s00338-001-0201-x; Hernandez-Pacheco R, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00065.1; Hewitson B., 2003, EOS T AM GEOPHYS UN, V84, P337; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; IPCC, 2000, SPECIAL REPORT WORKI; Johns GM., 2001, REPORT PREPARED BROW; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Kragt ME, 2009, AUST J AGR RESOUR EC, V53, P213, DOI 10.1111/j.1467-8489.2007.00444.x; Leeworthy V.R., 1997, NONMARKET EC USER VA; Leeworthy V.R., 2000, PROPOSED TORTUGAS 20; Londono LM, 2012, ECOL ECON, V78, P80, DOI 10.1016/j.ecolecon.2012.03.016; National Research Council (NRC), 2009, HIDD COSTS EN UNPR C; Navrud S., 2007, ENV VALUE TRANSFER I; NOAA, 2009, EXT REC SEA SURF TEM; NOAA-IRI, 2009, NOAA NCEP EMC CMB GL; Oh CO, 2008, SOC NATUR RESOUR, V21, P455, DOI 10.1080/08941920701681953; Pagiola S., 2004, MUCH IS ECOSYSTEM WO; Park T, 2002, J ENVIRON MANAGE, V65, P301, DOI 10.1006/jema.2002.0552; PCMDI, 2008, PROGR CLIM MOD DIAGN; Phaneuf DJ, 2009, J ENVIRON ECON MANAG, V57, P45, DOI 10.1016/j.jeem.2008.09.002; Randall A, 1991, MEASURING DEMAND ENV; Randall DA, 2007, CLIMATE CHANGE 2007; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; SANTER BD, 1990, 47 M PLANCK I MET; Secretariat of the Convention on Biological Diversity, 2009, SECR CONV BIOL DIV T; Shrestha RK, 2001, ECOL ECON, V39, P67, DOI 10.1016/S0921-8009(01)00193-8; SMITH SV, 1992, ANNU REV ECOL SYST, V23, P89, DOI 10.1146/annurev.es.23.110192.000513; Smith TM, 2004, J CLIMATE, V17, P2466, DOI 10.1175/1520-0442(2004)017<2466:IEROS>2.0.CO;2; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Solomon S., 2007, PHYS SCI BASIS WORKI; US Interagency Working Group on Social Cost of Carbon, 2010, TECHN SUPP DOC SOC C; US Office of Management and Budget, 2003, A4 US OFF MAN BUDG; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Wigley TML, 2008, MAGICC SCENGEN VERSI; Wilkinson C, 2008, STATUS CARIBBEAN COR	59	9	10	1	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82579	10.1371/journal.pone.0082579	http://dx.doi.org/10.1371/journal.pone.0082579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391717	Green Submitted, gold, Green Published			2022-12-27	WOS:000329325200014
J	Riazi, A; Strong, PCR; Coleman, R; Chen, WX; Hirama, T; van Faassen, H; Henry, M; Logan, SM; Szymanski, CM; MacKenzie, R; Ghahroudi, MA				Riazi, Ali; Strong, Philippa C. R.; Coleman, Russell; Chen, Wangxue; Hirama, Tomoko; van Faassen, Henk; Henry, Matthew; Logan, Susan M.; Szymanski, Christine M.; MacKenzie, Roger; Ghahroudi, Mehdi Arbabi			Pentavalent Single-Domain Antibodies Reduce Campylobacter jejuni Motility and Colonization in Chickens	PLOS ONE			English	Article							INTESTINAL COLONIZATION; BROILER-CHICKENS; POULTRY; FRAGMENTS; INFECTION; RESISTANCE; PROTECTION; IMMUNITY; HOST; BACTERIOPHAGE	Campylobacter jejuni is the leading cause of bacterial foodborne illness in the world, with symptoms ranging from acute diarrhea to severe neurological disorders. Contaminated poultry meat is a major source of C. jejuni infection, and therefore, strategies to reduce this organism in poultry, are expected to reduce the incidence of Campylobacter-associated diseases. We have investigated whether oral administration of C. jejuni-specific single-domain antibodies would reduce bacterial colonization levels in chickens. Llama single-domain antibodies specific for C. jejuni were isolated from a phage display library generated from the heavy chain IgG variable domain repertoire of a llama immunized with C. jejuni flagella. Two flagella-specific single-domain antibodies were pentamerized to yield high avidity antibodies capable of multivalent binding to the target antigen. When administered orally to C. jejuni-infected two-day old chicks, the pentabodies significantly reduced C. jejuni colonization in the ceca. In vitro, the motility of the bacteria was also reduced in the presence of the flagella-specific pentabodies, suggesting the mechanism of action is through either direct interference with flagellar motility or antibody-mediated aggregation. Fluorescent microscopy and Western blot analyses revealed specific binding of the anti-flagella pentabodies to the C. jejuni flagellin.	[Riazi, Ali] AbCelex Technol Inc, Toronto, ON, Canada; [Strong, Philippa C. R.; Coleman, Russell; Chen, Wangxue; Hirama, Tomoko; van Faassen, Henk; Logan, Susan M.; MacKenzie, Roger; Ghahroudi, Mehdi Arbabi] Natl Res Council Canada, Ottawa, ON, Canada; [Henry, Matthew] Dow AgroSci, Indianapolis, IN USA; [Szymanski, Christine M.; MacKenzie, Roger] Univ Alberta, Centennial Ctr Interdisciplinary Sci, Dept Biol Sci, Edmonton, AB, Canada; [Szymanski, Christine M.; MacKenzie, Roger] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB, Canada; [Ghahroudi, Mehdi Arbabi] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Ghahroudi, Mehdi Arbabi] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	National Research Council Canada; Dow Chemical Company; University of Alberta; University of Alberta; University of Guelph; Carleton University	Ghahroudi, MA (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	mehdi.arbabi@nrc-cnrc.gc.ca			Dow AgroSciences; AbCelex Technologies	Dow AgroSciences; AbCelex Technologies	The authors are grateful to Dow AgroSciences and AbCelex Technologies for partially funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredson DA, 2007, FEMS MICROBIOL LETT, V277, P123, DOI 10.1111/j.1574-6968.2007.00935.x; Arbabi-Ghahroudi Mehdi, 2009, V502, P341, DOI 10.1007/978-1-60327-565-1_20; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Behring E, 1890, DEUT MED WOCHENSCHR, V16, P1113, DOI [10.1055/s-0029-1207589, DOI 10.1055/S-0029-1207589]; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1986, J INFECT DIS, V153, P552, DOI 10.1093/infdis/153.3.552; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Boyd Y, 2005, IMMUNOGENETICS, V57, P248, DOI 10.1007/s00251-005-0790-6; BURR DH, 1988, INFECT IMMUN, V56, P99, DOI 10.1128/IAI.56.1.99-105.1988; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Castillo SL, 2011, J FOOD SCI, V76, pM421, DOI 10.1111/j.1750-3841.2011.02229.x; Cawthraw SA, 2000, CLIN EXP IMMUNOL, V122, P55, DOI 10.1046/j.1365-2249.2000.01349.x; Clark JD, 2012, VACCINE, V30, P2683, DOI 10.1016/j.vaccine.2012.02.002; de los Santos FS, 2009, POULTRY SCI, V88, P61, DOI 10.3382/ps.2008-00228; DOLBY JM, 1986, J HYG-CAMBRIDGE, V96, P143, DOI 10.1017/S0022172400065918; Dooley H, 2003, MOL IMMUNOL, V40, P25, DOI 10.1016/S0161-5890(03)00084-1; EFSA, 2011, EFSA J, V9, P2105, DOI DOI 10.2903/J.EFSA.2011.2105; El-Shibiny A, 2009, J FOOD PROTECT, V72, P733, DOI 10.4315/0362-028X-72.4.733; Gellynck X, 2008, J FOOD PROTECT, V71, P479, DOI 10.4315/0362-028X-71.3.479; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Guerry P, 2006, MOL MICROBIOL, V60, P299, DOI 10.1111/j.1365-2958.2006.05100.x; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hariharan H, 2004, VET MED-CZECH, V49, P441, DOI 10.17221/5736-VETMED; Harmsen MM, 2006, APPL MICROBIOL BIOT, V72, P544, DOI 10.1007/s00253-005-0300-7; Harmsen MM, 2005, VET MICROBIOL, V111, P89, DOI 10.1016/j.vetmic.2005.09.005; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Hermans D, 2010, POULTRY SCI, V89, P1144, DOI 10.3382/ps.2010-00717; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Kurekci C, 2012, PHYTOTHER RES, V26, P186, DOI 10.1002/ptr.3526; Layton SL, 2011, CLIN VACCINE IMMUNOL, V18, P449, DOI 10.1128/CVI.00379-10; Lin J, 2009, FOODBORNE PATHOG DIS, V6, P755, DOI 10.1089/fpd.2008.0247; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Mead GC, 2002, WORLD POULTRY SCI J, V58, P169, DOI 10.1079/WPS20020016; Messaoudi S, 2011, INT MICROBIOL, V14, P103, DOI 10.2436/20.1501.01.140; Molatova Z, 2010, FOLIA MICROBIOL, V55, P215, DOI 10.1007/s12223-010-0031-8; Muyldermans S, 2001, J Biotechnol, V74, P277; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; NURMI E, 1973, NATURE, V241, P210, DOI 10.1038/241210a0; Nyachuba DG, 2010, NUTR REV, V68, P257, DOI 10.1111/j.1753-4887.2010.00286.x; PAVLOVSKIS OR, 1991, INFECT IMMUN, V59, P2259, DOI 10.1128/IAI.59.7.2259-2264.1991; PENNER JL, 1980, J CLIN MICROBIOL, V12, P732, DOI 10.1128/JCM.12.6.732-737.1980; POWER ME, 1994, J BACTERIOL, V176, P3303, DOI 10.1128/jb.176.11.3303-3313.1994; RAUTELIN H, 1990, SCAND J INFECT DIS, V22, P321, DOI 10.3109/00365549009027054; Rice BE, 1997, VACCINE, V15, P1922, DOI 10.1016/S0264-410X(97)00126-6; ROLLWAGEN FM, 1993, VACCINE, V11, P1316, DOI 10.1016/0264-410X(93)90101-3; Sahin O, 2003, APPL ENVIRON MICROB, V69, P5372, DOI 10.1128/AEM.69.9.5372-5379.2003; Sambrook J., 2001, MOL CLONING LAB MANU; Santini C, 2010, INT J FOOD MICROBIOL, V141, pS98, DOI 10.1016/j.ijfoodmicro.2010.03.039; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Sklar IB, 2001, J FOOD SAFETY, V21, P15, DOI 10.1111/j.1745-4565.2001.tb00305.x; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; Smith JL, 2010, J FOOD PROTECT, V73, P1141, DOI 10.4315/0362-028X-73.6.1141; Stern NJ, 2003, J FOOD PROTECT, V66, P1557, DOI 10.4315/0362-028X-66.9.1557; STERN NJ, 1990, AVIAN DIS, V34, P595, DOI 10.2307/1591250; Suzuki H, 2009, J VET MED SCI, V71, P255, DOI 10.1292/jvms.71.255; Svetoch EA, 2010, POULTRY SCI, V89, P1763, DOI 10.3382/ps.2010-00659; SZYMANSKI CM, 1995, INFECT IMMUN, V63, P4295, DOI 10.1128/IAI.63.11.4295-4300.1995; UEKI Y, 1987, MICROBIOL IMMUNOL, V31, P1161, DOI 10.1111/j.1348-0421.1987.tb01350.x; Vanlandschoot P, 2011, ANTIVIR RES, V92, P389, DOI 10.1016/j.antiviral.2011.09.002; Wagenaar JA, 2006, REV SCI TECH OIE, V25, P581, DOI 10.20506/rst.25.2.1680; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002; Wagenaar JA, 2008, CAMPYLOBACTER, 3RD EDITION, P667; Widders PR, 1996, BRIT POULTRY SCI, V37, P765, DOI 10.1080/00071669608417906; Willis WL, 2008, POULTRY SCI, V87, P606, DOI 10.3382/ps.2006-00458; Zeng Ximin, 2010, J Vaccines Vaccin, V1; Zhang GD, 2007, J FOOD PROTECT, V70, P867, DOI 10.4315/0362-028X-70.4.867; Zhang JB, 2004, J MOL BIOL, V341, P161, DOI 10.1016/j.jmb.2004.05.069	72	33	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83928	10.1371/journal.pone.0083928	http://dx.doi.org/10.1371/journal.pone.0083928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391847	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200145
J	Sato, D; Bers, DM; Shiferaw, Y				Sato, Daisuke; Bers, Donald M.; Shiferaw, Yohannes			Formation of Spatially Discordant Alternans Due to Fluctuations and Diffusion of Calcium	PLOS ONE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; CARDIAC ALTERNANS; ELECTRICAL ALTERNANS; SUBCELLULAR ALTERNANS; TRANSIENT ALTERNANS; ARRHYTHMIAS; MECHANISM; HEART; MYOCYTES; TISSUE	Spatially discordant alternans (SDA) of action potential duration (APD) is a phenomenon where different regions of cardiac tissue exhibit an alternating sequence of APD that are out-of-phase. SDA is arrhythmogenic since it can induce spatial heterogeneity of refractoriness, which can cause wavebreak and reentry. However, the underlying mechanisms for the formation of SDA are not completely understood. In this paper, we present a novel mechanism for the formation of SDA in the case where the cellular instability leading to alternans is caused by intracellular calcium (Ca) cycling, and where Ca transient and APD alternans are electromechanically concordant. In particular, we show that SDA is formed when rapidly paced cardiac tissue develops alternans over many beats due to Ca accumulation in the sarcoplasmic reticulum (SR). The mechanism presented here relies on the observation that Ca cycling fluctuations dictate Ca alternans phase since the amplitude of Ca alternans is small during the early stages of pacing. Thus, different regions of a cardiac myocyte will typically develop Ca alternans which are opposite in phase at the early stages of pacing. These subcellular patterns then gradually coarsen due to interactions with membrane voltage to form steady state SDA of voltage and Ca on the tissue scale. This mechanism for SDA is distinct from well-known mechanisms that rely on conduction velocity restitution, and a Turing-like mechanism known to apply only in the case where APD and Ca alternans are electromechanically discordant. Furthermore, we argue that this mechanism is robust, and is likely to underlie a wide range of experimentally observed patterns of SDA.	[Sato, Daisuke; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Shiferaw, Yohannes] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA	University of California System; University of California Davis; California State University System; California State University Northridge	Sato, D (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	dsato@ucdavis.edu		Bers, Donald/0000-0002-2237-9483	National Institutes of Health [K99-HL111334, R37-HL30077, R01-HL105242, R01HL101196]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101196, R37HL030077, R01HL105242, K99HL111334, P01HL080101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant K99-HL111334 (DS), National Institutes of Health grant R37-HL30077 and R01-HL105242 (DMB), and National Institutes of Health grant R01HL101196 (YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistrup GL, 2006, CIRC RES, V99, pE65, DOI 10.1161/01.RES.0000244087.36230.bf; Aizawa Y, 2006, INT HEART J, V47, P381, DOI 10.1536/ihj.47.381; Chen W, 2011, AM J PHYSIOL-HEART C, V300, pH1794, DOI 10.1152/ajpheart.01121.2010; Chudin E, 1999, BIOPHYS J, V77, P2930, DOI 10.1016/S0006-3495(99)77126-2; Clusin WT, 2003, CRIT REV CL LAB SCI, V40, P337, DOI 10.1080/713609356; Coote JH, 2010, EXP PHYSIOL, V95, P431, DOI 10.1113/expphysiol.2009.047548; Cordeiro JM, 2007, AM J PHYSIOL-HEART C, V293, pH3506, DOI 10.1152/ajpheart.00757.2007; Diaz ME, 2004, CIRC RES, V94, P650, DOI 10.1161/01.RES.0000119923.64774.72; Echebarria B, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.208101; Echebarria B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051911; Euler DE, 1999, CARDIOVASC RES, V42, P583, DOI 10.1016/S0008-6363(99)00011-5; Fox JJ, 2002, AM J PHYSIOL-HEART C, V282, pH516, DOI 10.1152/ajpheart.00612.2001; Gaeta SA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00157; Gaeta SA, 2009, CIRC RES, V105, P335, DOI 10.1161/CIRCRESAHA.109.197590; Gizzi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00071; Gyorke S, 2009, HEART RHYTHM, V6, P123, DOI 10.1016/j.hrthm.2008.09.013; Hayashi H, 2007, BIOPHYS J, V92, P448, DOI 10.1529/biophysj.106.091009; Kang GX, 2010, CIRC RES, V107, P512, DOI 10.1161/CIRCRESAHA.110.221481; Langer GA, 1997, CIRCULATION, V96, P3761; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Laurita KR, 2008, J MOL CELL CARDIOL, V44, P31, DOI 10.1016/j.yjmcc.2007.10.012; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Lou Q, 2012, ADV EXP MED BIOL, V740, P1145, DOI 10.1007/978-94-007-2888-2_52; Mahajan A, 2008, BIOPHYS J, V94, P392, DOI 10.1529/biophysj.106.98160; Murphy CF, 1996, CARDIOVASC RES, V32, P138, DOI 10.1016/S0008-6363(96)00033-8; NOLASCO JB, 1968, J APPL PHYSIOL, V25, P191, DOI 10.1152/jappl.1968.25.2.191; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Picht E, 2006, CIRC RES, V99, P740, DOI 10.1161/01.RES.0000244002.88813.91; Pogwizd SM, 2002, J CARDIOVASC ELECTR, V13, P88, DOI 10.1046/j.1540-8167.2002.00088.x; Qian YW, 2001, CIRCULATION, V104, P2082, DOI 10.1161/hc4201.097136; Qu ZL, 2000, CIRCULATION, V102, P1664, DOI 10.1161/01.CIR.102.14.1664; Qu ZL, 1999, IEEE T BIO-MED ENG, V46, P1166, DOI 10.1109/10.784149; Restrepo JG, 2008, BIOPHYS J, V95, P3767, DOI 10.1529/biophysj.108.130419; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; RUBENSTEIN DS, 1995, CIRCULATION, V91, P201, DOI 10.1161/01.CIR.91.1.201; Sabir IN, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00126; Sato D, 2006, CIRC RES, V99, P520, DOI 10.1161/01.RES.0000240542.03986.e7; Shiferaw Y, 2006, P NATL ACAD SCI USA, V103, P5670, DOI 10.1073/pnas.0511061103; Shiferaw Y, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021903; Shiferaw Y, 2003, BIOPHYS J, V85, P3666, DOI 10.1016/S0006-3495(03)74784-5; Skardal PS, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.108103; Ter Keurs HEDJ, 2006, ANN NY ACAD SCI, V1080, P248, DOI 10.1196/annals.1380.020; Walker ML, 2003, CARDIOVASC RES, V57, P599, DOI 10.1016/S0008-6363(02)00737-X; Watanabe MA, 2001, J CARDIOVASC ELECTR, V12, P196, DOI 10.1046/j.1540-8167.2001.00196.x	44	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85365	10.1371/journal.pone.0085365	http://dx.doi.org/10.1371/journal.pone.0085365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392005	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900149
J	Tay, CS; Tagliani, E; Collins, MK; Erlebacher, A				Tay, Chin-Siean; Tagliani, Elisa; Collins, Mary K.; Erlebacher, Adrian			Cis-Acting Pathways Selectively Enforce the Non-Immunogenicity of Shed Placental Antigen for Maternal CD8 T Cells	PLOS ONE			English	Article							MINOR HISTOCOMPATIBILITY ANTIGENS; IMMUNE-RESPONSE; DENDRITIC CELLS; ALLOGENEIC FETUS; PREGNANCY; TOLERANCE; INTERFACE; OVALBUMIN; INFECTION; EXPANSION	Maternal immune tolerance towards the fetus and placenta is thought to be established in part by pathways that attenuate T cell priming to antigens released from the placenta into maternal blood. These pathways remain largely undefined and their existence, at face value, seems incompatible with a mother's need to maintain a functional immune system during pregnancy. A particular conundrum is evident if we consider that maternal antigen presenting cells, activated in order to prime T cells to pathogen-derived antigens, would also have the capacity to prime T cells to co-ingested placental antigens. Here, we address this paradox using a transgenic system in which placental membranes are tagged with a strong surrogate antigen (ovalbumin). We find that although a remarkably large quantity of acellular ovalbumin-containing placental material is released into maternal blood, splenic CD8 T cells in pregnant mice bearing unmanipulated T cell repertoires are not primed to ovalbumin even if the mice are intravenously injected with adjuvants. This failure was largely independent of regulatory T cells, and instead was linked to the intrinsic characteristics of the released material that rendered it selectively non-immunogenic, potentially by sequestering it from CD8 alpha(+) dendritic cells. The release of ovalbumin-containing placental material into maternal blood thus had no discernable impact on CD8 T cell priming to soluble ovalbumin injected intravenously during pregnancy, nor did it induce long-term tolerance to ovalbumin. Together, these results outline a major pathway governing the maternal immune response to the placenta, and suggest how tolerance to placental antigens can be maintained systemically without being detrimental to host defense.	[Tay, Chin-Siean; Tagliani, Elisa; Collins, Mary K.; Erlebacher, Adrian] NYU, Sch Med, Dept Pathol, New York, NY USA; [Erlebacher, Adrian] NYU, Sch Med, Inst Canc, New York, NY USA	New York University; New York University	Erlebacher, A (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY USA.	adrian.erlebacher@nyumc.org	Tagliani, Elisa/AAN-1955-2020		Leona M. and Harry B. Helmsley Charitable Trust [09PG-T1D028]; National Institutes of Health (NIH) National Cancer Institute [P30CA016087]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER	Leona M. and Harry B. Helmsley Charitable Trust; National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Leona M. and Harry B. Helmsley Charitable Trust to A. E. (09PG-T1D028). The NYU Cancer Institute's Immune Monitoring core facility was supported by a grant from the National Institutes of Health (NIH) National Cancer Institute (P30CA016087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; Benirschke K, 2006, PATHOLOGY HUMAN PLAC, V5th; Bevan MJ, 2001, NAT IMMUNOL, V2, P381, DOI 10.1038/87676; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Erlebacher A, 2007, J CLIN INVEST, V117, P1399, DOI 10.1172/JCI28214; Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361; Farrand KJ, 2009, J IMMUNOL, V183, P7732, DOI 10.4049/jimmunol.0902707; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; GUERIN LR, 2011, BIOL REPROD; Heesters BA, 2013, IMMUNITY, V38, P1164, DOI 10.1016/j.immuni.2013.02.023; Holland OJ, 2012, AM J PATHOL, V180, P256, DOI 10.1016/j.ajpath.2011.09.021; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Kastenmuller W, 2011, J IMMUNOL, V187, P3186, DOI 10.4049/jimmunol.1101649; Kemp RA, 2004, J IMMUNOL, V173, P2923, DOI 10.4049/jimmunol.173.5.2923; KINDBERG GM, 1990, BIOCHEM J, V270, P197, DOI 10.1042/bj2700197; Krishnan L, 2013, J REPROD IMMUNOL, V97, P62, DOI 10.1016/j.jri.2012.10.015; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Linscheid C, 2013, AM J REPROD IMMUNOL, V69, P304, DOI 10.1111/aji.12075; McCloskey ML, 2011, J EXP MED, V208, P135, DOI 10.1084/jem.20100354; McNally A, 2011, P NATL ACAD SCI USA, V108, P7529, DOI 10.1073/pnas.1103782108; Mincheva-Nilsson L, 2010, AM J REPROD IMMUNOL, V63, P520, DOI 10.1111/j.1600-0897.2010.00822.x; Moldenhauer LM, 2009, J IMMUNOL, V182, P8080, DOI 10.4049/jimmunol.0804018; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Rowe JH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002873; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005; Rowe JH, 2013, REPRODUCTION; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shima T, 2010, J REPROD IMMUNOL, V85, P121, DOI 10.1016/j.jri.2010.02.006; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Teles A, 2013, AM J REPROD IMMUNOL, V69, P331, DOI 10.1111/aji.12067; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007	42	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84064	10.1371/journal.pone.0084064	http://dx.doi.org/10.1371/journal.pone.0084064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391885	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900028
J	Wang, Y; Goh, JO; Resnick, SM; Davatzikos, C				Wang, Ying; Goh, Joshua O.; Resnick, Susan M.; Davatzikos, Christos			Imaging-Based Biomarkers of Cognitive Performance in Older Adults Constructed via High- Dimensional Pattern Regression Applied to MRI and PET	PLOS ONE			English	Article							FMRI TIME-SERIES; ALZHEIMERS-DISEASE; AGE; MEMORY; IMPAIRMENT; CLASSIFICATION; TRAJECTORIES; MULTIVARIATE; DIAGNOSIS; REGION	In this study, we used high-dimensional pattern regression methods based on structural (gray and white matter; GM and WM) and functional (positron emission tomography of regional cerebral blood flow; PET) brain data to identify cross-sectional imaging biomarkers of cognitive performance in cognitively normal older adults from the Baltimore Longitudinal Study of Aging (BLSA). We focused on specific components of executive and memory domains known to decline with aging, including manipulation, semantic retrieval, long-term memory (LTM), and short-term memory (STM). For each imaging modality, brain regions associated with each cognitive domain were generated by adaptive regional clustering. A relevance vector machine was adopted to model the nonlinear continuous relationship between brain regions and cognitive performance, with cross-validation to select the most informative brain regions (using recursive feature elimination) as imaging biomarkers and optimize model parameters. Predicted cognitive scores using our regression algorithm based on the resulting brain regions correlated well with actual performance. Also, regression models obtained using combined GM, WM, and PET imaging modalities outperformed models based on single modalities. Imaging biomarkers related to memory performance included the orbito-frontal and medial temporal cortical regions with LTM showing stronger correlation with the temporal lobe than STM. Brain regions predicting executive performance included orbito-frontal, and occipito-temporal areas. The PET modality had higher contribution to most cognitive domains except manipulation, which had higher WM contribution from the superior longitudinal fasciculus and the genu of the corpus callosum. These findings based on machine-learning methods demonstrate the importance of combining structural and functional imaging data in understanding complex cognitive mechanisms and also their potential usage as biomarkers that predict cognitive status.	[Wang, Ying; Davatzikos, Christos] Univ Penn, Dept Radiol, Sect Biomed Image Anal, Philadelphia, PA 19104 USA; [Goh, Joshua O.; Resnick, Susan M.] NIA, Lab Behav Neurosci, Baltimore, MD 21224 USA; [Goh, Joshua O.] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Taiwan University	Wang, Y (corresponding author), Univ Penn, Dept Radiol, Sect Biomed Image Anal, Philadelphia, PA 19104 USA.	ying.wang@uphs.upenn.edu	GOH, JOSHUA/C-8063-2016; Davatzikos, Christos/ABE-2057-2021	GOH, JOSHUA/0000-0001-7808-5452; Wang, Ying/0000-0001-8537-3954; Davatzikos, Christos/0000-0002-1025-8561	National Institutes of Health (NIH) [R01AG14971]; Intramural Research Program, National Institute on Aging, NIH;  [N01-AG-3-124]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014971, ZIAAG000191] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program, National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH) grant R01AG14971, by N01-AG-3-124, and by the Intramural Research Program, National Institute on Aging, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2012, NEUROPSYCHOLOGIA, V50, P3141, DOI 10.1016/j.neuropsychologia.2012.05.018; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Beason-Held LL, 2008, NEUROBIOL AGING, V29, P483, DOI 10.1016/j.neurobiolaging.2006.10.031; Beucher S., 1993, MATH MORPHOL IMAGE P, V34, P433, DOI [10.1201/9781482277234-12, DOI 10.1201/9781482277234-12]; BOWER GH, 1970, J VERB LEARN VERB BE, V9, P529, DOI 10.1016/S0022-5371(70)80096-2; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Chincarini A, 2012, EUR PHYS J PLUS, V127, DOI 10.1140/epjp/i2012-12135-6; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; Davis SW, 2012, CEREB CORTEX, V22, P232, DOI 10.1093/cercor/bhr123; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; de Rover M, 2011, NEUROPSYCHOLOGIA, V49, P2060, DOI 10.1016/j.neuropsychologia.2011.03.037; Delis DC., 2000, CALIFORNIA VERBAL LE; Driscoll I, 2006, ANN NEUROL, V60, P688, DOI 10.1002/ana.21031; Duchesne S, 2009, NEUROIMAGE, V47, P1363, DOI 10.1016/j.neuroimage.2009.04.023; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Filipovych R, 2011, INT J IMAG SYST TECH, V21, P173, DOI 10.1002/ima.20280; Formisano E, 2008, MAGN RESON IMAGING, V26, P921, DOI 10.1016/j.mri.2008.01.052; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Goh JO, 2013, NEUROIMAGE, V69, P43, DOI 10.1016/j.neuroimage.2012.12.026; Goh JO, 2012, PSYCHOL AGING, V27, P707, DOI 10.1037/a0026715; Golland P, 2002, LECT NOTES COMPUT SC, V2488, P508; GOLLAND P, 2001, ADV NEURAL INFORM PR, P745; Good P, 2000, PERMUTATION TESTS PR; Goodglass H., 1983, BOSTON NAMING TEST; Habeck C, 2008, NEUROIMAGE, V40, P1503, DOI 10.1016/j.neuroimage.2008.01.056; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Madden DJ, 2009, J COGNITIVE NEUROSCI, V21, P289, DOI 10.1162/jocn.2009.21047; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Monti MM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00028; Nyberg L, 2010, P NATL ACAD SCI USA, V107, P22682, DOI 10.1073/pnas.1012651108; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Pham DL, 1999, IEEE T MED IMAGING, V18, P737, DOI 10.1109/42.802752; Plant C, 2010, NEUROIMAGE, V50, P162, DOI 10.1016/j.neuroimage.2009.11.046; POLDRACK RA, 2006, TRENDS COGN SCI, V10, P352, DOI DOI 10.1016/J.TICS.2006.06.008.PUBMED:16843038; Poldrack RA, 2011, HDB FUNCTIONAL MRI D; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Resnick SM, 2003, J NEUROSCI, V23, P3295; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Teipel S, 2012, ADV BIOL PSYCH-KARG, V28, P80; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Tucker-Drob EM, 2011, DEV PSYCHOL, V47, P331, DOI 10.1037/a0021361; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhou JY, 2013, NEUROIMAGE, V78, P233, DOI 10.1016/j.neuroimage.2013.03.073	58	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85460	10.1371/journal.pone.0085460	http://dx.doi.org/10.1371/journal.pone.0085460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392010	Green Published, gold			2022-12-27	WOS:000329323900154
J	Yuan, WJ; Zhou, JF; Zhou, CS				Yuan, Wu-Jie; Zhou, Jian-Fang; Zhou, Changsong			Network Evolution Induced by Asynchronous Stimuli through Spike-Timing-Dependent Plasticity	PLOS ONE			English	Article							NEURONAL AVALANCHES; SYNAPTIC PLASTICITY; HUMAN HIPPOCAMPUS; NEURAL-NETWORKS; MECHANISMS; DEPRESSION; SEQUENCES; RECALL	In sensory neural system, external asynchronous stimuli play an important role in perceptual learning, associative memory and map development. However, the organization of structure and dynamics of neural networks induced by external asynchronous stimuli are not well understood. Spike-timing-dependent plasticity (STDP) is a typical synaptic plasticity that has been extensively found in the sensory systems and that has received much theoretical attention. This synaptic plasticity is highly sensitive to correlations between pre-and postsynaptic firings. Thus, STDP is expected to play an important role in response to external asynchronous stimuli, which can induce segregative pre-and postsynaptic firings. In this paper, we study the impact of external asynchronous stimuli on the organization of structure and dynamics of neural networks through STDP. We construct a two-dimensional spatial neural network model with local connectivity and sparseness, and use external currents to stimulate alternately on different spatial layers. The adopted external currents imposed alternately on spatial layers can be here regarded as external asynchronous stimuli. Through extensive numerical simulations, we focus on the effects of stimulus number and inter-stimulus timing on synaptic connecting weights and the property of propagation dynamics in the resulting network structure. Interestingly, the resulting feedforward structure induced by stimulus-dependent asynchronous firings and its propagation dynamics reflect both the underlying property of STDP. The results imply a possible important role of STDP in generating feedforward structure and collective propagation activity required for experience-dependent map plasticity in developing in vivo sensory pathways and cortices. The relevance of the results to cue-triggered recall of learned temporal sequences, an important cognitive function, is briefly discussed as well. Furthermore, this finding suggests a potential application for examining STDP by measuring neural population activity in a cultured neural network.	[Yuan, Wu-Jie; Zhou, Jian-Fang] Huaibei Normal Univ, Coll Phys & Elect Informat, Huaibei, Peoples R China; [Yuan, Wu-Jie; Zhou, Changsong] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China; [Yuan, Wu-Jie; Zhou, Changsong] Hong Kong Baptist Univ, Inst Computat & Theoret Studies, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Kowloon Tong, Hong Kong, Peoples R China; [Zhou, Changsong] Beijing Computat Sci Res Ctr, Beijing, Peoples R China; [Zhou, Changsong] HKBU Inst Res & Continuing Educ, Res Ctr, Shenzhen, Peoples R China	Huaibei Normal University; Hong Kong Baptist University; Hong Kong Baptist University; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC)	Yuan, WJ (corresponding author), Huaibei Normal Univ, Coll Phys & Elect Informat, Huaibei, Peoples R China.	yuanwj2005@163.com; cszhou@hkbu.edu.hk	Zhou, Changsong/F-4707-2010	Zhou, Changsong/0000-0002-4130-0216	Hong Kong Research Grant Council [HKBU202710]; National Natural Science Foundation of China [11275027, 11005047]; Young University Teacher's Fund of Anhui Provincein China [2008jql071]; Young Fund of Huaibei Normal University [2013xqz17]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young University Teacher's Fund of Anhui Provincein China; Young Fund of Huaibei Normal University	This work is supported by the Hong Kong Research Grant Council No. HKBU202710 (CZ), the National Natural Science Foundation of China under Grant Nos. 11275027 (CZ) and 11005047 (WJY), the Young University Teacher's Fund of Anhui Provincein China under Grant No. 2008jql071 (WJY), and the Young Fund of Huaibei Normal University under Grant No. 2013xqz17 (JFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Babadi B, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000961; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Butts DA, 2007, PLOS BIOL, V5, P651, DOI 10.1371/journal.pbio.0050061; Chance FS, 1998, J NEUROSCI, V18, P4785; D'Souza P, 2010, P NATL ACAD SCI USA, V107, P4722, DOI 10.1073/pnas.0909394107; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Dayan P, 2001, COMPUTATIONAL NEUROS; Drew PJ, 2006, P NATL ACAD SCI USA, V103, P8876, DOI 10.1073/pnas.0600676103; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Gilson M, 2009, BIOL CYBERN, V101, P81, DOI [10.1007/S00422-009-0319-4, 10.1007/s00422-009-0319-4]; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Hulata E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198105; Izhikevich EM, 2003, NEURAL COMPUT, V15, P1511, DOI 10.1162/089976603321891783; Jia L, 2007, INT J MOD PHYS B, V21, P4111; Kaiser M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036103; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; MAEDA E, 1995, J NEUROSCI, V15, P6834; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Perc M, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/252; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Santos GS, 2010, J NEUROSCI, V30, P8720, DOI 10.1523/JNEUROSCI.6141-09.2010; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sun XJ, 2008, CHAOS, V18, DOI 10.1063/1.2900402; Takahashi YK, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051904; Tsodyks M, 2004, NATURE, V431, P775, DOI 10.1038/nature03013; Varela JA, 1997, J NEUROSCI, V17, P7926; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011149; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yuan WJ, 2007, COMMUN THEOR PHYS, V47, P369; Yuan WJ, 2006, CHINESE PHYS LETT, V23, P3115, DOI 10.1088/0256-307X/23/11/064; Yuan WJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022818; Yuan WJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016116; Zhan X, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011907; Zhang HF, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18006; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007	52	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84644	10.1371/journal.pone.0084644	http://dx.doi.org/10.1371/journal.pone.0084644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391971	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900114
J	Zanforlin, T; Bayer-Santos, E; Cortez, C; Almeida, IC; Yoshida, N; da Silveira, JF				Zanforlin, Tamiris; Bayer-Santos, Ethel; Cortez, Cristian; Almeida, Igor C.; Yoshida, Nobuko; da Silveira, Jose Franco			Molecular Characterization of Trypanosoma cruzi SAP Proteins with Host-Cell Lysosome Exocytosis-Inducing Activity Required for Parasite Invasion	PLOS ONE			English	Article							SURFACE-ANTIGENS; METACYCLIC TRYPOMASTIGOTES; CHAGAS-DISEASE; ALANINE-RICH; SERINE-RICH; ACTIVATION; MEMBRANE; CYSTEINE; IDENTIFICATION; INFECTIVITY	Background: To invade target cells, Trypanosoma cruzi metacyclic forms engage distinct sets of surface and secreted molecules that interact with host components. Serine-, alanine-, and proline-rich proteins (SAP) comprise a multigene family constituted of molecules with a high serine, alanine and proline residue content. SAP proteins have a central domain (SAP-CD) responsible for interaction with and invasion of mammalian cells by metacyclic forms. Methods and Findings: Using a 513 bp sequence from SAP-CD in blastn analysis, we identified 39 full-length SAP genes in the genome of T. cruzi. Although most of these genes were mapped in the T. cruzi in silico chromosome TcChr41, several SAP sequences were spread out across the genome. The level of SAP transcripts was twice as high in metacyclic forms as in epimastigotes. Monoclonal (MAb-SAP) and polyclonal (anti-SAP) antibodies produced against the recombinant protein SAP-CD were used to investigate the expression and localization of SAP proteins. MAb-SAP reacted with a 55 kDa SAP protein released by epimastigotes and metacyclic forms and with distinct sets of SAP variants expressed in amastigotes and tissue culture-derived trypomastigotes (TCTs). Anti-SAP antibodies reacted with components located in the anterior region of epimastigotes and between the nucleus and the kinetoplast in metacyclic trypomastigotes. In contrast, anti-SAP recognized surface components of amastigotes and TCTs, suggesting that SAP proteins are directed to different cellular compartments. Ten SAP peptides were identified by mass spectrometry in vesicle and soluble-protein fractions obtained from parasite conditioned medium. Using overlapping sequences from SAP-CD, we identified a 54-aa peptide (SAP-CE) that was able to induce host-cell lysosome exocytosis and inhibit parasite internalization by 52%. Conclusions: This study provides novel information about the genomic organization, expression and cellular localization of SAP proteins and proposes a triggering role for extracellular SAP proteins in host-cell lysosome exocytosis during metacyclic internalization.	[Zanforlin, Tamiris; Bayer-Santos, Ethel; Cortez, Cristian; Yoshida, Nobuko; da Silveira, Jose Franco] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Almeida, Igor C.] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA	Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; University of Texas El Paso	da Silveira, JF (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	jose.franco@unifesp.br	cortez, cristian/GLT-4441-2022; Bayer-Santos, Ethel/Z-1923-2019; Yoshida, Nobuko/AAL-6082-2020; Bayer-Santos, Ethel/O-5505-2014; Almeida, Igor C./AAF-9409-2019; da Silveira, Jose Franco/F-5390-2012	Bayer-Santos, Ethel/0000-0003-3832-3449; Yoshida, Nobuko/0000-0002-3925-8557; Bayer-Santos, Ethel/0000-0003-3832-3449; Almeida, Igor C./0000-0002-2443-8213; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; National Institutes of Health (NIH) [R01AI070655-A5, R01AI070655-A5S1]; Research Centers in Minority Institutions program from the National Institutes on Minority Health and Health Disparities, a component of the NIH [8G12MD007592, 5G12RR008124-16A1, 5G12RR008124-16A1S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070655] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutions program from the National Institutes on Minority Health and Health Disparities, a component of the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (www.fapesp.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (www.cnpq.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) to JFS, and the National Institutes of Health (NIH) grants R01AI070655-A5 and R01AI070655-A5S1 to ICA. TZ was awarded a doctoral fellowship from FAPESP, and EBS and CC were awarded a doctoral fellowship from CNPq. The authors thank the Biomolecule Analysis Core Facility at the University of Texas at El Paso, supported by the Research Centers in Minority Institutions program, grants 8G12MD007592, 5G12RR008124-16A1, and 5G12RR008124-16A1S1, to the Border Biomedical Research Center, from the National Institutes on Minority Health and Health Disparities, a component of the NIH. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin G, 1996, BRAZ J MED BIOL RES, V29, P335; AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade D, 2012, BRIT J PHARMACOL, V165, P1333, DOI 10.1111/j.1476-5381.2011.01609.x; ANDREWS NW, 1990, CELL, V61, P1277, DOI 10.1016/0092-8674(90)90692-8; ANDREWS NW, 1987, EXP PARASITOL, V64, P474, DOI 10.1016/0014-4894(87)90062-2; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P334; Aparicio IM, 2004, INFECT IMMUN, V72, P5892, DOI 10.1128/IAI.72.10.5892-5902.2004; Baida RCP, 2006, INFECT IMMUN, V74, P1537, DOI 10.1128/IAI.74.3.1537-1546.2006; Bastos IMD, 2005, BIOCHEM J, V388, P29, DOI 10.1042/BJ20041049; Bayer-Santos E, 2013, J PROTEOME RES, V12, P883, DOI 10.1021/pr300947g; CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A; Carmo MS, 2001, INT J PARASITOL, V31, P259, DOI 10.1016/S0020-7519(00)00170-3; Cortez C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001804; Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221; Cuevas IC, 2005, EUKARYOT CELL, V4, P1550, DOI 10.1128/EC.4.9.1550-1561.2005; Doyle PS, 2011, PLOS PATHOG, V7, DOI DOI 10.1371/journal.ppat.1002139; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Giordanengo L, 2002, EUR J IMMUNOL, V32, P1003, DOI 10.1002/1521-4141(200204)32:4<1003::AID-IMMU1003>3.0.CO;2-P; GONCALVES MF, 1991, EXP PARASITOL, V72, P43, DOI 10.1016/0014-4894(91)90119-H; JAZIN EE, 1995, PARASITOLOGY, V110, P61, DOI 10.1017/S0031182000081051; Maeda FY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00361; Martins RM, 2011, CELL MICROBIOL, V13, P943, DOI 10.1111/j.1462-5822.2011.01590.x; MORO A, 1995, EMBO J, V14, P2483, DOI 10.1002/j.1460-2075.1995.tb07245.x; MURTA ACM, 1990, MOL BIOCHEM PARASIT, V43, P27, DOI 10.1016/0166-6851(90)90127-8; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; NORRIS KA, 1994, INFECT IMMUN, V62, P236, DOI 10.1128/IAI.62.1.236-243.1994; Ouaissi A, 1995, IMMUNOL LETT, V48, P221, DOI 10.1016/0165-2478(95)02463-8; RAMIREZ MI, 1993, INFECT IMMUN, V61, P3636, DOI 10.1128/IAI.61.9.3636-3641.1993; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Rodriguez A, 1996, J CELL BIOL, V134, P349, DOI 10.1083/jcb.134.2.349; Ruiz RC, 1998, BIOCHEM J, V330, P505; Savino W, 2007, CYTOKINE GROWTH F R, V18, P107, DOI 10.1016/j.cytogfr.2007.01.010; Scharfstein J, 2000, J EXP MED, V192, P1289, DOI 10.1084/jem.192.9.1289; Scharfstein J, 2006, IMMUNOBIOLOGY, V211, P117, DOI 10.1016/j.imbio.2005.10.014; Simpson R.J, 2012, J PROTEOM BIOINFORM, V5, P10000, DOI [10.4172/jpb.10000e10, DOI 10.4172/JPB.10000E10]; Souza RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023042; Stempin C, 2002, J LEUKOCYTE BIOL, V72, P727; TARDIEUX I, 1992, CELL, V71, P1117, DOI 10.1016/S0092-8674(05)80061-3; TEIXEIRA MMG, 1986, MOL BIOCHEM PARASIT, V18, P271, DOI 10.1016/0166-6851(86)90085-X; Torrecilhas ACT, 2009, MICROBES INFECT, V11, P29, DOI 10.1016/j.micinf.2008.10.003; Umezawa ES, 1996, J CLIN LAB ANAL, V10, P407, DOI 10.1002/(SICI)1098-2825(1996)10:6&lt;407::AID-JCLA16&gt;3.0.CO;2-0; VataruNakamura C, 2005, FEMS MICROBIOL LETT, V242, P227, DOI 10.1016/j.femsle.2004.11.008; Vazquez MP, 1999, GENE, V239, P217, DOI 10.1016/S0378-1119(99)00386-8; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; YOSHIDA N, 1989, INFECT IMMUN, V57, P1663, DOI 10.1128/IAI.57.6.1663-1667.1989	47	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83864	10.1371/journal.pone.0083864	http://dx.doi.org/10.1371/journal.pone.0083864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391838	Green Submitted, gold, Green Published			2022-12-27	WOS:000329325200136
J	Bajracharya, D; Khan, MI; Pach, A; Shrestha, P; Joshi, N; Upreti, SR; Wierzba, T; Puri, M; Sahastrabuddhe, S; Ochiai, RL				Bajracharya, Deepak; Khan, M. Imran; Pach, Alfred, III; Shrestha, Parisha; Joshi, Nilesh; Upreti, Shyam R.; Wierzba, Thomas; Puri, Mahesh; Sahastrabuddhe, Sushant; Ochiai, R. Leon			25 Years after Vi Typhoid Vaccine Efficacy Study, Typhoid Affects Significant Number of Population in Nepal	PLOS ONE			English	Article							SALMONELLA-TYPHI; FEVER; POLYSACCHARIDE; IMMUNIZATION; COUNTRIES	Salmonella Typhi, first isolated in 1884, results in infection of the intestines and can end in death and disability. Due to serious adverse events post vaccination, whole cell killed vaccines have been replaced with new generation vaccines. The efficacy of Vi polysaccharide (ViPS) vaccine, a new generation, single-dose intramuscular typhoid vaccine was assessed in Nepal in 1987. However, despite the availability of ViPS vaccine for more than 25 years, Nepal has one of the highest incidence of typhoid fever. Therefore we collected information from hospitals in the Kathmandu Valley from over the past five years. There were 9901 enteric fever cases between January 2008 and July 2012. 1,881 of these were confirmed typhoid cases from five hospitals in the Kathmandu district. Approximately 70% of the cases involved children under 15 years old. 1281 cases were confirmed as S. Paratyphi. Vaccines should be prioritized for control of typhoid in conjunction with improved water and sanitation conditions in Nepal and in endemic countries of Asia and Africa.	[Bajracharya, Deepak; Shrestha, Parisha; Joshi, Nilesh] MITRA Samaj Pani Pokhari, Kathmandu, Nepal; [Bajracharya, Deepak] Grp Tech Assistance, Sanepa, Nepal; [Khan, M. Imran; Pach, Alfred, III; Wierzba, Thomas; Puri, Mahesh; Sahastrabuddhe, Sushant; Ochiai, R. Leon] Int Vaccine Inst, Seoul, South Korea; [Upreti, Shyam R.] Minist Hlth & Populat, Dept Hlth Serv, Child Hlth Div, Kathmandu, Nepal	International Vaccine Institute	Khan, MI (corresponding author), MITRA Samaj Pani Pokhari, Kathmandu, Nepal.	imran@ivi.int		Ochiai, Leon/0000-0002-5079-6786; SAHASTRABUDDHE, SUSHANT/0000-0003-1751-3905	Bill and Melinda Gates foundation; government of the Republic of Korea; government of Sweden	Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); government of the Republic of Korea(Korean Government); government of Sweden	The project was conducted with the support of a grant from Bill and Melinda Gates foundation. The International Vaccine Institute receives core financial support from the governments of the Republic of Korea and Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya D, 2012, JPN J INFECT DIS, V65, P264, DOI 10.7883/yoken.65.264; ACHARYA IL, 1987, NEW ENGL J MED, V317, P1101, DOI 10.1056/NEJM198710293171801; Adhikari J, 1999, Stud Nepali Hist Soc, V4, P191; Agtini MD, 2006, PUBLIC HEALTH, V120, P1081, DOI 10.1016/j.puhe.2006.06.008; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P49; Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Berner Wlodzimierz, 2009, Przegl Epidemiol, V63, P149; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bhutta ZA, 1996, ARCH DIS CHILD, V75, P214, DOI 10.1136/adc.75.3.214; BODHIDATTA L, 1987, REV INFECT DIS, V9, P841; Crump JA, 2008, EPIDEMIOL INFECT, V136, P436, DOI 10.1017/S0950268807009338; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; DeRoeck D, 2008, EXPERT REV VACCINES, V7, P547, DOI 10.1586/14760584.7.5.547; EBERTH, 1880, VIRCHOWS ARCH PATH A, V81, P16; Levine MM, 1999, VACCINE, V17, pS22, DOI 10.1016/S0264-410X(99)00231-5; Levine OS, 2010, HUM VACCINES, V6, P1021, DOI 10.4161/hv.6.12.13076; Mahoney RT, 2007, VACCINE, V25, P4003, DOI 10.1016/j.vaccine.2007.02.047; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; Thiem Vu Dinh, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P515; World Health Organization, 2013, IMM STAND TYPH 20 DO	20	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e77974	10.1371/journal.pone.0077974	http://dx.doi.org/10.1371/journal.pone.0077974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400067	Green Published, gold, Green Submitted			2022-12-27	WOS:000329462700001
J	Hinrichsen, I; Kemp, M; Peveling-Oberhag, J; Passmann, S; Plotz, G; Zeuzem, S; Brieger, A				Hinrichsen, Inga; Kemp, Matthias; Peveling-Oberhag, Jan; Passmann, Sandra; Plotz, Guido; Zeuzem, Stefan; Brieger, Angela			Promoter Methylation of MLH1, PMS2, MSH2 and p16 Is a Phenomenon of Advanced-Stage HCCs	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN HEPATOCELLULAR-CARCINOMA; CORE-PROTEIN; COLORECTAL-CANCER; EXPRESSION; HMSH2; GENES; HMLH1; PATHOGENESIS; MUTATIONS	Epigenetic silencing of tumour suppressor genes has been observed in various cancers. Looking at hepatocellular carcinoma (HCC) specific protein silencing was previously demonstrated to be associated with the Hepatitis C virus (HCV). However, the proposed HCV dependent promoter methylation of DNA mismatch repair (MMR) genes and thereby enhanced progression of hepatocarcinogenesis has been the subject of controversial discussion. We investigated promoter methylation pattern of the MMR genes MLH1, MSH2 and PMS2 as well as the cyclin-dependent kinase inhibitor 2A gene (p16) in 61 well characterized patients with HCCs associated with HCV, Hepatitis B virus infection or alcoholic liver disease. DNA was isolated from formalin-fixed, paraffin-embedded tumour and non-tumour adjacent tissue and analysed by methylation-specific PCR. Moreover, microsatellite analysis was performed in tissues showing methylation in MMR gene promoters. Our data demonstrated that promoter methylation of MLH1, MSH2, PMS2 and p16 is present among all considered HCCs. Hereby, promoter silencing was detectable more frequently in advanced-stage HCCs than in low-stage ones. However, there was no significant correlation between aberrant DNA methylation of MMR genes or p16 and HCV infection in related HCC specimens. In summary, we show that promoter methylation of essential MMR genes and p16 is detectable in HCCs most dominantly in pT3 stage tumour cases. Since loss of MMR proteins was previously described to be not only responsible for tumour development but also for chemotherapy resistance, the knowledge of mechanisms jointly responsible for HCC progression might enable significant improvement of individual HCC therapy in the future.	[Hinrichsen, Inga; Kemp, Matthias; Peveling-Oberhag, Jan; Passmann, Sandra; Plotz, Guido; Zeuzem, Stefan; Brieger, Angela] Goethe Univ, Biomed Res Lab, Med Clin 1, Frankfurt, Germany	Goethe University Frankfurt	Brieger, A (corresponding author), Goethe Univ, Biomed Res Lab, Med Clin 1, Frankfurt, Germany.	a.brieger@em.uni-frankfurt.de	Plotz, Guido/K-8446-2012; Zeuzem, Stefan/AAE-7435-2019	Plotz, Guido/0000-0001-5314-9739	Deutsche Krebsstiftung [109651]; Goethe-University Frankfurt	Deutsche Krebsstiftung; Goethe-University Frankfurt	This work was supported by grant 109651 of the Deutsche Krebsstiftung and institutional funds (estate of Maria Christine Held und Erika Hecker) of the Goethe-University Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman N, 2001, J EGYPTIAN NAT CANC, V13, P129; Ahmed R, 2010, MED SCI MONITOR, V16, pCR410; Arora P, 2008, CANCER LETT, V261, P244, DOI 10.1016/j.canlet.2007.11.033; Benegiamo G, 2012, DIGEST DIS SCI, V57, P1598, DOI 10.1007/s10620-012-2160-1; Deng YB, 2010, CANCER SCI, V101, P1501, DOI 10.1111/j.1349-7006.2010.01549.x; Fang JY, 2006, CANCER LETT, V233, P124, DOI 10.1016/j.canlet.2005.03.005; Feitelson MA, 2006, CANCER LETT, V239, P10, DOI 10.1016/j.canlet.2005.07.009; Feng QH, 2010, EXP MOL PATHOL, V88, P287, DOI 10.1016/j.yexmp.2010.01.002; Helal TEA, 2010, APMIS, V118, P934, DOI 10.1111/j.1600-0463.2010.02658.x; ISHAK KG, 1994, HISTOLOGICAL TYPING; Kaneto H, 2001, GUT, V48, P372, DOI 10.1136/gut.48.3.372; Kondoh N, 2001, INT J ONCOL, V18, P1271; Li ZQ, 2012, CELL BIOL INT, V36, P427, DOI 10.1042/CBI20100851; Lim JS, 2012, CANCER LETT, V321, P154, DOI 10.1016/j.canlet.2012.01.044; LIU B, 1994, CANCER RES, V54, P4590; Matsukura S, 2003, BRIT J CANCER, V88, P521, DOI 10.1038/sj.bjc.6600743; Moradpour D, 2000, ZBL CHIR, V125, P592; Neumann O, 2012, HEPATOLOGY, V56, P1817, DOI 10.1002/hep.25870; Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110; PARSONS R, 1995, CANCER RES, V55, P5548; Pedroni M, 2007, DIS MARKERS, V23, P179, DOI 10.1155/2007/703129; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Wang LN, 2001, INT J ONCOL, V19, P567; Wang XW, 2002, TOXICOLOGY, V181, P43, DOI 10.1016/S0300-483X(02)00253-6; Wani Y, 2001, ACTA MED OKAYAMA, V55, P65; Zekri ARN, 2005, WORLD J GASTROENTERO, V11, P3020, DOI 10.3748/wjg.v11.i20.3020; Zhang Cui-juan, 2004, Zhonghua Bing Li Xue Za Zhi, V33, P433	28	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84453	10.1371/journal.pone.0084453	http://dx.doi.org/10.1371/journal.pone.0084453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400091	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700025
J	Mayr, A; Schmid, M				Mayr, Andreas; Schmid, Matthias			Boosting the Concordance Index for Survival Data - A Unified Framework To Derive and Evaluate Biomarker Combinations	PLOS ONE			English	Article							COX REGRESSION; SELECTION; CANCER; MODEL; DISCRIMINATION; CLASSIFICATION; PREDICTION; MARKERS	The development of molecular signatures for the prediction of time-to-event outcomes is a methodologically challenging task in bioinformatics and biostatistics. Although there are numerous approaches for the derivation of marker combinations and their evaluation, the underlying methodology often suffers from the problem that different optimization criteria are mixed during the feature selection, estimation and evaluation steps. This might result in marker combinations that are suboptimal regarding the evaluation criterion of interest. To address this issue, we propose a unified framework to derive and evaluate biomarker combinations. Our approach is based on the concordance index for time-to-event data, which is a non-parametric measure to quantify the discriminatory power of a prediction rule. Specifically, we propose a gradient boosting algorithm that results in linear biomarker combinations that are optimal with respect to a smoothed version of the concordance index. We investigate the performance of our algorithm in a large-scale simulation study and in two molecular data sets for the prediction of survival in breast cancer patients. Our numerical results show that the new approach is not only methodologically sound but can also lead to a higher discriminatory power than traditional approaches for the derivation of gene signatures.	[Mayr, Andreas] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany; [Schmid, Matthias] Univ Munich, Dept Stat, Munich, Germany	University of Erlangen Nuremberg; University of Munich	Mayr, A (corresponding author), Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany.	andreas.mayr@fau.de		Mayr, Andreas/0000-0001-7106-9732; Schmid, Matthias/0000-0002-0788-0317	Deutsche Forschungsgemeinschaft (DFG) [SCHM 2966/1-1]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg	The work of Andreas Mayr and Matthias Schmid was supported by Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de), grant SCHM 2966/1-1. The authors further acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PUBMED; Antolini L, 2005, STAT MED, V24, P3927, DOI 10.1002/sim.2427; Buhlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Buhlmann P, 2006, ANN STAT, V34, P559, DOI 10.1214/009053606000000092; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman JH, 1997, DATA MIN KNOWL DISC, V1, P55, DOI 10.1023/A:1009778005914; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goeman J., 2012, PENALIZED L1 LASSO F; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Gui J, 2005, BIOINFORMATICS, V21, P3001, DOI 10.1093/bioinformatics/bti422; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hothorn T, 2013, MBOOST MODEL BASED B; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Kaderali L, 2006, BIOINFORMATICS, V22, P1495, DOI 10.1093/bioinformatics/btl103; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Lecocke M, 2006, CANCER INFORM, V2, P313; Li H., 2002, PACIFIC S BIOCOMPUTI, V8, P65; Ma SG, 2005, BIOINFORMATICS, V21, P4356, DOI 10.1093/bioinformatics/bti724; Ma SG, 2011, BRIEF BIOINFORM, V12, P33, DOI 10.1093/bib/bbq069; Mayr A, 2012, METHOD INFORM MED, V51, P178, DOI 10.3414/ME11-02-0030; Mayr A, 2012, J R STAT SOC C-APPL, V61, P403, DOI 10.1111/j.1467-9876.2011.01033.x; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2008, LIFETIME DATA ANAL, V14, P86, DOI 10.1007/s10985-007-9073-x; Potapov S, 2012, SURVAUC ESTIMATORS P; R Core Team, 2013, R LANG ENV STAT COMP; Schmid M, 2013, BRIEFINGS BIOINFORMA; Schmid M, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1792; Schmid M, 2012, STAT MED, V31, P2588, DOI 10.1002/sim.5464; Schmid M, 2008, COMPUT STAT DATA AN, V53, P298, DOI 10.1016/j.csda.2008.09.009; Schmid M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-269; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tice JA, 2005, BREAST CANCER RES TR, V94, P115, DOI 10.1007/s10549-005-5152-4; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; van der Laan M.J., 2003, SPR S STAT; van Houwelingen HC, 2006, STAT MED, V25, P3201, DOI 10.1002/sim.2353; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZF, 2011, BIOSTATISTICS, V12, P369, DOI 10.1093/biostatistics/kxq052; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2; Witten DM, 2010, STAT METHODS MED RES, V19, P29, DOI 10.1177/0962280209105024; Zhang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057830; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017845	46	55	55	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84483	10.1371/journal.pone.0084483	http://dx.doi.org/10.1371/journal.pone.0084483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400093	gold, Green Published, Green Submitted			2022-12-27	WOS:000329462700027
J	Navarro-Gonzalez, I; Perez-Sanchez, H; Martin-Pozuelo, G; Garcia-Alonso, J; Periago, MJ				Navarro-Gonzalez, Inmaculada; Perez-Sanchez, Horacio; Martin-Pozuelo, Gala; Garcia-Alonso, Javier; Jesus Periago, Maria			The Inhibitory Effects of Bioactive Compounds of Tomato Juice Binding to Hepatic HMGCR: In Vivo Study and Molecular Modelling	PLOS ONE			English	Article							COENZYME-A REDUCTASE; CHLOROGENIC ACID; COA REDUCTASE; VITAMIN-C; LYCOPENE; METABOLISM; PRODUCTS; BIOAVAILABILITY; CAROTENOIDS; NARINGENIN	The hypocholesterolemic effect of tomato juice has been investigated in an intervention study with rats, along with the possible inhibition effect of bioactive tomato compounds binding to the HMGCR enzyme. Two experimental groups (n = 8 Sprague-Dawley rats) were fed ad libitum for five weeks, with water or tomato juice provided to the control and intervention groups, respectively. Total, LDL and HDL cholesterol, and total triglycerides were analysed in plasma, and the lycopene content and the expression and activity of the enzyme HMGCR were determined in liver samples. A computational molecular modelling was carried out to determine the interactions between HMGCR and lycopene, chlorogenic acid and naringenin. Total, LDL and HDL cholesterol were significantly lower in the intervention group after the intake of tomato juice. In addition, a significant reduction in HMGCR activity was observed, although this was not accompanied by changes in gene expression. The molecular modelling showed that components of tomato can bind to the active site of the enzyme and compete with the ligand HMGCoA. Lycopene, from tomato juice, accumulates in the liver and can inhibit the activity of the rate-limiting enzyme of cholesterol biosynthesis, HMGCR.	[Navarro-Gonzalez, Inmaculada; Martin-Pozuelo, Gala; Garcia-Alonso, Javier; Jesus Periago, Maria] Univ Murcia, Fac Vet Sci, Dept Food Sci & Nutr, Murcia, Spain; [Perez-Sanchez, Horacio] Catholic Univ Murcia UCAM, Dept Comp Sci, Murcia, Spain	University of Murcia; Universidad Catolica de Murcia	Navarro-Gonzalez, I (corresponding author), Univ Murcia, Fac Vet Sci, Dept Food Sci & Nutr, Campus Espinardo Reg Campus Int Excellence Campus, Murcia, Spain.	inmaculada.navarro@um.es; horacio@ucam.edu	Pérez-Sánchez, Horacio/O-5017-2016; Periago, María Jesús/K-5251-2017	Pérez-Sánchez, Horacio/0000-0003-4468-7898; 	projects MINECO (Spanish)/FEDER-EU [BIO2012-38103]; CONSOLIDER Fun-C-Food CSD; Research Regional Agency Fundacion Seneca (Murcia, Spain) [12031/PI/09]; Murcia University	projects MINECO (Spanish)/FEDER-EU; CONSOLIDER Fun-C-Food CSD; Research Regional Agency Fundacion Seneca (Murcia, Spain); Murcia University	This research was supported by the projects MINECO (Spanish)/FEDER-EU BIO2012-38103 and CONSOLIDER Fun-C-Food CSD2007, and by the Research Regional Agency Fundacion Seneca (Murcia, Spain) project 12031/PI/09. GMP acknowledges a PhD fellowship from Murcia University. The authors also thank Zumos Hesperia Filab and Juver Alimentacion (Cabezo de Torres, Murcia, Spain) for providing the tomato juice samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab L, 2000, AM J CLIN NUTR, V71, p1691S, DOI 10.1093/ajcn/71.6.1691S; BEG ZH, 1973, BIOCHEM BIOPH RES CO, V54, P1362, DOI 10.1016/0006-291X(73)91137-6; BILHEIMER DW, 1989, P NATL ACAD SCI USA, V80, P4142; Bohm V, 2001, J SEP SCI, V24, P955, DOI 10.1002/1615-9314(20011201)24:12&lt;955::AID-JSSC955&gt;3.0.CO;2-; BROWN MS, 1980, J LIPID RES, V21, P505; Chen ZY, 2008, J AGR FOOD CHEM, V56, P8761, DOI 10.1021/jf801566r; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Felgines C, 2000, AM J PHYSIOL-GASTR L, V279, pG1148, DOI 10.1152/ajpgi.2000.279.6.G1148; Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588; Frohlich K, 2007, INT J VITAM NUTR RES, V77, P369, DOI 10.1024/0300-9831.77.6.369; Fuhrman B, 1997, BIOCHEM BIOPH RES CO, V233, P658, DOI 10.1006/bbrc.1997.6520; Garcia-Alonso FJ, 2012, EUR J NUTR, V51, P415, DOI 10.1007/s00394-011-0225-0; Garcia-Valverde V, 2013, FOOD BIOPROCESS TECH, V6, P391, DOI 10.1007/s11947-011-0687-3; Gark VK, 1983, 3 HYDROXY 3 METHYLGL, P29; Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853; Hazai E, 2006, BIOORGAN MED CHEM, V14, P6859, DOI 10.1016/j.bmc.2006.06.045; Hsu YM, 2008, BIOSCI BIOTECH BIOCH, V72, P677, DOI 10.1271/bbb.70402; Hu MY, 2008, NUTRITION, V24, P1030, DOI 10.1016/j.nut.2008.05.006; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jacob K, 2008, BRIT J NUTR, V99, P137, DOI 10.1017/S0007114507791894; Periago MJ, 2009, INT J FOOD SCI NUTR, V60, P694, DOI 10.3109/09637480701833457; Karthikesan K, 2010, CHEM-BIOL INTERACT, V188, P643, DOI 10.1016/j.cbi.2010.07.026; Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192; Lafay S, 2006, BRIT J NUTR, V96, P39, DOI 10.1079/BJN20061714; Lee SH, 1999, ANN NUTR METAB, V43, P173, DOI 10.1159/000012783; Leopoldini M, 2010, J AGR FOOD CHEM, V58, P10768, DOI 10.1021/jf102576j; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordente A, 2011, CURR MED CHEM, V18, P1146, DOI 10.2174/092986711795029717; Navarro-Fernandez J, 2012, J MED CHEM, V55, P6403, DOI 10.1021/jm300621j; Omar MH, 2012, J AGR FOOD CHEM, V60, P5205, DOI 10.1021/jf3001185; Palozza P, 2010, CURR MED CHEM, V17, P2547, DOI 10.2174/092986710791556041; Palozza P, 2011, J NUTR BIOCHEM, V22, P971, DOI 10.1016/j.jnutbio.2010.08.010; Rai SK, 2009, LIFE SCI, V85, P211, DOI 10.1016/j.lfs.2009.05.020; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; RAO AV, 1975, CLIN CHEM, V21, P1523; Rao AV, 1998, FOOD RES INT, V31, P737, DOI 10.1016/S0963-9969(99)00053-8; Richelle M, 2010, BRIT J NUTR, V103, P1800, DOI 10.1017/S0007114510000103; Ried K, 2011, MATURITAS, V68, P299, DOI 10.1016/j.maturitas.2010.11.018; Sanchez-Moreno C, 2006, J NUTR BIOCHEM, V17, P183, DOI 10.1016/j.jnutbio.2005.07.001; Sesso HD, 2012, J NUTR, V142, P326, DOI 10.3945/jn.111.150631; Silaste ML, 2007, BRIT J NUTR, V98, P1251, DOI 10.1017/S0007114507787445; Stroganov OV, 2008, J CHEM INF MODEL, V48, P2371, DOI 10.1021/ci800166p; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Willcox JK, 2003, CRIT REV FOOD SCI, V43, P1, DOI 10.1080/10408690390826437	46	35	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83968	10.1371/journal.pone.0083968	http://dx.doi.org/10.1371/journal.pone.0083968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392102	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100026
J	Okamoto, N; Keeling, PJ				Okamoto, Noriko; Keeling, Patrick J.			The 3D Structure of the Apical Complex and Association with the Flagellar Apparatus Revealed by Serial TEM Tomography in Psammosa pacifica, a Distant Relative of the Apicomplexa	PLOS ONE			English	Article							RDNA-BASED PHYLOGENY; STRIATED FIBER ASSEMBLIN; SP-NOV; INTRACELLULAR PARASITE; FINE-STRUCTURE; CELL INVASION; POLAR RING; N-SP; ULTRASTRUCTURE; DINOFLAGELLATE	The apical complex is one of the defining features of apicomplexan parasites, including the malaria parasite Plasmodium, where it mediates host penetration and invasion. The apical complex is also known in a few related lineages, including several non-parasitic heterotrophs, where it mediates feeding behaviour. The origin of the apical complex is unclear, and one reason for this is that in apicomplexans it exists in only part of the life cycle, and never simultaneously with other major cytoskeletal structures like flagella and basal bodies. Here, we used conventional TEM and serial TEM tomography to reconstruct the three dimensional structure of the apical complex in Psammosa pacifica, a predatory relative of apicomplexans and dinoflagellates that retains the archetype apical complex and the flagellar apparatus simultaneously. The P. pacifica apical complex is associated with the gullet and consists of the pseudoconoid, micronemes, and electron dense vesicles. The pseudoconoid is a convex sheet consisting of eight short microtubules, plus a band made up of microtubules that originate from the flagellar apparatus. The flagellar apparatus consists of three microtubular roots. One of the microtubular roots attached to the posterior basal body is connected to bypassing microtubular strands, which are themselves connected to the extension of the pseudoconoid. These complex connections where the apical complex is an extension of the flagellar apparatus, reflect the ancestral state of both, dating back to the common ancestor of apicaomplexans and dinoflagellates.	[Okamoto, Noriko; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Okamoto, N (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	okamoton@mail.ubc.ca		Keeling, Patrick/0000-0002-7644-0745	Canadian Insititutes for Health Research [MOP-42517]; Tula Foundation	Canadian Insititutes for Health Research; Tula Foundation	This work was supported by a grant from the Canadian Insititutes for Health Research (MOP-42517) and from the Tula Foundation to the Centre for Microbial Diversity and Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZEVEDO C, 1989, J PARASITOL, V75, P627, DOI 10.2307/3282915; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; BRUGEROLLE G, 1979, PROTISTOLOGICA, V15, P183; Brugerolle G, 2002, EUR J PROTISTOL, V38, P113, DOI 10.1078/0932-4739-00864; Brugerolle G, 2002, EUR J PROTISTOL, V37, P379, DOI 10.1078/0932-4739-00837; Calado AJ, 2006, J PHYCOL, V42, P434, DOI 10.1111/j.1529-8817.2006.00195.x; Calado AJ, 2002, PHYCOLOGIA, V41, P567, DOI 10.2216/i0031-8884-41-6-567.1; Calado AJ, 2009, J PHYCOL, V45, P1195, DOI 10.1111/j.1529-8817.2009.00735.x; Calado SCFCM, 2010, THESIS U AVEIRO PORT; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; Craveiro SC, 2011, PROTIST, V162, P590, DOI 10.1016/j.protis.2011.03.003; Craveiro SC, 2010, J EUKARYOT MICROBIOL, V57, P568, DOI 10.1111/j.1550-7408.2010.00512.x; Cumbo VR, 2013, PROTIST, V164, P237, DOI 10.1016/j.protis.2012.08.003; Dalloul RA, 2006, EXPERT REV VACCINES, V5, P143, DOI 10.1586/14760584.5.1.143; de Leon JC, 2013, EUKARYOT CELL, V12, P1009, DOI 10.1128/EC.00096-13; DODGE J D, 1971, Protistologica, V7, P399; DYSON J, 1994, J NAT HIST, V28, P1, DOI 10.1080/00222939400770011; FOISSNER W, 1984, PROTISTOLOGICA, V20, P635; Francia ME, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001444; Garces E, 2010, HARMFUL ALGAE, V10, P64, DOI 10.1016/j.hal.2010.07.001; Geimer S, 2004, J CELL SCI, V117, P2663, DOI 10.1242/jcs.01120; Gubbels MJ, 2012, INT J PARASITOL, V42, P1071, DOI 10.1016/j.ijpara.2012.09.009; GUSTAFSON PV, 1954, AM J TROP MED HYG, V3, P1008, DOI 10.4269/ajtmh.1954.3.1008; Hansen G, 2007, PHYCOLOGIA, V46, P86, DOI 10.2216/0031-8884(2007)46[86:BAGESN]2.0.CO;2; Harper JDI, 2009, PROTOPLASMA, V236, P97, DOI 10.1007/s00709-009-0041-z; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Jacobson DM, 1996, J PHYCOL, V32, P279, DOI 10.1111/j.0022-3646.1996.00279.x; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Kato KH, 2000, BIOL CELL, V92, P583, DOI 10.1016/S0248-4900(00)01106-0; Kemp LE, 2013, FEMS MICROBIOL REV, V37, P607, DOI 10.1111/1574-6976.12013; Leander BS, 2008, EUR J PROTISTOL, V44, P55, DOI 10.1016/j.ejop.2007.08.004; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Lechtreck KF, 2003, MOL BIOCHEM PARASIT, V128, P95, DOI 10.1016/S0166-6851(03)00038-0; Lechtreck KF, 2002, J CELL SCI, V115, P1511; Miller JJ, 2012, PROTIST, V163, P720, DOI 10.1016/j.protis.2011.11.007; MOESTRUP O, 1982, PHYCOLOGIA, V21, P427, DOI 10.2216/i0031-8884-21-4-427.1; Moestrup O, 2000, SYST ASSOC SPEC VOL, V59, P69; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Myl'nikova ZM, 2009, INLAND WATER BIOL, V2, P199, DOI 10.1134/S199508290903002X; Mylnikov AP, 2009, BIOL BULL+, V36, P582, DOI 10.1134/S1062359009060065; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; Noren F, 1999, EUR J PROTISTOL, V35, P233, DOI 10.1016/S0932-4739(99)80001-7; Obornik M, 2011, PROTIST, V162, P115, DOI 10.1016/j.protis.2010.02.004; Okamoto N, 2008, FUTURE MICROBIOL, V3, P391, DOI 10.2217/17460913.3.4.391; Okamoto N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034900; PATERSON WB, 1988, J PROTOZOOL, V35, P73, DOI 10.1111/j.1550-7408.1988.tb04080.x; PERKINS FO, 1976, J PARASITOL, V62, P959, DOI 10.2307/3279192; Perkins FO, 1996, J SHELLFISH RES, V15, P67; Portman N, 2014, EUKARYOT CELL, V13, P10, DOI 10.1128/EC.00155-13; ROBERTS KR, 1985, J PHYCOL, V21, P641; ROBERTS KR, 1991, PROTOPLASMA, V164, P105, DOI 10.1007/BF01320818; RUSSELL DG, 1984, J CELL SCI, V65, P193; SCHNEPF E, 1984, NATURWISSENSCHAFTEN, V71, P218, DOI 10.1007/BF00490442; SCHOLTYSECK E, 1970, Z PARASITENK, V34, P68, DOI 10.1007/BF00629180; SCHOLTYSECK E, 1970, Z PARASITENK, V34, P97; Shanmugasundram A, 2013, NUCLEIC ACIDS RES, V41, pD706, DOI 10.1093/nar/gks1139; Shaw MK, 2003, TRENDS PARASITOL, V19, P2, DOI 10.1016/S1471-4922(02)00015-6; Shen B, 2012, CURR OPIN MICROBIOL, V15, P449, DOI 10.1016/j.mib.2012.02.007; Siddall ME, 1997, PARASITOLOGY, V115, P165, DOI 10.1017/S0031182097001157; Simpson AGB, 1996, SYST PARASITOL, V33, P187, DOI 10.1007/BF01531200; Tran JQ, 2010, CYTOSKELETON, V67, P586, DOI 10.1002/cm.20469; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Yubuki N, 2013, PLANT J, V75, P230, DOI 10.1111/tpj.12145	64	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84653	10.1371/journal.pone.0084653	http://dx.doi.org/10.1371/journal.pone.0084653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392150	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100073
J	Delwig, A; Majumdar, S; Ahern, K; LaVail, MM; Edwards, R; Hnasko, TS; Copenhagen, DR				Delwig, Anton; Majumdar, Sriparna; Ahern, Kelly; LaVail, Matthew M.; Edwards, Robert; Hnasko, Thomas S.; Copenhagen, David R.			Glutamatergic Neurotransmission from Melanopsin Retinal Ganglion Cells Is Required for Neonatal Photoaversion but Not Adult Pupillary Light Reflex	PLOS ONE			English	Article							RAT RETINA; PACAP; EXPRESSION; MICE; REFINEMENT; RESPONSES; NEURONS; PATHWAY; VGLUT2	Melanopsin-expressing retinal ganglion cells (mRGCs) in the eye play an important role in many light-activated non-image-forming functions including neonatal photoaversion and the adult pupillary light reflex (PLR). MRGCs rely on glutamate and possibly PACAP (pituitary adenylate cyclase-activating polypeptide) to relay visual signals to the brain. However, the role of these neurotransmitters for individual non-image-forming responses remains poorly understood. To clarify the role of glutamatergic signaling from mRGCs in neonatal aversion to light and in adult PLR, we conditionally deleted vesicular glutamate transporter (VGLUT2) selectively from mRGCs in mice. We found that deletion of VGLUT2 in mRGCs abolished negative phototaxis and light-induced distress vocalizations in neonatal mice, underscoring a necessary role for glutamatergic signaling. In adult mice, loss of VGLUT2 in mRGCs resulted in a slow and an incomplete PLR. We conclude that glutamatergic neurotransmission from mRGCs is required for neonatal photoaversion but is complemented by another non-glutamatergic signaling mechanism for the pupillary light reflex in adult mice. We speculate that this complementary signaling might be due to PACAP neurotransmission from mRGCs.	[Delwig, Anton; Majumdar, Sriparna; LaVail, Matthew M.; Copenhagen, David R.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Ahern, Kelly; LaVail, Matthew M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Edwards, Robert; Copenhagen, David R.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Edwards, Robert; Hnasko, Thomas S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Hnasko, Thomas S.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego	Copenhagen, DR (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	cope@phy.ucsf.edu		Hnasko, Thomas/0000-0001-6176-8513	National Institutes of Health (NIH) [EY01869, P30 EY002162]; Knights Templar Eye Foundation; That Man May See, UCSF/Research to Prevent Blindness (Department of Ophthalmology, UCSF); NATIONAL EYE INSTITUTE [R01EY001869, R37EY001869, P30EY002162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA026504] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knights Templar Eye Foundation; That Man May See, UCSF/Research to Prevent Blindness (Department of Ophthalmology, UCSF); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding from National Institutes of Health (NIH) EY01869 (DRC); NIH P30 EY002162 (Core Grant); Knights Templar Eye Foundation (AD), http://www.knightstemplar.org/ktef/; That Man May See, UCSF (DRC) http://thatmanmaysee.org/Research to Prevent Blindness (DRC, Department of Ophthalmology, UCSF) https://www.rpbusa.org/rpb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benezeth Y, 2008, REV EVALUATION COMMO, P1; Delwig A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043787; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Engelund A, 2012, BRAIN RES, V1453, P17, DOI 10.1016/j.brainres.2012.03.005; Engelund A, 2010, CELL TISSUE RES, V340, P243, DOI 10.1007/s00441-010-0950-3; Fahrenkrug J, 2004, NEUROREPORT, V15, P781, DOI 10.1097/00001756-200404090-00008; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fyk-Kolodziej B, 2004, J COMP NEUROL, V475, P518, DOI 10.1002/cne.20199; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Johnson J, 2004, J COMP NEUROL, V477, P386, DOI 10.1002/cne.20250; Johnson J, 2007, J NEUROSCI, V27, P7245, DOI 10.1523/JNEUROSCI.0815-07.2007; Johnson J, 2010, P NATL ACAD SCI USA, V107, P17374, DOI 10.1073/pnas.1008533107; Kawaguchi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009286; Koch SM, 2011, NEURON, V71, P235, DOI 10.1016/j.neuron.2011.05.045; McNeill DS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-8; Olianas MC, 1997, J NEUROCHEM, V69, P1213; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Scherrer G, 2010, P NATL ACAD SCI USA, V107, P22296, DOI 10.1073/pnas.1013413108; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Stella SL, 2008, BRAIN RES, V1215, P20, DOI 10.1016/j.brainres.2008.03.038; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Zagorodnyuk V, 1996, BRIT J PHARMACOL, V119, P779, DOI 10.1111/j.1476-5381.1996.tb15740.x	26	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83974	10.1371/journal.pone.0083974	http://dx.doi.org/10.1371/journal.pone.0083974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391855	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200153
J	Fang, SY; Han, JL; Zhang, MF; Wang, LE; Wei, QY; Amos, CI; Lee, JE				Fang, Shenying; Han, Jiali; Zhang, Mingfeng; Wang, Li-e; Wei, Qingyi; Amos, Christopher I.; Lee, Jeffrey E.			Joint Effect of Multiple Common SNPs Predicts Melanoma Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFYING INDIVIDUALS; GENETIC-DETERMINANTS; CUTANEOUS MELANOMA; HIGH-RISK; PIGMENTATION; VARIANTS; EYE; HAIR	Single genetic variants discovered so far have been only weakly associated with melanoma. This study aims to use multiple single nucleotide polymorphisms (SNPs) jointly to obtain a larger genetic effect and to improve the predictive value of a conventional phenotypic model. We analyzed 11 SNPs that were associated with melanoma risk in previous studies and were genotyped in MD Anderson Cancer Center (MDACC) and Harvard Medical School investigations. Participants with >= 15 risk alleles were 5-fold more likely to have melanoma compared to those carrying <= 6. Compared to a model using the most significant single variant rs12913832, the increase in predictive value for the model using a polygenic risk score (PRS) comprised of 11 SNPs was 0.07(95% Cl, 0.05-0.07). The overall predictive value of the PRS together with conventional phenotypic factors in the MDACC population was 0.69 (95% Cl, 0.64-0.69). PRS significantly improved the risk prediction and reclassification in melanoma as compared with the conventional model. Our study suggests that a polygenic profile can improve the predictive value of an individual gene polymorphism and may be able to significantly improve the predictive value beyond conventional phenotypic melanoma risk factors.	[Fang, Shenying; Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Han, Jiali; Zhang, Mingfeng] Harvard Univ, Sch Med, Dept Dermatol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med,Dept Med, Boston, MA 02115 USA; [Han, Jiali] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Wang, Li-e; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Amos, Christopher I.] Dartmouth Coll, Geisel Coll Med Community & Family Med, Lebanon, NH 03756 USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center; Dartmouth College	Lee, JE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	jelee@mdanderson.org		Fang, Shenying/0000-0002-0604-793X	National Cancer Institute SPORE grant [P50 CA093459]; Marit Peterson Fund for Melanoma Research; Michael W. McCarthy Foundation; Miriam and Jim Mulva Melanoma Research Fund; NATIONAL CANCER INSTITUTE [P50CA093459] Funding Source: NIH RePORTER	National Cancer Institute SPORE grant; Marit Peterson Fund for Melanoma Research; Michael W. McCarthy Foundation; Miriam and Jim Mulva Melanoma Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute SPORE grant P50 CA093459, the Marit Peterson Fund for Melanoma Research, the Michael W. McCarthy Foundation, and the Miriam and Jim Mulva Melanoma Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; [Anonymous], 2010, SURV HLTH POL RES; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Breitbart EW, 2012, J AM ACAD DERMATOL, V66, P201, DOI 10.1016/j.jaad.2010.11.016; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; de Snoo FA, 2005, CANCER LETT, V230, P153, DOI 10.1016/j.canlet.2004.12.033; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Domchek SM, 2013, J CLIN ONCOL, V31, P1267, DOI 10.1200/JCO.2012.46.9403; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Fears TR, 2006, J CLIN ONCOL, V24, P3590, DOI 10.1200/JCO.2005.04.1277; Fortes C, 2010, EUR J CANCER PREV, V19, P393, DOI 10.1097/CEJ.0b013e32833b492f; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Jannot AS, 2005, EUR J HUM GENET, V13, P913, DOI 10.1038/sj.ejhg.5201415; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Meyle KD, 2009, HUM GENET, V126, P499, DOI 10.1007/s00439-009-0715-9; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13	28	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85642	10.1371/journal.pone.0085642	http://dx.doi.org/10.1371/journal.pone.0085642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392023	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900167
J	Gu, S; Cheung, HH; Lee, TL; Lu, G; Poon, WS; Chan, WY				Gu, Shen; Cheung, Hoi Hung; Lee, Tin Lap; Lu, Gang; Poon, Wai Sang; Chan, Wai Yee			Molecular Mechanisms of Regulation and Action of microRNA-199a in Testicular Germ Cell Tumor and Glioblastomas	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CANCER CELLS; EXPRESSION; GENES; METHYLATION; RNAS; IDENTIFICATION; PROLIFERATION; MIR-199A; REVEALS	MicroRNA-199a (miRNA-199a) has been shown to have comprehensive functions and behave differently in different systems and diseases. It is encoded by two loci in the human genome, miR-199a-1 in chromosome 19 and miR-199a-2 in chromosome 1. Both loci give rise to the same miRNAs (miR-199a-5p and miR-199a-3p). The cause of the diverse action of the miRNA in different systems is not clear. However, it is likely due to different regulation of the two genomic loci and variable targets of the miRNA in different cells and tissues. Here we studied promoter methylation of miR-199a in testicular germ cell tumors (TGCTs) and glioblastomas (gliomas) and discovered that hypermethylation in TGCTs of both miR-199a-1 and -2 resulted in its reduced expression, while hypomethylation of miR-199a-2 but not -1 in gliomas may be related to its elevated expression. We also identified a common regulator, REST, which preferentially bound to the methylated promoters of both miR-199a-1 and miR-199a-2. The action of miR-199a is dependent on its downstream targets. We identified MAFB as a putative target of miRNA-199a-5p in TGCTs and confirmed that the tumor suppression activity of the microRNA is mediated by its target MAFB. By studying the mechanisms that control the expressions of miR-199a and its various downstream targets, we hope to use miR-199a as a model to understand the complexity of miRNA biology.	[Gu, Shen; Lee, Tin Lap; Lu, Gang; Chan, Wai Yee] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Cheung, Hoi Hung] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Clin & Dev Genom, NIH, Bethesda, MD USA; [Lu, Gang; Poon, Wai Sang] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese University of Hong Kong	Chan, WY (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	chanwy@cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Lee, Tin-Lap/A-7853-2009; Gu, Shen/AAE-2641-2020; Poon, Wai S/HGD-3084-2022; Cheung, Hoi-Hung/AAE-2670-2020; Chan, Wai Yee/R-7442-2018; Lee, Tin-Lap/W-6595-2019	Lee, Tin-Lap/0000-0002-6654-0988; Gu, Shen/0000-0003-3107-1218; Cheung, Hoi-Hung/0000-0001-7178-9289; Chan, Wai Yee/0000-0002-9714-0936; Lee, Tin-Lap/0000-0002-6654-0988; LU, Gang/0000-0001-5921-1839	Chinese University of Hong Kong; Vigconic International project fund; RGC GRF [475910]	Chinese University of Hong Kong(Chinese University of Hong Kong); Vigconic International project fund; RGC GRF(Hong Kong Research Grants Council)	This study is partially supported by the start-up fund provided to WYC by the Chinese University of Hong Kong, the Vigconic International project fund, and RGC GRF No: 475910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Carr IM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm330; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; Fang C, 2013, J CELL BIOCHEM, V114, P1457, DOI 10.1002/jcb.24487; Favreau AJ, 2012, AM J HEMATOL, V87, P442, DOI 10.1002/ajh.23129; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Gu S, 2012, INT J MOL SCI, V13, P8449, DOI 10.3390/ijms13078449; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim S, 2008, J BIOL CHEM, V283, P18158, DOI 10.1074/jbc.M800186200; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lauvrak SU, 2013, BR J CANC; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Magrelli A, 2009, TRANSL ONCOL, V2, P157, DOI 10.1593/tlo.09124; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Ogawa T, 2012, GUT, V61, P1600, DOI 10.1136/gutjnl-2011-300717; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Sayed D, 2010, CELL CYCLE, V9, P3213, DOI 10.4161/cc.9.16.12634; Sieweke MH, 1996, CELL, V85, P49, DOI 10.1016/S0092-8674(00)81081-8; Sieweke Michael H., 1997, Leukemia (Basingstoke), V11, P486; Singal R, 1997, P NATL ACAD SCI USA, V94, P13724, DOI 10.1073/pnas.94.25.13724; Tsukigi M, 2012, CANCER LETT, V315, P189, DOI 10.1016/j.canlet.2011.10.008; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Vicente-Duenas C, 2012, CELL CYCLE, V11, P3715, DOI 10.4161/cc.22178; Wang CX, 2011, J GASTROEN HEPATOL, V26, P1630, DOI 10.1111/j.1440-1746.2011.06758.x; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Won KY, 2013, HUM PATHOL, V44, P1648, DOI 10.1016/j.humpath.2013.01.016; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111	40	90	94	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83980	10.1371/journal.pone.0083980	http://dx.doi.org/10.1371/journal.pone.0083980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391856	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200154
J	de Maturana, EL; Ye, YQ; Calle, ML; Rothman, N; Urrea, V; Kogevinas, M; Petrus, S; Chanock, SJ; Tardon, A; Garcia-Closas, M; Gonzalez-Neira, A; Vellalta, G; Carrato, A; Navarro, A; Lorente-Galdos, B; Silverman, DT; Real, FX; Wu, XF; Malats, N				Lopez de Maturana, Evangelina; Ye, Yuanqing; Luz Calle, M.; Rothman, Nathaniel; Urrea, Victor; Kogevinas, Manolis; Petrus, Sandra; Chanock, Stephen J.; Tardon, Adonina; Garcia-Closas, Montserrat; Gonzalez-Neira, Anna; Vellalta, Gemma; Carrato, Alfredo; Navarro, Arcadi; Lorente-Galdos, Belen; Silverman, Debra T.; Real, Francisco X.; Wu, Xifeng; Malats, Nuria			Application of Multi-SNP Approaches Bayesian LASSO and AUC-RF to Detect Main Effects of Inflammatory-Gene Variants Associated with Bladder Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; REGRESSION; SUSCEPTIBILITY; POLYMORPHISM; SELECTION; PREDISPOSITION; IDENTIFICATION; EPIDEMIOLOGY; CHOLESTEROL; DISEASES	The relationship between inflammation and cancer is well established in several tumor types, including bladder cancer. We performed an association study between 886 inflammatory-gene variants and bladder cancer risk in 1,047 cases and 988 controls from the Spanish Bladder Cancer (SBC)/EPICURO Study. A preliminary exploration with the widely used univariate logistic regression approach did not identify any significant SNP after correcting for multiple testing. We further applied two more comprehensive methods to capture the complexity of bladder cancer genetic susceptibility: Bayesian Threshold LASSO (BTL), a regularized regression method, and AUC-Random Forest, a machine-learning algorithm. Both approaches explore the joint effect of markers. BTL analysis identified a signature of 37 SNPs in 34 genes showing an association with bladder cancer. AUC-RF detected an optimal predictive subset of 56 SNPs. 13 SNPs were identified by both methods in the total population. Using resources from the Texas Bladder Cancer study we were able to replicate 30% of the SNPs assessed. The associations between inflammatory SNPs and bladder cancer were reexamined among non-smokers to eliminate the effect of tobacco, one of the strongest and most prevalent environmental risk factor for this tumor. A 9 SNP-signature was detected by BTL. Here we report, for the first time, a set of SNP in inflammatory genes jointly associated with bladder cancer risk. These results highlight the importance of the complex structure of genetic susceptibility associated with cancer risk.	[Lopez de Maturana, Evangelina; Petrus, Sandra; Gonzalez-Neira, Anna; Real, Francisco X.; Malats, Nuria] Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain; [Ye, Yuanqing; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Luz Calle, M.; Urrea, Victor; Petrus, Sandra] Univ Vic, Dept Syst Biol, Vic, Spain; [Rothman, Nathaniel; Chanock, Stephen J.; Garcia-Closas, Montserrat; Silverman, Debra T.] NCI, Div Canc Epidemiol & Genet, US Dept HHS, Bethesda, MD 20892 USA; [Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis; Vellalta, Gemma] Inst Municipal Invest Med Hosp del Mar, Barcelona, Spain; [Tardon, Adonina] Univ Oviedo, Oviedo, Spain; [Carrato, Alfredo] Hosp Univ Elche, Elche, Spain; [Carrato, Alfredo] Hosp Univ Ramon y Cajal, Madrid, Spain; [Navarro, Arcadi; Lorente-Galdos, Belen; Real, Francisco X.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Navarro, Arcadi; Lorente-Galdos, Belen] Inst Biol Evolutiva UPF CSIC, Barcelona, Spain; [Navarro, Arcadi] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Spain; [Navarro, Arcadi; Lorente-Galdos, Belen] Inst Nacl Bioinformat, Barcelona, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; UTMD Anderson Cancer Center; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Oviedo; Hospital Universitario Ramon y Cajal; Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); ICREA	Malats, N (corresponding author), Spanish Natl Canc Res Ctr CNIO, Genet & Mol Epidemiol Grp, Madrid, Spain.	nmalats@cnio.es	TARDON, ADONINA/B-6563-2014; Urrea, Victor/ABF-9634-2021; Kogevinas, Manolis/C-3918-2017; Arribas, Francisco X Real/H-5275-2015; Gonzalez-Neira, Anna/C-5791-2015; Garcia-Closas, Montserrat/AAZ-6930-2021; Malats, Nuria/H-7041-2015; Garcia-Closas, Montserrat/F-3871-2015; Navarro, Arcadi/F-1592-2011; Calle, M.Luz/D-2704-2015	TARDON, ADONINA/0000-0001-5150-1209; Kogevinas, Manolis/0000-0002-9605-0461; Arribas, Francisco X Real/0000-0001-9501-498X; Gonzalez-Neira, Anna/0000-0002-5421-2020; Garcia-Closas, Montserrat/0000-0003-1033-2650; Malats, Nuria/0000-0003-2538-3784; Garcia-Closas, Montserrat/0000-0003-1033-2650; Navarro, Arcadi/0000-0003-2162-8246; Calle, M.Luz/0000-0001-9334-415X; Lopez de Maturana, Evangelina/0000-0001-9425-3911; Lorente-Galdos, Belen/0000-0001-5390-2452; Petrus-Reurer, Sandra/0000-0002-7051-1741; Urrea, Victor/0000-0002-2577-856X; CARRATO, ALFREDO/0000-0001-7749-8140	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [G03/174, 00/0745, PI051436, PI061614, PI09-02102]; Ministry of Science and Innovation, Spain [MTM2008-06747-C02-02]; AGAUR-Generalitat de Catalunya [2009SGR-581]; Fundaciola Maratode TV3; Red Tematica de Investigacion Cooperativa en Cancer (RTICC); Asociacion Espanola Contra el Cancer (AECC); Spanish National Institute for Bioinformatics; Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA; MD Anderson [U01 CA 127615, R01 CA 74880, P50 CA 91846]; Betty B. Marcus Chair fund in Cancer Prevention; UT Research Trust;  [EU-FP7-201663];  [RO1-CA089715];  [CA34627];  [R01 CA 131335]; NATIONAL CANCER INSTITUTE [R01CA074880, R01CA131335, P50CA091846, R01CA034627, R01CA089715, U01CA127615] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR-Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Fundaciola Maratode TV3; Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); Asociacion Espanola Contra el Cancer (AECC); Spanish National Institute for Bioinformatics; Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); MD Anderson; Betty B. Marcus Chair fund in Cancer Prevention; UT Research Trust; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)	The work was partially supported by the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (G03/174, 00/0745, PI051436, PI061614, PI09-02102, G03/174 and Sara Borrell fellowship to ELM) and Ministry of Science and Innovation (MTM2008-06747-C02-02 and FPU fellowship award to VU), Spain; AGAUR-Generalitat de Catalunya (Grant 2009SGR-581); Fundaciola Maratode TV3; Red Tematica de Investigacion Cooperativa en Cancer (RTICC); Asociacion Espanola Contra el Cancer (AECC); EU-FP7-201663; and RO1-CA089715 and CA34627; the Spanish National Institute for Bioinformatics (www.inab.org); and by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA. MD Anderson support for this project included U01 CA 127615 (XW); R01 CA 74880 (XW); P50 CA 91846 (XW, CPD); Betty B. Marcus Chair fund in Cancer Prevention (XW); UT Research Trust fund (XW) and R01 CA 131335 (JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Andrew AS, 2009, HUM GENET, V125, P527, DOI 10.1007/s00439-009-0645-6; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Banerjee I, 2009, J APPL GENET, V50, P153, DOI 10.1007/BF03195667; Birmann BM, 2009, CANCER EPIDEM BIOMAR, V18, P282, DOI 10.1158/1055-9965.EPI-08-0778; Bonferroni CE, 1937, TEORIA STAT CLASSI C; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen YT, 2011, BLOOD, V117, P585, DOI 10.1182/blood-2010-07-295097; Cole JW, 2008, THROMB J, V6, DOI 10.1186/1477-9560-6-11; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; DEMPSTER ER, 1950, GENETICS, V35, P212; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fortuny J, 2006, CANCER EPIDEM BIOMAR, V15, P1696, DOI 10.1158/1055-9965.EPI-06-0038; Foulkes AS, 2009, APPL STAT GENETICS R; Gao JF, 2007, SCAND J GASTROENTERO, V42, P345, DOI 10.1080/00365520600880856; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Garcia-Closas M, 2007, PLOS GENET, V3, P287, DOI 10.1371/journal.pgen.0030029; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; Gonzalez-Recio O, 2009, BMC P S7, V3; Han B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S3-S5; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; International Agency for Research on Cancer, 1994, IARC MONOGR EVAL CAR, V60, P389; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Koed K, 2005, CANCER RES, V65, P34; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Kyung M, 2010, BAYESIAN ANAL, V5, P369, DOI 10.1214/10-BA607; Li JH, 2011, BIOINFORMATICS, V27, P516, DOI 10.1093/bioinformatics/btq688; Lorente-Galdos B, 2012, INT J DATA MIN BIOIN, V6, P324, DOI 10.1504/IJDMB.2012.049249; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Calle ML, 2011, HUM HERED, V72, P121, DOI 10.1159/000330778; Mahajan R, 2008, JPN J CLIN ONCOL, V38, P626, DOI 10.1093/jjco/hyn075; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Malats N, 2008, SCAND J UROL NEPHROL, V42, P131, DOI 10.1080/03008880802285172; Mason TE, 2010, PROSTATE, V70, P262, DOI 10.1002/pros.21060; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Michaud DS, 2007, UROL ONCOL-SEMIN ORI, V25, P260, DOI 10.1016/j.urolonc.2006.10.002; Mostofi F, 1999, HISTOLOGICAL TYPING; Murta-Nascimento C, 2007, WORLD J UROL, V25, P285, DOI 10.1007/s00345-007-0168-5; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Reyes-Gibby CC, 2009, CANCER EPIDEM BIOMAR, V18, P2636, DOI 10.1158/1055-9965.EPI-09-0426; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Samanic C, 2006, CANCER EPIDEM BIOMAR, V15, P1348, DOI 10.1158/1055-9965.EPI-06-0021; Schwender H, 2007, THESIS U DORTMUND; Silverman DT, 2006, CANC EPIDEMIOLOGY PR, V3, P1101; Szymczak S, 2009, GENET EPIDEMIOL, V33, pS51, DOI 10.1002/gepi.20473; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589	60	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83745	10.1371/journal.pone.0083745	http://dx.doi.org/10.1371/journal.pone.0083745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391818	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200116
J	Gilman, E; Chaloupka, M; Wiedoff, B; Willson, J				Gilman, Eric; Chaloupka, Milani; Wiedoff, Brett; Willson, Jeremy			Mitigating Seabird Bycatch during Hauling by Pelagic Longline Vessels	PLOS ONE			English	Article							CATCH RATES; BY-CATCH; ALBATROSSES; FISHERIES; MORTALITY; BAIT	Bycatch in longline fisheries threatens the viability of some seabird populations. The Hawaii longline swordfish fishery reduced seabird captures by an order of magnitude primarily through mitigating bycatch during setting. Now, 75% of captures occur during hauling. We fit observer data to a generalized additive regression model with mixed effects to determine the significance of the effect of various factors on the standardized seabird haul catch rate. Density of albatrosses attending vessels during hauling, leader length and year had largest model effects. The standardized haul catch rate significantly increased with increased albatross density during hauling. The standardized catch rate was significantly higher the longer the leader: shorter leaders place weighted swivels closer to hooks, reducing the likelihood of baited hooks becoming available to surface-scavenging albatrosses. There was a significant linear increasing temporal trend in the standardized catch rate, possibly partly due to an observed increasing temporal trend in the local abundance of albatrosses attending vessels during hauling. Swivel weight, Beaufort scale and season were also significant but smaller model effects. Most (81%) haul captures were on branchlines actively being retrieved. Future haul mitigation research should therefore focus on reducing bird access to hooks as crew coil branchlines, including methods identified here of shorter leaders and heavier swivels, and other potentially effective methods, including faster branchline coiling and shielding the area where hooks becomes accessible. The proportion of Laysan albatross (Phoebastria immutabilis) captures that occurred during hauling was significantly, 1.6 times, higher than for black-footed albatrosses (P. nigripes), perhaps due to differences in the time of day of foraging and in daytime scavenging competitiveness; mitigating haul bycatch would therefore be a larger benefit to Laysans. Locally, findings identify opportunities to nearly eliminate seabird bycatch. Globally, findings fill a gap in knowledge of methods to mitigate seabird bycatch during pelagic longline hauling.	[Gilman, Eric] Hawaii Pacific Univ, Coll Nat Sci, Honolulu, HI 96813 USA; [Chaloupka, Milani] Ecol Modeling Serv, St Lucia, Qld, Australia; [Wiedoff, Brett; Willson, Jeremy] Natl Marine Fisheries Serv, Pacific Islands Reg Off, Honolulu, HI USA	National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Gilman, E (corresponding author), Hawaii Pacific Univ, Coll Nat Sci, Honolulu, HI 96813 USA.	EricLGilman@gmail.com	Gilman, Eric/AAF-2147-2019; Fennell, Hannah/AAI-1408-2019	Gilman, Eric/0000-0002-4216-2513; 				ACAP, 2013, 14 ACAP AC7 SEAB BYC; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Aragon TJ, 2012, EPITOOLS R PACKAGE E; Baker GB, 2007, BIOL CONSERV, V137, P319, DOI 10.1016/j.biocon.2007.02.012; Beverly S, 1996, SPC FISHERIES NEWSLE, V79, P22; Brothers N, 1999, BIOL CONSERV, V88, P85, DOI 10.1016/S0006-3207(98)00085-8; Brothers N, 2006, TECHNICAL ASSISTANCE; Brothers N. P., 1999, 937 FAO UN; Brothers N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012491; CCAMLR, 2009, CONS MEAS 25 02 MIN; Cocking LJ, 2008, BIOL CONSERV, V141, P1354, DOI 10.1016/j.biocon.2008.03.003; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Fernandez P, 2001, J ZOOL, V254, P391, DOI 10.1017/S0952836901000899; Fernandez P, 2000, CONDOR, V102, P577, DOI 10.1650/0010-5422(2000)102[0577:NADFAO]2.0.CO;2; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Food and Agriculture Organization of the United Nations (FAO), 2011, INT GUID BYC MAN RED; Gilman E, 2006, FISH FISH, V7, P2, DOI 10.1111/j.1467-2979.2006.00196.x; Gilman E, 2005, FISH FISH, V6, P35, DOI 10.1111/j.1467-2679.2005.00175.x; Gilman E, 2003, OCEAN COAST MANAGE, V46, P985, DOI 10.1016/j.ocecoaman.2003.12.001; Gilman E, 2013, P 6 WORLD FISH C ED, P711; Gilman E., 2012, ANN REPORT SEABIRD I; Gilman E., 2011, ANN REPORT SEABIRD I; Gilman E, 2007, SHARK DEPREDATION UN, P121; Gilman E, 2007, 1025 FAO UN; Gilman Eric, 2008, Endangered Species Research, V5, P309, DOI 10.3354/esr00133; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Gilman E, 2007, FISHERIES SCI, V73, P208, DOI 10.1111/j.1444-2906.2007.01321.x; Gilman E, 2014, FISH FISH, V15, P327, DOI 10.1111/faf.12021; Gilman E, 2012, AQUAT CONSERV, V22, P446, DOI 10.1002/aqc.2237; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Gould P, 1997, CAN J ZOOL, V75, P549, DOI 10.1139/z97-068; Gould P, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P199; HASTIE T. J., 1990, MONOGRAPHS STAT APPL, V43; Hyrenbach K. David, 2002, Marine Ornithology, V30, P85; Hyrenbach KD, 2003, BIOL CONSERV, V112, P391, DOI 10.1016/S0006-3207(02)00337-3; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; IUCN, 2012, UCN RED LIST THREAT; Kammann EE, 2003, J R STAT SOC C-APPL, V52, P1, DOI 10.1111/1467-9876.00385; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; McCracken M. L., 2004, NMFSPIFSC3 NOAA; NMFS, 2012, DR12008 NMFS PIFSC; NMFS, 2004, FED REGISTER, V69, P17329; NMFS, 2005, FED REGISTER, V70, P75075; NMFS, 2012, HAW LONGL FISH LOGB; NMFS (National Marine Fisheries Service), 2010, HAW LONGL OBS PROGR; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Reid E, 2010, CCAMLR SCI, V17, P155; Reid TA, 2004, POLAR BIOL, V27, P131, DOI 10.1007/s00300-003-0547-3; RICKER W E, 1975, P382; Ricker W. E., 1958, BULLETIN, V119; Seber G.A.F., 1973, ESTIMATION ANIMAL AB; Sullivan BJ, 2012, FISH RES, V134, P125, DOI 10.1016/j.fishres.2012.07.024; Tasker Mark L., 1992, Netherlands Journal of Aquatic Ecology, V26, P59, DOI 10.1007/BF02298028; Ward P, 2008, FISH RES, V90, P100, DOI 10.1016/j.fishres.2007.09.034; WEIMERSKIRCH H, 1987, OIKOS, V49, P315, DOI 10.2307/3565767; Wood S., 2011, R PACKAGE VERSION, V0, P1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	58	16	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84499	10.1371/journal.pone.0084499	http://dx.doi.org/10.1371/journal.pone.0084499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400096	Green Published, gold, Green Submitted			2022-12-27	WOS:000329462700030
J	Cengiz, P; Kintner, DB; Chanana, V; Yuan, H; Akture, E; Kendigelen, P; Begum, G; Fidan, E; Uluc, K; Ferrazzano, P; Sun, DD				Cengiz, Pelin; Kintner, Douglas B.; Chanana, Vishal; Yuan, Hui; Akture, Erinc; Kendigelen, Pinar; Begum, Gulnaz; Fidan, Emin; Uluc, Kutluay; Ferrazzano, Peter; Sun, Dandan			Sustained Na+/H+ Exchanger Activation Promotes Gliotransmitter Release from Reactive Hippocampal Astrocytes following Oxygen-Glucose Deprivation	PLOS ONE			English	Article							INTRACELLULAR PH REGULATION; CULTURED ASTROCYTES; IN-VITRO; GLUTAMATE TRANSPORTER; RAT HIPPOCAMPUS; KAPPA-B; EXPRESSION; ISOFORM-1; INHIBITION; PHOSPHORYLATION	Hypoxia ischemia (HI)-related brain injury is the major cause of long-term morbidity in neonates. One characteristic hallmark of neonatal HI is the development of reactive astrogliosis in the hippocampus. However, the impact of reactive astrogliosis in hippocampal damage after neonatal HI is not fully understood. In the current study, we investigated the role of Na+/H+ exchanger isoform 1 (NHE1) protein in mouse reactive hippocampal astrocyte function in an in vitro ischemia model (oxygen/glucose deprivation and reoxygenation, OGD/REOX). 2 h OGD significantly increased NHE1 protein expression and NHE1-mediated H+ efflux in hippocampal astrocytes. NHE1 activity remained stimulated during 1-5 h REOX and returned to the basal level at 24 h REOX. NHE1 activation in hippocampal astrocytes resulted in intracellular Na+ and Ca2+ overload. The latter was mediated by reversal of Na+/Ca2+ exchange. Hippocampal astrocytes also exhibited a robust release of gliotransmitters (glutamate and pro-inflammatory cytokines IL-6 and TNF alpha) during 1-24 h REOX. Interestingly, inhibition of NHE1 activity with its potent inhibitor HOE 642 not only reduced Na+ overload but also gliotransmitter release from hippocampal astrocytes. The noncompetitive excitatory amino acid transporter inhibitor TBOA showed a similar effect on blocking the glutamate release. Taken together, we concluded that NHE1 plays an essential role in maintaining H+ homeostasis in hippocampal astrocytes. Over-stimulation of NHE1 activity following in vitro ischemia disrupts Na+ and Ca2+ homeostasis, which reduces Na+-dependent glutamate uptake and promotes release of glutamate and cytokines from reactive astrocytes. Therefore, blocking sustained NHE1 activation in reactive astrocytes may provide neuroprotection following HI.	[Cengiz, Pelin; Kintner, Douglas B.; Chanana, Vishal; Kendigelen, Pinar; Fidan, Emin; Ferrazzano, Peter] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Cengiz, Pelin; Kintner, Douglas B.; Chanana, Vishal; Ferrazzano, Peter] Univ Wisconsin, Dept Waisman Ctr, Sch Med & Publ Hlth, Madison, WI USA; [Akture, Erinc; Uluc, Kutluay] Univ Wisconsin, Dept Neurol Surg, Sch Med & Publ Hlth, Madison, WI USA; [Yuan, Hui; Begum, Gulnaz; Sun, Dandan] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Kendigelen, Pinar] Istanbul Univ, Cerrahpasa Med Sch, Dept Anesthesiol, Istanbul, Turkey	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Istanbul University; Istanbul University - Cerrahpasa	Cengiz, P (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	cengiz@pediatrics.wisc.edu	KENDIGELEN, PINAR/U-8532-2017; sun, dandan/GZG-6540-2022; chanana, vishal/F-3738-2014	KENDIGELEN, PINAR/0000-0001-6224-0585; 	National Institutes of Health (NIH) [RO1NS38118, RO1NS48216, P30 HD03352]; Univ. of Wis. Dept. of Pediatrics.;  [CTSA/NCATS: UL1 TR0000427]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, KL2TR000428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048216, R01NS038118] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Univ. of Wis. Dept. of Pediatrics.; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health (NIH) RO1NS38118, RO1NS48216 (Sun D) and P30 HD03352 (Waisman Center); Univ. of Wis. Dept. of Pediatrics., R&D grant (Cengiz P), CTSA/NCATS: UL1 TR0000427 (Cengiz P and Ferrazzano P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2000, GLIA, V32, P1; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Baker-Andresen D, 2013, LEARN MEMORY, V20, P237, DOI 10.1101/lm.029520.112; Bevensee MO, 1997, J GEN PHYSIOL, V110, P453, DOI 10.1085/jgp.110.4.453; Bevensee MO, 1997, J GEN PHYSIOL, V110, P467, DOI 10.1085/jgp.110.4.467; BOYARSKY G, 1993, GLIA, V8, P241, DOI 10.1002/glia.440080404; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Cengiz P, 2011, ANTIOXID REDOX SIGN, V14, P1803, DOI 10.1089/ars.2010.3468; Chen Shih-Heng, 2013, Methods Mol Biol, V1041, P231, DOI 10.1007/978-1-62703-520-0_21; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; ERECINSKA M, 1990, PROG NEUROBIOL, V35, P245, DOI 10.1016/0301-0082(90)90013-7; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hamby ME, 2006, J NEUROSCI METH, V150, P128, DOI 10.1016/j.jneumeth.2005.06.016; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Kintner DB, 2004, AM J PHYSIOL-CELL PH, V287, pC12, DOI 10.1152/ajpcell.00560.2003; Kintner DB, 2007, AM J PHYSIOL-CELL PH, V292, pC1113, DOI 10.1152/ajpcell.00412.2006; Koizumi S, 2002, LIFE SCI, V72, P431, DOI 10.1016/S0024-3205(02)02273-7; Lai PC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-69; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; Li S, 1999, J Neurosci, V19, pRC16; Liu Y, 2010, J NEUROSCI, V30, P15210, DOI 10.1523/JNEUROSCI.3950-10.2010; LONGUEMARE MC, 1995, J NEUROSCI RES, V40, P379, DOI 10.1002/jnr.490400312; Luo J, 2005, J NEUROSCI, V25, P11256, DOI 10.1523/JNEUROSCI.3271-05.2005; Luo J, 2007, J BIOL CHEM, V282, P28274, DOI 10.1074/jbc.M702373200; Ma E, 1997, NEUROSCIENCE, V79, P591, DOI 10.1016/S0306-4522(96)00674-4; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; McKhann GM, 1997, J NEUROSCI, V17, P6850; MILLER RT, 1991, J BIOL CHEM, V266, P10813; OGATA T, 1995, NEUROCHEM RES, V20, P737, DOI 10.1007/BF01705543; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Owe SG, 2006, J PHYSIOL-LONDON, V577, P591, DOI 10.1113/jphysiol.2006.116830; PAPPAS CA, 1994, J NEUROPHYSIOL, V72, P2816, DOI 10.1152/jn.1994.72.6.2816; PAPPAS CA, 1993, GLIA, V9, P280, DOI 10.1002/glia.440090406; Perego C, 2000, J NEUROCHEM, V75, P1076, DOI 10.1046/j.1471-4159.2000.0751076.x; Pizzonia JH, 1996, J NEUROSCI RES, V44, P191, DOI 10.1002/(SICI)1097-4547(19960415)44:2<191::AID-JNR12>3.0.CO;2-9; Rutledge EM, 1996, J NEUROSCI, V16, P7803; Seki Y, 1999, STROKE, V30, P433, DOI 10.1161/01.STR.30.2.433; Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Swanson RA, 1997, J NEUROSCI, V17, P932; Szabo EZ, 2000, J BIOL CHEM, V275, P6302, DOI 10.1074/jbc.275.9.6302; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Wang YP, 2008, EUR J NEUROSCI, V28, P51, DOI 10.1111/j.1460-9568.2008.06304.x; WUTTKE WA, 1990, NEUROSCI LETT, V117, P105, DOI 10.1016/0304-3940(90)90127-U; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xie MJ, 2008, J CEREBR BLOOD F MET, V28, P456, DOI 10.1038/sj.jcbfm.9600545; Xiong M, 2009, BRAIN RES BULL, V79, P351, DOI 10.1016/j.brainresbull.2009.03.011; Xue J, 2003, NEUROSCIENCE, V122, P37, DOI 10.1016/S0306-4522(03)00598-0; Zeevalk GD, 1998, J NEUROCHEM, V71, P2373	53	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84294	10.1371/journal.pone.0084294	http://dx.doi.org/10.1371/journal.pone.0084294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392123	gold, Green Accepted, Green Published			2022-12-27	WOS:000329460100046
J	Kheradpisheh, SR; Nowzari-Dalini, A; Ebrahimpour, R; Ganjtabesh, M				Kheradpisheh, Saeed Reza; Nowzari-Dalini, Abbas; Ebrahimpour, Reza; Ganjtabesh, Mohammad			An Evidence-Based Combining Classifier for Brain Signal Analysis	PLOS ONE			English	Article							SINGLE-TRIAL EEG; COMPUTER INTERFACES; SPATIAL FILTERS; COMBINATION; BCI; MOVEMENT; ENSEMBLE	Nowadays, brain signals are employed in various scientific and practical fields such as Medical Science, Cognitive Science, Neuroscience, and Brain Computer Interfaces. Hence, the need for robust signal analysis methods with adequate accuracy and generalizability is inevitable. The brain signal analysis is faced with complex challenges including small sample size, high dimensionality and noisy signals. Moreover, because of the non-stationarity of brain signals and the impacts of mental states on brain function, the brain signals are associated with an inherent uncertainty. In this paper, an evidence-based combining classifiers method is proposed for brain signal analysis. This method exploits the power of combining classifiers for solving complex problems and the ability of evidence theory to model as well as to reduce the existing uncertainty. The proposed method models the uncertainty in the labels of training samples in each feature space by assigning soft and crisp labels to them. Then, some classifiers are employed to approximate the belief function corresponding to each feature space. By combining the evidence raised from each classifier through the evidence theory, more confident decisions about testing samples can be made. The obtained results by the proposed method compared to some other evidence-based and fixed rule combining methods on artificial and real datasets exhibit the ability of the proposed method in dealing with complex and uncertain classification problems.	[Kheradpisheh, Saeed Reza; Nowzari-Dalini, Abbas; Ganjtabesh, Mohammad] Univ Tehran, Sch Math Stat & Comp Sci, Dept Comp Sci, Tehran, Iran; [Ebrahimpour, Reza] Shahid Rajaee Teacher Training Univ, Dept Elect & Comp Engn, Brain & Intelligent Syst Res Lab, Tehran, Iran; [Kheradpisheh, Saeed Reza; Ebrahimpour, Reza; Ganjtabesh, Mohammad] Inst Res Fundamental Sci IPM, SCS, Tehran, Iran	University of Tehran; Shahid Rajaee Teacher Training University (SRTTU)	Ebrahimpour, R (corresponding author), Shahid Rajaee Teacher Training Univ, Dept Elect & Comp Engn, Brain & Intelligent Syst Res Lab, Tehran, Iran.	ebrahimpour@ipm.ir	nowzari-dalini, abbas/X-8074-2019; Kheradpisheh, Saeed Reza/Q-1161-2017; Ebrahimpour, Reza/AAH-8531-2019; Ebrahimpour, Reza/A-9721-2009	Kheradpisheh, Saeed Reza/0000-0001-6168-4379; Ebrahimpour, Reza/0000-0002-7013-8078; 				Alexandre LA, 2001, PATTERN RECOGN LETT, V22, P1283, DOI 10.1016/S0167-8655(01)00073-3; Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; ARROYO S, 1993, ELECTROEN CLIN NEURO, V87, P76, DOI 10.1016/0013-4694(93)90114-B; Blankertz B, 2002, ADV NEUR IN, V14, P157; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Brunner C, 2008, BCI COMPETITION 2008; Cobb BR, 2006, INT J APPROX REASON, V41, P314, DOI 10.1016/j.ijar.2005.06.008; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Ebrahimpour Reza, 2012, 2012 16th CSI International Symposium on Artificial Intelligence and Signal Processing (AISP), P458, DOI 10.1109/AISP.2012.6313791; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Furdea A, 2012, J NEUROSCI METH, V203, P233, DOI 10.1016/j.jneumeth.2011.09.013; Hayashi I, 2012, 2012 IEEE INT C FUZZ, P1; Herman P, 2005, P ANN INT IEEE EMBS, P5354, DOI 10.1109/IEMBS.2005.1615691; Hsu WY, 2010, J NEUROSCI METH, V189, P295, DOI 10.1016/j.jneumeth.2010.03.030; Hui-Min Feng, 2010, 2010 International Conference on Machine Learning and Cybernetics (ICMLC 2010), P332, DOI 10.1109/ICMLC.2010.5581040; Kheradpisheh SR, 2013, APPL SOFT COMPUT, V13, P4570, DOI 10.1016/j.asoc.2013.07.028; Khorshidtalab A, 2011, 2011 4 INT C MECH IC, P1, DOI DOI 10.1109/1COM.2011.5937154; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Kuncheva LI, 2002, IEEE T PATTERN ANAL, V24, P281, DOI 10.1109/34.982906; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Lin CJ, 2009, NEUROCOMPUTING, V72, P1121, DOI 10.1016/j.neucom.2008.02.017; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; Lou B, 2008, J NEURAL ENG, V5, P342, DOI 10.1088/1741-2560/5/3/007; Martin RE, 2004, J NEUROPHYSIOL, V92, P2428, DOI 10.1152/jn.01144.2003; Millan JD, 2004, IEEE IJCNN, P2877; Millan JD, 2003, IEEE T NEUR SYS REH, V11, P159, DOI 10.1109/TNSRE.2003.814435; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Naseem I, 2010, COMBINING CLASSIFIER; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Polikar R, 2012, ENSEMBLE MACHINE LEARNING: METHODS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-9326-7_1; Qin JZ, 2005, LECT NOTES COMPUT SC, V3496, P973; Quost B., 2009, P 1 ACM SIGKDD WORKS, P38; Quost B, 2007, PATTERN RECOGN LETT, V28, P644, DOI 10.1016/j.patrec.2006.11.002; Rakotomamonjy A, 2005, LECT NOTES COMPUT SC, V3696, P45, DOI 10.1007/11550822_8; ROGOVA G, 1994, NEURAL NETWORKS, V7, P777, DOI 10.1016/0893-6080(94)90099-X; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Ruta D., 2005, Information Fusion, V6, P63, DOI 10.1016/j.inffus.2004.04.008; Sanei S, 2007, EEG SIGNAL PROCESSIN; Shafer G., 1976, MATH THEORY EVIDENCE; Smets P, 2005, INT J APPROX REASON, V38, P133, DOI 10.1016/j.ijar.2004.05.003; SMETS P, 1994, ARTIF INTELL, V66, P191, DOI 10.1016/0004-3702(94)90026-4; Soria-Frisch A, 2013, PRACTICAL BRAIN COMP, P41; Sun SL, 2007, PATTERN RECOGN LETT, V28, P2157, DOI 10.1016/j.patrec.2007.06.018; Tabassian M, 2012, EXPERT SYST APPL, V39, P1698, DOI 10.1016/j.eswa.2011.06.061; Tao Geng, 2010, International Journal of Advanced Mechatronic Systems, V2, P28, DOI 10.1504/IJAMECHS.2010.030846; Ubeyli ED, 2009, DIGIT SIGNAL PROCESS, V19, P297, DOI 10.1016/j.dsp.2008.07.004; Ulas A, 2009, INFORM SCIENCES, V179, P1298, DOI 10.1016/j.ins.2008.12.024; Wang D, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00151; Wu W, 2005, P ANN INT IEEE EMBS, P2387; Windeatt T., 2003, Information Fusion, V4, P11, DOI 10.1016/S1566-2535(02)00101-X; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu SL, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE, COGNITIVE ALGORITHMS, MIND, AND BRAIN (CCMB), P146, DOI 10.1109/CCMB.2013.6609178; Yager RR, 2008, STUD FUZZ SOFT COMP, V219, P1, DOI 10.1007/978-3-540-44792-4; Yazdani A, 2009, I IEEE EMBS C NEUR E, P320	56	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84341	10.1371/journal.pone.0084341	http://dx.doi.org/10.1371/journal.pone.0084341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392125	Green Published, gold			2022-12-27	WOS:000329460100048
J	Sotgia, S; Zinellu, A; Mangoni, AA; Pintus, G; Attia, J; Carru, C; McEvoy, M				Sotgia, Salvatore; Zinellu, Angelo; Mangoni, Arduino A.; Pintus, Gianfranco; Attia, John; Carru, Ciriaco; McEvoy, Mark			Clinical and Biochemical Correlates of Serum L-Ergothioneine Concentrations in Community-Dwelling Middle-Aged and Older Adults	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PLASMA TOTAL HOMOCYSTEINE; CAPILLARY-ELECTROPHORESIS; CATION TRANSPORTER; GENES; ASSOCIATION; PERFORMANCE; SLC22A4; BLOOD	Background: Despite the increasing interest towards the biological role of L-ergothioneine, little is known about the serum concentrations of this unusual aminothiol in older adults. We addressed this issue in a representative sample of community-dwelling middle-aged and older adults. Methods: Body mass index, estimated glomerular filtration rate, serum concentrations of L-ergothioneine, taurine, homocysteine, cysteine, glutathione, cysteinylglycine, and glutamylcysteine were evaluated in 439 subjects (age 55-85 years) randomly selected from the Hunter Community Study. Results: Median L-ergothioneine concentration in the entire cohort was 1.01 IQR 0.78-1.33 mu mol/L. Concentrations were not affected by gender (P = 0.41) or by presence of chronic medical conditions (P = 0.15). By considering only healthy subjects, we defined a reference interval for L-ergothioneine serum concentrations from 0.36 (90% CI 0.31-0.44) to 3.08 (90% CI 2.45-3.76) mu mol/L. Using stepwise multiple linear regression analysis L-ergothioneine was negatively correlated with age (rpartial = -0.15; P = 0.0018) and with glutamylcysteine concentrations (rpartial = -0.13; P = 0.0063). Conclusions: A thorough analysis of serum L-ergothioneine concentrations was performed in a large group of community-dwelling middle-aged and older adults. Reference intervals were established. Age and glutamylcysteine were independently negatively associated with L-ergothioneine serum concentration.	[Sotgia, Salvatore; Zinellu, Angelo; Pintus, Gianfranco; Carru, Ciriaco] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Mangoni, Arduino A.] Flinders Univ S Australia, Sch Med, Dept Clin Pharmacol, Adelaide, SA 5001, Australia; [Attia, John] Univ Newcastle, Sch Med & Publ Hlth, Level Hunter Med Res Inst 3, Newcastle, NSW 2300, Australia; [McEvoy, Mark] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia	University of Sassari; Flinders University South Australia; Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Sotgia, S (corresponding author), Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy.	salvatore.sotgia@gmail.com	Attia, John R/F-5376-2013; Pintus, Gianfranco/C-2975-2009; Carru, Ciriaco/AAI-9996-2021; Mangoni, Arduino Aleksander/I-5109-2019; Sotgia, Salvatore/T-6598-2019	Attia, John R/0000-0001-9800-1308; Pintus, Gianfranco/0000-0002-3031-7733; Mangoni, Arduino Aleksander/0000-0001-8699-1412; Zinellu, Angelo/0000-0002-8396-0968; Carru, Ciriaco/0000-0002-6985-4907; McEvoy, Mark/0000-0002-5505-5557; Sotgia, Salvatore/0000-0002-3717-3437	University of Newcastle Strategic Initiative Fund; "Fondazione Banco di Sardegna - Sassari'' Italy; "Ministero dell'Universita e della Ricerca'' Italy	University of Newcastle Strategic Initiative Fund; "Fondazione Banco di Sardegna - Sassari'' Italy(Fondazione Banco di Sardegna); "Ministero dell'Universita e della Ricerca'' Italy(Ministry of Education, Universities and Research (MIUR))	Funding were provided by the University of Newcastle Strategic Initiative Fund, by the "Fondazione Banco di Sardegna - Sassari'' Italy, and by the "Ministero dell'Universita e della Ricerca'' Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, C28A3 CLSI; Arnadottir M, 1996, SCAND J CLIN LAB INV, V56, P41, DOI 10.3109/00365519609088586; Aruoma OI, 1999, FOOD CHEM TOXICOL, V37, P1043, DOI 10.1016/S0278-6915(99)00098-8; Cheah IK, 2012, BBA-MOL BASIS DIS, V1822, P784, DOI 10.1016/j.bbadis.2011.09.017; Ey J, 2007, J AGR FOOD CHEM, V55, P6466, DOI 10.1021/jf071328f; Giustarini D, 2006, J GERONTOL A-BIOL, V61, P1030, DOI 10.1093/gerona/61.10.1030; Grundemann D, 2012, PREV MED, V54, pS71, DOI 10.1016/j.ypmed.2011.12.001; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Kimmons Joel E, 2006, MedGenMed, V8, P59; Kumosani TA, 2001, EXP MOL MED, V33, P20, DOI 10.1038/emm.2001.4; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343; Mitsuyama H, 1999, CLIN SCI, V97, P407, DOI 10.1042/CS19990111; Nakamura YK, 2012, LIFE SCI, V90, P116, DOI 10.1016/j.lfs.2011.10.016; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Paul BD, 2010, CELL DEATH DIFFER, V17, P1134, DOI 10.1038/cdd.2009.163; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Pfeiffer C, 2011, FOOD CHEM, V129, P1766, DOI 10.1016/j.foodchem.2011.06.047; Quintana-Cabrera R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1722; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Santiago JL, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-54; Schauss AG, 2010, TOXICOLOGY, V278, P39, DOI 10.1016/j.tox.2010.07.015; Soltaninassab SR, 2000, J CELL PHYSIOL, V182, P163, DOI 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1; Sotgia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070374; Sotgia S, 2013, J SEP SCI, V36, P1002, DOI 10.1002/jssc.201201016; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Waller S, 2006, GUT, V55, P809, DOI 10.1136/gut.2005.084574; Wollesen F, 1999, KIDNEY INT, V55, P1028, DOI 10.1046/j.1523-1755.1999.0550031028.x; Zinellu A, 2003, ELECTROPHORESIS, V24, P2796, DOI 10.1002/elps.200305570; Zinellu A, 2009, AMINO ACIDS, V36, P35, DOI 10.1007/s00726-007-0022-5	30	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84918	10.1371/journal.pone.0084918	http://dx.doi.org/10.1371/journal.pone.0084918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392160	Green Published, gold			2022-12-27	WOS:000329460100083
J	Zhang, Y; Yang, E; Pu, J; Liu, LD; Che, YC; Wang, JJ; Liao, Y; Wang, LC; Ding, D; Zhao, T; Ma, N; Song, M; Wang, X; Shen, D; Tang, DH; Huang, HT; Zhang, ZX; Chen, D; Feng, MF; Li, QH				Zhang, Ying; Yang, Erxia; Pu, Jing; Liu, Longding; Che, Yanchun; Wang, Jingjing; Liao, Yun; Wang, Lichun; Ding, Dong; Zhao, Ting; Ma, Na; Song, Ming; Wang, Xi; Shen, Dong; Tang, Donghong; Huang, Hongtai; Zhang, Zhixiao; Chen, Dai; Feng, Mingfei; Li, Qihan			The Gene Expression Profile of Peripheral Blood Mononuclear Cells from EV71-Infected Rhesus Infants and the Significance in Viral Pathogenesis	PLOS ONE			English	Article							SUBSTANCE-P; CHEMOKINE RELEASE; GRO-ALPHA; IL-17; ENTEROVIRUS-71; CYTOKINES; PROTEIN; NEUROPEPTIDES; TACHYKININS; LYMPHOCYTES	Enterovirus 71 (EV71) is the major pathogen responsible for fatal hand, foot and mouth disease (HFMD). Our previous work reported on an EV71-infected rhesus monkey infant model that presented with histo-pathologic changes of the central nervous system (CNS) and lungs. This study is focused on the correlated modulation of gene expression in the peripheral blood mononuclear cells (PBMCs) from EV71-infected rhesus monkey infants. The expression of more than 500 functional genes associated with multiple pathways was modulated. The expression of genes associated with immune inflammatory responses was up-regulated during the period from days 4 to 10 post-infection. The expression of two genes (TAC1 and IL17A), which play major roles in inflammatory reactions, was remarkably up-regulated during the infection period. Furthermore, a higher expression level of the TAC1 gene was identified in the CNS compared to the lungs, but a high expression level of the IL-17A gene was observed in the lungs and not in the CNS. The results of this study suggest at least two facts about EV71 infection, which are that: the TAC1 gene that encodes substance P and neurokinin-A is present in both PBMCs and the hypothalamus; and the up-regulation of IL-17A is sustained in the peripheral blood.	[Zhang, Ying; Yang, Erxia; Pu, Jing; Liu, Longding; Che, Yanchun; Wang, Jingjing; Liao, Yun; Wang, Lichun; Ding, Dong; Zhao, Ting; Ma, Na; Song, Ming; Wang, Xi; Shen, Dong; Tang, Donghong; Huang, Hongtai; Zhang, Zhixiao; Li, Qihan] Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China; [Zhang, Ying; Yang, Erxia; Pu, Jing; Liu, Longding; Che, Yanchun; Wang, Jingjing; Liao, Yun; Wang, Lichun; Ding, Dong; Zhao, Ting; Ma, Na; Song, Ming; Wang, Xi; Shen, Dong; Tang, Donghong; Huang, Hongtai; Zhang, Zhixiao; Li, Qihan] Peking Union Med Coll, Kunming, Peoples R China; [Chen, Dai; Feng, Mingfei] Novel Bioinformat Co Ltd, Dept Bioinformat Anal, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, QH (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China.	liqihan@imbcams.com.cn		Zhang, Zhixiao/0000-0002-2307-880X	National Basic Research Program [2011CB504903, 2012CB518901]; National High-Tech RD Program [2012AA02A404]; National Natural Sciences Foundation of China [81171573, 31100127]; Yunnan Natural Science Foundation [2011FB116]; Youth Foundation of Peking Union Medical College [3332013083]	National Basic Research Program(National Basic Research Program of China); National High-Tech RD Program(National High Technology Research and Development Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); Youth Foundation of Peking Union Medical College	This work was supported by the National Basic Research Program (2011CB504903 and 2012CB518901), National High-Tech R&D Program (2012AA02A404), National Natural Sciences Foundation of China (81171573 and 31100127), the Yunnan Natural Science Foundation (2011FB116) and Youth Foundation of Peking Union Medical College (3332013083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA H, 1990, RESPIRATION, V57, P338; Anim L, 2011, GUIDE CARE USE LAB A; Arita M, 2006, J GEN VIROL, V87, P3317, DOI 10.1099/vir.0.82172-0; BARNES PJ, 1991, AM REV RESPIR DIS, V144, P1391, DOI 10.1164/ajrccm/144.6.1391; BARNES PJ, 1991, AM REV RESPIR DIS, V144, P1187, DOI 10.1164/ajrccm/144.5.1187; Carlson MJ, 2009, BLOOD, V113, P1365, DOI 10.1182/blood-2008-06-162420; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; Chen HC, 2012, VIROLOGY, V432, P417, DOI 10.1016/j.virol.2012.06.026; Chen LCYT, 2009, J BIOMED LAB SCI, V21, P82; Chen R, 1999, CLIN CHEM, V45, P1693; Cheung PFY, 2008, J IMMUNOL, V180, P5625, DOI 10.4049/jimmunol.180.8.5625; China, 2006, GUIDANCE EXPT ANIMAL; Cunin P, 2011, J IMMUNOL, V186, P4175, DOI 10.4049/jimmunol.1002535; Delves PJ, 2017, ROITTS ESSENTIAL IMM; HALL AK, 1989, BRIT J PHARMACOL, V97, P274, DOI 10.1111/j.1476-5381.1989.tb11951.x; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; HARTUNG HP, 1983, EUR J PHARMACOL, V89, P301, DOI 10.1016/0014-2999(83)90511-3; Ho WZ, 1997, J IMMUNOL, V159, P5654; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang SW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-147; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kawaguchi M, 2004, J ALLERGY CLIN IMMUN, V114, P1265, DOI 10.1016/j.jaci.2004.10.019; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Laan M, 1999, J IMMUNOL, V162, P2347; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; LEMBECK F, 1979, N-S ARCH PHARMACOL, V310, P175, DOI 10.1007/BF00500282; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Lin YW, 2009, EXP BIOL MED, V234, P1166, DOI 10.3181/0903-RM-116; Liu LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054451; Liu LD, 2011, VIROLOGY, V412, P91, DOI 10.1016/j.virol.2010.12.058; LUNDBERG JM, 1987, ANNU REV PHYSIOL, V49, P557; Ma Shao-hui, 2009, Virologica Sinica, V24, P162, DOI 10.1007/s12250-009-3033-4; MAGGI CA, 1993, EUR RESPIR J, V6, P735; Maggi CA, 2000, REGUL PEPTIDES, V93, P53, DOI 10.1016/S0167-0115(00)00177-4; Marui T, 2007, BRAIN DEV-JPN, V29, P510, DOI 10.1016/j.braindev.2007.01.010; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Page NM, 2003, P NATL ACAD SCI USA, V100, P6245, DOI 10.1073/pnas.0931458100; PAYAN DG, 1989, ANNU REV MED, V40, P341; Prause O, 2003, EUR J PHARMACOL, V462, P193, DOI 10.1016/S0014-2999(03)01341-4; Romagnani S, 2002, MOL IMMUNOL, V38, P881, DOI 10.1016/S0161-5890(02)00013-5; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Wang JJ, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.44; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wang SM, 2006, J CLIN VIROL, V37, P47, DOI 10.1016/j.jcv.2006.05.009; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; *WHO, 1988, PROC US LYOPH LBM PO; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Zaborowska J, 2012, TRANSCR-AUSTIN, V3, P92, DOI 10.4161/trns.19783; Zhang Y, 2011, LAB INVEST, V91, P1337, DOI 10.1038/labinvest.2011.82	62	5	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83766	10.1371/journal.pone.0083766	http://dx.doi.org/10.1371/journal.pone.0083766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392094	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100018
J	Canessa, P; Schumacher, J; Hevia, MA; Tudzynski, P; Larrondo, LF				Canessa, Paulo; Schumacher, Julia; Hevia, Montserrat A.; Tudzynski, Paul; Larrondo, Luis F.			Assessing the Effects of Light on Differentiation and Virulence of the Plant Pathogen Botrytis cinerea: Characterization of the White Collar Complex	PLOS ONE			English	Article							BLUE-LIGHT; PHYSICAL INTERACTION; MOLECULAR-GENETICS; SEXUAL DEVELOPMENT; NEUROSPORA-CRASSA; NEAR-ULTRAVIOLET; CIRCADIAN CLOCK; NADPH OXIDASES; GRAY MOLD; RED-LIGHT	Organisms are exposed to a tough environment, where acute daily challenges, like light, can strongly affect several aspects of an individual's physiology, including pathogenesis. While several fungal models have been widely employed to understand the physiological and molecular events associated with light perception, various other agricultural-relevant fungi still remain, in terms of their responsiveness to light, in the dark. The fungus Botrytis cinerea is an aggressive pathogen able to cause disease on a wide range of plant species. Natural B. cinerea isolates exhibit a high degree of diversity in their predominant mode of reproduction. Thus, the majority of naturally occurring strains are known to reproduce asexually via conidia and sclerotia, and sexually via apothecia. Studies from the 1970's reported on specific developmental responses to treatments with near-UV, blue, red and far-red light. To unravel the signaling machinery triggering development - and possibly also connected with virulence - we initiated the functional characterization of the transcription factor/photoreceptor BcWCL1 and its partner BcWCL2, that form the White Collar Complex (WCC) in B. cinerea. Using mutants either abolished in or exhibiting enhanced WCC signaling (overexpression of both bcwcl1 and bcwcl2), we demonstrate that the WCC is an integral part of the mentioned machinery by mediating transcriptional responses to white light and the inhibition of conidiation in response to this stimulus. Furthermore, the WCC is required for coping with excessive light, oxidative stress and also to achieve full virulence. Although several transcriptional responses are abolished in the absence of bcwcl1, the expression of some genes is still light induced and a distinct conidiation pattern in response to daily light oscillations is enhanced, revealing a complex underlying photobiology. Though overlaps with well-studied fungal systems exist, the light-associated machinery of B. cinerea appears more complex than those of Neurospora crassa and Aspergillus nidulans.	[Canessa, Paulo; Hevia, Montserrat A.; Larrondo, Luis F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Santiago, Chile; [Schumacher, Julia; Tudzynski, Paul] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany	Pontificia Universidad Catolica de Chile; University of Munster	Larrondo, LF (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Alameda 340, Santiago, Chile.	llarrondo@bio.puc.cl	Hevia, Montserrat/N-2667-2018; Schumacher, Julia/B-9142-2019; Larrondo, Luis/J-1086-2016	Hevia, Montserrat/0000-0002-6478-6490; Schumacher, Julia/0000-0001-9120-9675; Canessa, Paulo/0000-0003-3138-8223; Larrondo, Luis/0000-0002-8832-7109	Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt-Chile [1131030]; Fondecyt [3110127]; P. Universidad Catolica de Chile; CONICYT Chile [AT-24121100]	Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); P. Universidad Catolica de Chile; CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Research was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt-Chile 1131030 to LFL, Fondecyt Postdoc 3110127 and Postdoc-VRI from P. Universidad Catolica de Chile to PC. MH is a predoctoral fellow supported by CONICYT Chile (AT-24121100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Bayram O, 2008, MOL BIOL CELL, V19, P3254, DOI 10.1091/mbc.E08-01-0061; Bayram O, 2010, FUNGAL GENET BIOL, V47, P900, DOI 10.1016/j.fgb.2010.05.008; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Brierley WB, 1918, B MISCELLANEOUS INFO, V1918, P129; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Carreras-Villasenor N, 2012, MICROBIOL-SGM, V158, P3, DOI 10.1099/mic.0.052688-0; Carvalho LC, 2008, J PLANT PHYSIOL, V165, P1300, DOI 10.1016/j.jplph.2007.04.009; Casas-Flores S, 2004, MICROBIOL-SGM, V150, P3561, DOI 10.1099/mic.0.27346-0; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Cerrudo I, 2012, PLANT PHYSIOL, V158, P2042, DOI 10.1104/pp.112.193359; Chen CH, 2010, FUNGAL GENET BIOL, V47, P922, DOI 10.1016/j.fgb.2010.07.005; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Chen CH, 2009, EMBO J, V28, P1029, DOI 10.1038/emboj.2009.54; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chung DW, 2011, FUNGAL GENET BIOL, V48, P370, DOI 10.1016/j.fgb.2010.12.008; Coley-Smith JR, 1980, BIOL BOTRYTIS CINERE; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Corrochano LM, 2011, IMA FUNGUS, V2, P25, DOI 10.5598/imafungus.2011.02.01.04; de Wit M, 2013, PLANT J, V75, P90, DOI 10.1111/tpj.12203; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Demkura PV, 2012, MOL PLANT, V5, P642, DOI 10.1093/mp/sss025; Derckel JP, 1999, PHYTOPATHOLOGY, V89, P197, DOI 10.1094/PHYTO.1999.89.3.197; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; FARETRA F, 1988, J GEN MICROBIOL, V134, P2543; Faretra F., 1987, Phytopathologia Mediterranea, V26, P29; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Fuller KK, 2013, MBIO, V4, DOI 10.1128/mBio.00142-13; Gettkandt G, 1952, KENNTNIS PHOTOTROPIS; Godfrey GH, 1923, J AGRIC RES, V23, P0679; Goyal A, 2013, TRENDS PLANT SCI, V18, P393, DOI 10.1016/j.tplants.2013.03.002; GRINDLE M, 1979, J GEN MICROBIOL, V111, P109, DOI 10.1099/00221287-111-1-109; Han Kap-Hoon, 2009, Mycobiology, V37, P171, DOI 10.4489/MYCO.2009.37.3.171; Hatakeyama R, 2007, BIOSCI BIOTECH BIOCH, V71, P1844, DOI 10.1271/bbb.60713; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Herrera-Estrella A, 2007, MOL MICROBIOL, V64, P5, DOI 10.1111/j.1365-2958.2007.05632.x; HONDA Y, 1978, PLANT PHYSIOL, V61, P711, DOI 10.1104/pp.61.5.711; Hunt SM, 2010, P NATL ACAD SCI USA, V107, P16709, DOI 10.1073/pnas.1009474107; Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Idnurm A, 2010, FUNGAL GENET BIOL, V47, P881, DOI 10.1016/j.fgb.2010.04.009; Idnurm A, 2010, MICROBIOL-SGM, V156, P2393, DOI 10.1099/mic.0.039222-0; Idnurm A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000470; Islam SZ, 1998, PLANT DIS, V82, P850, DOI 10.1094/PDIS.1998.82.8.850; JAFFE L, 1962, J CELL BIOL, V13, P13, DOI 10.1083/jcb.13.1.13; JARVIS WR, 1972, T BRIT MYCOL SOC, V58, P526, DOI 10.1016/S0007-1536(72)80108-6; Jarvis WR, 1977, BOTRYOTINIA BOTRYTIS; Kim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002113; Kim S, 2011, FUNGAL GENET BIOL, V48, P400, DOI 10.1016/j.fgb.2011.01.004; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Lakin-Thomas PL, 2011, ADV GENET, V74, P55, DOI 10.1016/B978-0-12-387690-4.00003-9; Levis C, 1997, FEMS MICROBIOL LETT, V157, P267, DOI 10.1111/j.1574-6968.1997.tb12783.x; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Montenegro-Montero A, 2013, NEUROSPORA: GENOMICS AND MOLECULAR BIOLOGY, P243; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Patel RM, 2008, J GEN APPL MICROBIOL, V54, P367; PAUL W. R. C., 1929, TRANS BRIT MYCOL SOC, V14, P118; Peltier GL, 1912, MISSOURI BOT GARDEN, V1912, P41; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Purschwitz J, 2006, CURR OPIN MICROBIOL, V9, P566, DOI 10.1016/j.mib.2006.10.011; Quidde T, 1998, PHYSIOL MOL PLANT P, V52, P151, DOI 10.1006/pmpp.1998.0142; Rebordinos Laureana, 2000, Revista Iberoamericana de Micologia, V17, pS37; Reino JL, 2004, J PHYTOPATHOL, V152, P563, DOI 10.1111/j.1439-0434.2004.00896.x; Robinson W, 1914, ANN BOT-LONDON, V28, P331, DOI 10.1093/oxfordjournals.aob.a089507; Roca MG, 2012, FUNGAL BIOL-UK, V116, P379, DOI 10.1016/j.funbio.2011.12.007; Roden LC, 2009, PLANT CELL, V21, P2546, DOI 10.1105/tpc.109.069922; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; Rohrig J, 2013, CURR GENET, V59, P55, DOI 10.1007/s00294-013-0387-9; Ruger-Herreros C, 2011, GENETICS, V188, P809, DOI 10.1534/genetics.111.130096; Ruiz-Roldan MC, 2008, EUKARYOT CELL, V7, P1227, DOI 10.1128/EC.00072-08; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanz C, 2009, P NATL ACAD SCI USA, V106, P7095, DOI 10.1073/pnas.0900879106; Schumacher J, 2013, PLOS GENET IN PRESS; Schumacher J, 2012, MORPHOGENESIS PATHOG, V22, P225, DOI DOI 10.1007/978-3-642-22916-9_11; Schumacher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053729; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Segmuller N, 2007, EUKARYOT CELL, V6, P211, DOI 10.1128/EC.00153-06; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Staats M, 2012, EUKARYOT CELL, V11, P1413, DOI 10.1128/EC.00164-12; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; STEWART TM, 1987, NEW ZEAL J EXP AGR, V15, P389, DOI 10.1080/03015521.1987.10425587; SUZUKI Y, 1979, Annals of the Phytopathological Society of Japan, V45, P54, DOI 10.3186/jjphytopath.45.54; SUZUKI Y, 1977, J GEN MICROBIOL, V98, P199, DOI 10.1099/00221287-98-1-199; TAN KK, 1973, T BRIT MYCOL SOC, V61, P147; TAN KK, 1975, T BRIT MYCOL SOC, V64, P215, DOI 10.1016/S0007-1536(75)80105-7; TAN KK, 1974, J GEN MICROBIOL, V82, P191, DOI 10.1099/00221287-82-1-191; TAN KK, 1975, T BRIT MYCOL SOC, V64, P223, DOI 10.1016/S0007-1536(75)80106-9; Tan KK, 1974, T BR MYCOL SOC, V62; Tudzynski P., 2009, MYCOTA, P29; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	107	96	104	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84223	10.1371/journal.pone.0084223	http://dx.doi.org/10.1371/journal.pone.0084223			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391918	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900061
J	Dunham, Y				Dunham, Yarrow			Balanced Identity in the Minimal Groups Paradigm	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; IN-GROUP BIAS; SELF-ESTEEM; CONSISTENCY; ATTITUDES; CHILDREN	Balanced Identity Theory [1] formalizes a set of relationships between group attitude, group identification, and self-esteem. While these relationships have been demonstrated for familiar and highly salient social categories, questions remain regarding the generality of the balance phenomenon and its causal versus descriptive status. Supporting the generality and rapidity of cognitive balance, four studies demonstrate that the central predictions of balance are supported even for previously unfamiliar "minimal" social groups to which participants have just been randomly assigned. Further, supporting a causal as opposed to merely descriptive interpretation, manipulating any one component of the balance model (group attitude, group identification, or self-esteem) affects at least one of the related components. Interestingly, the broader pattern of cognitive balance was preserved across such manipulations only when the manipulation strengthens as opposes to weakens the manipulated construct. Taken together, these findings indicate that Balanced Identity Theory has promise as a general theory of intergroup attitudes, and that it may be able to shed light on prior inconsistencies concerning the relationship between self-esteem and intergroup bias.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Dunham, Y (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	yarrow.dunham@yale.edu						ABRAMS D, 1988, EUR J SOC PSYCHOL, V18, P317, DOI 10.1002/ejsp.2420180403; Ashburn-Nardo L, 2001, J PERS SOC PSYCHOL, V81, P789, DOI 10.1037//0022-3514.81.5.789; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Cvencek D., 2012, COGNITIVE CONSISTENC, P157; Dunham Y, J SOCIAL IS IN PRESS; Dunham Y, 2007, SELF IDENTITY, V6, P238, DOI 10.1080/15298860601115344; Dunham Y, 2011, CHILD DEV, V82, P793, DOI 10.1111/j.1467-8624.2011.01577.x; Dunham Y, 2011, J EXP SOC PSYCHOL, V47, P668, DOI 10.1016/j.jesp.2011.01.003; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Gramzow RH, 2005, J PERS SOC PSYCHOL, V88, P801, DOI 10.1037/0022-3514.88.5.801; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2002, J PERS SOC PSYCHOL, V83, P367, DOI 10.1037//0022-3514.83.2.367; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Lane KA, 2005, SOC COGNITION, V23, P353, DOI 10.1521/soco.2005.23.4.353; Nosek B.A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1037/0022-3514.89.3.277; Otten S, 1999, EUR J SOC PSYCHOL, V29, P1049, DOI 10.1002/(SICI)1099-0992(199912)29:8<1049::AID-EJSP985>3.0.CO;2-Q; Pinter B, 2011, GROUP PROCESS INTERG, V14, P81, DOI 10.1177/1368430210375251; Rubin M, 1998, Pers Soc Psychol Rev, V2, P40, DOI 10.1207/s15327957pspr0201_3; Rudman LA, 2004, J PERS SOC PSYCHOL, V87, P494, DOI 10.1037/0022-3514.87.4.494; Tajfel H., 1971, INTERGROUP RELATIONS, P178, DOI 10.1038/scientificamerican1170-96; Turner J., 1986, PSYCHOL INTERGROUP R, P7, DOI DOI 10.1038/NATURE02121; Van Bavel JJ, 2008, PSYCHOL SCI, V19, P1131, DOI 10.1111/j.1467-9280.2008.02214.x; Yamaguchi S, 2007, PSYCHOL SCI, V18, P498, DOI 10.1111/j.1467-9280.2007.01928.x	27	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84205	10.1371/journal.pone.0084205	http://dx.doi.org/10.1371/journal.pone.0084205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391912	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900055
J	Faso, C; Bischof, S; Hehl, AB				Faso, Carmen; Bischof, Sylvain; Hehl, Adrian B.			The Proteome Landscape of Giardia lamblia Encystation	PLOS ONE			English	Article							LIFE-CYCLE; CYST WALL; TRANSCRIPTIONAL RESPONSE; SECRETORY APPARATUS; ANTIGENIC VARIATION; VENTRAL DISC; PROTEINS; DIFFERENTIATION; GENOME; EXPRESSION	Giardia lamblia is an intestinal protozoan parasite required to survive in the environment in order to be transmitted to a new host. To ensure parasite survival, flagellated trophozoites colonizing the small intestine differentiate into non-motile environmentally-resistant cysts which are then shed in the environment. This cell differentiation process called encystation is characterized by significant morphological remodeling which includes secretion of large amounts of cyst wall material. Although much is known about the transcriptional regulation of encystation and the synthesis and trafficking of cyst wall material, the investigation of global changes in protein content and abundance during G. lamblia encystation is still unaddressed. In this study, we report on the quantitative analysis of the G. lamblia proteome during encystation using tandem mass spectrometry. Quantification of more than 1000 proteins revealed major changes in protein abundance in early, mid and late encystation, notably in constitutive secretory protein trafficking. Early stages of encystation were marked by a striking decrease of endoplasmic reticulum-targeted variant-specific surface proteins and significant increases in cytoskeleton regulatory components, NEK protein kinases and proteins involved in protein folding and glycolysis. This was in stark contrast to cells in the later stages of encystation which presented a surprisingly similar proteome composition to non-encysting trophozoites. Altogether these data constitute the first quantitative atlas of the Giardia proteome covering the whole process of encystation and point towards an important role for post-transcriptional control of gene expression in Giardia differentiation. Furthermore, our data provide a valuable resource for the community-based annotation effort of the G. lamblia genome, where almost 70% of all predicted gene models remains "hypothetical''.	[Faso, Carmen; Hehl, Adrian B.] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; [Bischof, Sylvain] ETH, Dept Biol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Faso, C (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.	carmen.faso@access.uzh.ch; adrian.hehl@access.uzh.ch	Faso, Carmen/B-2141-2018	Faso, Carmen/0000-0002-1831-9365; Hehl, Adrian/0000-0002-2110-4445	Swiss National Science Foundation [31003A_140803]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by Swiss National Science Foundation grant (#31003A_140803) to ABH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; ALEY SB, 1993, EXP PARASITOL, V77, P295, DOI 10.1006/expr.1993.1087; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; ARROYOBEGOVICH A, 1980, J PARASITOL, V66, P735, DOI 10.2307/3280662; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bernander R, 2001, CELL MICROBIOL, V3, P55, DOI 10.1046/j.1462-5822.2001.00094.x; Birkeland SR, 2010, MOL BIOCHEM PARASIT, V174, P62, DOI 10.1016/j.molbiopara.2010.05.010; Bischof S, 2011, PLANT CELL, V23, P3911, DOI 10.1105/tpc.111.092882; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Castillo-Romero A, 2012, MOL BIOCHEM PARASIT, V184, P122, DOI 10.1016/j.molbiopara.2012.04.011; Chiu PW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000677; Davids BJ, 2011, MOL BIOCHEM PARASIT, V175, P169, DOI 10.1016/j.molbiopara.2010.11.008; Davids BJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000044; DuBois KN, 2008, J BIOL CHEM, V283, P18024, DOI 10.1074/jbc.M802133200; Ehrenkaufer GM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r77; Elmendorf HG, 2005, INT J PARASITOL, V35, P1001, DOI 10.1016/j.ijpara.2005.03.009; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Faghiri Z, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-91; Faso C, 2013, CELL MICROBIOL, V15, P537, DOI 10.1111/cmi.12054; Faso C, 2011, INT J PARASITOL, V41, P471, DOI 10.1016/j.ijpara.2010.12.014; FRANZEN O, 2013, PLOS COMPUT BIOL, V0009; Furness B W, 2000, MMWR CDC Surveill Summ, V49, P1; GILLIN FD, 1989, EXP PARASITOL, V69, P164, DOI 10.1016/0014-4894(89)90185-9; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Hagen KD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001442; Hehl AB, 2000, MOL BIOL CELL, V11, P1789, DOI 10.1091/mbc.11.5.1789; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; KANE AV, 1991, J PARASITOL, V77, P974, DOI 10.2307/3282752; Kim J, 2009, PARASITOL RES, V104, P475, DOI 10.1007/s00436-008-1223-x; Knodler LA, 1999, J BIOL CHEM, V274, P29805, DOI 10.1074/jbc.274.42.29805; Konrad C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000835; Lauwaet T, 2007, CURR OPIN MICROBIOL, V10, P554, DOI 10.1016/j.mib.2007.09.011; Lauwaet T, 2007, MOL BIOCHEM PARASIT, V152, P80, DOI 10.1016/j.molbiopara.2006.12.001; Lauwaet T, 2011, INT J PARASITOL, V41, P1079, DOI 10.1016/j.ijpara.2011.06.001; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Lorente-Rodriguez A., 2011, COLD SPRING HARBOR P, V3; Lourenco Daniela, 2012, BMC Research Notes, V5, P41, DOI 10.1186/1756-0500-5-41; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Marti M, 2003, J BIOL CHEM, V278, P24837, DOI 10.1074/jbc.M302082200; Marti M, 2003, MOL BIOL CELL, V14, P1433, DOI 10.1091/mbc.E02-08-0467; Mastronicola D, 2011, IUBMB LIFE, V63, P21, DOI 10.1002/iub.409; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Morf L, 2010, EUKARYOT CELL, V9, P1566, DOI 10.1128/EC.00100-10; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Munasinghe VS, 2013, INT J PARASITOL, V43, P879, DOI 10.1016/j.ijpara.2013.06.003; Palm D, 2005, MOL BIOCHEM PARASIT, V141, P199, DOI 10.1016/j.molbiopara.2005.03.005; Prucca CG, 2009, CELL MICROBIOL, V11, P1706, DOI 10.1111/j.1462-5822.2009.01367.x; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; RASCON AJ, 2013, CURRENT MED CHEM; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Ringqvist E, 2008, MOL BIOCHEM PARASIT, V159, P85, DOI 10.1016/j.molbiopara.2008.02.005; Rivero MR, 2010, BIOCHEM J, V428, P33, DOI 10.1042/BJ20100096; Saraiya AA, 2011, RNA, V17, P2152, DOI 10.1261/rna.028118.111; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Sener K, 2004, MICROBIOL-SGM, V150, P1225, DOI 10.1099/mic.0.26898-0; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Smith AJ, 2012, INT J PARASITOL, V42, P411, DOI 10.1016/j.ijpara.2012.03.001; Sonda S, 2010, MOL MICROBIOL, V76, P48, DOI 10.1111/j.1365-2958.2010.07062.x; Spycher C, 2013, MOL MICROBIOL, V88, P754, DOI 10.1111/mmi.12218; Stefanic S, 2006, J BIOL CHEM, V281, P7595, DOI 10.1074/jbc.M510940200; Sun CH, 2003, J BIOL CHEM, V278, P21701, DOI 10.1074/jbc.M302023200; Sun CH, 2002, MOL MICROBIOL, V46, P971, DOI 10.1046/j.1365-2958.2002.03233.x; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vizcaino JA, 2010, CURR PROTOC PROTEIN; WAGENBACH GE, 1969, J PROTOZOOL, V16, P257, DOI 10.1111/j.1550-7408.1969.tb02266.x; Wu G, 2000, MOL BIOL EVOL, V17, P1156, DOI 10.1093/oxfordjournals.molbev.a026398; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yee J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-26	78	29	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83207	10.1371/journal.pone.0083207	http://dx.doi.org/10.1371/journal.pone.0083207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391747	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000329325200044
J	Haimerl, M; Verloh, N; Zeman, F; Fellner, C; Muller-Wille, R; Schreyer, AG; Stroszczynski, C; Wiggermann, P				Haimerl, Michael; Verloh, Niklas; Zeman, Florian; Fellner, Claudia; Mueller-Wille, Rene; Schreyer, Andreas G.; Stroszczynski, Christian; Wiggermann, Philipp			Assessment of Clinical Signs of Liver Cirrhosis Using T1 Mapping on Gd-EOB-DTPA-Enhanced 3T MRI	PLOS ONE			English	Article							RELAXATION-TIME; HEPATOCELLULAR-CARCINOMA; QUANTITATIVE-EVALUATION; MOLECULAR-MECHANISMS; CHRONIC HEPATITIS; CONTRAST AGENT; PHASE-III; FIBROSIS; RATS; INFECTION	Objectives: To assess the differences between normal and cirrhotic livers by means of T1 mapping of liver parenchyma on gadoxetic acid (Gd-EOB-DTPA)-enhanced 3 Tesla (3T) MR imaging (MRI). Methods: 162 patients with normal (n = 96) and cirrhotic livers (n = 66; Child-Pugh class A, n = 30; B, n = 28; C, n = 8) underwent Gd-EOB-DTPA-enhanced 3T MRI. To obtain T1 maps, two TurboFLASH sequences (TI = 400 ms and 1000 ms) before and 20 min after Gd-EOB-DTPA administration were acquired. T1 relaxation times of the liver and the reduction rate between pre-and post-contrast enhancement images were measured. Results: The T1 relaxation times for Gd-EOB-DTPA-enhanced MRI showed significant differences between patients with normal liver function and patients with Child-Pugh class A, B, and C (p < 0.001). The T1 relaxation times showed a constant significant increase from Child-Pugh class A up to class C (Child-Pugh class A, 335 ms +/- 80 ms; B, 431 ms +/- 75 ms; C, 557 ms +/- 99 ms; Child-Pugh A to B, p < 0.001; Child-Pugh A to C, p < 0.001; Child-Pugh B to C, p < 0.001) and a constant decrease of the reduction rate of T1 relaxation times (Child-Pugh class A, 57.1% +/- 8.8%; B, 44.3% +/- 10.2%, C, 29.9% +/- 6.9%; Child-Pugh A to B, p < 0.001; Child-Pugh A to C, p < 0.001; Child-Pugh B to C, p < 0.001). Conclusion: Gd-EOB-DTPA-enhanced T1 mapping of the liver parenchyma may present a useful method for determining severity of liver cirrhosis.	[Haimerl, Michael; Verloh, Niklas; Fellner, Claudia; Mueller-Wille, Rene; Schreyer, Andreas G.; Stroszczynski, Christian; Wiggermann, Philipp] Univ Hosp Regensburg, Dept Radiol, Regensburg, Germany; [Zeman, Florian] Univ Hosp Regensburg, Ctr Clin Trials, Regensburg, Germany	University of Regensburg; University of Regensburg	Haimerl, M (corresponding author), Univ Hosp Regensburg, Dept Radiol, Regensburg, Germany.	michael.haimerl@ukr.de	Zeman, Florian/GNH-3239-2022; Wiggermann, Philipp/AAY-6759-2021; Schreye, Andreas/ABC-3197-2020; Verloh, Niklas/AAS-5386-2021; WIGGERMANN, Philipp/AAX-6721-2021	Verloh, Niklas/0000-0002-8424-5827; Schreyer, Andreas/0000-0002-2539-059X				AISEN AM, 1994, MAGNET RESON MED, V31, P551, DOI 10.1002/mrm.1910310513; Aube C, 2007, DIGEST DIS SCI, V52, P2601, DOI 10.1007/s10620-006-9143-z; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Bota S, 2012, ULTRASOUND MED BIOL, V38, P1103, DOI 10.1016/j.ultrasmedbio.2012.02.032; CHAMULEAU RAFM, 1988, HEPATOLOGY, V8, P217, DOI 10.1002/hep.1840080204; Chow AM, 2012, J MAGN RESON IMAGING, V36, P152, DOI 10.1002/jmri.23606; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Geier A, 2003, HEPATOLOGY, V38, P345, DOI 10.1053/jhep.2003.50317; GOLDBERG HI, 1984, RADIOLOGY, V153, P737, DOI 10.1148/radiology.153.3.6494469; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Heye T, 2012, EUR RADIOL, V22, P1224, DOI 10.1007/s00330-012-2378-5; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Ito K, 1999, RADIOLOGY, V212, P235, DOI 10.1148/radiology.212.1.r99jl41235; Katsube T, 2011, INVEST RADIOL, V46, P277, DOI 10.1097/RLI.0b013e318200f67d; Kim AI, 2005, AM J MED, V118, P808, DOI 10.1016/j.amjmed.2005.01.073; Kim KA, 2012, J MAGN RESON IMAGING, V36, P405, DOI 10.1002/jmri.23620; Kreft B, 1999, INVEST RADIOL, V34, P360, DOI 10.1097/00004424-199905000-00006; Kumada H, 2010, HEPATOL RES, V40, P1, DOI 10.1111/j.1872-034X.2009.00633.x; LEE JKT, 1990, RADIOLOGY, V177, P21, DOI 10.1148/radiology.177.1.2399319; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Nojiri S, 2013, J GASTROENTEROL HEPA; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028; Seale MK, 2009, RADIOGRAPHICS, V29, P1725, DOI 10.1148/rg.296095515; Tamada T, 2011, EUR J RADIOL, V80, pE311, DOI 10.1016/j.ejrad.2011.01.020; THOMSEN C, 1990, MAGN RESON IMAGING, V8, P599, DOI 10.1016/0730-725X(90)90137-Q; Tschirch FTC, 2008, EUR RADIOL, V18, P1577, DOI 10.1007/s00330-008-0929-6; Tsuda N, 2007, INVEST RADIOL, V42, P242, DOI 10.1097/01.rli.0000258058.44876.a5; Tsuda N, 2011, J GASTROEN HEPATOL, V26, P568, DOI 10.1111/j.1440-1746.2010.06494.x; Tsuda N, 2010, RADIOLOGY, V256, P767, DOI 10.1148/radiol.10092065; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zech Christoph J, 2007, Magn Reson Med Sci, V6, P43, DOI 10.2463/mrms.6.43	35	70	84	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85658	10.1371/journal.pone.0085658	http://dx.doi.org/10.1371/journal.pone.0085658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392025	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900169
J	Hsin, KY; Ghosh, S; Kitano, H				Hsin, Kun-Yi; Ghosh, Samik; Kitano, Hiroaki			Combining Machine Learning Systems and Multiple Docking Simulation Packages to Improve Docking Prediction Reliability for Network Pharmacology	PLOS ONE			English	Article							SCORING FUNCTIONS; MOLECULAR DOCKING; BINDING-AFFINITY; PROTEIN; INHIBITOR; CARDIOTOXICITY; DISCOVERY; SOFTWARE; PROGRAMS; ACCURATE	Increased availability of bioinformatics resources is creating opportunities for the application of network pharmacology to predict drug effects and toxicity resulting from multi-target interactions. Here we present a high-precision computational prediction approach that combines two elaborately built machine learning systems and multiple molecular docking tools to assess binding potentials of a test compound against proteins involved in a complex molecular network. One of the two machine learning systems is a re-scoring function to evaluate binding modes generated by docking tools. The second is a binding mode selection function to identify the most predictive binding mode. Results from a series of benchmark validations and a case study show that this approach surpasses the prediction reliability of other techniques and that it also identifies either primary or off-targets of kinase inhibitors. Integrating this approach with molecular network maps makes it possible to address drug safety issues by comprehensively investigating network-dependent effects of a drug or drug candidate.	[Hsin, Kun-Yi; Kitano, Hiroaki] Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa, Japan; [Ghosh, Samik; Kitano, Hiroaki] Syst Biol Inst, Minato Ku, Tokyo, Japan; [Ghosh, Samik; Kitano, Hiroaki] RIKEN Ctr Integrat Med Sci, Lab Dis Syst Modeling, Yokohama, Kanagawa, Japan	Okinawa Institute of Science & Technology Graduate University; RIKEN	Hsin, KY (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa, Japan.	kunyi.hsin@oist.jp; kitano@sbi.jp	Ghosh, Samik/AAF-6207-2021; Kitano, Hiroaki/A-6460-2016	Ghosh, Samik/0000-0002-0239-5400; 	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the HD-Physiology Project of the Japan Society for the Promotion of Science (JSPS) to the Okinawa Institute of Science and Technology Graduate University (OIST). This work, in part, has been carried out as research collaboration between the United States Food and Drug Administration (FDA) and the Systems Biology Institute (SBI) under Memorandum of Understanding Number 225-12-8000. Funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JPF, 2013, ANNU REV PHARMACOL, V53, P451, DOI 10.1146/annurev-pharmtox-011112-140248; Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; BOHNING D, 1992, ANN I STAT MATH, V44, P197, DOI 10.1007/bf00048682; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caron E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.108; Cases M, 2009, DRUG DISCOV TODAY, V14, P479, DOI 10.1016/j.drudis.2009.02.010; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; DALBY A, 1992, J CHEM INF COMP SCI, V32, P244, DOI 10.1021/ci00007a012; EMBL-EBI, 2013, BIOINF SERV MOL DAT; Englebienne P, 2009, J CHEM INF MODEL, V49, P1568, DOI 10.1021/ci8004308; Ferguson J, 2013, ONCOGENE, V32, P86, DOI 10.1038/onc.2012.25; Force T, 2007, NAT REV CANCER, V7, P332, DOI 10.1038/nrc2106; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Geldenhuys WJ, 2013, EXPERT OPINION DRUG, P1; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kerkela R, 2009, CTS-CLIN TRANSL SCI, V2, P15, DOI 10.1111/j.1752-8062.2008.00090.x; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Manousaridis I, 2013, J EUR ACAD DERMATOL, V27, P11, DOI 10.1111/j.1468-3083.2012.04546.x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; OBOYLE NM, 2011, J CHEMINFORMATICS, V3, DOI [DOI 10.1186/1758-2946-3-33, 10.1186/1758-2946-3-33]; Oda A, 2006, J CHEM INF MODEL, V46, P380, DOI 10.1021/ci050283k; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Plewczynski D, 2011, J COMPUT CHEM, V32, P742, DOI 10.1002/jcc.21643; Plewczynski D, 2011, J COMPUT CHEM, V32, P568, DOI 10.1002/jcc.21642; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; Teramoto R, 2008, J CHEM INF MODEL, V48, P288, DOI 10.1021/ci700239t; Trepalin SV, 2006, MOLECULES, V11, P219, DOI 10.3390/11040219; Tripos, 2009, TRIP SYB MOL2 FIL FO; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Zsoldos Z, 2006, CURR PROTEIN PEPT SC, V7, P421, DOI 10.2174/138920306778559412	44	144	201	13	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83922	10.1371/journal.pone.0083922	http://dx.doi.org/10.1371/journal.pone.0083922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391846	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200144
J	Karnik, R; Ludlow, MJ; Abuarab, N; Smith, AJ; Hardy, MEL; Elliott, DJS; Sivaprasadarao, A				Karnik, Rucha; Ludlow, Melanie J.; Abuarab, Nada; Smith, Andrew J.; Hardy, Matthew E. L.; Elliott, David J. S.; Sivaprasadarao, Asipu			Endocytosis of hERG Is Clathrin-Independent and Involves Arf6	PLOS ONE			English	Article							LONG QT SYNDROME; K+ CHANNEL FUNCTION; CELL-SURFACE; POTASSIUM CHANNELS; RAB GTPASES; LIPID RAFTS; TRAFFICKING; MECHANISMS; ENDOSOMES; DEGRADATION	The hERG potassium channel is critical for repolarisation of the cardiac action potential. Reduced expression of hERG at the plasma membrane, whether caused by hereditary mutations or drugs, results in long QT syndrome and increases the risk of ventricular arrhythmias. Thus, it is of fundamental importance to understand how the density of this channel at the plasma membrane is regulated. We used antibodies to an extracellular native or engineered epitope, in conjunction with immunofluorescence and ELISA, to investigate the mechanism of hERG endocytosis in recombinant cells and validated the findings in rat neonatal cardiac myocytes. The data reveal that this channel undergoes rapid internalisation, which is inhibited by neither dynasore, an inhibitor of dynamin, nor a dominant negative construct of Rab5a, into endosomes that are largely devoid of the transferrin receptor. These results support a clathrin-independent mechanism of endocytosis and exclude involvement of dynamin-dependent caveolin and RhoA mechanisms. In agreement, internalised hERG displayed marked overlap with glycosylphosphatidylinositol-anchored GFP, a clathrin-independent cargo. Endocytosis was significantly affected by cholesterol extraction with methyl-beta-cyclodextrin and inhibition of Arf6 function with dominant negative Arf6-T27N-eGFP. Taken together, we conclude that hERG undergoes clathrin-independent endocytosis via a mechanism involving Arf6.	[Karnik, Rucha; Ludlow, Melanie J.; Abuarab, Nada; Smith, Andrew J.; Hardy, Matthew E. L.; Elliott, David J. S.; Sivaprasadarao, Asipu] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Ludlow, Melanie J.; Sivaprasadarao, Asipu] Univ Leeds, Fac Biol Sci, Multidisciplinary Cardiovasc Ctr, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Sivaprasadarao, A (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England.	a.sivaprasadarao@leeds.ac.uk	Hardy, Matt/ABD-1397-2022	Hardy, Matt/0000-0002-3129-9549; Ludlow, Melanie/0000-0002-0720-5581; Sivaprasadarao, Asipu/0000-0002-6755-3502; Karnik, Rucha Anil/0000-0001-6876-4099	British Heart Foundation [PG/10/68/28528]	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation (grant number PG/10/68/28528; http://www.bhf.org. uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Balijepalli RC, 2007, CHANNELS, V1, P263, DOI 10.4161/chan.4946; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Bingham AJ, 2007, MOL CELL BIOL, V27, P4082, DOI 10.1128/MCB.00269-07; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; Delisle BP, 2009, J BIOL CHEM, V284, P2844, DOI 10.1074/jbc.M807289200; Dennis AT, 2011, J BIOL CHEM, V286, P34413, DOI 10.1074/jbc.M111.254367; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; El Azreq MA, 2010, J IMMUNOL, V184, P637, DOI 10.4049/jimmunol.0901654; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ganapathi SB, 2010, AM J PHYSIOL-CELL PH, V299, pC74, DOI 10.1152/ajpcell.00462.2009; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Gong Q, 2007, J BIOL CHEM, V282, P13087, DOI 10.1074/jbc.M700767200; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Guo J, 2011, MOL PHARMACOL, V79, P806, DOI 10.1124/mol.110.069419; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hashimoto S, 2004, J BIOL CHEM, V279, P37677, DOI 10.1074/jbc.M404196200; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Mankouri J, 2006, EMBO J, V25, P4142, DOI 10.1038/sj.emboj.7601275; Manna PT, 2010, J BIOL CHEM, V285, P5963, DOI 10.1074/jbc.M109.066902; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mitcheson JS, 2008, CHEM RES TOXICOL, V21, P1005, DOI 10.1021/tx800035b; Murphy JE, 2008, J CELL SCI, V121, P2136, DOI 10.1242/jcs.020917; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Papini E, 1997, EMBO J, V16, P15, DOI 10.1093/emboj/16.1.15; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; Ramstrom C, 2010, CELL MOL LIFE SCI, V67, P157, DOI 10.1007/s00018-009-0176-2; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Rodman JS, 2000, J CELL SCI, V113, P183; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Wible Barbara A., 2005, Journal of Pharmacological and Toxicological Methods, V52, P136, DOI 10.1016/j.vascn.2005.03.008; Zhang YQ, 2006, AM J PHYSIOL-HEART C, V291, pH1446, DOI 10.1152/ajpheart.01356.2005; Zhang YQ, 2003, J BIOL CHEM, V278, P10417, DOI 10.1074/jbc.M211044200; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	70	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85630	10.1371/journal.pone.0085630	http://dx.doi.org/10.1371/journal.pone.0085630			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392021	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000329323900165
J	Kaufmann, E; Reips, UD; Wittmann, WW				Kaufmann, Esther; Reips, Ulf-Dietrich; Wittmann, Werner W.			A Critical Meta-Analysis of Lens Model Studies in Human Judgment and Decision-Making	PLOS ONE			English	Article							CLINICAL JUDGMENT; CORRELATION-COEFFICIENTS; PREDICTIONS; RELIABILITY; ACCURACY; ACHIEVEMENT; STRATEGY; TASK	Achieving accurate judgment ('judgmental achievement') is of utmost importance in daily life across multiple domains. The lens model and the lens model equation provide useful frameworks for modeling components of judgmental achievement and for creating tools to help decision makers (e. g., physicians, teachers) reach better judgments (e. g., a correct diagnosis, an accurate estimation of intelligence). Previous meta-analyses of judgment and decision-making studies have attempted to evaluate overall judgmental achievement and have provided the basis for evaluating the success of bootstrapping (i.e., replacing judges by linear models that guide decision making). However, previous meta-analyses have failed to appropriately correct for a number of study design artifacts (e. g., measurement error, dichotomization), which may have potentially biased estimations (e. g., of the variability between studies) and led to erroneous interpretations (e. g., with regards to moderator variables). In the current study we therefore conduct the first psychometric meta-analysis of judgmental achievement studies that corrects for a number of study design artifacts. We identified 31 lens model studies (N = 1,151, k = 49) that met our inclusion criteria. We evaluated overall judgmental achievement as well as whether judgmental achievement depended on decision domain (e. g., medicine, education) and/or the level of expertise (expert vs. novice). We also evaluated whether using corrected estimates affected conclusions with regards to the success of bootstrapping with psychometrically-corrected models. Further, we introduce a new psychometric trim-and-fill method to estimate the effect sizes of potentially missing studies correct psychometric meta-analyses for effects of publication bias. Comparison of the results of the psychometric meta-analysis with the results of a traditional meta-analysis (which only corrected for sampling error) indicated that artifact correction leads to a) an increase in values of the lens model components, b) reduced heterogeneity between studies, and c) increases the success of bootstrapping. We argue that psychometric meta-analysis is useful for accurately evaluating human judgment and show the success of bootstrapping.	[Kaufmann, Esther] Univ Zurich, Inst Educ, Zurich, Switzerland; [Kaufmann, Esther] Univ Konstanz, Dept Econ, Chair Business & Econ Educ 2, Constance, Germany; [Reips, Ulf-Dietrich] Univ Konstanz, Dept Psychol, Constance, Germany; [Wittmann, Werner W.] Univ Mannheim, Otto Selz Inst Appl Psychol, Mannheim, Germany	University of Zurich; University of Konstanz; University of Konstanz; University of Mannheim	Kaufmann, E (corresponding author), Univ Zurich, Inst Educ, Zurich, Switzerland.	esther.kaufmann@gmx.ch	Reips, Ulf-Dietrich/A-5177-2012; Reips, Ulf-Dietrich/AAA-3467-2019; kaufmann, esther/AAJ-7670-2021	Reips, Ulf-Dietrich/0000-0002-1566-4745; Reips, Ulf-Dietrich/0000-0002-1566-4745; kaufmann, esther/0000-0003-1177-5146	Excellence Intitiative of the Deutsche Forschungsgemeinschaft	Excellence Intitiative of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work is funded by a fellowship for Esther Kaufmann to attend the Graduate School of Economics & Social Sciences in Mannheim (Germany) offered by the Excellence Intitiative of the Deutsche Forschungsgemeinschaft (see: http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEgisdottir S, 2006, COUNS PSYCHOL, V34, P341, DOI 10.1177/0011000005285875; Armstrong JS, 2001, INT SER OPER RES MAN, V30, P171; ASHTON AH, 1982, J ACCOUNTING RES, V20, P440, DOI 10.2307/2490751; Ashton RH, 2000, J BEHAV DECIS MAKING, V13, P277, DOI 10.1002/1099-0771(200007/09)13:3<277::AID-BDM350>3.0.CO;2-B; BANGERTDROWNS RL, 1986, PSYCHOL BULL, V99, P388, DOI 10.1037/0033-2909.99.3.388; Bernieri FJ, 1996, J PERS SOC PSYCHOL, V71, P110, DOI 10.1037/0022-3514.71.1.110; Brunswik E., 1952, INT ENCY UNIFIED SCI; CAMERER C, 1981, ORGAN BEHAV HUM PERF, V27, P411, DOI 10.1016/0030-5073(81)90031-3; Cooksey RW, 2007, EDUC RES EVAL, V13, P401, DOI 10.1080/13803610701728311; COOKSEY RW, 1986, AM EDUC RES J, V23, P41, DOI 10.2307/1163041; Cooksey RW, 2001, J VOCATIONAL ED RES, V26, P1; COOPER RP, 1990, CRIM JUSTICE BEHAV, V17, P431, DOI 10.1177/0093854890017004004; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; EINHORN HJ, 1974, ORGAN BEHAV HUM PERF, V12, P30, DOI 10.1016/0030-5073(74)90035-X; Eysenck H.J., 1952, J CONSULT PSYCHOL, V16, P319, DOI [10.1037/h0063633, DOI 10.1037/H0063633]; Field AP, 2005, PSYCHOL METHODS, V10, P444, DOI 10.1037/1082-989X.10.4.444; Field AP, 2001, PSYCHOL METHODS, V6, P161, DOI 10.1037//1082-989X.6.2.161; GOLDBERG LR, 1976, ORGAN BEHAV HUM PERF, V16, P13, DOI 10.1016/0030-5073(76)90003-9; GORMAN CD, 1978, ORGAN BEHAV HUM PERF, V22, P165, DOI 10.1016/0030-5073(78)90011-9; Hammond K.R., 2001, ESSENTIAL BRUNSWIK B; HAMMOND KR, 1964, PSYCHOL REV, V71, P438, DOI 10.1037/h0040736; Harvey N, 2004, INT J FORECASTING, V20, P391, DOI 10.1016/j.ijforecast.2003.09.012; Hattie JAC, 2009, VISIBLE LEARNING: A SYNTHESIS OF OVER 800 META-ANALYSES RELATING TO ACHIEVEMENT, P1; Hedges LV, 2014, STAT METHODS META AN; Herzog SM, 2009, PSYCHOL SCI, V20, P231, DOI 10.1111/j.1467-9280.2009.02271.x; Hogarth RM, 2006, INFORMATION SAMPLING AND ADAPTIVE COGNITION, P456; Hunter J.E., 2004, METHODS META ANAL CO; HURSCH CJ, 1964, PSYCHOL REV, V71, P42, DOI 10.1037/h0041729; Ioannidisa JPA, 2010, RES SYNTH METHODS, V1, P169, DOI 10.1002/jrsm.19; Jenny MA, 2013, J APPL RES MEM COGN, V2, P149, DOI 10.1016/j.jarmac.2013.06.001; Karelaia N, 2008, PSYCHOL BULL, V134, P404, DOI 10.1037/0033-2909.134.3.404; Kaufmann E, 2007, INT J IDIOGRAPHIC SC, P2; Kaufmann E, 2009, DO WE UNDERRESTIMATE; Kaufmann E, 2010, THESIS U MANNHEIM; Kaufmann E, 2013, WORKING PAPER; Kaufmann E, 2009, SWISS J PSYCHOL, V68, P99, DOI 10.1024/1421-0185.68.2.99; Kim CN, 1997, DECIS SUPPORT SYST, V21, P83, DOI 10.1016/S0167-9236(97)00022-5; LADUCA A, 1988, EVAL HEALTH PROF, V11, P178, DOI 10.1177/016327878801100203; Lehman HA, 1992, THESIS CALIFORNIA CH; Lichtenstein S, 1981, PTR1092816; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; MacGregor D., 1986, HUMAN COMPUTER INTER, V2, P179, DOI DOI 10.1207/S15327051HCI0203_; MCCLELLAN PG, 1984, PERCEPT PSYCHOPHYS, V36, P234, DOI 10.3758/BF03206364; MEAR R, 1987, ACCOUNT ORG SOC, V12, P331, DOI 10.1016/0361-3682(87)90022-5; Meehl P. E., 1954, CLIN VS STAT PREDICT; Morgan JF, 2004, J AM ACAD BUSINESS, V3, P42; Mutz R, 2010, Z PSYCHOL, V218, P175, DOI 10.1027/0044-3409/a000027; NYSTEDT L, 1975, PERCEPT MOTOR SKILL, V40, P343, DOI 10.2466/pms.1975.40.2.343; Renkewitz F, 2011, JUDGM DECIS MAK, V6, P870; Reynolds DJ, 2001, PERS SOC PSYCHOL B, V27, P187, DOI 10.1177/0146167201272005; ROOSE JE, 1976, ORGAN BEHAV HUM PERF, V16, P231, DOI 10.1016/0030-5073(76)90015-5; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Rosenthal R, 1991, METAANALYTIC PROCEDU; Rothstein HR., 2008, J EXP CRIMINOL, V4, P61, DOI [10.1007/s11292-007-9046-9, DOI 10.1007/S11292-007-9046-9]; Shanteau J, 2002, WORKING PAPER; Simpson RJS, 1904, BRIT MED J, V1904, P1243; SINGH H, 1990, Q REV ECON BUS, V30, P64; Smith L, 2003, APPL COGNITIVE PSYCH, V17, P51, DOI 10.1002/acp.844; SMITH ML, 1977, AM PSYCHOL, V32, P752, DOI 10.1037/0003-066X.32.9.752; SPEROFF T, 1989, MED DECIS MAKING, V9, P243, DOI 10.1177/0272989X8900900403; STEINMANN DO, 1972, ORGAN BEHAV HUM PERF, V8, P450, DOI 10.1016/0030-5073(72)90062-1; STEWART TR, 1990, WEATHER FORECAST, V5, P661, DOI 10.1175/1520-0434(1990)005<0661:ADOTCC>2.0.CO;2; Stewart TR, 1997, ORGAN BEHAV HUM DEC, V69, P205, DOI 10.1006/obhd.1997.2682; SZUCKO JJ, 1981, AM PSYCHOL, V36, P488, DOI 10.1037/0003-066X.36.5.488; TUCKER LR, 1964, PSYCHOL REV, V71, P528, DOI 10.1037/h0047061; Vacha-Haase T, 1998, EDUC PSYCHOL MEAS, V58, P6, DOI 10.1177/0013164498058001002; WERNER PD, 1983, J CONSULT CLIN PSYCH, V51, P815, DOI 10.1037/0022-006X.51.6.815; WERNER PD, 1989, SOC WORK RES ABSTR, V25, P17, DOI 10.1093/swra/25.3.17; WIGGINS N, 1971, J PERS SOC PSYCHOL, V19, P100, DOI 10.1037/h0031147; Wittmann W.W., 1988, HDB MULTIVARIATE EXP, P505, DOI [10.1007/978-1-4613-0893-5_16, DOI 10.1007/978-1-4613-0893-5_16]; WITTMANN WW, 1986, PSYCHOL RUNDSCH, V37, P20; Wittmann WW, 2009, EVALUATION, V1, P59; Wittmann WW, 1985, EVALUATIONSFORSUNGE; WRIGHT WF, 1979, ORGAN BEHAV HUM PERF, V23, P73, DOI 10.1016/0030-5073(79)90047-3	76	19	20	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83528	10.1371/journal.pone.0083528	http://dx.doi.org/10.1371/journal.pone.0083528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284NF	24391781	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000329325200078
J	Nielsen, TK; Xu, ZF; Gozdereliler, E; Aamand, J; Hansen, LH; Sorensen, SR				Nielsen, Tue Kjaergaard; Xu, Zhuofei; Gozdereliler, Erkin; Aamand, Jens; Hansen, Lars Hestbjerg; Sorensen, Sebastian R.			Novel Insight into the Genetic Context of the cadAB Genes from a 4-chloro-2-methylphenoxyacetic Acid-Degrading Sphingomonas	PLOS ONE			English	Article							2,4-DICHLOROPHENOXYACETIC ACID; COMPLETE SEQUENCE; DEGRADATION; ALPHA; TRANSPOSITION; ACCURATE; PLASMID; PATHWAY; TFDA; MONOOXYGENASE	The 2-methyl-4-chlorophenoxyacetic (MCPA) acid-degrader Sphingomonas sp. ERG5 has recently been isolated from MCPA-degrading bacterial communities. Using Illumina-sequencing, the 5.7 Mb genome of this isolate was sequenced in this study, revealing the 138 kbp plasmid pCADAB1 harboring the 32.5 kbp composite transposon Tn6228 which contains genes encoding proteins for the removal of 2,4-dichlorophenoxyacetic acid (2,4-D) and MCPA, as well as the regulation of this pathway. Transposon Tn6228 was confirmed by PCR to be situated on the plasmid and also exist in a circular intermediate state - typical of IS3 elements. The canonical tfdA alpha-gene of group III 2,4-D degraders, encoding the first step in degradation of 2,4-D and related compounds, was not present in the chromosomal contigs. However, the alternative cadAB genes, also providing the initial degradation step, were found in Tn6228, along with the 2,4-D-degradation-associated genes tfdBCDEFKR and cadR. Putative reductase and ferredoxin genes cadCD of Rieske non-heme iron oxygenases were also present in close proximity to cadAB, suggesting that these might have an unknown role in the initial degradation reaction. Parts of the composite transposon contain sequence displaying high similarity to previously analyzed 2,4-D degradation genes, suggesting rapid dissemination and high conservation of the chlorinated-phenoxyacetic acid (PAA)-degradation genotype among the sphingomonads.	[Nielsen, Tue Kjaergaard; Gozdereliler, Erkin; Aamand, Jens; Sorensen, Sebastian R.] Geol Survey Denmark & Greenland, Dept Geochem, Copenhagen, Denmark; [Nielsen, Tue Kjaergaard; Xu, Zhuofei; Hansen, Lars Hestbjerg] Univ Copenhagen, Microbiol Sect, Copenhagen, Denmark	Geological Survey Of Denmark & Greenland; University of Copenhagen	Hansen, LH (corresponding author), Aarhus Univ, ENVS Dept Environm Sci, Roskilde, Denmark.	lhha@dmu.dk	Sørensen, Sebastian R./A-4305-2014; Sørensen, Søren J/J-5015-2014; Sørensen, Sebastian Reinhold/AAM-2406-2020	Sørensen, Søren J/0000-0001-6227-9906; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Aamand, Jens/0000-0002-4641-639X; Nielsen, Tue/0000-0001-6610-8450	Center for Environmental and Agricultural Microbiology - CREAM; Lundbeck Foundation project DK [R44-A4384]; VILLUM FOUNDATION; Lundbeck Foundation [R44-2009-4384] Funding Source: researchfish	Center for Environmental and Agricultural Microbiology - CREAM; Lundbeck Foundation project DK; VILLUM FOUNDATION(Villum Fonden); Lundbeck Foundation(Lundbeckfonden)	This study was partly funded by the Center for Environmental and Agricultural Microbiology - CREAM and the Lundbeck Foundation (www.lundbeckfoundation.com) project DK nr R44-A4384 (Lars Hestbjerg Hansen). CREAM is funded by the VILLUM FOUNDATION (www.villumfoundation.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Basta T, 2004, J BACTERIOL, V186, P3862, DOI 10.1128/JB.186.12.3862-3872.2004; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ditterich F, 2013, FEMS MICROBIOL ECOL; DON RH, 1985, J BACTERIOL, V161, P85, DOI 10.1128/JB.161.1.85-90.1985; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Filer K, 1997, APPL ENVIRON MICROB, V63, P317, DOI 10.1128/AEM.63.1.317-320.1997; FUKUMORI F, 1993, J BIOL CHEM, V268, P24311; FUKUMORI F, 1993, J BACTERIOL, V175, P2083, DOI 10.1128/JB.175.7.2083-2086.1993; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Gozdereliler E, 2013, APPL ENVIRON MICROB, V79, P367, DOI 10.1128/AEM.02536-12; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Huong NL, 2007, MICROBES ENVIRONMENT, V22, P243, DOI 10.1264/jsme2.22.243; Hurtubise Y, 1998, J BACTERIOL, V180, P5828, DOI 10.1128/JB.180.22.5828-5835.1998; Itoh K, 2004, APPL ENVIRON MICROB, V70, P2110, DOI 10.1128/AEM.70.4.2110-2118.2004; Itoh K, 2002, APPL ENVIRON MICROB, V68, P3449, DOI 10.1128/AEM.68.7.3449-3454.2002; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kamagata Y, 1997, APPL ENVIRON MICROB, V63, P2266, DOI 10.1128/AEM.63.6.2266-2272.1997; Kitagawa W, 2002, J BACTERIOL, V184, P509, DOI 10.1128/JB.184.2.509-518.2002; Larsen TS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-21; Ledger T, 2002, MICROBIOL-SGM, V148, P3431, DOI 10.1099/00221287-148-11-3431; Leveau JHJ, 1998, J BACTERIOL, V180, P2237, DOI 10.1128/JB.180.8.2237-2243.1998; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McGowan C, 1998, APPL ENVIRON MICROB, V64, P4089; Muller TA, 2004, APPL ENVIRON MICROB, V70, P6066, DOI 10.1128/AEM.70.10.6066-6075.2004; Nagarajan N, 2013, NAT REV GENET, V14, P157, DOI 10.1038/nrg3367; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Nojiri H, 2004, APPL MICROBIOL BIOT, V64, P154, DOI 10.1007/s00253-003-1509-y; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohtsubo E, 2004, ADV BIOPHYS, V38, P125, DOI 10.1016/S0065-227X(04)80121-7; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romine MF, 1999, J BACTERIOL, V181, P1585, DOI 10.1128/JB.181.5.1585-1602.1999; Sekine Y, 1999, J MOL BIOL, V294, P21, DOI 10.1006/jmbi.1999.3181; Shimojo M, 2009, J BIOSCI BIOENG, V108, P56, DOI 10.1016/j.jbiosc.2009.02.018; Shintani M, 2007, J BACTERIOL, V189, P2007, DOI 10.1128/JB.01486-06; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Stolz A, 2009, APPL MICROBIOL BIOT, V81, P793, DOI 10.1007/s00253-008-1752-3; STREBER WR, 1987, J BACTERIOL, V169, P2950, DOI 10.1128/jb.169.7.2950-2955.1987; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thiel M, 2005, ARCH MICROBIOL, V183, P80, DOI 10.1007/s00203-004-0748-3; Thorling L, 2011, GEUS 2011; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	54	21	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83346	10.1371/journal.pone.0083346	http://dx.doi.org/10.1371/journal.pone.0083346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391756	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200053
J	Park, J; Werley, CA; Venkatachalam, V; Kralj, JM; Dib-Hajj, SD; Waxman, SG; Cohen, AE				Park, Jeehae; Werley, Christopher A.; Venkatachalam, Veena; Kralj, Joel M.; Dib-Hajj, Sulayman D.; Waxman, Stephen G.; Cohen, Adam E.			Screening Fluorescent Voltage Indicators with Spontaneously Spiking HEK Cells	PLOS ONE			English	Article							ACTION-POTENTIALS; MICROBIAL RHODOPSIN; NEURONS; PROTEIN; NA(V)1.3; CURRENTS; TISSUES	Development of improved fluorescent voltage indicators is a key challenge in neuroscience, but progress has been hampered by the low throughput of patch-clamp characterization. We introduce a line of non-fluorescent HEK cells that stably express Na-V 1.3 and K-IR 2.1 and generate spontaneous electrical action potentials. These cells enable rapid, electrode-free screening of speed and sensitivity of voltage sensitive dyes or fluorescent proteins on a standard fluorescence microscope. We screened a small library of mutants of archaerhodopsin 3 (Arch) in spiking HEK cells and identified two mutants with greater voltage-sensitivity than found in previously published Arch voltage indicators.	[Park, Jeehae; Werley, Christopher A.; Venkatachalam, Veena; Kralj, Joel M.; Cohen, Adam E.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, West Haven, CT 06516 USA; [Dib-Hajj, Sulayman D.; Waxman, Stephen G.] Vet Affairs Hosp, Neurorehabil Res Ctr, West Haven, CT USA; [Cohen, Adam E.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Harvard University	Cohen, AE (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	cohen@chemistry.harvard.edu	Waxman, Stephen/Z-2507-2019	Waxman, Stephen/0000-0001-5718-7177	PECASE [N00014-11-1-0549]; Harvard Center for Brain Science; NIH [1-R01-EB012498-01, 1-DP2-OD007428]; Harvard/Massachusetts Institute of Technology Joint Research Grants Program in Basic Neuroscience; Sloan Foundation fellowship; Dreyfus Teacher Scholar award; Rehabilitation Research Service and Biomedical Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007428] Funding Source: NIH RePORTER	PECASE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Center for Brain Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard/Massachusetts Institute of Technology Joint Research Grants Program in Basic Neuroscience; Sloan Foundation fellowship(Alfred P. Sloan Foundation); Dreyfus Teacher Scholar award; Rehabilitation Research Service and Biomedical Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by PECASE award N00014-11-1-0549, the Harvard Center for Brain Science, NIH grants 1-R01-EB012498-01 and New Innovator grant 1-DP2-OD007428, the Harvard/Massachusetts Institute of Technology Joint Research Grants Program in Basic Neuroscience, a Sloan Foundation fellowship, a Dreyfus Teacher Scholar award, and by grants from the Rehabilitation Research Service and Biomedical Research Service, Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; BUTTERWECK A, 1994, J MEMBRANE BIOL, V141, P247; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; Del Re AM, 2005, DRUG ALCOHOL DEPEN, V78, P221, DOI 10.1016/j.drugalcdep.2004.10.005; GRINVALD A, 1982, BIOPHYS J, V39, P301, DOI 10.1016/S0006-3495(82)84520-7; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kirkton RD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1302; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Maclaurin D, 2013, P NATL ACAD SCI USA, V110, P5939, DOI 10.1073/pnas.1215595110; Marshall JD, 2013, ACS NANO, V7, P4601, DOI 10.1021/nn401410k; MERON E, 1992, PHYS REP, V218, P1, DOI 10.1016/0370-1573(92)90098-K; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Opitz T, 2002, J NEUROPHYSIOL, V88, P2196, DOI 10.1152/jn.00316.2002; Park K, 2012, ACS NANO, V6, P10013, DOI 10.1021/nn303719m; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Pucihar G, 2009, J VIS EXP, V33, pe1659; Samad OA, 2013, MOL THER, V21, P49, DOI 10.1038/mt.2012.169; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Shah BS, 2004, J NEUROSCI, V24, P7387, DOI 10.1523/JNEUROSCI.0322-04.2004; Zhang J, 1998, BIOPHYS J, V74, P48, DOI 10.1016/S0006-3495(98)77765-3	25	39	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85221	10.1371/journal.pone.0085221	http://dx.doi.org/10.1371/journal.pone.0085221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391999	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900142
J	Shi, JY; Yiu, SM; Zhang, YN; Chin, FYL				Shi, Jian-Yu; Yiu, Siu-Ming; Zhang, Yan-Ning; Chin, Francis Yuk-Lun			Effective Moment Feature Vectors for Protein Domain Structures	PLOS ONE			English	Article							SCOP-FOLD CLASSIFICATION; STRUCTURE SPACE; MEAN SHIFT; REPRESENTATION; SUPERFAMILIES; CONSERVATION; RETRIEVAL; DATABASE; HISTORY; GENE	Imaging processing techniques have been shown to be useful in studying protein domain structures. The idea is to represent the pairwise distances of any two residues of the structure in a 2D distance matrix (DM). Features and/or submatrices are extracted from this DM to represent a domain. Existing approaches, however, may involve a large number of features (100-400) or complicated mathematical operations. Finding fewer but more effective features is always desirable. In this paper, based on some key observations on DMs, we are able to decompose a DM image into four basic binary images, each representing the structural characteristics of a fundamental secondary structure element (SSE) or a motif in the domain. Using the concept of moments in image processing, we further derive 45 structural features based on the four binary images. Together with 4 features extracted from the basic images, we represent the structure of a domain using 49 features. We show that our feature vectors can represent domain structures effectively in terms of the following. (1) We show a higher accuracy for domain classification. (2) We show a clear and consistent distribution of domains using our proposed structural vector space. (3) We are able to cluster the domains according to our moment features and demonstrate a relationship between structural variation and functional diversity.	[Shi, Jian-Yu] Northwestern Polytech Univ, Sch Life Sci, Xian, Shaanxi Provinc, Peoples R China; [Shi, Jian-Yu; Yiu, Siu-Ming; Chin, Francis Yuk-Lun] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Yan-Ning] Northwestern Polytech Univ, Sch Comp Sci, Xian, Shaanxi Provinc, Peoples R China	Northwestern Polytechnical University; University of Hong Kong; Northwestern Polytechnical University	Chin, FYL (corresponding author), Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China.	chin@cs.hku.hk	Shi, Jian-Yu/S-4485-2019; Yiu, Siu Ming/C-1843-2009	Shi, Jian-Yu/0000-0002-2303-273X; Yiu, Siu Ming/0000-0002-3975-8500	Hong Kong Scholars Program [XJ2011028]; University of Hong Kong [201209176053]; Fundamental Research Foundation of Northwestern Polytechnical University in China [JC201164]	Hong Kong Scholars Program; University of Hong Kong(University of Hong Kong); Fundamental Research Foundation of Northwestern Polytechnical University in China	This work was supported by Hong Kong Scholars Program (No. XJ2011028, http://www.hkscholars.org/) and Small Project Funding of the University of Hong Kong(No. 201209176053, http://www2.caes.hku.hk/research/research-funding/), and partially supported by Fundamental Research Foundation of Northwestern Polytechnical University in China (No. JC201164, http://www.nwpu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aung Z, 2007, DRUG DISCOV TODAY, V12, P732, DOI 10.1016/j.drudis.2007.07.014; Bartenhagen C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-567; Bashton M, 2007, STRUCTURE, V15, P85, DOI 10.1016/j.str.2006.11.009; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; Budowski-Tal I, 2010, P NATL ACAD SCI USA, V107, P3481, DOI 10.1073/pnas.0914097107; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790, DOI 10.1109/34.400568; Chi PH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-362; Chi PH, 2009, BIOINFORMATICS, V25, P2559, DOI 10.1093/bioinformatics/btp474; Choi IG, 2004, P NATL ACAD SCI USA, V101, P3797, DOI 10.1073/pnas.0308656100; Choi IG, 2006, P NATL ACAD SCI USA, V103, P14056, DOI 10.1073/pnas.0606239103; Chothia C, 2009, BIOCHEM J, V419, P15, DOI 10.1042/BJ20090122; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Dessailly BH, 2010, STRUCTURE, V18, P1522, DOI 10.1016/j.str.2010.08.017; Dessailly BH, 2009, CURR OPIN STRUC BIOL, V19, P349, DOI 10.1016/j.sbi.2009.03.009; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hou JT, 2005, P NATL ACAD SCI USA, V102, P3651, DOI 10.1073/pnas.0409772102; Hou JT, 2003, P NATL ACAD SCI USA, V100, P2386, DOI 10.1073/pnas.2628030100; Kaufman L, 1990, FINDING GROUPS DATA, P68163; Minary P, 2008, J MOL BIOL, V375, P920, DOI 10.1016/j.jmb.2007.10.087; Morais DADL, 2011, NUCLEIC ACIDS RES, V39, pD427, DOI 10.1093/nar/gkq1130; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Osadchy M, 2011, P NATL ACAD SCI USA, V108, P12301, DOI 10.1073/pnas.1102727108; Penner RC, 2010, COMMUN PUR APPL MATH, V63, P1249, DOI 10.1002/cpa.20340; Penner RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019670; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; PORAT M, 1988, IEEE T PATTERN ANAL, V10, P452, DOI 10.1109/34.3910; Reeves GA, 2006, J MOL BIOL, V360, P725, DOI 10.1016/j.jmb.2006.05.035; Rogen P, 2003, MATH BIOSCI, V182, P167, DOI 10.1016/S0025-5564(02)00216-X; Rogen P, 2003, P NATL ACAD SCI USA, V100, P119, DOI 10.1073/pnas.2636460100; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Shi JY, 2009, LECT N BIOINFORMAT, V5780, P344; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Swalla BM, 2003, NUCLEIC ACIDS RES, V31, P805, DOI 10.1093/nar/gkg142; TEH CH, 1988, IEEE T PATTERN ANAL, V10, P496, DOI 10.1109/34.3913; Valas RE, 2009, CURR OPIN STRUC BIOL, V19, P329, DOI 10.1016/j.sbi.2009.03.011; WALKER JE, 1990, PHILOS T ROY SOC B, V326, P367, DOI 10.1098/rstb.1990.0018; Yang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008378	42	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83788	10.1371/journal.pone.0083788	http://dx.doi.org/10.1371/journal.pone.0083788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391828	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200126
J	Stadelmann, D; Torgler, B				Stadelmann, David; Torgler, Benno			Bounded Rationality and Voting Decisions over 160 Years: Voter Behavior and Increasing Complexity in Decision-Making	PLOS ONE			English	Article							RULES	Using a quasi-natural voting experiment encompassing a 160-year period (1848-2009) in Switzerland, we investigate whether a higher level of complexity leads to increased reliance on trusted parliamentary representatives. We find that when more referenda are held on the same day, constituents are more likely to refer to parliamentary recommendations when making their decisions. This finding holds true even when we narrow our focus to referenda with a relatively lower voter turnout on days on which more than one referendum is held. We also demonstrate that when constituents face a higher level of complexity, they follow the parliamentary recommendations rather than those of interest groups. "Viewed as a geometric figure, the ant's path is irregular, complex, hard to describe. But its complexity is really a complexity in the surface of the beach, not a complexity in the ant." ([1] p. 51)	[Stadelmann, David] Univ Bayreuth, Fac Law Business & Econ, Bayreuth, Germany; [Stadelmann, David; Torgler, Benno] CREMA, Basel, Switzerland; [Torgler, Benno] Queensland Univ Technol, Sch Econ & Finance, Brisbane, Qld 4001, Australia; [Torgler, Benno] EBS Univ Wirtschaft & Recht, Oestrich Winkel, Germany	University of Bayreuth; Queensland University of Technology (QUT); European Business School (EBS) University	Stadelmann, D (corresponding author), Univ Bayreuth, Fac Law Business & Econ, Bayreuth, Germany.	david.stadelmann@uni-bayreuth.de	Stadelmann, David/I-1116-2019; Torgler, Benno/W-4556-2019; Torgler, Benno/J-1140-2012	Stadelmann, David/0000-0002-1211-9936; Torgler, Benno/0000-0002-9809-963X; Torgler, Benno/0000-0002-9809-963X	German Research Foundation (DFG); University of Bayreuth; Australian Research Council [FT110100463]	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth; Australian Research Council(Australian Research Council)	This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing. The authors acknowledge financial support from the Australian Research Council (FT110100463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; BAUMOL WJ, 1964, AM ECON REV, V54, P23; Benz M, 2004, PUBLIC CHOICE, V119, P31, DOI 10.1023/B:PUCH.0000024161.44798.ef; BOHNET I, 1994, KYKLOS, V47, P341, DOI 10.1111/j.1467-6435.1994.tb02742.x; Clark JM, 1918, J POLIT ECON, V26, P1, DOI 10.1086/253060; Downs A., 1957, EC THEORY DEMOCRACY; Eichenberger R, 1996, PUBLIC CHOICE, V86, P137, DOI 10.1007/BF00114879; Feld LP., 2000, EUR J POLIT ECON, V16, P287, DOI [DOI 10.1016/S0176-2680(00)00003-3, 10.1016/S0176-2680(00)00003-3]; FREY BS, 1994, AM ECON REV, V84, P338; Gronlund K., 2007, COMP EUR POLIT, V5, P400, DOI [DOI 10.1057/PALGRAVE.CEP.6110113, 10.1057/palgrave.cep.6110113]; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; SCHNEIDER F, 1982, PUBLIC CHOICE, V38, P281, DOI 10.1007/BF00144854; Schneider F., 1981, CONT POLITICAL EC ST; Shachar R, 1999, AM ECON REV, V89, P525, DOI 10.1257/aer.89.3.525; Simon H. A., 1957, MODELS MAN; Simon H. A., 1996, SCI ARTIFICIAL, V3rd; Simon H. A., 1983, REASON HUMAN AFFAIRS; SIMON HA, 1978, AM ECON REV, V68, P1; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; SIMON HA, 1986, J BUS, V59, pS209, DOI 10.1086/296363; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Stadelmann D, 2013, J COMP ECON, V41, P170, DOI 10.1016/j.jce.2012.05.005	23	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84078	10.1371/journal.pone.0084078	http://dx.doi.org/10.1371/journal.pone.0084078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391888	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900031
J	Vardakis, JC; Tully, BJ; Ventikos, Y				Vardakis, John C.; Tully, Brett J.; Ventikos, Yiannis			Exploring the Efficacy of Endoscopic Ventriculostomy for Hydrocephalus Treatment via a Multicompartmental Poroelastic Model of CSF Transport: A Computational Perspective	PLOS ONE			English	Article							CEREBROSPINAL-FLUID FLOW; 3RD VENTRICULOSTOMY; MICROSURGICAL ANATOMY; CHOROIDAL ARTERIES; BRAIN; DYNAMICS; PRESSURE; PHYSIOLOGY; SHUNT	This study proposes the implementation of a Multiple-Network Poroelastic Theory (MPET) model coupled with finite-volume computational fluid dynamics for the purpose of studying, in detail, the effects of obstructing CSF transport within an anatomically accurate cerebral environment. The MPET representation allows the investigation of fluid transport between CSF, brain parenchyma and cerebral blood, in an integral and comprehensive manner. A key novelty in the model is the amalgamation of anatomically accurate choroid plexuses with their feeding arteries and a simple relationship relaxing the constraint of a unique permeability for the CSF compartment. This was done in order to account for the Aquaporin-4mediated swelling characteristics. The aim of this varying permeability compartment was to bring to light a feedback mechanism that could counteract the effects of ventricular dilation and subsequent elevations of CSF pressure through the efflux of excess CSF into the blood system. This model is used to demonstrate the impact of aqueductal stenosis and fourth ventricle outlet obstruction (FVOO). The implications of treating such a clinical condition with the aid of endoscopic third (ETV) and endoscopic fourth (EFV) ventriculostomy are considered. We observed peak CSF velocities in the aqueduct of the order of 15.6 cm/s in the healthy case, 45.4 cm/s and 72.8 cm/s for the mild and severe cases respectively. The application of ETV reduced the aqueductal velocity to levels around 16-17 cm/s. Ventricular displacement, CSF pressure, wall shear stress (WSS) and pressure difference between lateral and fourth ventricles (DP) increased with applied stenosis, and subsequently dropped to nominal levels with the application of ETV. The greatest reversal of the effects of atresia come by opting for ETV rather than the more complicated procedure of EFV.	[Vardakis, John C.] Univ Oxford, Inst Biomed Engn, Oxford, England; [Vardakis, John C.] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Tully, Brett J.] Univ Oxford, Dept Engn Sci, Oxyntix Ltd, Oxford OX1 3PJ, England; [Ventikos, Yiannis] UCL, Dept Mech Engn, London, England	University of Oxford; University of Oxford; University of Oxford; University of London; University College London	Ventikos, Y (corresponding author), UCL, Dept Mech Engn, London, England.	y.ventikos@ucl.ac.uk	Vardakis, John/AAF-3070-2019; Vardakis, John/N-4625-2013	Vardakis, John/0000-0003-2391-5257; Vardakis, John/0000-0003-2391-5257; Tully, Brett/0000-0001-6892-2771; Ventikos, Yiannis/0000-0002-8589-8117	Digital Economy Programme; Research Councils UK cross-Council initiative led by the Engineering and Physical Sciences Research Council (EPSRC); Cooperation specific programme of the Seventh Framework Programme of the European Union for research, technological development and demonstration activities; EPSRC [EP/F033710/1]; Engineering and Physical Sciences Research Council [EP/F033710/1] Funding Source: researchfish	Digital Economy Programme; Research Councils UK cross-Council initiative led by the Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cooperation specific programme of the Seventh Framework Programme of the European Union for research, technological development and demonstration activities; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is financially supported by the Digital Economy Programme; a Research Councils UK cross-Council initiative led by the Engineering and Physical Sciences Research Council (EPSRC) and contributed to by AHRC, ESRC, and MRC. VPH-DARE@ IT, a collaborative Research Project funded under the Cooperation specific programme of the Seventh Framework Programme of the European Union for research, technological development and demonstration activities, is also kindly acknowledged. The EPSRC is further acknowledged for providing the resources necessary for the High Performance Computing simulations conducted in this study, through grant EP/F033710/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Bammer R, 2007, MAGN RESON MED, V57, P127, DOI 10.1002/mrm.21109; Barbara B, 2010, CURR NEUROPHARMACOL, V8, P97, DOI 10.2174/157015910791233204; BECKETT RS, 1950, AM J PATHOL, V26, P755; Belonogov A, 2005, TOR CAN INT S SOC CO; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Bradbury M, 1993, HYDROCEPHALUS SERIES; Buonocore MH, 1998, MAGN RESON MED, V40, P210, DOI 10.1002/mrm.1910400207; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Cheng SK, 2010, J BIOMECH, V43, P579, DOI 10.1016/j.jbiomech.2009.10.002; Drake JM, 2009, CHILD NERV SYST, V25, P467, DOI 10.1007/s00381-008-0761-y; Dutta-Roy T, 2008, J BIOMECH, V41, P2263, DOI 10.1016/j.jbiomech.2008.04.014; Edsbagge M, 2004, AM J PHYSIOL-REG I, V287, pR1450, DOI 10.1152/ajpregu.00215.2004; Fay J., 1994, INTRO FLUID MECH; Ferrer A, 2012, WORLD NEUROSURGERY; FUJII K, 1980, J NEUROSURG, V52, P165, DOI 10.3171/jns.1980.52.2.0165; FUJII K, 1980, J NEUROSURG, V52, P504, DOI 10.3171/jns.1980.52.4.0504; Giannetti AV, 2011, J NEUROSURG-PEDIATR, V7, P152, DOI 10.3171/2010.11.PEDS1080; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Gupta S, 2009, BIOMECHANICAL ENG, V131; Hatem SM, 2010, BRAIN, V133, P3409, DOI 10.1093/brain/awq244; Hellwig D, 2005, NEUROSURG REV, V28, P1, DOI 10.1007/s10143-004-036-2; Howden L, 2008, COMPUT METHOD BIOMEC, V11, P123, DOI 10.1080/10255840701492118; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Irani DN., 2009, CEREBROSPINAL FLUID; Jacobson EE, 1999, MED BIOL ENG COMPUT, V37, P59, DOI 10.1007/BF02513267; Jacobson EE, 1996, PEDIATR NEUROSURG, V24, P229, DOI 10.1159/000121044; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kaczmarek M, 1997, B MATH BIOL, V59, P295; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Kulkarni AV, 2010, NEUROSURGERY, V67, P588, DOI 10.1227/01.NEU.0000373199.79462.21; Kurtcuoglu V, 2005, J BIOMECH ENG-T ASME, V127, P264, DOI 10.1115/1.1865191; Levine DN, 2008, J NEUROL SCI, V269, P1, DOI 10.1016/j.jns.2007.12.022; Levine DN, 1999, B MATH BIOL, V61, P875, DOI 10.1006/bulm.1999.0116; Levine DN, 2000, J NEUROL SCI, V177, P85, DOI 10.1016/S0022-510X(00)00348-8; Linninger AA, 2007, IEEE T BIO-MED ENG, V54, P291, DOI 10.1109/TBME.2006.886853; Mallucci C, 2009, CEREBROSPINAL FLUID; Marinkovic S, 2005, NEUROSURGERY, V57, P22, DOI 10.1227/01.NEU.0000163479.41621.39; Martin, 2012, SURGERY, V30, P142, DOI 10.1016/j.mpsur.2011.12.010; Mohanty A, 2008, NEUROSURGERY, V63, P905, DOI 10.1227/01.NEU.0000333262.38548.E1; Mugamba J, 2012, WORLD NEUROSURGERY; Owler B, 2010, CEREBROSPINAL FLUID, V7, P1; Patwardhan RV, 2005, NEUROSURGERY, V56, P139, DOI 10.1227/01.NEU.0000146206.40375.41; Penn RD, 2009, PEDIATR NEUROSURG, V45, P161, DOI 10.1159/000218198; POLLAY M, 1967, AM J PHYSIOL, V213, P1031, DOI 10.1152/ajplegacy.1967.213.4.1031; Pollay M, 2010, CEREBROSPINAL FLUID, V7, P1; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, P59; Redzic ZB, 2004, ADV DRUG DELIVER REV, V56, P1695, DOI 10.1016/j.addr.2004.07.005; Redzic ZB, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-10; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sakka L, 2011, EUR ANN OTORHINOLARY, V128, P309, DOI 10.1016/j.anorl.2011.03.002; Shen XQ, 2006, J NEUROSURG, V105, P459, DOI 10.3171/ped.2006.105.6.459; Sivaloganathan S, 2005, INT J NONLIN MECH, V40, P1149, DOI 10.1016/j.ijnonlinmec.2005.04.004; Skjolding AD, 2010, CEREBROSPINAL FLUID, V5, P7; Smillie A, 2005, J FLUID MECH, V539, P417, DOI 10.1017/S0022112005005707; Sobey I, 2006, MATH MED BIOL, V23, P339, DOI 10.1093/imammb/dql015; Spennato P, 2013, WORLD NEUROSURGERY; Stadlbauer A, 2012, EUR RADIOL, V22, P232, DOI 10.1007/s00330-011-2247-7; Stadlbauer A, 2010, NEUROIMAGE, V51, P42, DOI 10.1016/j.neuroimage.2010.01.110; Stagno V, 2012, WORLD NEUROSURGERY; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Sweetman B, 2011, COMPUT BIOL MED, V41, P67, DOI 10.1016/j.compbiomed.2010.12.001; Symss NP, 2013, J NEUROSURG-PEDIATR, V11, P170, DOI 10.3171/2012.3.PEDS0934; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Thompson DN, 2009, CLASSIFICATION HYDRO, V27, P130, DOI 10.1016/j.mpsur.2009.02.005; Tully B, 2011, J FLUID MECH, V667, P188, DOI 10.1017/S0022112010004428; Tully B, 2009, IEEE T BIO-MED ENG, V56, P1644, DOI 10.1109/TBME.2009.2016427; Vardakis JC, 2013, COMPUTER MODELS BIOM, P305; Vogel TW, 2013, J NEUROSURG PEDIAT, P1; Wang ZJ, 2002, INT J NUMER METH FL, V39, P703, DOI 10.1002/fld.344; Wetzel S, 2007, AM J NEURORADIOL, V28, P433; Wilson R, 2009, CEREBROSPINAL FLUID, P99; Wirth B, 2006, MATH MED BIOL, V23, P1, DOI DOI 10.1093/IMAMMB/DQL014); Woodworth GF, 2012, WORLD NEUROSURG, V78, P312, DOI 10.1016/j.wneu.2011.09.018; Zelenina M, 2010, NEUROCHEM INT, V57, P468, DOI 10.1016/j.neuint.2010.03.022; Zhang Y, 2012, NEUROSURGERY	78	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84577	10.1371/journal.pone.0084577	http://dx.doi.org/10.1371/journal.pone.0084577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391968	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900111
J	Ferreira, NC; Marques, IA; Conceicao, WA; Macedo, B; Machado, CS; Mascarello, A; Chiaradia-Delatorre, LD; Yunes, RA; Nunes, RJ; Hughson, AG; Raymond, LD; Pascutti, PG; Caughey, B; Cordeiro, Y				Ferreira, Natalia C.; Marques, Icaro A.; Conceicao, Wesley A.; Macedo, Bruno; Machado, Clarice S.; Mascarello, Alessandra; Chiaradia-Delatorre, Louise Domeneghini; Yunes, Rosendo Augusto; Nunes, Ricardo Jose; Hughson, Andrew G.; Raymond, Lynne D.; Pascutti, Pedro G.; Caughey, Byron; Cordeiro, Yraima			Anti-Prion Activity of a Panel of Aromatic Chemical Compounds: In Vitro and In Silico Approaches	PLOS ONE			English	Article							QUINOLINE DERIVATIVES; ANTIPRION ACTIVITY; PROTEIN; INHIBITORS; CHALCONES; AGGREGATION; QUINACRINE; MECHANISM; DISEASES; ASSAYS	The prion protein (PrP) is implicated in the Transmissible Spongiform Encephalopathies (TSEs), which comprise a group of fatal neurodegenerative diseases affecting humans and other mammals. Conversion of cellular PrP (PrPC) into the scrapie form (PrPSc) is the hallmark of TSEs. Once formed, PrPSc aggregates and catalyzes PrPC misfolding into new PrPSc molecules. Although many compounds have been shown to inhibit the conversion process, so far there is no effective therapy for TSEs. Besides, most of the previously evaluated compounds failed in vivo due to poor pharmacokinetic profiles. In this work we propose a combined in vitro/in silico approach to screen for active anti-prion compounds presenting acceptable drugability and pharmacokinetic parameters. A diverse panel of aromatic compounds was screened in neuroblastoma cells persistently infected with PrPSc (ScN2a) for their ability to inhibit PK-resistant PrP (PrPRes) accumulation. From,200 compounds, 47 were effective in decreasing the accumulation of PrPRes in ScN2a cells. Pharmacokinetic and physicochemical properties were predicted in silico, allowing us to obtain estimates of relative blood brain barrier permeation and mutagenicity. MTT reduction assays showed that most of the active compounds were non cytotoxic. Compounds that cleared PrPRes from ScN2a cells, were non-toxic in the MTT assay, and presented a good pharmacokinetic profile were investigated for their ability to inhibit aggregation of an amyloidogenic PrP peptide fragment (PrP109-149). Molecular docking results provided structural models and binding affinities for the interaction between PrP and the most promising compounds. In summary, using this combined in vitro/in silico approach we have identified new small organic anti-scrapie compounds that decrease the accumulation of PrPRes in ScN2a cells, inhibit the aggregation of a PrP peptide, and possess pharmacokinetic characteristics that support their drugability. These compounds are attractive candidates for prion disease therapy.	[Ferreira, Natalia C.; Marques, Icaro A.; Conceicao, Wesley A.; Macedo, Bruno; Machado, Clarice S.; Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil; [Conceicao, Wesley A.; Pascutti, Pedro G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Mascarello, Alessandra; Chiaradia-Delatorre, Louise Domeneghini; Yunes, Rosendo Augusto; Nunes, Ricardo Jose] Univ Fed Santa Catarina, Dept Quim, Florianopolis, SC, Brazil; [Hughson, Andrew G.; Raymond, Lynne D.; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Santa Catarina (UFSC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cordeiro, Y (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil.	yraima@pharma.ufrj.br	Ferreira, Natália/S-2158-2017; Pascutti, Pedro/AAP-7752-2020; Cordeiro, Yraima/J-7619-2012	Ferreira, Natália/0000-0002-5381-6666; Cordeiro, Yraima/0000-0003-4278-212X; Pascutti, Pedro/0000-0002-5454-560X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) from Brazil; Intramural Research Program of the NIAID, NIH, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001087] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) from Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Intramural Research Program of the NIAID, NIH, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), from the Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) from Brazil, and by the Intramural Research Program of the NIAID, NIH, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Borchhardt DM, 2010, J BRAZIL CHEM SOC, V21, P142, DOI 10.1590/S0103-50532010000100021; Cashman NR, 2004, NAT REV DRUG DISCOV, V3, P874, DOI 10.1038/nrd1525; Caughey B, 2006, ACCOUNTS CHEM RES, V39, P646, DOI 10.1021/ar050068p; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Chiaradia LD, 2008, BIOORG MED CHEM LETT, V18, P6227, DOI 10.1016/j.bmcl.2008.09.105; Chiaradia LD, 2012, J MED CHEM, V55, P390, DOI 10.1021/jm2012062; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Collinge J, 2009, LANCET NEUROL, V8, P334, DOI 10.1016/S1474-4422(09)70049-3; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; Cordeiro Y, 2004, J BIOL CHEM, V279, P5346, DOI 10.1074/jbc.M312262200; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2009, J COMPUT CHEM, V30, P2021, DOI 10.1002/jcc.21202; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hosokawa-Muto J, 2009, ANTIMICROB AGENTS CH, V53, P765, DOI 10.1128/AAC.01112-08; Huang ZW, 1996, FOLD DES, V1, P13, DOI 10.1016/S1359-0278(96)00007-7; Kamatari YO, 2013, PROTEIN SCI, V22, P22, DOI 10.1002/pro.2180; Klingenstein R, 2006, J MED CHEM, V49, P5300, DOI 10.1021/jm0602763; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Kocisko DA, 2006, J VIROL, V80, P1044, DOI 10.1128/JVI.80.2.1044-1046.2006; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Kocisko DA, 2007, ANAL BIOCHEM, V363, P154, DOI 10.1016/j.ab.2006.11.007; Kocisko DA, 2006, METHOD ENZYMOL, V412, P223, DOI 10.1016/S0076-6879(06)12014-5; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Macedo B, 2012, BIOCHEMISTRY-US, V51, P5402, DOI 10.1021/bi300440e; Macedo B, 2010, EUR J MED CHEM, V45, P5468, DOI 10.1016/j.ejmech.2010.07.054; Marzo L, 2013, J CELL SCI, V126, P1345, DOI 10.1242/jcs.114801; Mays CE, 2012, BIOMATERIALS, V33, P6808, DOI 10.1016/j.biomaterials.2012.06.004; Mielcke TR, 2012, EUR J MED CHEM, V48, P255, DOI 10.1016/j.ejmech.2011.12.023; Murakami-Kubo I, 2004, J VIROL, V78, P1281, DOI 10.1128/JVI.78.3.1281-1288.2004; Nunes RJ, 2012, Brazilian patent, Patent No. [PCT/BR2012/000480, 2012000480]; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Osorio TM, 2012, BIOORG MED CHEM LETT, V22, P225, DOI 10.1016/j.bmcl.2011.11.059; Poncet-Montange G, 2011, J BIOL CHEM, V286, P27718, DOI 10.1074/jbc.M111.234393; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Silva JL, 2010, FRONT BIOSCI-LANDMRK, V15, P132, DOI 10.2741/3611; Sim Valerie L., 2012, Infectious Disorders - Drug Targets, V12, P144; STICH I, 1989, PHYS REV B, V39, P4997, DOI 10.1103/PhysRevB.39.4997; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Votano JR, 2004, MOL DIVERS, V8, P379, DOI 10.1023/B:MODI.0000047512.82293.75; Wadsworth JD, 2003, BRIT MED BULL, V66, P241, DOI 10.1093/bmb/66.1.241; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575	54	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84531	10.1371/journal.pone.0084531	http://dx.doi.org/10.1371/journal.pone.0084531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400098	gold, Green Submitted, Green Published			2022-12-27	WOS:000329462700032
J	Ciappio, ED; Krausz, KW; Rochman, M; Furusawa, T; Bonzo, JA; Tessarollo, L; Gonzalez, FJ; Bustin, M				Ciappio, Eric D.; Krausz, Kristopher W.; Rochman, Mark; Furusawa, Takashi; Bonzo, Jessica A.; Tessarollo, Lino; Gonzalez, Frank J.; Bustin, Michael			Metabolomics Reveals a Role for the Chromatin-Binding Protein HMGN5 in Glutathione Metabolism	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; HISTONE H1; FAMILY; METLIN	High mobility group nucleosome-binding protein 5 (HMGN5) is a chromatin architectural protein that binds specifically to nucleosomes and reduces the compaction of the chromatin fiber. The protein is present in most vertebrate tissues however the physiological function of this protein is unknown. To examine the function of HMGN5 in vivo, mice lacking the nucleosome-binding domain of HMGN5 were generated and characterized. Serological analysis revealed that compared to wild-type littermates (Hmgn5(+/Y)), mice with a targeted mutation in the HMGN5 gene (Hmgn5(tm1/Y)), had elevated serum albumin, non-HDL cholesterol, triglycerides, and alanine transaminase, suggesting mild hepatic abnormalities. Metabolomics analysis of liver extracts and urine revealed clear differences in metabolites between Hmgn5(tm1/Y) and their Hmgn5(+/Y) littermates. Hmgn5(tm1/Y) mice had a significant increase in hepatic glutathione levels and decreased urinary concentrations of betaine, phenylacetylglycine, and creatine, all of which are metabolically related to the glutathione precursor glycine. Microarray and qPCR analysis revealed that expression of two genes affecting glutathione metabolism, glutathione peroxidase 6 (Gpx6) and hexokinase 1 (Hk1), was significantly decreased in Hmgn5(tm1/Y) mouse liver tissue. Analysis of chromatin structure by DNase I digestion revealed alterations in the chromatin structure of these genes in the livers of Hmgn5(tm1/Y) mice. Thus, functional loss of HMGN5 leads to changes in transcription of Gpx6 and Hk1 that alter glutathione metabolism.	[Ciappio, Eric D.; Krausz, Kristopher W.; Rochman, Mark; Furusawa, Takashi; Bonzo, Jessica A.; Gonzalez, Frank J.; Bustin, Michael] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Tessarollo, Lino] NCI, Neural Dev Sect, Mouse Canc Genet Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bustin, M (corresponding author), NCI, Lab Metab, NIH, Bethesda, MD 20892 USA.	bustin@helix.nih.gov	Bustin, Michael/G-6155-2015	Rochman, Mark/0000-0002-0818-927X; Bustin, Michael/0000-0002-5147-7242	Center for Cancer Research, intramural program of the National Cancer Institute, National Institutes of Health; United States-Israeli Binational foundation [2009326]; NATIONAL CANCER INSTITUTE [ZIABC011154, ZIABC004496] Funding Source: NIH RePORTER	Center for Cancer Research, intramural program of the National Cancer Institute, National Institutes of Health; United States-Israeli Binational foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This was funded by the Center for Cancer Research, intramural program of the National Cancer Institute, National Institutes of Health, and by grant #2009326 from the United States-Israeli Binational foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhatzira L, 2011, J BIOL CHEM, V286, P42051, DOI 10.1074/jbc.M111.300541; Bi HC, 2013, ANAL BIOANAL CHEM, V405, P5279, DOI 10.1007/s00216-013-6927-9; Birger Y, 2005, CANCER RES, V65, P6711, DOI 10.1158/0008-5472.CAN-05-0310; Bonin A, 2000, METH MOL B, V158, P121; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Deng T, 2013, MOL CELL BIOL; Huang Z.Z., 2000, FASEB J; Huang ZZ, 2000, BBA-GENE STRUCT EXPR, V1493, P48, DOI 10.1016/S0167-4781(00)00156-1; Kugler JE, 2013, J BIOL CHEM, V288, P16690, DOI 10.1074/jbc.M113.463315; Kugler JE, 2012, BBA-GENE REGUL MECH, V1819, P652, DOI 10.1016/j.bbagrm.2012.01.013; Liu HL, 2004, ANN NY ACAD SCI, V1019, P346, DOI 10.1196/annals.1297.059; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; LU SC, 1992, J CLIN INVEST, V90, P524, DOI 10.1172/JCI115890; Pallardo FV, 2009, MOL ASPECTS MED, V30, P77, DOI 10.1016/j.mam.2009.01.001; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Rochman M, 2011, NUCLEIC ACIDS RES, V39, P4076, DOI 10.1093/nar/gkq1343; Rochman M, 2010, BBA-GENE REGUL MECH, V1799, P86, DOI 10.1016/j.bbagrm.2009.09.012; Rochman M, 2009, MOL CELL, V35, P642, DOI 10.1016/j.molcel.2009.07.002; Shirakawa H, 2000, J BIOL CHEM, V275, P6368, DOI 10.1074/jbc.275.9.6368; Slyshenkov VS, 2004, FEBS LETT, V569, P169, DOI 10.1016/j.febslet.2004.05.044; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Tessarollo L, 2000, METH MOL B, V158, P47; Ueda T, 2009, MOL CELL BIOL, V29, P5264, DOI 10.1128/MCB.00526-09; West KL, 2003, METHOD ENZYMOL, V371, P521; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489	32	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84583	10.1371/journal.pone.0084583	http://dx.doi.org/10.1371/journal.pone.0084583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392144	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100067
J	Hamamoto, G; Suzuki, T; Suzuki, MG; Aoki, F				Hamamoto, Go; Suzuki, Tsukasa; Suzuki, Masataka G.; Aoki, Fugaku			Regulation of Transketolase Like 1 Gene Expression in the Murine One-Cell Stage Embryos	PLOS ONE			English	Article							PREIMPLANTATION MOUSE EMBRYO; RNA-POLYMERASE-II; DNA-REPLICATION; 1ST MITOSIS; ACTIVATION; TRANSCRIPTION; PROMOTER; SP1; IDENTIFICATION; REPRESSION	In mice, transcription from the zygotic genome starts at the mid-one-cell stage after fertilization. Previous studies showed that an enhancer is not required for transcription at this stage, and that the enhancer-dependent mechanism of transcription is established during the two-cell stage. However, these results were obtained using reporter gene assays with promoters derived from viruses, rather than from endogenous genes. We conducted a reporter-gene assay using the promoter of Tktl1, which is transcribed after fertilization, to investigate the mechanism regulating gene expression at the one-cell stage. When a plasmid containing the 2467 bp upstream and 25 bp downstream of the Tktl1 transcription start site (TSS) was microinjected into the nuclei of growing oocytes, and one-cell stage and early and late two-cell-stage embryos, transcriptional activity was detected in the one-cell- and two-cell-stage embryos, but not in the oocytes. It was highest at the early two-cell stage and was reduced at the late two-cell stage. The decrease in activity at the late two-cell stage was prevented by inhibiting the second round of DNA replication, suggesting that the transcriptionally repressive state is established during the two-cell stage by a mechanism coupled to DNA replication. When the Tktl1 promoter was deleted to leave 56 bp upstream of the TSS which includes GC and TATA boxes, transcriptional activity was still detected in one-cell-stage embryos, but not early or late two-cell-stage embryos. The core promoter of Tktl1 alone seems to be able to induce basal transcription at the one-cell stage. These results suggest that repressive chromatin is established after fertilization in two steps, which occur during the transition from the one-to two-cell stage and during DNA replication at the two-cell stage.	[Hamamoto, Go; Suzuki, Tsukasa; Suzuki, Masataka G.; Aoki, Fugaku] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	University of Tokyo	Aoki, F (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	aokif@k.u-tokyo.ac.jp	AOKI, FUGAKU/AAO-7617-2021		Ministry of Education, Culture, Sports, Science and Technology of Japan [20062002]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid (to F.A.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#20062002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Bevilacqua A, 2000, DEVELOPMENT, V127, P1541; Bevilacqua A, 1997, NUCLEIC ACIDS RES, V25, P1333, DOI 10.1093/nar/25.7.1333; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; BOUNIOL C, 1995, EXP CELL RES, V218, P57, DOI 10.1006/excr.1995.1130; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Cho T., 2002, Animal Science Journal, V73, P113, DOI 10.1046/j.1344-3941.2002.00017.x; CHRISTIANS E, 1995, DEVELOPMENT, V121, P113; CONOVER JC, 1991, DEV BIOL, V144, P392, DOI 10.1016/0012-1606(91)90431-2; Davis W, 1996, DEV BIOL, V174, P190, DOI 10.1006/dbio.1996.0065; Forlani S, 1998, DEVELOPMENT, V125, P3153; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; HENERY CC, 1995, DEV BIOL, V169, P448, DOI 10.1006/dbio.1995.1160; Kageyama S, 2007, ZYGOTE, V15, P117, DOI 10.1017/S096719940700411X; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Liu HL, 2005, CELL RES, V15, P127, DOI 10.1038/sj.cr.7290277; MAJUMDER S, 1993, EMBO J, V12, P1131, DOI 10.1002/j.1460-2075.1993.tb05754.x; MATSUMOTO K, 1994, MOL REPROD DEV, V39, P136, DOI 10.1002/mrd.1080390203; QUINN P, 1984, AUST J BIOL SCI, V37, P147, DOI 10.1071/BI9840147; RAM PT, 1993, DEV BIOL, V156, P552, DOI 10.1006/dbio.1993.1101; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; TURNER BM, 1991, J CELL SCI, V99, P13; Wang Y, 1996, NUCLEIC ACIDS RES, V24, P3100, DOI 10.1093/nar/24.15.3100; WIEKOWSKI M, 1991, DEV BIOL, V147, P403, DOI 10.1016/0012-1606(91)90298-H; WIEKOWSKI M, 1993, DEV BIOL, V159, P366, DOI 10.1006/dbio.1993.1248; WORRAD DM, 1995, DEVELOPMENT, V121, P2949; WORRAD DM, 1994, DEVELOPMENT, V120, P2347	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e82087	10.1371/journal.pone.0082087	http://dx.doi.org/10.1371/journal.pone.0082087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392079	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100003
J	Mattioli, MC; Boehm, AB; Davis, J; Harris, AR; Mrisho, M; Pickering, AJ				Mattioli, Mia Catharine; Boehm, Alexandria B.; Davis, Jennifer; Harris, Angela R.; Mrisho, Mwifadhi; Pickering, Amy J.			Enteric Pathogens in Stored Drinking Water and on Caregiver's Hands in Tanzanian Households with and without Reported Cases of Child Diarrhea	PLOS ONE			English	Article							ESCHERICHIA-COLI; DEVELOPING-COUNTRIES; MICROBIAL-CONTAMINATION; BACTERIAL INDICATORS; HUMAN ADENOVIRUSES; HYGIENE BEHAVIORS; FECAL INDICATORS; COASTAL WATERS; RISK; QUALITY	Background: Diarrhea is one of the leading causes of mortality in young children. Diarrheal pathogens are transmitted via the fecal-oral route, and for children the majority of this transmission is thought to occur within the home. However, very few studies have documented enteric pathogens within households of low-income countries. Methods and Findings: The presence of molecular markers for three enteric viruses (enterovirus, adenovirus, and rotavirus), seven Escherichia coli virulence genes (ECVG), and human-specific Bacteroidales was assessed in hand rinses and household stored drinking water in Bagamoyo, Tanzania. Using a matched case-control study design, we examined the relationship between contamination of hands and water with these markers and child diarrhea. We found that the presence of ECVG in household stored water was associated with a significant decrease in the odds of a child within the home having diarrhea (OR = 0.51; 95% confidence interval 0.27-0.93). We also evaluated water management and hygiene behaviors. Recent hand contact with water or food was positively associated with detection of enteric pathogen markers on hands, as was relatively lower volumes of water reportedly used for daily hand washing. Enteropathogen markers in stored drinking water were more likely found among households in which the markers were also detected on hands, as well as in households with unimproved water supply and sanitation infrastructure. Conclusions: The prevalence of enteric pathogen genes and the human-specific Bacteroidales fecal marker in stored water and on hands suggests extensive environmental contamination within homes both with and without reported child diarrhea. Better stored water quality among households with diarrhea indicates caregivers with sick children may be more likely to ensure safe drinking water in the home. Interventions to increase the quantity of water available for hand washing, and to improve food hygiene, may reduce exposure to enteric pathogens in the domestic environment.	[Mattioli, Mia Catharine; Boehm, Alexandria B.; Davis, Jennifer; Harris, Angela R.; Pickering, Amy J.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Davis, Jennifer; Pickering, Amy J.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Mrisho, Mwifadhi] Bagamoyo Res & Training Unit, Ifakara Hlth Inst, Bagamoyo, Tanzania	Stanford University; Stanford University; Ifakara Health Institute	Pickering, AJ (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.	amyjanel@stanford.edu	Richardson, Mary/M-9299-2016	Boehm, Alexandria/0000-0002-8162-5090; Harris, Angela/0000-0001-8639-8539	National Science Foundation [SES-0827384]; Stanford University Shah Research Fellowship; Divn Of Social and Economic Sciences [0827384] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Stanford University Shah Research Fellowship(Stanford University); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was supported by the National Science Foundation (SES-0827384) and by the Stanford University Shah Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ML, 2005, APPL ENVIRON MICROB, V71, P3041, DOI 10.1128/AEM.71.6.3041-3048.2005; Ashbolt NJ, 2004, TOXICOLOGY, V198, P229, DOI 10.1016/j.tox.2004.01.030; Baggi F, 2001, RES MICROBIOL, V152, P743, DOI 10.1016/S0923-2508(01)01255-4; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P4571, DOI 10.1128/AEM.66.10.4571-4574.2000; BLACK RE, 1981, B WORLD HEALTH ORGAN, V59, P263; Bonadonna L, 2002, ENVIRON MONIT ASSESS, V75, P241, DOI 10.1023/A:1014852201424; Brown JM, 2008, WATER SCI TECHNOL, V58, P757, DOI 10.2166/wst.2008.439; Brown J, 2013, TROP MED INT HEALTH, V18, P65, DOI 10.1111/tmi.12010; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; Byappanahalli MN, 2006, ENVIRON MICROBIOL, V8, P504, DOI 10.1111/j.1462-2920.2005.00916.x; CAIRNCROSS AM, 1990, J INST WATER ENV MAN, V4, P571; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Davis J, 2011, AM J TROP MED HYG, V84, P184, DOI 10.4269/ajtmh.2011.10-0126; DAY NE, 1980, AM J EPIDEMIOL, V112, P696, DOI 10.1093/oxfordjournals.aje.a113042; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Dufour AP, 1986, AMBIENT WATER QUALIT; Ferguson AS, 2012, SCI TOTAL ENVIRON, V431, P314, DOI 10.1016/j.scitotenv.2012.05.060; Ferguson AS, 2011, J WATER HEALTH, V9, P708, DOI 10.2166/wh.2011.106; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; FUJIOKA RS, 1988, TOXIC ASSESS, V3, P613, DOI 10.1002/tox.2540030514; Gasana J, 2002, ENVIRON RES, V90, P76, DOI 10.1006/enrs.2002.4394; Gascon J, 2000, J CLIN MICROBIOL, V38, P4459; Gundry S, 2004, J WATER HEALTH, V2, P1; HAAS CN, 1993, RISK ANAL, V13, P545, DOI 10.1111/j.1539-6924.1993.tb00013.x; Harwood VJ, 2005, APPL ENVIRON MICROB, V71, P3163, DOI 10.1128/AEM.71.6.3163-3170.2005; Horman A, 2004, APPL ENVIRON MICROB, V70, P87, DOI 10.1128/AEM.70.1.87-95.2004; Howard CM, 2010, AM J TROP MED HYG, V83, P1170, DOI 10.4269/ajtmh.2010.10-0384; Howard G., 2003, DOMESTIC WATER QUANT; Jensen PK, 2004, TROP MED INT HEALTH, V9, P1210, DOI 10.1111/j.1365-3156.2004.01329.x; Jensen PK, 2002, TROP MED INT HEALTH, V7, P604, DOI 10.1046/j.1365-3156.2002.00901.x; Jiang S, 2001, APPL ENVIRON MICROB, V67, P179, DOI 10.1128/AEM.67.1.179-184.2001; Jothikumar N, 2009, J VIROL METHODS, V155, P126, DOI 10.1016/j.jviromet.2008.09.025; Jothikumar N, 2005, APPL ENVIRON MICROB, V71, P3131, DOI 10.1128/AEM.71.6.3131-3136.2005; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Keating DTK, 2008, EXP LUNG RES, V34, P455, DOI 10.1080/01902140802093162; Khush RS, 2013, AM J TROP MED HYG, V89, P251, DOI 10.4269/ajtmh.13-0067; Kildare BJ, 2007, WATER RES, V41, P3701, DOI 10.1016/j.watres.2007.06.037; Kotloff KL, 2013, LANCET; Kremer M, 2011, Q J ECON, V126, P145, DOI 10.1093/qje/qjq010; Lemarchand K, 2003, FEMS MICROBIOL LETT, V218, P203, DOI 10.1111/j.1574-6968.2003.tb11519.x; Levine MM, 2012, CLIN INFECT DIS, V55, pS303, DOI 10.1093/cid/cis789; Levy K, 2008, ENVIRON HEALTH PERSP, V116, P1533, DOI 10.1289/ehp.11296; Levy K, 2012, AM J TROP MED HYG, V86, P499, DOI 10.4269/ajtmh.2012.11-0263; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luby SP, 2001, EPIDEMIOL INFECT, V127, P237, DOI 10.1017/S0950268801005829; Luby SP, 2007, TROP MED INT HEALTH, V12, P765, DOI 10.1111/j.1365-3156.2007.01847.x; Mattioli MC, 2013, ENVIRON SCI TECHNOL, V47, P355, DOI 10.1021/es303878d; MOE CL, 1991, B WORLD HEALTH ORGAN, V69, P305; Noble RT, 2001, HYDROBIOLOGIA, V460, P175, DOI 10.1023/A:1013121416891; Organization WH UNICeF, 2012, PROGR SAN DRINK WAT; Pickering AJ, 2012, ENV SCI TECHNOL; Pickering AJ, 2011, TROP MED INT HEALTH, V16, P233, DOI 10.1111/j.1365-3156.2010.02677.x; Pickering AJ, 2010, ENVIRON SCI TECHNOL, V44, P3267, DOI 10.1021/es903524m; PINFOLD JV, 1990, EPIDEMIOL INFECT, V105, P377, DOI 10.1017/S0950268800047968; Power ML, 2005, ENVIRON MICROBIOL, V7, P631, DOI 10.1111/j.1462-2920.2005.00729.x; Pruss-Ustun A., 2008, SAFER WATER BETTER H; Pusch D, 2005, ARCH VIROL, V150, P929, DOI 10.1007/s00705-004-0467-8; Ramani S, 2009, CURR OPIN INFECT DIS, V22, P477, DOI 10.1097/QCO.0b013e328330662f; Silva PA, 2008, J MED VIROL, V80, P1790, DOI 10.1002/jmv.21231; Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n; Thompson J., 2001, DRAWERS WATER, VII; Trevett Andrew Francis, 2005, Journal of Water and Health, V3, P259; USEPA, 2002, 1604 USEPA OFF WAT; USEPA, 2009, 1600 USEPA OFF WAT; Valentiner-Branth P, 2003, J CLIN MICROBIOL, V41, P4238, DOI 10.1128/JCM.41.9.4238-4245.2003; VANDERSLICE J, 1995, AM J EPIDEMIOL, V141, P135, DOI 10.1093/oxfordjournals.aje.a117401; VANDERSLICE J, 1993, WATER RESOUR RES, V29, P1983, DOI 10.1029/92WR02994; Viau EJ, 2011, WATER RES, V45, P3279, DOI 10.1016/j.watres.2011.03.033; Victoria M, 2009, J VIROL METHODS, V156, P73, DOI 10.1016/j.jviromet.2008.11.003; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walters SP, 2009, WATER RES, V43, P4929, DOI 10.1016/j.watres.2009.05.047; WHO UNICEF, 2012, PROGR DRINK WAT SAN; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Wu J, 2011, J WATER HEALTH, V9, P265, DOI 10.2166/wh.2011.117; Yamahara KM, 2009, APPL ENVIRON MICROB, V75, P1517, DOI 10.1128/AEM.02278-08	77	44	45	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84939	10.1371/journal.pone.0084939	http://dx.doi.org/10.1371/journal.pone.0084939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286ID	24392161	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100084
J	Cesbron, F; Brunner, M; Diernfellner, ACR				Cesbron, Francois; Brunner, Michael; Diernfellner, Axel C. R.			Light-Dependent and Circadian Transcription Dynamics In Vivo Recorded with a Destabilized Luciferase Reporter in Neurospora	PLOS ONE			English	Article							WHITE-COLLAR COMPLEX; FIREFLY LUCIFERASE; GENE-EXPRESSION; CLOCK GENE; PHOSPHORYLATION; FREQUENCY; FEEDBACK; RHYTHMS; PROTEIN; CRASSA	We show that firefly luciferase is a stable protein when expressed at 25 degrees C in Neurospora, which limits its use as transcription reporter. We created a short-lived luciferase by fusing a PEST signal to its C-terminus (LUC-PEST) and applied the LUC-PEST reporter system to record in vivo transcription dynamics associated with the Neurospora circadian clock and its blue-light photosensory system over the course of several days. We show that the tool is suitable to faithfully monitor rapid, but also subtle changes in transcription in a medium to high throughput format.	[Cesbron, Francois; Brunner, Michael; Diernfellner, Axel C. R.] Heidelberg Univ, Biochem Ctr BZH, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Diernfellner, ACR (corresponding author), Heidelberg Univ, Biochem Ctr BZH, Heidelberg, Germany.	axel.diernfellner@bzh.uni-heidelberg.de		Brunner, Michael/0000-0001-9798-3047	Deutsche Forschungsgemeinschaft: DFG [DI 1874/1-1]	Deutsche Forschungsgemeinschaft: DFG(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft: DFG DI 1874/1-1 to AD (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Brandes C, 1996, NEURON, V16, P687, DOI 10.1016/S0896-6273(00)80088-4; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; DANIELS MC, 1993, MOL ENDOCRINOL, V7, P1041, DOI 10.1210/me.7.8.1041; DILELLA AG, 1988, NUCLEIC ACIDS RES, V16, P4159, DOI 10.1093/nar/16.9.4159; Dolz-Edo L, 2013, MOL CELL BIOL, V33, P2228, DOI 10.1128/MCB.00240-13; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Geusz ME, 1997, CURR BIOL, V7, P758, DOI 10.1016/S0960-9822(06)00334-4; Gin E, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.24; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Koksharov MI, 2011, PHOTOCH PHOTOBIO SCI, V10, P931, DOI 10.1039/c0pp00318b; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Larrondo LF, 2012, FUNGAL GENET BIOL, V49, P681, DOI 10.1016/j.fgb.2012.06.001; Leclerc GM, 2000, BIOTECHNIQUES, V29, P590, DOI 10.2144/00293rr02; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Merrow M, 2007, COLD SPRING HARB SYM, V72, P279, DOI 10.1101/sqb.2007.72.032; Merrow M, 2011, FEBS LETT, V585, P1383, DOI 10.1016/j.febslet.2011.04.055; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; Morgan LW, 2003, FUNGAL GENET BIOL, V38, P327, DOI 10.1016/S1087-1845(02)00562-5; OW DW, 1986, SCIENCE, V234, P856, DOI 10.1126/science.234.4778.856; Paguio Aileen, 2010, Curr Chem Genomics, V4, P43, DOI 10.2174/1875397301004010043; PALOMARES AJ, 1989, GENE, V81, P55, DOI 10.1016/0378-1119(89)90336-3; Price-Lloyd N, 2005, BIOCHEM SOC T, V33, P949, DOI 10.1042/BST0330949; Robertson JB, 2008, P NATL ACAD SCI USA, V105, P17988, DOI 10.1073/pnas.0809482105; Roenneberg T, 2007, COLD SPRING HARB SYM, V72, P293, DOI 10.1101/sqb.2007.72.043; Sancar G, 2011, MOL CELL, V44, P687, DOI 10.1016/j.molcel.2011.10.019; Schafmeier T, 2006, GENE DEV, V20, P297, DOI 10.1101/gad.360906; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2011, FEBS LETT, V585, P1467, DOI 10.1016/j.febslet.2011.03.050; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Schwerdtfeger C, 2001, MOL MICROBIOL, V39, P1080, DOI 10.1046/j.1365-2958.2001.02306.x; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Tan Y, 2004, CURR BIOL, V14, P433, DOI 10.1016/j.cub.2004.02.035; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906	42	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83660	10.1371/journal.pone.0083660	http://dx.doi.org/10.1371/journal.pone.0083660			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391804	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200102
J	Dong, ZH; Imai, A; Krishnamurthy, S; Zhang, ZC; Zeitlin, BD; Nor, JE				Dong, Zhihong; Imai, Atsushi; Krishnamurthy, Sudha; Zhang, Zhaocheng; Zeitlin, Benjamin D.; Noer, Jacques E.			Xenograft Tumors Vascularized with Murine Blood Vessels May Overestimate the Effect of Anti-Tumor Drugs: A Pilot Study	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL-CELLS; CROSS-TALK; IN-VITRO; BCL-2; ANGIOGENESIS; DIFFERENTIATION; INDUCTION; MODELS	Recent evidence demonstrated that endothelial cells initiate signaling events that enhance tumor cell survival, proliferation, invasion, and tumor recurrence. Under this new paradigm for cellular crosstalk within the tumor microenvironment, the origin of endothelial cells and tumor cells may have a direct impact on the pathobiology of cancer. The purpose of this pilot study was to evaluate the effect of endothelial cell species (i.e. murine or human) on xenograft tumor growth and response to therapy. Tumor xenografts vascularized either with human or with murine microvascular endothelial cells were engineered, side-by-side, subcutaneously in the dorsum of immunodefficient mice. When tumors reached 200 mm(3), mice were treated for 30 days with either 4 mg/kg cisplatin (i.p.) every 5 days or with 40 mg/kg sunitinib (p.o.) daily. Xenograft human tumors vascularized with human endothelial cells grow faster than xenograft tumors vascularized with mouse endothelial cells (P<0.05). Notably, human tumors vascularized with human endothelial cells exhibited nuclear translocation of p65 (indicative of high NF-kB activity), and were more resistant to treatment with cisplatin or sunitinib than the contralateral tumors vascularized with murine endothelial cells (P<0.05). Collectively, these studies suggest that the species of endothelial cells has a direct impact on xenograft tumor growth and response to treatment with the chemotherapeutic drug cisplatin or with the anti-angiogenic drug sunitinib.	[Dong, Zhihong; Imai, Atsushi; Krishnamurthy, Sudha; Zhang, Zhaocheng; Zeitlin, Benjamin D.; Noer, Jacques E.] Univ Michigan, Sch Dent, Dept Restorat Sci, Angiogenesis Res Lab, Ann Arbor, MI 48109 USA; [Noer, Jacques E.] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Noer, Jacques E.] Univ Michigan, Dept Otolaryngol, Sch Med, Ann Arbor, MI 48109 USA; [Noer, Jacques E.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nor, JE (corresponding author), Univ Michigan, Sch Dent, Dept Restorat Sci, Angiogenesis Res Lab, Ann Arbor, MI 48109 USA.	jenor@umich.edu	Nor, Jacques/AAJ-6139-2021; Zeitlin, Benjamin/B-9628-2008	Nor, Jacques/0000-0002-4056-0235; Zeitlin, Benjamin/0000-0003-0110-0188	National Institutes of Health [P50-CA97248, R01-DE16586, R01-DE21139, R01-DE23220]; NATIONAL CANCER INSTITUTE [P50CA097248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021139, R01DE023220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by grants P50-CA97248 (University of Michigan Head & Neck SPORE), R01-DE16586, R01-DE21139, R01-DE23220 from the National Institutes of Health (JEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkan MC, 2011, CURR TOP MICROBIOL, V349, P159, DOI 10.1007/82_2010_97; Damia G, 2009, EUR J CANCER, V45, P2768, DOI 10.1016/j.ejca.2009.08.008; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dong ZH, 2007, EXP CELL RES, V313, P3645, DOI 10.1016/j.yexcr.2007.07.023; Dong ZD, 2007, BIOTECHNIQUES, V43, P73, DOI 10.2144/000112457; Enis DR, 2005, P NATL ACAD SCI USA, V102, P425, DOI 10.1073/pnas.0408357102; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Kaneko T, 2007, CANCER RES, V67, P9685, DOI 10.1158/0008-5472.CAN-07-1497; Karl E, 2007, CELL DEATH DIFFER, V14, P1657, DOI 10.1038/sj.cdd.4402174; Karl E, 2005, CANCER RES, V65, P5063, DOI 10.1158/0008-5472.CAN-05-0140; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; LAW LW, 1954, CANCER RES, V14, P695; Mischek D, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/437284; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Neiva KG, 2009, NEOPLASIA, V11, P583, DOI 10.1593/neo.09266; Nor JE, 2001, LAB INVEST, V81, P453, DOI 10.1038/labinvest.3780253; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; Nor JE, 2001, CANCER RES, V61, P2183; POVLSEN CO, 1972, ACTA PATH MICRO IM A, VA 80, P713; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Sanz L, 2009, LAB INVEST, V89, P91, DOI 10.1038/labinvest.2008.108; Skakkebaek N E, 1974, Acta Obstet Gynecol Scand Suppl, V29, P73; Skovseth DK, 2002, AM J PATHOL, V160, P1629, DOI 10.1016/S0002-9440(10)61110-8; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Warner KA, 2008, NEOPLASIA, V10, P131, DOI 10.1593/neo.07815; WATANABE K, 1993, EUR J BIOCHEM, V214, P267, DOI 10.1111/j.1432-1033.1993.tb17920.x; YOSHIMURA T, 1993, J IMMUNOL, V151, P6225; Zeitlin BD, 2006, CANCER RES, V66, P8698, DOI 10.1158/0008-5472.CAN-05-3691; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	30	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84236	10.1371/journal.pone.0084236	http://dx.doi.org/10.1371/journal.pone.0084236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391922	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900065
J	Guo, XF; Li, J; Wei, QL; Fan, XD; Kennedy, DN; Shen, YD; Chen, HF; Zhao, JP				Guo, Xiaofeng; Li, Jun; Wei, Qinling; Fan, Xiaoduo; Kennedy, David N.; Shen, Yidong; Chen, Huafu; Zhao, Jingping			Duration of Untreated Psychosis Is Associated with Temporal and Occipitotemporal Gray Matter Volume Decrease in Treatment Naive Schizophrenia	PLOS ONE			English	Article							1ST-EPISODE SCHIZOPHRENIA; PRODROMAL PHASE; ABNORMALITIES; GYRUS; MRI; ILLNESS; MIDDLE; METAANALYSIS; ONSET	Background: Long duration of untreated psychosis (DUP) is associated with poor treatment outcome. Whether or not DUP is related to brain gray matter volume abnormalities in antipsychotic medication treatment naive schizophrenia remains unclear at this time. Methods: Patients with treatment-naive schizophrenia and healthy controls went through brain scan using high resolution Magnetic Resonance Imaging. DUP was evaluated using the Nottingham Onset Schedule (NOS), and dichotomized as short DUP (<= 26 weeks) or long DUP (>26 weeks). Voxel-based methods were used for volumetric measure in the brain. Results: Fifty-seven patients (27 short DUP and 30 long DUP) and 30 healthy controls were included in the analysis. There were significant gray matter volumetric differences among the 3 groups in bilateral parahippocampus gyri, right superior temporal gyrus, left fusiform gyrus, left middle temporal gyrus, and right superior frontal gyrus (p's<0.01). Compared with healthy controls, the long DUP group had significantly smaller volume in all these regions (p's<0.05). Compared with the short-DUP group, the long-DUP group had significantly smaller volume in right superior temporal gyrus, left fusiform gyrus, and left middle temporal gyrus (p's<0.01). Conclusion: Our findings suggest that DUP is associated with temporal and occipitotemporal gray matter volume decrease in treatment naive schizophrenia. The brain structural changes in untreated psychosis might contribute to poor treatment response and long-term prognosis in this patient population.	[Guo, Xiaofeng; Shen, Yidong; Zhao, Jingping] Cent S Univ, Inst Mental Hlth, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Li, Jun; Chen, Huafu] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Wei, Qinling] Sun Yat Sen Univ, Dept Psychiat, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Fan, Xiaoduo; Kennedy, David N.] Univ Massachusetts, Sch Med, UMass Mem Med Ctr, Worcester, MA USA	Central South University; University of Electronic Science & Technology of China; Sun Yat Sen University; University of Massachusetts System; University of Massachusetts Worcester	Zhao, JP (corresponding author), Cent S Univ, Inst Mental Hlth, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	chenhf@uestc.edu.cn; zhaojingpingcsu@163.com	Fan, Xiaoduo/AAV-1268-2020; zhao, jing/B-3868-2019	Fan, Xiaoduo/0000-0003-4299-8924; 	National Natural Science Foundation of China [30900485, 81270019]; National R&D Special Fund for Health Profession [201002003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD004147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083320] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National R&D Special Fund for Health Profession; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Natural Science Foundation of China (grant No. 30900485 and 81270019); and by the National R&D Special Fund for Health Profession (grant No. 201002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelopoulos EK, 2002, PSYCHIAT RES, V110, P9, DOI 10.1016/S0165-1781(02)00037-9; Asami T, 2012, NEUROIMAGE, V59, P986, DOI 10.1016/j.neuroimage.2011.08.066; Bachmann S, 2004, SCHIZOPHR RES, V67, P301, DOI 10.1016/S0920-9964(03)00002-1; Bangalore SS, 2009, NEUROREPORT, V20, P729, DOI 10.1097/WNR.0b013e32832ae501; Butler PD, 2005, CURR OPIN PSYCHIATR, V18, P151, DOI 10.1097/00001504-200503000-00008; Chang WC, 2012, PLOS ONE, V7, P1; Crespo-Facorro B, 2007, SCHIZOPHR RES, V91, P87, DOI 10.1016/j.schres.2006.12.015; Crumlish N, 2009, BRIT J PSYCHIAT, V194, P18, DOI 10.1192/bjp.bp.107.048942; Emsley R, 2008, CURR OPIN PSYCHIATR, V21, P173, DOI 10.1097/YCO.0b013e3282f33f76; First MB SRGM, 1996, STRUCTURED CLIN INTE; Haijma S.V., 2012, SCHIZOPHR B; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Hu MR, 2013, SCHIZOPHR RES, V144, P37, DOI 10.1016/j.schres.2012.12.018; Jackson HJ, 1996, AUST NZ J PSYCHIAT, V30, P498, DOI 10.3109/00048679609065023; Kay S, 1987, SCHIZOPHR B, V1, P261, DOI DOI 10.1093/SCHBUL/13.2.261; Keshavan MS, 1998, J PSYCHIAT RES, V32, P161, DOI 10.1016/S0022-3956(97)00038-1; Kuroki N, 2006, AM J PSYCHIAT, V163, P2103, DOI 10.1176/appi.ajp.163.12.2103; Lappin JM, 2006, SCHIZOPHR RES, V83, P145, DOI 10.1016/j.schres.2005.11.018; Lappin JM, 2007, BRIT J PSYCHIAT, V191, pS123, DOI 10.1192/bjp.191.51.s123; Malla AK, 2011, SCHIZOPHR RES, V125, P13, DOI 10.1016/j.schres.2010.09.021; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; Matsumoto H, 2001, AM J PSYCHIAT, V158, P1299, DOI 10.1176/appi.ajp.158.8.1299; Morris RW, 2009, CURR OPIN PSYCHIATR, V22, P140, DOI 10.1097/YCO.0b013e328324f895; Nakamura M, 2008, BRAIN, V131, P180, DOI 10.1093/brain/awm265; Onitsuka T, 2004, AM J PSYCHIAT, V161, P1603, DOI 10.1176/appi.ajp.161.9.1603; Owens DC, 2010, BRIT J PSYCHIAT, V196, P296, DOI 10.1192/bjp.bp.109.067694; Pantelis C, 2003, AUST NZ J PSYCHIAT, V37, P399, DOI 10.1046/j.1440-1614.2003.01193.x; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785; Selten JP, 2007, SCHIZOPHR RES, V97, P79, DOI 10.1016/j.schres.2007.07.008; Singh SP, 2005, SCHIZOPHR RES, V80, P117, DOI 10.1016/j.schres.2005.04.018; Takahashi T, 2007, PSYCHIAT RES-NEUROIM, V154, P209, DOI 10.1016/j.pscychresns.2006.10.001; Vita A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.116; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353	33	34	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83679	10.1371/journal.pone.0083679	http://dx.doi.org/10.1371/journal.pone.0083679			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391807	Green Published, gold			2022-12-27	WOS:000329325200105
J	Jimenez-Diaz, A; Remacha, M; Ballesta, JPG; Berlanga, JJ				Jimenez-Diaz, Antonio; Remacha, Miguel; Ballesta, Juan P. G.; Jose Berlanga, Juan			Phosphorylation of Initiation Factor eIF2 in Response to Stress Conditions Is Mediated by Acidic Ribosomal P1/P2 Proteins in Saccharomyces cerevisiae	PLOS ONE			English	Article							FACTOR 2-ALPHA KINASE; TRANSLATION INITIATION; P-PROTEINS; EXTRARIBOSOMAL FUNCTIONS; DIMERIZATION DOMAIN; STRUCTURAL BASIS; GENE-EXPRESSION; TRANSFER-RNA; IN-VIVO; STALK	Eukaryotic cells contain an unusually large cytoplasmic pool of P1/P2 phosphoproteins, which form the highly flexible 60S subunit stalk that is required to interact with and activate soluble translation factors. In cells, cytoplasmic P1/P2 proteins are exchanged for ribosome-bound proteins in a process that can modulate ribosome function and translation. Here, we analysed different S. cerevisiae stalk mutants grown under stress conditions that result in eIF2 alpha phosphorylation. These mutants either lack a cytoplasmic pool of stalk proteins or contain free but not ribosome-bound proteins. Only cells that contain free P1/P2 proteins induce eIF2 phosphorylation in vivo in response to glucose starvation or osmotic stress. Moreover, we show that free S. cerevisiae P1/P2 proteins can induce in vitro phosphorylation of the initiation factor eIF2 by stimulating the autophosphorylation and activation of GCN2 kinase. Indeed, these ribosomal proteins do not stimulate other eIF2 alpha kinases, such as PKR and HRI. P1/P2 and the known GCN2 activator deacylated tRNA compete for stimulating the eIF2 alpha kinase activity of GCN2, although the P1/P2 proteins are considerably more active. These findings reveal a capacity of free cytoplasmic ribosomal stalk components to stimulate eIF2 alpha phosphorylation, which in turn would modulate translation in response to specific forms of stress that may be linked with the previously described regulatory function of the ribosomal stalk.	[Ballesta, Juan P. G.] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; Univ Autonoma Madrid, CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Ballesta, JPG (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jpgballesta@cbm.uam.es; jberlanga@cbm.uam.es	Remacha, Miguel/G-1250-2016; Berlanga, Juan José/N-1718-2015	Berlanga, Juan José/0000-0002-2408-6561	Spanish Ministry of Science and Innovation [BFU2009-09738, BFU2009-09469]; Fundacion Ramon Areces	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces	This work was supported by grants from the Spanish Ministry of Science and Innovation BFU2009-09738 to J.P.G.B. and BFU2009-09469 to J.J.B., and by an Institutional Grant to Centro de Biologia Molecular Severo Ochoa (CBMSO) from Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub MJ, 2005, GENE, V357, P129, DOI 10.1016/j.gene.2005.06.006; Ballesta JPG, 1999, FEMS MICROBIOL REV, V23, P537, DOI 10.1111/j.1574-6976.1999.tb00412.x; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; BELTRAME M, 1990, MOL CELL BIOL, V10, P2341, DOI 10.1128/MCB.10.5.2341; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; BERMEJO B, 1994, J BIOL CHEM, V269, P3968; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Chiou JC, 2011, INT J BIOCHEM CELL B, V43, P1792, DOI 10.1016/j.biocel.2011.08.018; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Das S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002858; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; del Pino J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047272; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; FAKUNDING JL, 1973, J BIOL CHEM, V248, P8555; GALLIS BM, 1975, BIOCHEMISTRY-US, V14, P1038, DOI 10.1021/bi00676a024; Garriz A, 2009, MOL CELL BIOL, V29, P1592, DOI 10.1128/MCB.01446-08; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; Gonzalo P, 2001, J BIOL CHEM, V276, P19762, DOI 10.1074/jbc.M101398200; Goossens A, 2001, J BIOL CHEM, V276, P30753, DOI 10.1074/jbc.M102960200; Guarinos E, 2003, MOL MICROBIOL, V50, P703, DOI 10.1046/j.1365-2958.2003.03733.x; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Huang CH, 2010, J MOL BIOL, V399, P145, DOI 10.1016/j.jmb.2010.04.009; KAY A, 1973, BIOCHEM BIOPH RES CO, V51, P979, DOI 10.1016/0006-291X(73)90023-5; KISCHA K, 1971, NATURE-NEW BIOL, V233, P62, DOI 10.1038/newbio233062a0; Krokowski D, 2006, MOL MICROBIOL, V60, P386, DOI 10.1111/j.1365-2958.2006.05117.x; Lee KM, 2012, NUCLEIC ACIDS RES, V40, P3172, DOI 10.1093/nar/gkr1143; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; Mandava CS, 2012, NUCLEIC ACIDS RES, V40, P2054, DOI 10.1093/nar/gkr1031; Martinez-Azorin F, 2008, FEBS LETT, V582, P3029, DOI 10.1016/j.febslet.2008.07.039; MITSUI K, 1989, BIOCHEM BIOPH RES CO, V161, P1001, DOI 10.1016/0006-291X(89)91342-9; NEWTON CH, 1990, J BACTERIOL, V172, P579, DOI 10.1128/jb.172.2.579-588.1990; Nusspaumer G, 2000, EMBO J, V19, P6075, DOI 10.1093/emboj/19.22.6075; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Perez-Fernandez J, 2005, BIOCHEMISTRY-US, V44, P5532, DOI 10.1021/bi047332r; Qiu H, 2001, EMBO J, V20, P1425, DOI 10.1093/emboj/20.6.1425; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; REMACHA M, 1992, J BIOL CHEM, V267, P12061; REMACHA M, 1995, MOL CELL BIOL, V15, P4754; REMACHA M, 1988, J BIOL CHEM, V263, P9094; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; SANCHEZMADRID F, 1979, EUR J BIOCHEM, V98, P409, DOI 10.1111/j.1432-1033.1979.tb13200.x; SANTOS C, 1993, BIOCHEMISTRY-US, V32, P4231, DOI 10.1021/bi00067a010; Szick K, 1998, P NATL ACAD SCI USA, V95, P2378, DOI 10.1073/pnas.95.5.2378; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WEK RC, 1990, MOL CELL BIOL, V10, P2820, DOI 10.1128/MCB.10.6.2820; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Zambrano R, 1997, BIOCHEMISTRY-US, V36, P14439, DOI 10.1021/bi971494o; Zurdo J, 2000, BIOCHEMISTRY-US, V39, P8929, DOI 10.1021/bi000362j; Zurdo J, 1997, BIOCHEMISTRY-US, V36, P9625, DOI 10.1021/bi9702400	62	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84219	10.1371/journal.pone.0084219	http://dx.doi.org/10.1371/journal.pone.0084219			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391917	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900060
J	Liu, S; Dunwell, TL; Pfeifer, GP; Dunwell, JM; Ullah, I; Wang, YS				Liu, Shuo; Dunwell, Thomas L.; Pfeifer, Gerd P.; Dunwell, Jim M.; Ullah, Ihsan; Wang, Yinsheng			Detection of Oxidation Products of 5-Methyl-2'-Deoxycytidine in Arabidopsis DNA	PLOS ONE			English	Article							MASS-SPECTROMETRY; MAMMALIAN DNA; TET PROTEINS; 5-METHYLCYTOSINE; METHYLATION; DEMETHYLATION; 5-FORMYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; 5-CARBOXYLCYTOSINE; GLYCOSYLASE	Epigenetic regulations play important roles in plant development and adaptation to environmental stress. Recent studies from mammalian systems have demonstrated the involvement of ten-eleven translocation (Tet) family of dioxygenases in the generation of a series of oxidized derivatives of 5-methylcytosine (5-mC) in mammalian DNA. In addition, these oxidized 5-mC nucleobases have important roles in epigenetic remodeling and aberrant levels of 5-hydroxymethyl-2'-deoxycytidine (5-HmdC) were found to be associated with different types of human cancers. However, there is a lack of evidence supporting the presence of these modified bases in plant DNA. Here we reported the use of a reversed-phase HPLC coupled with tandem mass spectrometry method and stable isotope-labeled standards for assessing the levels of the oxidized 5-mC nucleosides along with two other oxidatively induced DNA modifications in genomic DNA of Arabidopsis. These included 5-HmdC, 5-formyl-2'-deoxycytidine (5-FodC), 5-carboxyl-2'-deoxycytidine (5-CadC), 5-hydroxymethyl-2'-deoxyuridine (5HmdU), and the (5'S) diastereomer of 8,5';-cyclo-2'-deoxyguanosine (S-cdG). We found that, in Arabidopsis DNA, the levels of 5-HmdC, 5-FodC, and 5-CadC are approximately 0.8 modifications per 10(6) nucleosides, with the frequency of 5-HmdC (per 5-mdC) being comparable to that of 5-HmdU (per thymidine). The relatively low levels of the 5-mdC oxidation products suggest that they arise likely from reactive oxygen species present in cells, which is in line with the lack of homologous Tetfamily dioxygenase enzymes in Arabidopsis.	[Liu, Shuo; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Dunwell, Thomas L.; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Dunwell, Jim M.; Ullah, Ihsan] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Ullah, Ihsan] Agr Biotechnol Res Inst, Faisalabad, Pakistan; [Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; City of Hope; Beckman Research Institute of City of Hope; University of Reading; University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.	yinsheng.wang@ucr.edu	Dunwell, Jim/AAS-6217-2020; Liu, Shuo/F-8229-2017	Dunwell, Jim/0000-0003-2147-665X; Ullah, Ihsan/0000-0002-9367-6741; Dunwell, Thomas/0000-0001-9985-3828	National Institutes of Health [R01 CA101864, CA160965]; NATIONAL CANCER INSTITUTE [R01CA101864, R01CA160965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA101864 to Y.W. and CA160965 to G.P.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2011, PROG MOL BIOL TRANSL, V101, P105, DOI 10.1016/B978-0-12-387685-0.00004-4; Cao HC, 2006, J AM SOC MASS SPECTR, V17, P1335, DOI 10.1016/j.jasms.2006.05.019; Chen ML, 2013, CLIN CHEM, V59, P824, DOI 10.1373/clinchem.2012.193938; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Frelon S, 2000, CHEM RES TOXICOL, V13, P1002, DOI 10.1021/tx000085h; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Gehring Mary, 2008, Arabidopsis Book, V6, pe0102, DOI 10.1199/tab.0102; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hong HZ, 2006, CHEM RES TOXICOL, V19, P614, DOI 10.1021/tx060025x; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jin SG, 2011, CANCER RES, V71, P7360, DOI 10.1158/0008-5472.CAN-11-2023; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Krais AM, 2011, EPIGENETICS-US, V6, P560, DOI 10.4161/epi.6.5.15678; Liu S, 2013, NUCLEIC ACIDS RES, V41, P6421, DOI 10.1093/nar/gkt360; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mitra D, 2012, NATURE, V491, P449, DOI 10.1038/nature11624; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rangwala SH, 2004, CURR OPIN GENET DEV, V14, P686, DOI 10.1016/j.gde.2004.09.009; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2012, NAT METHODS, V9, P75, DOI [10.1038/NMETH.1779, 10.1038/nmeth.1779]; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wang J, 2012, AGING CELL; Wang J, 2011, ANAL CHEM, V83, P2201, DOI 10.1021/ac103099s; Yao Q, 2012, PROTEIN EXPRES PURIF, V83, P104, DOI 10.1016/j.pep.2012.03.003; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	35	23	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84620	10.1371/journal.pone.0084620	http://dx.doi.org/10.1371/journal.pone.0084620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391970	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000329323900113
J	Mannino, GC; Greco, A; De Lorenzo, C; Andreozzi, F; Marini, MA; Perticone, F; Sesti, G				Mannino, Gaia Chiara; Greco, Annalisa; De Lorenzo, Carlo; Andreozzi, Francesco; Marini, Maria A.; Perticone, Francesco; Sesti, Giorgio			A Fasting Insulin-Raising Allele at IGF1 Locus Is Associated with Circulating Levels of IGF-1 and Insulin Sensitivity	PLOS ONE			English	Article							GROWTH-FACTOR-I; HYBRID RECEPTORS; SKELETAL-MUSCLE; GLUCOSE; HOMEOSTASIS; EXPRESSION; RESISTANCE; GENE	Background: A meta-analysis of genome-wide data reported the discovery of the rs35767 polymorphism near IGF1 with genome-wide significant association with fasting insulin levels. However, it is unclear whether the effects of this polymorphism on fasting insulin are mediated by a reduced insulin sensitivity or impaired insulin clearance. We investigated the effects of the rs35767 polymorphism on circulating IGF-1 levels, insulin sensitivity, and insulin clearance. Methodology/Principal Findings: Two samples of adult nondiabetic white Europeans were studied. In sample 1 (n=569), IGF-1 levels were lower in GG genotype carriers compared with A allele carriers (190 +/- 77 vs. 218 +/- 97 ng/ml, respectively; P=0.007 after adjusting for age, gender, and BMI). Insulin sensitivity assessed by euglycaemic-hyperinsulinemic clamp was lower in GG genotype carriers compared with A allele carriers (8.9 +/- 4.1 vs. 10.1 +/- 5.1 mg x Kg(-1) free fat mass x min(-1), respectively; P=0.03 after adjusting for age, gender, and BMI). The rs35767 polymorphism did not show significant association with insulin clearance. In sample 2 (n=859), IGF-1 levels were lower in GG genotype carriers compared with A allele carriers (155 +/- 60 vs. 164 +/- 63 ng/ml, respectively; P=0.02 after adjusting for age, gender, and BMI). Insulin sensitivity, as estimated by the HOMA index, was lower in GG genotype carriers compared with A allele carriers (2.8 +/- 2.2 vs. 2.5 +/- 1.3, respectively; P=0.03 after adjusting for age, gender, and BMI). Conclusion/Significance: The rs35767 polymorphism near IGF1 was associated with circulating IGF-1 levels, and insulin sensitivity with carriers of the GG genotype exhibiting lower IGF-1 concentrations and insulin sensitivity as compared with subjects carrying the A allele.	[Mannino, Gaia Chiara; Greco, Annalisa; De Lorenzo, Carlo; Andreozzi, Francesco; Perticone, Francesco; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Marini, Maria A.] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy	Magna Graecia University of Catanzaro; University of Rome Tor Vergata	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	sesti@unicz.it	DE LORENZO, Carlo/R-4050-2016; Sesti, Giorgio/B-1509-2012; Mannino, Gaia C/K-1580-2016; Perticone, Francesco/I-4260-2017; Andreozzi, Francesco/J-4073-2018	Mannino, Gaia C/0000-0002-6341-4572; Andreozzi, Francesco/0000-0001-9375-1513; De Lorenzo, Carlo/0000-0002-2579-683X; Sesti, Giorgio/0000-0002-1618-7688	European Community [Medigene-FP7-279171-1]	European Community(European Commission)	This work was supported, in part, by the European Community (grant number Medigene-FP7-279171-1) to Giorgio Sesti. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Federici M, 1996, J CLIN INVEST, V98, P2887, DOI 10.1172/JCI119117; Federici M, 1997, MOL CELL ENDOCRINOL, V129, P121, DOI 10.1016/S0303-7207(97)04050-1; Federici M, 1998, DIABETES, V47, P87, DOI 10.2337/diabetes.47.1.87; Federici M, 1998, J CLIN ENDOCR METAB, V83, P2911, DOI 10.1210/jc.83.8.2911; Goodarzi MO, 2013, DIABETOLOGIA, V56, P1282, DOI 10.1007/s00125-013-2880-6; Goodarzi MO, 2011, AM J PHYSIOL-ENDOC M, V301, pE402, DOI 10.1152/ajpendo.00013.2011; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Marini MA, 2003, J CLIN ENDOCR METAB, V88, P3368, DOI 10.1210/jc.2002-021716; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moses AC, 1996, DIABETES, V45, P91, DOI 10.2337/diabetes.45.1.91; Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5; Scarpelli D, 2006, DIABETES, V55, P1529, DOI 10.2337/db06-0047; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Sesti G, 2005, DIABETES CARE, V28, P120, DOI 10.2337/diacare.28.1.120; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Succurro E, 2009, NUTR METAB CARDIOVAS, V19, P713, DOI 10.1016/j.numecd.2008.12.011; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110	20	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85483	10.1371/journal.pone.0085483	http://dx.doi.org/10.1371/journal.pone.0085483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392014	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900158
J	Paul, C; Robaire, B				Paul, Catriona; Robaire, Bernard			Impaired Function of the Blood-Testis Barrier during Aging Is Preceded by a Decline in Cell Adhesion Proteins and GTPases	PLOS ONE			English	Article							BROWN-NORWAY RAT; ADHERENS JUNCTIONS; SEMINIFEROUS EPITHELIUM; ECTOPLASMIC SPECIALIZATION; SEMEN QUALITY; GERM-CELLS; MALE AGE; DYNAMICS; SPERMATOGENESIS; SERTOLI	With increasing age comes many changes in the testis, including germ cell loss. Cell junctions in the testis tether both seminiferous epithelial and germ cells together and assist in the formation of the blood-testis barrier (BTB), which limits transport of biomolecules, ions and electrolytes from the basal to the adluminal compartment and protects post-meiotic germ cells. We hypothesize that as male rats age the proteins involved in forming the junctions decrease and that this alters the ability of the BTB to protect the germ cells. Pachytene spermatocytes were isolated from Brown Norway rat testes at 4 (young) and 18 (aged) months of age using STA-PUT velocity sedimentation technique. RNA was extracted and gene expression was assessed using Affymetrix rat 230 2.0 whole rat genome microarrays. Microarray data were confirmed by qRT- PCR and protein expression by Western blotting. Of the genes that were significantly decreased by at least 1.5 fold, 70 were involved in cell adhesion; of these, at least 20 are known to be specifically involved in junction dynamics within the seminiferous epithelium. The mRNA and protein levels of Jam2, Ocln, cdh2 (N-cadherin), ctnna (a-catenin), and cldn11 (involved in adherens junctions), among others, were decreased by approximately 50% in aged spermatocytes. In addition, the GTPases Rac1 and cdc42, involved in the recruitment of cadherins to the adherens junctions, were similarly decreased. It is therefore not surprising that with lower expression of these proteins that the BTB becomes diminished with age. We saw, using a FITC tracer, a gradual collapse of the BTB between 18 and 24 months. This provides the opportunity for harmful substances and immune cells to cross the BTB and cause the disruption of spermatogenesis that is observed with increasing age.	[Paul, Catriona; Robaire, Bernard] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Robaire, Bernard] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Robaire, B (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	bernard.robaire@mcgill.ca			CIHR [MOP-89767]	CIHR(Canadian Institutes of Health Research (CIHR))	These studies were funded by grant MOP-89767 from CIHR. CP was funded by a CIHR postdoctoral fellowship. BR is a James McGill professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Mahecha A, 2001, BIOL REPROD, V65, P119, DOI 10.1095/biolreprod65.1.119; Anway MD, 2003, BIOL REPROD, V68, P996, DOI 10.1095/biolreprod.102.008045; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Maya WC, 2009, AGING MALE, V12, P100, DOI 10.3109/13685530903322841; Citi S, 2011, MOL MEMBR BIOL, V28, P427, DOI 10.3109/09687688.2011.603101; Duncan MC, 2008, J CELL BIOL, V183, P971, DOI 10.1083/jcb.200811057; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; Genetos DC, 2012, J ORTHOP RES, V30, P1979, DOI 10.1002/jor.22172; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isabel Molina Rosa, 2010, Archivos Espanoles de Urologia, V63, P214; Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; Levy S, 1999, J ANDROL, V20, P356; Lie PPY, 2010, PHILOS T R SOC B, V365, P1581, DOI 10.1098/rstb.2009.0261; Lui WY, 2003, BIOL REPROD, V68, P2189, DOI 10.1095/biolreprod.102.011379; Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452; Mok KW, 2012, INT J ANDROL, V35, P86, DOI 10.1111/j.1365-2605.2011.01183.x; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mulholland DJ, 2001, BIOL REPROD, V64, P396, DOI 10.1095/biolreprod64.1.396; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Paul C, 2011, BIOL REPROD, V85, P1269, DOI 10.1095/biolreprod.111.094219; RUSSELL L, 1977, TISSUE CELL, V9, P475, DOI 10.1016/0040-8166(77)90007-6; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Syntin P, 2001, J ANDROL, V22, P235; WANG C, 1993, ENDOCRINOLOGY, V133, P2773, DOI 10.1210/en.133.6.2773; Wong CH, 2005, ENDOCRINOLOGY, V146, P1192, DOI 10.1210/en.2004-1275; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Wong EWP, 2009, INT REV CEL MOL BIO, V278, P309, DOI 10.1016/S1937-6448(09)78007-4; Yan HHN, 2005, P NATL ACAD SCI USA, V102, P11722, DOI 10.1073/pnas.0503855102; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31	33	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84354	10.1371/journal.pone.0084354	http://dx.doi.org/10.1371/journal.pone.0084354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391944	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900087
J	Petri, RM; Schwaiger, T; Penner, GB; Beauchemin, KA; Forster, RJ; McKinnon, JJ; McAllister, TA				Petri, Renee M.; Schwaiger, Tyler; Penner, Greg B.; Beauchemin, Karen A.; Forster, Robert J.; McKinnon, John J.; McAllister, Tim A.			Characterization of the Core Rumen Microbiome in Cattle during Transition from Forage to Concentrate as Well as during and after an Acidotic Challenge	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; HIGH-GRAIN DIET; REAL-TIME PCR; BACTERIAL DIVERSITY; GUT MICROBIOME; RUMINAL ACIDOSIS; RELATIVE QUANTIFICATION; RIBOSOMAL-RNA; BEEF-CATTLE; COW RUMEN	This study investigated the effect of diet and host on the rumen bacterial microbiome and the impact of an acidotic challenge on its composition. Using parallel pyrosequencing of the V3 hypervariable region of 16S rRNA gene, solid and liquid associated bacterial communities of 8 heifers were profiled. Heifers were exclusively fed forage, before being transitioned to a concentrate diet, subjected to an acidotic challenge and allowed to recover. Samples of rumen digesta were collected when heifers were fed forage, mixed forage, high grain, during challenge (4 h and 12 h) and recovery. A total of 560,994 high-quality bacterial sequences were obtained from the solid and liquid digesta. Using cluster analysis, prominent bacterial populations differed (P <= 0.10) in solid and liquid fractions between forage and grain diets. Differences among hosts and diets were not revealed by DGGE, but real time qPCR showed that several bacteria taxon were impacted by changes in diet, with the exception of Streptococcus bovis. Analysis of the core rumen microbiome identified 32 OTU's representing 10 distinct bacterial taxa including Bacteroidetes (32.8%), Firmicutes (43.2%) and Proteobacteria (14.3%). Diversity of OTUs was highest with forage with 38 unique OTUs identified as compared to only 11 with the high grain diet. Comparison of the microbial profiles of clincial vs. subclinical acidotic heifers found a increases in the relative abundances of Acetitomaculum, Lactobacillus, Prevotella, and Streptococcus. Increases in Streptococcus and Lactobacillus likely reflect the tolerance of these species to low pH and their ability to proliferate on surplus fermentable carbohydrate. The acetogen, Acetitomaculum may thereforeplay a role in the conversion of lactate to acetate in acidotic animals. Further profiling of the bacterial populations associated with subclinical and clinical acidosis could establish a microbial fingerprint for these disorders and provide insight into whether there are causative microbial populations that could potentially be therapeutically manipulated.	[Petri, Renee M.; Schwaiger, Tyler; Beauchemin, Karen A.; Forster, Robert J.; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Petri, Renee M.; Schwaiger, Tyler; Penner, Greg B.; McKinnon, John J.] Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 0W0, Canada	Agriculture & Agri Food Canada; University of Saskatchewan	McAllister, TA (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	tim.mcallister@agr.gc.ca	Petri, Renee Maxine/J-6102-2019; Schwaiger, Tyler/ABG-7401-2021; McAllister, Tim A./R-9201-2017	Petri, Renee Maxine/0000-0002-8209-8261; McAllister, Tim A./0000-0002-8266-6513	Alberta Crop Industry Development Fund; Genome Alberta; Agriculture Bio-products Innovation Program	Alberta Crop Industry Development Fund; Genome Alberta; Agriculture Bio-products Innovation Program	Funding support from the Alberta Crop Industry Development Fund, Genome Alberta and the Agriculture Bio-products Innovation Program are greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YH, 2011, APPL ENVIRON MICROB, V77, P5770, DOI 10.1128/AEM.00375-11; CHENG KJ, 1997, RUMEN MICROBIAL ECOS, P492; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cotta MA, 2004, ANAEROBE, V10, P191, DOI 10.1016/j.anaerobe.2004.04.001; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fernando SC, 2010, APPL ENVIRON MICROB, V76, P7482, DOI 10.1128/AEM.00388-10; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Goad DW, 1998, J ANIM SCI, V76, P234; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hungate R.E., 1969, METHODS MICROBIOLO B, P117, DOI [DOI 10.1016/S0580-9517(08)70503-8, 10.1016/S0580-9517(08)70503-8]; HUNGATE RE, 1952, CORNELL VET, V42, P423; HUNGATE RE, 1966, RUMEN ITS MICROBES; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Jouany J. P., 1991, RUMEN MICROBIAL META; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Khafipour E, 2011, J DAIRY SCI, V94, P351, DOI 10.3168/jds.2010-3435; Khafipour E, 2009, APPL ENVIRON MICROB, V75, P7115, DOI 10.1128/AEM.00739-09; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Kocherginskaya SA, 2001, ANAEROBE, V7, P119, DOI 10.1006/anae.2001.0378; Koike S, 2003, FEMS MICROBIOL LETT, V229, P23, DOI 10.1016/S0378-1097(03)00760-2; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Krause DO, 1996, J DAIRY SCI, V79, P1467, DOI 10.3168/jds.S0022-0302(96)76506-2; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li RW, 2012, ENVIRON MICROBIOL, V14, P129, DOI 10.1111/j.1462-2920.2011.02543.x; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Mackie RI, 2003, APPL ENVIRON MICROB, V69, P6808, DOI 10.1128/AEM.69.11.6808-6815.2003; Malmuthuge N, 2012, FEMS MICROBIOL ECOL, V79, P337, DOI 10.1111/j.1574-6941.2011.01220.x; MCALLISTER TA, 1994, J ANIM SCI, V72, P3004, DOI 10.2527/1994.72113004x; Mohammed R, 2012, J DAIRY SCI; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nagaraja TG, 2007, J DAIRY SCI, V90, pE17, DOI 10.3168/jds.2006-478; Nagaraja TG, 2007, VET CLIN N AM-FOOD A, V23, P333, DOI 10.1016/j.cvfa.2007.04.002; Olfert ED, 1993, GUIDE CARE USE EXPT; Penner GB, 2006, J DAIRY SCI, V89, P2132, DOI 10.3168/jds.S0022-0302(06)72284-6; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Petri RM, 2012, J APPL MICROBIOL, V112, P1152, DOI 10.1111/j.1365-2672.2012.05295.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Sadet S, 2007, ANIMAL, V1, P939, DOI 10.1017/S1751731107000304; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwaiger T, 2013, J ANIMAL SC IN PRESS; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; THURING RWJ, 1975, ANAL BIOCHEM, V66, P213, DOI 10.1016/0003-2697(75)90739-3; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WALLACE RJ, 1979, NATURE, V279, P424, DOI 10.1038/279424a0; Wang P, 2011, CAN J MICROBIOL, V57, P590, DOI [10.1139/w11-048, 10.1139/W11-048]; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500	58	228	243	2	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83424	10.1371/journal.pone.0083424	http://dx.doi.org/10.1371/journal.pone.0083424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391765	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200062
J	Singh, A; Soltani, M				Singh, Abhyudai; Soltani, Mohammad			Quantifying Intrinsic and Extrinsic Variability in Stochastic Gene Expression Models	PLOS ONE			English	Article							NEGATIVE FEEDBACK; NOISE; FLUCTUATIONS; SYSTEMS; PROTEIN; DISTRIBUTIONS; INFORMATION; SIMULATION; DYNAMICS	Genetically identical cell populations exhibit considerable intercellular variation in the level of a given protein or mRNA. Both intrinsic and extrinsic sources of noise drive this variability in gene expression. More specifically, extrinsic noise is the expression variability that arises from cell-to-cell differences in cell-specific factors such as enzyme levels, cell size and cell cycle stage. In contrast, intrinsic noise is the expression variability that is not accounted for by extrinsic noise, and typically arises from the inherent stochastic nature of biochemical processes. Two-color reporter experiments are employed to decompose expression variability into its intrinsic and extrinsic noise components. Analytical formulas for intrinsic and extrinsic noise are derived for a class of stochastic gene expression models, where variations in cell-specific factors cause fluctuations in model parameters, in particular, transcription and/ or translation rate fluctuations. Assuming mRNA production occurs in random bursts, transcription rate is represented by either the burst frequency (how often the bursts occur) or the burst size (number of mRNAs produced in each burst). Our analysis shows that fluctuations in the transcription burst frequency enhance extrinsic noise but do not affect the intrinsic noise. On the contrary, fluctuations in the transcription burst size or mRNA translation rate dramatically increase both intrinsic and extrinsic noise components. Interestingly, simultaneous fluctuations in transcription and translation rates arising from randomness in ATP abundance can decrease intrinsic noise measured in a two-color reporter assay. Finally, we discuss how these formulas can be combined with single-cell gene expression data from two-color reporter experiments for estimating model parameters.	[Singh, Abhyudai; Soltani, Mohammad] Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA; [Singh, Abhyudai] Univ Delaware, Dept Biomed Engn, Newark, DE USA; [Singh, Abhyudai] Univ Delaware, Dept Math Sci, Newark, DE 19716 USA	University of Delaware; University of Delaware; University of Delaware	Singh, A (corresponding author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.	absingh@udel.edu	Singh, Abhyudai/D-3948-2014		National Science Foundation [DMS-1312926]; University of Delaware Research Foundation (UDRF); Oak Ridge Associated Universities (ORAU); Direct For Mathematical & Physical Scien [1312926] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Delaware Research Foundation (UDRF); Oak Ridge Associated Universities (ORAU); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is funded by the National Science Foundation Grant DMS-1312926, University of Delaware Research Foundation (UDRF) and Oak Ridge Associated Universities (ORAU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arkin A, 1998, GENETICS, V149, P1633; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bleris L, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.49; Bokes P, 2012, J MATH BIOL, V64, P829, DOI 10.1007/s00285-011-0433-5; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; El-Samad H, 2006, BIOPHYS J, V90, P3749, DOI 10.1529/biophysj.105.060491; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hespanha JP, 2005, INT J ROBUST NONLIN, V15, P669, DOI 10.1002/rnc.1017; Hilfinger A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248104; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Hornung G, 2012, GENOME RES, V22, P2409, DOI 10.1101/gr.139378.112; Jia T, 2011, J MATH BIOL, V106; Johnston IG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002416; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kemkemer R, 2002, P NATL ACAD SCI USA, V99, P13783, DOI 10.1073/pnas.212386999; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lehner B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.11; Libby E, 2007, P NATL ACAD SCI USA, V104, P7151, DOI 10.1073/pnas.0608963104; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Morishita Y, 2004, J THEOR BIOL, V228, P315, DOI 10.1016/j.jtbi.2004.01.007; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Orrell D, 2004, J THEOR BIOL, V230, P301, DOI 10.1016/j.jtbi.2004.05.013; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Scott M, 2006, CHAOS, V16, DOI 10.1063/1.2211787; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Singh Abhyudai, 2007, 2007 American Control Conference, P1299; Singh A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.38; Singh A, 2011, IEEE T NANOBIOSCI, V10, P194, DOI 10.1109/TNB.2011.2168826; Singh A, 2011, IEEE T AUTOMAT CONTR, V56, P414, DOI 10.1109/TAC.2010.2088631; Singh A, 2010, PHILOS T R SOC A, V368, P4995, DOI 10.1098/rsta.2010.0211; Singh A, 2010, BIOPHYS J, V98, pL32, DOI 10.1016/j.bpj.2010.03.001; Singh A, 2009, BIOPHYS J, V96, P4013, DOI 10.1016/j.bpj.2009.02.064; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Veening J. W., 2008, ANNU REV MICROBIOL, V62; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wilkinson D.J, 2011, STOCHASTIC MODELLING	61	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84301	10.1371/journal.pone.0084301	http://dx.doi.org/10.1371/journal.pone.0084301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391934	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900077
J	Ticha, I; Gnosa, S; Lindblom, A; Liu, T; Sun, XF				Ticha, Ivana; Gnosa, Sebastian; Lindblom, Annika; Liu, Tao; Sun, Xiao-Feng			Variants of the PPARD Gene and Their Clinicopathological Significance in Colorectal Cancer	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-DELTA; HUMAN BREAST; COLON; CELLS; MUTATIONS; HETEROGENEITY; BETA/DELTA; EVOLUTION; SELECTION; MODEL	Background: Peroxisome proliferator-activated receptor delta (PPARD) is nuclear hormone receptor involved in colorectal cancer (CRC) differentiation and progression. The purpose of this study was to determine prevalence and spectrum of variants in the PPARD gene in CRC, and their contribution to clinicopathological endpoints. Methods and Findings: Direct sequencing of the PPARD gene was performed in 303 primary tumors, in blood samples from 50 patients with >= 3 affected first-degree relatives, 50 patients with 2 affected first-degree relatives, 50 sporadic patients, 360 healthy controls, and in 6 colon cancer cell lines. Mutation analysis revealed 22 different transversions, 7 of them were novel. Three of all variants were somatic (c. 548A>G, p.Y183C, c.425-9C>T, and c.628-16G>A). Two missense mutations (p.Y183C and p.R258Q) were pathogenic using in silico predictive program. Five recurrent variants were detected in/adjacent to the exons 4 (c.1-87T>C, c.1-67G>A, c.130+3G>A, and c.1-101-8C>T) and exon 7 (c.489T>C). Variant c.489C/C detected in tumors was correlated to worse differentiation (P=0.0397). Conclusions: We found 7 novel variants among 22 inherited or acquired PPARD variants. Somatic and/or missense variants detected in CRC patients are rare but indicate the clinical importance of the PPARD gene.	[Ticha, Ivana; Gnosa, Sebastian; Sun, Xiao-Feng] Linkoping Univ, Fac Hlth Sci, Cty Council Ostergotland, Div Oncol,Dept Clin & Expt Med, Linkoping, Sweden; [Lindblom, Annika; Liu, Tao] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	City Council Ostergotland; Linkoping University; Karolinska Institutet	Ticha, I (corresponding author), Linkoping Univ, Fac Hlth Sci, Cty Council Ostergotland, Div Oncol,Dept Clin & Expt Med, Linkoping, Sweden.	ivana.ticha@liu.se; xiao-feng.sun@liu.se	Ticha, Ivana/D-7033-2017; Stružinská, Ivana/AAD-7278-2019	Ticha, Ivana/0000-0002-8451-4222; Stružinská, Ivana/0000-0002-8451-4222	Swedish Cancer Foundation; Swedish Research Council; Health Research Council in the South-East of Sweden	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Health Research Council in the South-East of Sweden	Grant Support: This work was supported by grants from Swedish Cancer Foundation, Swedish Research Council, and by the Health Research Council in the South-East of Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Caldas C, 2012, NAT BIOTECHNOL, V30, P408, DOI 10.1038/nbt.2213; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chang WCL, 2005, ANN NY ACAD SCI, V1059, P41, DOI 10.1196/annals.1339.020; den Dunnen JT, 2000, HUM MUTAT, V15, P7; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feenstra M, 1999, TISSUE ANTIGENS, V54, P235, DOI 10.1034/j.1399-0039.1999.540304.x; Fernandez-Rozadilla C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012673; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Garrido F, 1995, ADV CANCER RES, V67, P155, DOI 10.1016/S0065-230X(08)60713-7; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grarup N, 2007, DIABETOLOGIA, V50, P1201, DOI 10.1007/s00125-007-0668-2; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; Hemminki K, 2004, CANCER EPIDEM BIOMAR, V13, P1253; Hewitt RE, 2000, J PATHOL, V192, P446; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lee CH, 2006, P NATL ACAD SCI USA, V103, P2434, DOI 10.1073/pnas.0510815103; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034895; MORIKAWA K, 1988, CANCER RES, V48, P1943; MORIKAWA K, 1988, CANCER RES, V48, P6863; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park JI, 2012, PPAR RES, V2012, DOI 10.1155/2012/876418; Peters JM, 2008, CLIN SCI, V115, P107, DOI 10.1042/CS20080022; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Peters JM, 2011, CANCER METAST REV, V30, P619, DOI 10.1007/s10555-011-9320-1; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Skogsberg J, 2003, J INTERN MED, V254, P597, DOI 10.1111/j.1365-2796.2003.01236.x; Skogsberg J, 2000, INT J MOL MED, V6, P73; Spurdle AB, 2008, HUM MUTAT, V29, P1304, DOI 10.1002/humu.20901; Takahashi S, 2006, PHARMACOL RES, V53, P501, DOI 10.1016/j.phrs.2006.03.019; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang L, 2008, DIS COLON RECTUM, V51, P318, DOI 10.1007/s10350-007-9145-8; Yang L, 2006, EJSO-EUR J SURG ONC, V32, P181, DOI 10.1016/j.ejso.2005.11.005; Yang L, 2010, ONCOGENE, V29, P516, DOI 10.1038/onc.2009.370; Yang L, 2011, CLIN CANCER RES, V17, P3760, DOI 10.1158/1078-0432.CCR-10-2779	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83952	10.1371/journal.pone.0083952	http://dx.doi.org/10.1371/journal.pone.0083952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391853	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200151
J	van den Oever, JME; Balkassmi, S; Segboer, T; Verweij, EJ; van der Velden, PA; Oepkes, D; Bakker, E; Boon, EMJ				van den Oever, Jessica M. E.; Balkassmi, Sahila; Segboer, Tim; Verweij, E. Joanne; van der Velden, Pieter A.; Oepkes, Dick; Bakker, Egbert; Boon, Elles M. J.			Mrassf1a-Pap, a Novel Methylation-Based Assay for the Detection of Cell-Free Fetal DNA in Maternal Plasma	PLOS ONE			English	Article							NONINVASIVE-PRENATAL-DIAGNOSIS; PYROPHOSPHOROLYSIS-ACTIVATED POLYMERIZATION; PLACENTAL EPIGENETIC SIGNATURE; RASSF1A GENE; HYPERMETHYLATED RASSF1A; PCR; POLYMORPHISMS; RELIABILITY; MARKERS; ORIGIN	Objectives: RASSF1A has been described to be differentially methylated between fetal and maternal DNA and can therefore be used as a universal sex-independent marker to confirm the presence of fetal sequences in maternal plasma. However, this requires highly sensitive methods. We have previously shown that Pyrophosphorolysis-activated Polymerization (PAP) is a highly sensitive technique that can be used in noninvasive prenatal diagnosis. In this study, we have used PAP in combination with bisulfite conversion to develop a new universal methylation-based assay for the detection of fetal methylated RASSF1A sequences in maternal plasma. Methods: Bisulfite sequencing was performed on maternal genomic (g) DNA and fetal gDNA from chorionic villi to determine differentially methylated regions in the RASSF1A gene using bisulfite specific PCR primers. Methylation specific primers for PAP were designed for the detection of fetal methylated RASSF1A sequences after bisulfite conversion and validated. Results: Serial dilutions of fetal gDNA in a background of maternal gDNA show a relative percentage of similar to 3% can be detected using this assay. Furthermore, fetal methylated RASSF1A sequences were detected both retrospectively as well as prospectively in all maternal plasma samples tested (n = 71). No methylated RASSF1A specific bands were observed in corresponding maternal gDNA. Specificity was further determined by testing anonymized plasma from non-pregnant females (n = 24) and males (n = 21). Also, no methylated RASSF1A sequences were detected here, showing this assay is very specific for methylated fetal DNA. Combining all samples and controls, we obtain an overall sensitivity and specificity of 100% (95% CI 98.4%-100%). Conclusions: Our data demonstrate that using a combination of bisulfite conversion and PAP fetal methylated RASSF1A sequences can be detected with extreme sensitivity in a universal and sex-independent manner. Therefore, this assay could be of great value as an addition to current techniques used in noninvasive prenatal diagnostics.	[van den Oever, Jessica M. E.; Balkassmi, Sahila; Segboer, Tim; Bakker, Egbert; Boon, Elles M. J.] Leiden Univ, Med Ctr, LDGA, Dept Clin Genet, Leiden, Netherlands; [Verweij, E. Joanne; Oepkes, Dick] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [van der Velden, Pieter A.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Boon, EMJ (corresponding author), Leiden Univ, Med Ctr, LDGA, Dept Clin Genet, Leiden, Netherlands.	E.M.J.Boon@lumc.nl	Bakker, Egbert/D-3525-2009	Bakker, Egbert/0000-0002-2843-7357; Verweij, E.J. (Joanne)/0000-0002-9343-9957; van der Velden, Pieter/0000-0002-5710-9256	EU [FP7 - HEALTH-F4-2010-261469]	EU(European Commission)	EuroGentest2 Coordination Action 2011 - EU Contract no.: FP7 - HEALTH-F4-2010-261469. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Alizadeh M, 2002, BLOOD, V99, P4618, DOI 10.1182/blood.V99.12.4618; Bachmann N, 2012, ARCH PEDIATRIE, V19, P1145, DOI 10.1016/j.arcped.2012.08.004; Bianchi DW, 2004, PLACENTA, V25, pS93, DOI 10.1016/j.placenta.2004.01.005; Boon EMJ, 2007, PRENATAL DIAG, V27, P932, DOI 10.1002/pd.1804; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Della Ragione F, 2010, J MOL DIAGN, V12, P797, DOI 10.2353/jmoldx.2010.090199; Faas BHW, 2012, EXPERT OPIN BIOL TH, V12, pS19, DOI 10.1517/14712598.2012.670632; Hill M, 2011, CLIN GENET, V80, P68, DOI 10.1111/j.1399-0004.2010.01533.x; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu Q, 2004, HUM MUTAT, V23, P426, DOI 10.1002/humu.20036; Liu Q, 2000, BIOTECHNIQUES, V29, P1072, DOI 10.2144/00295rr03; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Lun FMF, 2007, CLIN CHEM, V53, P796, DOI 10.1373/clinchem.2006.084350; Bellido ML, 2010, BIOL REPROD, V82, P745, DOI 10.1095/biolreprod.109.082271; Maat W, 2007, INVEST OPHTH VIS SCI, V48, P486, DOI 10.1167/iovs.06-0781; Majchrzak-Celinska A, 2013, J APPL GENET, V54, P335, DOI 10.1007/s13353-013-0149-x; Milbury CA, 2009, CLIN CHEM, V55, P632, DOI 10.1373/clinchem.2008.113035; Page-Christiaens GCML, 2006, ANN NY ACAD SCI, V1075, P123, DOI 10.1196/annals.1368.016; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Phylipsen M, 2012, PRENATAL DIAG, V32, P578, DOI 10.1002/pd.3864; Ponomaryova AA, 2013, LUNG CANCER, V81, P397, DOI 10.1016/j.lungcan.2013.05.016; Poon LLM, 2002, CLIN CHEM, V48, P35; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; Shi JX, 2007, HUM MUTAT, V28, P131, DOI 10.1002/humu.20423; Tang NLS, 1999, CLIN CHEM, V45, P2033; Tjoa ML, 2006, AM J PATHOL, V169, P400, DOI 10.2353/ajpath.2006.060161; Tong YK, 2007, CLIN CHEM, V53, P1906, DOI 10.1373/clinchem.2007.092619; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tsui DWY, 2007, PRENATAL DIAG, V27, P1212, DOI 10.1002/pd.1897; van den Oever JME, 2012, CLIN CHEM, V58, P699, DOI 10.1373/clinchem.2011.174698; White HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045073; Zhang Q, 2013, GYNECOL ONCOL, V130, P132, DOI 10.1016/j.ygyno.2013.04.048; Zhao FX, 2010, PRENATAL DIAG, V30, P778, DOI 10.1002/pd.2546	38	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84051	10.1371/journal.pone.0084051	http://dx.doi.org/10.1371/journal.pone.0084051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391879	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900022
J	White, O; Davare, M; Andres, M; Olivier, E				White, Olivier; Davare, Marco; Andres, Michael; Olivier, Etienne			The Role of Left Supplementary Motor Area in Grip Force Scaling	PLOS ONE			English	Article							INTERNAL-MODELS; PRECISION GRIP; MAGNETIC STIMULATION; BRAIN ACTIVITY; PREMOTOR; ACTIVATION; OBJECTS; SMA; CONNECTIVITY; MANIPULATION	Skilled tool use and object manipulation critically relies on the ability to scale anticipatorily the grip force (GF) in relation to object dynamics. This predictive behaviour entails that the nervous system is able to store, and then select, the appropriate internal representation of common object dynamics, allowing GF to be applied in parallel with the arm motor commands. Although psychophysical studies have provided strong evidence supporting the existence of internal representations of object dynamics, known as "internal models", their neural correlates are still debated. Because functional neuroimaging studies have repeatedly designated the supplementary motor area (SMA) as a possible candidate involved in internal model implementation, we used repetitive transcranial magnetic stimulation (rTMS) to interfere with the normal functioning of left or right SMA in healthy participants performing a grip-lift task with either hand. TMS applied over the left, but not right, SMA yielded an increase in both GF and GF rate, irrespective of the hand used to perform the task, and only when TMS was delivered 130-180 ms before the fingers contacted the object. We also found that both left and right SMA rTMS led to a decrease in preload phase durations for contralateral hand movements. The present study suggests that left SMA is a crucial node in the network processing the internal representation of object dynamics although further experiments are required to rule out that TMS does not affect the GF gain. The present finding also further substantiates the left hemisphere dominance in scaling GF.	[Davare, Marco; Andres, Michael; Olivier, Etienne] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [White, Olivier] Univ Bourgogne, Unite Format & Rech Sci & Tech Act Phys & Sport, Dijon, France; [White, Olivier] INSERM, U1093, Dijon, France; [Davare, Marco] UCL, UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Andres, Michael] Catholic Univ Louvain, Inst Rech Sci Psychol, B-1348 Louvain, Belgium	Universite Catholique Louvain; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University of London; University College London; Universite Catholique Louvain	Olivier, E (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium.	etienne.olivier@uclouvain.be	White, Olivier/AAJ-6914-2020; Andres, Michael/I-2306-2019	White, Olivier/0000-0002-9119-1329; Andres, Michael/0000-0002-7505-8157; Davare, Marco/0000-0002-4670-0251	ARC [07/12-007]; "Fonds Speciaux de Recherche" (FSR) of the Universite catholique de Louvain; "Fonds de la Recherche Scientifique Medicale" (FRSM); BBSRC [BB/J014184/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014184/1] Funding Source: researchfish	ARC(Australian Research Council); "Fonds Speciaux de Recherche" (FSR) of the Universite catholique de Louvain; "Fonds de la Recherche Scientifique Medicale" (FRSM)(Fonds de la Recherche Scientifique - FNRS); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an ARC grant 07/12-007 (Communaute Francaise de Belgique - Actions de Recherche Concertees), the "Fonds Speciaux de Recherche" (FSR) of the Universite catholique de Louvain and the "Fonds de la Recherche Scientifique Medicale" (FRSM) to E.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkal D, 2007, J NEUROSCI, V27, P10659, DOI 10.1523/JNEUROSCI.3134-07.2007; Andres M., 2012, CORTEX; Andres M, 2011, NEUROIMAGE, V54, P3048, DOI 10.1016/j.neuroimage.2010.11.009; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Borra E, 2008, CEREB CORTEX, V18, P1094, DOI 10.1093/cercor/bhm146; Bursztyn LLCD, 2006, CURR BIOL, V16, P2440, DOI 10.1016/j.cub.2006.10.051; Cadoret G, 1997, J NEUROPHYSIOL, V77, P153, DOI 10.1152/jn.1997.77.1.153; Dancause N, 2006, CEREB CORTEX, V16, P1057; Davare M, 2006, J NEUROSCI, V26, P2260, DOI 10.1523/JNEUROSCI.3386-05.2006; Davare M, 2007, J NEUROSCI, V27, P3974, DOI 10.1523/JNEUROSCI.0426-07.2007; Davare M, 2011, CURR OPIN NEUROBIOL, V21, P565, DOI 10.1016/j.conb.2011.05.021; Davidson PR, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S11; Davidson PR, 2004, EXP BRAIN RES, V155, P334, DOI 10.1007/s00221-003-1730-z; Dawson AM, 2010, BRAIN RES, V1317, P124, DOI 10.1016/j.brainres.2009.11.034; DETTMERS C, 1995, J NEUROPHYSIOL, V74, P802, DOI 10.1152/jn.1995.74.2.802; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Duque J, 2003, BRAIN, V126, P732, DOI 10.1093/brain/awg069; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Forssberg H, 1999, BRAIN, V122, P1157, DOI 10.1093/brain/122.6.1157; Hattori N, 2009, J NEUROPHYSIOL, V101, P1267, DOI 10.1152/jn.90249.2008; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Imamizu H, 2007, CORTEX, V43, P338, DOI 10.1016/S0010-9452(08)70459-3; Jenmalm P, 2006, J NEUROSCI, V26, P9015, DOI 10.1523/JNEUROSCI.5045-05.2006; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Johnson-Frey SH, 2004, TRENDS COGN SCI, V8, P71, DOI 10.1016/j.tics.2003.12.002; Kawato M, 1998, NOVART FDN SYMP, V218, P291; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kinoshita H, 2000, BRAIN RES, V857, P119, DOI 10.1016/S0006-8993(99)02416-6; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; Matsunaga K, 2005, J PHYSIOL-LONDON, V562, P295, DOI 10.1113/jphysiol.2004.070755; Milner TE, 2007, NEUROIMAGE, V36, P388, DOI 10.1016/j.neuroimage.2007.01.057; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Noirhomme Q, 2004, IEEE T BIO-MED ENG, V51, P1994, DOI 10.1109/TBME.2004.834266; Nowak DA, 2007, NEUROPSYCHOLOGIA, V45, P696, DOI 10.1016/j.neuropsychologia.2006.08.011; Nowak DA, 2006, BRAIN RES REV, V51, P108, DOI 10.1016/j.brainresrev.2005.10.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olivier E, 2007, CURR OPIN NEUROBIOL, V17, P644, DOI 10.1016/j.conb.2008.01.008; Pazzaglia M, 2008, J NEUROSCI, V28, P3030, DOI 10.1523/JNEUROSCI.5748-07.2008; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Picard N, 2003, CEREB CORTEX, V13, P977, DOI 10.1093/cercor/13.9.977; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; SMITH AM, 1979, BRAIN RES, V172, P315, DOI 10.1016/0006-8993(79)90541-9; SMITH AM, 1981, BRAIN RES, V222, P395, DOI 10.1016/0006-8993(81)91043-X; Steyvers M, 2003, EXP BRAIN RES, V151, P309, DOI 10.1007/s00221-003-1490-9; Sunderland A, 2007, CORTEX, V43, P359, DOI 10.1016/S0010-9452(08)70461-1; Terao Y, 2000, BRAIN RES, V859, P137, DOI 10.1016/S0006-8993(00)01975-2; Vaillancourt DE, 2003, J NEUROPHYSIOL, V90, P3330, DOI 10.1152/jn.00394.2003; White O, 2008, J NEUROPHYSIOL; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Zosso D, 2006, P 14 EUR SIGN PROC C	59	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83812	10.1371/journal.pone.0083812	http://dx.doi.org/10.1371/journal.pone.0083812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391832	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200130
J	Dolinska, MB; Kovaleva, E; Backlund, P; Wingfield, PT; Brooks, BP; Sergeev, YV				Dolinska, Monika B.; Kovaleva, Elena; Backlund, Peter; Wingfield, Paul T.; Brooks, Brian P.; Sergeev, Yuri V.			Albinism-Causing Mutations in Recombinant Human Tyrosinase Alter Intrinsic Enzymatic Activity	PLOS ONE			English	Article							I OCULOCUTANEOUS ALBINISM; MOLECULAR-BASIS; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; MELANOSOMAL PH; TYPE-1 OCA1; MELANOMA; PROTEIN; MUTANT; BRENDA	Background: Tyrosinase (TYR) catalyzes the rate-limiting, first step in melanin production and its gene (TYR) is mutated in many cases of oculocutaneous albinism (OCA1), an autosomal recessive cause of childhood blindness. Patients with reduced TYR activity are classified as OCA1B; some OCA1B mutations are temperature-sensitive. Therapeutic research for OCA1 has been hampered, in part, by the absence of purified, active, recombinant wild-type and mutant human enzymes. Methodology/Principal Findings: The intra-melanosomal domain of human tyrosinase (residues 19-469) and two OCA1B related temperature-sensitive mutants, R422Q and R422W were expressed in insect cells and produced in T. ni larvae. The short trans-membrane fragment was deleted to avoid potential protein insolubility, while preserving all other functional features of the enzymes. Purified tyrosinase was obtained with a yield of > 1 mg per 10 g of larval biomass. The protein was a monomeric glycoenzyme with maximum enzyme activity at 37 degrees C and neutral pH. The two purified mutants when compared to the wild-type protein were less active and temperature sensitive. These differences are associated with conformational perturbations in secondary structure. Conclusions/Significance: The intramelanosomal domains of recombinant wild-type and mutant human tyrosinases are soluble monomeric glycoproteins with activities which mirror their in vivo function. This advance allows for the structure - function analyses of different mutant TYR proteins and correlation with their corresponding human phenotypes; it also provides an important tool to discover drugs that may improve tyrosinase activity and treat OCA1.	[Dolinska, Monika B.; Brooks, Brian P.; Sergeev, Yuri V.] NEI, NIH, Bethesda, MD 20892 USA; [Kovaleva, Elena] Chesapeake PERL, Savage, MD USA; [Backlund, Peter] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Wingfield, Paul T.] NIAMSD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Brooks, BP (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	brooksb@nei.nih.gov; sergeevy@nei.nih.gov		Wingfield, Paul/0000-0002-9515-4752	Intramural program of National Eye Institute, National Institutes of Health [Z01-EY000476-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD001421] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER	Intramural program of National Eye Institute, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Intramural program of National Eye Institute, National Institutes of Health (Z01-EY000476-01 to YVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancans J, 2001, J INVEST DERMATOL, V117, P158, DOI 10.1046/j.0022-202x.2001.01397.x; Ancans J, 2001, EXP CELL RES, V268, P26, DOI 10.1006/excr.2001.5251; Berson JF, 2000, J BIOL CHEM, V275, P12281, DOI 10.1074/jbc.275.16.12281; BHATNAGAR V, 1993, ARCH BIOCHEM BIOPHYS, V307, P183, DOI 10.1006/abbi.1993.1577; Branza-Nichita N, 2000, J BIOL CHEM, V275, P8169, DOI 10.1074/jbc.275.11.8169; Branza-Nichita N, 2000, CHEM REV, V100, P4697, DOI 10.1021/cr990291y; Cohn E. J., 1943, PROTEINS AMINO ACIDS; Garcia-Borron JC, 2002, PIGM CELL RES, V15, P162, DOI 10.1034/j.1600-0749.2002.02012.x; GIEBEL LB, 1991, J CLIN INVEST, V87, P1119, DOI 10.1172/JCI115075; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; HALABAN R, 1988, P NATL ACAD SCI USA, V85, P7241, DOI 10.1073/pnas.85.19.7241; Halaban R, 2002, J INVEST DERMATOL, V119, P481, DOI 10.1046/j.1523-1747.2002.01824.x; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; HEARING VJ, 1987, METHOD ENZYMOL, V142, P154; HEARING VJ, 1976, BIOCHEM J, V157, P549, DOI 10.1042/bj1570549; IMOKAWA G, 1982, CANCER RES, V42, P1994; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; Jeong CH, 2004, BIOSCI BIOTECH BIOCH, V68, P1984, DOI 10.1271/bbb.68.1984; Kong JN, 2010, PROTEIN PEPTIDE LETT, V17, P1026, DOI 10.2174/092986610791498957; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger Elmar, 2003, Methods Biochem Anal, V44, P509; KUBELKA V, 1994, ARCH BIOCHEM BIOPHYS, V308, P148, DOI 10.1006/abbi.1994.1021; KWON BS, 1989, J INVEST DERMATOL, V93, P589, DOI 10.1111/1523-1747.ep12319693; KWON BS, 1989, BIOCHEM BIOPH RES CO, V161, P252, DOI 10.1016/0006-291X(89)91588-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE C, 1991, J MOL BIOL, V217, P373, DOI 10.1016/0022-2836(91)90550-P; LEE C, 1994, J MOL BIOL, V236, P918, DOI 10.1006/jmbi.1994.1198; LERCH K, 1987, METHOD ENZYMOL, V142, P165; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Lopez-Serrano D, 2007, MICROBIOL-SGM, V153, P2241, DOI 10.1099/mic.0.2007/006833-0; Lyons LA, 2005, ANIM GENET, V36, P119, DOI 10.1111/j.1365-2052.2005.01253.x; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Oetting WS, 2000, PIGM CELL RES, V13, P320, DOI 10.1034/j.1600-0749.2000.130503.x; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Onojafe IF, 2011, J CLIN INVEST, V121, P3914, DOI 10.1172/JCI59372; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P4367, DOI 10.1073/pnas.071066498; Schomburg I, 2002, TRENDS BIOCHEM SCI, V27, P54, DOI 10.1016/S0968-0004(01)02027-8; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SHIBAHARA S, 1988, TOHOKU J EXP MED, V156, P403, DOI 10.1620/tjem.156.403; Shire SJ, 1992, DS837; Simeonov DR, 2013, HUM MUTAT, V34, P827, DOI 10.1002/humu.22315; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Spritz RA, 1997, HUM MUTAT, V10, P171, DOI 10.1002/(SICI)1098-1004(1997)10:2<171::AID-HUMU11>3.3.CO;2-9; Summers C G, 1996, Trans Am Ophthalmol Soc, V94, P1095; Toyofuku K, 2001, FASEB J, V15, P2149, DOI 10.1096/fj.01-0216com; Toyofuku K, 2001, BIOCHEM J, V355, P259, DOI 10.1042/0264-6021:3550259; Ujvari A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200; Wang T, 2005, BRIT J OPHTHALMOL, V89, P1383, DOI 10.1136/bjo.2005.070243; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WITTBJER A, 1990, PIGM CELL RES, V3, P168, DOI 10.1111/j.1600-0749.1990.tb00283.x; WITTBJER A, 1990, ACTA DERM-VENEREOL, V70, P291; WITTBJER A, 1989, ACTA DERM-VENEREOL, V69, P125	60	25	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84494	10.1371/journal.pone.0084494	http://dx.doi.org/10.1371/journal.pone.0084494			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392141	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100064
J	Earland, K; Lee, M; Shaw, P; Law, J				Earland, Kevin; Lee, Mark; Shaw, Patricia; Law, James			Overlapping Structures in Sensory-Motor Mappings	PLOS ONE			English	Article							RECEPTIVE-FIELDS; MAPS; EYE; INTEGRATION; NEURONS; VISION	This paper examines a biologically-inspired representation technique designed for the support of sensory-motor learning in developmental robotics. An interesting feature of the many topographic neural sheets in the brain is that closely packed receptive fields must overlap in order to fully cover a spatial region. This raises interesting scientific questions with engineering implications: e. g. is overlap detrimental? does it have any benefits? This paper examines the effects and properties of overlap between elements arranged in arrays or maps. In particular we investigate how overlap affects the representation and transmission of spatial location information on and between topographic maps. Through a series of experiments we determine the conditions under which overlap offers advantages and identify useful ranges of overlap for building mappings in cognitive robotic systems. Our motivation is to understand the phenomena of overlap in order to provide guidance for application in sensory-motor learning robots.	[Earland, Kevin; Lee, Mark; Shaw, Patricia; Law, James] Aberystwith Univ, Dept Comp Sci, Aberystwyth, Dyfed, Wales	Aberystwyth University	Earland, K (corresponding author), Aberystwith Univ, Dept Comp Sci, Aberystwyth, Dyfed, Wales.	kee8@aber.ac.uk		Law, James/0000-0002-4966-3556; Shaw, Patricia/0000-0002-6994-8647	European Commission [ICT-IP-231722]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research has received funds from the European Commission 7th Framework Programme (FP7/2007-2013), Challenge 2 - Cognitive Systems, Interaction, Robotics, grant agreement No. ICT-IP-231722, project IM- CLeVeR - Intrinsically Motivated Cumulative Learning Versatile Robots. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT LF, 1994, Q REV BIOPHYS, V27, P291, DOI 10.1017/S0033583500003024; Anishchenko A, 2010, J NEUROPHYSIOL, V103, P1856, DOI 10.1152/jn.00896.2009; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; Balasuriya S, 2005, IEEE IJCNN, P3069; BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; Braitenberg V, 2001, J COMPUT NEUROSCI, V10, P71, DOI 10.1023/A:1008920127052; Braitenberg V, 1991, ANATOMY OF THE CORTE; Carreira-Perpinan MA, 2005, CEREB CORTEX, V15, P1222, DOI 10.1093/cercor/bhi004; Chaisanguanthum KS, 2011, J NEUROSCI, V31, P4868, DOI 10.1523/JNEUROSCI.6776-10.2011; Dayan P, 2001, COMPUTATIONAL NEUROS; Derdikman D, 2010, TRENDS COGN SCI, V14, P561, DOI 10.1016/j.tics.2010.09.004; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; Einarsdottir H, 2007, INT C DEVEL LEARN, P28; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P430; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Goodhill GJ, 2005, NETWORK-COMP NEURAL, V16, P5, DOI 10.1080/09548980500254654; Hulse M, 2010, IEEE T AUTON MENT DE, V2, P355, DOI 10.1109/TAMD.2010.2081667; Hulse M., 2009, P IEEE 8 INT C DEV L, P1; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; KANDEL ER, 2000, PRINCIPLES OF NEURAL, V4; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Lee MH, 2007, ADAPT BEHAV, V15, P241, DOI 10.1177/1059712307082085; Lehky SR, 2010, FRONTIERS IN COMPUTA, P4; Liu YS, 2009, P NATL ACAD SCI USA, V106, P16499, DOI 10.1073/pnas.0908926106; LO SH, 1989, INT J NUMER METH ENG, V28, P2695, DOI 10.1002/nme.1620281113; MacLennan B, 1997, ADV PSYCHOL, V119, P37; MALLOT HA, 1990, NEURAL NETWORKS, V3, P245, DOI 10.1016/0893-6080(90)90069-W; Manolakis DE, 1996, IEEE T AERO ELEC SYS, V32, P1239, DOI 10.1109/7.543845; Meng QG, 2007, CONNECT SCI, V19, P25, DOI 10.1080/09540090600971302; Natale L., 2013, INTRINSICALLY MOTIVA, P433, DOI DOI 10.1007/978-3-642-32375-1_17; Nummela SU, 2011, J NEUROSCI, V31, P8059, DOI 10.1523/JNEUROSCI.5480-10.2011; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; Roka A., 2007, ACTA POLYTECH HUNG, V4, P31; Sterling P, 1999, NAT NEUROSCI, V2, P851, DOI 10.1038/13142; Utans J., 1996, P AAAI 96 WORKSH INT, P133; Van der Willigen RF, 2011, J INTEGR NEUROSCI, V10, P277, DOI 10.1142/S0219635211002750; VANGISBERGEN JAM, 1987, NEUROSCIENCE, V21, P541, DOI 10.1016/0306-4522(87)90140-0; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Weng J, 2006, 5TH INTERNATIONAL CO	43	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84240	10.1371/journal.pone.0084240	http://dx.doi.org/10.1371/journal.pone.0084240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392118	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000329460100041
J	Kang, HS; Ahn, SH; Mishra, SK; Hong, KM; Lee, ES; Shin, KH; Ro, J; Lee, KS; Kim, MK				Kang, Han-Sung; Ahn, Sei Hyun; Mishra, Siddhartha Kumar; Hong, Kyeong-Man; Lee, Eun Sook; Shin, Kyung Hwan; Ro, Jungsil; Lee, Keun Seok; Kim, Mi Kyung			Association of Polymorphisms and Haplotypes in the Insulin-Like Growth Factor 1 Receptor (IGF1R) Gene with the Risk of Breast Cancer in Korean Women	PLOS ONE			English	Article							FACTOR-I RECEPTOR; GENOME-WIDE ASSOCIATION; PROSTATE-CANCER; BINDING PROTEIN-3; COPY NUMBER; CELL-LINES; SUSCEPTIBILITY; TUMORS; EXPRESSION; MUTATIONS	The insulin-like growth factor (IGF) signaling pathway plays an important role in cancer biology. The IGF 1 receptor (IGF1R) overexpression has been associated with a number of hematological neoplasias and solid tumors including breast cancer. However, molecular mechanism involving IGF1R in carcinogenic developments is clearly not known. We investigated the genetic variations across the IGF1R polymorphism and the risk of breast cancer risk in Korean women. A total of 1418 individuals comprising 1026 breast cancer cases and 392 age-matched controls of Korean were included for the analysis. Genomic DNA was extracted from whole blood and single nucleotide polymorphisms (SNPs) were analyzed on the GoldenGate Assay system by Illumina's Custom Genetic Analysis service. SNPs were selected for linkage disequilibrium (LD) analysis by Haploview. We genotyped total 51 SNPs in the IGF1R gene and examined for association with breast cancer. All the SNPs investigated were in Hardy-Weinberg equilibrium. These SNPs tested were significantly associated with breast cancer risk, after correction for multiple comparisons by adjusting for age at diagnosis, BMI, age at menarche, and age at first parturition. Among 51 IGF1R SNPs, five intron located SNPs (rs8032477, rs7175052, rs12439557, rs11635251 and rs12916884) with homozygous genotype (variant genotype) were associated with decreased risk of breast cancer. Fisher's combined p-value for the five SNPs was 0.00032. Three intron located SNPs with heterozygous genotypes also had decreased risk of breast cancer. Seven of the 51 IGF1R SNPs were in LD and in one haplotype block, and were likely to be associated with breast cancer risk. Overall, this case-control study demonstrates statistically significant associations between breast cancer risk and polymorphisms in IGF1R gene.	[Kang, Han-Sung; Lee, Eun Sook; Shin, Kyung Hwan; Ro, Jungsil; Lee, Keun Seok] Natl Canc Ctr, Ctr Breast Canc, Goyang Si, Gyeonggi Do, South Korea; [Ahn, Sei Hyun] Asan Med Ctr, Div Breast & Endocrine Surg, Dept Surg, Seoul, South Korea; [Mishra, Siddhartha Kumar; Kim, Mi Kyung] Natl Canc Ctr, Div Canc Epidemiol, Goyang Si, Gyeonggi Do, South Korea; [Hong, Kyeong-Man] Natl Canc Ctr, Div Canc Biol, Goyang Si, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC); University of Ulsan; Asan Medical Center; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kim, MK (corresponding author), Natl Canc Ctr, Div Canc Epidemiol, Goyang Si, Gyeonggi Do, South Korea.	alrud@ncc.re.kr	Mishra, Siddhartha Kumar/A-4344-2016	Mishra, Siddhartha Kumar/0000-0003-1627-1377	Korea National Cancer Center [NCC-0910310, NCC-1310361]; Asan Institute for Life Sciences, Seoul, Republic of Korea [2009-022]	Korea National Cancer Center; Asan Institute for Life Sciences, Seoul, Republic of Korea	This study was supported by grant-in-aids from the Korea National Cancer Center (grant nos. NCC-0910310, NCC-1310361) and a grant (2009-022) from the Asan Institute for Life Sciences, Seoul, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; ALMEIDA A, 1994, GENE CHROMOSOME CANC, V11, P63, DOI 10.1002/gcc.2870110110; Althuis MD, 2004, CANCER EPIDEM BIOMAR, V13, P1558; Armengol G, 2000, CANCER GENET CYTOGEN, V116, P133, DOI 10.1016/S0165-4608(99)00118-1; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BONNETERRE J, 1990, CANCER RES, V50, P6931; Browne BC, 2012, BREAST CANCER RES TR, V136, P717, DOI 10.1007/s10549-012-2260-9; Chakraborty AK, 2010, BREAST CANCER RES TR, V120, P327, DOI 10.1007/s10549-009-0382-5; Chan JM, 2002, J NATL CANCER I, V94, P1099; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Fu PF, 2011, BREAST CANCER RES TR, V130, P307, DOI 10.1007/s10549-011-1605-0; Hartog H, 2011, BREAST CANCER RES TR, V129, P725, DOI 10.1007/s10549-010-1256-6; Jin Q, 2008, J MAMMARY GLAND BIOL, V13, P485, DOI 10.1007/s10911-008-9107-3; Kaplan RC, 2011, HUM MOL GENET, V20, P1241, DOI 10.1093/hmg/ddq560; Kleinberg DL, 2009, ENDOCR REV, V30, P51, DOI 10.1210/er.2008-0022; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu L, 2011, BREAST CANCER RES TR, V125, P479, DOI 10.1007/s10549-010-0959-z; Nakagawa M, 2012, CLIN LUNG CANCER, V13, P136, DOI 10.1016/j.cllc.2011.10.006; Natrajan R, 2006, CANCER RES, V66, P11148, DOI 10.1158/0008-5472.CAN-06-1931; NCC, 2011, CANC FACTS FIG 2011; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Renehan AG, 2005, INT J CANCER, V115, P1006, DOI 10.1002/ijc.20975; Resnik JL, 1998, CANCER RES, V58, P1159; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Shi R, 2001, BRIT J CANCER, V85, P991, DOI 10.1054/bjoc.2001.1961; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stattin P, 2004, J CLIN ONCOL, V22, P3104, DOI 10.1200/JCO.2004.10.105; Surmacz E, 2003, ONCOGENE, V22, P6589, DOI 10.1038/sj.onc.1206772; Tamimi RM, 2011, BREAST CANCER RES TR, V128, P243, DOI 10.1007/s10549-010-1313-1; Tamimi RM, 2010, CANCER-AM CANCER SOC, V116, P4944, DOI 10.1002/cncr.25386; Tarn C, 2008, P NATL ACAD SCI USA, V105, P8387, DOI 10.1073/pnas.0803383105; Tushir JS, 2010, MOL BIOL CELL, V21, P2355, DOI 10.1091/mbc.E09-09-0824; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	41	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84532	10.1371/journal.pone.0084532	http://dx.doi.org/10.1371/journal.pone.0084532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392142	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100065
J	Forbes, N; Selman, M; Pelchat, M; Jia, JJ; Stintzi, A; Brown, EG				Forbes, Nicole; Selman, Mohammed; Pelchat, Martin; Jia, Jian Jun; Stintzi, Alain; Brown, Earl G.			Identification of Adaptive Mutations in the Influenza A Virus Non-Structural 1 Gene That Increase Cytoplasmic Localization and Differentially Regulate Host Gene Expression	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; NS1 PROTEIN TARGETS; STRIKING DIFFERENCES; BETA-INTERFERON; RNA-BINDING; MOUSE LUNG; RIG-I; INHIBITION; VIRULENCE; HEMAGGLUTININ	The NS1 protein of influenza A virus (IAV) is a multifunctional virulence factor. We have previously characterized gain-offunction mutations in the NS1 protein arising from the experimental adaptation of the human isolate A/ Hong Kong/ 1/ 1968(H3N2) (HK) to the mouse. The majority of these mouse adapted NS1 mutations were demonstrated to increase virulence, viral fitness, and interferon antagonism, but differ in binding to the post-transcriptional processing factor cleavage and polyadenylation specificity factor 30 (CPSF30). Because nuclear trafficking is a major genetic determinant of influenza virus host adaptation, we assessed subcellular localization and host gene expression of NS1 adaptive mutations. Recombinant HK viruses with adaptive mutations in the NS1 gene were assessed for NS1 protein subcellular localization in mouse and human cells using confocal microscopy and cellular fractionation. In human cells the HK wild-type (HK-wt) virus NS1 protein partitioned equivalently between the cytoplasm and nucleus but was defective in cytoplasmic localization in mouse cells. Several adaptive mutations increased the proportion of NS1 in the cytoplasm of mouse cells with the greatest effects for mutations M106I and D125G. The host gene expression profile of the adaptive mutants was determined by microarray analysis of infected mouse cells to show either high or low extents of host-gene regulation (HGR or LGR) phenotypes. While host genes were predominantly down regulated for the HGR group of mutants (D2N, V23A, F103L, M106I+ L98S, L98S, M106V, and M106V+ M124I), the LGR phenotype mutants (D125G, M106I, V180A, V226I, and R227K) were characterized by a predominant up regulation of host genes. CPSF30 binding affinity of NS1 mutants did not predict effects on host gene expression. To our knowledge this is the first report of roles of adaptive NS1 mutations that impact intracellular localization and regulation of host gene expression.	[Forbes, Nicole; Selman, Mohammed; Pelchat, Martin; Jia, Jian Jun; Stintzi, Alain; Brown, Earl G.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Forbes, Nicole; Selman, Mohammed; Brown, Earl G.] Univ Ottawa, Fac Med, Emerging Pathogens Res Ctr, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Brown, EG (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	ebrown@uottawa.ca		Forbes, Nicole/0000-0002-2645-695X; Selman, Mohammed/0000-0002-3265-2009	Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team [TPA-90188]; CIHR [MOP-74526]; Ontario Graduate Scholarship in Science and Technology	Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship in Science and Technology	This project has been funded by the Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team grant to the CIHR Canadian Influenza Pathogenesis Team (EGB) TPA-90188, and CIHR operating grant MOP-74526 (EGB); http:// www.cihr-irsc.gc.ca/. NE Forbes was funded from an Ontario Graduate Scholarship in Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Brown EG, 1999, VIRUS RES, V61, P63, DOI 10.1016/S0168-1702(99)00027-1; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Dankar SK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-243; Dankar SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-13; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Forbes NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031839; Fulcher AJ, 2011, BBA-MOL CELL RES, V1813, P2176, DOI 10.1016/j.bbamcr.2011.03.019; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Han H, 2010, J GEN VIROL, V91, P2907, DOI 10.1099/vir.0.024943-0; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Keleta L, 2008, J VIROL, V82, P11599, DOI 10.1128/JVI.01393-08; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kuo RL, 2009, J VIROL, V83, P1611, DOI 10.1128/JVI.01491-08; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li W, 2011, J GEN VIROL, V92, P1832, DOI 10.1099/vir.0.031336-0; Li Y, 2010, J VIROL, V84, P7204, DOI 10.1128/JVI.00203-10; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Melen K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-167; Meng J, 2012, SCI CHINA LIFE SCI, V55, P933, DOI 10.1007/s11427-012-4393-9; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; Rahim MN, 2013, J GEN VIROL, V94, P593, DOI 10.1099/vir.0.046649-0; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Resa-Infante P, 2013, BIOESSAYS, V35, P23, DOI 10.1002/bies.201200138; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Selman M, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.38; SHAW MW, 1978, J VIROL, V25, P608, DOI 10.1128/JVI.25.2.608-615.1978; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tan SL, 1998, J INTERF CYTOK RES, V18, P757, DOI 10.1089/jir.1998.18.757; Volmer R, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-63	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84673	10.1371/journal.pone.0084673	http://dx.doi.org/10.1371/journal.pone.0084673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391972	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900115
J	Li, XH; Tan, QM				Li, Xiaohui; Tan, Qingmei			Vehicle Scheduling Schemes for Commercial and Emergency Logistics Integration	PLOS ONE			English	Article							DISASTER RELIEF	In modern logistics operations, large-scale logistics companies, besides active participation in profit-seeking commercial business, also play an essential role during an emergency relief process by dispatching urgently-required materials to disaster-affected areas. Therefore, an issue has been widely addressed by logistics practitioners and caught researchers' more attention as to how the logistics companies achieve maximum commercial profit on condition that emergency tasks are effectively and performed satisfactorily. In this paper, two vehicle scheduling models are proposed to solve the problem. One is a prediction-related scheme, which predicts the amounts of disaster-relief materials and commercial business and then accepts the business that will generate maximum profits; the other is a priority-directed scheme, which, firstly groups commercial and emergency business according to priority grades and then schedules both types of business jointly and simultaneously by arriving at the maximum priority in total. Moreover, computer-based simulations are carried out to evaluate the performance of these two models by comparing them with two traditional disaster-relief tactics in China. The results testify the feasibility and effectiveness of the proposed models.	[Li, Xiaohui] Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, Nanjing, Jiangsu, Peoples R China; [Li, Xiaohui; Tan, Qingmei] Yantai Univ, Coll Foreign Languages, Yantai, Shandong, Peoples R China	Nanjing University of Aeronautics & Astronautics; Yantai University	Li, XH (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Econ & Management, Nanjing, Jiangsu, Peoples R China.	grace_725@163.com		Asim, Zeeshan/0000-0002-2156-5006	National Natural Science Foundation of China [71073079]; National Social Science Foundation Youth Project [12CGL042, 12BGL104]; Shandong Natural Science Foundation of China [ZR2011GL019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation Youth Project; Shandong Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	Funding was provided by the National Natural Science Foundation of China (Grant Number: 71073079), National Social Science Foundation Youth Project (Grant Number: 12CGL042), National Social Science Foundation Youth Project (Grant Number: 12BGL104), and Shandong Natural Science Foundation of China (Grant Number: ZR2011GL019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, J BUS LOGIST; ARDEKANI SA, 1988, TRANSPORT Q, V42, P107; Asakura Y, 2004, P 2 INT S TRANSP NET, P20; Ballou R., 1999, BUSINESS LOGISTICS M; Barbarosoglu G, 2002, EUR J OPER RES, V140, P118, DOI 10.1016/S0377-2217(01)00222-3; Bent R, 2006, COMPUT OPER RES, V33, P875, DOI 10.1016/j.cor.2004.08.001; Bowersox D.J., 1996, LOGISTICAL MANAGEMEN; BROWN GG, 1993, NAV RES LOG, V40, P1, DOI 10.1002/1520-6750(199302)40:1<1::AID-NAV3220400102>3.0.CO;2-S; Cherrie W, 2006, P 39 HAW INT C SYST; Dalziell E.P., 2004, 1 INT FORUM ENG DECI; ESRI, 1999, TECHNICAL REPORT; Fiedrich F, 2000, SAFETY SCI, V35, P41, DOI 10.1016/S0925-7535(00)00021-7; Fu L, 2006, COMPUT OPER RES, V33, P3324, DOI 10.1016/j.cor.2005.03.027; Johnson J. C., 1999, CONT LOGISTICS; KEMBALLCOOK D, 1984, DISASTERS, V8, P57, DOI 10.1111/j.1467-7717.1984.tb00853.x; KNOTT R, 1987, DISASTERS, V11, P113, DOI 10.1111/j.1467-7717.1987.tb00624.x; KNOTT RP, 1988, DISASTERS, V12, P285, DOI 10.1111/j.1467-7717.1988.tb00678.x; Liu B, 1997, IEEE T SYST MAN CY A, V27, P436, DOI 10.1109/3468.594911; Liu Henry X., 2006, P 85 ANN M TRANSP RE; Liu Ying, 2006, P 85 ANN M TRANSP RE; Lyles A, 2005, CLIN THER, V27, P1464, DOI 10.1016/S0149-2918(05)80247-4; Moriarty K, 2007, 86 TRB ANN M, P21; Nicholson A., 2007, P 3 INT S TRANSP NET; Ozdamar L, 2004, ANN OPER RES, V129, P217, DOI 10.1023/B:ANOR.0000030690.27939.39; RATHI AK, 1992, LOGIST TRANSPORT REV, V28, P167; Takeuchi T, 2003, 8 INT C COMP URB PLA; Tzeng GH, 2007, TRANSPORT RES E-LOG, V43, P673, DOI 10.1016/j.tre.2006.10.012; Yi W, 2007, TRANSPORT RES E-LOG, V43, P660, DOI 10.1016/j.tre.2006.05.004	28	1	1	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82866	10.1371/journal.pone.0082866	http://dx.doi.org/10.1371/journal.pone.0082866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391724	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200021
J	Tibely, G; Pollner, P; Vicsek, T; Palla, G				Tibely, Gergely; Pollner, Peter; Vicsek, Tamas; Palla, Gergely			Extracting Tag Hierarchies	PLOS ONE			English	Article							COLLECTIVE DYNAMICS; COMMUNITY STRUCTURE; NETWORKS; IDENTIFICATION; EMERGENCE	Tagging items with descriptive annotations or keywords is a very natural way to compress and highlight information about the properties of the given entity. Over the years several methods have been proposed for extracting a hierarchy between the tags for systems with a "flat", egalitarian organization of the tags, which is very common when the tags correspond to free words given by numerous independent people. Here we present a complete framework for automated tag hierarchy extraction based on tag occurrence statistics. Along with proposing new algorithms, we are also introducing different quality measures enabling the detailed comparison of competing approaches from different aspects. Furthermore, we set up a synthetic, computer generated benchmark providing a versatile tool for testing, with a couple of tunable parameters capable of generating a wide range of test beds. Beside the computer generated input we also use real data in our studies, including a biological example with a pre-defined hierarchy between the tags. The encouraging similarity between the pre-defined and reconstructed hierarchy, as well as the seemingly meaningful hierarchies obtained for other real systems indicate that tag hierarchy extraction is a very promising direction for further research with a great potential for practical applications. Tags have become very prevalent nowadays in various online platforms ranging from blogs through scientific publications to protein databases. Furthermore, tagging systems dedicated for voluntary tagging of photos, films, books, etc. with free words are also becoming popular. The emerging large collections of tags associated with different objects are often referred to as folksonomies, highlighting their collaborative origin and the "flat" organization of the tags opposed to traditional hierarchical categorization. Adding a tag hierarchy corresponding to a given folksonomy can very effectively help narrowing or broadening the scope of search. Moreover, recommendation systems could also benefit from a tag hierarchy.	[Tibely, Gergely; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Pollner, Peter; Palla, Gergely] HAS, Stat & Biol Phys Res Grp, Budapest, Hungary; [Tibely, Gergely; Pollner, Peter; Vicsek, Tamas; Palla, Gergely] Eotvos Lorand Univ, Reg Knowledge Ctr, Szekesfehervar, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University	Palla, G (corresponding author), HAS, Stat & Biol Phys Res Grp, Budapest, Hungary.	pallag@hal.elte.hu	Tibely, Gergely/AAE-6348-2019; Palla, Gergely/H-1767-2016; Pollner, Peter/N-3975-2016	Palla, Gergely/0000-0002-3406-4200; Pollner, Peter/0000-0003-0464-4893	European Union; European Social Fund through project FuturICT.hu [TAMOP-4.2.2.C-11/1/KONV-2012-0013]; Hungarian National Science Fund [OTKA K105447]	European Union(European Commission); European Social Fund through project FuturICT.hu; Hungarian National Science Fund	The research was partially supported by the European Union and the European Social Fund through project FuturICT.hu (grant no.:TAMOP-4.2.2.C-11/1/KONV-2012-0013) and by the Hungarian National Science Fund (OTKA K105447). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Cattuto C, 2009, P NATL ACAD SCI USA, V106, P10511, DOI 10.1073/pnas.0901136106; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Corominas-Murtra B, 2013, ARXIV13032503; Corominas-Murtra B, 2011, CHAOS, V21, DOI 10.1063/1.3562548; Damme C.V., 2007, SOC NETWORKS, V2, P57; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Finocchiaro G, 2007, NUCLEIC ACIDS RES, V35, P2343, DOI 10.1093/nar/gkm119; Floeck F, 2010, ADV INTEL SOFT COMPU, V76, P75; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fred ALN, 2003, PROC CVPR IEEE, P128; Fushing H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017817; Garcia-Molina H., 2006, TECHNICAL REPORT; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Holme P, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.056108; IMDb, MOV TV CEL; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Jonsson PF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-2; Juszczyszyn K, 2010, STUD COMPUT INTELL, V289, P275; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kozma B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016102; Kuncheva LI, 2004, IEEE SYS MAN CYBERN, P1214; Lambiotte R, 2006, LECT NOTES COMPUT SC, V3993, P1114; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Mendes J. F. F., 2003, EVOLUTION NETWORKS B; Mika P, 2005, LECT NOTES COMPUT SC, V3729, P522, DOI 10.1007/11574620_38; Mones E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033799; Musial Katarzyna, 2008, Systems Science, V34, P97; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Plangprasopchok A., 2011, P 4 ACM WEB SEARCH D; Plangprasopchok A., 2009, P 18 INT C WORLD WID, P781; Pollner P, 2006, EUROPHYS LETT, V73, P478, DOI 10.1209/epl/i2005-10414-6; Pumain D, 2006, METHODS SER, V3, P1, DOI 10.1007/1-4020-4127-6; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schmitz P., 2006, P COLL WEB TAGG WORK; Spyns P, 2006, P OTM C, P1738; Tibely G, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053009; Trusina A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178702; Valverde S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046118; Vazquez F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108702; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707; Zlatic V, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036118	59	18	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84133	10.1371/journal.pone.0084133	http://dx.doi.org/10.1371/journal.pone.0084133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391901	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900044
J	Wahidullah, S; Naik, DN; Devi, P				Wahidullah, Solimabi; Naik, Deepak N.; Devi, Prabha			Fermentation Products of Solvent Tolerant Marine Bacterium Moraxella spp. MB1 and Its Biotechnological Applications in Salicylic Acid Bioconversion	PLOS ONE			English	Article							PHENYLALANINE AMMONIA-LYASE; ESCHERICHIA-COLI; DEGRADATION; PLANT; BIOSYNTHESIS; PATHWAY; HYDROXYBENZOATE; CONSTITUENTS; GENTISATE; ENZYMES	As part of a proactive approach to environmental protection, emerging issues with potential impact on the environment is the subject of ongoing investigation. One emerging area of environmental research concerns pharmaceuticals like salicylic acid, which is the main metabolite of various analgesics including aspirin. It is a common component of sewage effluent and also an intermediate in the degradation pathway of various aromatic compounds which are introduced in the marine environment as pollutants. In this study, biotransformation products of salicylic acid by seaweed, Bryopsis plumosa, associated marine bacterium, Moraxella spp. MB1, have been investigated. Phenol, conjugates of phenol and hydroxy cinnamic acid derivatives (coumaroyl, caffeoyl, feruloyl and trihydroxy cinnamyl) with salicylic acid (3-8) were identified as the bioconversion products by electrospray ionization mass spectrometry. These results show that the microorganism do not degrade phenolic acid but catalyses oxygen dependent transformations without ring cleavage. The degradation of salicylic acid is known to proceed either via gentisic acid pathway or catechol pathway but this is the first report of biotransformation of salicylic acid into cinnamates, without ring cleavage. Besides cinnamic acid derivatives (9-12), metabolites produced by the bacterium include antimicrobial indole (13) and beta-carbolines, norharman (14), harman (15) and methyl derivative (16), which are beneficial to the host and the environment.	[Wahidullah, Solimabi; Naik, Deepak N.; Devi, Prabha] Natl Inst Oceanog, CSIR, Chem Oceanog Div, Bioorgan Chem Lab, Panaji, Goa, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Wahidullah, S (corresponding author), Natl Inst Oceanog, CSIR, Chem Oceanog Div, Bioorgan Chem Lab, Panaji, Goa, India.	solima@nio.org			NIO-CSIR	NIO-CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by NIO-CSIR. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bae FA, 1998, BIOL PHARM BULL, V21, P990, DOI 10.1248/bpb.21.990; Barnes CC, 2003, J NAT PROD, V66, P1457, DOI 10.1021/np030197j; Berner M, 2006, J BACTERIOL, V188, P2666, DOI 10.1128/JB.188.7.2666-2673.2006; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; BUSWELL JA, 1980, FEMS MICROBIOL LETT, V8, P135, DOI 10.1016/0378-1097(80)90016-6; Cardoso AM, 1999, EUR MASS SPECTROM, V5, P11, DOI 10.1255/ejms.244; Chalabaev S, 2008, APPL ENVIRON MICROB, V74, P1717, DOI 10.1128/AEM.02589-07; Cheng KC, 2011, APPL MICROBIOL BIOT, V92, P29, DOI 10.1007/s00253-011-3477-y; COHEN SP, 1993, J BACTERIOL, V175, P7856, DOI 10.1128/JB.175.24.7856-7862.1993; CRAWFORD RL, 1976, CAN J MICROBIOL, V22, P276, DOI 10.1139/m76-037; Crouse BA, 2012, ENVIRON RES, V112, P92, DOI 10.1016/j.envres.2011.11.011; Devi P, 2006, MAR BIOTECHNOL, V8, P129, DOI 10.1007/s10126-005-5021-5; Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8; Fang NB, 2002, J AGR FOOD CHEM, V50, P3579, DOI 10.1021/jf0201327; FINKLE BJ, 1962, J BIOL CHEM, V237, P2926; Gaille C, 2002, J BIOL CHEM, V277, P21768, DOI 10.1074/jbc.M202410200; GOETZ FE, 1992, FEMS MICROBIOL LETT, V97, P45; GREGG K, 1994, BIO-TECHNOL, V12, P1361, DOI 10.1038/nbt1294-1361; GRUND E, 1990, APPL ENVIRON MICROB, V56, P1459, DOI 10.1128/AEM.56.5.1459-1464.1990; Hakkinen S, 2000, THESIS; HARIBABU B, 1984, FEMS MICROBIOL LETT, V21, P197; Henschel KP, 1997, REGUL TOXICOL PHARM, V25, P220, DOI 10.1006/rtph.1997.1102; Hossain MB, 2010, J AGR FOOD CHEM, V58, P10576, DOI 10.1021/jf102042g; Ishiyama D, 2004, APPL ENVIRON MICROB, V70, P1297, DOI 10.1128/AEM.70.3.1297-1306.2004; Jia Yan, 2008, Huanjing Kexue, V29, P756; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; Karegoudar TB, 2000, J MICROBIOL, V38, P53; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; Lemoigne M, 1923, CR HEBD ACAD SCI, V176, P1761; Manohar S., 1995, Indian Journal of Experimental Biology, V33, P353; McIntyre C, 2001, RAPID COMMUN MASS SP, V15, P1974, DOI 10.1002/rcm.452.abs; Crotti AEM, 2010, MOL NUTR FOOD RES, V54, P433, DOI 10.1002/mnfr.200900064; OGINO H, 1994, APPL ENVIRON MICROB, V60, P3884, DOI 10.1128/AEM.60.10.3884-3886.1994; Parveen I, 2011, PHYTOCHEMISTRY, V72, P2376, DOI 10.1016/j.phytochem.2011.08.015; Rani M, 1996, BIOCHEM BIOPH RES CO, V220, P377, DOI 10.1006/bbrc.1996.0413; SHAMSUZZ.KM, 1974, J GEN MICROBIOL, V83, P165, DOI 10.1099/00221287-83-1-165; SPAIN JC, 1979, BIOCHEM BIOPH RES CO, V88, P634, DOI 10.1016/0006-291X(79)92095-3; STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O; STOLZ A, 1993, FEMS MICROBIOL LETT, V108, P219, DOI 10.1111/j.1574-6968.1993.tb06102.x; SUEMORI A, 1995, FEMS MICROBIOL LETT, V125, P31, DOI 10.1111/j.1574-6968.1995.tb07331.x; SUZUKI K, 1981, BIOCHIM BIOPHYS ACTA, V657, P530, DOI 10.1016/0005-2744(81)90337-5; Tao XQ, 2007, PROCESS BIOCHEM, V42, P401, DOI 10.1016/j.procbio.2006.09.018; Travkin VM, 1997, FEBS LETT, V407, P69, DOI 10.1016/S0014-5793(97)00297-4; Wells JE, 2005, APPL ENVIRON MICROB, V71, P7974, DOI 10.1128/AEM.71.12.7974-7979.2005; Williams JS, 2005, MICROBIOL-SGM, V151, P2543, DOI 10.1099/mic.0.28136-0; Xiang LK, 2002, J BIOL CHEM, V277, P32505, DOI 10.1074/jbc.M204171200	46	3	3	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83647	10.1371/journal.pone.0083647	http://dx.doi.org/10.1371/journal.pone.0083647			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391802	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200100
J	Xiao, X; Yang, JK; Li, RJ; Liu, SF; Xu, YX; Zheng, WL; Yi, Y; Luo, YY; Gong, FJ; Peng, HL; Pei, MF; Deng, MY; Zhang, GS				Xiao, Xiang; Yang, Jingke; Li, Ruijuan; Liu, Sufang; Xu, Yunxiao; Zheng, Wenli; Yi, Yan; Luo, Yunya; Gong, Fanjie; Peng, Honglin; Pei, Minfei; Deng, Mingyang; Zhang, Guangsen			Deregulation of Mitochondrial ATPsyn-beta in Acute Myeloid Leukemia Cells and with Increased Drug Resistance	PLOS ONE			English	Article							BIOENERGETIC SIGNATURE; CANCER-CELLS; OXIDATIVE-PHOSPHORYLATION; DOWN-REGULATION; PROTEIN MRP; LUNG; METABOLISM; EXPRESSION; DIAGNOSIS; SYNTHASE	The mechanisms underlying the development of multidrug resistance in acute myeloid leukemia are not fully understood. Here we analyzed the expressions of mitochondrial ATPsyn-beta in adriamycin-resistant cell line HL-60/ADM and its parental cell line HL-60. Meanwhile we compared the differences of mitochondrial ATPsyn-beta expression and ATP synthase activity in 110 acute myeloid leukemia (AML, non-M3) patients between relapsed/refractory and those in remission. Our results showed that down-regulation of ATPsyn-beta expression by siRNA in HL-60 cells increased cell viability and apoptotic resistance to adriamycin, while up-regulation of mitochondrial ATPsyn-beta in HL-60/ADM cells enhanced cell sensitivity to adriamycin and promoted apoptosis. Mitochondrial ATPsyn-beta expression and ATP synthase activity in relapsed/refractory acute myeloid leukemia patients were downregulated. This downregulated ATPsyn-beta expression exhibited a positive correlation with the response to adriamycin of primary cells. A lower expression of ATPsyn-beta in newly diagnosed or relapsed/refractory patients was associated with a shorter first remission duration or overall survival. Our findings show mitochondrial ATPsyn-beta plays an important role in the mechanism of multidrug resistance in AML thus may present both a new marker for prognosis assessment and a new target for reversing drug resistance.	[Xiao, Xiang; Yang, Jingke; Li, Ruijuan; Liu, Sufang; Xu, Yunxiao; Zheng, Wenli; Yi, Yan; Luo, Yunya; Gong, Fanjie; Peng, Honglin; Pei, Minfei; Deng, Mingyang; Zhang, Guangsen] Cent S Univ, Xiangya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China	Central South University	Zhang, GS (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Mol Hematol, Div Hematol, Changsha, Hunan, Peoples R China.	zgsllzy@163.com	Yang, Jingke/ABH-8787-2020; xiao, xiang/GWU-6035-2022		Doctor training foundation of Ministry of Education of P.R of China; Scientific Research Program for Public Interests from Health Ministry of China [201202017]; Clinical Research Program from Health Ministry of China	Doctor training foundation of Ministry of Education of P.R of China; Scientific Research Program for Public Interests from Health Ministry of China; Clinical Research Program from Health Ministry of China	This study was supported by Doctor training foundation of Ministry of Education of P.R of China (2010-2012), Scientific Research Program for Public Interests from The Health Ministry of China (No: 201202017) and Clinical Research Program from Health Ministry of China (key project 2011-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2011, CANCER LETT, V311, P210, DOI 10.1016/j.canlet.2011.07.022; ARBER DA, 2008, ACUTE MYELOID LEUKEM; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Chevallier P, 2011, LEUKEMIA, V25, P939, DOI 10.1038/leu.2011.25; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 2002, CANCER RES, V62, P6674; Cuezva JM, 2009, BBA-MOL BASIS DIS, V1792, P1145, DOI 10.1016/j.bbadis.2009.01.006; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Formentini L, 2010, IUBMB LIFE, V62, P554, DOI 10.1002/iub.352; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Harris MH, 2000, MOL CELL BIOL, V20, P3590, DOI 10.1128/MCB.20.10.3590-3596.2000; Harris NL, 1999, ANN ONCOL, V10, P1419, DOI 10.1023/A:1008375931236; He SM, 2011, CURR MED CHEM, V18, P439, DOI 10.2174/092986711794839197; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; Hernlund E, 2009, MOL CANCER THER, V8, P1916, DOI 10.1158/1535-7163.MCT-09-0179; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Isidoro A, 2004, BIOCHEM J, V378, P17, DOI 10.1042/BJ20031541; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Leith CP, 1997, BLOOD, V89, P3323; Li RJ, 2010, ANN ONCOL, V21, P1506, DOI 10.1093/annonc/mdp569; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; Milligan DW, 2006, BRIT J HAEMATOL, V135, P450, DOI 10.1111/j.1365-2141.2006.06314.x; Oguri T, 1998, BRIT J CANCER, V77, P1089, DOI 10.1038/bjc.1998.181; Ortega AD, 2005, NEW FRONTIERS IN MITOCHONDRIAL BIOGENESIS AND DISEASE 2005, P111; Ortega AD, 2008, CARCINOGENESIS, V29, P2053, DOI 10.1093/carcin/bgn185; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Sanchez-Arago M, 2010, CARCINOGENESIS, V31, P567, DOI 10.1093/carcin/bgq012; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; SANCHEZARAGO M, 2012, ANTIOXID REDOX SIGN; SANCHEZARAGO M, 2011, BIOENERGTIC SINGA T; Santamaria G, 2006, CARCINOGENESIS, V27, P925, DOI 10.1093/carcin/bgi315; Schulz TJ, 2006, J BIOL CHEM, V281, P977, DOI 10.1074/jbc.M511064200; Shin YK, 2005, CANCER RES, V65, P3162, DOI 10.1158/0008-5472.CAN-04-3300; SLAPAK CA, 1994, CANCER RES, V54, P5607; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Wang XD, 2001, GENE DEV, V15, P2922; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Willers IM, 2011, BBA-BIOENERGETICS, V1807, P543, DOI 10.1016/j.bbabio.2010.10.016	47	16	18	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83610	10.1371/journal.pone.0083610	http://dx.doi.org/10.1371/journal.pone.0083610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391795	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200092
J	Zhen, S; Hu, CM; Bian, LH				Zhen, Shuai; Hu, Chen-Ming; Bian, Li-Hong			Glutathione S-Transferase Polymorphism Interactions with Smoking Status and HPV Infection in Cervical Cancer Risk: An Evidence-Based Meta-Analysis	PLOS ONE			English	Article							CIGARETTE-SMOKING; GENETIC POLYMORPHISMS; INTRAEPITHELIAL LESIONS; GSTT1 POLYMORPHISMS; GSTM1; SUSCEPTIBILITY; P53; NEOPLASIA; CYP1A1; ASSOCIATION	Background: Human papillomavirus (HPV) infection is considered the major cause of cervical cancer (CC), but a number of infected women do not develop invasive lesions, suggesting the role of genetic susceptibility and environmental co-factors for cancer outbreak. Glutathione S- transferases (GSTs) are multifunctional enzymes that play a key role in the detoxification of varieties of both endogenous products of oxidative stress and exogenous carcinogens. Methods: MEDLINE, EMBASE, and Cochrane databases were searched. All studies evaluating the association between GSTM1 polymorphisms and cervical cancer were included. Pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using fixed-or random-effects model. Results: A total of 23 case-control studies were included in the meta-analysis. The overall result showed that the association between GSTM1 null genotype and risk for cervical cancer was statistically significant (OR = 1.56; 95% CI, 1.39-1.75). Subgroup analyses were performed based on ethnicity, smoking and HPV infection. Our results showed that smokers with null GSTM1 genotype had higher risk of cervical cancer (OR = 2.27, 95% CI, 1.46-3.54). For the ethnicity stratification, significant increased risk of null GSTM1 genotype was found in Chinese and Indian population, but no increased risk in other population was found. Conclusions: this meta-analysis provided strong evidence that the GSTM1 genotype is associated with CC development, especially in Chinese and Indian populations. Smoking and HPV infection modified the association between the null GSTM1 genotype and CC.	[Zhen, Shuai] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Peoples R China; [Zhen, Shuai; Hu, Chen-Ming; Bian, Li-Hong] Acad Mil Med Sci, Hosp 307, Beijing, Peoples R China	Air Force Military Medical University; Academy of Military Medical Sciences - China	Bian, LH (corresponding author), Acad Mil Med Sci, Hosp 307, Beijing, Peoples R China.	lihong_bian@163.com	Zhen, Shuai/AFP-1233-2022; Zhen, Shuai/AFK-3016-2022					Agodi A, 2010, INT J GYNECOL CANCER, V20, P141, DOI 10.1111/IGC.0b013e3181c20842; Agorastos T, 2007, EUR J CANCER PREV, V16, P498, DOI 10.1097/01.cej.0000243859.99265.92; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Giuliano AR, 2002, CANCER CAUSE CONTROL, V13, P839, DOI 10.1023/A:1020668232219; Goodman MT, 2001, GYNECOL ONCOL, V81, P263, DOI 10.1006/gyno.2001.6154; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hengstler JG, 1998, RECENT RES CANCER, V154, P47; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang YK, 2006, TZU CHI MED J, V18, P267; Jee SH, 2002, YONSEI MED J, V43, P712, DOI 10.3349/ymj.2002.43.6.712; Joseph T, 2006, GYNECOL ONCOL, V101, P411, DOI 10.1016/j.ygyno.2005.10.033; Kim JW, 2000, CANCER-AM CANCER SOC, V88, P2082, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2082::AID-CNCR14>3.0.CO;2-D; Kiran B, 2010, J GYNECOL ONCOL, V21, P169, DOI 10.3802/jgo.2010.21.3.169; Kjellberg L, 2000, BRIT J CANCER, V82, P1332, DOI 10.1054/bjoc.1999.1100; Lee SA, 2004, GYNECOL ONCOL, V93, P14, DOI 10.1016/j.ygyno.2003.11.045; Liu Y., 2009, IEEE VTC SPRING 2009, V1, P1; Liu Y, 2012, ASIAN PAC J TROP MED, V5, P480, DOI 10.1016/S1995-7645(12)60083-2; Miller MC, 2001, TOXICOL LETT, V120, P269, DOI 10.1016/S0378-4274(01)00279-X; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nishino K, 2008, J OBSTET GYNAECOL RE, V34, P994, DOI 10.1111/j.1447-0756.2008.00798.x; Niwa Y, 2005, GYNECOL ONCOL, V96, P423, DOI 10.1016/j.ygyno.2004.10.015; de Carvalho CRN, 2008, EUR J GYNAECOL ONCOL, V29, P590; Palma S, 2010, J CANCER RES CLIN, V136, P1101, DOI 10.1007/s00432-009-0757-3; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prokopczyk B, 1997, J NATL CANCER I, V89, P868, DOI 10.1093/jnci/89.12.868; Settheetham-Ishida W, 2009, ASIAN PAC J CANCER P, V10, P365; Sharma A, 2004, NEOPLASMA, V51, P12; Sierra-Torres CH, 2006, ENVIRON MOL MUTAGEN, V47, P553, DOI 10.1002/em.20228; Sierra-Torres CH, 2003, ENVIRON MOL MUTAGEN, V41, P69, DOI 10.1002/em.10132; Singh H, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.046; SLATTERY ML, 1989, JAMA-J AM MED ASSOC, V261, P1593, DOI 10.1001/jama.261.11.1593; Sobti RC, 2006, CANCER GENET CYTOGEN, V166, P117, DOI 10.1016/j.cancergencyto.2005.10.001; Song G. Y., 2008, CHINESE J CANC PREVE, V15, P1054; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Trimble CL, 2005, OBSTET GYNECOL, V105, P174, DOI 10.1097/01.AOG.0000148268.43584.03; Ueda M, 2008, HUM CELL, V21, P95, DOI 10.1111/j.1749-0774.2008.00058.x; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zeller John L, 2007, JAMA, V298, P2336, DOI 10.1001/jama.298.19.2336; Zhou Q, 2006, MODERN PREVENTIVE ME, V33, P269; 马彩玲, 2009, [中华妇产科杂志, Chinese Journal of Obstetrics and Gynecology], V44, P629	43	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83497	10.1371/journal.pone.0083497	http://dx.doi.org/10.1371/journal.pone.0083497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391774	Green Submitted, gold, Green Published			2022-12-27	WOS:000329325200071
J	Zhu, GM; Ou, Q; Zhang, T; Jiang, XD; Sun, GZ; Zhang, N; Wang, KF; Fang, H; Wang, MF; Sun, J; Ge, TD				Zhu, Guiming; Ou, Qin; Zhang, Tao; Jiang, Xudong; Sun, Guozhi; Zhang, Ning; Wang, Kunfu; Fang, Heng; Wang, Mingfu; Sun, Jie; Ge, Tangdong			A More Desirable Balanced Polyunsaturated Fatty Acid Composition Achieved by Heterologous Expression of Delta 15/Delta 4 Desaturases in Mammalian Cells	PLOS ONE			English	Article							ALPHA-LINOLENIC ACID; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; EUGLENA-GRACILIS; MARINE CYANOBACTERIUM; SYNECHOCOCCUS SP; GENE-CLUSTER; IDENTIFICATION; N-3; BIOSYNTHESIS	Arachidonic (ARA), eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids are the most biologically active polyunsaturated fatty acids, but their biosyntheses in mammals are very limited. The biosynthesis of DHA is the most difficult, because this undergoes the Sprecher pathway-a further elongation step from docosapentaenoic acid (DPA), a Delta 6-desaturase acting on a C24 fatty acid substrate followed by a peroxisomal chain shortening step. This paper reports the successful heterologous expression of two non-mammalian genes (with modification of codon usage), coding for Euglena gracilis Delta 4-desaturase and Siganus canaliculatus Delta 4-desaturase respectively, in mammalian cells (HEK293 cell line). Both of the Delta 4-desaturases can efficiently function, directly converting DPA into DHA. Moreover, the cooperation of the E. gracilis Delta 4-desaturase with C. elegans Delta 15-desaturase (able to convert a number of n-6 PUFAs to their corresponding n-3 PUFAs) in transgenic HEK293 cells made a more desirable fatty acid composition -a drastically reduced n-6/ n-3 PUFAs ratio and a high level of DHA as well as EPA and ARA. Our findings provide a basis for potential applications of the gene constructs for expression of Delta 15/Delta 4-desaturases in transgenic livestock to produce such a fatty acid profile in the related products, which certainly will bring benefit to human health.	[Zhu, Guiming; Ou, Qin; Zhang, Tao; Jiang, Xudong; Sun, Guozhi; Wang, Kunfu; Wang, Mingfu; Sun, Jie; Ge, Tangdong] Jiamusi Univ, Coll Basic Med, Lab Biochem & Mol Biol, Jiamusi, Heilongjiang, Peoples R China; [Zhang, Ning] Heilongjiang Univ Chinese Med, Jiamusi Coll, Jiamusi, Heilongjiang, Peoples R China; [Fang, Heng] Jiamusi Univ, Coll Pharm, Jiamusi, Heilongjiang, Peoples R China	Jiamusi University; Heilongjiang University of Chinese Medicine; Jiamusi University	Zhu, GM (corresponding author), Jiamusi Univ, Coll Basic Med, Lab Biochem & Mol Biol, Jiamusi, Heilongjiang, Peoples R China.	xi78926@sina.com	wang, kunfu/AAS-2456-2021		National Natural Science Foundation of China [31000984]; Science and Technology Research Project of Heilongjiang Provincal Education Department [12511563]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Project of Heilongjiang Provincal Education Department	This work was supported by grants from the National Natural Science Foundation of China (No. 31000984) and Science and Technology Research Project of Heilongjiang Provincal Education Department (No. 12511563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EE, 2002, MICROBIOL-SGM, V148, P1903, DOI 10.1099/00221287-148-6-1903; BAJPAI PK, 1991, J AM OIL CHEM SOC, V68, P509, DOI 10.1007/BF02663823; Chajes V, 2012, CANCER EPIDEM BIOMAR, V21, P319, DOI 10.1158/1055-9965.EPI-11-0896; CLANDININ MT, 1985, CAN J PHYSIOL PHARM, V63, P546, DOI 10.1139/y85-094; Cook H.W., 2004, BIOCH LIPIDS LIPOPRO, P181; EMKEN EA, 1994, BBA-LIPID LIPID MET, V1213, P277, DOI 10.1016/0005-2760(94)00054-9; Gao F, 2010, J LIPID RES, V51, P2940, DOI 10.1194/jlr.M005595; Grenon SM, 2012, VASC MED, V17, P51, DOI 10.1177/1358863X11429175; Hussein N, 2005, J LIPID RES, V46, P269, DOI 10.1194/jlr.M400225-JLR200; Institute of Medicine, 2005, DIET REF INT EN CARB; Jiang Y, 2000, PROCESS BIOCHEM, V35, P1205, DOI 10.1016/S0032-9592(00)00163-1; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kang ZB, 2001, P NATL ACAD SCI USA, V98, P4050, DOI 10.1073/pnas.061040198; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; KORN ED, 1964, J LIPID RES, V5, P352; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; MCLENNAN PL, 1988, AM HEART J, V116, P709, DOI 10.1016/0002-8703(88)90328-6; Merle BMJ, 2013, J NUTR, V143, P505, DOI 10.3945/jn.112.171033; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Meyer A, 2003, BIOCHEMISTRY-US, V42, P9779, DOI 10.1021/bi034731y; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Perica MM, 2011, NUTR CLIN PRACT, V26, P409, DOI 10.1177/0884533611411306; Qi BX, 2002, FEBS LETT, V510, P159, DOI 10.1016/S0014-5793(01)03247-1; Qiu X, 2001, J BIOL CHEM, V276, P31561, DOI 10.1074/jbc.M102971200; Simopoulos AP, 2003, WORLD REV NUTR DIET, V92, P1; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Spychalla JP, 1997, P NATL ACAD SCI USA, V94, P1142, DOI 10.1073/pnas.94.4.1142; Takeyama H, 1997, MICROBIOL-UK, V143, P2725, DOI 10.1099/00221287-143-8-2725; Tanaka M, 1999, BIOTECHNOL LETT, V21, P939, DOI 10.1023/A:1005601606929; Tonon T, 2003, FEBS LETT, V553, P440, DOI 10.1016/S0014-5793(03)01078-0; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Wallis JG, 1999, ARCH BIOCHEM BIOPHYS, V365, P307, DOI 10.1006/abbi.1999.1167; Yazawa K, 1996, LIPIDS, V31, pS297, DOI 10.1007/BF02637095; Yokochi T, 1998, APPL MICROBIOL BIOT, V49, P72, DOI 10.1007/s002530051139; Yu R, 2000, LIPIDS, V35, P1061, DOI 10.1007/s11745-000-0619-6	37	5	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84871	10.1371/journal.pone.0084871	http://dx.doi.org/10.1371/journal.pone.0084871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391980	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900123
J	Gejl, M; Lerche, S; Mengel, A; Moller, N; Bibby, BM; Smidt, K; Brock, B; Sondergaard, H; Botker, HE; Gjedde, A; Holst, JJ; Hansen, SB; Rungby, J				Gejl, Michael; Lerche, Susanne; Mengel, Annette; Moller, Niels; Bibby, Bo Martin; Smidt, Kamille; Brock, Birgitte; Sondergaard, Hanne; Botker, Hans Erik; Gjedde, Albert; Holst, Jens Juul; Hansen, Soren Baarsgaard; Rungby, Jorgen			Influence of GLP-1 on Myocardial Glucose Metabolism in Healthy Men during Normo- or Hypoglycemia	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; NITRIC-OXIDE; RECEPTOR ACTIVATION; INSULIN-SECRETION; SKELETAL-MUSCLE; HEART; BLOOD; TRANSPORT; INFUSION; CHROMATOGRAPHY	Background and Aims: Glucagon-like peptide-1 (GLP-1) may provide beneficial cardiovascular effects, possibly due to enhanced myocardial energetic efficiency by increasing myocardial glucose uptake (MGU). We assessed the effects of GLP-1 on MGU in healthy subjects during normo- and hypoglycemia. Materials and Methods: We included eighteen healthy men in two randomized, double-blinded, placebo-controlled crossover studies. MGU was assessed with GLP-1 or saline infusion during pituitary-pancreatic normo-(plasma glucose (PG): 4.5 mM, n = 10) and hypoglycemic clamps (PG: 3.0 mM, n = 8) by positron emission tomography with 18 fluoro-deoxyglucose (F-18-FDG) as tracer. Results: In the normoglycemia study mean (+/- SD) age was 25+/-3 years, and BMI was 22.6+/-0.6 kg/m(2) and in the hypoglycemia study the mean age was 23+/-2 years with a mean body mass index of 23+/-2 kg/m(2). GLP-1 did not change MGU during normoglycemia (mean (+/2 SD) 0.15+/20.04 and 0.16+/20.03 mmol/g/min, P = 0.46) or during hypoglycemia (0.16+/20.03 and 0.13+/20.04 mmol/g/min, P = 0.14). However, the effect of GLP-1 on MGU was negatively correlated to baseline MGU both during normo-and hypoglycemia, (P = 0.006, r(2) = 0.64 and P = 0.018, r(2) = 0.64, respectively) and changes in MGU correlated positively with the level of insulin resistance (HOMA 2IR) during hypoglycemia, P = 0.04, r(2) = 0.54. GLP-1 mediated an increase in circulating glucagon levels at PG levels below 3.5 mM and increased glucose infusion rates during the hypoglycemia study. No differences in other circulating hormones or metabolites were found. Conclusions: While GLP-1 does not affect overall MGU, GLP-1 induces changes in MGU dependent on baseline MGU such that GLP-1 increases MGU in subjects with low baseline MGU and decreases MGU in subjects with high baseline MGU. GLP-1 preserves MGU during hypoglycemia in insulin resistant subjects.	[Gejl, Michael; Lerche, Susanne; Smidt, Kamille; Brock, Birgitte; Rungby, Jorgen] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Mengel, Annette; Moller, Niels; Rungby, Jorgen] Aarhus Univ Hosp, Dept Endocrinol, DK-8000 Aarhus, Denmark; [Brock, Birgitte] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Brock, Birgitte] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Gjedde, Albert] Aarhus Univ Hosp, PET Ctr, DK-8000 Aarhus, Denmark; [Gjedde, Albert] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Holst, Jens Juul] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Bibby, Bo Martin] Aarhus Univ, Dept Biostat, Aarhus, Denmark; [Sondergaard, Hanne] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Rungby, Jorgen] Rigshosp, Dept Endocrinol, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of Copenhagen; University of Copenhagen; Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen	Gejl, M (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	mg@farm.au.dk	Rungby, Jørgen/AAQ-4332-2021; Gjedde, Albert/I-2452-2019; Moller, Niels/E-5091-2011; Holst, Jens/AAA-8022-2022; Gjedde, Albert/U-3751-2019	Moller, Niels/0000-0001-5627-7322; Gjedde, Albert/0000-0002-3756-7401; Holst, Jens Juul/0000-0001-6853-3805; Botker, Hans Erik/0000-0001-6358-8962	Danish Strategic Research Council; Desire and Niels Ydes Foundation; Medical Research Council [G0801418B] Funding Source: researchfish; Novo Nordisk Fonden [NNF13OC0007447] Funding Source: researchfish	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Desire and Niels Ydes Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	Supported by grants from The Danish Strategic Research Council (the DD2 Study), Desire and Niels Ydes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2009, J CLIN ENDOCR METAB, V94, P1236, DOI 10.1210/jc.2008-2152; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Bhashyam S, 2010, CIRC-HEART FAIL, V3, P512, DOI 10.1161/CIRCHEARTFAILURE.109.900282; Botker HE, 1997, J NUCL CARDIOL, V4, P125, DOI 10.1016/S1071-3581(97)90061-1; Botker HE, 1999, J NUCL MED, V40, P1186; Chinda K, 2012, DIABETES VASC DIS RE, V9, P256, DOI 10.1177/1479164112440816; CHOI Y, 1993, EUR J NUCL MED, V20, P308; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Degn KB, 2004, DIABETES, V53, P2397, DOI 10.2337/diabetes.53.9.2397; Ding SY, 2011, J BIOL CHEM, V286, P16768, DOI 10.1074/jbc.M110.192799; ERIKSSON BM, 1982, J CHROMATOGR, V228, P143, DOI 10.1016/S0378-4347(00)80427-2; Espelund U, 2005, J CLIN ENDOCR METAB, V90, P741, DOI 10.1210/jc.2004-0604; Etgen GJ, 1997, DIABETES, V46, P1915, DOI 10.2337/diabetes.46.11.1915; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gejl M, 2012, J CLIN ENDOCR METAB, V97, pE1165, DOI 10.1210/jc.2011-3456; Gejl Michael, 2013, Front Neuroenergetics, V5, P2, DOI 10.3389/fnene.2013.00002; Gejl M, 2012, J CEREBR BLOOD F MET, V32, P2146, DOI 10.1038/jcbfm.2012.118; GJEDDE A, 1981, J NEUROCHEM, V36, P1463, DOI 10.1111/j.1471-4159.1981.tb00587.x; GJEDDE A, 1982, BRAIN RES REV, V4, P237, DOI 10.1016/0165-0173(82)90018-2; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; HALL JL, 1995, J APPL PHYSIOL, V78, P76, DOI 10.1152/jappl.1995.78.1.76; Holst JJ, 2004, HORM METAB RES, V36, P747, DOI 10.1055/s-2004-826158; KAINULAINEN H, 1994, BBA-MOL BASIS DIS, V1225, P275, DOI 10.1016/0925-4439(94)90007-8; Kim M, 2013, NAT MED, V19, P567, DOI 10.1038/nm.3128; Kudoh A, 2002, J CARDIOVASC PHARM, V40, P601, DOI 10.1097/00005344-200210000-00014; Larsen PJ, 1997, ENDOCRINOLOGY, V138, P4445, DOI 10.1210/en.138.10.4445; Lerche S, 2008, DIABETES, V57, P325, DOI 10.2337/db07-1162; Lonborg J, 2012, EUR HEART J, V33, P1491, DOI 10.1093/eurheartj/ehr309; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; MALLET RT, 1990, EUR J BIOCHEM, V188, P481, DOI 10.1111/j.1432-1033.1990.tb15426.x; Moberly SP, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0365-x; Nauck MA, 2011, DIABETOLOGIA, V54, P10, DOI 10.1007/s00125-010-1896-4; Nauck MA, 2002, J CLIN ENDOCR METAB, V87, P1239, DOI 10.1210/jc.87.3.1239; Nielsen R, 2012, EXP CLIN ENDOCR DIAB, V120, P266, DOI 10.1055/s-0032-1304605; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535; ORSKOV H, 1968, NATURE, V219, P193, DOI 10.1038/219193b0; OWEN P, 1990, CIRC RES, V66, P344, DOI 10.1161/01.RES.66.2.344; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Pyke C, 2013, ENDOCRINOLOGY, V154, P4, DOI 10.1210/en.2012-2124; Ravassa S, 2012, CARDIOVASC RES, V94, P316, DOI 10.1093/cvr/cvs123; Ryan AS, 1998, J CLIN ENDOCR METAB, V83, P2399, DOI 10.1210/jc.83.7.2399; Sivertsen J, 2012, NAT REV CARDIOL, V9, P209, DOI 10.1038/nrcardio.2011.211; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Sun F, 2012, DIABETES RES CLIN PR, V98, P386, DOI 10.1016/j.diabres.2012.09.004; Taegtmeyer H, 2002, CIRCULATION, V105, P1727, DOI 10.1161/01.CIR.0000012466.50373.E8; Toft-Nielsen MB, 1999, DIABETES CARE, V22, P1137, DOI 10.2337/diacare.22.7.1137; van den Brom CE, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-42; Van Dyke DA, 2003, LIFE SCI, V72, P2321, DOI 10.1016/S0024-3205(03)00119-X; Vella A, 2002, DIABETOLOGIA, V45, P1410, DOI 10.1007/s00125-002-0924-4; Vella A, 2001, DIABETES, V50, P565, DOI 10.2337/diabetes.50.3.565; Vyas AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017178; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wilken M, 1999, DIABETOLOGIA, V42, pA196; Zhao TC, 2006, J PHARMACOL EXP THER, V317, P1106, DOI 10.1124/jpet.106.100982	57	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83758	10.1371/journal.pone.0083758	http://dx.doi.org/10.1371/journal.pone.0083758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400077	Green Submitted, gold, Green Published			2022-12-27	WOS:000329462700011
J	Lin, RS; Jimenez-Movilla, M; Dean, J				Lin, Ruei-Shiuan; Jimenez-Movilla, Maria; Dean, Jurrien			Figla-Cre Transgenic Mice Expressing Myristoylated EGFP in Germ Cells Provide a Model for Investigating Perinatal Oocyte Dynamics	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; PRIMORDIAL FOLLICLES; GENE-EXPRESSION; UNDIFFERENTIATED SPERMATOGONIA; MEIOTIC PROPHASE; OVARIAN-FOLLICLE; SPERM CHROMATIN; MOUSE OOCYTES; APOPTOSIS; DNA	FIGLA (Factor in the germline, alpha) is a bHLH transcription factor expressed abundantly in female and less so in male germ cells. Mice lacking FIGLA do not form primordial follicles in the ovary and females are sterile, but there is no obvious phenotype in males. Using the Figla promoter to express Cre recombinase, we have established mEGFP/mTomato reporter mice with green germ cells and red somatic tissue. These mice were crossed into the Figla null background to accelerate perinatal oocyte loss. Live imaging of cultured newborn ovaries provides evidence that few oocytes egress and the vast majority disappear within the confines of the ovary. Although a cohort of mobile, phagocytic cells was observed, macrophage depletion in Csf1(op/op) mice did not affect oocyte loss. Investigations with TUNEL assays and caspase inhibitors suggest that apoptosis plays a role in the perinatal loss of oocyte in female mice. These results establish the utility of Figla-EGFP/Cre; mTomato/mEGFP in investigating germ cell dynamics in prepubertal mice.	[Lin, Ruei-Shiuan; Jimenez-Movilla, Maria; Dean, Jurrien] Natl Inst Diabet & Digest & Kidney Dis, Lab Cellular & Dev Biol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dean, J (corresponding author), Natl Inst Diabet & Digest & Kidney Dis, Lab Cellular & Dev Biol, NIH, Bethesda, MD USA.	jurriend@helix.nih.gov	Movilla, Maria Jiménez/I-1004-2015	Movilla, Maria Jiménez/0000-0002-1572-8219	Intramural Research Program of the National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015603] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton M, 2007, J CELL SCI, V120, P417, DOI 10.1242/jcs.03332; Amleh A, 2002, HUM REPROD UPDATE, V8, P395, DOI 10.1093/humupd/8.5.395; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; Cohen PE, 1997, BIOL REPROD, V56, P110, DOI 10.1095/biolreprod56.1.110; Ene AC, 2013, DEV BIOL, V377, P213, DOI 10.1016/j.ydbio.2013.01.027; Erkek S, 2013, NAT STRUCT MOL BIOL; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; GATEWOOD JM, 1987, SCIENCE, V236, P962, DOI 10.1126/science.3576213; Gawriluk TR, 2011, REPRODUCTION, V141, P759, DOI 10.1530/REP-10-0489; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hu W, 2010, MOL CELL BIOL, V30, P3661, DOI 10.1128/MCB.00201-10; Joshi S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-67; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li J, 2010, P NATL ACAD SCI USA, V107, P10280, DOI 10.1073/pnas.1001198107; Liang LF, 1997, DEVELOPMENT, V124, P4939; Matikainen T, 2001, ENDOCRINOLOGY, V142, P2468, DOI 10.1210/en.142.6.2468; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; MILLAR SE, 1991, MOL CELL BIOL, V11, P6197, DOI 10.1128/MCB.11.12.6197; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; MOTTA PM, 1994, ARCH HISTOL CYTOL, V57, P369, DOI 10.1679/aohc.57.369; MOTTA PM, 1986, EUR J OBSTET GYN R B, V22, P271, DOI 10.1016/0028-2243(86)90115-2; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029; Pellegrini M, 2011, J CELL SCI, V124, P91, DOI 10.1242/jcs.072959; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299; Pittoggi C, 1999, J CELL SCI, V112, P3537; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Rodrigues P, 2009, REPRODUCTION, V137, P709, DOI 10.1530/REP-08-0203; Rucker EB, 2000, MOL ENDOCRINOL, V14, P1038, DOI 10.1210/me.14.7.1038; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; WORDINGER R, 1990, ANAT REC, V227, P187, DOI 10.1002/ar.1092270207; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38	42	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84477	10.1371/journal.pone.0084477	http://dx.doi.org/10.1371/journal.pone.0084477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400092	gold, Green Published, Green Submitted			2022-12-27	WOS:000329462700026
J	Hoeksema, L; Los, LI				Hoeksema, Lisette; Los, Leonoor I.			Vision-Related Quality of Life in Herpetic Anterior Uveitis Patients	PLOS ONE			English	Article							VISUAL FUNCTION QUESTIONNAIRE; INFLAMMATORY DISEASE; DEPRESSION	We investigated the vision-related quality of life (VR-QOL) and the prevalence and severity of depression in patients with herpetic anterior uveitis (AU). This study was conducted in 2012 at the ophthalmology department of the University Medical Center of Groningen (tertiary referral center). We selected patients from an existing uveitis database, all eligible patients were approached. Thirty-six of 66 (55%) patients with herpetic AU (herpes simplex virus or varicella zoster virus) participated, patients were 18 years or older. The diagnosis was made by clinical presentation or a positive anterior chamber tap. All patients received an information letter, informed consent form, National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25), Beck Depression Inventory (BDI-II), Social Support List - Interactions (SSL-I), Social Support List - Discrepancies (SSL-D) and an additional questionnaire for gathering general information. Medical records were reviewed for clinical characteristics. Analyses were conducted on various patient and ocular characteristics. We compared our NEI VFQ-25 scores with those previously found in the literature. Our main outcome measures were VR-QOL, prevalence and severity of depression, social support and various patient and ocular characteristics that could influence the VR-QOL. We found that the NEI VFQ-25 mean overall composite score (OCS) was 88.1 +/- 10.6. Compared with other ocular diseases our OCS is relatively high, but lower than that found in a normal working population. The mean general health score was 59.0 +/- 19.0; this score is lower than in patients with other ocular diseases, except for untreated Behcet's patients. Depression was scarce, with only one patient (2.8%) having a moderate depression (BDI-II score of 21). We concluded that herpetic AU affects the VR-QOL in a moderate way. The prevalence of depression in our group of herpetic AU patients was low and therefore does not seem to indicate a need for specific screening and intervention measures in these patients.	[Hoeksema, Lisette; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Hoeksema, Lisette; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands	University of Groningen; University of Groningen	Hoeksema, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	l.hoeksema@umcg.nl			Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek, Stichting Blindenhulp	Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek, Stichting Blindenhulp	Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek, Stichting Blindenhulp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Bartley EJ, 2013, BRIT J ANAESTH, V111, P52, DOI 10.1093/bja/aet127; Cahill MT, 2005, OPHTHALMOLOGY, V112, P152, DOI 10.1016/j.ophtha.2004.06.036; de Graaf R, 2012, Tijdschr Psychiatr, V54, P27; Hirneiss C, 2010, GRAEF ARCH CLIN EXP, V248, P85, DOI 10.1007/s00417-009-1186-3; Huang JJ, 2010, OCULAR INFLAMMATORY, P41; Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057; Jakob E, 2009, J RHEUMATOL, V36, P127, DOI 10.3899/jrheum.080102; Jap A, 2011, CURR OPIN OPHTHALMOL, V22, P483, DOI 10.1097/ICU.0b013e32834be021; Kuiper JJW, 2013, ACTA OPHTHALMOL, V91, pE329, DOI 10.1111/aos.12054; Li MY, 2012, INVEST OPHTH VIS SCI, V53, P5722, DOI 10.1167/iovs.11-9094; Lukas K, 2012, J PUBLIC HEALTH-HEID, V20, P441, DOI 10.1007/s10389-011-0481-8; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Mangione CM, 2000, NEI VFO SCORING ALGO; PavanLangston D, 1995, NEUROLOGY, V45, pS50, DOI 10.1212/WNL.45.12_Suppl_8.S50; Qian Y, 2012, AM J OPHTHALMOL, V153, P370, DOI 10.1016/j.ajo.2011.06.028; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; Sakai T, 2013, BRIT J OPHTHALMOL, V97, P338, DOI 10.1136/bjophthalmol-2012-302515; Schiffman RM, 2001, ARCH OPHTHALMOL-CHIC, V119, P841; Schweitzer KD, 2011, CAN J OPHTHALMOL, V46, P232, DOI 10.1016/j.jcjo.2011.05.010; Wensing B, 2011, OPHTHALMOLOGY, V118, P1905, DOI 10.1016/j.ophtha.2011.03.033	22	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e85224	10.1371/journal.pone.0085224	http://dx.doi.org/10.1371/journal.pone.0085224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392164	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100087
J	Tian, HF; Zhang, Y; Sun, Q; Zhu, SL; Li, XJ; Pan, Z; Xu, WB; Xu, BH				Tian, Huifang; Zhang, Yong; Sun, Qiang; Zhu, Shuangli; Li, Xiujuan; Pan, Zhuo; Xu, Wenbo; Xu, Baohong			Prevalence of Multiple Enteroviruses Associated with Hand, Foot, and Mouth Disease in Shijiazhuang City, Hebei Province, China: Outbreaks of Coxsackieviruses A10 and B3	PLOS ONE			English	Article							ACUTE-FLACCID-PARALYSIS; MALAYSIA; A6; EPIDEMIC	Hand, foot, and mouth disease (HFMD) has been one of the most common infectious diseases in Shijiazhuang City, as is the situation in China overall. In the National HFMD surveillance system, the pathogen detection was focused on EV-A71 and CVA16, and therefore, information on the other EVs is very limited. In order to identify the circulating EV serotypes in the HFMD outbreaks in Shijiazhuang City during 2010-2012, 4045 patients presented with HFMD were recruited in the study, and clinical samples were investigated. Typing of EV serotypes was performed using the molecular typing methods, and phylogenetic analyses based on entire VP1 sequences of human enterovirus 71 (EV-A71), coxsackievirus A16 (CVA16), CVA10 and CVB3 was performed. The results revealed that EV-A71 and CVA16 were the 2 most important pathogens but the circulating trends of the 2 viruses showed a shift, the spread of EV-A71 became increasingly weak, whereas the spread of CVA16 became increasingly stronger. CVA10 and CVB3 were the third and fourth most prevalent pathogens, respectively. Co-infection of two viruses at the same time was not found in these samples. Based on entire VP1 region sequences, the phylogenetic analysis revealed that C4a subgenotype EV-A71, B1a and B1b subgenotype CVA16 continued to evolve. The CVA10 strains were assigned to 4 genotypes (A-D), whereas the CVB3 strains were assigned to 5 genotypes (A-E), with clear geographical and temporal-specific distributions. The Shijiazhuang CVA10 sequences belonged to 4 epidemic lineages within genotype C, whereas the Shijiazhuang CVB3 sequences belonged to 2 epidemic lineages within genotype E, which may have the same origins as the strains reported in other part of China. CVA10 and CVB3, 2 pathogens that were previously infrequently detected, were identified as pathogens causing the HFMD outbreaks. This study underscores the need for detailed laboratory-based surveillances of HFMD in mainland China.	[Tian, Huifang; Li, Xiujuan; Pan, Zhuo; Xu, Baohong] Shijiazhuang Ctr Dis Control & Prevent, Microbiol Lab, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yong; Sun, Qiang; Zhu, Shuangli; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, WHO WPRO Reg Polio Reference Lab, Minist Hlth Key Lab Med Virol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xu, BH (corresponding author), Shijiazhuang Ctr Dis Control & Prevent, Microbiol Lab, Shijiazhuang, Hebei, Peoples R China.	wsws661120@126.com	li, xiu/GXV-1745-2022	Zhang, Yong/0000-0002-2692-5437	National Natural Science Foundation of China [30900063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (project no. 30900063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chan YF, 2012, TROP BIOMED, V29, P451; Fowlkes AL, 2008, J INFECT DIS, V198, P1685, DOI 10.1086/592988; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Herrero LJ, 2003, ARCH VIROL, V148, P1369, DOI 10.1007/s00705-003-0100-2; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu YF, 2012, J INFECTION, V65, P189, DOI 10.1016/j.jinf.2012.03.021; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Knowles N., 2011, VIRUS TAXONOMY CLASS, P855; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Oberste MS, 2006, J GEN VIROL, V87, P119, DOI 10.1099/vir.0.81179-0; Shahmahmoodi S, 2008, J CLIN VIROL, V42, P409, DOI 10.1016/j.jcv.2008.02.013; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J INFECT DIS, V202, P1780, DOI 10.1086/657410; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu J, 2013, PLOS ONE, V8; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	23	47	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84233	10.1371/journal.pone.0084233	http://dx.doi.org/10.1371/journal.pone.0084233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392117	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100040
J	de Souza, JDA; Coelho, RR; Lourenco, IT; Fragoso, RD; Viana, AAB; de Macedo, LLP; da Silva, MCM; Carneiro, RMG; Engler, G; de Almeida-Engler, J; Grossi-de-Sa, MF				Antonino de Souza Junior, Jose Dijair; Coelho, Roberta Ramos; Lourenco, Isabela Tristan; Fragoso, Rodrigo da Rocha; Barbosa Viana, Antonio Americo; Pepino de Macedo, Leonardo Lima; Mattar da Silva, Maria Cristina; Gomes Carneiro, Regina Maria; Engler, Gilbert; de Almeida-Engler, Janice; Grossi-de-Sa, Maria Fatima			Knocking-Down Meloidogyne incognita Proteases by Plant-Delivered dsRNA Has Negative Pleiotropic Effect on Nematode Vigor	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; CATHEPSIN-L PROTEASE; PARASITIC NEMATODE; HETERODERA-GLYCINES; PROTEINASE-INHIBITORS; MOLECULAR-CLONING; GENE-EXPRESSION; INTERFERENCE; GROWTH; HOST	The root-knot nematode Meloidogyne incognita causes serious damage and yield losses in numerous important crops worldwide. Analysis of the M. incognita genome revealed a vast number of proteases belonging to five different catalytic classes. Several reports indicate that M. incognita proteases could play important roles in nematode parasitism, besides their function in ordinary digestion of giant cell contents for feeding. The precise roles of these proteins during parasitism however are still unknown, making them interesting targets for gene silencing to address protein function. In this study we have knocked-down an aspartic (Mi-asp-1), a serine (Mi-ser-1) and a cysteine protease (Mi-cpl-1) by RNAi interference to get an insight into the function of these enzymes during a host/nematode interaction. Tobacco lines expressing dsRNA for Mi-ser-1 (dsSER), Mi-cpl-1 (dsCPL) and for the three genes together (dsFusion) were generated. Histological analysis of galls did not show clear differences in giant cell morphology. Interestingly, nematodes that infected plants expressing dsRNA for proteases produced a reduced number of eggs. In addition, nematode progeny matured in dsSER plants had reduced success in egg hatching, while progeny resulting from dsCPL and dsFusion plants were less successful to infect wild-type host plants. Quantitative PCR analysis confirmed a reduction in transcripts for Mi-cpl-1 and Mi-ser-1 proteases. Our results indicate that these proteases are possibly involved in different processes throughout nematode development, like nutrition, reproduction and embryogenesis. A better understanding of nematode proteases and their possible role during a plant-nematode interaction might help to develop new tools for phytonematode control.	[Antonino de Souza Junior, Jose Dijair; Coelho, Roberta Ramos; Lourenco, Isabela Tristan] Univ Brasilia, Grad Program Biol Mol, Brasilia, DF, Brazil; [Antonino de Souza Junior, Jose Dijair; Coelho, Roberta Ramos; Lourenco, Isabela Tristan; Pepino de Macedo, Leonardo Lima; Mattar da Silva, Maria Cristina; Gomes Carneiro, Regina Maria; Grossi-de-Sa, Maria Fatima] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil; [Fragoso, Rodrigo da Rocha] Embrapa Cerrados, Planaltina, DF, Brazil; [Barbosa Viana, Antonio Americo; Grossi-de-Sa, Maria Fatima] Univ Catolica Brasilia, Grad Program Genom Sci & Biotechnol, Brasilia, DF, Brazil; [Engler, Gilbert; de Almeida-Engler, Janice] Univ Nice Sophia Antipolis, CNRS, INRA, UMR ISA,UMR ISA 1355,UMR ISA 7254, Sophia Antipolis, France	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Grossi-de-Sa, MF (corresponding author), Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	fatima.grossi@embrapa.br	Grossi-de-Sa, Maria Fatima/N-7856-2017; de Souza, Jose Dijair Antonino/I-1028-2014	de Souza, Jose Dijair Antonino/0000-0002-4992-0698; Fragoso, Rodrigo/0000-0003-4337-1947; GROSSI-DE-SA, MARIA FATIMA/0000-0001-8184-9599	'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico' - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico from Brazil [142341/2007-0]	'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico' - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico from Brazil	JDASJ has been supported by a doctoral scholarship from 'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico' - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br), from Brazil (142341/2007-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atkinson HJ, 1996, J NEMATOL, V28, P209; Bakhetia M, 2008, INT J PARASITOL, V38, P1589, DOI 10.1016/j.ijpara.2008.05.003; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Beynon RJ, 1994, PROTEOLYTIC ENZIMES; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; BOLTER CJ, 1995, J INSECT PHYSIOL, V41, P1071, DOI 10.1016/0022-1910(95)00073-4; Britton C, 2002, MOL BIOCHEM PARASIT, V122, P21, DOI 10.1016/S0166-6851(02)00066-X; Castagnone-Sereno P, 2011, GENOMICS, V97, P29, DOI 10.1016/j.ygeno.2010.10.002; Charlton WL, 2010, INT J PARASITOL, V40, P855, DOI 10.1016/j.ijpara.2010.01.003; Chitwood DJ, 2003, PEST MANAG SCI, V59, P748, DOI 10.1002/ps.684; Craig H, 2007, TRENDS PARASITOL, V23, P248, DOI 10.1016/j.pt.2007.04.003; Dalzell JJ, 2010, INT J PARASITOL, V40, P91, DOI 10.1016/j.ijpara.2009.07.003; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Souza DDDE, 2011, PLANT SCI, V180, P276, DOI 10.1016/j.plantsci.2010.09.003; Dowen RH, 2009, J BIOL CHEM, V284, P15867, DOI 10.1074/jbc.M900519200; Dubreuil G, 2009, J EXP BOT, V60, P4041, DOI 10.1093/jxb/erp237; Dubreuil G, 2011, INT J PARASITOL, V41, P385, DOI 10.1016/j.ijpara.2010.10.008; Fanelli E, 2005, GENE, V349, P87, DOI 10.1016/j.gene.2004.11.045; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fragoso RD, 2005, EXP PARASITOL, V110, P123, DOI 10.1016/j.exppara.2005.02.010; Fragoso RD, 2009, EXP PARASITOL, V121, P115, DOI 10.1016/j.exppara.2008.09.017; Gallois P, 1995, PLANT GENE TRASNFER, P38; Gatehouse LN, 1997, INSECT BIOCHEM MOLEC, V27, P929, DOI 10.1016/S0965-1748(97)00074-X; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Hashmi S, 2002, J BIOL CHEM, V277, P3477, DOI 10.1074/jbc.M106117200; Hewezi T, 2008, PLANT CELL, V20, P3080, DOI 10.1105/tpc.108.063065; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huang GZ, 2006, MOL PLANT MICROBE IN, V19, P463, DOI 10.1094/MPMI-19-0463; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Klink VP, 2009, PLANTA, V230, P53, DOI 10.1007/s00425-009-0926-2; Li JR, 2010, PLANTA, V232, P775, DOI 10.1007/s00425-010-1209-7; Li JR, 2010, PLANT CELL REP, V29, P113, DOI 10.1007/s00299-009-0803-2; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Matsunaga Y, 2012, BIOSCI BIOTECH BIOCH, V76, P378, DOI 10.1271/bbb.110661; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neveu C, 2003, PHYSIOL MOL PLANT P, V63, P159, DOI 10.1016/j.pmpp.2003.10.005; Patel N, 2010, J EXP BOT, V61, P235, DOI 10.1093/jxb/erp293; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosso MN, 2009, ANNU REV PHYTOPATHOL, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Rosso MN, 2005, MOL PLANT MICROBE IN, V18, P615, DOI 10.1094/MPMI-18-0615; Shingles J, 2007, EXP PARASITOL, V115, P114, DOI 10.1016/j.exppara.2006.07.008; Sindhu AS, 2009, J EXP BOT, V60, P315, DOI 10.1093/jxb/ern289; Steeves RM, 2006, FUNCT PLANT BIOL, V33, P991, DOI 10.1071/FP06130; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Urwin PE, 2002, MOL PLANT MICROBE IN, V15, P747, DOI 10.1094/MPMI.2002.15.8.747; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; VRAIN TC, 1977, J NEMATOL, V9, P249; Wu YR, 1997, MOL BREEDING, V3, P371, DOI 10.1023/A:1009681323131; Yadav BC, 2006, MOL BIOCHEM PARASIT, V148, P219, DOI 10.1016/j.molbiopara.2006.03.013; Youssef RM, 2013, EXP PARASITOL, V134, P266, DOI 10.1016/j.exppara.2013.03.009; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	57	35	35	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85364	10.1371/journal.pone.0085364	http://dx.doi.org/10.1371/journal.pone.0085364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392004	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900148
J	Chen, BB; Zhang, Y; Chen, LH; Huang, SW; Li, ST; Yao, JY				Chen, Binbin; Zhang, Yi; Chen, Lianhua; Huang, Shiwei; Li, Shitong; Yao, Junyan			Dose-Effects of Aorta-Infused Clenbuterol on Spinal Cord Ischemia-Reperfusion Injury in Rabbits	PLOS ONE			English	Article							TRANSIENT FOREBRAIN ISCHEMIA; DELAYED-ONSET PARAPLEGIA; BETA(2)-ADRENOCEPTOR AGONIST; BETA-2-ADRENERGIC RECEPTOR; ACTIVATES ASTROCYTES; CEREBRAL-ISCHEMIA; RAT HIPPOCAMPUS; STROKE MODEL; BRAIN-INJURY; DAMAGE	Background: The beta(2) adrenergic receptor (beta(2)AR) plays an important role in ischemia-reperfusion (I/R) injury in various organs. Recently, a selective beta(2)AR agonist clenbuterol was suggested to protect against cerebral I/R injury. This study was designed to investigate changes of beta(2)ARs after spinal cord I/R injury and dose-effects of aorta-infused clenbuterol on spinal cord I/R injury in rabbits. Methods: Spinal cord ischemia was induced in New Zealand white rabbits by infrarenal abdominal aortic occlusion with a balloon catheter for 30 minutes except the sham group. During occlusion, nothing (I/R group), normal saline (NS group) or clenbuterol at different doses of 0.005, 0.01, 0.05, 0.1, 0.5, or 1 mg/kg (C-0.005, C-0.01, C-0.05, C-0.1, C-0.5, and C-1 groups) was infused into the occluded aortic segments. The hemodynamic data, blood glucose and serum electrolytes were measured during experimental period. Neurological function was assessed according to the modified Tarlov scales until 48 hours after reperfusion. After that, the lumbar spinal cord was harvested for beta(2)AR immunohistochemistry and histopathologic evaluation in the anterior horns. Results: The beta(2)AR expression in the anterior horns of the spinal cord was significantly higher in the I/R group than in the sham group. Tarlov scores and the number of viable a-motor neurons were higher in C-0.01-C-0.5 groups than in the NS group, C0.005 and C-1 groups and were highest in the C-0.1 group. Hypotension and hyperglycemia were found in the C-1 group. Conclusion: beta(2)ARs in the anterior horn were upregulated after spinal cord I/R injury. Aortic-infused clenbuterol (0.01-0.5 mg/kg) can attenuate spinal cord I/R injury dose-dependently during the ischemic period. The Optimal dosage was 0.1 mg/kg. Activation of beta(2)AR could be a new therapeutic strategy for the treatment of spinal cord I/R injury.	[Chen, Binbin; Zhang, Yi; Chen, Lianhua; Huang, Shiwei; Li, Shitong; Yao, Junyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Anesthesiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yao, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Anesthesiol, Shanghai 200030, Peoples R China.	sunshineyao@163.com			National Natural Science Foundation of China [30901392]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 30901392, www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apaydin AZ, 2001, TEX HEART I J, V28, P172; Bai FS, 2010, PFLUG ARCH EUR J PHY, V460, P657, DOI 10.1007/s00424-010-0852-y; Ballard Jeffrey L, 2005, Perspect Vasc Surg Endovasc Ther, V17, P207, DOI 10.1177/153100350501700305; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Culmsee C, 2004, STROKE, V35, P1197, DOI 10.1161/01.STR.0000125855.17686.6d; Culmsee C, 1999, EUR J PHARMACOL, V379, P33, DOI 10.1016/S0014-2999(99)00452-5; Culmsee C, 1999, NEUROCHEM INT, V35, P47, DOI 10.1016/S0197-0186(99)00032-7; Culmsee C, 2009, ANESTH ANALG, V108, P3, DOI 10.1213/ane.0b013e31818db6f6; de Haan P, 2001, J NEUROSURG ANESTH, V13, P3, DOI 10.1097/00008506-200101000-00002; Ehrlich M, 1999, J THORAC CARDIOV SUR, V117, P285, DOI 10.1016/S0022-5223(99)70424-1; Hamaishi M, 2009, ANN VASC SURG, V23, P128, DOI 10.1016/j.avsg.2008.05.010; Han RQ, 2009, ANESTH ANALG, V108, P280, DOI 10.1213/ane.0b013e318187ba6b; Herlambang B, 2011, J VASC SURG, V54, P1109, DOI 10.1016/j.jvs.2011.04.043; Hoffman RJ, 2001, J TOXICOL-CLIN TOXIC, V39, P339, DOI 10.1081/CLT-100105152; Hwang J, 2012, SPINAL CORD, V50, P208, DOI 10.1038/sc.2011.136; Iwamoto Satoshi, 2009, Interact Cardiovasc Thorac Surg, V8, P606, DOI 10.1510/icvts.2008.197244; JACOBS TP, 1987, STROKE, V18, P741, DOI 10.1161/01.STR.18.4.741; Junker V, 2002, EUR J PHARMACOL, V446, P25, DOI 10.1016/S0014-2999(02)01814-9; Kaptanoglu E, 2002, J NEUROSURG ANESTH, V14, P114, DOI 10.1097/00008506-200204000-00005; Kiyoshima T, 2003, ANESTH ANALG, V96, P839, DOI 10.1213/01.ANE.0000047268.41102.D4; Lee BY, 2011, ARCH MED SCI, V7, P597, DOI 10.5114/aoms.2011.24128; Maslov L N, 2012, Angiol Sosud Khir, V18, P27; Mieno S, 2005, SCAND CARDIOVASC J, V39, P313, DOI 10.1080/14017430510009104; Mizukami Tetsuya, 2004, Kurume Medical Journal, V51, P175; MOORE WM, 1991, ANN SURG, V213, P427, DOI 10.1097/00000658-199105000-00007; MUTCH WAC, 1993, STROKE, V24, P1554, DOI 10.1161/01.STR.24.10.1554; Okita Y, 2011, GEN THORAC CARDIOVAS, V59, P79, DOI 10.1007/s11748-010-0668-x; OSBORNE KA, 1987, J NEUROL NEUROSUR PS, V50, P402, DOI 10.1136/jnnp.50.4.402; Patterson AJ, 2004, CRIT CARE MED, V32, P1041, DOI 10.1097/01.CCM.0000120049.43113.90; Penna C, 2007, J STEROID BIOCHEM, V107, P106, DOI 10.1016/j.jsbmb.2007.05.005; Rami A, 2003, NEUROSCI RES, V47, P373, DOI 10.1016/j.neures.2003.07.002; SALORINNE Y, 1975, EUR J CLIN PHARMACOL, V8, P189, DOI 10.1007/BF00567113; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Semkova I, 1996, BRAIN RES, V717, P44, DOI 10.1016/0006-8993(95)01567-1; Shi EY, 2007, J THORAC CARDIOV SUR, V133, P942, DOI 10.1016/j.jtcvs.2006.12.017; SMITH ML, 1988, ACTA NEUROPATHOL, V76, P253, DOI 10.1007/BF00687772; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Takahashi S, 2013, J VASC SURG IN PRESS; TARLOV IM, 1972, J NEUROSURG, V36, P10, DOI 10.3171/jns.1972.36.1.0010; WARNER DS, 1987, STROKE, V18, P464, DOI 10.1161/01.STR.18.2.464; WATERFIELD CJ, 1995, EUR J PHARM-ENVIRON, V293, P141, DOI 10.1016/0926-6917(95)00010-0; White R, 2012, FILM QUART, V65, P4, DOI 10.1525/FQ.2012.65.3.04; Wu Q, 2008, EXP PHYSIOL, V93, P1034, DOI 10.1113/expphysiol.2007.041939; Yu QJ, 2008, ANN VASC SURG, V22, P432, DOI 10.1016/j.avsg.2008.03.003; Zeman RJ, 2006, J NEUROTRAUM, V23, P170, DOI 10.1089/neu.2006.23.170; Zeman RJ, 1999, EXP NEUROL, V159, P267, DOI 10.1006/exnr.1999.7146; Zhang QF, 2010, BRIT J PHARMACOL, V160, P1561, DOI 10.1111/j.1476-5381.2010.00813.x; Zhu Y, 1998, J CEREBR BLOOD F MET, V18, P1032, DOI 10.1097/00004647-199809000-00013; Zhu Y, 1999, NEUROSCIENCE, V90, P1255, DOI 10.1016/S0306-4522(98)00564-8; ZIVIN JA, 1980, STROKE, V11, P200, DOI 10.1161/01.STR.11.2.200; Zvara David A, 2002, J Extra Corpor Technol, V34, P11	51	8	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84095	10.1371/journal.pone.0084095	http://dx.doi.org/10.1371/journal.pone.0084095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391890	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900033
J	Degos, B; Deniau, JM; Chavez, M; Maurice, N				Degos, Bertrand; Deniau, Jean-Michel; Chavez, Mario; Maurice, Nicolas			Subthalamic Nucleus High-Frequency Stimulation Restores Altered Electrophysiological Properties of Cortical Neurons in Parkinsonian Rat	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; MOTOR CORTEX EXCITABILITY; NIGRA PARS RETICULATA; GENETICALLY-DETERMINED SPIKE; BASAL GANGLIA; WAVE DISCHARGES; STRIATAL NEURONS; THALAMIC NEURONS; ABSENCE EPILEPSY; IN-VIVO	Electrophysiological recordings performed in parkinsonian patients and animal models have confirmed the occurrence of alterations in firing rate and pattern of basal ganglia neurons, but the outcome of these changes in thalamo-cortical networks remains unclear. Using rats rendered parkinsonian, we investigated, at a cellular level in vivo, the electrophysiological changes induced in the pyramidal cells of the motor cortex by the dopaminergic transmission interruption and further characterized the impact of high-frequency electrical stimulation of the subthalamic nucleus, a procedure alleviating parkinsonian symptoms. We provided evidence that a lesion restricted to the substantia nigra pars compacta resulted in a marked increase in the mean firing rate and bursting pattern of pyramidal neurons of the motor cortex. These alterations were underlain by changes of the electrical membranes properties of pyramidal cells including depolarized resting membrane potential and increased input resistance. The modifications induced by the dopaminergic loss were more pronounced in cortico-striatal than in cortico-subthalamic neurons. Furthermore, subthalamic nucleus high-frequency stimulation applied at parameters alleviating parkinsonian signs regularized the firing pattern of pyramidal cells and restored their electrical membrane properties.	[Degos, Bertrand; Deniau, Jean-Michel; Maurice, Nicolas] CNRS UMR7241, INSERM U1050, Coll France, Team Dynam & Pathophysiol Neuronal Networks,CIRB, Paris, France; [Degos, Bertrand] Hop La Pitie Salpetriere, APHP, Ctr Reference Malad Parkinson, Dept Neurol, Paris, France; [Chavez, Mario] Univ Paris 06, CNRS UMR 7225, Inst Cerveau & Moelle Epiniere, Ctr Rech, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Degos, B (corresponding author), CNRS UMR7241, INSERM U1050, Coll France, Team Dynam & Pathophysiol Neuronal Networks,CIRB, Paris, France.	bertrand.degos@psl.aphp.fr	Chavez, Mario/D-8495-2011	Chavez, Mario/0000-0003-0390-4833	Agence Nationale de la Recherche [ANR-05-JCJC-0076, ANR-05-NEUR-013]; Institut National de la Sante et de la Recherche Medicale (INSERM)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by Agence Nationale de la Recherche (grants number: ANR-05-JCJC-0076 and ANR-05-NEUR-013). B. D. was the recipient of a poste d'accueil from the Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1850, DOI 10.1152/jn.1993.69.6.1850; BENAZZOUZ A, 1993, EUR J NEUROSCI, V5, P382, DOI 10.1111/j.1460-9568.1993.tb00505.x; Blandini F, 1996, FUNCT NEUROL, V11, P3; Boraud T, 2002, PROG NEUROBIOL, V66, P265, DOI 10.1016/S0301-0082(01)00033-8; Bosch C, 2011, J PHYSIOL-LONDON, V589, P4189, DOI 10.1113/jphysiol.2011.211367; Bruno RM, 2003, J NEUROSCI, V23, P9565; Calabresi P, 2000, TRENDS NEUROSCI, V23, pS57, DOI 10.1016/S1471-1931(00)00017-3; CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M; Ceballos-Baumann AO, 1999, ARCH NEUROL-CHICAGO, V56, P997, DOI 10.1001/archneur.56.8.997; Chen R, 2001, CLIN NEUROPHYSIOL, V112, P600, DOI 10.1016/S1388-2457(01)00466-7; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Cunic D, 2002, NEUROLOGY, V58, P1665, DOI 10.1212/WNL.58.11.1665; Dauper J, 2002, NEUROLOGY, V59, P700, DOI 10.1212/WNL.59.5.700; Degenetais E, 2002, CEREB CORTEX, V12, P1, DOI 10.1093/cercor/12.1.1; Degos B, 2005, J NEUROSCI, V25, P7687, DOI 10.1523/JNEUROSCI.1056-05.2005; Degos B, 2008, EUR J NEUROSCI, V27, P2599, DOI 10.1111/j.1460-9568.2008.06229.x; Degos B, 2009, CEREB CORTEX, V19, P1616, DOI 10.1093/cercor/bhn199; Dejean C, 2009, CEREB CORTEX, V19, P1055, DOI 10.1093/cercor/bhn149; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; DOUDET DJ, 1990, EXP BRAIN RES, V80, P177; Fogelson N, 2006, CEREB CORTEX, V16, P64, DOI 10.1093/cercor/bhi084; Fraix V, 2008, CLIN NEUROPHYSIOL, V119, P2513, DOI 10.1016/j.clinph.2008.07.217; Galati S, 2006, EUR J NEUROSCI, V23, P2923, DOI 10.1111/j.1460-9568.2006.04816.x; Garcia L, 2003, J NEUROSCI, V23, P8743; Goldberg JA, 2002, J NEUROSCI, V22, P4639, DOI 10.1523/JNEUROSCI.22-11-04639.2002; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grill WM, 2008, J COMPUT NEUROSCI, V24, P81, DOI 10.1007/s10827-007-0043-9; Gubellini P, 2006, EUR J NEUROSCI, V24, P1802, DOI 10.1111/j.1460-9568.2006.05047.x; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Haslinger B, 2005, NEUROIMAGE, V28, P598, DOI 10.1016/j.neuroimage.2005.06.034; HERKENHAM M, 1979, J COMP NEUROL, V183, P487, DOI 10.1002/cne.901830304; Hershey T, 2003, NEUROLOGY, V61, P816, DOI 10.1212/01.WNL.0000083991.81859.73; Hilker R, 2003, MOVEMENT DISORD, V18, P41, DOI 10.1002/mds.10297; Kita T, 2012, J NEUROSCI, V32, P5990, DOI 10.1523/JNEUROSCI.5717-11.2012; Kuriakose R, 2010, CEREB CORTEX, V20, P1926, DOI 10.1093/cercor/bhp269; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Li Q, 2012, NEURON, V76, P1030, DOI 10.1016/j.neuron.2012.09.032; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; Limousin P, 1997, ANN NEUROL, V42, P283, DOI 10.1002/ana.410420303; Lopes da Silva F, 1989, Brain Topogr, V2, P9; Mahon S, 2003, J PHYSIOL-LONDON, V550, P947, DOI 10.1113/jphysiol.2003.043125; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Mallet N, 2008, J NEUROSCI, V28, P4795, DOI 10.1523/JNEUROSCI.0123-08.2008; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Parr-Brownlie LC, 2005, J NEUROSCI, V25, P5700, DOI 10.1523/JNEUROSCI.0523-05.2005; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Paz JT, 2007, J NEUROSCI, V27, P929, DOI 10.1523/JNEUROSCI.4677-06.2007; Paz JT, 2005, J NEUROSCI, V25, P2092, DOI 10.1523/JNEUROSCI.4689-04.2005; Pessiglione M, 2005, J NEUROSCI, V25, P1523, DOI 10.1523/JNEUROSCI.4056-04.2005; Pierantozzi M, 2002, CLIN NEUROPHYSIOL, V113, P108, DOI 10.1016/S1388-2457(01)00694-0; Pinault D, 1998, J PHYSIOL-LONDON, V509, P449, DOI 10.1111/j.1469-7793.1998.449bn.x; Polack PO, 2009, CEREB CORTEX, V19, P2078, DOI 10.1093/cercor/bhn237; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; Robin K, 2009, J NEUROSCI METH, V179, P142, DOI 10.1016/j.jneumeth.2009.01.020; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Scholz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001589; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Slaght S, 2004, J NEUROSCI, V24, P6816, DOI 10.1523/JNEUROSCI.1449-04.2004; Slaght SNJ, 2002, J NEUROSCI, V22, P2323, DOI 10.1523/JNEUROSCI.22-06-02323.2002; Strafella AP, 2000, CLIN NEUROPHYSIOL, V111, P1198, DOI 10.1016/S1388-2457(00)00316-3; Tai CH, 2003, FASEB J, V17, P1820, DOI 10.1096/fj.03-0163com; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; Welter ML, 2004, ARCH NEUROL-CHICAGO, V61, P89, DOI 10.1001/archneur.61.1.89; Wichmann T, 1999, EXP BRAIN RES, V125, P397, DOI 10.1007/s002210050696; ZHENG F, 2011, J PHYSL, V11, P2781; ZOLD CL, 2008, NEUR M PLANN	73	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83608	10.1371/journal.pone.0083608	http://dx.doi.org/10.1371/journal.pone.0083608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391793	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200090
J	Fornace, KM; Clark, EL; Macdonald, SE; Namangala, B; Karimuribo, E; Awuni, JA; Thieme, O; Blake, DP; Rushton, J				Fornace, Kimberly M.; Clark, Emily L.; Macdonald, Sarah E.; Namangala, Boniface; Karimuribo, Esron; Awuni, Joseph A.; Thieme, Olaf; Blake, Damer P.; Rushton, Jonathan			Occurrence of Eimeria Species Parasites on Small-Scale Commercial Chicken Farms in Africa and Indication of Economic Profitability	PLOS ONE			English	Article							BROILER-CHICKENS; AVIAN EIMERIA; COCCIDIOSIS; DIAGNOSIS; BIOLOGY; MODEL	Small-scale commercial poultry production is emerging as an important form of livestock production in Africa, providing sources of income and animal protein to many poor households, yet the occurrence and impact of coccidiosis on this relatively new production system remains unknown. The primary objective of this study was to examine Eimeria parasite occurrence on small-scale commercial poultry farms in Ghana, Tanzania and Zambia. Additionally, farm economic viability was measured by calculating the farm gross margin and enterprise budget. Using these economic measures as global assessments of farm productivity, encompassing the diversity present in regional husbandry systems with a measure of fundamental local relevance, we investigated the detection of specific Eimeria species as indicators of farm profitability. Faecal samples and data on production parameters were collected from small-scale (less than 2,000 birds per batch) intensive broiler and layer farms in peri-urban Ghana, Tanzania and Zambia. All seven Eimeria species recognised to infect the chicken were detected in each country. Furthermore, two of the three genetic variants (operational taxonomic units) identified previously in Australia have been described outside of Australia for the first time. Detection of the most pathogenic Eimeria species associated with decreased farm profitability and may be considered as an indicator of likely farm performance. While a causal link remains to be demonstrated, the presence of highly pathogenic enteric parasites may pose a threat to profitable, sustainable small-scale poultry enterprises in Africa.	[Fornace, Kimberly M.] London Sch Hyg & Trop Med, London WC1, England; [Clark, Emily L.; Macdonald, Sarah E.; Blake, Damer P.; Rushton, Jonathan] Royal Vet Coll, N Mymms, Herts, England; [Namangala, Boniface] Univ Zambia, Fac Vet Med, Dept Paraclin Studies, Lusaka, Zambia; [Karimuribo, Esron] Southern African Ctr Infect Dis Surveillance, Morogoro, Tanzania; [Awuni, Joseph A.] Accra Vet Lab, Accra, Ghana; [Thieme, Olaf] Food & Agr Org, Rome, Italy	University of London; London School of Hygiene & Tropical Medicine; University of London; University of London Royal Veterinary College; University of Zambia; Food & Agriculture Organization of the United Nations (FAO)	Blake, DP (corresponding author), Royal Vet Coll, N Mymms, Herts, England.	dblake@rvc.ac.uk; jrushton@rvc.ac.uk	Fornace, Kimberly/ABF-7147-2020; Rushton, Jonathan/I-3518-2014; Clark, Emily/GVR-7159-2022	Fornace, Kimberly/0000-0002-5484-241X; Rushton, Jonathan/0000-0001-5450-4202; Awuni, Joseph Agebase/0000-0003-0940-9462; Blake, Damer/0000-0003-1077-2306; Clark, Emily/0000-0002-9550-7407	Food and Agriculture Organization of the United Nations; Biotechnology and Biological Sciences Research Council/Department for International Development [BB/H009337/2]; Biotechnology and Biological Sciences Research Council [BB/H009337/2] Funding Source: researchfish; BBSRC [BB/H009337/2] Funding Source: UKRI	Food and Agriculture Organization of the United Nations; Biotechnology and Biological Sciences Research Council/Department for International Development(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by the Food and Agriculture Organization of the United Nations (www.fao.com) and the Biotechnology and Biological Sciences Research Council/Department for International Development grant BB/H009337/2 (www.bbsrc.ac.uk; www.gov.uk/government/organisations/department-for-international-development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; AgricultureFish F, 1986, MANUAL VET PARASITOL; Allen PC, 2002, CLIN MICROBIOL REV, V15, P58, DOI 10.1128/CMR.15.1.58-65.2002; Ashenafi H, 2004, TROP ANIM HEALTH PRO, V36, P693, DOI 10.1023/B:TROP.0000042852.82477.af; Babiker M. A., 2009, International Journal of Poultry Science, V8, P264; Barry A. M., 2009, Bulletin of Animal Health and Production in Africa, V57, P93; Bennett R, 2005, J AGR ECON, V56, P135, DOI 10.1111/j.1477-9552.2005.tb00126.x; Blake DP, 2006, INT J PARASITOL, V36, P97, DOI 10.1016/j.ijpara.2005.09.011; Bukar-Kolo Y. M., 2006, Nigerian Veterinary Journal, V27, P75; Cantacessi C, 2008, VET PARASITOL, V152, P226, DOI 10.1016/j.vetpar.2007.12.028; Chanie M, 2009, TROP ANIM HEALTH PRO, V41, P1309, DOI 10.1007/s11250-009-9316-9; Graat EAM, 1998, PREV VET MED, V33, P297, DOI 10.1016/S0167-5877(97)00008-1; Grossman M, 2001, POULTRY SCI, V80, P859, DOI 10.1093/ps/80.7.859; Haug A, 2008, AVIAN PATHOL, V37, P333, DOI 10.1080/03079450802050705; Kinung'hi S. M., 2002, Bulletin of Animal Health and Production in Africa, V50, P41; LONG P L, 1976, Folia Veterinaria Latina, V6, P201; McDonald V, 2009, PARASITOLOGY, P1, DOI 10.1017/S0031182009006349; Musa I. W., 2010, International Journal of Poultry Science, V9, P1112; Nowzari N, 2005, VET PARASITOL, V128, P59, DOI 10.1016/j.vetpar.2004.11.015; Nsamba P., 2000, Tanzanian Veterinary Journal, V20, P199; Ogedengbe M. E., 2009, Tropical Veterinarian, V27, P36; Otte MJ, 2007, IND LIVESTOCK PRODUC; Otte MJ, 2008, NUTR NATURAL RESOURC, V80, P1; Rushton J, 2009, ECONOMICS OF ANIMAL HEALTH AND PRODUCTION, P1; Rushton J, 1998, WORLD ANIM REV, P43; Schwarz RS, 2009, J PARASITOL, V95, P871, DOI 10.1645/GE-1898.1; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; Shirzad MR, 2011, TROP ANIM HEALTH PRO, V43, P1601, DOI 10.1007/s11250-011-9876-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; Vrba V, 2010, VET PARASITOL, V174, P183, DOI 10.1016/j.vetpar.2010.09.006; Williams RB, 1999, INT J PARASITOL, V29, P341, DOI 10.1016/S0020-7519(98)00212-4; Williams RB, 1999, INT J PARASITOL, V29, P1209, DOI 10.1016/S0020-7519(99)00086-7	33	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84254	10.1371/journal.pone.0084254	http://dx.doi.org/10.1371/journal.pone.0084254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391923	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000329323900066
J	Goemans, N; Klingels, K; van den Hauwe, M; Boons, S; Verstraete, L; Peeters, C; Feys, H; Buyse, G				Goemans, Nathalie; Klingels, Katrijn; van den Hauwe, Marleen; Boons, Stefanie; Verstraete, Liese; Peeters, Charlotte; Feys, Hilde; Buyse, Gunnar			Six-Minute Walk Test: Reference Values and Prediction Equation in Healthy Boys Aged 5 to 12 Years	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MUSCLE FORCE; CHILDREN; RELIABILITY; DISTANCE	OBJECTIVE: This study aimed to (1) generate normative data in healthy boys aged 5-12 years for the six-minute walk test (6MWT), an outcome measure currently used in clinical trials in Duchenne muscular dystrophy (DMD), (2) to describe the relation with anthropometric variables and myometry, and (3) to compare our data with published equations. METHODS: The 6MWT was conducted in 442 boys according to a standardized protocol, as currently used in clinical trials in DMD. Maximal voluntary isometric contractions for knee flexion and extension were recorded with a hand-held myometer. RESULTS: The 6MWD increased significantly with age, from 478.0 +/- 44.1 m at age 5, to 650.0 +/- 76.8 m at age 12, with the steepest increase between 5 and 8 years. Age-and height related percentile curves of the 6MWD were developed. Correlations with anthropometric variables were fair to good (age r = 0.60, height r = 0.57, weight r = 0.44). Myometric variables (knee flexors and extensors) showed correlations of 0.46 and 0.50 respectively. When dividing into two age categories (5-8 years, 9-12 years), these magnitudes of correlations only applied to the younger age group. Additionally, predicted values were calculated according to available reference equations (Geiger and Ben Saad), indicating an overestimation by those equations. Finally, the Geiger equation was refitted to our population. CONCLUSION: The percentile curves according to age and height provide a useful tool in the assessment of ambulatory capacity in boys aged 5 to 12 years. Significant correlations with anthropometric variables and myometry were only found in the 5-8 years age group. The Geiger prediction equation, currently used to assess ambulatory capacity in DMD was refitted to obtain a more accurate prediction model based on a large sample with a homogenous distribution across the age categories 5 to 12 years and applying the methodology as currently used in clinical trials in DMD.	[Goemans, Nathalie; van den Hauwe, Marleen; Buyse, Gunnar] Katholieke Univ Leuven Hosp, Dept Child Neurol, Louvain, Belgium; [Klingels, Katrijn; Boons, Stefanie; Verstraete, Liese; Peeters, Charlotte; Feys, Hilde] Katholieke Univ Leuven, Dept Rehabil Sci, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; KU Leuven	Goemans, N (corresponding author), Katholieke Univ Leuven Hosp, Dept Child Neurol, Louvain, Belgium.	nathalie.goemans@uzleuven.be	Akkal, Maureen/P-6919-2014	Klingels, Katrijn/0000-0001-5853-9680				Beenakker EAC, 2005, EUR J PAEDIATR NEURO, V9, P387, DOI 10.1016/j.ejpn.2005.06.004; Beenakker EAC, 2001, NEUROMUSCULAR DISORD, V11, P441, DOI 10.1016/S0960-8966(01)00193-6; Ben Saad H, 2009, PEDIATR PULM, V44, P316, DOI 10.1002/ppul.20942; Clarke LA, 2009, PEDIATRICS, V123, P229, DOI 10.1542/peds.2007-3847; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; D'silva C, 2012, INDIAN J PEDIATR, V79, P597, DOI 10.1007/s12098-011-0559-x; FELLINGHAM GW, 1978, MED SCI SPORT EXER, V10, P132; Geiger R, 2007, J PEDIAT, V150, P395; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Goemans N, 2013, NEUROMUSCUL DISORD; Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P19, DOI 10.1016/j.nmd.2012.10.019; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Henricson E, 2013, PLOS CURR, V5; Henricson Erik, 2012, PLoS Curr, V3, pRRN1297, DOI 10.1371/currents.RRN1297; Hinkle D., 2003, APPL STAT BEHAV SCI, P756; Klepper SE, 2011, PEDIATR PHYS THER, V23, P32, DOI 10.1097/PEP.0b013e3182095e44; Lammers AE, 2008, ARCH DIS CHILD, V93, P464, DOI 10.1136/adc.2007.123653; Li AM, 2007, AM J RESP CRIT CARE, V176, P174, DOI 10.1164/rccm.200607-883OC; Li AM, 2005, EUR RESPIR J, V25, P1057, DOI 10.1183/09031936.05.00134904; Limsuwan A, 2010, ACTA PAEDIATR, V99, P438, DOI 10.1111/j.1651-2227.2009.01602.x; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; MENIER DR, 1968, J PHYSIOL-LONDON, V197, P717, DOI 10.1113/jphysiol.1968.sp008584; Poh H, 2006, RESPIROLOGY, V11, P211, DOI 10.1111/j.1440-1843.2006.00820.x; Priesnitz CV, 2009, PEDIATR PULM, V44, P1174, DOI 10.1002/ppul.21062	29	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84120	10.1371/journal.pone.0084120	http://dx.doi.org/10.1371/journal.pone.0084120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391899	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900042
J	Schwartz, MW; Smith, LM; Steel, ZL				Schwartz, Mark W.; Smith, Lacy M.; Steel, Zachary L.			Conservation Investment for Rare Plants in Urban Environments	PLOS ONE			English	Article							EXTINCTION RATES; HABITAT; FRAGMENTATION; BIODIVERSITY; URBANIZATION; CALIFORNIA	Budgets for species conservation limit actions. Expending resources in areas of high human density is costly and generally considered less likely to succeed. Yet, coastal California contains both a large fraction of narrowly endemic at-risk plant species as well as the state's three largest metropolitan regions. Hence understanding the capacity to protect species along the highly urbanized coast is a conservation priority. We examine at-risk plant populations along California's coastline from San Diego to north of San Francisco to better understand whether there is a relationship between human population density and: i) performance of at-risk plant populations; and ii) conservation spending. Answering these questions can help focus appropriate strategic conservation investment. Rare plant performance was measured using the annualized growth rate estimate between census periods using the California Natural Diversity Database. Human density was estimated using Census Bureau statistics from the year 2000. We found strong evidence for a lack of a relationship between human population density and plant population performance in California's coastal counties. Analyzing US Endangered Species expenditure reports, we found large differences in expenditures among counties, with plants in San Diego County receiving much higher expenditures than other locations. We found a slight positive relationship between expenditures on behalf of endangered species and human density. Together these data support the argument that conservation efforts by protecting habitats within urban environments are not less likely to be successful than in rural areas. Expenditures on behalf of federally listed endangered and threatened plants do not appear to be related to proximity to human populations. Given the evidence of sufficient performance in urban environments, along with a high potential to leverage public support for nature in urban environments, expenditures in these areas appear to be an appropriate use of conservation funds.	[Schwartz, Mark W.] Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA; [Schwartz, Mark W.; Smith, Lacy M.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Steel, Zachary L.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Schwartz, MW (corresponding author), Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA.	mwschwartz@ucdavis.edu	Schwartz, Mark/G-1066-2011	Schwartz, Mark/0000-0002-3739-6542; Steel, Zachary/0000-0002-1659-3141				Akû║akaya H.R., 1999, APPL POPULATION ECOL; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; [Anonymous], POP STAT; Bastin L, 1999, LANDSCAPE ECOL, V14, P493, DOI 10.1023/A:1008036207944; California Department of Fish and Game [CDFG], 2003, ATL BIOD CAL; CNDDB, 2009, CAL NAT DIV DAT; [CNPS Society CNP], 2011, ONLN INV RAR END PLA; Dallimer M, 2012, BIOSCIENCE, V62, P47, DOI 10.1525/bio.2012.62.1.9; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Duncan RP, 2011, GLOBAL ECOL BIOGEOGR, V20, P509, DOI 10.1111/j.1466-8238.2010.00633.x; Feldman TD, 2000, ANN ASSOC AM GEOGR, V90, P256, DOI 10.1111/0004-5608.00195; Franklin J, 2011, AM J BOT, V98, P559, DOI 10.3732/ajb.1000292; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Gibb H, 2002, BIOL CONSERV, V106, P91, DOI 10.1016/S0006-3207(01)00232-4; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; Lawson DM, 2008, CONSERV BIOL, V22, P922, DOI 10.1111/j.1523-1739.2008.00936.x; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; Press DM., 2002, SAVING OPEN SPACE PO; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Schwartz MW, 2006, CONSERV BIOL, V20, P1550, DOI 10.1111/j.1523-1739.2006.00421.x; Schwartz MW, 2006, BIOL CONSERV, V127, P282, DOI 10.1016/j.biocon.2005.05.017; Schwartz MW, 2002, BIOSCIENCE, V52, P601, DOI 10.1641/0006-3568(2002)052[0601:CSDUP]2.0.CO;2; Schwartz MW, 1999, ANNU REV ECOL SYST, V30, P83, DOI 10.1146/annurev.ecolsys.30.1.83; Seabloom EW, 2002, P NATL ACAD SCI USA, V99, P11229, DOI 10.1073/pnas.162064899; Thomas CW, 2001, POLIT SOC, V29, P105, DOI 10.1177/0032329201029001005; U.S. Fish and Wildlife Service (USFWS), 2007, FED STAT END THREAT; Underwood EC, 2009, CONSERV LETT, V2, P130, DOI 10.1111/j.1755-263X.2008.00018.x; United Nations (UN), 2005, DEM YB 2005; [USFWS Interior Do], 2008, FED STAT END THREAT; USFWS, 2009, ENV CONS ONL SYST; [USFWS Interior UDf], 2006, FED AD STAT END THRE; Viers JH, 2006, SAN FRANCISCO ESTUAR; von der Dunk A, 2011, LANDSCAPE URBAN PLAN, V101, P149, DOI 10.1016/j.landurbplan.2011.02.007; West P, 2006, ANNU REV ANTHROPOL, V35, P251, DOI 10.1146/annurev.anthro.35.081705.123308; Williams NSG, 2009, J ECOL, V97, P4, DOI 10.1111/j.1365-2745.2008.01460.x	39	11	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83809	10.1371/journal.pone.0083809	http://dx.doi.org/10.1371/journal.pone.0083809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391830	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200128
J	Shaw, DJ; Czekoova, K; Chromec, J; Marecek, R; Brazdil, M				Shaw, Daniel Joel; Czekoova, Kristina; Chromec, Jakub; Marecek, Radek; Brazdil, Milan			Copying You Copying Me: Interpersonal Motor Co-Ordination Influences Automatic Imitation	PLOS ONE			English	Article							A-PRIORI LIKING; SOCIAL COGNITION; SYNCHRONY; SELF; MIRROR; EXPERIENCE; INHIBITION; MODULATION; MIMICRY; REPRESENTATIONS	Moving in a co-ordinated fashion with another individual changes our behaviour towards them; we tend to like them more, find them more attractive, and are more willing to co-operate with them. It is generally assumed that this effect on behaviour results from alterations in representations of self and others. Specifically, through neurophysiological perception-action matching mechanisms, interpersonal motor co-ordination (IMC) is believed to forge a neural coupling between actor and observer, which serves to blur boundaries in conceptual self-other representations and causes positive views of the self to be projected onto others. An investigation into this potential neural mechanism is lacking, however. Moreover, the specific components of IMC that might influence this mechanism have not yet been specified. In the present study we exploited a robust behavioural phenomenon -automatic imitation -to assess the degree to which IMC influences neural action observation-execution matching mechanisms. This revealed that automatic imitation is reduced when the actions of another individual are perceived to be synchronised in time, but are spatially incongruent, with our own. We interpret our findings as evidence that IMC does indeed exert an effect on neural perception-action matching mechanisms, but this serves to promote better self-other distinction. Our findings demonstrate that further investigation is required to understand the complex relationship between neural perception-action coupling, conceptual self-other representations, and social behaviour.	[Shaw, Daniel Joel; Czekoova, Kristina; Chromec, Jakub; Marecek, Radek; Brazdil, Milan] Masaryk Univ, CEITEC Cent European Inst Technol, Behav & Social Neurosci Res Grp, Brno, Czech Republic; [Chromec, Jakub; Marecek, Radek; Brazdil, Milan] Masaryk Univ, Fac Med, Dept Neurol 1, Brno, Czech Republic; [Chromec, Jakub; Marecek, Radek; Brazdil, Milan] Masaryk Univ, St Annes Univ Hosp, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Shaw, DJ (corresponding author), Masaryk Univ, CEITEC Cent European Inst Technol, Behav & Social Neurosci Res Grp, Brno, Czech Republic.	daniel.shaw@ceitec.muni.cz	Brazdil, Milan/D-6836-2012; Czekóová, Kristína/E-3233-2012; Marecek, Radek/AAM-4984-2020; Shaw, Daniel/E-3362-2012	Czekóová, Kristína/0000-0001-9198-1083; Shaw, Daniel/0000-0003-1139-8301; Marecek, Radek/0000-0001-8399-3455; Brazdil, Milan/0000-0001-7979-2343	CEITEC - Central European Institute of Technology from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; Laboratory for the Experimental Research of Religion (LEVYNA) [CZ.1.07/2.3.00/20.0048]; European Social Fund; state budget of the Czech Republic	CEITEC - Central European Institute of Technology from European Regional Development Fund; Laboratory for the Experimental Research of Religion (LEVYNA); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This work was supported by the project "CEITEC - Central European Institute of Technology" (CZ.1.05/1.1.00/02.0068) from European Regional Development Fund, and partly by the project "Laboratory for the Experimental Research of Religion (LEVYNA)" (CZ.1.07/2.3.00/20.0048), co-financed by the European Social Fund and the state budget of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Aron A., 2013, OXFORD HDB CLOSE REL; Bird G, 2007, P ROY SOC B-BIOL SCI, V274, P3027, DOI 10.1098/rspb.2007.1019; Brass M, 2005, NEUROPSYCHOLOGIA, V43, P89, DOI 10.1016/j.neuropsychologia.2004.06.018; Brass M, 2003, NEUROPSYCHOLOGY, V17, P265, DOI 10.1037/0894-4105.17.2.265; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Brass M, 2001, NEUROIMAGE, V14, P1416, DOI 10.1006/nimg.2001.0944; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Catmur C, 2011, J COGNITIVE NEUROSCI, V23, P2352, DOI 10.1162/jocn.2010.21590; Catmur C, 2009, PHILOS T R SOC B, V364, P2369, DOI 10.1098/rstb.2009.0048; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cook J, 2011, EXP BRAIN RES, V211, P601, DOI 10.1007/s00221-011-2584-4; Cook JL, 2012, J AUTISM DEV DISORD, V42, P1045, DOI 10.1007/s10803-011-1341-7; Ebisch SJH, 2011, J COGNITIVE NEUROSCI, V23, P1808, DOI 10.1162/jocn.2010.21551; Farmer H, 2012, REV PHILOS PSYCHOL, V3, P125, DOI 10.1007/s13164-012-0092-5; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Galinsky AD, 2005, GROUP PROCESS INTERG, V8, P109, DOI 10.1177/1368430205051060; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gallese V, 2001, J CONSCIOUSNESS STUD, V8, P33; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; James W., 1890, PRINCIPLES PSYCHOL, V2; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Knoblich G, 2008, PHILOS T R SOC B, V363, P2021, DOI 10.1098/rstb.2008.0006; Lakens D, 2010, J EXP SOC PSYCHOL, V46, P701, DOI 10.1016/j.jesp.2010.03.015; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Launay J, 2013, EXP PSYCHOL, V60, P53, DOI 10.1027/1618-3169/a000173; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; Macrae CN, 2008, COGNITION, V109, P152, DOI 10.1016/j.cognition.2008.07.007; Maddux WW, 2008, J EXP SOC PSYCHOL, V44, P461, DOI 10.1016/j.jesp.2007.02.003; Mazzurega M, 2011, EXP BRAIN RES, V213, P213, DOI 10.1007/s00221-011-2744-6; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31; Miles LK, 2010, J EXP SOC PSYCHOL, V46, P457, DOI 10.1016/j.jesp.2009.12.006; Miles LK, 2009, J EXP SOC PSYCHOL, V45, P585, DOI 10.1016/j.jesp.2009.02.002; Oosterhof NN, 2010, J NEUROPHYSIOL, V104, P1077, DOI 10.1152/jn.00326.2010; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Press C, 2008, BRAIN COGNITION, V67, P44, DOI 10.1016/j.bandc.2007.11.001; Press C, 2007, P ROY SOC B-BIOL SCI, V274, P2509, DOI 10.1098/rspb.2007.0774; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Santiesteban I, 2012, COGNITION, V122, P228, DOI 10.1016/j.cognition.2011.11.004; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Smith ER, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P148; Spengler S, 2009, HUM BRAIN MAPP, V30, P3704, DOI 10.1002/hbm.20800; Stel M, 2010, EXP PSYCHOL, V57, P412, DOI 10.1027/1618-3169/a000050; Stel M, 2010, EUR J SOC PSYCHOL, V40, P867, DOI 10.1002/ejsp.655; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Swaab RI, 2011, J EXP SOC PSYCHOL, V47, P616, DOI 10.1016/j.jesp.2011.01.005; Tajadura-Jimenez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040682; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	66	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84820	10.1371/journal.pone.0084820	http://dx.doi.org/10.1371/journal.pone.0084820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391976	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900119
J	Wang, T; Kusudo, T; Takeuchi, T; Yamashita, Y; Kontani, Y; Okamatsu, Y; Saito, M; Mori, N; Yamashita, H				Wang, Ting; Kusudo, Tatsuya; Takeuchi, Tamaki; Yamashita, Yukari; Kontani, Yasuhide; Okamatsu, Yuko; Saito, Masayuki; Mori, Nozomu; Yamashita, Hitoshi			Evodiamine Inhibits Insulin-Stimulated mTOR-S6K Activation and IRS1 Serine Phosphorylation in Adipocytes and Improves Glucose Tolerance in Obese/Diabetic Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; PROTEIN-KINASE; 3T3-L1 ADIPOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR SUBSTRATE-1; GENE-EXPRESSION; ADULT HUMANS; ENERGY; HOMEOSTASIS	Evodiamine, an alkaloid extracted from the dried unripe fruit of the tree Evodia rutaecarpa Bentham (Rutaceae), reduces obesity and insulin resistance in obese/diabetic mice; however, the mechanism underlying the effect of evodiamine on insulin resistance is unknown. This study investigated the effect of evodiamine on signal transduction relating to insulin resistance using obese/diabetic KK-Ay mice and an in vitro adipocyte culture. There is a significant decrease in the mammalian target of rapamycin (mTOR) and ribosomal S6 protein kinase (S6K) signaling in white adipose tissue (WAT) in KK-Ay mice treated with evodiamine, in which glucose tolerance is improved. In addition, reduction of insulin receptor substrate 1 (IRS1) serine phosphorylation, an indicator of insulin resistance, was detected in their WAT, suggesting suppression of the negative feedback loop from S6K to IRS1. As well as the stimulation of IRS1 and Akt serine phosphorylation, insulin-stimulated phosphorylation of mTOR and S6K is time-dependent in 3T3-L1 adipocytes, whereas evodiamine does not affect their phosphorylation except for an inhibitory effect on mTOR phosphorylation. Moreover, evodiamine inhibits the insulin-stimulated phosphorylation of mTOR and S6K, leading to down-regulation of IRS1 serine phosphorylation in the adipocytes. Evodiamine also stimulates phosphorylation of AMP-activated protein kinase (AMPK), an important regulator of energy metabolism, which may cause down-regulation of mTOR signaling in adipocytes. A similar effect on AMPK, mTOR and IRS1 phosphorylation was found in adipocytes treated with rosiglitazone. These results suggest evodiamine improves glucose tolerance and prevents the progress of insulin resistance associated with obese/diabetic states, at least in part, through inhibition of mTOR-S6K signaling and IRS1 serine phosphorylation in adipocytes.	[Wang, Ting; Kusudo, Tatsuya; Takeuchi, Tamaki; Yamashita, Yukari; Yamashita, Hitoshi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan; [Yamashita, Yukari; Yamashita, Hitoshi] Chubu Univ, Nutrit Hlth Sci Res Ctr, Kasugai, Aichi 487, Japan; [Kontani, Yasuhide] Minami Kyushu Univ, Dept Food Sci Hlth, Miyazaki, Japan; [Okamatsu, Yuko] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido, Japan; [Saito, Masayuki] Tenshi Coll, Sch Nursing & Nutr, Dept Nutr, Sapporo, Hokkaido, Japan; [Mori, Nozomu] Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, Nagasaki 852, Japan	Chubu University; Chubu University; Hokkaido University; Nagasaki University	Yamashita, H (corresponding author), Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan.	hyamashi@isc.chubu.ac.jp		Yamashita, Hitoshi/0000-0002-5785-5208	MEXT	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from MEXT-Supported program for Strategic Research Foundation at Private Universities (to H.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak EJ, 2010, INT J OBESITY, V34, P250, DOI 10.1038/ijo.2009.223; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2012, J CLIN INVEST, V122, P486, DOI 10.1172/JCI60941; Ching LC, 2012, MOL MED, V18, P805, DOI 10.2119/molmed.2011.00461; CHIOU WF, 1992, EUR J PHARMACOL, V215, P277, DOI 10.1016/0014-2999(92)90039-7; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Draznin B, 2006, DIABETES, V55, P2392, DOI 10.2337/db06-0391; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Esposito DL, 2001, ENDOCRINOLOGY, V142, P2833, DOI 10.1210/en.142.7.2833; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913; Heo SK, 2009, J CELL BIOCHEM, V107, P123, DOI 10.1002/jcb.22109; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kennedy BK, 2007, CELL MOL LIFE SCI, V64, P1323, DOI 10.1007/s00018-007-6470-y; Kobayashi Y, 2001, PLANTA MED, V67, P628, DOI 10.1055/s-2001-17353; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saito K, 2011, ANAL BIOCHEM, V412, P9, DOI 10.1016/j.ab.2011.01.022; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Summers SA, 1998, BIOCHEM BIOPH RES CO, V246, P76, DOI 10.1006/bbrc.1998.8575; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Wang T, 2008, ENDOCRINOLOGY, V149, P358, DOI 10.1210/en.2007-0467; Wang YX, 2006, PFLUG ARCH EUR J PHY, V452, P363, DOI 10.1007/s00424-005-0036-3; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	27	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83264	10.1371/journal.pone.0083264	http://dx.doi.org/10.1371/journal.pone.0083264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391749	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200046
J	Yan, K; Zhang, R; Sun, CM; Chen, L; Li, P; Liu, Y; Peng, LM; Sun, HT; Qin, K; Chen, FF; Huang, WY; Chen, YX; Lv, BK; Du, MX; Zou, YX; Cai, YQ; Qin, LS; Tang, YP; Jiang, XD				Yan, Ke; Zhang, Run; Sun, Chengmei; Chen, Lei; Li, Peng; Liu, Yi; Peng, Lingmei; Sun, Haitao; Qin, Kun; Chen, Fanfan; Huang, Weiyi; Chen, Yuxin; Lv, Bingke; Du, Mouxuan; Zou, Yuxi; Cai, Yingqian; Qin, Lingsha; Tang, Yanping; Jiang, Xiaodan			Bone Marrow-Derived Mesenchymal Stem Cells Maintain the Resting Phenotype of Microglia and Inhibit Microglial Activation	PLOS ONE			English	Article							STROMAL CELLS; NITRIC-OXIDE; PROLIFERATION; BRAIN; INTERLEUKIN-10; PHAGOCYTOSIS; PROTECTION; NEURONS; MODEL	Many studies have shown that microglia in the activated state may be neurotoxic. It has been proven that uncontrolled or over-activated microglia play an important role in many neurodegenerative disorders. Bone marrow-derived mesenchymal stem cells (BMSCs) have been shown in many animal models to have a therapeutic effect on neural damage. Such a therapeutic effect is attributed to the fact that BMSCs have the ability to differentiate into neurons and to produce trophic factors, but there is little information available in the literature concerning whether BMSCs play a therapeutic role by affecting microglial activity. In this study, we triggered an inflammatory response situation in vitro by stimulating microglia with the bacterial endotoxin lipopolysaccharide (LPS), and then culturing these microglia with BMSC-conditioned medium (BMSC-CM). We found that BMSC-CM significantly inhibited proliferation and secretion of pro-inflammatory factors by activated microglia. Furthermore, we found that the phagocytic capacity of microglia was also inhibited by BMSC-CM. Finally, we investigated whether the induction of apoptosis and the production of nitric oxide (NO) were involved in the inhibition of microglial activation. We found that BMSC-CM significantly induced apoptosis of microglia, while no apoptosis was apparent in the LPS-stimulated microglia. Our study also provides evidence that NO participates in the inhibitory effect of BMSCs. Our experimental results provide evidence that BMSCs have the ability to maintain the resting phenotype of microglia or to control microglial activation through their production of several factors, indicating that BMSCs could be a promising therapeutic tool for treatment of diseases associated with microglial activation.	[Yan, Ke; Zhang, Run; Sun, Chengmei; Chen, Lei; Li, Peng; Liu, Yi; Peng, Lingmei; Sun, Haitao; Qin, Kun; Chen, Fanfan; Huang, Weiyi; Chen, Yuxin; Lv, Bingke; Du, Mouxuan; Zou, Yuxi; Cai, Yingqian; Qin, Lingsha; Tang, Yanping; Jiang, Xiaodan] Southern Med Univ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Neurosurg Inst Guangdong Prov, Natl Key Clin Specialty,Dept Neurosurg,Zhujian Ho, Guangzhou, Guangdong, Peoples R China; [Chen, Lei] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Dept Neurosurg, Shenzhen, Peoples R China; [Li, Peng; Chen, Fanfan] Guangzhou First Peoples Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Peng, Lingmei] First Peoples Hosp Foshan, Dept Neurol, Foshan, Peoples R China; [Qin, Kun] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Shenzhen University; South China University of Technology; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Jiang, XD (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Neurosurg Inst Guangdong Prov, Natl Key Clin Specialty,Dept Neurosurg,Zhujian Ho, Guangzhou, Guangdong, Peoples R China.	jiangxiao_dan@163.com		/0000-0001-7925-9506	funds for National Key Clinic Department; Natural Science Fund of China [81171179, 81272439]; Guandong Natural Science Foundation [S2013020012754]; Funds for Key Sci-Tech Research Projects of Guangdong [2008A030201019]; Funds for Key Sci-Tech Research Projects of Guangzhou [09B52120112-2009J1-C418-2, 2008A1-E4011-6]	funds for National Key Clinic Department; Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Guandong Natural Science Foundation; Funds for Key Sci-Tech Research Projects of Guangdong; Funds for Key Sci-Tech Research Projects of Guangzhou	This work was supported by grants from the funds for National Key Clinic Department, the Natural Science Fund of China (No. 81171179 and No. 81272439), the Guandong Natural Science Foundation (No. S2013020012754), the Funds for Key Sci-Tech Research Projects of Guangdong (No. 2008A030201019), and Funds for Key Sci-Tech Research Projects of Guangzhou (No. 09B52120112-2009J1-C418-2, No. 2008A1-E4011-6) to professor Xiaodan Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augello A, 2005, EUR J IMMUNOL, V35, P1482, DOI 10.1002/eji.200425405; Baker AH, 2007, P NATL ACAD SCI USA, V104, P3597, DOI 10.1073/pnas.0611112104; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hess DC, 2004, ARCH NEUROL-CHICAGO, V61, P483, DOI 10.1001/archneur.61.4.483; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Jeong SR, 2012, EXP NEUROL, V233, P312, DOI 10.1016/j.expneurol.2011.10.021; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kingham PJ, 1999, J NEUROCHEM, V73, P538, DOI 10.1046/j.1471-4159.1999.0730538.x; Koh SH, 2012, EXP NEUROL, V233, P472, DOI 10.1016/j.expneurol.2011.11.021; Kuo YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035459; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Levesque S, 2010, BRAIN, V133, P808, DOI 10.1093/brain/awp333; Liu W, 2013, THEOR APPL MECH LETT, V3, DOI [10.1186/2045-9912-3-3, 10.1063/2.1306201]; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Saijo K, 2013, GLIA, V61, P104, DOI 10.1002/glia.22423; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Walter L, 2009, SEMIN IMMUNOPATHOL, V31, P513, DOI 10.1007/s00281-009-0180-5; Wilkins A, 2009, STEM CELL RES, V3, P63, DOI 10.1016/j.scr.2009.02.006; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Zanone MM, 2010, J CLIN ENDOCR METAB, V95, P3788, DOI 10.1210/jc.2009-2350	42	45	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84116	10.1371/journal.pone.0084116	http://dx.doi.org/10.1371/journal.pone.0084116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391898	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900041
J	Yang, XJ; Guo, YZ; Luo, JS; Pu, XM; Li, ML				Yang, Xiaojiao; Guo, Yanzhi; Luo, Jiesi; Pu, Xuemei; Li, Menglong			Effective Identification of Gram-Negative Bacterial Type III Secreted Effectors Using Position-Specific Residue Conservation Profiles	PLOS ONE			English	Article							RNA-BINDING SITES; MESSENGER-RNA; SOLVENT ACCESSIBILITY; YERSINIA-ENTEROCOLITICA; CAMPYLOBACTER-JEJUNI; ACCURATE PREDICTION; VIRULENCE EFFECTORS; MUTATIONAL ANALYSIS; SIGNAL PEPTIDES; RANDOM FOREST	Backgroud: Type III secretion systems (T3SSs) are central to the pathogenesis and specifically deliver their secreted substrates (type III secreted proteins, T3SPs) into host cells. Since T3SPs play a crucial role in pathogen-host interactions, identifying them is crucial to our understanding of the pathogenic mechanisms of T3SSs. This study reports a novel and effective method for identifying the distinctive residues which are conserved different from other SPs for T3SPs prediction. Moreover, the importance of several sequence features was evaluated and further, a promising prediction model was constructed. Results: Based on the conservation profiles constructed by a position-specific scoring matrix (PSSM), 52 distinctive residues were identified. To our knowledge, this is the first attempt to identify the distinct residues of T3SPs. Of the 52 distinct residues, the first 30 amino acid residues are all included, which is consistent with previous studies reporting that the secretion signal generally occurs within the first 30 residue positions. However, the remaining 22 positions span residues 30-100 were also proven by our method to contain important signal information for T3SP secretion because the translocation of many effectors also depends on the chaperone-binding residues that follow the secretion signal. For further feature optimisation and compression, permutation importance analysis was conducted to select 62 optimal sequence features. A prediction model across 16 species was developed using random forest to classify T3SPs and non-T3 SPs, with high receiver operating curve of 0.93 in the 10-fold cross validation and an accuracy of 94.29% for the test set. Moreover, when performing on a common independent dataset, the results demonstrate that our method outperforms all the others published to date. Finally, the novel, experimentally confirmed T3 effectors were used to further demonstrate the model's correct application. The model and all data used in this paper are freely available at http://cic.scu.edu.cn/bioinformatics/ T3SPs.zip.	[Yang, Xiaojiao; Guo, Yanzhi; Luo, Jiesi; Pu, Xuemei; Li, Menglong] Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China	Sichuan University	Guo, YZ (corresponding author), Sichuan Univ, Coll Chem, Chengdu 610064, Peoples R China.	yzguo@scu.edu.cn; liml@scu.edu.cn	meng, li/GVT-2063-2022		National Natural Science Foundation of China [20905054, 20972103, 20973115]; Specialized Research Fund for the Doctoral Program of Higher Education [20090181120058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn; No. 20905054, 20972103, 20973115) and the Specialized Research Fund for the Doctoral Program of Higher Education (http://www.cutech.edu.cn; No. 20090181120058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Akeda Y, 2009, FEMS MICROBIOL LETT, V296, P18, DOI 10.1111/j.1574-6968.2009.01607.x; Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Anderson DM, 1999, P NATL ACAD SCI USA, V96, P12839, DOI 10.1073/pnas.96.22.12839; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Casper-Lindley C, 2002, P NATL ACAD SCI USA, V99, P8336, DOI 10.1073/pnas.122220299; Chauhan JS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-434; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Christensen JE, 2009, MOL MICROBIOL, V73, P650, DOI 10.1111/j.1365-2958.2009.06797.x; Cornelis GR, 2007, INT J MED MICROBIOL, V297, P28; Costa SCP, 2012, MBIO, V3, DOI 10.1128/mBio.00243-11; Crawford JA, 2002, MOL MICROBIOL, V46, P855, DOI 10.1046/j.1365-2958.2002.03214.x; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Deng WY, 2012, MOL CELL PROTEOMICS, V11, P692, DOI 10.1074/mcp.M111.013672; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Dong XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056632; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Garg A, 2005, PROTEINS, V61, P318, DOI 10.1002/prot.20630; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Karavolos MH, 2005, J BACTERIOL, V187, P1559, DOI 10.1128/JB.187.5.1559-1567.2005; Kaur H, 2003, PROTEIN SCI, V12, P627, DOI 10.1110/ps.0228903; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Konkel ME, 1999, MOL MICROBIOL, V32, P691, DOI 10.1046/j.1365-2958.1999.01376.x; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lee SH, 2003, J BACTERIOL, V185, P7279, DOI 10.1128/JB.185.24.7279-7284.2003; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Lower M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005917; Luo JS, 2012, CHEMOMETR INTELL LAB, V110, P163, DOI 10.1016/j.chemolab.2011.11.008; Ma WB, 2008, CURR OPIN PLANT BIOL, V11, P412, DOI 10.1016/j.pbi.2008.05.001; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Qin WL, 2012, COMPUT BIOL CHEM, V36, P31, DOI 10.1016/j.compbiolchem.2011.12.001; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1189, DOI 10.1046/j.1365-2958.2003.03772.x; Ramamurthi KS, 2002, J BACTERIOL, V184, P3321, DOI 10.1128/JB.184.12.3321-3328.2002; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Samudrala R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000375; Sato Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-442; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Swapna LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036688; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tay DMM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S4; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tomalka AG, 2012, MOL MICROBIOL, V86, P1464, DOI 10.1111/mmi.12069; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagner M, 2005, J COMPUT BIOL, V12, P355, DOI 10.1089/cmb.2005.12.355; Wang Y, 2008, AMINO ACIDS, V35, P295, DOI 10.1007/s00726-007-0634-9; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; Wilkins MR, 1999, METH MOL B, V112, P531; Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x; Xiao JM, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-165; Xiao JM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-427; Xue B, 2010, GENES CELLS, V15, P635, DOI 10.1111/j.1365-2443.2010.01407.x; Yahara Koji, 2011, Information and Media Technologies, V6, P39; Yan CH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-47; Yang Y, 2011, P 8 INT C FUZZ SYST, P1560; Yang Y, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/696190; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Yu LZ, 2010, PEPTIDES, V31, P574, DOI 10.1016/j.peptides.2009.12.026; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266	83	6	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84439	10.1371/journal.pone.0084439	http://dx.doi.org/10.1371/journal.pone.0084439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391954	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900097
J	Sjoerds, Z; van den Brink, W; Beekman, ATF; Penninx, BWJH; Veltman, DJ				Sjoerds, Zsuzsika; van den Brink, Wim; Beekman, Aartjan T. F.; Penninx, Brenda W. J. H.; Veltman, Dick J.			Cue Reactivity Is Associated with Duration and Severity of Alcohol Dependence: An fMRI Study	PLOS ONE			English	Article							DORSAL STRIATUM; PSYCHOMETRIC PROPERTIES; INDIVIDUAL-DIFFERENCES; ABSTINENT ALCOHOLICS; VENTRAL STRIATUM; COCAINE-SEEKING; DRUG-ADDICTION; DOPAMINE; ANXIETY; ACTIVATION	Introduction: With the progression of substance dependence, drug cue-related brain activation is thought to shift from motivational towards habit pathways. However, a direct association between cue-induced brain activation and dependence duration has not yet been shown. We therefore examined the relationship between alcohol cue-reactivity in the brain, cue-induced subjective craving and alcohol dependence duration and severity. Since alcohol dependence is highly comorbid with depression/anxiety, which may modulate brain responses to alcohol cues, we also examined the relation between comorbid depression/anxiety and cue-reactivity. Methods: We compared 30 alcohol dependent patients with 15 healthy controls and 15 depression/anxiety patients during a visual alcohol cue-reactivity task using functional magnetic resonance imaging blood oxygenated level-dependent responses and subjective craving as outcomes. Within the alcohol dependent group we correlated cue-reactivity with alcohol dependence severity and duration, with cue-induced craving and with depression/anxiety levels. Results: Alcohol dependent patients showed greater cue-reactivity in motivational brain pathways and stronger subjective craving than depression/anxiety patients and healthy controls. Depression/anxiety was not associated with cue-reactivity, but depression severity in alcohol dependent patients was positively associated with craving. Within alcohol dependence, longer duration of alcohol dependence was associated with stronger cue-related activation of the posterior putamen, a structure involved in habits, whereas higher alcohol dependence severity was associated with lower cue-reactivity in the anterior putamen, an area implicated in goal-directed behavior preceding habit formation. Conclusion: Cue-reactivity in alcohol dependence is not modulated by comorbid depression or anxiety. More importantly, the current data confirm the hypothesis of a ventral to dorsal striatal shift of learning processes with longer dependence duration, which could underlie increasingly habitual substance use with progressing substance dependence.	[Sjoerds, Zsuzsika; Beekman, Aartjan T. F.; Penninx, Brenda W. J. H.; Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Sjoerds, Zsuzsika; van den Brink, Wim] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Penninx, Brenda W. J. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen	Sjoerds, Z (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	sjoerds.zs@gmail.com	Sjoerds, Zsuzsika/E-9311-2012; Penninx, Brenda WJH/S-7627-2017	Sjoerds, Zsuzsika/0000-0001-9467-3772; Penninx, Brenda WJH/0000-0001-7779-9672	Netherlands Organization for Health Research and Development (Zon-Mw) [31160004]	Netherlands Organization for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development)	Funding for this study was provided by grant 31160004 from the Netherlands Organization for Health Research and Development (Zon-Mw), commissioned by the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2001, DIAGN STAT MAN MENT; BABOR TF, 1989, ADDICT BEHAV, V14, P139, DOI 10.1016/0306-4603(89)90043-9; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Boschloo L, 2011, J AFFECT DISORDERS, V131, P233, DOI 10.1016/j.jad.2010.12.014; Braus DF, 2001, J NEURAL TRANSM, V108, P887, DOI 10.1007/s007020170038; Breese GR, 2011, PHARMACOL THERAPEUT, V129, P149, DOI 10.1016/j.pharmthera.2010.09.007; de Wit S, 2012, J NEUROSCI, V32, P12066, DOI 10.1523/JNEUROSCI.1088-12.2012; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Demos KE, 2012, J NEUROSCI, V32, P5549, DOI 10.1523/JNEUROSCI.5958-11.2012; Dickinson A, 2000, BEHAV NEUROSCI, V114, P468, DOI 10.1037/0735-7044.114.3.468; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Ewing SWF, 2010, ALCOHOL CLIN EXP RES, V34, P396, DOI 10.1111/j.1530-0277.2009.01104.x; Fontenelle LF, 2011, DRUGS, V71, P827, DOI 10.2165/11591790-000000000-00000; FOX PT, 1994, SCIENCE, V266, P994, DOI 10.1126/science.7973682; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Heilig M, 2010, NEUROSCI BIOBEHAV R, V35, P334, DOI 10.1016/j.neubiorev.2009.11.018; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Heinz A, 2009, ADDICT BIOL, V14, P108, DOI 10.1111/j.1369-1600.2008.00136.x; Ito R, 2002, J NEUROSCI, V22, P6247; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Love A, 1998, ADDICTION, V93, P1091, DOI 10.1046/j.1360-0443.1998.937109113.x; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; MONTI PM, 1987, J ABNORM PSYCHOL, V96, P122, DOI 10.1037/0021-843X.96.2.122; Murdaugh DL, 2012, NEUROIMAGE, V59, P2709, DOI 10.1016/j.neuroimage.2011.10.071; Nielsen F.A., 2002, NEUROIMAGE, V16, P2; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pizzagalli DA, 2008, J PSYCHIATR RES, V43, P76, DOI 10.1016/j.jpsychires.2008.03.001; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Sayette MA, 2000, ADDICTION, V95, pS189; Schacht JP, 2012, ADDICT BIOL; Sjoerds Z, 2013, TRANSLATION IN PRESS; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Tiffany ST, 1998, J PSYCHOPHARMACOL, V12, P23, DOI 10.1177/026988119801200104; Tricomi E, 2009, EUR J NEUROSCI, V29, P2225, DOI 10.1111/j.1460-9568.2009.06796.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Strien J. W., 1992, NEDERLANDS TIJDSCHRI, V47, P88; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Volkow ND, 2008, NEUROIMAGE, V39, P1266, DOI 10.1016/j.neuroimage.2007.09.059; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Vollstadt-Klein S, 2010, ADDICTION, V105, P1741, DOI 10.1111/j.1360-0443.2010.03022.x; Wong DF, 2006, NEUROPSYCHOPHARMACOL, V31, P2716, DOI 10.1038/sj.npp.1301194; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zijlstra F, 2009, DRUG ALCOHOL DEPEN, V99, P183, DOI 10.1016/j.drugalcdep.2008.07.012	51	39	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84560	10.1371/journal.pone.0084560	http://dx.doi.org/10.1371/journal.pone.0084560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400099	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700033
J	Cerulo, L; Tagliaferri, D; Marotta, P; Zoppoli, P; Russo, F; Mazio, C; DeFelice, M; Ceccarelli, M; Falco, G				Cerulo, Luigi; Tagliaferri, Daniela; Marotta, Pina; Zoppoli, Pietro; Russo, Filomena; Mazio, Claudia; DeFelice, Mario; Ceccarelli, Michele; Falco, Geppino			Identification of a Novel Gene Signature of ES Cells Self-Renewal Fluctuation through System-Wide Analysis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENOMIC STABILITY; MOUSE; PLURIPOTENCY; ZSCAN4; PREIMPLANTATION; DIFFERENTIATION; EXPRESSION; POTENCY; ABSENCE	Embryonic Stem cells (ESCs) can be differentiated into ectoderm, endoderm, and mesoderm derivatives, producing the majority of cell types. In regular culture conditions, ESCs' self-renewal is maintained through molecules that inhibit spontaneous differentiation enabling long-term cellular expansion. This undifferentiating condition is characterized by multiple metastable states that fluctuate between self-renewal and differentiation balance. Here, we aim to characterize the high-pluripotent ESC metastate marked by the expression of Zscan4 through a supervised machine learning framework based on an ensemble of support vector machine (SVM) classifiers. Our study revealed a leukaemia inhibitor factor (Lif) dependent not-canonical pluripotency signature (AF067063, BC061212, Dub1, Eif1a, Gm12794, Gm13871, Gm4340, Gm4850, Tcstv1/3, and Zfp352), that specifically marks Zscan4 ESCs' fluctuation. This novel ESC metastate is enhanced by high-pluripotency culture conditions obtained through Extracellular signal Regulated-Kinase (ERK) and Glycogen synthase kinase-3 (Gsk-3) signaling inhibition (2i). Significantly, we reported that the conditional ablation of the novel ESC metastate marked by the expression of Gm12794 is required for ESCs self-renewal maintenance. In conclusion, we extend the comprehension of ESCs biology through the identification of a novel molecular signature associated to pluripotency programming.	[Cerulo, Luigi; Tagliaferri, Daniela; Marotta, Pina; Zoppoli, Pietro; Russo, Filomena; Mazio, Claudia; DeFelice, Mario; Ceccarelli, Michele; Falco, Geppino] Ist Ric Genet Gaetano Salvatore Biogem Scarl, Dept Stem Cell & Dev, Ariano Irpino, Italy; [Cerulo, Luigi; Tagliaferri, Daniela; Ceccarelli, Michele; Falco, Geppino] Univ Sannio, Dept Sci, Benevento, Italy; [DeFelice, Mario] Univ Naples Federico II, Dept Med Mol & Biotecnol Med, Naples, Italy	Italfarmaco; University of Sannio; University of Naples Federico II	Ceccarelli, M (corresponding author), Ist Ric Genet Gaetano Salvatore Biogem Scarl, Dept Stem Cell & Dev, Ariano Irpino, Italy.	michele.ceccarelli@unisannio.it; gfalco@unisannio.it	Ceccarelli, Michele/AGP-1739-2022; Marotta, Pina e/K-5785-2018; Marotta, Pina/W-5262-2019; Zoppoli, Pietro/J-9954-2018	Marotta, Pina e/0000-0001-6857-8325; Marotta, Pina/0000-0001-6857-8325; Zoppoli, Pietro/0000-0002-7860-9655; falco, geppino/0000-0001-6193-7233; Ceccarelli, Michele/0000-0002-4702-6617; Mazio, Claudia/0000-0002-6432-4907	European International Reintegration Grant [239519]; Basic research investment fund [RBFR10XCD3_002]; IRGS Biogem Institute	European International Reintegration Grant; Basic research investment fund; IRGS Biogem Institute	The study was funded by European International Reintegration Grant (number 239519), by Basic research investment fund (number RBFR10XCD3_002), and by IRGS Biogem Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2966; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Casanova EA, 2011, STEM CELLS, V29, P474, DOI 10.1002/stem.588; Cerulo L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-228; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Forrai A, 2006, STEM CELLS, V24, P604, DOI 10.1634/stemcells.2005-0323; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Guria A, 2011, RNA, V17, P1048, DOI 10.1261/rna.2607011; Halley JD, 2012, STEM CELL RES, V8, P324, DOI 10.1016/j.scr.2011.11.001; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Jiang J, 2013, CELL RES, V23, P92, DOI 10.1038/cr.2012.157; Liu TYC, 2003, MOL REPROD DEV, V64, P52, DOI 10.1002/mrd.10218; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Scheubert L, 2011, DNA RES, V18, P233, DOI 10.1093/dnares/dsr016; Shabalin AA, 2008, BIOINFORMATICS, V24, P1154, DOI 10.1093/bioinformatics/btn083; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Treff NR, 2006, STEM CELLS, V24, P2529, DOI 10.1634/stemcells.2006-0082; Vapnik V., 1998, STAT LEARNING THEORY; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882	30	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83235	10.1371/journal.pone.0083235	http://dx.doi.org/10.1371/journal.pone.0083235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392082	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100006
J	Hu, XL; Zhang, JW; Li, JM; Zhang, B				Hu, Xiaolin; Zhang, Jianwei; Li, Jianmin; Zhang, Bo			Sparsity-Regularized HMAX for Visual Recognition	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; OBJECT RECOGNITION; NEURONS; REPRESENTATION; ARCHITECTURE; EMERGENCE; FEATURES; STRIATE; SHIFT; MODEL	About ten years ago, HMAX was proposed as a simple and biologically feasible model for object recognition, based on how the visual cortex processes information. However, the model does not encompass sparse firing, which is a hallmark of neurons at all stages of the visual pathway. The current paper presents an improved model, called sparse HMAX, which integrates sparse firing. This model is able to learn higher-level features of objects on unlabeled training images. Unlike most other deep learning models that explicitly address global structure of images in every layer, sparse HMAX addresses local to global structure gradually along the hierarchy by applying patch-based learning to the output of the previous layer. As a consequence, the learning method can be standard sparse coding (SSC) or independent component analysis (ICA), two techniques deeply rooted in neuroscience. What makes SSC and ICA applicable at higher levels is the introduction of linear higher-order statistical regularities by max pooling. After training, high-level units display sparse, invariant selectivity for particular individuals or for image categories like those observed in human inferior temporal cortex (ITC) and medial temporal lobe (MTL). Finally, on an image classification benchmark, sparse HMAX outperforms the original HMAX by a large margin, suggesting its great potential for computer vision.	[Hu, Xiaolin; Li, Jianmin; Zhang, Bo] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, State Key Lab Intelligent Technol & Syst, Beijing 100084, Peoples R China; [Hu, Xiaolin; Li, Jianmin; Zhang, Bo] Tsinghua Univ, Dept Comp Sci & Technol, Beijing 100084, Peoples R China; [Zhang, Jianwei] Univ Hamburg, Dept Informat, Hamburg, Germany	Tsinghua University; Tsinghua University; University of Hamburg	Hu, XL (corresponding author), Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, State Key Lab Intelligent Technol & Syst, Beijing 100084, Peoples R China.	xlhu@tsinghua.edu.cn	Hu, Xiaolin/K-2443-2013; Tong, Raymond Kai-yu/C-3546-2009	Tong, Raymond Kai-yu/0000-0003-4375-653X	National Basic Research Program (973 Program) of China [2013CB329403, 2012CB316301]; National Natural Science Foundation of China [61273023]; Beijing Natural Science Foundation [4132046]; Tsinghua University Initiative Scientific Research Program [20121088071]; Deutsche Forschungsgemeinschaft-Chinese Ministry of Education International Research Training Group IGK 1247 CINACS	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Tsinghua University Initiative Scientific Research Program; Deutsche Forschungsgemeinschaft-Chinese Ministry of Education International Research Training Group IGK 1247 CINACS	This work was supported by the National Basic Research Program (973 Program) of China (Grant Nos. 2013CB329403 and 2012CB316301), the National Natural Science Foundation of China (Grant No. 61273023), the Beijing Natural Science Foundation (Grant No. 4132046), the Tsinghua University Initiative Scientific Research Program (Grant No. 20121088071), and the Deutsche Forschungsgemeinschaft-Chinese Ministry of Education International Research Training Group IGK 1247 CINACS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Barth AL, 2012, TRENDS NEUROSCI, V35, P345, DOI 10.1016/j.tins.2012.03.008; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carlson ET, 2011, CURR BIOL, V21, P288, DOI 10.1016/j.cub.2011.01.013; Coates A., 2012, NIPS, V25, P2690; Dayan P, 2001, COMPUTATIONAL NEUROS; DESIMONE R, 1984, J NEUROSCI, V4, P2051; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gutmann MU, 2013, 3 LAYER MODEL NATURA; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Hyvarinen A, 2000, NEURAL COMPUT, V12, P1705, DOI 10.1162/089976600300015312; Hyvarinen A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-12; Hyvarinen A, 1998, SIGNAL PROCESS, V64, P301, DOI 10.1016/S0165-1684(97)00197-7; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Hyvarinen A, 2009, COMPUT IMAGING VIS, V39, P1; Ito M, 2004, J NEUROSCI, V24, P3313, DOI 10.1523/JNEUROSCI.4364-03.2004; Kanan C, 2010, PROC CVPR IEEE, P2472, DOI 10.1109/CVPR.2010.5539947; Kavukcuoglu K., 2010, ADV NEURAL INFORM PR, P1090; Knoblich U, 2007, BIOPHYSICAL MODELS N; Kouh M, 2008, NEURAL COMPUT, V20, P1427, DOI 10.1162/neco.2008.02-07-466; Le Q, 2012, P 29 INT C MACH LEAR, P81, DOI DOI 10.1109/MSP.2011.940881; Lee H., 2006, ADV NEURAL INFORM PR, P801, DOI DOI 10.1371/J0URNAL.P0NE.0006098; Lee H., 2009, P ANN INT C MACH LEA, P609; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mairal J., 2009, P 26 INT C MACH LEAR; MUTCH J., 2006, P IEEE C COMP VIS PA; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ranzato M.A., 2007, ADV NEURAL INF PROCE, P1137, DOI DOI 10.7551/mitpress/7503.003.0147; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Serre T, 2005, PROC CVPR IEEE, P994; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shan H., 2006, ADV NEURAL INFORM PR, V19, P1273; Waydo S, 2008, NEURAL COMPUT, V20, P1165, DOI 10.1162/neco.2007.03-07-493; Willmore BDB, 2011, J NEUROPHYSIOL, V105, P2907, DOI 10.1152/jn.00594.2010; Yan KL, 2005, NEURAL COMPUT, V17, P397, DOI 10.1162/0899766053011474; Yang J., 2009, P IEEE C COMP VIS PA; Yu K., 2011, P IEEE C COMP VIS PA; Zeiler M. D., 2010, P IEEE C COMP VIS PA; Zeiler M. D., 2011, P INT C COMP VIS; Zou W., 2012, ADV NEURAL INFORM PR, P3203	46	41	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e81813	10.1371/journal.pone.0081813	http://dx.doi.org/10.1371/journal.pone.0081813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392078	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100002
J	Huang, YQ; Zhang, ZY; Cai, SH; Chen, Z				Huang, Yuqing; Zhang, Zhiyong; Cai, Shuhui; Chen, Zhong			A Novel Detection Scheme for High-Resolution Two-Dimensional Spin-Echo Correlated Spectra in Inhomogeneous Fields	PLOS ONE			English	Article							DIPOLAR FIELD; QUANTUM TREATMENT; NMR-SPECTRA; SPECTROSCOPY; SECSY; H-1-NMR	Background: Two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopy is a powerful and non-invasive tool for the analysis of molecular structures, conformations, and dynamics. However, the inhomogeneity of magnetic fields experienced by samples will destroy spectral information and hinder spectral analysis. In this study, a new pulse sequence is proposed based on the modulation of distant dipolar field to recover high-resolution 2D spin-echo correlated spectroscopy (SECSY) from inhomogeneous fields. Method and Material: By using the new sequence, the correlation information between coupled spins and the J coupled information with straightforward multiplet patterns can be obtained free from inhomogeneous line broadening. In addition, the new sequence is also suitable for non-J coupled spin systems. Although three-dimensional acquisition is needed, the evolution of indirect detection dimensions is carefully designed and the ultrafast acquisition scheme is utilized to improve the acquisition efficiency. A chemical solution of butyl methacrylate (C8H14O2) in DMSO (C2H6SO) in a deshimmed magnetic field was tested to demonstrate the implementation details of the new sequence. The performance of the new sequence relative to the conventional SECSY sequence was shown by using an aqueous solution of main brain metabolites in a deshimmed magnetic field. Conclusion: The results reveal that the new sequence provides an attractive way to eliminate the inhomogeneous spectral line broadening for the spin-echo correlated spectrum and is a promising tool for the study of metabolites in metabonomics, even for the applications on in vivo and in situ high-resolution 2D NMR spectroscopy.	[Huang, Yuqing; Zhang, Zhiyong; Cai, Shuhui; Chen, Zhong] Xiamen Univ, Dept Elect Sci, Fujian Prov Key Lab Plasma & Magnet Resonance, State Key Lab Phys Chem Solid Surfaces, Xiamen, Peoples R China	Xiamen University	Chen, Z (corresponding author), Xiamen Univ, Dept Elect Sci, Fujian Prov Key Lab Plasma & Magnet Resonance, State Key Lab Phys Chem Solid Surfaces, Xiamen, Peoples R China.	chenz@xmu.edu.cn	Cai, SH/G-3334-2010; Chen, Zhong/G-4601-2010	Cai, SH/0000-0003-2767-9490; chen, zhong/0000-0002-1473-2224	NNSF of China [11205129, 11174239, 11074209]; Prior Research Field Fund for the Doctoral Program of Higher Education of China [20120121130003]	NNSF of China(National Natural Science Foundation of China (NSFC)); Prior Research Field Fund for the Doctoral Program of Higher Education of China	This work was partially supported by the NNSF of China under Grants (11205129, 11174239 and 11074209). The URL for the grants is http://www.nsfc.gov.cn/Portal0/default152.htm. This work was also partially supported by the Prior Research Field Fund for the Doctoral Program of Higher Education of China under Grant 20120121130003. The URL is http://www.cutech.edu.cn/cn/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1997, J MAGN RESON, V128, P114, DOI 10.1006/jmre.1997.1226; AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; Balla DZ, 2008, CONCEPT MAGN RESON A, V32A, P117, DOI 10.1002/cmr.a.20104; Chen Z, 2004, J AM CHEM SOC, V126, P446, DOI 10.1021/ja036491f; Chin J, 1998, J ORG CHEM, V63, P1309, DOI 10.1021/jo970659w; DAVOUST D, 1985, CARBOHYD RES, V143, P233, DOI 10.1016/S0008-6215(00)90712-2; de Sousa PL, 2003, J MAGN RESON, V162, P356, DOI 10.1016/S1090-7807(03)00044-2; Enss T, 1999, CHEM PHYS LETT, V305, P101, DOI 10.1016/S0009-2614(99)00366-8; Frydman L, 2003, J AM CHEM SOC, V125, P9204, DOI 10.1021/ja030055b; Gao HC, 2013, MOL NEUROBIOL, V47, P123, DOI 10.1007/s12035-012-8336-z; Hoerr V, 2010, BIOPHYS J, V99, P2336, DOI 10.1016/j.bpj.2010.06.068; Huang SY, 2009, MAGN RESON MED, V61, P925, DOI 10.1002/mrm.21584; Huang YQ, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3374409; JEENER J, 1995, J CHEM PHYS, V103, P1309, DOI 10.1063/1.469808; Kirsch S, 2007, J MAGN RESON, V185, P183, DOI 10.1016/j.jmr.2006.10.011; Lee S, 1996, J CHEM PHYS, V105, P874, DOI 10.1063/1.471968; Lin YY, 2000, PHYS REV LETT, V85, P3732, DOI 10.1103/PhysRevLett.85.3732; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Mishkovsky M, 2009, J MAGN RESON, V200, P142, DOI 10.1016/j.jmr.2009.06.002; NAGAYAMA K, 1979, BIOCHEM BIOPH RES CO, V90, P305, DOI 10.1016/0006-291X(79)91625-5; NAGAYAMA K, 1981, EUR J BIOCHEM, V115, P653; Pelupessy P, 2003, J AM CHEM SOC, V125, P12345, DOI 10.1021/ja034958g; Pelupessy P, 2009, SCIENCE, V324, P1693, DOI 10.1126/science.1175102; RYNER LN, 1995, J MAGN RESON SER B, V107, P126, DOI 10.1006/jmrb.1995.1068; Shapira B, 2004, J MAGN RESON, V166, P152, DOI 10.1016/j.jmr.2003.09.014; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Vathyam S, 1996, SCIENCE, V272, P92, DOI 10.1126/science.272.5258.92; Yousif HA, 1997, COMPUT PHYS COMMUN, V106, P199, DOI 10.1016/S0010-4655(97)00087-8	29	1	1	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84032	10.1371/journal.pone.0084032	http://dx.doi.org/10.1371/journal.pone.0084032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392105	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100029
J	Cordeiro, CMM; Esmaili, H; Ansah, G; Hincke, MT				Cordeiro, Cristianne M. M.; Esmaili, Hamed; Ansah, George; Hincke, Maxwell T.			Ovocalyxin-36 Is a Pattern Recognition Protein in Chicken Eggshell Membranes	PLOS ONE			English	Article							BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; PSEUDOMONAS-AERUGINOSA; PROTEOMIC ANALYSIS; FUNCTIONAL VARIANT; TERMINAL FRAGMENT; STATISTICAL-MODEL; SPLUNC1 PROTEIN; BPI; IDENTIFICATION	The avian eggshell membranes are essential elements in the fabrication of the calcified shell as a defense against bacterial penetration. Ovocalyxin-36 (OCX-36) is an abundant avian eggshell membrane protein, which shares protein sequence homology to bactericidal permeability-increasing protein (BPI), lipopolysaccharide-binding protein (LBP) and palate, lung and nasal epithelium clone (PLUNC) proteins. We have developed an efficient method to extract OCX-36 from chicken eggshell membranes for purification with cation and anion exchange chromatographies. Purified OCX-36 protein exhibited lipopolysaccharide (LPS) binding activity and bound lipopolysaccharide (LPS) from Escherichia coli O111:B4 in a dose-dependent manner. OCX-36 showed inhibitory activity against growth of Staphylococcus aureus ATCC 6538. OCX-36 single nucleotide polymorphisms (SNPs) were verified at cDNA 211 position and the corresponding proteins proline-71 (Pro-71) or serine-71 (Ser-71) were purified from eggs collected from genotyped hens. A significant difference between Pro-71 and Ser71 OCX-36 for S. aureus lipoteichoic acid (LTA) binding activity was detected. The current study is a starting point to understand the innate immune role that OCX-36 may play in protection against bacterial invasion of both embryonated eggs (relevant to avian reproductive success) and unfertilized table eggs (relevant to food safety).	[Cordeiro, Cristianne M. M.; Esmaili, Hamed; Hincke, Maxwell T.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Ansah, George] ISA North Amer, Div Hendrix Genet, Kitchener, ON, Canada	University of Ottawa	Hincke, MT (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	mhincke@uottawa.ca	Cordeiro, Cristianne/AAT-7441-2020	Cordeiro, Cristianne/0000-0001-7970-7989	Canadian Natural Sciences and Engineering Research Council [STPGP 365046]	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by the Canadian Natural Sciences and Engineering Research Council (STPGP 365046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript (http://www.nserc-crsng.gc.ca/index_eng.asp).	Abdolhosseini M, 2012, PEPTIDES, V35, P231, DOI 10.1016/j.peptides.2012.03.017; Ahlborn GJ, 2006, PROTEIN J, V25, P71, DOI 10.1007/s10930-006-0010-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ARIAS JL, 1991, CONNECT TISSUE RES, V26, P37, DOI 10.3109/03008209109152162; Barber RC, 2003, AM J RESP CRIT CARE, V167, P1316, DOI 10.1164/rccm.200209-1064OC; Bartlett J, 2011, BIOCHEM SOC T, V39, P1012, DOI 10.1042/BST0391012; Bingle CD, 2011, BIOCHEM SOC T, V39, P977, DOI 10.1042/BST0390977; Chiang SC, 2011, DEV COMP IMMUNOL, V35, P285, DOI 10.1016/j.dci.2010.09.013; Chien JW, 2008, BLOOD, V111, P2462, DOI 10.1182/blood-2007-09-101709; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Cordeiro Cristianne M M, 2011, Recent Pat Food Nutr Agric, V3, P1; Fernandez MS, 1997, MATRIX BIOL, V16, P13, DOI 10.1016/S0945-053X(97)90112-8; Gautron J, 2001, CONNECT TISSUE RES, V42, P255, DOI 10.3109/03008200109016840; Gautron J, 2007, J BIOL CHEM, V282, P5273, DOI 10.1074/jbc.M610294200; Gautron J, 2011, BIOCHEM SOC T, V39, P971, DOI 10.1042/BST0390971; GAZZANOSANTORO H, 1992, INFECT IMMUN, V60, P4754, DOI 10.1128/IAI.60.11.4754-4761.1992; Ghafouri B, 2004, BBA-PROTEINS PROTEOM, V1699, P57, DOI 10.1016/j.bbapap.2004.01.001; Gorr SU, 2011, BIOCHEM SOC T, V39, P1028, DOI 10.1042/BST0391028; Guerin-Dubiard C, 2005, J CHROMATOGR A, V1090, P58, DOI 10.1016/j.chroma.2005.06.083; Haigh B, 2008, MOL IMMUNOL, V45, P1944, DOI 10.1016/j.molimm.2007.10.032; Hincke MT, 2012, FRONT BIOSCI-LANDMRK, V17, P1266, DOI 10.2741/3985; HINCKE MT, 1992, BIOCHEM J, V282, P877, DOI 10.1042/bj2820877; Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0; Horwitz AH, 1999, ANTIMICROB AGENTS CH, V43, P2314, DOI 10.1128/AAC.43.9.2314; Hubacek JA, 2001, CRIT CARE MED, V29, P557, DOI 10.1097/00003246-200103000-00015; Huebner C, 2010, INFLAMM BOWEL DIS, V16, P282, DOI 10.1002/ibd.21043; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kaweewong K, 2013, PROTEIN J, V32, P297, DOI 10.1007/s10930-013-9487-0; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klein W, 2005, J CLIN GASTROENTEROL, V39, P282, DOI 10.1097/01.mcg.0000155127.20290.07; Kodali VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018187; Krasity BC, 2011, BIOCHEM SOC T, V39, P1039, DOI 10.1042/BST0391039; Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4; Levison PR, 2003, J CHROMATOGR B, V790, P17, DOI 10.1016/S1570-0232(03)00087-4; Levy O, 2000, ANTIMICROB AGENTS CH, V44, P2925, DOI 10.1128/AAC.44.11.2925-2931.2000; Levy O, 2004, J LEUKOCYTE BIOL, V76, P909, DOI 10.1189/jlb.0604320; Lukinskiene L, 2011, J IMMUNOL, V187, P382, DOI 10.4049/jimmunol.1001769; Mann K, 2008, PROTEOMICS, V8, P2322, DOI 10.1002/pmic.200800032; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; MANNION BA, 1990, J CLIN INVEST, V85, P853, DOI 10.1172/JCI114512; Mueller M, 2006, J BIOL CHEM, V281, P31448, DOI 10.1074/jbc.M605966200; Nahid AM, 2006, DEV COMP IMMUNOL, V30, P335, DOI 10.1016/j.dci.2005.04.002; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002; OOI CE, 1991, J EXP MED, V174, P649, DOI 10.1084/jem.174.3.649; Rehault-Godbert S, 2011, WOODHEAD PUBL FOOD S, P183; Rose-Martel M, 2012, J PROTEOMICS, V75, P2697, DOI 10.1016/j.jprot.2012.03.019; Sayeed S, 2013, INFECT IMMUN, V81, P285, DOI 10.1128/IAI.00500-12; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schultz H, 2007, CLIN CHIM ACTA, V384, P12, DOI 10.1016/j.cca.2007.07.005; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Srivastava A, 2007, INFECT IMMUN, V75, P342, DOI 10.1128/IAI.01089-06; Tian X, 2010, BIOL REPROD, V83, P893, DOI 10.1095/biolreprod.110.085019; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; TUAN RS, 1986, J EMBRYOL EXP MORPH, V97, P63; van der Schaft DWJ, 2000, BLOOD, V96, P176, DOI 10.1182/blood.V96.1.176.013k32_176_181; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wittmann I, 2008, J IMMUNOL, V180, P7546, DOI 10.4049/jimmunol.180.11.7546; Yamagata M, 2006, FASEB J, V20, P2058, DOI 10.1096/05-5662com; Yew PY, 2012, MOL CARCINOGEN, V51, pE74, DOI 10.1002/mc.21857; Zeng L, 2012, ANN SURG, V255, P147, DOI 10.1097/SLA.0b013e3182389515; Zhou HD, 2008, MOL CELL BIOCHEM, V309, P191, DOI 10.1007/s11010-007-9659-3	63	37	38	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84112	10.1371/journal.pone.0084112	http://dx.doi.org/10.1371/journal.pone.0084112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391897	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900040
J	Dillon, ME; Frazier, MR				Dillon, Michael E.; Frazier, Melanie R.			Thermodynamics Constrains Allometric Scaling of Optimal Development Time in Insects	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT TIME; METABOLIC-RATE; GENERAL-MODEL; BODY-SIZE; INCUBATION-TEMPERATURE; REGRESSION EQUATIONS; ONTOGENIC GROWTH; 3/4-POWER LAW; LENGTH; BIOMASS	Development time is a critical life-history trait that has profound effects on organism fitness and on population growth rates. For ectotherms, development time is strongly influenced by temperature and is predicted to scale with body mass to the quarter power based on 1) the ontogenetic growth model of the metabolic theory of ecology which describes a bioenergetic balance between tissue maintenance and growth given the scaling relationship between metabolism and body size, and 2) numerous studies, primarily of vertebrate endotherms, that largely support this prediction. However, few studies have investigated the allometry of development time among invertebrates, including insects. Abundant data on development of diverse insects provides an ideal opportunity to better understand the scaling of development time in this ecologically and economically important group. Insects develop more quickly at warmer temperatures until reaching a minimum development time at some optimal temperature, after which development slows. We evaluated the allometry of insect development time by compiling estimates of minimum development time and optimal developmental temperature for 361 insect species from 16 orders with body mass varying over nearly 6 orders of magnitude. Allometric scaling exponents varied with the statistical approach: standardized major axis regression supported the predicted quarter-power scaling relationship, but ordinary and phylogenetic generalized least squares did not. Regardless of the statistical approach, body size alone explained less than 28% of the variation in development time. Models that also included optimal temperature explained over 50% of the variation in development time. Warm-adapted insects developed more quickly, regardless of body size, supporting the "hotter is better'' hypothesis that posits that ectotherms have a limited ability to evolutionarily compensate for the depressing effects of low temperatures on rates of biological processes. The remaining unexplained variation in development time likely reflects additional ecological and evolutionary differences among insect species.	[Dillon, Michael E.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Dillon, Michael E.] Univ Wyoming, Program Ecol, Laramie, WY 82071 USA; [Frazier, Melanie R.] US EPA, Pacific Coastal Ecol Branch, Western Ecol Div, Newport, OR USA	University of Wyoming; University of Wyoming; United States Environmental Protection Agency	Dillon, ME (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	Michael.Dillon@uwyo.edu	Frazier, Melanie R/A-2367-2012		U.S. Environmental Protection Agency [AMI/GEOSS EP08D00051]; NHEERL	U.S. Environmental Protection Agency(United States Environmental Protection Agency); NHEERL	MRF was supported by U.S. Environmental Protection Agency post-doctoral fellowships (AMI/GEOSS EP08D00051 and NHEERL) during the completion of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P197, DOI 10.1086/648567; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; BATES JM, 1969, OPER RES QUART, V20, P451, DOI 10.2307/3008764; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Blomberg SP, 2012, SYST BIOL, V61, P382, DOI 10.1093/sysbio/syr118; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; Bonner JT, 1965, SIZE CYCLE ESSAY STR; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; CALDER WA, 1983, ANNU REV ECOL SYST, V14, P213, DOI 10.1146/annurev.es.14.110183.001241; Calder WAI., 1996, SIZE FUNCTION LIFE H; Capellini I, 2010, ECOLOGY, V91, P2783, DOI 10.1890/09-0817.1; Charnov EL, 2003, EVOL ECOL RES, V5, P43; Chown SL, 2007, FUNCT ECOL, V21, P282, DOI 10.1111/j.1365-2435.2007.01245.x; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Davidson J, 1944, J ANIM ECOL, V13, P26, DOI 10.2307/1326; DeLong JP, 2010, P NATL ACAD SCI USA, V107, P12941, DOI 10.1073/pnas.1007783107; Ehnes RB, 2011, ECOL LETT, V14, P993, DOI 10.1111/j.1461-0248.2011.01660.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FENCHEL T, 1974, OECOLOGIA, V14, P317, DOI 10.1007/BF00384576; Frazier MR, 2006, AM NAT, V168, P512, DOI 10.1086/506977; Ganihar SR, 1997, J BIOSCIENCE, V22, P219, DOI 10.1007/BF02704734; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GASTON KJ, 1988, ECOL ENTOMOL, V13, P399, DOI 10.1111/j.1365-2311.1988.tb00372.x; Gillooly JF, 2000, FRESHWATER BIOL, V44, P595, DOI 10.1046/j.1365-2427.2000.00607.x; Gillooly JF, 2000, J ZOOL, V251, P369, DOI 10.1017/S095283690000710X; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Glazier DS, 2006, BIOSCIENCE, V56, P325, DOI 10.1641/0006-3568(2006)56[325:TPLINU]2.0.CO;2; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hamilton W.J., 1973, LIFES COLOR CODE; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hodar JA, 1996, ACTA OECOL, V17, P421; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Kipyatkov VE., 2010, ENTOMOLOGICAL REV, V90, P163, DOI [10.1134/S0013873810020041, DOI 10.1134/S0013873810020041]; Kozlowski J, 2005, FUNCT ECOL, V19, P739, DOI 10.1111/j.1365-2435.2005.01021.x; Krogh A., 1914, Zeitschrift fuer Allgemeine Physiologie Jena, V16; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; Moses ME, 2008, AM NAT, V171, P632, DOI 10.1086/587073; Orme D, 2012, CAPER COMP ANAL PHYL; Paradis E, 2011, ANAL PHYLOGENETICS E, DOI DOI 10.1086/523369; Pinheiro J., 2019, NLME LINEAR NONLINEA; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reiss M.J., 1991, ALLOMETRY GROWTH REP; ROGERS LE, 1976, ANN ENTOMOL SOC AM, V69, P387, DOI 10.1093/aesa/69.2.387; ROGERS LE, 1977, ANN ENTOMOL SOC AM, V70, P51, DOI 10.1093/aesa/70.1.51; SAMPLE BE, 1993, AM MIDL NAT, V129, P234, DOI 10.2307/2426503; Sanderson ED, 1910, J ECON ENTOMOL, V3, P113; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; SCHOENER TW, 1980, ANN ENTOMOL SOC AM, V73, P106, DOI 10.1093/aesa/73.1.106; Sieg AE, 2009, AM NAT, V174, P720, DOI 10.1086/606023; SMOCK LA, 1980, FRESHWATER BIOL, V10, P375, DOI 10.1111/j.1365-2427.1980.tb01211.x; Spicer J. I., 1999, PHYSL DIVERSITY ITS; Symonds MRE, 2002, EVOLUTION, V56, P2330, DOI 10.1111/j.0014-3820.2002.tb00156.x; Taskinen S, 2011, BIOMETRICAL J, V53, P652, DOI 10.1002/bimj.201000018; vanderHave TM, 1996, J THEOR BIOL, V183, P329, DOI 10.1006/jtbi.1996.0224; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; Walters RJ, 2006, AM NAT, V167, P510, DOI 10.1086/501029; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; Zuo WY, 2012, P ROY SOC B-BIOL SCI, V279, P1840, DOI 10.1098/rspb.2011.2000	76	20	20	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84308	10.1371/journal.pone.0084308	http://dx.doi.org/10.1371/journal.pone.0084308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391935	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900078
J	Du, HY; Liang, ZB; Zhang, YL; Jie, FL; Li, JL; Fei, Y; Huang, Z; Pei, NN; Wang, SH; Li, A; Chen, BH; Zhang, Y; Sumners, C; Li, M; Li, HW				Du, Hongyan; Liang, Zhibing; Zhang, Yanling; Jie, Feilong; Li, Jinlong; Fei, Yang; Huang, Zhi; Pei, Nana; Wang, Suihai; Li, Andrew; Chen, Baihong; Zhang, Yi; Sumners, Colin; Li, Ming; Li, Hongwei			Effects of Angiotensin II Type 2 Receptor Overexpression on the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITOR; TRANSGENE EXPRESSION; AT(2) RECEPTORS; OVARIAN-CANCER; TUMOR-GROWTH; GENE; ANGIOGENESIS; APOPTOSIS; THERAPY; TUMORIGENESIS	Increasing evidence suggests that the renin-angiotensin system (RAS) plays an important role in tumorigenesis. The interaction between Angiotensin II (AngII) and angiotensin type 1 receptor (AT1R) may have a pivotal role in hepatocellular carcinoma (HCC) and therefore, AT1R blocker and angiotensin I-converting enzyme (ACE) inhibitors may have therapeutic potential in the treatment of hepatic cancer. Although the involvement of AT1R has been well explored, the role of the angiotensin II Type 2 receptor (AT2R) in HCC progression remains poorly understood. Thus, the aim of this study was to explore the effects of AT2R overexpression on HCC cells in vitro and in mouse models of human HCC. An AT2R recombinant adenoviral vector (Ad-G-AT2R-EGFP) was transduced into HCC cell lines and orthotopic tumor grafts. The results indicate that the high dose of Ad-G-AT2R-EGFP-induced overexpression of AT2R in transduced HCC cell lines produced apoptosis. AT2R overexpression in SMMC7721 cells inhibited cell proliferation with a significant reduction of S-phase cells and an enrichment of G1-phase cells through changing expression of CDK4 and cyclinD1. The data also indicate that overexpression of AT2R led to apoptosis via cell death signaling pathway that is dependent on activation of p38 MAPK, pJNK, caspase-8 and caspase-3 and inactivation of pp42/44 MAPK (Erk1/2). Finally, we demonstrated that moderately increasing AT2R expression could increase the growth of HCC tumors and the proliferation of HCC cells in vivo. Our findings suggest that AT2R overexpression regulates proliferation of hepatocellular carcinoma cells in vitro and in vivo, and the precise mechanisms of this phenomenon are yet to be fully determined.	[Du, Hongyan; Liang, Zhibing; Zhang, Yanling; Jie, Feilong; Li, Jinlong; Fei, Yang; Huang, Zhi; Pei, Nana; Wang, Suihai; Chen, Baihong; Li, Ming; Li, Hongwei] Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China; [Li, Andrew] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Zhang, Yi] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA; [Sumners, Colin] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL USA	Southern Medical University - China; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Li, M (corresponding author), Southern Med Univ, Sch Biotechnol, Guangzhou, Guangdong, Peoples R China.	mingli1958@126.com; hongwei1@yahoo.com		Sumners, Colin/0000-0002-9689-2255	National Natural Science Foundation of China [81072113]; National 863 High Technique Development Projects of China [2012AA02A403, 2012AA020205]; State Key Laboratory of Pathogen and Biosecurity Program [SKLPBS1103]; Scientific Research Foundation of Southern Medical University [B1012076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 High Technique Development Projects of China(National High Technology Research and Development Program of China); State Key Laboratory of Pathogen and Biosecurity Program; Scientific Research Foundation of Southern Medical University	This work was supported by National Natural Science Foundation of China Grant 81072113 (H.L.), National 863 High Technique Development Projects of China Grant 2012AA02A403 (H.L.) and 2012AA020205 (M.L.), State Key Laboratory of Pathogen and Biosecurity Program SKLPBS1103 (H.L.), and Scientific Research Foundation of Southern Medical University (B1012076, H.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta O, 2005, BRIT J CANCER, V92, P1247, DOI 10.1038/sj.bjc.6602483; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; D'Amore A, 2005, HYPERTENSION, V46, P1347, DOI 10.1161/01.HYP.0000193504.51489.cf; Doi C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-67; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Fujita M, 2005, CARCINOGENESIS, V26, P271, DOI 10.1093/carcin/bgh324; Fujita M, 2002, BIOCHEM BIOPH RES CO, V294, P441, DOI 10.1016/S0006-291X(02)00496-5; Fujiyama S, 2001, CIRC RES, V88, P22, DOI 10.1161/01.RES.88.1.22; Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698; Grieger JC, 2012, METHOD ENZYMOL, V507, P229, DOI 10.1016/B978-0-12-386509-0.00012-0; Honigman A, 2001, MOL THER, V4, P239, DOI 10.1006/mthe.2001.0437; Horiuchi M, 1998, ENDOCR RES, V24, P307, DOI 10.3109/07435809809032610; Ino K, 2006, BRIT J CANCER, V94, P552, DOI 10.1038/sj.bjc.6602961; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kanehira T, 2005, CANCER RES, V65, P7660, DOI 10.1158/0008-5472.CAN-05-0275; Kawabata A, 2012, CANCER RES, V72, P2057, DOI 10.1158/0008-5472.CAN-11-3634; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Li HW, 2007, AM J PHYSIOL-HEART C, V292, pH727, DOI 10.1152/ajpheart.00938.2006; Li HW, 2009, MOL CANCER THER, V8, P3255, DOI 10.1158/1535-7163.MCT-09-0237; Li HW, 2005, BIOCHEM BIOPH RES CO, V336, P29, DOI 10.1016/j.bbrc.2005.08.035; Li HW, 2005, BIOCHEM BIOPH RES CO, V334, P1287, DOI 10.1016/j.bbrc.2005.07.025; Ma Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-85; Mitchell AM, 2010, CURR GENE THER, V10, P319; Miura SI, 2000, EMBO J, V19, P4026, DOI 10.1093/emboj/19.15.4026; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Noguchi R, 2003, CLIN CANCER RES, V9, P6038; Pickel L, 2010, CANCER BIOL THER, V9, P277, DOI 10.4161/cbt.9.4.10643; Qi YF, 2012, EXP PHYSIOL, V97, P89, DOI 10.1113/expphysiol.2011.060673; Revankar CM, 2004, J BIOL CHEM, V279, P24578, DOI 10.1074/jbc.M402121200; Rizkalla B, 2003, J AM SOC NEPHROL, V14, P3061, DOI 10.1097/01.ASN.0000099374.58607.C9; Silvestre JS, 2002, CIRC RES, V90, P1072, DOI 10.1161/01.RES.0000019892.41157.24; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Suganuma T, 2005, CLIN CANCER RES, V11, P2686, DOI 10.1158/1078-0432.CCR-04-1946; Sun LH, 2012, BIOCHEM BIOPH RES CO, V424, P663, DOI 10.1016/j.bbrc.2012.07.003; Suzuki J, 2002, CIRCULATION, V106, P847, DOI 10.1161/01.CIR.0000024103.04821.86; Takagi T, 2002, CARCINOGENESIS, V23, P1235, DOI 10.1093/carcin/23.7.1235; Tan NY, 2009, CIRC RES, V105, P422, DOI 10.1161/CIRCRESAHA.109.203323; Tejera N, 2004, AM J PATHOL, V164, P1817, DOI 10.1016/S0002-9440(10)63740-6; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Uemura H, 2005, MOL CANCER THER, V4, P1699, DOI 10.1158/1535-7163.MCT-04-0295; Walther T, 2003, FASEB J, V17, P2061, DOI 10.1096/fj.03-0129com; Wang SH, 2011, HEPATOLOGY, V53, P1932, DOI 10.1002/hep.24291; Wang XW, 2012, APOPTOSIS, V17, P908, DOI 10.1007/s10495-012-0721-6; Yan XH, 2003, AM J PHYSIOL-HEART C, V285, pH2179, DOI 10.1152/ajpheart.00361.2003; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Yoshiji H, 2006, ONCOL REP, V15, P155; Yoshiji H, 2005, ONCOL REP, V13, P491; Zhang XL, 2004, HYPERTENSION, V43, P276, DOI 10.1161/01.HYP.0000113628.94574.0f	49	28	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83754	10.1371/journal.pone.0083754	http://dx.doi.org/10.1371/journal.pone.0083754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391821	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200119
J	Fujita, Y; van Bodegom, PM; Witte, JPM				Fujita, Yuki; van Bodegom, Peter M.; Witte, Jan-Philip M.			Relationships between Nutrient-Related Plant Traits and Combinations of Soil N and P Fertility Measures	PLOS ONE			English	Article							ELLENBERG INDICATOR VALUES; NITROGEN; VEGETATION; PHOSPHORUS; MOISTURE; AVAILABILITY; STRATEGIES; GRADIENTS; RESPONSES; STRESS	Soil fertility and nutrient-related plant functional traits are in general only moderately related, hindering the progress in trait-based prediction models of vegetation patterns. Although the relationships may have been obscured by suboptimal choices in how soil fertility is expressed, there has never been a systematic investigation into the suitability of fertility measures. This study, therefore, examined the effect of different soil fertility measures on the strength of fertility-trait relationships in 134 natural plant communities. In particular, for eight plot-mean traits we examined (1) whether different elements (N or P) have contrasting or shared influences, (2) which timescale of fertility measures (e. g. mineralization rates for one or five years) has better predictive power, and (3) if integrated fertility measures explain trait variation better than individual fertility measures. Soil N and P had large mutual effects on leaf nutrient concentrations, whereas they had element-specific effects on traits related to species composition (e. g. Grime's CSR strategy). The timescale of fertility measures only had a minor impact on fertility-trait relationships. Two integrated fertility measures (one reflecting overall fertility, another relative availability of soil N and P) were related significantly to most plant traits, but were not better in explaining trait variation than individual fertility measures. Using all fertility measures together, between-site variations of plant traits were explained only moderately for some traits (e. g. 33% for leaf N concentrations) but largely for others (e. g. 66% for whole-canopy P concentration). The moderate relationships were probably due to complex regulation mechanisms of fertility on traits, rather than to a wrong choice of fertility measures. We identified both mutual (i.e. shared) and divergent (i.e. element-specific and stoichiometric) effects of soil N and P on traits, implying the importance of explicitly considering the roles of different elements to properly interpret fertility-trait relationships.	[Fujita, Yuki; Witte, Jan-Philip M.] KWR Watercycle Res Inst, Team Ecohydrol, Nieuwegein, Netherlands; [van Bodegom, Peter M.; Witte, Jan-Philip M.] Vrije Univ Amsterdam, Dept Syst Ecol, Amsterdam, Netherlands	KWR Watercycle Research Institute; Vrije Universiteit Amsterdam	Fujita, Y (corresponding author), KWR Watercycle Res Inst, Team Ecohydrol, Nieuwegein, Netherlands.	Yuki.Fujita@kwrwater.nl	van Bodegom, Peter M./N-8150-2015	van Bodegom, Peter M./0000-0003-0771-4500	Knowledge for Climate, Dutch Water Utility sector [B222044]	Knowledge for Climate, Dutch Water Utility sector	Knowledge for Climate (http://www.klimaatonderzoeknederland.nl/), Dutch Water Utility sector (B222044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; Ceulemans T, 2011, J APPL ECOL, V48, P1155, DOI 10.1111/j.1365-2664.2011.02023.x; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Del Grosso S, 2002, ENVIRON POLLUT, V116, pS75, DOI 10.1016/S0269-7491(01)00260-3; Douma JC, 2012, FUNCT ECOL, V26, P1355, DOI 10.1111/j.1365-2435.2012.02054.x; Douma JC, 2012, ECOGRAPHY, V35, P294, DOI 10.1111/j.1600-0587.2011.07140.x; Ertsen ACD, 1998, PLANT ECOL, V135, P113, DOI 10.1023/A:1009765529310; Fujita Y, 2013, SOIL BIOL BIOCHEM, V58, P302, DOI 10.1016/j.soilbio.2012.12.013; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; Garnier Eric, 1998, P155, DOI 10.1017/CBO9780511525445.008; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Horta MD, 2010, COMMUN SOIL SCI PLAN, V41, P2358, DOI 10.1080/00103624.2010.508296; Hunt R, 2004, APPL VEG SCI, V7, P163, DOI 10.1111/j.1654-109X.2004.tb00607.x; Kafer J, 2004, J VEG SCI, V15, P647, DOI 10.1111/j.1654-1103.2004.tb02306.x; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Klotz S, 2002, SCHRIFTENREIHE VEGET, V38; LOOKMAN R, 1995, GEODERMA, V66, P285, DOI 10.1016/0016-7061(94)00084-N; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Ordonez JC, 2010, ECOLOGY, V91, P3218, DOI 10.1890/09-1509.1; Ordonez JC, 2010, AM NAT, V175, P225, DOI 10.1086/649582; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Pakeman RJ, 2007, APPL VEG SCI, V10, P91, DOI 10.1111/j.1654-109X.2007.tb00507.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pugnaire F.I., 2007, FUNCTIONAL PLANT ECO; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Schaffers AP, 2000, J VEG SCI, V11, P225, DOI 10.2307/3236802; Schaffers AP, 2000, PLANT SOIL, V221, P205, DOI 10.1023/A:1004716619199; Sonnier G, 2010, J VEG SCI, V21, P1014, DOI 10.1111/j.1654-1103.2010.01210.x; van Dam JC, 2008, VADOSE ZONE J, V7, P640, DOI 10.2136/vzj2007.0060; Van Duren IC, 2000, PLANT SOIL, V220, P35, DOI 10.1023/A:1004735618905; VANBODEGOM PM, 2003, BIOGEOCHEMISTRY, V64, P231, DOI DOI 10.1023/A:1024935107543; Venterink HO, 2002, ECOL APPL, V12, P1010, DOI 10.1890/1051-0761(2002)012[1010:NPAKBA]2.0.CO;2; von Asmuth JR, 2012, ENVIRON MODELL SOFTW, V38, P178, DOI 10.1016/j.envsoft.2012.06.003; Walsh C., 2008, HIER PART HIERARCHIC; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Willby NJ, 2001, NEW PHYTOL, V152, P463, DOI 10.1046/j.0028-646X.2001.00274.x; Witte JPM, 2007, J VEG SCI, V18, P605, DOI 10.1111/j.1654-1103.2007.tb02574.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	44	19	20	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83735	10.1371/journal.pone.0083735	http://dx.doi.org/10.1371/journal.pone.0083735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391815	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200113
J	Ghosh, TS; Sen Gupta, S; Nair, GB; Mande, SS				Ghosh, Tarini Shankar; Sen Gupta, Sourav; Nair, Gopinath Balakrish; Mande, Sharmila S.			In Silico Analysis of Antibiotic Resistance Genes in the Gut Microflora of Individuals from Diverse Geographies and Age-Groups	PLOS ONE			English	Article							LONG-TERM IMPACTS; COMPARATIVE METAGENOMICS; TRANSPOSON; BACTERIA	The spread of antibiotic resistance, originating from the rampant and unrestrictive use of antibiotics in humans and livestock over the past few decades has emerged as a global health problem. This problem has been further compounded by recent reports implicating the gut microbial communities to act as reservoirs of antibiotic resistance. We have profiled the presence of probable antibiotic resistance genes in the gut flora of 275 individuals from eight different nationalities. For this purpose, available metagenomic data sets corresponding to 275 gut microbiomes were analyzed. Sequence similarity searches of the genomic fragments constituting each of these metagenomes were performed against genes conferring resistance to around 240 antibiotics. Potential antibiotic resistance genes conferring resistance against 53 different antibiotics were detected in the human gut microflora analysed in this study. In addition to several geography/country-specific patterns, four distinct clusters of gut microbiomes, referred to as 'Resistotypes', exhibiting similarities in their antibiotic resistance profiles, were identified. Groups of antibiotics having similarities in their resistance patterns within each of these clusters were also detected. Apart from this, mobile multi-drug resistance gene operons were detected in certain gut microbiomes. The study highlighted an alarmingly high abundance of antibiotic resistance genes in two infant gut microbiomes. The results obtained in the present study presents a holistic 'big picture' on the spectra of antibiotic resistance within our gut microbiota across different geographies. Such insights may help in implementation of new regulations and stringency on the existing ones.	[Ghosh, Tarini Shankar; Mande, Sharmila S.] Tata Consultancy Serv Ltd, TCS Innovat Labs, BioSci R&D Div, Pune, Maharashtra, India; [Sen Gupta, Sourav; Nair, Gopinath Balakrish] Translat Hlth Sci & Technol Inst, Gurgaon, Haryana, India	Tata Sons; Tata Consultancy Services Limited (TCS); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Mande, SS (corresponding author), Tata Consultancy Serv Ltd, TCS Innovat Labs, BioSci R&D Div, Pune, Maharashtra, India.	sharmila@atc.tcs.com	Ghosh, Tarini/AAW-5456-2020; PAN, ZEQIANG/X-6341-2018	Ghosh, Tarini/0000-0001-9570-0365; SEN GUPTA, SOURAV/0000-0001-5861-0600	University of Hyderabad	University of Hyderabad(University of Hyderabad)	The authors would like to acknowledge Mr. Deepak Yadav for his help during the course of this study. Tarini Shankar Ghosh is also a senior research fellow in the University of Hyderabad and would like to acknowledge the University for its support. We also thank Dr. Kristoffer Forlund for providing information on the datasets analyzed by him.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bean DC, 2009, ANTIMICROB AGENTS CH, V53, P1088, DOI 10.1128/AAC.00800-08; Boerlin Patrick, 2008, Animal Health Research Reviews, V9, P115, DOI 10.1017/S146625230800159X; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chung WO, 1999, J ANTIMICROB CHEMOTH, V44, P329, DOI 10.1093/jac/44.3.329; COURVALIN P, 1994, ANTIMICROB AGENTS CH, V38, P1447, DOI 10.1128/AAC.38.7.1447; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; GENTRY LO, 1991, ORTHOP CLIN N AM, V22, P379; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Goossens H, 2005, DIAGN MICR INFEC DIS, V53, P257, DOI 10.1016/j.diagmicrobio.2005.10.001; Graham JP, 2007, PUBLIC HEALTH REP, V122, P79, DOI 10.1177/003335490712200111; Grigoryan L, 2007, PHARMACOEPIDEM DR S, V16, P1234, DOI 10.1002/pds.1479; Gueimonde M, 2006, FEMS IMMUNOL MED MIC, V48, P21, DOI 10.1111/j.1574-695X.2006.00112.x; Guven GS, 2003, J HOSP INFECT, V53, P91, DOI 10.1053/jhin.2002.1353; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; McDermott PF, 2003, INT J TOXICOL, V22, P135, DOI 10.1080/10915810305089; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Okeke IN, 2001, CLIN INFECT DIS, V33, P364, DOI 10.1086/321877; Pallasch Thomas J, 2003, Dent Clin North Am, V47, P623, DOI 10.1016/S0011-8532(03)00039-9; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Song JH, 2000, J CLIN MICROBIOL, V38, P1641, DOI 10.1128/JCM.38.4.1641-1644.2000; Song XY, 2003, INFECT CONT HOSP EP, V24, P251, DOI 10.1086/502196; Tremblay CL, 2011, J FOOD PROTECT, V74, P1639, DOI 10.4315/0362-028X.JFP-10-451; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; VANTREECK U, 1981, ANTIMICROB AGENTS CH, V19, P371, DOI 10.1128/AAC.19.3.371; Vecchione JJ, 2009, ANTIMICROB AGENTS CH, V53, P4673, DOI 10.1128/AAC.00853-09; Wang J, 2000, J BACTERIOL, V182, P3559, DOI 10.1128/JB.182.12.3559-3571.2000	43	44	50	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83823	10.1371/journal.pone.0083823	http://dx.doi.org/10.1371/journal.pone.0083823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391833	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200131
J	He, LL; Parikh, NA				He, Lili; Parikh, Nehal A.			Atlas-Guided Quantification of White Matter Signal Abnormalities on Term-Equivalent Age MRI in Very Preterm Infants: Findings Predict Language and Cognitive Development at Two Years of Age	PLOS ONE			English	Article							HUMAN BRAIN; PROBABILISTIC ATLAS; NEURODEVELOPMENTAL OUTCOMES; SPATIOTEMPORAL ATLAS; CHILDREN; SEGMENTATION; INTENSITY; IMAGES; BIRTH; CONSTRUCTION	The developmental significance of the frequently encountered white matter signal abnormality (WMSA) findings on MRI around term-equivalent age (TEA) in very preterm infants, remains in question. The use of conventional qualitative analysis methods is subjective, lacks sufficient reliability for producing accurate and reproducible WMSA diagnosis, and possibly contributes to suboptimal neurodevelopmental outcome prediction. The advantages of quantitative over qualitative diagnostic approaches have been widely acknowledged and demonstrated. The purpose of this study is to objectively and accurately quantify WMSA on TEA T2-weighted MRI in very preterm infants and to assess whether such quantifications predict 2-year language and cognitive developmental outcomes. To this end, we constructed a probabilistic brain atlas, exclusively for very preterm infants to embed tissue distributions (i.e. to encode shapes, locations and geometrical proportion of anatomical structures). Guided with this atlas, we then developed a fully automated method for WMSA detection and quantification using T2-weighted images. Computer simulations and experiments using in vivo very preterm data showed very high detection accuracy. WMSA volume, particularly in the centrum semiovale, on TEA MRI was a significant predictor of standardized language and cognitive scores at 2 years of age. Independent validation of our automated WMSA detection algorithm and school age follow-up are important next steps.	[He, Lili; Parikh, Nehal A.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Parikh, Nehal A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	He, LL (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA.	Lili.He@NationwideChildrens.org; Nehal.Parikh@NationwideChildrens.org	Parikh, Nehal/AAB-9981-2022	Parikh, Nehal/0000-0002-1375-1247	National Center for Research Resources/The Eunice Kennedy Shriver National Institute of Child Health and Human Development [UL1 RR024148-04S3]; Research Institute at Nationwide Children's Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources/The Eunice Kennedy Shriver National Institute of Child Health and Human Development; Research Institute at Nationwide Children's Hospital(Ohio State University); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Center for Research Resources/The Eunice Kennedy Shriver National Institute of Child Health and Human Development grant UL1 RR024148-04S3 (Best Pharmaceuticals for Children Act) and The Research Institute at Nationwide Children's Hospital (to NAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Behrman RE, 2007, PRETERM BIRTH CAUSES, P346; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Brickman AM, 2011, PSYCHIAT RES-NEUROIM, V193, P101, DOI 10.1016/j.pscychresns.2011.03.007; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Counsell SJ, 2002, PEDIATR RES, V51, p438A; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Habas PA, 2010, NEUROIMAGE, V53, P460, DOI 10.1016/j.neuroimage.2010.06.054; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hagmann CF, 2009, RADIOLOGY, V252, P209, DOI 10.1148/radiol.2522080589; Hart A, 2011, PEDIATR RADIOL, V41, P1284, DOI 10.1007/s00247-011-2155-7; Hart AR, 2010, PEDIATR RADIOL, V40, P1390, DOI 10.1007/s00247-010-1633-7; He LL, 2013, NEUROIMAGE, V64, P328, DOI 10.1016/j.neuroimage.2012.08.081; Hernandez M, 2008, WORKSH MATH FDN COMP, P24; Hoeksma MR, 2005, CLIN NEUROPHYSIOL, V116, P1188, DOI 10.1016/j.clinph.2004.12.021; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Jeon TY, 2012, RADIOLOGY, V263, P518, DOI 10.1148/radiol.12111615; Judas M, 2005, AM J NEURORADIOL, V26, P2671; Kidokoro H, 2011, AM J NEURORADIOL, V32, P2005, DOI 10.3174/ajnr.A2703; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kostovic I, 2002, CEREB CORTEX, V12, P536, DOI 10.1093/cercor/12.5.536; Krishnan ML, 2007, PEDIATRICS, V120, pE604, DOI 10.1542/peds.2006-3054; Kuklisova-Murgasova M, 2011, NEUROIMAGE, V54, P2750, DOI 10.1016/j.neuroimage.2010.10.019; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Parikh NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062804; Pogribna U, AJNR AM J NEURORADIO; Potharst ES, 2011, J PEDIATR-US, V159, P79, DOI 10.1016/j.jpeds.2010.12.055; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Serag A, 2012, NEUROIMAGE, V59, P2255, DOI 10.1016/j.neuroimage.2011.09.062; Shi F, 2009, P SOC PHOTO-OPT INST, V1, P7259; Shi F, 2010, LECT NOTES COMPUT SC, V6326, P42; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Yu XT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013874	49	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85475	10.1371/journal.pone.0085475	http://dx.doi.org/10.1371/journal.pone.0085475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392012	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900156
J	Legagneux, P; Harms, NJ; Gauthier, G; Chastel, O; Gilchrist, HG; Bortolotti, G; Bety, J; Soos, C				Legagneux, Pierre; Harms, N. Jane; Gauthier, Gilles; Chastel, Olivier; Gilchrist, H. Grant; Bortolotti, Gary; Bety, Joel; Soos, Catherine			Does Feather Corticosterone Reflect Individual Quality or External Stress in Arctic-Nesting Migratory Birds?	PLOS ONE			English	Article							EIDERS SOMATERIA-MOLLISSIMA; CURRENT REPRODUCTIVE EFFORT; GREATER SNOW GEESE; LONG-LIVED BIRD; COMMON EIDERS; BODY CONDITION; AVIAN CHOLERA; BASE-LINE; MOLT; REPEATABILITY	The effects of environmental perturbations or stressors on individual states can be carried over to subsequent life stages and ultimately affect survival and reproduction. The concentration of corticosterone (CORT) in feathers is an integrated measure of hypothalamic-pituitary-adrenal activity during the molting period, providing information on the total baseline and stress-induced CORT secreted during the period of feather growth. Common eiders and greater snow geese replace all flight feathers once a year during the pre-basic molt, which occurs following breeding. Thus, CORT contained in feathers of pre-breeding individuals sampled in spring reflects the total CORT secreted during the previous molting event, which may provide insight into the magnitude or extent of stress experienced during this time period. We used data from multiple recaptures to disentangle the contribution of individual quality vs. external factors (i.e., breeding investment or environmental conditions) on feather CORT in arctic-nesting waterfowl. Our results revealed no repeatability of feather CORT within individuals of either species. In common eiders, feather CORT was not affected by prior reproductive investment, nor by pre-breeding (spring) body condition prior to the molting period. Individual feather CORT greatly varied according to the year, and August-September temperatures explained most of the annual variation in feather CORT. Understanding mechanisms that affect energetic costs and stress responses during molting will require further studies either using long-term data or experiments. Although our study period encompassed only five years, it nonetheless provides evidence that CORT measured in feathers likely reflects responses to environmental conditions experienced by birds during molt, and could be used as a metric to study carry-over effects.	[Legagneux, Pierre; Bety, Joel] Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada; [Legagneux, Pierre; Bety, Joel] Univ Quebec, Ctr Etud Nord, Rimouski, PQ G5L 3A1, Canada; [Harms, N. Jane; Soos, Catherine] Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada; [Gauthier, Gilles] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Gauthier, Gilles] Univ Laval, Ctr Etud Nord, Quebec City, PQ G1K 7P4, Canada; [Chastel, Olivier] CNRS UPR 1934, Ctr Etud Biol Chize, Carrefour Canauderie, Villiers En Boi, France; [Gilchrist, H. Grant] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Bortolotti, Gary] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Soos, Catherine] Environm Canada, Saskatoon, SK, Canada	University of Quebec; University of Quebec; University of Saskatchewan; Laval University; Laval University; Centre National de la Recherche Scientifique (CNRS); Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; University of Saskatchewan; Environment & Climate Change Canada	Legagneux, P (corresponding author), Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada.	legagneux@gmail.com	Soos, Catherine/Q-4983-2019	Soos, Catherine/0000-0003-4610-3614; Bety, Joel/0000-0002-8775-6411; Legagneux, Pierre/0000-0002-6366-0554	Environment Canada; Natural Sciences and Engineering Research Council of Canada [STPGP-396972-2010]; Western College of Veterinary Medicine Interprovincial Graduate Fellowship; W. Garfield Weston Award for Northern Research	Environment Canada(CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Western College of Veterinary Medicine Interprovincial Graduate Fellowship; W. Garfield Weston Award for Northern Research	This work was supported by Environment Canada (http://www.ec.gc.ca/), who supported all aspects of project including administrative, field and laboratory costs, and technical support; Natural Sciences and Engineering Research Council of Canada (Grant number STPGP-396972-2010; http://www.nserc-crsng.gc.ca/), who supported all aspects of project including administrative, field and laboratory costs, and technical support; Strategic Applications of Genomics in the Environment (http://www.ec.gc.ca/scitech/default.asp? lang = En&n = BA7C049C-1), who supported laboratory analyses, field travel costs, and costs of shipping equipment and samples to and from Arctic; Ducks Unlimited Institute for Wetland and Waterfowl Research (http://www.ducks.ca/our-science/), who supported field travel costs and laboratory analyses; Northern Scientific Training Program (http://www.polarcom.gc.ca/principal/eng/content/northern-scientific-training-program), who supported field travel costs for numerous graduate and undergraduate students; University of Saskatchewan's Wildlife Health Research Fund (http://www.usask.ca/wcvm/research/research_funds/wildlife_health_research_fund.php), who supported field travel costs and laboratory analyses; and Nunavut Wildlife Management Board (http://www.nwmb.com/), who supported all aspects of project including administrative, field and laboratory costs, and technical support. NJH was supported by a Western College of Veterinary Medicine Interprovincial Graduate Fellowship (http://www.usask.ca/wcvm/research/research_fellowships.php) and a W. Garfield Weston Award for Northern Research (http://www.westonfoundation.org/northern/Pages/gwanr.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2010, BIOL LETTERS, V6, P846, DOI 10.1098/rsbl.2010.0376; Bergeron P, 2011, J ANIM ECOL, V80, P361, DOI 10.1111/j.1365-2656.2010.01770.x; Beukema JJ, 2009, MAR ECOL PROG SER, V384, P135, DOI 10.3354/meps07952; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Buttler EI, 2011, J WILDLIFE MANAGE, V75, P283, DOI 10.1002/jwmg.38; Cockrem JF, 2009, GEN COMP ENDOCR, V163, P158, DOI 10.1016/j.ygcen.2009.03.029; Conklin JR, 2012, J AVIAN BIOL, V43, P252, DOI 10.1111/j.1600-048X.2012.05606.x; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2005, FUNCT ECOL, V19, P995, DOI 10.1111/j.1365-2435.2005.01061.x; Dawson A, 2004, IBIS, V146, P493, DOI 10.1111/j.1474-919x.2004.00290.x; Descamps S, 2011, J AVIAN BIOL, V42, P39, DOI 10.1111/j.1600-048X.2010.05196.x; Descamps S, 2010, OIKOS, V119, P1526, DOI 10.1111/j.1600-0706.2010.18508.x; Dietz MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053890; Fairhurst GD, 2013, J EXPT BIOL; Fairhurst GD, 2012, CAN J ZOOL, V90, P1422, DOI 10.1139/cjz-2012-0096; Fairhurst GD, 2012, P ROY SOC B-BIOL SCI, V279, P177, DOI 10.1098/rspb.2011.0884; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GABRIELSEN G W, 1991, Norsk Polarinstitutt Skrifter, P51; Gauthier G, 2001, ECOLOGY, V82, P3105, DOI 10.2307/2679838; Goudie R.I., 2000, BIRDS N AM ONLINE; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; HAHN TP, 1992, ORNIS SCAND, V23, P314, DOI 10.2307/3676655; Hemborg C, 1999, ANN ZOOL FENN, V36, P1; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; JENSSEN BM, 1989, CAN J ZOOL, V67, P669, DOI 10.1139/z89-096; Koren L, 2011, P ROYAL SOC B; Kralj-Fiser S, 2007, HORM BEHAV, V51, P239, DOI 10.1016/j.yhbeh.2006.10.006; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lattin CR, 2011, J AVIAN BIOL, V42, P247, DOI 10.1111/j.1600-048X.2010.05310.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Legagneux P, 2012, P ROY SOC B-BIOL SCI, V279, P876, DOI 10.1098/rspb.2011.1351; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; MIDDLETON ALA, 1986, CAN FIELD NAT, V100, P545; Morez V, 2000, J WILDLIFE MANAGE, V64, P875, DOI 10.2307/3802758; Mosbech A, 2006, ARDEA, V94, P651; Murphy Mary E., 1996, P158; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Norris DR, 2004, SCIENCE, V306, P2249, DOI 10.1126/science.1103542; Ouyang JQ, 2011, HORM BEHAV, V60, P559, DOI 10.1016/j.yhbeh.2011.08.004; Petersen JK, 2003, POLAR BIOL, V26, P334, DOI 10.1007/s00300-003-0483-2; Piersma T., 2011, FLEXIBLE PHENOTYPE B; Romero LM, 2008, GEN COMP ENDOCR, V156, P27, DOI 10.1016/j.ygcen.2007.10.001; Romero LM, 2002, CONDOR, V104, P129, DOI 10.1650/0010-5422(2002)104[0129:CRIWBT]2.0.CO;2; Saino N, 2012, J AVIAN BIOL, P1; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Senechal E, 2011, OECOLOGIA, V165, P593, DOI 10.1007/s00442-010-1853-4; Serra L, 2007, J EVOLUTION BIOL, V20, P2028, DOI 10.1111/j.1420-9101.2007.01360.x; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Stenseth NC, 2005, J ANIM ECOL, V74, P1195, DOI 10.1111/j.1365-2656.2005.01005.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Vagasi CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040651; Vagasi CI, 2011, ARDEA, V99, P53, DOI 10.5253/078.099.0107; Vagasi CI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014215; Vezina F, 2012, FUNCT ECOL, V26, P500, DOI 10.1111/j.1365-2435.2011.01955.x; Wada H, 2008, HORM BEHAV, V53, P472, DOI 10.1016/j.yhbeh.2007.11.018; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003; [No title captured], DOI DOI 10.1098/rstb.2007.0012	62	31	32	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82644	10.1371/journal.pone.0082644	http://dx.doi.org/10.1371/journal.pone.0082644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391720	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200017
J	Li, XL; Geng, ZR; Chang, JY; Wang, SP; Song, XL; Hu, X; Wang, ZL				Li, Xiangli; Geng, Zhirong; Chang, Jiayin; Wang, Shuping; Song, Xiaoli; Hu, Xin; Wang, Zhilin			Identification of the Third Binding Site of Arsenic in Human Arsenic (III) Methyltransferase	PLOS ONE			English	Article							OXIDATION-STATE METHYLTRANSFERASE; S-ADENOSYLMETHIONINE METHYLTRANSFERASE; PROTEIN SECONDARY STRUCTURE; DIMETHYLARSINOUS ACID; CIRCULAR-DICHROISM; CYSTEINE RESIDUES; METHYLATION; GLUTATHIONE; HAS3MT; RAT	Arsenic (III) methyltransferase (AS3MT) catalyzes the process of arsenic methylation. Each arsenite (iAs(3+)) binds to three cysteine residues, methylarsenite (MMA(3+)) binds to two, and dimethylarsenite (DMA(3+)) binds to one. However, only two As-binding sites (Cys156 and Cys206) have been confirmed on human AS3MT (hAS3MT). The third As-binding site is still undefined. Residue Cys72 in Cyanidioschyzon merolae arsenite S-adenosylmethyltransferase (CmArsM) may be the third As-binding site. The corresponding residue in hAS3MT is Cys61. Functions of Cys32, Cys61, and Cys85 in hAS3MT are unclear though Cys32, Cys61, and Cys85 in rat AS3MT have no effect on the enzyme activity. This is why the functions of Cys32, Cys61, and Cys85 in hAS3MT merit investigation. Here, three mutants were designed, C32S, C61S, and C85S. Their catalytic activities and conformations were determined, and the catalytic capacities of C156S and C206S were studied. Unlike C85S, mutants C32S and C61S were completely inactive in the methylation of iAs(3+) and active in the methylation of MMA(3+). The catalytic activity of C85S was also less pronounced than that of WT-hAS3MT. All these findings suggest that Cys32 and Cys61 markedly influence the catalytic activity of hAS3MT. Cys32 and Cys61 are necessary to the first step of methylation but not to the second. Cys156 and Cys206 are required for both the first and second steps of methylation. The S-C32 is located far from arsenic in the WT-hAS3MT-SAM-As model. The distances between S-C61 and arsenic in WT-hAS3MT-As and WT-hAS3MT-SAM-As models are 7.5 angstrom and 4.1 angstrom, respectively. This indicates that SAM-binding to hAS3MT shortens the distance between S-C61 and arsenic and promotes As-binding to hAS3MT. This is consistent with the fact that SAM is the first substrate to bind to hAS3MT and iAs is the second. Model of WT-hAS3MT-SAM-As and the experimental results indicate that Cys61 is the third As-binding site.	[Li, Xiangli; Geng, Zhirong; Chang, Jiayin; Wang, Shuping; Wang, Zhilin] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China; [Song, Xiaoli] Yangzhou Univ, Sch Chem & Chem Engn, Yangzhou, Peoples R China; [Hu, Xin] Nanjing Univ, Modern Anal Ctr, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Yangzhou University; Nanjing University	Geng, ZR (corresponding author), Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Coordinat Chem, Nanjing 210008, Jiangsu, Peoples R China.	gengzr@nju.edu.cn; wangzl@nju.edu.cn	Hu, Xin/B-1792-2009; Geng, Zhirong/HGC-1447-2022	Hu, Xin/0000-0003-3400-554X; Geng, Zhirong/0000-0003-3766-9034	National Basic Research Program of China [2013CB922102]; National Natural Science Foundation of China [21075064, 21027013, 21021062, 21275072, 21201101]; Scientific Research Foundation of Graduate School of Nanjing University [2012CL16]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Graduate School of Nanjing University(Nanjing University)	This study is supported by the National Basic Research Program of China (2013CB922102), the National Natural Science Foundation of China (21075064, 21027013, 21021062, 21275072 and 21201101) and Scientific Research Foundation of Graduate School of Nanjing University (2012CL16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajees AA, 2012, BIOCHEMISTRY-US, V51, P5476, DOI 10.1021/bi3004632; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cleland W.W., 1970, ENZYMES, P1; Coward JK, 1977, CHEM MECH METHYL TRA, P127; Delano W. L., 2004, PYMOL USERS GUIDE; DELNOMDEDIEU M, 1994, CHEM-BIOL INTERACT, V90, P139, DOI 10.1016/0009-2797(94)90099-X; Ding L, 2012, TOXICOL APPL PHARM, V264, P121, DOI 10.1016/j.taap.2012.07.024; Fass D, 2012, ANNU REV BIOPHYS, V41, P63, DOI 10.1146/annurev-biophys-050511-102321; Florea A.M., 2013, J LOCAL GLOBAL HLTH, V1, P1; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gailer J, 1999, APPL ORGANOMET CHEM, V13, P837, DOI 10.1002/(SICI)1099-0739(199911)13:11<837::AID-AOC924>3.0.CO;2-Z; Geng ZR, 2009, J BIOL INORG CHEM, V14, P485, DOI 10.1007/s00775-008-0464-6; Hayakawa T, 2005, ARCH TOXICOL, V79, P183, DOI 10.1007/s00204-004-0620-x; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Jiang GF, 2003, CHEM RES TOXICOL, V16, P873, DOI 10.1021/tx034053g; Kedderis GL, 2006, CHEM-BIOL INTERACT, V161, P139, DOI 10.1016/j.cbi.2006.04.001; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kuhn B, 2000, J AM CHEM SOC, V122, P2586, DOI 10.1021/ja992218v; KUROKI T, 1987, MUTAGENESIS, V2, P33, DOI 10.1093/mutage/2.1.33; Li JX, 2005, TOXICOL APPL PHARM, V204, P164, DOI 10.1016/j.taap.2004.12.002; Li XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076709; Li XL, 2013, FEBS LETT, V587, P2232, DOI 10.1016/j.febslet.2013.05.052; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Lu XF, 2003, ANAL CHEM, V75, P6463, DOI 10.1021/ac034868u; Marapakala K, 2012, BIOCHEMISTRY-US, V51, P944, DOI 10.1021/bi201500c; Mukhopadhyay R, 2002, ENVIRON HEALTH PERSP, V110, P745, DOI 10.1289/ehp.02110s5745; Naranmandura H, 2006, CHEM RES TOXICOL, V19, P1010, DOI 10.1021/tx060053f; Raber G, 2000, FRESEN J ANAL CHEM, V367, P181, DOI 10.1007/s002160051621; Rehman K, 2012, METALLOMICS, V4, P881, DOI 10.1039/c2mt00181k; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARVER RW, 1991, ANAL BIOCHEM, V199, P61, DOI 10.1016/0003-2697(91)90269-Y; SCOTT N, 1993, CHEM RES TOXICOL, V6, P102, DOI 10.1021/tx00031a016; Song XL, 2011, BIOCHIMIE, V93, P369, DOI 10.1016/j.biochi.2010.10.010; Song XL, 2010, BIOCHIMIE, V92, P1397, DOI 10.1016/j.biochi.2010.07.002; Song XL, 2010, J INORG BIOCHEM, V104, P541, DOI 10.1016/j.jinorgbio.2010.01.005; Song XL, 2009, CHEM-BIOL INTERACT, V179, P321, DOI 10.1016/j.cbi.2008.12.018; Soriano A, 2006, BIOCHEMISTRY-US, V45, P14917, DOI 10.1021/bi061319k; Sun GF, 2007, ENVIRON HEALTH PERSP, V115, P648, DOI 10.1289/ehp.9271; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Suzuki KT, 2004, CHEM RES TOXICOL, V17, P914, DOI 10.1021/tx049963s; Vahter Marie, 1999, Science Progress, V82, P69; Vilkaitis G, 2000, J BIOL CHEM, V275, P38722, DOI 10.1074/jbc.M005278200; Walton FS, 2003, CHEM RES TOXICOL, V16, P261, DOI 10.1021/tx025649r; Wang SP, 2012, J BIOL CHEM, V287, P38790, DOI 10.1074/jbc.M112.368050; Waters SB, 2004, CHEM RES TOXICOL, V17, P404, DOI 10.1021/tx0342161; Wood TC, 2006, J BIOL CHEM, V281, P7364, DOI 10.1074/jbc.M512227200; Wu RB, 2008, J COMPUT CHEM, V29, P350, DOI 10.1002/jcc.20793; Xu YY, 2008, TOXICOL APPL PHARM, V232, P142, DOI 10.1016/j.taap.2008.06.010; Yang YT, 1986, METHOD ENZYMOL, V130, P208; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	54	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84231	10.1371/journal.pone.0084231	http://dx.doi.org/10.1371/journal.pone.0084231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391919	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900062
J	Nisa-Martinez, R; Laporte, P; Jimenez-Zurdo, JI; Frugier, F; Crespi, M; Toro, N				Nisa-Martinez, Rafael; Laporte, Philippe; Ignacio Jimenez-Zurdo, Jose; Frugier, Florian; Crespi, Martin; Toro, Nicolas			Localization of a Bacterial Group II Intron-Encoded Protein in Eukaryotic Nuclear Splicing-Related Cell Compartments	PLOS ONE			English	Article							IN-VIVO; ENDONUCLEASE DOMAIN; RMINT1; DNA; RNA; ORIGIN; IDENTIFICATION; EVOLUTION; EXCISION; MOBILITY	Some bacterial group II introns are widely used for genetic engineering in bacteria, because they can be reprogrammed to insert into the desired DNA target sites. There is considerable interest in developing this group II intron gene targeting technology for use in eukaryotes, but nuclear genomes present several obstacles to the use of this approach. The nuclear genomes of eukaryotes do not contain group II introns, but these introns are thought to have been the progenitors of nuclear spliceosomal introns. We investigated the expression and subcellular localization of the bacterial RmInt1 group II intron-encoded protein (IEP) in Arabidopsis thaliana protoplasts. Following the expression of translational fusions of the wild-type protein and several mutant variants with EGFP, the full-length IEP was found exclusively in the nucleolus, whereas the maturase domain alone targeted EGFP to nuclear speckles. The distribution of the bacterial RmInt1 IEP in plant cell protoplasts suggests that the compartmentalization of eukaryotic cells into nucleus and cytoplasm does not prevent group II introns from invading the host genome. Furthermore, the trafficking of the IEP between the nucleolus and the speckles upon maturase inactivation is consistent with the hypothesis that the spliceosomal machinery evolved from group II introns.	[Nisa-Martinez, Rafael; Ignacio Jimenez-Zurdo, Jose] CSIC, Grp Ecol Genet, Estn Expt Zaidin, Granada, Spain; [Laporte, Philippe; Frugier, Florian; Crespi, Martin; Toro, Nicolas] CNRS, Inst Sci Vegetal, Gif Sur Yvette, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Toro, N (corresponding author), CNRS, Inst Sci Vegetal, Gif Sur Yvette, France.	ntoro@eez.csic.es	Toro, Nicolas/K-4909-2014; Crespi, Martin/AAB-1424-2020; Jiménez-Zurdo, José I./P-6474-2014	Toro, Nicolas/0000-0002-3614-807X; Crespi, Martin/0000-0002-5698-9482; Jiménez-Zurdo, José I./0000-0002-6378-2199	Consolider-Ingenio program, including ERDF (European Regional Development Funds) [CSD 2009-0006]; Ministerio de Economia y Competitividad [BIO2011-24401]; CSIC-CNRS [2002FR0032, 2005FR0004]; Spanish Ministerio de Ciencia e Innovacion	Consolider-Ingenio program, including ERDF (European Regional Development Funds); Ministerio de Economia y Competitividad(Spanish Government); CSIC-CNRS(Centre National de la Recherche Scientifique (CNRS)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by research grants CSD 2009-0006 from the Consolider-Ingenio program, including ERDF (European Regional Development Funds), BIO2011-24401 from the, currently Ministerio de Economia y Competitividad and CSIC-CNRS bilateral projects 2002FR0032 and 2005FR0004. RNM held an FPI fellowship from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Boeke JD, 2003, GENOME RES, V13, P1975, DOI 10.1101/gr.1392003; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; Chalamcharla VR, 2010, GENE DEV, V24, P827, DOI 10.1101/gad.1905010; Cui X, 2005, THESIS U TEXAS AUSTI; Molina-Sanchez MD, 2011, J BIOL CHEM, V286, P21154, DOI 10.1074/jbc.M110.210013; Droillard MJ, 2002, FEBS LETT, V527, P43, DOI 10.1016/S0014-5793(02)03162-9; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; Guo WH, 2013, J MOL EVOL, V77, P43, DOI 10.1007/s00239-013-9579-7; Jimenez-Zurdo JI, 2003, J MOL BIOL, V326, P413, DOI 10.1016/S0022-2836(02)01380-3; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Keating KS, 2010, RNA, V16, P1, DOI 10.1261/rna.1791310; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; Koonin EV, 2011, LOGIC CHANCE NATURE, P171; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Lorkovic ZJ, 2004, MOL BIOL CELL, V15, P3233, DOI 10.1091/mbc.E04-01-0055; Lynch M, 2003, MOL BIOL EVOL, V20, P563, DOI 10.1093/molbev/msg068; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Martinez-Abarca F, 2000, MOL MICROBIOL, V35, P1405, DOI 10.1046/j.1365-2958.2000.01804.x; Martinez-Abarca F, 2004, NUCLEIC ACIDS RES, V32, P2880, DOI 10.1093/nar/gkh616; Mastroianni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003121; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Mohr G, 2003, NUCLEIC ACIDS RES, V31, P647, DOI 10.1093/nar/gkg153; Molina-Sanchez MD, 2010, FEBS J, V277, P244, DOI 10.1111/j.1742-4658.2009.07478.x; Molina-Sanchez MD, 2006, J BIOL CHEM, V281, P28737, DOI 10.1074/jbc.M602695200; Munoz-Adelantado E, 2003, J MOL BIOL, V327, P931, DOI 10.1016/S0022-2836(03)00208-0; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Nisa-Martinez R, 2007, NUCLEIC ACIDS RES, V35, P214, DOI 10.1093/nar/gkl1072; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toro N, 2007, FEMS MICROBIOL REV, V31, P342, DOI 10.1111/j.1574-6976.2007.00068.x; VILLADAS PJ, 1995, FEMS MICROBIOL ECOL, V17, P161, DOI 10.1111/j.1574-6941.1995.tb00139.x; Zhao JH, 2005, P NATL ACAD SCI USA, V102, P16133, DOI 10.1073/pnas.0507057102	40	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84056	10.1371/journal.pone.0084056	http://dx.doi.org/10.1371/journal.pone.0084056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391881	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900024
J	Owczarek, TB; Suchanski, J; Pula, B; Kmiecik, AM; Chadalski, M; Jethon, A; Dziegiel, P; Ugorski, M				Owczarek, Tomasz B.; Suchanski, Jaroslaw; Pula, Bartosz; Kmiecik, Alicja M.; Chadalski, Marek; Jethon, Aleksandra; Dziegiel, Piotr; Ugorski, Maciej			Galactosylceramide Affects Tumorigenic and Metastatic Properties of Breast Cancer Cells as an Anti-Apoptotic Molecule	PLOS ONE			English	Article							ALTERED SPHINGOLIPID METABOLISM; DAUNORUBICIN-INDUCED APOPTOSIS; GLUCOSYLCERAMIDE SYNTHASE; CERAMIDE GALACTOSYLTRANSFERASE; NEUTRAL GLYCOSPHINGOLIPIDS; MICROARRAY ANALYSIS; OVARIAN-CANCER; DEATH; INHIBITION; ACCUMULATION	It was recently proposed that UDP-galactose: ceramide galactosyltransferase (UGT8), enzyme responsible for synthesis of galactosylceramide (GalCer), is a significant index of tumor aggressiveness and a potential marker for the prognostic evaluation of lung metastases in breast cancer. To further reveal the role of UGT8 and GalCer in breast cancer progression, tumorigenicity and metastatic potential of control MDA-MB-231 cells (MDA/LUC) and MDA-MB-231 cells (MDA/LUC-shUGT8) with highly decreased expression of UGT8 and GalCer after stable expression of shRNA directed against UGT8 mRNA was studied in vivo in athymic nu/nu mice. Control MDA/LUC cells formed tumors and metastatic colonies much more efficiently in comparison to MDA/LUC-shUGT8 cells with suppressed synthesis of GalCer after their, respectively, orthotopic and intracardiac transplantation. These findings indicate that UGT8 and GalCer have a profound effect on tumorigenic and metastatic properties of breast cancer cells. In accordance with this finding, immunohistochemical staining of tumor specimens revealed that high expression of UGT8 accompanied by accumulation of GalCer in MDA-MB-231 cells is associated with a much higher proliferative index and a lower number of apoptotic cells in comparison to the MDA/LUC-shUGT8 cells. In addition, it was found that expression of UGT8 in MDA-MB-231 cells increased their resistance to apoptosis induced by doxorubicin in vitro. Therefore, these data suggest that accumulation of GalCer in tumor cells inhibits apoptosis, which would facilitates metastatic cells to survive in the hostile microenvironment of tumor in target organ.	[Owczarek, Tomasz B.; Kmiecik, Alicja M.; Chadalski, Marek; Ugorski, Maciej] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol & Cell Interact, Wroclaw, Poland; [Owczarek, Tomasz B.; Suchanski, Jaroslaw; Ugorski, Maciej] Univ Environm & Life Sci, Dept Biochem Pharmacol & Toxicol, Fac Vet Med, Wroclaw, Poland; [Pula, Bartosz; Jethon, Aleksandra; Dziegiel, Piotr] Wroclaw Med Univ, Dept Histol & Embryol, Wroclaw, Poland; [Dziegiel, Piotr] Univ Wroclaw, Sch Phys Educ, Dept Physiotherapy, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw Medical University; University of Wroclaw	Ugorski, M (corresponding author), Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Glycobiol & Cell Interact, Wroclaw, Poland.	ugorski@iitd.pan.wroc.pl	Kmiecik, Alicja/AAY-1543-2020; Puła, Bartosz/AAO-3209-2020; Ugorsku, Maciej/AAJ-1050-2020	Kmiecik, Alicja/0000-0002-6498-717X; Puła, Bartosz/0000-0003-0116-5002; Ugorski, Maciej/0000-0003-0299-8372; Owczarek, Tomasz/0000-0002-5095-8642; Dziegiel, Piotr/0000-0002-8292-1385; Suchanski, Jaroslaw/0000-0002-2672-1020	National Science Center (Poland) [N N401 097936]	National Science Center (Poland)	Grant support for this work was provided by the National Science Center (Poland) URL: http://www.ncn.gov.pl/?language = en; grant no.: N N401 097936. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroui S, 2009, CANCER LETT, V285, P28, DOI 10.1016/j.canlet.2009.04.044; Bartkowiak K, 2012, CANCER MICROENVIRON, V5, P59, DOI 10.1007/s12307-011-0067-6; Beier UH, 2005, INT J CANCER, V115, P6, DOI 10.1002/ijc.20851; Bieberich E, 2004, GLYCOCONJUGATE J, V21, P315, DOI 10.1023/B:GLYC.0000046274.35732.47; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Carpinteiro A, 2008, CANCER LETT, V264, P1, DOI 10.1016/j.canlet.2008.02.020; CARTER HE, 1952, J BIOL CHEM, V199, P283; Davidoff MS, 2002, ACTA HISTOCHEM, V104, P39, DOI 10.1078/0065-1281-00630; Dziegiel P, 2010, BRIT J CANCER, V103, P524, DOI 10.1038/sj.bjc.6605750; Gomez-Munoz A, 2006, BBA-BIOMEMBRANES, V1758, P2049, DOI 10.1016/j.bbamem.2006.05.011; Grazide S, 2004, J BIOL CHEM, V279, P18256, DOI 10.1074/jbc.M314105200; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Hiraoka M, 2002, J BIOL CHEM, V277, P10090, DOI 10.1074/jbc.M111977200; Itoh M, 2003, CLIN CANCER RES, V9, P415; Kok JW, 2000, INT J CANCER, V87, P172, DOI 10.1002/1097-0215(20000715)87:2<172::AID-IJC3>3.0.CO;2-K; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Landemaine T, 2008, CANCER RES, V68, P6092, DOI 10.1158/0008-5472.CAN-08-0436; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Li CH, 2013, GASTROENTEROLOGY, V144, P1086, DOI 10.1053/j.gastro.2013.01.058; Liu Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-186; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Lucci A, 1999, CANCER-AM CANCER SOC, V86, P300, DOI 10.1002/(SICI)1097-0142(19990715)86:2<300::AID-CNCR14>3.0.CO;2-H; Marcus J, 2002, BBA-GEN SUBJECTS, V1573, P406, DOI 10.1016/S0304-4165(02)00410-5; MORELL P, 1969, BIOCHEMISTRY-US, V8, P506, DOI 10.1021/bi00830a008; Niimura Y, 2008, COMP BIOCHEM PHYS B, V149, P161, DOI 10.1016/j.cbpb.2007.09.002; Niimura Y, 2010, GLYCOBIOLOGY, V20, P710, DOI 10.1093/glycob/cwq018; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; NILSSON O, 1982, J LIPID RES, V23, P327; OGAWA K, 1988, J CHROMATOGR-BIOMED, V426, P188, DOI 10.1016/S0378-4347(00)81942-8; Ogretmen B, 2001, DRUG RESIST UPDATE, V4, P368, DOI 10.1054/drup.2001.0225; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Popko B, 2002, J NEUROPATH EXP NEUR, V61, P329, DOI 10.1093/jnen/61.4.329; Reynolds CP, 2004, CANCER LETT, V206, P169, DOI 10.1016/j.canlet.2003.08.034; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Solatycka A, 2012, GLYCOBIOLOGY, V22, P1042, DOI 10.1093/glycob/cws075; Spinedi A, 1998, CELL DEATH DIFFER, V5, P785, DOI 10.1038/sj.cdd.4400428; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; Sung CC, 1996, GLYCOCONJUGATE J, V13, P433, DOI 10.1007/BF00731476; Thudichum J. L. W., 1874, RESEARCHES CHEMICAL, V5, P113; Uchida Y, 2004, CANCER RES, V64, P6271, DOI 10.1158/0008-5472.CAN-03-1476; UGORSKI M, 1989, GLYCOCONJUGATE J, V6, P303, DOI 10.1007/BF01047850; Veldman RJ, 2002, FASEB J, V16, P1111, DOI 10.1096/fj.01-0863fje; Xie KP, 2003, CLIN EXP METASTAS, V20, P31, DOI 10.1023/A:1022590402748; Yang F, 2006, ONCOGENE, V25, P1413, DOI 10.1038/sj.onc.1209165; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zhang X, 2012, PLOS ONE, V7	52	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84191	10.1371/journal.pone.0084191	http://dx.doi.org/10.1371/journal.pone.0084191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391908	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900051
J	Park, JT; Leach, SD				Park, Joon Tae; Leach, Steven D.			TAILOR: Transgene Activation and Inactivation Using Lox and Rox in Zebrafish	PLOS ONE			English	Article							SITE-DIRECTED RECOMBINATION; GENE-EXPRESSION; CRE; SYSTEM; CELLS; TRAP; STRATEGIES; EMBRYOS; MODEL; LINES	The ability to achieve precisely tailored activation and inactivation of gene expression represents a critical utility for vertebrate model organisms. In this regard, Cre and other site-specific DNA recombinases have come to play a central role in achieving temporally regulated and cell type-specific genetic manipulation. In zebrafish, both Cre and Flp recombinases have been applied for inducible activation, inactivation and inversion of inserted genomic elements. Here we describe the addition of Dre, a heterospecific Cre-related site-specific recombinase, to the zebrafish genomic toolbox. Combining Dre-based recombination in zebrafish with established Cre/lox technology, we have established an effective strategy for transgene activation and inactivation using lox and rox (TAILOR). Using stable transgenic lines expressing tamoxifen-inducible CreER(T2) and RU486-inducible DrePR fusions, we demonstrate that Cre and Dre retain non-overlapping specificities for their respective lox and rox target sites in larval zebrafish, and that their combinatorial and sequential activation can achieve precisely timed transgene activation and inactivation. In addition to TAILOR, the successful application of Dre/rox technology in zebrafish will facilitate a variety of additional downstream genetic applications, including sequential lineage labeling, complex genomic rearrangements and the precise temporal and spatial control of gene expression through the intersection of partially overlapping promoter activities.	[Park, Joon Tae; Leach, Steven D.] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA; [Leach, Steven D.] Johns Hopkins Med Inst, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Leach, SD (corresponding author), Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21205 USA.	stleach@jhmi.edu			NIH [DK56211, HD058530]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056211] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK56211 and HD058530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2000, EXP CELL RES, V256, P282, DOI 10.1006/excr.2000.4805; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boniface EJ, 2009, GENESIS, V47, P484, DOI 10.1002/dvg.20526; Collins RT, 2010, NAT METHODS, V7, P219, DOI [10.1038/NMETH.1423, 10.1038/nmeth.1423]; Dymecki SM, 2010, METHOD ENZYMOL, V477, P183, DOI 10.1016/S0076-6879(10)77011-7; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hesselson D, 2011, CURR BIOL, V21, P712, DOI 10.1016/j.cub.2011.03.041; Hirsch MR, 2013, GENESIS; Huang CJ, 2005, DEV DYNAM, V233, P1294, DOI 10.1002/dvdy.20485; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jie D, 2004, METHOD CELL BIOL, V77, P363; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kellendonk C, 1996, NUCLEIC ACIDS RES, V24, P1404, DOI 10.1093/nar/24.8.1404; Knopf F, 2010, P NATL ACAD SCI USA, V107, P19933, DOI 10.1073/pnas.1007799107; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Le XN, 2007, P NATL ACAD SCI USA, V104, P9410, DOI 10.1073/pnas.0611302104; Liu WY, 2007, MAR BIOTECHNOL, V9, P420, DOI 10.1007/s10126-007-9000-x; Maddison LA, 2011, METHOD CELL BIOL, V104, P3, DOI 10.1016/B978-0-12-374814-0.00001-X; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Ni TT, 2012, P NATL ACAD SCI USA, V109, P15389, DOI 10.1073/pnas.1206131109; Pan XF, 2005, TRANSGENIC RES, V14, P217, DOI 10.1007/s11248-004-5790-z; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; Seok SH, 2010, CANCER SCI, V101, P149, DOI 10.1111/j.1349-7006.2009.01393.x; Sinha DK, 2010, ZEBRAFISH, V7, P199, DOI 10.1089/zeb.2009.0632; Speck NA, 2009, BLOOD CELL MOL DIS, V43, P6, DOI 10.1016/j.bcmd.2009.01.010; Thummel R, 2005, DEV DYNAM, V233, P1366, DOI 10.1002/dvdy.20475; Trinh LA, 2011, GENE DEV, V25, P2306, DOI 10.1101/gad.174037.111; Wang YY, 2011, DEVELOPMENT, V138, P609, DOI 10.1242/dev.059097; Wong AC, 2011, TRANSGENIC RES, V20, P409, DOI 10.1007/s11248-010-9410-9; Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543	35	17	19	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85218	10.1371/journal.pone.0085218	http://dx.doi.org/10.1371/journal.pone.0085218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391998	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900141
J	Sateriale, A; Roy, NH; Huston, CD				Sateriale, Adam; Roy, Nathan H.; Huston, Christopher D.			SNAP-Tag Technology Optimized for Use in Entamoeba histolytica	PLOS ONE			English	Article							HOST-CELLS; CYSTEINE PROTEINASES; FUSION PROTEINS; IN-VIVO; PARASITE; PHAGOCYTOSIS; CYTOTOXICITY; CULTIVATION; EXPRESSION; AMEBIASIS	Entamoeba histolytica is a protozoan parasite responsible for invasive intestinal and extraintestinal amebiasis. The pathology of amebiasis is still poorly understood, which can be largely attributed to lack of molecular tools. Here we present the optimization of SNAP-tag technology via codon optimization specific for E. histolytica. The resultant SNAP protein is highly expressed in amebic trophozoites, and shows proper localization when tagged with an endoplasmic reticulum retention signal. We further demonstrate the capabilities of this system using super resolution microscopy, done for the first time in E. histolytica.	[Sateriale, Adam; Roy, Nathan H.; Huston, Christopher D.] Univ Vermont, Cellular Mol & Biomed Sci Program, Burlington, VT 05405 USA; [Roy, Nathan H.; Huston, Christopher D.] Univ Vermont, Burlington, VT USA; [Sateriale, Adam; Huston, Christopher D.] Univ Vermont, Dept Med, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont	Huston, CD (corresponding author), Univ Vermont, Cellular Mol & Biomed Sci Program, Burlington, VT 05405 USA.	christopher.huston@uvm.edu		Sateriale, Adam/0000-0001-8947-2714	NIAID [R01 A1072021]; National Institutes of Health [R01 AI080302];  [T32 AI055402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080302, T32AI055402, R01AI072021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIAID R01 A1072021 to Christopher Huston. STORM microscopy was funded by National Institutes of Health grant R01 AI080302 to Markus Thali. Nathan Roy was supported by T32 AI055402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankri S, 1999, INFECT IMMUN, V67, P421, DOI 10.1128/IAI.67.1.421-422.1999; Bojkowska K, 2011, CHEM BIOL, V18, P805, DOI 10.1016/j.chembiol.2011.03.014; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Buss SN, 2010, INT J PARASITOL, V40, P833, DOI 10.1016/j.ijpara.2009.12.007; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Duggal P, 2011, J CLIN INVEST, V121, P1191, DOI 10.1172/JCI45294; Ghosh TC, 2000, INT J PARASITOL, V30, P715, DOI 10.1016/S0020-7519(00)00042-4; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Huston CD, 2003, INFECT IMMUN, V71, P964, DOI 10.1128/IAI.71.2.964-972.2003; Huston CD, 2000, CELL MICROBIOL, V2, P617, DOI 10.1046/j.1462-5822.2000.00085.x; Iversen L, 2008, LANGMUIR, V24, P6375, DOI 10.1021/la7037075; Juillerat A, 2003, CHEM BIOL, V10, P313, DOI 10.1016/S1074-5521(03)00068-1; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Keppler A, 2009, ACS CHEM BIOL, V4, P127, DOI 10.1021/cb800298u; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; LEIPPE M, 1994, MOL MICROBIOL, V14, P895, DOI 10.1111/j.1365-2958.1994.tb01325.x; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Marie CS, 2012, INFECT IMMUN, V80, P1934, DOI 10.1128/IAI.06140-11; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; MCCOY JJ, 1994, INFECT IMMUN, V62, P3045, DOI 10.1128/IAI.62.8.3045-3050.1994; Moncada D, 2003, INFECT IMMUN, V71, P838, DOI 10.1128/IAI.71.2.838-844.2003; Petri WA, 2002, ANNU REV MICROBIOL, V56, P39, DOI 10.1146/annurev.micro.56.012302.160959; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; Ramakrishnan G, 1997, MOL BIOCHEM PARASIT, V84, P93, DOI 10.1016/S0166-6851(96)02784-3; RAVDIN JI, 1981, J CLIN INVEST, V68, P1305, DOI 10.1172/JCI110377; Roy NH, 2013, J VIROL, V87, P7516, DOI 10.1128/JVI.00790-13; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Vaithilingam A, 2012, INFECT IMMUN, V80, P2008, DOI 10.1128/IAI.06287-11	30	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83997	10.1371/journal.pone.0083997	http://dx.doi.org/10.1371/journal.pone.0083997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391864	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900007
J	Zhang, YT; Tang, Y; Wang, PF; Zhao, X; Xu, SG; Zhang, CC				Zhang, Yuntong; Tang, Yang; Wang, Panfeng; Zhao, Xue; Xu, Shuogui; Zhang, Chuncai			Biomechanical Comparison of Different Stabilization Constructs for Unstable Posterior Wall Fractures of Acetabulum. A Cadaveric Study	PLOS ONE			English	Article							INTERNAL-FIXATION; OPERATIVE TREATMENT; PLATE-FIXATION; OPEN REDUCTION; SCREWS; DISLOCATIONS; STRENGTH; COLUMN	Purpose: Operative treatment of unstable posterior wall fractures of acetabulum has been widely recommended. This laboratory study was undertaken to evaluate static fixation strength of three common fixation constructs: interfragmentary screws alone, in combination with conventional reconstruction plate, or locking reconstruction plate. Methods: Six formalin-preserved cadaveric pelvises were used for this investigation. A posterior wall fracture was created along an arc of 40-90 degree about the acetabular rim. Three groups of different fixation constructs (two interfragmentary screws alone; two interfragmentary screws and a conventional reconstruction plate; two interfragmentary screws and a locking reconstruction) were compared. Pelvises were axial loaded with six cycles of 1500 N. Dislocation of superior and inferior fracture site was analysed with a multidirectional ultrasonic measuring system. Results: No statistically significant difference was found at each of the superior and inferior fracture sites between the three types of fixation. In each group, the vector dislocation at superior fracture site was significantly larger than inferior one. Conclusions: All those three described fixation constructs can provide sufficient stability for posterior acetabular fractures and allow early mobilization under experimental conditions. Higher posterior acetabular fracture line, transecting the weight-bearing surface, may indicate a substantial increase in instability, and need more stable pattern of fixation.	[Zhang, Yuntong; Tang, Yang; Wang, Panfeng; Zhao, Xue; Xu, Shuogui; Zhang, Chuncai] Second Mil Med Univ, Changhai Hosp, Dept Orthopaed, Shanghai, Peoples R China	Naval Medical University	Xu, SG (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Orthopaed, Shanghai, Peoples R China.	zone1030@gmail.com; mone1030@163.com						Baumgaertner M R, 1999, J Am Acad Orthop Surg, V7, P54; Chang JK, 2001, CLIN ORTHOP RELAT R, P433; Culemann U, 2010, INJURY, V41, P405, DOI 10.1016/j.injury.2009.12.001; Egol KA, 2004, J ORTHOP TRAUMA, V18, P488, DOI 10.1097/00005131-200409000-00003; Fulkerson E, 2006, J TRAUMA, V60, P830, DOI 10.1097/01.ta.0000195462.53525.0c; GOULET JA, 1994, J BONE JOINT SURG AM, V76A, P1457, DOI 10.2106/00004623-199410000-00004; Gras F, 2012, J TRAUMA ACUTE CARE, V72, P1664, DOI 10.1097/TA.0b013e3182463b45; Im GI, 2005, J TRAUMA, V58, P300, DOI 10.1097/01.TA.0000149329.86361.CE; JUDET R, 1964, J BONE JOINT SURG AM, V46, P1615, DOI 10.2106/00004623-196446080-00001; Konrath GA, 1998, J ORTHOP TRAUMA, V12, P152, DOI 10.1097/00005131-199803000-00003; Kreder HJ, 2006, J BONE JOINT SURG BR, V88B, P776, DOI 10.1302/0301-620X.00B6; Letournel E., 1993, FRACTURES ACETABULUM, V2nd; Liu XW, 2010, CLIN BIOMECH, V25, P312, DOI 10.1016/j.clinbiomech.2010.01.008; Marintschev I, 2012, INJURY, V43, P470, DOI 10.1016/j.injury.2011.11.009; Matta, 2006, J ORTHOP TRAUMA, V20, pS20, DOI [10.1097/01.bot.0000202389.40246.c0, DOI 10.1097/01.B0T.0000202389.40246.C0]; Matta JM, 1996, J BONE JOINT SURG AM, V78A, P1632, DOI 10.2106/00004623-199611000-00002; Mehin R, 2009, CAN J SURG, V52, P221; Mitsionis GI, 2012, J ORTHOP TRAUMA, V26, P460, DOI 10.1097/BOT.0b013e31822c4d6c; Moed BR, 2000, CLIN ORTHOP RELAT R, P57; Moed BR, 2003, J BONE JOINT SURG AM, V85A, P512, DOI 10.2106/00004623-200303000-00018; Moed BR, 2002, J BONE JOINT SURG AM, V84A, P752, DOI 10.2106/00004623-200205000-00008; Ochs BG, 2010, INJURY, V41, P839, DOI 10.1016/j.injury.2010.04.010; Olson SA, 1996, J ORTHOP TRAUMA, V10, P395, DOI 10.1097/00005131-199608000-00006; OLSON SA, 1995, J BONE JOINT SURG AM, V77A, P1184, DOI 10.2106/00004623-199508000-00007; Olson SA, 2007, J ORTHOP TRAUMA, V21, P608, DOI 10.1097/BOT.0b013e3181591397; ROWE CR, 1961, J BONE JOINT SURG AM, V43, P30, DOI 10.2106/00004623-196143010-00002; SAWAGUCHI T, 1984, ACTA ORTHOP SCAND, V55, P601, DOI 10.3109/17453678408992404; Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P447, DOI 10.1097/00005131-200608000-00001; SCHOPFER A, 1994, INT ORTHOP, V18, P96, DOI 10.1007/BF02484418; Schutz Michael, 2003, J Orthop Sci, V8, P252, DOI 10.1007/s007760300044; Shazar N, 1998, CLIN ORTHOP RELAT R, P215; SIMONIAN PT, 1995, CLIN ORTHOP RELAT R, P234; Tadros AMA, 2010, J TRAUMA, V68, P478, DOI 10.1097/TA.0b013e3181b28aee; Yoshida H, 2006, J BIOMECH, V39, P1996, DOI 10.1016/j.jbiomech.2005.06.026	34	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82993	10.1371/journal.pone.0082993	http://dx.doi.org/10.1371/journal.pone.0082993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391733	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200030
J	Al Sifri, SN; Almahmeed, W; Azar, S; Okkeh, O; Bramlage, P; Junger, C; Halawa, I; Ambegaonkar, B; Wajih, S; Brudi, P				Al Sifri, Saud N.; Almahmeed, Wael; Azar, Sami; Okkeh, Osama; Bramlage, Peter; Juenger, Claus; Halawa, Islam; Ambegaonkar, Baishali; Wajih, Sameh; Brudi, Philippe			Results of the Dyslipidemia International Study (DYSIS)-Middle East: Clinical Perspective on the Prevalence and Characteristics of Lipid Abnormalities in the Setting of Chronic Statin Treatment	PLOS ONE			English	Article							14 RANDOMIZED-TRIALS; CARDIOVASCULAR-DISEASE; CHOLESTEROL; MANAGEMENT; GUIDELINES; EFFICACY; THERAPY	Background: Therapeutic intervention with low-density lipoprotein cholesterol-lowering agents known as statins has been demonstrated to reduce cardiovascular risk. However, many patients on statin treatment have persistent dyslipidemia and remain at a high risk of cardiovascular disease. Therefore, the objective of this study was to assess the frequency of lipid abnormalities in patients receiving chronic statin treatment. Methods: As part of an international, cross-sectional, observational study, DYSIS-Middle East enrolled 2,182 patients in the United Arab Emirates (UAE), Saudi Arabia, Lebanon and Jordan. All patients were over 45 years of age and had been on statin treatment for at least three months. Data on demographics, lipid parameters and cardiovascular risk profile were recorded. Cardiovascular risk was defined according the guidelines of the European Society of Cardiology. Results: The majority of patients (82.6%) were classified as being at very high risk of cardiovascular events, and 61.8% of all patients did not attain LDL-C target levels. Low high-density lipoprotein cholesterol levels and elevated triglyceride levels were noted in 55.5% and 48.5% of patients, respectively. Multivariate logistical regression modeling indicated that factors independently associated with LDL-C levels not being at goal were lifestyle choices, diabetes mellitus, ischemic heart disease, and blood pressure >= 140/90 mmHg. Conclusions: Almost two-thirds of statin-treated patients in the United Arab Emirates, Saudi Arabia, Lebanon and Jordan had inadequately controlled lipid levels. More comprehensive surveillance, awareness and treatment regimens, as well as modification of lifestyle choices, is necessary to halt the rise in cardiovascular disease-related mortality.	[Al Sifri, Saud N.] Al Hada Mil Hosp, Dept Endocrinol, At Taif, Saudi Arabia; [Almahmeed, Wael] Sheikh Khalifa Med City, Inst Cardiac Sci, Abu Dhabi, U Arab Emirates; [Azar, Sami] Amer Univ, Beirut Med Ctr, Beirut, Lebanon; [Okkeh, Osama] Istishari Hosp, Amman, Jordan; [Bramlage, Peter] Inst Pharmakol & Pravent Med, Mahlow, Germany; [Juenger, Claus] Inst Herzinfarktforsch, Ludwigshafen, Germany; [Juenger, Claus] Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55122 Mainz, Germany; [Halawa, Islam] MSD Saudi Arabia, Dept Med, Riyadh, Saudi Arabia; [Ambegaonkar, Baishali; Brudi, Philippe] Merck & Co Inc, Whitehouse Stn, NJ USA; [Wajih, Sameh] MSD United Arab Emirates, Dept Med, Abu Dhabi, U Arab Emirates	American University of Beirut; Beirut Medical Center; Institute Heart Attack Research; Johannes Gutenberg University of Mainz; Merck & Company	Al Sifri, SN (corresponding author), Al Hada Mil Hosp, Dept Endocrinol, At Taif, Saudi Arabia.	saudnafa@hotmail.com		Bramlage, Peter/0000-0003-4970-2110	Merck & Co Ltd (New Jersey, United States)	Merck & Co Ltd (New Jersey, United States)	This study was funded by Merck & Co Ltd (New Jersey, United States). The funders (Merck & Co Ltd) participated in the study design, but had no role in the data collection and analysis, decision to publish, or preparation of the manuscript. Data collection was done by local CROs, the analyses were prepared by the Institut fur Herzinfarktforschung (Ludwigshafen, Germany) and the manuscript prepared by Peter Bramlage. The authors Islam Halawa, Baishali Ambegaonkar, Sameh Wajih and Philippe Brudi revised the manuscript and complied with all ICMJE defined criteria for authorship.	Al-Baghli NA, 2010, J FAM COMMUNITY MED, V17, P15, DOI 10.4103/1319-1683.68784; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bandgar Tushar R, 2011, J Indian Med Assoc, V109, P549; BOUMEDJOUT H, 2012, NATURE MIDDLE E; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028; Cziraky MJ, 2009, J MANAGE CARE PHARM, V14, pS3; Deedwania P, 2006, LANCET, V368, P919, DOI 10.1016/S0140-6736(06)69292-1; Eber B, 2012, CURR MED RES OPIN, V28, P1447, DOI 10.1185/03007995.2012.717919; Gitt AK, 2012, EUR J PREV CARDIOL, V19, P221, DOI 10.1177/1741826711400545; Goff DC, 2006, CIRCULATION, V113, P647, DOI 10.1161/CIRCULATIONAHA.105.552737; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Ito MK, 2012, ANN PHARMACOTHER, V46, P1368, DOI 10.1345/aph.1R127; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kotseva K, 2008, ATHEROSCLEROSIS, V197, P710, DOI 10.1016/j.atherosclerosis.2007.07.004; Kotseva K., 2011, HEART METAB, V50, P32; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Moss M, 2003, CHEST, V123, P923, DOI 10.1378/chest.123.3.923; Nesto Richard W, 2005, Am J Cardiovasc Drugs, V5, P379, DOI 10.2165/00129784-200505060-00005; *ORG WH, 2011, LEB WHO NCD COUNTR P; *ORG WH, 2011, SAUD AR WHO NCD COUN; *ORG WH, 2012, CARD DIS CVDS FACT S; Perk J, 2012, INT J BEHAV MED; Ramahi TM, 2010, ASIA-PAC J PUBLIC HE, V22, p83S, DOI 10.1177/1010539510373034; Roberts WC, 1997, AM J CARDIOL, V80, P106, DOI 10.1016/S0002-9149(97)00298-1; Shara NM, 2010, NUTR METAB CARDIOVAS, V20, P412, DOI 10.1016/j.numecd.2010.01.013; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427	26	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84350	10.1371/journal.pone.0084350	http://dx.doi.org/10.1371/journal.pone.0084350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400085	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700019
J	Ezkurdia, N; Raurell, I; Rodriguez, S; Gonzalez, A; Esteban, R; Genesca, J; Martell, M				Ezkurdia, Nahia; Raurell, Imma; Rodriguez, Sarai; Gonzalez, Antonio; Esteban, Rafael; Genesca, Joan; Martell, Maria			Inhibition of Neuronal Apoptosis and Axonal Regression Ameliorates Sympathetic Atrophy and Hemodynamic Alterations in Portal Hypertensive Rats	PLOS ONE			English	Article							HYPERDYNAMIC SPLANCHNIC CIRCULATION; SIGNALING PATHWAYS; GROWTH-FACTOR; NITRIC-OXIDE; CELL-DEATH; VASODILATION; ACTIVATION; CONTRIBUTE; CIRRHOSIS; SURVIVAL	Background and Aim: A neuronal pathway participates in the development of portal hypertension: blockade of afferent sensory nerves in portal vein ligated (PVL) rats simultaneously prevents brain cardiovascular regularory nuclei activation, neuromodulator overexpression in superior mesenteric ganglia, sympathetic atrophy of mesenteric innervation and hemodynamic alterations. Here we investigated in PVL rats alterations in neuromodulators and signaling pathways leading to axonal regression or apoptosis in the superior mesenteric ganglia and tested the effects of the stimulation of neuronal proliferation/survival by using a tyrosine kinase receptor A agonist, gambogic amide. Results: The neuronal pathway was confirmed by an increased neuronal afferent activity at the vagal nodose ganglia and the presence of semaphorin3A in sympathetic pre-ganglionic neurons at the intermediolateral nucleus of the spinal cord of PVL rats. Expression of the active form of tyrosine kinase receptor A (phosphorylated), leading to proliferation and survival signaling, showed a significant reduction in PVL comparing to sham rats. In contrast, the apoptotic and axonal retraction pathways were stimulated in PVL, demonstrated by a significant overexpression of semaphorin 3A and its receptor neuropilin1, together with increases of cleaved caspase7, inactive poly(ADP-ribose) polymerase and Rho kinase expression. Finally, the administration of gambogic amide in PVL rats showed an amelioration of hemodynamic alterations and sympathetic atrophy, through the activation of survival pathways together with the inhibition of apoptotic cascades and Rho kinase mediated axonal regression. Conclusion: The adrenergic alteration and sympathetic atrophy in mesenteric vessels during portal hypertension is caused by alterations on neuromodulation leading to post-ganglionic sympathetic regression and apoptosis and contributing to splanchnic vasodilation.	[Ezkurdia, Nahia; Raurell, Imma; Rodriguez, Sarai; Gonzalez, Antonio; Esteban, Rafael; Genesca, Joan; Martell, Maria] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, VHIR, Dept Internal Med,Hepat Dis Lab,Liver Unit, E-08193 Barcelona, Spain; [Esteban, Rafael; Genesca, Joan] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III	Genesca, J (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron, VHIR, Dept Internal Med,Hepat Dis Lab,Liver Unit, E-08193 Barcelona, Spain.	jgenesca@vhebron.net	Martell, Maria/J-8191-2013; Genesca, Joan/H-7467-2019; Rodriguez Navarro, Sarai/C-4500-2014	Martell, Maria/0000-0002-0935-0029; Genesca, Joan/0000-0002-0831-8422; esteban, rafael/0000-0001-5280-392X; Rodriguez Navarro, Sarai/0000-0002-7489-4532	VHIR; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion (MICINN) [SAF2009-08354]; Instituto de Salud Carlos III (ISCIII-FIS) [PI12/01759]	VHIR; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III (ISCIII-FIS)(Instituto de Salud Carlos III)	Nahia Ezkurdia is a recipient of a pre-doctoral fellowship grant from the VHIR and is enrolled in the postgraduate program of the Universitat Autonoma de Barcelona. Imma Raurell is a recipient of a fellowship grant from the Instituto de Salud Carlos III. CIBERehd is supported by Instituto de Salud Carlos III. The study was funded by grants from Ministerio de Ciencia e Innovacion (MICINN) SAF2009-08354 and Instituto de Salud Carlos III (ISCIII-FIS) PI12/01759. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal JK, 2003, J NEUROSCI, V23, P7602; Ben-Zvi A, 2008, CELL SIGNAL, V20, P467, DOI 10.1016/j.cellsig.2007.10.023; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Coll M, 2008, J HEPATOL, V49, P43, DOI 10.1016/j.jhep.2008.03.015; Coll M, 2010, LIVER INT, V30, P593, DOI 10.1111/j.1478-3231.2009.02176.x; Ezkurdia N, 2012, LIVER INT, V32, P1295, DOI 10.1111/j.1478-3231.2012.02762.x; Fernandez M, 2005, J HEPATOL, V43, P98, DOI 10.1016/j.jhep.2005.02.022; Fernandez M, 2007, HEPATOLOGY, V46, P1208, DOI 10.1002/hep.21785; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Iwakiri Y, 2007, J HEPATOL, V46, P927, DOI 10.1016/j.jhep.2007.02.006; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEE SS, 1993, AM J PHYSIOL, V264, pG868, DOI 10.1152/ajpgi.1993.264.5.G868; Lievremont JP, 1999, J BIOL CHEM, V274, P15466, DOI 10.1074/jbc.274.22.15466; Liu H, 2008, GUT, V57, P966, DOI 10.1136/gut.2007.135020; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Nangle MR, 2011, BRIT J PHARMACOL, V162, P1083, DOI 10.1111/j.1476-5381.2010.01108.x; Naska S, 2010, MOL CELL NEUROSCI, V45, P108, DOI 10.1016/j.mcn.2010.05.015; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Shirvan A, 1999, J NEUROCHEM, V73, P961, DOI 10.1046/j.1471-4159.1999.0730961.x; Sobottka B, 2008, J NEUROCHEM, V107, P1294, DOI 10.1111/j.1471-4159.2008.05690.x; Song DS, 2002, HEPATOLOGY, V35, P159, DOI 10.1053/jhep.2002.30417; Tang XQ, 2004, J NEUROSCI, V24, P819, DOI 10.1523/JNEUROSCI.1263-03.2004; Teng KK, 2010, DEV NEUROBIOL, V70, P350, DOI 10.1002/dneu.20768; Tonges L, 2011, J MOL NEUROSCI, V45, P284, DOI 10.1007/s12031-011-9519-1; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	30	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84374	10.1371/journal.pone.0084374	http://dx.doi.org/10.1371/journal.pone.0084374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400086	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700020
J	Sun, K; Zhao, Y; Wang, HT; Sun, H				Sun, Kun; Zhao, Yu; Wang, Huating; Sun, Hao			Sebnif: An Integrated Bioinformatics Pipeline for the Identification of Novel Large Intergenic Noncoding RNAs (lincRNAs) - Application in Human Skeletal Muscle Cells	PLOS ONE			English	Article							GENOME ANNOTATION; REVEALS; SEQ; TRANSCRIPTOMES; VERTEBRATE; EVOLUTION; GENCODE	Ab initio assembly of transcriptome sequencing data has been widely used to identify large intergenic non-coding RNAs (lincRNAs), a novel class of gene regulators involved in many biological processes. To differentiate real lincRNA transcripts from thousands of assembly artifacts, a series of filtering steps such as filters of transcript length, expression level and coding potential, need to be applied. However, an easy-to-use and publicly available bioinformatics pipeline that integrates these filters is not yet available. Hence, we implemented sebnif, an integrative bioinformatics pipeline to facilitate the discovery of bona fide novel lincRNAs that are suitable for further functional characterization. Specifically, sebnif is the only pipeline that implements an algorithm for identifying high-quality single-exonic lincRNAs that were often omitted in many studies. To demonstrate the usage of sebnif, we applied it on a real biological RNA-seq dataset from Human Skeletal Muscle Cells (HSkMC) and built a novel lincRNA catalog containing 917 highly reliable lincRNAs. Sebnif is available at http://sunlab.lihs.cuhk.edu.hk/sebnif/.	[Sun, Kun; Sun, Hao] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China; [Zhao, Yu; Wang, Huating] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Sun, H (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Dept Chem Pathol, Hong Kong, Hong Kong, Peoples R China.	haosun@cuhk.edu.hk	Zhao, Yu/AAF-9618-2019; Sun, Hao/T-5576-2019; Sun, Kun/Q-6479-2018; sun, hao/GRS-7732-2022; Sun, Hao/J-9964-2013; Wang, Huating/C-6719-2014	Sun, Hao/0000-0002-5547-9501; Sun, Kun/0000-0002-9883-1616; Sun, Hao/0000-0002-5547-9501; Wang, Huating/0000-0001-5474-2905; Zhao, Yu/0000-0002-0349-7206	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China [CUHK 476310, CUHK 473211]	Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	The work described in this paper was substantially supported by the General Research Funds (GRF) o HW and HS from the Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China (Project Code: CUHK 476310 to HW and CUHK 473211 to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Giles PJ, 2003, BIOINFORMATICS, V19, P2254, DOI 10.1093/bioinformatics/btg311; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003; Lu LN, 2013, EMBO J, V32, P2575, DOI 10.1038/emboj.2013.182; Managadze D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002917; Mourier Tobias, 2009, Briefings in Functional Genomics & Proteomics, V8, P493, DOI 10.1093/bfgp/elp036; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; RIPLEY WNV, 2002, PLOS BIOL, V9; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Sun K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S2-S7; Sun L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-331; Team RDC, 2012, R LANG ENV STAT COMP; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Washietl S, 2012, WIRES RNA, V3, P759, DOI 10.1002/wrna.1134; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	33	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84500	10.1371/journal.pone.0084500	http://dx.doi.org/10.1371/journal.pone.0084500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400097	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700031
J	Caspi, Y				Caspi, Yaron			Deformation of Filamentous Escherichia coli Cells in a Microfluidic Device: A New Technique to Study Cell Mechanics	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; ACTIN-LIKE CYTOSKELETON; HIGH-SPEED AFM; BACTERIAL-CELLS; NANOMECHANICAL PROPERTIES; FTSZ POLYMERIZATION; STRESS-BEARING; SINGLE-CELL; SHAPE; SURFACE	The mechanical properties of bacterial cells are determined by their stress-bearing elements. The size of typical bacterial cells, and the fact that different time and length scales govern their behavior, necessitate special experimental techniques in order to probe their mechanical properties under various spatiotemporal conditions. Here, we present such an experimental technique to study cell mechanics using hydrodynamic forces in a microfluidic device. We demonstrate the application of this technique by calculating the flexural rigidity of non-growing Escherichia coli cells. In addition, we compare the deformation of filamentous cells under growing and non-growing conditions during the deformation process. We show that, at low forces, the force needed to deform growing cells to the same extent as non-growing cells is approximately two times smaller. Following previous works, we interpret these results as the outcome of the difference between the elastic response of non-growing cells and the plastic-elastic response of growing cells. Finally, we observe some heterogeneity in the response of individual cells to the applied force. We suggest that this results from the individuality of different bacterial cells.	Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University	Caspi, Y (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	Y.Caspi@tudelft.nl	Caspi, Yaron/O-2518-2016	Caspi, Yaron/0000-0003-0328-0186	US National Institutes of Health [P50 GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research work has been partly supported by the US National Institutes of Health www.nih.gov/(grant P50 GM068763). The submission of this article is, however, done without the support of any grant or funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir A, ARXIV13055843CONDMAT; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004; Cabeen MT, 2007, J CELL BIOL, V179, P381, DOI 10.1083/jcb.200708001; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Cerf A, 2009, LANGMUIR, V25, P5731, DOI 10.1021/la9004642; Chen YY, 2009, LANGMUIR, V25, P4607, DOI 10.1021/la8036346; DEBOER PAJ, 1990, P NATL ACAD SCI USA, V87, P1129, DOI 10.1073/pnas.87.3.1129; Deng Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.158101; Dombrowski C, 2009, BIOPHYS J, V96, P4409, DOI 10.1016/j.bpj.2009.02.066; Dufrene YF, 2004, NAT REV MICROBIOL, V2, P451, DOI 10.1038/nrmicro905; Dupres V, 2010, TRENDS MICROBIOL, V18, P397, DOI 10.1016/j.tim.2010.06.004; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Felgner H, 1996, J CELL SCI, V109, P509; Gaboriaud F, 2007, COLLOID SURFACE B, V54, P10, DOI 10.1016/j.colsurfb.2006.09.014; Gondret P, 1997, PHYS FLUIDS, V9, P1841, DOI 10.1063/1.869301; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Jiang HY, 2011, BIOPHYS J, V101, P327, DOI 10.1016/j.bpj.2011.06.005; Jiang HY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.028101; Katan AJ, 2011, CELL, V147, P979, DOI 10.1016/j.cell.2011.11.017; KOCH AL, 1988, MICROBIOL REV, V52, P337, DOI 10.1128/MMBR.52.3.337-353.1988; Lan GH, 2007, P NATL ACAD SCI USA, V104, P16110, DOI 10.1073/pnas.0702925104; Landau L., 1986, THEORY ELASTICITY CO; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Mukherjee A, 1998, P NATL ACAD SCI USA, V95, P2885, DOI 10.1073/pnas.95.6.2885; Mukhopadhyay R, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.062901; Nezhad AS, 2013, LAB CHIP, V13, P2599, DOI [10.1039/c3lc00012e, 10.1039/c31c00012e]; Pilizota T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035205; Pozrikidis C, 2011, INT J SOLIDS STRUCT, V48, P137, DOI 10.1016/j.ijsolstr.2010.09.012; Sliusarenko O, 2010, P NATL ACAD SCI USA, V107, P10086, DOI 10.1073/pnas.1000737107; Sullivan CJ, 2007, ULTRAMICROSCOPY, V107, P934, DOI 10.1016/j.ultramic.2007.04.017; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Takeuchi S, 2005, NANO LETT, V5, P1819, DOI 10.1021/nl0507360; Tuson HH, 2012, MOL MICROBIOL, V84, P874, DOI 10.1111/j.1365-2958.2012.08063.x; Vadillo-Rodriguez V, 2008, J BACTERIOL, V190, P4225, DOI 10.1128/JB.00132-08; Vadillo-Rodriguez V, 2009, J BACTERIOL, V191, P5518, DOI 10.1128/JB.00528-09; VENIER P, 1994, J BIOL CHEM, V269, P13353; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Wang SY, 2010, P NATL ACAD SCI USA, V107, P9182, DOI 10.1073/pnas.0911517107; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; Yamashita H, 2012, J MOL BIOL, V422, P300, DOI 10.1016/j.jmb.2012.05.018; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999; Yao ZZ, 2012, MOL CELL, V48, P705, DOI 10.1016/j.molcel.2012.09.016; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06	54	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83775	10.1371/journal.pone.0083775	http://dx.doi.org/10.1371/journal.pone.0083775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392095	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100019
J	Tivers, MS; Handel, I; Gow, AG; Lipscomb, VJ; Jalan, R; Mellanby, RJ				Tivers, Mickey S.; Handel, Ian; Gow, Adam G.; Lipscomb, Vicky J.; Jalan, Rajiv; Mellanby, Richard J.			Hyperammonemia and Systemic Inflammatory Response Syndrome Predicts Presence of Hepatic Encephalopathy in Dogs with Congenital Portosystemic Shunts	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; AMMONIA; DIAGNOSIS; CIRRHOSIS; HYPONATREMIA; PATHOGENESIS; IMPAIRMENT; GLUTAMINE; SEVERITY; MODELS	Hepatic encephalopathy (HE) is an important cause of morbidity and mortality in patients with liver disease. The pathogenesis of he is incompletely understood although ammonia and inflammatory cytokines have been implicated as key mediators. To facilitate further mechanistic understanding of the pathogenesis of HE, a large number of animal models have been developed which often involve the surgical creation of an anastomosis between the hepatic portal vein and the caudal vena cava. One of the most common congenital abnormalities in dogs is a congenital portosystemic shunt (cpss), which closely mimics these surgical experimental models of HE. Dogs with a cPSS often have clinical signs which mimic clinical signs observed in humans with HE. Our hypothesis is that the pathogenesis of HE in dogs with a cPSS is similar to humans with HE. The aim of the study was to measure a range of clinical, haematological and biochemical parameters, which have been linked to the development of HE in humans, in dogs with a cPSS and a known HE grade. One hundred and twenty dogs with a cPSS were included in the study and multiple regression analysis of clinical, haematological and biochemical variables revealed that plasma ammonia concentrations and systemic inflammatory response syndrome scores predicted the presence of HE. Our findings further support the notion that the pathogenesis of canine and human HE share many similarities and indicate that dogs with cPSS may be an informative spontaneous model of human HE. Further investigations on dogs with cPSS may allow studies on HE to be undertaken without creating surgical models of HE thereby allowing the number of large animals used in animal experimentation to be reduced.	[Tivers, Mickey S.; Lipscomb, Vicky J.] Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England; [Handel, Ian; Gow, Adam G.; Mellanby, Richard J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Handel, Ian; Gow, Adam G.; Mellanby, Richard J.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Jalan, Rajiv] UCL Med Sch, UCL Inst Liver & Digest Hlth, London, England; [Mellanby, Richard J.] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland	University of London; University of London Royal Veterinary College; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; University College London; University of Edinburgh	Mellanby, RJ (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland.	Richard.Mellanby@ed.ac.uk	Gow, Adam/H-6623-2019	Gow, Adam/0000-0002-4297-8870; Tivers, Michael/0000-0001-7047-9334; Mellanby, Richard John/0000-0002-3467-7007	BSAVA Petsavers; MRC [G0701742] Funding Source: UKRI; Medical Research Council [G0701742] Funding Source: researchfish	BSAVA Petsavers; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by BSAVA Petsavers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Khalek Ehab E, 2011, Arab J Gastroenterol, V12, P173, DOI 10.1016/j.ajg.2011.11.006; Amodio P, 2001, J HEPATOL, V35, P37, DOI 10.1016/S0168-8278(01)00129-5; Angeli P, 2006, HEPATOLOGY, V44, P1535, DOI 10.1002/hep.21412; Aronson LR, 1997, VET SURG, V26, P189, DOI 10.1111/j.1532-950X.1997.tb01483.x; Butterworth RF, 2009, LIVER INT, V29, P783, DOI 10.1111/j.1478-3231.2009.02034.x; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; COHN R, 1966, J LAB CLIN MED, V68, P195; Cordoba J, 2010, METAB BRAIN DIS, V25, P73, DOI 10.1007/s11011-010-9172-3; D'Anjou MA, 2004, VET RADIOL ULTRASOUN, V45, P424, DOI 10.1111/j.1740-8261.2004.04076.x; EICHLER M, 1962, J NERV MENT DIS, V134, P539, DOI 10.1097/00005053-196206000-00007; Felipo V, 2012, METAB BRAIN DIS, V27, P51, DOI 10.1007/s11011-011-9269-3; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Gerritzen-Bruning MJ, 2006, J VET INTERN MED, V20, P13, DOI 10.1892/0891-6640(2006)20[13:DVOFPA]2.0.CO;2; Gines P, 2008, HEPATOLOGY, V48, P1002, DOI 10.1002/hep.22418; Gow AG, 2012, METAB BRAIN DIS, V27, P227, DOI 10.1007/s11011-012-9278-x; Gow AG, 2010, J VET INTERN MED, V24, P90, DOI 10.1111/j.1939-1676.2009.0408.x; Guevara M, 2010, LIVER INT, V30, P1137, DOI 10.1111/j.1478-3231.2010.02293.x; Guevara M, 2009, AM J GASTROENTEROL, V104, P1382, DOI 10.1038/ajg.2009.293; Hauptman JG, 1997, VET SURG, V26, P393, DOI 10.1111/j.1532-950X.1997.tb01699.x; Holt DE, 2002, AM J VET RES, V63, P1167, DOI 10.2460/ajvr.2002.63.1167; Jover R, 2005, METAB BRAIN DIS, V20, P399, DOI 10.1007/s11011-005-7925-1; MADDISON JE, 1992, J VET INTERN MED, V6, P341, DOI 10.1111/j.1939-1676.1992.tb00367.x; Mas A, 2006, DIGESTION, V73, P86, DOI 10.1159/000089783; Meyer HP, 1999, METAB BRAIN DIS, V14, P103, DOI 10.1023/A:1020757730386; Nelson NC, 2011, VET RADIOL ULTRASOUN, V52, P498, DOI 10.1111/j.1740-8261.2011.01827.x; Normandin L, 2002, METAB BRAIN DIS, V17, P375, DOI 10.1023/A:1021970120965; Odeh M, 2007, EUR J CLIN INVEST, V37, P291, DOI 10.1111/j.1365-2362.2007.01778.x; Odeh M, 2005, ANN MED, V37, P603, DOI 10.1080/07853890500317414; Odeh M, 2004, LIVER INT, V24, P110, DOI 10.1111/j.1478-3231.2004.0894.x; Ong JP, 2003, AM J MED, V114, P188, DOI 10.1016/S0002-9343(02)01477-8; Pelander L, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-35; Poordad FF, 2007, ALIMENT PHARM THERAP, V25, P3, DOI 10.1111/j.1746-6342.2006.03215.x; Prakash R, 2010, NAT REV GASTRO HEPAT, V7, P515, DOI 10.1038/nrgastro.2010.116; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; ROTHUIZEN J, 1982, RES VET SCI, V33, P17, DOI 10.1016/S0034-5288(18)32352-X; Seguin B, 1999, VET RADIOL ULTRASOUN, V40, P251, DOI 10.1111/j.1740-8261.1999.tb00357.x; Sharma P, 2009, LIVER INT, V29, P1365, DOI 10.1111/j.1478-3231.2009.02067.x; Shawcross D, 2005, CELL MOL LIFE SCI, V62, P2295, DOI 10.1007/s00018-005-5089-0; Shawcross DL, 2007, METAB BRAIN DIS, V22, P125, DOI 10.1007/s11011-006-9042-1; Shawcross DI, 2008, HEPATOLOGY, V48, P1202, DOI 10.1002/hep.22474; Shawcross DL, 2004, J HEPATOL, V40, P247, DOI 10.1016/j.jhep.2003.10.016; Shawcross DL, 2005, METAB BRAIN DIS, V20, P169, DOI 10.1007/s11011-005-7205-0; Sterczer A, 1999, RES VET SCI, V66, P63, DOI 10.1053/rvsc.1998.0243; TABOADA J, 1995, VET CLIN N AM-SMALL, V25, P337, DOI 10.1016/S0195-5616(95)50030-0; Tobias KM, 2003, J AM VET MED ASSOC, V223, P1636, DOI 10.2460/javma.2003.223.1636; Watanabe M, 1997, PHARMACOL BIOCHEM BE, V57, P367, DOI 10.1016/S0091-3057(96)00305-X; White RN, 2003, VET RADIOL ULTRASOUN, V44, P514, DOI 10.1111/j.1740-8261.2003.tb00499.x; Wilkinson DJ, 2011, METAB BRAIN DIS, V26, P203, DOI 10.1007/s11011-011-9251-0; Winkler JT, 2003, J AM ANIM HOSP ASSOC, V39, P169, DOI 10.5326/0390169; Wright G, 2007, HEPATOLOGY, V45, P1517, DOI 10.1002/hep.21599; Ytrebo LM, 2006, AM J PHYSIOL-GASTR L, V291, pG373, DOI 10.1152/ajpgi.00440.2005; Zandvliet MMJM, 2007, J VET INTERN MED, V21, P215	52	32	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e82303	10.1371/journal.pone.0082303	http://dx.doi.org/10.1371/journal.pone.0082303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392080	Green Accepted, Green Published, gold			2022-12-27	WOS:000329460100004
J	Troxell, B; Zhang, JJ; Bourret, TJ; Zeng, MY; Blum, J; Gherardini, F; Hassan, HM; Yang, XF				Troxell, Bryan; Zhang, Jun-Jie; Bourret, Travis J.; Zeng, Melody Yue; Blum, Janice; Gherardini, Frank; Hassan, Hosni M.; Yang, X. Frank			Pyruvate Protects Pathogenic Spirochetes from H2O2 Killing	PLOS ONE			English	Article							EXPERIMENTAL LYME ARTHRITIS; A DISULFIDE REDUCTASE; NF-KAPPA-B; BORRELIA-BURGDORFERI; HYDROGEN-PEROXIDE; NITRIC-OXIDE; LEPTOSPIRA-INTERROGANS; ANAEROBIC METABOLISM; SUPEROXIDE-DISMUTASE; BLOOD PYRUVATE	Pathogenic spirochetes cause clinically relevant diseases in humans and animals, such as Lyme disease and leptospirosis. The causative agent of Lyme disease, Borrelia burgdorferi, and the causative agent of leptospirosis, Leptospria interrogans, encounter reactive oxygen species (ROS) during their enzootic cycles. This report demonstrated that physiologically relevant concentrations of pyruvate, a potent H2O2 scavenger, and provided passive protection to B. burgdorferi and L. interrogans against H2O2. When extracellular pyruvate was absent, both spirochetes were sensitive to a low dose of H2O2 (approximate to 0.6 mu M per h) generated by glucose oxidase (GOX). Despite encoding a functional catalase, L. interrogans was more sensitive than B. burgdorferi to H2O2 generated by GOX, which may be due to the inherent resistance of B. burgdorferi because of the virtual absence of intracellular iron. In B. burgdorferi, the nucleotide excision repair (NER) and the DNA mismatch repair (MMR) pathways were important for survival during H2O2 challenge since deletion of the uvrB or the mutS genes enhanced its sensitivity to H2O2 killing; however, the presence of pyruvate fully protected Delta uvrB and Delta mutS from H2O2 killing further demonstrating the importance of pyruvate in protection. These findings demonstrated that pyruvate, in addition to its classical role in central carbon metabolism, serves as an important H2O2 scavenger for pathogenic spirochetes. Furthermore, pyruvate reduced ROS generated by human neutrophils in response to the Toll-like receptor 2 (TLR2) agonist zymosan. In addition, pyruvate reduced neutrophil-derived ROS in response to B. burgdorferi, which also activates host expression through TLR2 signaling. Thus, pathogenic spirochetes may exploit the metabolite pyruvate, present in blood and tissues, to survive H2O2 generated by the host antibacterial response generated during infection.	[Troxell, Bryan; Zhang, Jun-Jie; Zeng, Melody Yue; Blum, Janice; Yang, X. Frank] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Bourret, Travis J.] Univ Nebraska Kearney, Dept Biol, Kearney, NE USA; [Hassan, Hosni M.] N Carolina State Univ, Dept Microbiol, Raleigh, NC 27695 USA; [Gherardini, Frank] NIAID, Lab Zoonot Pathogens, NIH, Hamilton, MT USA	Indiana University System; Indiana University Bloomington; University of Nebraska System; University of North Carolina; North Carolina State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hassan, HM (corresponding author), N Carolina State Univ, Prestage Dept Poultry Sci, Raleigh, NC 27695 USA.	hmhassan@ncsu.edu; xfyang@iupui.edu	zhang, junjie/P-2376-2015; Bourret, Travis/J-4673-2019	zhang, junjie/0000-0002-5108-2072; Troxell, Bryan/0000-0002-0533-6721; Hassan, Hosni/0000-0002-3076-9772; Bourret, Travis/0000-0002-4154-929X	NIH [R01 AI083640]; Lilly Endowment, Inc.; National Center for Research Resources [5P20RR016469]; National Institute for General Medical Science (NIGMS) [5P20GM103427]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016469, C06RR015481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000905, R01AI083640, T32AI060519, R01AI079065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lilly Endowment, Inc.; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for General Medical Science (NIGMS); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was partially provided by NIH grant R01 AI083640, Indiana INGEN and METACyt grants of Indiana University, funded by the Lilly Endowment, Inc. (to XFY), National Center for Research Resources (5P20RR016469) and the National Institute for General Medical Science (NIGMS) (5P20GM103427) (to TJB). A component of the National Institutes of Health (NIH) and its contents are the sole responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. BT and MYZ were supported by NIH T32 training grant 5T32AI060519. This investigation was partially conducted in a facility constructed with support from research facilities improvement program grant number C06 RR015481-01 from National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; AUSTIN FE, 1981, INFECT IMMUN, V33, P372, DOI 10.1128/IAI.33.2.372-379.1981; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; BEERS RF, 1952, J BIOL CHEM, V195, P133; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; Bourret TJ, 2011, MOL MICROBIOL, V81, P259, DOI 10.1111/j.1365-2958.2011.07691.x; Boylan JA, 2006, MOL MICROBIOL, V59, P475, DOI 10.1111/j.1365-2958.2005.04963.x; Boylan JA, 2008, MOL MICROBIOL, V68, P786, DOI 10.1111/j.1365-2958.2008.06204.x; Brown CR, 1999, J INFECT DIS, V179, P1573, DOI 10.1086/314774; Brown CR, 2004, INFECT IMMUN, V72, P4956, DOI 10.1128/IAI.72.9.4956-4965.2004; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burritt JB, 2001, J BIOL CHEM, V276, P2053, DOI 10.1074/jbc.M006236200; Campbell JA, 1931, PHYSIOL REV, V11, P1; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Crandall H, 2005, AM J PATHOL, V167, P775, DOI 10.1016/S0002-9440(10)62050-0; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dai JF, 2009, CELL HOST MICROBE, V6, P482, DOI 10.1016/j.chom.2009.10.006; Debray FG, 2007, CLIN CHEM, V53, P916, DOI 10.1373/clinchem.2006.081166; DECHATELET LR, 1982, J IMMUNOL, V129, P1589; Desagher S, 1997, J NEUROSCI, V17, P9060; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eggers CH, 2011, MOL MICROBIOL, V82, P679, DOI 10.1111/j.1365-2958.2011.07845.x; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Eshghi A, 2012, INFECT IMMUN, V80, P3892, DOI 10.1128/IAI.00466-12; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; FAINE S, 1959, J GEN MICROBIOL, V20, P246, DOI 10.1099/00221287-20-2-246; Fang FC, 2011, MBIO, V2, DOI 10.1128/mBio.00141-11; Fedotcheva NI, 2006, FREE RADICAL BIO MED, V41, P56, DOI 10.1016/j.freeradbiomed.2006.02.012; FETTIPLACE R, 1978, BIOCHIM BIOPHYS ACTA, V513, P1, DOI 10.1016/0005-2736(78)90106-2; FIALKOW L, 1994, J BIOL CHEM, V269, P31234; Frank KL, 2003, J BACTERIOL, V185, P6723, DOI 10.1128/JB.185.22.6723-6727.2003; FULTON JD, 1960, BIOCHEM J, V76, P491, DOI 10.1042/bj0760491; Giandomenico AR, 1997, FREE RADICAL BIO MED, V23, P426, DOI 10.1016/S0891-5849(97)00113-5; GILBERT VE, 1968, METABOLISM, V17, P943, DOI 10.1016/0026-0495(68)90162-5; Gore DC, 1996, ANN SURG, V224, P97, DOI 10.1097/00000658-199607000-00015; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hardy PO, 2013, J BACTERIOL, V195, P2220, DOI 10.1128/JB.00043-13; Henard CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00084; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Holleman AF, 1904, RECL TRAV CH PAYS-BA, V23, P169; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; HUCKABEE WE, 1958, J CLIN INVEST, V37, P264, DOI 10.1172/JCI103605; HUCKABEE WE, 1958, J CLIN INVEST, V37, P244, DOI 10.1172/JCI103603; HUCKABEE WE, 1958, J CLIN INVEST, V37, P255, DOI 10.1172/JCI103604; HUGHES CAN, 1992, J CLIN MICROBIOL, V30, P698, DOI 10.1128/JCM.30.3.698-703.1992; Hyde JA, 2010, INFECT IMMUN, V78, P265, DOI 10.1128/IAI.01018-09; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; JOHNSON RC, 1973, APPL MICROBIOL, V26, P118, DOI 10.1128/AEM.26.1.118-119.1973; Jozsef L, 2003, FREE RADICAL BIO MED, V35, P1018, DOI 10.1016/S0891-5849(03)00439-8; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; KELLY R, 1971, SCIENCE, V173, P443, DOI 10.1126/science.173.3995.443; KRIEG NR, 1986, ANNU REV MICROBIOL, V40, P107, DOI 10.1146/annurev.micro.40.1.107; LANDON J, 1962, J CLIN PATHOL, V15, P579, DOI 10.1136/jcp.15.6.579; Li X, 2007, MOL MICROBIOL, V63, P694, DOI 10.1111/j.1365-2958.2006.05550.x; Lusitani D, 2002, J INFECT DIS, V185, P797, DOI 10.1086/339341; MARGOLIS SA, 1986, ANAL CHEM, V58, P2504, DOI 10.1021/ac00125a033; Mathioudakis D, 2011, AMINO ACIDS, V40, P1077, DOI 10.1007/s00726-010-0731-z; Menten-Dedoyart C, 2012, J IMMUNOL, V189, P5393, DOI 10.4049/jimmunol.1103771; Mik EG, 2004, J APPL PHYSIOL, V97, P1962, DOI 10.1152/japplphysiol.01399.2003; Narasimhan S, 2007, CELL HOST MICROBE, V2, P7, DOI 10.1016/j.chom.2007.06.001; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; NATH KA, 1994, KIDNEY INT, V45, P166, DOI 10.1038/ki.1994.20; NORROD EP, 1982, J CLIN MICROBIOL, V15, P103, DOI 10.1128/JCM.15.1.103-108.1982; ODONNELLTORMEY J, 1987, J EXP MED, V165, P500, DOI 10.1084/jem.165.2.500; OHNO Y, 1985, J BIOL CHEM, V260, P8438; PINE L, 1986, J CLIN MICROBIOL, V23, P33, DOI 10.1128/JCM.23.1.33-42.1986; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Ramakrishnan N, 1998, FREE RADICAL RES, V29, P283, DOI 10.1080/10715769800300321; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; RAO PJ, 1964, J BACTERIOL, V88, P1045, DOI 10.1128/JB.88.4.1045-1048.1964; Ritzman AM, 2010, INFECT IMMUN, V78, P4593, DOI 10.1128/IAI.00798-10; ROOT RK, 1975, J CLIN INVEST, V55, P945, DOI 10.1172/JCI108024; SALAHUDEEN AK, 1991, J CLIN INVEST, V88, P1886, DOI 10.1172/JCI115511; Sambir M, 2011, FEMS MICROBIOL LETT, V317, P172, DOI 10.1111/j.1574-6968.2011.02226.x; Samuels D S, 1995, Methods Mol Biol, V47, P253; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Schuijt TJ, 2008, INFECT IMMUN, V76, P2888, DOI 10.1128/IAI.00232-08; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Seshu J, 2004, MOL MICROBIOL, V54, P1352, DOI 10.1111/j.1365-2958.2004.04352.x; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; STERLING CR, 1981, VET PATHOL, V18, P628, DOI 10.1177/030098588101800508; THOMPSON TL, 1951, J BACTERIOL, V62, P39, DOI 10.1128/JB.62.1.39-44.1951; Tian W, 2008, BLOOD, V112, P3867, DOI 10.1182/blood-2007-11-126029; Troxell B, 2012, J BIOL CHEM, V287, P19284, DOI 10.1074/jbc.M112.344903; VasquezVivar J, 1997, CHEM RES TOXICOL, V10, P786, DOI 10.1021/tx970031g; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; VLESSIS AA, 1990, BIOCHEM BIOPH RES CO, V170, P1281, DOI 10.1016/0006-291X(90)90532-R; XIANG TX, 1994, J MEMBRANE BIOL, V140, P111; Xu QL, 2007, J IMMUNOL, V178, P5109, DOI 10.4049/jimmunol.178.8.5109; Xue F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000857; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Zouki C, 2001, J LEUKOCYTE BIOL, V69, P815	97	32	33	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84625	10.1371/journal.pone.0084625	http://dx.doi.org/10.1371/journal.pone.0084625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392147	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100070
J	Banke-Thomas, AO; Kouraogo, SF; Siribie, A; Taddese, HB; Mueller, JE				Banke-Thomas, Aduragbemi O.; Kouraogo, Salam F.; Siribie, Aboubacar; Taddese, Henock B.; Mueller, Judith E.			Knowledge of Obstetric Fistula Prevention amongst Young Women in Urban and Rural Burkina Faso: A Cross-Sectional Study	PLOS ONE			English	Article							HEALTH	Obstetric fistula is a sequela of complicated labour, which, if untreated, leaves women handicapped and socially excluded. In Burkina Faso, incidence of obstetric fistula is 6/10,000 cases amongst gynaecological patients, with more patients affected in rural areas. This study aims to evaluate knowledge on obstetric fistula among young women in a health district of Burkina Faso, comparing rural and urban communities. This cross-sectional study employed multi-stage sampling to include 121 women aged 18-20 years residing in urban and rural communities of Boromo health district. Descriptive statistics and multiple logistic regression analysis were used to compare differences between the groups and to identify predictors of observed knowledge levels. Rural women were more likely to be married (p<0.000) and had higher propensity to teenage pregnancy (p=0.006). The survey showed overall poor obstetric fistula awareness (36%). Rural residents were less likely to have adequate preventive knowledge than urban residents [OR=0.35 (95%-CI, 0.16-0.79)]. This effect was only slightly explained by lack of education [OR=0.41 (95%-CI, 0.18-0.93)] and only slightly underestimated due to previous pregnancy [OR=0.27 (95%-CI, 0.09-0.79)]. Media were the most popular source of awareness amongst urban young women in contrast to their rural counterparts (68% vs. 23%). Most rural young women became 'aware' through word-of-mouth (68% vs. 14%). All participants agreed that the hospital was safer for emergency obstetric care, but only 11.0% believed they could face pregnancy complications that would require emergency treatment. There is urgent need to increase emphasis on neglected health messages such as the risks of obstetric fistula. In this respect, obstetric fistula prevention programs need to be adapted to local contexts, whether urban or rural, and multi-sectoral efforts need to be exerted to maximise use of other sectoral resources and platforms, including existing routine health services and schools, to ensure sustainability of health literacy efforts.	[Banke-Thomas, Aduragbemi O.] Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool L3 5QA, Merseyside, England; [Banke-Thomas, Aduragbemi O.; Mueller, Judith E.] Ecole Hautes Etud Sante Publ, Epidemiol & Biostat Dept, Rennes, Bretagne, France; [Kouraogo, Salam F.; Siribie, Aboubacar] Dist Hosp, Ctr Med Avec Antenne Chirurg, Dept Surg, Boromo, Boucle Du Mouho, Burkina Faso; [Banke-Thomas, Aduragbemi O.; Taddese, Henock B.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	Liverpool School of Tropical Medicine; University of Liverpool; University of Sheffield	Banke-Thomas, AO (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool L3 5QA, Merseyside, England.	a.banke-thomas@liverpool.ac.uk	Banke-Thomas, Aduragbemi/AAM-5463-2020	Banke-Thomas, Aduragbemi/0000-0002-4449-0131				Agha S, 2002, INT FAM PLAN PERSPEC, V28, P151, DOI 10.2307/3088258; Ahmed S, 2011, HLTH FERTILITY STUDY; Ahmed S, 2013, GLOB HEALTH-SCI PRAC, V1, P262, DOI 10.9745/GHSP-D-13-00002; Bangser M, 2006, LANCET, V367, P535, DOI 10.1016/S0140-6736(06)68188-9; Barnett V., 2002, SAMPLE SURVEY PRINCI, Vthird; Boucle du Mouhoun DRS, 2012, PRES GEN REG SAN; Brady M, 2007, ADOLESCENCE FILLES B; Capes T, 2011, MT SINAI J MED, V78, P352, DOI 10.1002/msj.20265; Cook RJ, 2004, INT J GYNECOL OBSTET, V87, P72, DOI 10.1016/j.ijgo.2004.07.005; Cutler David., 2006, NATL BUREAU EC RES W; de Bernis L, 2007, INT J GYNECOL OBSTET, V99, pS117, DOI 10.1016/j.ijgo.2007.06.032; de Dedougou CHR, 2011, BUDGET CAMPAGNE CURE; de la justice Ministere, 1989, COD PERS FAM, P24; EFE-Burkina, 2012, MISS NOV 2012 RAPAP; GORGEN R, 1993, STUD FAMILY PLANN, V24, P283, DOI 10.2307/2939222; Hassan MA, 2009, ANN AFR MED, V8, P122, DOI 10.4103/1596-3519.56241; Hilton P, 2003, INT J GYNECOL OBSTET, V82, P285, DOI 10.1016/S0020-7292(03)00222-4; INSD, 2007, RES PREL REC GEN POP; INSD ICF International, 2010, ENQ DEM SANT IND MUL; Kalembo F, 2012, ARTS SOC SCI J, V2012; Kishk Nahla A, 2002, J Egypt Public Health Assoc, V77, P479; Konje JC, 2000, AM J CLIN NUTR, V72, p291S, DOI 10.1093/ajcn/72.1.291S; Lule E, 2003, ACHIEVING MILLENIUM; Montez D.., 2011, FAMILY PLANNING MATE; Mueller JE, 2011, J INFECT DIS, V204, P1787, DOI 10.1093/infdis/jir623; Paris 21, 2004, RAPP ET PAYS BURK FA; Plummer ML, 2007, HEALTH EDUC RES, V22, P500, DOI 10.1093/her/cyl103; Ridde V, 2011, HEALTH POLICY PLANN, V26, pII30, DOI 10.1093/heapol/czr060; Shefren JM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.03.008; Slinger G, 2011, PREVENTING OBSTET FI; Stanton C, 2007, INT J GYNECOL OBSTET, V99, pS4, DOI 10.1016/j.ijgo.2007.06.010; Tebeu PM, 2012, INT UROGYNECOL J, V23, P387, DOI 10.1007/s00192-011-1622-x; Tebeu PM, 2009, INT J GYNECOL OBSTET, V107, P12, DOI 10.1016/j.ijgo.2009.05.019; UNFPA, 2009, PROGR LUTT FIST OBST; UNFPA, 2012, MARR TOO YOUNG END C; UNFPA, 2012, PROGR NAT LUTT FIST, P2011; UNFPA and EngenderHealth, 2003, OBST FIST NEEDS ASS; UNFPA DSF, 2004, AN PRIS CHARG FIST U; Vangeenderhuysen C, 2001, AFRICA INT J GYNECOL, V73, P65, DOI [10.1016/S0020-7292(00)00374-X, DOI 10.1016/S0020-7292(00)00374-X]; Wall LL, 2012, OBSTET GYNECOL SURV, V67, P111, DOI 10.1097/OGX.0b013e3182438788; Wanyonyi KL, 2011, PATIENT EDUC COUNS, V85, P348, DOI 10.1016/j.pec.2011.02.006; WHEC, 2013, GLOB EFF END OBST 1; Zhang Y, 2006, COMP EDUC REV, V50, P581, DOI 10.1086/507056; Zhao Qi, 2009, BMC Womens Health, V9, P5, DOI 10.1186/1472-6874-9-5	44	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85921	10.1371/journal.pone.0085921	http://dx.doi.org/10.1371/journal.pone.0085921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24392032	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000329323900176
J	Borg, R; Cauchi, RJ				Borg, Rebecca; Cauchi, Ruben J.			The Gemin Associates of Survival Motor Neuron Are Required for Motor Function in Drosophila	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; NUCLEAR RIBONUCLEOPROTEIN BIOGENESIS; DEAD-BOX PROTEIN; SMN COMPLEX; MESSENGER-RNA; U-BODIES; SNRNP BIOGENESIS; CIRCUIT FUNCTION; INTERACTION MAP; AXON OUTGROWTH	Membership of the survival motor neuron (SMN) complex extends to nine factors, including the SMN protein, the product of the spinal muscular atrophy (SMA) disease gene, Gemins 2-8 and Unrip. The best-characterised function of this macromolecular machine is the assembly of the Sm-class of uridine-rich small nuclear ribonucleoprotein (snRNP) particles and each SMN complex member has a key role during this process. So far, however, only little is known about the function of the individual Gemin components in vivo. Here, we make use of the Drosophila model organism to uncover loss-of-function phenotypes of Gemin2, Gemin3 and Gemin5, which together with SMN form the minimalistic fly SMN complex. We show that ectopic overexpression of the dead helicase Gem3(Delta N) mutant or knockdown of Gemin3 result in similar motor phenotypes, when restricted to muscle, and in combination cause lethality, hence suggesting that Gem3(Delta N) overexpression mimics a loss-of-function. Based on the localisation pattern of Gem3(Delta N), we predict that the nucleus is the primary site of the antimorphic or dominant-negative mechanism of Gem3(Delta N)-mediated interference. Interestingly, phenotypes induced by human SMN overexpression in Drosophila exhibit similarities to those induced by overexpression of Gem3(Delta N). Through enhanced knockdown we also uncover a requirement of Gemin2, Gemin3 and Gemin5 for viability and motor behaviour, including locomotion as well as flight, in muscle. Notably, in the case of Gemin3 and Gemin5, such function also depends on adequate levels of the respective protein in neurons. Overall, these findings lead us to speculate that absence of any one member is sufficient to arrest the SMN-Gemins complex function in a nucleocentric pathway, which is critical for motor function in vivo.	[Borg, Rebecca; Cauchi, Ruben J.] Univ Malta, Dept Physiol & Biochem, Msida, Malta; [Borg, Rebecca] Univ Malta, Dept Appl Biomed Sci, Msida, Malta	University of Malta; University of Malta	Cauchi, RJ (corresponding author), Univ Malta, Dept Physiol & Biochem, Msida, Malta.	ruben.cauchi@um.edu.mt		Cauchi, Ruben/0000-0001-6150-1608	University of Malta [PHBRP09, MDSIN08-24]; Malta Council for Science & Technology through the National Research & Innovation Programme [RI-2012-066]	University of Malta; Malta Council for Science & Technology through the National Research & Innovation Programme	This work was supported by the University of Malta (PHBRP09; MDSIN08-24) and the Malta Council for Science & Technology through the National Research & Innovation Programme 2012 (R&I-2012-066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstead LL, 2007, GENE DEV, V21, P1086, DOI 10.1101/gad.1535607; Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Baumer D, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001523; Baumer D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000773; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; Briese M, 2005, BIOESSAYS, V27, P946, DOI 10.1002/bies.20283; Buckingham M, 2011, EXP CELL RES, V317, P2835, DOI 10.1016/j.yexcr.2011.09.001; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burt Emma C., 2006, Invertebrate Neuroscience, V6, P145, DOI 10.1007/s10158-006-0027-x; Campbell L, 2000, HUM MOL GENET, V9, P1093, DOI 10.1093/hmg/9.7.1093; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Cauchi RJ, 2006, NEURODEGENER DIS, V3, P338, DOI 10.1159/000097303; Cauchi Ruben J, 2012, BMC Res Notes, V5, P120, DOI 10.1186/1756-0500-5-120; Cauchi RJ, 2011, CELL BIOL INT, V35, P1233, DOI 10.1042/CBI20110147; Cauchi RJ, 2010, BIOESSAYS, V32, P1077, DOI 10.1002/bies.201000088; Cauchi RJ, 2010, EXP CELL RES, V316, P2354, DOI 10.1016/j.yexcr.2010.05.001; Cauchi RJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000265; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Crivat G, 2012, TRENDS BIOTECHNOL, V30, P8, DOI 10.1016/j.tibtech.2011.08.002; Dickinson M, 2006, CURR BIOL, V16, pR309, DOI 10.1016/j.cub.2006.03.087; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; Fallini C, 2011, J NEUROSCI, V31, P3914, DOI 10.1523/JNEUROSCI.3631-10.2011; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fierro-Monti I, 2006, J PROTEOME RES, V5, P1367, DOI 10.1021/pr0504539; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gates J, 2004, DEVELOPMENT, V131, P25, DOI 10.1242/dev.00920; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grice SJ, 2011, BIOESSAYS, V33, P956, DOI 10.1002/bies.201100082; Grice SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002030; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Guruharsha KG, 2012, FLY, V6, P246, DOI 10.4161/fly.22108; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Imlach WL, 2012, CELL, V151, P427, DOI 10.1016/j.cell.2012.09.011; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; Klowden M.J., 2007, PHYSL SYSTEMS INSECT; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Kolb SJ, 2010, MUSCLE NERVE, V41, P5, DOI 10.1002/mus.21428; Kroiss M, 2008, P NATL ACAD SCI USA, V105, P10045, DOI 10.1073/pnas.0802287105; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Lee L, 2009, DEV BIOL, V332, P142, DOI 10.1016/j.ydbio.2009.05.553; Lemmens R, 2010, TRENDS NEUROSCI, V33, P249, DOI 10.1016/j.tins.2010.02.003; Liu JL, 2007, P NATL ACAD SCI USA, V104, P11655, DOI 10.1073/pnas.0704977104; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1998, NAT GENET, V19, P63, DOI 10.1038/ng0598-63; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; McWhorter ML, 2008, DEV NEUROBIOL, V68, P182, DOI 10.1002/dneu.20582; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Miguel-Aliaga I, 2000, FEBS LETT, V486, P99, DOI 10.1016/S0014-5793(00)02243-2; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; MULLER H. J., 1932, Proceedings. 6th Int. Congr. Genet., V1, P213; Murashov AK, 2007, FASEB J, V21, P656, DOI 10.1096/fj.06-6155com; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pacheco A, 2009, NUCLEIC ACIDS RES, V37, P582, DOI 10.1093/nar/gkn979; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Praveen K, 2012, CELL REPORTS, V1, P624, DOI 10.1016/j.celrep.2012.05.014; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; Sen A, 2013, P NATL ACAD SCI USA, V110, pE2371, DOI 10.1073/pnas.1301738110; Sheean RK, 2013, DROSOPHILA MELANOGAS, P1; Shpargel KB, 2009, MOL BIOL CELL, V20, P90, DOI 10.1091/mbc.E08-01-0024; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Takaku M, 2011, BIOCHEMISTRY-US, V50, P6797, DOI 10.1021/bi200828g; Takizawa Y, 2010, NUCL ACIDS RES; Taylor MV, 2006, MUSCLE DEV DROSOPHIL; Timmerman C, 2012, BRAIN RES, V1489, P66, DOI 10.1016/j.brainres.2012.10.035; Todd AG, 2010, BIOCHEM BIOPH RES CO, V397, P479, DOI 10.1016/j.bbrc.2010.05.139; Todd AG, 2010, BIOCHEM BIOPH RES CO, V394, P211, DOI 10.1016/j.bbrc.2010.02.158; Vigoreaux JO, 2006, MUSCLE DEV DROSOPHIL; Walker MP, 2008, HUM MOL GENET, V17, P3399, DOI 10.1093/hmg/ddn234; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Workman E, 2012, BRAIN RES, V1462, P93, DOI 10.1016/j.brainres.2012.02.051; Workman E, 2009, HUM MOL GENET, V18, P2215, DOI 10.1093/hmg/ddp157; Wu YL, 2010, CELL CYCLE, V9, P4080, DOI 10.4161/cc.9.20.13667; Yan XM, 2003, MOL CELL BIOL, V23, P414, DOI 10.1128/MCB.23.1.414-423.2003; Yong J, 2010, MOL CELL, V38, P551, DOI 10.1016/j.molcel.2010.03.014; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zhang RD, 2011, CELL, V146, P384, DOI 10.1016/j.cell.2011.06.043; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	96	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83878	10.1371/journal.pone.0083878	http://dx.doi.org/10.1371/journal.pone.0083878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391840	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200138
J	Donati, S; Satolli, R; Colombo, C; Senatore, S; Cotichini, R; Da Cas, R; Alegiani, SS; Mosconi, P				Donati, Serena; Satolli, Roberto; Colombo, Cinzia; Senatore, Sabrina; Cotichini, Rodolfo; Da Cas, Roberto; Alegiani, Stefania Spila; Mosconi, Paola			Informing Women on Menopause and Hormone Therapy: Know the Menopause a Multidisciplinary Project Involving Local Healthcare System	PLOS ONE			English	Article								Background: Hormone therapy (HT) in the menopause is still a tricky question among healthcare providers, women and mass media. Informing women about hormone replacement therapy was a Consensus Conference (CC) organized in 2008: the project Know the Menopause has been launched to shift out the results to women and healthcare providers and to assess the impact of the cc's statement. Methods: And Findings: The project, aimed at women aged 45-60 years, was developed in four Italian Regions: Lombardy, Tuscany, Lazio, Sicily, each with one Local Health Unit (LHU) as "intervention" and one as "control". Activities performed were: survey on the press; training courses for health professionals; educational materials for target populations; survey aimed at women, general practitioners (GPs), and gynaecologists; data analysis on HT drugs' prescription. Local activities were: training courses; public meetings; dissemination on mass media. About 3,700 health professionals were contacted and 1,800 participated in the project. About 146,500 printed leaflets on menopause were distributed to facilitate the dialogue among women and health care professionals. Training courses and educational cascade-process activities: participation ranged 25-72% of GPs, 17-71% of gynaecologists, 14-78% of pharmacists, 34-85% of midwives. Survey: 1,281 women interviewed. More than 90% believed menopause was a normal phase in life. More than half did not receive information about menopause and therapies. HT prescription analysis: prevalence fell from 6% to 4% in five years. No differences in time trends before-after the intervention. Major limitations are: organizational difficulties met by LHU, too short time for some local activities. Conclusions: A huge amount of information was spread through health professionals and women. The issue of menopause was also used to discuss women's wellbeing. This project offered an opportunity to launch a multidisciplinary, multimodal approach to menopause looking not only at pharmacological aspects, but also at quality of life and information.	[Donati, Serena; Senatore, Sabrina; Cotichini, Rodolfo; Da Cas, Roberto; Alegiani, Stefania Spila] Ist Super Sanita, Ctr Nazl Epidemiol Sorveglianza & Promoz Salute, I-00161 Rome, Italy; [Satolli, Roberto] Agenzia Editoria Sci Zadig, Milan, Italy; [Colombo, Cinzia; Mosconi, Paola] IRCCS, Ist Ric Farmacol Mario Negri, Lab Med Res & Consumers Involvement, Milan, Italy	Istituto Superiore di Sanita (ISS); Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Mosconi, P (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, Lab Med Res & Consumers Involvement, Milan, Italy.	paola.mosconi@marionegri.it	Colombo, Cinzia/K-8981-2016; Paola, Mosconi/K-5596-2016; COLOMBO, CINZIA/ABG-6433-2020	Colombo, Cinzia/0000-0001-6639-694X; Paola, Mosconi/0000-0003-0415-3744; COLOMBO, CINZIA/0000-0001-6639-694X; Donati, Serena/0000-0002-4607-2072	Italian Agency for Drugs (AIFA)	Italian Agency for Drugs (AIFA)	This work was supported by the Italian Agency for Drugs (AIFA) in the context of a multi-regional project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a; Colombo C, 2010, EUR J OBSTET GYN R B, V153, P56, DOI 10.1016/j.ejogrb.2010.07.026; de Villiers TJ, 2013, CLIMACTERIC, V16, P203, DOI 10.3109/13697137.2013.771520; Donati S, 2009, MATURITAS, V63, P246, DOI 10.1016/j.maturitas.2009.04.001; Guallar E, 2013, ANN INTERN MED, V158, P69, DOI 10.7326/0003-4819-158-1-201301010-00015; Mosconi P, 2010, OBSTET GYNECOL, V116, P442, DOI 10.1097/AOG.0b013e3181eb539c; Mosconi Paola, 2009, BMC Womens Health, V9, P14, DOI 10.1186/1472-6874-9-14; Mosconi P, 2009, CANCER J, V15, P344, DOI 10.1097/PPO.0b013e3181b282c2; Moyer VA, 2013, ANN INTERN MED, V158, P47, DOI 10.7326/0003-4819-158-1-201301010-00553; NELSON HD, 2012, ANN INTERN MED, V157, pW1; Nelson HD, 2012, ANN INTERN MED, V157, P104, DOI 10.7326/0003-4819-157-2-201207170-00466; Pal L, 2012, MENOPAUSE, V19, P597, DOI 10.1097/gme.0b013e31825397f0; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409	13	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85121	10.1371/journal.pone.0085121	http://dx.doi.org/10.1371/journal.pone.0085121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391988	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900131
J	Garofalo, C; Capristo, M; Manara, MC; Mancarella, C; Landuzzi, L; Belfiore, A; Lollini, PL; Picci, P; Scotlandi, K				Garofalo, Cecilia; Capristo, Mariantonietta; Manara, Maria Cristina; Mancarella, Caterina; Landuzzi, Lorena; Belfiore, Antonino; Lollini, Pier-Luigi; Picci, Piero; Scotlandi, Katia			Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug	PLOS ONE			English	Article							INSULIN-RECEPTOR ISOFORM; HUMAN OSTEOSARCOMA CELLS; EWINGS-SARCOMA; BREAST-CANCER; P-GLYCOPROTEIN; METASTATIC ABILITY; INDUCIBLE FACTOR; AMPK ACTIVATION; IN-VITRO; GROWTH	Metformin, a well-known insulin-sensitizer commonly used for type 2 diabetes therapy, has recently emerged as potentially very attractive drug also in oncology. It is cheap, it is relatively safe and many reports have indicated effects in cancer prevention and therapy. These desirable features are particularly interesting for pediatric sarcomas, a group of rare tumors that have been shown to be dependent on IGF and insulin system for pathogenesis and progression. Metformin exerts anti-mitogenic activity in several cancer histotypes through several molecular mechanisms. In this paper, we analyzed its effects against osteosarcoma, Ewing sarcoma and rhabdomyosarcoma, the three most common pediatric sarcomas. Despite in vitro metformin gave remarkable antiproliferative and chemosensitizing effects both in sensitive and chemoresistant cells, its efficacy was not confirmed against Ewing sarcoma xenografts neither as single agent nor in combination with vincristine. This discrepancy between in vitro and in vivo effects may be due to hypoxia, a common feature of solid tumors. We provide evidences that in hypoxia conditions metformin was not able to activate AMPK and inhibit mTOR signaling, which likely prevents the inhibitory effects of metformin on tumor growth. Thus, although metformin may be considered a useful complement of conventional chemotherapy in normoxia, its therapeutic value in highly hypoxic tumors may be more limited. The impact of hypoxia should be considered when novel therapies are planned for pediatric sarcomas.	[Garofalo, Cecilia; Capristo, Mariantonietta; Manara, Maria Cristina; Mancarella, Caterina; Scotlandi, Katia] Rizzoli Orthoped Inst, CRS Dev Biomol Therapies, Expt Oncol Lab, Bologna, Italy; [Landuzzi, Lorena; Picci, Piero] Rizzoli Orthoped Inst, Expt Oncol Lab, Bologna, Italy; [Belfiore, Antonino] Univ Catanzaro, Dept Hlth, Catanzaro, Italy; [Lollini, Pier-Luigi] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy	IRCCS Istituto Ortopedico Rizzoli; IRCCS Istituto Ortopedico Rizzoli; Magna Graecia University of Catanzaro; University of Bologna	Scotlandi, K (corresponding author), Rizzoli Orthoped Inst, CRS Dev Biomol Therapies, Expt Oncol Lab, Bologna, Italy.	katia.scotlandi@ior.it	Belfiore, Antonino/B-4652-2011; Garofalo, Cecilia/B-3834-2017; Landuzzi, Lorena/J-6511-2016; Scotlandi, Katia/J-9009-2016; Capristo, Mariantonietta/K-7627-2016; Manara, Maria Cristina/K-3366-2018; Mancarella, Caterina/C-7463-2019; Lollini, Pier Luigi/A-7644-2008; Picci, Piero/J-5979-2016	Belfiore, Antonino/0000-0002-6181-4193; Garofalo, Cecilia/0000-0001-5334-8930; Scotlandi, Katia/0000-0001-6114-9499; Capristo, Mariantonietta/0000-0001-9774-3633; Manara, Maria Cristina/0000-0001-5686-720X; Mancarella, Caterina/0000-0002-5778-4251; Landuzzi, Lorena/0000-0001-9879-8118; Lollini, Pier Luigi/0000-0003-1702-4108; Picci, Piero/0000-0002-8519-4101	Italian Association for Cancer Research [MFAG 11584, IG 10452, IG 10353]; Italian Ministry of Health (Ricerca Finalizzata) [1628/2010]; Italian Ministry of Research and Instruction [SFC2EK]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health (Ricerca Finalizzata)(Ministry of Health, Italy); Italian Ministry of Research and Instruction	This work was funded by: Italian Association for Cancer Research grant (MFAG 11584 to CG; IG 10452 to KS; IG 10353 to PLL); The Italian Ministry of Health (Ricerca Finalizzata 2009 to KS 1628/2010); The Italian Ministry of Research and Instruction grant PRIN2009 cod. SFC2EK to KS. PRIN2009 to PLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algire C, 2011, ONCOGENE, V30, P1174, DOI 10.1038/onc.2010.483; [Anonymous], 2012, ANN ONCOL S7, V23, pvii100; Aryee DNT, 2010, CANCER RES, V70, P4015, DOI 10.1158/0008-5472.CAN-09-4333; Asensio-Lopez MC, 2011, FREE RADICAL BIO MED, V51, P1861, DOI 10.1016/j.freeradbiomed.2011.08.015; Avnet S, 2013, BBA-MOL BASIS DIS, V1832, P1105, DOI 10.1016/j.bbadis.2013.04.003; Avnet S, 2009, CANCER RES, V69, P2443, DOI 10.1158/0008-5472.CAN-08-2645; BAGNARA GP, 1990, INT J CELL CLONING, V8, P409, DOI 10.1002/stem.5530080644; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Benini S, 1999, INT J CANCER, V80, P581, DOI 10.1002/(SICI)1097-0215(19990209)80:4<581::AID-IJC16>3.3.CO;2-F; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Chen GF, 2012, J CLIN ENDOCR METAB, V97, pE510, DOI 10.1210/jc.2011-1754; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DEGIOVANNI C, 1989, ANTICANCER RES, V9, P1943; Dowling RJO, 2012, J MOL ENDOCRINOL, V48, pR31, DOI 10.1530/JME-12-0007; Forte V, 2012, CARDIORENAL MED, V2, P143, DOI 10.1159/000337314; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Garofalo C, 2011, ONCOGENE, V30, P2730, DOI 10.1038/onc.2010.640; Garofalo C, 2012, MOL ENDOCRINOL, V26, P1603, DOI 10.1210/me.2012-1142; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3271, DOI 10.1200/JCO.2009.22.1630; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Inoue M, 2012, ENDOCR-RELAT CANCER, V19, pF1, DOI 10.1530/ERC-12-0142; Jordan BF, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00094; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x; Knowles HJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-372; Kurmasheva RT, 2009, CANCER RES, V69, P7662, DOI 10.1158/0008-5472.CAN-09-1693; Ladanyi M, 2002, CANCER BIOL THER, V1, P330; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; LOLLINI PL, 1991, INVAS METAST, V11, P116; Magwere T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028558; Malempati S, 2012, PEDIATR BLOOD CANCER, V59, P5, DOI 10.1002/pbc.24118; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Mimeault M, 2013, J CELL MOL MED, V17, P30, DOI 10.1111/jcmm.12004; Naing A, 2012, CLIN CANCER RES, V18, P2625, DOI 10.1158/1078-0432.CCR-12-0061; Ohnstad HO, 2013, CANCER-AM CANCER SOC, V119, P1013, DOI 10.1002/cncr.27837; Oliveras-Ferraros C, 2009, CELL CYCLE, V8, P1633, DOI 10.4161/cc.8.10.8406; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; Pandini G, 1999, CLIN CANCER RES, V5, P1935; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Pierotti MA, 2013, ONCOGENE, V32, P1475, DOI 10.1038/onc.2012.181; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Potratz JC, 2010, CANCER RES, V70, P8770, DOI 10.1158/0008-5472.CAN-10-1093; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Sciacca L, 2002, ONCOGENE, V21, P8240, DOI 10.1038/sj.onc.1206058; Scotlandi K, 2000, CANCER RES, V60, P5134; Scotlandi K, 2005, CANCER RES, V65, P3868, DOI 10.1158/0008-5472.CAN-04-3192; Scotlandi K, 1999, ONCOGENE, V18, P739, DOI 10.1038/sj.onc.1202330; Scotlandi K, 2002, CLIN CANCER RES, V8, P3893; Scotlandi K, 2008, CURR OPIN ONCOL, V20, P419, DOI 10.1097/CCO.0b013e328302edab; Serra M, 2003, J CLIN ONCOL, V21, P536, DOI 10.1200/JCO.2003.03.144; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Stambolic V, 2009, BREAST CANCER RES TR, V114, P387, DOI 10.1007/s10549-008-0015-4; Subbiah V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018424; Sullivan A, 2004, ONCOGENE, V23, P3328, DOI 10.1038/sj.onc.1207428; Toguchida J, 2009, CANCER SCI, V100, P1573, DOI 10.1111/j.1349-7006.2009.01232.x; Vazquez-Martin A, 2009, CLIN TRANSL ONCOL, V11, P455, DOI 10.1007/s12094-009-0384-0; Wright JL, 2009, CANCER CAUSE CONTROL, V20, P1617, DOI 10.1007/s10552-009-9407-y; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9	65	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83832	10.1371/journal.pone.0083832	http://dx.doi.org/10.1371/journal.pone.0083832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391834	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200132
J	Kim, JY; Lee, J; Ko, YJ; Shin, JY; Jung, SY; Choi, NK; Park, BJ				Kim, Ji Young; Lee, Joongyub; Ko, Young-Jin; Shin, Ju-Young; Jung, Sun-Young; Choi, Nam-Kyong; Park, Byung-Joo			Multi-Indication Carbamazepine and the Risk of Severe Cutaneous Adverse Drug Reactions in Korean Elderly Patients: A Korean Health Insurance Data-Based Study	PLOS ONE			English	Article							STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; ANTIEPILEPTIC DRUGS; NEUROPATHIC PAIN; ASSOCIATION; EPILEPSY; EVENTS	Objective: To evaluate the risk of severe cutaneous adverse drug reactions (SCAR) after exposure to multi-indication antiepileptic drugs for in Korean elderly patients. Methods: We used a nationwide database from the Korean Health Insurance Review and Assessment Service claims constructed for the monitoring of drug utilization among the entire Korean elderly population from January 2005 to June 2006. We identified cases of SCARs among inpatients aged >= 65 years and those newly diagnosed with erythema multiforme according to the International Classification of Diseases, 10th revision code (L51). Each case was matched to four controls for gender, age, and the first hospitalization date as the index date. The use of carbamazepine, gabapentin, lamotrigine, topiramate, phenobarbital, phenytoin, and valproate during a 60-day period before the index date was compared. A conditional logistic regression analysis was performed to calculate the odds ratios (OR) and 95% confidence intervals (CI) of SCARs for antiepileptic drug. Results: We identified 286 cases of SCAR and 1,144 matched controls. Among the 25 patients who were prescribed antiepileptic drugs within 60 days of the index date. There were 11 cases (3.8%) of severe ocular manifestations, and most elderly patients were first-time or short-term users of antiepileptic drugs. Among the 10 cases of carbamazepine use, only 2 cases were prescribed carbamazepine for seizure. All antiepileptic drugs were associated with an increased SCAR risk (adjusted OR = 3.42, 95% CI: 1.75-6.63). The SCAR risk was highest in patients treated with carbamazepine (adjusted OR = 10.39, 95% CI: 2.64-40.86, for multi-indication; adjusted OR = 6.84, 95% CI: 1.55-30.10, for neuropathic pain). Conclusion: Carbamazepine use was associated with a nearly 10-fold increase in severe cutaneous drug reactions in Korean elderly patients. This association was consistently high with SCAR patients who received carbamazepine for neuropathic pain.	[Kim, Ji Young; Ko, Young-Jin; Park, Byung-Joo] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Lee, Joongyub; Choi, Nam-Kyong] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Shin, Ju-Young; Jung, Sun-Young; Park, Byung-Joo] Korea Inst Drug Safety & Risk Management, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, BJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	bjpark@snu.ac.kr		Choi, Nam-Kyong/0000-0003-1153-9928; Shin, Ju-Young/0000-0003-1010-7525	Korean Food and Drug Administration [07072KFDA224]	Korean Food and Drug Administration	This study was supported by a grant from the Korean Food and Drug Administration (07072KFDA224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2002, DRUG AGING, V19, P929, DOI 10.2165/00002512-200219120-00004; Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; BASTUJIGARIN S, 1993, AGE AGEING, V22, P450, DOI 10.1093/ageing/22.6.450; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Choi NK, 2011, WORLD J GASTROENTERO, V17, P651, DOI 10.3748/wjg.v17.i5.651; Chung WH, 2010, EXPERT OPIN DRUG SAF, V9, P15, DOI 10.1517/14740330903427969; Carneiro SCD, 2011, CLIN DERMATOL, V29, P43, DOI 10.1016/j.clindermatol.2010.07.006; DeToledo JC, 1999, THER DRUG MONIT, V21, P137, DOI 10.1097/00007691-199902000-00022; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Gau SSF, 2008, J CLIN PSYCHOPHARM, V28, P509, DOI 10.1097/JCP.0b013e3181845610; Genin E, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-52; GOLDEN HE, 1993, ARCH INTERN MED, V153, P1396, DOI 10.1001/archinte.1993.00410110088014; Gonzalez-Sicilia L, 1998, AM J MED, V105, P455; Green Jacqueline L, 2007, Am J Geriatr Pharmacother, V5, P31, DOI 10.1016/j.amjopharm.2007.03.004; Hall GC, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-26; Hollingworth SA, 2010, PHARMACOEPIDEM DR S, V19, P82, DOI 10.1002/pds.1871; Italiano D, 2013, CLIN PHARMACOKINET, V52, P627, DOI 10.1007/s40262-013-0067-4; Kim SH, 2011, EPILEPSY RES, V97, P190, DOI 10.1016/j.eplepsyres.2011.08.010; Landmark CJ, 2009, EPILEPSY RES, V87, P31, DOI 10.1016/j.eplepsyres.2009.07.005; Lee J, 2013, J GASTROENTEROL, V48, P1016, DOI 10.1007/s00535-012-0722-9; Levi N, 2009, PEDIATRICS, V123, pE297, DOI 10.1542/peds.2008-1923; Lin MS, 2005, INTERN MED J, V35, P188, DOI 10.1111/j.1445-5994.2005.00790.x; Mockenhaupt M, 2005, NEUROLOGY, V64, P1134, DOI 10.1212/01.WNL.0000156354.20227.F0; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; Paquet P, 2010, DRUG SAFETY, V33, P189, DOI 10.2165/11532540-000000000-00000; Park BJ, 2003, REPORT EVALUATION VA; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Rzany B, 1996, J CLIN EPIDEMIOL, V49, P769, DOI 10.1016/0895-4356(96)00035-2; Rzany B, 1996, BRIT J DERMATOL, V135, P6; Rzany B, 1999, LANCET, V353, P2190, DOI 10.1016/S0140-6736(98)05418-X; Sekula P, 2013, J INVEST DERMATOL, V133, P1197, DOI 10.1038/jid.2012.510; Shamliyan T, 2010, CLIN PHARMACOL-ADV A, V2, P41, DOI 10.2147/CPAA.S8779; Sheorajpanday RVA, 2007, CLIN NEUROL NEUROSUR, V109, P727, DOI 10.1016/j.clineuro.2007.07.002; STROM BL, 1991, ARCH DERMATOL, V127, P831, DOI 10.1001/archderm.127.6.831; Tsiropoulos I, 2006, ACTA NEUROL SCAND, V113, P405, DOI 10.1111/j.1600-0404.2006.00639.x; Wiffen PJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005451.pub2; Yang CY, 2011, NEUROLOGY, V77, P2025, DOI 10.1212/WNL.0b013e31823b478c; Yip LW, 2007, ALLERGY, V62, P527, DOI 10.1111/j.1398-9995.2006.01295.x; 마정은, 2007, 천식 및 알레르기, V27, P283	41	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83849	10.1371/journal.pone.0083849	http://dx.doi.org/10.1371/journal.pone.0083849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391836	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200134
J	Ming, X; Li, AA; Wu, JP; Yan, C; Ding, WX; Gong, H; Zeng, SQ; Liu, Q				Ming, Xing; Li, Anan; Wu, Jingpeng; Yan, Cheng; Ding, Wenxiang; Gong, Hui; Zeng, Shaoqun; Liu, Qian			Rapid Reconstruction of 3D Neuronal Morphology from Light Microscopy Images with Augmented Rayburst Sampling	PLOS ONE			English	Article							AUTOMATED RECONSTRUCTION; CONFOCAL IMAGES; ALGORITHMS; STACKS; RESOLUTION; BRAIN; MODEL	Digital reconstruction of three-dimensional (3D) neuronal morphology from light microscopy images provides a powerful technique for analysis of neural circuits. It is time-consuming to manually perform this process. Thus, efficient computer-assisted approaches are preferable. In this paper, we present an innovative method for the tracing and reconstruction of 3D neuronal morphology from light microscopy images. The method uses a prediction and refinement strategy that is based on exploration of local neuron structural features. We extended the rayburst sampling algorithm to a marching fashion, which starts from a single or a few seed points and marches recursively forward along neurite branches to trace and reconstruct the whole tree-like structure. A local radius-related but size-independent hemispherical sampling was used to predict the neurite centerline and detect branches. Iterative rayburst sampling was performed in the orthogonal plane, to refine the centerline location and to estimate the local radius. We implemented the method in a cooperative 3D interactive visualization-assisted system named flNeuronTool. The source code in C++ and the binaries are freely available at http://sourceforge.net/projects/flneurontool/. We validated and evaluated the proposed method using synthetic data and real datasets from the Digital Reconstruction of Axonal and Dendritic Morphology (DIADEM) challenge. Then, flNeuronTool was applied to mouse brain images acquired with the Micro-Optical Sectioning Tomography (MOST) system, to reconstruct single neurons and local neural circuits. The results showed that the system achieves a reasonable balance between fast speed and acceptable accuracy, which is promising for interactive applications in neuronal image analysis.	[Ming, Xing; Li, Anan; Wu, Jingpeng; Yan, Cheng; Ding, Wenxiang; Gong, Hui; Zeng, Shaoqun; Liu, Qian] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Ming, Xing; Li, Anan; Wu, Jingpeng; Yan, Cheng; Ding, Wenxiang; Gong, Hui; Zeng, Shaoqun; Liu, Qian] Huazhong Univ Sci & Technol, Dept Biomed Engn, MoE Key Lab Biomed Photon, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, Q (corresponding author), Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China.	qianliu@mail.hust.edu.cn	Ming, Xing/GQZ-6385-2022; liu, qian/HDM-2936-2022; Wu, Jingpeng/B-5489-2019; Qian, Liu/GYU-5886-2022; Wu, Jingpeng/H-3955-2019; Liu, Qian/D-8184-2011	Wu, Jingpeng/0000-0003-1604-8802; Liu, Qian/0000-0002-8398-1021	National Natural Science Foundation of China [81127002, 81171067, 61102122]; Science Fund for Creative Research Group of China [61121004]; Program for New Century Excellent Talents in University of China [NCET-10-0386]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Group of China(Science Fund for Creative Research Groups); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET))	This work is supported by National Natural Science Foundation of China (Grant Nos. 81127002, 81171067, 61102122); Science Fund for Creative Research Group of China (Grant No. 61121004); and Program for New Century Excellent Talents in University of China (Grant No. NCET-10-0386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Karim MA, 2003, MICROVASC RES, V66, P113, DOI 10.1016/S0026-2862(03)00039-6; Al-Kofahi KA, 2003, IEEE T INF TECHNOL B, V7, P302, DOI 10.1109/TITB.2003.816564; Al-Kofahi KA, 2002, IEEE T INF TECHNOL B, V6, P171, DOI 10.1109/TITB.2002.1006304; Al-Kofahi Y, 2008, CYTOM PART A, V73A, P36, DOI 10.1002/cyto.a.20499; Ascoli GA, 2001, PHILOS T R SOC B, V356, P1131, DOI 10.1098/rstb.2001.0905; Brown KM, 2011, NEUROINFORMATICS, V9, P143, DOI 10.1007/s12021-010-9095-5; Cai HM, 2006, NEUROIMAGE, V32, P1608, DOI 10.1016/j.neuroimage.2006.05.036; Choromanska A., 2012, FRONT NEURAL CIRCUIT, V6, P1; Chothani P, 2011, NEUROINFORMATICS, V9, P263, DOI 10.1007/s12021-011-9121-2; Donohue DE, 2011, BRAIN RES REV, V67, P94, DOI 10.1016/j.brainresrev.2010.11.003; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Gillette TA, 2011, NEUROINFORMATICS, V9, P233, DOI 10.1007/s12021-011-9117-y; Gong H, 2013, NEUROIMAGE, V74, P87, DOI 10.1016/j.neuroimage.2013.02.005; Gonzalez G, 2009, LECT NOTES COMPUT SC, V5762, P625, DOI 10.1007/978-3-642-04271-3_76; Halavi M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00049; Hamarneh G, 2010, COMPUT MED IMAG GRAP, V34, P605, DOI 10.1016/j.compmedimag.2010.06.002; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Liu Y, 2011, NEUROINFORMATICS, V9, P99, DOI 10.1007/s12021-011-9102-5; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005655; Lu J, 2009, PLOS BIOL, V7, P265, DOI 10.1371/journal.pbio.1000032; Luisi J, 2011, NEUROINFORMATICS, V9, P305, DOI 10.1007/s12021-011-9115-0; Mayerich D, 2009, IEEE T VIS COMPUT GR, V15, P670, DOI 10.1109/TVCG.2008.196; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895; Peng HC, 2011, BIOINFORMATICS, V27, pI239, DOI 10.1093/bioinformatics/btr237; Peng HC, 2011, NEUROINFORMATICS, V9, P103, DOI 10.1007/s12021-010-9090-x; Peng HC, 2010, BIOINFORMATICS, V26, pi38, DOI 10.1093/bioinformatics/btq212; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Rodriguez A, 2003, METHODS, V30, P94, DOI 10.1016/S1046-2023(03)00011-2; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Rodriguez A, 2009, J NEUROSCI METH, V184, P169, DOI 10.1016/j.jneumeth.2009.07.021; Roysam B, 2009, NEUROINFORMATICS, V7, P1, DOI 10.1007/s12021-008-9043-9; Schmitt S, 2004, NEUROIMAGE, V23, P1283, DOI 10.1016/j.neuroimage.2004.06.047; Sonka M., 2007, IMAGE PROCESSING ANA; Streekstra GJ, 2002, NETWORK-COMP NEURAL, V13, P381, DOI 10.1088/0954-898X/13/3/308; Turetken E, 2011, NEUROINFORMATICS, V9, P279, DOI 10.1007/s12021-011-9122-1; Vasilkoski Z, 2009, J NEUROSCI METH, V178, P197, DOI 10.1016/j.jneumeth.2008.11.008; Wang Y, 2011, NEUROINFORMATICS, V9, P193, DOI 10.1007/s12021-011-9110-5; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Weaver CM, 2004, NEURAL COMPUT, V16, P1353, DOI 10.1162/089976604323057425; Xie J, 2011, MED IMAGE ANAL, V15, P680, DOI 10.1016/j.media.2011.05.013; Yang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060877; Yuan XS, 2009, NEUROINFORMATICS, V7, P213, DOI 10.1007/s12021-009-9057-y; Zhang B, 2011, J NEUROSCI METH, V197, P1, DOI 10.1016/j.jneumeth.2010.10.001; Zhang Y, 2007, NEUROIMAGE, V35, P1502, DOI 10.1016/j.neuroimage.2007.01.014; Zhao T, 2011, NEUROINFORMATICS, V9, P247, DOI 10.1007/s12021-011-9120-3	47	35	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84557	10.1371/journal.pone.0084557	http://dx.doi.org/10.1371/journal.pone.0084557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391966	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900109
J	Park, SY; Baek, S; Kim, S; Yoon, SY; Kwon, HS; Chang, YS; Cho, YS; Jang, AS; Park, JW; Nahm, DH; Yoon, HJ; Cho, SH; Cho, YJ; Choi, B; Moon, HB; Kim, TB				Park, So Young; Baek, Seunghee; Kim, Sujeong; Yoon, Sun-young; Kwon, Hyouk-Soo; Chang, Yoon-Seok; Cho, You Sook; Jang, An-Soo; Park, Jung Won; Nahm, Dong-Ho; Yoon, Ho-Joo; Cho, Sang-Heon; Cho, Young-Joo; Choi, ByoungWhui; Moon, Hee-Bom; Kim, Tae-Bum		COREA Study Grp	Clinical Significance of Asthma Clusters by Longitudinal Analysis in Korean Asthma Cohort	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADULT ASTHMA; PHENOTYPES; IDENTIFICATION; PERCEPTION; SEVERITY; DYSPNEA	Background: We have previously identified four distinct groups of asthma patients in Korean cohorts using cluster analysis: (A) smoking asthma, (B) severe obstructive asthma, (C) early-onset atopic asthma, and (D) late-onset mild asthma. Methods and Results: A longitudinal analysis of each cluster in a Korean adult asthma cohort was performed to investigate the clinical significance of asthma clusters over 12 months. Cluster A showed relatively high asthma control test (ACT) scores but relatively low FEV1 scores, despite a high percentage of systemic corticosteroid use. Cluster B had the lowest mean FEV1, ACT, and the quality of life questionnaire for adult Korean asthmatics (QLQAKA) scores throughout the year, even though the percentage of systemic corticosteroid use was the highest among the four clusters. Cluster C was ranked second in terms of FEV1, with the second lowest percentage of systemic corticosteroid use, and showed a marked improvement in subjective symptoms over time. Cluster D consistently showed the highest FEV1, the lowest systemic corticosteroid use, and had high ACT and QLQAKA scores. Conclusion: Our asthma clusters had clinical significance with consistency among clusters over 12 months. These distinctive phenotypes may be useful in classifying asthma in real practice.	[Park, So Young; Kim, Sujeong; Yoon, Sun-young; Kwon, Hyouk-Soo; Cho, You Sook; Moon, Hee-Bom; Kim, Tae-Bum] Univ Ulsan, Coll Med, Asan Med Ctr, Div Allergy & Clin Immunol,Dept Internal Med, Seoul, South Korea; [Baek, Seunghee] Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Chang, Yoon-Seok; Cho, Sang-Heon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Jang, An-Soo] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon, South Korea; [Park, Jung Won] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Nahm, Dong-Ho] Ajou Univ, Coll Med, Dept Internal Med, Suwon 441749, South Korea; [Yoon, Ho-Joo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Cho, Young-Joo] Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Choi, ByoungWhui] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Seoul National University (SNU); Soonchunhyang University; Yonsei University; Yonsei University Health System; Ajou University; Hanyang University; Ewha Womans University; Chung Ang University; Chung Ang University Hospital	Kim, TB (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Allergy & Clin Immunol,Dept Internal Med, Seoul, South Korea.	allergy@medimail.co.kr	Chang, Yoon-Seok/J-5628-2012	Chang, Yoon-Seok/0000-0003-3157-0447; Cho, You Sook/0000-0001-8767-2667	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065, HI13C0776]	Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant no. A102065 & HI13C0776). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; BALL GH, 1967, BEHAV SCI, V12, P153, DOI 10.1002/bs.3830120210; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Green RH, 2007, CURR OPIN ALLERGY CL, V7, P43, DOI 10.1097/ACI.0b013e3280118a32; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Ibrahim JG, 2009, TEST-SPAIN, V18, P1, DOI 10.1007/s11749-009-0138-x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; Kim T.B, 2012, EUR RESP J; Kim TB, 2013, EUR RESPIR J, V41, P1308, DOI 10.1183/09031936.00100811; Kim TB, 2009, ANN ALLERG ASTHMA IM, V103, P311, DOI 10.1016/S1081-1206(10)60530-3; Kleis S, 2007, RESP MED, V101, P1426, DOI 10.1016/j.rmed.2007.01.019; Kwon HS, 2008, J KOREAN MED SCI, V23, P621, DOI 10.3346/jkms.2008.23.4.621; Lai CKW, 2011, RESPIROLOGY, V16, P688, DOI 10.1111/j.1440-1843.2011.01954.x; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LENFANT C, 2002, GLOBAL STRATEGY ASTH; Miller MK, 2005, J ALLERGY CLIN IMMUN, V116, P990, DOI 10.1016/j.jaci.2005.08.018; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Polosa R, 2012, EUR RESP J; Veen JCCMI, 1998, AM J RESP CRIT CARE, V158, P1134, DOI 10.1164/ajrccm.158.4.9710087; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	23	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83540	10.1371/journal.pone.0083540	http://dx.doi.org/10.1371/journal.pone.0083540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391784	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200081
J	Phillips, AC; Sleigh, A; McAllister, CJ; Brage, S; Carpenter, TA; Kemp, GJ; Holland, AJ				Phillips, Alexander C.; Sleigh, Alison; McAllister, Catherine J.; Brage, Soren; Carpenter, T. Adrian; Kemp, Graham J.; Holland, Anthony J.			Defective Mitochondrial Function In Vivo in Skeletal Muscle in Adults with Down's Syndrome: A P-31-MRS Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CHROMOSOME-21 TRISOMY; PRECURSOR PROTEIN; EXERCISE; DYSFUNCTION; METABOLISM; EXPRESSION; OBESITY; BRAINS; GENE	Down's syndrome (DS) is a developmental disorder associated with intellectual disability (ID). We have previously shown that people with DS engage in very low levels of exercise compared to people with ID not due to DS. Many aspects of the DS phenotype, such as dementia, low activity levels and poor muscle tone, are shared with disorders of mitochondrial origin, and mitochondrial dysfunction has been demonstrated in cultured DS tissue. We undertook a phosphorus magnetic resonance spectroscopy (P-31-MRS) study in the quadriceps muscle of 14 people with DS and 11 non-DS ID controls to investigate the post-exercise resynthesis kinetics of phosphocreatine (PCr), which relies on mitochondrial respiratory function and yields a measure of muscle mitochondrial function in vivo. We found that the PCr recovery rate constant was significantly decreased in adults with DS compared to non-DS ID controls (1.7 +/- 0.1 min(-1) vs 2.1 +/- 0.1 min(-1) respectively) who were matched for physical activity levels, indicating that muscle mitochondrial function in vivo is impaired in DS. This is the first study to investigate mitochondrial function in vivo in DS using P-31-MRS. Our study is consistent with previous in vitro studies, supporting a theory of a global mitochondrial defect in DS.	[Phillips, Alexander C.; McAllister, Catherine J.; Holland, Anthony J.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Sleigh, Alison; Carpenter, T. Adrian] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Brage, Soren] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Kemp, Graham J.] Univ Liverpool, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Liverpool	Sleigh, A (corresponding author), Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England.	as626@wbic.cam.ac.uk	Brage, Soren/C-6415-2013; Kemp, Graham J/A-7540-2008	Brage, Soren/0000-0002-1265-7355; Kemp, Graham J/0000-0002-8324-9666; Sleigh, Alison/0000-0002-3859-8701; McAllister, Catherine/0000-0001-6147-6449	DS Association; Special Olympics; Health Foundation; National Institute for Health Research (NIHR)/Wellcome Trust Cambridge Clinical Research Facility; NIHR Collaborations in Leadership for Applied Health Research (CLAHRC) for Cambridgeshire and Peterborough; Medical Research Council [MC_UU_12015/3, G0701532, MC_U106179473] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10211] Funding Source: researchfish; MRC [G0701532, MC_U106179473, MC_UU_12015/3] Funding Source: UKRI	DS Association; Special Olympics; Health Foundation; National Institute for Health Research (NIHR)/Wellcome Trust Cambridge Clinical Research Facility; NIHR Collaborations in Leadership for Applied Health Research (CLAHRC) for Cambridgeshire and Peterborough; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by grants from the DS Association, the Special Olympics and the Health Foundation. ACP was supported by a grant from the DS Association, AS by core staff funding from the National Institute for Health Research (NIHR)/Wellcome Trust Cambridge Clinical Research Facility, and AJH by funding from the Health Foundation and the NIHR Collaborations in Leadership for Applied Health Research (CLAHRC) for Cambridgeshire and Peterborough. The authors are grateful for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agiovlasitis S, 2011, MED SCI SPORT EXER, V43, P1322, DOI 10.1249/MSS.0b013e31820936c4; Apabhai S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022294; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314; BELL AJ, 1992, J INTELL DISABIL RES, V36, P359; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; COLDWELLS A, 1994, ERGONOMICS, V37, P79, DOI 10.1080/00140139408963625; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Coskun Pinar E, 2012, Curr Gerontol Geriatr Res, V2012, P383170, DOI 10.1155/2012/383170; Coskun PE, 2010, J ALZHEIMERS DIS, V20, pS293, DOI 10.3233/JAD-2010-100351; Devi L, 2010, BBA-MOL BASIS DIS, V1802, P11, DOI 10.1016/j.bbadis.2009.07.007; EYMAN RK, 1991, AM J MENT RETARD, V95, P603; Frid C, 1999, J INTELL DISABIL RES, V43, P234, DOI 10.1046/j.1365-2788.1999.00198.x; Helguera P, 2013, CELL METAB, V17, P132, DOI 10.1016/j.cmet.2012.12.005; Jawis MN, 2005, BRIT J SPORT MED, V39, P825, DOI 10.1136/bjsm.2004.016915; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; Kemp GJ, 2012, DIABETES, V61, P1927, DOI 10.2337/db11-1725; Kim SH, 2001, J NEURAL TRANSM-SUPP, P109; Kim SH, 2000, CELL MOL LIFE SCI, V57, P1810, DOI 10.1007/PL00000661; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; Larson-Meyer DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE153, DOI 10.1152/ajpendo.2000.278.1.E153; Lee SH, 2003, MOL CELLS, V15, P181; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lytle ME, 2004, ALZ DIS ASSOC DIS, V18, P57, DOI 10.1097/01.wad.0000126614.87955.79; Mendonca GV, 2010, THER CLIN RISK MANAG, V6, P601, DOI 10.2147/TCRM.S10235; Moreira PI, 2006, J ALZHEIMERS DIS, V9, P101; Mortensen SP, 2008, J PHYSIOL-LONDON, V586, P2621, DOI 10.1113/jphysiol.2007.149401; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Phillips AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028618; PRINCE J, 1994, J NEURAL TRANSM-PARK, V8, P171, DOI 10.1007/BF02260938; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Shields N, 2009, ADAPT PHYS ACT Q, V26, P307, DOI 10.1123/apaq.26.4.307; Sleigh A, 2011, J CLIN INVEST, V121, P2457, DOI 10.1172/JCI46405; Stoll C, 1998, ANN GENET-PARIS, V41, P44; TAYLOR DJ, 1994, J NEUROL SCI, V127, P198, DOI 10.1016/0022-510X(94)90073-6; Valenti D, 2010, BIOCHEM J, V431, P299, DOI 10.1042/BJ20100581; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Whitt-Glover Melicia C, 2006, Pediatr Rehabil, V9, P158, DOI 10.1080/13638490500353202	39	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84031	10.1371/journal.pone.0084031	http://dx.doi.org/10.1371/journal.pone.0084031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391872	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900015
J	Stanley, D; Geier, MS; Hughes, RJ; Denman, SE; Moore, RJ				Stanley, Dragana; Geier, Mark S.; Hughes, Robert J.; Denman, Stuart E.; Moore, Robert J.			Highly Variable Microbiota Development in the Chicken Gastrointestinal Tract	PLOS ONE			English	Article							BACTERIAL COMMUNITY; DIVERSITY; IDENTIFICATION; COLONIZATION; MICROFLORA; GUT	Studies investigating the role that complex microbiotas associated with animals and humans play in health and wellbeing have been greatly facilitated by advances in DNA sequencing technology. Due to the still relatively high sequencing costs and the expense of establishing and running animal trials and collecting clinical samples, most of the studies reported in the literature are limited to a single trial and relatively small numbers of samples. Results from different laboratories, investigating similar trials and samples, have often produced quite different pictures of microbiota composition. This study investigated batch to batch variations in chicken cecal microbiota across three similar trials, represented by individually analysed samples from 207 birds. Very different microbiota profiles were found across the three flocks. The flocks also differed in the efficiency of nutrient use as indicated by feed conversion ratios. In addition, large variations in the microbiota of birds within a single trial were noted. It is postulated that the large variability in microbiota composition is due, at least in part, to the lack of colonisation of the chicks by maternally derived bacteria. The high hygiene levels maintained in modern commercial hatcheries, although effective in reducing the burden of specific diseases, may have the undesirable effect of causing highly variable bacterial colonization of the gut. Studies in humans and other animals have previously demonstrated large variations in microbiota composition when comparing individuals from different populations and from different environments but this study shows that even under carefully controlled conditions large variations in microbiota composition still occur.	[Stanley, Dragana; Moore, Robert J.] CSIRO, Anim Food & Hlth Sci, Geelong, Vic, Australia; [Denman, Stuart E.] CSIRO, Anim Food & Hlth Sci, St Lucia, Qld, Australia; [Geier, Mark S.; Hughes, Robert J.] South Australian Res & Dev Inst, Pig & Poultry Prod Inst, Roseworthy, SA, Australia; [Stanley, Dragana; Geier, Mark S.; Hughes, Robert J.; Moore, Robert J.] Univ New England, Poultry Cooperat Res Ctr, Armidale, NSW, Australia; [Geier, Mark S.; Hughes, Robert J.] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Stanley, Dragana] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia; [Moore, Robert J.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); South Australian Research & Development Institute (SARDI); University of New England; University of Adelaide; Central Queensland University; Monash University	Moore, RJ (corresponding author), CSIRO, Anim Food & Hlth Sci, Geelong, Vic, Australia.	rob.moore@csiro.au	Moore, Robert J/D-8352-2011; Denman, Stuart E/A-5823-2011; Stanley, Dragana/AAC-2596-2020	Moore, Robert J/0000-0002-0776-5861; Denman, Stuart E/0000-0002-9910-3709; Stanley, Dragana/0000-0001-7019-4726; Geier, Mark/0000-0002-5152-3018	Australian Government's Cooperative Research Centres Program	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This project was conducted within the Poultry Cooperative Research Centre, established and supported under the Australian Government's Cooperative Research Centres Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2006, PEDIATR RES, V59, P96, DOI 10.1203/01.pdr.0000191137.12774.b2; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chessel D., 2004, R NEWS, V4, P5; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cressman MD, 2010, APPL ENVIRON MICROB, V76, P6572, DOI 10.1128/AEM.00180-10; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Edgar RC, 2011, OTUPIPE OTU CLUSTERI; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gong JH, 2007, FEMS MICROBIOL ECOL, V59, P147, DOI 10.1111/j.1574-6941.2006.00193.x; Lane DJ, 1991, 16S 23S RRNA SEQUENC, P115; Lee KW, 2010, COMP IMMUNOL MICROB, V33, pE105, DOI 10.1016/j.cimid.2010.06.001; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; SALANITRO JP, 1974, APPL MICROBIOL, V27, P678, DOI 10.1128/AEM.27.4.678-687.1974; Sekelja M, 2012, APPL ENVIRON MICROB, V78, P2941, DOI 10.1128/AEM.05391-11; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Stanley D, 2012, APPL MICROBIOL BIOT, V96, P1361, DOI 10.1007/s00253-011-3847-5; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	31	171	180	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84290	10.1371/journal.pone.0084290	http://dx.doi.org/10.1371/journal.pone.0084290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391931	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900074
J	Umemura, M; Koike, H; Nagano, N; Ishii, T; Kawano, J; Yamane, N; Kozone, I; Horimoto, K; Shin-ya, K; Asai, K; Yu, JJ; Bennett, JW; Machida, M				Umemura, Myco; Koike, Hideaki; Nagano, Nozomi; Ishii, Tomoko; Kawano, Jin; Yamane, Noriko; Kozone, Ikuko; Horimoto, Katsuhisa; Shin-ya, Kazuo; Asai, Kiyoshi; Yu, Jiujiang; Bennett, Joan W.; Machida, Masayuki			MIDDAS-M: Motif-Independent De Novo Detection of Secondary Metabolite Gene Clusters through the Integration of Genome Sequencing and Transcriptome Data	PLOS ONE			English	Article							FALSE SMUT BALLS; KOJIC ACID; AFLATOXIN BIOSYNTHESIS; ASPERGILLUS-ORYZAE; IDENTIFICATION; PERSPECTIVE; USTILOXIN; REGIONS	Many bioactive natural products are produced as "secondary metabolites" by plants, bacteria, and fungi. During the middle of the 20th century, several secondary metabolites from fungi revolutionized the pharmaceutical industry, for example, penicillin, lovastatin, and cyclosporine. They are generally biosynthesized by enzymes encoded by clusters of coordinately regulated genes, and several motif-based methods have been developed to detect secondary metabolite biosynthetic (SMB) gene clusters using the sequence information of typical SMB core genes such as polyketide synthases (PKS) and non-ribosomal peptide synthetases (NRPS). However, no detection method exists for SMB gene clusters that are functional and do not include core SMB genes at present. To advance the exploration of SMB gene clusters, especially those without known core genes, we developed MIDDAS-M, a motif-independent de novo detection algorithm for SMB gene clusters. We integrated virtual gene cluster generation in an annotated genome sequence with highly sensitive scoring of the cooperative transcriptional regulation of cluster member genes. MIDDAS-M accurately predicted 38 SMB gene clusters that have been experimentally confirmed and/or predicted by other motif-based methods in 3 fungal strains. MIDDAS-M further identified a new SMB gene cluster for ustiloxin B, which was experimentally validated. Sequence analysis of the cluster genes indicated a novel mechanism for peptide biosynthesis independent of NRPS. Because it is fully computational and independent of empirical knowledge about SMB core genes, MIDDAS-M allows a large-scale, comprehensive analysis of SMB gene clusters, including those with novel biosynthetic mechanisms that do not contain any functionally characterized genes.	[Umemura, Myco; Ishii, Tomoko; Kawano, Jin; Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Koike, Hideaki; Yamane, Noriko] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Nagano, Nozomi; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan; [Kozone, Ikuko; Shin-ya, Kazuo] Japan Biol Informat Consortium, Koto Ku, Tokyo, Japan; [Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo, Japan; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Koto Ku, Tokyo, Japan; [Yu, Jiujiang] USDA, Beltsville Agr Reg Res Ctr, Agr Res Serv, Beltsville, MD 20705 USA; [Bennett, Joan W.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); United States Department of Agriculture (USDA); Rutgers State University New Brunswick	Machida, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan.	m.machida@aist.go.jp	Umemura, Maiko/M-4092-2018; Asai, Kiyoshi/AAT-8344-2020; Bennett, Joan W./AAT-1267-2021; Nagano, Nozomi/A-5717-2017; Shin-ya, Kazuo/L-9613-2018	Umemura, Maiko/0000-0001-8730-1380; Asai, Kiyoshi/0000-0003-0909-4982; Nagano, Nozomi/0000-0002-2779-685X; Shin-ya, Kazuo/0000-0002-4702-0661; Kozone, Ikuko/0000-0001-6298-1121	commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan	commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan	This work was partly supported by the commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan (http://www.meti.go.jp/information/data/c120522aj.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen MR, 2013, P NATL ACAD SCI USA, V110, pE99, DOI 10.1073/pnas.1205532110; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bentley R, 2006, NAT PROD REP, V23, P1046, DOI 10.1039/b603758p; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Brown DW, 2012, FUNGAL GENET BIOL, V49, P521, DOI 10.1016/j.fgb.2012.05.010; CABANES J, 1994, J PHARM PHARMACOL, V46, P982, DOI 10.1111/j.2042-7158.1994.tb03253.x; Chang PK, 2009, FUNGAL GENET BIOL, V46, P176, DOI 10.1016/j.fgb.2008.11.002; Chang PK, 2005, FUNGAL GENET BIOL, V42, P914, DOI 10.1016/j.fgb.2005.07.004; Coleman JJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000486; Futamura T, 2001, J BIOSCI BIOENG, V92, P360, DOI 10.1263/jbb.92.360; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Hawksworth DL, 2004, STUD MYCOL, P9; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; KOISO Y, 1994, J ANTIBIOT, V47, P765, DOI 10.7164/antibiotics.47.765; Koiso Y, 1998, J ANTIBIOT, V51, P418, DOI 10.7164/antibiotics.51.418; KOISO Y, 1992, TETRAHEDRON LETT, V33, P4157, DOI 10.1016/S0040-4039(00)74677-6; Kusumoto K, 2000, CURR GENET, V37, P104, DOI 10.1007/s002940050016; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Machida M, 2008, FOOD ADDIT CONTAM A, V25, P1147, DOI 10.1080/02652030802273114; Marui J, 2011, J BIOSCI BIOENG, V112, P40, DOI 10.1016/j.jbiosc.2011.03.010; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Nicholson MJ, 2009, APPL ENVIRON MICROB, V75, P7469, DOI 10.1128/AEM.02146-08; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Rank C, 2010, ASPERGILLUS: MOLECULAR BIOLOGY AND GENOMICS, P173; Saito K, 1907, BOT MAG TOKYO, V21, P7, DOI [DOI 10.15281/JPLANTRES1887.21.240_7, 10.15281/jplantres1887.21.240_7]; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Tamano K, 2008, FUNGAL GENET BIOL, V45, P139, DOI 10.1016/j.fgb.2007.09.005; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terabayashi Y, 2010, FUNGAL GENET BIOL, V47, P953, DOI 10.1016/j.fgb.2010.08.014; Umemura M, 2012, DNA RES, V19, P375, DOI 10.1093/dnares/dss019; Wan HM, 2005, J IND MICROBIOL BIOT, V32, P227, DOI 10.1007/s10295-005-0230-5; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Weitzel C, 2013, PHYTOCHEM REV; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Yin WB, 2011, J MICROBIOL, V49, P329, DOI 10.1007/s12275-011-1009-1; Yu Jiujiang, 2002, Revista Iberoamericana de Micologia, V19, P191; Yu JJ, 2012, TOXINS, V4, P1024, DOI 10.3390/toxins4111024	45	65	67	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84028	10.1371/journal.pone.0084028	http://dx.doi.org/10.1371/journal.pone.0084028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391870	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900013
J	Zhang, T; Guo, YS; Guo, XJ; Zhou, T; Chen, DZ; Xiang, JY; Zhou, ZM				Zhang, Ting; Guo, Yueshuai; Guo, Xuejiang; Zhou, Tao; Chen, Daozhen; Xiang, Jingying; Zhou, Zuomin			Comparative Proteomics Analysis of Placenta from Pregnant Women with Intrahepatic Cholestasis of Pregnancy	PLOS ONE			English	Article							URSODEOXYCHOLIC ACID; APOPTOSIS; CELLS; STRESS; OVEREXPRESSION; IDENTIFICATION; PREECLAMPSIA; PEROXIDATION; EXPRESSION; PATHWAY	Introduction: Intrahepatic cholestasis of pregnancy (ICP) usually occurs in the third trimester and associated with increased risks in fetal complications. Currently, the exact cause of this disease is unknown. In this study we aim to investigate the potential proteins in placenta, which may participate in the molecular mechanisms of ICP-related fetal complications using iTRAQ-based proteomics approach. Methods: The iTRAQ analysis combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed to separate differentially expressed placental proteins from 4 pregnant women with ICP and 4 healthy pregnant women. Bioinformatics analysis was used to find the relative processes that these differentially expressed proteins were involved in. Three apoptosis related proteins ERp29, PRDX6 and MPO that resulted from iTRAQ-based proteomics were further verified in placenta by Western blotting and immunohistochemistry. Placental apoptosis was also detected by TUNEL assay. Results: Proteomics results showed there were 38 differentially expressed proteins from pregnant women with ICP and healthy pregnant women, 29 were upregulated and 9 were downregulated in placenta from pregnant women with ICP. Bioinformatics analysis showed most of the identified proteins was functionally related to specific cell processes, including apoptosis, oxidative stress, lipid metabolism. The expression levels of ERp29, PRDX6 and MPO were consistent with the proteomics data. The apoptosis index in placenta from ICP patients was significantly increased. Conclusion: This preliminary work provides a better understanding of the proteomic alterations of placenta from pregnant women with ICP and may provide us some new insights into the pathophysiology and potential novel treatment targets for ICP.	[Zhang, Ting; Guo, Yueshuai; Guo, Xuejiang; Zhou, Tao; Zhou, Zuomin] Nanjing Med Univ, Dept Histol & Embryol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Ting; Chen, Daozhen; Xiang, Jingying] Nanjing Med Univ, Wuxi Matern & Child Hlth Care Hosp, Wuxi, Peoples R China	Nanjing Medical University; Nanjing Medical University	Chen, DZ (corresponding author), Nanjing Med Univ, Wuxi Matern & Child Hlth Care Hosp, Wuxi, Peoples R China.	chendaozhen@163.com; zhouzm@njmu.edu.cn	Zhou, Tao/H-1094-2013; Guo, Xuejiang/J-9600-2014	Zhou, Tao/0000-0003-2219-6385; Guo, Xuejiang/0000-0002-0475-5705; Guo, Yueshuai/0000-0002-2719-1244; chen, daozhen/0000-0003-4791-8065	National Natural Science Foundation of China [81202043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81202043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacq Y, 2012, GASTROENTEROLOGY, V143, P1492, DOI 10.1053/j.gastro.2012.08.004; Bambang IF, 2009, LAB INVEST, V89, P1229, DOI 10.1038/labinvest.2009.87; Belkacemi L, 2009, PLACENTA, V30, P739, DOI 10.1016/j.placenta.2009.06.003; Chowdhury I, 2009, FREE RADICAL BIO MED, V46, P146, DOI 10.1016/j.freeradbiomed.2008.09.027; COSTOYA AL, 1980, PLACENTA, V1, P361, DOI 10.1016/S0143-4004(80)80038-5; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dixon PH, 2009, GUT, V58, P537, DOI 10.1136/gut.2008.159541; El Kebir D, 2008, CIRC RES, V103, P352, DOI 10.1161/01.RES.0000326772.76822.7a; Fang HY, 2011, PHYTOMEDICINE, V18, P697, DOI 10.1016/j.phymed.2010.11.012; Geenes VL, 2011, PLACENTA, V32, P1026, DOI 10.1016/j.placenta.2011.09.006; Geenes V, 2009, WORLD J GASTROENTERO, V15, P2049, DOI 10.3748/wjg.15.2049; Gharesi-Fard B, 2010, PLACENTA, V31, P121, DOI 10.1016/j.placenta.2009.11.004; Glantz A, 2004, HEPATOLOGY, V40, P467, DOI 10.1002/hep.20336; Glantz A, 2008, HEPATOLOGY, V47, P544, DOI 10.1002/hep.21987; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim YN, 2007, PROTEOM CLIN APPL, V1, P1625, DOI 10.1002/prca.200700034; Lee H, 2005, PLACENTA, V26, P226, DOI 10.1016/j.placenta.2004.05.012; Lee RH, 2009, OBSTET GYNECOL, V113, P528, DOI 10.1097/AOG.0b013e31818db1c9; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Marin JJG, 2003, PLACENTA, V24, P431, DOI 10.1053/plac.2002.0951; Marin Jose J. G., 2004, Current Drug Delivery, V1, P275, DOI 10.2174/1567201043334731; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Pak JH, 2002, J BIOL CHEM, V277, P49927, DOI 10.1074/jbc.M204222200; Perez MJ, 2006, PLACENTA, V27, P34, DOI 10.1016/j.placenta.2004.10.020; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rook M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028343; Saed GM, 2010, GYNECOL ONCOL, V116, P276, DOI 10.1016/j.ygyno.2009.11.004; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Wei J, 2010, ARCH GYNECOL OBSTET, V281, P801, DOI 10.1007/s00404-009-1156-3; Zhang DH, 2011, INT J BIOCHEM CELL B, V43, P33, DOI 10.1016/j.biocel.2010.09.019; Zhao C, 2009, PROTEOMICS, V9, P1385, DOI 10.1002/pmic.200800353	32	20	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83281	10.1371/journal.pone.0083281	http://dx.doi.org/10.1371/journal.pone.0083281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391750	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200047
J	Alemu, JB I; Clement, Y				Alemu, Jahson Berhane, I; Clement, Ysharda			Mass Coral Bleaching in 2010 in the Southern Caribbean	PLOS ONE			English	Article							CLIMATE-CHANGE; REEFS; MORTALITY; ISLAND	Ocean temperatures are increasing globally and the Caribbean is no exception. An extreme ocean warming event in 2010 placed Tobago's coral reefs under severe stress resulting in widespread coral bleaching and threatening the livelihoods that rely on them. The bleaching response of four reef building taxa was monitored over a six month period across three major reefs systems in Tobago. By identifying taxa resilient to bleaching we propose to assist local coral reef managers in the decision making process to cope with mass bleaching events. The bleaching signal (length of exposure to high ocean temperatures) varied widely between the Atlantic and Caribbean reefs, but regardless of this variation most taxa bleached. Colpophyllia natans, Montastraea faveolata and Siderastrea siderea were considered the most bleaching vulnerable taxa. Interestingly, reefs with the highest coral cover showed the greatest decline reef building taxa, and conversely, reefs with the lowest coral cover showed the most bleaching but lowest change in coral cover with little algal overgrowth post-bleaching.	[Alemu, Jahson Berhane, I; Clement, Ysharda] Inst Marine Affairs, Biodivers & Ecol Res Programme, Chaguaramas, Trinidad Tobago; [Alemu, Jahson Berhane, I] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago	University West Indies Mona Jamaica; University West Indies Saint Augustine	Alemu, JB I (corresponding author), Inst Marine Affairs, Biodivers & Ecol Res Programme, Hilltop Lane, Chaguaramas, Trinidad Tobago.	jalemu@ima.gov.tt		Alemu I, Jahson/0000-0002-6936-2857	IMA; DMRF	IMA; DMRF	This report is dedicated to the memory of the late Learmond Chapman, a friend and colleague who assisted in this assessment. Special thanks to the staff and support at the IMA and DMRF, TNC and reviewers RvW, RL, PK, RJ, SW, MCM, DATP, AG, ASC and PM.	Brandt ME, 2009, CORAL REEFS, V28, P911, DOI 10.1007/s00338-009-0548-y; Burke L., 2008, COASTAL CAPITAL EC V; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; EGANA AC, 1982, PAC SCI, V36, P61; Fitt WK, 1995, BIOL BULL, V189, P298, DOI 10.2307/1542147; Hill JJ, 2004, METHODS ECOLOGICAL M; JAAP WC, 1985, P 5 INT COR REEF C T, V6, P143; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; LANG JC, 1992, AM ZOOL, V32, P696; LAYDOO RS, 1991, GUIDE CORAL REEFS TO; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Mallela J, 2010, CARIBB J SCI, V46, P83; McClanahan T, 2002, CONSERV ECOL, V6; McClanahan TR, 2003, ECOSYSTEMS, V6, P551, DOI 10.1007/s10021-002-0104-x; McGrath TA, 1998, REV BIOL TROP, V46, P91; MULLERKARGER FE, 1988, NATURE, V333, P56, DOI 10.1038/333056a0; NOAA Coral Reef Watch, 2000, NOAA COR REEF WATCH; O'Farrell S, 2006, REPORT 2005 MASS C 1; Oxenford HA, 2008, CLIMATIC CHANGE, V87, P435, DOI 10.1007/s10584-007-9311-y; Phongsuwan N, 1998, CORAL REEFS, V17, P70, DOI 10.1007/s003380050097; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Tan J, 2012, IEEE POW ENER SOC GE; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilkinson C, 2008, STATUS CARIBBEAN COR; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1	27	42	42	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83829	10.1371/journal.pone.0083829	http://dx.doi.org/10.1371/journal.pone.0083829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400078	gold, Green Published, Green Submitted			2022-12-27	WOS:000329462700012
J	Boyer-Di Ponio, J; El-Ayoubi, F; Glacial, F; Ganeshamoorthy, K; Driancourt, C; Godet, M; Perriere, N; Guillevic, O; Couraud, PO; Uzan, G				Boyer-Di Ponio, Julie; El-Ayoubi, Fida; Glacial, Fabienne; Ganeshamoorthy, Kayathiri; Driancourt, Catherine; Godet, Maeva; Perriere, Nicolas; Guillevic, Oriane; Couraud, Pierre Olivier; Uzan, Georges			Instruction of Circulating Endothelial Progenitors In Vitro towards Specialized Blood-Brain Barrier and Arterial Phenotypes	PLOS ONE			English	Article							RISK-FACTORS; CELLS; DIFFERENTIATION; EXPRESSION; MODEL; NOTCH; IDENTIFICATION; ARTERIOGENESIS; ACTIVATION; INTEGRITY	Objective: The vascular system is adapted to specific functions in different tissues and organs. Vascular endothelial cells are important elements of this adaptation, leading to the concept of 'specialized endothelial cells'. The phenotype of these cells is highly dependent on their specific microenvironment and when isolated and cultured, they lose their specific features after few passages, making models using such cells poorly predictive and irreproducible. We propose a new source of specialized endothelial cells based on cord blood circulating endothelial progenitors (EPCs). As prototype examples, we evaluated the capacity of EPCs to acquire properties characteristic of cerebral microvascular endothelial cells (blood-brain barrier (BBB)) or of arterial endothelial cells, in specific inducing culture conditions. Approach and Results: First, we demonstrated that EPC-derived endothelial cells (EPDCs) co-cultured with astrocytes acquired several BBB phenotypic characteristics, such as restricted paracellular diffusion of hydrophilic solutes and the expression of tight junction proteins. Second, we observed that culture of the same EPDCs in a high concentration of VEGF resulted, through activation of Notch signaling, in an increase of expression of most arterial endothelial markers. Conclusions: We have thus demonstrated that in vitro culture of early passage human cord blood EPDCs under specific conditions can induce phenotypic changes towards BBB or arterial phenotypes, indicating that these EPDCs maintain enough plasticity to acquire characteristics of a variety of specialized phenotypes. We propose that this property of EPDCs might be exploited for producing specialized endothelial cells in culture to be used for drug testing and predictive in vitro assays.	[Boyer-Di Ponio, Julie; Driancourt, Catherine; Guillevic, Oriane; Uzan, Georges] Hop Paul Brousse, INSERM, U972, Villejuif, France; [El-Ayoubi, Fida] ABCell Bio, Paris, France; [Glacial, Fabienne; Ganeshamoorthy, Kayathiri; Godet, Maeva; Couraud, Pierre Olivier] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Glacial, Fabienne; Ganeshamoorthy, Kayathiri; Godet, Maeva; Couraud, Pierre Olivier] CNRS, UMR8104, Paris, France; [Glacial, Fabienne; Ganeshamoorthy, Kayathiri; Godet, Maeva; Couraud, Pierre Olivier] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Perriere, Nicolas] VigiCell Villejuif Biopk, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Uzan, G (corresponding author), Hop Paul Brousse, INSERM, U972, Villejuif, France.	georges.uzan@inserm.fr	Uzan, Georges/M-8199-2018	Uzan, Georges/0000-0002-0178-5386	National Research Agency (ANR, Barrier project, Fond unique d'investissement) [AAP7:109-2024/R]	National Research Agency (ANR, Barrier project, Fond unique d'investissement)(French National Research Agency (ANR))	This work was supported by a grant by the National Research Agency (ANR, Barrier project, Fond unique d'investissement AAP7:109-2024/R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GB, 2011, ARTERIOSCL THROM VAS, V31, P1476, DOI 10.1161/ATVBAHA.111.228999; Avouac J, 2008, JOINT BONE SPINE, V75, P131, DOI 10.1016/j.jbspin.2007.09.006; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cecchelli R, 1999, ADV DRUG DELIVER REV, V36, P165, DOI 10.1016/S0169-409X(98)00083-0; Chen JZ, 2004, CLIN SCI, V107, P273, DOI 10.1042/CS20030389; Disassa NM, 2009, PHYSIOL RES, V58, P193, DOI 10.33549/physiolres.931410; Egorova AD, 2012, IN VITRO CELL DEV-AN, V48, P21, DOI 10.1007/s11626-011-9470-z; FINA L, 1990, BLOOD, V75, P2417; Fujii T, 2008, ATHEROSCLEROSIS, V200, P51, DOI 10.1016/j.atherosclerosis.2007.12.012; Han JW, 2012, ANTIOXID REDOX SIGN, V17, P205, DOI 10.1089/ars.2011.4375; Hirashima M, 2009, ANAT SCI INT, V84, P95, DOI 10.1007/s12565-009-0026-1; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kikuchi R, 2011, LAB INVEST, V91, P691, DOI 10.1038/labinvest.2011.5; Lanner F, 2007, ARTERIOSCL THROM VAS, V27, P487, DOI 10.1161/01.ATV.0000255990.91805.6d; Lavergne M, 2011, CELL PROLIFERAT, V44, P44, DOI 10.1111/j.1365-2184.2010.00722.x; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Luissint AC, 2012, J CEREBR BLOOD F MET, V32, P860, DOI 10.1038/jcbfm.2011.202; Masuda H, 2003, CARDIOVASC RES, V58, P390, DOI 10.1016/S0008-6363(02)00785-X; Masumura T, 2009, ARTERIOSCL THROM VAS, V29, P2125, DOI 10.1161/ATVBAHA.109.193185; Michaud SE, 2006, ATHEROSCLEROSIS, V187, P423, DOI 10.1016/j.atherosclerosis.2005.10.009; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nanda V, 2012, J BIOL CHEM, V287, P2459, DOI 10.1074/jbc.M111.302224; Obi S, 2009, J APPL PHYSIOL, V106, P203, DOI 10.1152/japplphysiol.00197.2008; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Perriere N, 2007, BRAIN RES, V1150, P1, DOI 10.1016/j.brainres.2007.02.091; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Ribatti D, 2009, ANGIOGENESIS, V12, P101, DOI 10.1007/s10456-008-9125-1; Rocha SF, 2009, ANGIOGENESIS, V12, P139, DOI 10.1007/s10456-009-9132-x; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; SIFLINGERBIRNBOIM A, 1987, J CELL PHYSIOL, V132, P111, DOI 10.1002/jcp.1041320115; Umemura T, 2008, AM J HYPERTENS, V21, P1203, DOI 10.1038/ajh.2008.278; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yurugi-Kobayashi T, 2006, ARTERIOSCL THROM VAS, V26, P1977, DOI 10.1161/01.ATV.0000234978.10658.41	47	52	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84179	10.1371/journal.pone.0084179	http://dx.doi.org/10.1371/journal.pone.0084179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392113	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100037
J	Dehmer, M; Shi, YT				Dehmer, Matthias; Shi, Yongtang			The Uniqueness of D-MAX-Matrix Graph Invariants	PLOS ONE			English	Article							INFORMATION; DISCRIMINATION; INDEXES	In this paper, we examine the uniqueness (discrimination power) of a newly proposed graph invariant based on the matrix D-MAX defined by Randic et al. In order to do so, we use exhaustively generated graphs instead of special graph classes such as trees only. Using these graph classes allow us to generalize the findings towards complex networks as they usually do not possess any structural constraints. We obtain that the uniqueness of this newly proposed graph invariant is approximately as low as the uniqueness of the Balaban J index on exhaustively generated (general) graphs.	[Dehmer, Matthias] UMIT, Inst Bioinformat & Translat Res, Eduard Wallnoefer Zentrum 1, A-6060 Hall In Tirol, Austria; [Shi, Yongtang] Nankai Univ, Ctr Combinator, Tianjin 300071, Peoples R China; [Shi, Yongtang] Nankai Univ, LPMC TJKLC, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Dehmer, M (corresponding author), UMIT, Inst Bioinformat & Translat Res, Eduard Wallnoefer Zentrum 1, A-6060 Hall In Tirol, Austria.	matthias.dehmer@umit.at		Shi, Yongtang/0000-0001-9406-7967	Austrian Science Funds [P22029-N13]; National Science Foundation of China; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Matthias Dehmer thanks the Austrian Science Funds for supporting this work (project P22029-N13). Yongtang Shi has been supported by the National Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALABAN AT, 1991, J MATH CHEM, V8, P383, DOI 10.1007/BF01166951; BALABAN AT, 1982, CHEM PHYS LETT, V89, P399, DOI 10.1016/0009-2614(82)80009-2; BONCHEV D, 1981, J COMPUT CHEM, V2, P127, DOI 10.1002/jcc.540020202; Dehmer M, 2012, ADV COMPUTATIONAL MA; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031214; Dehmer M, 2012, MATCH-COMMUN MATH CO, V67, P147; Devillers J., 1999, TOPOLOGICAL INDICES; Diudea MV, 2011, COMPLEXITY, V16, P32, DOI 10.1002/cplx.20363; Hu CY, 1996, J CHEM INF COMP SCI, V36, P82, DOI 10.1021/ci9501150; Janezic D, 2007, MACH CHEM MONOGRAPHS; Konstantinova EV, 1996, J CHEM INF COMP SCI, V36, P54, DOI 10.1021/ci9502461; LIU X, 1991, J COMPUT CHEM, V12, P1243, DOI 10.1002/jcc.540121012; Mckay B. D, 2010, NAUTY; Randic M, 2013, MATCH-COMMUN MATH CO, V70, P239; Randic M, 2013, MATCH-COMMUN MATH CO, V70, P221; Todeschini R., 2002, HDB MOL DESCRIPTORS	16	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83868	10.1371/journal.pone.0083868	http://dx.doi.org/10.1371/journal.pone.0083868			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392099	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100023
J	Forterre, A; Jalabert, A; Berger, E; Baudet, M; Chikh, K; Errazuriz, E; De Larichaudy, J; Chanon, S; Weiss-Gayet, M; Hesse, AM; Record, M; Geloen, A; Lefai, E; Vidal, H; Coute, Y; Rome, S				Forterre, Alexis; Jalabert, Audrey; Berger, Emmanuelle; Baudet, Mathieu; Chikh, Karim; Errazuriz, Elisabeth; De Larichaudy, Joffrey; Chanon, Stephanie; Weiss-Gayet, Michele; Hesse, Anne-Marie; Record, Michel; Geloen, Alain; Lefai, Etienne; Vidal, Hubert; Coute, Yohann; Rome, Sophie			Proteomic Analysis of C2C12 Myoblast and Myotube Exosome-Like Vesicles: A New Paradigm for Myoblast-Myotube Cross Talk?	PLOS ONE			English	Article							CELL-DERIVED EXOSOMES; DENDRITIC CELLS; PROTEINS; DIFFERENTIATION; IDENTIFICATION; FUSION; MECHANISM; COMMITMENT; TRANSPORT; MICRORNAS	Exosomes are nanometer-sized microvesicles formed in multivesicular bodies (MVBs) during endosome maturation. Exosomes are released from cells into the microenvironment following fusion of MVBs with the plasma membrane. During the last decade, skeletal muscle-secreted proteins have been identified with important roles in intercellular communications. To investigate whether muscle-derived exosomes participate in this molecular dialog, we determined and compared the protein contents of the exosome-like vesicles (ELVs) released from C2C12 murine myoblasts during proliferation (ELV-MB), and after differentiation into myotubes (ELV-MT). Using a proteomic approach combined with electron microscopy, western-blot and bioinformatic analyses, we compared the protein repertoires within ELV-MB and ELV-MT. We found that these vesicles displayed the classical properties of exosomes isolated from other cell types containing components of the ESCRT machinery of the MVBs, as well as numerous tetraspanins. Specific muscle proteins were also identified confirming that ELV composition also reflects their muscle origin. Furthermore quantitative analysis revealed stage-preferred expression of 31 and 78 proteins in ELV-MB and ELV-MT respectively. We found that myotube-secreted ELVs, but not ELV-MB, reduced myoblast proliferation and induced differentiation, through, respectively, the down-regulation of Cyclin D1 and the up-regulation of myogenin. We also present evidence that proteins from ELV-MT can be incorporated into myoblasts by using the GFP protein as cargo within ELV-MT. Taken together, our data provide a useful database of proteins from C2C12-released ELVs throughout myogenesis and reveals the importance of exosome-like vesicles in skeletal muscle biology.	[Forterre, Alexis; Jalabert, Audrey; Berger, Emmanuelle; Chikh, Karim; De Larichaudy, Joffrey; Chanon, Stephanie; Geloen, Alain; Lefai, Etienne; Vidal, Hubert; Rome, Sophie] Univ Lyon, Fac Med Lyon Sud, CarMeN Lab, INSERM 1060,INRA 1362,INSA, Oullins, France; [Errazuriz, Elisabeth] Univ Lyon, SFR Sante Lyon Est, Ctr Commun Imagerie Laennec CeCIL, Lyon, France; [Baudet, Mathieu; Hesse, Anne-Marie; Coute, Yohann] CEA, IRTSV, Lab Biol Grande Echelle, Grenoble, France; [Record, Michel] CRCT, INSERM UMR 1037, Toulouse, France; [Baudet, Mathieu; Hesse, Anne-Marie; Coute, Yohann] INSERM, U1038, Grenoble, France; [Baudet, Mathieu; Hesse, Anne-Marie; Coute, Yohann] Grenoble Alpes Univ, IRTSV, Lab Biol Grande Echelle, Grenoble, France; [Weiss-Gayet, Michele] Univ Lyon, CNRS UMR5534, Ctr Genet & Physiol Mol & Cellulaire CGPhiMC, Lyon, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Rome, S (corresponding author), Univ Lyon, Fac Med Lyon Sud, CarMeN Lab, INSERM 1060,INRA 1362,INSA, Oullins, France.	srome@univ-lyon1.fr	Couté, Yohann/G-2695-2015; Carmen, Team1/Y-7382-2019; RECORD, Michel/G-3493-2017; Lefai, Etienne/E-9615-2019; Lefai, Etienne/L-7961-2019; Vidal, Hubert/M-6674-2017	Couté, Yohann/0000-0003-3896-6196; Carmen, Team1/0000-0003-4234-1746; RECORD, Michel/0000-0003-1893-0022; Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; Vidal, Hubert/0000-0002-9467-0317; GELOEN, Alain/0000-0001-7921-1254; CHIKH, Karim/0000-0002-1217-4193; Forterre, Alexis/0000-0002-5000-9009; Hesse, Anne-Marie/0000-0001-6110-0636; Lab, Carmen/0000-0002-5935-3236; ROME, SOPHIE/0000-0003-3986-5936; Chanon, Stephanie/0000-0001-6930-6671	Fondation pour la Recherche Medicale (FRM); Association Francaise de recherche sur les Myopathies (AFM); Association Francaise de Diabetologie (SDF/Rochediagnostics France); INRA specific grant (ANSSD)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association Francaise de recherche sur les Myopathies (AFM); Association Francaise de Diabetologie (SDF/Rochediagnostics France); INRA specific grant (ANSSD)	This work was supported by grants from Fondation pour la Recherche Medicale (FRM), Association Francaise de recherche sur les Myopathies (AFM), Association Francaise de Diabetologie (SDF/Rochediagnostics France) and INRA specific grant (ANSSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN JH, 1993, BLOOD, V81, P2442; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; BISCHOFF R, 1990, J CELL BIOL, V111, P201, DOI 10.1083/jcb.111.1.201; Bolton K, 2009, INT J OBESITY, V33, P1153, DOI 10.1038/ijo.2009.148; Bortoluzzi S, 2006, PROTEINS, V62, P776, DOI 10.1002/prot.20803; Bouzakri K, 2011, DIABETES, V60, P1111, DOI 10.2337/db10-1178; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Charlton CA, 2000, DEV BIOL, V221, P112, DOI 10.1006/dbio.2000.9654; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deng ZB, 2009, DIABETES, V58, P2498, DOI 10.2337/db09-0216; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; DOERING JL, 1977, EXP CELL RES, V105, P437, DOI 10.1016/0014-4827(77)90140-9; Estelles A, 2007, INT J NANOMED, V2, P751; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Grabowska I, 2011, CELL BIOL INT, V35, P125, DOI 10.1042/CBI20090335; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Haugen F, 2010, AM J PHYSIOL-CELL PH, V298, pC807, DOI 10.1152/ajpcell.00094.2009; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hindle AK, 2010, INT J OBESITY, V34, P1020, DOI 10.1038/ijo.2010.23; Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kislinger T, 2005, MOL CELL PROTEOMICS, V4, P887, DOI 10.1074/mcp.M400182-MCP200; KONIGSBERG IR, 1971, DEV BIOL, V26, P133, DOI 10.1016/0012-1606(71)90113-8; Le Bihan MC, 2012, J PROTEOMICS, V77, P344, DOI 10.1016/j.jprot.2012.09.008; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Azevedo LCP, 2007, CRIT CARE, V11, DOI 10.1186/cc6176; Qu JL, 2009, DIGEST LIVER DIS, V41, P875, DOI 10.1016/j.dld.2009.04.006; Rana S, 2012, INT J BIOCH CELL BIO; Sasaki T, 1998, BIOCHEM BIOPH RES CO, V245, P641, DOI 10.1006/bbrc.1998.8253; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takano H, 1998, MOL CELL BIOL, V18, P1580, DOI 10.1128/MCB.18.3.1580; Tannu NS, 2004, MOL CELL PROTEOMICS, V3, P1065, DOI 10.1074/mcp.M400020-MCP200; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Verweij FJ, 2011, EMBO J, V30, P2115, DOI 10.1038/emboj.2011.123; Viaud S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004942; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yoon JH, 2009, PROTEOMICS, V9, P51, DOI 10.1002/pmic.200800187; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163	64	117	120	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84153	10.1371/journal.pone.0084153	http://dx.doi.org/10.1371/journal.pone.0084153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392111	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100035
J	Haupert, S; Guerard, S; Peyrin, F; Mitton, D; Laugier, P				Haupert, Sylvain; Guerard, Sandra; Peyrin, Francoise; Mitton, David; Laugier, Pascal			Non Destructive Characterization of Cortical Bone Micro-Damage by Nonlinear Resonant Ultrasound Spectroscopy	PLOS ONE			English	Article							IN-VIVO; MICRODAMAGE ACCUMULATION; MECHANICAL-PROPERTIES; FATIGUE RESISTANCE; FRACTURE; ELASTICITY; MORPHOLOGY; TIME; MICROCRACKS; DEGRADATION	The objective of the study was to evaluate the ability of a nonlinear ultrasound technique, the so-called nonlinear resonant ultrasound spectroscopy (NRUS) technique, for detecting early microdamage accumulation in cortical bone induced by four-point bending fatigue. Small parallelepiped beam-shaped human cortical bone specimens were subjected to cyclic four-point bending fatigue in several steps. The specimens were prepared to control damage localization during four-point bending fatigue cycling and to unambiguously identify resonant modes for NRUS measurements. NRUS measurements were achieved to follow the evolution of the nonlinear hysteretic elastic behavior during fatigue-induced damage. After each fatigue step, a small number of specimens was removed from the protocol and set apart to quantitatively assess the microcrack number density and length using synchrotron radiation micro-computed tomography (SR-mu CT). The results showed a significant effect of damage steps on the nonlinear hysteretic elastic behavior. No significant change in the overall length of microcracks was observed in damaged regions compared to the load-free control regions. Only an increased number of shortest microcracks, those in the lowest quartile, was noticed. This was suggestive of newly formed microcracks during the early phases of damage accumulation. The variation of nonlinear hysteretic elastic behavior was significantly correlated to the variation of the density of short microcracks. Our results suggest that the nonlinear hysteretic elastic behavior is sensitive to early bone microdamage. Therefore NRUS technique can be used to monitor fatigue microdamage progression in in vitro experiments.	[Haupert, Sylvain; Laugier, Pascal] Univ Paris 06, CNRS UMR7623, Lab Imagerie Parametr, Paris, France; [Guerard, Sandra] Arts & Metiers ParisTech, LBM, Paris, France; [Peyrin, Francoise] Univ Lyon 1, INSA Lyon, CNRS 5220, CREATIS,INSERM U1044, F-69365 Lyon, France; [Peyrin, Francoise] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Mitton, David] Univ Lyon 1, IFSTTAR, LBMC, UMR T 9406, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Arts et Metiers Institute of Technology; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; European Synchrotron Radiation Facility (ESRF); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Gustave-Eiffel	Haupert, S (corresponding author), Univ Paris 06, CNRS UMR7623, Lab Imagerie Parametr, Paris, France.	sylvain.haupert@upmc.fr	Mitton, David/H-5695-2018; Peyrin, Francoise/G-2823-2013; Laugier, Pascal/P-1658-2017	Mitton, David/0000-0001-9260-0916; Peyrin, Francoise/0000-0002-1988-3435; Laugier, Pascal/0000-0002-7498-0262; haupert, sylvain/0000-0003-4705-4527; Guerard, Sandra/0000-0002-5601-1054	Agence Nationale pour la Recherche (ANR), France [BONUS_07BLAN0197]	Agence Nationale pour la Recherche (ANR), France(French National Research Agency (ANR))	This research was supported by the Agence Nationale pour la Recherche (ANR), France (Grant BONUS_07BLAN0197). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2011, BONE, V49, P56, DOI 10.1016/j.bone.2010.10.159; Arlot ME, 2008, J BONE MINER RES, V23, P1613, DOI 10.1359/JBMR.080517; ASTM, 2008, D6272 ASTM; BEHIRI JC, 1980, J MATER SCI, V15, P1841, DOI 10.1007/BF00550605; Bennell KL, 1998, CALCIFIED TISSUE INT, V63, P505, DOI 10.1007/s002239900565; Boyce TM, 1998, J ORTHOP RES, V16, P322, DOI 10.1002/jor.1100160308; Buehler MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/29/295102; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; Chapurlat RD, 2009, OSTEOPOROSIS INT, V20, P1299, DOI 10.1007/s00198-009-0899-9; CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1; Danova NA, 2003, BONE, V33, P197, DOI 10.1016/S8756-3282(03)00155-8; Diab T, 2006, BONE, V38, P427, DOI 10.1016/j.bone.2005.09.002; Diab T, 2005, BONE, V37, P96, DOI 10.1016/j.bone.2005.03.014; Diab T, 2007, BONE, V40, P612, DOI 10.1016/j.bone.2006.09.027; Donahue Seth W., 2006, Critical Reviews in Biomedical Engineering, V34, P215, DOI 10.1615/CritRevBiomedEng.v34.i3.20; Engan HE, 2006, ULTRASON, P2096, DOI 10.1109/ULTSYM.2006.502; Frost H, 1960, H FORD HOSP MED B, V8, P35; GRANATO A, 1956, J APPL PHYS, V27, P583, DOI 10.1063/1.1722436; Granke M, 2011, BONE, V49, P1020, DOI 10.1016/j.bone.2011.08.002; Griffin LV, 1997, J BIOMECH, V30, P185, DOI 10.1016/S0021-9290(96)00124-8; Gupta HS, 2008, MED ENG PHYS, V30, P1209, DOI 10.1016/j.medengphy.2008.09.007; Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b; Guyer RA, 1999, PHYS TODAY, V52, P30, DOI 10.1063/1.882648; Haupert S, 2011, J ACOUST SOC AM, V130, P2654, DOI 10.1121/1.3641405; Hoff L, 2003, ULTRASON, P1010; Huja SS, 1999, J BIOMECH, V32, P1243, DOI 10.1016/S0021-9290(99)00047-0; Johnson P, 2005, J ACOUST SOC AM, V117, P124, DOI 10.1121/1.1823351; Landrigan MD, 2011, BONE, V48, P443, DOI 10.1016/j.bone.2010.10.160; Landrigan MD, 2009, J BIOMECH, V42, P1212, DOI 10.1016/j.jbiomech.2009.03.016; Larrue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021297; Laugier P, 2008, IEEE T ULTRASON FERR, V55, P1179, DOI 10.1109/TUFFC.2008.782; Lee TC, 2000, J ORTHOPAED RES, V18, P322, DOI 10.1002/jor.1100180222; Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x; Lee TC, 1998, J ANAT, V193, P179, DOI 10.1046/j.1469-7580.1998.19320179.x; Li JL, 2005, BONE, V37, P819, DOI 10.1016/j.bone.2005.06.022; Li ZC, 2011, J NUCL MED, V52, P769, DOI 10.2967/jnumed.110.085456; Martin RB, 2007, BONE, V40, P1159, DOI 10.1016/j.bone.2006.11.014; Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895; Moreschi H, 2011, P I MECH ENG H, V225, P1; Muller M, 2008, J BIOMECH, V41, P1062, DOI 10.1016/j.jbiomech.2007.12.004; Muller M, 2006, ULTRASONICS, V44, pE245, DOI 10.1016/j.ultras.2006.06.043; Muller M, 2005, J ACOUST SOC AM, V118, P3946, DOI 10.1121/1.2126917; Nalla RK, 2005, BIOMATERIALS, V26, P2183, DOI 10.1016/j.biomaterials.2004.05.024; Nicholson PHF, 2000, J BONE MINER RES, V15, P2467, DOI 10.1359/jbmr.2000.15.12.2467; Nicolella DP, 2011, J MECH BEHAV BIOMED, V4, P383, DOI 10.1016/j.jmbbm.2010.11.007; Norman TL, 1997, BONE, V20, P375, DOI 10.1016/S8756-3282(97)00004-5; O'Brien FJ, 2007, INT J FATIGUE, V29, P1051, DOI 10.1016/j.ijfatigue.2006.09.017; O'Brien FJ, 2003, J BIOMECH, V36, P973, DOI 10.1016/S0021-9290(03)00066-6; Payan C, 2010, CEMENT CONCRETE RES, V40, P473, DOI 10.1016/j.cemconres.2009.10.021; Presbitero G, 2012, J THEOR BIOL, V304, P164, DOI 10.1016/j.jtbi.2012.03.027; REIFSNIDER KL, 1982, INT J FATIGUE, V4, P187, DOI 10.1016/0142-1123(82)90001-9; Renaud G, 2008, IEEE T ULTRASON FERR, V55, P1497, DOI 10.1109/TUFFC.2008.825; Renaud G, 2008, INT J NONLIN MECH, V43, P194, DOI 10.1016/j.ijnonlinmec.2007.12.007; Rho JY, 1999, J MATER SCI-MATER M, V10, P485, DOI 10.1023/A:1008901109705; Ritchie RO, 2009, PHYS TODAY, V62, P41, DOI 10.1063/1.3156332; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2; Sobelman OS, 2004, J BIOMECH, V37, P1295, DOI 10.1016/j.jbiomech.2003.12.034; Tai K, 2006, NANO LETT, V6, P2520, DOI 10.1021/nl061877k; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Thurner PJ, 2006, BONE, V39, P289, DOI 10.1016/j.bone.2006.01.147; Ulrich TJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2809565; Van Den Abeele K, 2009, J ACOUST SOC AM, V126, P963, DOI 10.1121/1.3184583; Van den Abeele K, 2001, POLYM COMPOSITE, V22, P555, DOI 10.1002/pc.10559; Van Den Abeele KEA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000368; Van den Abeele KEA, 2000, RES NONDESTRUCT EVAL, V12, P31, DOI 10.1080/09349840009409647; Voide R, 2011, BONE, V49, P1186, DOI 10.1016/j.bone.2011.08.011; Wasserman N, 2008, BONE, V43, P856, DOI 10.1016/j.bone.2008.07.238; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Wynnyckyj C, 2011, J ORTHOP RES, V29, P197, DOI 10.1002/jor.21228; Yeni YN, 2007, J BIOMED MATER RES A, V82A, P530, DOI 10.1002/jbm.a.31169; Yeni YN, 2002, BONE, V30, P509, DOI 10.1016/S8756-3282(01)00696-2; Zacharias K, 2009, J BIOMECH, V42, P581, DOI 10.1016/j.jbiomech.2008.12.018; Zioupos P, 2001, J MICROSC-OXFORD, V201, P270, DOI 10.1046/j.1365-2818.2001.00783.x	75	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83599	10.1371/journal.pone.0083599	http://dx.doi.org/10.1371/journal.pone.0083599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392089	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100013
J	Terzuoli, E; Meini, S; Cucchi, P; Catalani, C; Cialdai, C; Maggi, CA; Giachetti, A; Ziche, M; Donnini, S				Terzuoli, Erika; Meini, Stefania; Cucchi, Paola; Catalani, Claudio; Cialdai, Cecilia; Maggi, Carlo Alberto; Giachetti, Antonio; Ziche, Marina; Donnini, Sandra			Antagonism of Bradykinin B2 Receptor Prevents Inflammatory Responses in Human Endothelial Cells by Quenching the NF-kB Pathway Activation	PLOS ONE			English	Article							FACTOR-KAPPA-B; B-2 RECEPTOR; IN-VITRO; PHARMACOLOGICAL CHARACTERIZATION; RADIOLIGAND BINDING; UP-REGULATION; VE-CADHERIN; KNEE-JOINT; RAT; ANGIOGENESIS	Background: Bradykinin (BK) induces angiogenesis by promoting vessel permeability, growth and remodeling. This study aimed to demonstrate that the B2R antagonist, fasitibant, inhibits the BK pro-angiogenic effects. Methodology: We assesed the ability of fasibitant to antagonize the BK stimulation of cultured human cells (HUVEC) and circulating pro-angiogenic cells (PACs), in producing cell permeability (paracellular flux), migration and pseocapillary formation. The latter parameter was studied in vitro (matrigel assay) and in vivo in mice (matrigel plug) and in rat model of experimental osteoarthritis (OA). We also evaluated NF-kappa B activation in cultured cells by measuring its nuclear translocation and its downstream effectors such as the proangiogenic ciclooxygenase-2 (COX-2), prostaglandin E-2 and vascular endothelial growth factor (VEGF). Principal findings: HUVEC, exposed to BK (1-10 mu M), showed increased permeability, disassembly of adherens and tight-junction, increased cell migration, and pseudocapillaries formation. We observed a significant increase of vessel density in the matrigel assay in mice and in rats OA model. Importantly, B2R stimulation elicited, both in HUVEC and PACs, NF-kappa B activation, leading to COX-2 overexpression, enhanced prostaglandin E-2 production. and VEGF output. The BK/NF-kappa B axis, and the ensuing amplification of inflammatory/angiogenic responses were fully prevented by fasitibant as well as by IKK VII, an NF-kappa B. Inhibitor. Conclusion: This work illustrates the role of the endothelium in the inflammation provoked by the BK/NF-kappa B axis. It also demonstates that B2R blockade by the antaogonist fasibitant, abolishes both the initial stimulus and its amplification, strongly attenuating the propagation of inflammation.	[Terzuoli, Erika; Giachetti, Antonio; Ziche, Marina; Donnini, Sandra] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Meini, Stefania; Cucchi, Paola; Catalani, Claudio; Cialdai, Cecilia; Maggi, Carlo Alberto] Menarini Ric SpA, Dept Pharmacol, Florence, Italy	University of Siena; Menarini Group; University of Florence	Ziche, M (corresponding author), Univ Siena, Dept Life Sci, Via Laterina 8, I-53100 Siena, Italy.	marina.ziche@unisi.it; sandra.donnini@unisi.it	Donnini, Sandra/K-9252-2019; Terzuoli, Erika/M-7346-2016	Donnini, Sandra/0000-0001-6617-1644; Terzuoli, Erika/0000-0001-9248-4505; Ziche, Marina/0000-0002-9564-214X; Meini, Stefania/0000-0002-7155-599X	Fondazione Italiana per la Ricerca sul Cancro (FIRC); Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	Menarini Ricerche S.p.A. provided, in part, the resources for the study. Erika Terzuoli was supported by a fellowship from the Fondazione Italiana per la Ricerca sul Cancro (FIRC). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bas M, 2012, EXPERT REV CLIN IMMU, V8, P707, DOI [10.1586/ECI.12.67, 10.1586/eci.12.67]; Bellucci F, 2009, BRIT J PHARMACOL, V158, P1996, DOI 10.1111/j.1476-5381.2009.00511.x; Bond AP, 1997, IMMUNOPHARMACOLOGY, V36, P209, DOI 10.1016/S0162-3109(97)00023-4; Cao T, 2002, INFLAMM RES, V51, P295, DOI 10.1007/PL00000307; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Charignon D, 2012, EXPERT OPIN PHARMACO, V13, P2233, DOI 10.1517/14656566.2012.723692; Cialdai C, 2009, J PHARMACOL EXP THER, V331, P1025, DOI 10.1124/jpet.109.159657; Cucchi P, 2005, EUR J PHARMACOL, V528, P7, DOI 10.1016/j.ejphar.2005.10.014; Donnini S, 2010, FASEB J, V24, P2385, DOI 10.1096/fj.09-146456; Fincham CI, 2009, EXPERT OPIN THER PAT, V19, P919, DOI 10.1517/13543770902994389; Finetti F, 2009, CIRC RES, V105, P657, DOI 10.1161/CIRCRESAHA.109.203760; Frimm CD, 1996, J MOL CELL CARDIOL, V28, P1279; Gomis A, 2013, OSTEOARTHR CARTILAGE, V21, P1346, DOI 10.1016/j.joca.2013.03.013; Haywood L, 2003, ARTHRITIS RHEUM, V48, P2173, DOI 10.1002/art.11094; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Meini S, 2008, INFLAMM RES, V57, P351, DOI 10.1007/s00011-007-7204-1; Meini S, 2007, BRIT J PHARMACOL, V150, P313, DOI 10.1038/sj.bjp.0706995; Meini S, 2011, BRIT J PHARMACOL, V162, P1202, DOI 10.1111/j.1476-5381.2010.01133.x; Meini S, 2011, BRIT J PHARMACOL, V162, P611, DOI 10.1111/j.1476-5381.2010.01062.x; Meini S, 2010, EUR J PHARMACOL, V635, P34, DOI 10.1016/j.ejphar.2010.03.012; Meini S, 2009, EUR J PHARMACOL, V615, P10, DOI 10.1016/j.ejphar.2009.04.057; Morbidelli L, 1998, BRIT J PHARMACOL, V124, P1286, DOI 10.1038/sj.bjp.0701943; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Parenti A, 2001, FASEB J, V15, P1487, DOI 10.1096/fj.00-0503fje; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Shaw OM, 2011, BIOCHEM BIOPH RES CO, V416, P266, DOI 10.1016/j.bbrc.2011.10.137; Spinetti G, 2011, CIRC RES, V108, P284, DOI 10.1161/CIRCRESAHA.110.236786; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tirziu D, 2012, CIRCULATION, V126, P2589, DOI 10.1161/CIRCULATIONAHA.112.119321; Valenti C, 2010, BRIT J PHARMACOL, V161, P1616, DOI 10.1111/j.1476-5381.2010.00995.x; Valenti C, 2008, EUR J PHARMACOL, V579, P350, DOI 10.1016/j.ejphar.2007.10.025; Walsh DA, 2007, OSTEOARTHR CARTILAGE, V15, P743, DOI 10.1016/j.joca.2007.01.020; Walsh D A, 2001, Curr Opin Investig Drugs, V2, P1054; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wieczorek M, 1997, BIOCHEM PHARMACOL, V54, P283, DOI 10.1016/S0006-2952(97)00186-X; Wohlfart P, 1997, J PHARMACOL EXP THER, V280, P1109	38	41	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84358	10.1371/journal.pone.0084358	http://dx.doi.org/10.1371/journal.pone.0084358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392129	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100052
J	Debiec, R; Christofidou, P; Denniff, M; Bloomer, LD; Bogdanski, P; Wojnar, L; Musialik, K; Charchar, FJ; Thompson, JR; Waterworth, D; Song, KJ; Vollenweider, P; Waeber, G; Zukowska-Szczechowska, E; Samani, NJ; Lambert, D; Tomaszewski, M				Debiec, Radoslaw; Christofidou, Paraskevi; Denniff, Matthew; Bloomer, Lisa D.; Bogdanski, Pawel; Wojnar, Lukasz; Musialik, Katarzyna; Charchar, Fadi J.; Thompson, John R.; Waterworth, Dawn; Song, Kijoung; Vollenweider, Peter; Waeber, Gerard; Zukowska-Szczechowska, Ewa; Samani, Nilesh J.; Lambert, David; Tomaszewski, Maciej			Urotensin-II System in Genetic Control of Blood Pressure and Renal Function	PLOS ONE			English	Article							ESSENTIAL-HYPERTENSION; RECEPTOR GENE; ASSOCIATION; RAT; EXPRESSION; LINKAGE; PEPTIDE; IMMUNOREACTIVITY; VASOCONSTRICTOR; POLYMORPHISMS	Urotensin-II controls ion/water homeostasis in fish and vascular tone in rodents. We hypothesised that common genetic variants in urotensin-II pathway genes are associated with human blood pressure or renal function. We performed family-based analysis of association between blood pressure, glomerular filtration and genes of the urotensin-II pathway (urotensin-II, urotensin-II related peptide, urotensin-II receptor) saturated with 28 tagging single nucleotide polymorphisms in 2024 individuals from 520 families; followed by an independent replication in 420 families and 7545 unrelated subjects. The expression studies of the urotensin-II pathway were carried out in 97 human kidneys. Phylogenetic evolutionary analysis was conducted in 17 vertebrate species. One single nucleotide polymorphism (rs531485 in urotensin-II gene) was associated with adjusted estimated glomerular filtration rate in the discovery cohort (p = 0.0005). It showed no association with estimated glomerular filtration rate in the combined replication resource of 8724 subjects from 6 populations. Expression of urotensin-II and its receptor showed strong linear correlation (r = 0.86, p<0.0001). There was no difference in renal expression of urotensin-II system between hypertensive and normotensive subjects. Evolutionary analysis revealed accumulation of mutations in urotensin-II since the divergence of primates and weaker conservation of urotensin-II receptor in primates than in lower vertebrates. Our data suggest that urotensin-II system genes are unlikely to play a major role in genetic control of human blood pressure or renal function. The signatures of evolutionary forces acting on urotensin-II system indicate that it may have evolved towards loss of function since the divergence of primates.	[Debiec, Radoslaw; Christofidou, Paraskevi; Denniff, Matthew; Bloomer, Lisa D.; Thompson, John R.; Samani, Nilesh J.; Lambert, David; Tomaszewski, Maciej] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Bogdanski, Pawel; Musialik, Katarzyna] Med Univ Poznan, Dept Internal Med Metab Disorders & Hypertens, Poznan, Poland; [Wojnar, Lukasz] Med Univ Poznan, Dept Urol & Oncol Urol, Poznan, Poland; [Charchar, Fadi J.] Univ Ballarat, Sch Sci & Engn, Ballarat, Vic 3353, Australia; [Waterworth, Dawn; Song, Kijoung] GlaxoSmithKline, Philadelphia, PA USA; [Vollenweider, Peter; Waeber, Gerard] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland; [Zukowska-Szczechowska, Ewa] Med Univ Silesia, Dept Internal Med Diabetol & Nephrol, Zabrze, Poland	University of Leicester; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Federation University Australia; GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Medical University Silesia	Tomaszewski, M (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	mt142@le.ac.uk	Bogdański, Paweł/ABB-2938-2020; Charchar, Fadi/I-6656-2017; Colaus, PsyColaus/K-6607-2013	Bogdański, Paweł/0000-0002-0563-1624; Charchar, Fadi/0000-0002-6164-9941; Waeber, Gerard/0000-0003-4193-788X; Musialik, Katarzyna Maria/0000-0003-3299-5455; Tomaszewski, Maciej/0000-0001-8215-6567; Debiec, Radoslaw/0000-0003-2292-467X	University of Leicester Anniversary Scholarship; National Institute for Health Research [ACF-2012-11-001] Funding Source: researchfish	University of Leicester Anniversary Scholarship; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the University of Leicester Anniversary Scholarship to RD, DL and MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar N, 2004, PEPTIDES, V25, P1339, DOI 10.1016/j.peptides.2004.05.015; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Behm DJ, 2004, EUR J PHARMACOL, V492, P113, DOI 10.1016/j.ejphar.2004.03.059; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Charles CJ, 2005, PEPTIDES, V26, P2211, DOI 10.1016/j.peptides.2005.03.043; Cheung BMY, 2004, J HYPERTENS, V22, P1341, DOI 10.1097/01.hjh.0000125452.28861.f1; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; Delport W, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000885; DEWARDENER HE, 1978, AM J PHYSIOL, V235, pF163, DOI 10.1152/ajprenal.1978.235.3.F163; Dikensoy E, 2010, EUR J OBSTET GYN R B, V151, P140, DOI 10.1016/j.ejogrb.2010.03.030; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; Douglas SA, 2002, LANCET, V359, P1990, DOI 10.1016/S0140-6736(02)08831-1; Douglas SA, 2000, BRIT J PHARMACOL, V131, P1262, DOI 10.1038/sj.bjp.0703690; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; Hassan GS, 2005, PEPTIDES, V26, P2464, DOI 10.1016/j.peptides.2005.05.028; Heringlake M, 2004, REGUL PEPTIDES, V121, P129, DOI 10.1016/j.regpep.2004.04.012; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Langham RG, 2004, AM J KIDNEY DIS, V44, P826, DOI 10.1053/j.ajkd.2004.07.021; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marco J, 2008, PEPTIDES, V29, P852, DOI 10.1016/j.peptides.2007.08.025; Matsushita M, 2001, J HYPERTENS, V19, P2185, DOI 10.1097/00004872-200112000-00011; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ong KL, 2006, PEPTIDES, V27, P1659, DOI 10.1016/j.peptides.2006.02.008; PEARSON D, 1980, P NATL ACAD SCI-BIOL, V77, P5021, DOI 10.1073/pnas.77.8.5021; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Prosser HCG, 2006, PEPTIDES, V27, P3261, DOI 10.1016/j.peptides.2006.09.012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shenouda A, 2002, J HISTOCHEM CYTOCHEM, V50, P885, DOI 10.1177/002215540205000702; Shi Y, 2008, PEPTIDES, V29, P783, DOI 10.1016/j.peptides.2008.02.015; Tobin MD, 2008, HYPERTENSION, V51, P1658, DOI 10.1161/HYPERTENSIONAHA.108.112664; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Tomaszewski M, 2002, HYPERTENSION, V40, P286, DOI 10.1161/01.HYP.0000029105.21202.FE; Tomaszewski M, 2007, CIRCULATION, V116, P1915, DOI 10.1161/CIRCULATIONAHA.107.710293; Tomaszewski M, 2011, J AM SOC NEPHROL, V22, P947, DOI 10.1681/ASN.2010080829; Tomaszewski M, 2010, HYPERTENSION, V56, P1069, DOI 10.1161/HYPERTENSIONAHA.110.155721; Tomaszewski M, 2009, ARTERIOSCL THROM VAS, V29, P1316, DOI 10.1161/ATVBAHA.109.185355; Totsune K, 2001, LANCET, V358, P810, DOI 10.1016/S0140-6736(01)06002-0; Vaudry H, 2010, ANN NY ACAD SCI, V1200, P53, DOI 10.1111/j.1749-6632.2010.05514.x; Vogt L, 2010, HYPERTENSION, V55, P1206, DOI 10.1161/HYPERTENSIONAHA.109.149559; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Yi L, 2006, J INT MED RES, V34, P272, DOI 10.1177/147323000603400306; Zhang AY, 2003, AM J PHYSIOL-RENAL, V285, pF792, DOI 10.1152/ajprenal.00342.2002	50	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83137	10.1371/journal.pone.0083137	http://dx.doi.org/10.1371/journal.pone.0083137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391740	Green Published, gold			2022-12-27	WOS:000329325200037
J	Gao, P; Wang, B; Geng, GP; Zhang, GC				Gao Peng; Wang Bing; Geng Guangpo; Zhang Guangcan			Spatial Distribution of Soil Organic Carbon and Total Nitrogen Based on GIS and Geostatistics in a Small Watershed in a Hilly Area of Northern China	PLOS ONE			English	Article							LAND-USE CHANGE; LOESS PLATEAU; PREDICTION; SEQUESTRATION; CATCHMENT; VARIABLES	The spatial variability of soil organic carbon (SOC) and total nitrogen (STN) levels is important in both global carbon-nitrogen cycle and climate change research. There has been little research on the spatial distribution of SOC and STN at the watershed scale based on geographic information systems (GIS) and geostatistics. Ninety-seven soil samples taken at depths of 0-20 cm were collected during October 2010 and 2011 from the Matiyu small watershed (4.2 km(2)) of a hilly area in Shandong Province, northern China. The impacts of different land use types, elevation, vegetation coverage and other factors on SOC and STN spatial distributions were examined using GIS and a geostatistical method, regression-kriging. The results show that the concentration variations of SOC and STN in the Matiyu small watershed were moderate variation based on the mean, median, minimum and maximum, and the coefficients of variation (CV). Residual values of SOC and STN had moderate spatial autocorrelations, and the Nugget/Sill were 0.2% and 0.1%, respectively. Distribution maps of regression-kriging revealed that both SOC and STN concentrations in the Matiyu watershed decreased from southeast to northwest. This result was similar to the watershed DEM trend and significantly correlated with land use type, elevation and aspect. SOC and STN predictions with the regression-kriging method were more accurate than those obtained using ordinary kriging. This research indicates that geostatistical characteristics of SOC and STN concentrations in the watershed were closely related to both land-use type and spatial topographic structure and that regression-kriging is suitable for investigating the spatial distributions of SOC and STN in the complex topography of the watershed.	[Gao Peng; Geng Guangpo; Zhang Guangcan] Shandong Agr Univ, Coll Forestry, Taishan Mt Forest Ecosyst Res Stn, Shandong Prov Key Lab Soil Eros & Ecol Restorat, Tai An, Shandong, Peoples R China; [Wang Bing] Chinese Acad Forestry, Res Inst Forest Ecol Environm Protect, Beijing, Peoples R China	Shandong Agricultural University; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Gao, P (corresponding author), Shandong Agr Univ, Coll Forestry, Taishan Mt Forest Ecosyst Res Stn, Shandong Prov Key Lab Soil Eros & Ecol Restorat, Tai An, Shandong, Peoples R China.	gaopengy@163.com; wangbing@caf.ac.cn			Special Fund for Forestry Scientific Research in the Public Interest [201204101]; National Basic Research and Development Program of China (973 Program) [2011CB403201, 2012CB416904]; CFERN&GENE Award Funds on Ecological Paper	Special Fund for Forestry Scientific Research in the Public Interest; National Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); CFERN&GENE Award Funds on Ecological Paper	This research was funded by the Special Fund for Forestry Scientific Research in the Public Interest (No. 201204101), the National Basic Research and Development Program of China (973 Program, Nos. 2011CB403201 and 2012CB416904), and was subsidized by CFERN&GENE Award Funds on Ecological Paper. Funders had a role in the data collection and decision to publish the manuscript.	[Anonymous], 1982, AGRONOMY MONOGRAPH; Batjes NH, 1997, GLOBAL CHANGE BIOL, V3, P161, DOI 10.1046/j.1365-2486.1997.00062.x; Cao LiHua, 2007, Journal of Northwest A & F University - Natural Science Edition, V35, P177; Dou FG, 2010, GEODERMA, V154, P328, DOI 10.1016/j.geoderma.2009.10.020; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Fang X, 2012, CATENA, V88, P6, DOI 10.1016/j.catena.2011.07.012; Fantappie M, 2011, GEOMORPHOLOGY, V135, P343, DOI 10.1016/j.geomorph.2011.02.006; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harris P, 2010, MATH GEOSCI, V42, P657, DOI 10.1007/s11004-010-9284-7; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; HICKS RR, 1984, FOREST ECOL MANAG, V8, P281, DOI 10.1016/0378-1127(84)90060-4; Kucharik CJ, 2001, ECOSYSTEMS, V4, P237, DOI 10.1007/s10021\N001\N0007-2; Kumar S, 2012, GEODERMA, V189, P627, DOI 10.1016/j.geoderma.2012.05.022; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li Y, 2010, GEODERMA, V159, P63, DOI 10.1016/j.geoderma.2010.06.017; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; LIU S., 2010, J GEOINFORMATION SCI, V12, P180; Lu WD, 2005, SPSS12 0 WINDOWS STA, P1; McGrath DA, 2001, ECOSYSTEMS, V4, P625, DOI 10.1007/s10021-001-0033-0; Mohammadi J, 2011, PEDOSPHERE, V21, P389, DOI 10.1016/S1002-0160(11)60140-9; ODEH IOA, 1995, GEODERMA, V67, P215, DOI 10.1016/0016-7061(95)00007-B; Simbahan GC, 2006, GEODERMA, V132, P471, DOI 10.1016/j.geoderma.2005.07.001; Stacey KF, 2006, GEODERMA, V135, P107, DOI 10.1016/j.geoderma.2005.11.008; Su ZY, 2006, PEDOSPHERE, V16, P10, DOI 10.1016/S1002-0160(06)60020-9; Sumfleth K, 2008, ECOL INDIC, V8, P485, DOI 10.1016/j.ecolind.2007.05.005; Sun W, 2012, GEODERMA, V171, P16, DOI 10.1016/j.geoderma.2011.02.010; Tan ZX, 2005, AGR ECOSYST ENVIRON, V111, P140, DOI 10.1016/j.agee.2005.05.012; Tesfahunegn GB, 2011, SOIL TILL RES, V117, P124, DOI 10.1016/j.still.2011.09.005; Wang HJ, 2009, SOIL TILL RES, V105, P300, DOI 10.1016/j.still.2008.08.010; Wang HQ, 2002, LANDSCAPE ECOL, V17, P671, DOI 10.1023/A:1022962116313; Wang J, 2003, CATENA, V54, P17, DOI 10.1016/S0341-8162(03)00054-7; [王库 Wang Ku], 2013, [中国农学通报, Chinese Agricultural Science Bulletin], V29, P142; Wang YQ, 2009, PEDOSPHERE, V19, P486, DOI 10.1016/S1002-0160(09)60141-7; Zhang SW, 2012, GEODERMA, V171, P35, DOI 10.1016/j.geoderma.2011.07.012; Zhao YongCun, 2005, Acta Pedologica Sinica, V42, P379; Zhao Zhong, 2000, Yingyong Shengtai Xuebao, V11, P37	36	23	29	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83592	10.1371/journal.pone.0083592	http://dx.doi.org/10.1371/journal.pone.0083592			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391791	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200088
J	Gregori, J; Esteban, JI; Cubero, M; Garcia-Cehic, D; Perales, C; Casillas, R; Alvarez-Tejado, M; Rodriguez-Frias, F; Guardia, J; Domingo, E; Quer, J				Gregori, Josep; Esteban, Juan I.; Cubero, Maria; Garcia-Cehic, Damir; Perales, Celia; Casillas, Rosario; Alvarez-Tejado, Miguel; Rodriguez-Frias, Francisco; Guardia, Jaume; Domingo, Esteban; Quer, Josep			Ultra-Deep Pyrosequencing (UDPS) Data Treatment to Study Amplicon HCV Minor Variants	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GENERATION SEQUENCING DATA; QUASI-SPECIES RECONSTRUCTION; ERROR-CORRECTION; INFECTION; POPULATION; RESISTANCE; DIVERSITY; ACCURACY; SOFTWARE	We have investigated the reliability and reproducibility of HCV viral quasispecies quantification by ultra-deep pyrosequencing (UDPS) methods. Our study has been divided in two parts. First of all, by UDPS sequencing of clone mixes samples we have established the global noise level of UDPS and fine tuned a data treatment workflow previously optimized for HBV sequence analysis. Secondly, we have studied the reproducibility of the methodology by comparing 5 amplicons from two patient samples on three massive sequencing platforms (FLX+, FLX and Junior) after applying the error filters developed from the clonal/control study. After noise filtering the UDPS results, the three replicates showed the same 12 polymorphic sites above 0.7%, with a mean CV of 4.86%. Two polymorphic sites below 0.6% were identified by two replicates and one replicate respectively. A total of 25, 23 and 26 haplotypes were detected by GS-Junior, GS-FLX and GS-FLX+. The observed CVs for the normalized Shannon entropy (Sn), the mutation frequency (Mf), and the nucleotidic diversity (Pi) were 1.46%, 3.96% and 3.78%. The mean absolute difference in the two patients (5 amplicons each), in the GS-FLX and GS-FLX+, were 1.46%, 3.96% and 3.78% for Sn, Mf and Pi. No false polymorphic site was observed above 0.5%. Our results indicate that UDPS is an optimal alternative to molecular cloning for quantitative study of HCV viral quasispecies populations, both in complexity and composition. We propose an UDPS data treatment workflow for amplicons from the RNA viral quasispecies which, at a sequencing depth of at least 10,000 reads per strand, enables to obtain sequences and frequencies of consensus haplotypes above 0.5% abundance with no erroneous mutations, with high confidence, resistant mutants as minor variants at the level of 1%, with high confidence that variants are not missed, and highly confident measures of quasispecies complexity.	[Gregori, Josep; Esteban, Juan I.; Cubero, Maria; Garcia-Cehic, Damir; Casillas, Rosario; Guardia, Jaume; Quer, Josep] VHIR HUVH, Lab Malalties Hepatiques, Liver Unit, Barcelona, Spain; [Gregori, Josep; Alvarez-Tejado, Miguel] Roche Diagnost SL, Sant Cugat Del Valles, Spain; [Esteban, Juan I.; Cubero, Maria; Garcia-Cehic, Damir; Perales, Celia; Rodriguez-Frias, Francisco; Guardia, Jaume; Domingo, Esteban; Quer, Josep] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Esteban, Juan I.; Rodriguez-Frias, Francisco; Guardia, Jaume; Quer, Josep] Univ Autonoma Barcelona, Bellaterra, Spain; [Perales, Celia; Domingo, Esteban] UAM, Ctr Biol Mol Severo Ochoa CBM, Madrid, Spain; [Casillas, Rosario; Rodriguez-Frias, Francisco] HUVH, Biochem Unit, Barcelona, Spain	Roche Holding; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitari Vall d'Hebron	Gregori, J (corresponding author), VHIR HUVH, Lab Malalties Hepatiques, Liver Unit, Barcelona, Spain.	josep.gregori@vhir.org	Quer, Josep/A-6741-2012; Rodriguez-Frias, Francisco/AAC-3507-2020; Gregori, Josep/J-2586-2015; Domingo, Esteban/K-3937-2014	Quer, Josep/0000-0003-0014-084X; Gregori, Josep/0000-0002-4253-8015; Perales Viejo, Celia Belen/0000-0003-1618-1937; Casillas, Rosario/0000-0002-6758-6734; rodriguez-frias, francisco/0000-0002-9128-7013; Garcia-Cehic, Damir/0000-0002-0009-038X; Domingo, Esteban/0000-0002-0573-1676	CDTI (Centro para el Desarrollo Tecnologico Industrial); Spanish Ministry of Economics and Competitiveness (MINECO) [IDI-20110115]; MINECO projects [SAF 2009-10403]; Spanish Ministry of Health Instituto de Salud Carlos III (FISS) projects [PI10/01505]; Instituto de Salud Carlos III, Madrid; FIPSE; Fundacion Ramon.Areces;  [BFU2011-23604]	CDTI (Centro para el Desarrollo Tecnologico Industrial); Spanish Ministry of Economics and Competitiveness (MINECO)(Spanish Government); MINECO projects(Spanish Government); Spanish Ministry of Health Instituto de Salud Carlos III (FISS) projects; Instituto de Salud Carlos III, Madrid(Instituto de Salud Carlos III); FIPSE; Fundacion Ramon.Areces; 	This study has been supported by CDTI (Centro para el Desarrollo Tecnologico Industrial), Spanish Ministry of Economics and Competitiveness (MINECO), IDI-20110115. It has also been supported by MINECO projects SAF 2009-10403, and also by the Spanish Ministry of Health Instituto de Salud Carlos III (FISS) projects PI10/01505. CIBERehd is funded by the Instituto de Salud Carlos III, Madrid. Work at CBMSO was supported by grant BFU2011-23604, FIPSE and Fundacion Ramon.Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; C ore Team R, 2012, R LANG ENV STAT COMP; Cubero M, 2008, VIROLOGY, V370, P237, DOI 10.1016/j.virol.2007.10.006; Domingo E, 1988, RNA GENETICS, P3; Domingo Esteban, 1994, P161; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Herrmann E, 2000, ANTIVIR THER, V5, P85; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Kwong Ann D, 2011, Gastroenterology, V140, P755, DOI 10.1053/j.gastro.2011.01.029; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; OKAMOTO H, 1992, VIROLOGY, V190, P894, DOI 10.1016/0042-6822(92)90933-G; Pabinger S, 2013, BRIEF BIOINFORM; Pages H, 2012, BIOSTRINGS STRING OB; Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627; Prosperi MCF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-5; Quer J, 2005, J VIROL, V79, P15131, DOI 10.1128/JVI.79.24.15131-15141.2005; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Vermehren J, 2012, J VIRAL HEPATITIS, V19, P120, DOI 10.1111/j.1365-2893.2011.01449.x; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Zagordi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047046; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164	35	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83361	10.1371/journal.pone.0083361	http://dx.doi.org/10.1371/journal.pone.0083361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391758	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200055
J	Han, WGH; van Twillert, I; Poelen, MCM; Helm, K; van de Kassteele, J; Verheij, TJM; Versteegh, FGA; Boog, CJP; van Els, CACM				Han, Wanda G. H.; van Twillert, Inonge; Poelen, Martien C. M.; Helm, Kina; van de Kassteele, Jan; Verheij, Theo J. M.; Versteegh, Florens G. A.; Boog, Claire J. P.; van Els, Cecile A. C. M.			Loss of Multi-Epitope Specificity in Memory CD4(+) T Cell Responses to B-Pertussis with Age	PLOS ONE			English	Article							FACTOR P.69 PERTACTIN; ACELLULAR PERTUSSIS; WHOLE-CELL; RESPIRATORY-INFECTION; PRIMARY VACCINATION; UNITED-STATES; IMMUNITY; IMMUNODOMINANCE; CHILDREN; VACCINES	Pertussis is still occurring in highly vaccinated populations, affecting individuals of all ages. Long-lived Th1 CD4(+) T cells are essential for protective immunity against pertussis. For better understanding of the limited immunological memory to Bordetella pertussis, we used a panel of Pertactin and Pertussis toxin specific peptides to interrogate CD4(+) T cell responses at the epitope level in a unique cohort of symptomatic pertussis patients of different ages, at various time intervals after infection. Our study showed that pertussis epitope-specific T cell responses contained Th1 and Th2 components irrespective of the epitope studied, time after infection, or age. In contrast, the breadth of the pertussis-directed CD4(+) T cell response seemed dependent on age and closeness to infection. Multi-epitope specificity long-term after infection was lost in older age groups. Detailed knowledge on pertussis specific immune mechanisms and their insufficiencies is important for understanding resurgence of pertussis in highly vaccinated populations.	[Han, Wanda G. H.; van Twillert, Inonge; Poelen, Martien C. M.; Helm, Kina; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm, Ctr Immunol Infect Dis & Vaccines, NL-3720 BA Bilthoven, Netherlands; [van de Kassteele, Jan] Natl Inst Publ Hlth & Environm, Dept Stat Math Modelling & Data Logist, NL-3720 BA Bilthoven, Netherlands; [Verheij, Theo J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Versteegh, Florens G. A.] Groene Hart Ziekenhuis, Dept Pediat, Gouda, Netherlands; [Boog, Claire J. P.] Inst Translat Vaccinol, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Han, WGH (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Immunol Infect Dis & Vaccines, NL-3720 BA Bilthoven, Netherlands.	wanda.han@rivm.nl		Versteegh, Florens G.A./0000-0003-4773-5592; van de Kassteele, Jan/0000-0001-5926-6709	Dutch government	Dutch government	This work was funded by the Dutch government. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R, 1997, Commun Dis Intell, V21, P145; Ausiello CM, 1997, INFECT IMMUN, V65, P2168, DOI 10.1128/IAI.65.6.2168-2174.1997; Barnard A, 1996, IMMUNOLOGY, V87, P372, DOI 10.1046/j.1365-2567.1996.497560.x; BASS JW, 1994, PEDIATR INFECT DIS J, V13, P343, DOI 10.1097/00006454-199405000-00002; Bouchez V, 2009, VACCINE, V27, P6034, DOI 10.1016/j.vaccine.2009.07.074; Bruss JB, 1999, CLIN DIAGN LAB IMMUN, V6, P464, DOI 10.1128/CDLI.6.4.464-470.1999; Carollo M, 2012, VACCINE, V30, P1667, DOI 10.1016/j.vaccine.2011.12.104; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; De Serres G, 1995, Can Commun Dis Rep, V21, P45; DEMAGISTRIS MT, 1989, J EXP MED, V169, P1519, DOI 10.1084/jem.169.5.1519; deMelker HE, 1997, EMERG INFECT DIS, V3, P175, DOI 10.3201/eid0302.970211; Esposito S, 2001, INFECT IMMUN, V69, P4516, DOI 10.1128/IAI.69.7.4516-4520.2001; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gazagne A, 2003, J IMMUNOL METHODS, V283, P91, DOI 10.1016/j.jim.2003.08.013; Greenland S, 2006, INT J EPIDEMIOL, V35, P765, DOI 10.1093/ije/dyi312; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Gzyl A, 2004, INT J EPIDEMIOL, V33, P358, DOI 10.1093/ije/dyh012; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hijnen M, 2005, PROTEIN EXPRES PURIF, V41, P106, DOI 10.1016/j.pep.2005.01.014; Hodder SL, 2000, CLIN INFECT DIS, V31, P7, DOI 10.1086/313913; Kwok WW, 2012, J IMMUNOL, V188, P2537, DOI 10.4049/jimmunol.1102190; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Leef M, 2000, J EXP MED, V191, P1841, DOI 10.1084/jem.191.11.1841; Mahon BP, 2000, J INFECT DIS, V181, P2087, DOI 10.1086/315527; Mahon BP, 1997, J EXP MED, V186, P1843, DOI 10.1084/jem.186.11.1843; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Moore SM, 2006, J CLIN IMMUNOL, V26, P533, DOI 10.1007/s10875-006-9044-0; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; PEPPOLONI S, 1991, INFECT IMMUN, V59, P3768, DOI 10.1128/IAI.59.10.3768-3773.1991; Probst HC, 2003, J IMMUNOL, V171, P5415, DOI 10.4049/jimmunol.171.10.5415; REDHEAD K, 1993, INFECT IMMUN, V61, P3190, DOI 10.1128/IAI.61.8.3190-3198.1993; Ryan M, 1998, IMMUNOLOGY, V93, P1, DOI 10.1046/j.1365-2567.1998.00401.x; Sallusto F, 2011, NAT MED, V17, P1182, DOI 10.1038/nm.2502; Schindowski K, 2002, MECH AGEING DEV, V123, P375, DOI 10.1016/S0047-6374(01)00396-7; Schure RM, 2012, CLIN VACCINE IMMUNOL, V19, P1879, DOI 10.1128/CVI.00277-12; Schure RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041928; Sharma SK, 2012, CLIN EXP IMMUNOL, V169, P281, DOI 10.1111/j.1365-2249.2012.04613.x; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Stenger RM, 2009, INFECT IMMUN, V77, P896, DOI 10.1128/IAI.00769-08; Storsaeter J, 1998, VACCINE, V16, P1907, DOI 10.1016/S0264-410X(98)00227-8; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; van Hall T, 2006, NAT MED, V12, P417, DOI 10.1038/nm1381; Vermeulen F, 2010, CLIN VACCINE IMMUNOL, V17, P258, DOI 10.1128/CVI.00328-09; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; White OJ, 2012, VACCINE, V30, P1865, DOI 10.1016/j.vaccine.2011.12.118; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603	51	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83583	10.1371/journal.pone.0083583	http://dx.doi.org/10.1371/journal.pone.0083583			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391789	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200086
J	Jiang, WB; Zhu, JQ; Song, C; Li, XY; Yang, Y; Yu, WD				Jiang, Weibin; Zhu, Jianqing; Song, Chao; Li, Xiaoyan; Yang, Yue; Yu, Weidong			Molecular Phylogeny of the Butterfly Genus Polytremis (Hesperiidae, Hesperiinae, Baorini) in China	PLOS ONE			English	Article							BEETLES COLEOPTERA; LEPIDOPTERA; EVOLUTION; BIOLOGY	Background: The genus Polytremis, restricted to the continental part of the southeastern Palaearctic and northern Oriental regions, is one of the largest and most diverse lineages of the tribe Baorini. Previous studies on the genus were focused mainly on morphological classification and identification of new species. Due to the lack of effective and homologous traits of morphology, there were many challenges in the traditional classification. In this report, we reconstruct the phylogeny to provide a solid framework for these studies and to test the traditional limits and relationships of taxa. Methodology and Principal Findings: We sequenced a mitochondrial and three nuclear gene fragments, coupled with an evaluation of traditional morphological characters, to determine the phylogenetic relationships for a total of 15 species representing all major species groups of the Polytremis genus in China, and to elucidate their taxonomic status. Conclusions and Significance: Analysis of mitochrondial and nuclear DNA showed considerable congruent phylogenetic signal in topology at the inter-species level. We found strong support for the monophyly of Polytremis and some clades were recognized with morphological data. Thus, the COI sequence in our study could be used as a DNA barcode to identify almost all members of the genus. However, incongruences of phylogenetic analyses occurred: in contrast to the phylogenetic trees of mitochondrial COI, it was not possible for nuclear rDNA to discriminate P. gotama from P. caerulescens, suggesting a possible recent separation of these two species. Additionally, P. theca was the only species with a greater intraspecific genetic distance compared to some inter-specific genetic distances in this study and some problems associated with the cryptic diversity of the species are discussed. The results of this study will helpful to reveal the causes of the high degree of diversity of butterflies, and possibly other groups of insects in China.	[Jiang, Weibin; Song, Chao; Li, Xiaoyan; Yang, Yue; Yu, Weidong] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Zhu, Jianqing] Shanghai Zool Pk, Shanghai, Peoples R China	Shanghai Normal University	Zhu, JQ (corresponding author), Shanghai Zool Pk, Shanghai, Peoples R China.	zzzjjq@gmail.com; yuwd0127@gmail.com	Yu, Wei/GZL-3831-2022		Shanghai Municipal Education Commission [14YZ068]; Shanghai Normal University [SK201340]	Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Normal University	This study was financially supported by grants from Shanghai Municipal Education Commission (No. 14YZ068) and Shanghai Normal University (No. SK201340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boggs CL, 2003, BUTTERFLIES EVOLUTIO, P14; Chou I., 1994, MONOGRAPHIA RHOPALOC; Eastwood R, 2003, MOL PHYLOGENET EVOL, V27, P93, DOI 10.1016/S1055-7903(02)00370-6; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Eliot JN, 1992, BUTTERFLIES MALAY PE, P384; Evans WH, 1949, CATALOGUE HESPERIIDA, P1; Fan XL, 2006, THESIS S CHINA AGR U; Fordyce JA, 2008, ANN ENTOMOL SOC AM, V101, P794, DOI 10.1603/0013-8746(2008)101[794:POGVBT]2.0.CO;2; Forister ML, 2004, MOL ECOL, V13, P3489, DOI 10.1111/j.1365-294X.2004.02349.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gillespie JJ, 2008, ZOOL SCR, V37, P195, DOI 10.1111/j.1463-6409.2007.00320.x; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff P, 2008, CLADISTICS, V24, P91; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huang Hao, 2003, Neue Entomologische Nachrichten, V55, P3; Huang Hao, 2002, Atalanta (Marktleuthen), V33, P109; Hwang UW, 2000, ZOOL SCI, V17, P111, DOI 10.2108/zsj.17.111; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Liu J, 2011, MOL ECOL, V20, P4332, DOI 10.1111/j.1365-294X.2011.05275.x; Maddison WP, 2009, MESQUITE MODULAR SYS; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nixon KC, 2008, WINCLADA VER 1 7; Oliver JC, 2007, MOL ECOL, V16, P4308, DOI 10.1111/j.1365-294X.2007.03494.x; Rand DB, 2000, MOL PHYLOGENET EVOL, V17, P85, DOI 10.1006/mpev.2000.0820; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sugiyama H, 1999, PALLARGE, V6, P1; Sugiyama Hitoshi, 1999, Pallarge, V7, P1; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tsukiyama H, 1997, JAPANESE BUTTERFLIES, VI, P292; Vodolazhsky DI, 2010, MOSCOW U BIOL SCI B, V65, P158; Warren AD, 2008, CLADISTICS, V24, P642, DOI 10.1111/j.1096-0031.2008.00218.x; Warren AD, 2009, SYST ENTOMOL, V34, P467, DOI 10.1111/j.1365-3113.2008.00463.x; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zakharov EV, 2009, HEREDITY, V102, P590, DOI 10.1038/hdy.2009.26; Zhu JQ, 2012, ZOOTAXA, P63, DOI 10.11646/zootaxa.3274.1.7; Zhu JQ, 2012, THESIS SHANGHAI NORM	47	31	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84098	10.1371/journal.pone.0084098	http://dx.doi.org/10.1371/journal.pone.0084098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391893	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900036
J	Li, L; Nadanaciva, S; Berger, Z; Shen, W; Paumier, K; Schwartz, J; Mou, K; Loos, P; Milici, AJ; Dunlop, J; Hirst, WD				Li, Li; Nadanaciva, Sashi; Berger, Zdenek; Shen, Wei; Paumier, Katrina; Schwartz, Joel; Mou, Kewa; Loos, Paula; Milici, Anthony J.; Dunlop, John; Hirst, Warren D.			Human A53T alpha-Synuclein Causes Reversible Deficits in Mitochondrial Function and Dynamics in Primary Mouse Cortical Neurons	PLOS ONE			English	Article							AXONAL-TRANSPORT; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; MUTANT HUNTINGTIN; AUTOPHAGY; LOCALIZATION; MUTATIONS; PROTEIN; DEGENERATION; MITOPHAGY	Parkinson's disease (PD) is the second most common neurodegenerative disease. A key pathological feature of PD is Lewy bodies, of which the major protein component is a-synuclein (alpha-syn). Human genetic studies have shown that mutations (A53T, A30P, E46K) and multiplication of the a-syn gene are linked to familial PD. Mice overexpressing the human A53T mutant a-syn gene develop severe movement disorders. However, the molecular mechanisms of alpha-syn toxicity are not well understood. Recently, mitochondrial dysfunction has been linked with multiple neurodegenerative diseases including Parkinson's disease. Here we investigated whether mitochondrial motility, dynamics and respiratory function are affected in primary neurons from a mouse model expressing the human A53T mutation. We found that mitochondrial motility was selectively inhibited in A53T neurons while transport of other organelles was not affected. In addition, A53T expressing neurons showed impairment in mitochondrial membrane potential and mitochondrial respiratory function. Furthermore, we found that rapamycin, an autophagy inducer, rescued the decreased mitochondrial mobility. Taken together, these data demonstrate that A53T a-syn impairs mitochondrial function and dynamics and the deficit of mitochondrial transport is reversible, providing further understanding of the disease pathogenesis and a potential therapeutic strategy for PD.	[Li, Li; Berger, Zdenek; Shen, Wei; Paumier, Katrina; Schwartz, Joel; Mou, Kewa; Loos, Paula; Milici, Anthony J.; Dunlop, John; Hirst, Warren D.] Pfizer Inc, Neurosci Res Unit, Cambridge, MA USA; [Nadanaciva, Sashi] Pfizer Inc, Compound Safety Predict Grp, Groton, CT 06340 USA	Pfizer; Pfizer	Hirst, WD (corresponding author), Pfizer Inc, Neurosci Res Unit, Cambridge, MA USA.	warren.hirst@pfizer.com		Hirst, Warren/0000-0003-0389-8891	Michael J Fox Foundation	Michael J Fox Foundation	This work was funded, in part, by a grant from the Michael J Fox Foundation. www.michaeljfox.org. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin TA, 2011, MOL PSYCHIATR, V16, P122, DOI 10.1038/mp.2010.110; Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012; BANKER G, 1998, CULTURING NERVE CELL; BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brickley K, 2011, J BIOL CHEM, V286, P18079, DOI 10.1074/jbc.M111.236018; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chang KT, 2011, P NATL ACAD SCI USA, V108, P15456, DOI 10.1073/pnas.1106862108; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P895, DOI 10.1101/pdb.prot5641; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen YM, 2013, J CELL BIOL, V202, P351, DOI 10.1083/jcb.201302040; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Choubey V, 2011, J BIOL CHEM, V286, P10814, DOI 10.1074/jbc.M110.132514; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gui YX, 2012, NEUROBIOL AGING, V33, P2841, DOI 10.1016/j.neurobiolaging.2012.02.001; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hardy J, 2009, CURR OPIN GENET DEV, V19, P254, DOI 10.1016/j.gde.2009.03.008; Hettiarachchi NT, 2009, J NEUROCHEM, V111, P1192, DOI 10.1111/j.1471-4159.2009.06411.x; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kim-Han JS, 2011, J NEUROSCI, V31, P7212, DOI 10.1523/JNEUROSCI.0711-11.2011; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; Pathak D, 2010, J NEUROSCI, V30, P8984, DOI 10.1523/JNEUROSCI.1621-10.2010; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rose C, 2010, HUM MOL GENET, V19, P2144, DOI 10.1093/hmg/ddq093; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tang Y, 2012, TRAFFIC, V13, P681, DOI 10.1111/j.1600-0854.2012.01340.x; VALTORTA F, 1989, CELL BIOL INT REP, V13, P1023, DOI 10.1016/0309-1651(89)90017-9; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wang XN, 2009, METHOD ENZYMOL, V457, P319, DOI 10.1016/S0076-6879(09)05018-6; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xie WL, 2012, J NEUROCHEM, V122, P404, DOI 10.1111/j.1471-4159.2012.07769.x; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Yue Z, 2007, AUTOPHAGY, V3, P139, DOI 10.4161/auto.3602	78	35	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85815	10.1371/journal.pone.0085815	http://dx.doi.org/10.1371/journal.pone.0085815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392030	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900174
J	Simon, L; Kozak, LR; Simon, V; Czobor, P; Unoka, Z; Szabo, A; Csukly, G				Simon, Lajos; Kozak, Lajos R.; Simon, Viktoria; Czobor, Pal; Unoka, Zsolt; Szabo, Adam; Csukly, Gabor			Regional Grey Matter Structure Differences between Transsexuals and Healthy Controls-A Voxel Based Morphometry Study	PLOS ONE			English	Article							SEX HORMONAL TREATMENT.; WHITE-MATTER; GRAY-MATTER; FEMALE TRANSSEXUALS; HUMAN BRAIN; MICROSTRUCTURE; DIMORPHISM	Gender identity disorder (GID) refers to transsexual individuals who feel that their assigned biological gender is incongruent with their gender identity and this cannot be explained by any physical intersex condition. There is growing scientific interest in the last decades in studying the neuroanatomy and brain functions of transsexual individuals to better understand both the neuroanatomical features of transsexualism and the background of gender identity. So far, results are inconclusive but in general, transsexualism has been associated with a distinct neuroanatomical pattern. Studies mainly focused on male to female (MTF) transsexuals and there is scarcity of data acquired on female to male (FTM) transsexuals. Thus, our aim was to analyze structural MRI data with voxel based morphometry (VBM) obtained from both FTM and MTF transsexuals (n = 17) and compare them to the data of 18 age matched healthy control subjects (both males and females). We found differences in the regional grey matter (GM) structure of transsexual compared with control subjects, independent from their biological gender, in the cerebellum, the left angular gyrus and in the left inferior parietal lobule. Additionally, our findings showed that in several brain areas, regarding their GM volume, transsexual subjects did not differ significantly from controls sharing their gender identity but were different from those sharing their biological gender (areas in the left and right precentral gyri, the left postcentral gyrus, the left posterior cingulate, precuneus and calcarinus, the right cuneus, the right fusiform, lingual, middle and inferior occipital, and inferior temporal gyri). These results support the notion that structural brain differences exist between transsexual and healthy control subjects and that majority of these structural differences are dependent on the biological gender.	[Simon, Lajos; Simon, Viktoria; Czobor, Pal; Unoka, Zsolt; Csukly, Gabor] Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1085 Budapest, Hungary; [Kozak, Lajos R.; Szabo, Adam] Semmelweis Univ, Magnet Resonance Imaging Res Ctr, H-1085 Budapest, Hungary; [Czobor, Pal] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA	Semmelweis University; Semmelweis University; Nathan Kline Institute for Psychiatric Research	Simon, V (corresponding author), Semmelweis Univ, Dept Psychiat & Psychotherapy, H-1085 Budapest, Hungary.	simon.viktoria@med.semmelweis-univ.hu	Szabó, Ádám György/Q-7294-2016; Csukly, Gabor/J-8244-2017; Kozak, Lajos R/B-4194-2011; Unoka, Zsolt/R-3477-2018	Szabó, Ádám György/0000-0003-4014-3762; Kozak, Lajos R/0000-0003-0368-3663; Unoka, Zsolt/0000-0003-0103-5064; Csukly, Gabor/0000-0002-5006-9407	Moravcsik foundation; Hungarian Academy of Sciences	Moravcsik foundation; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was funded by the Moravcsik foundation, and L. R. K. has received funding from the Bolyai Research Fellowship of the Hungarian Academy of Sciences. The funding bodies had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the other authors have any financial interest to disclose.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bao AM, 2011, FRONT NEUROENDOCRIN, V32, P214, DOI 10.1016/j.yfrne.2011.02.007; BLANCHARD R, 1989, ARCH SEX BEHAV, V18, P315, DOI 10.1007/BF01541951; BLANCHARD R, 1987, ARCH SEX BEHAV, V16, P139, DOI 10.1007/BF01542067; BLANCHARD R, 1995, ARCH SEX BEHAV, V24, P543, DOI 10.1007/BF01541833; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; EMORY LE, 1991, ARCH SEX BEHAV, V20, P409, DOI 10.1007/BF01542620; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Ferreira LK, 2011, NEUROBIOL AGING, V32, P1733, DOI 10.1016/j.neurobiolaging.2009.11.008; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Garcia-Falgueras A, 2008, BRAIN, V131, P3132, DOI 10.1093/brain/awn276; Henley SMD, 2010, AM J NEURORADIOL, V31, P711, DOI 10.3174/ajnr.A1939; Hodzic A, 2009, NEUROIMAGE, V45, P1264, DOI 10.1016/j.neuroimage.2009.01.027; Kruijver FPM, 2000, J CLIN ENDOCR METAB, V85, P2034, DOI 10.1210/jc.85.5.2034; Luders Eileen, 2012, J Behav Brain Sci, V2, P357; Luders E, 2009, NEUROIMAGE, V46, P904, DOI 10.1016/j.neuroimage.2009.03.048; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Rametti G, 2012, PSYCHONEUROENDOCRINO, V37, P1261, DOI 10.1016/j.psyneuen.2011.12.019; Rametti G, 2011, J PSYCHIATR RES, V45, P949, DOI 10.1016/j.jpsychires.2010.11.007; Rametti G, 2011, J PSYCHIATR RES, V45, P199, DOI 10.1016/j.jpsychires.2010.05.006; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Rekkas PV, 2005, J COGNITIVE NEUROSCI, V17, P1950, DOI 10.1162/089892905775008652; Ridgway GR, 2008, NEUROIMAGE, V40, P1429, DOI 10.1016/j.neuroimage.2008.01.003; Savic I, 2011, CEREB CORTEX, V21, P2525, DOI 10.1093/cercor/bhr032; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Woermann FG, 1999, NEUROIMAGE, V10, P373, DOI 10.1006/nimg.1999.0481; Yokota Y, 2005, P 2005 IEEE ENG MED; ZHOU JN, 1995, NATURE, V378, P68, DOI 10.1038/378068a0; Zubiaurre-Elorza L, 2013, CEREB CORTEX, V23, P2855, DOI 10.1093/cercor/bhs267	36	58	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83947	10.1371/journal.pone.0083947	http://dx.doi.org/10.1371/journal.pone.0083947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391851	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000329325200149
J	Stock, M; Gretscher, RR; Groth, M; Eiserloh, S; Boland, W; Burse, A				Stock, Magdalena; Gretscher, Rene R.; Groth, Marco; Eiserloh, Simone; Boland, Wilhelm; Burse, Antje			Putative Sugar Transporters of the Mustard Leaf Beetle Phaedon cochleariae: Their Phylogeny and Role for Nutrient Supply in Larval Defensive Glands	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; TIGR GENE INDEXES; GLUCOSE-TRANSPORTER; TREHALOSE TRANSPORTER; CHEMICAL DEFENSE; APHIDIUS-ERVI; GLUT-FAMILY; FAT-BODY; INSECT; METABOLISM	Background: Phytophagous insects have emerged successfully on the planet also because of the development of diverse and often astonishing defensive strategies against their enemies. The larvae of the mustard leaf beetle Phaedon cochleariae, for example, secrete deterrents from specialized defensive glands on their back. The secretion process involves ATP-binding cassette transporters. Therefore, sugar as one of the major energy sources to fuel the ATP synthesis for the cellular metabolism and transport processes, has to be present in the defensive glands. However, the role of sugar transporters for the production of defensive secretions was not addressed until now. Results: To identify sugar transporters in P. cochleariae, a transcript catalogue was created by Illumina sequencing of cDNA libraries. A total of 68,667 transcripts were identified and 68 proteins were annotated as either members of the solute carrier 2 (SLC2) family or trehalose transporters. Phylogenetic analyses revealed an extension of the mammalian GLUT6/8 class in insects as well as one group of transporters exhibiting distinctive conserved motifs only present in the insect order Coleoptera. RNA-seq data of samples derived from the defensive glands revealed six transcripts encoding sugar transporters with more than 3,000 counts. Two of them are exclusively expressed in the glandular tissue. Reduction in secretions production was accomplished by silencing two of four selected transporters. RNA-seq experiments of transporter-silenced larvae showed the down-regulation of the silenced transporter but concurrently the up-regulation of other SLC2 transporters suggesting an adaptive system to maintain sugar homeostasis in the defensive glands. Conclusion: We provide the first comprehensive phylogenetic study of the SLC2 family in a phytophagous beetle species. RNAi and RNA-seq experiments underline the importance of SLC2 transporters in defensive glands to achieve a chemical defense for successful competitive interaction in natural ecosystems.	[Stock, Magdalena; Gretscher, Rene R.; Eiserloh, Simone; Boland, Wilhelm; Burse, Antje] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Thuringia, Germany; [Groth, Marco] Fritz Lipmann Inst, Leibniz Inst Age Res, Genome Anal Grp, Jena, Thuringia, Germany	Max Planck Society; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Burse, A (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Thuringia, Germany.	aburse@ice.mpg.de	Boland, Wilhelm/K-7762-2012	Boland, Wilhelm/0000-0001-6784-2534; Gretscher, Rene/0000-0002-0249-4978; Groth, Marco/0000-0002-9199-8990	Max Planck Society; Deutsche Forschungsgemeinschaft [BU1862/2-1]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors' work was funded by the Max Planck Society (http://www.mpg.de/en) and the Deutsche Forschungsgemeinschaft (grand number BU1862/2-1; http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bifano TD, 2010, COMP BIOCHEM PHYS B, V157, P1, DOI 10.1016/j.cbpb.2010.05.014; Bodemann RR, 2012, P ROY SOC B-BIOL SCI, V279, P4126, DOI 10.1098/rspb.2012.1342; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; BOUNIAS M, 1993, BIOCHEM MOL BIOL INT, V31, P249; Burse A, 2007, INSECT BIOCHEM MOLEC, V37, P255, DOI 10.1016/j.ibmb.2006.11.011; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caccia S, 2007, AM J PHYSIOL-REG I, V292, pR2284, DOI 10.1152/ajpregu.00847.2006; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; Caviedes-Vidal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001425; Chen ME, 2006, ARCH INSECT BIOCHEM, V62, P55, DOI 10.1002/arch.20119; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Cuthbertson JM, 2005, PROTEIN ENG DES SEL, V18, P295, DOI 10.1093/protein/gzi032; DEROE C, 1982, J CHEM ECOL, V8, P67, DOI 10.1007/BF00984006; Douady CJ, 2003, MOL BIOL EVOL, V20, P248, DOI 10.1093/molbev/msg042; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fraga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065125; Frick S, 2013, P NATL ACAD SCI USA, V110, P4194, DOI 10.1073/pnas.1221489110; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giordana B, 2003, J INSECT PHYSIOL, V49, P1115, DOI 10.1016/j.jinsphys.2003.08.010; Gomez-Zurita J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000360; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ibanez S, 2012, TOXINS, V4, P228, DOI 10.3390/toxins4040228; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kanamori Y, 2010, INSECT BIOCHEM MOLEC, V40, P30, DOI 10.1016/j.ibmb.2009.12.006; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Kikuta S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00290; Kikuta S, 2010, INSECT BIOCHEM MOLEC, V40, P805, DOI 10.1016/j.ibmb.2010.07.008; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhnle A, 2009, ENTOMOL EXP APPL, V131, P189, DOI 10.1111/j.1570-7458.2009.00848.x; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Laurent P, 2005, TOP CURR CHEM, V240, P167; Laurent P, 2003, EUR J ORG CHEM, V2003, P2733, DOI 10.1002/ejoc.200300008; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Meyer H, 2011, J CELL SCI, V124, P1984, DOI 10.1242/jcs.082024; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; NOIROT C, 1991, ANN SOC ENTOMOL FR, V27, P123; O'Donovan Claire, 2002, Brief Bioinform, V3, P275; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pascual I, 2006, COMP BIOCHEM PHYS B, V143, P20, DOI 10.1016/j.cbpb.2005.09.008; Pasteels J.M., 1989, Entomography, V6, P423; Pasteels Jacques M., 1994, Series Entomologica (Dordrecht), V50, P289; PASTEELS JM, 1982, TETRAHEDRON, V38, P1891, DOI 10.1016/0040-4020(82)80038-0; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petzold A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-185; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P307, DOI 10.1016/j.ibmb.2006.12.005; Price DRG, 2010, INSECT MOL BIOL, V19, P97, DOI 10.1111/j.1365-2583.2009.00918.x; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P1138, DOI 10.1016/j.ibmb.2007.07.001; Quackenbush J, 2000, NUCLEIC ACIDS RES, V28, P141, DOI 10.1093/nar/28.1.141; Quennedey A, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P177; RENNER K, 1970, Beitraege zur Entomologie, V20, P527; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; SCHURMANN A, 1993, BIOCHEM J, V290, P497, DOI 10.1042/bj2900497; SHIMADA S, 1979, J COMP PHYSIOL, V131, P333, DOI 10.1007/BF00688808; Silva MCP, 2010, INSECT BIOCHEM MOLEC, V40, P733, DOI 10.1016/j.ibmb.2010.07.006; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Termonia A, 2001, P NATL ACAD SCI USA, V98, P3909, DOI 10.1073/pnas.061034598; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tremmel M, 2013, J INSECT PHYSIOL, V59, P840, DOI 10.1016/j.jinsphys.2013.05.009; Uddin MM, 2009, J APPL BOT FOOD QUAL, V82, P108; Wegener G, 2010, J EXP BIOL, V213, P3852, DOI 10.1242/jeb.042028; Whitman DW, 1990, ALLOMONES CHEM DEFEN, P289; Wilson-O'Brien AL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-152; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	85	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84461	10.1371/journal.pone.0084461	http://dx.doi.org/10.1371/journal.pone.0084461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391959	Green Published, gold			2022-12-27	WOS:000329323900102
J	Weng, PH; Chen, JH; Chen, TF; Sun, Y; Wen, LL; Yip, PK; Chu, YM; Chen, YC				Weng, Pei-Hsuan; Chen, Jen-Hau; Chen, Ta-Fu; Sun, Yu; Wen, Li-Li; Yip, Ping-Keung; Chu, Yi-Min; Chen, Yen-Ching			CHRNA7 Polymorphisms and Response to Cholinesterase Inhibitors in Alzheimer's Disease	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CENTRAL-NERVOUS-SYSTEM; APOLIPOPROTEIN-E; DONEPEZIL; GALANTAMINE; GENOTYPE; EFFICACY; CHAT; THERAPY; GENES	Background: CHRNA7 encodes the alpha 7 nicotinic acetylcholine receptor subunit, which is important to Alzheimer's disease (AD) pathogenesis and cholinergic neurotransmission. Previously, CHRNA7 polymorphisms have not been related to cholinesterase inhibitors (ChEI) response. Methods: Mild to moderate AD patients received ChEIs were recruited from the neurology clinics of three teaching hospitals from 2007 to 2010 (n = 204). Nine haplotype-tagging single nucleotide polymorphisms of CHRNA7 were genotyped. Cognitive responders were those showing improvement in the Mini-Mental State Examination score >= 2 between baseline and 6 months after ChEI treatment. Results: AD women carrying rs8024987 variants [GG+GC vs. CC: adjusted odds ratio (AOR) = 3.62, 95% confidence interval (CI) = 1.47-8.89] and GG haplotype in block1 (AOR = 3.34, 95% CI = 1.38-8.06) had significantly better response to ChEIs (false discovery rate <0.05). These variant carriers using galantamine were 11 times more likely to be responders than female non-carriers using donepezil or rivastigmine. Conclusion: For the first time, this study found a significant association between CHRNA7 polymorphisms and better ChEI response. If confirmed by further studies, CHRNA7 polymorphisms may aid in predicting ChEI response and refining treatment choice.	[Weng, Pei-Hsuan] Taiwan Adventist Hosp, Dept Family Med, Taipei, Taiwan; [Weng, Pei-Hsuan; Chen, Jen-Hau; Chen, Yen-Ching] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Chen, Jen-Hau] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan; [Chen, Ta-Fu] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Sun, Yu] En Chu Kong Hosp, Dept Neurol, Taipei, Taiwan; [Wen, Li-Li] En Chu Kong Hosp, Dept Lab Med, Taipei, Taiwan; [Yip, Ping-Keung] Cardinal Tien Hosp, Ctr Neurol Med, Taipei, Taiwan; [Yip, Ping-Keung] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Chu, Yi-Min] Cardinal Tien Hosp, Dept Lab Med, Taipei, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; National Taiwan University; National Taiwan University	Chen, YC (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	karenchen@ntu.edu.tw	Chen, Yen-Ching/D-1098-2010; Chen, Jen-Hau/AFP-2878-2022	Chen, Yen-Ching/0000-0002-8159-7202; Chen, Ta-Fu/0000-0003-1988-6924	National Science Council [96-2314-B-002-197, 97-2314-B-002-168-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	Funding for the study was provided by National Science Council grants 96-2314-B-002-197 and 97-2314-B-002-168-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Albuquerque EX, 2001, ALZ DIS ASSOC DIS, V15, pS19, DOI 10.1097/00002093-200108001-00004; Barabash A, 2009, NEUROBIOL AGING, V30, P1254, DOI 10.1016/j.neurobiolaging.2007.11.003; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blesa R, 2006, PHARMACOGENET GENOM, V16, P771, DOI 10.1097/01.fpc.0000220573.05714.ac; Cacabelos R, 2008, EUR ARCH PSY CLIN N, V258, P28, DOI 10.1007/s00406-007-1006-x; Calabria M, 2009, ARCH GERONTOL GERIAT, V49, pE6, DOI 10.1016/j.archger.2008.07.006; Carson R, 2008, J MED GENET, V45, P244, DOI 10.1136/jmg.2007.052704; Chapman J, 1996, NEUROLOGY, V46, P1484, DOI 10.1212/WNL.46.5.1484-a; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Chianella C, 2011, EUR J CLIN PHARMACOL, V67, P1147, DOI 10.1007/s00228-011-1064-x; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Doraiswamy PM, 1997, NEUROLOGY, V48, P1511, DOI 10.1212/WNL.48.6.1511; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Geerts H, 2005, BRAIN RES, V1033, P186, DOI 10.1016/j.brainres.2004.11.042; Harold D, 2006, PHARMACOGENET GENOM, V16, P75, DOI 10.1097/01.fpc.0000189799.88596.04; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Koylu E, 1997, LIFE SCI, V61, pPL185, DOI 10.1016/S0024-3205(97)00665-6; Kumar V, 2000, EUR J NEUROL, V7, P159, DOI 10.1046/j.1468-1331.2000.00046.x; Kume T, 2005, EUR J PHARMACOL, V527, P77, DOI 10.1016/j.ejphar.2005.10.028; Lam Benjamin, 2009, Human Genomics, V4, P91; Liao PY, 2010, BIOCHEM ENG J, V49, P149, DOI 10.1016/j.bej.2009.12.021; Lin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020573; LONDON ED, 1989, NEUROCHEM RES, V14, P745, DOI 10.1007/BF00964952; LUINE VN, 1986, NEUROBIOL AGING, V7, P193, DOI 10.1016/0197-4580(86)90042-4; Mannens GSJ, 2002, DRUG METAB DISPOS, V30, P553, DOI 10.1124/dmd.30.5.553; Martinelli-Boneschi F, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.008; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MEHTA CR, 1995, STAT MED, V14, P2143, DOI 10.1002/sim.4780141908; Mitsushima D, 2010, VITAM HORM, V82, P263, DOI 10.1016/S0083-6729(10)82014-X; Murcray CE, 2009, AM J EPIDEMIOL, V169, P219, DOI 10.1093/aje/kwn353; Noetzli M, 2013, CLIN PHARMACOKINET, V52, P225, DOI 10.1007/s40262-013-0038-9; O'Brien KK, 2003, PHARMACOGENETICS, V13, P231, DOI 10.1097/00008571-200304000-00008; Patterson CE, 2011, PHARMACOGENOMICS J, V11, P444, DOI 10.1038/tpj.2010.61; Pilotto A, 2009, NEUROLOGY, V73, P761, DOI 10.1212/WNL.0b013e3181b6bbe3; Poirier J, 1995, P NATL ACAD SCI USA, V92, P12260, DOI 10.1073/pnas.92.26.12260; Rhodes ME, 1999, BRAIN RES REV, V30, P135, DOI 10.1016/S0165-0173(99)00011-9; Scacchi R, 2009, AM J MED GENET B, V150B, P502, DOI 10.1002/ajmg.b.30846; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Takada-Takatori Y, 2006, NEUROPHARMACOLOGY, V51, P474, DOI 10.1016/j.neuropharm.2006.04.007; Taylor P, 1998, NEUROLOGY, V51, pS30, DOI 10.1212/WNL.51.1_Suppl_1.S30; Texido L, 2005, BRIT J PHARMACOL, V145, P672, DOI 10.1038/sj.bjp.0706221; US Food and Drug Administration, 1989, PER CENTR NERV SYST, P227; Wonnacott S, 2006, J MOL NEUROSCI, V30, P137, DOI 10.1385/JMN:30:1:137	47	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84059	10.1371/journal.pone.0084059	http://dx.doi.org/10.1371/journal.pone.0084059			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391883	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900026
J	Xie, CH; Xu, SB; Ding, FF; Xie, MJ; Lv, JG; Yao, JH; Pan, DJ; Sun, Q; Liu, CC; Chen, T; Li, SS; Wang, W				Xie, Cuihong; Xu, Shabei; Ding, Fengfei; Xie, Minjie; Lv, Jiagao; Yao, Jihua; Pan, Dengji; Sun, Qian; Liu, Chenchen; Chen, Tie; Li, Shusheng; Wang, Wei			Clinical Features of Severe Wasp Sting Patients with Dominantly Toxic Reaction: Analysis of 1091 Cases	PLOS ONE			English	Article							HYMENOPTERA VENOM ALLERGY; ACUTE-RENAL-FAILURE; DIAGNOSIS; DYSFUNCTION	Background: Massive wasp stings have been greatly underestimated and have not been systematically studied. The aim of this study was to identify the clinical features and treatment strategies of severe wasp stings. Methods and Findings: A multicenter retrospective study was undertaken in 35 hospitals and medical centers including 12 tertiary care hospitals and 23 secondary care hospitals in the Hubei Province, China. The detailed clinical data of 1091 hospitalized wasp sting patients were investigated. Over three-fourths (76.9%) of the cases had 10 or more stings and the in-hospital mortality of patients was 5.1%. Forty-eight patients died of organ injury following toxic reactions to the stings, whereas six died from anaphylactic shock. The in-hospital mortality in patients with >10 stings was higher than that of <= 10 stings (5.2% vs. 1.0%, p = 0.02). Acute kidney injury (AKI) was seen in 21.0% patients and most patients required blood purification therapy. Rhabdomyolysis was seen in 24.1% patients, hemolysis in 19.2% patients, liver injury in 30.1% patients, and coagulopathy in 22.5% patients. Regression analysis revealed that high creatinine level, shock, oliguria, and anemia were risk factors for death. Blood purification therapy was beneficial for patients with >= 20 stings and delayed hospital admission of patients (>= 4 hours after sting). Conclusions: In China, most patients with multiple wasp stings presented with toxic reactions and multiple organ dysfunction caused by the venom rather than an anaphylactic reaction. AKI is the prominent clinical manifestation of wasp stings with toxic reaction. High creatinine levels, shock, oliguria, and anemia were risk factors for death.	[Xu, Shabei; Ding, Fengfei; Xie, Minjie; Pan, Dengji; Sun, Qian; Liu, Chenchen; Wang, Wei] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurol, Tongji Hosp, Wuhan 430074, Peoples R China; [Xie, Cuihong; Li, Shusheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Emergency, Tongji Hosp, Wuhan 430074, Peoples R China; [Lv, Jiagao; Yao, Jihua] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Cardiol, Tongji Hosp, Wuhan 430074, Peoples R China; [Chen, Tie] Huazhong Univ Sci & Technol, Tongji Med Coll, Div Clin Immunol, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, SS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Emergency, Tongji Hosp, Wuhan 430074, Peoples R China.	shushengli16@hotmail.com; wwang@tjh.tjmu.edu.cn	xu, shabei/C-9220-2014	xu, shabei/0000-0001-5409-2092	Natural Science Foundation of China [81030021]; National Basic Research Program [2006CB504502, 2011CB504403]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	This work was supported by grants from Natural Science Foundation of China (81030021 to WW) and National Basic Research Program (No. 2006CB504502 and 2011CB504403 to WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatta N, 2005, PEDIATR NEPHROL, V20, P1809, DOI 10.1007/s00467-005-2044-0; Bich HNX, 2010, NEPHROL DIAL TRANSPL, V25, P1146, DOI 10.1093/ndt/gfp583; Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; Brown SGA, 2004, EMERG MED J, V21, P149, DOI 10.1136/emj.2003.009449; Burns DA, 2008, ROOKS TXB DERMATOLOG, DOI [10.1002/9780470750520.ch33, DOI 10.1002/9780470750520.CH33]; Chen GuoZhu, 2009, Journal of the Fourth Military Medical University, V30, P371; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; Goodman JW, 2006, SEMIN DIALYSIS, V19, P402, DOI 10.1111/j.1525-139X.2006.00194.x; Hamilton RG, 2010, CURR OPIN ALLERGY CL, V10, P323, DOI 10.1097/ACI.0b013e32833bcf91; Hu DJ, 2010, J CLIN EMERG CALL, V11, P219; Klotz JH, 2009, J EMERG MED, V36, P148, DOI 10.1016/j.jemermed.2007.06.018; Lee H L, 2005, Trop Biomed, V22, P81; Lin CJ, 2011, SOUTH MED J, V104, P378, DOI 10.1097/SMJ.0b013e318213ebee; Loh H H, 2012, Med J Malaysia, V67, P133; Mueller H L, 1966, J Asthma Res, V3, P331; Muller UR, 2001, INT ARCH ALLERGY IMM, V124, P447, DOI 10.1159/000053779; Paudel B, 2009, Nepal Med Coll J, V11, P52; Pramanik S, 2007, INDIAN PEDIATR, V44, P788; Przybilla B, 2012, DTSCH ARZTEBL INT, V109, P238, DOI 10.3238/arztebl.2012.0238; RING J, 1977, LANCET, V1, P466; Sharmila RR, 2007, INDIAN J PEDIATR, V74, P1111, DOI 10.1007/s12098-007-0208-6; Shurong T, 2009, CHINA FOREIGN MED, V24, P73; Tracy JM, 2011, MT SINAI J MED, V78, P773, DOI 10.1002/msj.20286; Vikrant S, 2005, NEPHROLOGY, V10, P548, DOI 10.1111/j.1440-1797.2005.00482.x; Wen Y, 2009, CHIN J TCM WM CRIT C, V16, P371; Wiwanitkit V, 2005, NEPHROLOGY, V10, P537, DOI 10.1111/j.1440-1797.2005.00479.x	26	60	70	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83164	10.1371/journal.pone.0083164	http://dx.doi.org/10.1371/journal.pone.0083164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391743	Green Published, gold			2022-12-27	WOS:000329325200040
J	Zhou, H; Wan, JL; Wu, L; Yi, T; Liu, W; Xu, HB; Yang, XL				Zhou, Hui; Wan, Jiangling; Wu, Lei; Yi, Tao; Liu, Wei; Xu, Huibi; Yang, Xiangliang			A New Strategy for Enhancing the Oral Bioavailability of Drugs with Poor Water-Solubility and Low Liposolubility Based on Phospholipid Complex and Supersaturated SEDDS	PLOS ONE			English	Article							DELIVERY SYSTEMS SNEDDS; IN-VIVO PERFORMANCE; LIQUID-CHROMATOGRAPHY; SELF; VITRO; SCUTELLARIN; OPTIMIZATION; IMPACT; BREVISCAPINE; PERMEABILITY	A novel supersaturated self-emulsifying drug delivery system (Super-SEDDS) loaded with scutellarin-phospholipid complex (SPC) was developed. The system aimed to address the limitations presented by conventional SEDDS as delivery carriers for drugs with poor water-solubility, low liposolubility and high dose. As an intermediate, SPC was first prepared based on the response surface design. The presence of amorphous scutellarin was demonstrated through differential scanning calorimetry (DSC) and X-ray diffraction (XRD), while enhanced liposolubility was confirmed through comparison with scutellarin powder via an octanol/water distribution test. On the basis of the solubility study and ternary phase diagram, Super-SEDDS containing SPC of up to 200% equilibrium solubility (S-eq) was designed, which composed of ethyl oleate, Cremophor RH40 and Transcutol HP with a ratio of 60:25:15 (w/w%). The subsequent in vitro lipolysis study and ex vivo intestinal absorption test indicated that Super-SEDDS enhanced the cumulative dissolution from 70% to 100% and improved the intestinal absorption from 0.04 to 0.12 mu g/cm(2) compared with scutellarin powder. Furthermore, an in vivo study demonstrated that Super-SEDDS achieved the AUC(o-t) of scutellarin up to approximate 1.7-fold as scutellarin powder. It was also proved superior to SPC and the conventional SEDDS. Super-SEDDS showed great potential for expanding the usage of SEDDS and could act as an alternative to conventional SEDDS.	[Zhou, Hui; Wan, Jiangling; Wu, Lei; Liu, Wei; Xu, Huibi; Yang, Xiangliang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430074, Peoples R China; [Yi, Tao] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau Inst Appl Res Med & Hlth, Taipa, Macau, Peoples R China	Huazhong University of Science & Technology; Macau University of Science & Technology	Yi, T (corresponding author), Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau Inst Appl Res Med & Hlth, Taipa, Macau, Peoples R China.	yiaaron@outlook.com; nanomedicine@hust.edu.cn			Special Project on the Integration of Industry Education Research of Guangdong Province [2009B090300321]; Science and Technology Development Fund of Macao Special Administrative Region [094/2012/A3]; National High Technology Research and Development Program of China [2012AA022704]	Special Project on the Integration of Industry Education Research of Guangdong Province; Science and Technology Development Fund of Macao Special Administrative Region; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was financially supported by the Special Project on the Integration of Industry Education Research of Guangdong Province (No. 2009B090300321), the Science and Technology Development Fund of Macao Special Administrative Region (No. 094/2012/A3) and the National High Technology Research and Development Program of China (No. 2012AA022704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MA, 2012, J PHARM PHARMACOL, V64, P326, DOI 10.1111/j.2042-7158.2011.01391.x; Anby MU, 2012, MOL PHARMACEUT, V9, P2063, DOI 10.1021/mp300164u; Buyukozturk F, 2010, J CONTROL RELEASE, V142, P22, DOI 10.1016/j.jconrel.2009.10.005; Cao F, 2006, EUR J PHARM SCI, V29, P385, DOI 10.1016/j.ejps.2006.07.007; Cao Feng, 2006, Yaoxue Xuebao, V41, P595; [陈鹰 CHEN Ying], 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P374; Fei X, 2009, J DRUG TARGET, V17, P408, DOI 10.1080/10611860902913380; Fernandez S, 2009, PHARM RES-DORDR, V26, P1901, DOI 10.1007/s11095-009-9906-2; Gao P, 2009, J PHARM SCI-US, V98, P516, DOI 10.1002/jps.21451; Ju W Z, 2006, CHIN J CLIN PHARM TH, V11, P292; Kiss L, 2013, J PHARM SCI-US, V102, P1173, DOI 10.1002/jps.23458; Lu Y, 2013, INT J PHARMACEUT, V453, P198, DOI 10.1016/j.ijpharm.2012.08.042; Miller JM, 2011, MOL PHARMACEUT, V8, P1848, DOI 10.1021/mp200181v; Mukherjee T, 2010, J PHARM PHARMACOL, V62, P1112, DOI 10.1111/j.2042-7158.2010.01149.x; Peng Q, 2010, MOL PHARMACEUT, V7, P565, DOI 10.1021/mp900274u; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Prachi S., 2012, INT RES J PHARM, V3, P1; Ruan JH, 2010, INT J PHARMACEUT, V386, P282, DOI 10.1016/j.ijpharm.2009.11.026; Sakai K, 2012, DRUG DEV IND PHARM, V38, P1254, DOI 10.3109/03639045.2011.645832; Sarparanta MP, 2012, BIOMATERIALS, V33, P3353, DOI 10.1016/j.biomaterials.2012.01.029; Sassene PJ, 2010, J PHARM SCI-US, V99, P4982, DOI 10.1002/jps.22226; Villar AMS, 2012, INT J PHARMACEUT, V431, P161, DOI 10.1016/j.ijpharm.2012.04.001; Singh B, 2011, DRUG DELIV, V18, P599, DOI 10.3109/10717544.2011.604686; Tang SY, 2012, ULTRASON SONOCHEM, V19, P330, DOI 10.1016/j.ultsonch.2011.07.001; Tang Xiao-Qiao, 2005, Zhongguo Zhongyao Zazhi, V30, P222; Thomas N, 2012, J CONTROL RELEASE, V160, P25, DOI 10.1016/j.jconrel.2012.02.027; Ujhelyi Z, 2012, EUR J PHARM SCI, V47, P564, DOI 10.1016/j.ejps.2012.07.005; Ward, 2000, Pharm Sci Technol Today, V3, P346, DOI 10.1016/S1461-5347(00)00302-3; Williams H, 2013, PHARM RES, P1; Wu ZB, 2011, DRUG DEV IND PHARM, V37, P103, DOI 10.3109/03639045.2010.495752; Yang SC, 2004, PHARM RES-DORDR, V21, P261, DOI 10.1023/B:PHAM.0000016238.44452.f1; YOSHIMURA Y, 1989, J FOOD HYG SOC JPN, V30, P218; Yulan S, 2006, J CHROMATOGR B, V830, P1, DOI 10.1016/j.jchromb.2005.10.016; Zhang Hai-yan, 2005, Yaoxue Xuebao, V40, P563; Zhang JJ, 2011, INT J NANOMED, V6, P3405, DOI 10.2147/IJN.S25824; Zhang L, 2012, INT J NANOMED, V7, P151, DOI 10.2147/IJN.S27639; Zhang QY, 2012, J BIOMED NANOTECHNOL, V8, P90, DOI 10.1166/jbn.2012.1371; Zhang XY, 2009, HERALD MED, V5, P571; Zhang ZW, 2011, NANOSCALE, V3, P1780, DOI 10.1039/c0nr00879f; Zhong DF, 2003, J CHROMATOGR B, V796, P439, DOI 10.1016/j.jchromb.2003.08.002; Zhong HJ, 2005, PHARMAZIE, V60, P475	41	23	24	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84530	10.1371/journal.pone.0084530	http://dx.doi.org/10.1371/journal.pone.0084530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391965	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900108
J	Zimman, A; Titz, B; Komisopoulou, E; Biswas, S; Graeber, TG; Podrez, EA				Zimman, Alejandro; Titz, Bjoern; Komisopoulou, Evangelia; Biswas, Sudipta; Graeber, Thomas G.; Podrez, Eugene A.			Phosphoproteomic Analysis of Platelets Activated by Pro-Thrombotic Oxidized Phospholipids and Thrombin	PLOS ONE			English	Article							AORTIC ENDOTHELIAL-CELLS; LOW-DENSITY-LIPOPROTEIN; RECEPTOR GAMMA-CHAIN; LYN TYROSINE KINASE; OXIDATION-PRODUCTS; P-SELECTIN; PHOSPHORYLATION; IDENTIFICATION; CD36; FAMILY	Specific oxidized phospholipids (oxPC(CD36)) promote platelet hyper-reactivity and thrombosis in hyperlipidemia via the scavenger receptor CD36, however the signaling pathway(s) induced in platelets by oxPC(CD36) are not well defined. We have employed mass spectrometry-based tyrosine, serine, and threonine phosphoproteomics for the unbiased analysis of platelet signaling pathways induced by oxPC(CD36) as well as by the strong physiological agonist thrombin. oxPC(CD36) and thrombin induced differential phosphorylation of 115 proteins (162 phosphorylation sites) and 181 proteins (334 phosphorylation sites) respectively. Most of the phosphoproteome changes induced by either agonist have never been reported in platelets; thus they provide candidates in the study of platelet signaling. Bioinformatic analyses of protein phosphorylation dependent responses were used to categorize preferential motifs for (de) phosphorylation, predict pathways and kinase activity, and construct a phosphoproteome network regulating integrin activation. A putative signaling pathway involving Src-family kinases, SYK, and PLCc2 was identified in platelets activated by oxPC(CD36). Subsequent ex vivo studies in human platelets demonstrated that this pathway is downstream of the scavenger receptor CD36 and is critical for platelet activation by oxPC(CD36). Our results provide multiple insights into the mechanism of platelet activation and specifically in platelet regulation by oxPC(CD36).	[Zimman, Alejandro; Biswas, Sudipta; Podrez, Eugene A.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Titz, Bjoern; Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Inst Mol Med, Crump Inst Mol Imaging,Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Titz, Bjoern; Komisopoulou, Evangelia; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	Cleveland Clinic Foundation; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Podrez, EA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	podreze@ccf.org	Titz, Bjoern/G-6317-2017	Titz, Bjoern/0000-0003-4414-4105; Graeber, Thomas/0000-0001-8574-9181	National Institutes of Health [HL077213, HL077213-05S1, 5P01HL073311-06]; NCI/NIH [P01 CA168585, R21 CA169993]; American Cancer Society [RSG-12-257-01-TBE]; CalTech-UCLA Joint Center for Translational Medicine; UCLA Jonsson Cancer Center Foundation; UCLA Institute for Molecular Medicine; National Center for Advancing Translational Sciences UCLA CTSI [UL1TR000124]; Concern Fondation CONquer CanCER Now Award; NATIONAL CANCER INSTITUTE [R21CA169993, P01CA168585] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, R01HL077213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); CalTech-UCLA Joint Center for Translational Medicine; UCLA Jonsson Cancer Center Foundation; UCLA Institute for Molecular Medicine; National Center for Advancing Translational Sciences UCLA CTSI; Concern Fondation CONquer CanCER Now Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL077213, HL077213-05S1 and 5P01HL073311-06 (to EAP). TGG is supported by the NCI/NIH (P01 CA168585, R21 CA169993), an American Cancer Society Research Scholar Award (RSG-12-257-01-TBE), the CalTech-UCLA Joint Center for Translational Medicine, the UCLA Jonsson Cancer Center Foundation, the UCLA Institute for Molecular Medicine, the National Center for Advancing Translational Sciences UCLA CTSI Grant UL1TR000124, and a Concern Fondation CONquer CanCER Now Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Antl M, 2007, BLOOD, V109, P552, DOI 10.1182/blood-2005-10-026294; Bartsch I, 2011, THROMB HAEMOSTASIS, V106, P475, DOI 10.1160/TH11-05-0305; Berrou E, 2013, ARTERIOSCL THROM VAS, V33, pE11, DOI 10.1161/ATVBAHA.112.300603; Bleijerveld OB, 2013, ARTERIOSCLER THROMB; Buga GM, 2010, ARTERIOSCL THROM VAS, V30, P283, DOI 10.1161/ATVBAHA.109.200162; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Chen R, 2009, ARTERIOSCL THROM VAS, V29, P363, DOI 10.1161/ATVBAHA.108.178731; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Davi G, 1998, CIRCULATION, V97, P953; Edelstein LC, 2012, CIRCULATION, V125, P2762, DOI 10.1161/CIRCULATIONAHA.112.091462; Falet H, 2010, J EXP MED, V207, P1967, DOI 10.1084/jem.20100222; Gao DT, 2010, J BIOL CHEM, V285, P4447, DOI 10.1074/jbc.M109.082800; Garcia A, 2006, PROTEOMICS, V6, P5332, DOI 10.1002/pmic.200600299; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Goodall AH, 2010, BLOOD, V116, P4646, DOI 10.1182/blood-2010-04-280925; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; Hall KJ, 2007, BIOCHEM J, V406, P501, DOI 10.1042/BJ20070244; Herczenik E, 2007, ARTERIOSCL THROM VAS, V27, P1657, DOI 10.1161/ATVBAHA.107.143479; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Kar NS, 2008, J BIOL CHEM, V283, P8765, DOI 10.1074/jbc.M709195200; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Lemeer S, 2009, CURR OPIN CHEM BIOL, V13, P414, DOI 10.1016/j.cbpa.2009.06.022; Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184; Mahfouz MM, 1998, PROSTAG OTH LIPID M, V56, P197, DOI 10.1016/S0090-6980(98)00056-2; Meller J, 2012, J THROMB HAEMOST, V10, P1397, DOI 10.1111/j.1538-7836.2012.04768.x; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Murohara T, 1996, CIRC RES, V78, P780, DOI 10.1161/01.RES.78.5.780; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nergiz-Unal R, 2011, J THROMB HAEMOST, V9, P1835, DOI 10.1111/j.1538-7836.2011.04416.x; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Qureshi AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007627; Rubbi L, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001314; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Senis YA, 2009, BLOOD, V113, P4942, DOI 10.1182/blood-2008-08-174318; Severin S, 2012, J THROMB HAEMOST; Soito L, 2011, NUCLEIC ACIDS RES, V39, pD332, DOI 10.1093/nar/gkq1060; Springstead JR, 2012, J LIPID RES, V53, P1304, DOI 10.1194/jlr.M025320; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Szapacs ME, 2008, J PROTEOME RES, V7, P4237, DOI 10.1021/pr8001222; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; Udell CM, 2006, J BIOL CHEM, V281, P20949, DOI 10.1074/jbc.M604252200; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zimman A, 2007, ARTERIOSCL THROM VAS, V27, P332, DOI 10.1161/01.ATV.0000252842.57585.df; Zimman Alejandro, 2013, Methods Mol Biol, V1000, P53, DOI 10.1007/978-1-62703-405-0_5; Zimman A, 2010, J PROTEOME RES, V9, P2812, DOI 10.1021/pr901194x	61	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84488	10.1371/journal.pone.0084488	http://dx.doi.org/10.1371/journal.pone.0084488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400094	Green Submitted, gold, Green Published			2022-12-27	WOS:000329462700028
J	Chamie, G; Kwarisiima, D; Clark, TD; Kabami, J; Jain, V; Geng, E; Balzer, LB; Petersen, ML; Thirumurthy, H; Charlebois, ED; Kamya, MR; Havlir, DV				Chamie, Gabriel; Kwarisiima, Dalsone; Clark, Tamara D.; Kabami, Jane; Jain, Vivek; Geng, Elvin; Balzer, Laura B.; Petersen, Maya L.; Thirumurthy, Harsha; Charlebois, Edwin D.; Kamya, Moses R.; Havlir, Diane V.			Uptake of Community-Based HIV Testing during a Multi-Disease Health Campaign in Rural Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GENDER; HOME; INFECTION; HOUSEHOLD; CARE	Background: The high burden of undiagnosed HIV in sub-Saharan Africa is a major obstacle for HIV prevention and treatment. Multi-disease, community health campaigns (CHCs) offering HIV testing are a successful approach to rapidly increase HIV testing rates and identify undiagnosed HIV. However, a greater understanding of population-level uptake is needed to maximize effectiveness of this approach. Methods: After community sensitization and a census, a five-day campaign was performed in May 2012 in a rural Ugandan community. The census enumerated all residents, capturing demographics, household location, and fingerprint biometrics. The CHC included point-of-care screening for HIV, malaria, TB, hypertension and diabetes. Residents who attended vs. did not attend the CHC were compared to determine predictors of participation. Results: Over 12 days, 18 census workers enumerated 6,343 residents. 501 additional residents were identified at the campaign, for a total community population of 6,844. 4,323 (63%) residents and 556 non-residents attended the campaign. HIV tests were performed in 4,795/4,879 (98.3%) participants; 1,836 (38%) reported no prior HIV testing. Of 2674 adults tested, 257 (10%) were HIV-infected; 125/257 (49%) reported newly diagnosed HIV. In unadjusted analyses, adult resident campaign non-participation was associated with male sex (62% male vs. 67% female participation, p = 0.003), younger median age (27 years in non-participants vs. 32 in participants; p<0.001), and marital status (48% single vs. 71% married/widowed/divorced participation; p<0.001). In multivariate analysis, single adults were significantly less likely to attend the campaign than non-single adults (relative risk [RR]: 0.63 [95% CI: 0.53-0.74]; p<0.001), and adults at home vs. not home during census activities were significantly more likely to attend the campaign (RR: 1.20 [95% CI: 1.13-1.28]; p<0.001). Conclusions: CHCs provide a rapid approach to testing a majority of residents for HIV in rural African settings. However, complementary strategies are still needed to engage young, single adults and achieve universal testing.	[Chamie, Gabriel; Clark, Tamara D.; Jain, Vivek; Geng, Elvin; Havlir, Diane V.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA; [Chamie, Gabriel; Kwarisiima, Dalsone; Clark, Tamara D.; Kabami, Jane; Jain, Vivek; Geng, Elvin; Charlebois, Edwin D.; Kamya, Moses R.; Havlir, Diane V.] Makerere Univ Univ Calif San Francisco MU UCSF Re, Kampala, Uganda; [Chamie, Gabriel; Kwarisiima, Dalsone; Clark, Tamara D.; Kabami, Jane; Jain, Vivek; Geng, Elvin; Balzer, Laura B.; Petersen, Maya L.; Thirumurthy, Harsha; Charlebois, Edwin D.; Kamya, Moses R.; Havlir, Diane V.] Sustainable East Africa Res Community Hlth SEARCH, San Francisco, CA USA; [Kwarisiima, Dalsone] Mulago Mbarara Joint AIDS Program, Kampala, Uganda; [Kwarisiima, Dalsone] Mulago Mbarara Joint AIDS Program, Mbarara, Uganda; [Balzer, Laura B.; Petersen, Maya L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Thirumurthy, Harsha] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Charlebois, Edwin D.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; Makerere University	Chamie, G (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA.	Gabriel.chamie@ucsf.edu		Thirumurthy, Harsha/0000-0002-3308-7603	National Institutes of Health/National Institute of Allergy and Infectious Diseases [3P30AI027763-19S1]; Doris Duke Clinical Scientist Development Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U01AI099959] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sources of Funding - The National Institutes of Health/National Institute of Allergy and Infectious Diseases (grant 3P30AI027763-19S1 to DVH). Maya Petersen is a recipient of a Doris Duke Clinical Scientist Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WHO GUID INT TUB CAS; Bembom O, 2009, STAT MED, V28, P152, DOI 10.1002/sim.3414; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Chamie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043400; Cherutich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036797; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Dalal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027293; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Helleringer S, 2009, JAIDS-J ACQ IMM DEF, V51, P185, DOI 10.1097/QAI.0b013e31819c1726; Kranzer K, 2012, HIV MED, V13, P132, DOI 10.1111/j.1468-1293.2011.00947.x; Kranzer K, 2008, TROP MED INT HEALTH, V13, P1341, DOI 10.1111/j.1365-3156.2008.02148.x; Lugada E, 2010, JAIDS-J ACQ IMM DEF, V55, P245, DOI 10.1097/QAI.0b013e3181e9e069; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Marrazzo J, 2013, C RETR OPP INF CROI; Matovu JKB, 2002, TROP MED INT HEALTH, V7, P1064, DOI 10.1046/j.1365-3156.2002.00964.x; Ministry of Health, 2005, UG NAT POL GUID HIV; Mulogo EM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-54; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Ramirez-Avila L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045507; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Uganda Bureau of Statistics, 2008, POP PROJ 2008 2012; Uganda Ministry of Health and ICF International, 2012, 2011 UG AIDS IND SUR; UNICEF, 2011, OPP CRIS PREV HIV EA; Venkatesh KK, 2011, JAIDS-J ACQ IMM DEF, V56, P151, DOI 10.1097/QAI.0b013e318202c82c; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; [WHO UNAIDS UNICEF], 2009, UN ACC SCAL PRIOR HI	26	54	54	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84317	10.1371/journal.pone.0084317	http://dx.doi.org/10.1371/journal.pone.0084317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392124	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100047
J	Forbes, PA; Dakin, CJ; Geers, AM; Vlaar, MP; Happee, R; Siegmund, GP; Schouten, AC; Blouin, JS				Forbes, Patrick A.; Dakin, Christopher J.; Geers, Anoek M.; Vlaar, Martijn P.; Happee, Riender; Siegmund, Gunter P.; Schouten, Alfred C.; Blouin, Jean-Sebastien			Electrical Vestibular Stimuli to Enhance Vestibulo-Motor Output and Improve Subject Comfort	PLOS ONE			English	Article							GALVANIC STIMULATION; RESPONSES; REFLEXES; MODULATION; OTOLITH; TIME	Electrical vestibular stimulation is often used to assess vestibulo-motor and postural responses in both clinical and research settings. Stochastic vestibular stimulation (SVS) is a recently established technique with many advantages over its square-wave counterpart; however, the evoked muscle responses remain relatively small. Although the vestibular-evoked responses can be enhanced by increasing the stimulus amplitude, subjects often perceive these higher intensity electrical stimuli as noxious or painful. Here, we developed multisine vestibular stimulation (MVS) signals that include precise frequency contributions to increase signal-to-noise ratios (SNR) of stimulus-evoked muscle and motor responses. Subjects were exposed to three different MVS stimuli to establish that: 1) MVS signals evoke equivalent vestibulo-motor responses compared to SVS while improving subject comfort and reducing experimentation time, 2) stimulus-evoked vestibulo-motor responses are reliably estimated as a linear system and 3) specific components of the cumulant density time domain vestibulo-motor responses can be targeted by controlling the frequency content of the input stimulus. Our results revealed that in comparison to SVS, MVS signals increased the SNR 3-6 times, reduced the minimum experimentation time by 85% and improved subjective measures of comfort by 20-80%. Vestibulo-motor responses measured using both EMG and force were not substantially affected by nonlinear distortions. In addition, by limiting the contribution of high frequencies within the MVS input stimulus, the magnitude of the medium latency time domain motor output response was increased by 58%. These results demonstrate that MVS stimuli can be designed to target and enhance vestibulo-motor output responses while simultaneously improving subject comfort, which should prove beneficial for both research and clinical applications.	[Forbes, Patrick A.; Geers, Anoek M.; Vlaar, Martijn P.; Happee, Riender; Schouten, Alfred C.] Delft Univ Technol, Dept Biomech Engn, Fac Mech Maritime & Mat Engn, Delft, Netherlands; [Schouten, Alfred C.] Univ Twente, Lab Biomech Engn, Inst Biomed Technol & Tech Med MIRA, NL-7500 AE Enschede, Netherlands; [Dakin, Christopher J.; Siegmund, Gunter P.; Blouin, Jean-Sebastien] Univ British Columbia, Sch Kinesiol, Vancouver, BC V5Z 1M9, Canada; [Blouin, Jean-Sebastien] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Blouin, Jean-Sebastien] Univ British Columbia, Inst Comp Informat & Cognit Syst, Vancouver, BC V5Z 1M9, Canada; [Siegmund, Gunter P.] MEA Forens Engineers & Scientists, Richmond, BC, Canada	Delft University of Technology; University of Twente; University of British Columbia; University of British Columbia; University of British Columbia	Forbes, PA (corresponding author), Delft Univ Technol, Dept Biomech Engn, Fac Mech Maritime & Mat Engn, Delft, Netherlands.	p.a.forbes@tudelft.nl	Siegmund, Gunter P/B-7003-2013; Schouten, Alfred C./AAH-3560-2019; Happee, Riender/A-2621-2011; Forbes, Patrick/GZH-1852-2022	Schouten, Alfred C./0000-0003-3149-6726; Happee, Riender/0000-0001-5878-3472; Forbes, Patrick/0000-0002-0230-9971; Siegmund, Gunter/0000-0003-2387-941X; Dakin, Chris/0000-0002-6781-0281	Dutch Technology Foundation STW; Ministry of Economic Affairs, Agriculture and Innovation; Natural Sciences and Engineering Research Council of Canada (NSERC); Michael Smith Foundation for Health Research; Canadian Chiropractic Research Foundation; Canadian Institutes of Health Research	Dutch Technology Foundation STW(Technologiestichting STW); Ministry of Economic Affairs, Agriculture and Innovation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Chiropractic Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by (1) the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs, Agriculture and Innovation (PAF, MPV, AMG, RH and ACS), and (2) the Natural Sciences and Engineering Research Council of Canada (NSERC), the Michael Smith Foundation for Health Research, the Canadian Chiropractic Research Foundation and the Canadian Institutes of Health Research (CJD, GPS and JSB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blouin JS, 2011, J APPL PHYSIOL, V111, P1484, DOI 10.1152/japplphysiol.00621.2011; BRITTON TC, 1993, EXP BRAIN RES, V94, P143; Cathers I, 2005, J PHYSIOL-LONDON, V563, P229, DOI 10.1113/jphysiol.2004.079525; Dakin CJ, 2007, J PHYSIOL-LONDON, V583, P1117, DOI 10.1113/jphysiol.2007.133264; Dakin CJ, 2013, J NEUROPHYSIOL, V110, P86, DOI 10.1152/jn.00843.2012; Dakin CJ, 2011, EXP BRAIN RES, V209, P345, DOI 10.1007/s00221-011-2549-7; Dakin CJ, 2010, J NEUROPHYSIOL, V103, P1048, DOI 10.1152/jn.00881.2009; Day BL, 1997, J PHYSIOL-LONDON, V500, P661, DOI 10.1113/jphysiol.1997.sp022051; Ehtemam F, 2012, IEEE T BIO-MED ENG, V59, P1978, DOI 10.1109/TBME.2012.2195178; Fitzpatrick R, 1996, J NEUROPHYSIOL, V76, P3994, DOI 10.1152/jn.1996.76.6.3994; FITZPATRICK R, 1994, J PHYSIOL-LONDON, V478, P363, DOI 10.1113/jphysiol.1994.sp020257; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; Forbes PA, 2013, J NEUROPHYS IN PRESS; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; ILES JF, 1992, J PHYSIOL-LONDON, V455, P407, DOI 10.1113/jphysiol.1992.sp019308; Iles JF, 2004, BRAIN, V127, P1584, DOI 10.1093/brain/awh173; Iles JF, 2007, EXP BRAIN RES, V178, P151, DOI 10.1007/s00221-006-0721-2; Jankelowitz SK, 2004, CLIN NEUROPHYSIOL, V115, P1796, DOI 10.1016/j.clinph.2004.03.021; MacDougall HG, 2006, EXP BRAIN RES, V172, P208, DOI 10.1007/s00221-005-0329-y; MAKI BE, 1986, IEEE T BIO-MED ENG, V33, P775, DOI 10.1109/TBME.1986.325901; Mian OS, 2010, J PHYSIOL-LONDON, V588, P4441, DOI 10.1113/jphysiol.2010.195222; Mian OS, 2009, J PHYSIOL-LONDON, V587, P2869, DOI 10.1113/jphysiol.2009.171256; Monobe H, 2004, CLIN NEUROPHYSIOL, V115, P807, DOI 10.1016/j.clinph.2003.11.035; Mugge W, 2007, INT C REHAB ROBOT, P575, DOI 10.1109/ICORR.2007.4428483; NASHNER LM, 1974, BRAIN RES, V67, P255, DOI 10.1016/0006-8993(74)90276-5; PASTOR MA, 1993, BRAIN, V116, P1177, DOI 10.1093/brain/116.5.1177; Pavlik AE, 1999, EXP BRAIN RES, V124, P273, DOI 10.1007/s002210050623; Pintelon R., 2001, SYSTEM IDENTIFICATIO; Pintelon R., 2012, SYSTEM IDENTIFICATIO, V2nd, DOI DOI 10.1002/9781118287422; Reynolds RF, 2011, J PHYSIOL-LONDON, V589, P3943, DOI 10.1113/jphysiol.2011.209163; Reynolds RF, 2010, EXP BRAIN RES, V201, P133, DOI 10.1007/s00221-009-2017-9; Schoukens J, 1993, DESIGN BROADBAND EXC; Schouten AC, 2008, IEEE T BIO-MED ENG, V55, P1612, DOI 10.1109/TBME.2007.912432; Stuart A, 1998, KENDALLS ADV THEORY, V1; Tax CM, 2013, CLIN NEUROPHYSIOLOGY	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84385	10.1371/journal.pone.0084385	http://dx.doi.org/10.1371/journal.pone.0084385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392130	gold, Green Published			2022-12-27	WOS:000329460100053
J	Mikami, Y; Mizuno, S; Nakamoto, N; Hayashi, A; Sujino, T; Sato, T; Kamada, N; Matsuoka, K; Hisamatsu, T; Ebinuma, H; Hibi, T; Yoshimura, A; Kanai, T				Mikami, Yohei; Mizuno, Shinta; Nakamoto, Nobuhiro; Hayashi, Atsushi; Sujino, Tomohisa; Sato, Toshiro; Kamada, Nobuhiko; Matsuoka, Katsuyoshi; Hisamatsu, Tadakazu; Ebinuma, Hirotoshi; Hibi, Toshifumi; Yoshimura, Akihiko; Kanai, Takanori			Macrophages and Dendritic Cells Emerge in the Liver during Intestinal Inflammation and Predispose the Liver to Inflammation	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; DSS-INDUCED COLITIS; T-CELLS; BOWEL-DISEASE; ULCERATIVE-COLITIS; CROHNS-DISEASE; GUT MICROBIOTA; MICE; PATHOGENESIS; TOLERANCE	The liver is a physiological site of immune tolerance, the breakdown of which induces immunity. Liver antigen-presenting cells may be involved in both immune tolerance and activation. Although inflammatory diseases of the liver are frequently associated with inflammatory bowel diseases, the underlying immunological mechanisms remain to be elucidated. Here we report two murine models of inflammatory bowel disease: RAG-2(-/-) mice adoptively transferred with CD4(+)CD45RB(high) T cells; and IL-10(-/-) mice, accompanied by the infiltration of mononuclear cells in the liver. Notably, CD11b(-) CD11c(low)PDCA-1(+) plasmacytoid dendritic cells (DCs) abundantly residing in the liver of normal wild-type mice disappeared in colitic CD4(+)CD45RB(high) T cell-transferred RAG-2(-/-) mice and IL-10(-/-) mice in parallel with the emergence of macrophages (MQs) and conventional DCs (cDCs). Furthermore, liver MQ/cDCs emerging during intestinal inflammation not only promote the proliferation of naive CD4(+) T cells, but also instruct them to differentiate into IFN-gamma-producing Th1 cells in vitro. The emergence of pathological M phi/cDCs in the liver also occurred in a model of acute dextran sulfate sodium (DSS)-induced colitis under specific pathogen-free conditions, but was canceled in germ-free conditions. Last, the MQ/cDCs that emerged in acute DSS colitis significantly exacerbated Fas-mediated hepatitis. Collectively, intestinal inflammation skews the composition of antigen-presenting cells in the liver through signaling from commensal bacteria and predisposes the liver to inflammation.	[Mikami, Yohei; Mizuno, Shinta; Nakamoto, Nobuhiro; Hayashi, Atsushi; Sujino, Tomohisa; Sato, Toshiro; Matsuoka, Katsuyoshi; Hisamatsu, Tadakazu; Ebinuma, Hirotoshi; Hibi, Toshifumi; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Mikami, Yohei; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Hayashi, Atsushi] Miyarisan Pharmaceut, Res Lab, Tokyo, Japan; [Kamada, Nobuhiko] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Kamada, Nobuhiko] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA	Keio University; Keio University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan.	yoshimura@a6.keio.jp; takagast@z2.keio.jp	Kamada, Nobuhiko/AAW-3299-2020; MIKAMI, YOHEI/GRJ-8133-2022; Matsuoka, Katsuyoshi/AAB-1580-2022; Yoshimura, Akihiko/K-5515-2013; Sato, Toshiro/J-3522-2014	Kamada, Nobuhiko/0000-0002-1980-4178; MIKAMI, YOHEI/0000-0001-5104-4415; Matsuoka, Katsuyoshi/0000-0002-2950-7660; Sato, Toshiro/0000-0001-8353-8137; Sujino, Tomohisa/0000-0003-0699-6577; Kanai, Takanori/0000-0002-1466-4532	Japanese Ministry of Education, Culture, Sports, Science and Technology [21390233, 22021038]; Japanese Ministry of Health, Labour and Welfare [22790667]; Japanese MIKAMI ET AL Ministry of Health, Labour and Welfare	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese MIKAMI ET AL Ministry of Health, Labour and Welfare	This study was supported in part by Grants-in-Aid for Scientific Research [21390233], Scientific Research on Priority Areas [22021038] from the Japanese Ministry of Education, Culture, Sports, Science and Technology; a Grant-in-Aid for Young Scientists [22790667] from the Japanese Ministry of Health, Labour and Welfare; Health and Labour Sciences Research Grants for research on intractable diseases from the Japanese MIKAMI ET AL Ministry of Health, Labour and Welfare; a Keio University Grant-in-Aid for Encouragement of Young Medical Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bjornsson E, 2008, GASTROENTEROLOGY, V134, P975, DOI 10.1053/j.gastro.2008.01.042; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Gabele E, 2011, J HEPATOL, V55, P1391, DOI 10.1016/j.jhep.2011.02.035; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hayashi A, 2013, CELL HOST MICROBE, V13, P711, DOI 10.1016/j.chom.2013.05.013; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Ishii K, 2004, J GASTROEN HEPATOL, V19, P174, DOI 10.1111/j.1440-1746.2004.03202.x; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kamada N, 2005, J IMMUNOL, V175, P6900, DOI 10.4049/jimmunol.175.10.6900; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kimura K, 2012, BIOCHEM BIOPH RES CO, V427, P694, DOI 10.1016/j.bbrc.2012.09.091; KNOLLE P, 1995, J HEPATOL, V22, P226, DOI 10.1016/0168-8278(95)80433-1; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mikami Y, 2010, EUR J IMMUNOL, V40, P2409, DOI 10.1002/eji.201040379; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Murthy A, 2010, J CLIN INVEST, V120, P2731, DOI 10.1172/JCI42686; Nakamoto N, 2012, GASTROENTEROLOGY, V142, P366, DOI 10.1053/j.gastro.2011.10.039; Nemoto Y, 2009, J IMMUNOL, V183, P5059, DOI 10.4049/jimmunol.0803684; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ojiro K, 2010, BIOCHEM BIOPH RES CO, V399, P744, DOI 10.1016/j.bbrc.2010.08.012; OLSSON R, 1991, GASTROENTEROLOGY, V100, P1319; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rasmussen HH, 1997, SCAND J GASTROENTERO, V32, P604, DOI 10.3109/00365529709025107; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Tokita D, 2008, J HEPATOL, V49, P1008, DOI 10.1016/j.jhep.2008.07.028; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343	35	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84619	10.1371/journal.pone.0084619	http://dx.doi.org/10.1371/journal.pone.0084619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392145	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100068
J	Yuan, J; Kang, CY; Wang, M; Wang, Q; Li, PK; Liu, H; Hou, Y; Su, P; Yang, F; Wei, YJ; Yang, JZ				Yuan, Jing; Kang, ChuanYuan; Wang, Min; Wang, Qiang; Li, PeiKai; Liu, Hua; Hou, Yu; Su, Ping; Yang, Fan; Wei, YuJun; Yang, JianZhong			Association Study of Serotonin Transporter SLC6A4 Gene with Chinese Han Irritable Bowel Syndrome	PLOS ONE			English	Article							FUNCTIONAL POLYMORPHISM; 5-HYDROXYTRYPTAMINE; PREDOMINANT; CONSTIPATION; SYMPTOMS; PROTEIN	Objective: Irritable bowel syndrome (IBS) is a common clinical gastrointestinal dysfunction disorders. 5-sertonon (5-hydroxytryptamine, 5-HT) is a very important neurotransmitter, which is involved in gastrointestinal motion and sensation. Solute carrier family 6 member 4 (SLC6A4) gene encode serotonin transporter (SERT) which function is to rapidly reuptake the most of 5-HT. Therefore, it is needed to explore the association between SLC6A4 gene polymorphisms and IBS. Methods: 119 patients and 238 healthy controls were administrated to detect the SLC6A4 gene polymorphisms including 5-HT-transporter-gene-linked polymorphic region (5-HTTLPR), variable number of tandem repeats (VNTRs) and three selected tag Single Nucleotide Polymorphisms (SNPs) rs1042173, rs3794808, rs2020936 by using polymerase chain reaction (PCR) and TaqMan (R) SNP Genotyping. Results: There were significant difference for 5-HTTLPR between IBS and control groups (X2 = 106.168, P < 0.0001). In control group, genotypes were mainly L/L (58.4%), however, the genotypes in IBS were S/S (37.8%). The significant difference was shown in D-IBS subjects when compared to the controls (X-2 = 50.850, P < 0.0001) for 5-HTTLPR. For STin2 VNTR, rs1042173, rs3794808, and rs2020936 polymorphisms, there were no any significant differences between IBS and control groups. There were no statistical significantly haplotypes for 5-HTTLPR, VNTRs and the three SNPs between IBS and controls. Conclusion: The S allele in 5-HTTLPR was a susceptible allele with Chinese Han IBS, but other associations of VNTRs, three selected Tag SNPs and positive haplotype with IBS were not found. It is indicated that much research are needed to study the relationship between other polymorphisms in SLC6A4 gene and IBS.	[Yuan, Jing; Li, PeiKai; Hou, Yu; Su, Ping; Yang, Fan; Wei, YuJun; Yang, JianZhong] 2 Peoples Hosp Yunnan Prov, Dept Clin Psychol, Kunming, Peoples R China; [Kang, ChuanYuan] Kunming Med Univ, Affiliated Hosp 1, Dept Psychiat, Kunming, Peoples R China; [Wang, Min; Wang, Qiang] 2 Peoples Hosp Yunnan Prov, Dept Gastroenterol, Kunming, Peoples R China; [Liu, Hua] Kunming Med Univ, Affiliated Hosp 1, Dept Lab, Kunming, Peoples R China	Kunming Medical University; Kunming Medical University	Yang, JZ (corresponding author), 2 Peoples Hosp Yunnan Prov, Dept Clin Psychol, Kunming, Peoples R China.	jzhyang2004@163.com			National Natural Scientific Foundation of China [81160170]; National Key Technologies RD Program [2009BAI77B05]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program)	This work was supported by Grant 81160170 from the National Natural Scientific Foundation of China, Grant 2009BAI77B05 from National Key Technologies R&D Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areeshi MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075567; Atkinson W, 2006, GASTROENTEROLOGY, V130, P34, DOI 10.1053/j.gastro.2005.09.031; Chang Full-Young, 2010, J Neurogastroenterol Motil, V16, P389, DOI 10.5056/jnm.2010.16.4.389; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; De Ponti F, 2004, GUT, V53, P1520, DOI 10.1136/gut.2003.035568; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; Hotoleanu C, 2008, WORLD J GASTROENTERO, V14, P6636, DOI 10.3748/wjg.14.6636; Houghton LA, 2003, GUT, V52, P663, DOI 10.1136/gut.52.5.663; Jarrett ME, 2007, BIOL RES NURS, V9, P161, DOI 10.1177/1099800407307822; Kim HJ, 2004, GUT, V53, P829, DOI 10.1136/gut.2003.030882; Kohen R, 2009, DIGEST DIS SCI, V54, P2663, DOI 10.1007/s10620-008-0666-3; Lee Dok Yong, 2004, Korean J Gastroenterol, V43, P18; Lee Oh Young, 2010, J Neurogastroenterol Motil, V16, P5, DOI 10.5056/jnm.2010.16.1.5; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li YY, 2007, DIGEST DIS SCI, V52, P2942, DOI 10.1007/s10620-006-9679-y; Makharia GK, 2011, J NEUROGASTROENTEROL, V17, P82, DOI 10.5056/jnm.2011.17.1.82; Markoutsaki T, 2011, DIGEST DIS SCI, V56, P3276, DOI 10.1007/s10620-011-1726-7; Pata C, 2002, AM J GASTROENTEROL, V97, P1780; Saito YA, 2005, CLIN GASTROENTEROL H, V3, P1057, DOI 10.1016/S1542-3565(05)00184-9; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Van Kerkhoven LAS, 2007, ALIMENT PHARM THER, V26, P979, DOI 10.1111/j.1365-2036.2007.03453.x; Wang Bang-mao, 2004, Zhonghua Nei Ke Za Zhi, V43, P439; Yeo A, 2004, GUT, V53, P1452, DOI 10.1136/gut.2003.035451	25	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84414	10.1371/journal.pone.0084414	http://dx.doi.org/10.1371/journal.pone.0084414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392134	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100057
J	Biswal, AK				Biswal, Akshaya Kumar			An Absolute Index (Ab-index) to Measure a Researcher's Useful Contributions and Productivity	PLOS ONE			English	Article							SCIENTIFIC PERFORMANCE; INDICATORS; AUTHOR; COLLABORATION; PUBLICATIONS; CITATION; GENOME; MAP	Bibliographic analysis has been a very powerful tool in evaluating the effective contributions of a researcher and determining his/her future research potential. The lack of an absolute quantification of the author's scientific contributions by the existing measurement system hampers the decision-making process. In this paper, a new metric system, Absolute index (Ab-index), has been proposed that allows a more objective comparison of the contributions of a researcher. The Abindex takes into account the impact of research findings while keeping in mind the physical and intellectual contributions of the author(s) in accomplishing the task. The Ab-index and h-index were calculated for 10 highly cited geneticists and molecular biologist and 10 young researchers of biological sciences and compared for their relationship to the researchers input as a primary author. This is the first report of a measuring method clarifying the contributions of the first author, corresponding author, and other co-authors and the sharing of credit in a logical ratio. A java application has been developed for the easy calculation of the Ab-index. It can be used as a yardstick for comparing the credibility of different scientists competing for the same resources while the Productivity index (Pr-index), which is the rate of change in the Abindex per year, can be used for comparing scientists of different age groups. The Ab-index has clear advantage over other popular metric systems in comparing scientific credibility of young scientists. The sum of the Ab-indices earned by individual researchers of an institute per year can be referred to as Pr-index of the institute.	Int Rice Res Inst, Rice Ctr C4, Manila, Philippines	CGIAR; International Rice Research Institute (IRRI)	Biswal, AK (corresponding author), Int Rice Res Inst, Rice Ctr C4, Manila, Philippines.	a.biswal@irri.org	Biswal, Akshaya K/G-6694-2011	Biswal, Akshaya K/0000-0002-5652-6007	International Rice Research Institute (IRRI)	International Rice Research Institute (IRRI)	The author is thankful to International Rice Research Institute (IRRI) for providing necessary funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt HA, 2012, SCIENTOMETRICS, V91, P863, DOI 10.1007/s11192-011-0525-4; Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a; Allen M, 2003, AM J HUM GENET, V73, P430; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aziz NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059814; Baerlocher MO, 2007, J INVEST MED, V55, P174, DOI 10.2310/6650.2007.06044; Bollen J, 2008, J AM SOC INF SCI TEC, V59, P136, DOI 10.1002/asi.20746; Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Bornmann L, 2011, J INFORMETR, V5, P346, DOI 10.1016/j.joi.2011.01.006; Bornmann L, 2011, SCIENTOMETRICS, V86, P173, DOI 10.1007/s11192-010-0222-8; Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; Coccia M, 2009, P PMA THEOR PRACT PE, P1; Dance A, 2012, NATURE, V489, pS2, DOI 10.1038/489S2a; Daniel HD, 2005, LEARN PUBL, V18, P143, DOI 10.1087/0953151053584939; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Galam S, 2011, SCIENTOMETRICS, V89, P365, DOI 10.1007/s11192-011-0447-1; Goffman W., 1980, SCI INFORM SYSTEMS P; Greene M, 2007, NATURE, V450, P1165, DOI 10.1038/4501165a; Harzing A.-W, 2008, REFLECTIONS H INDEX; Hirsch JE, 2010, SCIENTOMETRICS, V85, P741, DOI 10.1007/s11192-010-0193-9; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hu XJ, 2010, J INF SCI, V36, P73, DOI 10.1177/0165551509348133; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Katsouyanni K, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-3; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Krauskopf E, 2008, QUANTIFYING COAUTHOR; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laudel G, 2005, RES EVALUAT, V14, P27, DOI 10.3152/147154405781776300; Lehmann S, 2008, SCIENTOMETRICS, V76, P369, DOI 10.1007/s11192-007-1868-8; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; Martinson BC, 2006, J EMPIR RES HUM RES, V1, P51, DOI 10.1525/jer.2006.1.1.51; NARIN F, 1991, SCIENTOMETRICS, V21, P313, DOI 10.1007/BF02093973; Oppenheim C, 1998, J AM SOC INFORM SCI, V49, P482, DOI 10.1002/(SICI)1097-4571(19980415)49:5<482::AID-ASI11>3.3.CO;2-8; Qiu J, 2010, NATURE, V463, P142, DOI 10.1038/463142a; Ruths D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012133; Schmoch U, 2010, RES EVALUAT, V19, P2, DOI 10.3152/095820210X492477; Schubert A, 1996, SCIENTOMETRICS, V36, P311, DOI 10.1007/BF02129597; Sekercioglu CH, 2008, SCIENCE, V322, P371, DOI 10.1126/science.322.5900.371a; Stallings J, 2013, P NATL ACAD SCI USA, V110, P9680, DOI 10.1073/pnas.1220184110; Van Raan AFJ, 1993, RES EVALUAT, V3, P151; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Zhang CT, 2009, EMBO REP, V10, P416, DOI 10.1038/embor.2009.74	42	21	21	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84334	10.1371/journal.pone.0084334	http://dx.doi.org/10.1371/journal.pone.0084334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391941	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900084
J	Cai, LB; Ma, X; Liu, S; Liu, JJ; Wang, W; Cui, YG; Ding, W; Mao, YD; Chen, HP; Huang, J; Zhou, ZM; Liu, JY				Cai, Lingbo; Ma, Xiang; Liu, Shan; Liu, Jinjuan; Wang, Wei; Cui, Yugui; Ding, Wei; Mao, Yundong; Chen, Huiping; Huang, Jie; Zhou, Zuomin; Liu, Jiayin			Effects of Upregulation of Hsp27 Expression on Oocyte Development and Maturation Derived from Polycystic Ovary Syndrome	PLOS ONE			English	Article							OXIDATIVE STRESS; CELL-DEATH; APOPTOSIS; ACTIVATION; RESISTANCE; PROGRESS; QUALITY; WOMEN	Heat shock protein 27 (Hsp27) is a heat shock protein family member which can inhibit apoptosis. Our previous studies reported down-regulated Hsp27 in ovarian tissue derived from women with polycystic ovary syndrome (PCOS) however, the exact effect of Hsp27 on oocyte maturation and developmental competence in PCOS is unclear. The effect of Hsp27 overexpression was studied in vitro using oocytes derived from PCOS patients. An artificial GFP-plasmid was injected into human oocyte to increase Hsp27 protein level. Oocyte maturation was evaluated by morphological observation. Mature oocytes were fertilized by intracytoplasmic sperm injection (ICSI) and embryonic developmental competence was evaluated. Critical apoptotic factors and cytokines were measured at both the mRNA and protein level. Our results revealed that Overexpression of HSP27 lowered the maturation rate of oocytes derived from PCOS patients. Meanwhile, fertilization rate and high quality embryo rate were similar between the Hsp27 overexpressing group and controls; however, the blastocyst formation rate in this group was significantly higher than control. Expression analysis revealed that the oocyte-secreted factors, BMP15 and GDF9, and the apoptotic-related regulators, Caspase 3, 8 and 9, were all significantly decreased in Hsp27 overexpressing oocytes. In conclusion, upregulation of Hsp27 inhibits oocyte maturation from PCOS patients, but improves embryonic developmental potential.	[Cai, Lingbo; Ma, Xiang; Liu, Shan; Liu, Jinjuan; Wang, Wei; Cui, Yugui; Ding, Wei; Mao, Yundong; Chen, Huiping; Huang, Jie; Zhou, Zuomin; Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, ZM (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	zhouzm@njmu.edu.cn; jyliu_nj@126.com		cai, lingbo/0000-0001-5094-0082	National Natural Projects of China [30800394, 81070465]; National Natural Projects of China 973 Program [2012CB944703, 2012CB944902]	National Natural Projects of China; National Natural Projects of China 973 Program(National Basic Research Program of China)	This work was supported by grants from the National Natural Projects of China (30800394 and 81070465) and 973 Program (2012CB944703 and 2012CB944902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-49; Behrman HR, 2001, J SOC GYNECOL INVEST, V8, pS40, DOI 10.1016/S1071-5576(00)00106-4; Bilodeau-Goeseels S, 2002, ANIM REPROD SCI, V71, P143, DOI 10.1016/S0378-4320(01)00188-9; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; de Wit AAC, 2001, ANIM REPROD SCI, V65, P51, DOI 10.1016/S0378-4320(00)00215-3; DELOOS F, 1992, MOL REPROD DEV, V31, P208, DOI 10.1002/mrd.1080310308; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Heijnen EMEW, 2006, HUM REPROD UPDATE, V12, P13, DOI 10.1093/humupd/dmi036; Hendriksen PJM, 2000, THERIOGENOLOGY, V53, P11, DOI 10.1016/S0093-691X(99)00236-8; Hooper PL, 2003, DIABETES CARE, V26, P951, DOI 10.2337/diacare.26.3.951; Hughes C, 2006, HUM REPROD, V21, P2766, DOI 10.1093/humrep/del222; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Kammanadiminti SJ, 2006, J BIOL CHEM, V281, P26112, DOI 10.1074/jbc.M601988200; Karlstrom PO, 1997, HUM REPROD, V12, P1263; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; Li HJ, 2009, ANIM REPROD SCI, V114, P89, DOI 10.1016/j.anireprosci.2008.09.018; Liu JJ, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-47; Ma X, 2007, MOL HUM REPROD, V13, P527, DOI 10.1093/molehr/gam036; Matwee C, 2000, ZYGOTE, V8, P57, DOI 10.1017/S0967199400000836; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; MEHLEN P, 1995, J IMMUNOL, V154, P363; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Pandey P, 2000, ONCOGENE, V19, P1975, DOI 10.1038/sj.onc.1203531; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Schoolcraft WB, 1999, FERTIL STERIL, V72, P604, DOI 10.1016/S0015-0282(99)00311-8; Tilly JL, 2001, NAT REV MOL CELL BIO, V2, P838, DOI 10.1038/35099086; Toulis KA, 2009, HUM REPROD UPDATE, V15, P297, DOI 10.1093/humupd/dmp006; VandenAbbeel E, 1997, HUM REPROD, V12, P2006, DOI 10.1093/humrep/12.9.2006; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1085, DOI 10.1167/iovs.04-0042; Wood JR, 2007, J CLIN ENDOCR METAB, V92, P705, DOI 10.1210/jc.2006-2123; Yuan YQ, 2005, THERIOGENOLOGY, V63, P2147, DOI 10.1016/j.theriogenology.2004.09.054	37	17	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83402	10.1371/journal.pone.0083402	http://dx.doi.org/10.1371/journal.pone.0083402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391762	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200059
J	de Oliveira, SV; Escobar, LE; Peterson, AT; Gurgel-Goncalves, R				de Oliveira, Stefan Vilges; Escobar, Luis E.; Peterson, A. Townsend; Gurgel-Goncalves, Rodrigo			Potential Geographic Distribution of Hantavirus Reservoirs in Brazil	PLOS ONE			English	Article							POPULATION-DYNAMICS; PULMONARY SYNDROME; NECROMYS-LASIURUS; WILD RODENTS; INFECTION; CERRADO; MAMMALS; RISK; SIGMODONTINAE; CONSERVATISM	Hantavirus cardiopulmonary syndrome is an emerging zoonosis in Brazil. Human infections occur via inhalation of aerosolized viral particles from excreta of infected wild rodents. Necromys lasiurus and Oligoryzomys nigripes appear to be the main reservoirs of hantavirus in the Atlantic Forest and Cerrado biomes. We estimated and compared ecological niches of the two rodent species, and analyzed environmental factors influencing their occurrence, to understand the geography of hantavirus transmission. N. lasiurus showed a wide potential distribution in Brazil, in the Cerrado, Caatinga, and Atlantic Forest biomes. Highest climate suitability for O. nigripes was observed along the Brazilian Atlantic coast. Maximum temperature in the warmest months and annual precipitation were the variables that most influence the distributions of N. lasiurus and O. nigripes, respectively. Models based on occurrences of infected rodents estimated a broader area of risk for hantavirus transmission in southeastern and southern Brazil, coinciding with the distribution of human cases of hantavirus cardiopulmonary syndrome. We found no demonstrable environmental differences among occurrence sites for the rodents and for human cases of hantavirus. However, areas of northern and northeastern Brazil are also apparently suitable for the two species, without broad coincidence with human cases. Modeling of niches and distributions of rodent reservoirs indicates potential for transmission of hantavirus across virtually all of Brazil outside the Amazon Basin.	[de Oliveira, Stefan Vilges] Univ Brasilia, Postgrad Program Trop Med, Brasilia, DF, Brazil; [de Oliveira, Stefan Vilges] Minist Saude, Unidade Tecn Vigilancia Zoonoses, Brasilia, DF, Brazil; [Escobar, Luis E.] Univ Andres Bello, Conservat Med Program, Fac Ecol & Recursos Nat, Santiago, Chile; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Gurgel-Goncalves, Rodrigo] Univ Brasilia, Lab Parasitol Med & Biol Vetores, Brasilia, DF, Brazil	Universidade de Brasilia; Universidad Andres Bello; University of Kansas; Universidade de Brasilia	Gurgel-Goncalves, R (corresponding author), Univ Brasilia, Lab Parasitol Med & Biol Vetores, Brasilia, DF, Brazil.	gurgelrg@hotmail.com	Escobar, Luis E./I-2204-2019; Gurgel-Goncalves, Rodrigo/AAD-7955-2020; Peterson, A. Townsend/I-5697-2013	Escobar, Luis E./0000-0001-5735-2750; Gurgel-Goncalves, Rodrigo/0000-0001-8252-8690; Peterson, A. Townsend/0000-0003-0243-2379	CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Stefan Vilges de Oliveira received financial support (scholarship) from CAPES, Brazil (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrellos R, 2012, ZOOTAXA, P1; Alger, 2003, CORREDOR BIODIVERSID, P1; Alho CJR, 2011, BRAZ J BIOL, V71, P297, DOI 10.1590/S1519-69842011000200009; ALHO C J R, 1982, Annals of Carnegie Museum, V51, P127; Anderson RP, 2002, GLOBAL ECOL BIOGEOGR, V11, P131, DOI 10.1046/j.1466-822X.2002.00275.x; Astua Diego, 2006, Boletim do Museu de Biologia Mello Leitao Nova Serie, V19, P31; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Becker Rafael G., 2007, Mastozool. neotrop., V14, P157; Bergallo HG, 1999, J MAMMAL, V80, P472, DOI 10.2307/1383294; Bezerra AMR, 2009, ZOOL STUD, V48, P861; Bonvicino C. R., 2005, Braz. J. Biol., V65, P395, DOI 10.1590/S1519-69842005000300004; Bonvicino CR, 2008, GUIA ROED BRAS COM C; Brasil, 2009, GUIA VIG EP; Cademartori Cristina Vargas, 2008, Biodiversidade Pampeana, V6, P34; Caldas EP, 2003, THESIS U FEDERAL DO, P63; Carbajo AE, 2007, J MAMMAL, V88, P1555, DOI 10.1644/06-MAMM-A-183R1.1; Cherem Jorge J., 2004, Mastozool. neotrop., V11, P151; Chioratto Gerlane Tavares de Souza, 2010, Revista de Patologia Tropical, V39, P1; D'Elia G, 2008, J MAMMAL, V89, P778, DOI 10.1644/07-MAMM-A-246R1.1; Donalisio MR, 2011, ACTA TROP, V119, P125, DOI 10.1016/j.actatropica.2011.04.019; Eisenberg JF, 1999, MAMMALS NEOTROPICS; Gazeta GS, 2004, ARQ BRAS MED VET ZOO, V56, P741, DOI 10.1590/S0102-09352004000600007; Ghizoni IR, 2005, J MAMMAL, V86, P677, DOI 10.1644/1545-1542(2005)086[0677:SEPDIA]2.0.CO;2; Glass GE, 2002, P NATL ACAD SCI USA, V99, P16817, DOI 10.1073/pnas.252617999; Glass GE, 2000, EMERG INFECT DIS, V6, P238, DOI 10.3201/eid0603.000303; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Katz G, 2001, ZOO DROSOPHILA INF S, V1, P181; Lemos Elba Regina S. de, 2004, Pesq. Vet. Bras., V24, P71, DOI 10.1590/S0100-736X2004000200004; Loehman RA, 2012, J WILDLIFE DIS, V48, P348, DOI 10.7589/0090-3558-48.2.348; Lustosa GS, 2007, AN 8 C EC BRAS 23 28; Machado Leonardo F., 2011, Pap. Avulsos Zool. (São Paulo), V51, P29, DOI 10.1590/S0031-10492011000300001; MELLO DA, 1982, REV SAUDE PUBL, V16, P282, DOI 10.1590/S0034-89101982000500003; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; OLIVEIRA F.F., 2004, REV NORDESTINA BIOL, V18, P19; Oliveira J., 2006, MAMIFEROS BRASIL, P347; OLIVEIRA J. A., 2003, ECOLOGIA CONSERVACAO, P275; Oliveira RC, 2009, ACTA TROP, V112, P212, DOI 10.1016/j.actatropica.2009.07.029; Oliveira RC, 2011, VECTOR BORNE ZOO DIS, V11, P302; Paglia AP., 2012, OCCAS PAP CONSERV BI, V4, P76; Paresque Roberta, 2004, Boletim do Museu de Biologia Mello Leitao Nova Serie, P5; Paresque R, 2007, GENET MOL BIOL, V30, P43, DOI 10.1590/S1415-47572007000100010; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pereira LE, 2006, THESIS SECRETARIA ES, P165; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qiao H, 2013, NICHEA VERSION 1 2 B; Raboni SM, 2009, J GEN VIROL, V90, P2166, DOI 10.1099/vir.0.011585-0; Raboni SM, 2009, J CLIN VIROL, V45, P153, DOI 10.1016/j.jcv.2009.03.015; Romano-Lieber Nicolina Silvana, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P325, DOI 10.1590/S0036-46652001000600005; Rosa EST, 2005, VECTOR-BORNE ZOONOT, V5, P11, DOI 10.1089/vbz.2005.5.11; Saavedra RD, 2011, REV SOC BRAS MED TRO, V44, P223, DOI 10.1590/S0037-86822011005000008; Santos JP, 2001, REV SOC BRAS MED TRO, V44, P53; Silva Marcos Vinicius Da, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P231; Sobreira M, 2008, ACTA TROP, V107, P150, DOI 10.1016/j.actatropica.2008.05.018; Sousa MAN, 2004, BREJOS ALTITUDE PERN, P229, DOI DOI 10.15560/9.6.1527; Suzuki A, 2004, EMERG INFECT DIS, V10, P2127, DOI 10.3201/eid1012.040295; da Rosa EST, 2012, EMERG INFECT DIS, V18, P982, DOI 10.3201/eid1806.110948; da Rosa EST, 2011, EMERG INFECT DIS, V17, P1527, DOI 10.3201/eid1708.101547; Travassos da Rosa ES, 2008, THESIS I O CRUZ RIO; Vasconcelos M I, 1997, Rev Inst Med Trop Sao Paulo, V39, P237; Vieira EM, 2005, MAMM BIOL, V70, P359, DOI 10.1016/j.mambio.2005.08.002; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weksler M., 2005, ARQUIVOS MUSEU NACL, V63, P113; Zhang WY, 2009, AM J TROP MED HYG, V80, P678, DOI 10.4269/ajtmh.2009.80.678	67	10	11	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85137	10.1371/journal.pone.0085137	http://dx.doi.org/10.1371/journal.pone.0085137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391989	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900132
J	Dehmer, M; Emmert-Streib, F; Tripathi, S				Dehmer, Matthias; Emmert-Streib, Frank; Tripathi, Shailesh			Large-Scale Evaluation of Molecular Descriptors by Means of Clustering	PLOS ONE			English	Article							TOPOLOGICAL INDEXES; GRAPH; ENTROPY	Molecular descriptors have been explored extensively. From these studies, it is known that a large number of descriptors are strongly correlated and capture similar characteristics of molecules. In this paper, we evaluate 919 Dragon-descriptors of 6 different categories by means of clustering. Also, we analyze these different categories of descriptors also find a subset of descriptors which are least correlated among each other and, hence, characterize molecular graphs distinctively.	[Dehmer, Matthias; Tripathi, Shailesh] Eduard Wallnoefer Zentrum 1, UMIT, Div Bioinformat & Translat Res, Hall In Tirol, Austria; [Emmert-Streib, Frank] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Dehmer, M (corresponding author), Eduard Wallnoefer Zentrum 1, UMIT, Div Bioinformat & Translat Res, Hall In Tirol, Austria.	matthias.dehmer@umit.at	Emmert-Streib, Frank/AAF-2878-2020; Emmert-Streib, Frank/G-8099-2011; Trpathi, Shailesh/T-2123-2017	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641; 	Austrian Science Funds [P22029-N13]; Austrian Science Fund (FWF) [P 22029] Funding Source: researchfish	Austrian Science Funds(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Matthias Dehmer and Shailesh Tripathi thank the Austrian Science Funds for supporting this work (project P22029-N13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, ELEMENTS STAT LEARNI; BASAK SC, 1988, DISCRETE APPL MATH, V19, P17, DOI 10.1016/0166-218X(88)90004-2; Basak SC, 2000, J CHEM INF COMP SCI, V40, P891, DOI 10.1021/ci990114y; Basak SC, 2004, CROAT CHEM ACTA, V77, P331; Best DJ, 1975, APPL STAT, V4, P377, DOI DOI 10.2307/2347111; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Dehmer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031214; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Dehmer M, 2009, J CHEM INF MODEL, V49, P1655, DOI 10.1021/ci900060x; Devillers J., 1999, TOPOLOGICAL INDICES; Dudoit S, 2008, SPRINGER SER STAT, P1; Halkidi M, 2002, SIGMOD REC, V31, P19, DOI 10.1145/601858.601862; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Hollander M., 2014, WILEY SERIES PROBABI, V3rd; HOSOYA H, 1971, B CHEM SOC JPN, V44, P2332, DOI 10.1246/bcsj.44.2332; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Janezic D, 2007, MATH CHEM MONOGRAPHS; Karelson M., 2000, MOL DESCRIPTORS QSAR; Khalifeh MH, 2009, DISCRETE APPL MATH, V157, P804, DOI 10.1016/j.dam.2008.06.015; Kier L, 1986, CHEMOMETRICS SERIES; Kier L., 1976, MOL CONNECTIVITY CHE; Kier L.B., 1999, MOL STRUCTURE DESCRI; KVALSETH TO, 1987, IEEE T SYST MAN CYB, V17, P517, DOI 10.1109/TSMC.1987.4309069; Mauri A, 2006, MATCH-COMMUN MATH CO, V56, P237; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Taraviras SL, 2000, J CHEM INF COMP SCI, V40, P1128, DOI 10.1021/ci990149y; TODESCHINI R, 1992, CHEMOMETR INTELL LAB, V15, P51, DOI 10.1016/0169-7439(92)80026-Z; Todeschini R., 2010, MOL DESCRIPTORS CHEM; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Zhongmou L, 2010, 2010 IEEE INT C DAT, V0, P911	32	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83956	10.1371/journal.pone.0083956	http://dx.doi.org/10.1371/journal.pone.0083956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391854	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200152
J	Kyogoku, C; Smiljanovic, B; Grun, JR; Biesen, R; Schulte-Wrede, U; Haupl, T; Hiepe, F; Alexander, T; Radbruch, A; Grutzkau, A				Kyogoku, Chieko; Smiljanovic, Biljana; Gruen, Joachim R.; Biesen, Robert; Schulte-Wrede, Ursula; Haeupl, Thomas; Hiepe, Falk; Alexander, Tobias; Radbruch, Andreas; Gruetzkau, Andreas			Cell-Specific Type I IFN Signatures in Autoimmunity and Viral Infection: What Makes the Difference?	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; YELLOW-FEVER VACCINE; DISEASE-ACTIVITY; GENE-EXPRESSION; BLOOD MONOCYTES; INTERFERON; INFLAMMATION; ARTHRITIS; RESPONSES; RECRUITS	Gene expression profiling of peripheral blood mononuclear cells (PBMCs) has revealed a crucial role for type I interferon (IFN) in the pathogenesis of systemic lupus erythematosus (SLE). However, it is unclear how particular leucocyte subsets contribute to the overall type I IFN signature of PBMCs and whole blood samples. Furthermore, a detailed analysis describing the differences in the IFN signature in autoimmune diseases from that observed after viral infection has not been performed to date. Therefore, in this study, the transcriptional responses in peripheral T helper cells (CD4(+)) and monocyte subsets (CD16(-) inflammatory and CD16(+) resident monocytes) isolated from patients with SLE, healthy donors (ND) immunised with the yellow fever vaccine YFV-17Dand untreated controls were compared by global gene expression profiling. It was striking that all of the transcripts that were regulated in response to viral exposure were also found to be differentially regulated in SLE, albeit with markedly lower fold-change values. In addition to this common IFN signature, a pathogenic IFN-associated gene signature was detected in the CD4+ T cells and monocytes from the lupus patients. IL-10, IL-9 and IL-15-mediated JAK/STAT signalling was shown to be involved in the pathological amplification of IFN responses observed in SLE. Type I IFN signatures identified were successfully applied for the monitoring of interferon responses in PBMCs of an independent cohort of SLE patients and virus-infected individuals. Moreover, these cell-type specific gene signatures allowed a correct classification of PBMCs independent from their heterogenic cellular composition. In conclusion, our data show for the first time that monocytes and CD4 cells are sensitive biosensors to monitor type I interferon response signatures in autoimmunity and viral infection and how these transriptional responses are modulated in a cell-and disease-specific manner.	[Kyogoku, Chieko; Smiljanovic, Biljana; Gruen, Joachim R.; Biesen, Robert; Schulte-Wrede, Ursula; Hiepe, Falk; Alexander, Tobias; Radbruch, Andreas; Gruetzkau, Andreas] German Rheumatism Res Ctr DRFZ Berlin, Berlin, Germany; [Biesen, Robert; Haeupl, Thomas; Hiepe, Falk; Alexander, Tobias] Humboldt Univ, Dept Rheumatol & Clin Immunol, Charite Univ Med Berlin, D-10099 Berlin, Germany; [Kyogoku, Chieko] Univ Tsukuba Hosp, Tsukuba, Ibaraki, Japan	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Tsukuba	Grutzkau, A (corresponding author), German Rheumatism Res Ctr DRFZ Berlin, Berlin, Germany.	gruetzkau@drfz.de		Hiepe, Falk/0000-0003-3584-5292; Radbruch, Andreas/0000-0001-5753-0000; Grun, Joachim R./0000-0002-2875-3691; Biesen, Robert/0000-0002-0434-7832	German Ministry of Education and Research (BMBF) within the National Genome Research Network NGFN [01GS0413]; German Research Foundation (Collaborative Research Centre) [SFB650, TP12]; European Union [LSHB-CT-2006-018861]; IMI JU [115142-2]; Alexander von Humboldt Foundation	German Ministry of Education and Research (BMBF) within the National Genome Research Network NGFN(Federal Ministry of Education & Research (BMBF)); German Research Foundation (Collaborative Research Centre)(German Research Foundation (DFG)); European Union(European Commission); IMI JU; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the German Ministry of Education and Research (BMBF) within the National Genome Research Network NGFN (01GS0413), the German Research Foundation (Collaborative Research Centre SFB650, TP12), by the European Union's Sixth Framework Programme (project AutoCure; LSHB-CT-2006-018861), and by the IMI JU funded project BeTheCure (contract no 115142-2). Chieko Kyogoku thanks the Alexander von Humboldt Foundation for her fellowship and funding. The funders had no role on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Ancuta P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-403; Aune TM, 2004, CELL BIOCHEM BIOPHYS, V40, P81, DOI 10.1385/CBB:40:2:081; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baranda L, 2005, RHEUMATOLOGY, V44, P1507, DOI 10.1093/rheumatology/kei083; Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018; Bauer JW, 2009, ARTHRITIS RHEUM-US, V60, P3098, DOI 10.1002/art.24803; Becker AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067003; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Biesen R, 2008, ARTHRITIS RHEUM-US, V58, P1136, DOI 10.1002/art.23404; Caligaris-Cappio F, 2011, HAEMATOL-HEMATOL J, V96, P353, DOI 10.3324/haematol.2010.039446; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; Deng YJ, 2006, MOL IMMUNOL, V43, P1497, DOI 10.1016/j.molimm.2005.07.039; Di Sabatino A, 2011, CYTOKINE GROWTH F R, V22, P19, DOI 10.1016/j.cytogfr.2010.09.003; Frankenberger M, 2012, EUR J IMMUNOL, V42, P957, DOI 10.1002/eji.201141907; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Haupl T, 2010, ANN RHEUM DIS, V69, P37, DOI 10.1136/ard.2009.119487; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Ivashkiv LB, 2003, AUTOIMMUNITY, V36, P473, DOI 10.1080/08916930310001605882; Kong KO, 2009, CLIN EXP IMMUNOL, V156, P134, DOI 10.1111/j.1365-2249.2009.03880.x; Kyogoku C, 2007, GENES IMMUN, V8, P445, DOI 10.1038/sj.gene.6364409; Luo N, 2009, CLIN IMMUNOL, V132, P349, DOI 10.1016/j.clim.2009.05.010; Lyons PA, 2010, ANN RHEUM DIS, V69, P1208, DOI 10.1136/ard.2009.108043; Maas K, 2002, J IMMUNOL, V169, P5, DOI 10.4049/jimmunol.169.1.5; Meazza R, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/861920; Menssen A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-98; Moriwaki A, 2011, AM J RESP CELL MOL, V44, P448, DOI 10.1165/rcmb.2009-0051OC; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ramgolam VS, 2011, J SIGNAL TRANSDUCT, V2011; Ramos PS, 2011, ARTHRITIS RHEUM-US, V63, P2049, DOI 10.1002/art.30356; Rose T, 2013, ANN RHEUM DIS, V72, P1639, DOI 10.1136/annrheumdis-2012-201586; Scherberich JE, 2003, INT J CLIN PHARM TH, V41, P459; Smiljanovic B, 2012, J MOL MED, V90, P1295, DOI 10.1007/s00109-012-0907-y; Smiljanovic B, 2010, J MOL MED, V88, P1065, DOI 10.1007/s00109-010-0648-8; Steinbrich-Zollner M, 2008, CYTOM PART A, V73A, P333, DOI 10.1002/cyto.a.20505; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Tsao JT, 2008, CLIN EXP MED, V8, P179, DOI 10.1007/s10238-008-0006-0; van Baarsen LGM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2557; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Wong LH, 1998, J IMMUNOL, V160, P5475; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	46	47	49	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83776	10.1371/journal.pone.0083776	http://dx.doi.org/10.1371/journal.pone.0083776			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391825	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200123
J	Paolella, G; Caputo, I; Marabotti, A; Lepretti, M; Salzano, AM; Scaloni, A; Vitale, M; Zambrano, N; Sblattero, D; Esposito, C				Paolella, Gaetana; Caputo, Ivana; Marabotti, Anna; Lepretti, Marilena; Salzano, Anna Maria; Scaloni, Andrea; Vitale, Monica; Zambrano, Nicola; Sblattero, Daniele; Esposito, Carla			Celiac Anti-Type 2 Transglutaminase Antibodies Induce Phosphoproteome Modification in Intestinal Epithelial Caco-2 Cells	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; TISSUE TRANSGLUTAMINASE; KINASE-ACTIVITY; POSTTRANSLATIONAL MODIFICATION; SURFACE TRANSGLUTAMINASE; ENDOPLASMIC-RETICULUM; CREATINE-KINASE; HUMAN-DISEASES; PHOSPHORYLATION; IDENTIFICATION	Background: Celiac disease is an inflammatory condition of the small intestine that affects genetically predisposed individuals after dietary wheat gliadin ingestion. Type 2-transglutaminase (TG2) activity seems to be responsible for a strong autoimmune response in celiac disease, TG2 being the main autoantigen. Several studies support the concept that celiac anti-TG2 antibodies may contribute to disease pathogenesis. Our recent findings on the ability of anti-TG2 antibodies to induce a rapid intracellular mobilization of calcium ions, as well as extracellular signal-regulated kinase phosphorylation, suggest that they potentially act as signaling molecules. In line with this concept, we have investigated whether anti-TG2 antibodies can induce phosphoproteome modification in an intestinal epithelial cell line. Methods and Principal Findings: We studied phosphoproteome modification in Caco-2 cells treated with recombinant celiac anti-TG2 antibodies. We performed a two-dimensional electrophoresis followed by specific staining of phosphoproteins and mass spectrometry analysis of differentially phosphorylated proteins. Of 14 identified proteins (excluding two uncharacterized proteins), three were hypophosphorylated and nine were hyperphosphorylated. Bioinformatics analyses confirmed the presence of phosphorylation sites in all the identified proteins and highlighted their involvement in several fundamental biological processes, such as cell cycle progression, cell stress response, cytoskeletal organization and apoptosis. Conclusions: Identification of differentially phosphorylated proteins downstream of TG2-antibody stimulation suggests that in Caco-2 cells these antibodies perturb cell homeostasis by behaving as signaling molecules. We hypothesize that anti-TG2 autoantibodies may destabilize the integrity of the intestinal mucosa in celiac individuals, thus contributing to celiac disease establishment and progression. Since several proteins here identified in this study were already known as TG2 substrates, we can also suppose that transamidating activity and differential phosphorylation of the same targets may represent a novel regulatory mechanism whose relevance in celiac disease pathogenesis is still unexplored.	[Paolella, Gaetana; Caputo, Ivana; Marabotti, Anna; Lepretti, Marilena; Esposito, Carla] Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy; [Caputo, Ivana; Esposito, Carla] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Salzano, Anna Maria; Scaloni, Andrea] CNR, ISPAAM, Prote & Mass Spectrometry Lab, Naples, Italy; [Vitale, Monica; Zambrano, Nicola] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Vitale, Monica; Zambrano, Nicola] CEINGE Biotecnol Avanzate, Naples, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, IRCAD, Novara, Italy	University of Salerno; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Caputo, I (corresponding author), Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy.	icaputo@unisa.it	Salzano, Anna Maria/C-7139-2012; Zambrano, Nicola/B-9352-2014	Salzano, Anna Maria/0000-0001-7192-8760; Zambrano, Nicola/0000-0001-9395-3481; Marilena, Lepretti/0000-0003-4441-7214; Caputo, Ivana/0000-0003-2825-9711; PAOLELLA, Gaetana/0000-0003-2188-3829; Scaloni, Andrea/0000-0001-9362-8515; VITALE, MONICA/0000-0003-1517-7426; Marabotti, Anna/0000-0002-9510-5205; Sblattero, Daniele/0000-0003-4309-242X	PRIN; P.O.R. Campania FSE; Project CREME; EC Marie Curie Research Training Network [MRTN-CT-20010-289964]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); P.O.R. Campania FSE(Regione Campania); Project CREME; EC Marie Curie Research Training Network(European Commission)	This work was supported by grants from PRIN 2008. It was supported also by P.O.R. Campania FSE 2007-2013, Project CREME and by the EC Marie Curie Research Training Network [contract no. MRTN-CT-20010-289964]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Berman HM, 2012, STRUCTURE, V20, P391, DOI 10.1016/j.str.2012.01.010; Biagi F, 2006, DIGEST LIVER DIS, V38, P652, DOI 10.1016/j.dld.2006.05.021; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Caja S, 2011, CELL MOL IMMUNOL, V8, P103, DOI 10.1038/cmi.2010.65; Caputo I, 2004, AMINO ACIDS, V26, P381, DOI 10.1007/s00726-004-0083-7; Caputo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045209; Caputo I, 2013, AMINO ACIDS, V44, P251, DOI 10.1007/s00726-011-1120-y; Caputo I, 2010, BBA-MOL BASIS DIS, V1802, P717, DOI 10.1016/j.bbadis.2010.05.010; Caputo I, 2009, AMINO ACIDS, V36, P693, DOI 10.1007/s00726-008-0120-z; D'Ambrosio C, 2008, PROTEOMICS, V8, P3657, DOI 10.1002/pmic.200701148; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Esposito C, 2003, AM J GASTROENTEROL, V98, P1813, DOI [10.1016/S0002-9270(03)00431-3, 10.1111/j.1572-0241.2003.07582.x]; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Facchiano A, 2009, AMINO ACIDS, V36, P599, DOI 10.1007/s00726-008-0124-8; Facchiano F, 2006, FRONT BIOSCI, V11, P1758, DOI 10.2741/1921; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Halttunen T, 1999, GASTROENTEROLOGY, V116, P566, DOI 10.1016/S0016-5085(99)70178-2; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Ientile R, 2007, AMINO ACIDS, V33, P385, DOI 10.1007/s00726-007-0517-0; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Joseph J, 1997, BRIT J CANCER, V76, P600, DOI 10.1038/bjc.1997.432; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kaukinen K, 2005, SCAND J GASTROENTERO, V40, P564, DOI 10.1080/00365520510023422; Khan IU, 1998, P NATL ACAD SCI USA, V95, P10425, DOI 10.1073/pnas.95.18.10425; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Lin G, 2009, CELL MOL LIFE SCI, V66, P135, DOI 10.1007/s00018-008-8575-3; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lumb RA, 2002, EMBO J, V21, P6763, DOI 10.1093/emboj/cdf685; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matysiak-Budnik T, 2008, J EXP MED, V205, P143, DOI 10.1084/jem.20071204; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Mishra S, 2007, J BIOL CHEM, V282, P18108, DOI 10.1074/jbc.M607413200; Monnier A, 2001, NUCLEIC ACIDS RES, V29, P1453, DOI 10.1093/nar/29.7.1453; Myrsky E, 2008, CLIN EXP IMMUNOL, V152, P111, DOI 10.1111/j.1365-2249.2008.03600.x; Myrsky E, 2009, SCAND J GASTROENTERO, V44, P162, DOI 10.1080/00365520802400875; Nagano-Ito M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/204960; Orru S, 2003, J BIOL CHEM, V278, P31766, DOI 10.1074/jbc.M305080200; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; QUEMENEUR E, 1994, J BIOL CHEM, V269, P5485; Sakly W, 2005, VIRCHOWS ARCH, V446, P613, DOI 10.1007/s00428-005-1237-z; Salmi TT, 2006, GUT, V55, P1746, DOI 10.1136/gut.2005.071514; Schuppan D, 1998, NAT MED, V4, P666, DOI 10.1038/nm0698-666; Sefton B M, 2001, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1401s00; Sivaramakrishnan M, 2013, AMINO ACIDS, V44, P19, DOI 10.1007/s00726-011-1113-x; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; Villanacci V, 2009, J CELL MOL MED, V13, P334, DOI 10.1111/j.1582-4934.2008.00325.x; Wang S, 2008, ACTA PHARMACOL SIN, V29, P135, DOI 10.1111/j.1745-7254.2008.00753.x; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358; Zemskov EA, 2009, J BIOL CHEM, V284, P16693, DOI 10.1074/jbc.M109.010769	71	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84403	10.1371/journal.pone.0084403	http://dx.doi.org/10.1371/journal.pone.0084403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391952	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900095
J	Park, S; Nahm, MH				Park, Saeyoung; Nahm, Moon H.			L-Rhamnose Is Often an Important Part of Immunodominant Epitope for Pneumococcal Serotype 23F Polysaccharide Antibodies in Human Sera Immunized with PPV23	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CAPSULAR POLYSACCHARIDE; CONJUGATE VACCINES; OLIGOSACCHARIDE-PROTEIN; GENE USAGE; IMMUNOGENICITY; IDENTIFICATION; REPERTOIRE; EMERGENCE; INFANTS	Streptococcus pneumoniae is a major human pathogen which expresses more than 90 serologically distinct capsular polysaccharides (PS) on the surface. Since pneumococcal PSs elicit protective antibodies against pneumococcal diseases, it is important to identify the immunological epitope eliciting anti-pneumococcal PS antibodies. L-rhamnose is a part of the 23F PS repeating unit and is known to be a critical part of immunodominant epitope which elicits antibodies against pneumococcal serotype 23F PS. In order to determine if L-rhamnose is a part of epitope recognized by functional antibodies specific for serotype 23F PS in human serum samples, we evaluated the opsonophagocytic killing of serotype 23F pneumococci by serum antibodies specific for L-rhamnose. Using 10 mM L-rhamnose, opsonic capacities (opsonic indices) of serum antibodies were inhibited by 60% in 19 sera (36%) and 30-60% in 16 sera (30%) out of 53 sera from young and old adults immunized with 23-valent pneumococcal polysaccharide vaccine (PPV23). Interestingly, when IgM antibodies were depleted from immune sera in order to preferentially study IgG antibodies, the proportion of young adult sera showing more than 60% inhibition in opsonic capacity by 10 mM of L-rhamnose increased from 33% (11/31) to 68% (21/31). On the other hand, IgM depletion did not alter the proportion for old adult sera. Therefore, young and old adults may produce different antigen binding profiles of IgG antibodies against serotype 23F PS.	[Park, Saeyoung; Nahm, Moon H.] Univ Alabama Birmingham, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Park, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA.	spark13@rics.bwh.harvard.edu		Nahm, Moon/0000-0002-6922-1042	National Institutes of Health from the National Institute of Allergy and Infectious Diseases [R01-AI-69509]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069509] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by the National Institutes of Health Grant R01-AI-69509 from the National Institute of Allergy and Infectious Diseases to MHN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; AVERY OSWALD T., 1931, JOUR EXP MED, V54, P73, DOI 10.1084/jem.54.1.73; Benaissa-Trouw B, 2001, INFECT IMMUN, V69, P4698, DOI 10.1128/IAI.69.7.4698-4701.2001; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Bryant KA, 2010, PEDIATRICS, V125, P866, DOI 10.1542/peds.2009-1405; Burton RL, 2006, CLIN VACCINE IMMUNOL, V13, P1004, DOI 10.1128/CVI.00112-06; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; CISAR J, 1975, J EXP MED, V142, P435, DOI 10.1084/jem.142.2.435; Danieli E, 2012, BIOORGAN MED CHEM, V20, P6403, DOI 10.1016/j.bmc.2012.08.048; DEVELASCO EA, 1994, INFECT IMMUN, V62, P799; Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283; Frasca D, 2009, CURR OPIN IMMUNOL, V21, P425, DOI 10.1016/j.coi.2009.06.001; Gening ML, 2010, INFECT IMMUN, V78, P764, DOI 10.1128/IAI.01093-09; HAGLUND LA, 1993, J INFECT DIS, V168, P1532, DOI 10.1093/infdis/168.6.1532; HEIDELBERGER M, 1967, J IMMUNOL, V99, P794; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Jackson LA, 2007, VACCINE, V25, P4029, DOI 10.1016/j.vaccine.2007.02.062; Jansen WTM, 2004, INDIAN J MED RES, V119, P7; Jansen WTM, 2001, INFECT IMMUN, V69, P787, DOI 10.1128/IAI.69.2.787-793.2001; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; Kolar GR, 2006, SCAND J IMMUNOL, V64, P314, DOI 10.1111/j.1365-3083.2006.01817.x; Leggat DJ, 2013, J INFECT DIS, V208, P101, DOI 10.1093/infdis/jit139; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Park S, 2011, INFECT IMMUN, V79, P314, DOI 10.1128/IAI.00768-10; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Reason DC, 2004, CLIN IMMUNOL, V111, P132, DOI 10.1016/j.clim.2003.12.004; Richter SS, 2009, CLIN INFECT DIS, V48, pE23, DOI 10.1086/595857; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; Rubins JB, 1998, J INFECT DIS, V178, P431, DOI 10.1086/515644; Safari D, 2008, INFECT IMMUN, V76, P4615, DOI 10.1128/IAI.00472-08; Shinefield HR, 2000, PEDIATR INFECT DIS J, V19, P394, DOI 10.1097/00006454-200004000-00036; Smithson SL, 2005, INFECT IMMUN, V73, P7477, DOI 10.1128/IAI.73.11.7477-7484.2005; Verez-Bencomo V, 2004, SCIENCE, V305, P522, DOI 10.1126/science.1095209; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, pS66, DOI 10.1097/INF.0b013e318199f8ef; Wernette CM, 2003, CLIN DIAGN LAB IMMUN, V10, P514, DOI 10.1128/CDLI.10.4.514-519.2003; Zhou JH, 2002, INFECT IMMUN, V70, P4083, DOI 10.1128/IAI.70.8.4083-4091.2002; Zhou ZH, 2007, J AUTOIMMUN, V29, P219, DOI 10.1016/j.jaut.2007.07.015; Zhou ZH, 2007, CELL HOST MICROBE, V1, P51, DOI 10.1016/j.chom.2007.01.002	39	7	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83810	10.1371/journal.pone.0083810	http://dx.doi.org/10.1371/journal.pone.0083810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391831	Green Submitted, gold, Green Published			2022-12-27	WOS:000329325200129
J	Pasin, L; Landoni, G; Castro, ML; Cabrini, L; Belletti, A; Feltracco, P; Finco, G; Carozzo, A; Chiesa, R; Zangrillo, A				Pasin, Laura; Landoni, Giovanni; Castro, Maria Lourdes; Cabrini, Luca; Belletti, Alessandro; Feltracco, Paolo; Finco, Gabriele; Carozzo, Andrea; Chiesa, Roberto; Zangrillo, Alberto			The Effect of Statins on Mortality in Septic Patients: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							REDUCTASE INHIBITION; CLINICAL-EVIDENCE; THERAPY; ATORVASTATIN; PRAVASTATIN; SEPSIS; INFECTIONS; PNEUMONIA	Objective: Statins are among the most prescribed drugs worldwide and their recently discovered anti-inflammatory effect seems to have an important role in inhibiting proinflammatory cytokine production, chemokines expression and counteracting the harmful effects of sepsis on the coagulation system. We decided to perform a meta-analysis of all randomized controlled trials ever published on statin therapy in septic patients to evaluate their effect on survival and length of hospital stay. Data sources and study selection: Articles were assessed by four trained investigators, with divergences resolved by consensus. BioMedCentral, PubMed, Embase and the Cochrane Central Register of clinical trials were searched for pertinent studies. Inclusion criteria were random allocation to treatment and comparison of statins versus any comparator in septic patients. Data extraction and synthesis: Data from 650 patients in 5 randomized controlled studies were analyzed. No difference in mortality between patients receiving statins versus control (44/322 [14%] in the statins group vs 50/328 [15%] in the control arm, RR = 0.90 [95% CI 0.65 to 1.26], p = 0.6) was observed. No differences in hospital stay (p = 0.7) were found. Conclusions: Published data show that statin therapy has no effect on mortality in the overall population of adult septic patients. Scientific evidence on statins role in septic patients is still limited and larger randomized trials should be performed on this topic.	[Pasin, Laura; Landoni, Giovanni; Cabrini, Luca; Belletti, Alessandro; Carozzo, Andrea; Zangrillo, Alberto] Ist Sci San Raffaele, Dept Anesthesia & Intens Care, I-20132 Milan, Italy; [Landoni, Giovanni] Maieut Fdn, Milan, Italy; [Castro, Maria Lourdes] Ctr Hosp Lisboa Cent, Dept Anesthesiol, Lisbon, Portugal; [Feltracco, Paolo] Univ Hosp Padua, Dept Anesthesia & Intens Care, Padua, Italy; [Finco, Gabriele] Univ Cagliari, Dept Med Sci M Aresu, Cagliari, Italy; [Chiesa, Roberto] Ist Sci San Raffaele, Dept Vasc Surg, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Cagliari; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Landoni, G (corresponding author), Ist Sci San Raffaele, Dept Anesthesia & Intens Care, I-20132 Milan, Italy.	landoni.giovanni@hsr.it	Roberto, Chiesa/AAV-6476-2021; Pasin, Laura/AAA-8188-2020; Finco, Gabriele/AAH-1697-2022; Finco, Gabriele/AFL-9587-2022; Giovanni, Landoni/AAH-1881-2019; Belletti, Alessandro/I-1981-2019; Zangrillo, Alberto/AAH-2037-2019	Finco, Gabriele/0000-0002-3059-9865; Finco, Gabriele/0000-0002-3059-9865; Giovanni, Landoni/0000-0002-8594-5980; Belletti, Alessandro/0000-0003-3131-0565; Zangrillo, Alberto/0000-0002-7687-7648; Grandi, Alessandro/0000-0002-2770-8266; Pasin, Laura/0000-0001-5757-4791				Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Biondi-Zoccai G, 2011, HEART LUNG VESSEL, V3, P161; Biondi-Zoccai G, 2011, HEART LUNG VESSEL, V3, P93; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Choi HS, 2008, MAY 16 18 2008 INT C; Chopra V, 2012, AM J MED, V125, P1111, DOI 10.1016/j.amjmed.2012.04.011; Craig TR, 2011, AM J RESP CRIT CARE, V183, P620, DOI 10.1164/rccm.201003-0423OC; Donnino MW, 2009, ACAD EMERG MED, V16, P230, DOI 10.1111/j.1553-2712.2009.00350.x; ENDO A, 1992, J LIPID RES, V33, P1569; Ferrari GL, 2011, CYTOKINE, V54, P144, DOI 10.1016/j.cyto.2011.02.005; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Janda Surinder, 2010, J Crit Care, V25, DOI 10.1016/j.jcrc.2010.02.013; Kopterides P, 2009, CLIN MICROBIOL INFEC, V15, P325, DOI 10.1111/j.1469-0691.2009.02750.x; Kruger P, 2013, AM J RESP CRIT CARE, V187, P743, DOI 10.1164/rccm.201209-1718OC; Kruger PS, 2011, AM J RESP CRIT CARE, V183, P774, DOI 10.1164/rccm.201006-0955OC; Kuoppala J, 2008, EUR J CANCER, V44, P2122, DOI 10.1016/j.ejca.2008.06.025; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Novack V, 2009, INTENS CARE MED, V35, P1255, DOI 10.1007/s00134-009-1429-0; Patel JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11895; PEDERSEN TR, 1994, LANCET, V344, P1383; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Robinson K, 2011, INTENS CARE MED, V37, P1388, DOI 10.1007/s00134-011-2247-8; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Shi JM, 2003, BLOOD COAGUL FIBRIN, V14, P575, DOI 10.1097/00001721-200309000-00010; Steiner S, 2005, CIRCULATION, V111, P1841, DOI 10.1161/01.CIR.0000158665.27783.0C; Trezzi M, 2013, ANN THORAC SURG, V95, P892, DOI 10.1016/j.athoracsur.2012.11.071; Tseng MY, 2007, STROKE, V38, P1545, DOI 10.1161/STROKEAHA.106.475905; Wang Y, 2011, BIOMED PHARMACOTHER, V65, P118, DOI 10.1016/j.biopha.2010.12.005; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zeiser R, 2007, BLOOD, V110, P4588, DOI 10.1182/blood-2007-08-106005	37	44	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82775	10.1371/journal.pone.0082775	http://dx.doi.org/10.1371/journal.pone.0082775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391721	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200018
J	Piper, SK; Habermehl, C; Schmitz, CH; Kuebler, WM; Obrig, H; Steinbrink, J; Mehnert, J				Piper, Sophie K.; Habermehl, Christina; Schmitz, Christoph H.; Kuebler, Wolfgang M.; Obrig, Hellmuth; Steinbrink, Jens; Mehnert, Jan			Towards Whole-Body Fluorescence Imaging in Humans	PLOS ONE			English	Article							INDOCYANINE GREEN; BREAST-CANCER; RELEVANCE; FUTURE; LIGHT	Dynamic near-infrared fluorescence (DNIF) whole-body imaging of small animals has become a popular tool in experimental biomedical research. In humans, however, the field of view has been limited to body parts, such as rheumatoid hands, diabetic feet or sentinel lymph nodes. Here we present a new whole-body DNIF-system suitable for adult subjects. We explored whether this system (i) allows dynamic whole-body fluorescence imaging and (ii) can detect modulations in skin perfusion. The non-specific fluorescent probe indocyanine green (ICG) was injected intravenously into two subjects, and fluorescence images were obtained at 5 Hz. The in-and out-flow kinetics of ICG have been shown to correlate with tissue perfusion. To validate the system, skin perfusion was modulated by warming and cooling distinct areas on the chest and the abdomen. Movies of fluorescence images show a bolus passage first in the face, then in the chest, abdomen and finally in the periphery (similar to 10, 15, 20 and 30 seconds, respectively). When skin perfusion is augmented by warming, bolus arrives about 5 seconds earlier than when the skin is cooled and perfusion decreased. Calculating bolus arrival times and spatial fitting of basis time courses extracted from different regions of interest allowed a mapping of local differences in subcutaneous skin perfusion. This experiment is the first to demonstrate the feasibility of whole-body dynamic fluorescence imaging in humans. Since the whole-body approach demonstrates sensitivity to circumscribed alterations in skinperfusion, it may be used to target autonomous changes in polyneuropathy and to screen for peripheral vascular diseases.	[Piper, Sophie K.; Habermehl, Christina; Schmitz, Christoph H.; Obrig, Hellmuth; Steinbrink, Jens; Mehnert, Jan] Charite, Dept Neurol, D-13353 Berlin, Germany; [Piper, Sophie K.; Habermehl, Christina; Mehnert, Jan] Berlin Inst Technol, Machine Learning Dept, Berlin, Germany; [Schmitz, Christoph H.] NIRx Med Tech, Berlin, Germany; [Kuebler, Wolfgang M.] Charite, Inst Physiol, D-13353 Berlin, Germany; [Obrig, Hellmuth] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Obrig, Hellmuth] Univ Hosp Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Piper, Sophie K.; Habermehl, Christina; Steinbrink, Jens; Mehnert, Jan] Charite, Ctr Stroke Res, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Piper, SK (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	sophie.piper@charite.de	Mehnert, Jan/AAX-8791-2020	Mehnert, Jan/0000-0001-7088-740X; Kuebler, Wolfgang/0000-0003-4100-2961; Piper, Sophie K./0000-0002-0147-8992; Habermehl, Christina/0000-0001-5245-9727	Sonnenfeld Stiftung; NIRx Medizintechnik GmbH	Sonnenfeld Stiftung; NIRx Medizintechnik GmbH	The technical equipment of this study was financed by the Sonnenfeld Stiftung (http://www.sonnenfeld-stiftung.de/) and NIRx Medizintechnik GmbH (http://www.nirx.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alacam B, 2008, PHYS MED BIOL, V53, P837, DOI 10.1088/0031-9155/53/4/002; Alander JT, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/940585; Corlu A, 2007, OPT EXPRESS, V15, P6696, DOI 10.1364/OE.15.006696; Ebert Bernd, 2013, Recent Results Cancer Res, V187, P331, DOI 10.1007/978-3-642-10853-2_11; Gao M, 2005, APPL OPTICS, V44, P5468, DOI 10.1364/AO.44.005468; Habermehl C, 2011, OPT EXPRESS, V19, P18636, DOI 10.1364/OE.19.018636; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Hillman EMC, 2011, PHILOS T R SOC A, V369, P4620, DOI 10.1098/rsta.2011.0264; Humeau-Heurtier A, 2013, IEEE T BIO-MED ENG, V60, P659, DOI 10.1109/TBME.2013.2243449; Imaizumi M, 2012, J NUCL MED, V53; Ingrisch M, 2013, J PHARMACOKINET PHAR; Jelzow A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.057003; Klohs J, 2008, STROKE, V39, P2845, DOI 10.1161/STROKEAHA.107.509844; Klohs J, 2006, MOL IMAGING, V5, P180; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Liebert A, 2006, NEUROIMAGE, V31, P600, DOI 10.1016/j.neuroimage.2005.12.046; Lodge M, 2012, J NUCL MED, V53; Marshall Milton V, 2010, Open Surg Oncol J, V2, P12; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Nuiachristos V, 2006, ANNU REV BIOMED ENG, V8, P1, DOI 10.1146/annurev.bioeng.8.061505.095831; Patel JK, 2008, EUR J DERMATOL, V18, P617, DOI 10.1684/ejd.2008.0508; Perry Diana, 2012, J Diabetes Sci Technol, V6, P204; Poellinger A, 2012, J BIOPHOTONICS, V5, P815, DOI 10.1002/jbio.201200123; Poellinger A, 2011, INVEST RADIOL, V46, P697, DOI 10.1097/RLI.0b013e318229ff25; Poellinger A, 2011, RADIOLOGY, V258, P409, DOI 10.1148/radiol.10100258; Polom K, 2012, BRIT J DERMATOL, V166, P682, DOI 10.1111/j.1365-2133.2011.10634.x; Polom K, 2011, CANCER-AM CANCER SOC, V117, P4812, DOI 10.1002/cncr.26087; Rasmussen JC, 2009, CURR OPIN BIOTECH, V20, P74, DOI 10.1016/j.copbio.2009.01.009; Redpath TW, 1997, BRIT J RADIOL, V70, pS70, DOI 10.1259/bjr.1997.0010; Rijpkema M, 2001, J MAGN RESON IMAGING, V14, P457, DOI 10.1002/jmri.1207; Ring Francis, 2010, J Diabetes Sci Technol, V4, P857; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Steinbrink J, 2006, J THORAC CARDIOV SUR, V132, P1172, DOI 10.1016/j.jtcvs.2006.05.065; Stemmer N, 2012, CURR MED CHEM, V19, P4786, DOI 10.2174/092986712803341494; Taruttis A, 2012, AM J ROENTGENOL, V199, P263, DOI 10.2214/AJR.11.8431; TOGAWA T, 1994, PHYSIOL MEAS, V15, P291, DOI 10.1088/0967-3334/15/3/007; VandenBrande P, 1997, INT J MICROCIRC, V17, P55, DOI 10.1159/000179207; Werner SG, 2012, ANN RHEUM DIS, V71, P504, DOI 10.1136/annrheumdis-2010-148288; Williams SP, 2012, AAPS J, V14, P389, DOI 10.1208/s12248-012-9348-3; Zhang Hua, 2011, Expert Opin Med Diagn, V5, P241	41	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83749	10.1371/journal.pone.0083749	http://dx.doi.org/10.1371/journal.pone.0083749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391820	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200118
J	Xu, BY; Tan, WT; Tan, S; Dan, YJ; Luo, XL; Deng, GH				Xu, Bao-Yan; Tan, Wen-Ting; Tan, Shun; Dan, Yun-Jie; Luo, Xiao-Li; Deng, Guo-Hong			Serum Testosterone Levels and Androgen Receptor CAG Polymorphism Correlate with Hepatitis B Virus (HBV)-Related Acute Liver Failure in Male HBV Carriers	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; X-CHROMOSOME; RISK; DISEASE; GENE; LOCALIZATION; EXACERBATION; ASSOCIATION; REPEATS; TRACT	Background: Augmentation of androgen/androgen receptor (AR) pathway may influence chronic hepatitis B (CHB) more likely in males. AR activity is modulated by a polymorphic CAG repeat sequence in AR exon 1. This study aimed to investigate the relationship between serum testosterone levels, CAG repeat numbers and hepatitis B virus (HBV)-related acute liver failure (ALF). Methods: Three hundred and seventy eight male CHB patients with ALF and 441 asymptomatic HBV carriers (AsCs) were recruited. AR CAG repeats numbers were analyzed. The serum testosterone levels of AsCs, ALFs and patients with hepatitis B flare groups, and sequential serum samples, were assessed quantitatively. Results: The median CAG repeat (M-CAG) frequency was significantly higher in ALF patients than AsCs (P<0.001). Patients with M-CAG alleles (P<0.001, OR 3.0, 95% CI 2.1-4.2) had the highest risk for ALF. Serum testosterone levels were significantly higher (P<0.001) at hepatitis flare point (8.2 +/- 3.0 ng/mL) than inactive phase (6.4 +/- 2.0 ng/mL). CHB (8.30 +/- 2.71 ng/mL, P = 7.6x10(-6)) and ALF group (2.61 +/- 1.83 ng/mL, P = 1.7x10(-17)) had significantly different levels of testosterone in comparison with AsCs group (6.56 +/- 2.36 ng/mL). The serum testosterone levels sharply decreased from hepatitis flare phase to liver failure phase, and tended to be normal at the recovery phase. Male AsCs with M-CAG alleles had significantly lower serum testosterone levels (P<0.05). Conclusions: There was a serum testosterone fluctuation during hepatitis B flare and HBV-related ALF, and the median CAG repeats in AR gene exon 1 were associated with lower serum testosterone levels in asymptomatic HBV carriers and an increased susceptibility to HBV-related ALF.	[Xu, Bao-Yan; Tan, Wen-Ting; Tan, Shun; Dan, Yun-Jie; Luo, Xiao-Li; Deng, Guo-Hong] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China; [Xu, Bao-Yan; Tan, Wen-Ting; Tan, Shun; Dan, Yun-Jie; Luo, Xiao-Li; Deng, Guo-Hong] Chongqing Key Lab Res Infect Dis, Chongqing, Peoples R China; [Deng, Guo-Hong] Third Mil Med Univ, Inst Immunol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Deng, GH (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China.	gh_deng@hotmail.com			Chongqing Natural Science Foundation [CSTC-2008BB5129, CSTC-2010BB5037, CSTC-2011JJJQ10005]; State Key Project Specialized for Infectious Diseases [2012ZX10002007-002-005]; Third Military Medical University (TMMU) [2012XLC05]	Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing); State Key Project Specialized for Infectious Diseases; Third Military Medical University (TMMU)	This work was supported by the Chongqing Natural Science Foundation [Grant numbers CSTC-2008BB5129, CSTC-2010BB5037, and CSTC-2011JJJQ10005]; the State Key Project Specialized for Infectious Diseases [2012ZX10002007-002-005]; and the Third Military Medical University (TMMU) key project for clinical research [2012XLC05]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN CJ, 1989, AM J HUM GENET, V44, P264; Buchanan G, 2004, HUM MOL GENET, V13, P1677, DOI 10.1093/hmg/ddh181; CHEN DS, 1993, J GASTROEN HEPATOL, V8, P470, DOI 10.1111/j.1440-1746.1993.tb01551.x; Chen S, 2009, HEPATOL RES, V39, P716, DOI 10.1111/j.1872-034X.2009.00503.x; Dasgupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012401; Evans AA, 2002, CANCER EPIDEM BIOMAR, V11, P369; Gapstur SM, 2002, CANCER EPIDEM BIOMAR, V11, P1041; Hsing AW, 2000, CANCER RES, V60, P5111; Huhtaniemi IT, 2009, J CLIN ENDOCR METAB, V94, P277, DOI 10.1210/jc.2008-0848; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Ke WM, 2006, J GASTROENTEROL, V41, P347, DOI 10.1007/s00535-005-1781-y; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lotter H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055694; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; Nenonen H, 2010, MOL HUM REPROD, V16, P153, DOI 10.1093/molehr/gap097; Nenonen HA, 2011, INT J ANDROL, V34, P327, DOI 10.1111/j.1365-2605.2010.01084.x; Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016; Rajender S, 2007, ASIAN J ANDROL, V9, P147, DOI 10.1111/j.1745-7262.2007.00250.x; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Tian YJ, 2012, J VIROL, V86, P1904, DOI 10.1128/JVI.06707-11; Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3; Wang SH, 2009, HEPATOLOGY, V50, P1392, DOI 10.1002/hep.23163; Wong VWS, 2009, J GASTROEN HEPATOL, V24, P1179, DOI 10.1111/j.1440-1746.2009.05924.x; Wu JF, 2010, GASTROENTEROLOGY, V138, P942, DOI 10.1053/j.gastro.2009.11.051; Xing T, 2007, CLIN EXP IMMUNOL, V147, P184, DOI 10.1111/j.1365-2249.2006.03259.x; Yang WJ, 2009, HEPATOLOGY, V49, P1515, DOI 10.1002/hep.22833; Yu MW, 2001, J NATL CANCER I, V93, P1644, DOI 10.1093/jnci/93.21.1644; Yu MW, 2000, J NATL CANCER I, V92, P2023, DOI 10.1093/jnci/92.24.2023; Yuen MF, 2003, CLIN INFECT DIS, V37, P593, DOI 10.1086/376988	29	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84213	10.1371/journal.pone.0084213	http://dx.doi.org/10.1371/journal.pone.0084213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391916	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900059
J	Zhang, JY; Li, YJ; Wu, CX				Zhang, Jingyu; Li, Yongjuan; Wu, Changxu			The Influence of Individual and Team Cognitive Ability on Operators' Task and Safety Performance: A Multilevel Field Study in Nuclear Power Plants	PLOS ONE			English	Article							GENERAL MENTAL-ABILITY; ACADEMIC SELF-CONCEPT; ORGANIZATIONAL CITIZENSHIP; JOB-SATISFACTION; WORK; PREDICTORS; METAANALYSIS; PERSONALITY; COMPLEXITY; EXPERIENCE	While much research has investigated the predictors of operators' performance such as personality, attitudes and motivation in high-risk industries, its cognitive antecedents and boundary conditions have not been fully investigated. Based on a multilevel investigation of 312 nuclear power plant main control room operators from 50 shift teams, the present study investigated how general mental ability (GMA) at both individual and team level can influence task and safety performance. At the individual level, operators' GMA was predictive of their task and safety performance and this trend became more significant as they accumulated more experience. At the team level, we found team GMA had positive influences on all three performance criteria. However, we also found a "big-fish-little-pond" effect insofar as team GMA had a relatively smaller effect and inhibited the contribution of individual GMA to workers' extra-role behaviors (safety participation) compared to its clear beneficial influence on in-role behaviors (task performance and safety compliance). The possible mechanisms related to learning and social comparison processes are discussed.	[Zhang, Jingyu; Li, Yongjuan; Wu, Changxu] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Wu, CX (corresponding author), Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China.	changxu.wu@gmail.com	Wu, Changxu/H-3247-2014		National Basic Research Program of China [2011CB302201]; Natural Scientific Foundation of China [31300875, 31070915, 71371179]; Key Research Program of the Chinese Academy of Sciences [KJZD-EW-L04]; Youth Project of the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y1CX333005]	National Basic Research Program of China(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Project of the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences	This work was jointly supported by the National Basic Research Program of China (Grant No. 2011CB302201), the Natural Scientific Foundation of China (Grant No. 31300875, 31070915 and 71371179), the Key Research Program of the Chinese Academy of Sciences (Grant No. KJZD-EW-L04), and the Youth Project of the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences (Grant No. Y1CX333005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur Jr W., 1991, HUM PERFORM, V4, P89, DOI [10.1207/s15327043hup0402_1, DOI 10.1207/S15327043HUP0402_1]; Barrick MR, 1998, J APPL PSYCHOL, V83, P377, DOI 10.1037/0021-9010.83.3.377; Bell ST, 2007, J APPL PSYCHOL, V92, P595, DOI 10.1037/0021-9010.92.3.595; Bono JE, 2003, EUR J PERSONALITY, V17, pS5, DOI 10.1002/per.481; Brown DJ, 2007, ORGAN BEHAV HUM DEC, V102, P59, DOI 10.1016/j.obhdp.2006.10.003; Burkolter D., 2009, HUMAN FACTORS SECURI, P77; Burkolter D, 2009, ERGONOMICS, V52, P302, DOI 10.1080/00140130802376067; Dai DY, 2008, EDUC PSYCHOL REV, V20, P283, DOI 10.1007/s10648-008-9071-x; Devine DJ, 2001, SMALL GR RES, V32, P507, DOI 10.1177/104649640103200501; Dilchert S, 2007, J APPL PSYCHOL, V92, P616, DOI 10.1037/0021-9010.92.3.616; Edwards BD, 2006, J APPL PSYCHOL, V91, P727, DOI 10.1037/0021-9010.91.3.727; Ellis APJ, 2003, J APPL PSYCHOL, V88, P821, DOI 10.1037/0021-9010.88.5.821; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Fang X, 2008, RELIAB ENG SYST SAFE, V93, P1244, DOI 10.1016/j.ress.2007.07.001; Ford MT, 2012, J OCCUP HEALTH PSYCH, V17, P268, DOI 10.1037/a0028143; Garcia SM, 2007, ORGAN BEHAV HUM DEC, V102, P95, DOI 10.1016/j.obhdp.2006.10.004; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Griffin M A, 2000, J Occup Health Psychol, V5, P347; Herrnstein RJ, 1996, BELL CURVE INTELLIGE; Hu J, 2013, PERS PSYCHOL, V66, P127, DOI 10.1111/peps.12008; Huepe D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024858; Jiang L, 2010, ACCIDENT ANAL PREV, V42, P1468, DOI 10.1016/j.aap.2009.08.017; Judge TA, 2010, J APPL PSYCHOL, V95, P92, DOI 10.1037/a0017594; Kolz AR, 1998, J PSYCHOL, V132, P539, DOI 10.1080/00223989809599286; Larrick RP, 2007, ORGAN BEHAV HUM DEC, V102, P76, DOI 10.1016/j.obhdp.2006.10.002; LePine JA, 2002, J APPL PSYCHOL, V87, P52, DOI 10.1037//0021-9010.87.1.52; LePine JA, 2008, PERS PSYCHOL, V61, P273, DOI 10.1111/j.1744-6570.2008.00114.x; Li X, 2011, MINER ENG, V24, P894, DOI 10.1016/j.mineng.2011.04.001; Marsh HW, 2003, AM PSYCHOL, V58, P364, DOI 10.1037/0003-066X.58.5.364; MARSH HW, 1995, AM EDUC RES J, V32, P285, DOI 10.3102/00028312032002285; Nahrgang JD, 2011, J APPL PSYCHOL, V96, P71, DOI 10.1037/a0021484; Neal A, 2006, J APPL PSYCHOL, V91, P946, DOI 10.1037/0021-9010.91.4.946; Organ DW, 1995, PERS PSYCHOL, V48, P775, DOI 10.1111/j.1744-6570.1995.tb01781.x; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Raven J.C., 1998, ADV PROGR MATRICES; Rynes SL, 2002, ACAD MANAGE EXEC, V16, P92, DOI 10.5465/AME.2002.8540341; Salas E, 2008, HUM FACTORS, V50, P540, DOI 10.1518/001872008X288457; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Schmidt FL, 2004, J PERS SOC PSYCHOL, V86, P162, DOI 10.1037/0022-3514.86.1.162; SCHMIDT FL, 1988, J APPL PSYCHOL, V73, P46, DOI 10.1037/0021-9010.73.1.46; Schmidt FL, 2002, HUM PERFORM, V15, P187, DOI 10.1207/S15327043HUP1501&02_12; Schumacher S, 2011, SAFETY SCI, V49, P394, DOI 10.1016/j.ssci.2010.10.002; Sebok A, 2000, ERGONOMICS, V43, P1210, DOI 10.1080/00140130050084950; Stanton N, 1996, HUMAN FACTORS NUCL S, P155; Stewart GL, 2006, J MANAGE, V32, P29, DOI 10.1177/0149206305277792; Turner N, 2012, ACCIDENT ANAL PREV, V45, P811, DOI 10.1016/j.aap.2011.07.005; Van Rooy DL, 2004, J VOCAT BEHAV, V65, P71, DOI 10.1016/S0001-8791(03)00076-9; Vicente KJ, 2001, INT J HUM-COMPUT ST, V54, P831, DOI 10.1006/ijhc.2001.0463; WILLIAMS LJ, 1991, J MANAGE, V17, P601, DOI 10.1177/014920639101700305; Zhang H., 1989, ACTA PSYCHOL SINICA, V21, P113; Zhang JY, 2013, PERS INDIV DIFFER, V55, P433, DOI 10.1016/j.paid.2013.04.004; Zohar D., 2007, International Journal of Risk Assessment & Management, V7, P122, DOI 10.1504/IJRAM.2007.011726	54	6	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84528	10.1371/journal.pone.0084528	http://dx.doi.org/10.1371/journal.pone.0084528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391964	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900107
J	Jiang, LY; Eriksson, J; Lage, S; Jonasson, S; Shams, S; Mehine, M; Ilag, LL; Rasmussen, U				Jiang, Liying; Eriksson, Johan; Lage, Sandra; Jonasson, Sara; Shams, Shiva; Mehine, Martin; Ilag, Leopold L.; Rasmussen, Ulla			Diatoms: A Novel Source for the Neurotoxin BMAA in Aquatic Environments	PLOS ONE			English	Article							METHYLAMINO-L-ALANINE; CYANOBACTERIAL NEUROTOXIN; CYCAD NEUROTOXINS; FLYING FOXES; DOMOIC ACID; AMINO-ACID; ALS-PDC; BIOMAGNIFICATION; CONSUMPTION; PATHWAYS	Amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease is a neurological disorder linked to environmental exposure to a non-protein amino acid, beta-N-methylamino-L-alanine (BMAA). The only organisms reported to be BMAA-producing, are cyanobacteria - prokaryotic organisms. In this study, we demonstrate that diatoms - eukaryotic organisms - also produce BMAA. Ultra-high-performance liquid chromatography coupled with tandem mass spectrometry revealed the occurrence of BMAA in six investigated axenic diatom cultures. BMAA was also detected in planktonic field samples collected on the Swedish west coast that display an overrepresentation of diatoms relative to cyanobacteria. Given the ubiquity of diatoms in aquatic environments and their central role as primary producers and the main food items of zooplankton, the use of filter and suspension feeders as livestock fodder dramatically increases the risk of human exposure to BMAA-contaminated food.	[Eriksson, Johan; Lage, Sandra; Jonasson, Sara; Rasmussen, Ulla] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Jiang, Liying; Mehine, Martin; Ilag, Leopold L.] Stockholm Univ, Dept Analyt Chem, S-10691 Stockholm, Sweden; [Shams, Shiva] Fdn Edmund Mach, IASMA Res & Innovat Ctr, Sustainable Agroecosyst & Bioresources Dept, Trento, Italy	Stockholm University; Stockholm University; Fondazione Edmund Mach	Rasmussen, U (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	ulla.rasmussen@su.se	Lage, Sandra/AAH-9309-2019	Lage, Sandra/0000-0003-0167-7163; Ilag, Leopold/0000-0003-3678-7100	Foundation for Strategic Environmental Research; Baltic Ecosystem Adaptive Management (BEAM); Swedish Research Council Formas	Foundation for Strategic Environmental Research; Baltic Ecosystem Adaptive Management (BEAM); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	The authors thank the Foundation for Strategic Environmental Research, the Baltic Ecosystem Adaptive Management (BEAM), the Swedish Research Council Formas for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R. A., 2005, ALGAL CULTURING TECH; Andjelkovic M, 2012, ENVIRON INT, V49, P115, DOI 10.1016/j.envint.2012.08.007; Banack SA, 2003, NEUROLOGY, V61, P387, DOI 10.1212/01.WNL.0000078320.18564.9F; Banack SA, 2003, BOT J LINN SOC, V143, P165, DOI 10.1046/j.1095-8339.2003.00217.x; Banack SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049043; Banack SA, 2010, TOXINS, V2, P2837, DOI 10.3390/toxins2122837; Banack SA, 2009, AMYOTROPH LATERAL SC, V10, P34, DOI 10.3109/17482960903278451; Bates S. S., 1998, PHYSL ECOLOGY HARMFU, P405; Brand LE, 2010, HARMFUL ALGAE, V9, P620, DOI 10.1016/j.hal.2010.05.002; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2002, NEUROLOGY, V58, P956, DOI 10.1212/WNL.58.6.956; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; DOUGLAS B, 1958, J ECOL, V46, P295, DOI 10.2307/2257397; Duncan M. W., 1989, J ANAL TOXICOL SA, V13; DUNCAN MW, 1990, NEUROLOGY, V40, P767, DOI 10.1212/WNL.40.5.767; Esterhuizen M, 2008, ECOTOX ENVIRON SAFE, V71, P309, DOI 10.1016/j.ecoenv.2008.04.010; Faassen EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036667; Graneli E, 1989, NOVEL PHYTOPLANKTON, V35, P407; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hallegraeff GM, 2012, HARMFUL ALGAE, V14, P130, DOI 10.1016/j.hal.2011.10.018; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Jiang LY, 2013, ANAL BIOANAL CHEM, V405, P1283, DOI 10.1007/s00216-012-6550-1; Jiang LY, 2012, ANAL BIOANAL CHEM, V403, P1719, DOI 10.1007/s00216-012-5966-y; Jonasson S, 2010, P NATL ACAD SCI USA, V107, P9252, DOI 10.1073/pnas.0914417107; Kruger T, 2010, TOXICON, V55, P547, DOI 10.1016/j.toxicon.2009.10.009; Kubo T, 2008, TOXICON, V51, P1264, DOI 10.1016/j.toxicon.2008.02.015; Lage S, 2012, MAR BIOL RES, V8, P784, DOI 10.1080/17451000.2012.659668; Lefebvre KA, 2002, MAR BIOL, V140, P625, DOI 10.1007/s00227-001-0713-5; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Mondo K, 2012, MAR DRUGS, V10, P509, DOI 10.3390/md10020509; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Murch SJ, 2004, ACTA NEUROL SCAND, V110, P267, DOI 10.1111/j.1600-0404.2004.00320.x; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Richardson RW, 2004, THESIS; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; Rosen J, 2008, ANALYST, V133, P1785, DOI 10.1039/b809231a; Smetacek V, 1999, PROTIST, V150, P25, DOI 10.1016/S1434-4610(99)70006-4; Spacil Z, 2010, ANALYST, V135, P127, DOI 10.1039/b921048b; STEWART PM, 1991, J FRESHWATER ECOL, V6, P249, DOI 10.1080/02705060.1991.9665301; Trainer VL, 2000, LIMNOL OCEANOGR, V45, P1818, DOI 10.4319/lo.2000.45.8.1818; VEGA A, 1967, PHYTOCHEMISTRY, V6, P759, DOI 10.1016/S0031-9422(00)86018-5; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71	42	160	163	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84578	10.1371/journal.pone.0084578	http://dx.doi.org/10.1371/journal.pone.0084578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392143	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100066
J	Braun, A; Schneider, S; Auerswald, K; Bellof, G; Schnyder, H				Braun, Alexander; Schneider, Stephan; Auerswald, Karl; Bellof, Gerhard; Schnyder, Hans			Forward Modeling of Fluctuating Dietary C-13 Signals to Validate C-13 Turnover Models of Milk and Milk Components from a Diet-Switch Experiment	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; STABLE-ISOTOPES; BREATH CO2; NITROGEN; CATTLE; HAIR; DIGESTION; ECOLOGY; RATES; COWS	Isotopic variation of food stuffs propagates through trophic systems. But, this variation is dampened in each trophic step, due to buffering effects of metabolic and storage pools. Thus, understanding of isotopic variation in trophic systems requires knowledge of isotopic turnover. In animals, turnover is usually quantified in diet-switch experiments in controlled conditions. Such experiments usually involve changes in diet chemical composition, which may affect turnover. Furthermore, it is uncertain if diet-switch based turnover models are applicable under conditions with randomly fluctuating dietary input signals. Here, we investigate if turnover information derived from diet-switch experiments with dairy cows can predict the isotopic composition of metabolic products (milk, milk components and feces) under natural fluctuations of dietary isotope and chemical composition. First, a diet-switch from a C-3-grass/maize diet to a pure C-3-grass diet was used to quantify carbon turnover in whole milk, lactose, casein, milk fat and feces. Data were analyzed with a compartmental mixed effects model, which allowed for multiple pools and intra-population variability, and included a delay between feed ingestion and first tracer appearance in outputs. The delay for milk components and whole milk was similar to 12 h, and that of feces similar to 20 h. The half-life (t(1/2)) for carbon in the feces was 9 h, while lactose, casein and milk fat had a t(1/2) of 10, 18 and 19 h. The C-13 kinetics of whole milk revealed two pools, a fast pool with a t(1/2) of 10 h (likely representing lactose), and a slower pool with a t(1/2) of 21 h (likely including casein and milk fat). The diet-switch based turnover information provided a precise prediction (RMSE similar to 0.2 parts per thousand) of the natural C-13 fluctuations in outputs during a 30 days-long period when cows ingested a pure C3 grass with naturally fluctuating isotope composition.	[Braun, Alexander; Auerswald, Karl; Schnyder, Hans] Tech Univ Munich, Dept Plant Sci, Lehrstuhl Grunlandlehre, Freising Weihenstephan, Germany; [Schneider, Stephan; Bellof, Gerhard] Hsch Weihenstephan Triesdorf, Fachgebiet Tierernahrung, Fak Land & Ernahrungswirtschaft, Freising Weihenstephan, Germany	Technical University of Munich	Auerswald, K (corresponding author), Tech Univ Munich, Dept Plant Sci, Lehrstuhl Grunlandlehre, Freising Weihenstephan, Germany.	Auerswald@wzw.tum.de	Schnyder, Hans/B-7089-2011; Auerswald, Karl/C-5186-2008; Braun, Alexander AB/G-2589-2010	Schnyder, Hans/0000-0002-0139-7535; Auerswald, Karl/0000-0001-5275-4320; Braun, Alexander AB/0000-0003-0610-9827	DFG [Au 183/3-1]	DFG(German Research Foundation (DFG))	The work was funded by the DFG, project number Au 183/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Stanley CD, 2009, J EXP BIOL, V212, P2349, DOI 10.1242/jeb.027565; Auerswald K, 2010, J APPL ECOL, V47, P936, DOI 10.1111/j.1365-2664.2009.01764.x; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Bahar B, 2009, J ANIM SCI, V87, P905, DOI 10.2527/jas.2008-1360; BOUTTON TW, 1988, J ANIM SCI, V66, P2636; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; CHATTERTON NJ, 1989, J PLANT PHYSIOL, V134, P169, DOI 10.1016/S0176-1617(89)80051-3; CHEESEMAN JM, 1986, PLANT PHYSIOL, V80, P1006, DOI 10.1104/pp.80.4.1006; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; del Rio CM, 2012, J MAMMAL, V93, P353, DOI 10.1644/11-MAMM-S-165.1; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Edwards JE, 2008, ANIMAL, V2, P653, DOI 10.1017/S1751731108002164; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FRY B, 1982, OECOLOGIA, V54, P200, DOI 10.1007/BF00378393; Gessler A, 2008, PLANT CELL ENVIRON, V31, P941, DOI 10.1111/j.1365-3040.2008.01806.x; Haramis GM, 2001, AUK, V118, P1008, DOI 10.1642/0004-8038(2001)118[1008:SIAOCW]2.0.CO;2; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; KLEIBER M, 1952, J BIOL CHEM, V195, P707; Klein PD, 1986, J ANIM SCI, V63, P102; Knobbe N, 2006, ANAL BIOANAL CHEM, V386, P104, DOI 10.1007/s00216-006-0644-6; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Kurle CM, 2009, FUNCT ECOL, V23, P733, DOI 10.1111/j.1365-2435.2009.01553.x; Lattanzi FA, 2012, J EXP BOT, V63, P2363, DOI 10.1093/jxb/ers020; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Martin O, 2007, ANIMAL, V1, P1143, DOI 10.1017/S1751731107000377; MARTINEAU A, 1985, ANAL BIOCHEM, V151, P495, DOI 10.1016/0003-2697(85)90210-6; Miller JF, 2008, CAN J ZOOL, V86, P685, DOI 10.1139/Z08-042; Miron MLL, 2006, J EXP BIOL, V209, P541, DOI 10.1242/jeb.02016; NOCEK JE, 1991, J DAIRY SCI, V74, P3598, DOI 10.3168/jds.S0022-0302(91)78552-4; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Pearson SF, 2003, OECOLOGIA, V135, P516, DOI 10.1007/s00442-003-1221-8; R Core Team, 2012, R LANG ENV STAT COMP; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Sarkar D., 2019, NLME LINEAR NONLINEA; Schneider S, 2011, ANIM FEED SCI TECH, V170, P1, DOI 10.1016/j.anifeedsci.2011.07.014; Schnyder H, 2012, ECOL STUD-ANAL SYNTH, V220, P157, DOI 10.1007/978-3-642-30645-7_7; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; Schwertl M, 2005, AGR ECOSYST ENVIRON, V109, P153, DOI 10.1016/j.agee.2005.01.015; Sponheimer M, 2006, RAPID COMMUN MASS SP, V20, P1395, DOI 10.1002/rcm.2454; SUSMEL P, 1991, ANIM PROD, V53, P305, DOI 10.1017/S0003356100020304; Tcherkez G, 2011, TRENDS PLANT SCI, V16, P499, DOI 10.1016/j.tplants.2011.05.010; Ungar ED, 1999, GRASS FORAGE SCI, V54, P357, DOI 10.1046/j.1365-2494.1999.00188.x; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; WILSON JR, 1994, J AGR SCI, V122, P173, DOI 10.1017/S0021859600087347; Wingfield WE, 2002, VET ICU BOOK; Witting DA, 2004, CAN J FISH AQUAT SCI, V61, P2069, DOI 10.1139/F04-156; Wittmer MHOM, 2008, BIOGEOSCIENCES, V5, P913, DOI 10.5194/bg-5-913-2008; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x; Woodward SJR, 1998, APPL ANIM BEHAV SCI, V56, P203, DOI 10.1016/S0168-1591(97)00089-0; Wright LE, 2012, J ANTHROPOL ARCHAEOL, V31, P334, DOI 10.1016/j.jaa.2012.02.001; Yang H, 2011, J EXP BOT, V62, P4143, DOI 10.1093/jxb/err102; Zazzo A, 2007, CAN J ZOOL, V85, P1239, DOI 10.1139/Z07-110; Zazzo A, 2008, RAPID COMMUN MASS SP, V22, P2937, DOI 10.1002/rcm.3693	56	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85235	10.1371/journal.pone.0085235	http://dx.doi.org/10.1371/journal.pone.0085235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392000	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900143
J	Griffin, ZM; Wangerman, T				Griffin, Zenzi M.; Wangerman, Thomas			Parents Accidentally Substitute Similar Sounding Sibling Names More Often than Dissimilar Names	PLOS ONE			English	Article							PICTURE-NAMING ERRORS; SPEECH PRODUCTION; SOCIAL-RELATIONS; WORD PRODUCTION; SPEAKERS; ADDRESS; MODELS; ACCESS; TERMS; FORMS	When parents select similar sounding names for their children, do they set themselves up for more speech errors in the future? Questionnaire data from 334 respondents suggest that they do. Respondents whose names shared initial or final sounds with a sibling's reported that their parents accidentally called them by the sibling's name more often than those without such name overlap. Having a sibling of the same gender, similar appearance, or similar age was also associated with more frequent name substitutions. Almost all other name substitutions by parents involved other family members and over 5% of respondents reported a parent substituting the name of a pet, which suggests a strong role for social and situational cues in retrieving personal names for direct address. To the extent that retrieval cues are shared with other people or animals, other names become available and may substitute for the intended name, particularly when names sound similar.	[Griffin, Zenzi M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Griffin, Zenzi M.; Wangerman, Thomas] Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA	University of Texas System; University of Texas Austin; University System of Georgia; Georgia Institute of Technology	Griffin, ZM (corresponding author), Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA.	zgriffin@utexas.edu	Griffin, Zenzi M./AAK-1000-2020	Griffin, Zenzi/0000-0003-4272-7630	National Science Foundation [0318456]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. 0318456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford Richard D., 1988, NAMING IDENTITY CROS; Archer J, 1997, EVOL HUM BEHAV, V18, P237, DOI 10.1016/S0162-3095(99)80001-4; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; Blanken G, 1998, COGNITIVE NEUROPSYCH, V15, P321, DOI 10.1080/026432998381122; BREDART S, 1992, COGNITION, V45, P187, DOI 10.1016/0010-0277(92)90017-C; Butterworth B., 1982, SLIPS TONGUE LANGUAG, P73; CHAO YR, 1956, LANGUAGE, V32, P217, DOI 10.2307/410666; Dell GS, 1997, PSYCHOL REV, V104, P801, DOI 10.1037/0033-295X.104.4.801; DELL GS, 1981, J VERB LEARN VERB BE, V20, P611, DOI 10.1016/S0022-5371(81)90202-4; Ferreira VS, 2003, PSYCHOL SCI, V14, P86, DOI 10.1111/1467-9280.01424; FISKE AP, 1991, J PERS SOC PSYCHOL, V60, P656, DOI 10.1037/0022-3514.60.5.656; FISKE AP, 1993, J CROSS CULT PSYCHOL, V24, P463, DOI 10.1177/0022022193244006; Fromkin, 1973, SPEECH ERRORS LINGUI, P144; Griffin Z.M., 2006, HDB PSYCHOLINGUISTIC, P21, DOI [10.1016/B978-012369374-7/50003-1, DOI 10.1016/B978-012369374-7/50003-1]; Griffin ZM, 2010, PSYCHOL LEARN MOTIV, V53, P345, DOI 10.1016/S0079-7421(10)53009-3; HARLEY TA, 1984, COGNITIVE SCI, V8, P191; Kittredge AK, 2008, COGN NEUROPSYCHOL, V25, P463, DOI 10.1080/02643290701674851; Krauss Robert M., 1998, HDB SOCIAL PSYCHOL, P41; LACHMAN R, 1973, J EXP PSYCHOL, V99, P199, DOI 10.1037/h0034633; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; MARTIN M, 1986, HUM LEARN, V5, P63; MARTIN N, 1989, J MEM LANG, V28, P462, DOI 10.1016/0749-596X(89)90022-3; Martin N, 1996, LANG COGNITIVE PROC, V11, P257, DOI 10.1080/016909696387187; Mitchell RW, 1999, SOC ANIM, V7, P55, DOI 10.1163/156853099X00167; OConnell A. A., 2006, LOGISTIC REGRESSION, DOI [10.4135/9781412984812, DOI 10.4135/9781412984812]; Rapp B, 2000, PSYCHOL REV, V107, P460, DOI 10.1037/0033-295X.107.3.460; Sedivy JC, 2011, PSYCHOL TODAY; Senay I, 2009, DISCOURSE PROCESS, V46, P401, DOI 10.1080/01638530902959596; VITKOVITCH M, 1993, J EXP PSYCHOL LEARN, V19, P243; YOUNG AW, 1986, J EXP PSYCHOL HUMAN, V12, P466, DOI 10.1037/0096-1523.12.4.466	30	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84444	10.1371/journal.pone.0084444	http://dx.doi.org/10.1371/journal.pone.0084444			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391955	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900098
J	Parente, DJ; Swint-Kruse, L				Parente, Daniel J.; Swint-Kruse, Liskin			Multiple Co-Evolutionary Networks Are Supported by the Common Tertiary Scaffold of the LacI/GalR Proteins	PLOS ONE			English	Article							ESCHERICHIA-COLI; CATABOLITE REPRESSION; CORRELATED MUTATIONS; TRANSCRIPTIONAL REGULATION; ALLOSTERIC COMMUNICATION; SPECIFICITY DETERMINANTS; SEQUENCE ALIGNMENTS; BACILLUS-SUBTILIS; PURINE REPRESSOR; FUNCTIONAL SITES	Protein families might evolve paralogous functions on their common tertiary scaffold in two ways. First, the locations of functionally-important sites might be "hard-wired'' into the structure, with novel functions evolved by altering the amino acid (e.g. Ala vs Ser) at these positions. Alternatively, the tertiary scaffold might be adaptable, accommodating a unique set of functionally important sites for each paralogous function. To discriminate between these possibilities, we compared the set of functionally important sites in the six largest paralogous subfamilies of the LacI/GalR transcription repressor family. LacI/GalR paralogs share a common tertiary structure, but have low sequence identity (<= 30%), and regulate a variety of metabolic processes. Functionally important positions were identified by conservation and co-evolutionary sequence analyses. Results showed that conserved positions use a mixture of the "hard-wired'' and "accommodating'' scaffold frameworks, but that the co-evolution networks were highly dissimilar between any pair of subfamilies. Therefore, the tertiary structure can accommodate multiple networks of functionally important positions. This possibility should be included when designing and interpreting sequence analyses of other protein families. Software implementing conservation and co-evolution analyses is available at https://sourceforge. net/projects/coevolutils/.	[Parente, Daniel J.; Swint-Kruse, Liskin] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Swint-Kruse, L (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA.	lswint-kruse@kumc.edu	Parente, Daniel/AAM-3887-2021	Parente, Daniel/0000-0002-7990-4576; Swint-Kruse, Liskin/0000-0002-5925-9741	NIH [GM 079423]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079423] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH GM 079423 to LSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, PDB 3HS3 CRYSTAL STR; Agarwal R, 2009, PDB 3CS3 CRYSTAL STR; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bagaria A, 2009, PDB 3GV0 CRYSTAL STR; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Bharatham K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024382; Bonanno JB, 2007, PDB 3BIL CRYSTAL STR; Bonanno JB, 2008, PDB 3E3M CRYSTAL STR; Brown C, 2002, EMBED SYST PROGRAM, V15, P55; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Cai ZH, 2004, HUM MUTAT, V24, P178, DOI 10.1002/humu.20063; CHOI KY, 1992, J BACTERIOL, V174, P6207, DOI 10.1128/JB.174.19.6207-6214.1992; CHOI KY, 1994, J BIOL CHEM, V269, P24066; de Vos MGJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003580; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; DEUTSCHER J, 1994, J BACTERIOL, V176, P3336, DOI 10.1128/jb.176.11.3336-3344.1994; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eick GN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003072; Flynn TC, 2003, PROTEIN SCI, V12, P2523, DOI 10.1110/ps.03188303; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Fukami-Kobayashi K, 2003, MOL BIOL EVOL, V20, P267, DOI 10.1093/molbev/msg038; Galinier A, 1999, J MOL BIOL, V286, P307, DOI 10.1006/jmbi.1998.2492; Geanacopoulos M, 1999, GENE DEV, V13, P1251, DOI 10.1101/gad.13.10.1251; Geanacopoulos M, 2002, J BIOL CHEM, V277, P33148, DOI 10.1074/jbc.M202445200; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Harms MJ, 2013, P NATL ACAD SCI USA, V110, P11475, DOI 10.1073/pnas.1303930110; Hars U, 1998, PROTEIN SCI, V7, P2511, DOI 10.1002/pro.5560071204; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Horlacher R, 1997, J BIOL CHEM, V272, P13026, DOI 10.1074/jbc.272.20.13026; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Izu H, 1997, J MOL BIOL, V267, P778, DOI 10.1006/jmbi.1996.0913; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jiang R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-417; JOBE A, 1972, J MOL BIOL, V69, P397, DOI 10.1016/0022-2836(72)90253-7; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kim JH, 1998, P NATL ACAD SCI USA, V95, P9590, DOI 10.1073/pnas.95.16.9590; Kraus A, 1998, MOL MICROBIOL, V30, P955, DOI 10.1046/j.1365-2958.1998.01123.x; Krishnan VG, 2003, BIOINFORMATICS, V19, P2199, DOI 10.1093/bioinformatics/btg297; La D, 2005, PROTEINS, V58, P309, DOI 10.1002/prot.20321; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008311; Lee Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038114; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lopez P, 2002, MOL BIOL EVOL, V19, P1; LOPILATO JE, 1984, J BACTERIOL, V158, P665, DOI 10.1128/JB.158.2.665-673.1984; MAJUMDAR A, 1987, J BIOL CHEM, V262, P2326; MAKAROFF CA, 1985, J BIOL CHEM, V260, P378; Malashkevich VN, 2009, PDB 3K4H CRYSTAL STR; Matthews KS, 1998, PROG NUCLEIC ACID RE, V58, P127; MAUZY CA, 1992, PROTEIN SCI, V1, P843, DOI 10.1002/pro.5560010702; MAUZY CA, 1992, PROTEIN SCI, V1, P831, DOI 10.1002/pro.5560010701; Meinhardt S, 2012, NUCLEIC ACIDS RES, V40, P11139, DOI 10.1093/nar/gks806; Meinhardt S, 2008, PROTEINS, V73, P941, DOI 10.1002/prot.22121; MENG LM, 1990, MOL MICROBIOL, V4, P2187, DOI 10.1111/j.1365-2958.1990.tb00580.x; Mironov AA, 1999, NUCLEIC ACIDS RES, V27, P2981, DOI 10.1093/nar/27.14.2981; Morgan DH, 2006, BIOINFORMATICS, V22, P2049, DOI 10.1093/bioinformatics/btl285; Needham CJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-405; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Palani K, 2009, PDB 3H5T CRYSTAL STR; Palani K, 2009, PDB 3KJX CRYSTAL STR; Patskovsky Y, 2009, PDB 3JVD CRYSTAL STR; Peekhaus N, 1998, J BACTERIOL, V180, P1777, DOI 10.1128/JB.180.7.1777-1785.1998; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Qian Z, 2012, P NATL ACAD SCI USA, V109, P11336, DOI 10.1073/pnas.1208595109; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; ROLFES RJ, 1988, J BIOL CHEM, V263, P19653; ROLFES RJ, 1990, J BACTERIOL, V172, P5637, DOI 10.1128/jb.172.10.5637-5642.1990; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; Schumacher MA, 1997, J BIOL CHEM, V272, P22648, DOI 10.1074/jbc.272.36.22648; Schumacher MA, 2007, J MOL BIOL, V368, P1042, DOI 10.1016/j.jmb.2007.02.054; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Swint-Kruse L, 2005, BIOINFORMATICS, V21, P3327, DOI 10.1093/bioinformatics/bti511; Swint-Kruse L, 2009, CURR OPIN MICROBIOL, V12, P129, DOI 10.1016/j.mib.2009.01.009; Syed Ibrahim B, 2009, PDB 3JY6 CRYSTAL STR; Tan K, 2008, PDB 3D8U CRYSTAL STR; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tungtur S, 2011, PROTEINS, V79, P1589, DOI 10.1002/prot.22985; Tungtur S, 2010, J MOL BIOL, V395, P785, DOI 10.1016/j.jmb.2009.10.001; Vicatos S, 2005, PROTEINS, V58, P935, DOI 10.1002/prot.20370; WEICKERT MJ, 1992, J MOL BIOL, V226, P69, DOI 10.1016/0022-2836(92)90125-4; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Wilson CJ, 2007, CELL MOL LIFE SCI, V64, P3, DOI 10.1007/s00018-006-6296-z; Ye K, 2008, BIOINFORMATICS, V24, P908, DOI 10.1093/bioinformatics/btn057; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	102	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84398	10.1371/journal.pone.0084398	http://dx.doi.org/10.1371/journal.pone.0084398			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391951	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900094
J	Sels, JWEM; Rutten, B; van Holten, TC; Hillaert, MAK; Waltenberger, J; Pijls, NHJ; Pasterkamp, G; de Groot, PG; Roest, M				Sels, Jan-Willem E. M.; Rutten, Bert; van Holten, Thijs C.; Hillaert, Marieke A. K.; Waltenberger, Johannes; Pijls, Nico H. J.; Pasterkamp, Gerard; de Groot, Philip G.; Roest, Mark			The Relationship between Fractional Flow Reserve, Platelet Reactivity and Platelet Leukocyte Complexes in Stable Coronary Artery Disease	PLOS ONE			English	Article							INCREMENTAL PROGNOSTIC VALUE; P-SELECTIN; ISCHEMIC-STROKE; CLOPIDOGREL; ACTIVATION; AGGREGATION; EXPRESSION; ASPIRIN	Background: The presence of stenoses that significantly impair blood flow and cause myocardial ischemia negatively affects prognosis of patients with stable coronary artery disease. Altered platelet reactivity has been associated with impaired prognosis of stable coronary artery disease. Platelets are activated and form complexes with leukocytes in response to microshear gradients caused by friction forces on the arterial wall or flow separation. We hypothesized that the presence of significantly flow-limiting stenoses is associated with altered platelet reactivity and formation of platelet-leukocyte complexes. Methods: One hundred patients with stable angina were studied. Hemodynamic significance of all coronary stenoses was assessed with Fractional Flow Reserve (FFR). Patients were classified FFR-positive (at least one lesion with FFR <= 0.75) or FFR-negative (all lesions FFR>0.80). Whole blood samples were stimulated with increasing concentrations of ADP, TRAP, CRP and Iloprost with substimulatory ADP. Expression of P-selectin as platelet activation marker and platelet-leukocyte complexes were measured by flowcytometry. Patients were stratified on clopidogrel use. FFR positive and negative patient groups were compared on platelet reactivity and platelet-leukocyte complexes. Results: Platelet reactivity between FFR-positive patients and FFR-negative patients did not differ. A significantly lower percentage of circulating platelet-neutrophil complexes in FFR-positive patients and a similar non-significant decrease in percentage of circulating platelet-monocyte complexes in FFR-positive patients was observed. Conclusion: The presence of hemodynamically significant coronary stenoses does not alter platelet reactivity but is associated with reduced platelet-neutrophil complexes in peripheral blood of patients with stable coronary artery disease.	[Sels, Jan-Willem E. M.; Pijls, Nico H. J.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands; [Rutten, Bert; van Holten, Thijs C.; de Groot, Philip G.; Roest, Mark] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands; [Pasterkamp, Gerard] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Sels, Jan-Willem E. M.; Pijls, Nico H. J.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Hillaert, Marieke A. K.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Waltenberger, Johannes] Maastricht Univ, Med Ctr, Dept Cardiol, Maastricht, Netherlands; [Waltenberger, Johannes] Univ Munster, Dept Cardiovasc Med, D-48149 Munster, Germany	Catharina Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Eindhoven University of Technology; Utrecht University; Utrecht University Medical Center; Maastricht University; University of Munster	Sels, JWEM (corresponding author), Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands.	janwillem.sels@gmail.com		Rutten, Bart/0000-0002-9834-6346	CTMM, the Center for Translational Molecular Medicine, project CIRCULATING CELLS [01C-102]; Dutch Heart Foundation	CTMM, the Center for Translational Molecular Medicine, project CIRCULATING CELLS; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project CIRCULATING CELLS (grant 01C-102), and supported by the Dutch Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti F, 2001, AM J CARDIOL, V87, P16, DOI 10.1016/S0002-9149(00)01265-0; Brambilla M, 2008, ARTERIOSCL THROM VAS, V28, P947, DOI 10.1161/ATVBAHA.107.161471; Braun OO, 2008, THROMB HAEMOSTASIS, V100, P626, DOI 10.1160/TH08-05-0313; Braunwald E, 2008, CLIN CARDIOL, V31, pI17, DOI 10.1002/clc.20363; Burdess A, 2010, J VASC SURG, V52, P697, DOI 10.1016/j.jvs.2010.04.024; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Bruyne B, 2008, HEART, V94, P949, DOI 10.1136/hrt.2007.122838; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Furman MI, 1998, J AM COLL CARDIOL, V31, P352, DOI 10.1016/S0735-1097(97)00510-X; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Geisler T, 2006, EUR HEART J, V27, P2420, DOI 10.1093/eurheartj/ehl275; Gurbel, 1995, J Thromb Thrombolysis, V1, P187, DOI 10.1007/BF01062577; Hachamovitch R, 1998, CIRCULATION, V97, P535; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Ishikawa T, 2012, J ATHEROSCLER THROMB, V19, P494; ISKANDRIAN AS, 1993, J AM COLL CARDIOL, V22, P665, DOI 10.1016/0735-1097(93)90174-Y; Klinkhardt U, 2003, CLIN PHARMACOL THER, V73, P232, DOI 10.1067/mcp.2003.13; KROLL MH, 1993, J BIOL CHEM, V268, P3520; Kroll MH, 1996, BLOOD, V88, P1525; Linden MD, 2006, J THROMB HAEMOST, V4, P2670, DOI 10.1111/j.1538-7836.2006.02228.x; Linden MD, 2010, INT J BIOCHEM CELL B, V42, P1762, DOI 10.1016/j.biocel.2010.07.012; Martins PD, 2004, ARTERIOSCL THROM VAS, V24, P193, DOI 10.1161/01.ATV.0000106320.40933.E5; Maugeri N, 2009, BLOOD, V113, P5254, DOI 10.1182/blood-2008-09-180794; McCabe DJH, 2005, J NEUROL NEUROSUR PS, V76, P1249, DOI 10.1136/jnnp.2004.051003; McCabe DJH, 2004, BRIT J HAEMATOL, V125, P777, DOI 10.1111/j.1365-2141.2004.04983.x; Milovanovic M, 2005, PLATELETS, V16, P211, DOI 10.1080/09537100400016813; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pijls NHJ, 2012, J AM COLL CARDIOL, V59, P1045, DOI 10.1016/j.jacc.2011.09.077; Sarma J, 2002, CIRCULATION, V105, P2166, DOI 10.1161/01.CIR.0000015700.27754.6F; Snoep JD, 2010, J THROMB HAEMOST, V8, P906, DOI 10.1111/j.1538-7836.2010.03786.x; Wallen NH, 1997, EUR HEART J, V18, P807; Yong ASC, 2011, BLOOD, V117, P11, DOI 10.1182/blood-2010-04-278812	34	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83198	10.1371/journal.pone.0083198	http://dx.doi.org/10.1371/journal.pone.0083198			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391745	Green Published, gold			2022-12-27	WOS:000329325200042
J	Siddon, EC; Kristiansen, T; Mueter, FJ; Holsman, KK; Heintz, RA; Farley, EV				Siddon, Elizabeth Calvert; Kristiansen, Trond; Mueter, Franz J.; Holsman, Kirstin K.; Heintz, Ron A.; Farley, Edward V.			Spatial Match-Mismatch between Juvenile Fish and Prey Provides a Mechanism for Recruitment Variability across Contrasting Climate Conditions in the Eastern Bering Sea	PLOS ONE			English	Article							POLLOCK THERAGRA-CHALCOGRAMMA; COD GADUS-MORHUA; WALLEYE POLLOCK; BIOENERGETICS MODEL; MALLOTUS-VILLOSUS; HABITAT SELECTION; BODY-SIZE; LARVAL; AGE-0; TEMPERATURE	Understanding mechanisms behind variability in early life survival of marine fishes through modeling efforts can improve predictive capabilities for recruitment success under changing climate conditions. Walleye pollock (Theragra chalcogramma) support the largest single-species commercial fishery in the United States and represent an ecologically important component of the Bering Sea ecosystem. Variability in walleye pollock growth and survival is structured in part by climate-driven bottom-up control of zooplankton composition. We used two modeling approaches, informed by observations, to understand the roles of prey quality, prey composition, and water temperature on juvenile walleye pollock growth: (1) a bioenergetics model that included local predator and prey energy densities, and (2) an individual-based model that included a mechanistic feeding component dependent on larval development and behavior, local prey densities and size, and physical oceanographic conditions. Prey composition in late-summer shifted from predominantly smaller copepod species in the warmer 2005 season to larger species in the cooler 2010 season, reflecting differences in zooplankton composition between years. In 2010, the main prey of juvenile walleye pollock were more abundant, had greater biomass, and higher mean energy density, resulting in better growth conditions. Moreover, spatial patterns in prey composition and water temperature lead to areas of enhanced growth, or growth 'hot spots', for juvenile walleye pollock and survival may be enhanced when fish overlap with these areas. This study provides evidence that a spatial mismatch between juvenile walleye pollock and growth 'hot spots' in 2005 contributed to poor recruitment while a higher degree of overlap in 2010 resulted in improved recruitment. Our results indicate that climate-driven changes in prey quality and composition can impact growth of juvenile walleye pollock, potentially severely affecting recruitment variability.	[Siddon, Elizabeth Calvert; Mueter, Franz J.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK USA; [Kristiansen, Trond] Inst Marine Res, N-5024 Bergen, Norway; [Holsman, Kirstin K.] Univ Washington, Joint Inst Study Atmosphere & Ocean, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv,Natl Ocean & Atmospher, Seattle, WA 98195 USA; [Heintz, Ron A.; Farley, Edward V.] Natl Ocean & Atmospher Adm, Ted Stevens Marine Res Inst, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Juneau, AK USA	University of Alaska System; University of Alaska Fairbanks; Institute of Marine Research - Norway; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Siddon, EC (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK USA.	ecsiddon@alaska.edu	Farley, E/HHM-4227-2022	Kristiansen, Trond/0000-0001-6121-297X	North Pacific Anadromous Fish Commission; North Pacific Research Board; Norwegian Research Council	North Pacific Anadromous Fish Commission; North Pacific Research Board; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the North Pacific Anadromous Fish Commission; North Pacific Research Board; and Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Buchheister A, 2005, J FISH BIOL, V67, P541, DOI 10.1111/j.0022-1112.2005.00741.x; Buchheister A, 2006, T AM FISH SOC, V135, P897, DOI 10.1577/T05-105.1; Ciannelli L, 1998, J FISH BIOL, V52, P879, DOI 10.1111/j.1095-8649.1998.tb00589.x; Coyle KO, 2011, FISH OCEANOGR, V20, P139, DOI 10.1111/j.1365-2419.2011.00574.x; Coyle KO, 2008, DEEP-SEA RES PT II, V55, P1775, DOI 10.1016/j.dsr2.2008.04.029; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Duffy-Anderson JT, 2006, FISH OCEANOGR, V15, P80, DOI 10.1111/j.1365-2419.2005.00348.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Farley Edward V. Jr, 2005, Alaska Fishery Research Bulletin, V11, P15; Fiksen O, 2002, MAR ECOL PROG SER, V243, P151, DOI 10.3354/meps243151; Hanson P. C., 1997, WISCUT97001 U WISC S; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; Hollowed AB, 2009, ICES J MAR SCI, V66, P1584, DOI 10.1093/icesjms/fsp057; Holsman KK, MAR ECOL PR IN PRESS; Hunt GL, 2011, ICES J MAR SCI, V68, P1230, DOI 10.1093/icesjms/fsr036; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; Ianelli JN, 2012, STOCK ASSESSMENT FIS; Kachel NB, 2002, DEEP-SEA RES PT II, V49, P5889, DOI 10.1016/S0967-0645(02)00324-7; KITCHELL JF, 1977, J FISH RES BOARD CAN, V34, P1922, DOI 10.1139/f77-258; Kristiansen T, 2007, CAN J FISH AQUAT SCI, V64, P136, DOI 10.1139/F06-176; Kristiansen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017456; Kristiansen T, 2009, MAR ECOL PROG SER, V376, P227, DOI 10.3354/meps07796; Litzow MA, 2006, MAR ECOL PROG SER, V315, P1, DOI 10.3354/meps315001; Logerwell EA, 2010, FISH OCEANOGR, V19, P262, DOI 10.1111/j.1365-2419.2010.00542.x; Moss JH, 2009, T AM FISH SOC, V138, P497, DOI 10.1577/T08-126.1; Mueter FJ, 2011, ICES J MAR SCI, V68, P1284, DOI 10.1093/icesjms/fsr022; Munk P, 1997, J FISH BIOL, V51, P340, DOI 10.1111/j.1095-8649.1997.tb06107.x; NEY JJ, 1990, REV AQUAT SCI, V2, P55; Paul AJ, 1998, J EXP MAR BIOL ECOL, V226, P75, DOI 10.1016/S0022-0981(97)00241-4; Peck MA, 2006, ENVIRON BIOL FISH, V75, P419, DOI 10.1007/s10641-006-0031-3; Ressler PH, 2012, DEEP-SEA RES PT II, V65-70, P184, DOI 10.1016/j.dsr2.2012.02.015; Siddon EC, 2013, DEEP-SEA RES PT II, V94, P140, DOI 10.1016/j.dsr2.2012.12.007; Sogard SM, 2000, J FISH BIOL, V56, P1; Stabeno PJ, 2012, DEEP-SEA RES PT II, V65-70, P31, DOI 10.1016/j.dsr2.2012.02.020; Volkov A.F., 2007, IZV TINRO, V151, P338	37	53	54	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84526	10.1371/journal.pone.0084526	http://dx.doi.org/10.1371/journal.pone.0084526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391963	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900106
J	Pais, RS; Moreno-Barriuso, N; Hernandez-Porras, I; Lopez, IP; De Las Rivas, J; Pichel, JG				Sofia Pais, Rosete; Moreno-Barriuso, Nuria; Hernandez-Porras, Isabel; Paula Lopez, Iciar; De Las Rivas, Javier; Garcia Pichel, Jose			Transcriptome Analysis in Prenatal IGF1-Deficient Mice Identifies Molecular Pathways and Target Genes Involved in Distal Lung Differentiation	PLOS ONE			English	Article							GROWTH-FACTOR-I; MESSENGER-RNA EXPRESSION; CELL-PROLIFERATION; BRANCHING MORPHOGENESIS; BINDING-PROTEINS; MOUSE LUNG; IGF-I; BRONCHOPULMONARY DYSPLASIA; ALVEOLAR DEVELOPMENT; ENTERIC INNERVATION	Background: Insulin-like Growth Factor 1 (IGF1) is a multifunctional regulator of somatic growth and development throughout evolution. IGF1 signaling through IGF type 1 receptor (IGF1R) controls cell proliferation, survival and differentiation in multiple cell types. IGF1 deficiency in mice disrupts lung morphogenesis, causing altered prenatal pulmonary alveologenesis. Nevertheless, little is known about the cellular and molecular basis of IGF1 activity during lung development. Methods/Principal Findings: Prenatal Igf1(-/-) mutant mice with a C57Bl/6J genetic background displayed severe disproportional lung hypoplasia, leading to lethal neonatal respiratory distress. Immuno-histological analysis of their lungs showed a thickened mesenchyme, alterations in extracellular matrix deposition, thinner smooth muscles and dilated blood vessels, which indicated immature and delayed distal pulmonary organogenesis. Transcriptomic analysis of Igf1(-/-) E18.5 lungs using RNA microarrays identified deregulated genes related to vascularization, morphogenesis and cellular growth, and to MAP-kinase, Wnt and cell-adhesion pathways. Up-regulation of immunity-related genes was verified by an increase in inflammatory markers. Increased expression of Nfib and reduced expression of Klf2, Egr1 and Ctgf regulatory proteins as well as activation of ERK2 MAP-kinase were corroborated by Western blot. Among IGF-system genes only IGFBP2 revealed a reduction in mRNA expression in mutant lungs. Immuno-staining patterns for IGF1R and IGF2, similar in both genotypes, correlated to alterations found in specific cell compartments of Igf1(-/-) lungs. IGF1 addition to Igf1(-/-) embryonic lungs cultured ex vivo increased airway septa remodeling and distal epithelium maturation, processes accompanied by upregulation of Nfib and Klf2 transcription factors and Cyr61 matricellular protein. Conclusions/Significance: We demonstrated the functional tissue specific implication of IGF1 on fetal lung development in mice. Results revealed novel target genes and gene networks mediators of IGF1 action on pulmonary cellular proliferation, differentiation, adhesion and immunity, and on vascular and distal epithelium maturation during prenatal lung development.	[Sofia Pais, Rosete; Paula Lopez, Iciar; Garcia Pichel, Jose] Fdn Rioja Salud, Ctr Invest Biomed Rioja, Logrono, Spain; [Moreno-Barriuso, Nuria; Hernandez-Porras, Isabel; De Las Rivas, Javier] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Pichel, JG (corresponding author), Fdn Rioja Salud, Ctr Invest Biomed Rioja, Logrono, Spain.	jgpichel@riojasalud.es	Pichel, Jose G/AAF-2255-2019; De Las Rivas, Javier/G-5936-2014	Pichel, Jose G/0000-0001-8580-0952; De Las Rivas, Javier/0000-0002-0984-9946	Fundacion Rioja Salud (Logrono); Ministerio de Ciencia e Innovacion (Spain) [BFU200501437]	Fundacion Rioja Salud (Logrono); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by the Fundacion Rioja Salud (Logrono) and Ministerio de Ciencia e Innovacion (BFU200501437) (Spain). R. S. P. was a pre-doctoral fellow from Fundacion Rioja Salud, N.M.-B. was a doctoral fellow from the Ministerio de Ciencia e Innovacion and I.H.-P. was a JAE fellow from the Consejo Superior de Investigaciones Cientificas (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Asaoka Y, 2010, J BIOCHEM, V148, P393, DOI 10.1093/jb/mvq098; Baguma-Nibasheka M, 2008, DEV DYNAM, V237, P485, DOI 10.1002/dvdy.21433; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Banski P, 2010, J BIOL CHEM, V285, P21858, DOI 10.1074/jbc.M110.117291; Berg K, 1996, BRIT J CANCER, V74, P688, DOI 10.1038/bjc.1996.423; Bourbon J, 2005, PEDIATR RES, V57, p38R, DOI 10.1203/01.PDR.0000159630.35883.BE; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Capoluongo E, 2008, CLIN CHEM LAB MED, V46, P1061, DOI 10.1515/CCLM.2008.211; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Castellano E, 2007, ONCOGENE, V26, P917, DOI 10.1038/sj.onc.1209845; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; CHEN JM, 1987, DEV BIOL, V120, P311, DOI 10.1016/0012-1606(87)90234-X; Chen PP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000534; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Chetty A, 2004, PEDIATR PULM, V37, P128, DOI 10.1002/ppul.10415; Chetty A, 2006, PEDIATR RES, V60, P389, DOI 10.1203/01.pdr.0000238257.15502.f4; Chien W, 2006, MOL CANCER RES, V4, P591, DOI 10.1158/1541-7786.MCR-06-0029; Chinoy MR, 2003, FRONT BIOSCI-LANDMRK, V8, pD392, DOI 10.2741/974; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Demidyuk IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055752; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Dupont J, 2001, ENDOCRINOLOGY, V142, P4969, DOI 10.1210/en.142.11.4969; Epaud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048071; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Frago LM, 2000, HISTOL HISTOPATHOL, V15, P657, DOI 10.14670/HH-15.657; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Ghosh MC, 2013, AM J PHYSIOL-LUNG C, V305, P1222, DOI 10.1152/ajplung.00014.2013; Grunder A, 2002, MECH DEVELOP, V112, P69, DOI 10.1016/S0925-4773(01)00640-2; Han RNN, 2003, AM J RESP CELL MOL, V28, P159, DOI 10.1165/rcmb.4764; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Hsieh T, 2003, J BIOL CHEM, V278, P42886, DOI 10.1074/jbc.M303835200; Hsu YC, 2011, DEV BIOL, V354, P242, DOI 10.1016/j.ydbio.2011.04.002; Inanlou MR, 2005, DEV DYNAM, V233, P772, DOI 10.1002/dvdy.20381; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang Y, 2006, J CELL BIOCHEM, V98, P208, DOI 10.1002/jcb.20771; Kang JH, 2004, EUR J BIOCHEM, V271, P2452, DOI 10.1111/j.1432-1033.2004.04175.x; Kim HS, 1997, P NATL ACAD SCI USA, V94, P12981, DOI 10.1073/pnas.94.24.12981; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Krein PM, 2002, CHEST, V122, p289S, DOI 10.1378/chest.122.6_suppl.289S; Krop I, 2005, CANCER RES, V65, P9659, DOI 10.1158/0008-5472.CAN-05-1663; Kruis T, 2010, J CLIN ENDOCR METAB, V95, P1137, DOI 10.1210/jc.2009-1433; Lawan A, 2013, CELL MOL LIFE SCI, V70, P223, DOI 10.1007/s00018-012-1041-2; Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0; Lee GH, 2003, ONCOGENE, V22, P2374, DOI 10.1038/sj.onc.1206387; Lee JH, 2001, AM J PHYSIOL-LUNG C, V280, pL1019, DOI 10.1152/ajplung.2001.280.5.L1019; Lee JI, 2003, J MOL BIOL, V328, P147, DOI 10.1016/S0022-2836(03)00237-7; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Liu Y, 2008, DEV BIOL, V314, P224, DOI 10.1016/j.ydbio.2007.12.003; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Mesas-Burgos C, 2009, J PEDIATR SURG, V44, P720, DOI 10.1016/j.jpedsurg.2008.06.020; Millien G, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-35; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miyazaki E, 1998, J PEDIATR SURG, V33, P1476, DOI 10.1016/S0022-3468(98)90478-X; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Moreno-Barriuso N, 2006, DEV DYNAM, V235, P2040, DOI 10.1002/dvdy.20842; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Muglia LJ, 1999, AM J RESP CELL MOL, V20, P181, DOI 10.1165/ajrcmb.20.2.3381; Nagata K, 2007, PEDIATR SURG INT, V23, P953, DOI 10.1007/s00383-007-1977-8; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nguyet NM, 2005, DEV BIOL, V282, P111, DOI 10.1016/j.ydbio.2005.02.031; Nogueira-Silva C, 2008, EARLY HUM DEV, V84, pS79; Pauling MH, 2004, CURR TOP DEV BIOL, V64, P73, DOI 10.1016/S0070-2153(04)64005-1; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Pichel JG, 1996, COLD SPRING HARB SYM, V61, P445; Pichel JG, 2003, MECH DEVELOP, V120, P349, DOI 10.1016/S0925-4773(02)00449-5; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ponticos M, 2013, VASC PHARMACOL, V58, P189, DOI 10.1016/j.vph.2013.01.004; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Prince LS, 2004, AM J PHYSIOL-LUNG C, V287, pL999, DOI 10.1152/ajplung.00111.2004; Qiang Y, 2003, J IMMUNOL, V170, P1473, DOI 10.4049/jimmunol.170.3.1473; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; RetschBogart GZ, 1996, AM J RESP CELL MOL, V14, P61, DOI 10.1165/ajrcmb.14.1.8534487; ROBACK EW, 1991, AM J MED GENET, V38, P74, DOI 10.1002/ajmg.1320380117; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Schniedermann J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-50; SCHULLER AGP, 1995, J MOL ENDOCRINOL, V14, P349, DOI 10.1677/jme.0.0140349; Shapiro P, 1997, AM J PHYSIOL-LUNG C, V273, pL459, DOI 10.1152/ajplung.1997.273.2.L459; Shen HC, 2012, FEBS OPEN BIO, V2, P1, DOI 10.1016/j.fob.2011.12.001; Silva D, 2006, ENDOCRINOLOGY, V147, P5584, DOI 10.1210/en.2006-0498; Soriano C, 2012, LUNG CANCER, V77, P38, DOI 10.1016/j.lungcan.2012.01.017; Srisuma S, 2010, AM J RESP CRIT CARE, V181, P838, DOI 10.1164/rccm.200904-0544OC; Starcher BC, 2000, CHEST, V117, p229S, DOI 10.1378/chest.117.5_suppl_1.229S-a; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Svegliati-Baroni G, 1999, HEPATOLOGY, V29, P1743, DOI 10.1002/hep.510290632; TENHAVEOPBROEK AAW, 1991, EXP LUNG RES, V17, P111, DOI 10.3109/01902149109064406; Thrane EV, 2001, EXP LUNG RES, V27, P387, DOI 10.1080/019021401750193638; Tong XJ, 2004, ONCOGENE, V23, P4847, DOI 10.1038/sj.onc.1207628; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Usui H, 2004, BIOCHEM BIOPH RES CO, V322, P887, DOI 10.1016/j.bbrc.2004.07.198; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner KF, 2004, AM J RESP CELL MOL, V31, P276, DOI 10.1165/rcmb.2003-0319OC; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Wang J, 2005, TISSUE CELL, V37, P25, DOI 10.1016/j.tice.2004.09.002; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; Werner Haim, 2008, Archives of Physiology and Biochemistry, V114, P17, DOI [10.1080/13813450801900694, 10.1080/13813450801900694 ]; Williams MC, 2003, ANNU REV PHYSIOL, V65, P669, DOI 10.1146/annurev.physiol.65.092101.142446; Winnay JN, 2000, J BIOL CHEM, V275, P10545, DOI 10.1074/jbc.275.14.10545; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Wu S, 2009, PEDIATR RES, V65, P381, DOI 10.1203/PDR.0b013e3181991c67; Xie P, 2011, BIOCHEM BIOPH RES CO, V407, P254, DOI 10.1016/j.bbrc.2011.03.016; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037046; Zhang YJ, 2013, TUMOR BIOL, V34, P1605, DOI 10.1007/s13277-013-0691-5; Zhao L, 2008, BLOOD CELL MOL DIS, V41, P188, DOI 10.1016/j.bcmd.2008.03.006	119	26	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83028	10.1371/journal.pone.0083028	http://dx.doi.org/10.1371/journal.pone.0083028			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391734	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200031
J	Alam, N; Townend, J				Alam, Nurul; Townend, John			The Neighbourhood Method for Measuring Differences in Maternal Mortality, Infant Mortality and Other Rare Demographic Events	PLOS ONE			English	Article							CHILD-MORTALITY; COUNTRIES; PROGRESS; LEVEL	In the absence of reliable systems for registering rare types of vital events large surveys are required to measure changes in their rates. However some events such as maternal deaths are widely known about in the community. This study examined the utility of asking respondents about events in their neighbourhood as an efficient method for measuring relative rates of rare health events such as maternal and infant deaths. A survey was conducted in the health and demographic surveillance system (HDSS) in Matlab, Bangladesh, which includes two areas with different health care regimes. Adult women were asked about any maternal deaths; multiple births; infant deaths, live births and some other events they knew of in a small specified area around their home. Agreement between HDSS records and survey responses was moderate or better (kappa >= 0.44) for all the events and greatest for maternal deaths (kappa = 0.77) with 84% being reported. Most events were more likely to be reported if they were recent (p<0.05). Infant mortality rate in one area was 0.56 times that in the other which was well reflected by the ratio of survey results (0.53). Simulations were used to study the ability of the method to detect differences in maternal mortality ratio. These suggested that a sample size around 5000 would give 80% power to detect a 50% decrease from a baseline of 183 which compared well with an estimated sample size around 10 times larger using the direct sisterhood method. The findings suggest that the Neighbourhood Method has potential for monitoring relative differences between areas or changes over time in the rates of rare demographic events, requiring considerably smaller sample sizes than traditional methods. This raises the possibility for interventions to demonstrate real effects on outcomes such as maternal deaths where previously this was only feasible by indirect methods.	[Alam, Nurul] ICDDR B, Ctr Populat Urbanizat & Climate Change, Dhaka, Bangladesh; [Townend, John] Univ Aberdeen, Med Stat Team, Div Appl Hlth Sci, Aberdeen, Scotland	International Centre for Diarrhoeal Disease Research (ICDDR); University of Aberdeen	Townend, J (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Oxford, England.	john.townend@npeu.ox.ac.uk		Alam, Nurul/0000-0002-1202-4451	SIDA (Swedish International Development Cooperation Agency)/SAREC (Swedish Agency for Research Cooperation with Developing Countries); icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh); Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	SIDA (Swedish International Development Cooperation Agency)/SAREC (Swedish Agency for Research Cooperation with Developing Countries); icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh); Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research protocol was funded by SIDA (Swedish International Development Cooperation Agency)/SAREC (Swedish Agency for Research Cooperation with Developing Countries) and icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh) and its core donors, which provide unrestricted support to icddr, b for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The authors gratefully acknowledge these donors for their support and commitment to icddr,b's research efforts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2011, B WORLD HEALTH ORGAN, V89, P12, DOI 10.2471/BLT.10.076851; Alam N, 2007, TROP MED INT HEALTH, V12, P1; Barnett S, 2008, BMC PREGNANCY CHILDB, V8, P1, DOI DOI 10.1186/1471-2393-8-6; BOERMA JT, 1989, STUD FAMILY PLANN, V20, P245, DOI 10.2307/1966761; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Burchett HE, 2009, INT J GYNECOL OBSTET, V105, P78, DOI 10.1016/j.ijgo.2008.12.022; Byass P, 2002, PUBLIC HEALTH, V116, P145, DOI 10.1038/sj.ph.1900837; Byass P, 2011, LANCET, V378, P1119, DOI 10.1016/S0140-6736(11)61419-0; Chou D, 2012, TRENDS MATERNAL MORT; Chou D, 2010, TRENDS MATERNAL MORT; GRAHAM W, 1989, STUD FAMILY PLANN, V20, P125, DOI 10.2307/1966567; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Graham WJ, 2008, BEST PRACT RES CL OB, V22, P425, DOI 10.1016/j.bpobgyn.2007.12.001; Hill K, 2006, B WORLD HEALTH ORGAN, V84, P173, DOI 10.2471/BLT.05.027714; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hill K, 2011, J POPUL RES, V28, P31, DOI 10.1007/s12546-011-9058-1; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horton R, 2008, LANCET, V371, P1217, DOI 10.1016/S0140-6736(08)60533-4; ICDDR,B, 2009, 106 ICDDRB; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Maine D, 1997, GUIDELINES MONITORIN, V1997; Maskey MK, 2011, INDIAN J MED RES, V133, P64; Masquelier B, 2013, DEMOGRAPHY, V50, P207, DOI 10.1007/s13524-012-0149-1; Mathers C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000265; Measure Evaluation, 2002, TOOL 20 REPR AG MORT; Merdad L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059834; Mills S, 2008, MATERN CHILD HLTH J, V12, P577, DOI 10.1007/s10995-007-0289-x; National Institute of Population Research and Training (NIPORT) ORC Macro John Hopkins University ICDDRB, 2003, BANGL MAT HLTH SERV; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Prata N, 2012, REPROD HEALTH MATTER, V20, P196, DOI 10.1016/S0968-8080(12)39606-7; Qomariyah SN, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-74; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Say L, 2008, INT ENCY PUBLIC HLTH, P222; Shankar A, 2008, LANCET, V371, P1223, DOI 10.1016/S0140-6736(08)60536-X; Stanton C, 2000, STUD FAMILY PLANN, V31, P111, DOI 10.1111/j.1728-4465.2000.00111.x; Stanton C, 2001, B WORLD HEALTH ORGAN, V79, P657; van den Broek NR, 2011, BRIT MED BULL, V99, P25, DOI 10.1093/bmb/ldr033; Wilmoth J, 2012, NEW METHOD DERIVIN S; Yazbeck AS, 2007, LANCET, V370, P1291, DOI 10.1016/S0140-6736(07)61553-0; You DZ, 2010, LANCET, V376, P931, DOI 10.1016/S0140-6736(10)61429-8	42	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83590	10.1371/journal.pone.0083590	http://dx.doi.org/10.1371/journal.pone.0083590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286ID	24392088	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100012
J	Chantratita, N; Tandhavanant, S; Myers, ND; Chierakul, W; Wuthiekanun, V; Mahavanakul, W; Limmathurotsakul, D; Peacock, SJ; West, TE				Chantratita, Narisara; Tandhavanant, Sarunporn; Myers, Nicolle D.; Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Mahavanakul, Weera; Limmathurotsakul, Direk; Peacock, Sharon J.; West, T. Eoin			Common TLR1 Genetic Variation Is Not Associated with Death from Melioidosis, a Common Cause of Sepsis in Rural Thailand	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; NORTHEAST THAILAND; SUSCEPTIBILITY; POLYMORPHISM; RESPONSES; TUBERCULOSIS; LEPROSY; INTERLEUKIN-6; PSEUDOMALLEI	Melioidosis, infection caused by the Gram-negative bacterium Burkholderia pseudomallei, is a common cause of sepsis in northeast Thailand. In white North Americans, common functional genetic variation in TLR1 is associated with organ failure and death from sepsis. We hypothesized that TLR1 variants would be associated with outcomes in Thais with melioidosis. We collated the global frequencies of three TLR1 variants that are common in white North American populations: rs5743551 (-7202A/G), rs4833095 (742A/G), and rs5743618 (1804G/T). We noted a reversal of the minor allele from white North American subjects to Asian populations that was particularly pronounced for rs5743618. In the Utah residents of European ancestry, the frequency of the rs5743618 T allele was 17% whereas in Vietnamese subjects the frequency was >99%. We conducted a genetic association study in 427 patients with melioidosis to determine the association of TLR1 variation with organ failure or death. We genotyped rs5743551 and rs4833095. The variants were in high linkage disequilibrium but neither variant was associated with organ failure or in-hospital death. In 300 healthy Thai individuals we further tested the association of TLR1 variation with ex vivo blood responses to Pam3CSK4, a TLR1 agonist. Neither variant was robustly associated with blood cytokine responses induced by Pam3CSK4. We identified additional common variation in TLR1 by searching public databases and the published literature and screened three additional TLR1 variants for associations with Pam3CSK4-induced responses but found none. We conclude that the genetic architecture of TLR1 variation differs substantially in southeast Asians compared to other populations and common variation in TLR1 in Thais is not associated with outcome from melioidosis or with altered blood responses to Pam3CSK4. Our findings highlight the need for additional studies of TLR1 and other innate immune genetic modulators of the inflammatory host response and determinants of sepsis in southeast Asian populations.	[Chantratita, Narisara; Tandhavanant, Sarunporn; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Chantratita, Narisara; Tandhavanant, Sarunporn; Chierakul, Wirongrong; Wuthiekanun, Vanaporn; Limmathurotsakul, Direk; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Myers, Nicolle D.; West, T. Eoin] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA USA; [Chierakul, Wirongrong] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Mahavanakul, Weera] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [West, T. Eoin] Univ Washington, Int Resp & Severe Illness Ctr, Seattle, WA 98195 USA	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Washington; University of Washington Seattle; Mahidol University; Mahidol University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Washington; University of Washington Seattle	Chantratita, N (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.	narisara@tropmedres.ac	Chantratita, Narisara/P-2169-2019; Tandhavanant, Sarunporn/R-7620-2019; Peacock, Sharon J/ABE-6331-2020; Chierakul, Wirongrong/AAC-3226-2020; Tandhavanant, Sarunporn/Q-7376-2019	Tandhavanant, Sarunporn/0000-0003-0261-3233; Chierakul, Wirongrong/0000-0003-2103-9425; Tandhavanant, Sarunporn/0000-0003-0261-3233; Limmathurotsakul, Direk/0000-0001-7240-5320; Peacock, Sharon/0000-0002-1718-2782; West, T Eoin/0000-0001-5503-7204	Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK [087769/Z/08/Z]; US National Institutes of Health [K08HL094759]; Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL094759] Funding Source: NIH RePORTER	Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by a Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK (grant 087769/Z/08/Z to NC), by the US National Institutes of Health award K08HL094759 (TEW), and by the Parker B. Francis Foundation (TEW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Cheng AC, 2006, T ROY SOC TROP MED H, V100, P64, DOI 10.1016/j.trstmh.2005.04.019; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; FRIEDLAND JS, 1992, INFECT IMMUN, V60, P2402, DOI 10.1128/IAI.60.6.2402-2408.1992; Hamann L, 2010, INFECT GENET EVOL, V10, P785, DOI 10.1016/j.meegid.2010.05.005; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lauw FN, 1999, J INFECT DIS, V180, P1878, DOI 10.1086/315155; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Marques CD, 2013, J INFECT DIS, V208, P120, DOI 10.1093/infdis/jit133; Mikacenic C, 2013, GENES IMMUN, V14, P52, DOI 10.1038/gene.2012.53; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Ocejo-Vinyals JG, 2013, INT J TUBERC LUNG D, V17, P652, DOI 10.5588/ijtld.12.0767; Pino-Yanes M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013759; Plantinga TS, 2012, J INFECT DIS, V205, P934, DOI 10.1093/infdis/jir867; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; SUPUTTAMONGKOL Y, 1992, J INFECT DIS, V165, P561, DOI 10.1093/infdis/165.3.561; Thompson CM, 2013, ANN SURG, DOI 10.1097/SLA.0b013e31828538e8 23478521; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Weighardt H, 2007, IMMUNOBIOLOGY, V212, P715, DOI 10.1016/j.imbio.2007.09.010; West TE, 2012, GENES IMMUN, V13, P38, DOI 10.1038/gene.2011.49; West TE, 2013, J IMMUNOL, V190, P3373, DOI 10.4049/jimmunol.1202974; West TE, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-46; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Wurfel MM, 2008, CURR PHARM DESIGN, V14, P1900, DOI 10.2174/138161208784980554; Wurfel MM, 2008, AM J RESP CRIT CARE, V178, P710, DOI 10.1164/rccm.200803-462OC; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83285	10.1371/journal.pone.0083285	http://dx.doi.org/10.1371/journal.pone.0083285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392083	Green Published, gold			2022-12-27	WOS:000329460100007
J	Kurczy, ME; Mellander, LJ; Najafinobar, N; Cans, AS				Kurczy, Michael E.; Mellander, Lisa J.; Najafinobar, Neda; Cans, Ann-Sofie			Composition Based Strategies for Controlling Radii in Lipid Nanotubes	PLOS ONE			English	Article							ENZYMATIC-REACTIONS; MEMBRANE CURVATURE; EXOCYTOSIS; PROTEINS; BILAYERS; VESICLES; LEAFLET; CELLS; SHAPE	Nature routinely carries out small-scale chemistry within lipid bound cells and organelles. Liposome-lipid nanotube networks are being developed by many researchers in attempt to imitate these membrane enclosed environments, with the goal to perform small-scale chemical studies. These systems are well characterized in terms of the diameter of the giant unilamellar vesicles they are constructed from and the length of the nanotubes connecting them. Here we evaluate two methods based on intrinsic curvature for adjusting the diameter of the nanotube, an aspect of the network that has not previously been controllable. This was done by altering the lipid composition of the network membrane with two different approaches. In the first, the composition of the membrane was altered via lipid incubation of exogenous lipids; either with the addition of the low intrinsic curvature lipid soy phosphatidylcholine (soy-PC) or the high intrinsic curvature lipid soy phosphatidylethanolamine (soy-PE). In the second approach, exogenous lipids were added to the total lipid composition during liposome formation. Here we show that for both lipid augmentation methods, we observed a decrease in nanotube diameter following soy-PE additions but no significant change in size following the addition of soy-PC. Our results demonstrate that the effect of soy-PE on nanotube diameter is independent of the method of addition and suggests that high curvature soy-PE molecules facilitate tube membrane curvature.	[Kurczy, Michael E.; Najafinobar, Neda; Cans, Ann-Sofie] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Mellander, Lisa J.] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden	Chalmers University of Technology; University of Gothenburg	Cans, AS (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	cans@chalmers.se	Cans, Ann-Sofie/A-5987-2011	Cans, Ann-Sofie/0000-0002-3059-2399; Kurczy, Michael/0000-0001-6579-9691	Swedish Research Council [80348401, 80348402, 349-2007-8680]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work has been funded by The Swedish Research Council with grant ID 80348401, 80348402, and 349-2007-8680. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2010, ANAL CHEM, V82, P1020, DOI 10.1021/ac902282d; Amatore C, 2006, CHEMBIOCHEM, V7, P1998, DOI 10.1002/cbic.200600194; Bashkirov PV, 2011, BIOL MEMBRANY, V28, P145; Baumgart T, 2005, BIOPHYS J, V89, P1067, DOI 10.1529/biophysj.104.049692; Cans AS, 2003, P NATL ACAD SCI USA, V100, P400, DOI 10.1073/pnas.232702599; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Cooke IR, 2006, BIOPHYS J, V91, P487, DOI 10.1529/biophysj.105.078683; Garcia-Manyes S, 2010, J AM CHEM SOC, V132, P12874, DOI 10.1021/ja1002185; GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665; Heinrich M, 2010, P NATL ACAD SCI USA, V107, P7208, DOI 10.1073/pnas.0913997107; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Holthuis JCM, 2003, MOL MEMBR BIOL, V20, P231, DOI 10.1080/0988768031000100768; HUI SW, 1995, BIOPHYS J, V68, P171, DOI 10.1016/S0006-3495(95)80172-4; Kamal MM, 2009, P NATL ACAD SCI USA, V106, P22245, DOI 10.1073/pnas.0907354106; Karlsson A, 2005, J PHYS CHEM B, V109, P1609, DOI 10.1021/jp0459716; Karlsson M, 2001, LANGMUIR, V17, P6754, DOI 10.1021/la0108611; Kurczy ME, 2010, P NATL ACAD SCI USA, V107, P2751, DOI 10.1073/pnas.0908101107; Lanekoff I, 2011, ANAL CHEM, V83, P5337, DOI 10.1021/ac200771g; LEIBLER S, 1986, J PHYS-PARIS, V47, P507, DOI 10.1051/jphys:01986004703050700; Lobovkina T., 2006, PHYS REV LETT, V97; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Mellander LJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00907; NANAVATI C, 1992, BIOPHYS J, V63, P1118, DOI 10.1016/S0006-3495(92)81679-X; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Ostrowski SG, 2004, SCIENCE, V305, P71, DOI 10.1126/science.1099791; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Sott K, 2006, NANO LETT, V6, P209, DOI 10.1021/nl052078p; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stepanyants N, 2012, NANO LETT, V12, P1372, DOI 10.1021/nl203983e; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Uchiyama Y, 2007, BRAIN RES, V1151, P46, DOI 10.1016/j.brainres.2007.03.012; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; ZIMMERBERG J, 1993, ANNU REV BIOPH BIOM, V22, P433, DOI 10.1146/annurev.bb.22.060193.002245	33	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e81293	10.1371/journal.pone.0081293	http://dx.doi.org/10.1371/journal.pone.0081293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392077	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100001
J	Zhang, XL; Cao, CX; Zhang, Q; Chen, Y; Gu, DY; Shen, YZ; Gong, YL; Chen, JF; Tang, CJ				Zhang, Xunlei; Cao, Chunxiang; Zhang, Qi; Chen, Yi; Gu, Dongying; Shen, Yunzhu; Gong, Yongling; Chen, Jinfei; Tang, Cuiju			Comparison of the Efficacy and Safety of S-1-Based and Capecitabine-Based Regimens in Gastrointestinal Cancer: A Meta-Analysis	PLOS ONE			English	Article							ADVANCED GASTRIC-CANCER; METASTATIC COLORECTAL-CANCER; ADVANCED ESOPHAGOGASTRIC CANCER; S-1 PLUS CISPLATIN; THYMIDINE-PHOSPHORYLASE EXPRESSION; PHASE-II TRIAL; 1ST-LINE TREATMENT; SOLID TUMORS; DIHYDROPYRIMIDINE DEHYDROGENASE; THYMIDYLATE SYNTHASE	Purpose: Oral fluoropyrimidine (S-1, capecitabine) has been considered as an important part of various regimens. We aimed to evaluate the efficacy and safety of S-1-based therapy versus capecitabine - based therapy in gastrointestinal cancers. Methods: Eligible studies were identified from Pubmed, EMBASE. Additionally, abstracts presented at American Society of Clinical Oncology (ASCO) conferences held between 2000 and 2013 were searched to identify relevant clinical trials. The outcome included overall survival (OS), progression-free survival (PFS), overall response rate (ORR), disease control rate (DCR) and advent events. Results: A total of 6 studies (4 RCTs and 2 retrospective analysis studies) containing 790 participants were included in this meta-analysis, including 401 patients in the S-1-based group and 389 patients in the capecitabine-based group. Results of our meta-analysis indicated that S-1-based and capecitabine-based regimens showed very similar efficacy in terms of PFS (HR 0.92, 95% CI 0.78-1.09, P = 0.360), OS (HR 1.01, 95% CI 0.84-1.21, P = 0.949), ORR (HR 1.04, 95% CI 0.87-1.25, P = 0.683) and DCR (HR 1.02, 95% CI 0.94-1.10, P = 0.639). There was also no significant difference in toxicity between regimens other than mild more hand-foot syndrome in capecitabine-based regimens. Conclusion: Both the S-1-based and capecitabine-based regimens are equally active and well tolerated, and have the potential of backbone chemotherapy regimen in further studies of gastrointestinal cancers.	[Zhang, Xunlei; Cao, Chunxiang; Zhang, Qi; Gu, Dongying; Shen, Yunzhu; Gong, Yongling; Chen, Jinfei; Tang, Cuiju] Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Chen, Yi] Southeast Univ, Nanjing Hosp 1, Dept Oncol, Sch Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China	Tang, CJ (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	tangcuiju@tom.com	Zhang, Xun/HHM-9059-2022	Zhang, Xun/0000-0001-5411-2727	Project of Plans for the Development of Science and Technology of Nanjing, China [201208020]	Project of Plans for the Development of Science and Technology of Nanjing, China	The work was supported by a grant from The Project of Plans for the Development of Science and Technology of Nanjing, China; Grant Number: 201208020; Website: http://www.njh.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2005, J CLIN ONCOL, V23, P6957, DOI 10.1200/JCO.2005.01.917; Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; [Anonymous], 1998, J CLIN ONCOL, V16, P301; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BOKU N, 2007, J CLIN ONCOL, V25, pS965, DOI DOI 10.1200/JCO.2006.10.0131; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Cassidy J, 2004, J CLIN ONCOL, V22, P2084, DOI 10.1200/JCO.2004.11.069; Cassidy J, 2002, ANN ONCOL, V13, P566, DOI 10.1093/annonc/mdf089; Chuah B, 2011, CANCER SCI, V102, P478, DOI 10.1111/j.1349-7006.2010.01793.x; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2010, NEW ENGL J MED, V362, P858, DOI 10.1056/NEJMc0911925; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Desauw C, 2010, EPIDEMIOLOGY RISK FA, P30; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Hoff PM, 2003, CLIN CANCER RES, V9, P134; Hong YS, 2012, LANCET ONCOL, V13, P1125, DOI 10.1016/S1470-2045(12)70363-7; Ichikawa W, 2003, CLIN CANCER RES, V9, P786; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; Kim GM, 2012, EUR J CANCER, V48, P518, DOI 10.1016/j.ejca.2011.12.017; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Lee JL, 2008, BRIT J CANCER, V99, P584, DOI 10.1038/sj.bjc.6604536; Maehara Yoshihiko, 2003, Gastric Cancer, V6 Suppl 1, P2, DOI 10.1007/s10120-003-0232-9; Meropol NJ, 2006, J CLIN ONCOL, V24, P4069, DOI 10.1200/JCO.2005.05.2084; Napieralski R, 2005, CLIN CANCER RES, V11, P3025, DOI 10.1158/1078-0432.CCR-04-1605; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Okines AFC, 2009, ANN ONCOL, V20, P1529, DOI 10.1093/annonc/mdp047; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Sakamoto J, 2006, ANTI-CANCER DRUG, V17, P231, DOI 10.1097/00001813-200602000-00016; Sakata Y, 1998, EUR J CANCER, V34, P1715, DOI 10.1016/S0959-8049(98)00211-1; Salonga D, 2000, CLIN CANCER RES, V6, P1322; Schoffski P, 2004, ANTI-CANCER DRUG, V15, P85, DOI 10.1097/01.cad.0000114631.91268.39; Seol YM, 2009, JPN J CLIN ONCOL, V39, P43, DOI 10.1093/jjco/hyn119; Shin A, 2011, J GASTRIC CANCER, V11, P135, DOI 10.5230/jgc.2011.11.3.135; Shitara K, 2013, INT J CLIN ONCOL, V18, P539, DOI 10.1007/s10147-012-0416-6; Shridhar R, 2011, CANCER-AM CANCER SOC, V117, P3908, DOI 10.1002/cncr.25995; Sutton AJ, 2000, STAT METHODS MED RES, V9, P421, DOI 10.1191/096228000701555244; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Yamada Y, 2009, J CLIN ONCOL S, V27, p15s; Zang DY, 2012, J CLIN ONCOL, V2012, P595	41	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84230	10.1371/journal.pone.0084230	http://dx.doi.org/10.1371/journal.pone.0084230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392116	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100039
J	Caudill, CC; Keefer, ML; Clabough, TS; Naughton, GP; Burke, BJ; Peery, CA				Caudill, Christopher C.; Keefer, Matthew L.; Clabough, Tami S.; Naughton, George P.; Burke, Brian J.; Peery, Christopher A.			Indirect Effects of Impoundment on Migrating Fish: Temperature Gradients in Fish Ladders Slow Dam Passage by Adult Chinook Salmon and Steelhead	PLOS ONE			English	Article							SOCKEYE-SALMON; COLUMBIA RIVER; BEHAVIORAL THERMOREGULATION; ONCORHYNCHUS-NERKA; SNAKE RIVER; WATER TEMPERATURE; MORTALITY; TROUT; FLOW; RESERVOIR	Thermal layering in reservoirs upstream from hydroelectric dams can create temperature gradients in fishways used by upstream migrating adults. In the Snake River, Washington, federally-protected adult salmonids (Oncorhynchus spp.) often encounter relatively cool water in dam tailraces and lower ladder sections and warmer water in the upstream portions of ladders. Using radiotelemetry, we examined relationships between fish passage behavior and the temperature difference between the top and bottom of ladders (Delta T) at four dams over four years. Some spring Chinook salmon (O. tshawytscha) experienced Delta T >= 0.5 degrees C. Many summer and fall Chinook salmon and summer steelhead (O. mykiss) experienced Delta T >= 1.0 degrees C, and some individuals encountered Delta T > 4.0 degrees C. As Delta T increased, migrants were consistently more likely to move down fish ladders and exit into dam tailraces, resulting in upstream passage delays that ranged from hours to days. Fish body temperatures equilibrated to ladder temperatures and often exceeded 20 degrees C, indicating potential negative physiological and fitness effects. Collectively, the results suggest that gradients in fishway water temperatures present a migration obstacle to many anadromous migrants. Unfavorable temperature gradients may be common at reservoir-fed fish passage facilities, especially those with seasonal thermal layering or stratification. Understanding and managing thermal heterogeneity at such sites may be important for ensuring efficient upstream passage and minimizing stress for migratory, temperature-sensitive species.	[Caudill, Christopher C.; Keefer, Matthew L.; Clabough, Tami S.; Naughton, George P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Burke, Brian J.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Fish Ecol Div, Seattle, WA 98115 USA; [Peery, Christopher A.] US Fish & Wildlife Serv, Idaho Fisheries Resource Off, Ahsahka, ID USA	Idaho; University of Idaho; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service	Caudill, CC (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	caudill@uidaho.edu	Caudill, Christopher C/M-7906-2014	Caudill, Christopher C/0000-0002-7129-8620	United States Army Corps of Engineers, Walla Walla District	United States Army Corps of Engineers, Walla Walla District	This study was funded by the United States Army Corps of Engineers, Walla Walla District, with assistance provided by M. Shutters and K. Zelch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2012, CATEGORICAL DATA ANA, P744; BERMAN CH, 1991, J FISH BIOL, V39, P301, DOI 10.1111/j.1095-8649.1991.tb04364.x; Bradford MJ, 2010, CAN J FISH AQUAT SCI, V67, P673, DOI 10.1139/F10-017; Brannon EL, 2004, REV FISH SCI, V12, P99, DOI 10.1080/10641260490280313; Brett J.R., 1995, P3; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Caudill CC, 2007, CAN J FISH AQUAT SCI, V64, P979, DOI 10.1139/F07-065; Clay C.H., 1995, DESIGN FISHWAYS OTHE, V2nd, DOI 10.1201/9781315141046; Connor WP, 2005, T AM FISH SOC, V134, P291, DOI 10.1577/T03-131.1; Dudgeon D, 2000, ANNU REV ECOL SYST, V31, P239, DOI 10.1146/annurev.ecolsys.31.1.239; Eaton JG, 1996, LIMNOL OCEANOGR, V41, P1109, DOI 10.4319/lo.1996.41.5.1109; Fowler SL, 2009, CAN J FISH AQUAT SCI, V66, P91, DOI 10.1139/F08-192; Geist DR, 2000, T AM FISH SOC, V129, P126, DOI 10.1577/1548-8659(2000)129&lt;0126:TUOETT&gt;2.0.CO;2; Goniea TM, 2006, T AM FISH SOC, V135, P408, DOI 10.1577/T04-113.1; Hamblin PF, 2003, HYDROBIOLOGIA, V504, P3, DOI 10.1023/B:HYDR.0000008503.75784.ee; Harmon JR, 2003, N AM J FISH MANAGE, V23, P989, DOI 10.1577/M02-035; Haro A, 2004, CAN J FISH AQUAT SCI, V61, P1590, DOI 10.1139/F04-093; Hasler CT, 2012, J THERM BIOL, V37, P265, DOI 10.1016/j.jtherbio.2011.02.003; Johnson EL, 2010, J FISH BIOL, V76, P1520, DOI 10.1111/j.1095-8649.2010.02578.x; Johnson EL, 2005, T AM FISH SOC, V134, P1213, DOI 10.1577/T04-116.1; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Keefer ML, 2008, ECOL FRESHW FISH, V17, P136, DOI 10.1111/j.1600-0633.2007.00267.x; Keefer ML, 2008, N AM J FISH MANAGE, V28, P81, DOI 10.1577/M07-011.1; Keefer ML, 2013, ENVIRON BIOL FISH, V96, P691, DOI 10.1007/s10641-012-0059-5; Keefer ML, 2009, CAN J FISH AQUAT SCI, V66, P1734, DOI 10.1139/F09-131; Keefer ML, 2005, CAN J FISH AQUAT SCI, V62, P930, DOI 10.1139/F04-246; Keefer ML, 2004, T AM FISH SOC, V133, P1413, DOI 10.1577/T03-223.1; Lund SG, 2002, CAN J FISH AQUAT SCI, V59, P1553, DOI [10.1139/f02-117, 10.1139/F02-117]; Macdonald JS, 2012, N AM J FISH MANAGE, V32, P415, DOI 10.1080/02755947.2012.675946; Mantua N, 2010, CLIMATIC CHANGE, V102, P187, DOI 10.1007/s10584-010-9845-2; McArdle BH, 2004, CAN J FISH AQUAT SCI, V61, P1294, DOI 10.1139/F04-051; Mccullough DA, 2009, REV FISH SCI, V17, P90, DOI 10.1080/10641260802590152; Mote PW, 2003, CLIMATIC CHANGE, V61, P45, DOI 10.1023/A:1026302914358; National Marine Fisheries Service, 2011, FED REGISTER, V76, P50448; Naughton GP, 2005, CAN J FISH AQUAT SCI, V62, P30, DOI 10.1139/F04-147; Odeh M., 1999, INNOVATIONS FISH PAS; Olden JD, 2010, FRESHWATER BIOL, V55, P86, DOI 10.1111/j.1365-2427.2009.02179.x; Pankhurst NW, 1996, AQUACULTURE, V146, P277, DOI 10.1016/S0044-8486(96)01374-9; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; Quinn TP, 1997, CAN J FISH AQUAT SCI, V54, P1349, DOI 10.1139/f97-038; Richter A, 2005, REV FISH SCI, V13, P23, DOI 10.1080/10641260590885861; Roscoe DW, 2010, FISH FISH, V11, P12, DOI 10.1111/j.1467-2979.2009.00333.x; Salinger DH, 2006, T AM FISH SOC, V135, P188, DOI 10.1577/T04-181.1; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Strange JS, 2012, T AM FISH SOC, V141, P1622, DOI 10.1080/00028487.2012.716010; Tiffan KF, 2009, J FISH BIOL, V74, P1562, DOI 10.1111/j.1095-8649.2009.02228.x; U.S. Army Corps of Engineers, 2004, WAT TEMP AD FISHW MA; U.S. Army Corps of Engineers, 2011, ANN FISH PASS REP; Young JL, 2006, CAN J FISH AQUAT SCI, V63, P1067, DOI 10.1139/F06-014	49	25	27	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85586	10.1371/journal.pone.0085586	http://dx.doi.org/10.1371/journal.pone.0085586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392020	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900164
J	Cheng, X; Li, H; Chen, YC; Luo, BH; Liu, XH; Liu, W; Xu, HB; Yang, XL				Cheng, Xin; Li, Huan; Chen, Yunchao; Luo, Binhua; Liu, Xuhan; Liu, Wei; Xu, Haibo; Yang, Xiangliang			Ultrasound-Triggered Phase Transition Sensitive Magnetic Fluorescent Nanodroplets as a Multimodal Imaging Contrast Agent in Rat and Mouse Model	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MULTIFUNCTIONAL NANOPARTICLES; POLYMERIC MICELLES; NANOBUBBLES; CANCER; EMULSIFICATION; MICROCAPSULES; MR	Ultrasound-triggered phase transition sensitive nanodroplets with multimodal imaging functionality were prepared via premix Shirasu porous glass (SPG) membrane emulsification method. The nanodroplets with fluorescence dye DiR and SPIO nanoparticles (DiR-SPIO-NDs) had a polymer shell and a liquid perfluoropentane (PFP) core. The as-formed DiR-SPIO-NDs have a uniform size of 385 +/- 5.0 nm with PDI of 0.169 +/- 0.011. The TEM and microscopy imaging showed that the DiR-SPIO-NDs existed as core-shell spheres, and DiR and SPIO nanoparticles dispersed in the shell or core. The MTT and hemolysis studies demonstrated that the nanodroplets were biocompatible and safe. Moreover, the proposed nanodroplets exhibited significant ultrasound-triggered phase transition property under clinical diagnostic ultrasound irradiation due to the vaporization of PFP inside. Meanwhile, the high stability and R-2 relaxivity of the DiR-SPIO-NDs suggested its applicability in MRI. The in vivo T-2-weighted images of MRI and fluorescence images both showed that the image contrast in liver and spleen of rats and mice model were enhanced after the intravenous injection of DiR-SPIO-NDs. Furthermore, the ultrasound imaging (US) in mice tumor as well as MRI and fluorescence imaging in liver of rats and mice showed that the DiR-SPIO-NDs had long-lasting contrast ability in vivo. These in vitro and in vivo findings suggested that DiR-SPIO-NDs could potentially be a great MRI/US/fluorescence multimodal imaging contrast agent in the diagnosis of liver tissue diseases.	[Cheng, Xin; Luo, Binhua; Liu, Xuhan; Liu, Wei; Yang, Xiangliang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Cheng, Xin; Luo, Binhua; Liu, Xuhan; Liu, Wei; Yang, Xiangliang] Huazhong Univ Sci & Technol, Natl Engn Res Ctr Nanomed, Wuhan 430074, Hubei, Peoples R China; [Cheng, Xin] Yunnan Univ Tradit Chinese Med, Coll Pharm, Kunming, Yunnan, Peoples R China; [Li, Huan; Xu, Haibo] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan 430074, Hubei, Peoples R China; [Chen, Yunchao] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Med Ultrasound, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Yunnan University of Chinese Medicine; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liu, W (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	wliu@hust.edu.cn; xuhaibo1120@hotmail.com			National Basic Research Program of China (973 Program) [2012CB932500]; National High Technology Research and Development Program of China (863 Program) [2012AA022704]; National Science Foundation of China (NSFC) [31170960]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is supported by National Basic Research Program of China (973 Program, 2012CB932500), National High Technology Research and Development Program of China (863 Program, 2012AA022704), National Science Foundation of China (NSFC, 31170960). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin O, 2012, CA-CANCER J CLIN, V62, P364, DOI 10.3322/caac.21156; Borden MA, 2010, MOL IMAGING, P425; Cho H, 2012, NANOMED-NANOTECHNOL, V8, P228, DOI 10.1016/j.nano.2011.06.009; Huang YR, 2012, NANOSCALE, V4, P6135, DOI 10.1039/c2nr31715j; Jin YS, 2013, BIOMATERIALS, V34, P4794, DOI 10.1016/j.biomaterials.2013.03.027; Ke H, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425105; Kiessling F, 2009, CURR MED CHEM, V16, P627, DOI 10.2174/092986709787458470; Kukizaki M, 2006, J MEMBRANE SCI, V281, P386, DOI 10.1016/j.memsci.2006.04.007; Lee DE, 2012, CHEM SOC REV, V41, P2656, DOI 10.1039/c2cs15261d; Li XL, 2012, BIOMATERIALS, V33, P3013, DOI 10.1016/j.biomaterials.2011.12.042; Liu R, 2006, COLLOID SURFACE B, V51, P30, DOI 10.1016/j.colsurfb.2006.05.014; Liu W, 2011, J PHARM SCI-US, V100, P75, DOI 10.1002/jps.22272; Liu Z, 2011, BIOMATERIALS, V32, P6155, DOI 10.1016/j.biomaterials.2011.05.019; Ma Y, 2013, BIOMATERIALS, V34, P7706, DOI 10.1016/j.biomaterials.2013.07.007; Mai LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061224; Nazir A, 2010, J MEMBRANE SCI, V362, P1, DOI 10.1016/j.memsci.2010.06.044; O'Neill BE, 2011, THER DELIV, V2, P1165, DOI [10.4155/tde.11.81, 10.4155/TDE.11.81]; Pan TL, 2012, FOOD CHEM TOXICOL, V50, P3892, DOI 10.1016/j.fct.2012.07.005; Park YI, 2011, J MATER CHEM, V21, P11472, DOI 10.1039/c1jm10432b; Platts DG, 2011, CRIT CARE RESUSC, V13, P44; Rapoport N, 2007, JNCI-J NATL CANCER I, V99, P1095, DOI 10.1093/jnci/djm043; Torigan DA, 2007, CA-CANCER J CLIN, V57, P206, DOI 10.3322/canjclin.57.4.206; Wang Y, 2010, INT J PHARMACEUT, V384, P148, DOI 10.1016/j.ijpharm.2009.09.027; Wei Q, 2008, J COLLOID INTERF SCI, V323, P267, DOI 10.1016/j.jcis.2008.04.058; Willmann JK, 2008, NAT REV DRUG DISCOV, V7, P591, DOI 10.1038/nrd2290; Wong ZZ, 2011, SOFT MATTER, V7, P4009, DOI 10.1039/c1sm00007a; Xie H, 2011, BIOMATERIALS, V32, P495, DOI 10.1016/j.biomaterials.2010.09.024; Xing HY, 2012, BIOMATERIALS, V33, P1079, DOI 10.1016/j.biomaterials.2011.10.039; Xu JS, 2010, BIOMATERIALS, V31, P1716, DOI 10.1016/j.biomaterials.2009.11.052; Xu RX, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3147424; Xu ZC, 2009, CHEM MATER, V21, P1778, DOI 10.1021/cm802978z; Yang F, 2009, BIOMATERIALS, V30, P3882, DOI 10.1016/j.biomaterials.2009.03.051; Yang H, 2010, BIOMATERIALS, V31, P3667, DOI 10.1016/j.biomaterials.2010.01.055; Yin TH, 2013, BIOMATERIALS, V34, P4532, DOI 10.1016/j.biomaterials.2013.02.067; Yin TH, 2012, INT J NANOMED, V7, P895, DOI 10.2147/IJN.S28830	35	21	23	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85003	10.1371/journal.pone.0085003	http://dx.doi.org/10.1371/journal.pone.0085003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391983	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900126
J	Chockalingam, S; Ghosh, SS				Chockalingam, S.; Ghosh, Siddhartha Sankar			Amelioration of Cancer Stem Cells in Macrophage Colony Stimulating Factor-Expressing U87MG-Human Glioblastoma upon 5-Fluorouracil Therapy	PLOS ONE			English	Article							DRUG-RESISTANCE; OVARIAN-CANCER; FACTOR-I; RECEPTOR; CSF-1; PHENOTYPE; MICE	Macrophage colony stimulating factor (MCSF) regulates growth, proliferation and differentiation of haematopoietic cell lineages. Many cancers are known to secrete high level of MCSF, which recruit macrophages into the tumour micro-environment, supporting tumour growth. Herein, we report the cloning of MCSF and subsequent generation of U87MG expressing MCSF stable cell line (U87-MCSF). Cytotoxicity of anti-cancer drug 5-fluorouracil (5-FU) was evaluated on both U87MG and U87-MCSF cells. Interestingly, the proliferation of U87-MCSF cells was less (p<0.001) than that of U87MG cells alone, after treatment with 5-FU. Significant decrease in expression levels of cyclin E and A2 quantified by real time PCR analysis corroborated the reduced proliferation of 5-FU treated U87-MCSF cells. However, JC-1 staining did not reveal any apoptosis upon 5-FU treatment. Notch-1 upregulation induced a possible epithelial-mesenchymal transition in U87-MCSF cells, which accounted for an increase in the proportion of CD24(high)/CD44(less) cancer stem cells in U87-MCSF cells after 5-FU treatment. The elevated resistance of U87-MCSF cells towards 5-FU was due to the increase in the expressions (10.2 and 6 fold) of ABCB1 and mdm2, respectively. Furthermore, increase in expressions of ABCG1, mdm2 and CD24 was also observed in U87MG cells after prolonged incubation with 5-FU. Our studies provided mechanistic insights into drug resistance of U87MG cells and also described the pivotal role played by MCSF in augmenting the resistance of U87MG cells to 5-FU.	[Chockalingam, S.; Ghosh, Siddhartha Sankar] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India; [Ghosh, Siddhartha Sankar] Indian Inst Technol Guwahati, Ctr Nanotechnol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Ghosh, SS (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	sghosh@iitg.ernet.in	S, Chockalingam/H-1666-2019	S, Chockalingam/0000-0003-2930-7658	Department of Biotechnology [BT/49/NE/TBP/2010, BT/01/NE/PS/08]	Department of Biotechnology	Funding provided by Department of Biotechnology No. BT/49/NE/TBP/2010 and BT/01/NE/PS/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MAH, 2012, BREAST CANCER RES TR, V133, P979, DOI 10.1007/s10549-011-1865-8; Awasthi S, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-61; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Bellail AC, 2004, INT J BIOCHEM CELL B, V36, P1046, DOI 10.1016/j.biocel.2004.01.013; Bredel M, 2002, LANCET ONCOL, V3, P397, DOI 10.1016/S1470-2045(02)00786-6; Chambers SK, 1997, CLIN CANCER RES, V3, P999; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Das AB, 2012, CANCER LETT, V318, P189, DOI 10.1016/j.canlet.2011.12.013; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dembinski JL, 2009, CLIN EXP METASTAS, V26, P611, DOI 10.1007/s10585-009-9260-0; Deng JP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/517172; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; Drake KJ, 2007, INT J ONCOL, V30, P139; Finkel E, 2001, SCIENCE, V292, P624, DOI 10.1126/science.292.5517.624; Jadus MR, 2003, CANCER GENE THER, V10, P411, DOI 10.1038/sj.cgt.7700583; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kawakami Y, 2000, EUR J CANCER, V36, P1991, DOI 10.1016/S0959-8049(00)00282-3; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Michaelson MD, 1996, DEVELOPMENT, V122, P2661; Mroczko B, 2007, CLIN CHIM ACTA, V380, P208, DOI 10.1016/j.cca.2007.02.037; Nakai E, 2009, CANCER INVEST, V27, P901, DOI 10.3109/07357900801946679; POLLARD JW, 1994, P NATL ACAD SCI USA, V91, P9312, DOI 10.1073/pnas.91.20.9312; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sethi N, 2011, BRIT J CANCER, V105, P1805, DOI 10.1038/bjc.2011.497; Sharma S, 2014, ADV HEALTHC MATER, V3, P106, DOI 10.1002/adhm.201300090; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; SMITH HO, 1995, CLIN CANCER RES, V1, P313; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; T Hoa N, 2007, LAB INVEST, V87, P115, DOI 10.1038/labinvest.3700506; YUE X, 1993, MOL CELL BIOL, V13, P3191, DOI 10.1128/MCB.13.6.3191; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5; Zwaenepoel O, 2012, FASEB J, V26, P691, DOI 10.1096/fj.11-189753	34	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83877	10.1371/journal.pone.0083877	http://dx.doi.org/10.1371/journal.pone.0083877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391839	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200137
J	Gan, HL; Zhang, JQ; Huang, XY; Yu, W				Gan, Hui-Li; Zhang, Jian-Qun; Huang, Xiao-Yong; Yu, Wei			The Wall Eclipsing Sign on Pulmonary Artery Computed Tomography Angiography Is Pathognomonic for Pulmonary Artery Sarcoma	PLOS ONE			English	Article							SURGICAL-TREATMENT; INTIMAL SARCOMA; DIAGNOSIS; LUNG	Background: The objective of this study was to evaluate the imaging characteristics of pulmonary artery sarcoma (PAS) on pulmonary artery computed tomography angiography (PACTA) that can be used to differentiate between PAS and pulmonary thromboembolic diseases, including chronic thromboembolic pulmonary hypertension (CTEPH) and acute pulmonary embolism (APE). Methods: The clinical data and imaging characteristics of 12 patients with PAS, 156 patients with CTEPH, and 426 patients with APE who were treated at Beijing Anzhen Hospital from January 2007 to August 2013 were retrospectively analyzed. All patients underwent PACTA before treatment, and the diagnoses of PAS and CTEPH were all confirmed by surgical biopsy. Results: All 12 PAS patients were initially misdiagnosed and received inappropriate thrombolytic and/or anticoagulant therapy before they were referred for surgical intervention. The mean time from PACTA to surgical intervention was 5.5 +/- 3.7 months (range 2-11 months). On PACTA, the PAS lesion always eclipsed the wall of the pulmonary artery before infiltrating outside the pulmonary artery, which was termed the wall eclipsing sign. This sign was observed in all PAS patients but was not observed in any CTEPH or APE patients. Conclusions: PAS is a rare neoplasm with a poor prognosis, and is easily misdiagnosed as thromboembolic disease. The wall eclipsing sign on PACTA is pathognomonic for PAS, and patients with this sign should be investigated to confirm the diagnosis and should undergo surgical intervention as soon as possible, rather than receiving thrombolytic or anticoagulant therapy.	[Gan, Hui-Li; Zhang, Jian-Qun] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Huang, Xiao-Yong; Yu, Wei] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Image Diagnosing, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Gan, HL (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Dept Cardiac Surg, Beijing, Peoples R China.	ganhuili@hotmail.com			China Nature Science Foundation Committee [81070041]; Beijing health system special foundation for building high-level health personnel [2013-2-002]; Beijing Science and Technology Project [Z121107001012067]	China Nature Science Foundation Committee; Beijing health system special foundation for building high-level health personnel; Beijing Science and Technology Project	This project was supported by a grant (#81070041) from China Nature Science Foundation Committee, a grant (#2013-2-002) from Beijing health system special foundation for building high-level health personnel, and a grant (#Z121107001012067) from the Beijing Science and Technology Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BM, 1995, ANN THORAC SURG, V59, P1487; Attina D, 2013, RADIOL MED; BURKE AP, 1993, CANCER, V71, P1761, DOI 10.1002/1097-0142(19930301)71:5<1761::AID-CNCR2820710510>3.0.CO;2-7; Chhaya NC, 2006, J THORAC CARDIOV SUR, V131, P1410, DOI 10.1016/j.jtcvs.2005.11.045; Coelho LS, 2010, BMJ CASE REP, V2010; Dimitrakakis G, 2006, HEART SURG FORUM, V9, pE897, DOI 10.1532/HSF98.20061112; Etienne-Mastroianni B, 2002, LUNG CANCER-J IASLC, V38, P283, DOI 10.1016/S0169-5002(02)00303-3; Furest I, 2006, ARCH BRONCONEUMOL, V42, P148, DOI 10.1157/13085566; Gan HL, 2011, J THORAC CARDIOV SUR, V142, P1469, DOI 10.1016/j.jtcvs.2011.03.013; Huo L, 2006, AM J CLIN PATHOL, V125, P419, DOI 10.1309/9H8RHUV1JL1WE0QF; Huo Lei, 2005, Ann Diagn Pathol, V9, P209, DOI 10.1016/j.anndiagpath.2005.04.012; KRUGER I, 1990, THORAC CARDIOV SURG, V38, P91, DOI 10.1055/s-2007-1014001; Mandelstamm M, 1923, VIRCHOWS ARCH A, V245, P43, DOI 10.1007/BF01992097; Mayer E, 2001, J THORAC CARDIOV SUR, V121, P77, DOI 10.1067/mtc.2001.111423; MCGLENNEN RC, 1989, MODERN PATHOL, V2, P486; Miura S, 2005, PATHOL RES PRACT, V201, P469, DOI 10.1016/j.prp.2005.06.001; NONOMURA A, 1988, ACTA PATHOL JAPON, V38, P883; Parish JM, 1996, CHEST, V110, P1480, DOI 10.1378/chest.110.6.1480; RAMP U, 1992, J CANCER RES CLIN, V118, P551, DOI 10.1007/BF01225272; Regnard JF, 1999, ANN THORAC SURG, V68, P227, DOI 10.1016/S0003-4975(99)00398-7; Scheffel H, 2008, J THORAC CARDIOV SUR, V135, P949, DOI 10.1016/j.jtcvs.2007.11.041; Shehatha J, 2009, ANN THORAC SURG, V87, P1269, DOI 10.1016/j.athoracsur.2008.08.030; Singh A, 2006, CHEST, V130, P1244, DOI 10.1378/chest.130.4.1244; Winchester PA, 1996, AM J ROENTGENOL, V167, P657, DOI 10.2214/ajr.167.3.8751674	24	38	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83200	10.1371/journal.pone.0083200	http://dx.doi.org/10.1371/journal.pone.0083200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391746	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200043
J	Graffelman, J; Sanchez, M; Cook, S; Moreno, V				Graffelman, Jan; Sanchez, Milagros; Cook, Samantha; Moreno, Victor			Statistical Inference for Hardy-Weinberg Proportions in the Presence of Missing Genotype Information	PLOS ONE			English	Article							EXACT TESTS; EQUILIBRIUM; DISEASE	In genetic association studies, tests for Hardy-Weinberg proportions are often employed as a quality control checking procedure. Missing genotypes are typically discarded prior to testing. In this paper we show that inference for Hardy-Weinberg proportions can be biased when missing values are discarded. We propose to use multiple imputation of missing values in order to improve inference for Hardy-Weinberg proportions. For imputation we employ a multinomial logit model that uses information from allele intensities and/or neighbouring markers. Analysis of an empirical data set of single nucleotide polymorphisms possibly related to colon cancer reveals that missing genotypes are not missing completely at random. Deviation from Hardy-Weinberg proportions is mostly due to a lack of heterozygotes. Inbreeding coefficients estimated by multiple imputation of the missings are typically lowered with respect to inbreeding coefficients estimated by discarding the missings. Accounting for missings by multiple imputation qualitatively changed the results of 10 to 17% of the statistical tests performed. Estimates of inbreeding coefficients obtained by multiple imputation showed high correlation with estimates obtained by single imputation using an external reference panel. Our conclusion is that imputation of missing data leads to improved statistical inference for Hardy-Weinberg proportions.	[Graffelman, Jan] Univ Politecn Cataluna, Dept Stat & Operat Res, Barcelona, Spain; [Sanchez, Milagros] Vall dHebron Res Inst, Biomed Res Unit, Barcelona, Spain; [Cook, Samantha] Financial Network Analyt, Barcelona, Spain; [Moreno, Victor] CIBERESP, Biomed Res Inst Bellvitge IDIBELL, ICO, Canc Prevent & Control Program, Barcelona, Spain; [Moreno, Victor] UB, Sch Med, Barcelona, Spain	Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Graffelman, J (corresponding author), Univ Politecn Cataluna, Dept Stat & Operat Res, Barcelona, Spain.	jan.graffelman@upc.edu	Moreno, Victor/A-1697-2010; Graffelman, Jan/L-8056-2014; Sánchez-Mayor, Milagros/AFP-1432-2022	Moreno, Victor/0000-0002-2818-5487; Graffelman, Jan/0000-0003-3900-0780; Cook, Samantha/0000-0002-2173-4471; Sanchez-Mayor, Milagros/0000-0001-5243-7608	Spanish Ministry of Education and Science [ECO2011-28875, CODARSS MTM2012-33236]; Instituto de Salud Carlos III [PS09-1037, PI11-01439]; CIBERESP [CB07/02/2005]; Agencia d'Informacion Avaluacio i Qualitat en Salut [209/12/2009]; Catalan Government DURSI [2009SGR1489]	Spanish Ministry of Education and Science(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBERESP; Agencia d'Informacion Avaluacio i Qualitat en Salut; Catalan Government DURSI	This study was supported by grants ECO2011-28875 and CODARSS MTM2012-33236 of the Spanish Ministry of Education and Science. Data were obtained from the colorectal cancer study and the latter was supported by the Instituto de Salud Carlos III, grants PS09-1037 and PI11-01439, by CIBERESP CB07/02/2005, by Agencia d'Informacion Avaluacio i Qualitat en Salut, grant 209/12/2009 and by the Catalan Government DURSI, grant 2009SGR1489. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Attia J, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1463; Chen JB, 2007, HUM HERED, V63, P196, DOI 10.1159/000099996; Chen JB, 2012, STAT MED, V31, P2516, DOI 10.1002/sim.4460; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Gomes I, 1999, ANN HUM GENET, V63, P535, DOI 10.1017/S0003480099007824; Graffelman J, 2013, J STAT SOFT IN PRESS; Graffelman J, 2008, HUM HERED, V65, P77, DOI 10.1159/000108939; Graffelman J, 2013, STAT APPL GENET MOL, V12, P433, DOI 10.1515/sagmb-2012-0039; Hardin JW., 2007, GEN LINEAR MODELS EX, V2, DOI DOI 10.1016/j.marpol.2012.12.026; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Hartl D.L., 1989, PRINCIPLES POPULATIO, V2nd; Hedrick P.W., 2011, GENETICS POPULATIONS; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Laird N.M., 2011, FUNDAMENTALS MODERN; Lee WC, 2003, AM J EPIDEMIOL, V158, P397, DOI 10.1093/aje/kwg150; Li MY, 2008, GENET EPIDEMIOL, V32, P589, DOI 10.1002/gepi.20335; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Little R.J.A., 2002, STAT ANAL MISSING DA; Rohlfs RV, 2008, GENETICS, V180, P1609, DOI 10.1534/genetics.108.088005; Rubin DB, 2004, MULTIPLE IMPUTATION; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; van Buuren S, 2011, J STAT SOFTW, V45, P1; Weinberg W., 1908, PAPERS HUMAN GENETIC; Weir BS., 1996, GENETIC DATA ANAL; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	30	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83316	10.1371/journal.pone.0083316	http://dx.doi.org/10.1371/journal.pone.0083316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391752	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200049
J	Luna, J; Plata, M; Gonzalez, M; Correa, A; Maldonado, I; Nossa, C; Radley, D; Vuocolo, S; Haupt, RM; Saah, A				Luna, Joaquin; Plata, Manuel; Gonzalez, Mauricio; Correa, Alfonso; Maldonado, Ivete; Nossa, Claudia; Radley, David; Vuocolo, Scott; Haupt, Richard M.; Saah, Alfred			Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil(TM) in Adult Women	PLOS ONE			English	Article							HPV TYPES; HIGH-RISK; VACCINE; INFECTION; EFFICACY	Background: Previous analyses from a randomized trial in women aged 24-45 have shown the quadrivalent HPV vaccine to be efficacious in the prevention of infection, cervical intraepithelial neoplasia (CIN) and external genital lesions (EGL) related to HPV 6/11/16/18 through 4 years. In this report we present long term follow-up data on the efficacy, safety and immunogenicity of the quadrivalent HPV vaccine in adult women. Methods: Follow-up data are from a study being conducted in 5 sites in Colombia designed to evaluate the long-term immunogenicity, effectiveness, and safety of the qHPV vaccine in women who were vaccinated at 24 to 45 years of age (in the original vaccine group during the base study [n = 684]) or 29 to 50 years of age (in the original placebo group during the base study [n = 651]). This analysis summarizes data collected as of the year 6 post-vaccination visit relative to day 1 of the base study (median follow-up of 6.26 years) from both the original base study and the Colombian follow-up. Results: There were no cases of HPV 6/11/16/18-related CIN or EGL during the extended follow-up phase in the per-protocol population. Immunogenicity persists against vaccine-related HPV types, and no evidence of HPV type replacement has been observed. No new serious adverse experiences have been reported. Conclusions: Vaccination with qHPV vaccine provides generally safe and effective protection from HPV 6-, 11-, 16-, and 18-related genital warts and cervical dysplasia through 6 years following administration to 24-45 year-old women.	[Luna, Joaquin; Gonzalez, Mauricio] Inst Nacl Cancerol, Bogota, Colombia; [Plata, Manuel] Fdn Cardioinfantil, Bogota, Colombia; [Correa, Alfonso] Clin Country, Bogota, Colombia; [Maldonado, Ivete] Fdn Santa Fe Bogota, Bogota, Colombia; [Nossa, Claudia] Cafam, Bogota, Colombia; [Radley, David; Vuocolo, Scott; Haupt, Richard M.; Saah, Alfred] Merck Sharp & Dohme Corp, Whitehouse Stn, NJ USA	Fundacion Cardioinfantil - Instituto de Cardiologia; Clinica del Country - Unidad Medica; Merck & Company	Luna, J (corresponding author), Inst Nacl Cancerol, Bogota, Colombia.	jgluna@gmail.com			Merck Co, Inc.	Merck Co, Inc.(Merck & Company)	The study was designed and funded by the sponsor (Merck & Co, Inc.) in collaboration with external investigators and an external data and safety monitoring board. The sponsor collated the data, monitored the conduct of the study, performed the statistical analysis and coordinated the writing of the manuscript with all authors. The authors were actively involved in the collection, analysis or interpretation of the data, the revising of the manuscript for intellectual content, and approved the final manuscript. All authors had access to data and took part in the decision on where to submit the paper for publication.	[Anonymous], 2007, HUM PAP; Brown DR, 2011, HUM VACCIN, V7; Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Castellsague X, 2009, GYNECOL ONCOL, V115, pS15, DOI 10.1016/j.ygyno.2009.09.021; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Jacobs MV, 2000, INT J CANCER, V87, P221, DOI 10.1002/1097-0215(20000715)87:2&lt;221::AID-IJC11&gt;3.0.CO;2-2; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Rositch AF, 2012, J INFECT DIS, V206, P669, DOI 10.1093/infdis/jis406; Schiffman Mark, 2003, J Natl Cancer Inst Monogr, P14; Schiller JT, 2009, J INFECT DIS, V200, P166, DOI 10.1086/599988; Smith JF, 2008, HUM VACCINES, V4, P134, DOI 10.4161/hv.4.2.5261; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180	16	59	65	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83431	10.1371/journal.pone.0083431	http://dx.doi.org/10.1371/journal.pone.0083431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391768	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200065
J	Moller, AP; Merino, S; Soler, JJ; Antonov, A; Badas, EP; Calero-Torralbo, MA; de Lope, F; Eeva, T; Figuerola, J; Flensted-Jensen, E; Garamszegi, LZ; Gonzalez-Braojos, S; Gwinner, H; Hanssen, SA; Heylen, D; Ilmonen, P; Klarborg, K; Korpimaki, E; Martinez, J; Martinez-de la Puente, J; Marzal, A; Matthysen, E; Matyjasiak, P; Molina-Morales, M; Moreno, J; Mousseau, TA; Nielsen, JT; Pap, PL; Rivero-de Aguilar, J; Shurulinkov, P; Slagsvold, T; Szep, T; Szollosi, E; Torok, J; Vaclav, R; Valera, F; Ziane, N				Moller, Anders Pape; Merino, Santiago; Jose Soler, Juan; Antonov, Anton; Badas, Elisa P.; Calero-Torralbo, Miguel A.; de Lope, Florentino; Eeva, Tapio; Figuerola, Jordi; Flensted-Jensen, Einar; Garamszegi, Laszlo Z.; Gonzalez-Braojos, Sonia; Gwinner, Helga; Hanssen, Sveinn Are; Heylen, Dieter; Ilmonen, Petteri; Klarborg, Kurt; Korpimaki, Erkki; Martinez, Javier; Martinez-de la Puente, Josue; Marzal, Alfonso; Matthysen, Erik; Matyjasiak, Piotr; Molina-Morales, Mercedes; Moreno, Juan; Mousseau, Timothy A.; Nielsen, Jan Tottrup; Pap, Peter Laszlo; Rivero-de Aguilar, Juan; Shurulinkov, Peter; Slagsvold, Tore; Szep, Tibor; Szoellosi, Eszter; Toeroek, Janos; Vaclav, Radovan; Valera, Francisco; Ziane, Nadia			Assessing the Effects of Climate on Host-Parasite Interactions: A Comparative Study of European Birds and Their Parasites	PLOS ONE			English	Article							COD GADUS-MORHUA; LATITUDINAL GRADIENTS; COASTAL LABRADOR; SAMPLE-SIZE; IMMUNITY; ECTOPARASITES; TEMPERATURE; VARIABILITY; INCREASES; INFECTION	Background: Climate change potentially has important effects on distribution, abundance, transmission and virulence of parasites in wild populations of animals. Methodology/Principal Finding: Here we analyzed paired information on 89 parasite populations for 24 species of bird hosts some years ago and again in 2010 with an average interval of 10 years. The parasite taxa included protozoa, feather parasites, diptera, ticks, mites and fleas. We investigated whether change in abundance and prevalence of parasites was related to change in body condition, reproduction and population size of hosts. We conducted analyses based on the entire dataset, but also on a restricted dataset with intervals between study years being 5-15 years. Parasite abundance increased over time when restricting the analyses to datasets with an interval of 5-15 years, with no significant effect of changes in temperature at the time of breeding among study sites. Changes in host body condition and clutch size were related to change in temperature between first and second study year. In addition, changes in clutch size, brood size and body condition of hosts were correlated with change in abundance of parasites. Finally, changes in population size of hosts were not significantly related to changes in abundance of parasites or their prevalence. Conclusions/Significance: Climate change is associated with a general increase in parasite abundance. Variation in laying date depended on locality and was associated with latitude while body condition of hosts was associated with a change in temperature. Because clutch size, brood size and body condition were associated with change in parasitism, these results suggest that parasites, perhaps mediated through the indirect effects of temperature, may affect fecundity and condition of their hosts. The conclusions were particularly in accordance with predictions when the restricted dataset with intervals of 515 years was used, suggesting that short intervals may bias findings.	[Moller, Anders Pape] Univ Paris 11, Lab Ecol Systemat & Evolut, AgroParisTech, CNRS,Unite Mixte Rech 8079, F-91405 Orsay, France; [Merino, Santiago; Badas, Elisa P.; Gonzalez-Braojos, Sonia; Moreno, Juan; Rivero-de Aguilar, Juan] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, E-28006 Madrid, Spain; [Jose Soler, Juan; Calero-Torralbo, Miguel A.; Valera, Francisco] CSIC, Estn Expt Zonas Aridas, Dept Ecol Func & Evolut, La Canada De San Urbano, Almeria, Spain; [Antonov, Anton; Shurulinkov, Peter] Bulgarian Acad Sci, Natl Museum Nat Hist Sofia, Sofia, Bulgaria; [de Lope, Florentino; Marzal, Alfonso] Univ Extremadura, Dept Anat Biol Celular & Zool, Badajoz, Spain; [Eeva, Tapio; Korpimaki, Erkki] Univ Turku, Dept Biol, Sect Ecol, FIN-20014 Turku, Finland; [Figuerola, Jordi; Martinez-de la Puente, Josue] CSIC, Estn Biol Donana, Dept Ecol Humedales, E-41080 Seville, Spain; [Garamszegi, Laszlo Z.] CSIC, Estn Biol Donana, Dept Ecol Evolut, E-41080 Seville, Spain; [Gwinner, Helga] Max Planck Inst Ornithol, Seewiesen, Germany; [Hanssen, Sveinn Are] Norwegian Inst Nat Res, Polar Environm Ctr, Tromso, Norway; [Heylen, Dieter; Matthysen, Erik] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, B-2020 Antwerp, Belgium; [Ilmonen, Petteri] Univ Turku, Div Genet & Physiol, FIN-20014 Turku, Finland; [Martinez, Javier] Univ Alcala de Henares, Dept Parasitol, Alcala De Henares, Spain; [Matyjasiak, Piotr] Cardinal Stefan Wyszynski Univ Warsaw, Fac Biol & Environm Sci, Warsaw, Poland; [Molina-Morales, Mercedes] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Mousseau, Timothy A.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Pap, Peter Laszlo] Univ Babes Bolyai, Hungarian Dept Biol & Ecol, Evolutionary Ecol Grp, R-3400 Cluj Napoca, Romania; [Slagsvold, Tore] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Oslo, Norway; [Szep, Tibor] Coll Nyiregyhaza, Inst Environm Sci, H-4400 Nyiregyhaza, Hungary; [Szoellosi, Eszter; Toeroek, Janos] Eotvos Lorand Univ, Dept Systemat Zool & Ecol, Behav Ecol Grp, Budapest, Hungary; [Vaclav, Radovan] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Ziane, Nadia] Badji Mokhtar Univ, Fac Sci, Dept Biol, Annaba, Algeria	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Bulgarian Academy of Sciences; Universidad de Extremadura; University of Turku; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Max Planck Society; Norwegian Institute Nature Research; University of Antwerp; University of Turku; Universidad de Alcala; Cardinal Stefan Wyszynski University in Warsaw; University of Granada; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Babes Bolyai University from Cluj; University of Oslo; Eotvos Lorand University; Slovak Academy of Sciences; Universite Badji Mokhtar - Annaba	Moller, AP (corresponding author), Univ Paris 11, Lab Ecol Systemat & Evolut, AgroParisTech, CNRS,Unite Mixte Rech 8079, Batiment 362, F-91405 Orsay, France.	anders.moller@u-psud.fr	Moller, Anders/O-6665-2016; Valera, Francisco/J-5951-2014; Martinez-de la Puente, Josue/B-1648-2008; Václav, Radovan/A-1244-2009; Merino, Santiago/A-6183-2008; la Puente, Josué Martínez-de/E-8597-2011; Moreno, Juan/AAB-1307-2019; Eeva, Tapio/V-8922-2018; Figuerola, Jordi/B-7917-2008; Valera, Francisco/R-3437-2019; Soler, J. J./H-2363-2011; Hanssen, Sveinn Are/C-9989-2009; de Aguilar, Juan Rivero/AAL-3311-2021; Matyjasiak, Piotr/AAT-8660-2021; Torok, Janos/C-6144-2008; Garamszegi, Laszlo/M-1488-2015; Szöllősi, Eszter/H-3673-2017; Shurulinkov, Peter/HHC-5484-2022; Marzal, Alfonso/J-6677-2012; Mousseau, Timothy A/A-1253-2011; Molina-Morales, Mercedes/I-8397-2019; Martinez, Javier/H-2827-2015	Moller, Anders/0000-0003-3739-4675; Valera, Francisco/0000-0003-2266-8899; Václav, Radovan/0000-0003-0396-8810; Merino, Santiago/0000-0003-0603-8280; la Puente, Josué Martínez-de/0000-0001-8055-4115; Moreno, Juan/0000-0003-1508-7295; Eeva, Tapio/0000-0002-0395-1536; Figuerola, Jordi/0000-0002-4664-9011; Valera, Francisco/0000-0003-2266-8899; Soler, J. J./0000-0003-2990-1489; Hanssen, Sveinn Are/0000-0003-1792-435X; Matyjasiak, Piotr/0000-0003-0384-2935; Torok, Janos/0000-0002-4799-5522; Garamszegi, Laszlo/0000-0001-8920-2183; Szöllősi, Eszter/0000-0003-2913-2894; Marzal, Alfonso/0000-0001-5872-1060; Martinez, Javier/0000-0003-2657-1154; RIVERO DE AGUILAR, JUAN/0000-0002-4746-5759; Molina Morales, Mercedes/0000-0001-8669-6624; Mousseau, Timothy/0000-0002-2235-4868	Academy of Finland [8119367, 250709]; Romanian Ministry of Education and Science [TE_291/2010]; OTKA [K69068, 75618]; JAE grant from Consejo Superior de Investigaciones Cientificas; Spanish Ministry of Science and Innovation [CGL2009-09439, CGL2012-36665, CGL2009- 11445, CGL2010-19233-C03-01, CGL2008-00562]; FEDER; Spanish Ministry of Health; European Regional Development Fund; FPU grant from the Spanish Ministry of Education [AP20043713]; Polish Ministry of Science and Higher Education [2P04F07030]; Foundation for Polish Science	Academy of Finland(Academy of Finland); Romanian Ministry of Education and Science(Ministry of Education and Research - Romania); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); JAE grant from Consejo Superior de Investigaciones Cientificas; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Regional Development Fund(European Commission); FPU grant from the Spanish Ministry of Education(German Research Foundation (DFG)); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	The Academy of Finland is acknowledged for a grant to TE (project 8119367) and EK (project 250709). PLP was supported by a research grant (TE_291/2010) offered by the Romanian Ministry of Education and Science. T. Szep received funding from OTKA K69068 and JT from OTKA 75618. JMP was supported by a JAE grant from Consejo Superior de Investigaciones Cientificas. SM-JM, FdL-AM, JF, JJS and FV were respectively supported by projects CGL2009-09439, CGL2012-36665, CGL2009- 11445, CGL2010-19233-C03-01 and CGL2008-00562 by the Spanish Ministry of Science and Innovation and FEDER and project EVITAR by the Spanish Ministry of Health. FV was also supported by the European Regional Development Fund. MACT was funded by a predoctoral FPU grant from the Spanish Ministry of Education (AP20043713). PM was supported by grant from the Polish Ministry of Science and Higher Education (project 2P04F07030), and the Foundation for Polish Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahraa H. G., 2008, International Journal of Poultry Science, V7, P964; Barbosa A, 2007, POLAR BIOL, V30, P219, DOI 10.1007/s00300-006-0175-9; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Brooks DR, 2007, TRENDS PARASITOL, V23, P571, DOI 10.1016/j.pt.2007.08.016; Cadenas FM, 2007, J MED ENTOMOL, V44, P683, DOI 10.1603/0022-2585(2007)44[683:POIRAI]2.0.CO;2; Calero-Torralbo MA, 2013, OIKOS, V122, P274, DOI 10.1111/j.1600-0706.2012.20374.x; Cattadori IM, 2005, NATURE, V433, P737, DOI 10.1038/nature03276; Combes Claude., 2001, PARASITISM ECOLOGY E; Dawson RD, 2005, ENVIRON ENTOMOL, V34, P563, DOI 10.1603/0046-225X-34.3.563; de la Roque S, 2008, REV SCI TECH OIE, V27, P339, DOI 10.20506/rst.27.2.1807; DELOPE F, 1993, OECOLOGIA, V95, P234, DOI 10.1007/BF00323495; Dobson A, 2009, ECOLOGY, V90, P920, DOI 10.1890/08-0736.1; Dufva R, 1996, IBIS, V138, P772, DOI 10.1111/j.1474-919X.1996.tb08835.x; Dunn Peter O., 2010, P113; Fichet-Calvet E, 2003, ANN TROP MED PARASIT, V97, P593, DOI 10.1179/000349803225001517; Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x; Garamszegi LZ, 2010, BIOL REV, V85, P797, DOI 10.1111/j.1469-185X.2010.00126.x; Gilbert M, 2008, REV SCI TECH OIE, V27, P459, DOI 10.20506/rst.27.2.1821; Guegan J.-F., 2005, P22; Guegan JF, 2001, EVOLUTION, V55, P1308; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Guirguis K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048762; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Haylock MR, 2008, J GEOPHYS RES-ATMOS, V116; Hudson PJ, 2006, J HELMINTHOL, V80, P175, DOI 10.1079/JOH2006357; Khan RA, 2008, J HELMINTHOL, V82, P203, DOI 10.1017/S0022149X0897615X; Khan RA, 2006, J HELMINTHOL, V80, P193, DOI 10.1079/JOH2006352; Lovejoy T, 2008, REV SCI TECH OIE, V27, P331, DOI 10.20506/rst.27.2.1808; Martinez J, 2011, CURR ZOOL, V57, P390, DOI 10.1093/czoolo/57.3.390; Martinez-de la Puente J, 2009, J AVIAN BIOL, V40, P653, DOI 10.1111/j.1600-048X.2009.04726.x; Mas-Coma S, 2008, REV SCI TECH OIE, V27, P443, DOI 10.20506/rst.27.2.1822; Merino S, 1996, ECOGRAPHY, V19, P107, DOI 10.1111/j.1600-0587.1996.tb00161.x; Merino S, 1997, J WILDLIFE DIS, V33, P638, DOI 10.7589/0090-3558-33.3.638; Merino S, 2008, AUSTRAL ECOL, V33, P329, DOI 10.1111/j.1442-9993.2008.01820.x; Merino Santiago, 2010, P213; Moller AP, 2006, OIKOS, V115, P463, DOI 10.1111/j.2006.0030-1299.15312.x; Moller AP, 2011, P ROY SOC B-BIOL SCI, V278, P733, DOI 10.1098/rspb.2010.1592; Moller AP, 2010, J ANIM ECOL, V79, P777, DOI 10.1111/j.1365-2656.2010.01677.x; Moller AP, 2010, GLOBAL CHANGE BIOL, V16, P1158, DOI 10.1111/j.1365-2486.2009.02035.x; Moller AP, 2009, BIOL REV, V84, P567, DOI 10.1111/j.1469-185X.2009.00087.x; Moller AP, 2007, BEHAV ECOL, V18, P62, DOI 10.1093/beheco/arl051; Moller AP, 2005, PARASITISM AND ECOSYSTEMS, P43; Moller AP, 2004, J ANIM ECOL, V73, P1035, DOI 10.1111/j.0021-8790.2004.00879.x; Moller AP, 2003, OECOLOGIA, V137, P621, DOI 10.1007/s00442-003-1378-1; Moller AP, 1998, OIKOS, V82, P265, DOI 10.2307/3546966; Moller AP, 2002, J ANIM ECOL, V71, P201, DOI 10.1046/j.1365-2656.2002.00589.x; Morley NJ, 2008, J HELMINTHOL, V82, P325, DOI 10.1017/S0022149X0802645X; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Plischke A, 2010, J ORNITHOL, V151, P347, DOI 10.1007/s10336-009-0461-8; Poulin R, 2006, J HELMINTHOL, V80, P183, DOI 10.1079/JOH2006341; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Price P. W., 1980, EVOLUTIONARY BIOL PA; Rohde K, 1998, OIKOS, V82, P184, DOI 10.2307/3546928; Saino N, 2009, BIOL LETTERS, V5, P539, DOI 10.1098/rsbl.2009.0312; Seed, 2001, PARASITISM DIVERSITY; Sinclair JA, 2000, CAN J ZOOL, V78, P254, DOI 10.1139/cjz-78-2-254; SOKAL RR, 2005, BIOMETRY; Statsoft Inc., 2011, STATISTICA DAT AN SO; Garamszegi LZ, 2011, SYST BIOL, V60, P876, DOI 10.1093/sysbio/syr060	60	31	33	3	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82886	10.1371/journal.pone.0082886	http://dx.doi.org/10.1371/journal.pone.0082886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391725	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000329325200022
J	Palazzo, P; Maggio, P; Altavilla, R; Di Flaviani, A; Giordani, I; Malandrucco, I; Picconi, F; Passarelli, F; Pasqualetti, P; Ercolani, M; Vernieri, F; Frontoni, S				Palazzo, Paola; Maggio, Paola; Altavilla, Riccardo; Di Flaviani, Alessandra; Giordani, Ilaria; Malandrucco, Ilaria; Picconi, Fabiana; Passarelli, Francesco; Pasqualetti, Patrizio; Ercolani, Matilde; Vernieri, Fabrizio; Frontoni, Simona			Cerebral Hemodynamics and Systemic Endothelial Function Are Already Impaired in Well-Controlled Type 2 Diabetic Patients, with Short-Term Disease	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; NITRIC-OXIDE SYNTHASE; CEREBROVASCULAR REACTIVITY; SYMPATHETIC ACTIVATION; VASOMOTOR REACTIVITY; COGNITIVE DECLINE; RESERVE CAPACITY; BRACHIAL-ARTERY; BLOOD-FLOW; RISK	Objective: Impaired cerebral vasomotor reactivity (VMR) and flow-mediated dilation (FMD) were found in selected subgroups of type 2 diabetes mellitus (T2DM) patients with long-term disease. Our study aimed to evaluate cerebral hemodynamics, systemic endothelial function and sympatho-vagal balance in a selected population of well-controlled T2DM patients with short-term disease and without cardiac autonomic neuropathy (CAN). Research Design and Methods: Twenty-six T2DM patients with short-term (4.40 +/- 4.80 years) and well-controlled (HbA1C = 6.71 +/- 1.29%) disease, without any complications, treated with diet and/or metformin, were consecutively recruited. Eighteen controls, comparable by sex and age, were enrolled also. Results: FMD and shear rate FMD were found to be reduced in T2DM subjects with short-term disease (8.5% SD 3.5 and 2.5 SD 1.3, respectively) compared to controls (15.4% SD 4.1 and 3.5 SD 1.4; p<.001 and p<.05). T2DM patients also displayed reduced VMR values than controls (39.4% SD 12.4 vs 51.7%, SD 15.5; p<.05). Sympatho-vagal balance was not different in T2DM patients compared to healthy subjects. FMD and shear rate FMD did not correlate with VMR in T2DM patients or in controls (p>.05). Conclusions: In well-controlled T2DM patients with short-term disease cerebral hemodynamics and systemic endothelial function are altered while autonomic balance appeared to be preserved.	[Palazzo, Paola; Maggio, Paola; Altavilla, Riccardo; Vernieri, Fabrizio] Campus Biomed Univ, Dept Neurol, Rome, Italy; [Palazzo, Paola; Passarelli, Francesco; Ercolani, Matilde] S Giovanni Calibita Fatebenefratelli Hosp, Dept Neurol, Rome, Italy; [Di Flaviani, Alessandra; Giordani, Ilaria; Malandrucco, Ilaria; Picconi, Fabiana; Frontoni, Simona] Univ Roma Tor Vergata, S Giovanni Calibita Fatebenefratelli Hosp, Rome, Italy; [Pasqualetti, Patrizio] Fatebenefratelli Assoc Res, Serv Med Stat & IT, SeSMIT, Rome, Italy	University Campus Bio-Medico - Rome Italy; University of Rome Tor Vergata	Palazzo, P (corresponding author), Campus Biomed Univ, Dept Neurol, Rome, Italy.	p.palazzo@unicampus.it	Picconi, Fabiana/AAB-9012-2019; Maggio, Paola/ABC-7526-2021; FRONTONI, SIMONA/J-4893-2012; Pasqualetti, Patrizio/D-4496-2013	Maggio, Paola/0000-0001-8393-7699; FRONTONI, SIMONA/0000-0001-8241-7552; VERNIERI, FABRIZIO/0000-0002-9594-9336; Pasqualetti, Patrizio/0000-0001-5560-1979				Agelink MW, 2001, CLIN AUTON RES, V11, P99, DOI 10.1007/BF02322053; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Cosentino F, 1997, CIRCULATION, V96, P25; Di Flaviani A, 2011, DIABETES CARE, V34, P1605, DOI 10.2337/dc11-0034; Dyson KS, 2006, AM J PHYSIOL-HEART C, V290, pH1446, DOI 10.1152/ajpheart.00771.2005; Engelke KA, 1997, CLIN AUTON RES, V7, P85, DOI 10.1007/BF02267752; EWING DJ, 1985, DIABETES CARE, V8, P491, DOI 10.2337/diacare.8.5.491; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Fulesdi B, 1999, J DIABETES COMPLICAT, V13, P191, DOI 10.1016/S1056-8727(99)00044-6; IADECOLA C, 1994, J CEREBR BLOOD F MET, V14, P175, DOI 10.1038/jcbfm.1994.25; Kotb NA, 2012, EXP CLIN ENDOCR DIAB, V120, P460, DOI 10.1055/s-0032-1306349; Kozera GM, 2009, DIABETES CARE, V32, P878, DOI 10.2337/dc08-1805; LeMarbre G, 2003, J PHYSIOL-LONDON, V551, P609, DOI 10.1113/jphysiol.2003.046987; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Moens AL, 2005, CHEST, V127, P2254, DOI 10.1378/chest.127.6.2254; Palazzo P, 2010, NEUROLOGY, V75, P2003, DOI 10.1212/WNL.0b013e3181ffe4e4; Palazzo P, 2013, ULTRASOUND MED BIOL, V39, P10, DOI 10.1016/j.ultrasmedbio.2012.08.022; PRETNAROBLAK J, 2007, ENDOTHELIUM, V14, P1; Pyke KE, 2005, J PHYSIOL-LONDON, V568, P357, DOI 10.1113/jphysiol.2005.089755; Santos-Garcia D, 2011, CEREBROVASC DIS, V32, P155, DOI 10.1159/000328651; Shechter M, 2009, INT J CARDIOL, V134, P52, DOI 10.1016/j.ijcard.2008.01.021; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Silvestrini M, 2006, STROKE, V37, P1010, DOI 10.1161/01.STR.0000206439.62025.97; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; van Oers CAMM, 2006, CEREBROVASC DIS, V22, P46, DOI 10.1159/000092337; Verdelho A, 2010, NEUROLOGY, V75, P160, DOI 10.1212/WNL.0b013e3181e7ca05; Vernieri F, 2001, STROKE, V32, P1552, DOI 10.1161/01.STR.32.7.1552; Vernieri F, 2010, STROKE, V41, P2087, DOI 10.1161/STROKEAHA.110.583088; Vuletic V, 2011, COLLEGIUM ANTROPOL, V35, P27; WANG Q, 1995, J CEREBR BLOOD F MET, V15, P774, DOI 10.1038/jcbfm.1995.97; White RP, 1998, STROKE, V29, P467, DOI 10.1161/01.STR.29.2.467; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; Yokoyama H, 2011, J ATHEROSCLER THROMB, V18, P744, DOI 10.5551/jat.7526	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83287	10.1371/journal.pone.0083287	http://dx.doi.org/10.1371/journal.pone.0083287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391751	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200048
J	Salaberria, C; Muriel, J; de Luna, M; Gil, D; Puerta, M				Salaberria, Concepcion; Muriel, Jaime; de Luna, Maria; Gil, Diego; Puerta, Marisa			The PHA Test as an Indicator of Phagocytic Activity in a Passerine Bird	PLOS ONE			English	Article							BACTERICIDAL ACTIVITIES; INNATE IMMUNITY; BLOOD-CHEMISTRY; WELCOME SWALLOW; TREE SWALLOWS; PHYTOHEMAGGLUTININ; IMMUNOCOMPETENCE; WHITE; CICONIA; AGE	Several techniques in ecological immunology have been used to assess bird immunocompetence thus providing useful information to understand the contribution of the immunological system in life-history decisions. The phytohaemagglutinin (PHA)-skin test has been the most widely employed technique being interpreted as the sole result of T lymphocytes proliferation and hence used to evaluate acquired immunological capacity. However, the presence of high numbers of phagocytic cells in the swelling point has cast some doubt about such an assumption. To address this issue, we collected blood from 14 days-old nestlings of spotless starling (Sturnus unicolor), administered subcutaneous PHA immediately after and then measured the swelling response 24 hours later. Differential counts of white blood cells suggested that an intense development of acquired immunological defences was taking place. The phagocytic activity of both heterophiles and monocytes was also very intense as it was the swelling response. Moreover, our results show, for the first time in birds, a positive relationship between the phagocytic activity of both kinds of cells and the swelling response. This broadens the significance of the PHA test from reflecting T lymphocytes proliferation -as previously proposed but still undetermined in vivo-to evaluate phagocytosis as well. In other words, our data suggest that the PHA swelling response may not be considered as the only consequence of processes of specific and induced immunity -T lymphocytes proliferation-but also of constitutive and nonspecific immunity -heterophiles and monocytes phagocytosis. We propose the extensive use of PHA-skin test as an optimal technique to assess immunocompetence.	[Salaberria, Concepcion; Muriel, Jaime; de Luna, Maria; Gil, Diego] CSIC, Museo Nacl Ciencias Nat, Dept Evolut Ecol, E-28006 Madrid, Spain; [de Luna, Maria; Puerta, Marisa] Univ Complutense Madrid, Fac Ciencias Biol, Dept Anim Physiol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid	Salaberria, C (corresponding author), Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Dept Funct Ecol, Morelia, Michoacan, Mexico.	salaberria@cieco.unam.mx	Gil, Diego/L-1666-2014; Muriel, Jaime/C-3000-2016	Gil, Diego/0000-0003-3179-1987; Muriel, Jaime/0000-0003-4580-6406; SALABERRIA, CONCEPCION/0000-0003-4196-9443	Spanish Ministry of Science [CGL2008-03501/BOS]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the grant "Las hormonas esteroideas como moduladores de los compromisos de historia vital en aves" (CGL2008-03501/BOS) from the Spanish Ministry of Science given to Diego Gil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELENDA M, 1993, COMP BIOCHEM PHYS A, V104, P575, DOI 10.1016/0300-9629(93)90466-H; ALONSO JC, 1991, COMP BIOCHEM PHYS A, V98, P395, DOI 10.1016/0300-9629(91)90421-8; Alonso-Alvarez C, 2001, CAN J ZOOL, V79, P101, DOI 10.1139/cjz-79-1-101; ANDERSON EL, 1970, APPL MICROBIOL, V19, P726, DOI 10.1128/AEM.19.5.726-730.1970; Ardia DR, 2005, ECOLOGY, V86, P2040, DOI 10.1890/04-1619; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Bonato M, 2009, ANIM BEHAV, V77, P1027, DOI 10.1016/j.anbehav.2008.12.019; Brommer JE, 2004, P ROY SOC B-BIOL SCI, V271, pS110, DOI 10.1098/rsbl.2003.0103; BROWN SJ, 1982, J IMMUNOL, V129, P790; Christe P, 2001, OECOLOGIA, V126, P333, DOI 10.1007/s004420000527; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Cucco M, 2006, CAN J ZOOL, V84, P72, DOI 10.1139/Z05-179; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Dehnhard N, 2011, J COMP PHYSIOL B, V181, P83, DOI 10.1007/s00360-010-0508-4; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Demas GE, 2011, J ANIM ECOL, V80, P710, DOI 10.1111/j.1365-2656.2011.01813.x; Dhabhar FS, 2002, INTEGR COMP BIOL, V42, P556, DOI 10.1093/icb/42.3.556; Duffy DL, 2002, P ROY SOC B-BIOL SCI, V269, P847, DOI 10.1098/rspb.2002.1956; Finkelstein M, 2003, ARCH ENVIRON CON TOX, V44, P502, DOI 10.1007/s00244-002-2075-5; Gil D, 2011, FUNCT ECOL, V25, P1278, DOI 10.1111/j.1365-2435.2011.01878.x; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; GOTO N, 1978, POULTRY SCI, V57, P246, DOI 10.3382/ps.0570246; Hoffmann-Jagielska M, 2003, VET RES COMMUN, V27, P643, DOI 10.1023/A:1027376530463; Howlett JC, 2002, J WILDLIFE DIS, V38, P804, DOI 10.7589/0090-3558-38.4.804; Kampen AH, 2004, VET IMMUNOL IMMUNOP, V97, P105, DOI 10.1016/j.vetimm.2003.08.018; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Krams I, 2012, COMP BIOCHEM PHYS A, V161, P422, DOI 10.1016/j.cbpa.2011.12.018; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; LOCHMILLER RL, 1993, AUK, V110, P503, DOI 10.2307/4088414; Lopez-Rull I, 2011, FUNCT ECOL, V25, P500, DOI 10.1111/j.1365-2435.2010.01783.x; Lowry VK, 1997, FEMS IMMUNOL MED MIC, V19, P95, DOI 10.1016/S0928-8244(97)00073-4; Lucas AM, 1974, ATLAS AVIAN HEMATOLO; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Martin LB, 2006, FUNCT ECOL, V20, P290, DOI 10.1111/j.1365-2435.2006.01094.x; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; MCCORKLE F, 1980, POULTRY SCI, V59, P616, DOI 10.3382/ps.0590616; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; MOLLER AP, 1990, ECOLOGY, V71, P2345, DOI 10.2307/1938645; Moreno J, 1999, BEHAV ECOL SOCIOBIOL, V47, P47, DOI 10.1007/s002650050648; NOWELL PC, 1960, CANCER RES, V20, P462; Owen JP, 2010, TRENDS PARASITOL, V26, P530, DOI 10.1016/j.pt.2010.06.005; Palacios MG, 2009, DEV COMP IMMUNOL, V33, P456, DOI 10.1016/j.dci.2008.09.006; PUERTA ML, 1989, COMP BIOCHEM PHYS A, V94, P201, DOI 10.1016/0300-9629(89)90535-5; PUERTA ML, 1992, COMP BIOCHEM PHYS A, V102, P683, DOI 10.1016/0300-9629(92)90723-4; Rogers CA, 1991, BIRD PARASITE INTERA, P123; Saino N, 2004, FUNCT ECOL, V18, P50, DOI 10.1046/j.0269-8463.2004.00808.x; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Simmons P, 2006, COMP BIOCHEM PHYS A, V143, P459, DOI 10.1016/j.cbpa.2005.12.018; Sindik A, 2009, J WILDLIFE DIS, V45, P1203, DOI 10.7589/0090-3558-45.4.1203; Smits JE, 1999, FUNCT ECOL, V13, P567, DOI 10.1046/j.1365-2435.1999.00338.x; Sorci G, 1997, P ROY SOC B-BIOL SCI, V264, P1593, DOI 10.1098/rspb.1997.0222; STABLER JG, 1994, VET MICROBIOL, V38, P293, DOI 10.1016/0378-1135(94)90148-1; STADECKER MJ, 1977, J IMMUNOL, V118, P1564; Stearns S.C., 1992, pi; Stearns SC, 2000, NATURWISSENSCHAFTEN, V87, P476, DOI 10.1007/s001140050763; STRAIN JG, 1991, AVIAN DIS, V35, P221, DOI 10.2307/1591318; Szabo Z, 2010, J ZOO WILDLIFE MED, V41, P17, DOI 10.1638/2008-0164.1; Tella JL, 2002, P ROY SOC B-BIOL SCI, V269, P1059, DOI 10.1098/rspb.2001.1951; Veiga JP, 2011, ESTORNINO NEGRO STUR; Vinkler M, 2010, FUNCT ECOL, V24, P1081, DOI 10.1111/j.1365-2435.2010.01711.x; Wells LL, 1998, DEV COMP IMMUNOL, V22, P103, DOI 10.1016/S0145-305X(97)00024-4; Zuk M, 1998, P ROY SOC B-BIOL SCI, V265, P1631, DOI 10.1098/rspb.1998.0481	64	29	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84108	10.1371/journal.pone.0084108	http://dx.doi.org/10.1371/journal.pone.0084108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391896	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900039
J	Shoji, A; Elliott, KH; O'Reilly, KM; Gaston, AJ				Shoji, Akiko; Elliott, Kyle H.; O'Reilly, Kathleen M.; Gaston, Anthony J.			High Corticosterone, Not High Energy Cost, Correlates with Reproductive Success in the Burrow-Nesting Ancient Murrelet	PLOS ONE			English	Article							BASE-LINE; FOOD AVAILABILITY; FORAGING BEHAVIOR; STRESS-RESPONSE; HORMONE-LEVELS; BODY CONDITION; LIFE-HISTORY; PERFORMANCE; EXPENDITURE; INCUBATION	Theory and observations suggest that offspring abandonment in animals may occur when the costs to future reproductive output of current reproductive effort outweigh the fitness benefits of rearing the current brood. While hormonal cues (i.e. corticosterone) or energy reserves are believed to be involved, few studies have directly focused on the proximate cues influencing behaviours directly related to reproductive success. To address this information gap, we determined the incubation metabolic rates and corticosterone (CORT) levels of naturally fasting and freely incubating ancient murrelets (Synthliboramphus antiquus). Respiratory quotient (RQ) increased with date, suggesting that incubating ancient murrelets shifted from strictly lipid-based metabolism towards more protein-based metabolism as incubation progressed. Birds that hatched only one nestling had higher levels of circulating CORT than those which hatched two, suggesting that birds which laid only a single egg found incubation more stressful than those which laid two. However, CORT levels and incubation shift lengths were not correlated, suggesting that birds that undertook prolonged incubation shifts did so only when their energy stores were not jeopardized.	[Shoji, Akiko; Gaston, Anthony J.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Elliott, Kyle H.] Univ Manitoba, Dept Zool, Winnipeg, MB R3T 2N2, Canada; [O'Reilly, Kathleen M.] Univ Portland, Dept Biol, Portland, OR 97203 USA; [Gaston, Anthony J.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; University of Manitoba; University of Portland; University of Ottawa	Shoji, A (corresponding author), Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada.	akikosho@gmail.com	Elliott, Kyle/S-9185-2019	Elliott, Kyle/0000-0001-5304-3993	M.J. Murdock Charitable Trust; Environment Canada	M.J. Murdock Charitable Trust; Environment Canada(CGIAR)	This work was supported by the M.J. Murdock Charitable Trust and Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2008, GEN COMP ENDOCR, V156, P134, DOI 10.1016/j.ygcen.2007.12.001; Angelier F, 2007, PHYSIOL BIOCHEM ZOOL, V80, P283, DOI 10.1086/512585; Angelier F, 2009, J EXP BIOL, V212, P2824, DOI 10.1242/jeb.027722; Angelier F, 2009, GEN COMP ENDOCR, V163, P142, DOI 10.1016/j.ygcen.2009.03.028; Angelier F, 2009, FUNCT ECOL, V23, P784, DOI 10.1111/j.1365-2435.2009.01545.x; Benowitz-Fredericks ZM, 2008, DEEP-SEA RES PT II, V55, P1868, DOI 10.1016/j.dsr2.2008.04.007; Bernard SF, 2003, AM J PHYSIOL-REG I, V285, pR313, DOI 10.1152/ajpregu.00094.2003; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Blackmer AL, 2005, BEHAV ECOL, V16, P906, DOI 10.1093/beheco/ari069; Bonier F, 2009, GEN COMP ENDOCR, V163, P208, DOI 10.1016/j.ygcen.2008.12.013; BROWN CR, 1988, OSTRICH, V59, P67, DOI 10.1080/00306525.1988.9633699; Buck CL, 2007, GEN COMP ENDOCR, V150, P430, DOI 10.1016/j.ygcen.2006.10.011; Buntin John D., 1996, Advances in the Study of Behavior, V25, P161; Chastel O, 2005, HORM BEHAV, V47, P459, DOI 10.1016/j.yhbeh.2004.10.009; CHAURAND T, 1994, IBIS, V136, P285, DOI 10.1111/j.1474-919X.1994.tb01097.x; Crespi EJ, 2013, FUNCT ECOL, V27, P93, DOI 10.1111/1365-2435.12009; Cyr NE, 2007, GEN COMP ENDOCR, V151, P82, DOI 10.1016/j.ygcen.2006.12.003; DRENT RH, 1980, ARDEA, V68, P225; Elliott KJ, 2013, J MOL CELL CARDIOL, V62, P1, DOI 10.1016/j.yjmcc.2013.05.005; Elliott KH, 2012, MAR ECOL PROG SER, V466, P1, DOI 10.3354/meps09975; Elliott KH, 2008, J AVIAN BIOL, V39, P619, DOI 10.1111/j.1600-048X.2008.04316.x; Ellis Hugh I., 2002, P359; Gaston, 1992, ANCIENT MURRELET NAT; Gaston A.J., 1998, AUKS ALCIDAE; Gaston AJ, 1996, COLON WATERBIRD, V19, P116, DOI 10.2307/1521814; GOODMAN MN, 1980, AM J PHYSIOL, V239, pE277; Groscolas R, 2001, COMP BIOCHEM PHYS A, V128, P645, DOI 10.1016/S1095-6433(00)00341-X; Groscolas R., 1990, P269; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; Heath JP, 2010, P ROY SOC B-BIOL SCI, V277, P3179, DOI 10.1098/rspb.2010.0812; Heidinger BJ, 2006, P ROY SOC B-BIOL SCI, V273, P2227, DOI 10.1098/rspb.2006.3557; Jacobs SR, 2011, COMP BIOCHEM PHYS B, V158, P77, DOI 10.1016/j.cbpb.2010.09.011; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; Kitaysky AS, 2006, P ROY SOC B-BIOL SCI, V273, P445, DOI 10.1098/rspb.2005.3351; Kitaysky AS, 2003, HORM BEHAV, V43, P140, DOI 10.1016/S0018-506X(02)00030-2; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; LEMAHO Y, 1981, AM J PHYSIOL, V241, pE342, DOI 10.1152/ajpendo.1981.241.5.E342; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Newman Scott H., 2005, Marine Ornithology, V33, P147; Niizuma Y, 2002, CAN J ZOOL, V80, P1549, DOI 10.1139/Z02-158; Ouyang JQ, 2011, P ROY SOC B-BIOL SCI, V278, P2537, DOI 10.1098/rspb.2010.2490; PETTIT TN, 1988, OECOLOGIA, V74, P546, DOI 10.1007/BF00380052; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; ROBIN JP, 1988, AM J PHYSIOL, V254, pR61, DOI 10.1152/ajpregu.1988.254.1.R61; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Shoji A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017760; SILVERIN B, 1990, COMP PHYSIOL, V9, P129; SILVERIN B, 1986, GEN COMP ENDOCR, V64, P67, DOI 10.1016/0016-6480(86)90029-8; Silverin B, 1998, ANIM BEHAV, V55, P1411, DOI 10.1006/anbe.1997.0717; Speakman J.R., 1997, DOUBLY LABELLED WATE; Speakman JR, 2004, PHYSIOL BIOCHEM ZOOL, V77, P900, DOI 10.1086/427059; Stearns S.C., 1992, pi; Walsberg GE, 1997, J EXP BIOL, V200, P2115; Weimerskirch H, 2002, J EXP BIOL, V205, P475; Whittow G. C., 1984, SEABIRD ENERGETICS; Williams CT, 2008, GEN COMP ENDOCR, V158, P29, DOI 10.1016/j.ygcen.2008.04.018; Williams T., 2012, PHYSL ADAPTATIONS BR	60	2	2	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84280	10.1371/journal.pone.0084280	http://dx.doi.org/10.1371/journal.pone.0084280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391929	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900072
J	Suttorp, MM; Hoekstra, T; Mittelman, M; Ott, I; Franssen, CFM; Dekker, FW				Suttorp, Marit M.; Hoekstra, Tiny; Mittelman, Moshe; Ott, Ilka; Franssen, Casper F. M.; Dekker, Friedo W.			Effect of Erythropoiesis-Stimulating Agents on Blood Pressure in Pre-Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE; HEMOGLOBIN TARGETS; DARBEPOETIN-ALPHA; CARDIAC-DISEASE; EPOETIN-ALPHA; RENAL-DISEASE; HYPERTENSION	Introduction: Erythropoiesis-Stimulating Agents (ESA) are hypothesized to increase cardiovascular mortality in patients with chronic kidney disease. One of the proposed mechanisms is the elevation of blood pressure (BP) by ESA. Therefore, we aimed to determine whether the use of ESA was associated with antihypertensive treatment and higher BP. Materials and Methods: In this cohort 502 incident pre-dialysis patients were included who started specialized pre-dialysis care in 25 clinics in the Netherlands. Data on medication including ESA use and dose, co-morbidities and BP were routinely collected every 6 months. Antihypertensive treatment and BP were compared for patients with and without ESA at baseline. Differences in antihypertensive medication and BP during pre-dialysis care were estimated with linear mixed models adjusted for age, sex, body mass index, cardiovascular disease, diabetes mellitus and estimated glomerular filtration rate. Results: At baseline, 95.6% of patients with ESA were treated with antihypertensive medication and 73.1% of patients without ESA. No relevant difference in BP was found. During pre-dialysis care patients with ESA used 0.77 (95% CI 0.63; 0.91) more classes of antihypertensive drugs. The adjusted difference in systolic blood pressure (SBP) was -0.3 (95% CI -22.7;2.0) mmHg and in diastolic blood pressure (DBP) was -1.0 (95% CI -2.1; 0.3) mmHg for patients with ESA compared to patients without ESA. Adjusted SBP was 3.7 (95% CI -1.6; 9.0) mmHg higher in patients with a high ESA dose compared to patients with a low ESA dose. Conclusions: Our study confirms the hypertensive effect of ESA, since ESA treated patients received more antihypertensive agents. However, no relevant difference in BP was found between patients with and without ESA, thus the increase in BP seems to be controlled for by antihypertensive medication.	[Suttorp, Marit M.; Hoekstra, Tiny; Dekker, Friedo W.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Mittelman, Moshe] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Dept Med, IL-69978 Tel Aviv, Israel; [Ott, Ilka] Tech Univ Munich, Deutsch Herzzentrum, D-80290 Munich, Germany; [Franssen, Casper F. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 AV Groningen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; University of Groningen	Suttorp, MM (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	M.M.Suttorp@lumc.nl	Dekker, Friedo W/B-6452-2011	Dekker, Friedo W/0000-0002-2433-2494; Franssen, Casper/0000-0003-1004-9994	Dutch Kidney Foundation [SB 110]; Amgen; FP7-Health European commission EpoCan [282551]	Dutch Kidney Foundation; Amgen(Amgen); FP7-Health European commission EpoCan(European Commission)	The PREPARE-2 study was supported by a grant from the Dutch Kidney Foundation (SB 110) and an unrestricted grant from Amgen. This work was supported by the FP7-Health European commission EpoCan grant (282551). None of the sponsors were involved in study design, collection of data, statistical analyses, interpretation of data, writing of the manuscript, or in the decision to submit the paper for publication.	[Anonymous], AM J KIDNEY DIS, V43, pS1; [Anonymous], AM J KIDNEY DIS, V39, pS1; Berns JS, 1999, KIDNEY INT, V56, P253, DOI 10.1046/j.1523-1755.1999.00531.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Briet M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000128; Buckalew VM, 1996, AM J KIDNEY DIS, V28, P811, DOI 10.1016/S0272-6386(96)90380-7; CARLINI R, 1993, AM J HYPERTENS, V6, P103, DOI 10.1093/ajh/6.2.103; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cody J, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003266.pub2, 10.1002/14651858.CD003895.pub2]; Conlon PJ, 2000, RENAL FAILURE, V22, P435, DOI 10.1081/JDI-100100885; de Goeij MCM, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-38; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; ERA-EDTA Registry, 2010, ERA EDTA REG ANN REP, P126; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Fishbane S, 2007, CLIN J AM SOC NEPHRO, V2, P1274, DOI 10.2215/CJN.02380607; Furuland H, 2005, SCAND J UROL NEPHROL, V39, P399, DOI 10.1080/00365590500192355; Ifudu O, 1998, NEPHRON, V79, P486, DOI 10.1159/000045103; Inrig JK, 2012, NEPHROL DIAL TRANSPL, V27, P3606, DOI 10.1093/ndt/gfs123; Kanbay M, 2007, ADV THER, V24, P346, DOI 10.1007/BF02849903; KAUPKE CJ, 1994, J AM SOC NEPHROL, V4, P1874; Krapf R, 2009, CLIN J AM SOC NEPHRO, V4, P470, DOI 10.2215/CJN.05040908; Kuriyama Satoru, 2007, Clin Exp Nephrol, V11, P66, DOI 10.1007/s10157-006-0446-3; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mallamaci F, 2013, KIDNEY INT, V84, P381, DOI 10.1038/ki.2013.132; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Miyashita K, 2004, HYPERTENS RES, V27, P79, DOI 10.1291/hypres.27.79; Muntner P, 2010, AM J KIDNEY DIS, V55, P441, DOI 10.1053/j.ajkd.2009.09.014; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Parikh NI, 2006, ARCH INTERN MED, V166, P1884, DOI 10.1001/archinte.166.17.1884; Peralta CA, 2005, HYPERTENSION, V45, P1119, DOI 10.1161/01.HYP.0000164577.81087.70; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; POLLOK M, 1989, CONTRIB NEPHROL, V76, P201; Sarafidis PA, 2008, AM J MED, V121, P332, DOI 10.1016/j.amjmed.2007.11.025; Sarafidis PA, 2012, NEPHRON CLIN PRACT, V120, pC147, DOI 10.1159/000337571; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Servilla KS, 2009, AM J KIDNEY DIS, V54, P498, DOI 10.1053/j.ajkd.2009.05.007; Singh AK, 2010, CURR OPIN NEPHROL HY, V19, P420, DOI 10.1097/MNH.0b013e32833cf1d6; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P3154, DOI 10.1097/01.ASN.0000145436.09176.A7; SUNDAL E, 1989, NEPHROL DIAL TRANSPL, V4, P979, DOI 10.1093/ndt/4.11.979; ter Wee P M, 2004, Ned Tijdschr Geneeskd, V148, P719; Thilly N, 2009, NEPHROL DIAL TRANSPL, V24, P934, DOI 10.1093/ndt/gfn566; Vaziri ND, 1999, AM J KIDNEY DIS, V33, P821, DOI 10.1016/S0272-6386(99)70413-0; Vaziri ND, 2009, NEPHROL DIAL TRANSPL, V24, P1082, DOI 10.1093/ndt/gfn601; Wang XQ, 1999, HYPERTENSION, V33, P894, DOI 10.1161/01.HYP.33.3.894; WHO Collaborating Centre for Drug Statistics Methodology, 2009, DDD DEF GEN CONS; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6; Zhang Y, 2011, KIDNEY INT, V80, P663, DOI 10.1038/ki.2011.188	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84848	10.1371/journal.pone.0084848	http://dx.doi.org/10.1371/journal.pone.0084848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391978	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900121
J	Villalba, JA; Liu, YS; Alvarez, MK; Calderon, L; Canache, M; Cardenas, G; Del Nogal, B; Takiff, HE; De Waard, JH				Villalba, Julian A.; Liu, Yushi; Alvarez, Mauyuri K.; Calderon, Luisana; Canache, Merari; Cardenas, Gaudymar; Del Nogal, Berenice; Takiff, Howard E.; De Waard, Jacobus H.			Low Child Survival Index in a Multi-Dimensionally Poor Amerindian Population in Venezuela	PLOS ONE			English	Article							PNEUMOCOCCAL CARRIAGE; MORTALITY; STILLBIRTH; COVERAGE; INFANT	Background: Warao Amerindians, who inhabit the Orinoco Delta, are the second largest indigenous group in Venezuela. High Warao general mortality rates were mentioned in a limited study 21 years ago. However, there have been no comprehensive studies addressing child survival across the entire population. Objectives: To determine the Child Survival-Index (CSI) (ratio: still-living children/total-live births) in the Warao population, the principal causes of childhood death and the socio-demographic factors associated with childhood deaths. Methods: We conducted a cross-sectional epidemiological survey of 688 women from 97 communities in 7 different subregions of the Orinoco Delta. Data collected included socio-demographic characteristics and the reproductive history of each woman surveyed. The multidimensional poverty index (MPI) was used to classify the households as deprived across the three dimensions of the Human Development Index. Multivariable linear regression and Generalized Linear Model Procedures were used to identify socioeconomic and environmental characteristics statistically associated with the CSI. Findings: The average CSI was 73.8% +/- 26. The two most common causes of death were gastroenteritis/ diarrhea (63%) and acute respiratory tract Infection/pneumonia (18%). Deaths in children under five years accounted for 97.3% of childhood deaths, with 54% occurring in the neonatal period or first year of life. Most of the women (95.5%) were classified as multidimensionally poor. The general MPI in the sample was 0.56. CSI was negatively correlated with MPI, maternal age, residence in a traditional dwelling and profession of the head of household other than nurse or teacher. Conclusions: The Warao have a low CSI which is correlated with MPI and maternal age. Infectious diseases are responsible for 85% of childhood deaths. The low socioeconomic development, lack of infrastructure and geographic and cultural isolation suggest that an integrated approach is urgently needed to improve the child survival and overall health of the Warao Amerindians.	[Villalba, Julian A.] Direcc Reg Salud Estado Delta Amacuro, Tucupita, Venezuela; [Villalba, Julian A.; De Waard, Jacobus H.] Inst Biomed, Lab TB, Caracas, Venezuela; [Villalba, Julian A.; Liu, Yushi] Lovelace Resp Res Inst, Albuquerque, NM USA; [Alvarez, Mauyuri K.; Calderon, Luisana; Canache, Merari; Cardenas, Gaudymar; Del Nogal, Berenice] Cent Univ Venezuela, Escuela Med Jose Maria Vargas, Caracas, Venezuela; [Del Nogal, Berenice] Hosp Ninos JM de los Rios, Dept Pediat, Caracas, Venezuela; [Takiff, Howard E.] Inst Venezolano Invest Cient, Lab Genet Mol, Caracas, Venezuela	Lovelace Respiratory Research Institute; University of Central Venezuela; Venezuelan Institute Science Research	Villalba, JA (corresponding author), Direcc Reg Salud Estado Delta Amacuro, Tucupita, Venezuela.	jvn1987@gmail.com	de Waard, Jacobus/AGM-8709-2022; Liu, Yushi/A-1533-2014; Villalba, Julian/AAK-4222-2020	Liu, Yushi/0000-0003-4185-4187; Villalba, Julian/0000-0001-9230-8747; de Waard, Jacobus H./0000-0003-4118-1015				Alkire S, 2011, MULTIDIMENSIONAL POV; Alkire S, 2010, 38 U OXF; Araujo Z, 2006, MEM I OSWALDO CRUZ, V101, P359, DOI 10.1590/S0074-02762006000400003; Assefa N, 2012, SEX REPROD HEALTHC, V3, P107, DOI 10.1016/j.srhc.2012.06.002; Australian Bureau of Statistics, 2011, HLTH WELF AUSTR AB T; Ayala-Lafee C, 2007, HIJAS LUNA ENCULTURA; Benefo K, 1996, WORLD BANK ECON REV, V10, P123, DOI 10.1093/wber/10.1.123; Briggs Cl, 2003, STORIES TIME CHOLERA; Devesa M, 2004, J MED VIROL, V72, P377, DOI 10.1002/jmv.20015; Domenico C, 1998, PRIMICIA, V14, P32; Epstein M, 1997, AM J PUBLIC HEALTH, V87, P1363, DOI 10.2105/AJPH.87.8.1363; Fernández de Larrea Carlos, 2002, Invest. clín, V43, P35; Ghosh R, 2010, ASIA-PAC J PUBLIC HE, V22, P63, DOI 10.1177/1010539509350758; Gonzalez AR, 2000, REV BIOL TROP, V48, P207; Gruson A, 2008, CONDICIONES VIDA WAR; HANSMAN D, 1985, J HYG-CAMBRIDGE, V95, P677, DOI 10.1017/S0022172400060782; Institute of Education Sciences National Center for Education Statistics, 2008, STAT TRENDS ED AM IN; Instituto Nacional de Estadistica, 2001, 3 CENS POBL COM IND; Instituto Nacional de Estadistica, 2001, 13 CENS NAC POBL VIV; Inter-American Commission on Human Rights, 2009, DEM HUM RIGHTS VEN, V54, P1076; Inter- American Commission on Human Rights, 2009, IND TRIB PEOPL RIGHT; Lavandero J, 2010, DELT AM C ART DOC NO; Levy J, 2010, PARTICIPACION SALUD; Martín Piñate Felipe, 2007, Gac Méd Caracas., V115, P325; Mathews TJ, 2011, INFANT MORTALITY STA; O'Brien KL, 2004, AM J EPIDEMIOL, V160, P270, DOI 10.1093/aje/kwh191; Oxford Poverty and Human Development Initiative, 2013, MULT POV IND MPI DAT; Perez-Molina J, 2012, REV INVEST CLIN, V64, P330; R Development Core Team, 2011, R PROJ STAT COMP; Rangel HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040626; Rivera-Olivero IA, 2007, CLIN INFECT DIS, V45, P1427, DOI 10.1086/522984; Singh GK, 2010, CHILD MORTALITY US 1; Smylie J, 2012, LANCET, V380, P1384, DOI 10.1016/S0140-6736(12)61797-8; Teixeira JC, 2012, REV PANAM SALUD PUBL, V32, P419, DOI 10.1590/S1020-49892012001400005; United Nations, 2012, MILLENNIUM DEV GOALS; United Nations Development Programme, 2013, EXPL NOT 2013 HDR CO; Verhagen LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077581; Verhagen LM, 2012, PEDIATR INFECT DIS J, V31, P255, DOI 10.1097/INF.0b013e31823eed8e; Villalba JA, 2013, AIDS, V27, P1783, DOI 10.1097/QAD.0b013e3283601bdb; VOSS L, 1994, PEDIATR INFECT DIS J, V13, P873, DOI 10.1097/00006454-199410000-00005; White WA, 2002, INTERCIENCIA, V27, P521; Wilbert J, 1993, MYSTIC ENDOWNMENT RE; Wilbert Johannes, 1980, DEMOGRAPHIC BIOL STU, P13; Wilbert W, 2007, SALUD INDIGENA VENEZ, P331; World Bank, 2012, DEATH RAT CRUD PER 1; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; World Health Organization, 2013, WHO VACC PREV DIS MO	47	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85638	10.1371/journal.pone.0085638	http://dx.doi.org/10.1371/journal.pone.0085638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392022	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900166
J	Westhoff, MA; Faham, N; Marx, D; Nonnenmacher, L; Jennewein, C; Enzenmuller, S; Gonzalez, P; Fulda, S; Debatin, KM				Westhoff, Mike-Andrew; Faham, Najmeh; Marx, Daniela; Nonnenmacher, Lisa; Jennewein, Claudia; Enzenmueller, Stefanie; Gonzalez, Patrick; Fulda, Simone; Debatin, Klaus-Michael			Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma	PLOS ONE			English	Article							HIGH-RISK NEUROBLASTOMA; CELL-DEATH; GLIOBLASTOMA CELLS; TOPOISOMERASE-II; AKT; ACTIVATION; INHIBITOR; APOPTOSIS; CHEMOTHERAPY; AUTOPHAGY	Breaking resistance to chemotherapy is a major goal of combination therapy in many tumors, including advanced neuroblastoma. We recently demonstrated that increased activity of the PI3K/Akt network is associated with poor prognosis, thus providing an ideal target for chemosensitization. Here we show that targeted therapy using the PI3K/mTOR inhibitor NVP-BEZ235 significantly enhances doxorubicin-induced apoptosis in neuroblastoma cells. Importantly, this increase in apoptosis was dependent on scheduling: while pretreatment with the inhibitor reduced doxorubicin-induced apoptosis, the sensitizing effect in co-treatment could further be increased by delayed addition of the inhibitor post chemotherapy. Desensitization for doxorubicin-induced apoptosis seemed to be mediated by a combination of cell cycle-arrest and autophagy induction, whereas sensitization was found to occur at the level of mitochondria within one hour of NVP-BEZ235 posttreatment, leading to a rapid loss of mitochondrial membrane potential with subsequent cytochrome c release and caspase-3 activation. Within the relevant time span we observed marked alterations in a similar to 30 kDa protein associated with mitochondrial proteins and identified it as VDAC1/Porin protein, an integral part of the mitochondrial permeability transition pore complex. VDAC1 is negatively regulated by the PI3K/Akt pathway via GSK3 beta and inhibition of GSK3b, which is activated when Akt is blocked, ablated the sensitizing effect of NVP-BEZ235 posttreatment. Our findings show that cancer cells can be sensitized for chemotherapy induced cell death - at least in part - by NVP-BEZ235-mediated modulation of VDAC1. More generally, we show data that suggest that sequential dosing, in particular when multiple inhibitors of a single pathway are used in the optimal sequence, has important implications for the general design of combination therapies involving molecular targeted approaches towards the PI3K/Akt/mTOR signaling network.	[Westhoff, Mike-Andrew; Faham, Najmeh; Marx, Daniela; Nonnenmacher, Lisa; Jennewein, Claudia; Enzenmueller, Stefanie; Gonzalez, Patrick; Fulda, Simone; Debatin, Klaus-Michael] Univ Med Ctr Ulm, Dept Pediat & Adolescent Med, Ulm, Germany	Ulm University	Fulda, S (corresponding author), Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, Frankfurt, Germany.	simone.fulda@kgu.de; klaus-michael.debatin@uniklinik-ulm.de	Westhoff, Mike-Andrew/ABA-9272-2021; Debatin, Klaus-Michael/J-9704-2014	Westhoff, Mike-Andrew/0000-0003-3256-7100; Debatin, Klaus-Michael/0000-0002-8397-1886; Fulda, Simone/0000-0002-0459-6417	Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft; International Graduate School in Molecular Medicine Ulm	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School in Molecular Medicine Ulm	This work has been partially supported by grants from Deutsche Krebshilfe (SF and KMD), Deutsche Forschungsgemeinschaft (LN) and the International Graduate School in Molecular Medicine Ulm (CJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Bender A, 2011, ONCOGENE, V30, P494, DOI 10.1038/onc.2010.429; Berthold F, 2005, LANCET ONCOL, V6, P649, DOI 10.1016/S1470-2045(05)70291-6; Bien S, 2010, BIOCHEM PHARMACOL, V80, P1466, DOI 10.1016/j.bcp.2010.07.036; Boller D, 2008, CLIN CANCER RES, V14, P1172, DOI 10.1158/1078-0432.CCR-07-0737; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Buki A, 2000, J NEUROSCI, V20, P2825; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Caren H, 2010, P NATL ACAD SCI USA, V107, P4323, DOI 10.1073/pnas.0910684107; Caren H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-353; CHEUNG NKV, 1991, J CLIN ONCOL, V9, P1050, DOI 10.1200/JCO.1991.9.6.1050; Coughlin CM, 2010, BREAST CANCER RES TR, V124, P1, DOI 10.1007/s10549-010-1108-4; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davidoff AM, 2012, SEMIN PEDIATR SURG, V21, P2, DOI 10.1053/j.sempedsurg.2011.10.009; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Dubrovska A, 2010, CLIN CANCER RES, V16, P5692, DOI 10.1158/1078-0432.CCR-10-1601; Enzenmuller S, 2013, CANCER LETT, V329, P27, DOI 10.1016/j.canlet.2012.09.007; Enzenmuller S, 2013, ANTI-CANCER DRUG, V24, P14, DOI 10.1097/CAD.0b013e32835a36db; Ferraro C, 2000, CANCER RES, V60, P1901; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hixon ML, 2010, REV RECENT CLIN TRIA, V5, P189, DOI 10.2174/157488710792007329; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li XQ, 2005, BREAST CANCER RES, V7, pR589, DOI 10.1186/bcr1259; Li ZJ, 2007, EXPERT OPIN THER TAR, V11, P1611, DOI 10.1517/14728222.11.12.1611; Magan N, 2012, ANTI-CANCER DRUG, V23, P627, DOI 10.1097/CAD.0b013e328350900f; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Mueller S, 2011, CANCER LETT, V306, P223, DOI 10.1016/j.canlet.2011.03.010; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Paz-Ares L, 2009, CLIN TRANSL ONCOL, V11, P572, DOI 10.1007/s12094-009-0407-x; Prasad G, 2011, NEURO-ONCOLOGY, V13, P384, DOI 10.1093/neuonc/noq193; Qayum N, 2012, CLIN CANCER RES, V18, P161, DOI 10.1158/1078-0432.CCR-11-1413; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; ROSS RA, 1983, J NATL CANCER I, V71, P741; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sims JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055509; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; Westhoff MA, 2009, ONCOGENE, V28, P3586, DOI 10.1038/onc.2009.215; Zeng R, 2012, ACTA PHARMACOL SIN, V33, P91, DOI 10.1038/aps.2011.143	49	40	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83128	10.1371/journal.pone.0083128	http://dx.doi.org/10.1371/journal.pone.0083128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391739	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200036
J	Yamanaka, T; Tosaki, A; Kurosawa, M; Akimoto, K; Hirose, T; Ohno, S; Hattori, N; Nukina, N				Yamanaka, Tomoyuki; Tosaki, Asako; Kurosawa, Masaru; Akimoto, Kazunori; Hirose, Tomonori; Ohno, Shigeo; Hattori, Nobutaka; Nukina, Nobuyuki			Loss of aPKC lambda in Differentiated Neurons Disrupts the Polarity Complex but Does Not Induce Obvious Neuronal Loss or Disorientation in Mouse Brains	PLOS ONE			English	Article							PROTEIN-KINASE-C; DENDRITIC SPINE MORPHOGENESIS; ASYMMETRIC CELL-DIVISION; TRANSCRIPTION FACTOR; EPITHELIAL POLARITY; CEREBRAL-CORTEX; PAR-COMPLEX; PKM-ZETA; MICE; ESTABLISHMENT	Cell polarity plays a critical role in neuronal differentiation during development of the central nervous system (CNS). Recent studies have established the significance of atypical protein kinase C (aPKC) and its interacting partners, which include PAR-3, PAR-6 and Lgl, in regulating cell polarization during neuronal differentiation. However, their roles in neuronal maintenance after CNS development remain unclear. Here we performed conditional deletion of aPKC lambda, a major aPKC isoform in the brain, in differentiated neurons of mice by camk2a-cre or synapsinI-cre mediated gene targeting. We found significant reduction of aPKC lambda and total aPKCs in the adult mouse brains. The aPKC lambda deletion also reduced PAR-6 beta, possibly by its destabilization, whereas expression of other related proteins such as PAR-3 and Lgl-1 was unaffected. Biochemical analyses suggested that a significant fraction of aPKC lambda formed a protein complex with PAR-6 beta and Lgl-1 in the brain lysates, which was disrupted by the aPKC lambda deletion. Notably, the aPKC lambda deletion mice did not show apparent cell loss/degeneration in the brain. In addition, neuronal orientation/distribution seemed to be unaffected. Thus, despite the polarity complex disruption, neuronal deletion of aPKC lambda does not induce obvious cell loss or disorientation in mouse brains after cell differentiation.	[Yamanaka, Tomoyuki; Tosaki, Asako; Kurosawa, Masaru; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Saitama, Japan; [Yamanaka, Tomoyuki; Kurosawa, Masaru; Nukina, Nobuyuki] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan; [Akimoto, Kazunori] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Med Sci, Chiba, Japan; [Hirose, Tomonori; Ohno, Shigeo] Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Yokohama, Kanagawa 232, Japan; [Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Nukina, Nobuyuki] Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Tokyo, Japan	RIKEN; Juntendo University; Tokyo University of Science; Yokohama City University; Juntendo University; Japan Science & Technology Agency (JST)	Yamanaka, T (corresponding author), RIKEN Brain Sci Inst, Lab Struct Neuropathol, Saitama, Japan.	yamanakat@brain.riken.jp; nnukina@juntendo.ac.jp	Hirose, Tomonori/F-6015-2010; Hirose, Tomonori/M-8872-2019; Hattori, Nobutaka/ACR-0069-2022; Nukina, Nobuyuki/GPP-6265-2022; Ohno, Shigeo/B-1768-2010	Hirose, Tomonori/0000-0003-2428-0919; Hirose, Tomonori/0000-0003-2428-0919; Ohno, Shigeo/0000-0002-1294-5269	Ministry of Education, Culture, Sports, Science and Technology of Japan [24111553, 23700430, 22110004, 22240037, 24659436]; RIKEN; Japan Science and Technology Agency; Ministry of Health, Welfare and Labor	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Welfare and Labor(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid from Ministry of Education, Culture, Sports, Science and Technology of Japan for TY (24111553, 23700430) and NN (22110004, 22240037, 24659436) (http://www.mext.go.jp/), by Special Postdoctoral Researchers Program of RIKEN for TY. (http://www.riken.go.jp/en/careers/programs/spdr/), by Core Research for Evolutionary Science and Technology from Japan Science and Technology Agency for NN. (http://www.jst.go.jp/kisoken/crest/); and by Grant-in-Aid for the Research on Measures for Ataxic Diseases from the Ministry of Health, Welfare and Labor for NN (http://ataxia.umin.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Atwood SX, 2013, NATURE, V494, P484, DOI 10.1038/nature11889; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Cheng PL, 2011, NEURON, V69, P231, DOI 10.1016/j.neuron.2010.12.021; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Duman JG, 2013, J NEUROSCI, V33, P6964, DOI 10.1523/JNEUROSCI.3978-12.2013; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Halpain S, 2005, PROG BRAIN RES, V147, P29, DOI 10.1016/S0079-6123(04)47003-4; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; Hirano Y, 2004, J BIOL CHEM, V279, P31883, DOI 10.1074/jbc.M403092200; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Hirose T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004194; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Insolera R, 2011, DEV NEUROBIOL, V71, P483, DOI 10.1002/dneu.20867; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kobayashi Y, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00017; Koike C, 2005, J NEUROSCI, V25, P10290, DOI 10.1523/JNEUROSCI.3657-05.2005; Lee AM, 2013, NATURE, V493, P416, DOI 10.1038/nature11803; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Rempe D, 2006, GENESIS, V44, P44, DOI 10.1002/gene.20183; Ren SQ, 2013, EMBO J, V32, P1365, DOI 10.1038/emboj.2013.60; Rolls MM, 2004, NAT NEUROSCI, V7, P1293, DOI 10.1038/nn1346; Sabherwal N, 2009, DEVELOPMENT, V136, P2767, DOI 10.1242/dev.034454; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seidl S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062756; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Sugiyama Y, 2009, DEV BIOL, V336, P246, DOI 10.1016/j.ydbio.2009.10.010; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tanabe K, 2010, J NEUROSCI, V30, P16983, DOI 10.1523/JNEUROSCI.3352-10.2010; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802; Wang T, 2011, DEV CELL, V21, P431, DOI 10.1016/j.devcel.2011.07.007; Wilson MI, 2003, MOL CELL, V12, P39, DOI 10.1016/S1097-2765(03)00246-6; Wodarz A, 2005, CURR OPIN CELL BIOL, V17, P475, DOI 10.1016/j.ceb.2005.08.005; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yamanaka T, 2001, GENES CELLS, V6, P721, DOI 10.1046/j.1365-2443.2001.00453.x; Yamanaka T, 2008, FRONT BIOSCI-LANDMRK, V13, P6693, DOI 10.2741/3182; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938; Yamanaka T, 2010, HUM MOL GENET, V19, P2099, DOI 10.1093/hmg/ddq087; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Zarnescu DC, 2005, DEV CELL, V8, P43, DOI 10.1016/j.devcel.2004.10.020; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	73	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84036	10.1371/journal.pone.0084036	http://dx.doi.org/10.1371/journal.pone.0084036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391875	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900018
J	Zhao, B; Zhang, M; Han, X; Zhang, XY; Xing, Q; Dong, X; Shi, QJ; Huang, P; Lu, YB; Wei, EQ; Xia, Q; Zhang, WP; Tang, C				Zhao, Bing; Zhang, Meng; Han, Xue; Zhang, Xia-Yan; Xing, Qiong; Dong, Xu; Shi, Qiao-Juan; Huang, Peng; Lu, Yun-Bi; Wei, Er-Qing; Xia, Qiang; Zhang, Wei-Ping; Tang, Chun			Cerebral Ischemia Is Exacerbated by Extracellular Nicotinamide Phosphoribosyltransferase via a Non-Enzymatic Mechanism	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; VISFATIN CONCENTRATIONS; NEUROPROTECTION; METABOLISM; EXPRESSION; PROTECTS; STROKE; NAD(+); MODEL	Intracellular nicotinamide phosphoribosyltransferase (iNAMPT) in neuron has been known as a protective factor against cerebral ischemia through its enzymatic activity, but the role of central extracellular NAMPT (eNAMPT) is not clear. Here we show that eNAMPT protein level was elevated in the ischemic rat brain after middle-cerebral-artery occlusion (MCAO) and reperfusion, which can be traced to at least in part from blood circulation. Administration of recombinant NAMPT protein exacerbated MCAO-induced neuronal injury in rat brain, while exacerbated oxygen-glucose-deprivation (OGD) induced neuronal injury only in neuron-glial mixed culture, but not in neuron culture. In the mixed culture, NAMPT protein promoted TNF-alpha release in a time-and concentration-dependent fashion, while TNF-alpha neutralizing antibody protected OGD-induced, NAMPT-enhanced neuronal injury. Importantly, H247A mutant of NAMPT with essentially no enzymatic activity exerted similar effects on ischemic neuronal injury and TNF-alpha release as the wild type protein. Thus, eNAMPT is an injurious and inflammatory factor in cerebral ischemia and aggravates ischemic neuronal injury by triggering TNF-alpha release from glia cells, via a mechanism not related to NAMPT enzymatic activity.	[Zhao, Bing; Han, Xue; Zhang, Xia-Yan; Shi, Qiao-Juan; Huang, Peng; Lu, Yun-Bi; Wei, Er-Qing; Zhang, Wei-Ping] Zhejiang Univ, Sch Med, Dept Pharmacol,Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China, Hangzhou 310003, Zhejiang, Peoples R China; [Xing, Qiong; Dong, Xu; Tang, Chun] Chinese Acad Sci, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Ctr Magnet, Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Zhang, Meng; Xia, Qiang] Zhejiang Univ, Sch Med, Dept Physiol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Bing] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Anesthesiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Zhejiang University; Zhejiang University	Zhang, WP (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol,Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China, Hangzhou 310003, Zhejiang, Peoples R China.	weiping601@zju.edu.cn	Tang, Chun/P-4060-2019	Tang, Chun/0000-0001-6477-6500	Ministry of Science and Technology [2013CB910200]; National Natural Sciences Foundation [81072619, 81373392, 81173041, 81272594, 81273491, 30873053]; Zhejiang Provincial Natural Science Foundation of China [Z2110059]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The work was supported by funds from the Ministry of Science and Technology (2013CB910200), the National Natural Sciences Foundation (81072619, 81373392, 81173041, 81272594, 81273491 and 30873053) and Zhejiang Provincial Natural Science Foundation of China (Z2110059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bi J, 2012, J NEUROCHEM, V120, P334, DOI 10.1111/j.1471-4159.2011.07566.x; Borradaile NM, 2009, CURR PHARM DESIGN, V15, P110, DOI 10.2174/138161209787185742; Chan TF, 2007, FERTIL STERIL, V88, P401, DOI 10.1016/j.fertnstert.2006.11.120; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; ERECINSKA M, 1978, AM J PHYSIOL, V234, pC82, DOI 10.1152/ajpcell.1978.234.3.C82; Filippatos TD, 2013, NUTR METAB CARDIOVAS, V23, P330, DOI 10.1016/j.numecd.2011.07.002; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Garten A, 2010, BIOCHEM BIOPH RES CO, V391, P376, DOI 10.1016/j.bbrc.2009.11.066; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Jin H, 2008, DIABETES RES CLIN PR, V79, P412, DOI 10.1016/j.diabres.2007.09.019; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu P, 2009, J BIOL CHEM, V284, P27344, DOI 10.1074/jbc.M109.002519; Love S, 1999, BRAIN PATHOL, V9, P119; Lu LF, 2009, J STROKE CEREBROVASC, V18, P354, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.003; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Pillai VB, 2013, AM J PHYSIOL-HEART C, V304, pH415, DOI 10.1152/ajpheart.00468.2012; Presumey J, 2013, ANN RHEUM DIS, V72, P1717, DOI 10.1136/annrheumdis-2012-202403; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Siegel C, 2011, ACTA PHYSIOL, V203, P225, DOI 10.1111/j.1748-1716.2010.02229.x; Surjana D, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/157591; Taskesen D, 2012, J CLIN RES PEDIATR E, V4, P76, DOI [10.4274/Jcrpe.547, 10.4274/jcrpe.547]; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wang P, 2012, J CARDIOVASC PHARM, V59, P1, DOI 10.1097/FJC.0b013e31820eb8f6; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhang WP, 2010, J CEREBR BLOOD F MET, V30, P1962, DOI 10.1038/jcbfm.2010.71; Zhao CZ, 2011, NEUROSCIENCE, V189, P1, DOI 10.1016/j.neuroscience.2011.05.066	40	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85403	10.1371/journal.pone.0085403	http://dx.doi.org/10.1371/journal.pone.0085403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392007	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900151
J	Kedracka-Krok, S; Jankowska, U; Elas, M; Sowa, U; Swakon, J; Cierniak, A; Olko, P; Romanowska-Dixon, B; Urbanska, K				Kedracka-Krok, Sylwia; Jankowska, Urszula; Elas, Martyna; Sowa, Urszula; Swakon, Jan; Cierniak, Agnieszka; Olko, Pawel; Romanowska-Dixon, Bozena; Urbanska, Krystyna			Proteomic Analysis of Proton Beam Irradiated Human Melanoma Cells	PLOS ONE			English	Article							MAJOR VAULT PROTEIN; RECEPTOR-ASSOCIATED PROTEIN; CHINESE-HAMSTER CELLS; STRESS GRANULES; PROSTATE-CANCER; TGF-BETA; UVEAL MELANOMA; LAMIN A/C; RADIATION; APOPTOSIS	Proton beam irradiation is a form of advanced radiotherapy providing superior distributions of a low LET radiation dose relative to that of photon therapy for the treatment of cancer. Even though this clinical treatment has been developing for several decades, the proton radiobiology critical to the optimization of proton radiotherapy is far from being understood. Proteomic changes were analyzed in human melanoma cells treated with a sublethal dose (3 Gy) of proton beam irradiation. The results were compared with untreated cells. Two-dimensional electrophoresis was performed with mass spectrometry to identify the proteins. At the dose of 3 Gy a minimal slowdown in proliferation rate was seen, as well as some DNA damage. After allowing time for damage repair, the proteomic analysis was performed. In total 17 protein levels were found to significantly (more than 1.5 times) change: 4 downregulated and 13 upregulated. Functionally, they represent four categories: (i) DNA repair and RNA regulation (VCP, MVP, STRAP, FAB-2, Lamine A/C, GAPDH), (ii) cell survival and stress response (STRAP, MCM7, Annexin 7, MVP, Caprin-1, PDCD6, VCP, HSP70), (iii) cell metabolism (TIM, GAPDH, VCP), and (iv) cytoskeleton and motility (Moesin, Actinin 4, FAB-2, Vimentin, Annexin 7, Lamine A/C, Lamine B). A substantial decrease (2.3 x) was seen in the level of vimentin, a marker of epithelial to mesenchymal transition and the metastatic properties of melanoma.	[Kedracka-Krok, Sylwia; Jankowska, Urszula; Elas, Martyna; Cierniak, Agnieszka; Urbanska, Krystyna] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Sowa, Urszula; Swakon, Jan; Olko, Pawel] PAS, Inst Nucl Phys, Krakow, Poland; [Romanowska-Dixon, Bozena] Jagiellonian Univ, Coll Med, Dept Ophthalmol & Ophthalm Oncol, Krakow, Poland; [Kedracka-Krok, Sylwia; Jankowska, Urszula] Malopolska Ctr Biotechnol, Krakow, Poland	Jagiellonian University; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University	Elas, M (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	martyna.elas@uj.edu.pl	Jankowska, Urszula/C-4898-2015; Olko, Pawel/AAM-4279-2021; Swakoń, Jan/M-5808-2018; Olko, Pawel/V-9030-2018; Elas, Martyna/E-3584-2017; Cierniak, Agnieszka/O-3139-2019; Sowa, Urszula/N-7162-2018	Jankowska, Urszula/0000-0002-7165-8964; Olko, Pawel/0000-0001-5554-8178; Swakoń, Jan/0000-0001-9262-7326; Olko, Pawel/0000-0001-5554-8178; Elas, Martyna/0000-0001-6296-2844; Cierniak, Agnieszka/0000-0001-6537-2954; Sowa, Urszula/0000-0002-0619-4358; Urbanska, Krystyna/0000-0001-9643-4740	European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program [POIG.02.01.00-12-167/08]	European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program	The MS measurements were performed using the spectrometer MicroTOF purchased by the European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program (contract No. POIG.02.01.00-12-167/08, project Malopolska Center of Biotechnology, http://www.poig.gov.pl/english/Strony/Introduction. aspx), supported by grant Nr 2023/B/P01/2010/39 (K/PBW/000676) from the Polish Ministry of Science and Higher Education (http://www.nauka.gov.pl/en/), and by grants UMO-2012/05/B/NZ4/02428 (K/PBO/000134) and 012/07/B/NZ4/01657 from the National Science Center, Krakow, Poland (http://www.ncn.gov.pl/?language=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaan OD, 2013, EXP CELL RES, V319, P1, DOI 10.1016/j.yexcr.2012.09.003; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; Atkinson MJ, 2013, ADV EXP MED BIOL, V990, P49, DOI 10.1007/978-94-007-5896-4_3; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; BENZEEV A, 1985, CANCER RES, V45, P2632; Berardi MJ, 2011, CURR OPIN GENET DEV, V21, P59, DOI 10.1016/j.gde.2010.10.001; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun RJ, 2008, BBA-MOL CELL RES, V1783, P1418, DOI 10.1016/j.bbamcr.2008.01.015; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Calugaru V, 2011, INT J RADIAT ONCOL, V81, P1136, DOI 10.1016/j.ijrobp.2010.09.003; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Cukier CD, 2010, NAT STRUCT MOL BIOL, V17, P1058, DOI 10.1038/nsmb.1883; Di Pietro C, 2006, APOPTOSIS, V11, P57, DOI 10.1007/s10495-005-3346-1; Estecha A, 2009, J CELL SCI, V122, P3492, DOI 10.1242/jcs.053157; Fernandez-Flores A, 2012, ROM J MORPHOL EMBRYO, V53, P449; Finnberg N, 2008, CANCER BIOL THER, V7, P2023, DOI 10.4161/cbt.7.12.7417; Fokas E, 2009, BBA-REV CANCER, V1796, P216, DOI 10.1016/j.bbcan.2009.07.005; Formentini L, 2010, IUBMB LIFE, V62, P554, DOI 10.1002/iub.352; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Ghosh S, 2010, CANCER INVEST, V28, P615, DOI 10.3109/07357901003630991; Girdhani S., 2013, RADIAT RES, V179, P1; Gridley DS, 2011, INT J RADIAT BIOL, V87, P1173, DOI 10.3109/09553002.2011.624393; Hada M, 2006, RADIAT RES, V165, P223, DOI 10.1667/RR3498.1; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; He M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-170; Helfand BT, 2012, J PATHOL, V226, P735, DOI 10.1002/path.3033; Hofmann UB, 2000, J INVEST DERMATOL, V2; Huang SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004430; Ianzini F, 1999, INT J RADIAT BIOL, V75, P717, DOI 10.1080/095530099140050; Ibanez IL, 2009, INT J RADIAT ONCOL, V74, P1226, DOI 10.1016/j.ijrobp.2009.02.070; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Ivaska Johanna, 2011, Small GTPases, V2, P51; Kim W, 2008, MOL BIOL CELL, V19, P2135, DOI 10.1091/mbc.E07-10-0991; Kong L, 2012, CARCINOGENESIS, V33, P751, DOI 10.1093/carcin/bgs022; Koricanac L, 2007, RUSS J PHYS CHEM A+, V81, P1467, DOI 10.1134/S0036024407090233; Koricanac LB, 2010, CHEMOTHERAPY, V56, P214, DOI 10.1159/000316333; Lara PC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-148; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; Lee KB, 2008, EXP MOL MED, V40, P118, DOI 10.3858/emm.2008.40.1.118; Lee KB, 2008, INT J ONCOL, V33, P1247, DOI 10.3892/ijo_00000115; Leloup C, 2005, INT J RADIAT BIOL, V81, P41, DOI 10.1080/09553000400017895; Li M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-109; Linge A, 2012, INVEST OPHTH VIS SCI, V53, P4634, DOI 10.1167/iovs.11-9019; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035800; Lloret M, 2009, INT J RADIAT ONCOL, V73, P976, DOI 10.1016/j.ijrobp.2008.11.013; LOCKSHIN A, 1985, CANCER RES, V45, P345; Luo JH, 2011, WORLD J CLIN ONCOL, V2, P120, DOI 10.5306/wjco.v2.i2.120; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Malz M, 2009, HEPATOLOGY, V50, P1130, DOI 10.1002/hep.23051; Marchetti F, 2006, INT J RADIAT BIOL, V82, P605, DOI 10.1080/09553000600930103; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meir T, 2007, INVEST OPHTH VIS SCI, V48, P4890, DOI 10.1167/iovs.07-0215; Meyer H, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-48; Mukherjee P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005462; Ogata T, 2005, CANCER RES, V65, P113; Osugi K, 2012, J BIOCHEM, V151, P657, DOI 10.1093/jb/mvs029; Pardo M, 2005, PROTEOMICS, V5, P4980, DOI 10.1002/pmic.200500030; Park SH, 2012, CELL SIGNAL, V24, P726, DOI 10.1016/j.cellsig.2011.11.006; Petrovic I, 2006, INT J RADIAT BIOL, V82, P251, DOI 10.1080/09553000600669859; Petrovic I, 2010, INT J RADIAT BIOL, V86, P742, DOI 10.3109/09553002.2010.481322; Petrovic IM, 2007, ANN NY ACAD SCI, V1095, P154, DOI 10.1196/annals.1397.019; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Redwood AB, 2011, CELL CYCLE, V10, P3652, DOI 10.4161/cc.10.21.18201; Reiner JE, 2011, FRONT BIOSCI-LANDMRK, V16, P105, DOI 10.2741/3678; Rho SB, 2012, CELL SIGNAL, V24, P131, DOI 10.1016/j.cellsig.2011.08.013; Ristic-Fira A, 2004, ONCOL REP, V12, P1323; Ristic-Fira A, 2001, J EXP CLIN CANC RES, V20, P135; Ristic-Fira AM, 2007, ANN NY ACAD SCI, V1095, P165, DOI 10.1196/annals.1397.020; Ristic-Fira AM, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-50; Ristic-Fira AM, 2008, PHYS MEDICA, V24, P187, DOI 10.1016/j.ejmp.2008.04.002; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Rodriguez-Cerdeira Carmen, 2011, Open Biochem J, V5, P60, DOI 10.2174/1874091X01105010060; Saffari M, 2009, CANCER LETT, V273, P316, DOI 10.1016/j.canlet.2008.08.020; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Seong HA, 2011, J BIOL CHEM, V286, P7439, DOI 10.1074/jbc.M110.184382; Sgura A, 2000, INT J RADIAT BIOL, V76, P367, DOI 10.1080/095530000138709; Shi YK, 2008, AM J PATHOL, V173, P1758, DOI 10.2353/ajpath.2008.080363; Shimamoto Y, 2006, ONCOL REP, V15, P645; Silva P, 2007, INT J RADIAT ONCOL, V69, P133, DOI 10.1016/j.ijrobp.2007.02.025; SINGH NP, 1994, INT J RADIAT BIOL, V66, P23, DOI 10.1080/09553009414550911; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Sprung R, 2008, J PROTEOME RES, V7, P1001, DOI [10.1021/pr0705338, 10.1021/pr8005155]; Sun MZ, 2009, PROTEOMICS, V9, P3285, DOI 10.1002/pmic.200701002; Suzuki K, 2012, CANCER SCI, V103, P1788, DOI 10.1111/j.1349-7006.2012.02362.x; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Todorovic D, 2008, J MICROSC-OXFORD, V232, P517, DOI 10.1111/j.1365-2818.2008.02151.x; Torosyan Y, 2009, INT J CANCER, V125, P2528, DOI 10.1002/ijc.24592; Toyokawa G, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-65; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Valenciano A, 2012, TRANSL ONCOL, V5, P1, DOI 10.1593/tlo.11265; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729; Wang B, 2005, J IMMUNOL, V175, P4274, DOI 10.4049/jimmunol.175.7.4274; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Willis ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002988; Wloga D, 2011, J CELL SCI, V124, P154, DOI 10.1242/jcs.083576; Wu Y, 2002, ONCOGENE, V21, P6801, DOI 10.1038/sj.onc.1205849; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Zhou YM, 2012, LIVER INT, V32, P1505, DOI 10.1111/j.1478-3231.2012.02846.x	106	19	20	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84621	10.1371/journal.pone.0084621	http://dx.doi.org/10.1371/journal.pone.0084621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392146	gold, Green Published			2022-12-27	WOS:000329460100069
J	Figueiredo, J; Simoes, MJ; Gomes, P; Barroso, C; Pinho, D; Conceicao, L; Fonseca, L; Abrantes, I; Pinheiro, M; Egas, C				Figueiredo, Joana; Simoes, Maria Jose; Gomes, Paula; Barroso, Cristina; Pinho, Diogo; Conceicao, Luci; Fonseca, Luis; Abrantes, Isabel; Pinheiro, Miguel; Egas, Conceicao			Assessment of the Geographic Origins of Pinewood Nematode Isolates via Single Nucleotide Polymorphism in Effector Genes	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS NEMATODA; ROOT-LESION NEMATODE; WOOD NEMATODE; WILT DISEASE; TRANSCRIPTOME ANALYSIS; SPREAD ROUTES; SNP DISCOVERY; APHELENCHOIDIDAE; EVOLUTION; IDENTIFICATION	The pinewood nematode, Bursaphelenchus xylophilus, is native to North America but it only causes damaging pine wilt disease in those regions of the world where it has been introduced. The accurate detection of the species and its dispersal routes are thus essential to define effective control measures. The main goals of this study were to analyse the genetic diversity among B. xylophilus isolates from different geographic locations and identify single nucleotide polymorphism (SNPs) markers for geographic origin, through a comparative transcriptomic approach. The transcriptomes of seven B. xylophilus isolates, from Continental Portugal (4), China (1), Japan (1) and USA (1), were sequenced in the next generation platform Roche 454. Analysis of effector gene transcripts revealed inter-isolate nucleotide diversity that was validated by Sanger sequencing in the genomic DNA of the seven isolates and eight additional isolates from different geographic locations: Madeira Island (2), China (1), USA (1), Japan (2) and South Korea (2). The analysis identified 136 polymorphic positions in 10 effector transcripts. Pairwise comparison of the 136 SNPs through Neighbor-Joining and the Maximum Likelihood methods and 5-mer frequency analysis with the alignment-independent bilinear multivariate modelling approach correlated the SNPs with the isolates geographic origin. Furthermore, the SNP analysis indicated a closer proximity of the Portuguese isolates to the Korean and Chinese isolates than to the Japanese or American isolates. Each geographic cluster carried exclusive alleles that can be used as SNP markers for B. xylophilus isolate identification.	[Figueiredo, Joana] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Simoes, Maria Jose; Gomes, Paula; Barroso, Cristina; Pinho, Diogo; Pinheiro, Miguel; Egas, Conceicao] Genoinseq, Next Generat Sequencing Unit, Biocant, Cantanhede, Portugal; [Conceicao, Luci; Fonseca, Luis; Abrantes, Isabel] Univ Coimbra, Dept Life Sci, IMAR CMA, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Egas, C (corresponding author), Genoinseq, Next Generat Sequencing Unit, Biocant, Cantanhede, Portugal.	cegas@biocant.pt	Conceição, I L/AAC-8173-2020; Simoes, Manuel J/H-2642-2014; Abrantes, Isabel/CAG-1426-2022; Egas, Conceição/K-4866-2014; Pinho, Diogo/ABG-5993-2021; Pinheiro, Miguel/K-4467-2017	Conceição, I L/0000-0002-3017-0639; Simoes, Manuel J/0000-0003-2770-8618; Abrantes, Isabel/0000-0002-8761-2151; Egas, Conceição/0000-0002-2307-5414; Pinho, Diogo/0000-0002-0377-2802; Barroso, Cristina/0000-0001-5476-0986; Pinheiro, Miguel/0000-0002-6601-7513; Figueiredo, Joana/0000-0002-1995-1231; Fonseca, Luis/0000-0001-7405-8916; Pinto Simoes, Maria Jose/0000-0001-9810-1683	FEDER funds through Programa Operacional Factores de Competitividade (COMPETE); Portuguese Foundation for Science and Technology, FCT [PTDC/AGR-CFL/098916/2008, FCOMP-01-0124-FEDER-008794]; Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional	FEDER funds through Programa Operacional Factores de Competitividade (COMPETE); Portuguese Foundation for Science and Technology, FCT(Portuguese Foundation for Science and Technology); Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional	The study was funded from FEDER funds through the Programa Operacional Factores de Competitividade (COMPETE) and by national funds through the Portuguese Foundation for Science and Technology, FCT project PTDC/AGR-CFL/098916/2008, FCOMP-01-0124-FEDER-008794 (www.fct.pt), and from Direccao Regional de Florestas, Fundo Florestal Permanente and Autoridade Florestal Nacional, through a national project "O nematode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Akbulut S, 2012, FOREST PATHOL, V42, P89, DOI 10.1111/j.1439-0329.2011.00733.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Baum Thomas J, 2007, Genet Eng (N Y), V28, P17, DOI 10.1007/978-0-387-34504-8_2; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Davis EL, 2004, TRENDS PARASITOL, V20, P134, DOI 10.1016/j.pt.2004.01.005; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; EPPO/OEPP, 1986, B OEPP EPPO, V16, P55; Estelle M, 2001, CURR OPIN PLANT BIOL, V4, P254, DOI 10.1016/S1369-5266(00)00169-2; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fonseca L, 2012, HELMINTHOLOGIA, V49, P96, DOI 10.2478/s11687-012-0020-3; Fonseca L, 2008, PHYTOPATHOL MEDITERR, V47, P223; Fu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041639; Gao BL, 2003, MOL PLANT MICROBE IN, V16, P720, DOI 10.1094/MPMI.2003.16.8.720; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Haegeman A, 2009, MOL BIOCHEM PARASIT, V167, P32, DOI 10.1016/j.molbiopara.2009.04.004; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Ichihara Y, 2000, PLANT DIS, V84, P675, DOI 10.1094/PDIS.2000.84.6.675; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; JUKES T H, 1969, P21; Jung J, 2010, ANIM CELLS SYST, V14, P31, DOI 10.1080/19768351003770889; Kawasaki T, 1999, DEV GROWTH DIFFER, V41, P273; Kikuchi T, 2006, MOL PLANT MICROBE IN, V19, P280, DOI 10.1094/MPMI-19-0280; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kikuchi T, 2007, MOL BIOCHEM PARASIT, V155, P9, DOI 10.1016/j.molbiopara.2007.05.002; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T, 2009, NEMATOLOGY, V11, P355, DOI 10.1163/156854109X446953; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuroda K, PINE WILT DIS, P204; Lin SF, 2011, EXP PARASITOL, V127, P440, DOI 10.1016/j.exppara.2010.10.013; Mamiya Y, 2004, NEMATOL MONOGR PERSP, V1, P9; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159, DOI 10.1163/187529272X00395; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021388; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metge K, 2006, J PLANT DIS PROTECT, V113, P275, DOI 10.1007/BF03356193; Mitchum MG, 2007, BIOTECHNOLOGY AND PLANT DISEASE MANAGEMENT, P58, DOI 10.1079/9781845932886.0058; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Mota MM, 2006, J NEMATOL, V38, P429; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Oliver RE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-77; Pereira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056288; Rudi K, 2006, INT J SYST EVOL MICR, V56, P1565, DOI 10.1099/ijs.0.63936-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samarakoon U, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-116; Santos CS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-599; Schuster LN, 2012, GENE, V506, P274, DOI 10.1016/j.gene.2012.07.013; Sekelja M, 2011, ISME J, V5, P519, DOI 10.1038/ismej.2010.129; Sommer RJ, 2011, ANNU REV GENET, V45, P1, DOI 10.1146/annurev-genet-110410-132417; Sousa E, 2001, NEMATOLOGY, V3, P89, DOI 10.1163/156854101300106937; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; Umebayashi T, 2011, PLANT PHYSIOL, V156, P943, DOI 10.1104/pp.110.170282; Valadas V, 2013, J HELMINTHOL, V87, P457, DOI 10.1017/S0022149X12000673; Valadas V, 2012, NEMATOLOGY, V14, P899, DOI 10.1163/156854112X632673; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vieira P, 2007, J NEMATOL, V39, P118; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-307; Wheat Christopher W, 2012, Methods Mol Biol, V888, P33, DOI 10.1007/978-1-61779-870-2_3; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yoo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-290; Zhang KY, 2008, J NEMATOL, V40, P127; Zhang Q, 2006, BIOSCI BIOTECH BIOCH, V70, P2727, DOI 10.1271/bbb.60330; Zhou ZH, 2007, PHYTOPATHOLOGY, V97, P304, DOI 10.1094/PHYTO-97-3-0304; Zhulidov PA, 2005, RUSS J BIOORG CHEM+, V31, P170, DOI 10.1007/s11171-005-0023-7	87	19	22	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83542	10.1371/journal.pone.0083542	http://dx.doi.org/10.1371/journal.pone.0083542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391785	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200082
J	Roach, KM; Duffy, SM; Coward, W; Feghali-Bostwick, C; Wulff, H; Bradding, P				Roach, Katy Morgan; Duffy, Stephen Mark; Coward, William; Feghali-Bostwick, Carol; Wulff, Heike; Bradding, Peter			The K+ Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; EXTRACELLULAR-MATRIX; CELL PROLIFERATION; UP-REGULATION; LUNG; FIBROBLASTS; GROWTH; 1-ETHYL-2-BENZIMIDAZOLINONE; DIFFERENTIATION; MYOFIBROBLASTS	Background: Idiopathic pulmonary fibrosis (IPF) is a common, progressive and invariably lethal interstitial lung disease with no effective therapy. We hypothesised that K(Ca)3.1 K+ channel-dependent cell processes contribute to IPF pathophysiology. Methods: K(Ca)3.1 expression in primary human lung myofibroblasts was examined using RT-PCR, western blot, immunofluorescence and patch-clamp electrophysiology. The role of K(Ca)3.1 channels in myofibroblast proliferation, wound healing, collagen secretion and contraction was examined using two specific and distinct K(Ca)3.1 blockers (TRAM-34 and ICA-17043 [Senicapoc]). Results: Both healthy non fibrotic control and IPF-derived human lung myofibroblasts expressed K(Ca)3.1 channel mRNA and protein. K(Ca)3.1 ion currents were elicited more frequently and were larger in IPF-derived myofibroblasts compared to controls. K(Ca)3.1 currents were increased in myofibroblasts by TGF beta 1 and basic FGF. K(Ca)3.1 was expressed strongly in IPF tissue. K(Ca)3.1 pharmacological blockade attenuated human myofibroblast proliferation, wound healing, collagen secretion and contractility in vitro, and this was associated with inhibition of TGF beta 1-dependent increases in intracellular free Ca2+. Conclusions: K(Ca)3.1 activity promotes pro-fibrotic human lung myofibroblast function. Blocking K(Ca)3.1 may offer a novel approach to treating IPF with the potential for rapid translation to the clinic.	[Roach, Katy Morgan; Duffy, Stephen Mark; Bradding, Peter] Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England; [Coward, William] Univ Nottingham, Div Resp Med, Ctr Resp Res, Nottingham NG7 2RD, England; [Coward, William] Univ Nottingham, Nottingham Resp Biomed Res Unit, Nottingham NG7 2RD, England; [Feghali-Bostwick, Carol] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Leicester; University of Nottingham; University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis	Bradding, P (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England.	pbradding@hotmail.com	wulff, Heike/Z-2056-2019	Bradding, Peter/0000-0001-8403-0319; Roach, Katy M/0000-0002-4825-8719	College of Medicine, Biological Sciences and Psychology, University of Leicester, United Kingdom; Dunhill Medical Trust [R270/1112]; National Institute for Health Research Leicester Respiratory Biomedical Research Unit; National Institute of Health [RO1 GM076063]; The Dunhill Medical Trust [R270/1112] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076063] Funding Source: NIH RePORTER	College of Medicine, Biological Sciences and Psychology, University of Leicester, United Kingdom; Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research Leicester Respiratory Biomedical Research Unit; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Dunhill Medical Trust(Dunhill Medical Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Katy Roach was supported by a PhD Studentship from the College of Medicine, Biological Sciences and Psychology, University of Leicester, United Kingdom, and project grant R270/1112 from Dunhill Medical Trust. The work was also supported in part by supported by the National Institute for Health Research Leicester Respiratory Biomedical Research Unit. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. HW was supported by RO1 GM076063 from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataga KI, 2008, BLOOD, V111, P3991, DOI 10.1182/blood-2007-08-110098; Bi D, 2013, J BIOL CHEM, V288, P15843, DOI 10.1074/jbc.M112.427187; Chen MX, 2004, N-S ARCH PHARMACOL, V369, P602, DOI 10.1007/s00210-004-0934-5; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Cruse G, 2011, J ALLERGY CLIN IMMUN, V128, P1303, DOI 10.1016/j.jaci.2011.07.047; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P311, DOI 10.1002/art.22314; Duffy SM, 2004, J ALLERGY CLIN IMMUN, V114, P66, DOI 10.1016/j.jaci.2004.04.005; Duffy SM, 2003, J ALLERGY CLIN IMMUN, V112, P965, DOI 10.1016/j.jaci.2003.07.004; Duffy SM, 2001, J IMMUNOL, V167, P4261, DOI 10.4049/jimmunol.167.8.4261; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Keira Sidney Mamoru, 2004, Acta Cir. Bras., V19, P11, DOI 10.1590/S0102-86502004000700004; Koegel H, 2003, J BIOL CHEM, V278, P3323, DOI 10.1074/jbc.M208914200; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kotaru C, 2006, AM J RESP CRIT CARE, V173, P1208, DOI 10.1164/rccm.200508-1218OC; Kroigaard C, 2012, BRIT J PHARMACOL, V167, P37, DOI 10.1111/j.1476-5381.2012.01986.x; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Ohya S, 2011, J BIOL CHEM, V286, P16940, DOI 10.1074/jbc.M110.184192; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pilewski JM, 2005, AM J PATHOL, V166, P399, DOI 10.1016/S0002-9440(10)62263-8; RAGHU G, 1989, AM REV RESPIR DIS, V140, P95, DOI 10.1164/ajrccm/140.1.95; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Stankevicius E, 2011, J PHARMACOL EXP THER, V339, P842, DOI 10.1124/jpet.111.179242; Stocker JW, 2003, BLOOD, V101, P2412, DOI 10.1182/blood-2002-05-1433; Strieter RM, 2005, CHEST, V128, p526S, DOI 10.1378/chest.128.5_suppl_1.526S; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Woodman L, 2008, J IMMUNOL, V181, P5001, DOI 10.4049/jimmunol.181.7.5001; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Zhou X, 2011, AM J RESP CELL MOL B	40	41	42	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85244	10.1371/journal.pone.0085244	http://dx.doi.org/10.1371/journal.pone.0085244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392001	Green Accepted, Green Published, gold			2022-12-27	WOS:000329323900144
J	Shen, HL; Tao, DC; Ma, DF				Shen, Hualei; Tao, Dacheng; Ma, Dianfu			Dual-Force ISOMAP: A New Relevance Feedback Method for Medical Image Retrieval	PLOS ONE			English	Article							DIMENSIONALITY REDUCTION; CLASSIFICATION; ANNOTATION; SUBSPACE	With great potential for assisting radiological image interpretation and decision making, content-based image retrieval in the medical domain has become a hot topic in recent years. Many methods to enhance the performance of content-based medical image retrieval have been proposed, among which the relevance feedback (RF) scheme is one of the most promising. Given user feedback information, RF algorithms interactively learn a user's preferences to bridge the "semantic gap" between low-level computerized visual features and high-level human semantic perception and thus improve retrieval performance. However, most existing RF algorithms perform in the original high-dimensional feature space and ignore the manifold structure of the low-level visual features of images. In this paper, we propose a new method, termed dual-force ISOMAP (DFISOMAP), for content-based medical image retrieval. Under the assumption that medical images lie on a low-dimensional manifold embedded in a high-dimensional ambient space, DFISOMAP operates in the following three stages. First, the geometric structure of positive examples in the learned low-dimensional embedding is preserved according to the isometric feature mapping (ISOMAP) criterion. To precisely model the geometric structure, a reconstruction error constraint is also added. Second, the average distance between positive and negative examples is maximized to separate them; this margin maximization acts as a force that pushes negative examples far away from positive examples. Finally, the similarity propagation technique is utilized to provide negative examples with another force that will pull them back into the negative sample set. We evaluate the proposed method on a subset of the IRMA medical image dataset with a RF-based medical image retrieval framework. Experimental results show that DFISOMAP outperforms popular approaches for content-based medical image retrieval in terms of accuracy and stability.	[Shen, Hualei; Ma, Dianfu] Beihang Univ, Sch Comp Sci & Engn, State Key Lab Software Dev Environm, Beijing, Peoples R China; [Tao, Dacheng] Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia; [Shen, Hualei] Henan Normal Univ, Sch Comp & Informat Engn, Xinxiang, Peoples R China	Beihang University; University of Technology Sydney; Henan Normal University	Tao, DC (corresponding author), Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia.	dacheng.tao@uts.edu.au; dfma@buaa.edu.cn			National Natural Science Foundation of China [61003017]; Project of State Key Laboratory of Software Development Environment [SKLSDE-2013ZX-30]; ARC [DP140102164]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of State Key Laboratory of Software Development Environment; ARC(Australian Research Council)	This work was supported in part by the following projects: 1. National Natural Science Foundation of China under grant number 61003017, 2. Project of State Key Laboratory of Software Development Environment under grant number SKLSDE-2013ZX-30, 3. ARC Discovery Project under grant number DP140102164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul CB, 2011, J DIGIT IMAGING, V24, P208, DOI 10.1007/s10278-010-9290-9; Barlow WE, 2004, JNCI-J NATL CANCER I, V96, P1840, DOI 10.1093/jnci/djh333; Bian W, 2010, IEEE T IMAGE PROCESS, V19, P545, DOI 10.1109/TIP.2009.2035223; Datta R, 2008, ACM COMPUT SURV, V40, DOI 10.1145/1348246.1348248; Deselaers T, 2008, INFORM RETRIEVAL, V11, P77, DOI 10.1007/s10791-007-9039-3; Deserno TM, 2009, 15363 IRMA IMAGES 19; Dimitrovski I, 2011, PATTERN RECOGN, V44, P2436, DOI 10.1016/j.patcog.2011.03.026; Doulamis N, 2006, SIGNAL PROCESS-IMAGE, V21, P334, DOI 10.1016/j.image.2005.11.006; Duda R.O., 2006, PATTERN CLASSIFICATI; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Fu Y, 2008, IEEE T IMAGE PROCESS, V17, P226, DOI 10.1109/TIP.2007.914203; Guo GD, 2002, IEEE T NEURAL NETWOR, V13, P811, DOI 10.1109/TNN.2002.1021882; He XF, 2004, ADV NEUR IN, V16, P153; Hoi CH, 2004, IEEE IJCNN, P3189; Hoi SCH, 2009, ACM T INFORM SYST, V27, DOI 10.1145/1508850.1508854; Hong ZB, 2012, LECT NOTES COMPUT SC, V7572, P513, DOI 10.1007/978-3-642-33718-5_37; Huiskes MJ, 2008, P 2008 INT C CONT BA, P239; Kherfi ML, 2006, IEEE T IMAGE PROCESS, V15, P1017, DOI 10.1109/TIP.2005.863969; Ko BC, 2012, J DIGIT IMAGING, V25, P454, DOI 10.1007/s10278-011-9443-5; Kurita T., 1993, Proceedings of the Second International Conference on Document Analysis and Recognition (Cat. No.93TH0578-5), P547, DOI 10.1109/ICDAR.1993.395676; Lehmann TM, 2003, PROC SPIE, V5033, P440, DOI 10.1117/12.480677; Liu W, 2010, AAAI CONF ARTIF INTE, P518; Liu WF, 2013, IEEE T IMAGE PROCESS, V22, P2676, DOI 10.1109/TIP.2013.2255302; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Rahman MM, 2007, IEEE T INF TECHNOL B, V11, P58, DOI 10.1109/TITB.2006.884364; Rahman MM, 2011, IEEE T INF TECHNOL B, V15, P640, DOI 10.1109/TITB.2011.2151258; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Rui Y, 2000, PROC CVPR IEEE, P236, DOI 10.1109/CVPR.2000.855825; Siegle RL, 1998, ACAD RADIOL, V5, P148, DOI 10.1016/S1076-6332(98)80277-8; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; Tao DC, 2006, IEEE T MULTIMEDIA, V8, P716, DOI 10.1109/TMM.2005.861375; Tao DC, 2009, IEEE T PATTERN ANAL, V31, P260, DOI 10.1109/TPAMI.2008.70; Tao DC, 2006, IEEE T PATTERN ANAL, V28, P1088, DOI 10.1109/TPAMI.2006.134; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tong S., 2020, P ACM INT C MULT C E, P107; Wang JY, 2011, IEEE T MED IMAGING, V30, P1996, DOI 10.1109/TMI.2011.2161673; Wang SJ, 2011, NEUROCOMPUTING, V74, P3654, DOI 10.1016/j.neucom.2011.07.007; Xu D, 2007, IEEE T IMAGE PROCESS, V16, P2811, DOI 10.1109/TIP.2007.906769; Xu X, 2006, MED IMAGING 2006 PAC; Xu XQ, 2009, NEUROCOMPUTING, V72, P2259, DOI 10.1016/j.neucom.2008.12.029; Yang L, 2010, IEEE T PATTERN ANAL, V32, P30, DOI 10.1109/TPAMI.2008.273; Zhou TY, 2013, IEEE T IMAGE PROCESS, V22, P244, DOI 10.1109/TIP.2012.2202678; Zhou XS, 2001, PROC CVPR IEEE, P11; Zhou XS, 2003, MULTIMEDIA SYST, V8, P536, DOI 10.1007/s00530-002-0070-3	45	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84096	10.1371/journal.pone.0084096	http://dx.doi.org/10.1371/journal.pone.0084096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391891	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900034
J	Shi, XB; Pan, HP; Xie, W; Wu, QJ; Wang, SL; Liu, Y; Fang, Y; Chen, G; Gao, XW; Zhang, YJ				Shi, Xiaobin; Pan, Huipeng; Xie, Wen; Wu, Qingjun; Wang, Shaoli; Liu, Yang; Fang, Yong; Chen, Gong; Gao, Xiwu; Zhang, Youjun			Plant Virus Differentially Alters the Plant's Defense Response to Its Closely Related Vectors	PLOS ONE			English	Article							LEAF-CURL-VIRUS; BEMISIA-TABACI; SALICYLIC-ACID; MEDIATED INTERACTIONS; TOMATO DEFENSE; ARABIDOPSIS; INSECT; TRANSMISSION; MECHANISMS; INFECTION	Background: The whitefly, Bemisia tabaci (Hemiptera: Aleyrodidae), is one of the most widely distributed agricultural pests. In recent years, B. tabaci Q has invaded China, and Q has displaced B in many areas now. In a number of regions of the world, invasion by B and/or Q has been followed by outbreaks of tomato yellow leaf curl virus (TYLCV). Our previous study showed TYLCV directly and indirectly modified the feeding behavior of B. tabaci in favor of Q rather than B. Methodology/Principal Findings: In this study, we quantified the salicylic acid (SA) titers and relative gene expression of SA in tomato leaves that were infested with viruliferous or non-viruliferous B and Q. We also measured the impacts of exogenous SA on the performance of B and Q, including the effects on ovary development. SA titer was always higher in leaves that were infested with viruliferous B than with viruliferous Q, whereas the SA titer did not differ between leaves infested with non-viruliferous B and Q. The relative gene expression of SA signaling was increased by feeding of viruliferous B but was not increased by feeding of viruliferous Q. The life history traits of B and Q were adversely affected on SA-treated plants. On SA-treated plants, both B and Q had lower fecundity, shorter longevity, longer developmental time and lower survival rate than on untreated plants. Compared with whiteflies feeding on control plants, those feeding on SA-treated plants had fewer oocytes and slower ovary development. On SA-treated plants, viruliferous B had fewer oocytes than viruliferous Q. Conclusions/Significance: These results indicate that TYLCV tends to induce SA-regulated plant defense against B but SA-regulated plant defense against Q was reduced. In other words, Q may have a mutualistic relationship with TYLCV that results in the reduction of the plant's defense response.	[Shi, Xiaobin; Pan, Huipeng; Xie, Wen; Wu, Qingjun; Wang, Shaoli; Liu, Yang; Fang, Yong; Chen, Gong; Zhang, Youjun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China; [Shi, Xiaobin; Gao, Xiwu] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; China Agricultural University	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China.	zhangyoujun@caas.cn	Khitov, Sergey/P-1280-2019; Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	National Science Fund for Distinguished Young Scholars [31025020]; Beijing Natural Science Foundation [6131002]; 973 Program [2013CB127602]; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Beijing Natural Science Foundation(Beijing Natural Science Foundation); 973 Program(National Basic Research Program of China); Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the Beijing Natural Science Foundation (6131002), the 973 Program (2013CB127602), and the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2012, PLANT CELL PHYSIOL, V53, P204, DOI 10.1093/pcp/pcr173; Alba JM, 2011, J PLANT INTERACT, V6, P221, DOI 10.1080/17429145.2010.551670; Andret-Link P, 2005, J PLANT PATHOL, V87, P153; Avila CA, 2012, PLANT PHYSIOL, V158, P2028, DOI 10.1104/pp.111.191262; Barrett LG, 2012, TRENDS PLANT SCI, V17, P282, DOI 10.1016/j.tplants.2012.02.009; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Blande JD, 2010, TREE PHYSIOL, V30, P404, DOI 10.1093/treephys/tpp124; Bosque-Perez NA, 2011, VIRUS RES, V159, P201, DOI 10.1016/j.virusres.2011.04.020; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; COHEN S, 1966, PHYTOPATHOLOGY, V56, P1127; Colvin J, 2006, ADV VIRUS RES, V67, P419, DOI 10.1016/S0065-3527(06)67011-5; Czosnek H, 1997, ARCH VIROL, V142, P1391, DOI 10.1007/s007050050168; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; de Vos M, 2007, BIOESSAYS, V29, P871, DOI 10.1002/bies.20624; De Vos M, 2009, PLANT CELL ENVIRON, V32, P1548, DOI 10.1111/j.1365-3040.2009.02019.x; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Donovan MP, 2013, ARTHROPOD-PLANT INTE, V7, P45, DOI 10.1007/s11829-012-9220-5; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Giordanengo P, 2010, CR BIOL, V333, P516, DOI 10.1016/j.crvi.2010.03.007; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Guo JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011713; Gutierrez S, 2013, FUNCT ECOL, V27, P610, DOI 10.1111/1365-2435.12070; Hohn T, 2007, P NATL ACAD SCI USA, V104, P17905, DOI 10.1073/pnas.0709178104; Huang L, 2012, PLANT BIOLOGY, V14, P905, DOI 10.1111/j.1438-8677.2012.00582.x; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kachroo A, 2009, ANNU REV PHYTOPATHOL, V47, P153, DOI 10.1146/annurev-phyto-080508-081820; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Liu BM, 2013, J VIROL, V87, P4929, DOI 10.1128/JVI.03571-12; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Matros A, 2006, PLANT CELL ENVIRON, V29, P126, DOI 10.1111/j.1365-3040.2005.01406.x; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034817; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Pegadaraju V, 2005, PLANT PHYSIOL, V139, P1927, DOI 10.1104/pp.105.070433; Peng JY, 2004, Z NATURFORSCH C, V59, P856; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Polston JE, 1999, PLANT DIS, V83, P984, DOI 10.1094/PDIS.1999.83.4.397A; Rodriguez-Saona CR, 2010, J CHEM ECOL, V36, P1043, DOI 10.1007/s10886-010-9854-7; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Sarmento RA, 2011, ECOL LETT, V14, P229, DOI 10.1111/j.1461-0248.2010.01575.x; Schulze B, 2006, ANAL BIOCHEM, V348, P269, DOI 10.1016/j.ab.2005.10.021; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Thaler JS, 2010, ECOLOGY, V91, P1075, DOI 10.1890/08-2347.1; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Walling LL, 2009, ADV BOT RES, V51, P551, DOI 10.1016/S0065-2296(09)51013-0; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Wu JB, 2006, PLANT DIS, V90, P1359, DOI 10.1094/PD-90-1359C; Wu W, 2012, ANN APPL BIOL, V161, P36, DOI 10.1111/j.1744-7348.2012.00550.x; Yang JW, 2011, J ECOL, V99, P46, DOI 10.1111/j.1365-2745.2010.01756.x; Zambrano K, 2007, PLANT DIS, V91, P768, DOI 10.1094/PDIS-91-6-0768A; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhou Y, 1949, CHIN J ENTOMOL, V3, P1	66	37	42	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83520	10.1371/journal.pone.0083520	http://dx.doi.org/10.1371/journal.pone.0083520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391779	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200076
J	Smith, TJS; Rubenstein, LS; Nachman, KE				Smith, Tyler J. S.; Rubenstein, Leonard S.; Nachman, Keeve E.			Availability of Information about Airborne Hazardous Releases from Animal Feeding Operations	PLOS ONE			English	Article							EASTERN NORTH-CAROLINA; QUALITY-OF-LIFE; NEIGHBORING RESIDENTS; HEALTH; AMMONIA; EXPOSURE; ODORS; HOMES	Introduction: Air from animal feeding operations (AFOs) has been shown to transport numerous contaminants of public health concern. While federal statutes like the Emergency Planning and Community Right-to-Know Act (EPCRA) generally require that facilities report hazardous releases, AFOs have been exempted from most of these requirements by the U. S. Environmental Protection Agency (EPA). We assessed the availability of information about AFO airborne hazardous releases following these exemptions. Methods: We submitted public records requests to 7 states overlapping with or adjacent to the Chesapeake Bay watershed for reports of hazardous releases made by AFOs under EPCRA. From the records received, we calculated the proportion of AFOs in each state for which >= 1 reports were available. We also determined the availability of specific types of information required under EPCRA. The numbers of AFOs permitted under the Clean Water Act (CWA) or analogous state laws, as determined from permitting databases obtained from states, were used as denominators. Results: We received both EPCRA reports and permitting databases from 4 of 7 states. Across these 4 states, the mean proportion of AFOs for which >= 1 EPCRA reports were available was 15% (range: 2-33%). The mean proportions of AFOs for which the name or identity of the substance released, >= 1 estimates of quantity released, and information about nearby population density and sensitive populations were available were 15% (range: 2-33%), 8% (range: 0-22%), and 14% (range: 2-8%), respectively. Discussion: These results suggest that information about the airborne hazardous releases of a large majority of AFOs is not available under federal law in the states that we investigated. While the results cannot be attributed to specific factors by this method, attention to multiple factors, including revision of the EPA's exemptions, may increase the availability of information relevant to the health of populations living or working near AFOs.	[Smith, Tyler J. S.; Rubenstein, Leonard S.; Nachman, Keeve E.] Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21218 USA; [Smith, Tyler J. S.; Nachman, Keeve E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Rubenstein, Leonard S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Nachman, Keeve E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nachman, KE (corresponding author), Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD 21218 USA.	knachman@jhsph.edu		Smith, Tyler/0000-0003-4692-2206; Nachman, Keeve/0000-0003-4925-4151	Johns Hopkins Center for a Livable Future	Johns Hopkins Center for a Livable Future	The study was funded by a Directed Research grant from the Johns Hopkins Center for a Livable Future. The Center (aside from TJSS and KEN, who are both authors and CLF staff members) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja VP, 2009, ENVIRON SCI TECHNOL, V43, P4234, DOI 10.1021/es8024403; Assardourian E, 2004, STAT WORLD 2004 WORL; Blunden J, 2008, ATMOS ENVIRON, V42, P3315, DOI 10.1016/j.atmosenv.2007.06.040; Bullers S, 2005, HUM ECOL, V33, P1, DOI 10.1007/s10745-005-1653-3; Centner TJ, 2010, ENVIRON INT, V36, P237, DOI 10.1016/j.envint.2009.11.007; Chapin A, 2005, ENVIRON HEALTH PERSP, V113, P137, DOI 10.1289/ehp.7473; Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721; Copeland C, 2011, ANIMAL WASTE HAZARDO; DEMARCHI S, 2006, ASSESSING ACCURACY, V32, P57; Donham Kelley J, 2006, J Agromedicine, V11, P15, DOI 10.1300/J096v11n03_03; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Graham JP, 2010, J WATER HEALTH, V8, P646, DOI 10.2166/wh.2010.075; Heinzen T, 2008, NY U ENV LAW J, V17, P1482; Ko G, 2010, ENVIRON SCI TECHNOL, V44, P3442, DOI 10.1021/es9026024; Merchant JA, 2005, ENVIRON HEALTH PERSP, V113, P350, DOI 10.1289/ehp.7240; National Chicken Council U.S. Poultry & Egg Association National Turkey Federation, PET EX EPCRA CERCLA; Radon K, 2004, ANN AGR ENV MED, V11, P59; Radon K, 2007, EPIDEMIOLOGY, V18, P300, DOI 10.1097/01.ede.0000259966.62137.84; SCHIFFMAN SS, 1995, BRAIN RES BULL, V37, P369, DOI 10.1016/0361-9230(95)00015-1; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Thu K., 1997, Journal of Agricultural Safety and Health, V3, P13; US Department of Agriculture, 2007, CENS AGR STAT PROF N; US Environmental Protection Agency, CERCLA EPCRA ADM REP; US Environmental Protection Agency, SAB REV EMISSIONS LA; US Environmental Protection Agency, 1985, FED REGISTER, V50, P13456; US Environmental Protection Agency, 2007, FED REG, V72, P73700; US Environmental Protection Agency, 2012, FED REGISTER, V77, P42679; US Environmental Protection Agency, 2011, FED REGISTER, V76, P65431; US Environmental Protection Agency Agriculture, AIR MON; US Government Accountability Office, CONC AN FEED OP EPA; US National Research Council, 2002, AIR EM AN FEED OP CU; USEPA, 2008, FED REGISTER, V73, P76948; Williams DL, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-72; Wilson SM, 2007, ATMOS ENVIRON, V41, P4977, DOI 10.1016/j.atmosenv.2006.12.055; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P225, DOI 10.2307/3454438; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P233, DOI 10.2307/3454439; 2005, FED REG, V70, P4958	37	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85342	10.1371/journal.pone.0085342	http://dx.doi.org/10.1371/journal.pone.0085342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24400039	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900147
J	White, WT; Furumitsu, K; Yamaguchi, A				White, William T.; Furumitsu, Keisuke; Yamaguchi, Atsuko			A New Species of Eagle Ray Aetobatus narutobiei from the Northwest Pacific: An Example of the Critical Role Taxonomy Plays in Fisheries and Ecological Sciences	PLOS ONE			English	Article							FLAGELLUM; IDENTIFICATION	Recent taxonomic and molecular work on the eagle rays (Family Myliobatidae) revealed a cryptic species in the northwest Pacific. This species is formally described as Aetobatus narutobiei sp. nov. and compared to its congeners. Aetobatus narutobiei is found in eastern Vietnam, Hong Kong, China, Korea and southern Japan. It was previously considered to be conspecific with Aetobatus flagellum, but these species differ in size, structure of the NADH2 and CO1 genes, some morphological and meristic characters and colouration. Aetobatus narutobiei is particularly abundant in Ariake Bay in southern Japan where it is considered a pest species that predates heavily on farmed bivalve stocks and is culled annually as part of a 'predator control' program. The discovery of A. narutobiei highlights the paucity of detailed taxonomic research on this group of rays. This discovery impacts on current conservation assessments of A. flagellum and these need to be revised based on the findings of this study.	[White, William T.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia; [Furumitsu, Keisuke; Yamaguchi, Atsuko] Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Nagasaki University	White, WT (corresponding author), CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia.	william.white@csiro.au	White, William T/B-9748-2009	White, William T/0000-0001-9705-2453	National Science Foundation (NSF) [DEB-01132229]; CSIRO;  [20580205];  [23380112]	National Science Foundation (NSF)(National Science Foundation (NSF)); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); ; 	The senior author was supported by a National Science Foundation (NSF; http://www.nsf.gov) grant (Jaws and Backbone: Chondrichthyan Phylogeny and a Spine for the Vertebrate Tree of Life; DEB-01132229; www.nsf.gov) and the CSIRO's Wealth from Oceans Flagship. The other authors (AY and KF) were supported by Grant-in-Aid for Scientific Research (C) 20580205, Grant-in-Aid for Scientific Research (B) 23380112 (www.jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 1846, REP BRIT ASS ADVANCE, DOI 10.5962/bhl.title.59530; Bleeker P, 1852, VERHANDELINGEN BATAV, V24, P1, DOI DOI 10.1163/22134379-90000832; BRANDER K, 1981, NATURE, V290, P48, DOI 10.1038/290048a0; COMPAGNO LJV, 1999, FAO SPECIES IDENTIFI, V3, P1511; Dulvy NK, 2013, E LIFE IN PRESS; Fukuda Y, 2010, NIPPON SUISAN GAKK, V76, P10, DOI 10.2331/suisan.76.10; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; Kamei Y, 2009, B FISH EXP STN OKAYA, V24, P32; Kamei Y, 2009, B FISHERIES EXPT STA, V24, P28; Manjaji B.M., 2004, THESIS U TASMANIA HO; Nakabo T, 2001, FISH KUROSHIO CURREN, P143; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Ni IH, 1999, ZOOL STUD, V38, P130; NISHDA K, 1990, Memoirs of the Faculty of Fisheries Hokkaido University, V37, P1; Oh Jina, 2006, Ocean Science Journal, V41, P53; Richards VP, 2009, J HERED, V100, P273, DOI 10.1093/jhered/esp005; Sakiyama T, 2011, KANAGAWA NATURE ARTI, V32, P101; Schwartz FJ, 2007, RAFFLES B ZOOL, P121; Shimizu Takaaki, 1997, I.O.P. Diving News, V8, P2; SIMPFENDORFER CA, 2011, MARINE FRESHWATER RE, V62, P583; Suzuki Toshiyuki, 1994, I.O.P. Diving News, V5, P2; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; White WT, 2006, AETOBATUS FLAGELLUM; White WT, 2013, ZOOTAXA IN PRESS; White WT, 2010, DESCRIPTIONS NEW SHA, P141; Yagishita N, 2009, MOL ECOL RESOUR, V9, P1034, DOI 10.1111/j.1755-0998.2009.02568.x; Yamada U, 1989, SEIKAIKU SUISAN KENK, V61, P1; Yamaguchi A, 2005, ENVIRON BIOL FISH, V74, P229, DOI 10.1007/s10641-005-0217-0; Yamaguchi A, 2013, FISHES JAPAN PICTORI, P228; Yoon HK, 2009, BIOCHIP J, V3, P87; Zhu Y, 2001, FAUNA SINICA CYCLOST, P450	31	11	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83785	10.1371/journal.pone.0083785	http://dx.doi.org/10.1371/journal.pone.0083785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391827	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200125
J	Belloni, V; Sorci, G; Paccagnini, E; Guerreiro, R; Bellenger, J; Faivre, B				Belloni, Virginia; Sorci, Gabriele; Paccagnini, Eugenio; Guerreiro, Romain; Bellenger, Jerome; Faivre, Bruno			Disrupting Immune Regulation Incurs Transient Costs in Male Reproductive Function	PLOS ONE			English	Article							SPERM PRODUCTION; TESTES SIZE; EVOLUTION; LIPOPOLYSACCHARIDE; IMMUNOPATHOLOGY; INFLAMMATION; COMPETITION; CYTOKINES; STRESS; CONSEQUENCES	Background: Immune protection against pathogenic organisms has been shown to incur costs. Previous studies investigating the cost of immunity have mostly focused on the metabolic requirements of immune maintenance and activation. In addition to these metabolic costs, the immune system can induce damage to the host if the immune response is mis-targeted or over-expressed. Given its non-specific nature, an over-expressed inflammatory response is often associated with substantial damage for the host. Here, we investigated the cost of an over-expressed inflammatory response in the reproductive function of male mice. Methodology/Principal Findings: We experimentally blocked the receptors of an anti-inflammatory cytokine (IL-10) in male mice exposed to a mild inflammatory challenge, with each treatment having an appropriate control group. The experiment was conducted on two age classes, young (3 month old) and old (15 month old) mice, to assess any age-related difference in the cost of a disrupted immune regulation. We found that the concomitant exposure to an inflammatory insult and the blockade of IL-10 induced a reduction in testis mass, compared to the three other groups. The frequency of abnormal sperm morphology was also higher in the group of mice exposed to the inflammatory challenge but did not depend on the blockade of the IL-10. Conclusions: Our results provide evidence that immune regulation confers protection against the risk of inflammation-induced infertility during infection. They also suggest that disruption of the effectors involved in the regulation of the inflammatory response can have serious fitness consequences even under mild inflammatory insult and benign environmental conditions.	[Belloni, Virginia; Sorci, Gabriele; Guerreiro, Romain; Faivre, Bruno] Univ Bourgogne, CNRS UMR 6282, Dijon, France; [Belloni, Virginia] Tulane Univ, Dept Trop Med, New Orleans, LA 70118 USA; [Paccagnini, Eugenio] Univ Siena, Dipartimento Biol Evolutiva, I-53100 Siena, Italy; [Bellenger, Jerome] Univ Bourgogne, INSERM, UMR 866, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Bourgogne; Tulane University; University of Siena; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Belloni, V (corresponding author), Univ Bourgogne, CNRS UMR 6282, Dijon, France.	vbelloni@tulane.edu	Guerreiro, Rita J L/A-1327-2011; BELLENGER, Jerome/AAC-9423-2022	BELLENGER, Jerome/0000-0001-8643-6195; Paccagnini, Eugenio/0000-0002-9784-2057; Belloni, Virginia/0000-0001-9807-1912; Sorci, Gabriele/0000-0002-0799-3995	Region Bourgogne; ANR - Project EVOREGIM	Region Bourgogne(Region Bourgogne-Franche-Comte); ANR - Project EVOREGIM(French National Research Agency (ANR))	Financial support was received from the Region Bourgogne and ANR - Project EVOREGIM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RP, 1970, FERTIL STERIL, V21, P662; Belloni V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012940; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Bornstein SR, 2004, MOL CELL ENDOCRINOL, V215, P135, DOI 10.1016/j.mce.2003.11.022; Byrne PG, 2002, J EVOLUTION BIOL, V15, P347, DOI 10.1046/j.1420-9101.2002.00409.x; Day T, 2007, P ROY SOC B-BIOL SCI, V274, P2685, DOI 10.1098/rspb.2007.0809; Dejaco C, 2006, EXP GERONTOL, V41, P339, DOI 10.1016/j.exger.2006.01.008; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Eraud C, 2009, EVOLUTION, V63, P1036, DOI 10.1111/j.1558-5646.2008.00540.x; Firman RC, 2008, J EVOLUTION BIOL, V21, P1524, DOI 10.1111/j.1420-9101.2008.01612.x; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Freitak D, 2003, P ROY SOC B-BIOL SCI, V270, pS220, DOI 10.1098/rsbl.2003.0069; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Graham AL, 2005, ANNU REV ECOL EVOL S, V36, P373, DOI 10.1146/annurev.ecolsys.36.102003.152622; Graham AL, 2002, Q REV BIOL, V77, P409, DOI 10.1086/344414; Graham AL, 2010, SCIENCE, V330, P662, DOI 10.1126/science.1194878; Guerreiro R, 2012, EVOLUTION, V66, P3615, DOI 10.1111/j.1558-5646.2012.01708.x; HARCOURT AH, 1995, FUNCT ECOL, V9, P468, DOI 10.2307/2390011; Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8; JOUANNET P, 1988, INT J ANDROL, V11, P379, DOI 10.1111/j.1365-2605.1988.tb01011.x; Kawai Y, 2006, J REPROD DEVELOP, V52, P561, DOI 10.1262/jrd.18023; Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4; Licastro Federico, 2005, Immun Ageing, V2, P8; Liew SH, 2007, J ANDROL, V28, P176, DOI 10.2164/jandrol.106.000752; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Long GH, 2011, TRENDS PARASITOL, V27, P300, DOI 10.1016/j.pt.2011.03.012; Long GH, 2011, EVOL APPL, V4, P278, DOI 10.1111/j.1752-4571.2010.00178.x; Long GH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-128; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Max EE, 2001, IMMUNOLOGY IMMUNOPAT; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; Meinhardt A, 2011, MOL CELL ENDOCRINOL, V335, P60, DOI 10.1016/j.mce.2010.03.022; Menkveld R, 2001, HUM REPROD, V16, P1165, DOI 10.1093/humrep/16.6.1165; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nussey D, 2011, IMMUNOLOGY, V135, P30; O'Bryan MK, 2000, BIOL REPROD, V63, P1285, DOI 10.1095/biolreprod63.5.1285; O'Bryan MK, 2005, AM J PHYSIOL-REG I, V288, pR1744, DOI 10.1152/ajpregu.00651.2004; O'Bryan MK, 2000, ENDOCRINOLOGY, V141, P238, DOI 10.1210/en.141.1.238; Panda A, 2009, TRENDS IMMUNOL, V30, P325, DOI 10.1016/j.it.2009.05.004; Plas E, 2000, EXP GERONTOL, V35, P543, DOI 10.1016/S0531-5565(00)00120-0; Preston BT, 2003, P ROY SOC B-BIOL SCI, V270, P633, DOI 10.1098/rspb.2002.2268; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Raberg L, 2002, P ROY SOC B-BIOL SCI, V269, P817, DOI 10.1098/rspb.2001.1953; RATHJE TA, 1995, J ANIM SCI, V73, P2177; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Scharer L, 2007, EVOL ECOL, V21, P295, DOI 10.1007/s10682-006-9101-4; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Schradin C, 2009, BIOL REPROD, V81, P111, DOI 10.1095/biolreprod.108.075838; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Winnall WR, 2011, J LEUKOCYTE BIOL, V90, P133, DOI 10.1189/jlb.1010557; Zhang M, 2012, POULTRY SCI, V91, P1997, DOI 10.3382/ps.2012-02236	56	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84606	10.1371/journal.pone.0084606	http://dx.doi.org/10.1371/journal.pone.0084606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400103	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700037
J	Lopez, AV; Garcia, MNV; Melen, GJ; Martinez, AE; Moreno, IC; Garcia-Castro, J; Orellana, MR; Gonzalez, AGZ				Vicente Lopez, Angeles; Vazquez Garcia, Miriam Nohemi; Melen, Gustavo J.; Entrena Martinez, Ana; Cubillo Moreno, Isabel; Garcia-Castro, Javier; Ramirez Orellana, Manuel; Zapata Gonzalez, Agustin Gregorio			Mesenchymal Stromal Cells Derived from the Bone Marrow of Acute Lymphoblastic Leukemia Patients Show Altered BMP4 Production: Correlations with the Course of Disease	PLOS ONE			English	Article							CANCER STEM-CELLS; HEMATOPOIETIC STEM; SONIC HEDGEHOG; PROLIFERATION; DIFFERENTIATION; MAINTENANCE; INDUCTION; SURVIVAL; ADIPOCYTES; EXPRESSION	The relevance of tumor microenvironment for the development and progression of tumor cells in hematological malignancies has been extensively reported. Identification of factors involved in the information exchange between the malignant cells and the bone marrow mesenchymal stem cells (BM-MSCs) and the knowledge on their functioning may provide important information to eliminate leukemic cells from protective BM niches. We evaluated changes in BM-MSCs obtained from children with acute lymphoblastic leukemia (ALL) at different times in the course of disease. Whereas ALL-MSCs did not exhibit phenotypic changes compared to BM-derived MSCs isolated from healthy donors, they exhibited increased adipogenic capacity. In addition, the viability of healthy CD34+ hematopoietic progenitors was significantly reduced when co-cultured with ALL-MSCs. ALL-MSCs grow less efficiently, although gradually recover normal growth with treatment. Accordingly, proliferation is particularly low in MSCs obtained at diagnosis and in the first days of treatment (+15 days), recovering to control levels after 35 days of treatment. Correlating these results with bone morphogenetic protein 4 (BMP4) production, a molecule demonstrated to affect MSC biology, we found higher production of BMP4 in ALL-MSCs derived from patients over the course of disease but not in those free of leukemia. However, no significant differences in the expression of different members of the BMP4 signaling pathway were observed. Furthermore, an inverse correlation between high levels of BMP4 production in the cultures and MSC proliferation was found, as observed in MSCs derived from patients at diagnosis that produce high BMP4 levels. In addition, co-culturing ALL-MSC with the REH leukemia cell line, but not CD34+ hematopoietic progenitors, powerfully enhanced BMP4 production, suggesting an intimate crosstalk among ALL-MSCs isolated from BM colonized by ALL cells that presumably also occurs in situ conditions. Our data may support the participation of BMP4 in BM niche, but the mechanism remains to be elucidated.	[Vicente Lopez, Angeles; Vazquez Garcia, Miriam Nohemi; Entrena Martinez, Ana] Univ Complutense Madrid, Sch Med, Dept Cell Biol, Madrid, Spain; [Melen, Gustavo J.; Ramirez Orellana, Manuel] Hosp Nino Jesus, Dept Oncohematol, Madrid, Spain; [Cubillo Moreno, Isabel; Garcia-Castro, Javier] Inst Hlth Carlos III, Cellular Biotechnol Unit, Madrid, Spain; [Zapata Gonzalez, Agustin Gregorio] Univ Complutense Madrid, Fac Biol, Dept Cell Biol, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Lopez, AV (corresponding author), Univ Complutense Madrid, Sch Med, Dept Cell Biol, Madrid, Spain.	avicente@bio.ucm.es; zapata@ucm.es	Garcia-Castro, Javier/ABC-9741-2021; Garcia-Castro, Javier/H-5274-2011; Melen, Gustavo/L-5918-2014; GARCIA, MIRIAM NOHEMI N VAZQUEZ/G-8866-2017; Vicente, Angeles/B-7951-2015; García, Miriam/HGD-0780-2022; VICENTE, LIERN/B-6112-2008; Ramirez, Manuel/H-7710-2015	Garcia-Castro, Javier/0000-0001-7604-1640; Garcia-Castro, Javier/0000-0001-7604-1640; Melen, Gustavo/0000-0001-9743-8903; GARCIA, MIRIAM NOHEMI N VAZQUEZ/0000-0002-9810-884X; Vicente, Angeles/0000-0002-9456-5541; VICENTE, LIERN/0000-0001-5883-9640; Ramirez, Manuel/0000-0003-0332-6973; Zapata, Agustin G/0000-0003-0576-2672	Spanish Ministry of Science and Innovation [BFU2009-10315, SAF2012-33180, BFU2010-18250]; Spanish Association Against Cancer AECC; Regional Government of Madrid [P2010/BMD-2420-CellCAM]; Network from the Health Institute Carlos III [RD12/0019/0007-TerCell]; Comunidad de Madrid [50053735]; Ministry of Education, Culture and Sports [AP2010-0795]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Association Against Cancer AECC; Regional Government of Madrid; Network from the Health Institute Carlos III; Comunidad de Madrid(Comunidad de Madrid); Ministry of Education, Culture and Sports	This work was supported by grands BFU2009-10315, SAF2012-33180, and BFU2010-18250 from the Spanish Ministry of Science and Innovation, Spanish Association Against Cancer 2010 AECC; P2010/BMD-2420-CellCAM from Regional Government of Madrid and RD12/0019/0007-TerCell Network from the Health Institute Carlos III. MNVG contract UCM number 50053735 by Comunidad de Madrid. AE grant number AP2010-0795 of Ministry of Education, Culture and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Campioni D, 2006, HAEMATOLOGICA, V91, P364; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chen D, 2004, FRONT BIOSCI-LANDMRK, V9, P349, DOI 10.2741/1090; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Detmer K, 1999, BLOOD CELL MOL DIS, V25, P310, DOI 10.1006/bcmd.1999.0259; Detmer K, 2002, CYTOKINE, V17, P36, DOI 10.1006/cyto.2001.0984; Dias S, 2002, BLOOD, V99, P2179, DOI 10.1182/blood.V99.6.2179; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Dosen-Dahl G, 2008, INT J CANCER, V123, P2759, DOI 10.1002/ijc.23833; Farre J, 2007, GROWTH FACTORS, V25, P71, DOI 10.1080/08977190701345200; Flores-Figueroa E, 2008, LEUKEMIA RES, V32, P1407, DOI 10.1016/j.leukres.2008.02.013; Fong YC, 2008, J CELL PHYSIOL, V217, P846, DOI 10.1002/jcp.21568; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Grassinger J, 2007, CYTOKINE, V40, P165, DOI 10.1016/j.cyto.2007.09.004; Guo J, 2012, CYTOKINE GROWTH F R, V23, P61, DOI 10.1016/j.cytogfr.2012.02.001; Juarez J, 2007, HAEMATOLOGICA, V92, P450, DOI 10.3324/haematol.10621; Kallioniemi A, 2012, CANCER GENET-NY, V205, P267, DOI 10.1016/j.cancergen.2012.05.009; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Khurana S, 2013, BLOOD, V121, P781, DOI 10.1182/blood-2012-07-446443; Klaus M, 2010, STEM CELLS DEV, V19, P1043, DOI 10.1089/scd.2009.0286; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Laperrousaz B, 2013, BLOOD, V122, P3767, DOI 10.1182/blood-2013-05-501460; Le Page C, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-4; Lee JS, 2013, BIOCHEM BIOPH RES CO, V435, P696, DOI 10.1016/j.bbrc.2013.05.045; Lopez-Villar O, 2009, LEUKEMIA, V23, P664, DOI 10.1038/leu.2008.361; MANABE A, 1992, BLOOD, V79, P2370; Martinez-Laperche C, 2013, AM J HEMATOL, V88, P359, DOI 10.1002/ajh.23407; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Mesa RA, 2005, BLOOD, V105, P973, DOI 10.1182/blood-2004-07-2864; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Ortega JJ, 2001, HAEMATOLOGICA, V86, P586; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Rifas L, 2006, J CELL BIOCHEM, V98, P706, DOI 10.1002/jcb.20933; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schindeler A, 2005, BIOCHEM BIOPH RES CO, V338, P710, DOI 10.1016/j.bbrc.2005.09.198; Schulz TJ, 2009, CYTOKINE GROWTH F R, V20, P523, DOI 10.1016/j.cytogfr.2009.10.019; Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Solmesky LJ, 2009, STEM CELLS DEV, V18, P1283, DOI 10.1089/scd.2009.0020; Tabe Y, 2004, BLOOD, V103, P1815, DOI 10.1182/blood-2003-03-0802; Varas A, 2009, CELL CYCLE, V8, P4119, DOI 10.4161/cc.8.24.10149; Varga G, 2007, PATHOL ONCOL RES, V13, P311, DOI 10.1007/BF02940310; Lopez MAV, 2011, STEM CELLS DEV, V20, P1011, DOI 10.1089/scd.2010.0355; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhao ZG, 2007, STEM CELLS DEV, V16, P637, DOI 10.1089/scd.2007.0008	55	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84496	10.1371/journal.pone.0084496	http://dx.doi.org/10.1371/journal.pone.0084496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400095	Green Published, gold, Green Submitted			2022-12-27	WOS:000329462700029
J	Chen, SH; Plank, JL; Willcox, S; Griffith, JD; Hsieh, TS				Chen, Stefanie Hartman; Plank, Jody L.; Willcox, Smaranda; Griffith, Jack D.; Hsieh, Tao-shih			Top3 alpha Is Required during the Convergent Migration Step of Double Holliday Junction Dissolution	PLOS ONE			English	Article							TOPOISOMERASE-III-ALPHA; BLOOMS-SYNDROME HELICASE; BRANCH MIGRATION; SYNDROME PROTEIN; BREAK REPAIR; DNA; BLM; MOLECULE; RECOMBINATION; FLUORESCENCE	Although Blm and Top3 alpha are known to form a minimal dissolvasome that can uniquely undo a double Holliday junction structure, the details of the mechanism remain unknown. It was originally suggested that Blm acts first to create a hemicatenane structure from branch migration of the junctions, followed by Top3 alpha performing strand passage to decatenate the interlocking single strands. Recent evidence suggests that Top3 alpha may also be important for assisting in the migration of the junctions. Using a mismatch-dHJ substrate (MM-DHJS) and eukaryotic Top1 (in place of Top3 alpha), we show that the presence of a topoisomerase is required for Blm to substantially migrate a topologically constrained Holliday junction. When investigated by electron microscopy, these migrated structures did not resemble a hemicatenane. However, when Blm is together with Top3 alpha, the dissolution reaction is processive with no pausing at a partially migrated structure. Potential mechanisms are discussed.	[Chen, Stefanie Hartman; Hsieh, Tao-shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Plank, Jody L.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA; [Hsieh, Tao-shih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Duke University; University of California System; University of California Davis; University of North Carolina; University of North Carolina Chapel Hill; Academia Sinica - Taiwan	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	thsieh@duke.edu		Chen, Stefanie/0000-0002-9550-971X; Plank, Jody/0000-0002-8025-7935	NIH [GM 29006, GM031819]; NSC, Taiwan; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM029006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSC, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH GM 29006 and NSC, Taiwan (TSH), and NIH GM031819 (JDG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Chen SH, 2012, J BIOL CHEM; Chen SH, 2012, J BIOL CHEM, V287, P19346, DOI 10.1074/jbc.M112.363044; Cheok CF, 2005, BIOCHEM SOC T, V33, P1456, DOI 10.1042/BST0331456; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cloutier TE, 2005, P NATL ACAD SCI USA, V102, P3645, DOI 10.1073/pnas.0409059102; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hu P, 2001, HUM MOL GENET, V10, P1287, DOI 10.1093/hmg/10.12.1287; Johnson FB, 2000, CANCER RES, V60, P1162; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karymov MA, 2008, BIOPHYS J, V95, P4372, DOI 10.1529/biophysj.108.135103; Killen MW, 2009, HUM MOL GENET, V18, P3417, DOI 10.1093/hmg/ddp282; Larocque JR, 2011, P NATL ACAD SCI US; Li WH, 2004, J CELL BIOL, V165, P801, DOI 10.1083/jcb.200402095; Mayanagi K, 2008, BIOCHEM BIOPH RES CO, V365, P273, DOI 10.1016/j.bbrc.2007.10.165; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Plank J, 2009, J BIOL CHEM, V284, P30737, DOI 10.1074/jbc.R109.051268; Plank JL, 2006, J BIOL CHEM, V281, P17510, DOI 10.1074/jbc.M602933200; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Shaiu WL, 1998, MOL CELL BIOL, V18, P4358, DOI 10.1128/MCB.18.7.4358; SHORE D, 1981, P NATL ACAD SCI-BIOL, V78, P4833, DOI 10.1073/pnas.78.8.4833; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Wang X, 2010, P NATL ACAD SCI USA, V107, P12547, DOI 10.1073/pnas.1000105107; Weinstein J, 2008, DNA REPAIR, V7, P558, DOI 10.1016/j.dnarep.2007.12.010; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu YN, 2012, NUCLEIC ACIDS RES, V40, P9802, DOI 10.1093/nar/gks728; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216	32	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83582	10.1371/journal.pone.0083582	http://dx.doi.org/10.1371/journal.pone.0083582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392087	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100011
J	Kim, WK; Kim, D; Cui, J; Jang, HH; Kim, KS; Lee, HJ; Kim, SU; Ahn, SM				Kim, Woo Kyung; Kim, Deokhoon; Cui, Jun; Jang, Ho Hee; Kim, Kwang Sei; Lee, Hong Jun; Kim, Seung U.; Ahn, Sung-Min			Secretome Analysis of Human Oligodendrocytes Derived from Neural Stem Cells	PLOS ONE			English	Article							RECEPTOR/IL-6 FUSION PROTEIN; IN-VITRO DIFFERENTIATION; GROWTH-FACTOR; SPINAL-CORD; MATRIX-METALLOPROTEINASE; INTERLEUKIN-6 IL-6; BRAIN EXPRESSION; PROGENITOR CELLS; MYELIN FORMATION; HUMAN FETAL	In this study, we investigated the secretome of human oligodendrocytes (F3.Olig2 cells) generated from human neural stem cells by transduction with the gene encoding the Olig2 transcription factor. Using mRNA sequencing and protein cytokine arrays, we identified a number of biologically important secretory proteins whose expression has not been previously reported in oligodendrocytes. We found that F3.Olig2 cells secrete IL-6, PDGF-AA, GRO, GM-CSF, and M-CSF, and showed prominent expression of their corresponding receptors. Co-expression of ligands and receptors suggests that autocrine signaling loops may play important roles in both differentiation and maintenance of oligodendrocytes. We also found that F3.Olig2 cells secrete matrix metalloproteinases and matrix metalloproteinase-associated proteins associated with functional competence of oligodendrocytes. The results of our secretome analysis provide insights into the functional and molecular details of human oligodendrocytes. To the best of our knowledge, this is the first systematic analysis of the secretome of oligodendrocytes.	[Kim, Woo Kyung; Cui, Jun; Jang, Ho Hee] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Kim, Woo Kyung; Kim, Deokhoon; Ahn, Sung-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Ctr Canc Genome Discovery,Asan Inst Life Sci, Seoul, South Korea; [Kim, Woo Kyung] BRC Genome Res Ctr, Inchon, South Korea; [Ahn, Sung-Min] Univ Ulsan, Coll Med, Dept Oncol, Seoul, South Korea; [Kim, Kwang Sei; Lee, Hong Jun; Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada	Gachon University; University of Ulsan; Asan Medical Center; University of Ulsan; Chung Ang University; Chung Ang University Hospital; University of British Columbia	Kim, SU (corresponding author), Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea.	sukim@mail.ubc.ca; smahn@amc.seoul.kr		Ahn, Sung-Min/0000-0002-5031-1929	National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning [NRF-2011-0014717]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by basic science research program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2011-0014717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody KS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000023; Ahmed S, 2009, CELL ADHES MIGR, V3, P412, DOI 10.4161/cam.3.4.8803; Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003917; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Balabanov R, 2007, J NEUROSCI, V27, P2013, DOI 10.1523/JNEUROSCI.4689-06.2007; Bansal R, 2002, DEV NEUROSCI-BASEL, V24, P35, DOI 10.1159/000064944; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; BUNGE MB, 1962, J CELL BIOL, V12, P448, DOI 10.1083/jcb.12.2.448; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Choi JK, 2007, NEUROSCI LETT, V420, P217, DOI 10.1016/j.neulet.2007.03.065; Choi JK, 2011, APOPTOSIS, V16, P127, DOI 10.1007/s10495-010-0552-2; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chun SJ, 2003, J CELL BIOL, V163, P397, DOI 10.1083/jcb.200304154; Copray S, 2006, STEM CELLS, V24, P1001, DOI 10.1634/stemcells.2005-0239; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; delosMonteros AE, 1997, J NEUROSCI RES, V50, P872; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Erlandsson A, 2004, EXP CELL RES, V301, P201, DOI 10.1016/j.yexcr.2004.08.009; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; FERNANDEZVALLE C, 1993, DEVELOPMENT, V119, P867; Filipovic R, 2003, DEV NEUROSCI-BASEL, V25, P279, DOI 10.1159/000072275; Furusho M, 2011, J NEUROSCI, V31, P5055, DOI 10.1523/JNEUROSCI.4800-10.2011; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Guillemin G, 1996, GLIA, V16, P71, DOI 10.1002/(SICI)1098-1136(199601)16:1<71::AID-GLIA8>3.0.CO;2-E; Hosking MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011340; Hwang DH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-117; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kadi L, 2006, J NEUROIMMUNOL, V174, P133, DOI 10.1016/j.jneuroim.2006.01.011; KAHN MA, 1994, GLIA, V12, P87, DOI 10.1002/glia.440120202; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kim Seung U., 2008, V438, P103, DOI 10.1007/978-1-59745-133-8_10; KIM SU, 1990, J NEUROSCI RES, V27, P712, DOI 10.1002/jnr.490270432; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; KIM SU, 1985, J NEUROIMMUNOL, V10, P141, DOI 10.1016/0165-5728(85)90004-9; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; Kitada M, 2006, GLIA, V54, P35, DOI 10.1002/glia.20354; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Larsen PH, 2006, J NEUROSCI, V26, P2207, DOI 10.1523/JNEUROSCI.1880-05.2006; Larsen PH, 2004, J NEUROSCI, V24, P7597, DOI 10.1523/JNEUROSCI.2092-04.2004; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; LEE SC, 1994, GLIA, V12, P309, DOI 10.1002/glia.440120407; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Masaki T, 2012, ISRN NEUROL, V2012, P1; Matsumura K, 1997, NEUROMUSCULAR DISORD, V7, P7, DOI 10.1016/S0960-8966(96)00402-6; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1246, DOI 10.1056/NEJM198211113072005; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Messersmith DJ, 2000, J NEUROSCI RES, V62, P241, DOI 10.1002/1097-4547(20001015)62:2<241::AID-JNR9>3.0.CO;2-D; Mewar R, 1997, J NEUROSCI RES, V50, P721, DOI 10.1002/(SICI)1097-4547(19971201)50:5<721::AID-JNR9>3.0.CO;2-J; Mey J, 2002, CELL TISSUE RES, V310, P155, DOI 10.1007/s00441-002-0624-x; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Murtie JC, 2005, GLIA, V49, P542, DOI 10.1002/glia.20142; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; OCHIENG J, 1994, BIOCHEMISTRY-US, V33, P14109, DOI 10.1021/bi00251a020; Oh LYS, 1999, J NEUROSCI, V19, P8464; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Ould-yahoui A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008289; Pasquini LA, 2011, CELL DEATH DIFFER, V18, P1746, DOI 10.1038/cdd.2011.40; Paty D, 1988, MULTIPLE SCLEROSIS; PETERS A, 1964, J ANAT, V98, P125; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Pizzi M, 2004, MOL CELL NEUROSCI, V25, P301, DOI 10.1016/j.mcn.2003.10.022; Relucio J, 2012, GLIA, V60, P1451, DOI 10.1002/glia.22365; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Robinson S, 1998, J NEUROSCI, V18, P10457; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Schabitz WR, 2008, J CEREBR BLOOD F MET, V28, P29, DOI 10.1038/sj.jcbfm.9600496; Schmitz T, 2008, THESCIENTIFICWORLDJO, V8, P1119, DOI 10.1100/tsw.2008.140; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Sole S, 2004, J NEUROPATH EXP NEUR, V63, P338, DOI 10.1093/jnen/63.4.338; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Tsiper MV, 2002, J CELL SCI, V115, P1005; Uhm JH, 1998, GLIA, V22, P53, DOI 10.1002/(SICI)1098-1136(199801)22:1<53::AID-GLIA5>3.0.CO;2-9; Valerio A, 2002, MOL CELL NEUROSCI, V21, P602, DOI 10.1006/mcne.2002.1208; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003; Wen S, 2009, CELL ADHES MIGR, V3, P107, DOI 10.4161/cam.3.1.7602; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Zhang PL, 2004, STEM CELLS, V22, P344, DOI 10.1634/stemcells.22-3-344	97	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84292	10.1371/journal.pone.0084292	http://dx.doi.org/10.1371/journal.pone.0084292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392122	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100045
J	Zhang, WD; Zu, ZH; Xu, Q; Xu, ZJ; Liu, JJ; Zheng, T				Zhang, Wen-Dou; Zu, Zheng-Hu; Xu, Qing; Xu, Zhi-Jing; Liu, Jin-Jie; Zheng, Tao			Optimized Strategy for the Control and Prevention of Newly Emerging Influenza Revealed by the Spread Dynamics Model	PLOS ONE			English	Article							2009 H1N1 INFLUENZA; TRANSMISSION DYNAMICS; VIRUS-INFECTION; QUARANTINE; HUMANS; SARS	No matching vaccine is immediately available when a novel influenza strain breaks out. Several nonvaccine-related strategies must be employed to control an influenza epidemic, including antiviral treatment, patient isolation, and immigration detection. This paper presents the development and application of two regional dynamic models of influenza with Pontryagin's Maximum Principle to determine the optimal control strategies for an epidemic and the corresponding minimum antiviral stockpiles. Antiviral treatment was found to be the most effective measure to control new influenza outbreaks. In the case of inadequate antiviral resources, the preferred approach was the centralized use of antiviral resources in the early stage of the epidemic. Immigration detection was the least cost-effective; however, when used in combination with the other measures, it may play a larger role. The reasonable mix of the three control measures could reduce the number of clinical cases substantially, to achieve the optimal control of new influenza.	[Zhang, Wen-Dou; Zu, Zheng-Hu; Xu, Qing; Xu, Zhi-Jing; Liu, Jin-Jie; Zheng, Tao] Beijing Inst Biotechnol, Ctr Biosecur Strategy Management, Beijing, Peoples R China		Zheng, T (corresponding author), Beijing Inst Biotechnol, Ctr Biosecur Strategy Management, Beijing, Peoples R China.	zt19721@hotmail.com	Xu, Zhijing/E-3220-2013	Xu, Zhijing/0000-0003-1792-4229	Mega-Project on Infectious Disease Prevention of China [2013ZX10004-605, 2012ZX10004-402]; National High Technology Research and Development Program of China (863 Program) [2012AA022007]; Medical Science and Technology Research Projects of Chinese Army [AWS11L009, 13QNP156]; National Natural Science Foundation of China (NSFC) [90924019]	Mega-Project on Infectious Disease Prevention of China; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Medical Science and Technology Research Projects of Chinese Army; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Funding was provided by Mega-Project on Infectious Disease Prevention of China (No. 2013ZX10004-605, No. 2012ZX10004-402 (http://www.moh.gov.cn/qjjys/crbfz/list.shtml), National High Technology Research and Development Program of China (863 Program) (No. 2012AA022007), Medical Science and Technology Research Projects of Chinese Army (No. AWS11L009, No. 13QNP156), and National Natural Science Foundation of China (NSFC) (No. 90924019) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barucci E, 2012, APPL MATH COMPUT, V218, P5588, DOI 10.1016/j.amc.2011.11.052; Breban R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000282; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; Falagas ME, 2010, EUR J CLIN MICROBIOL, V29, P1327, DOI 10.1007/s10096-010-1002-3; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gani R, 2001, NATURE, V414, P748, DOI 10.1038/414748a; Girard MP, 2010, VACCINE, V28, P4895, DOI [10.1016/j.vaccine.2010.05.031, 10.1016/j.vaccine.2010.07.034]; Gupta AG, 2005, J INFECTION, V50, P386, DOI 10.1016/j.jinf.2004.08.006; Howlett P, 1996, AUTOMATICA, V32, P519, DOI 10.1016/0005-1098(95)00184-0; Hsu SB, 2008, B MATH BIOL, V70, P134, DOI 10.1007/s11538-007-9245-6; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jung E, 2009, J THEOR BIOL, V260, P220, DOI 10.1016/j.jtbi.2009.05.031; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kieny MP, 2006, VACCINE, V24, P6367, DOI 10.1016/j.vaccine.2006.07.021; Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076; Lau JTF, 2006, PREV MED, V43, P406, DOI 10.1016/j.ypmed.2006.06.007; Lee BY, 2010, VACCINE, V28, P4875, DOI 10.1016/j.vaccine.2010.05.002; Lee S, 2010, J THEOR BIOL, V265, P136, DOI 10.1016/j.jtbi.2010.04.003; Liang W, 2012, PUBLIC HEALTH, V126, P427, DOI 10.1016/j.puhe.2012.02.008; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; LOURIZ M, 2009, INT ARCH MED, V3, P26; McLeod MA, 2008, EMERG INFECT DIS, V14, P468, DOI 10.3201/eid1403.070927; Newall AT, 2010, EMERG INFECT DIS, V16, P224, DOI 10.3201/eid1602.090571; Poletti P, 2011, PLOS ONE, V7, P1; Pontryagin LS, 1987, MATH THEORY OPTIMAL; Shim E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S4; Uyeki Tim, 2009, N Engl J Med, V361, pe110, DOI 10.1056/NEJMopv0910738; Yan X, 2008, MATH COMPUT MODEL, V47, P235, DOI 10.1016/j.mcm.2007.04.003; Yang J, 2009, CLIN INFECT DIS, V49, P1622, DOI 10.1086/644775	34	3	3	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84694	10.1371/journal.pone.0084694	http://dx.doi.org/10.1371/journal.pone.0084694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392151	Green Published, gold			2022-12-27	WOS:000329460100074
J	Abraham, AB; Bronstein, R; Reddy, AS; Maletic-Savatic, M; Aguirre, A; Tsirka, SE				Abraham, Ariel B.; Bronstein, Robert; Reddy, Avanish S.; Maletic-Savatic, Mirjana; Aguirre, Adan; Tsirka, Stella E.			Aberrant Neural Stem Cell Proliferation and Increased Adult Neurogenesis in Mice Lacking Chromatin Protein HMGB2	PLOS ONE			English	Article							OLFACTORY-BULB; PROGENITOR CELLS; GERMINAL ZONE; NEURONS; ASTROCYTES; ORGANIZATION; DEMONSTRATE; POPULATION; PRECURSORS; MIGRATE	Neural stem and progenitor cells (NSCs/NPCs) are distinct groups of cells found in the mammalian central nervous system (CNS). Previously we determined that members of the High Mobility Group (HMG) B family of chromatin structural proteins modulate NSC proliferation and self-renewal. Among them HMGB2 was found to be dynamically expressed in proliferating and differentiating NSCs, suggesting that it may regulate NSC maintenance. We report now that Hmgb2(-/-) mice exhibit SVZ hyperproliferation, increased numbers of SVZ NSCs, and a trend towards aberrant increases in newly born neurons in the olfactory bulb (OB) granule cell layer. Increases in the levels of the transcription factor p21 and the Neural cell adhesion molecule (NCAM), along with down-regulation of the transcription/pluripotency factor Oct4 in the Hmgb2(-/-) SVZ point to a possible pathway for this increased proliferation/differentiation. Our findings suggest that HMGB2 functions as a modulator of neurogenesis in young adult mice through regulation of NSC proliferation, and identify a potential target via which CNS repair could be amplified following trauma or disease-based neuronal degeneration.	[Abraham, Ariel B.; Tsirka, Stella E.] SUNY Stony Brook, Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Bronstein, Robert] SUNY Stony Brook, Program Neurosci, Stony Brook, NY 11794 USA; [Maletic-Savatic, Mirjana] Texas Childrens Hosp, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Abraham, Ariel B.] SUNY Stony Brook, Med Scientist Training Program, Stony Brook, NY 11794 USA; [Abraham, Ariel B.; Bronstein, Robert; Reddy, Avanish S.; Aguirre, Adan; Tsirka, Stella E.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tsirka, SE (corresponding author), SUNY Stony Brook, Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA.	styliani-anna.tsirka@stonybrook.edu	Tsirka, Stella/AAD-4018-2019	Maletic-Savatic, Mirjana/0000-0002-6548-4662	National Institute of General Medical Sciences Medical Scientist Training Program [T32GM080444]; American Heart Association [12PRE12060489]; NIH [R01NS42168]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444, T32GM007518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042168] Funding Source: NIH RePORTER	National Institute of General Medical Sciences Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by National Institute of General Medical Sciences Medical Scientist Training Program (T32GM080444 to ABA), American Heart Association predoctoral fellowship (12PRE12060489 to RB), and NIH (R01NS42168 to SET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AB, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-18; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Campbell PA, 2013, STEM CELLS; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gritti A, 1999, J NEUROSCI, V19, P3287; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Kirschenbaum B, 1999, J NEUROSCI, V19, P2171; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mirzadeh Z., 2010, J VIS EXP; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Petreanu L, 2002, J NEUROSCI, V22, P6106; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ronfani L, 2001, DEVELOPMENT, V128, P1265; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Taniguchi N, 2011, J BIOL CHEM, V286, P41489, DOI 10.1074/jbc.M111.236984; Taniguchi N, 2009, P NATL ACAD SCI USA, V106, P1181, DOI 10.1073/pnas.0806062106; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Zhen HY, 2012, BIOCHEM BIOPH RES CO, V421, P44, DOI 10.1016/j.bbrc.2012.03.105	39	20	23	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84838	10.1371/journal.pone.0084838	http://dx.doi.org/10.1371/journal.pone.0084838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391977	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900120
J	Capomaccio, S; Vitulo, N; Verini-Supplizi, A; Barcaccia, G; Albiero, A; D'Angelo, M; Campagna, D; Valle, G; Felicetti, M; Silvestrelli, M; Cappelli, K				Capomaccio, Stefano; Vitulo, Nicola; Verini-Supplizi, Andrea; Barcaccia, Gianni; Albiero, Alessandro; D'Angelo, Michela; Campagna, Davide; Valle, Giorgio; Felicetti, Michela; Silvestrelli, Maurizio; Cappelli, Katia			RNA Sequencing of the Exercise Transcriptome in Equine Athletes	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; NONCODING RNAS; DIFFERENTIAL EXPRESSION; ANTISENSE TRANSCRIPTS; MICROARRAY ANALYSIS; OXIDATIVE STRESS; REVEALS; HORSES; INTERLEUKIN-6	The horse is an optimal model organism for studying the genomic response to exercise-induced stress, due to its natural aptitude for athletic performance and the relative homogeneity of its genetic and environmental backgrounds. Here, we applied RNA-sequencing analysis through the use of SOLiD technology in an experimental framework centered on exercise-induced stress during endurance races in equine athletes. We monitored the transcriptional landscape by comparing gene expression levels between animals at rest and after competition. Overall, we observed a shift from coding to non-coding regions, suggesting that the stress response involves the differential expression of not annotated regions. Notably, we observed significant post-race increases of reads that correspond to repeats, especially the intergenic and intronic L1 and L2 transposable elements. We also observed increased expression of the antisense strands compared to the sense strands in intronic and regulatory regions (1 kb up- and downstream) of the genes, suggesting that antisense transcription could be one of the main mechanisms for transposon regulation in the horse under stress conditions. We identified a large number of transcripts corresponding to intergenic and intronic regions putatively associated with new transcriptional elements. Gene expression and pathway analysis allowed us to identify several biological processes and molecular functions that may be involved with exercise-induced stress. Ontology clustering reflected mechanisms that are already known to be stress activated (e.g., chemokine-type cytokines, Toll-like receptors, and kinases), as well as "nucleic acid binding" and "signal transduction activity" functions. There was also a general and transient decrease in the global rates of protein synthesis, which would be expected after strenuous global stress. In sum, our network analysis points toward the involvement of specific gene clusters in equine exercise-induced stress, including those involved in inflammation, cell signaling, and immune interactions.	[Capomaccio, Stefano; Verini-Supplizi, Andrea; Felicetti, Michela; Silvestrelli, Maurizio; Cappelli, Katia] Univ Perugia, Sport Horse Res Ctr, Diagnost & Vet Clin, Dept Pathol, I-06100 Perugia, Italy; [Vitulo, Nicola; Albiero, Alessandro; D'Angelo, Michela; Campagna, Davide; Valle, Giorgio] Univ Padua, CRIBI, Padua, Italy; [Barcaccia, Gianni] Univ Padua, DAFNAE, Lab Genet & Genom, Legnaro, Italy	University of Perugia; University of Padua; University of Padua	Capomaccio, S (corresponding author), Univ Perugia, Sport Horse Res Ctr, Diagnost & Vet Clin, Dept Pathol, I-06100 Perugia, Italy.	capemaster@gmail.com	Vitulo, Nicola/GVT-2319-2022; CAPPELLI, Katia/K-6047-2015; Capomaccio, Stefano/K-6042-2015	CAPPELLI, Katia/0000-0002-3141-771X; Capomaccio, Stefano/0000-0002-0004-9272; Vitulo, Nicola/0000-0002-9571-0747; VALLE, GIORGIO/0000-0003-4377-5685; BARCACCIA, GIANNI/0000-0001-7478-5048	Progetto Ricerca e INNOVAzione nelle attivita di miglioramento GENetico animale (INNOVAGEN) [J81J11000500001]; Ministero delle Politiche Agricole e Forestali	Progetto Ricerca e INNOVAzione nelle attivita di miglioramento GENetico animale (INNOVAGEN); Ministero delle Politiche Agricole e Forestali	This research received support from "Progetto Ricerca e INNOVAzione nelle attivita di miglioramento GENetico animale (INNOVAGEN)" J81J11000500001, funded by the "Ministero delle Politiche Agricole e Forestali." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Art T, 2006, Equine Vet J Suppl, P298; Beyeen AD, 2010, J IMMUNOL, V185, P6883, DOI 10.4049/jimmunol.1001392; Bowman TV, 2006, STEM CELLS, V24, P662, DOI 10.1634/stemcells.2005-0552; Bu D., 2011, NUCL ACIDS RES; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Capomaccio S, 2010, ANIM GENET, V41, P166, DOI 10.1111/j.1365-2052.2010.02129.x; Capomaccio S, 2010, ANIM GENET, V41, P23, DOI 10.1111/j.1365-2052.2010.02094.x; Cappelli K, 2013, VET J, V195, P373, DOI 10.1016/j.tvjl.2012.07.021; Cappelli K, 2007, RES VET SCI, V82, P335, DOI 10.1016/j.rvsc.2006.08.009; Cappelli Katia, 2009, BMC Physiology, V9, P12, DOI 10.1186/1472-6793-9-12; Cappelli K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-49; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Fernandes JMO, 2007, J EXP BIOL, V210, P3461, DOI 10.1242/jeb.009183; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hashimoto K, 2009, J TOXICOL SCI, V34, P445, DOI 10.2131/jts.34.445; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Klevebring D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009762; Konig D, 2001, EXERC IMMUNOL REV, V7, P108; Lira FS, 2009, CELL BIOCHEM FUNCT, V27, P458, DOI 10.1002/cbf.1594; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mastorakos G, 2006, ANN NY ACAD SCI, V1088, P373, DOI 10.1196/annals.1366.021; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Morrissy AS, 2011, GENOME RES, V21, P1203, DOI 10.1101/gr.113431.110; Muller-Werdan U, 2003, INTERNIST, V44, P864, DOI 10.1007/s00108-003-0956-y; Nakamura S, 2010, BIOCHEM BIOPH RES CO, V391, P846, DOI 10.1016/j.bbrc.2009.11.150; Neubauer O, 2008, EXERC IMMUNOL REV, V14, P51; Numata K, 2012, FRONT BIOSCI-LANDMRK, V17, P300, DOI 10.2741/3928; Nurmi JT, 2005, PROSTAG LEUKOTR ESS, V73, P343, DOI 10.1016/j.plefa.2005.07.004; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pandey R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r117; Park SJ, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/170208; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Petersen AMW, 2006, J PHYSIOL PHARMACOL, V57, P43; Purvis D, 2010, PM&R, V2, P442, DOI 10.1016/j.pmrj.2010.03.025; Radom-Aizik S, 2009, PEDIATR RES, V65, P447, DOI 10.1203/PDR.0b013e3181993473; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmitz J, 2011, BIOCHIMIE, V93, P1928, DOI 10.1016/j.biochi.2011.07.014; Sela N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010907; Smith LL, 2003, SPORTS MED, V33, P347, DOI 10.2165/00007256-200333050-00002; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Su WY, 2010, BIOCHEM BIOPH RES CO, V396, P177, DOI 10.1016/j.bbrc.2010.04.147; Tariq MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr547; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Werner A, 2009, RNA BIOL, V6, P43, DOI 10.4161/rna.6.1.7568; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	57	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83504	10.1371/journal.pone.0083504	http://dx.doi.org/10.1371/journal.pone.0083504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391776	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200073
J	Cohen, MR; Huynh, KW; Cawley, D; Moiseenkova-Bell, VY				Cohen, Matthew R.; Huynh, Kevin W.; Cawley, Daniel; Moiseenkova-Bell, Vera Y.			Understanding the Cellular Function of TRPV2 Channel through Generation of Specific Monoclonal Antibodies	PLOS ONE			English	Article							CAPSAICIN-RECEPTOR; ION-CHANNEL; CATION CHANNELS; LINE F-11; TRANSLOCATION; NOCICEPTION; ACTIVATION; EXPRESSION; RESISTANCE; MIGRATION	Transient receptor potential vanilloid 2 (TRPV2) is a Ca2+-permeable nonselective cation channel proposed to play a critical role in a wide array of cellular processes. Although TRPV2 surface expression was originally determined to be sensitive to growth factor signaling, regulated trafficking of TRPV2 has remained controversial. TRPV2 has proven difficult to study due to the lack of specific pharmacological tools to modulate channel activity; therefore, most studies of the cellular function of TRPV2 rely on immuno-detection techniques. Polyclonal antibodies against TRPV2 have not been properly validated and characterized, which may contribute to conflicting results regarding its function in the cell. Here, we developed monoclonal antibodies using full-length TRPV2 as an antigen. Extensive characterization of these antibodies and comparison to commonly used commercially available TRPV2 antibodies revealed that while monoclonal antibodies generated in our laboratory were suitable for detection of endogenous TRPV2 by western blot, immunoprecipitation and immunocytochemistry, the commercially available polyclonal antibodies we tested were not able to recognize endogenous TRPV2. We used our newly generated and validated TRPV2 antibodies to determine the effects of insulin-like growth factor 1 (IGF-1) on TRPV2 surface expression in heterologous and endogenous expression systems. We found that IGF-1 had little to no effect on trafficking and plasma membrane expression of TRPV2. Overall, these new TRPV2 monoclonal antibodies served to dispel the controversy of the effects of IGF-1 on TRPV2 plasma membrane expression and will clarify the role TRPV2 plays in cellular function. Furthermore, our strategy of using full-length tetrameric TRP channels may allow for the generation of antibodies against other TRP channels of unclear function.	[Cohen, Matthew R.; Moiseenkova-Bell, Vera Y.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Cohen, Matthew R.; Huynh, Kevin W.; Moiseenkova-Bell, Vera Y.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Cawley, Daniel] Oregon Hlth & Sci Univ, Monoclonal Antibody Core Facil, Vaccine & Gene Therapy Inst, Beaverton, OR USA	Case Western Reserve University; Case Western Reserve University; Oregon Health & Science University	Moiseenkova-Bell, VY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	vxm102@case.edu			American Heart Association (NCRP Scientist Development Grant) [11SDG5280029]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103899] Funding Source: NIH RePORTER	American Heart Association (NCRP Scientist Development Grant); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association (NCRP Scientist Development Grant 11SDG5280029)[www.heart.org]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender FLP, 2005, CELL PHYSIOL BIOCHEM, V15, P183, DOI 10.1159/000083651; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Colton C. K., 2007, V179, P173; Harlow D., 1988, ANTIBODIES LAB MANUA; Hisanaga E, 2009, DIABETES, V58, P174, DOI 10.2337/db08-0862; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Jahnel R, 2003, EUR J BIOCHEM, V270, P4264, DOI 10.1046/j.1432-1033.2003.03811.x; Jang Y, 2012, ARCH PHARM RES, V35, P1823, DOI 10.1007/s12272-012-1016-8; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Meissner M, 2012, LESSONS STUDYING TRP; Mercado J, 2010, J NEUROSCI, V30, P13338, DOI 10.1523/JNEUROSCI.2108-10.2010; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Monet M, 2010, CANCER RES, V70, P1225, DOI 10.1158/0008-5472.CAN-09-2205; Monet M, 2009, BBA-MOL CELL RES, V1793, P528, DOI 10.1016/j.bbamcr.2009.01.003; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Nabissi M, 2013, CARCINOGENESIS, V34, P48, DOI 10.1093/carcin/bgs328; Nabissi M, 2010, CARCINOGENESIS, V31, P794, DOI 10.1093/carcin/bgq019; Nedungadi TP, 2012, EXP NEUROL, V237, P223, DOI 10.1016/j.expneurol.2012.06.017; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Penna A, 2006, CELL CALCIUM, V39, P495, DOI 10.1016/j.ceca.2006.01.009; Peralvarez-Marin A, 2013, FEBS J; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18	29	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85392	10.1371/journal.pone.0085392	http://dx.doi.org/10.1371/journal.pone.0085392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392006	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900150
J	Fekete, T; Zach, N; Mujica-Parodi, LR; Turner, MR				Fekete, Tomer; Zach, Neta; Mujica-Parodi, Lilianne R.; Turner, Martin R.			Multiple Kernel Learning Captures a Systems-Level Functional Connectivity Biomarker Signature in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							DIFFUSION TENSOR; BRAIN NETWORK; ALS; NEURODEGENERATION; DEGENERATION; PEOPLE; CORTEX; SCALE	There is significant clinical and prognostic heterogeneity in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), despite a common immunohistological signature. Consistent extra-motor as well as motor cerebral, spinal anterior horn and distal neuromuscular junction pathology supports the notion of ALS a system failure. Establishing a disease biomarker is a priority but a simplistic, coordinate-based approach to brain dysfunction using MRI is not tenable. Resting-state functional MRI reflects the organization of brain networks at the systems-level, and so changes in of motor functional connectivity were explored to determine their potential as the substrate for a biomarker signature. Intra-as well as inter-motor functional networks in the 0.03-0.06 Hz frequency band were derived from 40 patients and 30 healthy controls of similar age, and used as features for pattern detection, employing multiple kernel learning. This approach enabled an accurate classification of a group of patients that included a range of clinical sub-types. An average of 13 regions-of-interest were needed to reach peak discrimination. Subsequent analysis revealed that the alterations in motor functional connectivity were widespread, including regions not obviously clinically affected such as the cerebellum and basal ganglia. Complex network analysis showed that functional networks in ALS differ markedly in their topology, reflecting the underlying altered functional connectivity pattern seen in patients: 1) reduced connectivity of both the cortical and subcortical motor areas with non motor areas 2) reduced subcortical-cortical motor connectivity and 3) increased connectivity observed within sub-cortical motor networks. This type of analysis has potential to non-invasively define a biomarker signature at the systems-level. As the understanding of neurodegenerative disorders moves towards studying pre-symptomatic changes, there is potential for this type of approach to generate biomarkers for the testing of neuroprotective strategies.	[Fekete, Tomer; Mujica-Parodi, Lilianne R.] SUNY Stony Brook, Dept Biomed Engn, New York, NY USA; [Zach, Neta] Univ Penn, Biol Basis Behav Program, Philadelphia, PA 19104 USA; [Turner, Martin R.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Pennsylvania; University of Oxford	Turner, MR (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	martin.turner@ndcn.ox.ac.uk		Turner, Martin/0000-0003-0267-3180; Fekete, Tomer/0000-0003-3164-125X; Mujica-Parodi, Lilianne Rivka/0000-0002-3752-5519	National Science Foundation; Medical Research Council & Motor Neuron Disease Association UK Lady Edith Wolfson Fellowship; MRC [MR/K01014X/1, G0701923] Funding Source: UKRI; Medical Research Council [G0701923, MR/K01014X/1] Funding Source: researchfish; Motor Neurone Disease Association [Turner/Jan13/944-795] Funding Source: researchfish; Div Of Chem, Bioeng, Env, & Transp Sys [0954643] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Medical Research Council & Motor Neuron Disease Association UK Lady Edith Wolfson Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Motor Neurone Disease Association; Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	TF and LRMP are funded by the National Science Foundation. MRT is funded by the Medical Research Council & Motor Neuron Disease Association UK Lady Edith Wolfson Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Agosta F, 2011, CEREB CORTEX, V21, P2291, DOI 10.1093/cercor/bhr002; Agosta F, 2013, NEUROBIOL AGING, V34, P419, DOI 10.1016/j.neurobiolaging.2012.04.015; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Benatar M, 2012, NEUROLOGY, V79, P1732, DOI 10.1212/WNL.0b013e31826e9b1d; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cao J, 1999, ADV APPL PROBAB, V31, P579, DOI 10.1239/aap/1029955192; Carew JD, 2011, NEUROLOGY, V77, P1370, DOI 10.1212/WNL.0b013e318231526a; Castro E, 2011, NEUROIMAGE, V58, P526, DOI 10.1016/j.neuroimage.2011.06.044; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Douaud G, 2011, BRAIN, V134, P3467, DOI 10.1093/brain/awr279; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Eisen A, 2013, AMYOTROPH LATERAL SC; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Fekete T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062867; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gordon PH, 2006, NEUROLOGY, V66, P647, DOI 10.1212/01.wnl.0000200962.94777.71; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Jelsone-Swain LM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00158; Keil C, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-141; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kloft M, 2011, J MACH LEARN RES, V12, P953; Kollewe K, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/608501; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Leung CC, 2007, PHYSICA A, V378, P591, DOI 10.1016/j.physa.2006.12.022; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Luo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045470; Mahoney CJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt144; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mitchell JD, 2010, AMYOTROPH LATERAL SC, V11, P537, DOI 10.3109/17482968.2010.495158; Mohammadi B, 2009, EXP NEUROL, V217, P147, DOI 10.1016/j.expneurol.2009.01.025; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ng MC, 2008, J MAGN RESON IMAGING, V27, P8, DOI 10.1002/jmri.21217; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Radulescu AR, 2008, NEUROPSYCHOBIOLOGY, V57, P206, DOI 10.1159/000151731; Reading SAJ, 2004, ANN NEUROL, V55, P879, DOI 10.1002/ana.20121; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sherman AV, 2013, AMYOTROPH LAT SCL FR, V14, P53, DOI 10.3109/21678421.2013.779058; SMITH MC, 1960, J NEUROL NEUROSUR PS, V23, P269, DOI 10.1136/jnnp.23.4.269; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Tedeschi G, 2012, NEUROBIOL AGING, V33, P886, DOI 10.1016/j.neurobiolaging.2010.07.011; Trojsi F, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/473538; Turner MR, 2013, AMYOTROPH LAT SCL FR, V14, P19, DOI 10.3109/21678421.2013.778554; Turner MR, 2012, BIOMARK MED, V6, P319, DOI [10.2217/BMM.12.26, 10.2217/bmm.12.26]; Turner MR, 2012, AMYOTROPH LATERAL SC, V13, P245, DOI 10.3109/17482968.2011.636050; Turner MR, 2011, LANCET NEUROL, V10, P400, DOI 10.1016/S1474-4422(11)70049-7; Turner MR, 2005, BRAIN, V128, P1323, DOI 10.1093/brain/awh509; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Verstraete E., 2013, HUM BRAIN MAPP; Verstraete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024239; Verstraete E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013664; Welsh Robert C, 2013, Front Hum Neurosci, V7, P251, DOI 10.3389/fnhum.2013.00251; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008	59	44	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85190	10.1371/journal.pone.0085190	http://dx.doi.org/10.1371/journal.pone.0085190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391997	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900140
J	Monahan, WB; Cook, T; Melton, F; Connor, J; Bobowski, B				Monahan, William B.; Cook, Tammy; Melton, Forrest; Connor, Jeff; Bobowski, Ben			Forecasting Distributional Responses of Limber Pine to Climate Change at Management-Relevant Scales in Rocky Mountain National Park	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; UNITED-STATES; FLEXILIS; COLORADO; FOREST; RANGE; CONSERVATION; MECHANISMS; SUCCESSION; DISPERSAL	Resource managers at parks and other protected areas are increasingly expected to factor climate change explicitly into their decision making frameworks. However, most protected areas are small relative to the geographic ranges of species being managed, so forecasts need to consider local adaptation and community dynamics that are correlated with climate and affect distributions inside protected area boundaries. Additionally, niche theory suggests that species' physiological capacities to respond to climate change may be underestimated when forecasts fail to consider the full breadth of climates occupied by the species rangewide. Here, using correlative species distribution models that contrast estimates of climatic sensitivity inferred from the two spatial extents, we quantify the response of limber pine (Pinus flexilis) to climate change in Rocky Mountain National Park (Colorado, USA). Models are trained locally within the park where limber pine is the community dominant tree species, a distinct structural-compositional vegetation class of interest to managers, and also rangewide, as suggested by niche theory. Model forecasts through 2100 under two representative concentration pathways (RCP 4.5 and 8.5 W/m(2)) show that the distribution of limber pine in the park is expected to move upslope in elevation, but changes in total and core patch area remain highly uncertain. Most of this uncertainty is biological, as magnitudes of projected change are considerably more variable between the two spatial extents used in model training than they are between RCPs, and novel future climates only affect local model predictions associated with RCP 8.5 after 2091. Combined, these results illustrate the importance of accounting for unknowns in species' climatic sensitivities when forecasting distributional scenarios that are used to inform management decisions. We discuss how our results for limber pine may be interpreted in the context of climate change vulnerability and used to help guide adaptive management.	[Monahan, William B.] Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO 80525 USA; [Cook, Tammy] Natl Pk Serv, Biol Resource Management Div, Ft Collins, CO USA; [Melton, Forrest] Calif State Univ Monterey Bay, Seaside, CA USA; [Melton, Forrest] NASA, Ames Res Ctr, Cooperat Res Earth Sci & Technol, Moffett Field, CA 94035 USA; [Connor, Jeff; Bobowski, Ben] Rocky Mt Natl Pk, Estes Pk, CO USA	United States Department of the Interior; United States Department of the Interior; California State University System; California State University Monterey Bay; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Monahan, WB (corresponding author), Natl Pk Serv, Inventory & Monitoring Div, Ft Collins, CO 80525 USA.	Bill_Monahan@nps.gov	Connor, Jeff/T-7345-2019		National Park Service; NASA Applied Sciences program [10-BIOCLIM10-0034]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER	National Park Service; NASA Applied Sciences program(National Aeronautics & Space Administration (NASA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Support for this study was provided by the National Park Service, and by the NASA Applied Sciences program through award number 10-BIOCLIM10-0034. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RS, 2000, PALAEOGEOGR PALAEOCL, V155, P31, DOI 10.1016/S0031-0182(99)00093-0; [Anonymous], 2011, SCANNING CONSERVATIO; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Ashton I, 2010, NPSROMNNRR2010277; Ashton I, 2011, NPSROMNNRDS2011148; Baumeister D, 2006, ECOLOGY, V87, P1816, DOI 10.1890/0012-9658(2006)87[1816:FBPFDS]2.0.CO;2; BENKMAN CW, 1995, EVOLUTION, V49, P585, DOI 10.2307/2410312; Boland GJ, 2004, CAN J PLANT PATHOL, V26, P335; Brown PM, 2013, OLDLIST; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cheever F, 1997, DENVER U LAW REV, V74, P625; Commission for Environmental Cooperation, 2011, N AM TERR EC LEV 3; Coop JD, 2009, FOREST ECOL MANAG, V257, P893, DOI 10.1016/j.foreco.2008.10.034; CORTNER HJ, 1994, ENVIRON MANAGE, V18, P167, DOI 10.1007/BF02393759; Donnegan JA, 1999, ECOLOGY, V80, P1370, DOI 10.1890/0012-9658(1999)080[1370:RAMOSF]2.0.CO;2; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gibson K., 2008, MOUNTAIN PINE BEETLE; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hannah L, 2002, CONSERV BIOL, V16, P264, DOI 10.1046/j.1523-1739.2002.00465.x; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Hessl AE, 1997, ARCTIC ALPINE RES, V29, P173, DOI 10.2307/1552044; Hijmans R, 2006, BIOCLIM AML VERSION; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Johnson D. W., 2000, Plant Disease, V84, P595, DOI 10.1094/PDIS.2000.84.5.595D; LANNER RM, 1980, J FOREST, V78, P637; Little EL, 1971, USDA MISCELLANEOUS P, V1; Lockman I. Blakey, 2007, R6NRFHP200701 USDA F; Logan J.A., 2001, AM ENTOMOL, V47, P160; Maurer EP, 2008, HYDROL EARTH SYST SC, V12, P551; McCutchen HE, 1996, GREAT BASIN NAT, V56, P90; McLaughlin BC, 2012, GLOBAL CHANGE BIOL, V18, P2301, DOI 10.1111/j.1365-2486.2011.02630.x; McWethy D., 2010, NPSGRYNNRR2010260; Means RE, 2011, FUTURE HIGH ELEVATIO; Midgley GF, 2010, ECOGRAPHY, V33, P612, DOI 10.1111/j.1600-0587.2009.06000.x; Millar CI, 2007, CAN J FOREST RES, V37, P2508, DOI 10.1139/X07-097; Mitton JB, 2012, AM NAT, V179, pE163, DOI 10.1086/665007; Moyes AB, 2013, OECOLOGIA, V171, P271, DOI 10.1007/s00442-012-2410-0; Natural Resources Conservation Service, 2006, SOIL SURV ROCK MOUNT; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PRISM Climate Group, 2012, PRISM CLIM DAT; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; REBERTUS AJ, 1991, J VEG SCI, V2, P445, DOI 10.2307/3236026; Reinhardt K, 2011, TREE PHYSIOL, V31, P615, DOI 10.1093/treephys/tpr055; Rochefort R. M., 1994, Holocene, V4, P89, DOI 10.1177/095968369400400112; Rocky Mountain National Park, 2010, LIST SPEC MAN; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Salas DE, 2005, 82600502 BUR RECL; Schoettle AW, 2007, J FOREST RES-JPN, V12, P327, DOI 10.1007/s10310-007-0024-x; Schoettle AW, 2000, AM J BOT, V87, P1797, DOI 10.2307/2656832; Schoettle AW, 2011, FUTURE HIGH ELEVATIO; Schoettle AW, 2004, USDA FOR SERV P; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Secretary of the Interior, 2009, 3289 SECR INT; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; Sibold JS, 2006, J BIOGEOGR, V33, P833, DOI 10.1111/j.1365-2699.2006.01456.x; Smith CM, 2011, FUTURE HIGH ELEVATIO; Soulu M., 1999, CONTINENTAL CONSERVA; Stohlgren TJ, 1997, ECOLOGY, V78, P632, DOI 10.1890/0012-9658(1997)078[0632:LPPCEI]2.0.CO;2; Stohlgren TJ, 2000, BIODIVERS CONSERV, V9, P65, DOI 10.1023/A:1008995726486; Thrasher Bridget, 2013, Eos, Transactions American Geophysical Union, V94, P321; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wood AW, 2004, CLIMATIC CHANGE, V62, P189, DOI 10.1023/B:CLIM.0000013685.99609.9e; Wood AW, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000659	70	17	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83163	10.1371/journal.pone.0083163	http://dx.doi.org/10.1371/journal.pone.0083163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391742	gold, Green Published, Green Submitted			2022-12-27	WOS:000329325200039
J	Oba, Y; Yoshida, N; Kanie, S; Ojika, M; Inouye, S				Oba, Yuichi; Yoshida, Naoki; Kanie, Shusei; Ojika, Makoto; Inouye, Satoshi			Biosynthesis of Firefly Luciferin in Adult Lantern: Decarboxylation of L-Cysteine Is a Key Step for Benzothiazole Ring Formation in Firefly Luciferin Synthesis	PLOS ONE			English	Article							COLEOPTERA; BIOLUMINESCENCE; BENZOQUINONES; HILGENDORFII	Background: Bioluminescence in fireflies and click beetles is produced by a luciferase-luciferin reaction. The luminescence property and protein structure of firefly luciferase have been investigated, and its cDNA has been used for various assay systems. The chemical structure of firefly luciferin was identified as the D-form in 1963 and studies on the biosynthesis of firefly luciferin began early in the 1970's. Incorporation experiments using C-14-labeled compounds were performed, and cysteine and benzoquinone/hydroquinone were proposed to be biosynthetic component for firefly luciferin. However, there have been no clear conclusions regarding the biosynthetic components of firefly luciferin over 30 years. Methodology/Principal Findings: Incorporation studies were performed by injecting stable isotope-labeled compounds, including L-[U-C-13(3)]-cysteine, L-[1-C-13]-cysteine, L-[3-C-13]-cysteine, 1,4-[D-6]-hydroquinone, and p-[2,3,5,6-D]-benzoquinone, into the adult lantern of the living Japanese firefly Luciola lateralis. After extracting firefly luciferin from the lantern, the incorporation of stable isotope-labeled compounds into firefly luciferin was identified by LC/ESI-TOF-MS. The positions of the stable isotope atoms in firefly luciferin were determined by the mass fragmentation of firefly luciferin. Conclusions: We demonstrated for the first time that D-and L-firefly luciferins are biosynthesized in the lantern of the adult firefly from two L-cysteine molecules with p-benzoquinone/1,4-hydroquinone, accompanied by the decarboxylation of L-cysteine.	[Oba, Yuichi; Yoshida, Naoki; Kanie, Shusei; Ojika, Makoto] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Inouye, Satoshi] JNC Corp, Yokohama Res Ctr, Yokohama, Kanagawa, Japan	Nagoya University	Oba, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	oba@agr.nagoya-u.ac.jp; sinouye@jnc-corp.co.jp	YOSHIDA, NAOKI/G-4986-2014; Oba, Yuichi/AAZ-7796-2021	Inouye, Satoshi/0000-0001-8732-7839	Japan Society for the Promotion of Science [23310159]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant from Japan Society for the Promotion of Science (23310159). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHADHA MS, 1961, J INSECT PHYSIOL, V7, P46, DOI 10.1016/0022-1910(61)90043-9; COLEPICOLO P, 1988, COMP BIOCHEM PHYS B, V91, P143, DOI 10.1016/0305-0491(88)90126-5; da Silva LP, 2011, PHOTOCH PHOTOBIO SCI, V10, P1039, DOI 10.1039/c0pp00379d; Derikvand F, 2010, J CATAL, V271, P99, DOI 10.1016/j.jcat.2010.02.015; GNANASUNDERAM C, 1985, J CHEM ECOL, V11, P465, DOI 10.1007/BF00989557; Gomi K, 2001, J BIOL CHEM, V276, P36508, DOI 10.1074/jbc.M105528200; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; Holliday AE, 2009, J CHEM ECOL, V35, P1302, DOI 10.1007/s10886-009-9712-7; Inouye S, 2010, CELL MOL LIFE SCI, V67, P387, DOI 10.1007/s00018-009-0170-8; Kato S, 2004, TETRAHEDRON, V60, P11427, DOI 10.1016/j.tet.2004.09.080; Kato S, 2007, HETEROCYCLES, V72, P673; Lembert N, 1996, BIOCHEM J, V317, P273, DOI 10.1042/bj3170273; Lloyd J.E., 1978, P241; MCCAPRA F, 1976, J CHEM SOC CHEM COMM, P153, DOI 10.1039/c39760000153; MCCAPRA F, 1975, J CHEM SOC CHEM COMM, P42, DOI 10.1039/c3975000042b; Niwa K, 2006, FEBS LETT, V580, P5283, DOI 10.1016/j.febslet.2006.08.073; Oba Y, 2002, TETRAHEDRON LETT, V43, P2389, DOI 10.1016/S0040-4039(02)00257-5; Oba Y, 2008, BIOSCI BIOTECH BIOCH, V72, P1384, DOI 10.1271/bbb.80017; Oba Y, 2013, PHOTOCH PHOTOBIO SCI, V12, P854, DOI 10.1039/c3pp25363e; Oba Y, 2009, BIOCHEM BIOPH RES CO, V390, P684, DOI 10.1016/j.bbrc.2009.10.028; OKADA K, 1976, J CHEM SOC CHEM COMM, P32, DOI 10.1039/c39760000032; OKADA K, 1974, TETRAHEDRON LETT, P2771; Reinhard J, 2002, J CHEM ECOL, V28, P1, DOI 10.1023/A:1013554100310; SELIGER HH, 1961, P NATL ACAD SCI USA, V47, P1129, DOI 10.1073/pnas.47.8.1129; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Toya Y, 2005, Bioluminescence & Chemiluminescence: Progress and Perspectives, P129, DOI 10.1142/9789812702203_0030; WHITE EH, 1961, J AM CHEM SOC, V83, P2402, DOI 10.1021/ja01471a051; WHITE EH, 1963, J AM CHEM SOC, V85, P337, DOI 10.1021/ja00886a019; Wilson T., 2013, BIOLUMINESCENCE LIVI; Zhao W, 2011, BIOORGAN MED CHEM, V19, P3192, DOI 10.1016/j.bmc.2011.03.063	30	34	35	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84023	10.1371/journal.pone.0084023	http://dx.doi.org/10.1371/journal.pone.0084023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391868	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900011
J	Ogawa, K; Ishizaki, A; Takai, K; Kitamura, Y; Kiwada, T; Shiba, K; Odani, A				Ogawa, Kazuma; Ishizaki, Atsushi; Takai, Kenichiro; Kitamura, Yoji; Kiwada, Tatsuto; Shiba, Kazuhiro; Odani, Akira			Development of Novel Radiogallium-Labeled Bone Imaging Agents Using Oligo-Aspartic Acid Peptides as Carriers	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEM; CONJUGATED BISPHOSPHONATE; CALCIUM MINERALIZATION; RADIONUCLIDE UPTAKE; F-18-FLUORIDE PET; SEEKING AGENT; METASTASES; SCINTIGRAPHY; PALLIATION; THERAPY	Ga-68 (T-1/2 = 68 min, a generator-produced nuclide) has great potential as a radionuclide for clinical positron emission tomography (PET). Because poly-glutamic and poly-aspartic acids have high affinity for hydroxyapatite, to develop new bone targeting Ga-68-labeled bone imaging agents for PET, we used 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) as a chelating site and conjugated aspartic acid peptides of varying lengths. Subsequently, we compared Ga complexes, Ga-DOTA-(Asp) n (n = 2, 5, 8, 11, or 14) with easy-to-handle Ga-67, with the previously described Ga-67-DOTA complex conjugated bisphosphonate, Ga-67-DOTA-Bn-SCN-HBP. After synthesizing DOTA-(Asp) n by a Fmoc-based solidphase method, complexes were formed with Ga-67, resulting in Ga-67-DOTA-(Asp)(n) with a radiochemical purity of over 95% after HPLC purification. In hydroxyapatite binding assays, the binding rate of Ga-67-DOTA-(Asp)(n) increased with the increase in the length of the conjugated aspartate peptide. Moreover, in biodistribution experiments, Ga-67-DOTA-(Asp)(8), Ga-67-DOTA(Asp)(11), and Ga-67-DOTA-(Asp)(14) showed high accumulation in bone (10.5 +/- 1.5, 15.1 +/- 2.6, and 12.8 +/- 1.7% ID/g, respectively) but were barely observed in other tissues at 60 min after injection. Although bone accumulation of Ga-67-DOTA-(Asp)(n) was lower than that of Ga-67-DOTA-Bn-SCN-HBP, blood clearance of Ga-67-DOTA-(Asp)(n) was more rapid. Accordingly, the bone/blood ratios of Ga-67-DOTA-(Asp)(11) and Ga-67-DOTA-(Asp)(14) were comparable with those of Ga-67-DOTA-Bn-SCN-HBP. In conclusion, these data provide useful insights into the drug design of Ga-68-PET tracers for the diagnosis of bone disorders, such as bone metastases.	[Ogawa, Kazuma; Ishizaki, Atsushi; Takai, Kenichiro; Kiwada, Tatsuto; Odani, Akira] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Kitamura, Yoji; Shiba, Kazuhiro] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Ogawa, K (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.	kogawa@p.kanazawa-u.ac.jp	ODANI, Akira/B-3043-2011; Ogawa, Kazuma/D-8406-2015	ODANI, Akira/0000-0003-3786-6740; Ogawa, Kazuma/0000-0002-1691-7302	Ministry of Education, Culture, Sports, Science and Technology of Japan [21791174, 23791401]; Terumo Life Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Terumo Life Science Foundation(Terumo Life Science Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported in part by Grants-in-Aid for Young Scientists (B) (KAKENHI Grant Number 21791174 and 23791401) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Terumo Life Science Foundation, and Mochida Memorial Foundation for Medical and Pharmaceutical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAU M, 1962, J NUCL MED, V3, P332; BUDD RS, 1989, BRIT J RADIOL, V62, P314, DOI 10.1259/0007-1285-62-736-314; BUDD RS, 1989, BRIT J RADIOL, V62, P318, DOI 10.1259/0007-1285-62-736-318; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; de Rosales RTM, 2009, CHEM COMMUN, P4847, DOI 10.1039/b908652h; de Rosales RTM, 2010, BIOCONJUGATE CHEM, V21, P811, DOI 10.1021/bc100071k; Demirkan B, 2005, TUMORI, V91, P77, DOI 10.1177/030089160509100115; DOMSTAD PA, 1980, RADIOLOGY, V136, P209, DOI 10.1148/radiology.136.1.6446106; Even-Sapir E, 2006, J NUCL MED, V47, P287; Fellner M, 2012, NUCL MED BIOL, V39, P993, DOI 10.1016/j.nucmedbio.2012.04.007; Fellner M, 2010, EUR J NUCL MED MOL I, V37, P834, DOI 10.1007/s00259-009-1355-y; GALASKO CSB, 1980, CLIN NUCL MED, V5, P565; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kasugai S, 2000, J BONE MINER RES, V15, P936, DOI 10.1359/jbmr.2000.15.5.936; Kruger S, 2009, EUR J NUCL MED MOL I, V36, P1807, DOI 10.1007/s00259-009-1181-2; Kubicek V, 2005, J AM CHEM SOC, V127, P16477, DOI 10.1021/ja054905u; LAVENDER JP, 1979, J NUCL MED, V20, P413; LIBSON K, 1980, J AM CHEM SOC, V102, P2476, DOI 10.1021/ja00527a066; Love C, 2003, RADIOGRAPHICS, V23, P341, DOI 10.1148/rg.232025103; Mari C, 1999, Q J NUCL MED, V43, P259; MEYER JL, 1973, CALC TISS RES, V13, P295, DOI 10.1007/BF02015419; Notni J, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-28; Notni J, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-13; Ogawa K, 2005, BIOCONJUGATE CHEM, V16, P751, DOI 10.1021/bc040249w; Ogawa K, 2004, J LABELLED COMPD RAD, V47, P753, DOI 10.1002/jlcr.864; Ogawa K, 2012, CURR MED CHEM, V19, P3290, DOI 10.2174/092986712801215865; Ogawa K, 2009, J DRUG DELIV SCI TEC, V19, P171, DOI 10.1016/S1773-2247(09)50032-9; Ogawa K, 2011, INT J MOL IMAGING, V2011; Ogawa K, 2007, J NUCL MED, V48, P122; Ogawa K, 2006, NUCL MED BIOL, V33, P513, DOI 10.1016/j.nucmedbio.2006.03.006; Ogawa K, 2011, NUCL MED BIOL, V38, P631, DOI 10.1016/j.nucmedbio.2010.12.004; Ogawa K, 2009, EUR J NUCL MED MOL I, V36, P115, DOI 10.1007/s00259-008-0925-8; Ogawa K, 2009, NUCL MED BIOL, V36, P129, DOI 10.1016/j.nucmedbio.2008.11.007; Ogawa K, 2006, J NUCL MED, V47, P2042; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; OLDBERG A, 1988, J BIOL CHEM, V263, P19430; Palma E, 2007, J BIOL INORG CHEM, V12, P667, DOI 10.1007/s00775-007-0215-0; Sekido T, 2001, J DRUG TARGET, V9, P111, DOI 10.3109/10611860108997922; SUBRAMANIAN G, 1975, J NUCL MED, V16, P744; Suzuki K, 2011, NUCL MED BIOL, V38, P1011, DOI 10.1016/j.nucmedbio.2011.02.015; TANABE S, 1983, INT J APPL RADIAT IS, V34, P1577, DOI 10.1016/0020-708X(83)90002-9; Uehara T, 2007, NUCL MED BIOL, V34, P79, DOI 10.1016/j.nucmedbio.2006.10.001; Verbeke K, 2002, BIOCONJUGATE CHEM, V13, P16, DOI 10.1021/bc0001600; Vitha T, 2008, J MED CHEM, V51, P677, DOI 10.1021/jm7012776; Wang D, 2003, BIOCONJUGATE CHEM, V14, P853, DOI 10.1021/bc034090j; Wang D, 2007, BIOCONJUGATE CHEM, V18, P1375, DOI 10.1021/bc7002132; Yokogawa K, 2001, ENDOCRINOLOGY, V142, P1228, DOI 10.1210/en.142.3.1228; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208; Zhernosekov KP, 2007, J NUCL MED, V48, P1741, DOI 10.2967/jnumed.107.040378	49	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84335	10.1371/journal.pone.0084335	http://dx.doi.org/10.1371/journal.pone.0084335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391942	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900085
J	Parker, D; Picone, J; Harati, A; Lu, S; Jenkyns, MH; Polgreen, PM				Parker, Danny; Picone, Joseph; Harati, Amir; Lu, Shuang; Jenkyns, Marion H.; Polgreen, Philip M.			Detecting Paroxysmal Coughing from Pertussis Cases Using Voice Recognition Technology	PLOS ONE			English	Article							PATIENT	Background: Pertussis is highly contagious; thus, prompt identification of cases is essential to control outbreaks. Clinicians experienced with the disease can easily identify classic cases, where patients have bursts of rapid coughing followed by gasps, and a characteristic whooping sound. However, many clinicians have never seen a case, and thus may miss initial cases during an outbreak. The purpose of this project was to use voice-recognition software to distinguish pertussis coughs from croup and other coughs. Methods: We collected a series of recordings representing pertussis, croup and miscellaneous coughing by children. We manually categorized coughs as either pertussis or non-pertussis, and extracted features for each category. We used Mel-frequency cepstral coefficients (MFCC), a sampling rate of 16 KHz, a frame Duration of 25 msec, and a frame rate of 10 msec. The coughs were filtered. Each cough was divided into 3 sections of proportion 3-4-3. The average of the 13 MFCCs for each section was computed and made into a 39-element feature vector used for the classification. We used the following machine learning algorithms: Neural Networks, K-Nearest Neighbor (KNN), and a 200 tree Random Forest (RF). Data were reserved for cross-validation of the KNN and RF. The Neural Network was trained 100 times, and the averaged results are presented. Results: After categorization, we had 16 examples of non-pertussis coughs and 31 examples of pertussis coughs. Over 90% of all pertussis coughs were properly classified as pertussis. The error rates were: Type I errors of 7%, 12%, and 25% and Type II errors of 8%, 0%, and 0%, using the Neural Network, Random Forest, and KNN, respectively. Conclusion: Our results suggest that we can build a robust classifier to assist clinicians and the public to help identify pertussis cases in children presenting with typical symptoms.	[Parker, Danny] GTD Unltd, Oxford, MS USA; [Picone, Joseph; Harati, Amir; Lu, Shuang] Temple Univ, Dept Elect & Comp Engn, Philadelphia, PA 19122 USA; [Jenkyns, Marion H.] Jenkyns Oxford High Sch, Oxford, England; [Polgreen, Philip M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Polgreen, Philip M.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Iowa; University of Iowa	Polgreen, PM (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	Philip-polgreen@uiowa.edu		Polgreen, Philip/0000-0002-0630-5898	National Institute of Allergy and Infectious Diseases/National Institutes of Health [AI75089]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI075089] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part by a K01 award (AI75089) from The National Institute of Allergy and Infectious Diseases/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Banfield RE, 2007, IEEE T PATTERN ANAL, V29, P173, DOI 10.1109/TPAMI.2007.250609; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Cherry James D, 2005, Pediatr Infect Dis J, V24, pS25, DOI 10.1097/01.inf.0000160926.89577.3b; Cornia PB, 2010, JAMA-J AM MED ASSOC, V304, P890, DOI 10.1001/jama.2010.1181; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Ganapathiraju A, 2004, IEEE T SIGNAL PROCES, V52, P2348, DOI 10.1109/TSP.2004.831018; Lippmann R. P., 1987, IEEE ASSP Magazine, V4, P4, DOI 10.1145/44571.44572; Matos S, 2006, IEEE T BIO-MED ENG, V53, P1078, DOI 10.1109/TBME.2006.873548; PICONE JW, 1993, P IEEE, V81, P1215, DOI 10.1109/5.237532; Smith J, 2008, LUNG, V186, pS48, DOI 10.1007/s00408-007-9059-1; Tracey BH, 2011, IEEE ENG MED BIO, P6017, DOI 10.1109/IEMBS.2011.6091487; Versteegh FGA, 2012, ARCH PEDIAT ADOL MED, V166, P389, DOI 10.1001/archpediatrics.2011.1243; Wood N, 2008, PAEDIATR RESPIR REV, V9, P201, DOI 10.1016/j.prrv.2008.05.010	13	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82971	10.1371/journal.pone.0082971	http://dx.doi.org/10.1371/journal.pone.0082971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391730	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200027
J	Smith, AO; Bowers, SLK; Stratman, AN; Davis, GE				Smith, Annie O.; Bowers, Stephanie L. K.; Stratman, Amber N.; Davis, George E.			Hematopoietic Stem Cell Cytokines and Fibroblast Growth factor-2 Stimulate Human Endothelial Cell-Pericyte Tube Co-Assembly in 3D Fibrin Matrices under Serum-Free Defined Conditions	PLOS ONE			English	Article							AORTIC RING MODEL; LUMEN FORMATION; EXTRACELLULAR-MATRIX; VASCULAR MORPHOGENESIS; MOLECULAR-MECHANISMS; CAPILLARY LUMEN; ANGIOGENESIS; REQUIRES; REGRESSION; VASCULOGENESIS	We describe a novel 3D fibrin matrix model using recombinant hematopoietic stem cell cytokines under serum-free defined conditions which promotes the assembly of human endothelial cell (EC) tubes with co-associated pericytes. Individual ECs and pericytes are randomly mixed together and EC tubes form that is accompanied by pericyte recruitment to the EC tube abluminal surface over a 3-5 day period. These morphogenic processes are stimulated by a combination of the hematopoietic stem cell cytokines, stem cell factor, interleukin-3, stromal derived factor-1 alpha, and Flt-3 ligand which are added in conjunction with fibroblast growth factor (FGF)-2 into the fibrin matrix. In contrast, this tube morphogenic response does not occur under serum-free defined conditions when VEGF and FGF-2 are added together in the fibrin matrices. We recently demonstrated that VEGF and FGF-2 are able to prime EC tube morphogenic responses (i.e. added overnight prior to the morphogenic assay) to hematopoietic stem cell cytokines in collagen matrices and, interestingly, they also prime EC tube morphogenesis in 3D fibrin matrices. EC-pericyte interactions in 3D fibrin matrices leads to marked vascular basement membrane assembly as demonstrated using immunofluorescence and transmission electron microscopy. Furthermore, we show that hematopoietic stem cell cytokines and pericytes stimulate EC sprouting in fibrin matrices in a manner dependent on the alpha 5 beta 1 integrin. This novel co-culture system, under serum-free defined conditions, allows for a molecular analysis of EC tube assembly, pericyte recruitment and maturation events in a critical ECM environment (i.e. fibrin matrices) that regulates angiogenic events in postnatal life.	[Davis, George E.] Dalton Cardiovasc Sci Ctr, Dept Med Pharmacol & Physiol, Columbia, MO USA; Univ Missouri, Sch Med, Columbia, MO USA	University of Missouri System; University of Missouri Columbia	Davis, GE (corresponding author), Dalton Cardiovasc Sci Ctr, Dept Med Pharmacol & Physiol, Columbia, MO USA.	davisgeo@health.missouri.edu			NIH [HL108670, HL105606]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105606, R01HL108670] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by two NIH grants that are listed, which are HL105606 and HL108670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AC, 2009, AM J PHYSIOL-CELL PH, V297, pC471, DOI 10.1152/ajpcell.00019.2009; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Arroyo AG, 2010, CARDIOVASC RES, V86, P226, DOI 10.1093/cvr/cvq049; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Davis GE, 2001, J CELL SCI, V114, P917; Davis GE, 2012, MOL TRANSLATIONAL VA, P169; Davis GE, 2008, CURR OPIN HEMATOL, V15, P197, DOI 10.1097/MOH.0b013e3282fcc321; Davis GE, 2013, METHODS MOL BIOL, V1066, P17, DOI 10.1007/978-1-62703-604-7_2; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Gelati M, 2008, J IMMUNOL, V181, P5711, DOI 10.4049/jimmunol.181.8.5711; Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Howson KM, 2005, AM J PHYSIOL-CELL PH, V289, pC1396, DOI 10.1152/ajpcell.00168.2005; Hughes CCW, 2008, CURR OPIN HEMATOL, V15, P204, DOI 10.1097/MOH.0b013e3282f97dbc; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Iacobas I, 2010, ARTERIOSCL THROM VAS, V30, P1110, DOI 10.1161/ATVBAHA.109.191601; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Nicosia RF, 2011, INT J DEV BIOL, V55, P447, DOI 10.1387/ijdb.103222rn; Sacharidou A, 2010, BLOOD; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Saunders WB, 2005, J CELL SCI, V118, P2325, DOI 10.1242/jcs.02360; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Stratman AN, 2012, TXB ANGIOGENESIS LYM, P101; Xu K, 2011, SEMIN CELL DEV BIOL, V22, P993, DOI 10.1016/j.semcdb.2011.05.001; Zhu WH, 2003, J VASC RES, V40, P140, DOI 10.1159/000070711	47	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85147	10.1371/journal.pone.0085147	http://dx.doi.org/10.1371/journal.pone.0085147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391990	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900133
J	Wium, C; Gulseth, HL; Eriksen, EF; Birkeland, KI				Wium, Cecilie; Gulseth, Hanne Lovdal; Eriksen, Erik Fink; Birkeland, Kare Inge			Characteristics of Glucose Metabolism in Nordic and South Asian Subjects with Type 2 Diabetes	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; RANDOMIZED CONTROLLED-TRIAL; PLASMA 25-HYDROXYVITAMIN D; PLACEBO-CONTROLLED TRIAL; INSULIN-RESISTANCE; SKELETAL-MUSCLE; CLAMP TECHNIQUE; FAT MASS; SECRETION; SENSITIVITY	Background: Insulin resistance and type 2 diabetes are more prevalent in people of South Asian ethnicity than in people of Western European origin. To investigate the source of these differences, we compared insulin sensitivity, insulin secretion, glucose and lipid metabolism in South Asian and Nordic subjects with type 2 diabetes. Methods: Forty-three Nordic and 19 South Asian subjects with type 2 diabetes were examined with intra-venous glucose tolerance test, euglycemic clamp including measurement of endogenous glucose production, indirect calorimetry measuring glucose and lipid oxidation, and dual x-ray absorptiometry measuring body composition. Results: Despite younger mean +/- SD age (49.7 +/- 9.4 vs 58.3 +/- 8.3 years, p = 0.001), subjects of South Asian ethnicity had the same diabetes duration (9.3 +/- 5.5 vs 9.6 +/- 7.0 years, p = 0.86), significantly higher median [inter-quartile range] HbA(1c) (8.5 [1.6] vs 7.3 [1.6] %, p = 0.024) and lower BMI (28.7 +/- 4.0 vs 33.2 +/- 4.7 kg/m(2), p, 0.001). The South Asian group exhibited significantly higher basal endogenous glucose production (19.1 [9.1] vs 14.4 [6.8] mu mol/kgFFM.min, p = 0.003). There were no significant differences between the groups in total glucose disposal (39.1 +/- 20.4 vs 39.2 +/- 17.6 mu mol/kgFFM.min, p = 0.99) or first phase insulin secretion (AUC(0-8) (min): 220 [302] vs 124 [275] pM, p = 0.35). In South Asian subjects there was a tendency towards positive correlations between endogenous glucose production and resting and clamp energy expenditure. Conclusions: Subjects of South Asian ethnicity with type 2 diabetes, despite being younger and leaner, had higher basal endogenous glucose production, indicating higher hepatic insulin resistance, and a trend towards higher use of carbohydrates as fasting energy substrate compared to Nordic subjects. These findings may contribute to the understanding of the observed differences in prevalence of type 2 diabetes between the ethnic groups.	[Wium, Cecilie; Gulseth, Hanne Lovdal; Eriksen, Erik Fink; Birkeland, Kare Inge] Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Wium, Cecilie; Gulseth, Hanne Lovdal] Oslo Univ Hosp, Hormone Lab, Oslo, Norway; [Wium, Cecilie; Gulseth, Hanne Lovdal; Eriksen, Erik Fink; Birkeland, Kare Inge] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Wium, C (corresponding author), Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway.	cecilie.wium@medisin.uio.no	Eriksen, Erik Fink/AAF-5056-2020; Birkeland, Kåre I/E-9750-2010		South Eastern Norway Regional Health Authority; EXTRA Foundation; Norwegian Diabetes Association; Freia Chokolade Fabrik's Medical Foundation	South Eastern Norway Regional Health Authority; EXTRA Foundation; Norwegian Diabetes Association; Freia Chokolade Fabrik's Medical Foundation	The study was funded with grants from the South Eastern Norway Regional Health Authority, the EXTRA Foundation, The Norwegian Diabetes Association, and Freia Chokolade Fabrik's Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S S, 1999, Ethn Health, V4, P241, DOI 10.1080/13557859998029; Basu R, 2005, DIABETES, V54, P1942, DOI 10.2337/diabetes.54.7.1942; Belenchia AM, 2013, AM J CLIN NUTR, V97, P774, DOI 10.3945/ajcn.112.050013; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Davidson MB, 2013, DIABETES CARE, V36, P260, DOI 10.2337/dc12-1204; DEFRONZO R, 1979, J CLIN INVEST, V63, P939, DOI 10.1172/JCI109394; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Gastaldelli A, 2004, J CLIN ENDOCR METAB, V89, P3914, DOI 10.1210/jc.2003-031941; Ghanassia E, 2007, CLIN CHIM ACTA, V383, P1, DOI 10.1016/j.cca.2007.04.006; Grimnes G, 2011, DIABETES, V60, P2748, DOI 10.2337/db11-0650; Gujral UP, 2013, ANN NY ACAD SCI, V1281, P51, DOI 10.1111/j.1749-6632.2012.06838.x; Gulseth HL, 2010, DIABETES CARE, V33, P923, DOI 10.2337/dc09-1692; Harris SS, 2012, DIABETES OBES METAB, V14, P789, DOI 10.1111/j.1463-1326.2012.01605.x; HENRY CJK, 1991, EUR J CLIN NUTR, V45, P177; Hoseini SA, 2013, J RES MED SCI, V18, P47; Jayawardena R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-380; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; Kayaniyil S, 2010, DIABETES CARE, V33, P1379, DOI 10.2337/dc09-2321; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556; Pittas AG, 2012, DIABETES CARE, V35, P565, DOI 10.2337/dc11-1795; POWRIE JK, 1992, EUR J CLIN INVEST, V22, P244, DOI 10.1111/j.1365-2362.1992.tb01458.x; Radziuk J, 2002, DIABETOLOGIA, V45, P1053, DOI 10.1007/s00125-002-0841-6; REAVEN GM, 1983, DIABETES, V32, P600, DOI 10.2337/diabetes.32.7.600; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Shetty P, 2005, PUBLIC HEALTH NUTR, V8, P994, DOI 10.1079/PHN2005792; Sniderman AD, 2007, INT J EPIDEMIOL, V36, P220, DOI 10.1093/ije/dyl245; Soares MJ, 1998, BRIT J NUTR, V79, P333, DOI 10.1079/BJN19980057; Stanfield KM, 2012, INT J EPIDEMIOL, V41, P1409, DOI 10.1093/ije/dys139; TAPPY L, 1995, CLIN PHYSIOL, V15, P1; van de Weijer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051648; Vella A, 2009, DIABETES, V58, P2168, DOI 10.2337/db09-0318; von Hurst PR, 2010, BRIT J NUTR, V103, P549, DOI 10.1017/S0007114509992017; Wolsk E, 2011, AM J CLIN NUTR, V94, P1533, DOI 10.3945/ajcn.111.012260	40	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83983	10.1371/journal.pone.0083983	http://dx.doi.org/10.1371/journal.pone.0083983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391858	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900001
J	Zajac, P; Islam, S; Hochgerner, H; Lonnerberg, P; Linnarsson, S				Zajac, Pawel; Islam, Saiful; Hochgerner, Hannah; Lonnerberg, Peter; Linnarsson, Sten			Base Preferences in Non-Templated Nucleotide Incorporation by MMLV-Derived Reverse Transcriptases	PLOS ONE			English	Article							FULL-LENGTH CDNA; RNA-SEQ; SAMPLES; BIAS	Reverse transcriptases derived from Moloney Murine Leukemia Virus (MMLV) have an intrinsic terminal transferase activity, which causes the addition of a few non-templated nucleotides at the 3' end of cDNA, with a preference for cytosine. This mechanism can be exploited to make the reverse transcriptase switch template from the RNA molecule to a secondary oligonucleotide during first-strand cDNA synthesis, and thereby to introduce arbitrary barcode or adaptor sequences in the cDNA. Because the mechanism is relatively efficient and occurs in a single reaction, it has recently found use in several protocols for single-cell RNA sequencing. However, the base preference of the terminal transferase activity is not known in detail, which may lead to inefficiencies in template switching when starting from tiny amounts of mRNA. Here, we used fully degenerate oligos to determine the exact base preference at the template switching site up to a distance of ten nucleotides. We found a strong preference for guanosine at the first non-templated nucleotide, with a greatly reduced bias at progressively more distant positions. Based on this result, and a number of careful optimizations, we report conditions for efficient template switching for cDNA amplification from single cells.	[Zajac, Pawel; Islam, Saiful; Hochgerner, Hannah; Lonnerberg, Peter; Linnarsson, Sten] Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet	Linnarsson, S (corresponding author), Karolinska Inst, Mol Neurobiol Lab, Dept Med Biochem & Biophys, Stockholm, Sweden.	sten.linnarsson@ki.se	Linnarsson, Sten/HCH-3909-2022	Hochgerner, Hannah/0000-0002-7739-666X	Swedish Foundation for Strategic Research [MDB09-0052]; European Research Council [261063/BRAINCELL]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Swedish Foundation for Strategic Research (MDB09-0052) and the European Research Council (261063/BRAINCELL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Casbon JA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr217; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; HUBER HE, 1989, J BIOL CHEM, V264, P4669; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Kapteyn J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-413; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pinto FL, 2010, ANAL BIOCHEM, V397, P227, DOI 10.1016/j.ab.2009.10.022; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/NMETH.1470, 10.1038/nmeth.1470]; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Salimullah M., 2011, COLD SPRING HARBOR P, V2011; Schmidt W M, 1999, Nucleic Acids Res, V27, pe31, DOI 10.1093/nar/27.21.e31; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Tang DTP, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1128; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Zajac P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00821; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	24	39	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85270	10.1371/journal.pone.0085270	http://dx.doi.org/10.1371/journal.pone.0085270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392002	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900145
J	Roer, JP; Bell, R; Buchner, A				Roeer, Jan P.; Bell, Raoul; Buchner, Axel			What Determines Auditory Distraction? On the Roles of Local Auditory Changes and Expectation Violations	PLOS ONE			English	Article							SHORT-TERM-MEMORY; TOKEN SET SIZE; IRRELEVANT-SOUND; MISMATCH NEGATIVITY; INVOLUNTARY ATTENTION; SPEECH; DISRUPTION; HABITUATION; INFORMATION; MECHANISMS	Both the acoustic variability of a distractor sequence and the degree to which it violates expectations are important determinants of auditory distraction. In four experiments we examined the relative contribution of local auditory changes on the one hand and expectation violations on the other hand in the disruption of serial recall by irrelevant sound. We present evidence for a greater disruption by auditory sequences ending in unexpected steady state distractor repetitions compared to auditory sequences with expected changing state endings even though the former contained fewer local changes. This effect was demonstrated with piano melodies (Experiment 1) and speech distractors (Experiment 2). Furthermore, it was replicated when the expectation violation occurred after the encoding of the target items (Experiment 3), indicating that the items' maintenance in short-term memory was disrupted by attentional capture and not their encoding. This seems to be primarily due to the violation of a model of the specific auditory distractor sequences because the effect vanishes and even reverses when the experiment provides no opportunity to build up a specific neural model about the distractor sequence (Experiment 4). Nevertheless, the violation of abstract long-term knowledge about auditory regularities seems to cause a small and transient capture effect: Disruption decreased markedly over the course of the experiments indicating that participants habituated to the unexpected distractor repetitions across trials. The overall pattern of results adds to the growing literature that the degree to which auditory distractors violate situation-specific expectations is a more important determinant of auditory distraction than the degree to which a distractor sequence contains local auditory changes.	[Roeer, Jan P.; Bell, Raoul; Buchner, Axel] Univ Dusseldorf, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Roer, JP (corresponding author), Univ Dusseldorf, Dusseldorf, Germany.	jan.roeer@hhu.de		Bell, Raoul/0000-0002-0592-0362	German Research Foundation [BU 945/9-1]	German Research Foundation(German Research Foundation (DFG))	This research was supported by a grant from the German Research Foundation (BU 945/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres P, 2006, NEUROPSYCHOLOGIA, V44, P2564, DOI 10.1016/j.neuropsychologia.2006.05.005; Banbury SP, 2001, HUM FACTORS, V43, P12, DOI 10.1518/001872001775992462; Beaman CP, 2005, EUR J COGN PSYCHOL, V17, P241, DOI 10.1080/09541440440000023; Bell R, 2007, MEM COGNITION, V35, P352, DOI 10.3758/BF03193456; Bell R, 2013, EXP PSYCHOL, V60, P376, DOI 10.1027/1618-3169/a000212; Bell R, 2012, J EXP PSYCHOL LEARN, V38, P1542, DOI 10.1037/a0028459; Bell R, 2011, Q J EXP PSYCHOL, V64, P146, DOI 10.1080/17470218.2010.483769; Bell R, 2010, PSYCHOPHYSIOLOGY, V47, P1182, DOI 10.1111/j.1469-8986.2010.01029.x; Bendixen A, 2007, J COGNITIVE NEUROSCI, V19, P1664, DOI 10.1162/jocn.2007.19.10.1664; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Buchner A, 1996, Q J EXP PSYCHOL-A, V49, P765, DOI 10.1080/713755633; Buchner A, 2004, MEM COGNITION, V32, P722, DOI 10.3758/BF03195862; Campbell T, 2003, COGNITIVE BRAIN RES, V18, P39, DOI 10.1016/j.cogbrainres.2003.09.001; Campbell T, 2002, MEMORY, V10, P199, DOI 10.1080/09658210143000335; Cock JJ, 2002, EUR J COGN PSYCHOL, V14, P27, DOI 10.1080/09541440042000151; COLLE HA, 1976, J VERB LEARN VERB BE, V15, P17, DOI 10.1016/S0022-5371(76)90003-7; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; Cowan N., 1995, ATTENTION MEMORY INT; Escera C, 2000, AUDIOL NEURO-OTOL, V5, P151, DOI 10.1159/000013877; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2002, COGNITIVE BRAIN RES, V14, P325, DOI 10.1016/S0926-6410(02)00135-0; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Hughes RW, 2007, J EXP PSYCHOL LEARN, V33, P1050, DOI 10.1037/0278-7393.33.6.1050; Hughes RW, 2005, J EXP PSYCHOL LEARN, V31, P736, DOI 10.1037/0278-7393.31.4.736; Jaramillo M, 2000, NEUROSCI LETT, V290, P101, DOI 10.1016/S0304-3940(00)01344-6; JONES D, 1992, Q J EXP PSYCHOL-A, V44, P645, DOI 10.1080/14640749208401304; Jones DM., 1993, ATTENTION SELECTION, P87, DOI DOI 10.1037/A0017008; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lange EB, 2005, J MEM LANG, V53, P513, DOI 10.1016/j.jml.2005.07.002; LECOMPTE DC, 1995, PSYCHON B REV, V2, P391, DOI 10.3758/BF03210978; LeCompte DC, 1997, J EXP PSYCHOL LEARN, V23, P472, DOI 10.1037/0278-7393.23.2.472; Marsh JE, 2008, J MEM LANG, V58, P682, DOI 10.1016/j.jml.2007.05.002; MILES C, 1991, J EXP PSYCHOL LEARN, V17, P578, DOI 10.1037/0278-7393.17.3.578; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Neath I, 2001, SCI CON SER, P247, DOI 10.1037/10394-013; Nostl A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048569; Ohman A., 1979, ORIENTING REFLEX HUM, P443; Parmentier FBR, 2011, COGNITION, V119, P374, DOI 10.1016/j.cognition.2011.02.001; Roer JP, 2014, MEM COGNITION, V42, P609, DOI 10.3758/s13421-013-0381-y; Roer JP, 2013, J COGN PSYCHOL, V25, P925, DOI 10.1080/20445911.2013.828063; Roer JP, 2011, MEM COGNITION, V39, P839, DOI 10.3758/s13421-010-0070-z; Schroger E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001131; Schroger E, 1996, J COGNITIVE NEUROSCI, V8, P527, DOI 10.1162/jocn.1996.8.6.527; Schroger E, 1998, COGNITIVE BRAIN RES, V7, P71, DOI 10.1016/S0926-6410(98)00013-5; Sokolov E.N., 1963, PERCEPTION CONDITION; Tremblay S, 1998, J EXP PSYCHOL LEARN, V24, P659, DOI 10.1037/0278-7393.24.3.659; Vachon F, 2012, J EXP PSYCHOL LEARN, V38, P164, DOI 10.1037/a0025054; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Yago E, 2001, NEUROREPORT, V12, P4093, DOI 10.1097/00001756-200112210-00046	52	32	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84166	10.1371/journal.pone.0084166	http://dx.doi.org/10.1371/journal.pone.0084166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286IW	24400081	gold, Green Published			2022-12-27	WOS:000329462700015
J	Young, C; Wong, KY; Cheung, LK				Young, Cecilia; Wong, Kin Yau; Cheung, Lim K.			A Survey on Hong Kong Secondary School Students' Knowledge of Emergency Management of Dental Trauma	PLOS ONE			English	Article							PERMANENT TEETH; INJURIES; SCHOOLCHILDREN; AVULSION; GUIDELINES; CHILDREN; PREVALENCE; TEACHERS; ETIOLOGY	Objectives: To investigate Hong Kong secondary school students' knowledge of emergency management of dental trauma. Method: A questionnaire survey on randomly selected secondary school students using cluster sampling. Results: Only 36.6% (209/571) of the respondents were able to correctly identify the appropriate place for treatment of dental injury. 55.2% of the respondents knew the suitable time for treatment. Only 24.7% of the respondents possessed the knowledge of how to correctly manage fractured teeth. Only 23.6% of them knew how to manage displaced teeth. 62.5% of them correctly answered that knocked-out deciduous teeth should not be replanted to the original position, but few of them (23.6%) knew that permanent teeth should be replanted. Moreover, 37.1% of the respondents correctly identified at least one of the appropriate media for storing a knocked-out tooth. First-aid training and acquisition of dental injury information from other sources were significant factors that positive responses from these questions would lead to higher scores. Conclusion: Hong Kong secondary school students' knowledge of emergency management of dental trauma is considered insufficient. An educational campaign in secondary schools dedicated to students is recommended. Prior first-aid training and acquisition of dental injury information from other sources positively relate to the level of knowledge. Dental trauma emergency management is recommended to be added to first-aid publications and be taught to students and health professionals.	[Wong, Kin Yau] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Cheung, Lim K.] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of Hong Kong		ceciliatyp@yahoo.com.hk	Young, Cecilia/K-1699-2018	Young, Cecilia/0000-0003-1698-7738; , Kin Yau/0000-0001-9066-1619				Andersson L, 2006, DENT TRAUMATOL, V22, P57, DOI 10.1111/j.1600-9657.2006.00338.x; Andersson L, 2012, DENT TRAUMATOL, V28, P88, DOI 10.1111/j.1600-9657.2012.01125.x; Andreasen FM, 2007, TXB COLOUR ATLAS TRA; Andreasen FM, 2007, TXB COLOR ATLAS TRAU, P290; Andreasen JO, 2002, DENT TRAUMATOL, V18, P116, DOI 10.1034/j.1600-9657.2002.00079.x; Andreasen JO, 2007, TXB COLOUR ATLAS TRA, P444; Bendo CB, 2010, J PUBLIC HEALTH DENT, V70, P313, DOI 10.1111/j.1752-7325.2010.00190.x; Biagi R, 2010, EUR J PAEDIATR DENT, V11, P66; Castilho LR, 2009, DENT TRAUMATOL, V25, P429, DOI 10.1111/j.1600-9657.2008.00756.x; Fakhruddin KS, 2008, DENT TRAUMATOL, V24, P305, DOI 10.1111/j.1600-9657.2007.00548.x; Fariniuk LF, 2010, J APPL ORAL SCI, V18, P343, DOI 10.1590/S1678-77572010000400004; Faus-Damia M, 2011, MED ORAL PATOL ORAL, V16, pE292, DOI 10.4317/medoral.16.e292; Flores MT, 2007, DENT TRAUMATOL, V23, P196, DOI 10.1111/j.1600-9657.2007.00627.x; Flores MT, 2007, DENT TRAUMATOL, V23, P130, DOI 10.1111/j.1600-9657.2007.00605.x; Flores MT, 2007, TXB COLOUR ATLAS TRA, P869; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Huang BY, 2009, DENT TRAUMATOL, V25, P64, DOI 10.1111/j.1600-9657.2008.00685.x; Lam R, 2008, DENT TRAUMATOL, V24, P663, DOI 10.1111/j.1600-9657.2008.00689.x; Levin L, 2007, DENT TRAUMATOL, V23, P356, DOI 10.1111/j.1600-9657.2006.00473.x; Lieger O, 2009, DENT TRAUMATOL, V25, P406, DOI 10.1111/j.1600-9657.2009.00798.x; Naidoo S, 2009, DENT TRAUMATOL, V25, P224, DOI 10.1111/j.1600-9657.2008.00749.x; Navabazam A, 2010, DENT TRAUMATOL, V26, P154, DOI 10.1111/j.1600-9657.2009.00861.x; Noori AJ, 2009, DENT TRAUMATOL, V25, P442, DOI 10.1111/j.1600-9657.2009.00791.x; Thelen DS, 2010, DENT TRAUMATOL, V26, P284, DOI 10.1111/j.1600-9657.2010.00918.x; Underwood M, 1998, BRIT J GEN PRACT, V48, P1089; Wilson S, 1997, PEDIATR EMERG CARE, V13, P12, DOI 10.1097/00006565-199702000-00004; Young C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074833; Young C, 2012, HONG KONG MED J, V18, P362	28	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84406	10.1371/journal.pone.0084406	http://dx.doi.org/10.1371/journal.pone.0084406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400088	Green Published, Green Submitted, gold			2022-12-27	WOS:000329462700022
J	Cho, YR; Lim, JH; Kim, MY; Kim, TW; Hong, BY; Kim, YS; Chang, YS; Kim, HW; Park, CW				Cho, Ye Rim; Lim, Ji Hee; Kim, Min Young; Kim, Tae Woo; Hong, Bo Young; Kim, Yong-Soo; Chang, Yoon Sik; Kim, Hye Won; Park, Cheol Whee			Therapeutic Effects of Fenofibrate on Diabetic Peripheral Neuropathy by Improving Endothelial and Neural Survival in db/db Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-ALPHA; GROWTH-FACTOR; CELL-SURVIVAL; PEPTIDE; VEGF; ANGIOGENESIS; PATHOGENESIS; INFLAMMATION; EXPRESSION; APOPTOSIS	Neural vascular insufficiency plays an important role in diabetic peripheral neuropathy (DPN). Peroxisome proliferative-activated receptor (PPAR)alpha has an endothelial protective effect related to activation of PPAR gamma coactivator (PGC)-1 alpha and vascular endothelial growth factor (VEGF), but its role in DPN is unknown. We investigated whether fenofibrate would improve DPN associated with endothelial survival through AMPK-PGC-1 alpha-eNOS pathway. Fenofibrate was given to db/db mice in combination with anti-flt-1 hexamer and anti-flk-1 heptamer (VEGFR inhibition) for 12 weeks. The db/db mice displayed sensory-motor impairment, nerve fibrosis and inflammation, increased apoptotic cells, disorganized myelin with axonal shrinkage and degeneration, fewer unmyelinated fibers, and endoneural vascular rarefaction in the sciatic nerve compared to db/m mice. These findings were exacerbated with VEGFR inhibition in db/db mice. Increased apoptotic cell death and endothelial dysfunction via inactivation of the PPAR alpha-AMPK-PGC-1 alpha pathway and their downstream PI3K-Akt-eNOS-NO pathway were noted in db/db mice, human umbilical vein endothelial cells (HUVECs) and human Schwann cells (HSCs) in high-glucose media. The effects were more prominent in response to VEGFR inhibition. In contrast, fenofibrate treatment ameliorated neural and endothelial damage by activating the PPAR alpha-AMPK-PGC-1 alpha-eNOS pathway in db/db mice, HUVECs and HSCs. Fenofibrate could be a promising therapy to prevent DPN by protecting endothelial cells through VEGF-independent activation of the PPAR alpha-AMPK-PGC-1 alpha-eNOS-NO pathway.	[Lim, Ji Hee; Kim, Min Young; Kim, Tae Woo; Kim, Yong-Soo; Chang, Yoon Sik; Park, Cheol Whee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Cho, Ye Rim; Hong, Bo Young; Kim, Hye Won] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, HW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	kimhw@catholic.ac.kr; cheolwhee@hanmail.net			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111055]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A3020151]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (C.W.P; A111055) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (H.W.K; 2012R1A1A3020151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Anand P, 1996, NAT MED, V2, P703, DOI 10.1038/nm0696-703; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bae DG, 2005, CLIN CANCER RES, V11, P2651, DOI 10.1158/1078-0432.CCR-04-1564; BEHSE F, 1977, J NEUROL NEUROSUR PS, V40, P1072, DOI 10.1136/jnnp.40.11.1072; Bento-Abreu A, 2007, J NEUROCHEM, V103, P871, DOI 10.1111/j.1471-4159.2007.04807.x; Binetruy-Tournaire R, 2000, EMBO J, V19, P1525, DOI 10.1093/emboj/19.7.1525; Biscetti F, 2008, DIABETES, V57, P1394, DOI 10.2337/db07-0765; Britland ST, 1985, LIFE SUPPORT SYST S, V1, P525; Cameron NE, 2001, DIABETOLOGIA, V44, P1973, DOI 10.1007/s001250100001; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Davis TME, 2008, DIABETOLOGIA, V51, P562, DOI 10.1007/s00125-007-0919-2; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Finck BN, 2007, CIRCULATION, V115, P2540, DOI 10.1161/CIRCULATIONAHA.107.670588; Fioretto P, 2010, NAT REV ENDOCRINOL, V6, P19, DOI 10.1038/nrendo.2009.213; Fissithaler B, 2009, CIRC RES, V105, P1114; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; GREENE DA, 1988, DIABETES, V37, P688, DOI 10.2337/diabetes.37.6.688; Greene Douglas A., 1999, American Journal of Medicine, V107, p2S; Iversen N, 2011, EXP GERONTOL, V46, P670, DOI 10.1016/j.exger.2011.03.004; JAKOBSEN J, 1976, DIABETOLOGIA, V12, P539, DOI 10.1007/BF01220629; Kilo S, 2000, NEUROLOGY, V54, P1246, DOI 10.1212/WNL.54.6.1246; Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Nissen NN, 1998, AM J PATHOL, V152, P1445; Okayasu T, 2008, LIFE SCI, V82, P884, DOI 10.1016/j.lfs.2008.02.002; Park CW, 2009, DIABETES, V58, P2666, DOI 10.2337/db09-0136; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Ropper AH, 2009, ANN NEUROL, V65, P386, DOI 10.1002/ana.21675; Schratzberger P, 2001, J CLIN INVEST, V107, P1083, DOI 10.1172/JCI12188; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sima AAF, 1997, DIABETOLOGIA, V40, pB74, DOI 10.1007/BF03168192; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005; Stevens EJ, 1994, DIABETOLOGIA, V36, P1266; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Tomizawa A, 2011, METABOLISM, V60, P513, DOI 10.1016/j.metabol.2010.04.020; van Dam PS, 2002, DIABETES-METAB RES, V18, P176, DOI 10.1002/dmrr.287; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wiggin TD, 2009, DIABETES, V58, P1634, DOI 10.2337/db08-1771; Xu JH, 2007, J NEUROCHEM, V103, P1801, DOI 10.1111/j.1471-4159.2007.04875.x; YOUNG MJ, 1992, DIABETOLOGIA, V35, P1146, DOI 10.1007/BF00401368	44	33	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83204	10.1371/journal.pone.0083204	http://dx.doi.org/10.1371/journal.pone.0083204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392081	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100005
J	Gu, SH; Zhang, W; Chen, J; Ma, RL; Xiao, X; Ma, XT; Yao, Z; Chen, YF				Gu, Shenhong; Zhang, Wei; Chen, Ji; Ma, Ruilian; Xiao, Xiang; Ma, Xiaotang; Yao, Zhen; Chen, Yanfang			EPC-Derived Microvesicles Protect Cardiomyocytes from Ang II-Induced Hypertrophy and Apoptosis	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; INDUCED CARDIAC-HYPERTROPHY; CHRONIC PRESSURE-OVERLOAD; MEMBRANE MICROPARTICLES; VASCULAR CELLS; NADPH OXIDASE; IN-VITRO; PATHWAY; INJURY; INFORMATION	Cell-released microvesicles (MVs) represent a novel way of cell-to-cell communication. Previous evidence indicates that endothelial progenitor cells (EPCs)-derived MVs can modulate endothelial cell survival and proliferation. In this study, we evaluated whether EPC-MVs protect cardiomyocytes (CMs) against angiotensin II (Ang II)-induced hypertrophy and apoptosis. The H9c2 CMs were exposed to Ang II in the presence or absence of EPC-MVs. Cell viability, apoptosis, surface area and beta-myosin heavy chain (beta-MHC) expression were analyzed. Meanwhile, reactive oxygen species (ROS), serine/threonine kinase (Akt), endothelial nitric oxide synthase (eNOS), and their phosphorylated proteins (p-Akt, p-eNOS) were measured. Phosphatidylinositol-3-kinase (PI3K) and NOS inhibitors were used for pathway verification. The role of MV-carried RNAs in mediating these effects was also explored. Results showed 1) EPC-MVs were able to protect CMs against Ang II-induced changes in cell viability, apoptosis, surface area, beta-MHC expression and ROS over-production; 2) The effects were accompanied with the up-regulation of Akt/p-Akt and its downstream eNOS/p-eNOS, and were abolished by PI3K inhibition or partially blocked by NOS inhibition; 3) Depletion of RNAs from EPC-MVs partially or totally eliminated the effects of EPC-MVs. Our data indicate that EPC-MVs protect CMs from hypertrophy and apoptosis through activating the PI3K/Akt/eNOS pathway via the RNAs carried by EPC-MVs.	[Gu, Shenhong; Chen, Ji; Ma, Ruilian; Xiao, Xiang; Chen, Yanfang] Wright State Univ, Boonshoft Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA; [Gu, Shenhong] Hainan Med Coll, Affiliated Hosp, Dept Gerontol, Haikou, Peoples R China; [Zhang, Wei; Ma, Ruilian; Yao, Zhen] Peoples Hosp Sanya, Dept Cardiol, Sanya, Peoples R China; [Chen, Ji; Ma, Xiaotang; Chen, Yanfang] Guangdong Med Coll, Affiliated Hosp, Dept Neurol, Zhanjiang, Guangdong, Peoples R China	University System of Ohio; Wright State University Dayton; Hainan Medical University; Guangdong Medical University	Yao, Z (corresponding author), Peoples Hosp Sanya, Dept Cardiol, Sanya, Peoples R China.	yao.zhen@126.com; yanfang.chen@wright.edu		Bihl, Ji/0000-0003-2404-1782	National Heart, Lung, and Blood Institute [HL-098637]; American Heart Association (AHA) [13POST14780018]; National Natural Science Foundation of China (NSFC) [81260060, 81300079]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098637] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA)(American Heart Association); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (HL-098637, YC), the American Heart Association (AHA, 13POST14780018 to JC) and the National Natural Science Foundation of China (NSFC, #81260060, #81300079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, FASEB J, V21, P2735, DOI 10.1096/fj.07-8079com; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Buys ES, 2007, AM J PHYSIOL-HEART C, V293, pH620, DOI 10.1152/ajpheart.01236.2006; Cantaluppi V, 2012, CELL TRANSPLANT, V21, P1305, DOI 10.3727/096368911X627534; Canton M, 2011, J AM COLL CARDIOL, V57, P300, DOI 10.1016/j.jacc.2010.06.058; Chavakis E, 2001, CIRCULATION, V103, P2102; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050105; Chen J, 2011, AM J PHYSIOL-ENDOC M, V301, pE62, DOI 10.1152/ajpendo.00026.2011; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Hong HJ, 2010, ACTA PHARMACOL SIN, V31, P1569, DOI 10.1038/aps.2010.176; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Izumiya Y, 2012, INT J VASC MED, V2012, P1155, DOI DOI 10.1155/2012/246058; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; Li LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046957; Liou SF, 2012, J NAT MED-TOKYO, V66, P311, DOI 10.1007/s11418-011-0592-0; Liu AH, 2008, CELL PHYSIOL BIOCHEM, V22, P177, DOI 10.1159/000149795; Liu JJ, 2011, APOPTOSIS, V16, P94, DOI 10.1007/s10495-010-0549-x; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; McVey M, 2012, AM J PHYSIOL-LUNG C, V303, pL364, DOI 10.1152/ajplung.00354.2011; Meziani F, 2008, PHARMACOL REP, V60, P75; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Nakagami H, 2003, J MOL CELL CARDIOL, V35, P851, DOI 10.1016/S0022-2828(03)00145-7; Qin FZ, 2006, FREE RADICAL BIO MED, V40, P236, DOI 10.1016/j.freeradbiomed.2005.08.010; Ruetten H, 2005, CARDIOVASC RES, V66, P444, DOI 10.1016/j.cardiores.2005.01.021; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Shanmugam P, 2011, J MOL CELL CARDIOL, V50, P928, DOI 10.1016/j.yjmcc.2011.02.012; SIMPSON P, 1982, CIRC RES, V50, P101, DOI 10.1161/01.RES.50.1.101; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Ullal AJ, 2010, CYTOM PART A, V77A, P294, DOI 10.1002/cyto.a.20833; Valente AJ, 2012, J MOL CELL CARDIOL, V53, P113, DOI 10.1016/j.yjmcc.2012.04.009; Venkatachalam K, 2009, J BIOL CHEM, V284, P7853, DOI 10.1074/jbc.M808824200; Wang S, 2012, N-S ARCH PHARMACOL, V385, P823, DOI 10.1007/s00210-012-0740-4; Wen Y, 2009, SCAND J CLIN LAB INV, V69, P518, DOI 10.1080/00365510902802286; Wu Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/384627; Yang CY, 2012, J CARDIOVASC PHARM, V59, P465, DOI 10.1097/FJC.0b013e31824a7b60	40	55	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e85396	10.1371/journal.pone.0085396	http://dx.doi.org/10.1371/journal.pone.0085396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392165	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100088
J	Poutahidis, T; Springer, A; Levkovich, T; Qi, PM; Varian, BJ; Lakritz, JR; Ibrahim, YM; Chatzigiagkos, A; Alm, EJ; Erdman, SE				Poutahidis, Theofilos; Springer, Alex; Levkovich, Tatiana; Qi, Peimin; Varian, Bernard J.; Lakritz, Jessica R.; Ibrahim, Yassin M.; Chatzigiagkos, Antonis; Alm, Eric J.; Erdman, Susan E.			Probiotic Microbes Sustain Youthful Serum Testosterone Levels and Testicular Size in Aging Mice	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; LEYDIG-CELLS; RAT TESTIS; VITAMIN-D; REPLACEMENT THERAPY; GUT MICROBIOTA; T-LYMPHOCYTES; MEN; MOUSE; DIET	The decline of circulating testosterone levels in aging men is associated with adverse health effects. During studies of probiotic bacteria and obesity, we discovered that male mice routinely consuming purified lactic acid bacteria originally isolated from human milk had larger testicles and increased serum testosterone levels compared to their age-matched controls. Further investigation using microscopy-assisted histomorphometry of testicular tissue showed that mice consuming Lactobacillus reuteri in their drinking water had significantly increased seminiferous tubule cross-sectional profiles and increased spermatogenesis and Leydig cell numbers per testis when compared with matched diet counterparts This showed that criteria of gonadal aging were reduced after routinely consuming a purified microbe such as L. reuteri. We tested whether these features typical of sustained reproductive fitness may be due to anti-inflammatory properties of L. reuteri, and found that testicular mass and other indicators typical of old age were similarly restored to youthful levels using systemic administration of antibodies blocking pro-inflammatory cytokine interleukin-17A. This indicated that uncontrolled host inflammatory responses contributed to the testicular atrophy phenotype in aged mice. Reduced circulating testosterone levels have been implicated in many adverse effects; dietary L. reuteri or other probiotic supplementation may provide a viable natural approach to prevention of male hypogonadism, absent the controversy and side-effects of traditional therapies, and yield practical options for management of disorders typically associated with normal aging. These novel findings suggest a potential high impact for microbe therapy in public health by imparting hormonal and gonad features of reproductive fitness typical of much younger healthy individuals.	[Poutahidis, Theofilos; Springer, Alex; Levkovich, Tatiana; Qi, Peimin; Varian, Bernard J.; Lakritz, Jessica R.; Ibrahim, Yassin M.; Erdman, Susan E.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Poutahidis, Theofilos; Chatzigiagkos, Antonis] Aristotle Univ Thessaloniki, Fac Vet Med, Pathol Lab, GR-54006 Thessaloniki, Greece; [Springer, Alex; Alm, Eric J.] MIT, Cambridge, MA 02139 USA; [Alm, Eric J.] Broad Inst MIT & Harvard, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Aristotle University of Thessaloniki; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Alm, EJ (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu; serdman@mit.edu		Lakritz, Jessica/0000-0003-2510-3869	National Institutes of Health [P30-ES002109, U01 CA164337, RO1CA108854]; NATIONAL CANCER INSTITUTE [R01CA108854, U01CA164337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants P30-ES002109 (pilot project award to SEE and EJA), U01 CA164337 (to SEE and EJA), and RO1CA108854 (to SEE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanassova N, 1999, ENDOCRINOLOGY, V140, P5364, DOI 10.1210/en.140.11.5364; Axling U, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-105; Baer Janine T, 2012, Nurse Pract, V37, P39, DOI 10.1097/01.NPR.0000415874.61843.a6; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; Bassil Nazem, 2009, Ther Clin Risk Manag, V5, P427; Bassil N, 2010, CLIN GERIATR MED, V26, P197, DOI 10.1016/j.cger.2010.02.003; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Chang SH, 2010, J BIOL CHEM, V285, P38751, DOI 10.1074/jbc.C110.185777; Chen HL, 2009, MOL CELL ENDOCRINOL, V306, P9, DOI 10.1016/j.mce.2009.01.023; CHRISTENSEN AK, 1980, BIOL REPROD, V22, P383; Dombrowicz D, 1996, J ANDROL, V17, P639; Duckett RJ, 1997, J ANDROL, V18, P417; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Fak F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046837; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; Gounaris E, 2009, CANCER RES, V69, P5490, DOI 10.1158/0008-5472.CAN-09-0304; HAFFNER SM, 1993, INT J OBESITY, V17, P643; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Harris DM, 2004, J NUTR, V134, p3463S, DOI 10.1093/jn/134.12.3463S; Hijazi RA, 2005, ANNU REV MED, V56, P117, DOI 10.1146/annurev.med.56.082103.104518; Ibrahim HAM, 2012, BIOL TRACE ELEM RES, V147, P251, DOI 10.1007/s12011-011-9308-2; Kang JH, 2010, J MICROBIOL, V48, P712, DOI 10.1007/s12275-010-0363-8; Kelly DM, 2013, J ENDOCRINOL, V217, pR25, DOI 10.1530/JOE-12-0455; KERR JB, 1985, CELL TISSUE RES, V239, P405, DOI 10.1007/BF00218021; Kim SW, 2013, BIOCHEM BIOPH RES CO, V431, P258, DOI 10.1016/j.bbrc.2012.12.121; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Liva SM, 2001, J IMMUNOL, V167, P2060, DOI 10.4049/jimmunol.167.4.2060; Mah PM, 2010, MOL CELL ENDOCRINOL, V316, P180, DOI 10.1016/j.mce.2009.06.007; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Matsumoto AM, 2002, J GERONTOL A-BIOL, V57, pM76, DOI 10.1093/gerona/57.2.M76; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; MORI H, 1980, J CELL BIOL, V84, P340, DOI 10.1083/jcb.84.2.340; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x; NAKAGATA N, 1992, THERIOGENOLOGY, V37, P1283, DOI 10.1016/0093-691X(92)90183-R; NAKAGATA N, 1994, EXP ANIM TOKYO, V43, P11, DOI 10.1538/expanim1978.43.1_11; Oksaharju A., 2012, BR J NUTR, P1; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Payne A.H., 2007, LEYDIG CELL HLTH DIS; Pines A, 2011, CLIMACTERIC, V14, P15, DOI 10.3109/13697137.2010.507442; Poutahidis T, 2007, CARCINOGENESIS, V28, P2614, DOI 10.1093/carcin/bgm180; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078898; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Saulnier DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018783; Stanworth RD, 2008, CLIN INTERV AGING, V3, P25; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; TAKANO H, 1987, ARCH HISTOL CYTOL, V50, P533, DOI 10.1679/aohc.50.533; Thornton CE, 1999, MAMM GENOME, V10, P987, DOI 10.1007/s003359901145; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107	58	86	93	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84877	10.1371/journal.pone.0084877	http://dx.doi.org/10.1371/journal.pone.0084877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392159	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100082
J	Becker, SFS; Mayor, R; Kashef, J				Becker, Sarah F. S.; Mayor, Roberto; Kashef, Jubin			Cadherin-11 Mediates Contact Inhibition of Locomotion during Xenopus Neural Crest Cell Migration	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; REQUIRES; GTPASES; TRIO; POPULATIONS; MECHANISMS; EXPRESSION; PROMOTES; RHO	Collective cell migration is an essential feature both in embryonic development and cancer progression. The molecular mechanisms of these coordinated directional cell movements still need to be elucidated. The migration of cranial neural crest (CNC) cells during embryogenesis is an excellent model for collective cell migration in vivo. These highly motile and multipotent cells migrate directionally on defined routes throughout the embryo. Interestingly, local cell-cell interactions seem to be the key force for directionality. CNC cells can change their migration direction by a repulsive cell response called contact inhibition of locomotion (CIL). Cell protrusions collapse upon homotypic cell-cell contact and internal repolarization leads to formation of new protrusions toward cell-free regions. Wnt/PCP signaling was shown to mediate activation of small RhoGTPase RhoA and inhibition of cell protrusions at the contact side. However, the mechanism how a cell recognizes the contact is poorly understood. Here, we demonstrate that Xenopus cadherin-11 (Xcad-11) mediated cell-cell adhesion is necessary in CIL for directional and collective migration of CNC cells. Reduction of Xcad-11 adhesive function resulted in higher invasiveness of CNC due to loss of CIL. Additionally, transplantation analyses revealed that CNC migratory behaviour in vivo is non-directional and incomplete when Xcad-11 adhesive function is impaired. Blocking Wnt/PCP signaling led to similar results underlining the importance of Xcad-11 in the mechanism of CIL and directional migration of CNC.	[Becker, Sarah F. S.; Kashef, Jubin] Karlsruhe Inst Technol, Zool Inst Cell & Dev Biol, D-76021 Karlsruhe, Germany; [Mayor, Roberto] UCL, Dept Cell & Dev Biol, London, England	Helmholtz Association; Karlsruhe Institute of Technology; University of London; University College London	Kashef, J (corresponding author), Karlsruhe Inst Technol, Zool Inst Cell & Dev Biol, D-76021 Karlsruhe, Germany.	jubin.kashef@kit.edu		Mayor, Roberto/0000-0001-9053-9613	DFG [WE-1208-13-1, FOR 1756]; "Concept for the Future'' of the Karlsruhe Institute of Technology; Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology; MRC [MR/J000655/1, G117/506, G0801145] Funding Source: UKRI; Medical Research Council [G117/506, MR/J000655/1, G0801145] Funding Source: researchfish	DFG(German Research Foundation (DFG)); "Concept for the Future'' of the Karlsruhe Institute of Technology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is partially supported by the DFG WE-1208-13-1 and DFG FOR 1756 (www.dfg.de). J. Kashef's Young Investigator Group received financial support from the "Concept for the Future'' of the Karlsruhe Institute of Technology within the framework of the German Excellence Initiative. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128; ABERCROMBIE M, 1962, CANCER RES, V22, P525; Alfandari D, 2010, CELL ADHES MIGR, V4, P553, DOI 10.4161/cam.4.4.12202; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Backer S, 2007, J NEUROSCI, V27, P10323, DOI 10.1523/JNEUROSCI.1102-07.2007; Becker SF, 2012, ARCH BIOCHEM BIOPHYS, V524, P30, DOI 10.1016/j.abb.2012.02.013; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Borchers A, 2001, DEVELOPMENT, V128, P3049; Bussemakers MJG, 2000, INT J CANCER, V85, P446, DOI 10.1002/(SICI)1097-0215(20000201)85:3<446::AID-IJC23>3.3.CO;2-2; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; De Calisto J, 2005, DEVELOPMENT, V132, P2587, DOI 10.1242/dev.01857; Hadeball B, 1998, MECH DEVELOP, V72, P101, DOI 10.1016/S0925-4773(98)00022-7; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; Le Douarin NM, 1999, NEURAL CREST, V2; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Mayor R, 2013, DEVELOPMENT, V140, P2247, DOI 10.1242/dev.091751; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; McCusker C, 2009, MOL BIOL CELL, V20, P78, DOI 10.1091/mbc.E08-05-0535; Moore R, 2013, DEVELOPMENT; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Pishvaian MJ, 1999, CANCER RES, V59, P947; SADAGHIANI B, 1987, DEV BIOL, V124, P91, DOI 10.1016/0012-1606(87)90463-5; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Shoval I, 2012, DEV DYNAM, V241, P1155, DOI 10.1002/dvdy.23799; Steventon B, 2012, DEV BIOL, V365, P196, DOI 10.1016/j.ydbio.2012.02.029; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Tomita K, 2000, CANCER RES, V60, P3650; Vallin J, 1998, MECH DEVELOP, V75, P171, DOI 10.1016/S0925-4773(98)00099-9; van Rijssel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029912; Watanabe T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003020	39	65	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85717	10.1371/journal.pone.0085717	http://dx.doi.org/10.1371/journal.pone.0085717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392028	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900172
J	Butzin, NC; Lapierre, P; Green, AG; Swithers, KS; Gogarten, JP; Noll, KM				Butzin, Nicholas C.; Lapierre, Pascal; Green, Anna G.; Swithers, Kristen S.; Gogarten, J. Peter; Noll, Kenneth M.			Reconstructed Ancestral Myo-Inositol-3-Phosphate Synthases Indicate That Ancestors of the Thermococcales and Thermotoga Species Were More Thermophilic than Their Descendants	PLOS ONE			English	Article							DIFFERENTIAL SCANNING FLUOROMETRY; SP-NOV; RESURRECTED PROTEINS; EVOLUTION; BACTERIA; MARITIMA; SEQUENCE; MODELS; ORIGIN; ALGORITHM	The bacterial genomes of Thermotoga species show evidence of significant interdomain horizontal gene transfer from the Archaea. Members of this genus acquired many genes from the Thermococcales, which grow at higher temperatures than Thermotoga species. In order to study the functional history of an interdomain horizontally acquired gene we used ancestral sequence reconstruction to examine the thermal characteristics of reconstructed ancestral proteins of the Thermotoga lineage and its archaeal donors. Several ancestral sequence reconstruction methods were used to determine the possible sequences of the ancestral Thermotoga and Archaea myo-inositol-3-phosphate synthase (MIPS). These sequences were predicted to be more thermostable than the extant proteins using an established sequence composition method. We verified these computational predictions by measuring the activities and thermostabilities of purified proteins from the Thermotoga and the Thermococcales species, and eight ancestral reconstructed proteins. We found that the ancestral proteins from both the archaeal donor and the Thermotoga most recent common ancestor recipient were more thermostable than their descendants. We show that there is a correlation between the thermostability of MIPS protein and the optimal growth temperature (OGT) of its host, which suggests that the OGT of the ancestors of these species of Archaea and the Thermotoga grew at higher OGTs than their descendants.	[Butzin, Nicholas C.; Lapierre, Pascal; Green, Anna G.; Swithers, Kristen S.; Gogarten, J. Peter; Noll, Kenneth M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06260 USA	University of Connecticut	Butzin, NC (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06260 USA.	nicholas.butzin@gmail.edu	Green, Anna/AAE-7645-2019	Green, Anna/0000-0001-7548-3682; Gogarten, Johann Peter/0000-0001-6459-6518; Butzin, Nicholas/0000-0003-3807-8666	National Aeronautics and Space Administration Exobiology program [NNX08AQ10G]; US Department of Energy Office of Biological and Environmental Research [DE-PS02-08ER08-12]; National Science Foundation Assembling the Tree of Life program [DEB0830024]	National Aeronautics and Space Administration Exobiology program(National Aeronautics & Space Administration (NASA)); US Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation Assembling the Tree of Life program(National Science Foundation (NSF))	This work was supported by funds from the National Aeronautics and Space Administration Exobiology program (NNX08AQ10G), the US Department of Energy Office of Biological and Environmental Research (DE-PS02-08ER08-12), and the National Science Foundation Assembling the Tree of Life program (DEB0830024). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akanuma S, 2013, P NATL ACAD SCI USA, V110, P11067, DOI 10.1073/pnas.1308215110; Barabote RD, 2009, GENOME RES, V19, P1033, DOI 10.1101/gr.084848.108; Boucher N, 2011, APPL ENVIRON MICROB, V77, P6395, DOI 10.1128/AEM.05418-11; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Chen LJ, 2000, BIOCHEMISTRY-US, V39, P12415, DOI 10.1021/bi001517q; Dutheil J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-255; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EISENBERG F, 1987, METHOD ENZYMOL, V141, P127; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Goncalves LG, 2011, ENV MICROBIOL; Green AG, 2013, MOL BIOL EVOL; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Hobbs JK, 2012, MOL BIOL EVOL, V29, P825, DOI 10.1093/molbev/msr253; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; JANNASCH HW, 1988, ARCH MICROBIOL, V150, P103, DOI 10.1007/BF00409725; Ju SL, 2004, J BIOL CHEM, V279, P21759, DOI 10.1074/jbc.M312078200; Maddison WP, 2011, MESQUITE MODULAR SYS; Majumder A.L., 2006, BIOL INOSITOLS PHOSP; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Michell RH, 2011, ADV ENZYME REGUL, V51, P84, DOI 10.1016/j.advenzreg.2010.10.002; Mizuguchi K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S15; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Nesbo CL, 2001, MOL BIOL EVOL, V18, P362, DOI 10.1093/oxfordjournals.molbev.a003812; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Park SH, 2004, J MICROBIOL, V42, P20; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; Rodionov DA, 2007, P NATL ACAD SCI USA, V104, P4279, DOI 10.1073/pnas.0609279104; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F., 2003, BIOINFORMATICS, V19, P1572; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; Takahata Y, 2001, INT J SYST EVOL MICR, V51, P1901, DOI 10.1099/00207713-51-5-1901; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P62, DOI 10.1371/journal.pcbi.0030005; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106	40	20	21	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84300	10.1371/journal.pone.0084300	http://dx.doi.org/10.1371/journal.pone.0084300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391933	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900076
J	Duijvesz, D; Burnum-Johnson, KE; Gritsenko, MA; Hoogland, AM; Vredenbregt-van den Berg, MS; Willemsen, R; Luider, T; Pasa-Tolic, L; Jenster, G				Duijvesz, Diederick; Burnum-Johnson, Kristin E.; Gritsenko, Marina A.; Hoogland, A. Marije; Vredenbregt-van den Berg, Mirella S.; Willemsen, Rob; Luider, Theo; Pasa-Tolic, Ljiljana; Jenster, Guido			Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; GENE-EXPRESSION; MODEL SYSTEM; XENOGRAFT; THROUGHPUT; DATABASE; DISPLAY; REGION; SIGNAL; ATLAS	Background: Current markers for prostate cancer, such as PSA lack specificity. Therefore, novel biomarkers are needed. Unfortunately, the complexity of body fluids often hampers biomarker discovery. An attractive alternative approach is the isolation of small vesicles, i.e. exosomes, similar to 100 nm, which contain proteins that are specific to the tissue from which they are derived and therefore can be considered as treasure chests for disease-specific biomarker discovery. Materials and Methods: Exosomes were isolated from 2 immortalized primary prostate epithelial cells (PNT2C2 and RWPE-1) and 2 PCa cell lines (PC346C and VCaP) by ultracentrifugation. After tryptic digestion, proteomic analyses utilized a nanoLC coupled with an LTQ-Orbitrap operated in tandem MS (MS/MS) mode. Accurate Mass and Time (AMT) tag approach was employed for peptide identification and quantitation. Candidate biomarkers were validated by Western blotting and Immunohistochemistry. Results: Proteomic characterization resulted in the identification of 248, 233, 169, and 216 proteins by at least 2 peptides in exosomes from PNT2C2, RWPE-1, PC346C, and VCaP, respectively. Statistical analyses revealed 52 proteins differently abundant between PCa and control cells, 9 of which were more abundant in PCa. Validation by Western blotting confirmed a higher abundance of FASN, XPO1 and PDCD6IP (ALIX) in PCa exosomes. Conclusions: Identification of exosomal proteins using high performance LC-FTMS resulted in the discovery of PDCD6IP, FASN, XPO1 and ENO1 as new candidate biomarkers for prostate cancer.	[Duijvesz, Diederick; Vredenbregt-van den Berg, Mirella S.; Jenster, Guido] Erasmus MC, Dept Urol, Rotterdam, Netherlands; [Burnum-Johnson, Kristin E.; Gritsenko, Marina A.] Pacific NW Natl Lab, Fundamental & Computat Sci Div, Richland, WA 99352 USA; [Hoogland, A. Marije] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Willemsen, Rob] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [Luider, Theo] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Pasa-Tolic, Ljiljana] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA	Erasmus University Rotterdam; Erasmus MC; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Jenster, G (corresponding author), Erasmus MC, Dept Urol, Rotterdam, Netherlands.	g.jenster@erasmusmc.nl	Duijvesz, Diederick/W-6029-2019; Burnum, Kristin E/B-1308-2011	Burnum, Kristin E/0000-0002-2722-4149; Duijvesz, Diederick/0000-0001-6678-3384	Department of Energy's Office of Biological and Environmental Research	Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE))	We would like to acknowledge Prof. Dr. N. Maitland from the University of York for kindly providing us with the PNT2C2 cell line. Proteomic analyses were performed using EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; BERTHON P, 1995, INT J ONCOL, V6, P333; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; Duijvesz D, 2010, EUR UROL; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Hegmans JPJJ, 2004, AM J PATHOL, V164, P1807, DOI 10.1016/S0002-9440(10)63739-X; Hemming FJ, 2004, NEUROSCIENCE, V123, P887, DOI 10.1016/j.neuroscience.2003.10.036; Hosseini-Beheshti E, 2012, MOL CELL PROTEOMICS, V11, P863, DOI 10.1074/mcp.M111.014845; Jansen FH, 2009, MOL CELL PROTEOMICS, V8, P1192, DOI 10.1074/mcp.M800443-MCP200; JIMENEZ CR, 2010, PROTEOMICS, V73, P1873; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Korenchuk S, 2001, IN VIVO, V15, P163; Liu Hailan, 2010, Int J Biochem Mol Biol, V1, P69; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Marques RB, 2006, EUR UROL, V49, P245, DOI 10.1016/j.eururo.2005.12.035; MATHIVANAN S, 2010, PROTEOMICS, V9, P197; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Principe S, 2013, PROTEOMICS, V13, P1667, DOI 10.1002/pmic.201200561; Raj DA, 2012, KIDNEY INT; Sandvig K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012914; Saporita AJ, 2003, J BIOL CHEM, V278, P41998, DOI 10.1074/jbc.M302460200; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; vanWeerden WM, 1996, AM J PATHOL, V149, P1055; Veldhoven A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-192; WELTON JL, 2010, PROTEOMICS, V9, P1324; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	44	152	157	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82589	10.1371/journal.pone.0082589	http://dx.doi.org/10.1371/journal.pone.0082589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391718	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200015
J	Mahajan, L; Pandit, H; Madan, T; Gautam, P; Yadav, AK; Warke, H; Sundaram, CS; Sirdeshmukh, R; Sarma, PU; Kishore, U; Surolia, A				Mahajan, Lakshna; Pandit, Hrishikesh; Madan, Taruna; Gautam, Poonam; Yadav, Ajit K.; Warke, Himangi; Sundaram, Curam S.; Sirdeshmukh, Ravi; Sarma, P. Usha; Kishore, Uday; Surolia, Avadhesha			Human Surfactant Protein D Alters Oxidative Stress and HMGA1 Expression to Induce p53 Apoptotic Pathway in Eosinophil Leukemic Cell Line	PLOS ONE			English	Article							SP-A; PROLIFERATION; SURVIVAL; MODEL; SURVEILLANCE; ANTIGENS; THERAPY; ARREST; ROLES; GENE	Surfactant protein D (SP-D), an innate immune molecule, has an indispensable role in host defense and regulation of inflammation. Immune related functions regulated by SP-D include agglutination of pathogens, phagocytosis, oxidative burst, antigen presentation, T lymphocyte proliferation, cytokine secretion, induction of apoptosis and clearance of apoptotic cells. The present study unravels a novel ability of SP-D to reduce the viability of leukemic cells (eosinophilic leukemic cell line, AML14.3D10; acute myeloid leukemia cell line, THP-1; acute lymphoid leukemia cell lines, Jurkat, Raji; and human breast epithelial cell line, MCF-7), and explains the underlying mechanisms. SP-D and a recombinant fragment of human SP-D (rhSP-D) induced G2/M phase cell cycle arrest, and dose and time-dependent apoptosis in the AML14.3D10 eosinophilic leukemia cell line. Levels of various apoptotic markers viz. activated p53, cleaved caspase-9 and PARP, along with G2/M checkpoints (p21 and Tyr15 phosphorylation of cdc2) showed significant increase in these cells. We further attempted to elucidate the underlying mechanisms of rhSP-D induced apoptosis using proteomic analysis. This approach identified large scale molecular changes initiated by SP-D in a human cell for the first time. Among others, the proteomics analysis highlighted a decreased expression of survival related proteins such as HMGA1, overexpression of proteins to protect the cells from oxidative burst, while a drastic decrease in mitochondrial antioxidant defense system. rhSP-D mediated enhanced oxidative burst in AML14.3D10 cells was confirmed, while antioxidant, N-acetyl-L-cysteine, abrogated the rhSP-D induced apoptosis. The rhSP-D mediated reduced viability was specific to the cancer cell lines and viability of human PBMCs from healthy controls was not affected. The study suggests involvement of SP-D in host's immunosurveillance and therapeutic potential of rhSP-D in the eosinophilic leukemia and cancers of other origins.	[Mahajan, Lakshna; Madan, Taruna; Gautam, Poonam; Sarma, P. Usha] IGIB, Delhi, India; [Mahajan, Lakshna; Surolia, Avadhesha] NII, Ctr Mol Med, New Delhi, India; [Pandit, Hrishikesh; Madan, Taruna; Yadav, Ajit K.] NIRRH, Bombay, Maharashtra, India; [Gautam, Poonam; Sundaram, Curam S.; Sirdeshmukh, Ravi] CCMB, Prote Res Facil, Hyderabad, Andhra Pradesh, India; [Warke, Himangi] King Edward Mem Hosp, Dept Obstet & Gynecol, Bombay, Maharashtra, India; [Warke, Himangi] Seth GS Med Coll, Bombay, Maharashtra, India; [Kishore, Uday] Brunel Univ, CIIDM, London, England	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Brunel University	Madan, T (corresponding author), IGIB, Delhi, India.	taruna_m@hotmail.com; Uday.Kishore@brunel.ac.uk	Kishore, Uday/Y-7976-2018; Pandit, Hrishikesh/GON-8428-2022; Pandit, Hrishikesh/AGZ-4050-2022	Kishore, Uday/0000-0002-6033-6759; Pandit, Hrishikesh/0000-0003-0994-6778	DBT Research Associateship under DBT-RA program	DBT Research Associateship under DBT-RA program	This work was supported by DBT Research Associateship under DBT-RA program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan MK, 2009, ANTIOXID REDOX SIGN, V11, P2741, DOI [10.1089/ars.2009.2683, 10.1089/ARS.2009.2683]; Baumann MA, 1998, STEM CELLS, V16, P16, DOI 10.1002/stem.160016; Borron PJ, 1998, J IMMUNOL, V161, P4599; Brinker KG, 2001, AM J PHYSIOL-LUNG C, V281, pL1453, DOI 10.1152/ajplung.2001.281.6.L1453; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cleynen I, 2008, INT J ONCOL, V32, P289; Dong JM, 2004, FREE RADICAL RES, V38, P629, DOI 10.1080/10715760410001694053; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Esposito F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.126; Feng RT, 2007, J BIOL CHEM, V282, P13468, DOI 10.1074/jbc.M610616200; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hermans C, 1999, AM J RESP CRIT CARE, V159, P646, DOI 10.1164/ajrccm.159.2.9806064; Ito K, 2004, CANCER RES, V64, P1071, DOI 10.1158/0008-5472.CAN-03-1670; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Li LY, 2011, J VIROL, V85, P6774, DOI 10.1128/JVI.02577-10; Madan T, 2005, J IMMUNOL, V174, P6943, DOI 10.4049/jimmunol.174.11.6943; Madan T, 2001, J CLIN INVEST, V107, P467, DOI 10.1172/JCI10124; Mahajan L, 2008, INT IMMUNOL, V20, P993, DOI 10.1093/intimm/dxn058; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; Paul CC, 1997, AM J HEMATOL, V56, P79, DOI 10.1002/(SICI)1096-8652(199710)56:2<79::AID-AJH2>3.0.CO;2-Y; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Scala S, 2000, P NATL ACAD SCI USA, V97, P4256, DOI 10.1073/pnas.070029997; Schagat TL, 2003, AM J PHYSIOL-LUNG C, V284, pL140, DOI 10.1152/ajplung.00125.2002; Schuldenfrei A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-549; Shiels MS, 2011, CANCER EPIDEM BIOMAR, V20, P2262, DOI 10.1158/1055-9965.EPI-11-0326; Silva J, 2004, PROTEIN PEPTIDE LETT, V11, P189, DOI 10.2174/0929866043478293; Singh M, 2003, IMMUNOL LETT, V86, P299, DOI 10.1016/S0165-2478(03)00033-6; STEWART N, 1995, ONCOGENE, V10, P109; Strong P, 1998, J IMMUNOL METHODS, V220, P139, DOI 10.1016/S0022-1759(98)00160-4; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Waters P, 2009, ADV EXP MED BIOL, V653, P74; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Yamaguchi H, 2011, CANCER CHEMOTH PHARM, V67, P331, DOI 10.1007/s00280-010-1325-x; Zhang GH, 1997, BIOTECHNIQUES, V23, P525, DOI 10.2144/97233pf01	42	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85046	10.1371/journal.pone.0085046	http://dx.doi.org/10.1371/journal.pone.0085046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391984	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900127
J	McDermott, AM; Kerin, MJ; Miller, N				McDermott, Ailbhe M.; Kerin, Michael J.; Miller, Nicola			Identification and Validation of miRNAs as Endogenous Controls for RQ-PCR in Blood Specimens for Breast Cancer Studies	PLOS ONE			English	Article							MICRORNA EXPRESSION; CIRCULATING MICRORNAS; COLORECTAL-CANCER; PROSTATE-CANCER; REFERENCE GENES; ORAL-CANCER; STEM-CELLS; SERUM; DISEASE; NORMALIZATION	Introduction: A prerequisite to accurate interpretation of RQ-PCR data is robust data normalization. A commonly used method is to compare the cycle threshold (C-T) of target miRNAs with those of a stably expressed endogenous (EC) miRNA(s) from the same sample. Despite the large number of studies reporting miRNA expression patterns, comparatively few appropriate ECs have been reported thus far. The purpose of this study was to identify stably expressed miRNAs with which to normalize RQ-PCR data derived from human blood specimens. Methods: MiRNA profiling of approximately 380 miRNAs was performed on RNA derived from blood specimens from 10 women with breast cancer and 10 matched controls. Analysis of mean expression values across the dataset (GME) identified stably expressed candidates. Additional candidates were selected from the literature and analyzed by the geNorm algorithm. Further validation of three candidate ECs by RQ-PCR was performed in a larger cohort (n = 40 cancer, n = 20 control) was performed, including analysis by geNorm and NormFinder algorithms. Results: Microarray screening identified 10 candidate ECs with expression patterns closest to the global mean. Geometric averaging of candidate ECs from the literature using geNorm identified miR-425 as the most stably expressed miRNA. MiR425 and miR-16 were the best combination, achieving the lowest V-value of 0.185. Further validation by RQ-PCR confirmed that miR-16 and miR-425 were the most stably expressed ECs overall. Their combined use to normalize expression data enabled the detection of altered target miRNA expression that reliably differentiated between cancers and controls in human blood specimens. Conclusion: This study identified that the combined use of 2 miRNAs, (miR-16 and miR-425) to normalize RQ-PCR data generated more reliable results than using either miRNA alone, or use of U6. Further investigation into suitable ECs for use in miRNA RQ-PCR studies is warranted.	[McDermott, Ailbhe M.; Kerin, Michael J.; Miller, Nicola] Natl Univ Ireland, Discipline Surg, Sch Med, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	McDermott, AM (corresponding author), Natl Univ Ireland, Discipline Surg, Sch Med, Galway, Ireland.	ailbhemcdermott@gmail.com	Miller, Nicola/F-4009-2018	Miller, Nicola/0000-0002-5416-7047; Kerin, Michael/0000-0003-4164-5561	National Breast Cancer Research Institute (NBCRI)	National Breast Cancer Research Institute (NBCRI)	AM McDermott received a funding scholarship from the National Breast Cancer Research Institute (NBCRI, www.nbcri.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Appaiah HN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2943; Avgeris M, 2013, BRIT J CANCER, V108, P2573, DOI 10.1038/bjc.2013.250; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chang KH, 2011, INT J COLORECTAL DIS, V26, P1415, DOI 10.1007/s00384-011-1279-4; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Genovesi Laura A, 2012, BMC Res Notes, V5, P507, DOI 10.1186/1756-0500-5-507; Guo LJ, 2012, INT J MOL MED, V30, P680, DOI 10.3892/ijmm.2012.1021; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Heffelfinger C, 2012, G3-GENES GENOM GENET, V2, P279, DOI 10.1534/g3.111.001115; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Le XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041170; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Liu JJ, 2013, CHINESE J CANCER RES, V25, P46, DOI 10.3978/j.issn.1000-9604.2012.11.04; Lu ZD, 2012, ONCOL LETT, V4, P1027, DOI 10.3892/ol.2012.841; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; McDermott AM, 2011, PHARM RES-DORDR, V28, P3016, DOI 10.1007/s11095-011-0550-2; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nugent M, 2012, J SURG ONCOL, V106, P947, DOI 10.1002/jso.23174; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Schee K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-505; Schmitz KJ, 2009, VIRCHOWS ARCH, V455, P49, DOI 10.1007/s00428-009-0804-0; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang G, 2011, LUPUS, V20, P493, DOI 10.1177/0961203310389841; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wang Xiaopai, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P631; Wu Q, 2012, CLIN CHIM ACTA, V413, P1058, DOI 10.1016/j.cca.2012.02.016; Yamamoto M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-655; Yamamoto Y, 2009, BIOMARKERS, V14, P529, DOI 10.3109/13547500903150771; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zahm AM, 2011, J PEDIATR GASTR NUTR, V53, P26, DOI 10.1097/MPG.0b013e31822200cc; Zhang S, 2010, CLIN PHARMACOL THER, V87, P754, DOI 10.1038/clpt.2010.46; Zhang Y, 2013, NAT CELL BIOL, V15, P284, DOI 10.1038/ncb2690; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	63	76	78	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83718	10.1371/journal.pone.0083718	http://dx.doi.org/10.1371/journal.pone.0083718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391813	Green Submitted, gold, Green Published			2022-12-27	WOS:000329325200111
J	Oksuz, M; Sadikoglu, H; Cakir, T				Oksuz, Melik; Sadikoglu, Hasan; Cakir, Tunahan			Sparsity as Cellular Objective to Infer Directed Metabolic Networks from Steady-State Metabolome Data: A Theoretical Analysis	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; RECONSTRUCTION; YEAST	Since metabolome data are derived from the underlying metabolic network, reverse engineering of such data to recover the network topology is of wide interest. Lyapunov equation puts a constraint to the link between data and network by coupling the covariance of data with the strength of interactions (Jacobian matrix). This equation, when expressed as a linear set of equations at steady state, constitutes a basis to infer the network structure given the covariance matrix of data. The sparse structure of metabolic networks points to reactions which are active based on minimal enzyme production, hinting at sparsity as a cellular objective. Therefore, for a given covariance matrix, we solved Lyapunov equation to calculate Jacobian matrix by a simultaneous use of minimization of Euclidean norm of residuals and maximization of sparsity (the number of zeros in Jacobian matrix) as objective functions to infer directed small-scale networks from three kingdoms of life (bacteria, fungi, mammalian). The inference performance of the approach was found to be promising, with zero False Positive Rate, and almost one True positive Rate. The effect of missing data on results was additionally analyzed, revealing superiority over similarity-based approaches which infer undirected networks. Our findings suggest that the covariance of metabolome data implies an underlying network with sparsest pattern. The theoretical analysis forms a framework for further investigation of sparsity-based inference of metabolic networks from real metabolome data.	[Oksuz, Melik; Cakir, Tunahan] Gebze Inst Technol, Dept Bioengn, TR-41400 Gebze, Kocaeli, Turkey; [Oksuz, Melik; Sadikoglu, Hasan] Gebze Inst Technol, Dept Chem Engn, TR-41400 Gebze, Kocaeli, Turkey	Gebze Technical University; Gebze Technical University	Cakir, T (corresponding author), Gebze Inst Technol, Dept Bioengn, TR-41400 Gebze, Kocaeli, Turkey.	tcakir@gyte.edu.tr	ÖKSÜZ, Melik/AAA-4737-2020; Cakir, Tunahan/F-4523-2011; SADIKOGLU, Hasan/AAZ-4975-2020	Cakir, Tunahan/0000-0001-8262-4420; SADIKOGLU, HASAN/0000-0002-0234-8428	TUBITAK, The Scientific and Technological Research Council of Turkey [110M464]	TUBITAK, The Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The financial support by TUBITAK, The Scientific and Technological Research Council of Turkey, through a career grant (Project Code: 110M464) is gratefully acknowledged. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert A, 2001, ACTA BIOTHEOR, V49, P301, DOI 10.1023/A:1014286728421; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; Cakir T, 2004, BIOTECHNOL BIOENG, V86, P251, DOI 10.1002/bit.20020; Cakir T, 2009, METABOLOMICS, V5, P318, DOI 10.1007/s11306-009-0156-4; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Hendrickx DM, 2011, MOL BIOSYST, V7, P511, DOI 10.1039/c0mb00083c; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kresnowati MTAP, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100083; Kubat M, 1998, MACH LEARN, V30, P195, DOI 10.1023/A:1007452223027; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Markowetz F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S5; McClean MN, 2007, NAT GENET, V39, P409, DOI 10.1038/ng1957; Nemenman I, 2007, ANN NY ACAD SCI, V1115, P102, DOI 10.1196/annals.1407.013; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Patil KR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-308; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Sontag E, 2004, BIOINFORMATICS, V20, P1877, DOI 10.1093/bioinformatics/bth173; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Sun N, 2009, STAT METHODS MED RES, V18, P595, DOI 10.1177/0962280209351890; Sun XL, 2012, METABOLOMICS, V8, pS81, DOI 10.1007/s11306-012-0399-3; Tegner J, 2007, TRENDS GENET, V23, P34, DOI 10.1016/j.tig.2006.11.003; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; Yang L, 2010, P AMER CONTR CONF, P5143; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Yizhak K, 2010, BIOINFORMATICS, V26, pi255, DOI 10.1093/bioinformatics/btq183	33	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84505	10.1371/journal.pone.0084505	http://dx.doi.org/10.1371/journal.pone.0084505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391961	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900104
J	Paroly, SS; Wang, FW; Spraggon, L; Merregaert, J; Batourina, E; Tycko, B; Schmidt-Ott, KM; Grimmond, S; Little, M; Mendelsohn, C				Paroly, Suneeta S.; Wang, Fengwei; Spraggon, Lee; Merregaert, Joseph; Batourina, Ekatherina; Tycko, Benjamin; Schmidt-Ott, Kai M.; Grimmond, Sean; Little, Melissa; Mendelsohn, Cathy			Stromal Protein Ecm1 Regulates Ureteric Bud Patterning and Branching	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEIN-1; RETINOL-BINDING-PROTEIN; LIPOID PROTEINOSIS; KIDNEY DEVELOPMENT; RENAL DEVELOPMENT; VITAMIN-A; MOLECULAR-CLONING; LICHEN-SCLEROSUS; GENE ECM1; MORPHOGENESIS	The interactions between the nephrogenic mesenchyme and the ureteric bud during kidney development are well documented. While recent studies have shed some light on the importance of the stroma during renal development, many of the signals generated in the stroma, the genetic pathways and interaction networks involving the stroma are yet to be identified. Our previous studies demonstrate that retinoids are crucial for branching of the ureteric bud and for patterning of the cortical stroma. In the present study we demonstrate that autocrine retinoic acid (RA) signaling in stromal cells is critical for their survival and patterning, and show that Extracellular matrix 1, Ecm1, a gene that in humans causes irritable bowel syndrome and lipoid proteinosis, is a novel RA-regulated target in the developing kidney, which is secreted from the cortical stromal cells surrounding the cap mesenchyme and ureteric bud. Our studies suggest that Ecm1 is required in the ureteric bud for regulating the distribution of Ret which is normally restricted to the tips, as inhibition of Ecm1 results in an expanded domain of Ret expression and reduced numbers of branches. We propose a model in which retinoid signaling in the stroma activates expression of Ecm1, which in turn down-regulates Ret expression in the ureteric bud cleft, where bifurcation normally occurs and normal branching progresses.	[Paroly, Suneeta S.; Wang, Fengwei; Spraggon, Lee; Batourina, Ekatherina; Mendelsohn, Cathy] Columbia Univ, Irving Canc Res Ctr, Dept Urol, New York, NY USA; [Tycko, Benjamin] Columbia Univ, Inst Canc Genet, New York, NY USA; [Tycko, Benjamin] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Merregaert, Joseph] Univ Antwerp, Dept Biochem, Mol Biotechnol Lab, Antwerp, Belgium; [Schmidt-Ott, Kai M.] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Grimmond, Sean; Little, Melissa] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	Columbia University; Columbia University; Columbia University; University of Antwerp; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Queensland	Paroly, SS (corresponding author), Early Coll, Bard High Sch, Long Isl City, NY USA.	sparoly@bhsec.bard.edu	Schmidt-Ott, Kai/F-4588-2011; Little, Melissa H/A-6170-2010; Grimmond, Sean M/J-5304-2016; Mendelsohn, Cathy/H-4280-2016; Grimmond, Sean/K-3246-2019	Schmidt-Ott, Kai/0000-0002-7700-7142; Little, Melissa H/0000-0003-0380-2263; Grimmond, Sean M/0000-0002-8102-7998; Mendelsohn, Cathy/0000-0002-4026-4073; Grimmond, Sean/0000-0002-8102-7998	NIH [DK055388]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant DK055388 to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoglu G, 2011, J DERMATOL TREAT, V22, P178, DOI 10.3109/09546631003639407; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BHALERAO J, 1995, J BIOL CHEM, V270, P16385, DOI 10.1074/jbc.270.27.16385; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; Challen G, 2005, PHYSIOL GENOMICS, V23, P159, DOI 10.1152/physiolgenomics.00043.2005; Chan I, 2004, CLIN EXP DERMATOL, V29, P52, DOI 10.1111/j.1365-2230.2004.01440.x; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; DALY AK, 1990, METHOD ENZYMOL, V189, P239; de The H, 1990, Nouv Rev Fr Hematol, V32, P30; Dressler GR, 2002, TRENDS CELL BIOL, V12, P390, DOI 10.1016/S0962-8924(02)02334-6; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Frey-Wagner I, 2013, INFLAMM BOWEL DIS; Gruber F, 1996, ACTA DERM-VENEREOL, V76, P154; Hamada T, 2003, J INVEST DERMATOL, V120, P345, DOI 10.1046/j.1523-1747.2003.12073.x; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Jain S, 2009, ORGANOGENESIS, V5, P177, DOI 10.4161/org.5.4.10048; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kim HY, 2012, ORGANOGENESIS, V8, P56, DOI 10.4161/org.19813; Kong L, 2010, MATRIX BIOL, V29, P276, DOI 10.1016/j.matbio.2010.01.007; Levinson R, 2003, SEMIN CELL DEV BIOL, V14, P225, DOI 10.1016/S1084-9521(03)00025-9; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; MENDELSOHN C, 1994, DEV BIOL, V166, P246, DOI 10.1006/dbio.1994.1311; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; Patterson LT, 2001, DEVELOPMENT, V128, P2153; Powell J, 2002, J REPROD MED, V47, P706; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Sariola H, 1997, CURR OPIN CELL BIOL, V9, P877, DOI 10.1016/S0955-0674(97)80091-9; Sercu S, 2009, MATRIX BIOL, V28, P160, DOI 10.1016/j.matbio.2009.02.003; Smits P, 1999, GENE, V226, P253, DOI 10.1016/S0378-1119(98)00558-7; Stine ZE, 2011, HUM MOL GENET, V20, P3746, DOI 10.1093/hmg/ddr291; Tasker GL, 2003, CLIN EXP DERMATOL, V28, P128, DOI 10.1046/j.1365-2230.2003.01211.x; Toosi S, 2009, J EUR ACAD DERMATOL, V23, P482, DOI 10.1111/j.1468-3083.2008.02928.x; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Vilar J, 1996, KIDNEY INT, V49, P1478, DOI 10.1038/ki.1996.208; Yallowitz AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023410	41	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84155	10.1371/journal.pone.0084155	http://dx.doi.org/10.1371/journal.pone.0084155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391906	Green Published, gold, Green Accepted			2022-12-27	WOS:000329323900049
J	Talley, LE; Boyd, E				Talley, Leisel E.; Boyd, Erin			Challenges to the Programmatic Implementation of Ready to Use Infant Formula in the Post-Earthquake Response, Haiti, 2010: A Program Review	PLOS ONE			English	Review								Background and Objectives: Following the 2010 earthquake in Haiti, infant and young child feeding was identified as a priority nutrition intervention. A new approach to support breastfeeding mothers and distribute ready-to-use infant formula (RUIF) to infants unable to breastfeed was established. The objective of the evaluation was to assess the implementation of infant feeding programs using RUIF in displaced persons camps in Port-au-Prince, Haiti during the humanitarian response. Methods: A retrospective record review was conducted from April-July, 2010 to obtain data on infants receiving RUIF in 30 baby tents. A standardized data collection form was created based on data collected across baby tents and included: basic demographics, admission criteria, primary caretaker, feeding practices, and admission and follow-up anthropometrics. Main Findings: Orphans and abandoned infants were the most frequent enrollees (41%) in the program. While the program targeted these groups, it is unlikely that this is a true reflection of population demographics. Despite programmatic guidance, admission criteria were not consistently applied across programs. Thirty-four percent of infants were undernourished (weight for age Z score <-2) at the time of admission. Defaulting accounted for 50% of all program exits and there was no follow-up of these children. Low data quality was a significant barrier. Conclusions: The design, implementation and magnitude of the 'baby tents' using RUIF was novel in response to infant and young child feeding (IYCF) in emergencies and presented multiple challenges that should not be overlooked, including adherence to protocols and the adaption of emergency programs to existing programs. The implementation of IYCF programs should be closely monitored to ensure that they achieve the objectives set by the humanitarian community and national government. IYCF is an often overlooked component of emergency preparedness; however to improve response, generic protocols and pre-emergency training and preparedness should be established for humanitarian agencies.	[Talley, Leisel E.] Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Atlanta, GA 30329 USA; [Boyd, Erin] United Nations Childrens Fund, Nutr Sect, Program Div, New York, NY USA	Centers for Disease Control & Prevention - USA; UNICEF	Talley, LE (corresponding author), Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Atlanta, GA 30329 USA.	Ltalley@cdc.gov						Angood C, 2007, WEIGHING SCALES USED; Ayoya MA, 2013, B WORLD HEALTH ORGAN, V91, P612, DOI 10.2471/BLT.12.113936; Dean AG, 2007, EPI INFO DATABASE ST; Infant Feeding in Emergencies Core Group, 2007, OP GUID INF YOUNG CH; Kliegman RM, 2011, NELSON TXB PEDIAT; Le Cluster Nutrition Ministere de la Sante Publique et de la Population, 2010, POINTS CONS NUTR BEB; Ministry of Public Health and Population of Haiti Action Contre la Faim United Nations Children's Fund & European Commission, 2009, ANTHR SURV CHILDR 6; NutritionWorks Emergency Nutriton Network and the Global Nutrition Cluster, 2011, HARM TRAIN PACK HTP; O'Connor M E, 2001, Prehosp Disaster Med, V16, P231; *SAS I INC, 1999, SAS ONLINEDOC VERS 8; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA	12	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84043	10.1371/journal.pone.0084043	http://dx.doi.org/10.1371/journal.pone.0084043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391877	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900020
J	Vega-Zuniga, T; Medina, FS; Fredes, F; Zuniga, C; Severin, D; Palacios, AG; Karten, HJ; Mpodozis, J				Vega-Zuniga, Tomas; Medina, Felipe S.; Fredes, Felipe; Zuniga, Claudio; Severin, Daniel; Palacios, Adrian G.; Karten, Harvey J.; Mpodozis, Jorge			Does Nocturnality Drive Binocular Vision? Octodontine Rodents as a Case Study	PLOS ONE			English	Article							VISUAL-FIELDS; ORBIT ORIENTATION; RETINOFUGAL PROJECTIONS; SUPERIOR COLLICULUS; RETINAL PROJECTIONS; EVOLUTION; MAMMALS; EYE; PRIMATES; ACUITY	Binocular vision is a visual property that allows fine discrimination of in-depth distance (stereopsis), as well as enhanced light and contrast sensitivity. In mammals enhanced binocular vision is structurally associated with a large degree of frontal binocular overlap, the presence of a corresponding retinal specialization containing a fovea or an area centralis, and well-developed ipsilateral retinal projections to the lateral thalamus (GLd). We compared these visual traits in two visually active species of the genus Octodon that exhibit contrasting visual habits: the diurnal Octodon degus, and the nocturnal Octodon lunatus. The O. lunatus visual field has a prominent 100 degrees frontal binocular overlap, much larger than the 50 degrees of overlap found in O. degus. Cells in the retinal ganglion cell layer were 40% fewer in O. lunatus (180,000) than in O. degus (300,000). O. lunatus has a poorly developed visual streak, but a well developed area centralis, located centrally near the optic disk (peak density of 4,352 cells/mm(2)). O. degus has a highly developed visual streak, and an area centralis located more temporally (peak density of 6,384 cells/mm(2)). The volumes of the contralateral GLd and superior colliculus (SC) are 15% larger in O. degus compared to O. lunatus. However, the ipsilateral projections to GLd and SC are 500% larger in O. lunatus than in O. degus. Other retinorecipient structures related to ocular movements and circadian activity showed no statistical differences between species. Our findings strongly suggest that nocturnal visual behavior leads to an enhancement of the structures associated with binocular vision, at least in the case of these rodents. Expansion of the binocular visual field in nocturnal species may have a beneficial effect in light and contrast sensitivity, but not necessarily in stereopsis. We discuss whether these conclusions can be extended to other mammalian and non-mammalian amniotes.	[Vega-Zuniga, Tomas; Medina, Felipe S.; Fredes, Felipe; Zuniga, Claudio; Severin, Daniel; Mpodozis, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile; [Palacios, Adrian G.] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Karten, Harvey J.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	Universidad de Chile; Universidad de Valparaiso; University of California System; University of California San Diego	Mpodozis, J (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile.	epistemo@uchile.cl	Palacios, Adrian G/E-9846-2015; Vega-Zuniga, Tomas/AFQ-2110-2022	Palacios, Adrian G/0000-0003-1532-7527; 	Fondecyt [1080094, 1120124, 1090794]; Iniciativa Cientifica Milenio [ICM-P05-002]; Proyecto Fondo Basal [PFB-23-CONICYT]; STFC [ST/I005765/1, ST/L001314/1] Funding Source: UKRI	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio; Proyecto Fondo Basal(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by Fondecyt 1080094, Fondecyt 1120124 to Jorge Mpodozis; Fondecyt 1090794, Iniciativa Cientifica Milenio ICM-P05-002, Proyecto Fondo Basal PFB-23-CONICYT to Rodrigo Vasquez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Barton RA, 2004, P NATL ACAD SCI USA, V101, P10113, DOI 10.1073/pnas.0401955101; BISHOP PO, 1986, VISION RES, V26, P1587, DOI 10.1016/0042-6989(86)90177-X; CAMPBELL FW, 1965, NATURE, V208, P191, DOI 10.1038/208191a0; Cartmill Matt, 1992, Evolutionary Anthropology, V1, P105, DOI 10.1002/evan.1360010308; Chavez AE, 2003, INVEST OPHTH VIS SCI, V44, P2290, DOI 10.1167/iovs.02-0670; Clark B, 1935, AM J PSYCHOL, V47, P485, DOI 10.2307/1416342; Corfield JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022945; FITE KV, 1973, VISION RES, V13, P219, DOI 10.1016/0042-6989(73)90101-6; FUKUDA Y, 1989, J NEUROSCI, V9, P2353; Gaillard Frederic, 2013, J Comp Neurol, V521, pSpc1, DOI 10.1002/cne.23330; Gallardo Milton H., 2001, Journal of Mammalian Evolution, V8, P73, DOI 10.1023/A:1011345000786; Glanz WE, 1982, ECOLOGICAL COMP SMAL, P220; GROBSTEIN P, 1980, J COMP NEUROL, V190, P175, DOI 10.1002/cne.901900112; GULLEY RL, 1975, J COMP NEUROL, V162, P309, DOI 10.1002/cne.901620303; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; Hanke FD, 2009, BRAIN BEHAV EVOLUT, V74, P102, DOI 10.1159/000235612; Heesy CP, 2008, BRAIN BEHAV EVOLUT, V71, P54, DOI 10.1159/000108621; Heesy CP, 2010, BRAIN BEHAV EVOLUT, V75, P195, DOI 10.1159/000314278; Heesy CP, 2009, EVOL ANTHROPOL, V18, P21, DOI 10.1002/evan.20195; Heesy CP, 2004, ANAT REC PART A, V281A, P1104, DOI 10.1002/ar.a.20116; Hilbig H, 2000, BRAIN RES BULL, V51, P255, DOI 10.1016/S0361-9230(99)00230-0; Hughes A., 1977, VISUAL SYSTEM VERTEB; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Iwaniuk AN, 2006, J COMP PHYSIOL A, V192, P1313, DOI 10.1007/s00359-006-0161-2; Iwaniuk AN, 2007, J COMP NEUROL, V500, P211, DOI 10.1002/cne.21098; Jeffery G, 2005, PROG RETIN EYE RES, V24, P721, DOI 10.1016/j.preteyeres.2005.04.005; Katzir G, 1998, IBIS, V140, P157, DOI 10.1111/j.1474-919X.1998.tb04554.x; Land MF, 2012, OXF ANIMAL BIOL SER, P1; LENT R, 1976, BRAIN RES, V107, P9, DOI 10.1016/0006-8993(76)90092-5; Major DE, 2003, J COMP NEUROL, V463, P317, DOI 10.1002/cne.10764; MARTIN GR, 1994, J COMP PHYSIOL A, V174, P787; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Martin GR, 2009, J VISION, V9, DOI 10.1167/9.11.14; McComb DM, 2009, J EXP BIOL, V212, P4010, DOI 10.1242/jeb.032615; McComb DM, 2008, J EXP BIOL, V211, P482, DOI 10.1242/jeb.014506; Merzin M, 2008, THESIS U TARTU ESTON; MESERVE PL, 1993, OECOLOGIA, V94, P153, DOI 10.1007/BF00341311; MUNOZ A, 1990, ACTA OECOL, V11, P251; OSWALDOCRUZ E, 1979, VISION RES, V19, P263, DOI 10.1016/0042-6989(79)90172-X; Pettigrew J.D., 1986, P208; Pettigrew JD, 2010, BRAIN BEHAV EVOLUT, V75, P251, DOI 10.1159/000314898; RAPAPORT DH, 1984, NEUROSCIENCE, V11, P289, DOI 10.1016/0306-4522(84)90024-1; REESE BE, 1988, BRAIN RES REV, V13, P119, DOI 10.1016/0165-0173(88)90017-3; REESE BE, 1987, NEUROSCIENCE, V20, P951, DOI 10.1016/0306-4522(87)90255-7; REESE BE, 1983, NEUROSCIENCE, V10, P1233, DOI 10.1016/0306-4522(83)90110-0; RETTIG G, 1986, CELL TISSUE RES, V243, P385; ROSA MGP, 1994, VISUAL NEUROSCI, V11, P1037, DOI 10.1017/S0952523800006878; Ross CF, 2007, J HUM EVOL, V52, P294, DOI 10.1016/j.jhevol.2006.09.006; Ross CF, 2000, ANNU REV ANTHROPOL, V29, P147, DOI 10.1146/annurev.anthro.29.1.147; ROYCE GJ, 1976, J COMP NEUROL, V170, P391, DOI 10.1002/cne.901700309; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SANDERSON KJ, 1969, VISION RES, V9, P1297, DOI 10.1016/0042-6989(69)90117-5; SILVEIRA LCL, 1989, VISUAL NEUROSCI, V2, P221, DOI 10.1017/S0952523800001140; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; TIGGES J, 1970, BRAIN BEHAV EVOLUT, V3, P121, DOI 10.1159/000125466; Troscianko J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2111; Upham NS, 2012, MOL PHYLOGENET EVOL, V63, P417, DOI 10.1016/j.ympev.2012.01.020; VAIDYA PRABHAKER GOPAL, 1965, Z ANAT ENTWICK LUNGSGESCH, V124, P505, DOI 10.1007/BF00520843; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Watson P., 2006, RAT BRAIN STEREOTAXI	62	19	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84199	10.1371/journal.pone.0084199	http://dx.doi.org/10.1371/journal.pone.0084199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391911	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900054
J	Wang, YY; Liu, XY; Winterton, SL; Yan, Y; Chang, WC; Yang, D				Wang, Yuyu; Liu, Xingyue; Winterton, Shaun L.; Yan, Yan; Chang, Wencheng; Yang, Ding			Comparative Mitogenomic Analysis Reveals Sexual Dimorphism in a Rare Montane Lacewing (Insecta: Neuroptera: Ithonidae)	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; RNA GENES; PHYLOGENY; SEQUENCE; PATTERN; POLYSTOECHOTIDAE; ORGANIZATION; LEPIDOPTERA; MEGALOPTERA; BUTTERFLIES	Rapisma McLachlan, 1866 (Neuroptera: Ithonidae) is a rarely encountered genus of lacewings found inmontane tropical or subtropical forests in Oriental Asia. In Xizang Autonomous Region (Tibet) of China there are two sympatrically distributed species of Rapisma, i.e. Rapisma xizangense Yang, 1993 and Rapisma zayuanum Yang, 1993, in which R. xizangense is only known as male and has dull brownish body and wing coloration, while R. zayuanum is only known as female and has bright green body and wing coloration. In order to clarify the relationship between these two species, we determined the complete mitochondrial (mt) genomes of R. xizangense and R. zayuanum for the first time. The mt genomes are 15,961 and 15,984 bp in size, respectively, and comprised 37 genes (13 protein coding genes, 22 tRNA genes and 2 rRNA genes). A major noncoding (control) region was 1,167 bp in R. xizangense and 1,193 bp in R. zayuanum with structural organizations simpler than that reported in other Neuropterida species, notably lacking conserved blocks or long tandem repeats. Besides similar mitogenomic structure, the genetic distance between R. xizangense and R. zayuanum based on two rRNAs and 13 protein coding genes (PCGs) as well as the genetic distance between each of these two Tibetan Rapisma species and a Thai Rapisma species (R. cryptunum) based on partial rrnL show that R. xizangense and R. zayuanum are most likely conspecific. Thus, R. zayuanum syn. nov. is herein treated as a junior synonym of R. xizangense. The present finding represents a rare example of distinct sexual dimorphism in lacewings. This comparative mitogenomic analysis sheds new light on the identification of rare species with sexual dimorphism and the biology of Neuroptera.	[Wang, Yuyu; Liu, Xingyue; Yan, Yan; Chang, Wencheng; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Winterton, Shaun L.] Calif Dept Food & Agr, Calif State Arthropod Collect, Sacramento, CA 95814 USA	China Agricultural University; California Department of Food & Agriculture	Liu, XY (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	xingyue_liu@yahoo.com; dyangcau@126.com	Wang, Yuyu/J-3117-2019; Winterton, Shaun L/C-3804-2009; Liu, Xingyue/A-3019-2013	Liu, Xingyue/0000-0002-9168-0659; Yan, Yan/0000-0002-4994-2651	National Key Basic Research Program of China (973 Program) [2013CB127600]; National Natural Science Foundation of PR China [31322501, 31320103902, 41271063]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201178]; Direct For Biological Sciences [1144119] Funding Source: National Science Foundation	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of PR China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Key Basic Research Program of China (973 Program) (No. 2013CB127600), the National Natural Science Foundation of PR China (Nos. 31322501, 31320103902, 41271063), and the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 201178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Aspock U, 2002, ZOOL SCR, V31, P51, DOI 10.1046/j.0300-3256.2001.00087.x; Aspock U, 2008, SYST ENTOMOL, V33, P97, DOI 10.1111/j.1365-3113.2007.00396.x; Aspock U, 2012, ARTHROPOD SYST PHYLO, V70, P119; BARNARD P C, 1986, Neuroptera International, V4, P125; BARNARD P C, 1985, Neuroptera International, V3, P165; BARNARD PC, 1981, SYST ENTOMOL, V6, P121, DOI 10.1111/j.1365-3113.1981.tb00430.x; Beckenbach AT, 2009, GENOME, V52, P31, DOI 10.1139/G08-098; Buckley TR, 2000, INSECT MOL BIOL, V9, P565, DOI 10.1046/j.1365-2583.2000.00220.x; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Comstock J.H., 1899, AM NAT, V33, P843, DOI [10.1086/277462, DOI 10.1086/277462]; De Giosa M, 2013, ITAL J ZOOL, P1, DOI DOI 10.1049/IET-SMT.2013.0135; FAULKNER DK, 1990, ADVANCES IN NEUROPTEROLOGY, P197; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Franklin RG, 2013, J EXP SOC PSYCHOL, V49, P344, DOI 10.1016/j.jesp.2012.12.008; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Grebennikov VV, 2004, EUR J ENTOMOL, V101, P409, DOI 10.14411/eje.2004.056; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haring E, 2004, SYST ENTOMOL, V29, P415, DOI 10.1111/j.0307-6970.2004.00263.x; Haruyama N, 2011, MOL BIOL REP, V38, P3367, DOI 10.1007/s11033-010-0444-0; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; He K, 2012, MITOCHONDR DNA, V23, P373, DOI 10.3109/19401736.2012.696631; Hua JM, 2009, MOL BIOL REP, V36, P1757, DOI 10.1007/s11033-008-9379-0; Huang H, 2010, STAG BEETLES CHINA; Huemer Peter, 2012, Forest Observer, V6, P75; Johnsen A, 2003, P ROY SOC B-BIOL SCI, V270, P1263, DOI 10.1098/rspb.2003.2375; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lourenco P, 2006, J ZOOL SYST EVOL RES, V44, P180, DOI 10.1111/j.1439-0469.2006.00352.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Makarkin VN, 2007, CRETACEOUS RES, V28, P743, DOI 10.1016/j.cretres.2006.11.003; Makarkin VN, 2009, ZOOTAXA, P55, DOI 10.11646/zootaxa.2063.1.3; Navas L., 1929, Annali del Museo Civico di Storia Naturale di Genova, V53, P354; Negrisolo E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-221; New T. R., 2003, FAUNA MALESIANA, V4; Park DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018749; Penny ND, 1996, J KANSAS ENTOMOL SOC, V69, P81; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rojas B, 2013, EVOL ECOL, V27, P739, DOI 10.1007/s10682-013-9640-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roques S, 2006, GENE, V383, P12, DOI 10.1016/j.gene.2006.06.018; Roy D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-135; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatsuta H, 1998, CAN J ZOOL, V76, P1450, DOI 10.1139/cjz-76-8-1450; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tillyard R. J., 1922, Bulletin of Entomological Research London, V13, P205, DOI 10.1017/S000748530002811X; Wang Meng-Qing, 2005, Chinese Bulletin of Entomology, V42, P721; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047302; Winterton SL, 2010, ANN ENTOMOL SOC AM, V103, P511, DOI 10.1603/AN10026; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang CK, 1993, SCI TREAT SYST EVOL, V2, P145; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062943	61	10	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83986	10.1371/journal.pone.0083986	http://dx.doi.org/10.1371/journal.pone.0083986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391859	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900002
J	Hughes, GM; Teeling, EC; Higgins, DG				Hughes, Graham M.; Teeling, Emma C.; Higgins, Desmond G.			Loss of Olfactory Receptor Function in Hominin Evolution	PLOS ONE			English	Article							DNA-SEQUENCING DATA; GENOME; GENERATION; REPERTOIRES; NEANDERTHAL; FRAMEWORK; SIBERIA	The mammalian sense of smell is governed by the largest gene family, which encodes the olfactory receptors (ORs). The gain and loss of OR genes is typically correlated with adaptations to various ecological niches. Modern humans have 853 OR genes but 55% of these have lost their function. Here we show evidence of additional OR loss of function in the Neanderthal and Denisovan hominin genomes using comparative genomic methodologies. Ten Neanderthal and 8 Denisovan ORs show evidence of loss of function that differ from the reference modern human OR genome. Some of these losses are also present in a subset of modern humans, while some are unique to each lineage. Morphological changes in the cranium of Neanderthals suggest different sensory arrangements to that of modern humans. We identify differences in functional olfactory receptor genes among modern humans, Neanderthals and Denisovans, suggesting varied loss of function across all three taxa and we highlight the utility of using genomic information to elucidate the sensory niches of extinct species.	[Hughes, Graham M.; Teeling, Emma C.] Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 2, Ireland; [Hughes, Graham M.; Higgins, Desmond G.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin	Teeling, EC (corresponding author), Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 2, Ireland.	emma.teeling@ucd.ie		Higgins, Des/0000-0002-3952-3285; Teeling, Emma/0000-0002-3309-1346; Hughes, Graham/0000-0003-3088-345X	Irish Research Council (IRC) Graduate Research Education Programme (GREP); Science Foundation Ireland PIYRA [06/YI3/B932]	Irish Research Council (IRC) Graduate Research Education Programme (GREP)(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland PIYRA(Science Foundation Ireland)	This project was funded: by the Irish Research Council (IRC) Graduate Research Education Programme (GREP) awarded to GH, ECT and DH; a Science Foundation Ireland PIYRA 06/YI3/B932 awarded to ECT. (http://www.research.ie/) (http://www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bastir M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1593; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Gaillard I, 2004, CELL MOL LIFE SCI, V61, P456, DOI 10.1007/s00018-003-3273-7; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Go Y, 2008, MOL BIOL EVOL, V25, P1897, DOI 10.1093/molbev/msn135; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Martin F, 2011, J INSECT PHYSIOL, V57, P1631, DOI 10.1016/j.jinsphys.2011.08.016; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75	20	18	18	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84714	10.1371/journal.pone.0084714	http://dx.doi.org/10.1371/journal.pone.0084714			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392153	Green Submitted, gold, Green Published			2022-12-27	WOS:000329460100076
J	Liaw, WJ; Tsao, CM; Huang, GS; Wu, CC; Ho, ST; Wang, JJ; Tao, YX; Shui, HA				Liaw, Wen-Jinn; Tsao, Cheng-Ming; Huang, Go-Shine; Wu, Chin-Chen; Ho, Shung-Tai; Wang, Jhi-Joung; Tao, Yuan-Xiang; Shui, Hao-Ai			Phosphoproteomics and Bioinformatics Analyses of Spinal Cord Proteins in Rats with Morphine Tolerance	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; SIGNAL-TRANSDUCTION; PROTEOMIC ANALYSIS; CHAPERONE PROTEIN-14-3-3; PHOSPHOTYROSYL PROTEINS; ALPHA-INTERNEXIN; GAMMA-ENOLASE; UP-REGULATION; KINASE; EXPRESSION	Introduction: Morphine is the most effective pain-relieving drug, but it can cause unwanted side effects. Direct neuraxial administration of morphine to spinal cord not only can provide effective, reliable pain relief but also can prevent the development of supraspinal side effects. However, repeated neuraxial administration of morphine may still lead to morphine tolerance. Methods: To better understand the mechanism that causes morphine tolerance, we induced tolerance in rats at the spinal cord level by giving them twice-daily injections of morphine (20 mu g/10 mu L) for 4 days. We confirmed tolerance by measuring paw withdrawal latencies and maximal possible analgesic effect of morphine on day 5. We then carried out phosphoproteomic analysis to investigate the global phosphorylation of spinal proteins associated with morphine tolerance. Finally, pull-down assays were used to identify phosphorylated types and sites of 14-3-3 proteins, and bioinformatics was applied to predict biological networks impacted by the morphine-regulated proteins. Results: Our proteomics data showed that repeated morphine treatment altered phosphorylation of 10 proteins in the spinal cord. Pull-down assays identified 2 serine/threonine phosphorylated sites in 14-3-3 proteins. Bioinformatics further revealed that morphine impacted on cytoskeletal reorganization, neuroplasticity, protein folding and modulation, signal transduction and biomolecular metabolism. Conclusions: Repeated morphine administration may affect multiple biological networks by altering protein phosphorylation. These data may provide insight into the mechanism that underlies the development of morphine tolerance.	[Liaw, Wen-Jinn] Tungs Taichung MetroHarbor Hosp, Dept Anesthesiol, Taichung, Taiwan; [Liaw, Wen-Jinn; Tsao, Cheng-Ming; Huang, Go-Shine] Natl Def Med Ctr, Triserv Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Liaw, Wen-Jinn; Wu, Chin-Chen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Tsao, Cheng-Ming; Ho, Shung-Tai] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tsao, Cheng-Ming; Ho, Shung-Tai] Natl Yang Ming Univ, Taipei 112, Taiwan; [Wu, Chin-Chen] Taipei Med Univ, Coll Med, Dept Pharmacol, Taipei, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Tao, Yuan-Xiang] Rutgers State Univ, Dept Anesthesiol, New Jersey Med Sch, Newark, NJ 07102 USA; [Shui, Hao-Ai] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Tungs' Taichung MetroHarbor Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Chi Mei Hospital; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Defense Medical Center	Shui, HA (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	haoai@ndmctsgh.edu.tw			National Science Council [NSC 99-2628-B-016 -013 -MY3]; Tri-Service General Hospital, Taiwan, R.O.C. [TSGH-C97-13-S03, TSGH-C98-05-S03]; NIH [RO1 NS058886, NS072206]; Rita Allen Foundation; Mr. David Koch and the Patrick C. Walsh Prostate Cancer Research Fund; Blaustein Pain Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072206, R01NS058886] Funding Source: NIH RePORTER	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital, Taiwan, R.O.C.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Allen Foundation; Mr. David Koch and the Patrick C. Walsh Prostate Cancer Research Fund; Blaustein Pain Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants NSC 99-2628-B-016 -013 -MY3 from the National Science Council and TSGH-C97-13-S03, TSGH-C98-05-S03, and TSGH-C98-05-S03 from the Tri-Service General Hospital, Taiwan, R.O.C. to W.-J.L. and by the NIH grants RO1 NS058886 and NS072206, the Rita Allen Foundation, Mr. David Koch and the Patrick C. Walsh Prostate Cancer Research Fund, and the Blaustein Pain Research Fund to Y.X.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso E, 2007, NEUROSCI LETT, V412, P163, DOI 10.1016/j.neulet.2006.11.002; Berhow MT, 1996, J NEUROSCI, V16, P4707; Chan CC, 2009, J PROTEOME RES, V8, P5382, DOI 10.1021/pr9003932; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Chen PH, 2011, J PROTEOMICS, V74, P2760, DOI 10.1016/j.jprot.2011.09.019; Cherny N, 2001, J CLIN ONCOL, V19, P2542, DOI 10.1200/JCO.2001.19.9.2542; Dobashi T, 2010, J CELL MOL MED, V14, P2816, DOI 10.1111/j.1582-4934.2009.00932.x; Exley R, 2006, J NEUROCHEM, V98, P876, DOI 10.1111/j.1471-4159.2006.03915.x; Ferrer-Alcon M, 2000, J NEUROSCI RES, V61, P338, DOI 10.1002/1097-4547(20000801)61:3<338::AID-JNR12>3.0.CO;2-5; Foucault I, 2003, J BIOL CHEM, V278, P7146, DOI 10.1074/jbc.M209509200; Gerber Helmut R, 2003, Best Pract Res Clin Anaesthesiol, V17, P429, DOI 10.1016/S1521-6896(03)00014-4; GUTSTEIN HB, 1993, BRAIN RES, V626, P332, DOI 10.1016/0006-8993(93)90597-G; Guzel E, 2011, BIOL REPROD, V85, P121, DOI 10.1095/biolreprod.110.089532; Hafner A, 2013, AGING CELL, V12, P604, DOI 10.1111/acel.12093; Hafner A, 2012, BIOCHEM J, V443, P439, DOI 10.1042/BJ20111351; Hafner A, 2010, NEUROSIGNALS, V18, P246, DOI 10.1159/000324292; Hauser KF, 1998, PERSPECT DEV NEUROBI, V5, P437; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kim S, 2011, BEHAV NEUROSCI, V125, P404, DOI 10.1037/a0023185; Kim SY, 2004, J NEUROSCI RES, V77, P867, DOI 10.1002/jnr.20214; Kim SY, 2005, MOL BRAIN RES, V133, P58, DOI 10.1016/j.molbrainres.2004.09.018; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lelevich S. V., 2007, Biomeditsinskaya Khimiya, V53, P284; Lelevich S. V., 2004, Biomeditsinskaya Khimiya, V50, P273; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Li JG, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.359679; Liaw WJ, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-45; Liaw WJ, 2004, NEUROSCIENCE, V123, P11, DOI 10.1016/j.neuroscience.2003.09.007; MAO J, 1994, J NEUROSCI, V14, P2301; MENARD DP, 1995, J PHARMACOL EXP THER, V273, P887; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Mumby M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-230; O'Callaghan James P, 2005, Expert Opin Drug Saf, V4, P433, DOI 10.1517/14740338.4.3.433; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; OLASMAA M, 1988, BRAIN RES, V475, P291, DOI 10.1016/0006-8993(88)90617-8; Osenbach R K, 2001, Curr Pain Headache Rep, V5, P241, DOI 10.1007/s11916-001-0038-6; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI 10.1016/j.mito.2011.09.001; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Ram PT, 2012, MOL ONCOL, V6, P147, DOI 10.1016/j.molonc.2012.01.008; Ramagli LS, 1999, METH MOL B, V112, P99; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Rodnight R, 1997, BRAZ J MED BIOL RES, V30, P325, DOI 10.1590/S0100-879X1997000300005; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Sharma SK, 2003, NEUROCHEM RES, V28, P1369, DOI 10.1023/A:1024996415795; Shea TB, 1999, CELL MOTIL CYTOSKEL, V43, P322, DOI 10.1002/(SICI)1097-0169(1999)43:4<322::AID-CM5>3.0.CO;2-B; Shui HA, 2007, PROTEOMICS, V7, P796, DOI 10.1002/pmic.200600699; Shui HA, 2012, J PROTEOMICS, V75, P1170, DOI 10.1016/j.jprot.2011.10.029; Sluchanko NN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1528, DOI 10.1134/S0006297910130031; Tao F, 2001, NEUROREPORT, V12, P3251, DOI 10.1097/00001756-200110290-00022; Tao YX, 2000, NEUROSCIENCE, V95, P525; Tao YX, 2002, NEUROSCIENCE, V112, P439, DOI 10.1016/S0306-4522(02)00075-1; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Ueda H, 2009, FRONT BIOSCI, V14, P5260, DOI 10.2741/3596; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; YAKSH TL, 1976, SCIENCE, V192, P1357, DOI 10.1126/science.1273597; Yamaguchi Y, 2008, J BIOL CHEM, V283, P17020, DOI 10.1074/jbc.M802466200; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Zhou P, 2012, J NEUROSCI, V32, P583, DOI 10.1523/JNEUROSCI.2849-11.2012	62	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83817	10.1371/journal.pone.0083817	http://dx.doi.org/10.1371/journal.pone.0083817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392096	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100020
J	Tserevelakis, GJ; Megalou, EV; Filippidis, G; Petanidou, B; Fotakis, C; Tavernarakis, N				Tserevelakis, George J.; Megalou, Evgenia V.; Filippidis, George; Petanidou, Barbara; Fotakis, Costas; Tavernarakis, Nektarios			Label-Free Imaging of Lipid Depositions in C. elegans Using Third-Harmonic Generation Microscopy	PLOS ONE			English	Article							FAT REGULATORY GENES; CAENORHABDITIS-ELEGANS; SRS MICROSCOPY; STORAGE	Elucidation of the molecular mechanisms regulating lipid storage and metabolism is essential for mitigating excess adiposity and obesity, which has been associated with increased prevalence of severe pathological conditions such as cardiovascular disorders and type II diabetes, worldwide. However, imaging fatty acid distribution and dynamics in vivo, at the cellular or organismal level is challenging. We developed a label-free method for visualizing lipid depositions in vivo, based on third harmonic generation (THG) microscopy. THG imaging requires a single pulsed-laser light source, alleviating the technical challenges of implementing coherent anti-Stokes Raman scattering spectroscopy (CARS) to detect fat stores in living cells. We demonstrate that THG can be used to efficiently and reliably visualize lipid droplets in Caenorhabditis elegans. Thus, THG microscopy offers a versatile alternative to fluorescence and dye-based approaches for lipid biology research.	[Tserevelakis, George J.; Filippidis, George; Petanidou, Barbara; Fotakis, Costas] Fdn Res & Technol, Inst Elect Struct & Laser, Iraklion, Greece; [Tserevelakis, George J.; Petanidou, Barbara; Fotakis, Costas] Univ Crete, Dept Phys, Iraklion, Greece; [Megalou, Evgenia V.; Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Tavernarakis, Nektarios] Univ Crete, Sch Med, Iraklion, Greece	University of Crete; University of Crete	Tavernarakis, N (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013; Filippidis, George/A-2473-2014; Tserevelakis, George/ABB-5778-2020; Fotakis, Costas/G-8751-2011	Tavernarakis, Nektarios/0000-0002-5253-1466; Filippidis, George/0000-0003-4748-5968; Tserevelakis, George/0000-0002-9938-3472; FOTAKIS, COSTAS/0000-0001-9526-6714	Bodossaki Foundation; European Research Council [ADG - 233358]	Bodossaki Foundation; European Research Council(European Research Council (ERC)European Commission)	Funding replacement: E.V.M. was supported by a postdoctoral fellowship from the Bodossaki Foundation. This work was in part funded by grants from the European Research Council (Grant ERC 2008 ADG - 233358 NEURONAGE), the European Commission Marie Curie Programme Grant ITN CodeAge 264049), and the General Secretariat for Research and Technology of Greece Grant Aristeia 1823 - Necrosis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Barros AGD, 2012, METHOD CELL BIOL, V107, P383, DOI 10.1016/B978-0-12-394620-1.00013-8; Debarre D, 2006, NAT METHODS, V3, P47, DOI 10.1038/NMETH813; Debarre D, 2005, OPT LETT, V30, P2134, DOI 10.1364/OL.30.002134; Debarre D, 2007, OPT EXPRESS, V15, P8913, DOI 10.1364/OE.15.008913; Debarre D, 2007, BIOPHYS J, V92, P603, DOI 10.1529/biophysj.106.094946; Folick A, 2011, CURR OPIN GENET DEV, V21, P585, DOI 10.1016/j.gde.2011.09.003; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060; Min W, 2011, ANNU REV PHYS CHEM, V62, P507, DOI 10.1146/annurev.physchem.012809.103512; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ranall MV, 2011, BIOTECHNIQUES, V51, P35, DOI 10.2144/000113702; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Squier J, 2001, REV SCI INSTRUM, V72, P2855, DOI 10.1063/1.1379598; Wang MC, 2011, NAT METHODS, V8, P135, DOI 10.1038/NMETH.1556; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810	20	29	30	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84431	10.1371/journal.pone.0084431	http://dx.doi.org/10.1371/journal.pone.0084431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392137	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100060
J	Boutin, RD; Buonocore, MH; Immerman, I; Ashwell, Z; Sonico, GJ; Szabo, RM; Chaudhari, AJ				Boutin, Robert D.; Buonocore, Michael H.; Immerman, Igor; Ashwell, Zachary; Sonico, Gerald J.; Szabo, Robert M.; Chaudhari, Abhijit J.			Real-Time Magnetic Resonance Imaging (MRI) during Active Wrist Motion-Initial Observations	PLOS ONE			English	Article							DISTAL RADIOULNAR JOINT; CARPAL INSTABILITY; LIGAMENT INJURIES; STRESS VIEWS; STEADY-STATE; ARTHROGRAPHY; KINEMATICS; TRUEFISP; CT; MOVEMENT	Background: Non-invasive imaging techniques such as magnetic resonance imaging (MRI) provide the ability to evaluate the complex anatomy of bone and soft tissues of the wrist without the use of ionizing radiation. Dynamic instability of wrist - occurring during joint motion - is a complex condition that has assumed increased importance in musculoskeletal medicine. The objective of this study was to develop an MRI protocol for evaluating the wrist during continuous active motion, to show that dynamic imaging of the wrist is realizable, and to demonstrate that the resulting anatomical images enable the measurement of metrics commonly evaluated for dynamic wrist instability. Methods: A 3-Tesla "active-MRI" protocol was developed using a bSSFP sequence with 475 ms temporal resolution for continuous imaging of the moving wrist. Fifteen wrists of 10 asymptomatic volunteers were scanned during active supination/pronation, radial/ulnar deviation, "clenched-fist", and volarflexion/dorsiflexion maneuvers. Two physicians evaluated distal radioulnar joint (DRUJ) congruity, extensor carpi ulnaris (ECU) tendon translation, the scapholunate (SL) interval, and the SL, radiolunate (RL) and capitolunate (CL) angles from the resulting images. Results: The mean DRUJ subluxation ratio was 0.04 in supination, 0.10 in neutral, and 0.14 in pronation. The ECU tendon was subluxated or translated out of its groove in 3 wrists in pronation, 9 wrists in neutral, and 11 wrists in supination. The mean SL interval was 1.43 mm for neutral, ulnar deviation, radial deviation positions, and increased to 1.64 mm during the clenched-fist maneuver. Measurement of SL, RL and CL angles in neutral and dorsiflexion was also accomplished. Conclusion: This study demonstrates the initial performance of active-MRI, which may be useful in the investigation of dynamic wrist instability in vivo.	[Boutin, Robert D.; Buonocore, Michael H.; Ashwell, Zachary; Chaudhari, Abhijit J.] Univ Calif Davis, Sch Med, Dept Radiol, Sacramento, CA 95817 USA; [Buonocore, Michael H.] Univ Calif Davis, Imaging Res Ctr, Sacramento, CA 95817 USA; [Immerman, Igor; Sonico, Gerald J.; Szabo, Robert M.] Univ Calif Davis, Sch Med, Dept Orthoped Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chaudhari, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Radiol, Sacramento, CA 95817 USA.	ajchaudhari@ucdavis.edu	Chaudhari, Abhijit/P-4982-2019	Chaudhari, Abhijit/0000-0002-4211-1900	Building Interdisciplinary Research Careers in Women's Health award [K12 HD051958]; National Institute of Child Health and Human Development of the National Institutes of Health (NIH); Office of Research on Women's Health of the National Institutes of Health (NIH); Office of Dietary Supplements of the National Institutes of Health (NIH); National Institute of Aging of the National Institutes of Health (NIH); NIH-NIBIB [R03EB015099]; UC Davis Imaging Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB015099] Funding Source: NIH RePORTER	Building Interdisciplinary Research Careers in Women's Health award; National Institute of Child Health and Human Development of the National Institutes of Health (NIH); Office of Research on Women's Health of the National Institutes of Health (NIH); Office of Dietary Supplements of the National Institutes of Health (NIH); National Institute of Aging of the National Institutes of Health (NIH); NIH-NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); UC Davis Imaging Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Building Interdisciplinary Research Careers in Women's Health award (K12 HD051958) funded by the National Institute of Child Health and Human Development, Office of Research on Women's Health, Office of Dietary Supplements, and the National Institute of Aging of the National Institutes of Health (NIH) to AJC, the NIH-NIBIB R03EB015099 grant to AJC and the UC Davis Imaging Research Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess RA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-273; Cerezal L, 2005, RADIOL CLIN N AM, V43, P709, DOI 10.1016/j.rcl.2005.02.004; Cerezal L, 2012, SEMIN MUSCULOSKEL R, V16, P27, DOI 10.1055/s-0032-1304299; Choi YS, 2013, YONSEI MED J, V54, P1026, DOI 10.3349/ymj.2013.54.4.1026; Crisco JJ, 2005, J BONE JOINT SURG AM, V87A, P2729, DOI 10.2106/JBJS.D.03058; d'Entremont AG, 2013, MAGN RESON MED, V69, P1634, DOI 10.1002/mrm.24425; Foumani M, 2009, J BIOMECH, V42, P2664, DOI 10.1016/j.jbiomech.2009.08.016; Garcia-Elias M, 1999, J HAND SURG-AM, V24A, P866; GarciaElias M, 1997, J BONE JOINT SURG BR, V79B, P684, DOI 10.1302/0301-620X.79B4.14192; Gheno R, 2010, SKELETAL RADIOL, V39, P799, DOI 10.1007/s00256-009-0796-5; Haims AH, 2003, RADIOLOGY, V227, P701, DOI 10.1148/radiol.2273020398; Huang JI, 2012, HAND CLIN, V28, P157, DOI 10.1016/j.hcl.2012.03.002; Huang TY, 2002, MAGNET RESON MED, V48, P684, DOI 10.1002/mrm.10260; Kalia V, 2009, AM J ROENTGENOL, V192, pW295, DOI 10.2214/AJR.08.1793; Kwon BC, 2008, CLIN ORTHOP RELAT R, V466, P969, DOI 10.1007/s11999-008-0126-6; LARSEN CF, 1991, J HAND SURG-AM, V16A, P888; Lee KS, 2009, AM J ROENTGENOL, V193, P651, DOI 10.2214/AJR.08.1725; Lee SK, 2011, J HAND SURG-AM, V36A, P1149, DOI 10.1016/j.jhsa.2011.05.009; Leng SA, 2011, MED PHYS, V38, pS50, DOI 10.1118/1.3577759; Maizlin ZV, 2012, J DIGIT IMAGING, P1; Matsuki KO, 2010, CLIN BIOMECH, V25, P979, DOI 10.1016/j.clinbiomech.2010.07.006; MIKIC ZD, 1984, J BONE JOINT SURG AM, V66A, P371, DOI 10.2106/00004623-198466030-00009; Moser T, 2007, AM J ROENTGENOL, V188, P1278, DOI 10.2214/AJR.06.0288; Park MJ, 2008, J BONE JOINT SURG AM, V90A, P145, DOI 10.2106/JBJS.F.01603; Quick HH, 2002, J MAGN RESON IMAGING, V15, P710, DOI 10.1002/jmri.10120; Sanderson PL, 1997, J HAND SURG-BRIT EUR, V22B, P21, DOI 10.1016/S0266-7681(97)80007-1; Scheffler K, 2001, MAGNET RESON MED, V45, P1075, DOI 10.1002/mrm.1142; SCHERNBERG F, 1990, J HAND SURG-BRIT EUR, V15B, P220, DOI 10.1016/0266-7681(90)90127-P; Shapiro LM, 2012, OSTEOARTHR CARTILAGE, V20, P69, DOI 10.1016/j.joca.2011.11.003; Shores JT, 2013, EPLASTY, V13; TALEISNIK J, 1988, J BONE JOINT SURG AM, V70A, P1262, DOI 10.2106/00004623-198870080-00025; Theumann NH, 2006, RADIOLOGY, V238, P950, DOI 10.1148/radiol.2383050013; TON ERTA, 1995, RADIOLOGY, V196, P863, DOI 10.1148/radiology.196.3.7644657; WATSON HK, 1986, J BONE JOINT SURG AM, V68A, P345, DOI 10.2106/00004623-198668030-00005; Wolfe SW, 2000, J HAND SURG-AM, V25A, P860, DOI 10.1053/jhsu.2000.9423; Yen P, 2013, AM J NEURORADIOL, V34, pE24, DOI 10.3174/ajnr.A2734; Zanetti M, 1997, JMRI-J MAGN RESON IM, V7, P590, DOI 10.1002/jmri.1880070322	37	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84004	10.1371/journal.pone.0084004	http://dx.doi.org/10.1371/journal.pone.0084004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391865	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900008
J	Brimblecombe, J; Ferguson, M; Liberato, SC; O'Dea, K; Riley, M				Brimblecombe, Julie; Ferguson, Megan; Liberato, Selma C.; O'Dea, Kerin; Riley, Malcolm			Optimisation Modelling to Assess Cost of Dietary Improvement in Remote Aboriginal Australia	PLOS ONE			English	Article							SOCIOECONOMIC DIFFERENCES; NUTRIENT DENSITY; HEALTHY DIET; PATTERNS; ADULTS; CONSUMPTION; VEGETABLES; CONSTRAINT; QUALITY; WOMEN	Background: The cost and dietary choices required to fulfil nutrient recommendations defined nationally, need investigation, particularly for disadvantaged populations. Objective: We used optimisation modelling to examine the dietary change required to achieve nutrient requirements at minimum cost for an Aboriginal population in remote Australia, using where possible minimally-processed whole foods. Design: A twelve month cross-section of population-level purchased food, food price and nutrient content data was used as the baseline. Relative amounts from 34 food group categories were varied to achieve specific energy and nutrient density goals at minimum cost while meeting model constraints intended to minimise deviation from the purchased diet. Results: Simultaneous achievement of all nutrient goals was not feasible. The two most successful models (A & B) met all nutrient targets except sodium (146.2% and 148.9% of the respective target) and saturated fat (12.0% and 11.7% of energy). Model A was achieved with 3.2% lower cost than the baseline diet (which cost approximately AUD$13.01/person/day) and Model B at 7.8% lower cost but with a reduction in energy of 4.4%. Both models required very large reductions in sugar sweetened beverages (-90%) and refined cereals (-90%) and an approximate four-fold increase in vegetables, fruit, dairy foods, eggs, fish and seafood, and wholegrain cereals. Conclusion: This modelling approach suggested population level dietary recommendations at minimal cost based on the baseline purchased diet. Large shifts in diet in remote Aboriginal Australian populations are needed to achieve national nutrient targets. The modeling approach used was not able to meet all nutrient targets at less than current food expenditure.	[Brimblecombe, Julie; Ferguson, Megan; Liberato, Selma C.; O'Dea, Kerin] Menzies Sch Hlth Res, Darwin, NT, Australia; [O'Dea, Kerin] Univ S Australia, Sch Populat Hlth, Div Hlth Sci, Adelaide, SA 5001, Australia; [Riley, Malcolm] Commonwealth Sci Ind Res Org Anim Food & Hlth Sci, Parkville, Vic, Australia	Charles Darwin University; Menzies School of Health Research; University of South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Brimblecombe, J (corresponding author), Menzies Sch Hlth Res, Darwin, NT, Australia.	julie.brimblecombe@menzies.edu.au	Ferguson, Megan/Y-3511-2018; Riley, Malcolm/B-5296-2011	Ferguson, Megan/0000-0002-4435-0948; Riley, Malcolm/0000-0003-3040-8616; Brimblecombe, Julie/0000-0002-1977-276X	National Aboriginal and Torres Strait Islander Health Equity Council; National Health and Medical Research Council [NHMRC] [ID545253, 1039074]	National Aboriginal and Torres Strait Islander Health Equity Council; National Health and Medical Research Council [NHMRC](National Health and Medical Research Council (NHMRC) of Australia)	The study was funded through the National Aboriginal and Torres Strait Islander Health Equity Council. The National Health and Medical Research Council provided people support for JB Salary support for JB [NHMRC: Public Health Training Fellowship ID545253] and MF [NHMRC PhD scholarship ID 1039074] to conduct this work. The views expressed in this publication are those of the authors and do not reflect the views of NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An RP, 2013, PUBLIC HEALTH NUTR, V16, P1215, DOI 10.1017/S1368980012004715; [Anonymous], 2006, NUTR REF VAL AUSTR N; Australian Bureau of Statistics, 2011, 12160 AUSTR BUR STAT; Australian Bureau of Statistics, 2013, 13700 AUSTR BUR STA; Australian Bureau of Statistics, 2007, BIRTHS AUSTR 2006; Australian Bureau of Statistics, 2007, 2006 CENS POP HOUS; Australian Government Department of Health and Ageing National Health and Medical Research Council, 2011, MOD SYSTEM INFORM RE; Australian Government National Health and Medical Council Ministry of Health: Manatu Hauora, 2011, NUTR REF VAL AUSTR N; Ball K, 2004, PUBLIC HEALTH NUTR, V7, P443, DOI 10.1079/PHN2003538; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; Briend A, 2000, PEDIATRICS, V106, P1288; Brimblecombe J, 2008, KEEPING TRACK HLTH; Brimblecombe J., 2012, PUBLIC HEALTH NUTR, P1; Brimblecombe JK, 2013, MED J AUSTRALIA, V198, P380, DOI 10.5694/mja12.11407; Burns C M, 2004, Rural Remote Health, V4, P311; Cade J, 1999, PUBLIC HEALTH NUTR, V2, P505, DOI 10.1017/S1368980099000683; Conforti P, 2000, PUBLIC HEALTH NUTR, V3, P367, DOI 10.1017/S1368980000000410; Darmon N, 2006, J NUTR EDUC BEHAV, V38, P82, DOI 10.1016/j.jneb.2005.11.028; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; Darmon N, 2002, AM J CLIN NUTR, V75, P245, DOI 10.1093/ajcn/75.2.245; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; Drewnowski A, 2004, AM J PUBLIC HEALTH, V94, P1555, DOI 10.2105/AJPH.94.9.1555; Food Standards Australia New Zealand (FSANZ), 1999, AUSNUT; Food Standards Australia New Zealand (FSANZ), NUTT; Food Standards Australia New Zealand (FSANZ), AUSNUT 2007 DAT FIL; Giskes K, 2002, J HUM NUTR DIET, V15, P375, DOI 10.1046/j.1365-277X.2002.00387.x; Guenther PM, 2013, AM J CLIN NUTR, V97, P842, DOI 10.3945/ajcn.112.047779; Harrison MS, 2007, MED J AUSTRALIA, V186, P9, DOI 10.5694/j.1326-5377.2007.tb00778.x; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; Jetter KM, 2006, AM J PREV MED, V30, P38, DOI 10.1016/j.amepre.2005.08.039; Lasdon LS, 1982, GRG2 USERS GUIDE; LEE AJ, 1995, ECOL FOOD NUTR, V34, P19, DOI 10.1080/03670244.1995.9991444; Lino M, 2001, FAM EC NUTR REV, V13, P50; Mackerras D, 1997, AUST NZ J PUBL HEAL, V21, P218, DOI 10.1111/j.1467-842X.1997.tb01689.x; Martikainen P, 2003, SOC SCI MED, V56, P1397, DOI 10.1016/S0277-9536(02)00137-5; Masset G, 2009, J NUTR, V139, P1541, DOI 10.3945/jn.109.104398; MATTES RD, 1991, J AM COLL NUTR, V10, P383; MCALLISTER M, 1994, J NUTR EDUC, V26, P131; Mhurchu CN, 2012, HEALTH PROMOT INT, V27, P331, DOI 10.1093/heapro/dar042; Mishra G, 2002, EUR J CLIN NUTR, V56, P687, DOI 10.1038/sj.ejcn.1601391; National Health and Medical Research Council, 2000, NUTR AB TORR STRAIT; Ni Mhurchu Cliona, 2007, N Z Med J, V120, pU2388; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; Northern Territory Government, 2012, NO TERR MARK BASK SU; Rambeloson ZJ, 2008, PUBLIC HEALTH NUTR, V11, P395, DOI 10.1017/S1368980007000511; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; ROSS R, 1992, AUST J SOC ISSUES, V27, P92, DOI 10.1002/j.1839-4655.1992.tb01280.x; Strategic Inter-Governmental Nutrition Alliance of the National Public Health Partnership, 2001, EAT WELL AUSTR AG AC; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; US Department of Agriculture Food and Nutrition Service, SUPPL NUTR ASS PROGR; WHO, 2003, DIET NUTR PREVENTION, V916; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059648	53	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83587	10.1371/journal.pone.0083587	http://dx.doi.org/10.1371/journal.pone.0083587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284NF	24391790	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000329325200087
J	Chen, Y; Xu, JJ; Liu, S; Hou, XH				Chen, Yan; Xu, Juan Juan; Liu, Shi; Hou, Xiao Hua			Electroacupuncture at ST36 Ameliorates Gastric Emptying and Rescues Networks of Interstitial Cells of Cajal in the Stomach of Diabetic Rats	PLOS ONE			English	Article							ADULT GUINEA-PIGS; DYSPEPTIC SYMPTOMS; REPERFUSION INJURY; SMALL-INTESTINE; CONSCIOUS RATS; IN-VIVO; GASTROPARESIS; MECHANISMS; MOTILITY; PROLIFERATION	Depletion of interstitial cells of Cajal (ICC) is certified in the stomach of diabetic patients. Though electroacupuncture (EA) at ST36 is an effective therapy to regulate gastric motility, the mechanisms of EA at ST36 on gastric emptying and networks of ICC remain to be elucidated. The aims of this study were to investigate the effects of EA on gastric emptying and on the alterations of ICC networks. Rats were randomized into the control, diabetic rats (DM), diabetic rats with sham EA (DM+SEA), diabetic rats with low frequency EA (DM+LEA) and diabetic rats with high frequency EA groups (DM+HEA). The expression of c-kit in each layer of gastric wall was assessed by western blotting. The proliferation of ICC was identified by immunolabeling of c-kit and Ki67 as the apoptosis of ICC was examined by TUNEL staining. The results were as follows: (1) Gastric emptying was severely delayed in the DM group, but accelerated in the LEA and HEA group, especially in the LEA group. (2) The expression of c-kit in each layer was reduced apparently in the DM group, but also up-regulated in the LEA and HEA group. (3) Plentiful proliferated ICC (c-kit+/Ki67+) forming bushy networks with c-kit+cells were observed in the LEA and HEA group, while the apoptotic cells (c-kit+/TUNEL+) were hardly captured in the LEA and HEA group. Collectively, low and high frequency EA at ST36 rescue the damaged networks of ICC by inhibiting the apoptosis and enhancing the proliferation in the stomach of diabetic rats, resulting in an improved gastric emptying.	[Chen, Yan; Xu, Juan Juan; Liu, Shi; Hou, Xiao Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Div Gastroenterol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Liu, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Div Gastroenterol, Wuhan 430074, Peoples R China.	shiliugao@yahoo.com		Liu, Shi/0000-0003-2289-9160	National Natural Science Foundation of China [30670775, 81270458]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was partially supported by grants from the National Natural Science Foundation of China (No. 30670775, No. 81270458). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rodrigues MLC, 2012, J PEDIAT-BRAZIL, V88, P17, DOI 10.2223/JPED.2153; Deng Jing-Jing, 2011, Zhen Ci Yan Jiu, V36, P176; Di Marzo V, 2008, BRIT J PHARMACOL, V153, P1272, DOI 10.1038/sj.bjp.0707682; Farrugia G, 2008, NEUROGASTROENT MOTIL, V20, P54, DOI 10.1111/j.1365-2982.2008.01109.x; Forster J, 2005, J GASTROINTEST SURG, V9, P102, DOI 10.1016/j.gassur.2004.10.001; Gao JF, 2011, NEUROL SCI, V32, P369, DOI 10.1007/s10072-010-0402-6; Gibbons SJ, 2009, NEUROGASTROENT MOTIL, V21, P85, DOI 10.1111/j.1365-2982.2008.01185.x; Harberson J, 2010, DIGEST DIS SCI, V55, P359, DOI 10.1007/s10620-009-1071-2; Hirst GDS, 2006, J PHYSIOL-LONDON, V576, P659, DOI 10.1113/jphysiol.2006.116491; Imai K, 2008, AUTON NEUROSCI-BASIC, V138, P91, DOI 10.1016/j.autneu.2007.11.003; Iwa M, 2006, DIGEST DIS SCI, V51, P1493, DOI 10.1007/s10620-006-9083-7; Kim EH, 2002, NEUROSCI LETT, V327, P33, DOI 10.1016/S0304-3940(02)00372-5; Komuro T, 1996, J AUTONOM NERV SYST, V61, P169, DOI 10.1016/S0165-1838(96)00078-1; Luo D, 2008, DIGEST DIS SCI, V53, P689, DOI 10.1007/s10620-007-9929-7; Manneschi LI, 2004, HISTOL HISTOPATHOL, V19, P1153, DOI 10.14670/HH-19.1153; Mei F, 2006, VIRCHOWS ARCH, V449, P348, DOI 10.1007/s00428-006-0258-6; Mei F, 2009, ANAT REC, V292, P985, DOI 10.1002/ar.20928; Mei F, 2009, VIRCHOWS ARCH, V454, P401, DOI 10.1007/s00428-009-0739-5; Ordog T, 2000, DIABETES, V49, P1731, DOI 10.2337/diabetes.49.10.1731; Ouyang H, 2002, AM J PHYSIOL-GASTR L, V282, pG390, DOI 10.1152/ajpgi.00272.2001; Sfarti C, 2010, J GASTROINTEST LIVER, V19, P279; Shuai X, 2008, DIS ESOPHAGUS, V21, P170, DOI 10.1111/j.1442-2050.2007.00757.x; Silva JRT, 2011, J PAIN, V12, P51, DOI 10.1016/j.jpain.2010.04.008; Sun Jian-Hua, 2011, Zhen Ci Yan Jiu, V36, P171; Tharayil VS, 2010, NEUROGASTROENT MOTIL, V22, P462, DOI 10.1111/j.1365-2982.2009.01435.x; Vittal H, 2007, NAT CLIN PRACT GASTR, V4, P336, DOI 10.1038/ncpgasthep0838; Wang XY, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01336.x; Wang Yan-chun, 2010, Zhen Ci Yan Jiu, V35, P415; Xu JJ, 2012, J EVID-BASED INTEGR, V17, P117, DOI 10.1177/2156587211436235; Xu SP, 2006, DIGEST DIS SCI, V51, P2154, DOI 10.1007/s10620-006-9412-x; Yin J, 2008, J CELL MOL MED, V12, P1118, DOI 10.1111/j.1582-4934.2008.00352.x; Yin JY, 2010, AM J PHYSIOL-GASTR L, V298, pG563, DOI 10.1152/ajpgi.00252.2009; Zhao JX, 2011, J TRADIT CHIN MED, V31, P349, DOI 10.1016/S0254-6272(12)60017-X	34	21	30	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83904	10.1371/journal.pone.0083904	http://dx.doi.org/10.1371/journal.pone.0083904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391842	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200140
J	Cizmeci, D; Arkun, Y				Cizmeci, Deniz; Arkun, Yaman			Regulatory Networks and Complex Interactions between the Insulin and Angiotensin II Signalling Systems: Models and Implications for Hypertension and Diabetes	PLOS ONE			English	Article							NITRIC-OXIDE; RECEPTOR SUBSTRATE-1; OXIDATIVE STRESS; FEEDBACK LOOPS; KINASE-B; AKT; SENSITIVITY; MTOR; RESISTANCE; PHOSPHORYLATION	The cross-talk between insulin and angiotensin II signalling pathways plays a significant role in the co-occurrence of diabetes and hypertension. We developed a mathematical model of the system of interactions among the biomolecules that are involved in the cross-talk between the insulin and angiotensin II signalling pathways. We have identified several feedback structures that regulate the dynamic behavior of the individual signalling pathways and their interactions. Different scenarios are simulated and dominant steady-state, dynamic and stability characteristics are revealed. The proposed mechanistic model describes how angiotensin II inhibits the actions of insulin and impairs the insulin-mediated vasodilation. The model also predicts that poor glycaemic control induced by diabetes contributes to hypertension by activating the renin angiotensin aystem.	[Cizmeci, Deniz; Arkun, Yaman] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey	Koc University	Arkun, Y (corresponding author), Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey.	yarkun@ku.edu.tr		Cizmeci, Deniz/0000-0003-3231-7726	Koc University	Koc University(Koc University)	Koc University supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2006, DIABETES OBES METAB, V8, P396, DOI 10.1111/j.1463-1326.2005.00526.x; Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Blendea MC, 2005, AM J PHYSIOL-ENDOC M, V288, pE353, DOI 10.1152/ajpendo.00402.2004; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Ceriello A, 2004, DIABETOLOGIA, V47, P1535, DOI 10.1007/s00125-004-1487-3; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; CIZMECI D, 2012, REGULATORY NETWORKS; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Csibi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010070; de Kloet AD, 2010, PHYSIOL BEHAV, V100, P525, DOI 10.1016/j.physbeh.2010.03.018; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fan QL, 2004, NEPHROL DIAL TRANSPL, V19, P3012, DOI 10.1093/ndt/gfh499; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Giri Lopamudra, 2004, Theor Biol Med Model, V1, P2, DOI 10.1186/1742-4682-1-2; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guo W, 2003, AM J PHYSIOL-HEART C, V285, pH1396, DOI 10.1152/ajpheart.00096.2003; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Henriksen EJ, 2001, HYPERTENSION, V38, P884, DOI 10.1161/hy1101.092970; Henriksen EJ, 2007, AM J PHYSIOL-REG I, V293, pR974, DOI 10.1152/ajpregu.00147.2007; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JR, 2008, BIOPHYS J, V94, P359, DOI 10.1529/biophysj.107.105106; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Kurtz A, 1998, AM J PHYSIOL-RENAL, V275, pF849, DOI 10.1152/ajprenal.1998.275.6.F849; Kwon YK, 2008, BIOINFORMATICS, V24, P1926, DOI 10.1093/bioinformatics/btn337; Liao Y, 2010, AM J TRANSL RES, V2, P19; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Nawano M, 1999, METABOLISM, V48, P1248, DOI 10.1016/S0026-0495(99)90263-9; Nayak S, 2011, IET SYST BIOL, V5, P2, DOI 10.1049/iet-syb.2009.0065; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Paz K, 1999, J BIOL CHEM, V274, P28816, DOI 10.1074/jbc.274.40.28816; Perkins JM, 2008, CURR OPIN ENDOCRINOL, V15, P147, DOI 10.1097/MED.0b013e3282f7026f; Peti-Peterdi J, 2008, NEPHROL DIAL TRANSPL, V23, P3047, DOI 10.1093/ndt/gfn377; Pueyo ME, 1998, AM J PHYSIOL-CELL PH, V274, pC214, DOI 10.1152/ajpcell.1998.274.1.C214; Pulakat L, 2011, CARDIORENAL MED, V1, P102, DOI 10.1159/000327140; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scheen AJ, 2004, DIABETES METAB, V30, P498, DOI 10.1016/S1262-3636(07)70147-7; SOWERS JR, 1990, MOL CELL ENDOCRINOL, V74, pC87, DOI 10.1016/0303-7207(90)90110-T; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Wang GY, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046015; Wattanapitayakul SK, 2000, FASEB J, V14, P271, DOI 10.1096/fasebj.14.2.271; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Wenzel P, 2008, FREE RADICAL BIO MED, V45, P619, DOI 10.1016/j.freeradbiomed.2008.05.009; Winter JN, 2011, AM J PHYSIOL-CELL PH, V300, pC1172, DOI 10.1152/ajpcell.00504.2010; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539	55	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83640	10.1371/journal.pone.0083640	http://dx.doi.org/10.1371/journal.pone.0083640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24400038	Green Published, gold			2022-12-27	WOS:000329325200098
J	Danda, R; Krishnan, G; Ganapathy, K; Krishnan, UM; Vikas, K; Elchuri, S; Chatterjee, N; Krishnakumar, S				Danda, Ravikanth; Krishnan, Gopinath; Ganapathy, Kalaivani; Krishnan, Uma Maheswari; Vikas, Khetan; Elchuri, Sailaja; Chatterjee, Nivedita; Krishnakumar, Subramanian			Targeted Expression of Suicide Gene by Tissue-Specific Promoter and MicroRNA Regulation for Cancer Gene Therapy	PLOS ONE			English	Article							VIRUS-THYMIDINE-KINASE; MALIGNANT BRAIN-TUMORS; TRANSGENE EXPRESSION; HUMAN RETINOBLASTOMA; BREAST-CANCER; MURINE MODEL; PHASE-I; CELLS; GANCICLOVIR; CARCINOMA	In order to realise the full potential of cancer suicide gene therapy that allows the precise expression of suicide gene in cancer cells, we used a tissue specific Epithelial cell adhesion molecule (EpCAM) promoter (EGP-2) that directs transgene Herpes simplex virus-thymidine kinase (HSV-TK) expression preferentially in EpCAM over expressing cancer cells. EpCAM levels are considerably higher in retinoblastoma (RB), a childhood eye cancer with limited expression in normal cells. Use of miRNA regulation, adjacent to the use of the tissue-specific promoter, would provide the second layer of control to the transgene expression only in the tumor cells while sparing the normal cells. To test this hypothesis we cloned let-7b miRNA targets in the 3'UTR region of HSV-TK suicide gene driven by EpCAM promoter because let-7 family miRNAs, including let7b, were found to be down regulated in the RB tumors and cell lines. We used EpCAM over expressing and let-7 down regulated RB cell lines Y79, WERI-Rb1 (EpCAM (+ve)/let-7b(down-regulated)), EpCAM down regulated, let-7 over expressing normal retinal Muller glial cell line MIO-M1(EpCAM (-ve)/let-7b(up-regulated)), and EpCAM up regulated, let-7b up-regulated normal thyroid cell line N-Thy-Ori-3.1(EpCAM (+ve)/let-7b (up-regulated)) in the study. The cell proliferation was measured by MTT assay, apoptosis was measured by probing cleaved Caspase3, EpCAM and TK expression were quantified by Western blot. Our results showed that the EGP2-promoter HSV-TK (EGP2-TK) construct with 2 or 4 copies of let-7b miRNA targets expressed TK gene only in Y79, WERI-Rb-1, while the TK gene did not express in MIO-M1. In summary, we have developed a tissuespecific, miRNA-regulated dual control vector, which selectively expresses the suicide gene in EpCAM over expressing cells.	[Danda, Ravikanth; Krishnan, Gopinath; Ganapathy, Kalaivani; Elchuri, Sailaja; Chatterjee, Nivedita; Krishnakumar, Subramanian] Sankara Nethralaya, Vis Res Fdn, Dept Ocular Pathol, Madras, Tamil Nadu, India; [Danda, Ravikanth; Krishnan, Gopinath; Krishnan, Uma Maheswari] Shanmugha Arts Sci Technol & Res Acad Univ, Ctr Nanotechnol & Adv Biomat, Tanjore, India; [Vikas, Khetan] Sankara Nethralaya, Med Res Fdn, Dept Ocular Oncol, Madras, Tamil Nadu, India; [Vikas, Khetan] Sankara Nethralaya, Med Res Fdn, Dept Vitreoretina, Madras, Tamil Nadu, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Krishnakumar, S (corresponding author), Sankara Nethralaya, Vis Res Fdn, Dept Ocular Pathol, Madras, Tamil Nadu, India.	drkk@snmail.org	Krishnan, Gopinath/AGZ-1565-2022	Krishnan, Gopinath/0000-0002-3508-1133; Khetan, Vikas/0000-0003-4396-9877	Indian Council of Medical Research [35/6/2010/-BMS]; Department of Biotechnology, Government of India [BT/01/CE1B/11/V/16]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Indian Council of Medical Research, Grant no 35/6/2010/-BMS Nano for performing cloning, transfection, and functional analysis. In part this work was supported by the Department of Biotechnology, Government of India, Grant no BT/01/CE1B/11/V/16 for performing the let-7miRNA family profile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2000, CANCER RES, V60, P4305; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Card PB, 2012, CANCER GENE THER, V19, P451, DOI 10.1038/cgt.2012.16; Chevez-Barrios P, 2005, J CLIN ONCOL, V23, P7927, DOI 10.1200/JCO.2004.00.1883; Denny WA, 2001, EUR J MED CHEM, V36, P577, DOI 10.1016/S0223-5234(01)01253-3; Duarte S, 2012, CANCER LETT, V324, P160, DOI 10.1016/j.canlet.2012.05.023; Ebara S, 2002, PROSTATE CANCER P D, V5, P316, DOI 10.1038/sj.pcan.4500610; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gommans WM, 2006, CANCER GENE THER, V13, P150, DOI 10.1038/sj.cgt.7700882; Gunduz K, 2004, OPHTHALMOLOGY, V111, P1917, DOI 10.1016/j.ophtha.2004.04.016; Haviv YS, 2001, ADV DRUG DELIVER REV, V53, P135, DOI 10.1016/S0169-409X(01)00225-3; Hayashi N, 1999, INVEST OPHTH VIS SCI, V40, P265; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Hurwitz MY, 1999, HUM GENE THER, V10, P441, DOI 10.1089/10430349950018887; Ji XD, 2009, EXP EYE RES, V89, P193, DOI 10.1016/j.exer.2009.03.007; Kelly EJ, 2009, MOL THER, V17, P409, DOI 10.1038/mt.2008.288; Krishnakumar S, 2004, INVEST OPHTH VIS SCI, V45, P4247, DOI 10.1167/iovs.04-0591; Kucharczuk JC, 1996, HUM GENE THER, V7, P2225, DOI 10.1089/hum.1996.7.18-2225; Kuzmin D, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-58; Lanuti M, 1999, HUM GENE THER, V10, P463, DOI 10.1089/10430349950018904; LEMOINE NR, 1989, BRIT J CANCER, V60, P897, DOI 10.1038/bjc.1989.387; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Majumdar AS, 2001, GENE THER, V8, P568, DOI 10.1038/sj.gt.3301421; Mathis JM, 2006, J GENE MED, V8, P1105, DOI 10.1002/jgm.935; McLaughlin PMJ, 2004, CANCER GENE THER, V11, P603, DOI 10.1038/sj.cgt.7700725; Mu GY, 2010, HUM PATHOL, V41, P493, DOI 10.1016/j.humpath.2009.08.022; Nanda D, 2001, CANCER RES, V61, P8743; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Pichard V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051952; Qiao J, 2002, GENE THER, V9, P168, DOI 10.1038/sj.gt.3301618; Ram Z, 1997, NAT MED, V3, P1354, DOI 10.1038/nm1297-1354; Rodriguez-Galindo Carlos, 2007, Curr Treat Options Neurol, V9, P294, DOI 10.1007/s11940-007-0015-4; Sakurai F, 2011, FRONT BIOSCI-LANDMRK, V16, P2389, DOI 10.2741/3861; Sastre X, 2009, ARCH PATHOL LAB MED, V133, P1199, DOI 10.1043/1543-2165-133.8.1199; Sengupta S, 2013, PEDIATR BLOOD CANCER, V60, P336, DOI 10.1002/pbc.24357; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Sterman DH, 2005, CLIN CANCER RES, V11, P7444, DOI 10.1158/1078-0432.CCR-05-0405; Sterman DH, 1998, HUM GENE THER, V9, P1083, DOI 10.1089/hum.1998.9.7-1083; Suzuki T, 2008, MOL THER, V16, P1719, DOI 10.1038/mt.2008.159; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Trask TW, 2000, MOL THER, V1, P195, DOI 10.1006/mthe.2000.0030; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Tuncel M, 2007, CANCER BIOTHER RADIO, V22, P443, DOI 10.1089/cbr.2006.319.A; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vassaux G, 2004, EXPERT OPIN BIOL TH, V4, P519; Wang Y, 2009, J CELL MOL MED, V13, P12, DOI 10.1111/j.1582-4934.2008.00510.x; Wu CX, 2009, MOL THER, V17, P2058, DOI 10.1038/mt.2009.225; Xu Y, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-39; Yazawa K, 2002, WORLD J SURG, V26, P783, DOI 10.1007/s00268-002-4053-5; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	51	20	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83398	10.1371/journal.pone.0083398	http://dx.doi.org/10.1371/journal.pone.0083398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391761	gold, Green Submitted, Green Published			2022-12-27	WOS:000329325200058
J	Dong, J; Xu, H; Xu, H; Wang, PF; Cai, GJ; Song, HF; Wang, CC; Dong, ZT; Ju, YJ; Jiang, ZY				Dong, Jing; Xu, Huan; Xu, Huan; Wang, Peng-fei; Cai, Gui-ju; Song, Hai-feng; Wang, Chang-chen; Dong, Zhao-tong; Ju, Yan-jiao; Jiang, Zheng-yao			Nesfatin-1 Stimulates Fatty-Acid Oxidation by Activating AMP-Activated Protein Kinase in STZ-Induced Type 2 Diabetic Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; INSULIN SENSITIVITY; ENERGY-BALANCE; SECRETION; NUTRIENT; RECEPTOR; GLUCOSE; MODEL; RAT	Nesfatin-1 is an anorexigenic peptide involved in energy homeostasis. Recently, nesfatin-1 was reported to decrease blood glucose level and improve insulin sensitivity in high-fat diet-fed rats. However, little information is known about the influence of nesfatin-1 on lipid metabolism either in physiological or diabetic condition. This study undertook whether nesfatin-1 was involved in the pathophysiology in Streptozotocin-induced type 2 diabetic mice (T2DM), which was induced by a combination of high-calorie diet and two low-doses Streptozotocin. We observed that plasma nesfatin-1 was significantly increased while expression of nesfatin-1 neurons were decreased in hypothalamus in diabetes group compared to only high-calorie diet control group; intravenous injection of nesfatin-1 decreased 0-1h, 0-2h, 0-3h cumulative food intake in T2DM, but 0-24h total food intake had no difference between groups. Body weight and plasma FFA were normalized after nesfatin-1(10 mu g/Kg) administration for 6 days. These results suggested that nesfatin-1 improved lipid disorder in T2DM. It was found that blood glucose and insulin resistance coefficient decreased with treatment of nesfatin-1 (both in 1 mu g/Kg and 10 mu g/Kg doses) in diabetes mice. For further understanding the role of nesfatin-1 on lipid metabolism, we detected p-AMPK and p-ACC of skeletal muscle in T2DM using western blotting. The expression of p-AMPK and p-ACC increased when nesfatin-1 was given with doses 1 mu g/Kg but not in doses 10 mu g/Kg. Taken together, nesfatin-1 participated in the development of T2DM and stimulated free fatty acid utilization via AMPK-ACC pathway in skeletal muscle in T2DM.	[Dong, Jing; Jiang, Zheng-yao] Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Peoples R China; [Dong, Jing] Qingdao Univ, Coll Med, Special Med Dept, Qingdao 266071, Peoples R China; [Xu, Huan; Xu, Huan; Wang, Peng-fei; Cai, Gui-ju; Song, Hai-feng; Wang, Chang-chen; Dong, Zhao-tong; Ju, Yan-jiao] Qingdao Univ, Coll Med, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Dong, J (corresponding author), Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Peoples R China.	dongjing6@hotmail.com; qd-zyj@163.com		wang, pengfei/0000-0003-0416-2632	Natural Science Foundation of China [31371168, 31071013]; Qingdao Municipal of Science and Technology Commission, Shandong, China [09-2-1-4-nsh]; Natural Science Foundation of Shandong Province China [Y2008C60]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qingdao Municipal of Science and Technology Commission, Shandong, China; Natural Science Foundation of Shandong Province China(Natural Science Foundation of Shandong Province)	This work is supported by the Natural Science Foundation of China (No. 31371168 to J. Dong and No. 31071013 to Z-Y Jiang); Qingdao Municipal of Science and Technology Commission (NO. 09-2-1-4-nsh), Shandong, China; and Natural Science Foundation of Shandong Province China (No. Y2008C60). The funders had no role in our study design, data collection and analysis, decision to publish and preparation for the manuscript.	Abbott MJ, 2012, EXP PHYSIOL, V97, P603, DOI 10.1113/expphysiol.2012.064402; Atkinson BJ, 2013, DIABETES; Bikman BT, 2010, J OBES, V2010, DOI 10.1155/2010/970865; Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Chow L, 2010, METABOLISM, V59, P70, DOI 10.1016/j.metabol.2009.07.009; Foo KS, 2010, J ENDOCRINOL, V204, P255, DOI 10.1677/JOE-09-0254; Gantulga D, 2012, BIOCHEM BIOPH RES CO, V420, P811, DOI 10.1016/j.bbrc.2012.03.079; Goebel-Stengel M, 2013, CURRENT PHARM DESIGN; Gonzalez R, 2011, ENDOCRINOLOGY, V152, P3628, DOI 10.1210/en.2010-1471; KIM J, 2013, NATL GEOGR, V224, P8; Li QC, 2010, REGUL PEPTIDES, V159, P72, DOI 10.1016/j.regpep.2009.11.003; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Nakata M, 2011, ENDOCR J, V58, P305, DOI 10.1507/endocrj.K11E-056; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Pan WH, 2007, PEPTIDES, V28, P2223, DOI 10.1016/j.peptides.2007.09.005; Poucher SM, 2012, DIABETES OBES METAB, V14, P918, DOI 10.1111/j.1463-1326.2012.01619.x; Price TO, 2007, PEPTIDES, V28, P2372, DOI 10.1016/j.peptides.2007.10.008; Ramanjaneya M, 2010, ENDOCRINOLOGY, V151, P3169, DOI 10.1210/en.2009-1358; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Riva M, 2011, CELL TISSUE RES, V346, P393, DOI 10.1007/s00441-011-1268-5; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Su YJ, 2010, BIOCHEM BIOPH RES CO, V391, P1039, DOI 10.1016/j.bbrc.2009.12.014; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Xia YQ, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-31; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Yang ML, 2012, DIABETES, V61, P1959, DOI 10.2337/db11-1755; Zhang Z, 2012, EXP CLIN ENDOCR DIAB, V120, P91, DOI 10.1055/s-0031-1286339	30	30	33	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83397	10.1371/journal.pone.0083397	http://dx.doi.org/10.1371/journal.pone.0083397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391760	Green Submitted, gold, Green Published			2022-12-27	WOS:000329325200057
J	Fairweather-Tait, SJ; Guile, GR; Valdes, AM; Wawer, AA; Hurst, R; Skinner, J; Macgregor, AJ				Fairweather-Tait, Susan J.; Guile, Geoffrey R.; Valdes, Ana M.; Wawer, Anna A.; Hurst, Rachel; Skinner, Jane; Macgregor, Alexander J.			The Contribution of Diet and Genotype to Iron Status in Women: A Classical Twin Study	PLOS ONE			English	Article							MENSTRUAL BLOOD-LOSS; NONHEME-IRON; HEME-IRON; ABSORPTION; CALCIUM; STORES; GENE	This is the first published report examining the combined effect of diet and genotype on body iron content using a classical twin study design. The aim of this study was to determine the relative contribution of genetic and environmental factors in determining iron status. The population was comprised of 200 BMI- and age-matched pairs of MZ and DZ healthy twins, characterised for habitual diet and 15 iron-related candidate genetic markers. Variance components analysis demonstrated that the heritability of serum ferritin (SF) and soluble transferrin receptor was 44% and 54% respectively. Measured single nucleotide polymorphisms explained 5% and selected dietary factors 6% of the variance in iron status; there was a negative association between calcium intake and body iron (p = 0.02) and SF (p = 0.04).	[Fairweather-Tait, Susan J.; Guile, Geoffrey R.; Wawer, Anna A.; Hurst, Rachel; Skinner, Jane; Macgregor, Alexander J.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Valdes, Ana M.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England	University of East Anglia; University of London; King's College London	Fairweather-Tait, SJ (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	s.fairweather-tait@uea.ac.uk		Valdes, Ana M./0000-0003-1141-4471; Fairweather-Tait, Susan/0000-0002-1413-5569; MacGregor, Alex/0000-0003-2163-2325; Hurst, Rachel/0000-0001-8066-324X; Wawer, Anna/0000-0002-3308-3645	Wellcome Trust; BBSRC-CASE studentship [BB/G53015X]	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC-CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research was supported by the Wellcome Trust. Anna Wawer is funded by a BBSRC-CASE studentship [BB/G53015X]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The data are available on application from the Twin Unit.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gaitan D, 2011, J NUTR, V141, P1652, DOI 10.3945/jn.111.138651; HALLBERG L, 1991, AM J CLIN NUTR, V53, P112, DOI 10.1093/ajcn/53.1.112; Harvey LJ, 2005, BRIT J NUTR, V94, P557, DOI 10.1079/BJN20051493; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Lonnerdal B, 2010, INT J VITAM NUTR RES, V80, P293, DOI 10.1024/0300-9831/a000036; McLaren CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017390; Minihane AM, 1998, AM J CLIN NUTR, V68, P96, DOI 10.1093/ajcn/68.1.96; Oexle K, 2011, HUM MOL GENET, V20, P1042, DOI 10.1093/hmg/ddq538; RYBO G, 1966, ACTA OBSTET GYN SCAN, V45, P389, DOI 10.3109/00016346609158460; Teucher B, 2007, TWIN RES HUM GENET, V10, P734, DOI 10.1375/twin.10.5.734; Thompson BAV, 2010, J AGR FOOD CHEM, V58, P8414, DOI 10.1021/jf101388z; Thorpe SJ, 2010, CLIN CHEM LAB MED, V48, P815, DOI 10.1515/CCLM.2010.167; Visscher PM, 2004, TWIN RES, V7, P505, DOI 10.1375/1369052042335250; Whitfield JB, 2000, AM J HUM GENET, V66, P1246, DOI 10.1086/302862; Whitfield JB, 2003, BRIT J HAEMATOL, V120, P860, DOI 10.1046/j.1365-2141.2003.04224.x	20	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83047	10.1371/journal.pone.0083047	http://dx.doi.org/10.1371/journal.pone.0083047			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391736	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000329325200033
J	Gautier, L; Lund, O				Gautier, Laurent; Lund, Ole			Low-Bandwidth and Non-Compute Intensive Remote Identification of Microbes from Raw Sequencing Reads	PLOS ONE			English	Article							ALIGNMENT	Cheap DNA sequencing may soon become routine not only for human genomes but also for practically anything requiring the identification of living organisms from their DNA: tracking of infectious agents, control of food products, bioreactors, or environmental samples. We propose a novel general approach to the analysis of sequencing data where a reference genome does not have to be specified. Using a distributed architecture we are able to query a remote server for hints about what the reference might be, transferring a relatively small amount of data. Our system consists of a server with known reference DNA indexed, and a client with raw sequencing reads. The client sends a sample of unidentified reads, and in return receives a list of matching references. Sequences for the references can be retrieved and used for exhaustive computation on the reads, such as alignment. To demonstrate this approach we have implemented a web server, indexing tens of thousands of publicly available genomes and genomic regions from various organisms and returning lists of matching hits from query sequencing reads. We have also implemented two clients: one running in a web browser, and one as a python script. Both are able to handle a large number of sequencing reads and from portable devices (the browser-based running on a tablet), perform its task within seconds, and consume an amount of bandwidth compatible with mobile broadband networks. Such client-server approaches could develop in the future, allowing a fully automated processing of sequencing data and routine instant quality check of sequencing runs from desktop sequencers. A web access is available at http://tapir.cbs.dtu.dk. The source code for a python command-line client, a server, and supplementary data are available at http://bit.ly/1aURxkc.	[Gautier, Laurent; Lund, Ole] Tech Univ Denmark, Ctr Biol Sequence Anal CBS, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Gautier, Laurent] Tech Univ Denmark, DTU Multiassay Core DMAC, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Gautier, L (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal CBS, Dept Syst Biol, DK-2800 Lyngby, Denmark.	laurent@cbs.dtu.dk	Lund, Ole/F-4437-2014	Lund, Ole/0000-0003-1108-0491	DTU Multi-Assay Core; Technical University of Denmark; Danish Council for Strategic Research [09-067103/DSF]	DTU Multi-Assay Core; Technical University of Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	Laurent Gautier's work was supported by the DTU Multi-Assay Core funded by the Technical University of Denmark, and Ole Lund was funded by grant 09-067103/DSF from the Danish Council for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cormen Thomas H., 2009, INTRO ALGORITHMS; Cox AJ, 2012, BIOINFORMATICS, V28, P1415, DOI 10.1093/bioinformatics/bts173; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Hirabayashi M, KYOTO CABINET STRAIG; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lindner MS, 2013, BIOINFORMATICS, V29, P1260, DOI 10.1093/bioinformatics/btt147; Ning Z, 2004, COMP SYST BIOINF C, P519; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Rusk N, 2009, NAT METHODS, V6, P244, DOI 10.1038/nmeth0409-244a; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5	20	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83784	10.1371/journal.pone.0083784	http://dx.doi.org/10.1371/journal.pone.0083784			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391826	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200124
J	Hayakawa, EH; Mochizuki, E; Tsuda, T; Akiyoshi, K; Matsuoka, H; Kuwabata, S				Hayakawa, Eri H.; Mochizuki, Eiko; Tsuda, Tetsuya; Akiyoshi, Kazunari; Matsuoka, Hiroyuki; Kuwabata, Susumu			The Effect of Hydrophilic Ionic Liquids 1-Ethyl-3-Methylimidazolium Lactate and Choline Lactate on Lipid Vesicle Fusion	PLOS ONE			English	Article							MEMBRANE-FUSION; MASS-SPECTROMETRY; POLYETHYLENE-GLYCOL; GENE DELIVERY; CELL-FUSION; CHROMATOGRAPHY; PARAMETERS; MECHANISM; MATRICES; POLAR	Ionic liquids (ILs) are room-temperature molten salts that have applications in both physical sciences and more recently in the purification of proteins and lipids, gene transfection and sample preparation for electron microscopy (EM) studies. Transfection of genes into cells requires membrane fusion between the cell membrane and the transfection reagent, thus, ILs may be induce a membrane fusion event. To clarify the behavior of ILs with cell membranes the effect of ILs on model membranes, i.e., liposomes, were investigated. We used two standard ILs, 1-ethyl-3-methylimidazolium lactate ([EMI][Lac]) and choline lactate ([Ch][Lac]), and focused on whether these ILs can induce lipid vesicle fusion. Fluorescence resonance energy transfer and dynamic light scattering were employed to determine whether the ILs induced vesicle fusion. Vesicle solutions at low IL concentrations showed negligible fusion when compared with the controls in the absence of ILs. At concentrations of 30% (v/v), both types of ILs induced vesicle fusion up to 1.3 and 1.6 times the fluorescence intensity of the control in the presence of [Ch][Lac] and [EMI] [Lac], respectively. This is the first demonstration that [EMI][Lac] and [Ch][Lac] induce vesicle fusion at high IL concentrations and this observation should have a significant influence on basic biophysical studies. Conversely, the ability to avoid vesicle fusion at low IL concentrations is clearly advantageous for EM studies of lipid samples and cells. This new information describing IL-lipid membrane interactions should impact EM observations examining cell morphology.	[Hayakawa, Eri H.; Matsuoka, Hiroyuki] Jichi Med Univ, Dept Infect & Immun, Lab Med Zool & Parasitol, Shimotsuke, Tochigi, Japan; [Mochizuki, Eiko; Tsuda, Tetsuya; Kuwabata, Susumu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka, Japan; [Akiyoshi, Kazunari] Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto, Japan; [Akiyoshi, Kazunari] Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama, Japan; [Kuwabata, Susumu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Jichi Medical University; Osaka University; Kyoto University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Hayakawa, EH (corresponding author), Jichi Med Univ, Dept Infect & Immun, Lab Med Zool & Parasitol, Shimotsuke, Tochigi, Japan.	erihayakawa@jichi.ac.jp; kuwabata@chem.eng.osaka-u.ac.jp	Kuwabata, Susumu/N-3492-2018; Tsuda, Tetsuya/F-7234-2014	Kuwabata, Susumu/0000-0002-4606-964X; Tsuda, Tetsuya/0000-0001-9462-8066; Matsuoka, Hiroyuki/0000-0001-8839-0012; Hayakawa, Eri/0000-0001-5067-2161	CREST of the Japan Science and Technology Agency; Ohyama Health Foundation Inc	CREST of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ohyama Health Foundation Inc	This work was supported by grants from CREST of the Japan Science and Technology Agency to SK and EHH was supported by Ohyama Health Foundation Inc. and Grant-in-Aid for Scientific Research (C), partially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2011, ANALYST, V136, P4020, DOI 10.1039/c1an15350a; Cherta L, 2013, J CHROMATOGR A, V1314, P224, DOI 10.1016/j.chroma.2013.09.029; Cromie SRT, 2009, J PHYS CHEM B, V113, P11642, DOI 10.1021/jp904060y; Delmonte P, 2012, J CHROMATOGR A, V1233, P137, DOI 10.1016/j.chroma.2012.02.012; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Dyson PJ, 2003, CHEM COMMUN, P2418, DOI 10.1039/b308309h; Fitzgerald JJD, 2010, ANAL CHEM, V82, P4413, DOI 10.1021/ac100133c; Fujita K, 2012, RSC ADV, V2, P4018, DOI 10.1039/c2ra01045c; Fukaya Y, 2006, BIOMACROMOLECULES, V7, P3295, DOI 10.1021/bm060327d; Giese G, 2013, J CHROMATOGR B, V938, P14, DOI 10.1016/j.jchromb.2013.08.029; Hayakawa E, 2007, BIOPHYS J, V93, P4018, DOI 10.1529/biophysj.107.104075; He ZY, 2013, APPL MICROBIOL BIOT, V97, P9175, DOI 10.1007/s00253-013-5195-0; Jessop PG, 2012, GREEN CHEM, V14, P1245, DOI 10.1039/c2gc16670d; Lee JM, 2008, J PHYS CHEM B, V112, P1473, DOI 10.1021/jp076895k; Lentz BR, 1999, MOL MEMBR BIOL, V16, P279, DOI 10.1080/096876899294508; LENTZ BR, 1994, CHEM PHYS LIPIDS, V73, P91, DOI 10.1016/0009-3084(94)90176-7; Li JG, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919565; LI LH, 1994, BIOPHYS J, V67, P2361, DOI 10.1016/S0006-3495(94)80722-2; Li YL, 2005, J AM SOC MASS SPECTR, V16, P679, DOI 10.1016/j.jasms.2005.01.017; Malinin VS, 2001, BIOCHEMISTRY-US, V40, P8292, DOI 10.1021/bi010570r; Murphy PJ, 2011, J VIS EXP; Pedrazzoli F, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-32; Schmieder AH, 2007, BIOTECHNOL BIOENG, V96, P967, DOI 10.1002/bit.21199; Suh JH, 2013, J PHARMACEUT BIOMED, V75, P214, DOI 10.1016/j.jpba.2012.11.041; Tamura K, 2012, BIOTECHNOL BIOENG, V109, P729, DOI 10.1002/bit.24357; Tsuda T, 2011, CHEMBIOCHEM, V12, P2547, DOI 10.1002/cbic.201100476; Weingartner H, 2012, PHYS CHEM CHEM PHYS, V14, P415, DOI 10.1039/c1cp21947b; Weinreb G, 2007, BIOPHYS J, V92, P4012, DOI 10.1529/biophysj.106.090043; Xu W, 2003, J PHYS CHEM B, V107, P6170, DOI 10.1021/jp0275894; Zhang QG, 2010, J PHYS CHEM B, V114, P4747, DOI 10.1021/jp1009498; Zhang YY, 2009, CHEM BIOL DRUG DES, V74, P282, DOI 10.1111/j.1747-0285.2009.00858.x	31	14	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85467	10.1371/journal.pone.0085467	http://dx.doi.org/10.1371/journal.pone.0085467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392011	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900155
J	Kilgour, AHM; Gallagher, IJ; MacLullich, AMJ; Andrew, R; Gray, CD; Hyde, P; Wackerhage, H; Husi, H; Ross, JA; Starr, JM; Chapman, KE; Fearon, KCH; Walker, BR; Greig, CA				Kilgour, Alixe H. M.; Gallagher, Iain J.; MacLullich, Alasdair M. J.; Andrew, Ruth; Gray, Calum D.; Hyde, Philippa; Wackerhage, Henning; Husi, Holger; Ross, James A.; Starr, John M.; Chapman, Karen E.; Fearon, Kenneth C. H.; Walker, Brian R.; Greig, Carolyn A.			Increased Skeletal Muscle 11 beta HSD1 mRNA Is Associated with Lower Muscle Strength in Ageing	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; GLUCOCORTICOID-RECEPTOR; BODY-COMPOSITION; ELDERLY-MEN; IN-VIVO; SARCOPENIA; CORTISOL; DIAGNOSIS; MASS; PATHOGENESIS	Background: Sarcopenia, the loss of muscle mass and function with age, is associated with increased morbidity and mortality. Current understanding of the underlying mechanisms is limited. Glucocorticoids (GC) in excess cause muscle weakness and atrophy. We hypothesized that GC may contribute to sarcopenia through elevated circulating levels or increased glucocorticoid receptor (GR) signaling by increased expression of either GR or the GC-amplifying enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11 beta HSD1) in muscle. Methods: There were 82 participants; group 1 comprised 33 older men (mean age 70.2years, SD 4.4) and 19 younger men (22.2years, 1.7) and group 2 comprised 16 older men (79.1years, 3.4) and 14 older women (80.1years, 3.7). We measured muscle strength, mid-thigh cross-sectional area, fasting morning plasma cortisol, quadriceps muscle GR and 11 beta HSD1 mRNA, and urinary glucocorticoid metabolites. Data were analysed using multiple linear regression adjusting for age, gender and body size. Results: Muscle strength and size were not associated with plasma cortisol, total urinary glucocorticoids or the ratio of urinary 5 beta-tetrahydrocortisol + 5 alpha-tetrahydrocortisol to tetrahydrocortisone (an index of systemic 11 beta HSD activity). Muscle strength was associated with 11 beta HSD1 mRNA levels (beta -0.35, p = 0.04), but GR mRNA levels were not significantly associated with muscle strength or size. Conclusion: Although circulating levels of GC are not associated with muscle strength or size in either gender, increased cortisol generation within muscle by 11 beta HSD1 may contribute to loss of muscle strength with age, a key component of sarcopenia. Inhibition of 11 beta HSD1 may have therapeutic potential in sarcopenia.	[Kilgour, Alixe H. M.; MacLullich, Alasdair M. J.; Starr, John M.] Univ Edinburgh, Geriatr Med Unit, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Gallagher, Iain J.; MacLullich, Alasdair M. J.; Hyde, Philippa; Husi, Holger; Ross, James A.; Fearon, Kenneth C. H.; Greig, Carolyn A.] Univ Edinburgh, Sch Clin Sci, Div Hlth Sci, Dept Clin & Surg Sci, Edinburgh, Midlothian, Scotland; [Andrew, Ruth; Chapman, Karen E.; Walker, Brian R.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland; [Gray, Calum D.] Univ Edinburgh, Queens Med Res Inst, Clin Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Wackerhage, Henning] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Aberdeen	Kilgour, AHM (corresponding author), Univ Edinburgh, Geriatr Med Unit, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	a.kilgour@ed.ac.uk	Andrew, Ruth/C-2727-2008; Greig, Carolyn/AAN-5132-2020	Andrew, Ruth/0000-0002-6916-2994; Greig, Carolyn/0000-0003-1704-9997; Gallagher, Iain James/0000-0002-8630-7235; Chapman, Karen/0000-0001-7777-6817; MacLullich, Alasdair/0000-0003-3159-9370; Gray, Calum/0000-0002-2816-4707; Kilgour, Alixe/0000-0003-1270-821X	British Heart Foundation; Chief Scientist Office of the Scottish Government; BBSRC; EPSRC; ESRC; MRC; MRC [G0700704, MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K026992/1, 1578687, MR/K00414X/1, G0700704] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Chief Scientist Office of the Scottish Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the British Heart Foundation and Chief Scientist Office of the Scottish Government for financial support. AHJK, AMJM and JMS are members of The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative. Funding from the BBSRC, EPSRC, ESRC and MRC is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANIANSSON A, 1986, MUSCLE NERVE, V9, P585, DOI 10.1002/mus.880090702; ANIANSSON A, 1992, J APPL PHYSIOL, V73, P812, DOI 10.1152/jappl.1992.73.3.812; ANIANSSON A, 1983, SCAND J REHABIL MED, P92; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Best R, 1997, CLIN ENDOCRINOL, V47, P231, DOI 10.1046/j.1365-2265.1997.2471061.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Edwards R H, 1977, Physiotherapy, V63, P51; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; Gardner MP, 2011, INT J EPIDEMIOL, V40, P1693, DOI 10.1093/ije/dyr113; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Gray C, 2011, CLIN NUTR, V30, P106, DOI 10.1016/j.clnu.2010.07.012; GREIG CA, 1994, AGE AGEING, V23, P185, DOI 10.1093/ageing/23.3.185; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; Hook P, 2001, AM J PHYSIOL-CELL PH, V280, pC782, DOI 10.1152/ajpcell.2001.280.4.C782; Hughes KA, 2008, EXPERT OPIN INV DRUG, V17, P481, DOI [10.1517/13543784.17.4.481, 10.1517/13543784.17.4.481 ]; Hughes KA, 2012, DIABETES, V61, P1357, DOI 10.2337/db11-1345; Izquierdo M, 2001, MED SCI SPORT EXER, V33, P1577, DOI 10.1097/00005768-200109000-00022; Jang C, 2006, CLIN ENDOCRINOL, V65, P800, DOI 10.1111/j.1365-2265.2006.02669.x; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Mitsui T, 2002, J NEUROL, V249, P1004, DOI 10.1007/s00415-002-0774-5; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Peeters GMEE, 2008, CLIN ENDOCRINOL, V69, P673, DOI 10.1111/j.1365-2265.2008.03212.x; Rantanen T, 2003, SCAND J MED SCI SPOR, V13, P3, DOI 10.1034/j.1600-0838.2003.00298.x; Sayer AA, 2013, AGE AGEING, V42, P145, DOI 10.1093/ageing/afs191; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; SKELTON DA, 1994, AGE AGEING, V23, P371, DOI 10.1093/ageing/23.5.371; Starr JM, 2011, AGE AGEING, V40, P749, DOI 10.1093/ageing/afr070; Stephens NA, 2010, GENOME MED, V2, DOI 10.1186/gm122; Tiganescu A, 2013, J CLIN INVEST, V123, P3051, DOI 10.1172/JCI64162; van Rossum EFC, 2004, J CLIN ENDOCR METAB, V89, P4004, DOI 10.1210/jc.2003-031422; Wake DJ, 2003, J CLIN ENDOCR METAB, V88, P3983, DOI 10.1210/jc.2003-030286; Waters DL, 2008, J GERONTOL A-BIOL, V63, P536, DOI 10.1093/gerona/63.5.536; Welle S, 2002, CAN J APPL PHYSIOL, V27, P19, DOI 10.1139/h02-002; Whorwood CB, 2001, J CLIN ENDOCR METAB, V86, P2296, DOI 10.1210/jc.86.5.2296; YOUNG A, 1985, CLIN PHYSIOL, V5, P145	39	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84057	10.1371/journal.pone.0084057	http://dx.doi.org/10.1371/journal.pone.0084057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391882	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900025
J	Kraemer, A; Chen, IP; Henning, S; Faust, A; Volkmer, B; Atkinson, MJ; Moertl, S; Greinert, R				Kraemer, Anne; Chen, I-Peng; Henning, Stefan; Faust, Alexandra; Volkmer, Beate; Atkinson, Michael J.; Moertl, Simone; Greinert, Ruediger			UVA and UVB Irradiation Differentially Regulate microRNA Expression in Human Primary Keratinocytes	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; BASAL-CELL CARCINOMA; INDUCED DNA-DAMAGE; THYROID-HORMONE; TARGET GENES; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; MALIGNANT-MELANOMA; RADIATION; IDENTIFICATION	MicroRNA (miRNA)-mediated regulation of the cellular transcriptome is an important epigenetic mechanism for fine-tuning regulatory pathways. These include processes related to skin cancer development, progression and metastasis. However, little is known about the role of microRNA as an intermediary in the carcinogenic processes following exposure to UV-radiation. We now show that UV irradiation of human primary keratinocytes modulates the expression of several cellular miRNAs. A common set of miRNAs was influenced by exposure to both UVA and UVB. However, each wavelength band also activated a distinct subset of miRNAs. Common sets of UVA- and UVB-regulated miRNAs harbor the regulatory elements GLYCA-nTRE, GATA-1-undefined-site-13 or Hox-2.3-undefined-site-2 in their promoters. In silico analysis indicates that the differentially expressed miRNAs responding to UV have potential functions in the cellular pathways of cell growth and proliferation. Interestingly, the expression of miR-23b, which is a differentiation marker of human keratinocytes, is remarkably up-regulated after UVA irradiation. Studying the interaction between miR-23b and its putative skin-relevant targets using a Luciferase reporter assay revealed that RRAS2 (related RAS viral oncogene homolog 2), which is strongly expressed in highly aggressive malignant skin cancer, to be a direct target of miR-23b. This study demonstrates for the first time a differential miRNA response to UVA and UVB in human primary keratinocytes. This suggests that selective regulation of signaling pathways occurs in response to different UV energies. This may shed new light on miRNA-regulated carcinogenic processes involved in UV-induced skin carcinogenesis.	[Kraemer, Anne; Atkinson, Michael J.; Moertl, Simone] Helmholtz Ctr Munich, Inst Radiat Biol, Neuherberg, Germany; [Chen, I-Peng; Henning, Stefan; Faust, Alexandra; Volkmer, Beate; Greinert, Ruediger] Elbekliniken Stade Buxtehude, Dept Mol Cell Biol, Ctr Dermatol, Buxtehude, Germany; [Atkinson, Michael J.] Tech Univ Munich, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Greinert, R (corresponding author), Elbekliniken Stade Buxtehude, Dept Mol Cell Biol, Ctr Dermatol, Buxtehude, Germany.	ruediger.greinert@elbekliniken.de	Atkinson, Michael/AAU-5127-2020; Moertl, Simone/M-7353-2014; Atkinson, Michael J/E-5537-2011	Atkinson, Michael/0000-0003-3358-2089; Moertl, Simone/0000-0003-0644-0878; Atkinson, Michael J/0000-0003-3358-2089	Bundesministerium fuer Bildung und Forschung, Germany [BMBF-02NUK003D]	Bundesministerium fuer Bildung und Forschung, Germany	The work was supported by BMBF-02NUK003D (Bundesministerium fuer Bildung und Forschung, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r166; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boehnke K, 2012, CARCINOGENESIS; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; Chaudhry MA, 2013, J RADIAT RES, V54, P808, DOI 10.1093/jrr/rrt014; Chen LC, 2012, NEURO-ONCOLOGY, V14, P1026, DOI 10.1093/neuonc/nos122; Davalos V, 2010, CURR OPIN ONCOL, V22, P35, DOI 10.1097/CCO.0b013e328333dcbb; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; de Gruijl FR, 2008, PHOTOCHEM PHOTOBIOL, V84, P382, DOI 10.1111/j.1751-1097.2007.00275.x; Dong HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012136; Dong HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004610; Duan HH, 2010, TOXICOL IN VITRO, V24, P928, DOI 10.1016/j.tiv.2009.11.013; Dziunycz P, 2010, J INVEST DERMATOL, V130, P2686, DOI 10.1038/jid.2010.169; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; ELWOOD JM, 1993, MELANOMA RES, V3, P113; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Greinert R, 2009, PATHOBIOLOGY, V76, P64, DOI 10.1159/000201675; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo L, 2009, PHOTOCHEM PHOTOBIOL, V85, P765, DOI 10.1111/j.1751-1097.2008.00482.x; Guo Z, 2013, J DERMATOL SCI, V69, P68, DOI 10.1016/j.jdermsci.2012.10.014; He YH, 2011, NEOPLASIA, V13, P841, DOI 10.1593/neo.11698; Heffelfinger C, 2012, G3-GENES GENOM GENET, V2, P279, DOI 10.1534/g3.111.001115; Hildebrand J, 2011, J INVEST DERMATOL, V131, P20, DOI 10.1038/jid.2010.268; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Huang XX, 2012, MOL GENET METAB, V106, P127, DOI 10.1016/j.ymgme.2012.02.017; Huang YH, 2013, CANCER RES, V73, P2505, DOI 10.1158/0008-5472.CAN-12-2218; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Kanitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049568; Kanwar Jagat R, 2010, Front Biosci (Schol Ed), V2, P1113; Kim WK, 2011, CLIN CANCER RES, V17, P7584, DOI 10.1158/1078-0432.CCR-11-0166; Kraemer A, 2011, RADIAT RES, V176, P575, DOI 10.1667/RR2638.1; Kunz M, 2013, ADV EXP MED BIOL, V774, P103, DOI 10.1007/978-94-007-5590-1_6; Laczny C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-36; Lavon I, 2010, NEURO-ONCOLOGY, V12, P422, DOI 10.1093/neuonc/nop061; Lee HST, 1997, EXP DERMATOL, V6, P105, DOI 10.1111/j.1600-0625.1997.tb00155.x; Lee JH, 2011, INT J DERMATOL, V50, P956, DOI 10.1111/j.1365-4632.2010.04846.x; Leidinger P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-262; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Lena AM, 2012, BIOCH BIOPHYS RES CO; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li AGQ, 2006, MOL CARCINOGEN, V45, P389, DOI 10.1002/mc.20229; Lin YH, 2013, ONCOGENE, V32, P4509, DOI 10.1038/onc.2013.309; Liu LH, 2010, LIFE SCI, V86, P192, DOI 10.1016/j.lfs.2009.12.002; Lu XZ, 2013, CELL SIGNAL, V25, P1949, DOI 10.1016/j.cellsig.2013.06.005; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Mouret S, 2010, ORG BIOMOL CHEM, V8, P1706, DOI 10.1039/b924712b; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Park SW, 2005, MOL CELL, V19, P643, DOI 10.1016/j.molcel.2005.08.008; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pinheiro I, 2011, BIOESSAYS, V33, P791, DOI 10.1002/bies.201100047; Pothof J, 2009, EMBO J, V28, P2090, DOI 10.1038/emboj.2009.156; Rong R, 2002, ONCOGENE, V21, P1062, DOI 10.1038/sj.onc.1205154; Ruan W, 2012, CARDIOVASC RES, V93, P623, DOI 10.1093/cvr/cvr290; Sand M, 2012, MOL CARCINOGEN, V51, P916, DOI 10.1002/mc.20861; Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112; Syed DN, 2012, PHOTOCHEM PHOTOBIOL; Voller D, 2013, CLIN BIOCHEM, V46, P909, DOI 10.1016/j.clinbiochem.2013.01.008; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Ye G, 2011, J CELL SCI, V124, P359, DOI 10.1242/jcs.072223; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555; Zhang SA, 2011, BIOMED PHARMACOTHER, V65, P436, DOI 10.1016/j.biopha.2011.04.010; Zhang Y, 2013, NEOPLASMA, V60, P247, DOI 10.4149/neo_2013_033; Zhou BR, 2012, EXP DERMATOL, V21, P317, DOI 10.1111/j.1600-0625.2012.01465.x	74	39	41	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83392	10.1371/journal.pone.0083392	http://dx.doi.org/10.1371/journal.pone.0083392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391759	Green Submitted, gold, Green Published			2022-12-27	WOS:000329325200056
J	Lee, JK; Park, SR; Jung, BK; Jeon, YK; Lee, YS; Kim, MK; Kim, YG; Jang, JY; Kim, CW				Lee, Jong-Kuen; Park, Sae-Ra; Jung, Bong-Kwang; Jeon, Yoon-Kyung; Lee, Yeong-Shin; Kim, Min-Kyoung; Kim, Yong-Goo; Jang, Ji-Young; Kim, Chul-Woo			Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-GROWTH; MICRORNAS; INHIBITION; GENE; PROLIFERATION; MECHANISM; THERAPY	Exosomes are small membrane vesicles released by a variety of cell types. Exosomes contain genetic materials, such as mRNAs and microRNAs (miRNAs), implying that they may play a pivotal role in cell-to-cell communication. Mesenchymal stem cells (MSCs), which potentially differentiate into multiple cell types, can migrate to the tumor sites and have been reported to exert complex effects on tumor progression. To elucidate the role of MSCs within the tumor microenvironment, previous studies have suggested various mechanisms such as immune modulation and secreted factors of MSCs. However, the paracrine effects of MSC-derived exosomes on the tumor microenvironment remain to be explored. The hypothesis of this study was that MSC-derived exosomes might reprogram tumor behavior by transferring their molecular contents. To test this hypothesis, exosomes from MSCs were isolated and characterized. MSC-derived exosomes exhibited different protein and RNA profiles compared with their donor cells and these vesicles could be internalized by breast cancer cells. The results demonstrated that MSC-derived exosomes significantly down-regulated the expression of vascular endothelial growth factor (VEGF) in tumor cells, which lead to inhibition of angiogenesis in vitro and in vivo. Additionally, miR-16, a miRNA known to target VEGF, was enriched in MSC-derived exosomes and it was partially responsible for the anti-angiogenic effect of MSC-derived exosomes. The collective results suggest that MSC-derived exosomes may serve as a significant mediator of cell-to-cell communication within the tumor microenvironment and suppress angiogenesis by transferring anti-angiogenic molecules.	[Lee, Jong-Kuen; Park, Sae-Ra; Jung, Bong-Kwang; Jeon, Yoon-Kyung; Lee, Yeong-Shin; Kim, Min-Kyoung; Kim, Yong-Goo; Jang, Ji-Young; Kim, Chul-Woo] Seoul Natl Univ, Coll Med, Canc Res Inst, Tumor Immun Med Res Ctr, Seoul, South Korea; [Jeon, Yoon-Kyung; Kim, Chul-Woo] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Jang, JY (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Tumor Immun Med Res Ctr, Seoul, South Korea.	jjy93@daum.net; cwkim@snu.ac.kr	Jung, Bong-Kwang/GYQ-6442-2022	Jung, Bong-Kwang/0000-0001-7581-3899; Park, Sae-ra/0000-0003-0910-3471	Global Core Research Center (GCRC) from the National Research Foundation (NRF) [2012-0001190]; Ministry of Education, Science and Technology (MEST), Republic of Korea	Global Core Research Center (GCRC) from the National Research Foundation (NRF); Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Global Core Research Center (GCRC) grant (No. 2012-0001190) from the National Research Foundation (NRF), Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Bernatchez PN, 1999, J BIOL CHEM, V274, P31047, DOI 10.1074/jbc.274.43.31047; Borgstrom P, 1996, CANCER RES, V56, P4032; Camussi G, 2012, CURR MOL MED; Camussi G, 2011, AM J CANCER RES, V1, P98; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Cho JA, 2009, CANCER LETT, V275, P256, DOI 10.1016/j.canlet.2008.10.021; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Dejean E, 2011, LEUKEMIA, V25, P1882, DOI 10.1038/leu.2011.168; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Galie M, 2008, ONCOGENE, V27, P2542, DOI 10.1038/sj.onc.1210920; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Hall B., 2007, V180, P263; Ho IA, 2012, STEM CELLS; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Itoh T, 1998, CANCER RES, V58, P1048; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Lee YS, 2011, EXP MOL MED, V43, P281, DOI 10.3858/emm.2011.43.5.029; Liu BS, 2012, INT J ANAL CHEM, V2012, DOI 10.1155/2012/408057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Viaud S, 2008, HORM METAB RES, V40, P82, DOI 10.1055/s-2007-1022548; Wagatsuma A, 2007, MOL CELL BIOCHEM, V298, P151, DOI 10.1007/s11010-006-9361-x; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Yu H, 2007, BIOCHEM BIOPH RES CO, V361, P946, DOI 10.1016/j.bbrc.2007.07.114; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002; Zhu Y, 2009, LEUKEMIA, V23, P925, DOI 10.1038/leu.2008.384	45	430	461	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84256	10.1371/journal.pone.0084256	http://dx.doi.org/10.1371/journal.pone.0084256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391924	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900067
J	Mulero, M; Perroy, J; Federici, C; Cabello, G; Ollendorff, V				Mulero, Miquel; Perroy, Julie; Federici, Carole; Cabello, Gerard; Ollendorff, Vincent			Analysis of RXR/THR and RXR/PPARG2 Heterodimerization by Bioluminescence Resonance Energy Transfer (BRET)	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; PPAR-GAMMA-RXR; PEROXISOME PROLIFERATOR; DNA-BINDING; PRIMARY TARGET; IDENTIFICATION; MOBILITY; AGONISTS; COMPLEX; GENES	Background: Nuclear receptors (NR) regulate transcription of genes involved in many biological processes such as development, cell proliferation, differentiation and cell death. Amongst them, PPARG2 and THR control tissue glucose and lipid homeostasis which are deregulated in severe pathophysiological conditions such as metabolic syndromes. Methodology/Principal Findings: Here, we describe a real time BRET approach to monitor heterodimerization between RXR and PPARG2 or THR in vitro or in living cells. The presence of a specific DNA target was required to induce in vitro a BRET shift reflecting heterodimerization of RXR/PPARG2 or RXR/THR. As in electrophoretic mobility shift assay (EMSA), the stringency and specificity of the BRET shift assay depended upon assay condition optimization including MgCl2 concentration. For the nuclear receptors, we found by mutagenesis analysis that each heterodimer partner must harbor an intact DNA binding domain to induce BRET and heterodimerization on a DNA target. Moreover the interaction between the PPARG2 ligand binding domain and the RXR DNA binding domain stabilized the heterodimer on its DNA target. BRET microscopy in living cells highlighted the heterodimerization of RXR/PPARG2 within the nucleus clustered in discrete foci that may represent active target gene transcription regulation regions. BRET imaging also suggested that heterodimerization between RXR and PPARG2 required the DNA binding of PPARG2. Conclusions/Significance: The BRET approach described here allowed us to study the dynamic interactions which exist between NR in vitro or in living cells and can provide important information on heterodimerization modes, affinity with a given RE and subcellular localization of the heterodimers. This method could be used to study real time changes of NR heterodimers occurring on DNA depending upon cell activation, chromatin state and help to define the mechanisms of ligands or drug action designed to target NRs.	[Mulero, Miquel; Federici, Carole; Cabello, Gerard; Ollendorff, Vincent] INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France; [Cabello, Gerard; Ollendorff, Vincent] Univ Montpellier I, Montpellier, France; [Mulero, Miquel] Univ Rovira & Virgili, Nutrigen Res Grp, Dept Biochem & Biotechnol, E-43007 Tarragona, Spain; [Perroy, Julie] CNRS, UMR 5203, Inst Genom Fonct, Montpellier, France; [Perroy, Julie] INSERM, U661, Montpellier, France; [Perroy, Julie] Univ Montpellier I, UMR 5203, Montpellier, France; [Perroy, Julie] Univ Montpellier 2, UMR 5203, Montpellier, France	INRAE; Universite de Montpellier; Universite de Montpellier; Universitat Rovira i Virgili; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Ollendorff, V (corresponding author), INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France.	ollendor@supagro.inra.fr	Mulero, Miquel/L-4672-2014	Mulero, Miquel/0000-0003-2545-2065; perroy, julie/0000-0001-6199-0448; Ollendorff, Vincent/0000-0001-9751-2202	INRA (Institut National de la Recherche Agronomique); Ministerio de Educacion y Ciencia of the Spanish Government [AGL2011-25831]	INRA (Institut National de la Recherche Agronomique); Ministerio de Educacion y Ciencia of the Spanish Government(Spanish Government)	This work was supported by grants from INRA (Institut National de la Recherche Agronomique) and Miquel Mulero was supported by a grant AGL2011-25831 from the Ministerio de Educacion y Ciencia of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Akiyama Taro E, 2005, Curr Diab Rep, V5, P45, DOI 10.1007/s11892-005-0067-3; Akiyama TE, 2002, MOL ENDOCRINOL, V16, P707, DOI 10.1210/me.16.4.707; Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Chan LS, 2007, BIOCHEM BIOPH RES CO, V358, P1080, DOI 10.1016/j.bbrc.2007.05.051; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; CHU RY, 1995, P NATL ACAD SCI USA, V92, P11593, DOI 10.1073/pnas.92.25.11593; Coulon V, 2008, BIOPHYS J, V94, P1001, DOI 10.1529/biophysj.107.117275; Degenhardt T, 2006, J BIOL CHEM, V281, P39607, DOI 10.1074/jbc.M605623200; Gaikwad AB, 2007, PHARMACOL RES, V55, P400, DOI 10.1016/j.phrs.2007.01.015; Glass CK, 2000, GENE DEV, V14, P121; Gross B, 2007, BEST PRACT RES CL EN, V21, P687, DOI 10.1016/j.beem.2007.09.004; Haakonsson AK, 2013, MOL ENDOCRINOL, V27, P1536, DOI 10.1210/me.2013-1080; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Khorasanizadeh S, 2001, TRENDS BIOCHEM SCI, V26, P384, DOI 10.1016/S0968-0004(01)01800-X; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Lemay DG, 2006, J LIPID RES, V47, P1583, DOI 10.1194/jlr.M500504-JLR200; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Moll JR, 2002, NUCLEIC ACIDS RES, V30, P1240, DOI 10.1093/nar/30.5.1240; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Padron A, 2007, MOL ENDOCRINOL, V21, P49, DOI 10.1210/me.2006-0075; Perlmann T, 1996, MOL ENDOCRINOL, V10, P958, DOI 10.1210/me.10.8.958; Perroy J, 2010, METHODS MOL BIOL, V591, P325, DOI 10.1007/978-1-60761-404-3_19; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pott S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048102; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; van Royen ME, 2007, J CELL BIOL, V177, P63, DOI 10.1083/jcb.200609178; Velasco LFR, 2007, J BIOL CHEM, V282, P12458, DOI 10.1074/jbc.M610700200	36	8	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84569	10.1371/journal.pone.0084569	http://dx.doi.org/10.1371/journal.pone.0084569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391967	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900110
J	Sheehan, EV; Stevens, TF; Gall, SC; Cousens, SL; Attrill, MJ				Sheehan, Emma V.; Stevens, Timothy F.; Gall, Sarah C.; Cousens, Sophie L.; Attrill, Martin J.			Recovery of a Temperate Reef Assemblage in a Marine Protected Area following the Exclusion of Towed Demersal Fishing	PLOS ONE			English	Article							COMMUNITY STRUCTURE; TRAWL DISTURBANCE; RESERVES; MANAGEMENT; HABITAT; IMPACT; BOUNDARIES; BENEFITS; SIZE	Marine Protected Areas MPA have been widely used over the last 2 decades to address human impacts on marine habitats within an ecosystem management context. Few studies have quantified recovery of temperate rocky reef communities following the cessation of scallop dredging or demersal trawling. This is critical information for the future management of these habitats to contribute towards conservation and fisheries targets. The Lyme Bay MPA, in south west UK, has excluded towed demersal fishing gear from 206 km(2) of sensitive reef habitat using a Statutory Instrument since July 2008. To assess benthic recovery in this MPA we used a flying video array to survey macro epi-benthos annually from 2008 to 2011. 4 treatments (the New Closure, previously voluntarily Closed Controls and Near or Far Open to fishing Controls) were sampled to test a recovery hypothesis that was defined as 'the New Closure becoming more similar to the Closed Controls and less similar to the Open Controls'. Following the cessation of towed demersal fishing, within three years positive responses were observed for species richness, total abundance, assemblage composition and seven of 13 indicator taxa. Definitive evidence of recovery was noted for species richness and three of the indicator taxa (Pentapora fascialis, Phallusia mammillata and Pecten maximus). While it is hoped that MPAs, which exclude anthropogenic disturbance, will allow functional restoration of goods and services provided by benthic communities, it is an unknown for temperate reef systems. Establishing the likely timescales for restoration is key to future marine management. We demonstrate the early stages of successful recruitment and link these to the potential wider ecosystem benefits including those to commercial fisheries.	[Sheehan, Emma V.; Gall, Sarah C.; Cousens, Sophie L.; Attrill, Martin J.] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England; [Stevens, Timothy F.] Griffith Univ, Griffith Sch Environm, Gold Coast, NSW, Australia; [Stevens, Timothy F.] Griffith Univ, Australian Rivers Inst Coasts & Estuaries, Gold Coast, NSW, Australia	University of Plymouth; Griffith University; Griffith University	Sheehan, EV (corresponding author), Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England.	emma.sheehan@plymouth.ac.uk		Sheehan, Emma/0000-0002-1066-8237; Gall, Sarah/0000-0002-1187-3267; Attrill, Martin/0000-0002-4039-031X	Department for Environment, Food and Rural Affairs (United Kingdom)	Department for Environment, Food and Rural Affairs (United Kingdom)(Department for Environment, Food & Rural Affairs (DEFRA))	The Department for Environment, Food and Rural Affairs (United Kingdom) funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Auster Peter J., 1996, Reviews in Fisheries Science, V4, P185; Auster Peter J., 2000, Northeastern Naturalist, V7, P419, DOI 10.1656/1092-6194(2000)007[0419:MPAFTT]2.0.CO;2; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Babcock RC, 1999, MAR ECOL PROG SER, V189, P125, DOI 10.3354/meps189125; Beaumont NJ, 2009, EVOL BIOL, V36, P256, DOI 10.1007/s11692-008-9047-2; Beukers-Stewart BD, 2005, MAR ECOL PROG SER, V298, P189, DOI 10.3354/meps298189; Blyth RE, 2004, J APPL ECOL, V41, P951, DOI 10.1111/j.0021-8901.2004.00945.x; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Bradshaw C, 2003, MAR BIOL, V143, P783, DOI 10.1007/s00227-003-1115-7; Bradshaw C, 2001, HYDROBIOLOGIA, V465, P129, DOI 10.1023/A:1014573731609; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cocito S, 2001, FACIES, V45, P25, DOI 10.1007/BF02668102; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; De Groot S.J, 1994, ENV IMPACT BOTTOM GE; Elliott M, 2007, ESTUAR COAST SHELF S, V74, P349, DOI 10.1016/j.ecss.2007.05.034; Foden J, 2010, MAR ECOL PROG SER, V411, P259, DOI 10.3354/meps08662; Freese L, 1999, MAR ECOL PROG SER, V182, P119, DOI 10.3354/meps182119; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gauthier C, 2008, COMP BIOCHEM PHYS A, V151, P526, DOI 10.1016/j.cbpa.2008.07.010; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Glasby TM, 1997, AUST J ECOL, V22, P448, DOI 10.1111/j.1442-9993.1997.tb00696.x; Grecian WJ, 2010, IBIS, V152, P683, DOI 10.1111/j.1474-919X.2010.01048.x; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, OC 2003 P, V1; Hiddink JG, 2006, ECOSYSTEMS, V9, P1190, DOI 10.1007/s10021-005-0164-9; Hiddink JG, 2008, CAN J FISH AQUAT SCI, V65, P1393, DOI 10.1139/F08-064; Hinz H, 2011, MAR ECOL PROG SER, V432, P91, DOI 10.3354/meps09166; Hiscock K., 2007, MARINE BIODIVERSITY; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; Jackson D, 2000, HDB UK STATUS EC HAB, P180; Jackson E., 2008, IDENTIFICATION INDIC; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 1996, AMBIO, V25, P44; Kaiser MJ, 1996, J ANIM ECOL, V65, P348, DOI 10.2307/5881; Langmead O, 2010, ASSESSMENT LONG TERM; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; McKinney F.K., 1989, BRYOZOAN EVOLUTION; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Murawski SA, 2000, B MAR SCI, V66, P775; Parsons DM, 2004, MAR FRESHWATER RES, V55, P257, DOI 10.1071/MF03190; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Sheehan EV, 2013, MAR POLLUT BULL, V76, P194, DOI 10.1016/j.marpolbul.2013.09.004; Sheehan EV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014461; Smith F, 1999, ECOLOGY, V80, P51, DOI 10.2307/176979; Stevens T, MONITORING IN PRESS; Stokesbury KDE, 2004, J SHELLFISH RES, V23, P33; Walters K, 2006, J EXP MAR BIOL ECOL, V330, P81, DOI 10.1016/j.jembe.2005.12.018	56	48	48	4	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83883	10.1371/journal.pone.0083883	http://dx.doi.org/10.1371/journal.pone.0083883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391841	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200139
J	Vecsler, M; Lazar, I; Tzur, A				Vecsler, Manuela; Lazar, Itay; Tzur, Amit			Using Standard Optical Flow Cytometry for Synchronizing Proliferating Cells in the G1 Phase	PLOS ONE			English	Article							SIZE HOMEOSTASIS; MITOSIS; UBIQUITIN; COMPLEX; GROWTH	Cell cycle research greatly relies on synchronization of proliferating cells. However, effective synchronization of mammalian cells is commonly achieved by long exposure to one or more cell cycle blocking agents. These chemicals are, by definition, hazardous (some more than others), pose uneven cell cycle arrest, thus introducing unwanted variables. The challenge of synchronizing proliferating cells in G1 is even greater; this process typically involves the release of drug-arrested cells into the cycle that follows, a heterogeneous process that can truly limit synchronization. Moreover, drug-based synchronization decouples the cell cycle from cell growth in ways that are understudied and intolerable for those who investigate the relationship between these two processes. In this study we showed that cell size, as approximated by a single light-scatter parameter available in all standard sorters, can be used for synchronizing proliferating mammalian cells in G1 with minimal or no risk to either the cell cycle or cell growth. The power and selectivity of our method are demonstrated for human HEK293 cells that, despite their many advantages, are suboptimal for synchronization, let alone in G1. Our approach is readily available, simple, fast, and inexpensive; it is independent of any drugs or dyes, and nonhazardous. These properties are relevant for the study of the mammalian cell cycle, specifically in the context of G1 and cell growth.	[Vecsler, Manuela; Lazar, Itay; Tzur, Amit] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Vecsler, Manuela; Tzur, Amit] Bar Ilan Univ, Adv Mat & Nanotechnol Inst, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Tzur, A (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	amit.tzur@biu.ac.il			Marie Curie International Reintegration Grant [PIRG-GA-2010-277062]; Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease, Center [41/11]; Israel Cancer Research Fund (ICRF) postdoctoral fellowship	Marie Curie International Reintegration Grant(European Commission); Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease, Center; Israel Cancer Research Fund (ICRF) postdoctoral fellowship	Funding by the Marie Curie International Reintegration Grant no. PIRG-GA-2010-277062 (A. T.); the Israeli Centers of Research Excellence (I-CORE), Gene Regulation in Complex Human Disease, Center no. 41/11 (A. T.); and the Israel Cancer Research Fund (ICRF) postdoctoral fellowship (M. V.) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper S, 2006, CELL TISSUE RES, V324, P237, DOI 10.1007/s00441-005-0118-8; Cooper S, 2003, CELL MOL LIFE SCI, V60, P1099, DOI 10.1007/s00018-003-2253-2; GORDON CN, 1977, J BACTERIOL, V129, P97, DOI 10.1128/JB.129.1.97-100.1977; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; LeBleu VS, 2006, CYTOTECHNOLOGY, V51, P149, DOI 10.1007/s10616-006-9024-5; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Pfleger CM, 2000, GENE DEV, V14, P655; Shaw J, 2012, LAB CHIP, V12, P2656, DOI [10.1039/c21c40277g, 10.1039/c2lc40277g]; Son S, 2012, NAT METHODS, V9, P910, DOI 10.1038/nmeth.2133; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Sung YJ, 2013, P NATL ACAD SCI USA, V110, P16687, DOI 10.1073/pnas.1315290110; Tzur A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016053; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Walker Graeme M., 1999, Methods in Cell Science, V21, P87, DOI 10.1023/A:1009824520278	15	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83935	10.1371/journal.pone.0083935	http://dx.doi.org/10.1371/journal.pone.0083935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391848	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200146
J	Verani, JR; McCracken, J; Arvelo, W; Estevez, A; Lopez, MR; Reyes, L; Moir, JC; Bernart, C; Moscoso, F; Gray, J; Olsen, SJ; Lindblade, KA				Verani, Jennifer R.; McCracken, John; Arvelo, Wences; Estevez, Alejandra; Renee Lopez, Maria; Reyes, Lissette; Carlos Moir, Juan; Bernart, Chris; Moscoso, Fabiola; Gray, Jennifer; Olsen, Sonja J.; Lindblade, Kim A.			Surveillance for Hospitalized Acute Respiratory Infection in Guatemala	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; SYNCYTIAL VIRUS-INFECTIONS; CLINICAL CHARACTERISTICS; YOUNG-CHILDREN; EPIDEMIOLOGY; DIAGNOSIS; ETIOLOGY; RADIOGRAPHS; POPULATION; AMERICA	Acute respiratory infections (ARI) are an important cause of illness and death worldwide, yet data on the etiology of ARI and the population-level burden in developing countries are limited. Surveillance for ARI was conducted at two hospitals in Guatemala. Patients admitted with at least one sign of acute infection and one sign or symptom of respiratory illness met the criteria for a case of hospitalized ARI. Nasopharyngeal/oropharyngeal swabs were collected and tested by polymerase chain reaction for adenovirus, parainfluenza virus types 1,2 and 3, respiratory syncytial virus, influenza A and B viruses, human metapneumovirus, Chlamydia pneumioniae, and Mycoplasma pneumoniae. Urine specimens were tested for Streptococcus pneumoniae antigen. Blood culture and chest radiograph were done at the discretion of the treating physician. Between November 2007 and December 2011, 3,964 case-patients were enrolled. While cases occurred among all age groups, 2,396 (60.4%) cases occurred in children <5 years old and 463 (11.7%) among adults >= 65 years old. Viruses were found in 52.6% of all case-patients and 71.8% of those aged <1 year old; the most frequently detected was respiratory syncytial virus, affecting 26.4% of case-patients. Urine antigen testing for Streptococcus pneumoniae performed for case-patients >= 15 years old was positive in 15.1% of those tested. Among 2,364 (59.6%) of case-patients with a radiograph, 907 (40.0%) had findings suggestive of bacterial pneumonia. Overall, 230 (5.9%) case-patients died during the hospitalization. Using population denominators, the observed hospitalized ARI incidence was 128 cases per 100,000, with the highest rates seen among children <1 year old (1,703 per 100,000), followed by adults >= 65 years old (292 per 100,000). These data, which demonstrate a substantial burden of hospitalized ARI in Guatemala due to a variety of pathogens, can help guide public health policies aimed at reducing the burden of illness and death due to respiratory infections.	[Verani, Jennifer R.] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; [McCracken, John; Estevez, Alejandra; Renee Lopez, Maria; Bernart, Chris; Moscoso, Fabiola; Gray, Jennifer] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala; [Arvelo, Wences; Lindblade, Kim A.] Ctr Dis Control & Prevent, Reg Off Cent Amer & Panama, Int Emerging Infect Program, Guatemala City, Guatemala; [Arvelo, Wences; Lindblade, Kim A.] Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Atlanta, GA USA; [Reyes, Lissette] Minist Salud Publ & Asistencia Social, Field Epidemiol Training Program, Guatemala City, Guatemala; [Reyes, Lissette] Minist Salud Publ & Asistencia Social, Area Salud Santa Rosa, Cuilapa, Guatemala; [Carlos Moir, Juan] Minist Salud Publ & Asistencia Social, Area Salud Quetzaltenango, Quetzaltenango, Guatemala; [Olsen, Sonja J.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Universidad del Valle de Guatemala; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Verani, JR (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA.	qzr7@cdc.gov		Lindblade, Kim/0000-0002-5593-0470	United States Centers for Disease Control and Prevention (CDC) [UO1 GH000028-02]	United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication was supported by Cooperative Agreement Number UO1 GH000028-02 from the United States Centers for Disease Control and Prevention (CDC). The CDC participated in all aspects of study design, data collection, data analysis and manuscript preparation.	Andrade AL, 2011, VACCINE; [Anonymous], 2005, TECHN UPD GUID INT M; Asturias Edwin J., 2003, Rev Panam Salud Publica, V14, P377, DOI 10.1590/S1020-49892003001100002; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bruno R, 2009, NEW MICROBIOL, V32, P297; Carneiro BM, 2009, J MED VIROL, V81, P1814, DOI 10.1002/jmv.21555; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Danovaro-Holliday MC, 2008, PLOS MED, V5, P530, DOI 10.1371/journal.pmed.0050087; Dean AG, OPENEPI OPEN SOURCE; Debiaggi M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-247; Deutscher M, 2012, J EPIDEMIOL GLOB HEA, V2, P73, DOI 10.1016/j.jegh.2012.03.001; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Gentile A, INT J INFECT DIS; Instituto Nacional de Estadistica, 2004, EST PROYECC POBL PER; Isturiz RE, 2010, INT J INFECT DIS, V14, pE852, DOI 10.1016/j.ijid.2010.02.2262; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Juven T, 2004, EUR J PEDIATR, V163, P140, DOI 10.1007/s00431-003-1397-2; Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405; Kwofie TB, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-78; Langley GF, 2013, PEDIATR INFECT DIS J, V32, P629, DOI 10.1097/INF.0b013e318289e3bc; Langley GF, 2011, PEDIATR INFECT DIS J, V30, P510, DOI 10.1097/INF.0b013e3182184ae7; Lindblade KA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-885; Lindblade KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015826; Mathisen M, 2011, PEDIATR INFECT DIS J, V30, P1032, DOI 10.1097/INF.0b013e31822f845f; Mathisen Maria, 2010, Pediatr Infect Dis J, V29, pe1, DOI 10.1097/INF.0b013e3181c2a1b9; Matute AJ, 2006, INT J ANTIMICROB AG, V28, P423, DOI 10.1016/j.ijantimicag.2006.07.016; Morgan OW, 2010, INT C EM INF DIS ATL; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Noyola DE, 2005, J MED MICROBIOL, V54, P969, DOI 10.1099/jmm.0.46052-0; Olsen SJ, 2006, INT J INFECT DIS, V10, P439, DOI 10.1016/j.ijid.2006.06.004; Reyes L, 2010, INFLUENZA OTHER RESP, V4, P129, DOI 10.1111/j.1750-2659.2010.00138.x; Ropero-Alvarez AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-361; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Suzuki A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-267; Thavagnanam S, 2010, ACTA PAEDIATR, V99, P394, DOI 10.1111/j.1651-2227.2009.01627.x; Tondella MLC, 2002, J CLIN MICROBIOL, V40, P575, DOI 10.1128/JCM.40.2.575-583.2002; Vernet G, 2011, CLIN MICROBIOL INFEC, V17, P1, DOI 10.1111/j.1469-0691.2011.03496.x; Watt JP, 2010, EPIDEMIOL INFECT, V138, P1146, DOI 10.1017/S0950268809991464; Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798; Whitehouse RW, 1999, J ROY SOC MED, V92, P178, DOI 10.1177/014107689909200404; World Health Organization, 2001, STAND INT CHEST RAD; World Health Organization/The United Nations Children's Fund, 2013, PREV DEATHS GLOB ACT; Zhang M, 1999, 99 GEN M AM SOC MICR	50	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83600	10.1371/journal.pone.0083600	http://dx.doi.org/10.1371/journal.pone.0083600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391792	Green Published, gold			2022-12-27	WOS:000329325200089
J	Powe, DG; Dhondalay, GKR; Lemetre, C; Allen, T; Habashy, HO; Ellis, IO; Rees, R; Ball, GR				Powe, Desmond G.; Dhondalay, Gopal Krishna R.; Lemetre, Christophe; Allen, Tony; Habashy, Hany O.; Ellis, Ian O.; Rees, Robert; Ball, Graham R.			DACH1: Its Role as a Classifier of Long Term Good Prognosis in Luminal Breast Cancer	PLOS ONE			English	Article							FATE DETERMINATION FACTOR; ESTROGEN-RECEPTOR; CYCLIN D1; EXPRESSION; DACHSHUND; PREDICTION; HOMOLOG; GATA-3; EYE	Background: Oestrogen receptor (ER) positive (luminal) tumours account for the largest proportion of females with breast cancer. Theirs is a heterogeneous disease presenting clinical challenges in managing their treatment. Three main biological luminal groups have been identified but clinically these can be distilled into two prognostic groups in which Luminal A are accorded good prognosis and Luminal B correlate with poor prognosis. Further biomarkers are needed to attain classification consensus. Machine learning approaches like Artificial Neural Networks (ANNs) have been used for classification and identification of biomarkers in breast cancer using high throughput data. In this study, we have used an artificial neural network (ANN) approach to identify DACH1 as a candidate luminal marker and its role in predicting clinical outcome in breast cancer is assessed. Materials and methods: A reiterative ANN approach incorporating a network inferencing algorithm was used to identify ER-associated biomarkers in a publically available cDNA microarray dataset. DACH1 was identified in having a strong influence on ER associated markers and a positive association with ER. Its clinical relevance in predicting breast cancer specific survival was investigated by statistically assessing protein expression levels after immunohistochemistry in a series of unselected breast cancers, formatted as a tissue microarray. Results: Strong nuclear DACH1 staining is more prevalent in tubular and lobular breast cancer. Its expression correlated with ER-alpha positive tumours expressing PgR, epithelial cytokeratins (CK) 18/19 and 'luminal-like' markers of good prognosis including FOXA1 and RERG (p < 0.05). DACH1 is increased in patients showing longer cancer specific survival and disease free interval and reduced metastasis formation (p < 0.001). Nuclear DACH1 showed a negative association with markers of aggressive growth and poor prognosis. Conclusion: Nuclear DACH1 expression appears to be a Luminal A biomarker predictive of good prognosis, but is not independent of clinical stage, tumour size, NPI status or systemic therapy.	[Powe, Desmond G.; Dhondalay, Gopal Krishna R.; Rees, Robert; Ball, Graham R.] Nottingham Trent Univ, John van Geest Canc Res Ctr, Nottingham, England; [Powe, Desmond G.; Ellis, Ian O.] Nottingham Univ Hosp NHS Trust, Dept Cellular Pathol, Nottingham, England; [Lemetre, Christophe] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Allen, Tony] Nottingham Trent Univ, Dept Comp & Informat, Nottingham, England; [Habashy, Hany O.] Mansoura Univ, Fac Med, Dept Pathol, Mansoura, Daqahlia, Egypt	Nottingham Trent University; Nottingham University Hospital NHS Trust; Yeshiva University; Albert Einstein College of Medicine; Nottingham Trent University; Egyptian Knowledge Bank (EKB); Mansoura University	Powe, DG (corresponding author), Nottingham Trent Univ, John van Geest Canc Res Ctr, Nottingham, England.	des.powe@nottingham.ac.uk	Habashy, Hany Onsy/N-1488-2018; Dhondalay, Gopal Krishna Ramadas/A-3369-2014	Habashy, Hany Onsy/0000-0003-3685-5273; Dhondalay, Gopal Krishna Ramadas/0000-0002-1020-0175; Ellis, Ian/0000-0001-5292-8474; Ball, Graham/0000-0001-5828-7129	John and Lucille van Geest Foundation	John and Lucille van Geest Foundation	This study received financial support from the John and Lucille van Geest Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim DM, 2005, INT J CANCER, V116, P340, DOI 10.1002/ijc.21004; Cruz JA, 2006, CANCER INFORM, V2, P59; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeAngelis T, 2011, CELL CYCLE, V10, P1956, DOI 10.4161/cc.10.12.15800; Dhondalay GK, 2011, ESTROGE RECEPTOR STA, P727; Fang SH, 2009, J SURG RES, V157, P290, DOI 10.1016/j.jss.2008.07.015; Gasparri F, 2009, EUR J CELL BIOL, V88, P779, DOI 10.1016/j.ejcb.2009.06.005; Habashy HO, 2008, EUR J CANCER, V44, P1541, DOI 10.1016/j.ejca.2008.04.020; Habashy HO, 2013, BREAST CANCER RES TR, V140, P307, DOI 10.1007/s10549-013-2614-y; Habashy HO, 2010, BREAST CANCER RES TR, V120, P603, DOI 10.1007/s10549-009-0419-9; Habashy HO, 2010, BREAST CANC RES TREA; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Heanue TA, 2002, MECH DEVELOP, V111, P75, DOI 10.1016/S0925-4773(01)00611-6; Hoch RV, 1999, INT J CANCER, V84, P122; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kim HJ, 2006, CLIN CANCER RES, V12, p1013S, DOI 10.1158/1078-0432.CCR-05-2128; Lancashire LJ, 2010, BREAST CANCER RES TR, V120, P83, DOI 10.1007/s10549-009-0378-1; Lancashire LJ, 2008, ARTIF INTELL MED, V43, P99, DOI 10.1016/j.artmed.2008.03.001; Lancashire LJ, 2011, INT J CANCER, V128, P1843, DOI 10.1002/ijc.25513; Lemetre C, 2009, LECT NOTES COMPUT SC, V5517, P877, DOI 10.1007/978-3-642-02478-8_110; Liang F, 2012, INT J GYNECOL CANCER, V22, P386, DOI 10.1097/IGC.0b013e31824311e6; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lisboa PJ, 2006, NEURAL NETWORKS, V19, P408, DOI 10.1016/j.neunet.2005.10.007; MARDON G, 1994, DEVELOPMENT, V120, P3473; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Nan FF, 2009, CANCER BIOL THER, V8, P1534, DOI 10.4161/cbt.8.16.8963; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Popov VM, 2009, CANCER RES, V69, P5752, DOI 10.1158/0008-5472.CAN-08-3992; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Ward S, 2012, GENE EXPRESSION PROF; Watanabe A, 2011, P NATL ACAD SCI USA, V108, P12384, DOI 10.1073/pnas.0906930108; Wu KM, 2003, J BIOL CHEM, V278, P51673, DOI 10.1074/jbc.M310021200; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Wu KM, 2011, J BIOL CHEM, V286, P2132, DOI 10.1074/jbc.M110.148395; Wu KM, 2009, CANCER RES, V69, P3347, DOI 10.1158/0008-5472.CAN-08-3821; Wykoff CC, 2001, AM J PATHOL, V158, P1011, DOI 10.1016/S0002-9440(10)64048-5	42	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84428	10.1371/journal.pone.0084428	http://dx.doi.org/10.1371/journal.pone.0084428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392136	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000329460100059
J	Altobelli, G; Bogdarina, IG; Stupka, E; Clark, AJL; Langley-Evans, S				Altobelli, Gioia; Bogdarina, Irina G.; Stupka, Elia; Clark, Adrian J. L.; Langley-Evans, Simon			Genome-Wide Methylation and Gene Expression Changes in Newborn Rats following Maternal Protein Restriction and Reversal by Folic Acid	PLOS ONE			English	Article							JUVENILE-PUBERTAL PERIOD; EMBRYONIC STEM-CELLS; DNA METHYLATION; PRENATAL EXPOSURE; BLOOD-PRESSURE; EPIGENETIC MODIFICATION; DEVELOPMENTAL ORIGINS; PREGNANT RATS; DIET; SUPPLEMENTATION	A large body of evidence from human and animal studies demonstrates that the maternal diet during pregnancy can programme physiological and metabolic functions in the developing fetus, effectively determining susceptibility to later disease. The mechanistic basis of such programming is unclear but may involve resetting of epigenetic marks and fetal gene expression. The aim of this study was to evaluate genome-wide DNA methylation and gene expression in the livers of newborn rats exposed to maternal protein restriction. On day one postnatally, there were 618 differentially expressed genes and 1183 differentially methylated regions (FDR 5%). The functional analysis of differentially expressed genes indicated a significant effect on DNA repair/cycle/maintenance functions and of lipid, amino acid metabolism and circadian functions. Enrichment for known biological functions was found to be associated with differentially methylated regions. Moreover, these epigenetically altered regions overlapped genetic loci associated with metabolic and cardiovascular diseases. Both expression changes and DNA methylation changes were largely reversed by supplementing the protein restricted diet with folic acid. Although the epigenetic and gene expression signatures appeared to underpin largely different biological processes, the gene expression profile of DNA methyl transferases was altered, providing a potential link between the two molecular signatures. The data showed that maternal protein restriction is associated with widespread differential gene expression and DNA methylation across the genome, and that folic acid is able to reset both molecular signatures.	[Altobelli, Gioia; Bogdarina, Irina G.; Clark, Adrian J. L.] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Ctr, Ctr Endocrinol, London, England; [Stupka, Elia] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Cell & Mol Biosci, London, England; [Langley-Evans, Simon] Univ Nottingham, Sch Biosci, Loughborough, Leics, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of Nottingham	Altobelli, G (corresponding author), UCL, Ctr Rheumatol Res, London, England.	g.altobelli@ucl.ac.uk	Langley-Evans, Simon C/F-3564-2012; Langley-Evans, Simon/AAR-4181-2020	Langley-Evans, Simon C/0000-0002-1969-8416; Altobelli, Gioia/0000-0001-9338-3466; Stupka, Elia/0000-0003-3154-4011	Medical Research Council (MRC) [G0801269]; Diabetes UK [12/0004456] Funding Source: researchfish; Medical Research Council [G0801269] Funding Source: researchfish; MRC [G0801269] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council (MRC) under grant no. G0801269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MRC website: http://www.mrc.ac.uk/index.htm.	Barker DJP, 2006, HYPERTENSION, V48, P357, DOI 10.1161/01.HYP.0000236552.04251.42; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Blue GM, 2012, MED J AUSTRALIA, V197, P155, DOI 10.5694/mja12.10811; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Bogdarina I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009237; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brinkman AB, 2010, METHODS, V52, P232, DOI 10.1016/j.ymeth.2010.06.012; Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; da Costa RMA, 2005, ONCOGENE, V24, P1359, DOI 10.1038/sj.onc.1208288; Delage B, 2008, ANNU REV NUTR, V28, P347, DOI 10.1146/annurev.nutr.28.061807.155354; Engeham SF, 2010, BRIT J NUTR, V103, P996, DOI 10.1017/S0007114509992662; Erhuma A, 2007, BRIT J NUTR, V98, P517, DOI 10.1017/S0007114507721505; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Erhuma A, 2009, ENDOCRINE, V36, P333, DOI 10.1007/s12020-009-9225-8; Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602; Eriksson JG, 2007, J NUTR, V137, P1063, DOI 10.1093/jn/137.4.1063; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Foundation BH, 2010, COR HEART DIS STAT 2; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Jackson AA, 2002, CLIN SCI, V103, P633, DOI 10.1042/cs1030633; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Langley-Evans SC, 2009, J ANAT, V215, P36, DOI 10.1111/j.1469-7580.2008.00977.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Lillycrop KA, 2011, J DEV ORIG HLTH DIS, V2, pS7; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; McMullen S, 2004, BRIT J NUTR, V91, P133, DOI 10.1079/BJN20031029; McMullen S, 2012, MED HYPOTHESES, V78, P88, DOI 10.1016/j.mehy.2011.09.047; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nuytten M, 2008, ONCOGENE, V27, P1449, DOI 10.1038/sj.onc.1210774; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Rees WD, 2002, P NUTR SOC, V61, P71, DOI 10.1079/PNS2001137; Roychoudhuri R, 2013, NATURE; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swali A, 2012, PLOS ONE IN PRESS; Swali A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023189; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Yu XP, 2009, INT J EXP PATHOL, V90, P638, DOI 10.1111/j.1365-2613.2009.00687.x; Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109; Zhou ZF, 2011, P NATL ACAD SCI USA, V108, P6626, DOI 10.1073/pnas.1018514108	58	41	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82989	10.1371/journal.pone.0082989	http://dx.doi.org/10.1371/journal.pone.0082989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391732	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200029
J	Andreyenkova, NG; Kolesnikova, TD; Makunin, IV; Pokholkova, GV; Boldyreva, LV; Zykova, TY; Zhimulev, IF; Belyaeva, ES				Andreyenkova, Natalya G.; Kolesnikova, Tatyana D.; Makunin, Igor V.; Pokholkova, Galina V.; Boldyreva, Lidiya V.; Zykova, Tatyana Yu.; Zhimulev, Igor F.; Belyaeva, Elena S.			Late Replication Domains Are Evolutionary Conserved in the Drosophila Genome	PLOS ONE			English	Article							HUMAN COMPARATIVE MAP; MAMMALIAN CHROMOSOMAL EVOLUTION; INTERCALARY HETEROCHROMATIN; DNA UNDERREPLICATION; PERICENTRIC HETEROCHROMATIN; POLYTENE CHROMOSOMES; BREAKPOINT REUSE; GENE ORDER; MELANOGASTER; CHROMATIN	Drosophila chromosomes are organized into distinct domains differing in their predominant chromatin composition, replication timing and evolutionary conservation. We show on a genome-wide level that genes whose order has remained unaltered across 9 Drosophila species display late replication timing and frequently map to the regions of repressive chromatin. This observation is consistent with the existence of extensive domains of repressive chromatin that replicate extremely late and have conserved gene order in the Drosophila genome. We suggest that such repressive chromatin domains correspond to a handful of regions that complete replication at the very end of S phase. We further demonstrate that the order of genes in these regions is rarely altered in evolution. Substantial proportion of such regions significantly coincide with large synteny blocks. This indicates that there are evolutionary mechanisms maintaining the integrity of these late-replicating chromatin domains. The synteny blocks corresponding to the extremely late-replicating regions in the D. melanogaster genome consistently display two-fold lower gene density across different Drosophila species.	[Andreyenkova, Natalya G.; Kolesnikova, Tatyana D.; Makunin, Igor V.; Pokholkova, Galina V.; Boldyreva, Lidiya V.; Zykova, Tatyana Yu.; Zhimulev, Igor F.; Belyaeva, Elena S.] Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Makunin, Igor V.] Univ Queensland, Ctr Res Comp, St Lucia, Qld, Australia	Russian Academy of Sciences; University of Queensland	Zhimulev, IF (corresponding author), Russian Acad Sci, Siberian Branch, Inst Mol & Cellular Biol, Novosibirsk, Russia.	zhimulev@mcb.nsc.ru	Pokholkova, Galina/N-7554-2015; Zykova (Vatolina), Tatyana/I-3897-2014; Zhimulev, Igor F/N-7978-2015; Belyaeva, Elena S/N-8066-2015; Kolesnikova, Tatyana/N-5461-2015; Andreyenkova, Natalya G/N-4003-2015; Boldyreva, Lidiya/N-6978-2015	Kolesnikova, Tatyana/0000-0002-5107-1445; Andreyenkova, Natalya G/0000-0002-5981-8857; Boldyreva, Lidiya/0000-0003-0716-4545; Zhimulev, Igor/0000-0002-6220-3028	Russian Academy of Sciences; SB RAS [51, 82]; Russian Foundation for Basic Research [13-04-01669-a]	Russian Academy of Sciences(Russian Academy of Sciences); SB RAS(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The research was funded by program of Russian Academy of Sciences "Molecular and Cellular Biology" 6.3; Integration projects of SB RAS #51 and #82, and the Russian Foundation for Basic Research (#13-04-01669-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva EN, 2008, CHROMOSOME RES, V16, P851, DOI 10.1007/s10577-008-1244-4; Attie O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S1; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Belyaeva ES, 2008, CHROMOSOMA, V117, P411, DOI 10.1007/s00412-008-0163-7; Belyaeva ES, 2006, CHROMOSOMA, V115, P355, DOI 10.1007/s00412-006-0063-7; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Belyaeva ES, 1998, P NATL ACAD SCI USA, V95, P7532, DOI 10.1073/pnas.95.13.7532; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Bhutkar A, 2008, GENETICS, V179, P1657, DOI 10.1534/genetics.107.086108; Bulazel KV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r170; Cardoso-Moreira M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002340; Cardoso-Moreira MM, 2010, TRENDS GENET, V26, P243, DOI 10.1016/j.tig.2010.03.002; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; de Wit E, 2009, CHROMOSOMA, V118, P25, DOI 10.1007/s00412-008-0186-0; Diaz-Castillo C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002475; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Everts-van der Wind A, 2005, P NATL ACAD SCI USA, V102, P18526, DOI 10.1073/pnas.0509285102; Everts-van der Wind A, 2004, GENOME RES, V14, P1424, DOI 10.1101/gr.2554404; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; HAMMOND MP, 1985, CHROMOSOMA, V91, P279, DOI 10.1007/BF00328223; Kaufmann BP, 1939, P NATL ACAD SCI USA, V25, P571, DOI 10.1073/pnas.25.11.571; Kemkemer C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-84; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Larkin DM, 2003, GENOME RES, V13, P1966, DOI 10.1101/gr.1560203; Leach TJ, 2000, MOL CELL BIOL, V20, P6308, DOI 10.1128/MCB.20.17.6308-6316.2000; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Makunin IV, 2002, GENETICS, V160, P1023; Moshkin YM, 2002, CHROMOSOMA, V111, P114, DOI 10.1007/s00412-002-0190-8; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Nordman J, 2011, GENOME RES, V21, P175, DOI 10.1101/gr.114611.110; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ranz JM, 2012, MOL BIOL EVOL, V29, P13, DOI 10.1093/molbev/msr178; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Sahagun V, 2012, GENOME BIOL EVOL, V4, P1054, DOI 10.1093/gbe/evs089; Schibler L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-194; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; van Bemmel JG, 2013, MOL CELL, V49, P759, DOI 10.1016/j.molcel.2013.01.040; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Weber CC, 2012, MOL BIOL EVOL, V29, P873, DOI 10.1093/molbev/msr265; Weber CC, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r23; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0	52	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83319	10.1371/journal.pone.0083319	http://dx.doi.org/10.1371/journal.pone.0083319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391753	Green Submitted, gold, Green Published			2022-12-27	WOS:000329325200050
J	Chen, H; Dong, SF; Liu, L; Ma, CA; Zhang, T; Zhu, XM; Mo, JM				Chen, Hao; Dong, Shaofeng; Liu, Lei; Ma, Chuan; Zhang, Tao; Zhu, Xiaomin; Mo, Jiangming			Effects of Experimental Nitrogen and Phosphorus Addition on Litter Decomposition in an Old-Growth Tropical Forest	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; SIMULATED N DEPOSITION; FATTY-ACID ANALYSIS; SOUTHERN CHINA; ORGANIC-MATTER; TERRESTRIAL ECOSYSTEMS; SUBTROPICAL FORESTS; INORGANIC NITROGEN; MATURE FORESTS; FOLIAR LITTER	The responses of litter decomposition to nitrogen (N) and phosphorus (P) additions were examined in an old-growth tropical forest in southern China to test the following hypotheses: (1) N addition would decrease litter decomposition; (2) P addition would increase litter decomposition, and (3) P addition would mitigate the inhibitive effect of N addition. Two kinds of leaf litter, Schima superba Chardn. & Champ. (S.S.) and Castanopsis chinensis Hance (C.C.), were studied using the litterbag technique. Four treatments were conducted at the following levels: control, N-addition (150 kg N ha(-1) yr(-1)), P-addition (150 kg P ha(-1) yr(-1)) and NP-addition (150 kg N ha(-1) yr(-1) plus 150 kg P ha(-1) yr(-1)). While N addition significantly decreased the decomposition of both litters, P addition significantly inhibited decomposition of C.C., but did not affect the decomposition of S.S. The negative effect of N addition on litter decomposition might be related to the high N-saturation in this old-growth tropical forest; however, the negative effect of P addition might be due to the suppression of "microbial P mining". Significant interaction between N and P addition was found on litter decomposition, which was reflected by the less negative effect in NP-addition plots than those in N-addition plots. Our results suggest that P addition may also have negative effect on litter decomposition and that P addition would mitigate the negative effect of N deposition on litter decomposition in tropical forests.	[Chen, Hao; Dong, Shaofeng; Liu, Lei; Ma, Chuan; Zhang, Tao; Zhu, Xiaomin; Mo, Jiangming] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Liu, Lei] Chinese Acad Sci, State Key Lab Urban & Reg Ecol, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Zhang, Tao] Zhanjiang Normal Univ, Inst Trop Pratacultural Sci, Zhanjiang, Peoples R China; [Chen, Hao; Zhu, Xiaomin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); LingNan Normal University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Mo, JM (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	mojm@scib.ac.cn	Lei, Liu/J-7929-2017; Chen, Hao/U-4752-2017	Lei, Liu/0000-0002-8063-610X; Chen, Hao/0000-0003-3577-2345	National Natural Science Foundation of China [41273143]; National Key Basic Research 973 Programme [2010CB833502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research 973 Programme(National Basic Research Program of China)	This study was founded by National Natural Science Foundation of China (No: 41273143) and the National Key Basic Research 973 Programme (2010CB833502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, ECOLOGY, V78, P244, DOI 10.1890/0012-9658(1997)078[0244:NAPMCO]2.0.CO;2; Agren GI, 2001, OECOLOGIA, V128, P94, DOI 10.1007/s004420100646; Anderson J.M., 1989, TROPICAL SOIL BIOL F; [Anonymous], 1982, TROP SUBTROP ECOSYS; Barantal S, 2012, ECOSYSTEMS, V15, P1039, DOI 10.1007/s10021-012-9564-9; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Cleveland CC, 2006, ECOLOGY, V87, P492, DOI 10.1890/05-0525; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Demoling F, 2008, SOIL BIOL BIOCHEM, V40, P370, DOI 10.1016/j.soilbio.2007.08.019; Downs MR, 1996, OECOLOGIA, V105, P141, DOI 10.1007/BF00328539; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Fang H, 2007, PLANT SOIL, V297, P233, DOI 10.1007/s11104-007-9339-9; Fang YT, 2008, BIOGEOSCIENCES, V5, P339, DOI 10.5194/bg-5-339-2008; Fang YT, 2011, GLOBAL CHANGE BIOL, V17, P872, DOI 10.1111/j.1365-2486.2010.02283.x; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Fraterrigo JM, 2006, ECOLOGY, V87, P570, DOI 10.1890/05-0638; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hammel K. E., 1997, P33; Hietz P, 2011, SCIENCE, V334, P664, DOI 10.1126/science.1211979; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Huang WJ, 2012, ACTA OECOL, V44, P20, DOI 10.1016/j.actao.2011.06.005; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; Lu XK, 2012, BIOTROPICA, V44, P302, DOI 10.1111/j.1744-7429.2011.00831.x; Magill AH, 1998, PLANT SOIL, V203, P301, DOI 10.1023/A:1004367000041; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; McGroddy ME, 2004, ECOSYSTEMS, V7, P172, DOI 10.1007/s10021-003-0208-y; Micks P, 2004, FOREST ECOL MANAG, V196, P71, DOI 10.1016/j.foreco.2004.03.013; Mo HM, 2003, FOREST ECOL MANAG, V175, P573; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; OCONNELL AM, 1994, BIOL FERT SOILS, V17, P159, DOI 10.1007/BF00337749; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Osono T, 2004, ECOL RES, V19, P593, DOI 10.1111/j.1440-1703.2004.00675.x; Prescott CE, 1999, CAN J FOREST RES, V29, P393, DOI 10.1139/cjfr-29-3-393; PRESCOTT CE, 1995, PLANT SOIL, V168, P83, DOI 10.1007/BF00029316; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Sollins P, 1996, GEODERMA, V74, P65, DOI 10.1016/S0016-7061(96)00036-5; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; TUNLID A, 1989, APPL ENVIRON MICROB, V55, P1368, DOI 10.1128/AEM.55.6.1368-1374.1989; Vestgarden LS, 2001, SOIL BIOL BIOCHEM, V33, P465, DOI 10.1016/S0038-0717(00)00187-5; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vitousek PM, 1998, ECOSYSTEMS, V1, P401, DOI 10.1007/s100219900033; Waldrop MP, 2004, SOIL BIOL BIOCHEM, V36, P1443, DOI 10.1016/j.soilbio.2004.04.023; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Xu GL, 2006, PEDOSPHERE, V16, P596, DOI 10.1016/S1002-0160(06)60093-3; Zak DR, 1996, ECOL APPL, V6, P257, DOI 10.2307/2269568; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zhang D.Q., 2000, ACTA ECOL SIN, V20, P938; Zhang T, 2011, BIOGEOSCIENCES, V8, P2847, DOI 10.5194/bg-8-2847-2011	62	48	56	14	173	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84101	10.1371/journal.pone.0084101	http://dx.doi.org/10.1371/journal.pone.0084101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391895	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900038
J	Hittinger, M; Czyz, ZT; Huesemann, Y; Maneck, M; Botteron, C; Kaeufl, S; Klein, CA; Polzer, B				Hittinger, Markus; Czyz, Zbigniew T.; Huesemann, Yves; Maneck, Matthias; Botteron, Catherine; Kaeufl, Stephanie; Klein, Christoph A.; Polzer, Bernhard			Molecular Profiling of Single Sca-1(+)/CD34(+,-) Cells-The Putative Murine Lung Stem Cells	PLOS ONE			English	Article							ADULT-MOUSE LUNG; GENE-EXPRESSION; QUANTIFICATION; ADENOCARCINOMA; IDENTIFICATION; GELSOLIN; PROTEIN; AIRWAY; NOISE	Murine bronchioalveolar stem cells play a key role in pulmonary epithelial maintenance and repair but their molecular profile is poorly described so far. In this study, we used antibodies directed against Sca-1 and CD34, two markers originally ascribed to pulmonary cells harboring regenerative potential, to isolate single putative stem cells from murine lung tissue. The mean detection rate of positive cells was 8 per 10(6) lung cells. We then isolated and globally amplified the mRNA of positive cells to analyze gene expression in single cells. The resulting amplicons were then used for molecular profiling by transcript specific polymerase chain reaction (PCR) and global gene expression analysis using microarrays. Single marker-positive cells displayed a striking heterogeneity for the expression of epithelial and mesenchymal transcripts on the single cell level. Nevertheless, they could be subdivided into two cell populations: Sca-1(+)/CD34(-) and Sca-1(+)/CD34(+) cells. In these subpopulations, transcripts of the epithelial marker Epcam (CD326) were exclusively detected in Sca-1(+)/CD34(-) cells (p = 0.03), whereas mRNA of the mesenchymal marker Pdgfr alpha (CD140a) was detected in both subpopulations and more frequently in Sca-1(+)/CD34(+) cells (p = 0.04). FACS analysis confirmed the existence of a Pdgfra positive subpopulation within Epcam(+)/Sca-1(+)/CD34(-) epithelial cells. Gene expression analysis by microarray hybridization identified transcripts differentially expressed between the two cell types as well as between epithelial reference cells and Sca-1(+)/CD34(+) single cells, and selected transcripts were validated by quantitative PCR. Our results suggest a more mesenchymal commitment of Sca-1(+)/CD34(+) cells and a more epithelial commitment of Sca-1(+)/CD34(-) cells. In summary, the study shows that single cell analysis enables the identification of novel molecular markers in yet poorly characterized populations of rare cells. Our results could further improve our understanding of Sca-1(+)/CD34(+,-) cells in the biology of the murine lung.	[Hittinger, Markus; Czyz, Zbigniew T.; Huesemann, Yves; Maneck, Matthias; Kaeufl, Stephanie; Klein, Christoph A.; Polzer, Bernhard] Univ Regensburg, Chair Expt Med & Therapy Res, D-93053 Regensburg, Germany; [Maneck, Matthias] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Botteron, Catherine; Klein, Christoph A.; Polzer, Bernhard] Fraunhofer Inst Expt Med & Toxicol, Project Grp Personalized Tumor Therapy, Regensburg, Germany	University of Regensburg; University of Regensburg; Fraunhofer Gesellschaft	Polzer, B (corresponding author), Univ Regensburg, Chair Expt Med & Therapy Res, D-93053 Regensburg, Germany.	Bernhard.polzer@klinik.uni-regensburg.de		Klein, Christoph A./0000-0001-7128-1725	German Research Foundation (DFG) [HI 1101/1]; Bavarian Genome Research Network (BayGene)	German Research Foundation (DFG)(German Research Foundation (DFG)); Bavarian Genome Research Network (BayGene)	The work was supported by German Research Foundation (DFG) grant HI 1101/1 (to M. H.) and the Bavarian Genome Research Network (BayGene, C. A. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; BEARER EL, 1991, J CELL BIOL, V115, P1629, DOI 10.1083/jcb.115.6.1629; Bengtsson M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-63; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chen HY, 2012, STEM CELLS, V30, P1948, DOI 10.1002/stem.1150; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Fine A, 2009, CELL STEM CELL, V4, P468, DOI 10.1016/j.stem.2009.05.012; Hartmann CH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl740; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; LEE WH, 1986, P NATL ACAD SCI USA, V83, P6790, DOI 10.1073/pnas.83.18.6790; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Nolen-Walston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL1158, DOI 10.1152/ajplung.00298.2007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360; Reiter M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr505; ROMARIS M, 1991, BIOCHIM BIOPHYS ACTA, V1093, P229, DOI 10.1016/0167-4889(91)90127-J; Shao FC, 2011, TOHOKU J EXP MED, V225, P95, DOI 10.1620/tjem.225.95; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spence HJ, 2000, ONCOGENE, V19, P1266, DOI 10.1038/sj.onc.1203433; Summer R, 2003, AM J PHYSIOL-LUNG C, V285, pL97, DOI 10.1152/ajplung.00009.2003; Teisanu RM, 2009, STEM CELLS, V27, P612, DOI 10.1634/stemcells.2008-0838; Tiozzo C, 2009, AM J RESP CRIT CARE, V180, P701, DOI 10.1164/rccm.200901-0100OC; Tufvesson E, 2003, J CELL SCI, V116, P4857, DOI 10.1242/jcs.00808; Wiedl T, 2011, J PROTEOMICS, V74, P1884, DOI 10.1016/j.jprot.2011.04.030	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83917	10.1371/journal.pone.0083917	http://dx.doi.org/10.1371/journal.pone.0083917			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391845	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200143
J	Karami, N; Helldal, L; Welinder-Olsson, C; Ahren, C; Moore, ERB				Karami, Nahid; Helldal, Lisa; Welinder-Olsson, Christina; Ahren, Christina; Moore, Edward R. B.			Sub-Typing of Extended-Spectrum-beta-Lactamase-Producing Isolates from a Nosocomial Outbreak: Application of a 10-Loci Generic Escherichia coli Multi-Locus Variable Number Tandem Repeat Analysis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; RAPID DETECTION; ENTEROBACTERIACEAE; COLLECTION; CTX-M-15	Extended-spectrum beta-lactamase producing Escherichia coli (ESBL-E. coli) were isolated from infants hospitalized in a neonatal, post-surgery ward during a four-month-long nosocomial outbreak and six-month follow-up period. A multi-locus variable number tandem repeat analysis (MLVA), using 10 loci (GECM-10), for 'generic' (i.e., non-STEC) E. coli was applied for sub-species-level (i.e., sub-typing) delineation and characterization of the bacterial isolates. Ten distinct GECM-10 types were detected among 50 isolates, correlating with the types defined by pulsed-field gel electrophoresis (PFGE), which is recognized to be the 'gold-standard' method for clinical epidemiological analyses. Multi-locus sequence typing (MLST), multiplex PCR genotyping of bla(CTX-M), bla(TEM), bla(OXA) and bla(SHV) genes and antibiotic resistance profiling, as well as a PCR assay specific for detecting isolates of the pandemic O25b-ST131 strain, further characterized the outbreak isolates. Two clusters of isolates with distinct GECM-10 types (G06-04 and G07-02), corresponding to two major PFGE types and the MLST-based sequence types (STs) 131 and 1444, respectively, were confirmed to be responsible for the outbreak. The application of GECM-10 sub-typing provided reliable, rapid and cost-effective epidemiological characterizations of the ESBL-producing isolates from a nosocomial outbreak that correlated with and may be used to replace the laborious PFGE protocol for analyzing generic E. coli.	[Karami, Nahid; Helldal, Lisa; Welinder-Olsson, Christina; Ahren, Christina; Moore, Edward R. B.] Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Univ Hosp, Dept Clin Microbiol, Gothenburg, Sweden; [Karami, Nahid; Helldal, Lisa; Welinder-Olsson, Christina; Ahren, Christina; Moore, Edward R. B.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Ahren, Christina] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Ahren, Christina] Swedish Strateg Programme Antibiot Resistance STR, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital	Moore, ERB (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Sahlgrenska Univ Hosp, Dept Clin Microbiol, Gothenburg, Sweden.	erbmoore@ccug.se			Vastra Gotaland Region projects [ALFGBG-11574, ALFGBG-210591, VGFOUREG-30781, VGFOUREG-157801]; STRAMA (the Swedish Strategic Programme against Antibiotic Resistance)	Vastra Gotaland Region projects; STRAMA (the Swedish Strategic Programme against Antibiotic Resistance)	The study described in this manuscript was supported by funding from Vastra Gotaland Region projects: ALFGBG-11574; ALFGBG-210591; VGFOUREG-30781; VGFOUREG-157801; and from STRAMA (the Swedish Strategic Programme against Antibiotic Resistance). http://www.fou.nu/is/alfgbg/. http://www.fou.nu/is/vgregion. http://en.strama.se/dyn/,84,,.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita-Lopez BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051565; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Bustamante AV, 2010, INT J MED MICROBIOL, V300, P212, DOI 10.1016/j.ijmm.2009.08.020; Christiansson M, 2011, SCAND J INFECT DIS, V43, P579, DOI 10.3109/00365548.2011.568953; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997; Helldal L, 2013, CLIN MICROBIOL INFEC, V19, pE87, DOI 10.1111/1469-0691.12086; Hussein AIA, 2009, MICROBIOL IMMUNOL, V53, P595, DOI 10.1111/j.1348-0421.2009.00168.x; Jenke C, 2011, J CLIN MICROBIOL, V49, P3644, DOI 10.1128/JCM.05035-11; Johnson JR, 2012, ANTIMICROB AGENTS CH, V56, P2364, DOI 10.1128/AAC.05824-11; Johnson JR, 2012, EMERG INFECT DIS, V18, P598, DOI 10.3201/eid1804.111627; Karama M, 2010, ZOONOSES PUBLIC HLTH, V57, P447, DOI 10.1111/j.1863-2378.2009.01259.x; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; LEGRAND P, 1989, EUR J CLIN MICROBIOL, V8, P527, DOI 10.1007/BF01967473; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Lobersli I, 2012, J MICROBIOL METH, V88, P134, DOI 10.1016/j.mimet.2011.11.003; Melzer M, 2007, J INFECTION, V55, P254, DOI 10.1016/j.jinf.2007.04.007; Naseer U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041232; Noller AC, 2003, J CLIN MICROBIOL, V41, P5389, DOI 10.1128/JCM.41.12.5389-5397.2003; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Peirano G, 2010, INT J ANTIMICROB AG, V36, P19, DOI 10.1016/j.ijantimicag.2010.02.016; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; Svensson-Stadler LA, 2012, FEMS MICROBIOL LETT, V327, P15, DOI 10.1111/j.1574-6968.2011.02452.x; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Welinder-Olsson C, 2000, EUR J CLIN MICROBIOL, V19, P843, DOI 10.1007/s100960000380; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Xu L, 2011, J ANTIMICROB CHEMOTH, V66, P505, DOI 10.1093/jac/dkq482	29	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83030	10.1371/journal.pone.0083030	http://dx.doi.org/10.1371/journal.pone.0083030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391735	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200032
J	Lustgarten, MS; Price, LL; Phillips, EM; Fielding, RA				Lustgarten, Michael S.; Price, Lori Lyn; Phillips, Edward M.; Fielding, Roger A.			Serum Glycine Is Associated with Regional Body Fat and Insulin Resistance in Functionally-Limited Older Adults	PLOS ONE			English	Article							ADIPOSE-TISSUE DISTRIBUTION; HOMEOSTASIS MODEL ASSESSMENT; AMINO-ACID-METABOLISM; INDUCED DIABETIC-RATS; CARDIOVASCULAR-DISEASE; DEHYDROGENASE-DEFICIENCY; ABDOMINAL OBESITY; SKELETAL-MUSCLE; GLUCOSE; PLASMA	Background: Metabolic profiling may provide insight into biologic mechanisms related to age-related increases in regional adiposity and insulin resistance. Objectives: The objectives of the current study were to characterize the association between mid-thigh intermuscular and subcutaneous adipose tissue (IMAT, SCAT, respectively) and, abdominal adiposity with the serum metabolite profile, to identify significant metabolites as further associated with the homeostasis model assessment of insulin resistance (HOMA-IR), and, to develop a HOMA-IR associated metabolite predictor set representative of regional adiposity, in 73 functionally-limited (short physical performance battery <= 10; SPPB) older adults (age range, 70-85 y). Methods: Fasting levels of 181 total metabolites, including amino acids, fatty acids and acylcarnitines were measured with use of an untargeted mass spectrometry-based metabolomic approach. Multivariable-adjusted linear regression was used in all analyses. Results: Thirty-two, seven and one metabolite(s) were found to be associated with IMAT, abdominal adiposity and, SCAT, respectively, including the amino acid glycine, which was positively associated with SCAT and, negatively associated with both IMAT and abdominal adiposity. Glycine and four metabolites found to be significantly associated with regional adiposity were additionally associated with HOMA-IR. Separate stepwise regression models identified glycine as a HOMA-IR associated marker of both IMAT (model R-2 = 0.51, p < 0.0001) and abdominal adiposity (model R-2 = 0.41, p < 0.0001). Conclusion: Our findings for a positive association between glycine with SCAT but, a negative association between glycine with IMAT and abdominal adiposity supports the hypothesis that SCAT metabolic processes are different from that found in other fat depots. In addition, because of the significant associations found between glycine with HOMA-IR, IMAT, SCAT and abdominal adiposity, our results suggest glycine as a serum biomarker of both insulin sensitivity and regional fat mass in functionally-limited older adults.	[Lustgarten, Michael S.; Phillips, Edward M.; Fielding, Roger A.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Nutr Exercise Physiol & Sarcopenia Lab, Boston, MA 02111 USA; [Price, Lori Lyn] Tufts Univ, Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Price, Lori Lyn] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA	Tufts University; United States Department of Agriculture (USDA); Tufts Medical Center; Tufts University; Tufts University	Fielding, RA (corresponding author), Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr, Nutr Exercise Physiol & Sarcopenia Lab, Boston, MA 02111 USA.	Roger.Fielding@tufts.edu	Phillips, Edward/AAN-9693-2020		Dairy Research Institute; Boston Claude D. Pepper Older Americans Independence Center [1P30AG031679]; DOD [W911SR06C0001]; U.S. Department of Agriculture [58-1950-0-014]; NATIONAL INSTITUTE ON AGING [P30AG031679] Funding Source: NIH RePORTER	Dairy Research Institute; Boston Claude D. Pepper Older Americans Independence Center; DOD(United States Department of Defense); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Dairy Research Institute, the Boston Claude D. Pepper Older Americans Independence Center (1P30AG031679), DOD contract #W911SR06C0001 and in part by the U.S. Department of Agriculture, under agreement No. 58-1950-0-014. Any opinions, findings, conclusion, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Dept. of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albu JB, 2007, AM J CLIN NUTR, V86, P100, DOI 10.1093/ajcn/86.1.100; Alvarado-Vasquez N, 2003, COMP BIOCHEM PHYS C, V134, P521, DOI 10.1016/S1532-0456(03)00046-2; AVOGARO A, 1989, J LIPID RES, V30, P1811; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Barbieri M, 2001, DIABETES-METAB RES, V17, P19, DOI 10.1002/dmrr.178; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BODEN G, 1995, J CLIN INVEST, V96, P1261, DOI 10.1172/JCI118160; Boden G, 2001, ENDOCRIN METAB CLIN, V30, P801, DOI 10.1016/S0889-8529(05)70216-4; Bonora E, 2007, DIABETES CARE, V30, P318, DOI 10.2337/dc06-0919; Chale A, 2012, J GERONTOL A; Chen KH, 2011, AM J PHYSIOL-ENDOC M, V301, pE853, DOI 10.1152/ajpendo.00048.2011; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; Chevalier S, 2006, DIABETES, V55, P675, DOI 10.2337/diabetes.55.03.06.db05-1117; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Cruz M, 2008, J ENDOCRINOL INVEST, V31, P694, DOI 10.1007/BF03346417; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; El Hafidi M, 2004, AM J PHYSIOL-REG I, V287, pR1387, DOI 10.1152/ajpregu.00159.2004; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Ferrier D.R., 2013, LIPPINCOTTS ILLUSTRA; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Friedrich N, 2012, OMICS, V16, P612, DOI 10.1089/omi.2012.0066; Frontera WR, 2008, J APPL PHYSIOL, V105, P637, DOI 10.1152/japplphysiol.90332.2008; Gannon MC, 2002, AM J CLIN NUTR, V76, P1302, DOI 10.1093/ajcn/76.6.1302; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Goss AM, 2012, METABOLISM, V61, P1817, DOI 10.1016/j.metabol.2012.05.016; Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Jethva R, 2008, MOL GENET METAB, V95, P195, DOI 10.1016/j.ymgme.2008.09.007; KOHRT WM, 1993, DIABETES, V42, P273, DOI 10.2337/diabetes.42.2.273; Kohrt WM, 1998, CORONARY ARTERY DIS, V9, P489, DOI 10.1097/00019501-199809080-00004; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lim SC, 2002, INT J OBESITY, V26, P1511, DOI 10.1038/sj.ijo.0802140; Lim U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043502; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; MAGGS DG, 1995, J CLIN INVEST, V96, P370, DOI 10.1172/JCI118043; Magnusson M, 2012, EUR HEART J; MAMER OA, 1992, J BIOL CHEM, V267, P22141; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MCFARLAN.IG, 1969, BIOCHEM J, V111, P557, DOI 10.1042/bj1110557; Memisogullari R, 2003, CELL BIOCHEM FUNCT, V21, P291, DOI 10.1002/cbf.1025; Meyers KJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-160; Murin R, 2008, J NEUROCHEM, V105, P1176, DOI 10.1111/j.1471-4159.2008.05298.x; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nguyen D, 2013, AGING CELL; Noale M, 2012, DIABETES METAB, V38, P135, DOI 10.1016/j.diabet.2011.09.005; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Sekhar RV, 2011, DIABETES CARE, V34, P162, DOI 10.2337/dc10-1006; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; VESSBY B, 1994, DIABETOLOGIA, V37, P1044, DOI 10.1007/s001250050215; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; Wu TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037210; Yang J, 2004, J CHROMATOGR B, V813, P59, DOI 10.1016/j.jchromb.2004.09.032; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104	65	50	50	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84034	10.1371/journal.pone.0084034	http://dx.doi.org/10.1371/journal.pone.0084034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391874	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900017
J	Paton, D; Toure, M; Sacko, A; Coulibaly, MB; Traore, SF; Tripet, F				Paton, Doug; Toure, Mahamoudou; Sacko, Adama; Coulibaly, Mamadou B.; Traore, Sekou F.; Tripet, Frederic			Genetic and Environmental Factors Associated with Laboratory Rearing Affect Survival and Assortative Mating but Not Overall Mating Success in Anopheles gambiae Sensu Stricto	PLOS ONE			English	Article							COMPLEX CHROMOSOMAL-ABERRATION; MOLECULAR-FORMS; INCIPIENT SPECIATION; MALARIA VECTORS; MOSQUITOS; FIELD; DIPTERA; COMPETITIVENESS; MALES; CULICIDAE	Anopheles gambiae sensu stricto, the main vector of malaria in Africa, is characterized by its vast geographical range and complex population structure. Assortative mating amongst the reproductively isolated cryptic forms that co-occur in many areas poses unique challenges for programs aiming to decrease malaria incidence via the release of sterile or genetically-modified mosquitoes. Importantly, whether laboratory-rearing affects the ability of An. gambiae individuals of a given cryptic taxa to successfully mate with individuals of their own form in field conditions is still unknown and yet crucial for mosquito-releases. Here, the independent effects of genetic and environmental factors associated with laboratory rearing on male and female survival, mating success and assortative mating were evaluated in the Mopti form of An. gambiae over 2010 and 2011. In semi-field enclosures experiments and despite strong variation between years, the overall survival and mating success of male and female progeny from a laboratory strain was not found to be significantly lower than those of the progeny of field females from the same population. Adult progeny from field-caught females reared at the larval stage in the laboratory and from laboratory females reared outdoors exhibited a significant decrease in survival but not in mating success. Importantly, laboratory individuals reared as larvae indoors were unable to mate assortatively as adults, whilst field progeny reared either outdoors or in the laboratory, as well as laboratory progeny reared outdoors all mated significantly assortatively. These results highlight the importance of genetic and environment interactions for the development of An. gambiae's full mating behavioral repertoire and the challenges this creates for mosquito rearing and release-based control strategies.	[Paton, Doug; Tripet, Frederic] Keele Univ, Inst Sci & Technol Med, Ctr Appl Entomol & Parasitol, Keele, Staffs, England; [Toure, Mahamoudou; Sacko, Adama; Coulibaly, Mamadou B.; Traore, Sekou F.] Univ Sci Tech & Technol Bamako, Fac Med Pharm & Dent, Malaria Res & Training Ctr, Bamako, Mali	Keele University; University of Science & Technology of Bamako	Tripet, F (corresponding author), Keele Univ, Inst Sci & Technol Med, Ctr Appl Entomol & Parasitol, Keele, Staffs, England.	f.tripet@keele.ac.uk	Paton, Douglas/ABB-4877-2020; Coulibaly, Mamadou/AAE-7006-2019; Tripet, Frederic/M-6693-2015	Tripet, Frederic/0000-0002-7939-0712; Paton, Douglas/0000-0001-5755-2410	Wellcome Trust [041085]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust (www.wellcome.ac.uk/) Program Grant (#041085) to FT (co-PI) and PE (PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye-Antwi F, 2010, MALARIA J, V9; Aboagye-Antwi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-243; Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; ASMAN SM, 1981, ANNU REV ENTOMOL, V26, P289, DOI 10.1146/annurev.en.26.010181.001445; BAKER RH, 1980, ANN ENTOMOL SOC AM, V73, P581, DOI 10.1093/aesa/73.5.581; BAKER RH, 1979, ANN ENTOMOL SOC AM, V72, P751, DOI 10.1093/aesa/72.6.751; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Benedict MQ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S4; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; CHARLWOOD JD, 1980, PHYSIOL ENTOMOL, V5, P315, DOI 10.1111/j.1365-3032.1980.tb00241.x; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Costantini C, 1996, MED VET ENTOMOL, V10, P203, DOI 10.1111/j.1365-2915.1996.tb00733.x; Coulibaly MB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-133; Dao A, 2008, J MED ENTOMOL, V45, P643, DOI 10.1603/0022-2585(2008)45[643:AOAMSI]2.0.CO;2; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; Diabate A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-184; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Facchinelli L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002001; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Gary RE, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-19; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; GROVER KK, 1976, B ENTOMOL RES, V66, P469, DOI 10.1017/S0007485300006878; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Hassan MM, 2010, MALAR WORLD J, V1, P2; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Howell PI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S8; JONES MDR, 1978, PHYSIOL ENTOMOL, V3, P213, DOI 10.1111/j.1365-3032.1978.tb00151.x; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; Lanzaro GC, 2003, WAG UR FRON, V2, P109; Lee HL, 2013, TRANSGENIC RES, V22, P47, DOI 10.1007/s11248-012-9625-z; Lee Y, 2009, J MED ENTOMOL, V46, P316, DOI 10.1603/033.046.0216; Lengeler C, 2004, B WORLD HEALTH ORGAN, V82, P84; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; MARCHAND RP, 1985, J AM MOSQUITO CONTR, V1, P234; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Norris DE, 2001, J MED ENTOMOL, V38, P336, DOI 10.1603/0022-2585-38.2.336; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; REISEN WK, 1980, ANN ENTOMOL SOC AM, V73, P479, DOI 10.1093/aesa/73.4.479; Reisen WK, 2003, WAG UR FRON, V2, P25; Sanford MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027920; Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; Takken W, 2006, BRIDGING LAB FIELD R, P157; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; Tripet F, 2005, J MED ENTOMOL, V42, P596, DOI 10.1603/0022-2585(2005)042[0596:EOSFIM]2.0.CO;2; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; WEIDHAAS DE, 1974, AM J TROP MED HYG, V23, P298, DOI 10.4269/ajtmh.1974.23.298	57	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e82631	10.1371/journal.pone.0082631	http://dx.doi.org/10.1371/journal.pone.0082631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391719	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000329325200016
J	van Berlo, JH; Aronow, BJ; Molkentin, JD				van Berlo, Jop H.; Aronow, Bruce J.; Molkentin, Jeffery D.			Parsing the Roles of the Transcription Factors GATA-4 and GATA-6 in the Adult Cardiac Hypertrophic Response	PLOS ONE			English	Article								The transcriptional code that programs cardiac hypertrophy involves the zinc finger-containing DNA binding factors GATA-4 and GATA-6, both of which are required to mount a hypertrophic response of the adult heart. Here we performed conditional gene deletion of Gata4 or Gata6 in the mouse heart in conjunction with reciprocal gene replacement using a transgene encoding either GATA-4 or GATA-6 in the heart as a means of parsing dosage effects of GATA-4 and GATA-6 versus unique functional roles. We determined that GATA-4 and GATA-6 play a redundant and dosage-sensitive role in programming the hypertrophic growth response of the heart following pressure overload stimulation. However, nonredundant functions were identified in allowing the heart to compensate and resist heart failure after pressure overload stimulation, as neither Gata4 nor Gata6 deletion was fully rescued by expression of the reciprocal transgene. For example, only Gata4 heart-specific deletion blocked the neoangiogenic response to pressure overload stimulation. Gene expression profiling from hearts of these gene-deleted mice showed both overlapping and unique transcriptional codes, which is presented. These results indicate that GATA-4 and GATA-6 play a dosage-dependent and redundant role in programming cardiac hypertrophy, but that each has a more complex role in maintaining cardiac homeostasis and resistance to heart failure following injury that cannot be compensated by the other.	[van Berlo, Jop H.; Aronow, Bruce J.; Molkentin, Jeffery D.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45221 USA; [Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45221 USA.	Jeff.Molkentin@cchmc.org		Molkentin, Jeffery/0000-0002-3558-6529; van Berlo, Jop/0000-0001-9229-4429	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL060562, R00HL112852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (J.D.M., J.H.v.B.) and the Howard Hughes Medical Institute (J.D.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charron F, 1999, MOL CELL BIOL, V19, P4355; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; van Berlo JH, 2011, P NATL ACAD SCI USA, V108, P12331, DOI 10.1073/pnas.1104499108; van Berlo JH, 2010, CIRC RES, V107, P1032, DOI 10.1161/CIRCRESAHA.110.220764; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013	11	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84591	10.1371/journal.pone.0084591	http://dx.doi.org/10.1371/journal.pone.0084591			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391969	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900112
J	Wang, CM; Li, TC; Jhan, YL; Weng, JH; Chou, CH				Wang, Chao-Min; Li, Tsai-Chi; Jhan, Yun-Lian; Weng, Jen-Hsien; Chou, Chang-Hung			The Impact of Microbial Biotransformation of Catechin in Enhancing the Allelopathic Effects of Rhododendron formosanum	PLOS ONE			English	Article							GREEN TEA EXTRACT; ALLELOCHEMICAL (+/-)-CATECHIN; CHLOROPHYLL FLUORESCENCE; BACTERIAL-DEGRADATION; LITTER DECOMPOSITION; ROOT EXUDATE; SOIL BIOTA; A-RING; PLANT; FLAVONOIDS	Rhododendron formosanum is distributed widely in the central mountains in Taiwan and the major allelopathic compound in the leaves has been identified as (-)-catechin, which is also a major allelochemical of an invasive spotted knapweed in North America. Soil microorganisms play key roles in ecosystems and influence various important processes, including allelopathy. However, no microorganism has been identified as an allelochemical mediator. This study focused on the role of microorganisms in the allelopathic effects of R. formosanum. The microorganism population in the rhizosphere of R. formosanum was investigated and genetic analysis revealed that the predominant genera of microorganisms in the rhizosphere of R. formosanum were Pseudomonas, Herbaspirillum, and Burkholderia. The dominant genera Pseudomonas utilized (-)-catechin as the carbon source and catalyzed the conversion of (-)-catechin into protocatechuic acid in vitro. The concentrations of allelochemicals in the soil were quantified by liquid chromatography-electrospray ionization/tandem mass spectrometry. The concentration of (-)-catechin in the soil increased significantly during the extreme rainfall in the summer season and suppressed total bacterial populations. Protocatechuic acid accumulation was observed while total bacterial populations increased abundantly in both laboratory and field studies. Allelopathic interactions were tested by evaluating the effects of different allelochemicals on the seed germination, radicle growth, and photosynthesis system II of lettuce. Protocatechuic acid exhibited higher phytotoxicity than (-)-catechin did and the effect of (-)-catechin on the inhibition of seed germination was enhanced by combining it with protocatechuic acid at a low concentration. This study revealed the significance of the allelopathic interactions between R. formosanum and microorganisms in the rhizosphere. These findings demonstrate that knowledge regarding the precise biotransformation process of (-)-catechin by microorganisms in the environment is necessary to increase our understanding of allelopathy.	[Wang, Chao-Min; Li, Tsai-Chi; Chou, Chang-Hung] China Med Univ, Res Ctr Biodivers, Taichung, Taiwan; [Jhan, Yun-Lian; Weng, Jen-Hsien; Chou, Chang-Hung] China Med Univ, Grad Inst Ecol & Evolutionary Biol, Taichung, Taiwan; [Chou, Chang-Hung] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan	China Medical University Taiwan; China Medical University Taiwan; National Cheng Kung University	Chou, CH (corresponding author), China Med Univ, Res Ctr Biodivers, Taichung, Taiwan.	choumasa@mail.cmu.edu.tw	Wang, Chao-Min/V-8680-2018	Wang, Chao-Min/0000-0002-8954-6151	National Science Council of Taiwan [NSC101-2811-B-039-013, NSC102-2811-B-039-005, NSC101-2621-B-039-001, NSC102-2313-B-039-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from the National Science Council of Taiwan (NSC101-2811-B-039-013, NSC102-2811-B-039-005, NSC101-2621-B-039-001 and NSC102-2313-B-039-001) to C. H. Chou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo PI, 2012, OECOLOGIA, V168, P221, DOI 10.1007/s00442-011-2063-4; Arunachalam M, 2003, BBA-GEN SUBJECTS, V1621, P261, DOI 10.1016/S0304-4165(03)00077-1; Arunachalam M, 2003, MICROBIOL RES, V158, P37, DOI 10.1078/0944-5013-00174; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Bais HP, 2003, J AGR FOOD CHEM, V51, P897, DOI 10.1021/jf020978a; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P457; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Blair AC, 2006, J CHEM ECOL, V32, P2327, DOI 10.1007/s10886-006-9168-y; Brennerova MV, 2009, ENVIRON MICROBIOL, V11, P2216, DOI 10.1111/j.1462-2920.2009.01943.x; Callaway RM, 2005, J ECOL, V93, P576, DOI 10.1111/j.1365-2745.2005.00994.x; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Carando S, 2000, BASIC LIFE SCI, V66, P725; Chobot V, 2009, J CHEM ECOL, V35, P980, DOI 10.1007/s10886-009-9681-x; Chou C.H., 1999, RECENT ADV ALLELOPAT, V1, P3; Chou CH, 1999, CRIT REV PLANT SCI, V18, P609, DOI 10.1016/S0735-2689(99)00393-7; Chou SC, 2010, ALLELOPATHY J, V25, P73; Chou SC, 2009, NAT PROD COMMUN, V4, P1189; Dai CM, 2010, ENVIRON TOXICOL PHAR, V30, P284, DOI 10.1016/j.etap.2010.08.002; Das S, 2006, J NAT PROD, V69, P499, DOI 10.1021/np0504659; Donovan JL, 2006, FREE RADICAL RES, V40, P1029, DOI 10.1080/10715760600868545; Duke SO, 2009, J CHEM ECOL, V35, P141, DOI 10.1007/s10886-008-9587-z; Ferrazzano GF, 2011, J MED FOOD, V14, P907, DOI 10.1089/jmf.2010.0196; Fitter A, 2003, SCIENCE, V301, P1337, DOI 10.1126/science.1089291; Harrison KA, 2010, J ECOL, V98, P384, DOI 10.1111/j.1365-2745.2009.01614.x; Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13; Hussain MI, 2011, PLANT PHYSIOL BIOCH, V49, P1290, DOI 10.1016/j.plaphy.2011.08.007; Inderjit, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002536; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; JEFFREY AM, 1972, BIOCHEM J, V130, P383, DOI 10.1042/bj1300383; JEFFREY AM, 1972, BIOCHEM J, V130, P373, DOI 10.1042/bj1300373; Keswani J, 2001, INT J SYST EVOL MICR, V51, P667, DOI 10.1099/00207713-51-2-667; Kim YO, 2005, J CHEM ECOL, V31, P1175, DOI 10.1007/s10886-005-4255-z; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Lin LC, 2011, MYCORRHIZA, V21, P331, DOI 10.1007/s00572-010-0342-2; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MULLER CH, 1966, B TORREY BOT CLUB, V93, P332, DOI 10.2307/2483447; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Perry LG, 2007, J CHEM ECOL, V33, P2337, DOI 10.1007/s10886-007-9383-1; Perry LG, 2005, J ECOL, V93, P1126, DOI 10.1111/j.1365-2745.2005.01044.x; Pollock JL, 2011, J CHEM ECOL, V37, P1044, DOI 10.1007/s10886-011-0005-6; Sakanaka S, 2000, J BIOSCI BIOENG, V90, P81, DOI 10.1016/S1389-1723(00)80038-9; Sanchez-Rabaneda F, 2003, J MASS SPECTROM, V38, P35, DOI 10.1002/jms.395; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P37, DOI 10.1093/pcp/pcn183; Schweizer HP, 1996, J BACTERIOL, V178, P5215, DOI 10.1128/jb.178.17.5215-5221.1996; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184; Tharayil N, 2008, J AGR FOOD CHEM, V56, P3706, DOI 10.1021/jf073310a; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; Valverde A, 2003, INT J SYST EVOL MICR, V53, P1979, DOI 10.1099/ijs.0.02677-0; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Van Der Putten WH, 2003, ECOLOGY, V84, P2269, DOI 10.1890/02-0284; Veluri R, 2004, J AGR FOOD CHEM, V52, P1077, DOI 10.1021/jf030653+; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Wang CM, 2007, MICROB ECOL, V54, P1, DOI 10.1007/s00248-006-9139-4; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	57	37	43	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85162	10.1371/journal.pone.0085162	http://dx.doi.org/10.1371/journal.pone.0085162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391991	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900134
J	Wolf, AB; Vos, M; de Boer, W; Kowalchuk, GA				Wolf, Alexandra B.; Vos, Michiel; de Boer, Wietse; Kowalchuk, George A.			Impact of Matric Potential and Pore Size Distribution on Growth Dynamics of Filamentous and Non-Filamentous Soil Bacteria	PLOS ONE			English	Article							ORGANIC-MATTER; FUNGI; RESPIRATION; DIVERSITY	The filamentous growth form is an important strategy for soil microbes to bridge air-filled pores in unsaturated soils. In particular, fungi perform better than bacteria in soils during drought, a property that has been ascribed to the hyphal growth form of fungi. However, it is unknown if, and to what extent, filamentous bacteria may also display similar advantages over non-filamentous bacteria in soils with low hydraulic connectivity. In addition to allowing for microbial interactions and competition across connected micro-sites, water films also facilitate the motility of non-filamentous bacteria. To examine these issues, we constructed and characterized a series of quartz sand microcosms differing in matric potential and pore size distribution and, consequently, in connection of micro-habitats via water films. Our sand microcosms were used to examine the individual and competitive responses of a filamentous bacterium (Streptomyces atratus) and a motile rod-shaped bacterium (Bacillus weihenstephanensis) to differences in pore sizes and matric potential. The Bacillus strain had an initial advantage in all sand microcosms, which could be attributed to its faster growth rate. At later stages of the incubation, Streptomyces became dominant in microcosms with low connectivity (coarse pores and dry conditions). These data, combined with information on bacterial motility (expansion potential) across a range of pore-size and moisture conditions, suggest that, like their much larger fungal counterparts, filamentous bacteria also use this growth form to facilitate growth and expansion under conditions of low hydraulic conductivity. The sand microcosm system developed and used in this study allowed for precise manipulation of hydraulic properties and pore size distribution, thereby providing a useful approach for future examinations of how these properties influence the composition, diversity and function of soil-borne microbial communities.	[Wolf, Alexandra B.; Vos, Michiel; de Boer, Wietse; Kowalchuk, George A.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands; [de Boer, Wietse] Wageningen Univ, Dept Soil Qual, NL-6700 AP Wageningen, Netherlands; [Kowalchuk, George A.] Free Univ Amsterdam, Dept Ecol Sci, Amsterdam, Netherlands; [Kowalchuk, George A.] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Vrije Universiteit Amsterdam; Utrecht University	Kowalchuk, GA (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	g.a.kowalchuk@uu.nl	Kowalchuk, George A/C-4298-2011; de Boer, Wietse/C-2737-2011; KNAW, NIOO-KNAW/A-4320-2012	de Boer, Wietse/0000-0002-5380-2993; Kowalchuk, George/0000-0003-3866-0832; KNAW, NIOO-KNAW/0000-0002-3835-159X	Vici grant of GAK from the Dutch Science Foundation (NWO)	Vici grant of GAK from the Dutch Science Foundation (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by the Vici grant of GAK from the Dutch Science Foundation (NWO) entitled "Crossing the frontiers of microbial ecology". MV was partly supported by investment from the European Regional Development Fund and the European Social Fund Convergence Program for Cornwall and the Isles of Scilly to the ECEHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JP, 1973, ARCH MIKROBIOL, V93, P113, DOI 10.1007/BF00424942; Baltz RH., 2007, MICROBE, V2, P125; Carson JK, 2010, APPL ENVIRON MICROB, V76, P3936, DOI 10.1128/AEM.03085-09; Chowdhury N, 2011, SOIL BIOL BIOCHEM, V43, P1229, DOI 10.1016/j.soilbio.2011.02.012; Crawford JW, 2005, TRENDS ECOL EVOL, V20, P81, DOI 10.1016/j.tree.2004.11.014; Danielson R. E., 1986, METHODS SOIL ANAL PH; FAEGRI A, 1977, SOIL BIOL BIOCHEM, V9, P105, DOI 10.1016/0038-0717(77)90045-1; Griffin DM, 1985, BACTERIA NATURE, P221; HORN R, 1994, SOIL TILL RES, V30, P187, DOI 10.1016/0167-1987(94)90005-1; Kohlmeier S, 2005, ENVIRON SCI TECHNOL, V39, P4640, DOI 10.1021/es047979z; Lehmann J, 2008, NAT GEOSCI, V1, P238, DOI 10.1038/ngeo155; MCCARTHY AJ, 1992, GENE, V115, P189, DOI 10.1016/0378-1119(92)90558-7; Nimmo J. R., 2004, ENCY SOILS ENV, V3, P295, DOI DOI 10.1016/B978-0-12-409548-9.05265-9; Or D, 2007, ADV WATER RESOUR, V30, P1505, DOI 10.1016/j.advwatres.2006.05.025; Otten W, 1999, SOIL BIOL BIOCHEM, V31, P1803, DOI 10.1016/S0038-0717(99)00099-1; Papendick R. I., 1981, SPECIAL PUBLICATION, V9, P1; Remus-Emsermann M, 2012, THESIS; Ruamps LS, 2011, SOIL BIOL BIOCHEM, V43, P280, DOI 10.1016/j.soilbio.2010.10.010; Schrempf H., 2007, PROKARYOTES HDB BIOL, P21; Treves DS, 2003, MICROB ECOL, V45, P20, DOI 10.1007/s00248-002-1044-x; van Genuchten M.T., 1991, EPA600291065 US SAL; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Vreeken-Buijs MJ, 1998, SOIL BIOL BIOCHEM, V30, P97, DOI 10.1016/S0038-0717(97)00064-3; Warmink JA, 2011, SOIL BIOL BIOCHEM, V43, P760, DOI 10.1016/j.soilbio.2010.12.009; Warmink JA, 2009, APPL ENVIRON MICROB, V75, P2820, DOI 10.1128/AEM.02110-08; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; WILSON JM, 1975, SOIL BIOL BIOCHEM, V7, P269, DOI 10.1016/0038-0717(75)90066-8; WONG PTW, 1976, SOIL BIOL BIOCHEM, V8, P215, DOI 10.1016/0038-0717(76)90006-7; Young IM, 2008, ADV AGRON, V100, P81, DOI 10.1016/S0065-2113(08)00604-4; Yuste JC, 2011, GLOBAL CHANGE BIOL, V17, P1475, DOI 10.1111/j.1365-2486.2010.02300.x	30	63	63	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83661	10.1371/journal.pone.0083661	http://dx.doi.org/10.1371/journal.pone.0083661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391805	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200103
J	Sakakura, H; Murakumo, Y; Mii, SJ; Hagiwara, S; Kato, T; Asai, M; Hoshino, A; Yamamoto, N; Sobue, S; Ichihara, M; Ueda, M; Takahashi, M				Sakakura, Hiroki; Murakumo, Yoshiki; Mii, Shinji; Hagiwara, Sumitaka; Kato, Takuya; Asai, Masato; Hoshino, Akiyoshi; Yamamoto, Noriyuki; Sobue, Sayaka; Ichihara, Masatoshi; Ueda, Minoru; Takahashi, Masahide			Detection of a Soluble Form of CD109 in Serum of CD109 Transgenic and Tumor Xenografted Mice	PLOS ONE			English	Article							CELL-SURFACE; HUMAN KERATINOCYTES; HUMAN PLATELETS; EXPRESSION; RECEPTOR; IDENTIFICATION; CARCINOMAS; CD34(+); PROTEIN; SYSTEM	CD109, a glycosylphosphatidylinositol-anchored glycoprotein, is expressed at high levels in some human tumors including squamous cell carcinomas. As CD109 is reportedly cleaved by furin and its soluble form is secreted into culture medium in vitro, we hypothesized that CD109 could serve as a tumor marker in vivo. In this study, we investigated CD109 as a novel serum tumor marker using transgenic mice that overexpress mouse CD109 (mCD109-TG mice) and tumor xenografted mice inoculated with human CD109 (hCD109)-overexpressing HEK293 cells. In sera and urine of mCD109-TG mice, mCD109 was detected using western blotting. In xenografted mice, hCD109 secreted from inoculated tumors was detected in sera, using western blotting and CD109 ELISA. Concentrations of tumor-secreted CD109 increased proportionally as tumors enlarged. Concentrations of secreted CD109 decreased notably by 17 h after tumor resection, and became undetectable 48 h after resection. The half-life of tumor-secreted CD109 was about 5.86+/-0.17 h. These results indicate that CD109 is present in serum as a soluble form, and suggest its potential as a novel tumor marker in patients with cancers that express CD109.	[Sakakura, Hiroki; Murakumo, Yoshiki; Mii, Shinji; Kato, Takuya; Asai, Masato; Hoshino, Akiyoshi; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan; [Sakakura, Hiroki; Hagiwara, Sumitaka; Yamamoto, Noriyuki; Ueda, Minoru] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4648601, Japan; [Murakumo, Yoshiki] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa 228, Japan; [Sobue, Sayaka; Ichihara, Masatoshi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan	Nagoya University; Nagoya University; Kitasato University; Chubu University	Takahashi, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4648601, Japan.	mtakaha@med.nagoya-u.ac.jp	Takahashi, Masahide/AAN-4770-2020; Mii, Shinji/I-7480-2014; TAKAHASHI, Masahide/I-7244-2014; asai, masato/I-7294-2014	Takahashi, Masahide/0000-0002-2803-2683; Mii, Shinji/0000-0001-8266-3235; 				Caccia D, 2011, J PROTEOME RES, V10, P4196, DOI 10.1021/pr200344n; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Giesert C, 2003, ANN NY ACAD SCI, V996, P227, DOI 10.1111/j.1749-6632.2003.tb03250.x; Hagikura M, 2010, PATHOL INT, V60, P735, DOI 10.1111/j.1440-1827.2010.02592.x; Hagiwara S, 2010, ONCOGENE, V29, P2181, DOI 10.1038/onc.2009.506; Hagiwara S, 2008, CANCER SCI, V99, P1916, DOI 10.1111/j.1349-7006.2008.00949.x; HAREGEWOIN A, 1994, CELL IMMUNOL, V156, P357, DOI 10.1006/cimm.1994.1181; Hasegawa M, 2008, PATHOL INT, V58, P288, DOI 10.1111/j.1440-1827.2008.02225.x; Hasegawa M, 2007, PATHOL INT, V57, P245, DOI 10.1111/j.1440-1827.2007.02097.x; Hashimoto M, 2004, ONCOGENE, V23, P3716, DOI 10.1038/sj.onc.1207418; Ichihara M, 1997, BLOOD, V90, P165; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Janik JE, 2004, BLOOD, V104, P3355, DOI 10.1182/blood-2003-11-3922; KELTON JG, 1990, BLOOD, V75, P2172; Kim Seung Cheol, 2004, J Low Genit Tract Dis, V8, P292, DOI 10.1097/00128360-200410000-00006; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Litvinov IV, 2011, EXP DERMATOL, V20, P627, DOI 10.1111/j.1600-0625.2011.01288.x; Mii S, 2012, AM J PATHOL, V181, P1180, DOI 10.1016/j.ajpath.2012.06.021; Murray LJ, 1999, EXP HEMATOL, V27, P1282, DOI 10.1016/S0301-472X(99)00071-5; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohshima Y, 2010, J DERMATOL SCI, V57, P140, DOI 10.1016/j.jdermsci.2009.11.004; Sato T, 2007, PATHOL INT, V57, P719, DOI 10.1111/j.1440-1827.2007.02168.x; SMITH JW, 1995, BLOOD, V86, P2807; SUTHERLAND DR, 1991, BLOOD, V77, P84; Vaidyanathan K, 2012, INDIAN J CLIN BIOCHE, V27, P110, DOI 10.1007/s12291-011-0173-8; Yoshimasu T, 1999, INT J BIOL MARKER, V14, P99, DOI 10.1177/172460089901400207; Zhang JM, 2005, PATHOL INT, V55, P165, DOI 10.1111/j.1440-1827.2005.01807.x	28	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83385	10.1371/journal.pone.0083385	http://dx.doi.org/10.1371/journal.pone.0083385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400073	Green Submitted, Green Published, gold			2022-12-27	WOS:000329462700007
J	Davies, GE; Thornton, CR				Davies, Genna E.; Thornton, Christopher R.			Differentiation of the Emerging Human Pathogens Trichosporon asahii and Trichosporon asteroides from Other Pathogenic Yeasts and Moulds by Using Species-Specific Monoclonal Antibodies	PLOS ONE			English	Article							HYPERSENSITIVITY PNEUMONITIS; INFECTIONS; IDENTIFICATION; SURVEILLANCE; DIAGNOSIS; HOUSES; SPP.; DNA	The fungal genus Trichosporon contains emerging opportunistic pathogens of humans, and is the third most commonly isolated non-candidal yeast from humans. Trichosporon asahii and T. asteroides are the most important species causing disseminated disease in immunocompromised patients, while inhalation of T. asahii spores is the most important cause of summer-type hypersensitivity pneumonitis in healthy individuals. Trichosporonosis is misdiagnosed as candidiasis or cryptococcosis due to a lack of awareness and the ambiguity of diagnostic tests for these pathogens. In this study, hybridoma technology was used to produce two murine monoclonal antibodies (MAbs), CA7 and TH1, for detection and differentiation of Trichosporon from other human pathogenic yeasts and moulds. The MAbs react with extracellular antigens from T. asahii and T. asteroides, but do not recognise other related Trichosporon spp., or unrelated pathogenic yeasts and moulds including Candida, Cryptococcus, Aspergillus, Fusarium, and Scedosporium spp., or the etiologic agents of mucormycosis. Immunofluorescence and Western blotting studies show that MAb CA7, an immunoglobulin G1 (IgG1), binds to a major 60 kDa glycoprotein antigen produced on the surface of hyphae, while TH1, an immunoglobulin M (IgM), binds to an antigen produced on the surface of conidia. The MAbs were used in combination with a standard mycological growth medium (Sabouraud Dextrose Agar) to develop an enzyme-linked immunosorbent assay (ELISA) for differentiation of T. asahii from Candida albicans and Cryptococcus neoformans in single and mixed species cultures. The MAbs represent a major advance in the identification of T. asahii and T. asteroides using standard mycological identification methods.	[Davies, Genna E.; Thornton, Christopher R.] Univ Exeter, Exeter, Devon, England	University of Exeter	Thornton, CR (corresponding author), Univ Exeter, Exeter, Devon, England.	C.R.Thornton@ex.ac.uk						Badiye Amit, 2012, J Assoc Physicians India, V60, P21; Bajwa SJ, 2013, ANN MED HEALTH SCI R, V3, P238, DOI 10.4103/2141-9248.113669; Biswas SK, 2005, J CLIN MICROBIOL, V43, P5171, DOI 10.1128/JCM.43.10.5171-5178.2005; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chagas-Neto TC, 2009, J CLIN MICROBIOL, V47, P1074, DOI 10.1128/JCM.01614-08; Colombo AL, 2011, CLIN MICROBIOL REV, V24, P682, DOI 10.1128/CMR.00003-11; Cordoba S, 2011, REV ARGENT MICROBIOL, V43, P176, DOI 10.1590/S0325-75412011000300003; Denning DW, 2010, TRENDS MICROBIOL, V18, P195, DOI 10.1016/j.tim.2010.02.004; Di Bonaventura G, 2006, ANTIMICROB AGENTS CH, V50, P3269, DOI 10.1128/AAC.00556-06; Fonseca FL, 2009, FUNGAL GENET BIOL, V46, P496, DOI 10.1016/j.fgb.2009.03.003; Heslop OD, 2011, J CLIN MICROBIOL, V49, P4405, DOI 10.1128/JCM.05028-11; Hirschi S, 2012, J CLIN MICROBIOL, V50, P4168, DOI 10.1128/JCM.01928-12; Kustimur S, 2002, DIAGN MICR INFEC DIS, V43, P167, DOI 10.1016/S0732-8893(02)00385-1; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Miyagawa T, 2000, AM J RESP CRIT CARE, V161, P961, DOI 10.1164/ajrccm.161.3.9802013; Ohtani Y, 2008, INTERNAL MED, V47, P857, DOI 10.2169/internalmedicine.47.0656; Pfaller MA, 2007, J CLIN MICROBIOL, V45, P1735, DOI 10.1128/JCM.00409-07; Sano M, 2007, VIRCHOWS ARCH, V451, P929, DOI 10.1007/s00428-007-0484-6; Shinozaki M, 2013, J CLIN MICROBIOL, V51, P295, DOI 10.1128/JCM.02221-12; Silva JO, 2004, MYCOPATHOLOGIA, V157, P29, DOI 10.1023/B:MYCO.0000012223.38967.7d; Sugita T, 2004, J CLIN MICROBIOL, V42, P5467, DOI 10.1128/JCM.42.12.5467-5471.2004; Sugita T, 2001, J CLIN MICROBIOL, V39, P2405, DOI 10.1128/JCM.39.7.2405-2411.2001; Thornton CR, 2008, CLIN VACCINE IMMUNOL, V15, P1095, DOI 10.1128/CVI.00068-08; Thornton CR, 2015, CRIT REV MICROBIOL, V41, P27, DOI 10.3109/1040841X.2013.788995; Thornton CR, 2009, CLIN VACCINE IMMUNOL, V16, P756, DOI 10.1128/CVI.00061-09; Tlamcani Z, 2013, J IMMUN TECH INFECT, V2, P1; Unoura K, 2011, RESP MED, V105, P1696, DOI 10.1016/j.rmed.2011.07.009; Vashishtha VM, 2012, INDIAN PEDIATR, V49, P745, DOI 10.1007/s13312-012-0137-y; Vazquez-Gonzalez D, 2013, J DTSCH DERMATOL GES, V11, P381, DOI 10.1111/ddg.12097; Yang YL, 2014, J MICROBIOL IMMUNOL, V47, P339, DOI 10.1016/j.jmii.2013.01.001	30	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84789	10.1371/journal.pone.0084789	http://dx.doi.org/10.1371/journal.pone.0084789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392156	Green Submitted, gold, Green Published			2022-12-27	WOS:000329460100079
J	Nardon, C; Schmitt, SM; Yang, HJ; Zuo, J; Fregona, D; Dou, QP				Nardon, Chiara; Schmitt, Sara M.; Yang, Huanjie; Zuo, Jian; Fregona, Dolores; Dou, Q. Ping			Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia	PLOS ONE			English	Article							GOLD(III) DITHIOCARBAMATE DERIVATIVES; COUPLED PEPTIDE TRANSPORTERS; PROTEASOME INHIBITORS; 20S PROTEASOME; CANCER CELLS; APOPTOSIS INDUCERS; BORTEZOMIB; COMPLEXES; DESIGN; OLIGOPEPTIDES	Since the serendipitous discovery of cisplatin, platinum-based drugs have become well-established antitumor agents, despite the fact that their clinical use is limited by many severe side-effects. In order to both improve the chemotherapeutic index and broaden the therapeutic spectrum of current drugs, our most recent anti-neoplastic agents, Au(III) complexes, were designed as carrier-mediated delivery systems exploiting peptide transporters, which are up-regulated in some cancers. Among all, we focused on two compounds and tested them on human MDA-MB-231 (resistant to cisplatin) breast cancer cell cultures and xenografts, discovering the proteasome as a major target both in vitro and in vivo. 53% inhibition of breast tumor growth in mice was observed after 27 days of treatment at 1.0 mg kg(-1) d(-1), compared to control. Remarkably, if only the most responsive mice are taken into account, 85% growth inhibition, with some animals showing tumor shrinkage, was observed after 13 days. These results led us to file an international patent, recognizing this class of gold(III) peptidomimetics as suitable candidates for entering phase I clinical trials.	[Nardon, Chiara; Yang, Huanjie; Fregona, Dolores] Univ Padua, Dept Chem Sci, Padua, Italy; [Nardon, Chiara; Schmitt, Sara M.; Zuo, Jian; Dou, Q. Ping] Wayne State Univ, Sch Med, Mol Therapeut Program, Barbara Ann Karmanos Canc Inst,Dept Oncol, Detroit, MI USA; [Nardon, Chiara; Schmitt, Sara M.; Zuo, Jian; Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pharmacol, Mol Therapeut Program,Barbara Ann Karmanos Canc I, Detroit, MI 48201 USA; [Nardon, Chiara; Schmitt, Sara M.; Zuo, Jian; Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pathol, Mol Therapeut Program,Barbara Ann Karmanos Canc I, Detroit, MI 48201 USA; [Zuo, Jian] Ocean Univ China, Coll Chem & Chem Engn, Qingdao, Shandong, Peoples R China	University of Padua; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Ocean University of China	Fregona, D (corresponding author), Univ Padua, Dept Chem Sci, Padua, Italy.	dolores.fregona@unipd.it; doup@karmanos.org	NARDON, CHIARA/AAQ-9251-2021	NARDON, CHIARA/0000-0002-9657-1486; Zuo, Jian/0000-0002-8279-9666; Dou, Qingping/0000-0002-6465-1473	A.R.TE.M.O association; National Cancer Institute [1R01CA120009, 3R01CA120009-04S1, 5R01CA127258-05]; NATIONAL CANCER INSTITUTE [R01CA127258, R21CA184788, R01CA120009] Funding Source: NIH RePORTER	A.R.TE.M.O association; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CN wishes to thank the Ph.D. School in Molecular Sciences (University of Padova) and the Ing. Aldo Gini Foundation (Italy) for supporting her overseas mobility. The A.R.TE.M.O association are gratefully acknowledged for financial support. This work was partially supported by grants from the National Cancer Institute (1R01CA120009, 3R01CA120009-04S1 and 5R01CA127258-05, to QPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2003, DRUG DISCOV TODAY, V8, P307, DOI 10.1016/S1359-6446(03)02647-3; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; An B, 1998, CELL DEATH DIFFER, V5, P1062, DOI 10.1038/sj.cdd.4400436; Arellano JB, 2011, BIOCHEMISTRY-US, V50, P8291, DOI 10.1021/bi201195u; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Biegel A, 2006, AMINO ACIDS, V31, P137, DOI 10.1007/s00726-006-0331-0; Brandsch M, 2009, EXPERT OPIN DRUG MET, V5, P887, DOI 10.1517/17425250903042292; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Bruijnincx PCA, 2008, CURR OPIN CHEM BIOL, V12, P197, DOI 10.1016/j.cbpa.2007.11.013; Casini A, 2009, J BIOL INORG CHEM, V14, P1139, DOI 10.1007/s00775-009-0558-9; Cattaruzza L, 2011, INT J CANCER, V128, P206, DOI 10.1002/ijc.25311; Chen D, 2005, BIOCHEM PHARMACOL, V69, P1421, DOI 10.1016/j.bcp.2005.02.022; Dalla Via L, 2012, FUTURE MED CHEM, V4, P525, DOI [10.4155/FMC.11.187, 10.4155/fmc.11.187]; Daniel KG, 2005, BREAST CANCER RES, V7, pR897, DOI 10.1186/bcr1322; Fregona D, 2010, 2009- EP53296( WO2010105691): 34, Patent No. 53296; Gao G, 2000, J CELL BIOCHEM, V80, P53; Geissler S, 2010, FEBS J, V277, P790, DOI 10.1111/j.1742-4658.2009.07528.x; Gonzalez DE, 1998, CANCER RES, V58, P519; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Hong Y, 2008, BBA-MOL BASIS DIS, V1782, P649, DOI 10.1016/j.bbadis.2008.09.008; Inoue M, 2005, CANCER LETT, V230, P72, DOI 10.1016/j.canlet.2004.12.023; Johnstone SA, 2000, ANTI-CANCER DRUG DES, V15, P151; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Knutter I, 2002, AM J PHYSIOL-GASTR L, V283, pG222, DOI 10.1152/ajpgi.00534.2001; Kostova I, 2006, RECENT PAT ANTI-CANC, V1, P1, DOI 10.2174/157489206775246458; Kouodom MN, 2012, J INORG BIOCHEM, V117, P248, DOI 10.1016/j.jinorgbio.2012.07.001; Kouodom MN, 2012, J MED CHEM, V55, P2212, DOI 10.1021/jm201480u; Marta E, 2012, MINI-REV MED CHEM, V12, P1216; Marzano C, 2011, INT J CANCER, V129, P487, DOI 10.1002/ijc.25684; Milacic V, 2006, CANCER RES, V66, P10478, DOI 10.1158/0008-5472.CAN-06-3017; Mitsuoka K, 2008, J NUCL MED, V49, P615, DOI 10.2967/jnumed.107.048231; Nakanishi T, 2000, INT J CANCER, V88, P274, DOI 10.1002/1097-0215(20001015)88:2<274::AID-IJC20>3.3.CO;2-X; Nakanishi T, 1997, CANCER RES, V57, P4118; PATERSON Y, 1981, J AM CHEM SOC, V103, P2947, DOI 10.1021/ja00401a007; Ronconi L, 2006, J MED CHEM, V49, P1648, DOI 10.1021/jm0509288; Ronconi L, 2005, POLYHEDRON, V24, P521, DOI 10.1016/j.poly.2004.12.015; Ronconi L, 2005, INORG CHEM, V44, P1867, DOI 10.1021/ic048260v; Ronconi L, 2009, DALTON T, P10670, DOI 10.1039/b913597a; Rubio-Aliaga I, 2008, XENOBIOTICA, V38, P1022, DOI [10.1080/00498250701875254, 10.1080/00498250701875254 ]; Terada T, 2005, BIOCHEM PHARMACOL, V70, P1756, DOI 10.1016/j.bcp.2005.09.027; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Zhang X, 2010, J CELL BIOCHEM, V109, P162, DOI 10.1002/jcb.22394; Zheng J, 2012, CELL PHYSIOL BIOCHEM, V29, P353, DOI 10.1159/000338490	51	39	42	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84248	10.1371/journal.pone.0084248	http://dx.doi.org/10.1371/journal.pone.0084248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392119	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100042
J	Papaiordanidou, M; Billot, M; Varray, A; Martin, A				Papaiordanidou, Maria; Billot, Maxime; Varray, Alain; Martin, Alain			Neuromuscular Fatigue Is Not Different between Constant and Variable Frequency Stimulation	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ELECTRICAL-STIMULATION; PRESYNAPTIC INHIBITION; ACTIVATION; VOLUNTARY; EXCITABILITY; CONTRACTIONS; RESPONSES; PROPERTY; PATTERNS	This study compared fatigue development of the triceps surae induced by two electrical stimulation protocols composed of constant and variable frequency trains (CFTs, VFTs, 450 trains, 30 Hz, 167 ms ON, 500 ms OFF and 146 ms ON, 500 ms OFF respectively). For the VFTs protocol a doublet (100 Hz) was used at the beginning of each train. The intensity used evoked 30% of a maximal voluntary contraction (MVC) and was defined using CFTs. Neuromuscular tests were performed before and after each protocol. Changes in excitation-contraction coupling were assessed by analysing the M-wave [at rest (M-max) and during MVC (M-sup)] and associated peak twitch (Pt). H-reflex [at rest (H-max) and during MVC (H-sup)] and the motor evoked potential (MEP) during MVC were studied to assess spinal and corticospinal excitability of the soleus muscle. MVC decrease was similar between the protocols (28%, P<0.05). M-max, M-sup and Pt decreased after both protocols (P<0.01). H-max/M-max was decreased (P<0.05), whereas H-sup/M-sup and MEP/M-sup remained unchanged after both protocols. The results indicate that CFTs and VFTs gave rise to equivalent neuromuscular fatigue. This fatigue resulted from alterations taking place at the muscular level. The finding that cortical and spinal excitability remained unchanged during MVC indicates that spinal and/or supraspinal mechanisms were activated to compensate for the loss of spinal excitability at rest.	[Papaiordanidou, Maria] Aix Marseille Univ, CNRS, ISM UMR 7287, Marseille, France; [Papaiordanidou, Maria; Billot, Maxime; Varray, Alain] Univ Montpellier I, Euromov, Movement Hlth Lab, Montpellier, France; [Billot, Maxime] Univ Laval, Fac Med, Dept Kinesiol, GRAME, Quebec City, PQ G1K 7P4, Canada; [Martin, Alain] Univ Bourgogne, UFR STAPS, INSERM Cognit Act & Plast Sensorimotrice U1093, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Papaiordanidou, M (corresponding author), Aix Marseille Univ, CNRS, ISM UMR 7287, Marseille, France.	maria.papaiordanidou@univ-amu.fr	Varray, Alain/P-6730-2019	Varray, Alain/0000-0003-3876-1211; Billot, Maxime/0000-0003-0979-2182	French Department of Superior Education and Research	French Department of Superior Education and Research	This study was supported by the French Department of Superior Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allen DG, 2001, J PHYSIOL-LONDON, V536, P657, DOI 10.1111/j.1469-7793.2001.t01-1-00657.x; Allen DG, 2002, CAN J APPL PHYSIOL, V27, P83, DOI 10.1139/h02-006; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Bigland-Ritchie B, 2000, MUSCLE NERVE, V23, P1348, DOI 10.1002/1097-4598(200009)23:9<1348::AID-MUS5>3.0.CO;2-0; Binder-Macleod S, 2005, MUSCLE NERVE, V31, P681, DOI 10.1002/mus.20290; Binder-Macleod SA, 1998, MUSCLE NERVE, V21, P1145, DOI 10.1002/(SICI)1097-4598(199809)21:9<1145::AID-MUS5>3.0.CO;2-7; Binder-MacLeod SA, 2001, ACTA PHYSIOL SCAND, V172, P195, DOI 10.1046/j.1365-201x.2001.00864.x; Binder-MacLeod SA, 1999, J APPL PHYSIOL, V86, P1337, DOI 10.1152/jappl.1999.86.4.1337; Boerio D, 2005, MED SCI SPORT EXER, V37, P973, DOI 10.1249/01.mss.0000166579.81052.9c; BOSTOCK H, 1994, BRAIN, V117, P913, DOI 10.1093/brain/117.5.913; BURKE RE, 1970, SCIENCE, V168, P122, DOI 10.1126/science.168.3927.122; Butler JE, 2003, J APPL PHYSIOL, V94, P567, DOI 10.1152/japplphysiol.01176.2001; Collins DF, 2007, EXERC SPORT SCI REV, V35, P102; Darques JL, 2003, J APPL PHYSIOL, V95, P1476, DOI 10.1152/japplphysiol.00230.2003; DUCHATEAU J, 1993, J PHYSIOL-LONDON, V471, P787, DOI 10.1113/jphysiol.1993.sp019928; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gerrits HL, 1999, MUSCLE NERVE, V22, P1249, DOI 10.1002/(SICI)1097-4598(199909)22:9<1249::AID-MUS13>3.3.CO;2-E; Gondin J, 2006, J NEUROPHYSIOL, V95, P3328, DOI 10.1152/jn.01002.2005; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; HICKS A, 1989, J PHYSIOL-LONDON, V414, P337, DOI 10.1113/jphysiol.1989.sp017691; Hortobagyi T, 2011, EUR J APPL PHYSIOL, V111, P2439, DOI 10.1007/s00421-011-2012-2; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; HULTMAN E, 1983, PFLUG ARCH EUR J PHY, V398, P139, DOI 10.1007/BF00581062; Kiernan MC, 1996, BRAIN, V119, P1099, DOI 10.1093/brain/119.4.1099; Maffiuletti NA, 2002, J APPL PHYSIOL, V92, P1383, DOI 10.1152/japplphysiol.00884.2001; Papaiordanidou M, 2010, MUSCLE NERVE, V41, P54, DOI 10.1002/mus.21427; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Sacco P, 1997, MUSCLE NERVE, V20, P1158, DOI 10.1002/(SICI)1097-4598(199709)20:9<1158::AID-MUS11>3.0.CO;2-P; Scott WB, 2005, MUSCLE NERVE, V31, P581, DOI 10.1002/mus.20300; Steele DS, 2003, ACTA PHYSIOL SCAND, V179, P39, DOI 10.1046/j.1365-201X.2003.01169.x; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Theurel J, 2007, RESP PHYSIOL NEUROBI, V157, P341, DOI 10.1016/j.resp.2006.12.002; Thomas CK, 2003, J NEUROPHYSIOL, V89, P2055, DOI 10.1152/jn.01002.2002; Vanderthommen M, 2003, J APPL PHYSIOL, V94, P1012, DOI 10.1152/japplphysiol.00887.2001; WESTERBLAD H, 1991, AM J PHYSIOL, V261, pC195, DOI 10.1152/ajpcell.1991.261.2.C195; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	37	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84740	10.1371/journal.pone.0084740	http://dx.doi.org/10.1371/journal.pone.0084740			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392155	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100078
J	Wei, L; Li, SH; Liu, SG; He, AN; Wang, D; Wang, J; Tang, YL; Wu, XJ				Wei, Lin; Li, Shenghua; Liu, Shenggui; He, Anna; Wang, Dan; Wang, Jie; Tang, Yulian; Wu, Xianjin			Transcriptome Analysis of Houttuynia cordata Thunb. by Illumina Paired-End RNA Sequencing and SSR Marker Discovery	PLOS ONE			English	Article							HEVEA-BRASILIENSIS; ANTIBACTERIAL ACTIVITIES; MICROSATELLITE MARKERS; INFLUENZA-VIRUS; WATER EXTRACT; SEQ DATA; TRANSFERABILITY; GENOMICS; LEAVES; GROWTH	Background: Houttuynia cordata Thunb. is an important traditional medical herb in China and other Asian countries, with high medicinal and economic value. However, a lack of available genomic information has become a limitation for research on this species. Thus, we carried out high-throughput transcriptomic sequencing of H. cordata to generate an enormous transcriptome sequence dataset for gene discovery and molecular marker development. Principal Findings: Illumina paired-end sequencing technology produced over 56 million sequencing reads from H. cordata mRNA. Subsequent de novo assembly yielded 63,954 unigenes, 39,982 (62.52%) and 26,122 (40.84%) of which had significant similarity to proteins in the NCBI nonredundant protein and Swiss-Prot databases (E-value <10(-5)), respectively. Of these annotated unigenes, 30,131 and 15,363 unigenes were assigned to gene ontology categories and clusters of orthologous groups, respectively. In addition, 24,434 (38.21%) unigenes were mapped onto 128 pathways using the KEGG pathway database and 17,964 (44.93%) unigenes showed homology to Vitis vinifera (Vitaceae) genes in BLASTx analysis. Furthermore, 4,800 cDNA SSRs were identified as potential molecular markers. Fifty primer pairs were randomly selected to detect polymorphism among 30 samples of H. cordata; 43 (86%) produced fragments of expected size, suggesting that the unigenes were suitable for specific primer design and of high quality, and the SSR marker could be widely used in marker-assisted selection and molecular breeding of H. cordata in the future. Conclusions: This is the first application of Illumina paired-end sequencing technology to investigate the whole transcriptome of H. cordata and to assemble RNA-seq reads without a reference genome. These data should help researchers investigating the evolution and biological processes of this species. The SSR markers developed can be used for construction of high-resolution genetic linkage maps and for gene-based association analyses in H. cordata. This work will enable future functional genomic research and research into the distinctive active constituents of this genus.	[Wei, Lin; Li, Shenghua; Liu, Shenggui; He, Anna; Wang, Dan; Wang, Jie; Tang, Yulian; Wu, Xianjin] Huaihua Univ, Coll Life Sci, Huaihua, Peoples R China; [Wei, Lin; Li, Shenghua; Liu, Shenggui; He, Anna; Tang, Yulian; Wu, Xianjin] Key Lab Hunan Prov Study & Utilizat Ethn Med Plan, Huaihua, Peoples R China; [Wei, Lin; Li, Shenghua; Liu, Shenggui; He, Anna; Tang, Yulian; Wu, Xianjin] Key Lab Hunan Higher Educ Hunan Western Med Plant, Huaihua, Peoples R China; [Wang, Jie] Hunan Univ, Coll Life Sci, Changsha 410082, Hunan, Peoples R China	Huaihua University; Hunan University	Wu, XJ (corresponding author), Huaihua Univ, Coll Life Sci, Huaihua, Peoples R China.	hhwuxianjin@163.com			National Natural Science Foundation of China [30870230]; Hunan Provincial Scientific Research Project Funding [12K132, 2013FJ6090]; Foundation of Hunan Key Discipline Construction Projects	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Scientific Research Project Funding; Foundation of Hunan Key Discipline Construction Projects	This work was supported by the National Natural Science Foundation of China (No. 30870230), Hunan Provincial Scientific Research Project Funding (No. 12K132 and No. 2013FJ6090) and the Foundation of Hunan Key Discipline Construction Projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Ze-Wei, 2009, Yichuan, V31, P311, DOI 10.3724/SP.J.1005.2009.00311; Arun KY, 2011, J PARASIT DIS, V35, P190; Brautigam A, 2011, J EXP BOT, V62, P3093, DOI 10.1093/jxb/err029; Chen XQ, 2011, ANTIVIR RES, V92, P341, DOI 10.1016/j.antiviral.2011.09.005; Chen YY, 2003, J NUTR SCI VITAMINOL, V49, P327, DOI 10.3177/jnsv.49.327; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Doyle J., 1991, MOL TECHNIQUES TAXON; Fang WP, 1981, FLORA SICHUANICA, P126; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; HAYASHI K, 1995, PLANTA MED, V61, P237, DOI 10.1055/s-2006-958063; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim Dajeong, 2012, Lab Anim Res, V28, P137, DOI 10.5625/lar.2012.28.2.137; Kim GS, 2008, BIOL PHARM BULL, V31, P2012, DOI 10.1248/bpb.31.2012; Lai KC, 2010, ANTICANCER RES, V30, P3549; Lau KM, 2008, J ETHNOPHARMACOL, V118, P79, DOI 10.1016/j.jep.2008.03.018; Lee JS, 2008, J ETHNOPHARMACOL, V117, P34, DOI 10.1016/j.jep.2008.01.013; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li GZ, 2005, BIOL PHARM BULL, V28, P1864, DOI 10.1248/bpb.28.1864; Li WF, 2011, J ETHNOPHARMACOL, V133, P922, DOI 10.1016/j.jep.2010.10.048; Li XiaoYing, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P285; Liang Han-Xing, 1995, Acta Botanica Yunnanica, V17, P255; [林美珍 Lin Meizhen], 2011, [中国药学杂志, Chinese Pharmaceutical Journal], V46, P1711; Liu Fang-zhou, 2010, Yaoxue Xuebao, V45, P399; Liu Fue, 2012, Liaoning Journal of Traditional Chinese Medicine, V39, P398; Lu HM, 2006, J ETHNOPHARMACOL, V104, P245, DOI 10.1016/j.jep.2005.09.012; Lu HM, 2006, CHEM PHARM BULL, V54, P936, DOI 10.1248/cpb.54.936; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Miyata M, 2010, J NUTR SCI VITAMINOL, V56, P150, DOI 10.3177/jnsv.56.150; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shin S, 2010, J VET SCI, V11, P273, DOI 10.4142/jvs.2010.11.3.273; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Toda S, 2005, J MED FOOD, V8, P266, DOI 10.1089/jmf.2005.8.266; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Tseng YC, 1982, FLORAE REIPUBLICAE P; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang D, 2012, HORTICULTURE SEED, V21, P75; Wang D, 2012, HORTICULTURE SEED, V21, P67; Wang Li, 2010, J Evid Based Med, V3, P168, DOI 10.1111/j.1756-5391.2010.01091.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang XiaoLi, 2012, China Journal of Traditional Chinese Medicine and Pharmacy, V27, P555; Wang XiaoPeng, 2012, Guangxi Zhiwu / Guihaia, V32, P107; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei L, 2012, INT J MOL SCI, V13, P8159, DOI 10.3390/ijms13078159; Wei W, 2005, GENET RESOUR CROP EV, V52, P473, DOI 10.1007/s10722-005-2261-1; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu W, 2005, HEREDITAS, V142, P24, DOI 10.1111/j.1601-5223.2005.01704.x; Wu Wei, 2002, Acta Pharmaceutica Sinica, V37, P986; Wu XJ, 2011, STUDY GERMPLASM PLAN; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh FC, 1991, BELG J BOT, V129, P157; Yin JC, 2011, AVIAN PATHOL, V40, P491, DOI 10.1080/03079457.2011.605107; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang Jinyu, 2011, Zhongguo Zhong Yao Za Zhi, V36, P97; Zhang WK, 2004, THEOR APPL GENET, V108, P1131, DOI 10.1007/s00122-003-1527-2; Zhou NN, 2012, LIFE SCI, V90, P770, DOI 10.1016/j.lfs.2012.03.035	68	34	39	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84105	10.1371/journal.pone.0084105	http://dx.doi.org/10.1371/journal.pone.0084105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392108	Green Submitted, gold, Green Published			2022-12-27	WOS:000329460100032
J	Brind'Amour, A; Dubois, SF				Brind'Amour, Anik; Dubois, Stanislas F.			Isotopic Diversity Indices: How Sensitive to Food Web Structure?	PLOS ONE			English	Article							COMMUNITY-WIDE MEASURES; TROPHIC STRUCTURE; STABLE-ISOTOPES; FUNCTIONAL DIVERSITY; SPATIAL VARIATION; RATIOS PROVIDE; NICHE; ASSEMBLAGES; POPULATION; DELTA-N-15	Recently revisited, the concept of niche ecology has lead to the formalisation of functional and trophic niches using stable isotope ratios. Isotopic diversity indices (IDI) derived from a set of measures assessing the dispersion/distribution of points in the delta-space were recently suggested and increasingly used in the literature. However, three main critics emerge from the use of these IDI: 1) they fail to account for the isotopic sources overlap, 2) some indices are highly sensitive to the number of species and/or the presence of rare species, and 3) the lack of standardization prevents any spatial and temporal comparisons. Using simulations we investigated the ability of six commonly used IDI to discriminate among different trophic food web structures, with a focus on the first two critics. We tested the sensitivity of the IDI to five food web structures along a gradient of sources overlap, varying from two distinct food chains with differentiated sources to two superimposed food chains sharing two sources. For each of the food web structure we varied the number of species (from 10 to 100 species) and the type of species feeding behaviour (i.e. random or selective feeding). Values of IDI were generally larger in food webs with distinct basal sources and tended to decrease as the superimposition of the food chains increased. This was more pronounced when species displayed food preferences in comparison to food webs where species fed randomly on any prey. The number of species composing the food web also had strong effects on the metrics, including those that were supposedly less sensitive to small sample size. In all cases, computing IDI on food webs with low numbers of species always increases the uncertainty of the metrics. A threshold of similar to 20 species was detected above which several metrics can be safely used.	[Brind'Amour, Anik] IFREMER, Fisheries Ecol & Modelling Dept, Nantes, France; [Dubois, Stanislas F.] IFREMER, DYNECO Benth Ecol Lab, Plouzane, France	Ifremer; Ifremer	Brind'Amour, A (corresponding author), IFREMER, Fisheries Ecol & Modelling Dept, Nantes, France.	Anik.Brindamour@ifremer.fr	Dubois, Stanislas/F-2939-2010	Brind'Amour, Anik/0000-0003-4072-2588; Dubois, Stanislas/0000-0002-3326-4892	EC2CO National program on Coastal Environments; Total Foundation for Biodiversity; Sea; EU project BENTHIS (Benthic ecosystem fisheries impact study)	EC2CO National program on Coastal Environments; Total Foundation for Biodiversity; Sea; EU project BENTHIS (Benthic ecosystem fisheries impact study)	Financial support comes from the EC2CO National program on Coastal Environments, by the Total Foundation for Biodiversity and the Sea, and from the EU project BENTHIS (Benthic ecosystem fisheries impact study). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolo A, 2005, OIKOS, V111, P534, DOI 10.1111/j.0030-1299.2005.13930.x; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Botto F, 2011, ESTUAR COAST SHELF S, V92, P70, DOI 10.1016/j.ecss.2010.12.014; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; COHEN JE, 1992, EVOL ECOL, V6, P73, DOI 10.1007/BF02285335; Colombo F, 2013, J SEA RES, V77, P93, DOI 10.1016/j.seares.2012.10.005; Cooper Ryan N, 2012, Aquat Biosyst, V8, P6, DOI 10.1186/2046-9063-8-6; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Costa MJ, 2002, FISHES IN ESTUARIES, P54, DOI 10.1002/9780470995228.ch3; Darnaude AM, 2004, MAR ECOL PROG SER, V275, P47, DOI 10.3354/meps275047; Daugherty MP, 2007, ENVIRON ENTOMOL, V36, P776, DOI 10.1603/0046-225X(2007)36[776:MSOIVI]2.0.CO;2; Dubois S, 2007, AQUACULTURE, V271, P336, DOI 10.1016/j.aquaculture.2007.03.023; Elton C., 1927, ANIMAL ECOLOGY; Flaherty EA, 2010, OIKOS, V119, P1409, DOI 10.1111/j.1600-0706.2010.18259.x; France R, 1995, OIKOS, V18, P318; Fry B., 2006, STABLE ISOTOPE ECOLO; Gido KB, 2006, ENVIRON BIOL FISH, V75, P197, DOI 10.1007/s10641-006-0009-1; Grippo MA, 2011, LIMNOL OCEANOGR, V56, P841, DOI 10.4319/lo.2011.56.3.0841; Hoeinghaus DJ, 2008, ECOLOGY, V89, P2353, DOI 10.1890/07-1143.1; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson M, 2012, BETWEEN ONE AND ONE ANOTHER, P1; Kopp D, 2013, J SEA RES, V81, P40, DOI 10.1016/j.seares.2013.03.013; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Le Loc'h F, 2008, J MARINE SYST, V72, P17, DOI 10.1016/j.jmarsys.2007.05.011; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Paez-Rosas D, 2012, J EXP MAR BIOL ECOL, V424, P44, DOI 10.1016/j.jembe.2012.05.001; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pigolotti S, 2010, THEOR ECOL-NETH, V3, P89, DOI 10.1007/s12080-009-0056-2; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; R Team, 2010, R LANG ENV STAT COMP; Ricklefs RE, 1998, FUNCT ECOL, V12, P871, DOI 10.1046/j.1365-2435.1998.00263.x; Schaal G, 2008, ESTUAR COAST SHELF S, V77, P523, DOI 10.1016/j.ecss.2007.10.008; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Sweetman AK, 2013, MAR ECOL PROG SER, V473, P115, DOI 10.3354/meps10050; Syvaranta J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056094; Syvaranta J, 2011, AQUAT SCI, V73, P79, DOI 10.1007/s00027-010-0161-8; Vander Zanden HB, 2010, BIOL LETTERS, V6, P711, DOI 10.1098/rsbl.2010.0124; Villeger S, 2008, MAR ECOL PROG SER, V364, P135, DOI 10.3354/meps07471; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1	50	34	34	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84198	10.1371/journal.pone.0084198	http://dx.doi.org/10.1371/journal.pone.0084198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391910	gold, Green Published			2022-12-27	WOS:000329323900053
J	Chen, PT; Lin, CJ; Jou, IM; Chieh, HF; Su, FC; Kuo, LC				Chen, Po-Tsun; Lin, Chien-Ju; Jou, I-Ming; Chieh, Hsiao-Feng; Su, Fong-Chin; Kuo, Li-Chieh			One Digit Interruption: The Altered Force Patterns during Functionally Cylindrical Grasping Tasks in Patients with Trigger Digits	PLOS ONE			English	Article							MULTIFINGER PREHENSION; PERCUTANEOUS RELEASE; COORDINATION; SYNERGIES; PULLEY	Most trigger digit (TD) patients complain that they have problems using their hand in daily or occupational tasks due to single or multiple digits being affected. Unfortunately, clinicians do not know much about how this disease affects the subtle force coordination among digits during manipulation. Thus, this study examined the differences in force patterns during cylindrical grasp between TD and healthy subjects. Forty-two TD patients with single digit involvement were included and sorted into four groups based on the involved digits, including thumb, index, middle and ring fingers. Twelve healthy subjects volunteered as healthy controls. Two testing tasks, holding and drinking, were performed by natural grasping with minimal forces. The relations between the force of the thumb and each finger were examined by Pearson correlation coefficients. The force amount and contribution of each digit were compared between healthy controls and each TD group by the independent t test. The results showed all TD groups demonstrated altered correlation patterns of the thumb relative to each finger. Larger forces and higher contributions of the index finger were found during holding by patients with index finger involved, and also during drinking by patients with affected thumb and with affected middle finger. Although no triggering symptom occurred during grasping, the patients showed altered force patterns which may be related to the role of the affected digit in natural grasping function. In conclusion, even if only one digit was affected, the subtle force coordination of all the digits was altered during simple tasks among the TD patients. This study provides the information for the future studies to further comprehend the possible injuries secondary to the altered finger coordination and also to adopt suitable treatment strategies.	[Chen, Po-Tsun; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Lin, Chien-Ju; Chieh, Hsiao-Feng; Su, Fong-Chin; Kuo, Li-Chieh] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan; [Jou, I-Ming] Natl Cheng Kung Univ, Dept Orthoped Surg, Tainan 70101, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Su, FC (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan.	fcsu@mail.ncku.edu.tw; jkkuo@mail.ncku.edu.tw	Lin, Chien-Ju/AAP-5725-2020; Chieh, Hsiao-Feng/AAP-5236-2020; SU, FONG-CHIN/C-8094-2011; Kuo, Li-Chieh/ABC-3826-2021	Lin, Chien-Ju/0000-0001-9571-8610; Chieh, Hsiao-Feng/0000-0001-8844-8026; SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0001-7728-0096; Chen, Po-Tsun/0000-0003-4913-6876; Kuo, Li-Chieh/0000-0002-5644-655X	National Science Council [NSC 99-2627-B-006-012]; National Health Research Institute of Taiwan [NHRI-EX100-10040EI]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This study was supported by National Science Council grant NSC 99-2627-B-006-012 and National Health Research Institute under grant NHRI-EX100-10040EI of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFIFI M, 2012, CLIN NEUROPHYSIOL; Budgeon MK, 2008, EXP BRAIN RES, V189, P345, DOI 10.1007/s00221-008-1430-9; Flanagan JR, 1999, J NEUROPHYSIOL, V81, P1706, DOI 10.1152/jn.1999.81.4.1706; Hsu HY, 2009, J ORTHOP RES, V27, P1534, DOI 10.1002/jor.20903; Jou IM, 2006, J HAND SURG-BRIT EUR, V31B, P191, DOI 10.1016/j.jhsb.2005.11.003; Kuo LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060509; Li ZN, 1998, EXP BRAIN RES, V122, P71, DOI 10.1007/s002210050492; LU SC, 2013, J ORTHOP RES; Rojo-Manaute JM, 2012, J ULTRAS MED, V31, P417, DOI 10.7863/jum.2012.31.3.417; Rearick MP, 2003, J NEUROPHYSIOL, V89, P1317, DOI 10.1152/jn.00581.2002; Redmond CL, 2009, J RHEUMATOL, V36, P2766, DOI 10.3899/jrheum.090239; Santello M, 2000, EXP BRAIN RES, V133, P457, DOI 10.1007/s002210000420; Shim JK, 2004, J APPL PHYSIOL, V97, P213, DOI 10.1152/japplphysiol.00045.2004; Tung WL, 2010, CLIN BIOMECH, V25, P535, DOI 10.1016/j.clinbiomech.2010.02.009; Zatsiorsky VM, 2008, J MOTOR BEHAV, V40, P446, DOI 10.3200/JMBR.40.5.446-476; Zatsiorsky VM, 2003, EXP BRAIN RES, V148, P77, DOI 10.1007/s00221-002-1278-3; Zatsiorsky VM, 2002, BIOL CYBERN, V87, P50, DOI 10.1007/s00422-002-0321-6; Zatsiorsky VM, 2000, EXP BRAIN RES, V131, P187, DOI 10.1007/s002219900261; Zhang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027715	19	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83632	10.1371/journal.pone.0083632	http://dx.doi.org/10.1371/journal.pone.0083632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391799	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200096
J	El Kaoutari, A; Armougom, F; Leroy, Q; Vialettes, B; Million, M; Raoult, D; Henrissat, B				El Kaoutari, Abdessamad; Armougom, Fabrice; Leroy, Quentin; Vialettes, Bernard; Million, Matthieu; Raoult, Didier; Henrissat, Bernard			Development and Validation of a Microarray for the Investigation of the CAZymes Encoded by the Human Gut Microbiome	PLOS ONE			English	Article							VIRAL COMMUNITY; OBESITY; METAGENOMICS; DIVERSITY	Distal gut bacteria play a pivotal role in the digestion of dietary polysaccharides by producing a large number of carbohydrate-active enzymes (CAZymes) that the host otherwise does not produce. We report here the design of a custom microarray that we used to spot non-redundant DNA probes for more than 6,500 genes encoding glycoside hydrolases and lyases selected from 174 reference genomes from distal gut bacteria. The custom microarray was tested and validated by the hybridization of bacterial DNA extracted from the stool samples of lean, obese and anorexic individuals. Our results suggest that a microarray-based study can detect genes from low-abundance bacteria better than metagenomic-based studies. A striking example was the finding that a gene encoding a GH6-family cellulase was present in all subjects examined, whereas metagenomic studies have consistently failed to detect this gene in both human and animal gut microbiomes. In addition, an examination of eight stool samples allowed the identification of a corresponding CAZome core containing 46 families of glycoside hydrolases and polysaccharide lyases, which suggests the functional stability of the gut microbiota despite large taxonomical variations between individuals.	[El Kaoutari, Abdessamad; Henrissat, Bernard] Aix Marseille Univ, Marseille, France; [Henrissat, Bernard] CNRS, UMR 7257, Marseille, France; [El Kaoutari, Abdessamad; Armougom, Fabrice; Leroy, Quentin; Million, Matthieu; Raoult, Didier] Aix Marseille Univ, Fac Med, INSERM 1095, URMITE,UM63,CNRS 7278,Inst Rech Dev 198, Marseille, France; [Henrissat, Bernard] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Vialettes, Bernard] CHU Timone, UMR INRA U1260, Serv Nutr Malad Metab & Endocrinol, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); University of Copenhagen; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Henrissat, B (corresponding author), Aix Marseille Univ, Marseille, France.	bernard.henrissat@afmb.univ-mrs.fr	Henrissat, Bernard/J-2475-2012; EL KAOUTARI, Abdessamad/AAR-8318-2021; RAOULT, Didier/A-8434-2008; Million, Matthieu/F-7693-2011	Henrissat, Bernard/0000-0002-3434-8588; EL KAOUTARI, Abdessamad/0000-0003-2334-3121; RAOULT, Didier/0000-0002-0633-5974; Million, Matthieu/0000-0002-5556-6947	Mediterranean Infection Foundation	Mediterranean Infection Foundation	This work has been supported by the Mediterranean Infection Foundation (http://www.mediterranee-infection.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Brulc JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025329; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DeVries JW, 2003, P NUTR SOC, V62, P37, DOI 10.1079/PNS2002234; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Ferraresso S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-580; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Million M, 2013, INT J OBES LOND; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; O'Keefe SJD, 2009, J NUTR, V139, P2044, DOI 10.3945/jn.109.104380; Pope PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038571; Pope PB, 2011, ISME J, V5, P341, DOI 10.1038/ismej.2010.116; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Smyth GK., 2005, LIMMA LINEAR MODELS; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Tsai Franklin, 2009, Curr Gastroenterol Rep, V11, P307, DOI 10.1007/s11894-009-0045-z; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zoetendal EG, 2006, NAT PROTOC, V1, P870, DOI 10.1038/nprot.2006.142	43	27	27	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84033	10.1371/journal.pone.0084033	http://dx.doi.org/10.1371/journal.pone.0084033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391873	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900016
J	Granek, JA; Pisella, L; Stemberger, J; Vighetto, A; Rossetti, Y; Sergio, LE				Granek, Joshua A.; Pisella, Laure; Stemberger, John; Vighetto, Alain; Rossetti, Yves; Sergio, Lauren E.			Decoupled Visually-Guided Reaching in Optic Ataxia: Differences in Motor Control between Canonical and Non-Canonical Orientations in Space	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; SENSORIMOTOR ADAPTATION; EXPLICIT STRATEGY; PRISM ADAPTATION; CORTICAL SYSTEMS; HAND MOVEMENTS; VISUOMOTOR; EYE; TARGET; MECHANISMS	Guiding a limb often involves situations in which the spatial location of the target for gaze and limb movement are not congruent (i.e. have been decoupled). Such decoupled situations involve both the implementation of a cognitive rule (i.e. strategic control) and the online monitoring of the limb position relative to gaze and target (i.e. sensorimotor recalibration). To further understand the neural mechanisms underlying these different types of visuomotor control, we tested patient IG who has bilateral caudal superior parietal lobule (SPL) damage resulting in optic ataxia (OA), and compared her performance with six age-matched controls on a series of center-out reaching tasks. The tasks comprised 1) directing a cursor that had been rotated (180 degrees or 90 degrees) within the same spatial plane as the visual display, or 2) moving the hand along a different spatial plane than the visual display (horizontal or para-sagittal). Importantly, all conditions were performed towards visual targets located along either the horizontal axis (left and right; which can be guided from strategic control) or the diagonal axes (top-left and top-right; which require on-line trajectory elaboration and updating by sensorimotor recalibration). The bilateral OA patient performed much better in decoupled visuomotor control towards the horizontal targets, a canonical situation in which well-categorized allocentric cues could be utilized (i.e. guiding cursor direction perpendicular to computer monitor border). Relative to neurologically intact adults, IG's performance suffered towards diagonal targets, a non-canonical situation in which only less-categorized allocentric cues were available (i.e. guiding cursor direction at an off-axis angle to computer monitor border), and she was therefore required to rely on sensorimotor recalibration of her decoupled limb. We propose that an intact caudal SPL is crucial for any decoupled visuomotor control, particularly when relying on the realignment between vision and proprioception without reliable allocentric cues towards non-canonical orientations in space.	[Granek, Joshua A.; Stemberger, John; Sergio, Lauren E.] York Univ, Ctr Vis Res, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Pisella, Laure; Vighetto, Alain; Rossetti, Yves] CNRS, INSERM, U1028, Impact Ctr Rech Neurosci Lyon,UMR 5092, Bron, France; [Vighetto, Alain; Rossetti, Yves] Univ Lyon, Lyon, France; [Rossetti, Yves] Hop Neurol & Neurochirurg P Wertheimer, Hosp Civils Lyon, Bron, France	York University - Canada; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Sergio, LE (corresponding author), York Univ, Ctr Vis Res, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	lsergio@yorku.ca	Rossetti, Yves/H-3693-2017; Sergio, Lauren/AAK-3274-2020; Pisella, Laure/H-6072-2017	Rossetti, Yves/0000-0001-8867-4496; Pisella, Laure/0000-0001-6550-3774; Granek, Joshua/0000-0002-7361-5095	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Canadian Institutes of Health Research Canada Graduate Scholarship (JG) and an Natural Sciences and Engineering Research Council discovery operating grant (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeele S, 2001, EXP BRAIN RES, V140, P407, DOI 10.1007/s002210100846; Andersen R A, 1992, Curr Opin Neurobiol, V2, P840, DOI 10.1016/0959-4388(92)90143-9; Batista AP, 2001, J NEUROPHYSIOL, V85, P539, DOI 10.1152/jn.2001.85.2.539; Battaglia-Mayer A, 2000, J NEUROPHYSIOL, V83, P2374, DOI 10.1152/jn.2000.83.4.2374; Battaglia-Mayer A, 2002, BRAIN, V125, P225, DOI 10.1093/brain/awf034; BATTAGLIAMAYER A, 2012, CEREB CORTEX; Battaglini PP, 2002, EXP BRAIN RES, V144, P419, DOI 10.1007/s00221-002-1099-4; BEDFORD FL, 1993, J EXP PSYCHOL HUMAN, V19, P517, DOI 10.1037/0096-1523.19.3.517; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; BIGUER B, 1984, EXP BRAIN RES, V55, P462; Blangero A, 2007, NEUROIMAGE, V36, pT61, DOI 10.1016/j.neuroimage.2007.03.039; Blangero A, 2009, NEUROPSYCHOLOGIA, V47, P1500, DOI 10.1016/j.neuropsychologia.2008.11.030; Blangero A, 2008, CORTEX, V44, P560, DOI 10.1016/j.cortex.2007.09.004; Blangero A, 2010, CORTEX, V46, P77, DOI 10.1016/j.cortex.2009.02.015; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; Bock O, 2003, EXP BRAIN RES, V152, P528, DOI 10.1007/s00221-003-1643-x; Bock O, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00081; Brogaard B, 2011, COGNITIVE SCI, V35, P1076, DOI 10.1111/j.1551-6709.2011.01171.x; Buiatti T, 2013, BRAIN COGNITION, V82, P6, DOI 10.1016/j.bandc.2013.02.004; Buxbaum LI, 2007, J INT NEUROPSYCH SOC, V13, P993, DOI 10.1017/S1355617707071573; Clavagnier S, 2007, NEUROSCIENTIST, V13, P22, DOI 10.1177/1073858406295688; Clower DM, 2000, J NEUROPHYSIOL, V84, P2703, DOI 10.1152/jn.2000.84.5.2703; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; CUNNINGHAM HA, 1989, J EXP PSYCHOL HUMAN, V15, P493, DOI 10.1037/0096-1523.15.3.493; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Fernandez-Ruiz J, 2007, CEREB CORTEX, V17, P2283, DOI 10.1093/cercor/bhl137; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Frey SH, 2007, CORTEX, V43, P368, DOI 10.1016/S0010-9452(08)70462-3; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; GIELEN CCAM, 1984, EXP BRAIN RES, V56, P154, DOI 10.1007/BF00237452; Gorbet DJ, 2009, BRAIN RES, V1284, P77, DOI 10.1016/j.brainres.2009.05.057; Gorbet DJ, 2004, NEUROIMAGE, V23, P1100, DOI 10.1016/j.neuroimage.2004.07.043; Granek JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046619; Granek JA, 2010, CORTEX, V46, P1165, DOI 10.1016/j.cortex.2009.10.009; Grea H, 2002, NEUROPSYCHOLOGIA, V40, P2471, DOI 10.1016/S0028-3932(02)00009-X; Hawkins KM, 2013, J COGNITIVE NEUROSCI, V25, P436, DOI 10.1162/jocn_a_00318; Himmelbach M, 2009, NEUROPSYCHOLOGIA, V47, P1508, DOI 10.1016/j.neuropsychologia.2009.01.033; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Inoue K, 2000, NEUROIMAGE, V11, P505, DOI 10.1006/nimg.2000.0554; Jackson SR, 2005, CURR BIOL, V15, P42, DOI 10.1016/S0960-9822(04)01046-2; Jackson SR, 2009, NEUROPSYCHOLOGIA, V47, P1397, DOI 10.1016/j.neuropsychologia.2009.01.035; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; JEANNEROD M, 1994, NEUROPSYCHOLOGIA, V32, P369, DOI 10.1016/0028-3932(94)90084-1; Jimenez L, 2006, J EXP PSYCHOL LEARN, V32, P475, DOI 10.1037/0278-7393.32.3.475; Karnath HO, 2005, CEREB CORTEX, V15, P1561, DOI 10.1093/cercor/bhi034; Khan AZ, 2007, J VISION, V7, DOI 10.1167/7.5.8; Khan AZ, 2005, NAT NEUROSCI, V8, P418, DOI 10.1038/nn1425; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Milner A. D., 1995, VISUAL BRAIN ACTION; Milner AD, 2003, PROG BRAIN RES, V142, P223; Milner AD, 2006, VISUAL BRAIN ACTION, DOI 10.1093/acprof:oso/9780198524724.001.0001; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Newport R, 2006, CORTEX, V42, P720, DOI 10.1016/S0010-9452(08)70410-6; Novak KE, 2002, EXP BRAIN RES, V144, P351, DOI 10.1007/s00221-002-1060-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pellijeff A, 2006, NEUROPSYCHOLOGIA, V44, P2685, DOI 10.1016/j.neuropsychologia.2006.01.009; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Pisella L, 2006, NEUROPSYCHOLOGIA, V44, P2734, DOI 10.1016/j.neuropsychologia.2006.03.027; Pisella L, 2013, NEUROPSYCHOLOGIA, V51, P106, DOI 10.1016/j.neuropsychologia.2012.11.015; Pisella L, 2009, NEUROPSYCHOLOGIA, V47, P3033, DOI 10.1016/j.neuropsychologia.2009.06.020; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; Redding GM, 1996, J EXP PSYCHOL HUMAN, V22, P379, DOI 10.1037/0096-1523.22.2.379; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Revol P, 2003, SPATIAL VISION, V16, P347, DOI 10.1163/156856803322467572; Rossetti Y, 2005, NEUROPSYCHOLOGIA, V43, P162, DOI 10.1016/j.neuropsychologia.2004.11.004; Rossetti Y, 2003, EXP BRAIN RES, V153, P171, DOI 10.1007/s00221-003-1590-6; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; SAYEGH PF, 2013, J NEUROPHYSIOL; Schenk T, 2006, NAT NEUROSCI, V9, P1369, DOI 10.1038/nn1784; Schenk T, 2010, COGN NEUROSCI-UK, V1, P52, DOI 10.1080/17588920903388950; Sergio LE, 2009, CORTICAL MECHANISMS OF VISION, P81; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Talairach J., 1988, COPLANAR STEREOTAXIC; Thaler L, 2011, EXP BRAIN RES, V211, P313, DOI 10.1007/s00221-011-2691-2; Toni I, 1999, EXP BRAIN RES, V127, P19, DOI 10.1007/s002210050770; Trillenberg P, 2007, NEUROIMAGE, V36, pT69, DOI 10.1016/j.neuroimage.2007.03.038; Vesia M, 2008, J NEUROPHYSIOL, V100, P2005, DOI 10.1152/jn.90519.2008; Vesia M, 2010, J NEUROSCI, V30, P13053, DOI 10.1523/JNEUROSCI.1644-10.2010; Werner S, 2007, EXP BRAIN RES, V178, P554, DOI 10.1007/s00221-007-0925-0; Werner S, 2010, HUM MOVEMENT SCI, V29, P172, DOI 10.1016/j.humov.2010.02.004; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469	90	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e86138	10.1371/journal.pone.0086138	http://dx.doi.org/10.1371/journal.pone.0086138			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392035	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900179
J	Janssen, SF; van der Spek, SJF; ten Brink, JB; Essing, AHW; Gorgels, TGMF; van der Spek, PJ; Jansonius, NM; Bergen, AAB				Janssen, Sarah F.; van der Spek, Sophie J. F.; ten Brink, Jacoline B.; Essing, Anke H. W.; Gorgels, Theo G. M. F.; van der Spek, Peter J.; Jansonius, Nomdo M.; Bergen, Arthur A. B.			Gene Expression and Functional Annotation of the Human and Mouse Choroid Plexus Epithelium	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRODUCTION; OPEN-ANGLE GLAUCOMA; EXTRAMEDULLARY HEMATOPOIESIS; MOLECULAR-MECHANISMS; BLOOD-BRAIN; CELLS; PRESSURE; CONSERVATION; TRANSPORTERS; ACETAZOLAMIDE	Background: The choroid plexus epithelium (CPE) is a lobed neuro-epithelial structure that forms the outer blood-brain barrier. The CPE protrudes into the brain ventricles and produces the cerebrospinal fluid (CSF), which is crucial for brain homeostasis. Malfunction of the CPE is possibly implicated in disorders like Alzheimer disease, hydrocephalus or glaucoma. To study human genetic diseases and potential new therapies, mouse models are widely used. This requires a detailed knowledge of similarities and differences in gene expression and functional annotation between the species. The aim of this study is to analyze and compare gene expression and functional annotation of healthy human and mouse CPE. Methods: We performed 44k Agilent microarray hybridizations with RNA derived from laser dissected healthy human and mouse CPE cells. We functionally annotated and compared the gene expression data of human and mouse CPE using the knowledge database Ingenuity. We searched for common and species specific gene expression patterns and function between human and mouse CPE. We also made a comparison with previously published CPE human and mouse gene expression data. Results: Overall, the human and mouse CPE transcriptomes are very similar. Their major functionalities included epithelial junctions, transport, energy production, neuro-endocrine signaling, as well as immunological, neurological and hematological functions and disorders. The mouse CPE presented two additional functions not found in the human CPE: carbohydrate metabolism and a more extensive list of (neural) developmental functions. We found three genes specifically expressed in the mouse CPE compared to human CPE, being ACE, PON1 and TRIM3 and no human specifically expressed CPE genes compared to mouse CPE. Conclusion: Human and mouse CPE transcriptomes are very similar, and display many common functionalities. Nonetheless, we also identified a few genes and pathways which suggest that the CPE between mouse and man differ with respect to transport and metabolic functions.	[Janssen, Sarah F.; van der Spek, Sophie J. F.; ten Brink, Jacoline B.; Essing, Anke H. W.; Gorgels, Theo G. M. F.; Bergen, Arthur A. B.] Royal Netherlands Acad Arts & Sci KNAW, NIN, Dept Clin & Mol Ophthalmogenet, Amsterdam, Netherlands; [van der Spek, Peter J.] Erasmus Univ, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands; [Jansonius, Nomdo M.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Bergen, Arthur A. B.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [Bergen, Arthur A. B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Janssen, SF (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, NIN, Dept Clin & Mol Ophthalmogenet, Amsterdam, Netherlands.	s.janssen@nin.knaw.nl		Bergen, Arthur/0000-0002-6333-9576; Jansonius, Nomdo/0000-0002-6495-6568; Spek, van der, Sophie J. F./0000-0002-9324-9571	General Dutch Foundation Preventing Blindness (ANVVB); National Foundation for Blinds and Low Vision (LSBS); Foundation Blinden-Penning; Foundation Glaucoomfonds; Rotterdam Foundation of Blinds; Professor Mulder Foundation; UitZicht [UitZicht2008-7]	General Dutch Foundation Preventing Blindness (ANVVB); National Foundation for Blinds and Low Vision (LSBS); Foundation Blinden-Penning; Foundation Glaucoomfonds; Rotterdam Foundation of Blinds; Professor Mulder Foundation; UitZicht	This study was supported by grants from the General Dutch Foundation Preventing Blindness (ANVVB), National Foundation for Blinds and Low Vision (LSBS), Foundation Blinden-Penning, Foundation Glaucoomfonds, Rotterdam Foundation of Blinds and the Professor Mulder Foundation (all together cooperated by UitZicht, project # UitZicht2008-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov Peter N, 2012, Int J Biochem Mol Biol, V3, P365; BECKER NH, 1960, J BIOPHYS BIOCHEM CY, V8, P649, DOI 10.1083/jcb.8.3.649; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; BIENZLE D, 1995, VET PATHOL, V32, P437, DOI 10.1177/030098589503200417; Booij Judith C, 2010, PLoS One, V5, pe9341, DOI 10.1371/journal.pone.0009341; Booij JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-164; Brightman M W, 1968, Prog Brain Res, V29, P19; Brown PD, 2004, NEUROSCIENCE, V129, P957, DOI 10.1016/j.neuroscience.2004.07.003; Carrion E, 2001, ARCH DIS CHILD, V84, P68, DOI 10.1136/adc.84.1.68; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Chalbot S, 2011, J ALZHEIMERS DIS, V25, P505, DOI 10.3233/JAD-2011-101959; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; CHANG Y, 1991, NEUROSURGERY, V29, P287, DOI 10.1227/00006123-199108000-00023; Cornford EM, 1997, EXP BRAIN RES, V116, P399, DOI 10.1007/PL00005768; Crossgrove JS, 2005, EXP BIOL MED, V230, P771, DOI 10.1177/153537020523001011; DHECHAKAISAYA S, 1979, J MED ASSOC THAILAND, V62, P503; DICKSON PW, 1986, J BIOL CHEM, V261, P3475; Eskazan AE, 2012, TRANSFUSION, V52, P1715, DOI 10.1111/j.1537-2995.2011.03499.x; Fonteh AN, 2013, J LIPID RES, V54, P2884, DOI 10.1194/jlr.M037622; HAROUSE JM, 1989, ANN NEUROL, V25, P406, DOI 10.1002/ana.410250414; Hasselblatt M, 2009, CANCER RES, V69, P2219, DOI 10.1158/0008-5472.CAN-08-3176; HOOPER NM, 1991, INT J BIOCHEM, V23, P641, DOI 10.1016/0020-711X(91)90032-I; Janssen SF, 2013, PROG RETIN EYE RES, V37, P31, DOI 10.1016/j.preteyeres.2013.09.001; Janssen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044973; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Johnson C, 2004, CEREBROSPINAL FLUID, V1; Kapoor KG, 2008, BRAIN RES BULL, V77, P327, DOI 10.1016/j.brainresbull.2008.08.009; Kuhn A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-26; Labonte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075603; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Liddelow SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033554; Liebeskind DS, 2004, AM J NEURORADIOL, V25, P289; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mahadevan A, 2007, J NEUROPATH EXP NEUR, V66, P799, DOI 10.1097/NEN.0b013e3181461d3e; Gonzalez AM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-4; Marques F, 2009, ENDOCRINOLOGY, V150, P2822, DOI 10.1210/en.2008-1610; Marques F, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-10; MCCARTHY KD, 1974, J PHARMACOL EXP THER, V189, P194; MILHORAT TH, 1973, SCIENCE, V180, P76, DOI 10.1126/science.180.4081.76; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Perez-Gracia E, 2009, ACTA NEUROPATHOL, V118, P497, DOI 10.1007/s00401-009-0574-4; Poca MA, 2005, EXPERT OPIN PHARMACO, V6, P1525, DOI 10.1517/14656566.6.9.1525; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Ren RJ, 2011, GRAEF ARCH CLIN EXP, V249, P1057, DOI 10.1007/s00417-011-1657-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Rouault TA, 2009, METAB BRAIN DIS, V24, P673, DOI 10.1007/s11011-009-9169-y; Sallusto F, 2012, IMMUNOL REV, V248, P216, DOI 10.1111/j.1600-065X.2012.01140.x; Sancesario GM, 2012, J ALZHEIMERS DIS, V31, P865, DOI 10.3233/JAD-2012-120211; Saunders NR, 2013, MOL ASPECTS MED, V34, P742, DOI 10.1016/j.mam.2012.11.006; Schneider H, 2012, VIRUS RES, V170, P66, DOI 10.1016/j.virusres.2012.08.019; Serot JM, 1997, NEUROREPORT, V8, P1995, DOI 10.1097/00001756-199705260-00039; Serot JM, 2000, ACTA NEUROPATHOL, V99, P105, DOI 10.1007/PL00007412; Smith DE, 2004, ADV DRUG DELIVER REV, V56, P1765, DOI 10.1016/j.addr.2004.07.008; Strand AD, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030059; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tabesh Homayoun, 2011, J Med Case Rep, V5, P580, DOI 10.1186/1752-1947-5-580; van Soest SS, 2007, MOL VIS, V13, P1608; Vercellino M, 2008, J NEUROIMMUNOL, V199, P133, DOI 10.1016/j.jneuroim.2008.04.035; Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8; Yablonski M, 1979, INVEST OPHTHALMOL S, V18; Zheng-Bradley X, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r124	65	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83345	10.1371/journal.pone.0083345	http://dx.doi.org/10.1371/journal.pone.0083345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391755	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200052
J	Kim, EC; Choi, SK; Lim, M; Yeon, SI; Lee, YH				Kim, Eok-Cheon; Choi, Soo-Kyoung; Lim, Mihwa; Yeon, Soo-In; Lee, Young-Ho			Role of Endogenous ENaC and TRP Channels in the Myogenic Response of Rat Posterior Cerebral Arteries	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; BLOOD-FLOW; CAENORHABDITIS-ELEGANS; SIGNALING MECHANISMS; ACTIVATION; TRANSDUCTION; PROTEINS; TONE; MECHANOTRANSDUCTION; AUTOREGULATION	Aims: Mechanogated ion channels are predicted to mediate pressure-induced myogenic vasoconstriction in small resistance arteries. Recent findings have indicated that transient receptor potential (TRP) channels and epithelial sodium channels (ENaC) are involved in mechanotransduction. The purpose of this study was to investigate the role of TRP channels and ENaC in the myogenic response. Our previous study suggested that ENaC could be a component of the mechanosensitive ion channels in rat posterior cerebral arteries (PCA). However, the specific ion channel proteins mediating myogenic constriction are unknown. Here we found, for the first time, that ENaC interacted with TRPM4 but not with TRPC6 using immunoprecipitation and confocal microscopy. Methods and Results: Treatment with a specific beta ENaC inhibitor, amiloride, a specific TRPM4 inhibitor, 9-phenanthrol, and a TRPC6 inhibitor, SKF96365, resulted in inhibition of the pressure-induced myogenic response. Moreover, the myogenic response was inhibited in rat PCA transfected with small interfering RNA of beta ENaC, TRPM4, and TRPC6. Co-treatment with amiloride and 9-phenanthrol showed a similar inhibitory effect on myogenic contraction compared to single treatment with amiloride or 9-phenanthrol. The myogenic response was not affected by 9-phenanthrol or amiloride treatment in PCA transfected with beta ENaC or TRPM4 siRNA, respectively. However, pressure-induced myogenic response was fully inhibited by co-treatment with amiloride, 9-phenanthrol, and SKF96365, and by treatment with SKF96365 in PCA transfected with beta ENaC siRNA. Conclusion: Our results suggest that ENaC, TRPM4, and TRPC6 play important roles in the pressure-induced myogenic response, and that ENaC and TRPM4 interact in rat PCA.	[Kim, Eok-Cheon; Choi, Soo-Kyoung; Lim, Mihwa; Yeon, Soo-In; Lee, Young-Ho] Yonsei Univ, Coll Med, Dept Physiol, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System	Lee, YH (corresponding author), Yonsei Univ, Coll Med, Dept Physiol, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.	yhlee@yuhs.ac		Lee, Young-Ho/0000-0002-5749-1045; Choi, Soo-Kyoung/0000-0002-7115-6358	Basic Science Research Program of the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0007540]	Basic Science Research Program of the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0007540). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broughton BRS, 2008, AM J PHYSIOL-LUNG C, V294, pL797, DOI 10.1152/ajplung.00253.2007; Chen XP, 2010, J CELL MOL MED, V14, P2483, DOI 10.1111/j.1582-4934.2009.00890.x; Cho YE, 2011, CARDIOVASC RES, V91, P162, DOI 10.1093/cvr/cvr043; Choi SK, 2009, CARDIOVASC RES, V82, P324, DOI 10.1093/cvr/cvp054; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; DANGELO G, 1994, HYPERTENSION, V23, P1096, DOI 10.1161/01.HYP.23.6.1096; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Dora KA, 2005, AM J PHYSIOL-HEART C, V289, pH1323, DOI 10.1152/ajpheart.00513.2005; Drummond HA, 2004, HYPERTENSION, V44, P643, DOI 10.1161/01.HYP.0000144465.56360.ad; Drummond HA, 2008, PHYSIOLOGY, V23, P23, DOI 10.1152/physiol.00034.2007; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Earley S, 2007, AM J PHYSIOL-HEART C, V292, pH2613, DOI 10.1152/ajpheart.01286.2006; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC1195, DOI 10.1152/ajpcell.00269.2010; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; Guan ZR, 2009, HYPERTENSION, V54, P1062, DOI 10.1161/HYPERTENSIONAHA.109.137992; Hill MA, 2006, CLIN HEMORHEOL MICRO, V34, P67; Hill MA, 2001, J APPL PHYSIOL, V91, P973, DOI 10.1152/jappl.2001.91.2.973; HUDSPETH AJ, 1992, SOC GEN PHY, V47, P357; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Jernigan NL, 2006, AM J PHYSIOL-RENAL, V291, pF1184, DOI 10.1152/ajprenal.00177.2006; Jernigan NL, 2005, AM J PHYSIOL-RENAL, V289, pF891, DOI 10.1152/ajprenal.00019.2005; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; Kim EC, 2012, EXP PHYSIOL, V97, P544, DOI 10.1113/expphysiol.2011.062232; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Liu Y, 2011, HYPERTENS RES, V34, P630, DOI 10.1038/hr.2011.5; Loutzenhiser R, 2002, CIRC RES, V90, P1316, DOI 10.1161/01.RES.0000024262.11534.18; Matchkov VV, 2002, AM J PHYSIOL-HEART C, V283, pH118, DOI 10.1152/ajpheart.00690.2001; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Oyabe A, 2000, FUND CLIN PHARMACOL, V14, P369, DOI 10.1111/j.1472-8206.2000.tb00418.x; Reading SA, 2007, STROKE, V38, P2322, DOI 10.1161/STROKEAHA.107.483404; Schubert R, 1999, CLIN SCI, V96, P313, DOI 10.1042/CS19980403; Sun YH, 2010, BIOCHEM BIOPH RES CO, V394, P955, DOI 10.1016/j.bbrc.2010.03.096; Syntichaki P, 2004, PHYSIOL REV, V84, P1097, DOI 10.1152/physrev.00043.2003; VanBavel E, 1998, CIRC RES, V82, P210; Voets T, 2003, J MEMBRANE BIOL, V192, P1, DOI 10.1007/s00232-002-1059-8; Welsh DG, 2002, CIRC RES, V90, P248, DOI 10.1161/hh0302.105662; Zhu ZM, 2011, PFLUG ARCH EUR J PHY, V461, P211, DOI 10.1007/s00424-010-0902-5; Zunker P, 2000, ULTRASOUND OBST GYN, V16, P179, DOI 10.1046/j.1469-0705.2000.00194.x	42	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84194	10.1371/journal.pone.0084194	http://dx.doi.org/10.1371/journal.pone.0084194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391909	Green Submitted, gold, Green Published			2022-12-27	WOS:000329323900052
J	Mongi, AS; Baisley, K; Ao, TTH; Chilongani, J; Aguirre-Andreasen, A; Francis, SC; Shao, J; Hayes, R; Kapiga, S				Mongi, Aika S.; Baisley, Kathy; Trong Thanh-Hoang Ao; Chilongani, Joseph; Aguirre-Andreasen, Aura; Francis, Suzanna C.; Shao, John; Hayes, Richard; Kapiga, Saidi			Factors Associated with Problem Drinking among Women Employed in Food and Recreational Facilities in Northern Tanzania	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; SUB-SAHARAN AFRICA; ALCOHOL-USE; SEXUAL-BEHAVIOR; HOTEL WORKERS; RISK-FACTORS; HIV-INFECTION; CAGE QUESTIONNAIRE; GLOBAL BURDEN; FEMALE BAR	Background: There is growing evidence that alcohol consumption is associated with increased risk of HIV infection. To determine factors associated with problem drinking, we analyzed data collected in two prospective cohorts of at-risk female food and recreational facility workers in northern Tanzania. Methods: We enrolled HIV seronegative women aged 18-44 years and employed in the towns of Geita, Kahama, Moshi, and Shinyanga. At enrolment, women were interviewed to obtain information about alcohol use, using CAGE and AUDIT screening scales, and risk factors for HIV infection. Blood and genital samples were collected for detection of HIV and sexually transmitted infections (STIs). We characterized alcohol use, concordance, and agreement of the scales, and examined the associations between characteristics of participants and problem drinking as defined by both scales using logistic regression. Lastly, we assessed problem drinking as a risk factor for recent sexual behavior and prevalent STIs. Results: Among enrollees, 68% women reported ever drinking alcohol; of these 76% reported drinking alcohol in the past 12 months. The prevalence of problem drinking was 20% using CAGE and 13% using AUDIT. Overall concordance between the scales was 75.0% with a Kappa statistic of 0.58. After adjusting for age, independent factors associated with problem drinking, on both scales, were marital status, occupation, facility type, increasing number of lifetime sexual partners, and transactional sex in the past 12 months. In addition, women who were problem drinkers on either scale were more likely to report having >= 1 sexual partner (CAGE: aOR = 1.56, 95% confidence interval, CI: 1.10-2.23; AUDIT: aOR = 2.00, 95% CI: 1.34-3.00) and transactional sex (CAGE: aOR = 1.79, 95% CI: 1.26-2.56; AUDIT: aOR = 1.51, 95% CI: 1.04-2.18), in the past 3 months. Conclusion: These findings suggest that interventions to reduce problem drinking in this population may reduce high-risk sexual behaviors and contribute in lowering the risk of HIV infection.	[Mongi, Aika S.; Trong Thanh-Hoang Ao; Francis, Suzanna C.; Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Baisley, Kathy; Trong Thanh-Hoang Ao; Aguirre-Andreasen, Aura; Francis, Suzanna C.; Hayes, Richard; Kapiga, Saidi] London Sch Hyg & Trop Med, London WC1, England; [Chilongani, Joseph] Natl Inst Med Res, Mwanza, Tanzania; [Shao, John] Kilimanjaro Christian Med Ctr, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; Kilimanjaro Christian Medical Centre	Kapiga, S (corresponding author), Mwanza Intervent Trials Unit, Mwanza, Tanzania.	Saidi.Kapiga@lshtm.ac.uk	shao, jianfu/N-2447-2018	shao, jianfu/0000-0002-6632-8207; Hayes, Richard/0000-0002-1729-9892; Kapiga, Saidi/0000-0003-1753-4060; Francis, Suzanna Carter/0000-0002-3724-4813; Andreasen, Aura/0000-0003-0664-7342	European and Developing Countries Clinical Trials Partnership (EDCTP) [CT_ct_05_ 32070_002]; EDCTP; Bill and Melinda Gates Foundation [CG_ct_06_33111]; UK aid from the Department of International Development [PHGHHD7610]; MRC [G1002369, G0901756, G0701039] Funding Source: UKRI; Medical Research Council [MR/K012126/1, G0701039, G1002369] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership (EDCTP); EDCTP; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK aid from the Department of International Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The microbicide preparedness study was funded by the European and Developing Countries Clinical Trials Partnership (EDCTP; project code: CT_ct_05_ 32070_002) and the HIV vaccines feasibility cohort was funded by EDCTP and the Bill and Melinda Gates Foundation (project code: CG_ct_06_33111). Partial support for drafting the manuscript was provided by STRIVE RPC with funding from the UK aid from the Department of International Development (DFID; project code: PHGHHD7610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao T, 2003, INT J STD AIDS, V14, P688, DOI 10.1258/095646203322387956; Ao TTH, 2006, SEX TRANSM DIS, V33, P163, DOI 10.1097/01.olq.0000187204.57006.b3; Babor TF., 2001, AUDIT ALCOHOL USE DI; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Bradley KA, 1998, JAMA-J AM MED ASSOC, V280, P166, DOI 10.1001/jama.280.2.166; Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI 10.1258/ijsa.2000.009432; Clift S, 2003, SEX TRANSM INFECT, V79, P307, DOI 10.1136/sti.79.4.307; Ewing JA, 1998, BRIT MED J, V316, P1827, DOI 10.1136/bmj.316.7147.1827; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Ewing JA, 1998, JAMA-J AM MED ASSOC, V280, P1904, DOI 10.1001/jama.280.22.1904; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Fisher JC, 2008, SEX TRANSM DIS, V35, P537, DOI 10.1097/OLQ.0b013e3181677547; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Fritz K, 2010, LANCET, V376, P398, DOI 10.1016/S0140-6736(10)60884-7; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P102, DOI 10.1097/OLQ.0b013e31818b20e6; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kapiga SH, 2006, AIDS CARE, V18, P379, DOI 10.1080/09540120500465012; Kapiga SH, 2007, J INFECT DIS, V195, P1260, DOI 10.1086/513566; Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825; Kapiga SH, 2003, SEX TRANSM DIS, V30, P187, DOI 10.1097/00007435-200303000-00001; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mahony JB, 2001, J CLIN MICROBIOL, V39, P1429, DOI 10.1128/JCM.39.4.1429-1435.2001; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Norris AH, 2009, SOC SCI MED, V69, P1167, DOI 10.1016/j.socscimed.2009.07.015; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; STEELE CM, 1990, AM PSYCHOL, V45, P921, DOI 10.1037/0003-066X.45.8.921; Tassiopoulos KK, 2006, AIDS BEHAV, V10, P405, DOI 10.1007/s10461-006-9112-8; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Walker Robert, 2004, Trauma Violence Abuse, V5, P143, DOI 10.1177/1524838003262333; Watson-Jones D, 2009, AIDS, V23, P415, DOI 10.1097/QAD.0b013e32831ef523; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Watt MH, 2012, SOC SCI MED, V74, P1005, DOI 10.1016/j.socscimed.2011.12.022; Weinhardt LS, 1998, ARCH SEX BEHAV, V27, P155, DOI 10.1023/A:1018682530519; Woolf-King SE, 2011, ARCH SEX BEHAV, V40, P17, DOI 10.1007/s10508-009-9516-4; World Health Organization, 2011, GLOB STAT REP ALC HL	42	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84447	10.1371/journal.pone.0084447	http://dx.doi.org/10.1371/journal.pone.0084447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391956	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000329323900099
J	Nishiyama, K; Ochiai, A; Tsubokawa, D; Ishihara, K; Yamamoto, Y; Mukai, T				Nishiyama, Keita; Ochiai, Ayaka; Tsubokawa, Daigo; Ishihara, Kazuhiko; Yamamoto, Yuji; Mukai, Takao			Identification and Characterization of Sulfated Carbohydrate-Binding Protein from Lactobacillus reuteri	PLOS ONE			English	Article							ELONGATION-FACTOR TU; HELICOBACTER-PYLORI; MYCOPLASMA-PNEUMONIAE; ADHESION PROPERTIES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PSEUDOMONAS-AERUGINOSA; FIBRONECTIN-BINDING; MUCUS GLYCOPROTEIN; SURFACE PROTEIN; GASTRIC MUCIN	We previously purified a putative sulfated-galactosylceramide (sulfatide)-binding protein with a molecular weight of 47 kDa from the cell surface of Lactobacillus reuteri JCM1081. The aim of this study was to identify the 47-kDa protein, examine its binding to sulfated glycolipids and mucins, and evaluate its role in bacterial adhesion to mucosal surfaces. By cloning and sequencing analysis, the 47-kDa protein was identified as elongation factor-Tu (EF-Tu). Adhesion properties were examined using 6xHistidine-fused EF-Tu (His(6)-EF-Tu). Surface plasmon resonance analysis demonstrated pH-dependent binding of His(6)-EF-Tu to sulfated glycolipids, but not to neutral or sialylated glycolipids, suggesting that a sulfated galactose residue was responsible for EF-Tu binding. Furthermore, His(6)-EF-Tu was found to bind to porcine gastric mucin (PGM) by enzyme-linked immunosorbent assay. Binding was markedly reduced by sulfatase treatment of PGM and in the presence of acidic and desialylated oligosaccharide fractions containing sulfated carbohydrate residues prepared from PGM, demonstrating that sulfated carbohydrate moieties mediated binding. Histochemical staining revealed similar localization of His(6)-EF-Tu and high iron diamine staining in porcine mucosa. These results indicated that EF-Tu bound PGM via sulfated carbohydrate moieties. To characterize the contribution of EF-Tu to the interaction between bacterial cells and PGM, we tested whether anti-EF-Tu antibodies could inhibit the interaction. Binding of L. reuteri JCM1081 to PGM was significantly blocked in a concentration-dependent matter, demonstrating the involvement of EF-Tu in bacterial adhesion. In conclusion, the present results demonstrated, for the first time, that EF-Tu bound sulfated carbohydrate moieties of sulfated glycolipids and sulfomucin, thereby promoting adhesion of L. reuteri to mucosal surfaces.	[Nishiyama, Keita; Ochiai, Ayaka; Yamamoto, Yuji; Mukai, Takao] Kitasato Univ, Dept Anim Sci, Sch Vet Med, Towada, Aomori, Japan; [Tsubokawa, Daigo] Kitasato Univ, Sch Med, Dept Parasitol, Sagamihara, Kanagawa 228, Japan; [Ishihara, Kazuhiko] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan	Kitasato University; Kitasato University; Kitasato University	Mukai, T (corresponding author), Kitasato Univ, Dept Anim Sci, Sch Vet Med, Towada, Aomori, Japan.	mukai@vmas.kitasato-u.ac.jp	Tsubokawa, Daigo/AHD-3762-2022	Tsubokawa, Daigo/0000-0002-4344-5128	Japan Society for the Promotion of Science (JSPS) [21580334, 24580397]; Grants-in-Aid for Scientific Research [24580397] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research C (21580334 and 24580397) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Antikainen J, 2007, J BACTERIOL, V189, P4539, DOI 10.1128/JB.00378-07; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Balasubramanian S, 2009, INFECT IMMUN, V77, P3533, DOI 10.1128/IAI.00081-09; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Brockhausen I, 2003, BIOCHEM SOC T, V31, P318, DOI 10.1042/BST0310318; Brockhausen I, 1997, TRENDS GLYCOSCI GLYC, V9, P379, DOI 10.4052/tigg.9.379; Coic YM, 2012, J BIOL CHEM, V287, P15916, DOI 10.1074/jbc.M111.310003; Croix JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024447; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dallo SF, 2012, SCI WORLD J, DOI 10.1100/2012/128705; de Leeuw E, 2006, FEMS MICROBIOL LETT, V260, P210, DOI 10.1111/j.1574-6968.2006.00313.x; Deepika G, 2010, ADV APPL MICROBIOL, V70, P127, DOI 10.1016/S0065-2164(10)70004-6; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dhanani AS, 2013, J APPL MICROBIOL, V115, P546, DOI 10.1111/jam.12249; Duary RK, 2012, MOL BIOL REP, V39, P2541, DOI 10.1007/s11033-011-1006-9; Francius G, 2008, ACS NANO, V2, P1921, DOI 10.1021/nn800341b; Goso Y, 1999, J BIOCHEM-TOKYO, V126, P375, DOI 10.1093/oxfordjournals.jbchem.a022460; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Gross G, 2010, BENEF MICROBES, V1, P61, DOI 10.3920/BM2008.1006; Huang IN, 2013, J APPL MICROBIOL, V114, P854, DOI 10.1111/jam.12063; Huesca M, 1998, INFECT IMMUN, V66, P4061; Jansson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004487; Kamisago S, 1996, INFECT IMMUN, V64, P624, DOI 10.1128/IAI.64.2.624-628.1996; Kinoshita H, 2008, RES MICROBIOL, V159, P685, DOI 10.1016/j.resmic.2008.07.005; Kobayashi M, 2009, GLYCOBIOLOGY, V19, P453, DOI 10.1093/glycob/cwp004; KOMURO Y, 1992, GASTROENTEROL JPN, V27, P466; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; LORTAL S, 1992, J GEN MICROBIOL, V138, P611, DOI 10.1099/00221287-138-3-611; MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mukai T, 2002, FEMS IMMUNOL MED MIC, V32, P105, DOI 10.1111/j.1574-695X.2002.tb00541.x; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; PLOUG M, 1989, ANAL BIOCHEM, V181, P33, DOI 10.1016/0003-2697(89)90390-4; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Ramiah K, 2007, INT J FOOD MICROBIOL, V116, P405, DOI 10.1016/j.ijfoodmicro.2007.02.011; ROBERTON AM, 1993, BIOCHEM J, V293, P683, DOI 10.1042/bj2930683; Rojas M, 2002, APPL ENVIRON MICROB, V68, P2330, DOI 10.1128/AEM.68.5.2330-2336.2002; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; Scharfman A, 2000, GLYCOCONJUGATE J, V17, P735, DOI 10.1023/A:1011091112884; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Servin AL, 2003, BEST PRACT RES CL GA, V17, P741, DOI 10.1016/S1521-6918(03)00052-0; SPICER SS, 1965, J HISTOCHEM CYTOCHEM, V13, P599, DOI 10.1177/13.7.599; Teneberg S, 1997, J BIOL CHEM, V272, P19067, DOI 10.1074/jbc.272.30.19067; Tsubokawa D, 2007, FEBS J, V274, P1833, DOI 10.1111/j.1742-4658.2007.05731.x; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; Veerman ECI, 1997, GLYCOBIOLOGY, V7, P737, DOI 10.1093/glycob/7.6.737; Velez MP, 2007, FEMS MICROBIOL LETT, V276, P140, DOI 10.1111/j.1574-6968.2007.00908.x; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09	49	33	34	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83703	10.1371/journal.pone.0083703	http://dx.doi.org/10.1371/journal.pone.0083703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391811	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200109
J	Caraballo, JC; Borcherding, J; Rector, M; Hornick, E; Stoltz, D; Zabner, J; Comellas, AP				Caraballo, Juan Carlos; Borcherding, Jennifer; Rector, Michael; Hornick, Emma; Stoltz, David; Zabner, Joseph; Comellas, Alejandro P.			Role of PON in Anoxia-Reoxygenation Injury: A Drosophila Melanogaster Transgenic Model	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; OXIDATIVE STRESS; GENE POLYMORPHISMS; PARAOXONASE 1; EXPRESSION; TISSUE; LIVER	Background: Paraoxonase 1 (PON1) is a protein found associated with high density lipoprotein (HDL), thought to prevent oxidative modification of low-density lipoprotein (LDL). This enzyme has been implicated in lowering the risk of cardiovascular disease. Anoxia-reoxygenation and oxidative stress are important elements in cardiovascular and cerebrovascular disease. However, the role of PON1 in anoxia-reoxygenation or anoxic injury is unclear. We hypothesize that PON1 prevents anoxia-reoxygenation injury. We set out to determine whether PON1 expression in Drosophila melanogaster protects against anoxia-reoxygenation (A-R) induced injury. Methods: Wild type (WT) and transgenic PON1 flies were exposed to anoxia (100% Nitrogen) for different time intervals (from 1 to 24 hours). After the anoxic period, flies were placed in room air for reoxygenation. Activity and survival of flies was then recorded. Results: Within 5 minutes of anoxia, all flies fell into a stupor state. After reoxygenation, survivor flies resumed activity with some delay. Interestingly, transgenic flies recovered from stupor later than WT. PON1 transgenic flies had a significant survival advantage after A-R stress compared with WT. The protection conferred by PON1 expression was present regardless of the age or dietary restriction. Furthermore, PON1 expression exclusively in CNS conferred protection. Conclusion: Our results support the hypothesis that PON1 has a protective role in anoxia-reoxygenation injury, and its expression in the CNS is sufficient and necessary to provide a 100% survival protection.	[Caraballo, Juan Carlos; Borcherding, Jennifer; Rector, Michael; Hornick, Emma; Stoltz, David; Zabner, Joseph; Comellas, Alejandro P.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa	Caraballo, JC (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	juan-caraballo@uiowa.edu	Comellas, Alejandro/AAE-5661-2019	Comellas, Alejandro/0000-0003-1521-7520; Zabner, Joseph/0000-0002-9606-1339; Stoltz, David/0000-0003-0893-9015	National Institutes of Health/National Heart, Lung, and Blood Institute [K01HL080966-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL080966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health/National Heart, Lung, and Blood Institute grant K01HL080966-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2010, EUR J EPIDEMIOL, V25, P449, DOI 10.1007/s10654-010-9470-4; Berrougui H, 2012, FREE RADICAL BIO MED, V52, P1372, DOI 10.1016/j.freeradbiomed.2012.01.019; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cherubini A, 2005, FREE RADICAL BIO MED, V39, P841, DOI 10.1016/j.freeradbiomed.2005.06.025; Dahabreh IJ, 2010, GENET MED, V12, P606, DOI 10.1097/GIM.0b013e3181ee81c6; Deakin SP, 2011, FREE RADICAL BIO MED, V50, P102, DOI 10.1016/j.freeradbiomed.2010.09.002; Estin ML, 2010, ADV EXP MED BIOL, V660, P183, DOI 10.1007/978-1-60761-350-3_17; Ferretti G, 2008, CLIN CHEM LAB MED, V46, P113, DOI 10.1515/CCLM.2008.011; Giordano G, 2013, FREE RADICAL BIO MED, V58, P98, DOI 10.1016/j.freeradbiomed.2013.01.019; Giordano G, 2011, TOXICOL APPL PHARM, V256, P369, DOI 10.1016/j.taap.2011.02.014; Gungor O, 2011, J ATHEROSCLEROSIS TH; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Huang Y, 2013, J CLIN INVESTIGATION; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Mackness B, 2004, BIOCHEM BIOPH RES CO, V318, P680, DOI 10.1016/j.bbrc.2004.04.056; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness B, 1997, ARTERIOSCL THROM VAS, V17, P1233, DOI 10.1161/01.ATV.17.7.1233; Mackness B, 2013, ARCH MED SCI, V9, P8, DOI 10.5114/aoms.2013.33189; Mackness B, 2010, IUBMB LIFE, V62, P480, DOI 10.1002/iub.347; Mohamed RH, 2010, CLIN BIOCHEM, V43, P553, DOI 10.1016/j.clinbiochem.2009.12.015; Motulsky H., 1995, INTUITIVE BIOSTATIST; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Pfohl M, 1999, DIABETES, V48, P623, DOI 10.2337/diabetes.48.3.623; Rice GI, 1997, CORONARY ARTERY DIS, V8, P677, DOI 10.1097/00019501-199711000-00001; Rodrigo L, 2001, CHEM-BIOL INTERACT, V137, P123, DOI 10.1016/S0009-2797(01)00225-3; Rozenberg O, 2003, FREE RADICAL BIO MED, V34, P774, DOI 10.1016/S0891-5849(02)01429-6; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Simon T, 2011, CLIN PHARMACOL THER, V90, P561, DOI 10.1038/clpt.2011.193; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Stoltz DA, 2008, J CLIN INVEST, V118, P3123, DOI 10.1172/JCI35147; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Tufek A, 2013, INT J SURG, V11, P96, DOI 10.1016/j.ijsu.2012.12.003; Unal E, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/979506; Vigne P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005422; Wang MS, 2011, ATHEROSCLEROSIS, V214, P377, DOI 10.1016/j.atherosclerosis.2010.11.028; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0	37	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84434	10.1371/journal.pone.0084434	http://dx.doi.org/10.1371/journal.pone.0084434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400090	Green Published, gold			2022-12-27	WOS:000329462700024
J	Inaba, H; Takeshita, K; Uchida, Y; Hayashi, M; Okumura, T; Hirashiki, A; Yoshikawa, D; Ishii, H; Yamamoto, K; Nakayama, T; Hirayama, M; Matsumoto, H; Matsushita, T; Murohara, T				Inaba, Hatsumi; Takeshita, Kyosuke; Uchida, Yasuhiro; Hayashi, Motoharu; Okumura, Takahiro; Hirashiki, Akihiro; Yoshikawa, Daiji; Ishii, Hideki; Yamamoto, Koji; Nakayama, Takayuki; Hirayama, Masaaki; Matsumoto, Hiroyuki; Matsushita, Tadashi; Murohara, Toyoaki			Recovery of Flow-Mediated Vasodilatation after Repetitive Measurements Is Involved in Early Vascular Impairment: Comparison with Indices of Vascular Tone	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; BRACHIAL-ARTERY; ULTRASOUND ASSESSMENT; CARDIOVASCULAR RISK; CIGARETTE-SMOKING; TIME-COURSE; DILATION; CONSTRICTION; DILATATION; STIFFNESS	In repetitive measurements of flow-mediated dilatation (FMD), the duration of the interval between measurements remains controversial. In this pilot study, we conducted three sequential measurements of low-flow-mediated constriction (L-FMC), FMD and flow-mediated total dilation (FMTD; L-FMC+FMD) at baseline and intervals of 15 and 60 min in 30 healthy males. FMD15, L-FMC15, and FMTD15 were significantly lower than the respective first measurements, but all indices showed full recovery at 60 min in all subjects. The baseline diameter was slightly increased at 15 min and restored at 60 min, but the maximum diameter, and the baseline and reactive flow velocity unchanged. We examined the relationship between recovery rate of FMTD at 15 min (FMTD-R) and cardio-ankle vascular index (CAVI). Univariate analysis showed moderate correlation between FMTD-R, and CAVI and L-FMC0. Patients were divided according to FMTD-R value; the low-FMTD-R group [below the median value (-26.2%)] included a significantly higher proportion of smokers and higher CAVI values than the high-FMTD-R group. The reproducibility of FMTD and FMTD-R was evaluated in another group of 25 healthy subjects. The range of variation across measurements was 1.1% for FMTD and 4.6% for FMTD-R; with intraclass correlation coefficients of 0.93 and 0.95, respectively. The present study demonstrated blunted recovery of FMD within 15 min, suggesting the need for selection of a more adequate interval between measurements to avoid underestimation of FMD in subsequent measurements. The findings demonstrated the reproducibility of FMTD-R and FMTD measurements, and that FMTD-R might be involved in arterial stiffness and early vascular impairment in the healthy subjects.	[Inaba, Hatsumi; Takeshita, Kyosuke; Hirayama, Masaaki; Matsumoto, Hiroyuki; Matsushita, Tadashi] Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan; [Takeshita, Kyosuke; Uchida, Yasuhiro; Hayashi, Motoharu; Okumura, Takahiro; Hirashiki, Akihiro; Yoshikawa, Daiji; Ishii, Hideki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Yamamoto, Koji; Matsushita, Tadashi] Nagoya Univ Hosp, Dept Transfus, Nagoya, Aichi, Japan; [Nakayama, Takayuki] Aichi Univ Hosp, Dept Transfus, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University	Takeshita, K (corresponding author), Nagoya Univ Hosp, Dept Clin Lab, Nagoya, Aichi, Japan.	kyousuke@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; Ishii, Hideki/M-4871-2014; Hirashiki, Akihiro/M-4855-2014; Hirayama, Masaaki/I-9341-2018; Takeshita, Kyosuke/B-7008-2012; Takeshita, Kyosuke/AAD-9515-2020; Hirayama, Masaaki/ABH-2669-2020; Matsushita, Tadadshi/I-7349-2014	Ishii, Hideki/0000-0003-4348-0123; Hirashiki, Akihiro/0000-0002-3234-3177; Hirayama, Masaaki/0000-0003-0092-7837; Takeshita, Kyosuke/0000-0002-8283-3799; Takeshita, Kyosuke/0000-0002-8283-3799; Nakayama, Takayuki/0000-0003-2389-2542	Aichi Health Promotion Foundation; SENSHIN Medical Research Foundation;  [Kakenhi 25461336]	Aichi Health Promotion Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); 	This work was supported by research grants from the Aichi Health Promotion Foundation (to KT), the SENSHIN Medical Research Foundation (to KT), and Grant-in-Aid for Scientific Research (Kakenhi 25461336 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton M, 2011, ULTRASOUND MED BIOL, V37, P879, DOI 10.1016/j.ultrasmedbio.2011.03.007; Black MA, 2008, HYPERTENSION, V51, P203, DOI 10.1161/HYPERTENSIONAHA.107.101014; Bots ML, 2005, EUR HEART J, V26, P363, DOI 10.1093/eurheartj/ehi017; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Charakida M, 2010, EUR HEART J, V31, P2854, DOI 10.1093/eurheartj/ehq340; Clarkson P, 1997, CIRCULATION, V96, P3378; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DeVan AE, 2011, AM J PHYSIOL-HEART C, V300, pH813, DOI 10.1152/ajpheart.00845.2010; Gori T, 2010, HEART, V96, P141, DOI 10.1136/hrt.2009.167213; Gori T, 2008, J AM COLL CARDIOL, V51, P1953, DOI 10.1016/j.jacc.2008.01.049; Gori T, 2012, EUR HEART J, V33, P363, DOI 10.1093/eurheartj/ehr361; Gori T, 2011, EUR HEART J, V32, P784, DOI 10.1093/eurheartj/ehq412; Harris RA, 2010, HYPERTENSION, V55, P1075, DOI 10.1161/HYPERTENSIONAHA.110.150821; Harrison M, 2011, CLIN PHYSIOL FUNCT I, V31, P394, DOI 10.1111/j.1475-097X.2011.01032.x; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Juonala M, 2007, CIRCULATION, V116, P1367, DOI 10.1161/CIRCULATIONAHA.107.690016; Kabutoya T, 2012, J AM SOC HYPERTENS, V6, P109, DOI 10.1016/j.jash.2011.11.005; Koivistoinen T, 2012, ATHEROSCLEROSIS, V220, P387, DOI 10.1016/j.atherosclerosis.2011.08.007; Ludvig J, 2005, AM HEART J, V149, P565, DOI 10.1016/j.ahj.2004.09.040; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Pyke KE, 2005, J PHYSIOL-LONDON, V568, P357, DOI 10.1113/jphysiol.2005.089755; Rakobowchuk M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055385; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101, DOI 10.5551/jat.13.101; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Talukder MAH, 2011, AM J PHYSIOL-HEART C, V300, pH388, DOI 10.1152/ajpheart.00868.2010; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Wilkinson IB, 2004, CLIN EXP PHARMACOL P, V31, P795, DOI 10.1111/j.1440-1681.2004.04074.x; Yeboah J, 2008, ATHEROSCLEROSIS, V197, P840, DOI 10.1016/j.atherosclerosis.2007.07.032	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83977	10.1371/journal.pone.0083977	http://dx.doi.org/10.1371/journal.pone.0083977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392103	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100027
J	Voth, WP; Takahata, S; Nishikawa, JL; Metcalfe, BM; Naar, AM; Stillman, DJ				Voth, Warren P.; Takahata, Shinya; Nishikawa, Joy L.; Metcalfe, Benjamin M.; Naeaer, Anders M.; Stillman, David J.			A Role for FACT in Repopulation of Nucleosomes at Inducible Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION-FACTORS; YEAST SACCHAROMYCES-CEREVISIAE; PLEIOTROPIC DRUG-RESISTANCE; MULTIDRUG-RESISTANCE; HISTONE CHAPERONE; ABC PROTEINS; IN-VIVO; CANDIDA-ALBICANS; H+-ATPASE	Xenobiotic drugs induce Pleiotropic Drug Resistance (PDR) genes via the orthologous Pdr1/Pdr3 transcription activators. We previously identified the Mediator transcription co-activator complex as a key target of Pdr1 orthologs and demonstrated that Pdr1 interacts directly with the Gal11/Med15 subunit of the Mediator complex. Based on an interaction between Pdr1 and the FACT complex, we show that strains with spt16 or pob3 mutations are sensitive to xenobiotic drugs and display diminished PDR gene induction. Although FACT acts during the activation of some genes by assisting in the nucleosomes eviction at promoters, PDR promoters already contain nucleosome-depleted regions (NDRs) before induction. To determine the function of FACT at PDR genes, we examined the kinetics of RNA accumulation and changes in nucleosome occupancy following exposure to a xenobiotic drug in wild type and FACT mutant yeast strains. In the presence of normal FACT, PDR genes are transcribed within 5 minutes of xenobiotic stimulation and transcription returns to basal levels by 30-40 min. Nucleosomes are constitutively depleted in the promoter regions, are lost from the open reading frames during transcription, and the ORFs are wholly repopulated with nucleosomes as transcription ceases. While FACT mutations cause minor delays in activation of PDR genes, much more pronounced and significant defects in nucleosome repopulation in the ORFs are observed in FACT mutants upon transcription termination. FACT therefore has a major role in nucleosome redeposition following cessation of transcription at the PDR genes, the opposite of its better-known function in nucleosome disassembly.	[Voth, Warren P.; Takahata, Shinya; Metcalfe, Benjamin M.; Stillman, David J.] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA; [Nishikawa, Joy L.; Naeaer, Anders M.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Nishikawa, Joy L.; Naeaer, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Stillman, DJ (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA.	david.stillman@path.utah.edu		Stillman, David/0000-0002-5268-2416	National Institutes of Health [GM39067, GM64649, GM071449]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064649, R01GM071449, R01GM039067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health, grant GM39067 awarded to D.J.S, grant GM64649 awarded to Tim Formosa, and grant GM071449 awarded to A.M.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 2004, J BIOENERG BIOMEMBR, V36, P5, DOI 10.1023/B:JOBB.0000019593.84933.e6; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BALZI E, 1995, J BIOENERG BIOMEMBR, V27, P71, DOI 10.1007/BF02110333; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Biswas D, 2007, MOL CELL BIOL, V27, P6279, DOI 10.1128/MCB.00978-07; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; Borecka-Melkusova S, 2008, FEMS YEAST RES, V8, P414, DOI 10.1111/j.1567-1364.2007.00352.x; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Colabufo NA, 2009, CURR TOP MED CHEM, V9, P119, DOI 10.2174/156802609787521553; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Fardeau V, 2007, J BIOL CHEM, V282, P5063, DOI 10.1074/jbc.M610197200; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2012, BBA-GENE REGUL MECH, V1819, P247, DOI 10.1016/j.bbagrm.2011.07.009; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Gao C, 2004, J BIOL CHEM, V279, P42677, DOI 10.1074/jbc.M406363200; GARCIAARRANZ M, 1994, J BIOL CHEM, V269, P18076; Gasparian AV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002530; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; Kemble DJ, 2013, J BIOL CHEM, V288, P10188, DOI 10.1074/jbc.C113.451369; Klein C, 2011, ESSAYS BIOCHEM, V50, P101, DOI [10.1042/bse0500101, 10.1042/BSE0500101]; Kolaczkowska A, 1999, DRUG RESIST UPDATE, V2, P403, DOI 10.1054/drup.1999.0113; Koman IE, 2012, CANCER PREV RES, V5, P1025, DOI 10.1158/1940-6207.CAPR-11-0529; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Lee SJ, 2007, TRENDS MICROBIOL, V15, P389, DOI 10.1016/j.tim.2007.08.002; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lolis AA, 2013, J BIOL CHEM, V288, P7676, DOI 10.1074/jbc.M112.426718; Ma MG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-660; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; McCullough L, 2011, GENETICS, V188, P835, DOI 10.1534/genetics.111.128769; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Monk BC, 2008, SCIENCE, V321, P367, DOI 10.1126/science.1159746; Naar AM, 2009, GENE DEV, V23, P419, DOI 10.1101/gad.1743009; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Schjerling P, 1996, NUCLEIC ACIDS RES, V24, P4599, DOI 10.1093/nar/24.23.4599; Schlesinger MB, 2000, GENETICS, V155, P1593; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Stavrovskaya AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P592, DOI 10.1134/S0006297908050118; Stillman DJ, 2010, BBA-GENE REGUL MECH, V1799, P175, DOI 10.1016/j.bbagrm.2009.11.010; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Thakur JK, 2008, NATURE, V452, P604, DOI 10.1038/nature06836; van Kempen GMP, 2000, CYTOMETRY, V39, P300, DOI 10.1002/(SICI)1097-0320(20000401)39:4<300::AID-CYTO8>3.3.CO;2-F; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; Wendler F, 1997, J BIOL CHEM, V272, P27091, DOI 10.1074/jbc.272.43.27091; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Yarnell AT, 2001, J BIOL CHEM, V276, P25736, DOI 10.1074/jbc.M101208200; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	70	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84092	10.1371/journal.pone.0084092	http://dx.doi.org/10.1371/journal.pone.0084092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392107	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100031
J	Carrillo-Bastos, A; Islebe, GA; Torrescano-Valle, N				Carrillo-Bastos, Alicia; Islebe, Gerald A.; Torrescano-Valle, Nuria			3800 Years of Quantitative Precipitation Reconstruction from the Northwest Yucatan Peninsula	PLOS ONE			English	Article							CLIMATE; HISTORY; COLLAPSE; RECORD; REGRESSION; VEGETATION; MEXICO; PLS	Precipitation over the last 3800 years has been reconstructed using modern pollen calibration and precipitation data. A transfer function was then performed via the linear method of partial least squares. By calculating precipitation anomalies, it is estimated that precipitation deficits were greater than surpluses, reaching 21% and < 9%, respectively. The period from 50 BC to 800 AD was the driest of the record. The drought related to the abandonment of the Maya Preclassic period featured a 21% reduction in precipitation, while the drought of the Maya collapse (800 to 860 AD) featured a reduction of 18%. The Medieval Climatic Anomaly was a period of positive phases (3.8-7.6%). The Little Ice Age was a period of climatic variability, with reductions in precipitation but without deficits.	[Carrillo-Bastos, Alicia; Islebe, Gerald A.; Torrescano-Valle, Nuria] Colegio Frontera Sur, Unidad Chetumal, Chetmal, Quintana Roo, Mexico	El Colegio de la Frontera Sur (ECOSUR)	Islebe, GA (corresponding author), Colegio Frontera Sur, Unidad Chetumal, Chetmal, Quintana Roo, Mexico.	gislebe@ecosur.mx	Islebe, Gerald Alexander/K-2376-2013; VALLE, NURIA TORRESCANO/F-6220-2010	Islebe, Gerald Alexander/0000-0002-9612-7756; VALLE, NURIA TORRESCANO/0000-0003-0362-2684	Conacyt [127613]	Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work received funding from: Conacyt funding project 127613. www.conacyt.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon-Moreno AA, 2012, REV PALAEOBOT PALYNO, V178, P35, DOI 10.1016/j.revpalbo.2012.04.002; Birks H.J.B., 1995, STAT MODELLING QUATE, P271; Birks HJ, 2005, GLOBAL CHANGE HOLOCE, P107; Birks HJB, 1998, J PALEOLIMNOL, V20, P307, DOI 10.1023/A:1008038808690; Carrillo-Bastos A, 2010, REV PALAEOBOT PALYNO, V160, P189, DOI 10.1016/j.revpalbo.2010.02.013; CNA, 2006, JEF PROYECT AG SUP S; CONANP, 2007, PROGR CONS MAN RES B; Correa-Metrio A, 2010, J VEG SCI, V21, P695, DOI 10.1111/j.1654-1103.2010.01178.x; Curtis JH, 1996, QUATERNARY RES, V46, P37, DOI 10.1006/qres.1996.0042; Erdtman, 1969, HDB PALYNOLOGY INTRO; Gill RB, 2008, GRANDES SEQUIAS MAYA; Grimm E., 2011, TILIA SOFTWARE VERSI; Haug GH, 2003, SCIENCE, V299, P1731, DOI 10.1126/science.1080444; Hodell DA, 2007, CLIMATIC CHANGE, V83, P215, DOI [10.1007/s10584-006-9177-4, 10.1007/s 10584-006-9177-4]; Hodell DA, 2001, SCIENCE, V292, P1367, DOI 10.1126/science.1057759; HODELL DA, 1995, NATURE, V375, P391, DOI 10.1038/375391a0; Hodell David A., 2000, IMPERFECT BALANCE LA, P13; Islebe GA, 1996, HOLOCENE, V6, P265, DOI 10.1177/095968369600600302; Juggins S, 2007, C2 VERSION 1 5 USER; Labeyrie L, 2003, GLO CH IGBP, P33; Leyden B.W., 2002, ANCIENT MESOAM, V13, P85, DOI [DOI 10.1017/S0956536102131099, 10.1017/S0956536102131099]; Mann M.E., 2002, ENCY GLOBAL ENV CHAN, V1, P514; Mann ME, 2007, ANNU REV EARTH PL SC, V35, P111, DOI 10.1146/annurev.earth.35.031306.140042; Medina-Elizalde M, 2012, SCIENCE, V335, P956, DOI 10.1126/science.1216629; Medina-Elizalde M, 2010, EARTH PLANET SC LETT, V298, P255, DOI 10.1016/j.epsl.2010.08.016; Palacios-Chavuz R., 1991, FLORA PALINOLOGICA R; Pennington D, 2005, ARBOLES TROPICALES M; Reimer PJ, 2002, RADIOCARBON, V44, P653, DOI 10.1017/S0033822200032100; Riehl H., 1979, CLIMATE WEATHER TROP; Steinhilber F., 2008, ASTROPHYS SPACE SCI, V4, P1, DOI [10.5194/astra-4-1-2008, DOI 10.5194/ASTRA-4-1-2008]; Stuiver M., 2005, CALIB 5 0; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Ter Braak CJF, 1987, UNIMODAL MODELS RELA, P83; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1993, HYDROBIOLOGIA, V269, P485, DOI 10.1007/BF00028046; Torrescano N, 2006, VEG HIST ARCHAEOBOT, V15, P191, DOI 10.1007/s00334-005-0007-9; Torrescano-Valle N, 2007, THESIS COLEGIO FRONT; Gutierrez-Ayala LV, 2012, REV MEX CIENC GEOL, V29, P749; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052	39	13	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84333	10.1371/journal.pone.0084333	http://dx.doi.org/10.1371/journal.pone.0084333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391940	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900083
J	Enders, J; Rief, M; Zimmermann, E; Asbach, P; Diederichs, G; Wetz, C; Siebert, E; Wagner, M; Hamm, B; Dewey, M				Enders, Judith; Rief, Matthias; Zimmermann, Elke; Asbach, Patrick; Diederichs, Gerd; Wetz, Christoph; Siebert, Eberhard; Wagner, Moritz; Hamm, Bernd; Dewey, Marc			High-Field Open versus Short-Bore Magnetic Resonance Imaging of the Spine: A Randomized Controlled Comparison of Image Quality	PLOS ONE			English	Article							MR-ANGIOGRAPHY; CONTRAST; PATIENT; CLAUSTROPHOBIA; STRENGTH; 0.5-T	Background: The purpose of the present study was to compare the image quality of spinal magnetic resonance (MR) imaging performed on a high-field horizontal open versus a short-bore MR scanner in a randomized controlled study setup. Methods: Altogether, 93 (80% women, mean age 53) consecutive patients underwent spine imaging after random assignement to a 1-T horizontal open MR scanner with a vertical magnetic field or a 1.5-T short-bore MR scanner. This patient subset was part of a larger cohort. Image quality was assessed by determining qualitative parameters, signal-to-noise (SNR) and contrast-to-noise ratios (CNR), and quantitative contour sharpness. Results: The image quality parameters were higher for short-bore MR imaging. Regarding all sequences, the relative differences were 39% for the mean overall qualitative image quality, 53% for the mean SNR values, and 34-37% for the quantitative contour sharpness (P<0.0001). The CNR values were also higher for images obtained with the short-bore MR scanner. No sequence was of very poor (nondiagnostic) image quality. Scanning times were significantly longer for examinations performed on the open MR scanner (mean: 32 +/- 22 min versus 20 +/- 69 min; P<0.0001). Conclusions: In this randomized controlled comparison of spinal MR imaging with an open versus a short-bore scanner, short-bore MR imaging revealed considerably higher image quality with shorter scanning times.	[Dewey, Marc] Humboldt Univ, Sch Med, Charite, Dept Radiol, Berlin, Germany; Free Univ Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Dewey, M (corresponding author), Humboldt Univ, Sch Med, Charite, Dept Radiol, Berlin, Germany.	marc.dewey@charite.de		Siebert, Eberhard/0000-0001-7395-6546; Asbach, Patrick/0000-0002-6885-3283; Dewey, Marc/0000-0002-4402-2733	GE Healthcare; Bracco; Guerbet; European Funds for Regional Development (EFRE); German Heart Foundation/German Foundation of Heart Research; Toshiba Medical Systems; Cardiac MR Academy Berlin; Bayer-Schering; Schering; Siemens Medical Solutions	GE Healthcare(General ElectricGE Healthcare); Bracco; Guerbet; European Funds for Regional Development (EFRE)(European Commission); German Heart Foundation/German Foundation of Heart Research; Toshiba Medical Systems; Cardiac MR Academy Berlin; Bayer-Schering(Bayer AG); Schering; Siemens Medical Solutions(Siemens AG)	Prof Dewey reported receiving grant support from GE Healthcare, Bracco, Guerbet, the European Funds for Regional Development (EFRE), the German Heart Foundation/German Foundation of Heart Research, and Toshiba Medical Systems and lecture fees from Toshiba Medical Systems, Cardiac MR Academy Berlin, Guerbet, and Bayer-Schering; he is also a consultant for Guerbet. Dr Rief reported receiving travel reimbursement from CMC contrast. Prof Hamm reported receiving grant support from GE Healthcare, Schering, Siemens Medical Solutions, and Toshiba Medical Systems, and lecture fees from Siemens Medical Solutions and Bayer-Schering. Furthermore, there are institutional master research agreements with Philips Medical Systems, Siemens Medical Solutions, and Toshiba Medical Systems. The other authors reported no financial disclosures. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	American College of Radiology, 2013, ACR APPR CRIT LOW BA; American College of Radiology, 2013, ACR APPR CRIT CHRON; Asbach P, 2006, J MAGN RESON IMAGING, V24, P1095, DOI 10.1002/jmri.20735; BALLON D, 1989, MAGN RESON IMAGING, V7, P155, DOI 10.1016/0730-725X(89)90699-1; Bangard C, 2007, EUR J RADIOL, V64, P152, DOI 10.1016/j.ejrad.2007.02.012; Berg WA, 2010, RADIOLOGY, V254, P79, DOI 10.1148/radiol.2541090953; Calabrese M, 2009, RADIOL MED, V114, P267, DOI 10.1007/s11547-008-0358-2; Corwin A, 2012, EMERG RADIOL, V19, P141, DOI 10.1007/s10140-011-1010-3; de Bucourt M, 2011, EUR RADIOL, V21, P1004, DOI 10.1007/s00330-010-2005-2; Dewey M, 2007, EUR J RADIOL, V63, P124, DOI 10.1016/j.ejrad.2007.01.025; Dewey M, 2007, J MAGN RESON IMAGING, V26, P1322, DOI 10.1002/jmri.21147; Enders J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023494; Enders J, 2011, BMC MED IMAGING, V11, DOI 10.1186/1471-2342-11-4; Gross JB, 1996, ANESTHESIOLOGY, V84, P459; Hailey D, 2006, Issues Emerg Health Technol, P1; Ham K, 2004, COMP IMAGE QUALITY O; HART HR, 1983, AM J ROENTGENOL, V141, P1195, DOI 10.2214/ajr.141.6.1195; Heuck A, 1997, RADIOLOGE, V37, P778, DOI 10.1007/s001170050282; Hunt CH, 2011, CLIN NEURORADIOL, V21, P141, DOI 10.1007/s00062-011-0075-4; JACK CR, 1990, J COMPUT ASSIST TOMO, V14, P505, DOI 10.1097/00004728-199007000-00002; Klein HM, 2007, J COMPUT ASSIST TOMO, V31, P430, DOI 10.1097/01.rct.0000238010.64931.c6; Maubon AJ, 1999, RADIOGRAPHICS, V19, P1057, DOI 10.1148/radiographics.19.4.g99jl281057; Mehdizade A, 2003, J NEURORADIOLOGY, V30, P25; Michel SCA, 2002, EUR RADIOL, V12, P2898, DOI 10.1007/s00330-002-1400-8; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Radomsky AS, 2001, J ANXIETY DISORD, V15, P287, DOI 10.1016/S0887-6185(01)00064-0; Rodenwaldt J, 1998, ROFO-FORTSCHR RONTG, V169, P616, DOI 10.1055/s-2007-1015351; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Spouse E, 2000, BRIT J RADIOL, V73, P146, DOI 10.1259/bjr.73.866.10884726; Vahlensieck M, 2003, ORTHOPADE, V32, P175, DOI 10.1007/s00132-002-0389-7; Waugh SA, 2009, J MAGN RESON IMAGING, V30, P1059, DOI 10.1002/jmri.21930; Xu S, 2003, MAGN RESON MED, V49, P551, DOI 10.1002/mrm.10397; Zhao JA, 2009, AM J ROENTGENOL, V192, P873, DOI 10.2214/AJR.08.1750	33	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83427	10.1371/journal.pone.0083427	http://dx.doi.org/10.1371/journal.pone.0083427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391767	Green Published, gold			2022-12-27	WOS:000329325200064
J	Guilbert, C; Annis, MG; Dong, ZF; Siegel, PM; Miller, WH; Mann, KK				Guilbert, Cynthia; Annis, Matthew G.; Dong, Zhifeng; Siegel, Peter M.; Miller, Wilson H., Jr.; Mann, Koren K.			Arsenic Trioxide Overcomes Rapamycin-Induced Feedback Activation of AKT and ERK Signaling to Enhance the Anti-Tumor Effects in Breast Cancer	PLOS ONE			English	Article							PROTEIN-KINASE-B; MAMMALIAN TARGET; TUBEROUS SCLEROSIS; INHIBITOR EVEROLIMUS; PHASE-I; MTOR; LEUKEMIA; PATHWAY; PHOSPHORYLATION; APOPTOSIS	Inhibitors of the mammalian target of rapamycin (mTORi) have clinical activity; however, the benefits of mTOR inhibition by rapamycin and rapamycin-derivatives (rapalogs) may be limited by a feedback mechanism that results in AKT activation. Increased AKT activity resulting from mTOR inhibition can be a result of increased signaling via the mTOR complex, TORC2. Previously, we published that arsenic trioxide (ATO) inhibits AKT activity and in some cases, decreases AKT protein expression. Therefore, we propose that combining ATO and rapamycin may circumvent the AKT feedback loop and increase the anti-tumor effects. Using a panel of breast cancer cell lines, we find that ATO, at clinically-achievable doses, can enhance the inhibitory activity of the mTORi temsirolimus. In all cell lines, temsirolimus treatment resulted in AKT activation, which was decreased by concomitant ATO treatment only in those cell lines where ATO enhanced growth inhibition. Treatment with rapalog also results in activated ERK signaling, which is decreased with ATO co-treatment in all cell lines tested. We next tested the toxicity and efficacy of rapamycin plus ATO combination therapy in a MDA-MB-468 breast cancer xenograft model. The drug combination was well-tolerated, and rapamycin did not increase ATO-induced liver enzyme levels. In addition, combination of these drugs was significantly more effective at inhibiting tumor growth compared to individual drug treatments, which corresponded with diminished phospho-Akt and phospho-ERK levels when compared with rapamycin-treated tumors. Therefore, we propose that combining ATO and mTORi may overcome the feedback loop by decreasing activation of the MAPK and AKT signaling pathways.	[Guilbert, Cynthia; Miller, Wilson H., Jr.; Mann, Koren K.] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Annis, Matthew G.; Dong, Zhifeng; Siegel, Peter M.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Miller, Wilson H., Jr.; Mann, Koren K.] McGill Univ, Dept Oncol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Mann, KK (corresponding author), McGill Univ, Lady Davis Inst Med Res, Montreal, PQ, Canada.	koren.mann@mcgill.ca		Annis, Matthew/0000-0002-8776-004X	Weekend to End Breast Cancer; Canadian Institutes of Health Research [MOP-43979, MOP-119401]	Weekend to End Breast Cancer; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Weekend to End Breast Cancer (KKM) and the Canadian Institutes of Health Research (MOP-43979 to WHM and KKM and MOP-119401 to PMS; http://www.cihr- irsc.gc.ca/e/193.html). KKM is a Junior 2 Chercheur Boursier of the FRSQ (http://www.frsq.gouv.qc.ca/fr/financement/programmes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Awada A, 2008, EUR J CANCER, V44, P84, DOI 10.1016/j.ejca.2007.10.003; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bolt AM, 2012, TOXICOL APPL PHARM, V264, P255, DOI 10.1016/j.taap.2012.08.006; Bolt AM, 2010, TOXICOL LETT, V199, P153, DOI 10.1016/j.toxlet.2010.08.017; Calvino E, 2011, BIOCHEM PHARMACOL, V82, P1619, DOI 10.1016/j.bcp.2011.08.017; Campone M, 2009, BRIT J CANCER, V100, P315, DOI 10.1038/sj.bjc.6604851; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Estan MC, 2012, BIOCHEM PHARMACOL, V84, P1604, DOI 10.1016/j.bcp.2012.09.022; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Diaz Z, 2007, LEUKEMIA, V21, P2117, DOI 10.1038/sj.leu.2404891; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HARDIN JA, 1992, J IMMUNOL METHODS, V154, P99, DOI 10.1016/0022-1759(92)90217-H; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang HS, 2011, TOXICOL SCI, V121, P101, DOI 10.1093/toxsci/kfr023; HUOBER J, 2013, EUR J CANC; Kasukabe T, 2013, INT J ONCOL, V42, P767, DOI 10.3892/ijo.2012.1745; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Liu N, 2012, ENDOCR-RELAT CANCER, V19, P711, DOI 10.1530/ERC-12-0150; Lunghi P, 2005, LEUKEMIA, V19, P234, DOI 10.1038/sj.leu.2403585; Lunghi P, 2006, BLOOD, V107, P4549, DOI 10.1182/blood-2005-07-2829; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Mann KK, 2008, MOL CANCER THER, V7, P1680, DOI 10.1158/1535-7163.MCT-07-2164; Mehrara E, 2007, CANCER RES, V67, P3970, DOI 10.1158/0008-5472.CAN-06-3822; Mi RF, 2009, J GENET GENOMICS, V36, P355, DOI 10.1016/S1673-8527(08)60124-1; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; Mosley JD, 2007, MOL CANCER THER, V6, P2188, DOI 10.1158/1535-7163.MCT-07-0235; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Noh EK, 2010, LEUKEMIA RES, V34, P1501, DOI 10.1016/j.leukres.2010.02.016; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Tamburini J, 2008, BLOOD, V111, P379, DOI 10.1182/blood-2007-03-080796; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wiza C, 2012, AM J PHYSIOL-ENDOC M, V302, pE1453, DOI 10.1152/ajpendo.00660.2011; Xue P, 2011, BIOCHEM BIOPH RES CO, V407, P360, DOI 10.1016/j.bbrc.2011.03.024; Yardley DA, 2013, BREAST CANCER-BASIC, V7, P7, DOI 10.4137/BCBCR.S10071; Yee KWL, 2006, CLIN CANCER RES, V12, P5165, DOI 10.1158/1078-0432.CCR-06-0764	45	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85995	10.1371/journal.pone.0085995	http://dx.doi.org/10.1371/journal.pone.0085995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392034	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900178
J	Hall, HI; Tang, T; Westfall, AO; Mugavero, MJ				Hall, H. Irene; Tang, Tian; Westfall, Andrew O.; Mugavero, Michael J.			HIV Care Visits and Time to Viral Suppression, 19 US Jurisdictions, and Implications for Treatment, Prevention and the National HIV/AIDS Strategy	PLOS ONE			English	Article							INFECTED PERSONS; ANTIRETROVIRAL TREATMENT; EARLY RETENTION; RECOMMENDATIONS; SOCIETY; ASSOCIATION; GUIDELINES; MANAGEMENT; ENGAGEMENT; SPECTRUM	Objective: Early and regular care and treatment for human immunodeficiency virus (HIV) infection are associated with viral suppression, reductions in transmission risk and improved health outcomes for persons with HIV. We determined, on a population level, the association of care visits with time from HIV diagnosis to viral suppression. Methods: Using data from 19 areas reporting HIV-related tests to national HIV surveillance, we determined time from diagnosis to viral suppression among 17,028 persons diagnosed with HIV during 2009, followed through December 2011, using data reported through December 2012. Using Cox proportional hazards models, we assessed factors associated with viral suppression, including linkage to care within 3 months of diagnosis, a goal set forth by the National HIV/AIDS Strategy, and number of HIV care visits as determined by CD4 and viral load test results, while controlling for demographic, clinical, and risk characteristics. Results: Of 17,028 persons diagnosed with HIV during 2009 in the 19 areas, 76.6% were linked to care within 3 months of diagnosis and 57.0% had a suppressed viral load during the observation period. Median time from diagnosis to viral suppression was 19 months overall, and 8 months among persons with an initial CD4 count <= 350 cells/mu L. During the first 12 months after diagnosis, persons linked to care within 3 months experienced shorter times to viral suppression (higher rate of viral suppression per unit time, hazard ratio [HR] = 4.84 versus not linked within 3 months; 95% confidence interval [CI] 4.27, 5.48). Persons with a higher number of time- updated care visits also experienced a shorter time to viral suppression (HR = 1.51 per additional visit, 95% CI 1.49, 1.52). Conclusions: Timely linkage to care and greater frequency of care visits were associated with faster time to viral suppression with implications for individual health outcomes and for secondary prevention.	[Hall, H. Irene] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA; [Tang, Tian] ICF Int, Atlanta, GA USA; [Westfall, Andrew O.; Mugavero, Michael J.] Univ Alabama Birmingham, Ctr AIDS Res, Birmingham, AL USA; [Mugavero, Michael J.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA	Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Hall, HI (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	ixh1@cdc.gov		Westfall, Andrew/0000-0002-0468-4695	Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Centers for Disease Control and Prevention (CDC) provides funding to state and local health departments to conduct surveillance of HIV disease in accordance with their own disease reporting regulations. CDC provides technical guidance for the collection of data by the state and local health departments and data are sent to CDC for national-level analyses. Role of the Sponsors: The CDC reviewed and approved final submission but the findings and conclusions in this report are those of the authors and do not necessarily represent the views of the CDC.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; [Anonymous], 2010, NAT HIV AIDS STRAT U; [Anonymous], MON HIV CAR US IND D; [Anonymous], 2011, GUID US ANT AG HIV 1, P1; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS85, DOI 10.1089/apc.2007.9983; Centers for Disease Control and Prevention, 2012, 17 CDCP A; Centers for Disease Control and Prevention, 2010, 16 CDCP; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Department of agriculture forestry and fisheries, 2012, GUID US ANT AG HIV 1, P1; Fleishman JA, 2012, JAIDS-J ACQ IMM DEF, V60, P249, DOI 10.1097/QAI.0b013e318258c696; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Gray KM, 2013, AM J PUBLIC HEALTH, V103, P141, DOI 10.2105/AJPH.2012.300859; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hall HI, 2012, JAIDS-J ACQ IMM DEF, V60, P77, DOI 10.1097/QAI.0b013e318249fe90; Higa DH, 2012, CURR HIV-AIDS REP, V9, P313, DOI 10.1007/s11904-012-0136-6; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Marks G, 2011, CLIN INFECT DIS, V53, P1168, DOI 10.1093/cid/cir678; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Rebeiro P, 2013, JAIDS-J ACQ IMM DEF, V62, P356, DOI 10.1097/QAI.0b013e31827f578a; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Smith JC., 2012, INCOME POVERTY HLTH; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; Wohl AR, 2011, AIDS BEHAV, V15, P1098, DOI 10.1007/s10461-010-9833-6; Wohl AR, 2011, AIDS CARE, V23, P988, DOI 10.1080/09540121.2010.542125	32	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84318	10.1371/journal.pone.0084318	http://dx.doi.org/10.1371/journal.pone.0084318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391937	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900080
J	Ibrahim, SA; Hassan, H; Vilardo, L; Kumar, SK; Kumar, AV; Kelsch, R; Schneider, C; Kiesel, L; Eich, HT; Zucchi, I; Reinbold, R; Greve, B; Gotte, M				Ibrahim, Sherif A.; Hassan, Hebatallah; Vilardo, Laura; Kumar, Sampath Katakam; Kumar, Archana Vijaya; Kelsch, Reinhard; Schneider, Cornelia; Kiesel, Ludwig; Eich, Hans Theodor; Zucchi, Ileana; Reinbold, Rolland; Greve, Burkhard; Goette, Martin			Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling	PLOS ONE			English	Article							E-CADHERIN; ALDEHYDE DEHYDROGENASE; GENE-EXPRESSION; SIDE-POPULATION; FLOW-CYTOMETRY; PHENOTYPE; CARCINOMA; MARKERS; DIFFERENTIATION; ACCUMULATION	Syndecan-1 (CD138), a heparan sulfate proteoglycan, acts as a coreceptor for growth factors and chemokines and is a molecular marker associated with epithelial-mesenchymal transition during development and carcinogenesis. Resistance of Syndecan-1-deficient mice to experimentally-induced tumorigenesis has been linked to altered Wnt-responsive precursor cell pools, suggesting a potential role of Syndecan-1 in breast cancer cell stem function. However, the precise molecular mechanism is still elusive. Here, we decipher the functional impact of Syndecan-1 knockdown using RNA interference on the breast cancer stem cell phenotype of human triple-negative MDA-MB-231 and hormone receptor-positive MCF-7 cells in vitro employing an analytical flow cytometric approach. Successful Syndecan-1 siRNA knockdown was confirmed by flow cytometry. Side population measurement by Hoechst dye exclusion and Aldehyde dehydrogenase-1 activity revealed that Syndecan-1 knockdown in MDA-MB-231 cells significantly reduced putative cancer stem cell pools by 60% and 27%, respectively, compared to controls. In MCF-7 cells, Syndecan-1 depletion reduced the side population by 40% and Aldehyde dehydrogenase-1 by 50%, repectively. In MDA-MB-231 cells, the CD44(+)CD24(-/low) phenotype decreased significantly by 6% upon siRNA-mediated Syndecan-1 depletion. Intriguingly, IL-6, its receptor sIL-6R, and the chemokine CCL20, implicated in regulating stemness-associated pathways, were downregulated by > 40% in Syndecan-1-silenced MDA-MB-231 cells, which showed a dysregulated response to IL-6-induced shifts in E-cadherin and vimentin expression. Furthermore, activation of STAT-3 and NFkB transcription factors and expression of a coreceptor for Wnt signaling, LRP-6, were reduced by > 45% in Syndecan-1-depleted cells compared to controls. At the functional level, Syndecan-1 siRNA reduced the formation of spheres and cysts in MCF-7 cells grown in suspension culture. Our study demonstrates the viability of flow cytometric approaches in analyzing cancer stem cell function. As Syndecan-1 modulates the cancer stem cell phenotype via regulation of the Wnt and IL-6/STAT3 signaling pathways, it emerges as a promising novel target for therapeutic approaches.	[Ibrahim, Sherif A.; Hassan, Hebatallah; Kumar, Sampath Katakam; Kumar, Archana Vijaya; Schneider, Cornelia; Kiesel, Ludwig; Goette, Martin] Univ Hosp Munster, Dept Gynecol & Obstet, Munster, Germany; [Kelsch, Reinhard] Univ Hosp Munster, Inst Transfus Med & Transplantat Immunol, Munster, Germany; [Eich, Hans Theodor; Greve, Burkhard] Univ Hosp Munster, Dept Radiotherapy Radiooncol, Munster, Germany; [Vilardo, Laura; Zucchi, Ileana; Reinbold, Rolland] ITB CNR, Segrate, Italy; [Ibrahim, Sherif A.; Hassan, Hebatallah] Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt	University of Munster; University of Munster; University of Munster; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Egyptian Knowledge Bank (EKB); Cairo University	Greve, B (corresponding author), Univ Hosp Munster, Dept Radiotherapy Radiooncol, Munster, Germany.	greveb@uni-muenster.de; mgotte@uni-muenster.de	Kiesel, Ludwig/ABC-5333-2020; reinbold, rolland/AAW-8940-2020; Götte, Martin/G-2254-2018; Gotte, M/Z-5878-2019	Kiesel, Ludwig/0000-0002-7247-9247; Götte, Martin/0000-0003-2360-2496; Gotte, M/0000-0003-2360-2496; Ibrahim, Sherif Abdelaziz/0000-0001-6403-7345; hassan, hebatallah/0000-0002-2815-7996	German Academic Exchange Service [DAAD A/06/90277, DAAD 56808461]; International Research Training Group "Molecular and Cellular GlycoSciences" [1549]; Maria Moller Stiftung	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); International Research Training Group "Molecular and Cellular GlycoSciences"; Maria Moller Stiftung	This work was supported by German Academic Exchange Service DAAD A/06/90277 (to SAI), DAAD 56808461 Al Tawasul (to MG and SAI), International Research Training Group "Molecular and Cellular GlycoSciences" Grant GRK 1549 (to MG and SKK), and Maria Moller Stiftung (to MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MAH, 2012, BREAST CANCER RES TR, V133, P979, DOI 10.1007/s10549-011-1865-8; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alaaeddine N, 2011, J RHEUMATOL, V38, P1858, DOI 10.3899/jrheum.110049; Barbareschi M, 2003, CANCER-AM CANCER SOC, V98, P474, DOI 10.1002/cncr.11515; Baston-Bust DM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-133; Battaglia F, 2008, J LEUKOCYTE BIOL, V83, P648, DOI 10.1189/jlb.0607349; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clarke RB, 2003, CELL PROLIFERAT, V36, P45, DOI 10.1046/j.1365-2184.36.s.1.5.x; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Downs-Holmes Catherine, 2011, Nurse Pract, V36, P20, DOI 10.1097/01.NPR.0000407602.29522.d7; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Fabian A, 2009, CYTOM PART A, V75A, P67, DOI 10.1002/cyto.a.20690; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gotte M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1641; Gotte M, 2011, INT J CANCER, V129, P2042, DOI 10.1002/ijc.25856; Gotte M, 2010, AM J PATHOL, V176, P25, DOI 10.2353/ajpath.2010.090775; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Greve B, 2012, CYTOM PART A, V81A, P284, DOI 10.1002/cyto.a.22022; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hernandez-Vargas H, 2011, EPIGENETICS-US, V6, P429, DOI 10.4161/epi.6.4.14515; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hosonuma S, 2011, HUM CELL, V24, P9, DOI 10.1007/s13577-010-0002-z; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; Iejima D, 2007, ARCH ORAL BIOL, V52, P924, DOI 10.1016/j.archoralbio.2007.04.004; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; JONES RJ, 1995, BLOOD, V85, P2742, DOI 10.1182/blood.V85.10.2742.bloodjournal85102742; KATO M, 1995, MOL BIOL CELL, V6, P559, DOI 10.1091/mbc.6.5.559; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; LaBarge MA, 2010, CLIN CANCER RES, V16, P3121, DOI 10.1158/1078-0432.CCR-09-2933; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lee HE, 2011, BRIT J CANCER, V104, P1730, DOI 10.1038/bjc.2011.159; Leiros GJ, 2011, CURR PHARM BIOTECHNO, V12, P1909; Leivonen M, 2004, ONCOLOGY-BASEL, V67, P11, DOI 10.1159/000080280; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu BY, 2003, ONCOGENE, V22, P9243, DOI 10.1038/sj.onc.1207217; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Luo WR, 2012, INT J CANCER, V131, P1863, DOI 10.1002/ijc.27467; Malhotra Gautam K, 2011, J Carcinog, V10, P38, DOI 10.4103/1477-3163.91413; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; McDermott SP, 2007, ONCOGENE, V26, P1407, DOI 10.1038/sj.onc.1209930; Moserle L, 2010, CANCER LETT, V288, P1, DOI 10.1016/j.canlet.2009.05.020; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schneider BP, 2008, CLIN CANCER RES, V14, P8010, DOI 10.1158/1078-0432.CCR-08-1208; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sun DZ, 1998, INT J DEV BIOL, V42, P733; Tarnok A, 2010, CYTOM PART A, V77A, P6, DOI 10.1002/cyto.a.20844; Tsai LL, 2011, J ORAL PATHOL MED, V40, P621, DOI 10.1111/j.1600-0714.2011.01015.x; Tsunoda Y, 2011, ONCOLOGY-BASEL, V81, P336, DOI 10.1159/000334690; Xie GZ, 2012, INT J ONCOL, V40, P1171, DOI 10.3892/ijo.2011.1275; Yip GW, 2006, MOL CANCER THER, V5, P2139, DOI 10.1158/1535-7163.MCT-06-0082; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zimmerlin L, 2011, METHODS MOL BIOL, V699, P251, DOI 10.1007/978-1-61737-950-5_12; Zucchi I, 2008, P NATL ACAD SCI USA, V105, P16940, DOI 10.1073/pnas.0808978105; Zucchi I, 2007, P NATL ACAD SCI USA, V104, P10476, DOI 10.1073/pnas.0703071104	73	87	90	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85737	10.1371/journal.pone.0085737	http://dx.doi.org/10.1371/journal.pone.0085737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392029	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900173
J	Price, CA; Knox, SJC; Brodribb, TJ				Price, Charles A.; Knox, Sarah-Jane C.; Brodribb, Tim J.			The Influence of Branch Order on Optimal Leaf Vein Geometries: Murray's Law and Area Preserving Branching	PLOS ONE			English	Article							WOOD SPECIFIC-GRAVITY; GENERAL-MODEL; SCALING LAWS; FORM; SIZE; ARCHITECTURE; PREVENTION; ALLOMETRY; GRADIENTS; TRANSPORT	Models that predict the form of hierarchical branching networks typically invoke optimization based on biomechanical similitude, the minimization of impedance to fluid flow, or construction costs. Unfortunately, due to the small size and high number of vein segments found in real biological networks, complete descriptions of networks needed to evaluate such models are rare. To help address this we report results from the analysis of the branching geometry of 349 leaf vein networks comprising over 1.5 million individual vein segments. In addition to measuring the diameters of individual veins before and after vein bifurcations, we also assign vein orders using the Horton-Strahler ordering algorithm adopted from the study of river networks. Our results demonstrate that across all leaves, both radius tapering and the ratio of daughter to parent branch areas for leaf veins are in strong agreement with the expectation from Murray's law. However, as veins become larger, area ratios shift systematically toward values expected under area-preserving branching. Our work supports the idea that leaf vein networks differentiate roles of leaf support and hydraulic supply between hierarchical orders.	[Price, Charles A.; Knox, Sarah-Jane C.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Brodribb, Tim J.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia	University of Western Australia; University of Tasmania	Price, CA (corresponding author), Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia.	charles.price@uwa.edu.au	Price, Chuck A/HIK-1431-2022; Price, Charles A/B-1171-2011; Brodribb, Timothy John/C-6797-2013	Brodribb, Timothy John/0000-0002-4964-6107	Australian Research Council [DE120101562]	Australian Research Council(Australian Research Council)	CAP acknowledges the support of a Discovery Early Career Research Award (DE120101562) from the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bohn S., 2002, PHYS REV E, V65, P1; BORCHERT R, 1981, BOT GAZ, V142, P394, DOI 10.1086/337238; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; CANNY MJ, 1993, PHILOS T R SOC B, V341, P87, DOI 10.1098/rstb.1993.0094; Coomes DA, 2008, BIOL LETTERS, V4, P302, DOI 10.1098/rsbl.2008.0094; Corson F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048703; Dodds PS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.048702; Ellis B, 2009, MANUAL LEAF; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; HICKEY LJ, 1973, AM J BOT, V60, P17, DOI 10.2307/2441319; HOLBROOK NM, 1989, AM J BOT, V76, P1740, DOI 10.2307/2444473; Horn HS, 2000, SCALING BIOL; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Huo YL, 2012, J R SOC INTERFACE, V9, P190, DOI 10.1098/rsif.2011.0270; Katifori E, 2010, NETWORKS PHYS REV LE, V104, P4; Katifori E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037994; LABARBERA M, 1990, SCIENCE, V249, P992, DOI 10.1126/science.2396104; McCulloh KA, 2004, FUNCT ECOL, V18, P931, DOI 10.1111/j.0269-8463.2004.00913.x; McCulloh KA, 2005, AM J BOT, V92, P985, DOI 10.3732/ajb.92.6.985; McCulloh KA, 2003, NATURE, V421, P939, DOI 10.1038/nature01444; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; Mileyko Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036715; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Niinemets U, 2006, NEW PHYTOL, V171, P91, DOI 10.1111/j.1469-8137.2006.01741.x; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 1999, NEW PHYTOL, V143, P19, DOI 10.1046/j.1469-8137.1999.00441.x; Niklas KJ, 1997, ANN BOT-LONDON, V79, P265, DOI 10.1006/anbo.1996.0340; Perna A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066106; Price C.A., 2012, METHODS MOL BIOL MET, V918; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Price CA, 2012, ECOL LETT, V15, P87, DOI 10.1111/j.1461-0248.2011.01712.x; Price CA, 2011, PLANT PHYSIOL, V155, P236, DOI 10.1104/pp.110.162834; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Restrepo JG, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.128101; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Sack L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1835; Savage VM, 2010, P NATL ACAD SCI USA, V107, P22722, DOI 10.1073/pnas.1012194108; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; SHERMAN TF, 1989, J THEOR BIOL, V136, P245, DOI 10.1016/S0022-5193(89)80162-6; Sperry JS, 2008, PLANT CELL ENVIRON, V31, P632, DOI 10.1111/j.1365-3040.2007.01765.x; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Turcotte DL, 1998, J THEOR BIOL, V193, P577, DOI 10.1006/jtbi.1998.0723; UYLINGS HBM, 1975, ADV NEUROL, V12, P247; Velleman P. F., 1981, APPL BASICS COMPUTIN; WANG XD, 1985, PLANT CELL ENVIRON, V8, P669, DOI 10.1111/j.1365-3040.1985.tb01707.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WIEMANN MC, 1989, AM J BOT, V76, P924, DOI 10.2307/2444548; WILLIAMSON GB, 1984, B TORREY BOT CLUB, V111, P51, DOI 10.2307/2996210; Zamir M, 1999, J THEOR BIOL, V197, P517, DOI 10.1006/jtbi.1998.0892; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178	52	29	30	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85420	10.1371/journal.pone.0085420	http://dx.doi.org/10.1371/journal.pone.0085420			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392008	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900152
J	Shahbaaz, M; Hassan, MI; Ahmad, F				Shahbaaz, Mohd.; Hassan, Md. Imtaiyaz; Ahmad, Faizan			Functional Annotation of Conserved Hypothetical Proteins from Haemophilus influenzae Rd KW20	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; BACTERIAL-INFECTION; VIRULENCE; DATABASE; PREDICTION; HOMOLOGY; SEQUENCE; CLASSIFICATION; TRANSFERRIN; SECRETION	Haemophilus influenzae is a Gram negative bacterium that belongs to the family Pasteurellaceae, causes bacteremia, pneumonia and acute bacterial meningitis in infants. The emergence of multi-drug resistance H. influenzae strain in clinical isolates demands the development of better/new drugs against this pathogen. Our study combines a number of bioinformatics tools for function predictions of previously not assigned proteins in the genome of H. influenzae. This genome was extensively analyzed and found 1,657 functional proteins in which function of 429 proteins are unknown, termed as hypothetical proteins (HPs). Amino acid sequences of all 429 HPs were extensively annotated and we successfully assigned the function to 296 HPs with high confidence. We also characterized the function of 124 HPs precisely, but with less confidence. We believed that sequence of a protein can be used as a framework to explain known functional properties. Here we have combined the latest versions of protein family databases, protein motifs, intrinsic features from the amino acid sequence, pathway and genome context methods to assign a precise function to hypothetical proteins for which no experimental information is available. We found these HPs belong to various classes of proteins such as enzymes, transporters, carriers, receptors, signal transducers, binding proteins, virulence and other proteins. The outcome of this work will be helpful for a better understanding of the mechanism of pathogenesis and in finding novel therapeutic targets for H. influenzae.	[Shahbaaz, Mohd.] Jamia Millia Islamia, Dept Comp Sci, New Delhi 110025, India; [Hassan, Md. Imtaiyaz; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India	Jamia Millia Islamia; Jamia Millia Islamia	Hassan, MI (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	mihassan@jmi.ac.in	Shahbaaz, Mohd/ABG-4269-2020; Ahmad, Faizan/AGH-4493-2022; Hassan, Imtaiyaz/ABF-6485-2020; Hassan, Mohammad/GZA-7507-2022; Hassan, Md Imtaiyaz/G-7072-2017	Shahbaaz, Mohd/0000-0001-8901-7113; Ahmad, Faizan/0000-0001-7021-7502; Hassan, Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004; Hassan, Md Imtaiyaz/0000-0002-3663-4940	Indian Council of Medical Research [BIC/12(04)/2012]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The authors sincerely thank Indian Council of Medical Research for financial assistance (Grant No. BIC/12(04)/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ariyachet C, 2013, INFECT IMMUN, V81, P1267, DOI 10.1128/IAI.00864-12; Attwood Terri K, 2002, Brief Bioinform, V3, P252, DOI 10.1093/bib/3.3.252; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Ball P, 1996, Curr Opin Pulm Med, V2, P181, DOI 10.1097/00063198-199605000-00004; Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bhasin M, 2005, BIOINFORMATICS, V21, P2522, DOI 10.1093/bioinformatics/bti309; BJORNSON HS, 1984, REV INFECT DIS, V6, pS21; Bru C, 2005, NUCLEIC ACIDS RES, V33, pD212, DOI 10.1093/nar/gki034; Bukowski M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3012; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Cash P, 1997, ELECTROPHORESIS, V18, P1472, DOI 10.1002/elps.1150180822; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Davey L, 2013, J BIOL CHEM, V288, P16416, DOI 10.1074/jbc.M113.464578; Doerks T, 2004, NUCLEIC ACIDS RES, V32, P6321, DOI 10.1093/nar/gkh973; Doern CD, 2008, MICROBIOL-SGM, V154, P1998, DOI 10.1099/mic.0.2007/013466-0; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Edelstein PH, 2005, INFECT IMMUN, V73, P6567, DOI 10.1128/IAI.73.10.6567-6576.2005; Edwards JS, 1999, J BIOL CHEM, V274, P17410, DOI 10.1074/jbc.274.25.17410; Ejim LJ, 2004, INFECT IMMUN, V72, P3310, DOI 10.1128/IAI.72.6.3310-3314.2004; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eng J, 2013, ROC ANAL WEB BASED C; Engh RA, 2002, PHARMACOL THERAPEUT, V93, P99, DOI 10.1016/S0163-7258(02)00180-8; Evers S, 1998, ELECTROPHORESIS, V19, P1980, DOI 10.1002/elps.1150191116; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Grinter R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033033; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hassan MI, 2007, J PEPT SCI, V13, P849, DOI 10.1002/psc.911; Hassan MI, 2007, CHEM BIOL DRUG DES, V70, P261, DOI 10.1111/j.1747-0285.2007.00553.x; Hawkins Troy, 2007, J Bioinform Comput Biol, V5, P1, DOI 10.1142/S0219720007002503; Henikoff JG, 1996, METHOD ENZYMOL, V266, P88; Herbert MA, 2002, MICROB PATHOGENESIS, V33, P211, DOI 10.1006/mpat.2002.0530; Huang JN, 2004, J BIOL CHEM, V279, P54110, DOI 10.1074/jbc.M410583200; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hubbard TJP, 1999, NUCLEIC ACIDS RES, V27, P254, DOI 10.1093/nar/27.1.254; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kanehisa M, 1997, TRENDS BIOCHEM SCI, V22, P442, DOI 10.1016/S0968-0004(97)01130-4; Kelil Abdellali, 2008, International Journal of Computational Biology and Drug Design, V1, P122, DOI 10.1504/IJCBDD.2008.020190; Kelil A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-286; Kondo Y, 2010, INFECT IMMUN, V78, P2846, DOI 10.1128/IAI.01448-09; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kratz F, 1998, J PHARM SCI-US, V87, P338, DOI 10.1021/js970246a; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li Q, 2012, BIOCHEM J, V441, P859, DOI 10.1042/BJ20111604; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001; Makioka A, 1995, J PARASITOL, V81, P1021, DOI 10.2307/3284064; McQuiston JR, 1999, INFECT IMMUN, V67, P3830, DOI 10.1128/IAI.67.8.3830-3835.1999; Meinel T, 2005, NUCLEIC ACIDS RES, V33, pD226; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; MURPHY TF, 1992, AM REV RESPIR DIS, V146, P1067, DOI 10.1164/ajrccm/146.4.1067; Nagy G, 2002, INFECT IMMUN, V70, P4406, DOI 10.1128/IAI.70.8.4406-4413.2002; Nimrod G, 2008, STRUCTURE, V16, P1755, DOI 10.1016/j.str.2008.10.017; Okan NA, 2013, MBIO, V4, DOI 10.1128/mBio.00638-12; Okugawa S, 2012, MOL MICROBIOL, V83, P96, DOI 10.1111/j.1365-2958.2011.07915.x; Olekhnovich IN, 2002, J BACTERIOL, V184, P4148, DOI 10.1128/JB.184.15.4148-4160.2002; Papin JA, 2002, J THEOR BIOL, V215, P67, DOI 10.1006/jtbi.2001.2499; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; Rappoport N, 2012, NUCLEIC ACIDS RES, V40, pD313, DOI 10.1093/nar/gkr1027; Reffuveille F, 2012, INFECT IMMUN, V80, P1728, DOI 10.1128/IAI.06251-11; Rost B, 1996, CURR OPIN BIOTECH, V7, P457, DOI 10.1016/S0958-1669(96)80124-8; SAaP Shanmughavel, 2008, J COMPUT SCI SYST BI, V1, P50; Saha Sudipto, 2006, Genomics Proteomics & Bioinformatics, V4, P42, DOI 10.1016/S1672-0229(06)60015-6; Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Singh M, 1999, CURR PHARM DESIGN, V5, P443; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stephenson K., 2002, Current Drug Targets - Infectious Disorders, V2, P235, DOI 10.2174/1568005023342443; Swets JA, 2000, SCI AM, V283, P82, DOI 10.1038/scientificamerican1000-82; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thakur Prasoon Kumar, 2013, J Nat Sci Biol Med, V4, P51, DOI 10.4103/0976-9668.107260; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vetrivel U, HUGO J, V5, P25; Wang L, 2013, J BACTERIOL, V195, P1959, DOI 10.1128/JB.02299-12; Wong Sandy M. S., 2008, V416, P27, DOI 10.1007/978-1-59745-321-9_3; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zehr ES, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-331; Zou KH, 2003, ACAD RADIOL, V10, P1359, DOI 10.1016/S1076-6332(03)00538-5	110	61	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84263	10.1371/journal.pone.0084263	http://dx.doi.org/10.1371/journal.pone.0084263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391926	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900069
J	Si, CC; Liu, XY; Wang, CY; Wang, L; Dai, ZC; Qi, SS; Du, DL				Si, Chuncan; Liu, Xueyan; Wang, Congyan; Wang, Lei; Dai, Zhicong; Qi, Shanshan; Du, Daolin			Different Degrees of Plant Invasion Significantly Affect the Richness of the Soil Fungal Community	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; FUNCTIONAL DIVERSITY; ENZYME-ACTIVITIES; NITROGEN; FOREST; INVASIBILITY; MOISTURE; BIOTA; ALLOCATION; FACILITATE	Several studies have shown that soil microorganisms play a key role in the success of plant invasion. Thus, ecologists have become increasingly interested in understanding the ecological effects of biological invasion on soil microbial communities given continuing increase in the effects of invasive plants on native ecosystems. This paper aims to provide a relatively complete depiction of the characteristics of soil microbial communities under different degrees of plant invasion. Rhizospheric soils of the notorious invasive plant Wedelia trilobata with different degrees of invasion (uninvaded, low-degree, and high-degree using its coverage in the invaded ecosystems) were collected from five discrete areas in Hainan Province, P. R. China. Soil physicochemical properties and community structure of soil microorganisms were assessed. Low degrees of W. trilobata invasion significantly increased soil pH values whereas high degrees of invasion did not significantly affected soil pH values. Moreover, the degree of W. trilobata invasion exerted significant effects on soil Ca concentration but did not significantly change other indices of soil physicochemical properties. Low and high degrees of W. trilobata invasion increased the richness of the soil fungal community but did not pose obvious effects on the soil bacterial community. W. trilobata invasion also exerted obvious effects on the community structure of soil microorganisms that take part in soil nitrogen cycling. These changes in soil physicochemical properties and community structure of soil microbial communities mediated by different degrees of W. trilobata invasion may present significant functions in further facilitating the invasion process.	[Si, Chuncan; Liu, Xueyan; Wang, Congyan; Wang, Lei; Dai, Zhicong; Qi, Shanshan; Du, Daolin] Jiangsu Univ, Sch Environm & Safety Engn, Zhenjiang, Jiangsu, Peoples R China; [Du, Daolin] Jiangsu Univ, Minist Educ & Jiangsu Prov, Key Lab Modern Agr Equipment & Technolu, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Wang, CY (corresponding author), Jiangsu Univ, Sch Environm & Safety Engn, Zhenjiang, Jiangsu, Peoples R China.	liuyuexue623@163.com; ddl@ujs.edu.cn	Du, Daolin/HHC-9359-2022; Wang, Congyan/B-1299-2010	Du, Daolin/0000-0003-1764-2205; Wang, Congyan/0000-0002-6132-3319; Dai, Zhi-Cong/0000-0002-0748-8059	National Natural Science Foundation of China [30970556, 31170386]; Doctoral Program of Higher Education of China [20093227110004]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Universities Natural Science Research Project of Jiangsu Province [13KJB610002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Universities Natural Science Research Project of Jiangsu Province	This study was partially supported by the National Natural Science Foundation of China (30970556, 31170386), the Doctoral Program of Higher Education of China (20093227110004), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Universities Natural Science Research Project of Jiangsu Province (13KJB610002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner GP, 2005, P NATL ACAD SCI USA, V102, P4383, DOI 10.1073/pnas.0500823102; Booth MS, 2003, J ECOL, V91, P36, DOI 10.1046/j.1365-2745.2003.00739.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Catford JA, 2012, PERSPECT PLANT ECOL, V14, P231, DOI 10.1016/j.ppees.2011.12.002; Chen Tong, 2012, Chinese Journal of Plant Ecology, V36, P253, DOI 10.3724/SP.J.1258.2012.00253; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Cui QG, 2009, WEED RES, V49, P201, DOI 10.1111/j.1365-3180.2008.00679.x; Dassonville N, 2011, BIOL INVASIONS, V13, P1115, DOI 10.1007/s10530-011-9954-5; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Dijkstra FA, 2007, SOIL BIOL BIOCHEM, V39, P2264, DOI 10.1016/j.soilbio.2007.03.026; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Ehrenfeld JG, 2001, ECOL APPL, V11, P1287, DOI 10.2307/3060920; Elgersma KJ, 2011, OECOLOGIA, V167, P733, DOI 10.1007/s00442-011-2022-0; Fan L, 2010, GEODERMA, V154, P370, DOI 10.1016/j.geoderma.2009.11.010; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Fu QL, 2012, J SOIL SEDIMENT, V12, P1134, DOI 10.1007/s11368-012-0544-7; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; Hackl E, 2005, SOIL BIOL BIOCHEM, V37, P661, DOI 10.1016/j.soilbio.2004.08.023; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Herr-Turoff A, 2005, PLANT SOIL, V277, P19, DOI 10.1007/s11104-004-5980-8; Hickman JE, 2010, P NATL ACAD SCI USA, V107, P10115, DOI 10.1073/pnas.0912279107; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hoshino YT, 2008, SOIL SCI PLANT NUTR, V54, P701, DOI 10.1111/j.1747-0765.2008.00289.x; Howard TG, 2004, BIOL INVASIONS, V6, P393, DOI 10.1023/B:BINV.0000041559.67560.7e; Huebner CD, 2006, PLANT ECOL, V186, P57, DOI 10.1007/s11258-006-9112-9; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Ikenaga M, 2010, MICROB ECOL, V59, P284, DOI 10.1007/s00248-009-9572-2; Jiang JP, 2009, PEDOSPHERE, V19, P735, DOI 10.1016/S1002-0160(09)60169-7; Jones RO, 2011, PLANT SOIL, V345, P257, DOI 10.1007/s11104-011-0778-y; [柯展鸿 Ke Zhanhong], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P432; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kuebbing SE, 2014, J APPL ECOL, V51, P124, DOI 10.1111/1365-2664.12161; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Laungani R, 2009, P NATL ACAD SCI USA, V106, P12400, DOI 10.1073/pnas.0900921106; Li WH, 2006, PLANT SOIL, V281, P309, DOI 10.1007/s11104-005-9641-3; Li WH, 2008, OPT EXPRESS, V16, P21616, DOI 10.1364/OE.16.021616; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Lorenzo P, 2010, APPL SOIL ECOL, V44, P245, DOI 10.1016/j.apsoil.2010.01.001; Lowe S, 2000, WORLDS WORST INVASIV, P100; May LA, 2001, CAN J MICROBIOL, V47, P829, DOI 10.1139/cjm-47-9-829; McLean MA, 2000, BIOL FERT SOILS, V32, P114, DOI 10.1007/s003740000225; Muyzer G., 1998, MOL MICROBIAL ECOLOG, P1; Niu HB, 2007, PLANT SOIL, V294, P73, DOI 10.1007/s11104-007-9230-8; Papatheodorou EM, 2004, APPL SOIL ECOL, V25, P37, DOI 10.1016/S0929-1393(03)00100-8; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Roesti D, 2006, SOIL BIOL BIOCHEM, V38, P1111, DOI 10.1016/j.soilbio.2005.09.010; Sanon A, 2012, J ENVIRON MANAGE, V95, pS275, DOI 10.1016/j.jenvman.2011.01.025; Scharfy D, 2010, J ECOL, V98, P1379, DOI 10.1111/j.1365-2745.2010.01722.x; Schmidt JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018654; SHANNON C. E., 1949, MATH THEORY COMMUNIC, P1, DOI DOI 10.1063/1.3067010; Sharma Gyan P., 2007, Applied Ecology and Environmental Research, V5, P109; Song LY, 2010, BIOL INVASIONS, V12, P1221, DOI 10.1007/s10530-009-9541-1; Suding KN, 2013, J ECOL, V101, P298, DOI 10.1111/1365-2745.12057; Svensson JR, 2013, J ECOL, V101, P140, DOI 10.1111/1365-2745.12028; te Beest M, 2009, J ECOL, V97, P1281, DOI 10.1111/j.1365-2745.2009.01574.x; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thorpe AS, 2006, APPL SOIL ECOL, V32, P118, DOI 10.1016/j.apsoil.2005.02.018; van der Wal R, 2008, GLOBAL CHANGE BIOL, V14, P1428, DOI 10.1111/j.1365-2486.2008.01576.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vivas A, 2009, BIORESOURCE TECHNOL, V100, P1319, DOI 10.1016/j.biortech.2008.08.014; Vivas A, 2008, J ENVIRON MONITOR, V10, P1287, DOI 10.1039/b808567f; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Weidenhamer JD, 2010, J CHEM ECOL, V36, P59, DOI 10.1007/s10886-009-9735-0; Wilson SD, 2013, OIKOS, V122, P129, DOI 10.1111/j.1600-0706.2012.20673.x; Windham L, 2003, ECOL APPL, V13, P883, DOI 10.1890/02-5005; Wood YA, 2006, J ENVIRON QUAL, V35, P76, DOI 10.2134/jeq2004.0465; Wu W, 2010, AM J BOT, V97, pE114, DOI 10.3732/ajb.1000327; Xie LJ, 2010, ALLELOPATHY J, V25, P31; Yelenik SG, 2004, RESTOR ECOL, V12, P44, DOI 10.1111/j.1061-2971.2004.00289.x; Zou JW, 2006, OECOLOGIA, V150, P272, DOI 10.1007/s00442-006-0512-2	74	39	44	13	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85490	10.1371/journal.pone.0085490	http://dx.doi.org/10.1371/journal.pone.0085490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392015	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900159
J	Tremblay, I; Pare, E; Arsenault, D; Douziech, M; Boucher, MJ				Tremblay, Isabelle; Pare, Emanuel; Arsenault, Dominique; Douziech, Melanie; Boucher, Marie-Josee			The MEK/ERK Pathway Promotes NOTCH Signalling in Pancreatic Cancer Cells	PLOS ONE			English	Article							DOWN-REGULATION; GROWTH-FACTOR; ACTIVATION; PROTEIN; KINASE; INHIBITION; TARGET; PHOSPHORYLATION; TRANSFORMATION; HYPERPHOSPHORYLATION	Activation of the NOTCH receptors relies on their intracellular proteolysis by the gamma-secretase complex. This cleavage liberates the NOTCH intracellular domain (NIC) thereby allowing the translocation of NIC towards the nucleus to assemble into a transcriptional platform. Little information is available regarding the regulatory steps operating on NIC following its release from the transmembrane receptor up to its association with transcriptional partners. Interfering with these regulatory steps might potentially influences the nuclear outcome of NOTCH signalling. Herein, we exploited a reliable model to study the molecular events occurring subsequent to NOTCH1 cleavage. In pancreatic cancer cells, pulse of NOTCH1 activation led to increased expression of NOTCH target genes namely HES1 and c-MYC. We uncovered that, upon its release, the NOTCH1 intracellular domain, NIC1, undergoes a series of post-translational modifications that include phosphorylation. Most interestingly, we found that activation of the MEK/ERK pathway promotes HES1 expression. Inhibition of the gamma-secretase complex prevented the MEK/ERK-induced HES1 expression suggesting a NOTCH-dependent mechanism. Finally, higher levels of NIC1 were found associated with its transcriptional partners [CBF1, Su(H) and LAG-1] (CSL) and MASTERMIND-LIKE 1 (MAML1) upon MEK/ERK activation providing a potential mechanism whereby the MEK/ERK pathway promotes expression of NOTCH target genes. For the first time, our data exposed a signalling pathway, namely the MEK/ERK pathway that positively impacts on NOTCH nuclear outcome.	[Tremblay, Isabelle; Pare, Emanuel; Arsenault, Dominique; Douziech, Melanie; Boucher, Marie-Josee] Univ Sherbrooke, Dept Med, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Boucher, MJ (corresponding author), Univ Sherbrooke, Dept Med, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	marie-josee.boucher@usherbrooke.ca		Boucher, Marie-Josee/0000-0002-7615-3121	Canadian Institutes for Health Research [IC1-102949, MOP-106456]; FRQ-S	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); FRQ-S	This work was supported by grants from the Canadian Institutes for Health Research (IC1-102949 and MOP-106456 to MJB). MJB is a scholar from the Fonds de Recherche Sante Quebec (FRQ-S) and member of the FRQ-S-funded Centre de Recherche Clinique Etienne-Le Bel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Boucher MJ, 2009, ENDOCRINOLOGY, V150, P87, DOI 10.1210/en.2007-0865; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Boucher MJ, 2004, AM J PHYSIOL-GASTR L, V286, pG736, DOI 10.1152/ajpgi.00453.2003; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Cook N, 2012, J EXP MED, V209, P437, DOI 10.1084/jem.20111923; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Fernandez-Martinez J, 2009, J CELL SCI, V122, P1574, DOI 10.1242/jcs.044354; Foltz DR, 2001, BIOCHEM BIOPH RES CO, V286, P484, DOI 10.1006/bbrc.2001.5421; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Housden BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003162; Ilagan MXG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001656; Ishitani T, 2010, NAT CELL BIOL, V12, P278, DOI 10.1038/ncb2028; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kawahashi K, 2010, GENES CELLS, V15, P749, DOI 10.1111/j.1365-2443.2010.01412.x; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; KIDD S, 1989, GENE DEV, V3, P1113, DOI 10.1101/gad.3.8.1113; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mittal S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-128; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Mysliwiec P, 2009, ADV MED SCI-POLAND, V54, P136, DOI 10.2478/v10039-009-0026-3; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Pui CH, 2009, CANCER CELL, V15, P85, DOI 10.1016/j.ccr.2009.01.007; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ranganathan P, 2011, J BIOL CHEM, V286, P28844, DOI 10.1074/jbc.M111.243600; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Ronchini C, 2000, ONCOGENE, V19, P3914, DOI 10.1038/sj.onc.1203719; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Stanger BZ, 2005, CANCER CELL, V8, P185, DOI 10.1016/j.ccr.2005.07.015; Stockhausen MT, 2005, EXP CELL RES, V310, P218, DOI 10.1016/j.yexcr.2005.07.011; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang ZW, 2006, CANCER RES, V66, P7653, DOI 10.1158/0008-5472.CAN-06-1019; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	56	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85502	10.1371/journal.pone.0085502	http://dx.doi.org/10.1371/journal.pone.0085502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392017	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900161
J	Wang, L; Xu, K; Lin, J; Shao, SM; Zhang, TT; Xu, HR; Wei, ZH; Zhang, ZY				Wang, Ling; Xu, Kun; Lin, Juan; Shao, Simin; Zhang, Tingting; Xu, Huarong; Wei, Zehui; Zhang, Zhiying			A Novel Genetic System Based on Zinc Finger Nucleases for the Identification of Interactions between Proteins In Vivo	PLOS ONE			English	Article							YEAST 2-HYBRID; DOMAIN; DROSOPHILA; NETWORK; CELLS; MAP	Yeast two-hybrid (Y2H) methods are powerful tools for detecting protein-protein interactions. The traditional Y2H method has been widely applied to screen novel protein interactions since it was established two decades ago. The high false-positive rate of the traditional method drove the development of modified Y2H systems. Here, we describe a novel Y2H system using zinc-finger nucleases (ZFNs). ZFNs contain two functional domains, a zinc-finger DNA-binding domain (ZFP) and a non-specific nuclease domain (FokI). In this system, the bait is expressed as a fusion protein with a specific ZFP, and the prey is fused to the FokI. A reporter vector is designed such that the ZFN target site disrupts the Gal4 open reading frame. By transforming the three plasmids into a yeast strain (AH109), the interaction between the bait and prey proteins reconstitutes ZFN function and generates the double-strand break (DSB) on its target site. The DNA DSB repair restores Gal4 function, which activates the expression of the four reporter genes. We used p53-SV40LT interacting proteins to prove the concept. In addition, 80% positive rate was observed in a cDNA screening test against WDSV orfA protein. Our results strongly suggested that this Y2H system could increase screening reliability and reproducibility, and provide a novel approach for interactomics research.	[Wang, Ling; Xu, Kun; Lin, Juan; Shao, Simin; Zhang, Tingting; Xu, Huarong; Wei, Zehui; Zhang, Zhiying] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, ZY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	zhangzhy@nwsuaf.edu.cn		Zhang, Zhiying/0000-0001-6012-0889	National Natural Science Foundation of China (NSFC) [31172186]; 973 program [2011CBA01002]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (NSFC) (31172186) (http://www.nsfc.gov.cn) and 973 program (2011CBA01002) (http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher Sharon L., 2008, Briefings in Functional Genomics & Proteomics, V7, P460, DOI 10.1093/bfgp/eln043; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bobis-Wozowicz S, 2011, METHODS, V53, P339, DOI 10.1016/j.ymeth.2010.12.019; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Cai CQ, 2009, PLANT MOL BIOL, V69, P699, DOI 10.1007/s11103-008-9449-7; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Handel EM, 2009, MOL THER, V17, P104, DOI 10.1038/mt.2008.233; Hastie AR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm894; Huang H, 2007, PLOS COMPUT BIOL, V3, P2155, DOI 10.1371/journal.pcbi.0030214; Hubsman M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e18; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Ichikawa K, 2006, J BIOCHEM, V139, P105, DOI 10.1093/jb/mvj011; IWABUCHI K, 1993, ONCOGENE, V8, P1693; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Xu K, 2013, MOL BIOL REP, V40, P1451, DOI 10.1007/s11033-012-2188-5	26	3	6	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85650	10.1371/journal.pone.0085650	http://dx.doi.org/10.1371/journal.pone.0085650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392024	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900168
J	Wu, B; Liu, K; Huang, HX; Yuan, J; Yuan, WQ; Wang, SQ; Chen, TT; Zhao, H; Yin, CJ				Wu, Bin; Liu, Kang; Huang, Huaxing; Yuan, Jun; Yuan, Wanqing; Wang, Shangqian; Chen, Tingting; Zhao, Hu; Yin, Changjun			MspI and Ile462Val Polymorphisms in CYP1A1 and Overall Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							METABOLIZING ENZYME POLYMORPHISMS; ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE POLYMORPHISMS; SUSCEPTIBILITY; TOXICITY; GSTM1	Background: Cytochrome P450 1A1 (CYP1A1) is a member of the CYP1 family, which is a key enzyme in the metabolism of many endogenous substrates and exogenous carcinogens. To date, many studies have examined the association between CYP1A1 MspI and Ile462Val polymorphisms and cancer risk in various populations, but their results have been conflicting rather than consistent. Methods: To assess this relationship more precisely, a meta-analysis based on 198 publications was performed. Odds ratios (OR) and corresponding 95% confidence intervals (CIs) were used to assess the association. The statistical heterogeneity across studies was examined with a chi-square-based Q-test. Results: Overall, a significant elevated risk of cancer was associated with CYP1A1 MspI and Ile462Val polymorphisms for all genetic models studied. Further stratified analysis by cancer types revealed that the MspI polymorphism may increase the risk of lung cancer and cervical cancer whereas the Ile462Val polymorphism may contribute to a higher risk of lung cancer, leukemia, esophageal carcinoma, and prostate cancer. In the subgroup analysis by ethnicity, obvious associations were found in the Asian population for the MspI polymorphism while an increased risk of cancer was observed in Asians and Caucasians for the Ile462Val polymorphism. Conclusions: The results of this meta-analysis suggest that CYP1A1 MspI and Ile462Val polymorphisms contribute to increased cancer susceptibility among Asians. Additional comprehensive system analyses are required to validate this association and other related polymorphisms.	[Wu, Bin; Yuan, Jun; Zhao, Hu] Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Urol, Wuxi, Peoples R China; [Liu, Kang; Wang, Shangqian; Chen, Tingting; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Huang, Huaxing] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China; [Yuan, Wanqing] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Orthoped, Qingdao 266071, Peoples R China	Southeast University - China; Nanjing Medical University; Nanjing Medical University; Qingdao University	Zhao, H (corresponding author), Southeast Univ, Coll Med, Affiliated Jiangyin Hosp, Dept Urol, Wuxi, Peoples R China.	doctorzhao11@163.com						Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; Bozina N, 2009, ARH HIG RADA TOKSIKO, V60, P217, DOI 10.2478/10004-1254-60-2009-1885; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Gonzalez FJ, 1997, REPROD TOXICOL, V11, P397, DOI 10.1016/S0890-6238(96)00154-2; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001; Gutman G, 2009, INT J GYNECOL CANCER, V19, P1300, DOI 10.1111/IGC.0b013e3181b9fa5d; Jin JQ, 2011, WORLD J GASTROENTERO, V17, P260, DOI 10.3748/wjg.v17.i2.260; Li M, 2008, CHINESE MED J-PEKING, V121, P305, DOI 10.1097/00029330-200802020-00005; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nebert DW, 1996, DNA CELL BIOL, V15, P273, DOI 10.1089/dna.1996.15.273; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Rodriguez-Antona C, 2010, HUM GENET, V127, P1, DOI 10.1007/s00439-009-0748-0; Sergentanis TN, 2012, MOL BIOL REP, V39, P6647, DOI 10.1007/s11033-012-1470-x; Sugawara T, 2003, INT J GYNECOL CANCER, V13, P785, DOI 10.1136/ijgc-00009577-200311000-00009; Varela-Lema L, 2008, GENET MED, V10, P369, DOI 10.1097/GIM.0b013e3181770196; Vijayakrishnan J, 2010, HAEMATOL-HEMATOL J, V95, P1405, DOI 10.3324/haematol.2010.022095; Wideroff L, 2007, CANCER DETECT PREV, V31, P233, DOI 10.1016/j.cdp.2007.03.004; Yu L, 2012, MOL BIOL REP, V39, P6641, DOI 10.1007/s11033-012-1469-3; Zhan P, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-99; Zheng Y, 2012, MOL BIOL REP, V39, P3533, DOI 10.1007/s11033-011-1126-2; Zhuo WL, 2012, GENE, V510, P14, DOI 10.1016/j.gene.2012.08.042; Zhuo XL, 2012, CANCER INVEST, V30, P552, DOI 10.3109/07357907.2012.716470	23	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85166	10.1371/journal.pone.0085166	http://dx.doi.org/10.1371/journal.pone.0085166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391993	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900136
J	Lu, HD; Dai, YH; Lv, LL; Zhao, HQ				Lu, Huading; Dai, Yuhu; Lv, Lulu; Zhao, Huiqing			Chitosan-Graft-Polyethylenimine/DNA Nanoparticles as Novel Non-Viral Gene Delivery Vectors Targeting Osteoarthritis	PLOS ONE			English	Article							MOLECULAR-WEIGHT POLYETHYLENIMINE; ADMINISTRATION IN-VIVO; TRANSFECTION EFFICIENCY; PHYSICOCHEMICAL PROPERTIES; DNA DELIVERY; VITRO; POLY(ETHYLENIMINE); COMPLEXES; SYSTEM; LUNG	The development of safe and efficient gene carriers is the key to the clinical success of gene therapy. The present study was designed to develop and evaluate the chitosan-graft-polyethylenimine (CP)/DNA nanoparticles as novel non-viral gene vectors for gene therapy of osteoarthritis. The CP/DNA nanoparticles were produced through a complex coacervation of the cationic polymers with pEGFP after grafting chitosan (CS) with a low molecular weight (Mw) PEI (Mw = 1.8 kDa). Particle size and zeta potential were related to the weight ratio of CP: DNA, where decreases in nanoparticle size and increases in surface charge were observed as CP content increased. The buffering capacity of CP was significantly greater than that of CS. The transfection efficiency of CP/DNA nanoparticles was similar with that of the Lipofectamine (TM) 2000, and significantly higher than that of CS/DNA and PEI (25 kDa)/DNA nanoparticles. The transfection efficiency of the CP/DNA nanoparticles was dependent on the weight ratio of CP: DNA (w/w). The average cell viability after the treatment with CP/DNA nanoparticles was over 90% in both chondrocytes and synoviocytes, which was much higher than that of PEI (25 kDa)/DNA nanoparticles. The CP copolymers efficiently carried the pDNA inside chondrocytes and synoviocytes, and the pDNA was detected entering into nucleus. These results suggest that CP/DNA nanoparticles with improved transfection efficiency and low cytotoxicity might be a safe and efficient non-viral vector for gene delivery to both chondrocytes and synoviocytes.	[Lu, Huading; Dai, Yuhu; Lv, Lulu; Zhao, Huiqing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lu, HD (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510275, Guangdong, Peoples R China.	johnniehuading@163.com			National Natural Science Foundation of China [81272040, 30600632]; Natural Science Foundation of Guangdong Province, P.R. China [S2011010004808]; Science and Technology Projects of Guangdong Province, P.R. China [2012B031800451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, P.R. China(National Natural Science Foundation of Guangdong Province); Science and Technology Projects of Guangdong Province, P.R. China	This study was supported by the National Natural Science Foundation of China (No. 81272040; 30600632), the Natural Science Foundation of Guangdong Province, P.R. China (No. S2011010004808), and the Science and Technology Projects of Guangdong Province, P.R. China (No. 2012B031800451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Chang KL, 2010, BIOCONJUGATE CHEM, V21, P1087, DOI 10.1021/bc1000609; Chang Y, 2009, J ETHNOPHARMACOL, V121, P43, DOI 10.1016/j.jep.2008.09.028; Choi S, 2008, J CONTROL RELEASE, V131, P70, DOI 10.1016/j.jconrel.2008.07.007; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Feng M, 2006, INT J PHARMACEUT, V311, P209, DOI 10.1016/j.ijpharm.2005.12.035; Gao JQ, 2010, INT J PHARMACEUT, V387, P286, DOI 10.1016/j.ijpharm.2009.12.033; Gao Y, 2008, INT J PHARMACEUT, V359, P241, DOI 10.1016/j.ijpharm.2008.03.037; Gao Y, 2009, INT J PHARMACEUT, V371, P156, DOI 10.1016/j.ijpharm.2008.12.012; Goyal R, 2012, NANOMED-NANOTECHNOL, V8, P167, DOI 10.1016/j.nano.2011.06.001; Hashimoto M, 2006, BIOCONJUGATE CHEM, V17, P309, DOI 10.1021/bc050228h; Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3; Honjo K, 2010, J GENE MED, V12, P219, DOI 10.1002/jgm.1378; Huang MJ, 2012, MED HYPOTHESES, V79, P614, DOI 10.1016/j.mehy.2012.07.035; Jeong JH, 2001, J CONTROL RELEASE, V73, P391, DOI 10.1016/S0168-3659(01)00310-8; Jere D, 2009, INT J PHARMACEUT, V378, P194, DOI 10.1016/j.ijpharm.2009.05.046; Jiang HL, 2007, J CONTROL RELEASE, V117, P273, DOI 10.1016/j.jconrel.2006.10.025; Jiang HL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025013; Kichler A, 2005, J GENE MED, V7, P1459, DOI 10.1002/jgm.805; Kim TH, 2005, J CONTROL RELEASE, V105, P354, DOI 10.1016/j.jconrel.2005.03.024; Kircheis R, 2001, ADV DRUG DELIVER REV, V53, P341, DOI 10.1016/S0169-409X(01)00202-2; Koping-Hoggard M, 2003, J GENE MED, V5, P130, DOI 10.1002/jgm.327; Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492; Kubota N, 2000, CARBOHYD RES, V324, P268, DOI 10.1016/S0008-6215(99)00263-3; Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449; Lu HD, 2011, INT J PHARMACEUT, V420, P358, DOI 10.1016/j.ijpharm.2011.08.046; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004; Petersen H, 2002, BIOMACROMOLECULES, V3, P926, DOI 10.1021/bm025539z; Pi YB, 2011, BIOMATERIALS, V32, P6324, DOI 10.1016/j.biomaterials.2011.05.017; Rekha M R, 2012, Recent Pat DNA Gene Seq, V6, P98; Sezer AD, 2009, AAPS PHARMSCITECH, V10, P1193, DOI 10.1208/s12249-009-9324-0; SIMON RH, 1993, HUM GENE THER, V4, P771, DOI 10.1089/hum.1993.4.6-771; Sun XL, 2010, MINI-REV MED CHEM, V10, P108, DOI 10.2174/138955710791185109; Tiera MJ, 2011, CURR GENE THER, V11, P288; Tripathi SK, 2012, NANOMED-NANOTECHNOL, V8, P337, DOI 10.1016/j.nano.2011.06.022; Tseng WC, 2004, J GENE MED, V6, P895, DOI 10.1002/jgm.572; Wong K, 2006, BIOCONJUGATE CHEM, V17, P152, DOI 10.1021/bc0501597; Zhang XL, 2006, BIOCHEM BIOPH RES CO, V341, P202, DOI 10.1016/j.bbrc.2005.12.171; Zhao QQ, 2008, J BIOSCI BIOENG, V105, P65, DOI 10.1263/jbb.105.65; Zhao QQ, 2009, BIOL PHARM BULL, V32, P706, DOI 10.1248/bpb.32.706	43	95	103	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84703	10.1371/journal.pone.0084703	http://dx.doi.org/10.1371/journal.pone.0084703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392152	Green Published, gold			2022-12-27	WOS:000329460100075
J	Fiorentino, M; Bastard, G; Sembene, M; Fortin, S; Traissac, P; Landais, E; Icard-Verniere, C; Wieringa, FT; Berger, J				Fiorentino, Marion; Bastard, Guillaume; Sembene, Malick; Fortin, Sonia; Traissac, Pierre; Landais, Edwige; Icard-Verniere, Christele; Wieringa, Frank T.; Berger, Jacques			Anthropometric and Micronutrient Status of School-Children in an Urban West Africa Setting: A Cross-Sectional Study in Dakar (Senegal)	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; PRIMARY-SCHOOL CHILDREN; IRON-DEFICIENCY; TRANSFERRIN RECEPTOR; NUTRITIONAL-STATUS; ZINC-DEFICIENCY; AGED CHILDREN; PREVALENCE; RETINOL; INDICATORS	Background: Urban areas in West Africa are not immune to undernutrition with recent urbanization and high food prices being important factors. School children often have a poor nutritional status, potentially affecting their health and schooling performance. Yet, generally school children do not benefit from nutrition programs. The objective of the study was to assess the anthropometric and micronutrient status of children from state schools in the Dakar area. Methods: School children (n = 604) aged from 5 to 17 y (52.5% girls, 47.5% >= 10 y) were selected through a two-stage random cluster sample of children attending urban primary state schools in the Dakar area (30 schools x 20 children). The prevalence of stunting (height-for-age <-2 z-scores) and thinness (BMI-for-age, <-2 z-scores, WHO 2006, and three grades of thinness corresponding to BMI of 18.5, 17.0 and 16.0 kg/m2 in adults) were calculated from weight and height. Hemoglobin, plasma concentrations of ferritin (FER), transferrin receptors (TfR), retinol binding protein (RBP), and zinc, and urinary iodine concentrations were measured. Correction factors were used for FER and RBP in subjects with inflammation determined with C-reactive protein and alpha 1-acid-glycoprotein. Results: 4.9% of children were stunted, 18.4% were thin, 5.6% had severe thinness (BMI-for-age,<-3 z-scores). Only one child had a BMI-for-age. > 2 z-scores. Prevalence of anemia, iron deficiency and iron deficiency anemia was 14.4%, 39.1% and 10.6% respectively. 3.0% had vitamin A deficiency, 35.9% a marginal vitamin A status, and 25.9% zinc deficiency. Urinary iodine was, < 50 mu g/L in 7.3% of children and >= 200 mu g/L in 22.3%. The prevalence of marginal vitamin A, zinc deficiency, high TfR was significantly higher in boys than in girls (P < 0.05). Height-for-age and retinol were significantly lower in participants >= 10 y and < 10 y respectively. Conclusion: Undernutrition, especially thinness, iron and zinc deficiencies in school children in the Dakar area requires special targeted nutrition interventions.	[Fiorentino, Marion; Bastard, Guillaume] GRET, Dakar, Senegal; [Sembene, Malick] Minist Educ Natl, DCMS, Dakar, Senegal; [Fortin, Sonia; Traissac, Pierre; Landais, Edwige; Icard-Verniere, Christele; Wieringa, Frank T.; Berger, Jacques] IRD UM2 UM1, UMR Nutripass 204, IRD, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Fiorentino, M (corresponding author), GRET, Dakar, Senegal.	marionfiorentino@hotmail.com	Wieringa, Frank Tammo/K-7565-2017; Bastard, Gerald A/K-8983-2017; ICARD-VERNIERE, Christèle CV/A-2625-2011; landais, edwige/AAK-2356-2020	Wieringa, Frank Tammo/0000-0002-6010-355X; ICARD-VERNIERE, Christèle CV/0000-0002-5626-6639; landais, edwige/0000-0002-7291-2012; fiorentino, marion/0000-0002-1615-4579; Traissac, Pierre/0000-0002-3184-5597	Danone	Danone(Danone Nutricia)	The study was funded by Danone. www.danone.com www.danonecommunities.com The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, ASS IOD DEF DIS MON; [Anonymous], 2004, ASS IR STAT POP INCL; ANSD, 2009, SIT EC SOC REG DAK A; Becquey E, 2010, IMP HAUSS PRIX SEC A, V140, p2079S; Becquey E, 2010, J NUTR, V140, p2079S, DOI 10.3945/jn.110.123356; Benkhala A, 2009, MEMOIRE DEA; Benkhala A., 2009, RECHERCHER REPONSES; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; Black RE, 2001, BRIT J NUTR, V85, pS125, DOI 10.1079/BJN2000304; Bovet P, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-65; Bryan J, 2004, NUTR REV, V62, P295, DOI 10.1301/nr.2004.aug.295-306; CAVAN KR, 1993, AM J CLIN NUTR, V57, P334, DOI 10.1093/ajcn/57.3.334; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Dabone C, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-34; de Benoist B, 2008, WHO GLOBAL DATABASE; de Benoist B, 2007, FOOD NUTR BULL, V28, pS480, DOI 10.1177/15648265070283S306; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Diagne I, 2003, MED TROPICALE, P513; Dijkhuizen MA, 2001, AM J CLIN NUTR, V73, P786; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; El Hioui M, 2008, East Afr J Public Health, V5, P62; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; FAO, 1999, DEV FOOD INS VULN MA; Gibson RS, 2007, BRIT J NUTR, V97, P167, DOI 10.1017/S0007114507250445; Gibson RS, PRINCIPLES NUTR ASSE, P378; Gordon RC, 2009, AM J CLIN NUTR, V90, P1264, DOI 10.3945/ajcn.2009.28145; Idohou-Dossou N, 2003, BRIT J NUTR, V90, P1123, DOI 10.1079/BJN2003990; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; Kaiser R, 2006, DISASTERS, V30, P199, DOI 10.1111/j.0361-3666.2006.00315.x; Kassaye T, 2001, B WORLD HEALTH ORGAN, V79, P415; Martorell R, FOOD NUTR B, V20; Pandey A, 1996, Indian J Public Health, V40, P13; Pino S, 1996, CLIN CHEM, V42, P239; Qin Y, 2009, ASIA PAC J CLIN NUTR, V18, P15; Thurlow RA, 2006, EUR J CLIN NUTR, V60, P623, DOI 10.1038/sj.ejcn.1602361; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; UNDP, 2011, HUMAN DEV REPORT; WAHED MA, 1995, AM J CLIN NUTR, V61, P1253, DOI 10.1093/ajcn/61.6.1253; WFP/UNICEF/FAO/ANSD, 2008, PROF NUTR SEN; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2012, SEN STAT; Wieringa FT, 2007, BRIT J NUTR, V98, P1070, DOI 10.1017/S0007114507756945; World Health Organization, 2011, HAEM CONC DIAGN AN A; World Health Organization, 2001, 2 DEC IMPR AD HLTH D; World Health Organization, 2010, AN NUTR LANDSC INF S; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3	50	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84328	10.1371/journal.pone.0084328	http://dx.doi.org/10.1371/journal.pone.0084328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391938	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900081
J	Geukes, S; Huster, RJ; Wollbrink, A; Junghofer, M; Zwitserlood, P; Dobel, C				Geukes, Sebastian; Huster, Rene J.; Wollbrink, Andreas; Junghoefer, Markus; Zwitserlood, Pienie; Dobel, Christian			A Large N400 but No BOLD Effect - Comparing Source Activations of Semantic Priming in Simultaneous EEG-fMRI	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; MINIMUM NORM; FIELD POTENTIALS; BRAIN ACTIVITY; WORDS; RESPONSES; NETWORK; CONTEXT; MEG; REPETITION	Numerous studies have reported neurophysiological effects of semantic priming in electroencephalography (EEG) and in functional magnetic resonance imaging (fMRI). Because of differing methodological constraints, the comparability of the observed effects remains unclear. To directly compare EEG and fMRI effects and neural sources of semantic priming, we conducted a semantic word-picture priming experiment while measuring EEG and fMRI simultaneously. The visually presented primes were pseudowords, words unrelated to the target, semantically related words and the identical names of the target. Distributed source analysis of the event-related potentials (ERPs) successfully revealed a large effect of semantic prime-target relatedness (the N400 effect), which was driven by activations in a left-temporal source region. However, no significantly differing activations between priming conditions were found in the fMRI data. Our results support the notion that, for joint interpretations of existing EEG and fMRI studies of semantic priming, we need to fully appreciate the respective methodological limitations. Second, they show that simultaneous EEG-fMRI, including ERP source localization, is a feasible and promising methodological advancement for the investigation of higher-cognitive processes. Third, they substantiate the finding that, compared to fMRI, ERPs are often more sensitive to subtle cognitive effects.	[Geukes, Sebastian; Zwitserlood, Pienie] Univ Munster, Inst Pathol, D-48149 Munster, Germany; [Huster, Rene J.] Carl von Ossietzky Univ Oldenburg, Dept Psychol, Expt Psychol Lab, D-26111 Oldenburg, Germany; [Wollbrink, Andreas; Junghoefer, Markus; Dobel, Christian] Univ Munster, Fac Med, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany	University of Munster; Carl von Ossietzky Universitat Oldenburg; University of Munster	Geukes, S (corresponding author), Univ Munster, Inst Pathol, D-48149 Munster, Germany.	sebastian.geukes@uni-muenster.de	Geukes, Sebastian/D-6222-2015; Junghoefer, Markus/AAA-2892-2021	Geukes, Sebastian/0000-0003-1693-2657; Junghoefer, Markus/0000-0002-8532-2986	Volkswagen Stiftung [I/80 708]	Volkswagen Stiftung(Volkswagen)	This research was partly supported by a Volkswagen Stiftung grant to Christian Dobel, grant number I/80 708 (http://www.volkswagenstiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; BARRETT SE, 1990, BRAIN COGNITION, V14, P201, DOI 10.1016/0278-2626(90)90029-N; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bolte J, 2010, NEUROSCI LETT, V469, P107, DOI 10.1016/j.neulet.2009.11.054; Breitenstein C, 2002, J NEUROSCI METH, V114, P173, DOI 10.1016/S0165-0270(01)00525-8; Breitenstein C, 2007, RESTOR NEUROL NEUROS, V25, P493; Chen Y, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00376; Copland DA, 2003, NEUROIMAGE, V20, P302, DOI 10.1016/S1053-8119(03)00279-9; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; de Zubicaray GI, 2001, HUM BRAIN MAPP, V14, P218, DOI 10.1002/hbm.1054; de Zubicaray GI, 2009, COGN AFFECT BEHAV NE, V9, P260, DOI 10.3758/CABN.9.3.260; Debener S., 2010, SIMULTANEOUS EEG FMR; Debener S, 2006, TRENDS COGN SCI, V10, P558, DOI 10.1016/j.tics.2006.09.010; Dobel C, 2010, J COGNITIVE NEUROSCI, V22, P1251, DOI 10.1162/jocn.2009.21297; Dobel C, 2009, PHILOS T R SOC B, V364, P3697, DOI 10.1098/rstb.2009.0158; Giesbrecht B, 2004, CEREB CORTEX, V14, P521, DOI 10.1093/cercor/bhh014; Gold BT, 2006, J NEUROSCI, V26, P6523, DOI 10.1523/JNEUROSCI.0808-06.2006; Haan H, 2000, HUM BRAIN MAPP, V11, P178; Hagoort P, 1996, BRAIN, V119, P627, DOI 10.1093/brain/119.2.627; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hamm JP, 2002, CLIN NEUROPHYSIOL, V113, P1339, DOI 10.1016/S1388-2457(02)00161-X; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Hirschfeld G, 2011, BRAIN LANG, V116, P91, DOI 10.1016/j.bandl.2010.07.002; HOLCOMB PJ, 1994, BRAIN COGNITION, V24, P259, DOI 10.1006/brcg.1994.1014; Huster RJ, 2012, J NEUROSCI, V32, P6053, DOI 10.1523/JNEUROSCI.0447-12.2012; Khateb A, 2010, BRAIN TOPOGR, V23, P311, DOI 10.1007/s10548-010-0149-7; Kherif F, 2011, CEREB CORTEX, V21, P103, DOI 10.1093/cercor/bhq063; Kiss GR, 1973, COMPUTER LIT STUDIES, P153; Kotz SA, 2002, NEUROIMAGE, V17, P1761, DOI 10.1006/nimg.2002.1316; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; Matsumoto A, 2005, NEUROIMAGE, V24, P624, DOI 10.1016/j.neuroimage.2004.09.008; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; McNamara T. P., 2005, SEMANTIC PRIMING PER, DOI DOI 10.4324/9780203338001; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Mormann F, 2005, HIPPOCAMPUS, V15, P890, DOI 10.1002/hipo.20117; Neely J.H., 1991, BASIC PROCESSES READ, V11, P264; NOBRE AC, 1995, J NEUROSCI, V15, P1090; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; PRATARELLI ME, 1994, BRAIN COGNITION, V24, P137, DOI 10.1006/brcg.1994.1008; Renoult L, 2011, J COGNITIVE NEUROSCI, V23, P905, DOI 10.1162/jocn.2009.21410; Ritter P, 2006, NEUROSCI BIOBEHAV R, V30, P823, DOI 10.1016/j.neubiorev.2006.06.008; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; RUGG MD, 1985, PSYCHOPHYSIOLOGY, V22, P642, DOI 10.1111/j.1469-8986.1985.tb01661.x; Shinkareva SV, 2011, NEUROIMAGE, V54, P2418, DOI 10.1016/j.neuroimage.2010.10.042; Simons JS, 2003, NEUROIMAGE, V19, P613, DOI 10.1016/S1053-8119(03)00096-X; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; Vartiainen J, 2011, J NEUROSCI, V31, P1048, DOI 10.1523/JNEUROSCI.3113-10.2011; Wible CG, 2006, BRAIN LANG, V97, P294, DOI 10.1016/j.bandl.2005.11.006	59	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84029	10.1371/journal.pone.0084029	http://dx.doi.org/10.1371/journal.pone.0084029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391871	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900014
J	Kisiel-Sajewicz, K; Siemionow, V; Seyidova-Khoshknabi, D; Davis, MP; Wyant, A; Ranganathan, VK; Walsh, D; Yan, JH; Hou, J; Yue, GH				Kisiel-Sajewicz, Katarzyna; Siemionow, Vlodek; Seyidova-Khoshknabi, Dilara; Davis, Mellar P.; Wyant, Alexandria; Ranganathan, Vinoth K.; Walsh, Declan; Yan, Jin H.; Hou, Juliet; Yue, Guang H.			Myoelectrical Manifestation of Fatigue Less Prominent in Patients with Cancer Related Fatigue	PLOS ONE			English	Article							MOTOR-UNIT RECRUITMENT; ELBOW FLEXOR MUSCLES; HUMAN BICEPS-BRACHII; CONDUCTION-VELOCITY; SUPRASPINAL FACTORS; FREQUENCY CONTENT; EMG AMPLITUDE; TASK FAILURE; FORCE; MECHANISMS	Purpose: A lack of fatigue-related muscle contractile property changes at time of perceived physical exhaustion and greater central than peripheral fatigue detected by twitch interpolation technique have recently been reported in cancer survivors with fatigue symptoms. Based on these observations, it was hypothesized that compared to healthy people, myoelectrical manifestation of fatigue in the performing muscles would be less significant in these individuals while sustaining a prolonged motor task to self-perceived exhaustion (SPE) since their central fatigue was more prominent. The purpose of this study was to test this hypothesis by examining electromyographic (EMG) signal changes during fatiguing muscle performance. Methods: Twelve individuals who had advanced solid cancer and cancer-related fatigue (CRF), and 12 age-and gender-matched healthy controls performed a sustained elbow flexion at 30% maximal voluntary contraction till SPE. Amplitude and mean power frequency (MPF) of EMG signals of the biceps brachii, brachioradialis, and triceps brachii muscles were evaluated when the individuals experienced minimal, moderate, and severe fatigue. Results: CRF patients perceived physical "exhaustion" significantly sooner than the controls. The myoelectrical manifestation of muscular fatigue assessed by EMG amplitude and MPF was less significant in CRF than controls. The lower MPF even at minimal fatigue stage in CRF may indicate pathophysiologic condition of the muscle. Conclusions: CRF patients experience less myoelectrical manifestation of muscle fatigue than healthy individuals near the time of SPE. The data suggest that central nervous system fatigue plays a more important role in limiting endurance-type of motor performance in patients with CRF.	[Kisiel-Sajewicz, Katarzyna; Siemionow, Vlodek; Wyant, Alexandria; Ranganathan, Vinoth K.; Yue, Guang H.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA; [Seyidova-Khoshknabi, Dilara; Davis, Mellar P.; Walsh, Declan] Cleveland Clin, Taussig Canc Ctr, Harry R Horvitz Ctr Palliat Med, Cleveland, OH 44106 USA; [Siemionow, Vlodek; Ranganathan, Vinoth K.; Hou, Juliet; Yue, Guang H.] Cleveland Clin, Neurol Inst, Dept Phys Med & Rehabil, Cleveland, OH 44106 USA; [Kisiel-Sajewicz, Katarzyna] Univ Sch Phys Educ Wroclaw, Fac Physiotherapy, Dept Kinesiol, Wroclaw, Poland; [Yan, Jin H.] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China; [Yan, Jin H.] Tsinghuan Univ, Dept Psychol, Beijing, Peoples R China; [Yue, Guang H.] Kessler Fdn Res Ctr, W Orange, NJ USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Shenzhen University; Tsinghua University; Kessler Institute for Rehabilitation	Yan, JH (corresponding author), Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China.	jin.yan@sjsu.edu; gyue@kesslerfoundation.org		Walsh, (Thomas) Declan/0000-0002-9310-1729; Seyidova-Khoshknabi, Dilara/0000-0003-2291-2185; Kisiel-Sajewicz, Katarzyna/0000-0002-3137-2646	Cleveland Clinic grant [RPC6700]; Ministry of Science and Higher Education of Republic of Poland [10/MOB/2007/0]	Cleveland Clinic grant; Ministry of Science and Higher Education of Republic of Poland(Ministry of Science and Higher Education, Poland)	This study was supported by a Cleveland Clinic grant [RPC6700]; and a Ministry of Science and Higher Education grant [10/MOB/2007/0] of Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; Andreasen AK, 2009, MULT SCLER J, V15, P818, DOI 10.1177/1352458509105383; Bilodeau M, 2003, J ELECTROMYOGR KINES, V13, P83, DOI 10.1016/S1050-6411(02)00050-0; Bilodeau M, 2001, J APPL PHYSIOL, V91, P2654, DOI 10.1152/jappl.2001.91.6.2654; Botter A, 2009, INT J SPORTS MED, V30, P408, DOI 10.1055/s-0028-1112142; BROMAN H, 1985, J APPL PHYSIOL, V58, P1428, DOI 10.1152/jappl.1985.58.5.1428; BUCHTHAL F, 1950, ELECTROEN CLIN NEURO, V2, P425, DOI 10.1016/0013-4694(50)90079-4; Burke R. E., 1981, HDB PHYSL NERVOUS SY, VII, P354; Cheville AL, 2008, J CLIN ONCOL, V26, P2621, DOI 10.1200/JCO.2007.12.3075; Dideriksen JL, 2012, J NEUROPHYSIOL, V107, P3357, DOI 10.1152/jn.00938.2011; Dideriksen JL, 2011, J APPL PHYSIOL, V111, P485, DOI 10.1152/japplphysiol.00186.2011; Dimitrova NA, 2002, J ELECTROMYOGR KINES, V12, P339, DOI 10.1016/S1050-6411(02)00046-9; EBERSTEIN A, 1985, MUSCLE NERVE, V8, P768, DOI 10.1002/mus.880080905; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Farina D, 2002, J APPL PHYSIOL, V93, P1753, DOI 10.1152/japplphysiol.00314.2002; Farina D, 2010, CLIN NEUROPHYSIOL, V121, P1616, DOI 10.1016/j.clinph.2009.10.040; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; FUGLEVAND AJ, 1993, J PHYSIOL-LONDON, V460, P549, DOI 10.1113/jphysiol.1993.sp019486; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Garland SJ, 1995, ADV EXP MED BIOL, V384, P271; GARLAND SJ, 1994, J APPL PHYSIOL, V76, P2411, DOI 10.1152/jappl.1994.76.6.2411; GERDLE B, 1990, Electromyography and Clinical Neurophysiology, V30, P483; HAGG GM, 1992, J APPL PHYSIOL, V73, P1211, DOI 10.1152/jappl.1992.73.4.1211; Holtermann A, 2009, J ELECTROMYOGR KINES, V19, P232, DOI 10.1016/j.jelekin.2007.08.008; Hunter SK, 2008, J APPL PHYSIOL, V105, P1199, DOI 10.1152/japplphysiol.01246.2007; Kattla S, 2010, EXP BRAIN RES, V202, P89, DOI 10.1007/s00221-009-2110-0; Kisiel-Sajewicz K, 2012, J PAIN SYMPTOM MANAG, V44, P351, DOI 10.1016/j.jpainsymman.2011.08.007; Klass M, 2008, J NEUROPHYSIOL, V99, P1096, DOI 10.1152/jn.01252.2007; KRANZ H, 1983, J APPL PHYSIOL, V55, P392, DOI 10.1152/jappl.1983.55.2.392; Levenez M, 2008, J NEUROPHYSIOL, V99, P554, DOI 10.1152/jn.00963.2007; Liu JZ, 2003, J NEUROPHYSIOL, V90, P300, DOI 10.1152/jn.00821.2002; Martin PG, 2006, J NEUROSCI, V26, P4796, DOI 10.1523/JNEUROSCI.5487-05.2006; MASUDA T, 1991, J ELECTROMYOGR KINES, V1, P116, DOI 10.1016/1050-6411(91)90005-P; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; MERLETTI R, 1990, J APPL PHYSIOL, V69, P1810, DOI 10.1152/jappl.1990.69.5.1810; Merletti R., 2004, ELECTROMYOGRAPHY PHY, DOI [10.1002/0471678384, DOI 10.1002/0471678384]; Mesin L, 2009, J ELECTROMYOGR KINES, V19, P851, DOI 10.1016/j.jelekin.2008.08.003; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Negro F, 2009, J PHYSIOL-LONDON, V587, P5925, DOI 10.1113/jphysiol.2009.178509; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Rainoldi A, 2008, PHYSIOL MEAS, V29, P331, DOI 10.1088/0967-3334/29/3/004; Rainoldi A, 2008, J ELECTROMYOGR KINES, V18, P1032, DOI 10.1016/j.jelekin.2007.05.008; Riley ZA, 2008, J PHYSIOL-LONDON, V586, P2183, DOI 10.1113/jphysiol.2008.150698; Ryan JL, 2007, ONCOLOGIST, V12, P22, DOI 10.1634/theoncologist.12-S1-22; Semmler JG, 2002, EXERC SPORT SCI REV, V30, P8, DOI 10.1097/00003677-200201000-00003; Siemionow V, 2004, CLIN NEUROPHYSIOL, V115, P2372, DOI 10.1016/j.clinph.2004.05.012; Siemionow V, 2008, SOC NEUROSCI; Smets EMA, 1998, BRIT J CANCER, V78, P907, DOI 10.1038/bjc.1998.600; Sood Amit, 2005, Curr Oncol Rep, V7, P277, DOI 10.1007/s11912-005-0051-8; Stephenson DG, 1995, ADV EXP MED BIOL, V384, P45; Swart J, 2012, BRIT J SPORT MED, V46, P42, DOI 10.1136/bjsports-2011-090337; Trontelj JV, 1995, ADV EXP MED BIOL, V384, P109; VANZUYLEN EJ, 1988, J BIOMECH, V21, P183, DOI 10.1016/0021-9290(88)90168-6; Vogelzang NJ, 1997, SEMIN HEMATOL, V34, P4; Weis J, 2011, EXPERT REV PHARM OUT, V11, P441, DOI [10.1586/ERP.11.44, 10.1586/erp.11.44]; Yao WX, 2004, MOTOR CONTROL, V8, P64, DOI 10.1123/mcj.8.1.64; Yao WX, 2000, J NEUROPHYSIOL, V83, P441, DOI 10.1152/jn.2000.83.1.441; Yavuzsen T, 2009, J PAIN SYMPTOM MANAG, V38, P587, DOI 10.1016/j.jpainsymman.2008.12.003; Yue GH, 1997, EXP PHYSIOL, V82, P567, DOI 10.1113/expphysiol.1997.sp004048; Zlott DA, 2010, PM&R, V2, P451, DOI 10.1016/j.pmrj.2010.04.018	62	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83636	10.1371/journal.pone.0083636	http://dx.doi.org/10.1371/journal.pone.0083636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391800	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200097
J	La Marca, M; Beffy, P; Pugliese, A; Longo, V				La Marca, Margherita; Beffy, Pascale; Pugliese, Annalisa; Longo, Vincenzo			Fermented Wheat Powder Induces the Antioxidant and Detoxifying System in Primary Rat Hepatocytes	PLOS ONE			English	Article							ALPHA-LIPOIC ACID; NF-KAPPA-B; HEME OXYGENASE-1 GENE; OXIDATIVE STRESS; LISOSAN-G; CHEMOPREVENTIVE COMPOUNDS; ENDOTHELIAL-CELLS; FREE-RADICALS; UP-REGULATION; WHOLE GRAINS	Many plants exhibit antioxidant properties which may be useful in the prevention of oxidative stress reactions, such as those mediated by the formation of free radical species in different pathological situations. In recent years a number of studies have shown that whole grain products in particular have strong antioxidant activity. Primary cultures of rat hepatocytes were used to investigate whether and how a fermented powder of wheat (Lisosan G) is able to modulate antioxidant and detoxifying enzymes, and whether or not it can activate Nrf2 transcription factor or inhibit NF-kB activation. All of the antioxidant and detoxifying enzymes studied were significantly up-regulated by 0.7 mg/ml Lisosan G treatment. In particular, NAD(P) H: quinone oxidoreductase and heme oxygenase-1 were induced, although to different degrees, at the transcriptional, protein and/or activity levels by the treatment. As for the Nrf2 transcription factor, a partial translocation of its protein from the cytosol to the nucleus after 1 h of Lisosan G treatment was revealed by immunoblotting. Lisosan G was also observed to decrease H2O2-induced toxicity Taken together, these results show that this powder of wheat is an effective inducer of ARE/Nrf2-regulated antioxidant and detoxifying genes and has the potential to inhibit the translocation of NF-kB into the nucleus.	[La Marca, Margherita; Pugliese, Annalisa; Longo, Vincenzo] CNR, Ist Biol & Biotecnol Agr, I-56100 Pisa, Italy; [Beffy, Pascale] CNR, Ist Fisiol Clin, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR)	Longo, V (corresponding author), CNR, Ist Biol & Biotecnol Agr, I-56100 Pisa, Italy.	v.longo@ibba.cnr.it	Longo, Vincenzo/K-3695-2018	Longo, Vincenzo/0000-0001-8972-8564				Alam J, 2000, J BIOL CHEM, V275, P27694; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bao W, 2010, J ETHNOPHARMACOL, V128, P549, DOI 10.1016/j.jep.2010.01.029; Baublis AJ, 2000, J AM COLL NUTR, V19, p308S, DOI 10.1080/07315724.2000.10718965; Beken S, 1998, Methods Mol Biol, V107, P303; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Buckley BJ, 2003, BIOCHEM BIOPH RES CO, V307, P973, DOI 10.1016/S0006-291X(03)01308-1; Cao ZX, 2002, BIOCHEM BIOPH RES CO, V292, P50, DOI 10.1006/bbrc.2002.6614; Chen C, 2004, FREE RADICAL BIO MED, V36, P1505, DOI 10.1016/j.freeradbiomed.2004.03.015; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; De Oliveira SQ, 2003, FREE RADICAL RES, V37, P555, DOI 10.1080/1071576031000076259; De Smet K, 1998, Methods Mol Biol, V107, P295; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Elangovan S, 2008, INT J ONCOL, V33, P833, DOI 10.3892/ijo_00000071; Flight I, 2006, EUR J CLIN NUTR, V60, P1145, DOI 10.1038/sj.ejcn.1602435; Gaesser GA, 2007, J AM DIET ASSOC, V107, P1768, DOI 10.1016/j.jada.2007.07.011; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HALLIWELL B, 1995, FOOD CHEM TOXICOL, V33, P601, DOI 10.1016/0278-6915(95)00024-V; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jeong WS, 2005, J BIOCHEM MOL BIOL, V38, P167; Jia ZQ, 2008, NEUROCHEM RES, V33, P790, DOI 10.1007/s11064-007-9496-5; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karuri AR, 2006, J PHARMACOL EXP THER, V317, P61, DOI 10.1124/jpet.105.096396; Kim HS, 2007, EXP MOL MED, V39, P106, DOI 10.1038/emm.2007.12; Kuhnt K, 2012, EUR J LIPID SCI TECH, V114, P153, DOI 10.1002/ejlt.201100008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laus MN, 2013, MED WETER, V69, P235; Lee SH, 2006, EUR J PHARMACOL, V532, P178, DOI 10.1016/j.ejphar.2006.01.005; Lii CK, 2010, J NUTR, V140, P885, DOI 10.3945/jn.110.121418; Liu YC, 2007, LIFE SCI, V80, P1420, DOI 10.1016/j.lfs.2006.12.040; Longo V, 2011, FOOD CHEM TOXICOL, V49, P233, DOI 10.1016/j.fct.2010.10.021; Longo V, 2007, BIOTECHNOL LETT, V29, P1155, DOI 10.1007/s10529-007-9378-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lubrano V, 2012, INDIAN J MED RES, V136, P82; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390; Naughton P, 2002, J BIOL CHEM, V277, P40666, DOI 10.1074/jbc.M203863200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Pal M, 2012, FOOD CHEM TOXICOL, V50, P1066, DOI 10.1016/j.fct.2011.12.042; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Payen L, 2001, BIOCHEM BIOPH RES CO, V282, P257, DOI 10.1006/bbrc.2001.4531; Prawan A, 2009, CHEM-BIOL INTERACT, V179, P202, DOI 10.1016/j.cbi.2008.12.014; Randi G, 2010, NUTR REV, V68, P389, DOI 10.1111/j.1753-4887.2010.00299.x; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Saw Constance Lay-Lay, 2010, Chin Med, V5, P37, DOI 10.1186/1749-8546-5-37; Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H; Slavin J, 2004, NUTR RES REV, V17, P99, DOI 10.1079/NRR200374; Slavin JL, 2001, J AM DIET ASSOC, V101, P780, DOI 10.1016/S0002-8223(01)00194-8; STACEY NH, 1980, TOXICOL APPL PHARM, V53, P470, DOI 10.1016/0041-008X(80)90359-2; Steffen LM, 2003, AM J CLIN NUTR, V78, P383, DOI 10.1093/ajcn/78.3.383; Storz Peter, 2006, Sci STKE, V2006, pre3, DOI 10.1126/stke.3322006re3; Swift B, 2010, DRUG METAB REV, V42, P446, DOI 10.3109/03602530903491881; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; VENN B, 2012, J NUTR METABOLISM, V2012, P1; VONJAGOW R, 1965, N-S ARCH EX PATH PH, V251, P73, DOI 10.1007/BF00245731; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Weisburger JH, 1999, FOOD CHEM TOXICOL, V37, P943, DOI 10.1016/S0278-6915(99)00086-1; Wu X, 2009, ACTA PHARMACOL SIN, V30, P501, DOI 10.1038/aps.2009.50	68	31	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83538	10.1371/journal.pone.0083538	http://dx.doi.org/10.1371/journal.pone.0083538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391783	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200080
J	Lee, HR; Kim, HJ; Ko, JS; Choi, YS; Ahn, MW; Kim, S; Do, SH				Lee, Hye-Rim; Kim, Han-Jun; Ko, Ji-Seung; Choi, Yong-Suk; Ahn, Myun-Whan; Kim, Sukyoung; Do, Sun Hee			Comparative Characteristics of Porous Bioceramics for an Osteogenic Response In Vitro and In Vivo	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CERAMICS; MATRIX METALLOPROTEINASE-13 PROMOTER; BONE-RESORPTION; PHENOTYPE EXPRESSION; ENDOTHELIAL-CELLS; RUBUS-COREANUS; STEM-CELLS; HYDROXYAPATITE; OSTEOBLASTS; DIFFERENTIATION	Porous calcium phosphate ceramics are used in orthopedic and craniofacial applications to treat bone loss, or in dental applications to replace missing teeth. The implantation of these materials, however, does not induce stem cell differentiation, so suitable additional materials such as porous calcium phosphate discs are needed to influence physicochemical responses or structural changes. Rabbit adipose-derived stem cells (ADSC) and mouse osteoblastic cells (MC3T3-E1) were evaluated in vitro by the MTT assay, semi-quantitative RT-PCR, and immunoblotting using cells cultured in medium supplemented with extracts from bioceramics, including calcium metaphosphate (CMP), hydroxyapatite (HA) and collagen-grafted HA (HA-col). In vivo evaluation of the bone forming capacity of these bioceramics in rat models using femur defects and intramuscular implants for 12 weeks was performed. Histological analysis showed that newly formed stromal-rich tissues were observed in all the implanted regions and that the implants showed positive immunoreaction against type I collagen and alkaline phosphatase (ALP). The intramuscular implant region, in particular, showed strong positive immunoreactivity for both type I collagen and ALP, which was further confirmed by mRNA expression and immunoblotting results, indicating that each bioceramic material enhanced osteogenesis stimulation. These results support our hypothesis that smart bioceramics can induce osteoconduction and osteoinduction in vivo, although mature bone formation, including lacunae, osteocytes, and mineralization, was not prominent until 12 weeks after implantation.	[Lee, Hye-Rim; Kim, Han-Jun; Ko, Ji-Seung; Do, Sun Hee] Konkuk Univ, Coll Vet Med, Dept Clin Pathol, Seoul, South Korea; [Choi, Yong-Suk] Kyung Hee Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Seoul, South Korea; [Ahn, Myun-Whan] Yeungnam Univ, Coll Med, Dept Orthoped Surg, Taegu, South Korea; [Kim, Sukyoung] Yeungnam Univ, Sch Mat Sci & Engn, Gyongsan, South Korea	Konkuk University; Konkuk University Medical Center; Kyung Hee University; Yeungnam University; Yeungnam University	Kim, S (corresponding author), Yeungnam Univ, Sch Mat Sci & Engn, Gyongsan, South Korea.	sykim@ynu.ac.kr; shdo@konkuk.ac.kr	Kim, Hanjun/AAJ-7528-2021	Kim, Hanjun/0000-0001-9238-7238; Do, Sun Hee/0000-0003-2372-5269; Choi, Yong-suk/0000-0001-5200-6250	Nano-Biotechnology Project (Regenomics), Ministry of Science and Technology, Republic of Korea [B020214]; Bio-industry Technology Development Program of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculature, Forestry and Fisherires), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [312062-5]	Nano-Biotechnology Project (Regenomics), Ministry of Science and Technology, Republic of Korea; Bio-industry Technology Development Program of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculature, Forestry and Fisherires), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This study was supported by grants of the Nano-Biotechnology Project (Regenomics), Ministry of Science and Technology, Republic of Korea (B020214), and by Bio-industry Technology Development Program (312062-5) of iPET (Korea Institute of Planning and Evaluation for Technology in Food, Agriculature, Forestry and Fisherires), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahane M, 1999, J BONE MINER RES, V14, P561, DOI 10.1359/jbmr.1999.14.4.561; Akita S, 2004, TISSUE ENG, V10, P789, DOI 10.1089/1076327041348338; Barron MJ, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/915620; Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007; Biancon LA, 2011, ACTA CIR BRAS, V26, P2, DOI 10.1590/S0102-86502011000100002; Bohner M, 2000, INJURY, V31, pS37; Borovecki F, 2007, INT ORTHOP, V31, P799, DOI 10.1007/s00264-007-0408-8; Bu YH, 2010, J ENDOCRINOL, V206, P271, DOI 10.1677/JOE-10-0064; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Choi C, 2012, MENOPAUSE, V19, P1043, DOI 10.1097/gme.0b013e31824b1cc5; Choi WS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044104; Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521; Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261; Do SH, 2008, MENOPAUSE, V15, P676, DOI 10.1097/gme.0b013e31815bb687; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Harris LJ, 2010, J SURG RES, V163, pE105, DOI 10.1016/j.jss.2010.04.025; Holliday LS, 1997, J BIOL CHEM, V272, P22053, DOI 10.1074/jbc.272.35.22053; Jung GY, 2010, J MATER SCI-MATER M, V21, P1649, DOI 10.1007/s10856-010-4011-y; Kim CW, 2010, J CONTROL RELEASE, V147, P45, DOI 10.1016/j.jconrel.2010.06.016; Kim HJ, 2009, TISSUE ENG PT A, V15, P1543, DOI 10.1089/ten.tea.2008.0368; KITSUGI T, 1995, BIOMATERIALS, V16, P1101, DOI 10.1016/0142-9612(95)98907-V; KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z; Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017; Mak IY, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/164197; Ning HX, 2009, DIFFERENTIATION, V77, P172, DOI 10.1016/j.diff.2008.09.019; Ogata K, 2005, J BIOMED MATER RES A, V72A, P127, DOI 10.1002/jbm.a.30146; Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.0.CO;2-I; Paulo Anderson de Oliveira, 2011, Braz. Dent. J., V22, P322, DOI 10.1590/S0103-64402011000400011; Pedrosa WF, 2009, CLIN ORAL IMPLAN RES, V20, P1254, DOI 10.1111/j.1600-0501.2009.01747.x; Rasheed Z, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3166; Rasheed Z, 2010, J PHARMACOL EXP THER, V333, P354, DOI 10.1124/jpet.109.165209; RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007; Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1; Selvamurugan N, 2006, J CELL BIOCHEM, V99, P545, DOI 10.1002/jcb.20878; Selvamurugan N, 2009, FEBS LETT, V583, P1141, DOI 10.1016/j.febslet.2009.02.040; Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021; Siclari A, 2012, CLIN ORTHOP RELAT R, V470, P910, DOI 10.1007/s11999-011-2107-4; Takeuchi H, 2009, DENT MATER J, V28, P595, DOI 10.4012/dmj.28.595; Tsai MT, 2012, INT ORTHOP, V36, P199, DOI 10.1007/s00264-011-1259-x; Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032; Varanasi VG, 2009, ACTA BIOMATER, V5, P3536, DOI 10.1016/j.actbio.2009.05.035; Vidal B de C, 1996, Tissue Eng, V2, P151, DOI 10.1089/ten.1996.2.151; Wang CY, 2004, BIOMATERIALS, V25, P2507, DOI 10.1016/j.biomaterials.2003.09.035; Xia LG, 2011, EUR CELLS MATER, V22, P68, DOI 10.22203/eCM.v022a06; Yang XF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-59; Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0; Zhang W, 2010, J ENDODONT, V36, P1978, DOI 10.1016/j.joen.2010.08.038; Zhao WG, 1999, J CLIN INVEST, V103, P517, DOI 10.1172/JCI5481	50	80	85	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84272	10.1371/journal.pone.0084272	http://dx.doi.org/10.1371/journal.pone.0084272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391927	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900070
J	Liu, Q; Li, H; Wang, NF; Chen, HH; Jin, QH; Zhang, RY; Wang, J; Chen, Y				Liu, Qiang; Li, Hong; Wang, Ningfu; Chen, Huaihong; Jin, Qihui; Zhang, Ruoyu; Wang, Jing; Chen, Ying			Polymorphism of rs1836882 in NOX4 Gene Modifies Associations between Dietary Caloric Intake and ROS Levels in Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASES; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; SUPEROXIDE-PRODUCTION; WEIGHT-LOSS; OLD MICE; RESTRICTION; DISEASE; OBESITY	Excessive caloric intake is a contributing risk factor for human metabolic disorders. Caloric restriction may prolong a person's life by lowering the incidence of deadly diseases. Reactive oxygen species (ROS) in peripheral blood mononuclear cells (PBMC) have been associated with the biochemical basis of the relationship between caloric intake and pathophysiologic processes. Polymorphisms associated with ROS generation genes are being increasingly implicated in inter-individual responses to daily caloric intake alterations. In the current study, a single nucleotide polymorphism, rs1836882, in the nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) gene's promoter region was found to modulate associations between dietary caloric intake and ROS levels in PBMC. Based on rs1836882, 656 Chinese Han participants were classified into CC, CT and TT genotypes. ROS levels in PBMC were significantly higher in the CC or CT genotypes compared with the TT genotype with the same increases in daily caloric intake. Using an electrophoretic mobility shift assay, NOX4 promoter region with rs1836882 (T) was observed to have a higher affinity for hepatocyte nuclear factor gamma (HNF3y) protein than rs1836882 (C). HNF3. protein over-expression decreased NOX4 gene transcriptional activity in the TT genotype more than in the CC genotype (5.68% vs. 2.12%, P < 0.05) in a dual luciferase reporter assay. By silencing the NOX4 gene using small interfering RNA or over-expressing HNF3. using an expression plasmid, serum from high dietary caloric intake participants decreased ROS levels in PBMC of the TT genotype more than in the CC or CT genotype via HNF3. down-regulating the NOX4 gene expression signaling pathway. This is the first study to report on the functions of phenotypes of rs1836882 in the NOX4 gene, and it suggests rs1836882 as a candidate gene for interpreting inter-individual ROS levels differences in PBMC induced by alterations in daily caloric intake.	[Liu, Qiang; Chen, Huaihong; Jin, Qihui; Zhang, Ruoyu; Wang, Jing; Chen, Ying] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Gerontol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Hong; Wang, Ningfu] Nanjing Med Univ, Dept Cardiol, Affiliated Hangzhou Hosp, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Nanjing Medical University	Li, H (corresponding author), Nanjing Med Univ, Dept Cardiol, Affiliated Hangzhou Hosp, Hangzhou, Zhejiang, Peoples R China.	rainbowheart2003@126.com	chen, ying/HHS-8254-2022		Public Welfare Projects of Science and Technology Department of Zhejiang Province [2011C23016]; Zhejiang Provincial Natural Science Foundation [Y2110033]; Zhejiang Provincial Qianjiang Talent Plan [2012R10041]	Public Welfare Projects of Science and Technology Department of Zhejiang Province; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Qianjiang Talent Plan	This research was supported by The Public Welfare Projects of Science and Technology Department of Zhejiang Province (2011C23016), The Zhejiang Provincial Natural Science Foundation(Y2110033) and The Zhejiang Provincial Qianjiang Talent Plan(2012R10041). The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay LR, 2013, NUTR REV, V71, P168, DOI 10.1111/j.1753-4887.2012.00533.x; Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Banasik K, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-10; Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005; Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148; Calo LA, 2011, BLOOD PRESSURE, V20, P376, DOI 10.3109/08037051.2011.575570; Cariello M, 2012, ANTIOXID REDOX SIGN, V16, P428, DOI 10.1089/ars.2011.4062; Chen F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00412; Crujeiras AB, 2008, OMICS, V12, P251, DOI 10.1089/omi.2008.0001; Donato AJ, 2013, AGING CELL, V12, P772, DOI 10.1111/acel.12103; El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003; Fenyo IM, 2011, VASC PHARMACOL, V54, P100, DOI 10.1016/j.vph.2011.03.006; Fitzgerald JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030712; Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378; Guo JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051082; Hursting SD, 2012, CANCER PREV RES, V5, P1260, DOI 10.1158/1940-6207.CAPR-12-0140; Ivanova Diana G, 2013, Folia Med (Plovdiv), V55, P33; Jenkins NT, 2011, J APPL PHYSIOL, V111, P929, DOI 10.1152/japplphysiol.00541.2011; Ketonen J, 2010, HEART VESSELS, V25, P254, DOI 10.1007/s00380-009-1182-x; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kofler PA, 2013, PLANTA MED, V79, P244, DOI 10.1055/s-0032-1328129; Landsberg L, 2013, J CLIN HYPERTENS, V15, P14, DOI 10.1111/jch.12049; Lee MS, 2006, ASIA PAC J CLIN NUTR, V15, P161; Li JZ, 2012, CAN J PHYSIOL PHARM, V90, P1569, DOI 10.1139/y2012-140; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Liu Qiang, 2012, Yichuan, V34, P573, DOI 10.3724/SP.J.1005.2012.00573; Matsuo T, 2012, OBESITY, V20, P1122, DOI 10.1038/oby.2011.322; Moreno Maria de Ujue, 2011, Front Biosci (Elite Ed), V3, P1467; Nabeebaccus A, 2011, HEART FAIL REV, V16, P5, DOI 10.1007/s10741-010-9186-2; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pisciotta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050542; Rippe C, 2010, AGING CELL, V9, P304, DOI 10.1111/j.1474-9726.2010.00557.x; Rothman SM, 2012, ANN NY ACAD SCI, V1264, P49, DOI 10.1111/j.1749-6632.2012.06525.x; Sevastianova K, 2011, AM J CLIN NUTR, V94, P104, DOI 10.3945/ajcn.111.012369; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Stasi MA, 2010, ARTERIOSCL THROM VAS, V30, P426, DOI 10.1161/ATVBAHA.109.201533; Vaccaro O, 2007, DIABETES CARE, V30, P1156, DOI 10.2337/dc06-1153; Varga ZV, 2013, J MOL CELL CARDIOL, V62, P111, DOI 10.1016/j.yjmcc.2013.05.009; Wilkinson-Berka JL, 2013, CLIN SCI, V124, P597, DOI 10.1042/CS20120212; Zanetti M, 2010, EXP GERONTOL, V45, P848, DOI 10.1016/j.exger.2010.07.002; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550; Zhang M, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt139	46	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85660	10.1371/journal.pone.0085660	http://dx.doi.org/10.1371/journal.pone.0085660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392026	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900170
J	Loncaric, I; Stalder, GL; Mehinagic, K; Rosengarten, R; Hoelzl, F; Knauer, F; Walzer, C				Loncaric, Igor; Stalder, Gabrielle L.; Mehinagic, Kemal; Rosengarten, Renate; Hoelzl, Franz; Knauer, Felix; Walzer, Chris			Comparison of ESBL - And AmpC Producing Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated from Migratory and Resident Population of Rooks (Corvus frugilegus) in Austria	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; MEDIATED QUINOLONE RESISTANCE; MUNICIPAL WASTE-WATER; ESCHERICHIA-COLI; EXTENDED-SPECTRUM; CTX-M; MULTIPLEX PCR; MOLECULAR CHARACTERIZATION; AQUATIC ENVIRONMENT; COMPANION ANIMALS	In order to test whether rooks (Corvus frugilegus) represent good indicators for the potential circulation of antibiotics in their native habitat, two populations with different migratory behavior were tested for the presence of beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA). In all, 54 and 102 samples of fresh feces of a migratory and a resident population were investigated. A total of 24 and 3 cefotaxime-resistant enterobacterial isolates were obtained from the migratory and resident population, respectively. In these isolates CTX-M-1 (n = 15), CTX-M-3 (n = 3), and CTX-M-15 (n = 3) genes were detected. TEM-1 and OXA-1 were associated with CTX-M in 3 and 2 isolates, respectively. In two E. coli isolates CMY-2 could be detected, where from one isolate displayed an overexpression of chromosomal AmpC as well. Among E. coli isolates the most common phylogenetic group was A (n = 11) and ST1683 (n = 5). In one E. coli of B2-ST131 the rfbO25b locus was detected. Three Enterobacter isolates were stably derepressed AmpC-producers. In five samples of the migratory population, PVL positive MRSA could be isolated. Two isolates were typed SCCmec IVa, spa type t127, and ST1. Three isolates carried a SCCmec type IVc, with spa type t852 and ST22. The highly significant difference of the occurrence of antibiotic resistance between the migratory population from eastern Europe compared to resident population in our study indicates that rooks may be good indicator species for the evaluation of environmental contamination with antibiotic resistant bacteria, especially due to their ecology, foraging behavior and differing migratory behavior.	[Loncaric, Igor; Mehinagic, Kemal; Rosengarten, Renate] Univ Vet Med Vienna, Unit Clin Microbiol & Infect Biol, Inst Bacteriol Mycol & Hyg, Vienna, Austria; [Stalder, Gabrielle L.; Hoelzl, Franz; Knauer, Felix; Walzer, Chris] Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Res Inst Wildlife Ecol, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Loncaric, I (corresponding author), Univ Vet Med Vienna, Unit Clin Microbiol & Infect Biol, Inst Bacteriol Mycol & Hyg, Vienna, Austria.	igor.loncaric@vetmeduni.ac.at		Hoelzl, Franz/0000-0001-9717-4338; Walzer, Chris/0000-0002-0437-5147; Mehinagic, Kemal/0000-0003-2192-0028	Unit of Clinical Microbiology and Infection Biology; Research Institute of Wildlife Ecology	Unit of Clinical Microbiology and Infection Biology; Research Institute of Wildlife Ecology	This study was supported by internal funding of Unit of Clinical Microbiology and Infection Biology and Research Institute of Wildlife Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer EB, 2005, KOMPENDIUM VOGEL MIT, V3; Boakes E, 2011, CLIN MICROBIOL INFEC, V17, P140, DOI 10.1111/j.1469-0691.2010.03199.x; Bonnedahl J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005958; Borjesson S, 2010, J APPL MICROBIOL, V108, P1244, DOI 10.1111/j.1365-2672.2009.04515.x; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Caroff N, 1999, FEMS MICROBIOL LETT, V173, P459, DOI 10.1016/S0378-1097(99)00111-1; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Chong Y, 2011, INFECT GENET EVOL, V11, P1499, DOI 10.1016/j.meegid.2011.06.001; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Clinical and Laboratory Standards Institute, 2013, M10023 CLSI; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Cuny C, 2008, MICROB DRUG RESIST, V14, P307, DOI 10.1089/mdr.2008.0845; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dierikx CM, 2012, J ANTIMICROB CHEMOTH, V67, P1368, DOI 10.1093/jac/dks049; Dolejska M, 2007, J APPL MICROBIOL, V103, P11, DOI 10.1111/j.1365-2672.2006.03241.x; Dolejska M, 2009, J APPL MICROBIOL, V106, P1941, DOI 10.1111/j.1365-2672.2009.04155.x; Dolejska M, 2011, J ANTIMICROB CHEMOTH, V66, P2784, DOI 10.1093/jac/dkr363; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Franco A, 2011, J ANTIMICROB CHEMOTH, V66, P1231, DOI 10.1093/jac/dkr115; Gay K, 2006, CLIN INFECT DIS, V43, P297, DOI 10.1086/505397; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Guenther S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053039; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Guenther S, 2010, ENV MICROBIOL REP, V2, P641, DOI 10.1111/j.1758-2229.2010.00148.x; Guenther S, 2010, SCI TOTAL ENVIRON, V408, P3519, DOI 10.1016/j.scitotenv.2010.05.005; Guenther S, 2010, J ANTIMICROB CHEMOTH, V65, P582, DOI 10.1093/jac/dkp496; Heininger A, 1999, J CLIN MICROBIOL, V37, P2479, DOI 10.1128/JCM.37.8.2479-2482.1999; Hernandez J, 2010, ENV MICROBIOL REP, V2, P329, DOI 10.1111/j.1758-2229.2010.00142.x; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Larsen AR, 2009, J CLIN MICROBIOL, V47, P73, DOI 10.1128/JCM.01557-08; Literak I, 2007, LETT APPL MICROBIOL, V45, P616, DOI 10.1111/j.1472-765X.2007.02236.x; Literak I, 2010, J APPL MICROBIOL, V108, P1702, DOI 10.1111/j.1365-2672.2009.04572.x; Literak I, 2012, MICROB DRUG RESIST, V18, P567, DOI 10.1089/mdr.2012.0075; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Livermore DM, 2001, J ANTIMICROB CHEMOTH, V48, P59, DOI 10.1093/jac/48.suppl_1.59; Loeffler A, 2005, J ANTIMICROB CHEMOTH, V56, P692, DOI 10.1093/jac/dki312; Loncaric I, 2013, J ANTIMICROB CHEMOTH, V68, P2222, DOI 10.1093/jac/dkt186; Loncaric I, 2013, J CLIN MICROBIOL, V51, P1625, DOI 10.1128/JCM.03052-12; Loncaric I, 2011, APIDOLOGIE, V42, P312, DOI 10.1007/s13592-011-0019-7; Lovseth A, 2004, J CLIN MICROBIOL, V42, P3869, DOI 10.1128/JCM.42.8.3869-3872.2004; Monecke S, 2012, ANTIMICROB AGENTS CH, V56, P5547, DOI 10.1128/AAC.00574-12; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Oteo J, 2009, J ANTIMICROB CHEMOTH, V64, P712, DOI 10.1093/jac/dkp288; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Paterson GK, 2012, J ANTIMICROB CHEMOTH, V67, P2809, DOI 10.1093/jac/dks329; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Pilla R, 2012, VET REC, V170, DOI 10.1136/vr.100510; Pinto L, 2010, APPL ENVIRON MICROB, V76, P4118, DOI 10.1128/AEM.02761-09; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P2756, DOI 10.1128/AAC.05982-11; Porrero MC, 2013, VET J, V198, P127, DOI 10.1016/j.tvjl.2013.06.004; R Development Core Team, 2012, R LANG ENV STAT COMP; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; SANDERS CC, 1982, ANTIMICROB AGENTS CH, V21, P968, DOI 10.1128/AAC.21.6.968; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; Silva N, 2010, SCI TOTAL ENVIRON, V408, P4871, DOI 10.1016/j.scitotenv.2010.06.046; Simoes RR, 2010, EMERG INFECT DIS, V16, P110, DOI 10.3201/eid1601.090896; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; Tausova D, 2012, J ANTIMICROB CHEMOTH, V67, P1103, DOI 10.1093/jac/dks017; Wallensten Anders, 2011, Infect Ecol Epidemiol, V1, DOI 10.3402/iee.v1i0.7030; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Wardyn SE, 2012, J WILDLIFE DIS, V48, P1069, DOI 10.7589/2011-10-295; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Yamane K, 2008, ANTIMICROB AGENTS CH, V52, P1564, DOI 10.1128/AAC.01137-07	78	49	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84048	10.1371/journal.pone.0084048	http://dx.doi.org/10.1371/journal.pone.0084048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391878	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900021
J	Rehman, A; Jarrott, RJ; Whitten, AE; King, GJ; Hu, SH; Christie, MP; Collins, BM; Martin, JL				Rehman, Asma; Jarrott, Russell J.; Whitten, Andrew E.; King, Gordon J.; Hu, Shu-Hong; Christie, Michelle P.; Collins, Brett M.; Martin, Jennifer L.			Milligram Quantities of Homogeneous Recombinant Full-Length Mouse Munc18c from Escherichia coli Cultures	PLOS ONE			English	Article							MEMBRANE-FUSION; N-PEPTIDE; SEC1/MUNC18 PROTEINS; VESICLE TRAFFICKING; BINDING MODE; SNARE; SYNTAXIN; EXOCYTOSIS; ISOFORMS; PARTNER	Vesicle fusion is an indispensable cellular process required for eukaryotic cargo delivery. The Sec/Munc18 protein Munc18c is essential for insulin-regulated trafficking of glucose transporter4 (GLUT4) vesicles to the cell surface in muscle and adipose tissue. Previously, our biophysical and structural studies have used Munc18c expressed in SF9 insect cells. However to maximize efficiency, minimize cost and negate any possible effects of post-translational modifications of Munc18c, we investigated the use of Escherichia coli as an expression host for Munc18c. We were encouraged by previous reports describing Munc18c production in E. coli cultures for use in in vitro fusion assay, pulldown assays and immunoprecipitations. Our approach differs from the previously reported method in that it uses a codon-optimized gene, lower temperature expression and autoinduction media. Three N-terminal His-tagged constructs were engineered, two with a tobacco etch virus (TEV) or thrombin protease cleavage site to enable removal of the fusion tag. The optimized protocol generated 1-2 mg of purified Munc18c per L of culture at much reduced cost compared to Munc18c generated using insect cell culture. The purified recombinant Munc18c protein expressed in bacteria was monodisperse, monomeric, and functional. In summary, we developed methods that decrease the cost and time required to generate functional Munc18c compared with previous insect cell protocols, and which generates sufficient purified protein for structural and biophysical studies.	[Rehman, Asma; Jarrott, Russell J.; Whitten, Andrew E.; King, Gordon J.; Hu, Shu-Hong; Christie, Michelle P.; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia; [Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia.	j.martin@imb.uq.edu.au	Collins, Brett/J-1563-2014; King, Gordon/J-8718-2014; Rehman, Asma/X-4632-2018; Martin, Jennifer L./A-6039-2010	Collins, Brett/0000-0002-6070-3774; Jarrott, Russell/0000-0003-4326-1203; Whitten, Andrew/0000-0001-8856-3120; Christie, Michelle/0000-0002-7001-3400; Rehman, Asma/0000-0002-0653-9053; Martin, Jennifer L./0000-0002-9225-8863	National Health and Medical Research Council of Australia (NHMRC) [535921]; ARC LIEF [LE110100186]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC LIEF(Australian Research Council)	This research was supported by the National Health and Medical Research Council of Australia (NHMRC) program grant 535921 to JLM. AEW is an NHMRC Peter Doherty Fellow (569864), BMC is an Australian Research Council (ARC) Future Fellow (FT100100027) and JLM is an ARC Australian Laureate Fellow (FL0992138) and Honorary NHMRC Fellow. The IMB Mass Spectrometry Facility used in this research was funded in part through an ARC LIEF grant (LE110100186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hawas R, 2012, BLOOD, V120, P2493, DOI 10.1182/blood-2012-05-430629; Aran V, 2009, BIOCHEM J, V419, P655, DOI 10.1042/BJ20082293; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Brochetta C, 2008, BBA-MOL CELL RES, V1783, P1781, DOI 10.1016/j.bbamcr.2008.05.023; Bryant NJ, 2011, TRAFFIC, V12, P657, DOI 10.1111/j.1600-0854.2011.01163.x; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Christie MP, 2012, P NATL ACAD SCI USA, V109, P9816, DOI 10.1073/pnas.1116975109; Colbert KN, 2013, P NATL ACAD SCI USA, V110, P12637, DOI 10.1073/pnas.1303753110; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Dulubova I, 2003, P NATL ACAD SCI USA, V100, P32, DOI 10.1073/pnas.232701299; Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2003, PROTEIN EXPRES PURIF, V31, P305, DOI 10.1016/S1046-5928(03)00197-9; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Latham CF, 2007, ACTA CRYSTALLOGR F, V63, P524, DOI 10.1107/S1744309107022361; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Misura KMS, 2000, CURR OPIN STRUC BIOL, V10, P662, DOI 10.1016/S0959-440X(00)00151-2; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Riento K, 2000, J BIOL CHEM, V275, P13476, DOI 10.1074/jbc.275.18.13476; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Schraw TD, 2003, BIOCHEM J, V374, P207, DOI 10.1042/BJ20030610; Scott BL, 2004, J CELL BIOL, V167, P75, DOI 10.1083/jcb.200405018; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thurmond DC, 2000, EMBO J, V19, P3565, DOI 10.1093/emboj/19.14.3565; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110	49	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83499	10.1371/journal.pone.0083499	http://dx.doi.org/10.1371/journal.pone.0083499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391775	Green Published, gold			2022-12-27	WOS:000329325200072
J	Siddharth, J; Holway, N; Parkinson, SJ				Siddharth, Jay; Holway, Nicholas; Parkinson, Scott J.			A Western Diet Ecological Module Identified from the 'Humanized' Mouse Microbiota Predicts Diet in Adults and Formula Feeding in Children	PLOS ONE			English	Article							GUT	The interplay between diet and the microbiota has been implicated in the growing frequency of chronic diseases associated with the Western lifestyle. However, the complexity and variability of microbial ecology in humans and preclinical models has hampered identification of the molecular mechanisms underlying the association of the microbiota in this context. We sought to address two key questions. Can the microbial ecology of preclinical models predict human populations? And can we identify underlying principles that surpass the plasticity of microbial ecology in humans? To do this, we focused our study on diet; perhaps the most influential factor determining the composition of the gut microbiota. Beginning with a study in 'humanized' mice we identified an interactive module of 9 genera allied with Western diet intake. This module was applied to a controlled dietary study in humans. The abundance of the Western ecological module correctly predicted the dietary intake of 19/21 top and 21/21 of the bottom quartile samples inclusive of all 5 Western and 'low-fat' diet subjects, respectively. In 98 volunteers the abundance of the Western module correlated appropriately with dietary intake of saturated fatty acids, fat-soluble vitamins and fiber. Furthermore, it correlated with the geographical location and dietary habits of healthy adults from the Western, developing and third world. The module was also coupled to dietary intake in children (and piglets) correlating with formula (vs breast) feeding and associated with a precipitous development of the ecological module in young children. Our study provides a conceptual platform to translate microbial ecology from preclinical models to humans and identifies an ecological network module underlying the association of the gut microbiota with Western dietary habits.	[Siddharth, Jay; Parkinson, Scott J.] Novartis Inst Biomed Res, Host Commensal Hub, Basel, Switzerland; [Holway, Nicholas] Novartis Inst Biomed Res, NIBR IT, Basel, Switzerland	Novartis; Novartis	Parkinson, SJ (corresponding author), Novartis Inst Biomed Res, Host Commensal Hub, Basel, Switzerland.	scott.parkinson@novartis.com		Siddharth, Jay/0000-0003-3288-400X; Holway, Nicholas/0000-0002-2126-5118				[Anonymous], 2003, DIET NUTR PREV CHRON; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Brenna JT, 2007, AM J CLIN NUTR, V85, P1457, DOI 10.1093/ajcn/85.6.1457; Cummings JH, 1997, JPEN-PARENTER ENTER, V21, P357, DOI 10.1177/0148607197021006357; Fewtrell M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c5955; GIBSON RA, 1981, AM J CLIN NUTR, V34, P252, DOI 10.1093/ajcn/34.2.252; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347; Hvistendahl M, 2012, SCIENCE, V336, P1250, DOI 10.1126/science.336.6086.1250; Koletzko B, 2009, ADV EXP MED BIOL, V646, P15, DOI 10.1007/978-1-4020-9173-5_2; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; McCance R, 2002, MCCANCE WIDDOWSONS C, P131; Poroyko V, 2011, NUTR HOSP, V26, P1283, DOI [10.3305/nh.2011.26.6.5362, 10.1590/S0212-16112011000600015]; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scientific Advisory Committee on Nutrition Subgroup on Maternal and Child Nutrition (SMCN), 2011, INFL MAT FET CHILD N; Smith P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030273; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; UNICEF, 2007, UNICEF PUBL; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	21	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83689	10.1371/journal.pone.0083689	http://dx.doi.org/10.1371/journal.pone.0083689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391809	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000329325200107
J	Twomey, EC; Cordasco, DF; Kozuch, SD; Wei, YF				Twomey, Edward C.; Cordasco, Dana F.; Kozuch, Stephen D.; Wei, Yufeng			Substantial Conformational Change Mediated by Charge-Triad Residues of the Death Effector Domain in Protein-Protein Interactions	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; DIPOLAR COUPLINGS; PHOSPHOLIPASE D1; PEA-15 REVEALS; ERK2; PED/PEA-15; MECHANISM; MACROMOLECULES; ALIGNMENT; BINDING	Protein conformational changes are commonly associated with the formation of protein complexes. The non-catalytic death effector domains (DEDs) mediate protein-protein interactions in a variety of cellular processes, including apoptosis, proliferation and migration, and glucose metabolism. Here, using NMR residual dipolar coupling (RDC) data, we report a conformational change in the DED of the phosphoprotein enriched in astrocytes, 15 kDa (PEA-15) protein in the complex with a mitogen-activated protein (MAP) kinase, extracellular regulated kinase 2 (ERK2), which is essential in regulating ERK2 cellular distribution and function in cell proliferation and migration. The most significant conformational change in PEA-15 happens at helices alpha 2, alpha 3, and alpha 4, which also possess the highest flexibility among the six-helix bundle of the DED. This crucial conformational change is modulated by the D/E-RxDL charge-triad motif, one of the prominent structural features of DEDs, together with a number of other electrostatic and hydrogen bonding interactions on the protein surface. Chargetriad motif promotes the optimal orientation of key residues and expands the binding interface to accommodate proteinprotein interactions. However, the charge-triad residues are not directly involved in the binding interface between PEA-15 and ERK2.	[Twomey, Edward C.; Cordasco, Dana F.; Wei, Yufeng] Seton Hall Univ, Inst NeuroImmune Pharmacol, S Orange, NJ 07079 USA; [Twomey, Edward C.; Cordasco, Dana F.; Kozuch, Stephen D.] Seton Hall Univ, Dept Chem & Biochem, S Orange, NJ 07079 USA; [Twomey, Edward C.] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, New York, NY USA	Seton Hall University; Seton Hall University; Columbia University	Wei, YF (corresponding author), Seton Hall Univ, Inst NeuroImmune Pharmacol, S Orange, NJ 07079 USA.	Yufeng.Wei@shu.edu	Wei, Yufeng/H-2733-2019	Wei, Yufeng/0000-0001-6608-8488; Twomey, Edward/0000-0002-1855-1586	United States National Institutes of Health [R15CA179410]; Eric F. Ross Research Foundation; Celgene Corporation/Independent College Fund of New Jersey; New Jersey Space Grant Consortium/National Aeronautics and Space Administration; NATIONAL CANCER INSTITUTE [R15CA179410] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eric F. Ross Research Foundation; Celgene Corporation/Independent College Fund of New Jersey; New Jersey Space Grant Consortium/National Aeronautics and Space Administration; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project was supported by United States National Institutes of Health grant R15CA179410 to YW, and the Eric F. Ross Research Foundation, Celgene Corporation/Independent College Fund of New Jersey, and New Jersey Space Grant Consortium/National Aeronautics and Space Administration to ECT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002; Callaway K, 2005, BBA-PROTEINS PROTEOM, V1754, P316, DOI 10.1016/j.bbapap.2005.11.002; Callaway K, 2007, BIOCHEMISTRY-US, V46, P9187, DOI 10.1021/bi700206u; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Courvoisier E, 2012, CHEM COMMUN, V48, P2761, DOI 10.1039/c2cc17203h; Farina B, 2013, BIOCH BIOPHYS ACTA; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hansen MR, 2000, METHOD ENZYMOL, V317, P220; Hill JM, 2002, EMBO J, V21, P6494, DOI 10.1093/emboj/cdf641; Kaoud TS, 2011, BIOCHEMISTRY-US, V50, P4568, DOI 10.1021/bi200202y; Lerche MH, 1999, J MAGN RESON, V140, P259, DOI 10.1006/jmre.1999.1820; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Mace PD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2687; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; McDermott A, 1998, ABSTR PAP AM CHEM S, V216, pU697; Meot-Ner M, 2012, CHEM REV, V112, pRP22, DOI 10.1021/cr200430n; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Thomas IR, 2010, J APPL CRYSTALLOGR, V43, P362, DOI 10.1107/S0021889810000452; Twomey EC, 2012, BBA-PROTEINS PROTEOM, V1824, P1382, DOI 10.1016/j.bbapap.2012.07.001; Twomey EC, 2012, BIOCHEM BIOPH RES CO, V424, P141, DOI 10.1016/j.bbrc.2012.06.091; Valmiki MG, 2009, CELL MOL LIFE SCI, V66, P814, DOI 10.1007/s00018-008-8489-0; Viparelli F, 2008, J BIOL CHEM, V283, P21769, DOI 10.1074/jbc.M803771200; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wei YF, 2006, J BIOMOL NMR, V35, P17, DOI 10.1007/s10858-006-9009-x; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Zhang Y, 2000, J BIOL CHEM, V275, P35224, DOI 10.1074/jbc.M003329200	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83421	10.1371/journal.pone.0083421	http://dx.doi.org/10.1371/journal.pone.0083421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391764	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200061
J	Wang, MY; Wang, FP; Yang, JB; Zhao, DF; Wang, HP; Shao, F; Wang, WJ; Sun, RL; Ling, MZ; Zhai, JJ; Song, SJ				Wang, Mingyong; Wang, Fanping; Yang, Jianbin; Zhao, Dongfang; Wang, Hongpo; Shao, Feng; Wang, Wenjun; Sun, Ruili; Ling, Mingzhi; Zhai, Jingjing; Song, Shijun			Mannan-Binding Lectin Inhibits Candida albicans-Induced Cellular Responses in PMA-Activated THP-1 Cells through Toll-Like Receptor 2 and Toll-Like Receptor 4	PLOS ONE			English	Article							INNATE IMMUNITY; DENDRITIC CELLS; INFLAMMATORY RESPONSES; ADAPTIVE IMMUNITY; RECOGNITION; LIPOPOLYSACCHARIDE; YEAST; TOLL-LIKE-RECEPTOR-2; OPSONIZATION; ASSOCIATION	Background: Candida albicans (C. albicans), the most common human fungal pathogen, can cause fatal systemic infections under certain circumstances. Mannan-binding lectin (MBL), a member of the collectin family in the C-type lectin superfamily, is an important serum component associated with innate immunity. Toll-like receptors (TLRs) are expressed extensively, and have been shown to be involved in C. albicans-induced cellular responses. We first examined whether MBL modulated heat-killed (HK) C. albicans-induced cellular responses in phorbol 12-myristate 13-acetate (PMA)-activated human THP-1 macrophages. We then investigated the possible mechanisms of its inhibitory effect. Methodology/Principal Finding: Enzyme-linked immunosorbent assay (ELISA) and reverse transcriptasepolymerase chain reaction (RT-PCR) analysis showed that MBL at higher concentrations (10-20 mu g/ml) significantly attenuated C. albicans-induced chemokine (e.g., IL-8) and proinflammatory cytokine (e.g., TNF-alpha) production from PMA-activated THP-1 cells at both protein and mRNA levels. Electrophoretic mobility shift assay (EMSA) and Western blot (WB) analysis showed that MBL could inhibit C. albicans-induced nuclear factor-kB (NF-kB) DNA binding and its translocation in PMA-activated THP-1 cells. MBL could directly bind to PMA-activated THP-1 cells in the presence of Ca2+, and this binding decreased TLR2 and TLR4 expressions in C. albicans-induced THP-1 macrophages. Furthermore, the binding could be partially inhibited by both anti-TLR2 monoclonal antibody (clone TL2.1) and anti-TLR4 monoclonal antibody (clone HTA125). In addition, coimmunoprecipitation experiments and microtiter wells assay showed that MBL could directly bind to the recombinant soluble form of extracellular TLR2 domain (sTLR2) and sTLR4. Conclusions/Significance: Our study demonstrates that MBL can affect proinflammatory cytokine and chemokine expressions by modifying C. albicans-/TLR-signaling pathways. This study supports an important role for MBL on the regulation of C. albicans-induced cellular responses.	[Wang, Mingyong; Wang, Fanping; Sun, Ruili; Ling, Mingzhi; Zhai, Jingjing] Xinxiang Med Univ, Dept Lab Med, Xinxiang, Peoples R China; [Yang, Jianbin; Zhao, Dongfang; Wang, Hongpo] Xinxiang Med Univ, Affiliated Hosp 1, Dept Clin Lab, Xinxiang, Peoples R China; [Shao, Feng; Song, Shijun] Xinxiang Med Univ, Affiliated Hosp 3, Dept Clin Lab, Xinxiang, Peoples R China; [Wang, Wenjun] Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Southern Medical University - China	Wang, MY (corresponding author), Xinxiang Med Univ, Dept Lab Med, Xinxiang, Peoples R China.	cxaini118@163.com			National Natural Science Foundation of China [31100645, 81373120]; Program for New Century Excellent Talents in University [NCET-13-0990]; Project of Science and Technology Innovation Talents in Universities of Henan Province [2012HASTIT024]; Foundation for University Key Teacher of Henan Province [2010GGJS-117]; Foundation of Henan Educational Committee [12A320017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Project of Science and Technology Innovation Talents in Universities of Henan Province; Foundation for University Key Teacher of Henan Province; Foundation of Henan Educational Committee	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31100645, 81373120), Program for New Century Excellent Talents in University (NCET-13-0990), Project of Science and Technology Innovation Talents in Universities of Henan Province (2012HASTIT024), Foundation for University Key Teacher of Henan Province (2010GGJS-117) and Foundation of Henan Educational Committee (12A320017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attas SA, 2010, ANN SAUDI MED, V30, P101, DOI 10.4103/0256-4947.60514; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bahri R, 2010, J CELL PHYSIOL, V222, P209, DOI 10.1002/jcp.21939; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Brouwer N, 2008, J IMMUNOL, V180, P4124, DOI 10.4049/jimmunol.180.6.4124; Clemons KV, 2011, IMMUNOL INVEST, V40, P553, DOI 10.3109/08820139.2011.569627; Dean MM, 2011, IMMUNOLOGY, V132, P296, DOI 10.1111/j.1365-2567.2010.03365.x; Decanis N, 2009, CYTOKINE, V45, P132, DOI 10.1016/j.cyto.2008.11.011; Downing I, 2005, SCAND J IMMUNOL, V62, P507, DOI 10.1111/j.1365-3083.2005.01693.x; Dumestre-Perard C, 2002, MOL IMMUNOL, V39, P465, DOI 10.1016/S0161-5890(02)00119-0; Ferwerda G, 2010, VACCINE, V28, P614, DOI 10.1016/j.vaccine.2009.10.082; Fischer J, 2008, INFECT IMMUN, V76, P4737, DOI 10.1128/IAI.00733-08; FLEIT HB, 1991, J LEUKOCYTE BIOL, V49, P556, DOI 10.1002/jlb.49.6.556; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; Jouault T, 2003, J INFECT DIS, V188, P165, DOI 10.1086/375784; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Li M, 2009, CHINESE MED J-PEKING, V122, P496, DOI 10.3760/cma.j.issn.0366-6999.2009.05.003; Gil ML, 2009, FRONT BIOSCI-LANDMRK, V14, P570, DOI 10.2741/3263; Nauta AJ, 2004, J IMMUNOL, V173, P3044, DOI 10.4049/jimmunol.173.5.3044; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Newman SL, 2001, INFECT IMMUN, V69, P6813, DOI 10.1128/IAI.69.11.6813-6822.2001; Oliveira PM, 2011, BRAZ J INFECT DIS, V15, P239, DOI 10.1016/S1413-8670(11)70182-9; Ono S, 2003, SURGERY, V134, P92, DOI 10.1067/msy.2003.189; Pereira CA, 2011, MYCOPATHOLOGIA, V171, P103, DOI 10.1007/s11046-010-9353-y; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Ren MY, 2010, IMMUNOL CELL BIOL, V88, P529, DOI 10.1038/icb.2010.6; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Shimizu T, 2009, BBA-GEN SUBJECTS, V1790, P1705, DOI 10.1016/j.bbagen.2009.10.006; SUPER M, 1989, LANCET, V2, P1236; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Torosantucci A, 2000, J LEUKOCYTE BIOL, V68, P923; Vallespi MG, 2003, INT IMMUNOPHARMACOL, V3, P247, DOI 10.1016/S1567-5769(02)00277-1; Van Asbeck EC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-229; Wang MY, 2011, CELL MOL IMMUNOL, V8, P265, DOI 10.1038/cmi.2011.1; Wang MY, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-1; Zheng XD, 2003, MOL MICROBIOL, V49, P1391, DOI 10.1046/j.1365-2958.2003.03646.x	44	13	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83517	10.1371/journal.pone.0083517	http://dx.doi.org/10.1371/journal.pone.0083517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391778	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200075
J	Wong, EB; Akilimali, NA; Govender, P; Sullivan, ZA; Cosgrove, C; Pillay, M; Lewinsohn, DM; Bishai, WR; Walker, BD; Ndung'u, T; Klenerman, P; Kasprowicz, VO				Wong, Emily B.; Akilimali, Ngomu Akeem; Govender, Pamla; Sullivan, Zuri A.; Cosgrove, Cormac; Pillay, Mona; Lewinsohn, David M.; Bishai, William R.; Walker, Bruce D.; Ndung'u, Thumbi; Klenerman, Paul; Kasprowicz, Victoria O.			Low Levels of Peripheral CD161++CD8+Mucosal Associated Invariant T (MAIT) Cells Are Found in HIV and HIV/TB Co-Infection	PLOS ONE			English	Article							CD161 EXPRESSION; TUBERCULOSIS; POPULATION; ACTIVATION; INFECTION; RESPONSES; PATHWAY; DEFINES; HEALTH; CXCR6	Background: High expression of CD161 on CD8+ T cells is associated with a population of cells thought to play a role in mucosal immunity. We wished to investigate this subset in an HIV and Mycobacterium tuberculosis (MTB) endemic African setting. Methods: A flow cytometric approach was used to assess the frequency and phenotype of CD161++CD8+ T cells. 80 individuals were recruited for cross-sectional analysis: controls (n = 18), latent MTB infection (LTBI) only (n = 16), pulmonary tuberculosis (TB) only (n = 8), HIV only (n = 13), HIV and LTBI co-infection (n = 15) and HIV and TB co-infection (n = 10). The impact of acute HIV infection was assessed in 5 individuals recruited within 3 weeks of infection. The frequency of CD161++CD8+ T cells was assessed prior to and during antiretroviral therapy (ART) in 14 HIV-positive patients. Results: CD161++CD8+ T cells expressed high levels of the HIV co-receptor CCR5, the tissue-homing marker CCR6, and the Mucosal-Associated Invariant T (MAIT) cell TCR V alpha 7.2. Acute and chronic HIV were associated with lower frequencies of CD161++CD8+ T cells, which did not correlate with CD4 count or HIV viral load. ART was not associated with an increase in CD161++CD8+ T cell frequency. There was a trend towards lower levels of CD161++CD8+ T cells in HIV-negative individuals with active and latent TB. In those co-infected with HIV and TB, CD161++CD8+T cells were found at low levels similar to those seen in HIV mono-infection. Conclusions: The frequencies and phenotype of CD161++CD8+ T cells in this South African cohort are comparable to those published in European and US cohorts. Low-levels of this population were associated with acute and chronic HIV infection. Lower levels of the tissue-trophic CD161++CD8+ T cell population may contribute to weakened mucosal immune defense, making HIV-infected subjects more susceptible to pulmonary and gastrointestinal infections and detrimentally impacting on host defense against TB.	[Wong, Emily B.; Akilimali, Ngomu Akeem; Govender, Pamla; Sullivan, Zuri A.; Bishai, William R.; Ndung'u, Thumbi; Kasprowicz, Victoria O.] KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Wong, Emily B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Akilimali, Ngomu Akeem; Govender, Pamla; Pillay, Mona; Walker, Bruce D.; Ndung'u, Thumbi; Kasprowicz, Victoria O.] Univ KwaZulu Natal, HIV Pathogenesis Programme, Durban, South Africa; [Sullivan, Zuri A.; Bishai, William R.] Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD USA; [Cosgrove, Cormac; Klenerman, Paul] Univ Oxford, Oxford, England; [Lewinsohn, David M.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Lewinsohn, David M.] Portland VA Med Ctr, Portland, OR USA; [Walker, Bruce D.; Ndung'u, Thumbi; Kasprowicz, Victoria O.] Harvard Univ, Sch Med, Ragon Inst MGH Massachusetts Inst Technol & Harva, Cambridge, MA 02138 USA; [Ndung'u, Thumbi] Max Planck Inst Infekt Biol, D-10117 Berlin, Germany	Harvard University; Massachusetts General Hospital; University of Kwazulu Natal; Johns Hopkins University; Johns Hopkins Medicine; University of Oxford; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Max Planck Society	Wong, EB (corresponding author), KwaZulu Natal Res Inst TB & HIV, Durban, South Africa.	emilybethwong@gmail.com	; Lewinsohn, David/I-4936-2013	Ndung'u, Thumbi/0000-0003-2962-3992; Sullivan, Zuri/0000-0002-6111-6512; Lewinsohn, David/0000-0001-9906-9494; klenerman, paul/0000-0003-4307-9161	Howard Hughes Medical Institute (HHMI); KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); Harvard University CFAR [P30 AI060354]; NIH [AI 097138, AI 007387]; Wellcome Trust [WT019663MA]; Oxford Martin School; NIAID U19 Bio-defense Program [NIH NIAID 1U19AI082630-01]; NIHR Biomedical Research Centre, Oxford; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, U01AI095776, R01AI097138, T32AI007387, U19AI082630] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0510-10204] Funding Source: researchfish	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); Harvard University CFAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Martin School; NIAID U19 Bio-defense Program; NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors would like to thank the following funders: the Howard Hughes Medical Institute (HHMI), the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), the Harvard University CFAR grant (P30 AI060354), the NIH (grant AI 097138 and AI 007387), the Wellcome Trust (WT019663MA), the Oxford Martin School, the NIAID U19 Bio-defense Program (NIH NIAID 1U19AI082630-01), and the NIHR Biomedical Research Centre, Oxford. PK is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bateman C, 2010, SAMJ S AFR MED J, V100, P207, DOI 10.7196/SAMJ.4103; Bateman C, 2009, SAMJ S AFR MED J, V99, P852; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Chua WJ, 2012, INFECT IMMUN, V80, P3256, DOI 10.1128/IAI.00279-12; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Morgan AJ, 2005, CLIN EXP ALLERGY, V35, P1572, DOI 10.1111/j.1365-2222.2005.02383.x; Morgan AJ, 2008, IMMUNOBIOLOGY, V213, P599, DOI 10.1016/j.imbio.2008.01.005; Nigam P, 2011, J IMMUNOL, V186, P745, DOI 10.4049/jimmunol.1002807; Northfield JW, 2008, HEPATOLOGY, V47, P396, DOI 10.1002/hep.22040; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Radebe M, 2011, J INFECT DIS, V204, P768, DOI 10.1093/infdis/jir394; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sandberg JK, 2013, AIDS; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sutherland R, 2006, AIDS, V20, P821, DOI 10.1097/01.aids.0000218545.31716.a4; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Turtle CJ, 2011, BLOOD, V118, P2752, DOI 10.1182/blood-2011-02-334698; UNAIDS G, 2008, REP GLOB AIDS EP; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789	33	68	70	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83474	10.1371/journal.pone.0083474	http://dx.doi.org/10.1371/journal.pone.0083474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391773	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200070
J	Ozer, A; Yuan, GH; Yang, GB; Wang, F; Li, WT; Yang, Y; Guo, F; Gao, QP; Shoff, L; Chen, Z; Gay, IC; Donly, KJ; MacDougall, M; Chen, S				Ozer, Alkan; Yuan, Guohua; Yang, Guobin; Wang, Feng; Li, Wentong; Yang, Yuan; Guo, Feng; Gao, Qingping; Shoff, Lisa; Chen, Zhi; Gay, Isabel C.; Donly, Kevin J.; MacDougall, Mary; Chen, Shuo			Domain of Dentine Sialoprotein Mediates Proliferation and Differentiation of Human Periodontal Ligament Stem Cells	PLOS ONE			English	Article							SIALOPHOSPHOPROTEIN DSPP; IN-VITRO; EXPRESSION PATTERNS; BONE-FORMATION; PHOSPHOPROTEIN; GROWTH; OSTERIX; GENE; BMP2; OSTEOPROTEGERIN	Classic embryological studies have documented the inductive role of root dentin on adjacent periodontal ligament differentiation. The biochemical composition of root dentin includes collagens and cleavage products of dentin sialophosphoprotein (DSPP), such as dentin sialoprotein (DSP). The high abundance of DSP in root dentin prompted us to ask the question whether DSP or peptides derived thereof would serve as potent biological matrix components to induce periodontal progenitors to further differentiate into periodontal ligament cells. Here, we test the hypothesis that domain of DSP influences cell fate. In situ hybridization and immunohistochemical analyses showed that the COOH-terminal DSP domain is expressed in mouse periodontium at various stages of root development. The recombinant COOH-terminal DSP fragment (rC-DSP) enhanced attachment and migration of human periodontal ligament stem cells (PDLSC), human primary PDL cells without cell toxicity. rC-DSP induced PDLSC cell proliferation as well as differentiation and mineralization of PDLSC and PDL cells by formation of mineralized tissue and ALPase activity. Effect of rC-DSP on cell proliferation and differentiation was to promote gene expression of tooth/bone-relate markers, transcription factors and growth factors. The results for the first time showed that rC-DSP may be one of the components of cell niche for stimulating stem/progenitor cell proliferation and differentiation and a natural scaffold for periodontal regeneration application.	[Ozer, Alkan; Wang, Feng; Li, Wentong; Yang, Yuan; Guo, Feng; Gao, Qingping; Shoff, Lisa; Donly, Kevin J.; Chen, Shuo] Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Dev Dent, San Antonio, TX 78229 USA; [Ozer, Alkan] Yuzuncu Yil Univ, Dept Orthodont, Fac Dent, Kampus Van, Turkey; [Yuan, Guohua; Yang, Guobin; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China; [Yuan, Guohua; Yang, Guobin; Chen, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan, Peoples R China; [Gay, Isabel C.] Univ Texas Hlth Sci Ctr Houston, Sch Dent, Dept Periodont & Dent Hyg, Houston, TX 77030 USA; [MacDougall, Mary] Univ Alabama Birmingham, Dept Oral Maxillofacial Surg, Birmingham, AL USA	University of Texas System; University of Texas Health San Antonio; Yuzuncu Yil University; Wuhan University; Wuhan University; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham	Chen, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Dev Dent, San Antonio, TX 78229 USA.	Chens0@uthscsa.edu	Chen, Zhi/V-2214-2017; MacDougall, Mary/ABG-8212-2021	Chen, Zhi/0000-0003-2095-1324; 	National Institute of Dental and Craniofacial Research (NIDCR) [DE019892]; National Natural Science Foundation of China (NNSFC) [81000436]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019892] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by grants from the National Institute of Dental and Craniofacial Research (NIDCR) DE019892 and National Natural Science Foundation of China (NNSFC) No. 81000436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C; Akintoye SO, 2008, CLIN ORAL IMPLAN RES, V19, P1197, DOI 10.1111/j.1600-0501.2008.01592.x; Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222; Baba O, 2004, EUR J ORAL SCI, V112, P163, DOI 10.1111/j.0909-8836.2004.00110.x; Cao ZG, 2012, J BONE MINER RES, V27, P1080, DOI 10.1002/jbmr.1552; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; d'Aquino R, 2011, EUR CELLS MATER, V21, P304, DOI 10.22203/eCM.v021a23; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Desvarieux M, 2004, STROKE, V35, P2029, DOI 10.1161/01.STR.0000136767.71518.36; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dunn MD, 2007, BONE, V41, P446, DOI 10.1016/j.bone.2007.04.194; Egusa H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012743; Evans ND, 2010, BIOMATERIALS, V31, P3244, DOI 10.1016/j.biomaterials.2010.01.039; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Feng JS, 2012, J MOL HISTOL, V43, P473, DOI 10.1007/s10735-012-9423-1; Feng JS, 2011, CELLS TISSUES ORGANS, V194, P216, DOI 10.1159/000324644; GAY I, 2013, J RES PERIODONT 0513, P14242, DOI DOI 10.1111/JRE.12086.[; Gay IC, 2007, ORTHOD CRANIOFAC RES, V10, P149, DOI 10.1111/j.1601-6343.2007.00399.x; Gibson MP, 2013, J PERIODONTAL RES, V48, P221, DOI 10.1111/j.1600-0765.2012.01523.x; GOTTLOW J, 1984, J CLIN PERIODONTOL, V11, P494, DOI 10.1111/j.1600-051X.1984.tb00901.x; GOULD TRL, 1980, J PERIODONTAL RES, V15, P20, DOI 10.1111/j.1600-0765.1980.tb00258.x; Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee SY, 2012, J DENT RES, V91, P407, DOI 10.1177/0022034511436113; Luan XG, 2006, STEM CELLS DEV, V15, P595, DOI 10.1089/scd.2006.15.595; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Matsubara T, 2005, J BONE MINER RES, V20, P399, DOI 10.1359/JBMR.041117; MCCULLOCH CAG, 1991, J PERIODONTAL RES, V26, P144, DOI 10.1111/j.1600-0765.1991.tb01638.x; McKnight DA, 2008, HUM MUTAT, V29, P1392, DOI 10.1002/humu.20783; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004; Murakami Y, 2003, J PERIODONTOL, V74, P780, DOI 10.1902/jop.2003.74.6.780; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Paine ML, 2005, J BIOL CHEM, V280, P31991, DOI 10.1074/jbc.M502991200; Park JC, 2011, J CLIN PERIODONTOL, V38, P721, DOI 10.1111/j.1600-051X.2011.01716.x; Perry JM, 2007, CELL, V129, P1045, DOI 10.1016/j.cell.2007.05.053; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pitaru S, 2002, CONNECT TISSUE RES, V43, P257, DOI 10.1080/03008200290001276; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; Qin CL, 2001, J BIOL CHEM, V276, P904, DOI 10.1074/jbc.M006271200; Ritchie HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041110; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Silva TA, 2004, CALCIFIED TISSUE INT, V74, P532, DOI 10.1007/s00223-003-0159-5; Silverio KG, 2010, J PERIODONTOL, V81, P1207, DOI 10.1902/jop.2010.090729; Singhatanadgit W, 2009, TISSUE ENG PT A, V15, P2625, DOI [10.1089/ten.tea.2008.0442, 10.1089/ten.TEA.2008.0442]; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Tang LA, 2011, J CELL PHYSIOL, V226, P832, DOI 10.1002/jcp.22405; Tomar GB, 2010, BIOCHEM BIOPH RES CO, V393, P377, DOI 10.1016/j.bbrc.2010.01.126; Trainor PA, 2005, SEMIN CELL DEV BIOL, V16, P683, DOI 10.1016/j.semcdb.2005.06.007; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Verdelis K, 2008, BONE, V43, P983, DOI 10.1016/j.bone.2008.08.110; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Wu L, 2008, CELLS TISSUES ORGANS, V187, P103, DOI 10.1159/000110079; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Yuan GH, 2012, CELL TISSUE RES, V349, P605, DOI 10.1007/s00441-012-1418-4; Yuan GH, 2009, CELL BIOL INT, V33, P816, DOI 10.1016/j.cellbi.2009.05.001; Yun YR, 2012, PROTEIN EXPRES PURIF, V83, P47, DOI 10.1016/j.pep.2012.03.005; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhou JP, 2011, J OROFAC ORTHOP, V72, P457, DOI 10.1007/s00056-011-0050-3	72	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81655	10.1371/journal.pone.0081655	http://dx.doi.org/10.1371/journal.pone.0081655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24400037	Green Published, gold, Green Submitted			2022-12-27	WOS:000327947800052
J	Kim, DS; Lee, MW; Yoo, KH; Lee, TH; Kim, HJ; Jang, IK; Chun, YH; Kim, HJ; Park, SJ; Lee, SH; Son, MH; Jung, HL; Sung, KW; Koo, HH				Kim, Dae Seong; Lee, Myoung Woo; Yoo, Keon Hee; Lee, Tae-Hee; Kim, Hye Jin; Jang, In Keun; Chun, Yong Hoon; Kim, Hyung Joon; Park, Seung Jo; Lee, Soo Hyun; Son, Meong Hi; Jung, Hye Lim; Sung, Ki Woong; Koo, Hong Hoe			Gene Expression Profiles of Human Adipose Tissue-Derived Mesenchymal Stem Cells Are Modified by Cell Culture Density	PLOS ONE			English	Article							GROWTH-FACTOR VEGF; BONE-MARROW; STROMAL CELLS; CXC CHEMOKINE; CORD BLOOD; MIGRATION; DIFFERENTIATION; PROLIFERATION; STIMULATION; EXPANSION	Previous studies conducted cell expansion ex vivo using low initial plating densities for optimal expansion and subsequent differentiation of mesenchymal stem cells (MSCs). However, MSC populations are heterogeneous and culture conditions can affect the characteristics of MSCs. In this study, differences in gene expression profiles of adipose tissue (AT)-derived MSCs were examined after harvesting cells cultured at different densities. AT-MSCs from three different donors were plated at a density of 200 or 5,000 cells/cm(2). After 7 days in culture, detailed gene expression profiles were investigated using a DNA chip microarray, and subsequently validated using a reverse transcription polymerase chain reaction (RT-PCR) analysis. Gene expression profiles were influenced primarily by the level of cell confluence at harvest. In MSCs harvested at similar to 90% confluence, 177 genes were up-regulated and 102 genes down-regulated relative to cells harvested at similar to 50% confluence (P<0.05, FC>2). Proliferation-related genes were highly expressed in MSCs harvested at low density, while genes that were highly expressed in MSCs harvested at high density (similar to 90% confluent) were linked to immunity and defense, cell communication, signal transduction and cell motility. Several cytokine, chemokine and growth factor genes involved in immunosuppression, migration, and reconstitution of damaged tissues were up-regulated in MSCs harvested at high density compared with MSCs harvested at low density. These results imply that cell density at harvest is a critical factor for modulating the specific gene-expression patterns of heterogeneous MSCs.	[Kim, Dae Seong; Lee, Myoung Woo; Yoo, Keon Hee; Kim, Hye Jin; Jang, In Keun; Park, Seung Jo; Lee, Soo Hyun; Son, Meong Hi; Jung, Hye Lim; Sung, Ki Woong; Koo, Hong Hoe] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea; [Lee, Tae-Hee] Sejong Univ, Plant Engn Inst, Dept Lab Canc & Stem Cell Biol, Seoul, South Korea; [Chun, Yong Hoon; Kim, Hyung Joon] Top Class Plast Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sejong University	Yoo, KH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul, South Korea.	hema2170@skku.edu; hhkoo@skku.edu	Kim, Dae Seong/GLU-0329-2022	Park, Seungjo/0000-0002-2087-9628	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0089787]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0089787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2009, ANN THORAC SURG, V88, P1036, DOI 10.1016/j.athoracsur.2009.02.093; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Battiwalla M, 2009, CYTOTHERAPY, V11, P503, DOI 10.1080/14653240903193806; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Braun J, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0263; Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Corre J, 2012, CANCER RES, V72, P1395, DOI 10.1158/0008-5472.CAN-11-0188; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Hwang JH, 2009, J KOREAN MED SCI, V24, P547, DOI 10.3346/jkms.2009.24.4.547; Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Keyser KA, 2007, CELL TRANSPLANT, V16, P555, DOI 10.3727/000000007783464939; Lee MW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/154919; Lee RH, 2006, BLOOD, V107, P2153, DOI 10.1182/blood-2005-07-2701; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Li JT, 2007, SCAND J IMMUNOL, V66, P555, DOI 10.1111/j.1365-3083.2007.02001.x; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Melief SM, 2013, STEM CELL TRANSL MED, V2, P455, DOI 10.5966/sctm.2012-0184; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Neuhuber B, 2008, EXP HEMATOL, V36, P1176, DOI 10.1016/j.exphem.2008.03.019; Ohnishi S, 2007, FEBS LETT, V581, P3961, DOI 10.1016/j.febslet.2007.07.028; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pricola KL, 2009, J CELL BIOCHEM, V108, P577, DOI 10.1002/jcb.22289; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Robinson SN, 2011, BEST PRACT RES CL HA, V24, P83, DOI 10.1016/j.beha.2010.11.001; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Schmal H, 2007, CYTOTHERAPY, V9, P69, DOI 10.1080/14653240601011557; Sezer O, 2001, EUR J HAEMATOL, V66, P83, DOI 10.1034/j.1600-0609.2001.00348.x; Shen W, 2012, ENDOCRINOLOGY, V153, P3482, DOI 10.1210/en.2011-1456; Shimomura T, 2007, HEPATOL RES, V37, P1068, DOI 10.1111/j.1872-034X.2007.00162.x; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Strieter Robert M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P23, DOI 10.2174/1568010053622902; Tian Y, 2008, IMMUNOL INVEST, V37, P29, DOI 10.1080/08820130701410223; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Webb TL, 2012, J FELINE MED SURG, V14, P165, DOI 10.1177/1098612X11429224; Wilbanks A, 2001, J IMMUNOL, V166, P5145, DOI 10.4049/jimmunol.166.8.5145; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	50	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e83363	10.1371/journal.pone.0083363	http://dx.doi.org/10.1371/journal.pone.0083363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400072	Green Published, gold, Green Submitted			2022-12-27	WOS:000329462700006
J	Chen, DW; Li, B; Aubeeluck, A; Yang, YF; Huang, YG; Zhou, JQ; Yu, GR				Chen, Da-wei; Li, Bing; Aubeeluck, Ashwin; Yang, Yun-feng; Huang, Yi-gang; Zhou, Jia-qian; Yu, Guang-rong			Anatomy and Biomechanical Properties of the Plantar Aponeurosis: A Cadaveric Study	PLOS ONE			English	Article							METATARSOPHALANGEAL JOINT; WINDLASS MECHANISM; HALLUX-RIGIDUS; HEEL PAIN; FOOT; FASCIA; CONSEQUENCES; FASCIOTOMY; KINEMATICS; RELEASE	Objectives: To explore the anatomy of the plantar aponeurosis (PA) and its biomechanical effects on the first metatarsophalangeal (MTP) joint and foot arch. Methods: Anatomic parameters (length, width and thickness of each central PA bundle and the main body of the central part) were measured in 8 cadaveric specimens. The ratios of the length and width of each bundle to the length and width of the central part were used to describe these bundles. Six cadaveric specimens were used to measure the range of motion of the first MTP joint before and after releasing the first bundle of the PA. Another 6 specimens were used to evaluate simulated static weight-bearing. Changes in foot arch height and plantar pressure were measured before and after dividing the first bundle. Results: The average width and thickness of the origin of the central part at the calcaneal tubercle were 15.45 mm and 2.79 mm respectively. The ratio of the length of each bundle to the length of the central part was (from medial to lateral) 0.29, 0.30, 0.28, 0.25, and 0.27, respectively. Similarly, the ratio of the widths was 0.26, 0.25, 0.23, 0.19 and 0.17. The thickness of each bundle at the bifurcation of the PA into bundles was (from medial to lateral) 1.26 mm, 1.04 mm, 0.91 mm, 0.84 mm and 0.72 mm. The average dorsiflexion of the first MTP joint increased 10.16 degrees after the first bundle was divided. Marked acute changes in the foot arch height and the plantar pressure were not observed after division. Conclusions: The first PA bundle was not the longest, widest, or the thickest bundle. Releasing the first bundle increased the range of motion of the first MTP joint, but did not acutely change foot arch height or plantar pressure during static load testing.	[Chen, Da-wei; Li, Bing; Aubeeluck, Ashwin; Yang, Yun-feng; Huang, Yi-gang; Zhou, Jia-qian; Yu, Guang-rong] Tongji Univ, Sch Med, Dept Orthopaed, Shanghai 200092, Peoples R China	Tongji University	Yu, GR (corresponding author), Tongji Univ, Sch Med, Dept Orthopaed, Shanghai 200092, Peoples R China.	yuguangrong2012@gmail.com			National Natural Science Foundation of China [10-81071471]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China No. 10-81071471 (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquino A, 1990, FOOT, V9, P73, DOI [10.1054/foot.1999.0520, DOI 10.1054/FOOT.1999.0520]; Arangio GA, 1997, CLIN ORTHOP RELAT R, P227; Berlet GC, 2008, FOOT ANKLE INT, V29, P10, DOI 10.3113/FAI.2008.0010; Cardinal E, 1996, RADIOLOGY, V201, P257, DOI 10.1148/radiology.201.1.8816554; Cattrysse E, 2005, ERGONOMICS, V48, P1657, DOI 10.1080/00140130500101189; Davies-Colley, 1887, BMJ-BRIT MED J, V1, P728; Erdemir A, 2004, J BIOMECH ENG-T ASME, V126, P237, DOI 10.1115/1.1691447; Flavin R, 2008, J BONE JOINT SURG BR, V90B, P1334, DOI 10.1302/0301-620X.90B10.20506; Fuller EA, 2000, J AM PODIAT MED ASSN, V90, P35, DOI 10.7547/87507315-90-1-35; Giannini S, 2011, P 78 ANN M AM AC ORT, P886; Harton FM, 2002, J AM PODIAT MED ASSN, V92, P532, DOI 10.7547/87507315-92-10-532; HICKS JH, 1954, J ANAT, V88, P25; KITAOKA HB, 1994, FOOT ANKLE INT, V15, P557, DOI 10.1177/107110079401501007; Maletsky LP, 2007, J BIOMECH, V40, P682, DOI 10.1016/j.jbiomech.2006.01.017; May Todd J, 2002, Curr Sports Med Rep, V1, P278; McMillan AM, 2009, J FOOT ANKLE RES, V2, DOI 10.1186/1757-1146-2-32; Murphy GA, 1998, FOOT ANKLE INT, V19, P149, DOI 10.1177/107110079801900306; Nester C, 2007, J BIOMECH, V40, P3412, DOI 10.1016/j.jbiomech.2007.05.019; Panchbhavi VK, 2009, J BONE JOINT SURG AM, V91A, P1143, DOI 10.2106/JBJS.H.00162; Sharkey NA, 1999, FOOT ANKLE INT, V20, P86, DOI 10.1177/107110079902000204; Sinnaeve F, 2008, ACTA ORTHOP BELG, V74, P483; Theodorou DJ, 2003, RADIOLOGY, V226, P857, DOI 10.1148/radiol.2263020284; Thordarson DB, 1997, FOOT ANKLE INT, V18, P16, DOI 10.1177/107110079701800104; Tsai WC, 2000, SCAND J RHEUMATOL, V29, P255; Tweed Jo L, 2009, Foot (Edinb), V19, P75, DOI 10.1016/j.foot.2008.11.014; Waldecker U, 2005, FOOT ANKLE SURG, V11, P207; Xia J, 2013, FOOT ANKLE INT, V34, P261, DOI 10.1177/1071100712464211; Yu X, 2011, J INT MED RES, V39, P2352, DOI 10.1177/147323001103900635	28	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84347	10.1371/journal.pone.0084347	http://dx.doi.org/10.1371/journal.pone.0084347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392127	Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100050
J	Minamide, R; Fujiwara, K; Hasegawa, K; Yoshikawa, K				Minamide, Ryohei; Fujiwara, Kazushiro; Hasegawa, Koichi; Yoshikawa, Kazuaki			Antagonistic Interplay between Necdin and Bmi1 Controls Proliferation of Neural Precursor Cells in the Embryonic Mouse Neocortex	PLOS ONE			English	Article							PRADER-WILLI-SYNDROME; MYC TRANSGENIC MICE; SELF-RENEWAL; STEM-CELLS; POSTEMBRYONIC NEUROGENESIS; TRANSCRIPTION FACTOR; POSTMITOTIC NEURONS; GROWTH SUPPRESSOR; GENE-EXPRESSION; PROTEIN	Neural precursor cells (NPCs) in the neocortex exhibit a high proliferation capacity during early embryonic development and give rise to cortical projection neurons after maturation. Necdin, a mammal-specific MAGE (melanoma antigen) family protein that possesses anti-mitotic and pro-survival activities, is expressed abundantly in postmitotic neurons and moderately in tissue-specific stem cells or progenitors. Necdin interacts with E2F transcription factors and suppresses E2F1-dependent transcriptional activation of the cyclin-dependent kinase Cdk1 gene. Here we show that necdin serves as a suppressor of NPC proliferation in the embryonic neocortex. Necdin is moderately expressed in the ventricular zone of mouse embryonic neocortex, in which proliferative cell populations are significantly increased in necdin-null mice. In the neocortex of necdin-null embryos, expression of Cdk1 and Sox2, a stem cell marker, is significantly increased, whereas expression of p16, a cyclin-dependent kinase inhibitor, is markedly diminished. Cdk1 and p16 expression levels are also significantly increased and decreased, respectively, in primary NPCs prepared from necdin-null embryos. Intriguingly, necdin interacts directly with Bmi1, a Polycomb group protein that suppresses p16 expression and promotes NPC proliferation. In HEK293A cells transfected with luciferase reporter constructs, necdin relieves Bmi1-dependent repression of p16 promoter activity, whereas Bmi1 counteracts necdin-mediated repression of E2F1-dependent Cdk1 promoter activity. In lentivirus-infected primary NPCs, necdin overexpression increases p16 expression, suppresses Cdk1 expression, and inhibits NPC proliferation, whereas Bmi1 overexpression suppresses p16 expression, increases Cdk1 expression, and promotes NPC proliferation. Our data suggest that embryonic NPC proliferation in the neocortex is regulated by the antagonistic interplay between necdin and Bmi1.	[Minamide, Ryohei; Fujiwara, Kazushiro; Hasegawa, Koichi; Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan	Osaka University	Yoshikawa, K (corresponding author), Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 565, Japan.	yoshikaw@protein.osaka-u.ac.jp			Japan Society for the Promotion of Science [24300134]; Grants-in-Aid for Scientific Research [24890104, 25830053] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research B2 (24300134) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023764; Aizawa T, 2011, CANCER SCI, V102, P122, DOI 10.1111/j.1349-7006.2010.01775.x; Andrieu D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-56; Asai T, 2012, BLOOD, V120, P1601, DOI 10.1182/blood-2011-11-393983; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Deponti D, 2007, J CELL BIOL, V179, P305, DOI 10.1083/jcb.200701027; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Forsberg K, 2013, J NEUROSCI, V33, P14318, DOI 10.1523/JNEUROSCI.1056-13.2013; Fujiwara K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030948; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; HAUPT Y, 1991, CELL, V65, P753, DOI 10.1016/0092-8674(91)90383-A; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; Huang ZY, 2013, J NEUROSCI, V33, P10362, DOI 10.1523/JNEUROSCI.5682-12.2013; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Jiang Z, 1997, ONCOGENE, V14, P1789, DOI 10.1038/sj.onc.1201014; Kobayashi M, 2002, J BIOL CHEM, V277, P42128, DOI 10.1074/jbc.M205024200; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; Kuwajima T, 2004, J BIOL CHEM, V279, P40484, DOI 10.1074/jbc.M404143200; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Kuwako K, 2005, J NEUROSCI, V25, P7090, DOI 10.1523/JNEUROSCI.2083-05.2005; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Meng S, 2010, J BIOL CHEM, V285, P33219, DOI 10.1074/jbc.M110.133686; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Niinobe M, 2000, DEV NEUROSCI-BASEL, V22, P310, DOI 10.1159/000017455; Nishimura I, 2008, NEUROSCIENCE, V154, P572, DOI 10.1016/j.neuroscience.2008.03.075; Nishimura I, 2007, GENE EXPR PATTERNS, V7, P244, DOI 10.1016/j.modgep.2006.09.008; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 2005, J CELL BIOCHEM, V94, P804, DOI 10.1002/jcb.20345; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Uetsuki T, 1996, J BIOL CHEM, V271, P918, DOI 10.1074/jbc.271.2.918; Uetsuki T, 1999, J NEUROSCI, V19, P6955, DOI 10.1523/JNEUROSCI.19-16-06955.1999; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Yadav AK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-158; Yadirgi G, 2011, STEM CELLS, V29, P700, DOI 10.1002/stem.614; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	56	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84460	10.1371/journal.pone.0084460	http://dx.doi.org/10.1371/journal.pone.0084460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392139	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100062
J	Salter, C; McDaid, L; Bhattacharya, D; Holland, R; Marshall, T; Howe, A				Salter, Charlotte; McDaid, Lisa; Bhattacharya, Debi; Holland, Richard; Marshall, Tarnya; Howe, Amanda			Abandoned Acid? Understanding Adherence to Bisphosphonate Medications for the Prevention of Osteoporosis among Older Women: A Qualitative Longitudinal Study	PLOS ONE			English	Article							PHARMACEUTICAL-INDUSTRY; EXPERIENCE; MEDICINES; DIAGNOSIS	Background: There is significant morbidity and mortality caused by the complications of osteoporosis, for which ageing is the greatest epidemiological risk factor. Preventive medications to delay osteoporosis are available, but little is known about motivators to adhere to these in the context of a symptomless condition with evidence based on screening results. Aim: To describe key perceptions that influence older women's adherence and persistence with prescribed medication when identified to be at a higher than average risk of fracture. Design of Study: A longitudinal qualitative study embedded within a multi-centre trial exploring the effectiveness of screening for prevention of fractures. Setting: Primary care, Norfolk. United Kingdom Methods: Thirty older women aged 70-85 years of age who were offered preventive medication for osteoporosis and agreed to undertake two interviews at 6 and 24 months post-first prescription. Results: There were no overall predictors of adherence which varied markedly over time. Participants' perceptions and motivations to persist with medication were influenced by six core themes: understanding adherence and non-adherence, motivations and self-care, appraising and prioritising risk, anticipating and managing side effects, problems of understanding, and decision making around medication. Those engaged with supportive professionals could better tolerate and overcome barriers such as side-effects. Conclusions: Many issues are raised following screening in a cohort of women who have not previously sought advice about their bone health. Adherence to preventive medication for osteoporosis is complex and multifaceted. Individual participant understanding, choice, risk and perceived need all interact to produce unpredictable patterns of usage and acceptability. There are clear implications for practice and health professionals should not assume adherence in any older women prescribed medication for the prevention of osteoporosis. The beliefs and motivations of participants and their healthcare providers regarding the need to establish acceptable medication regimes is key to promoting and sustaining adherence.	[Salter, Charlotte; McDaid, Lisa; Holland, Richard; Howe, Amanda] Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Bhattacharya, Debi] Univ E Anglia, Sch Pharm & Chem, Norwich NR4 7TJ, Norfolk, England; [Marshall, Tarnya] Norfolk & Norwich Univ Fdn Trust Hosp, Dept Rheumatol, Norwich, Norfolk, England	University of East Anglia; University of East Anglia	Salter, C (corresponding author), Univ E Anglia, Fac Med & Hlth Sci, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	c.salter@uea.ac.uk	Bhattacharya, Debi/F-8400-2011	Bhattacharya, Debi/0000-0003-3024-7453; Holland, Richard/0000-0002-4663-6923; McDaid, Lisa/0000-0001-5032-2380	Research for Patient Benefit Programme National Institute for Health Research [PG-PB-0807-14068]; ESRC [ES/J022497/1] Funding Source: UKRI; Economic and Social Research Council [ES/J022497/1] Funding Source: researchfish; National Institute for Health Research [PB-PG-0807-14068] Funding Source: researchfish	Research for Patient Benefit Programme National Institute for Health Research; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding came from Research for Patient Benefit Programme National Institute for Health Research PG-PB-0807-14068. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, OST ASS RISK FRAG FR; Britten N, 2004, SOC SCI MED, V59, P1495, DOI 10.1016/j.socscimed.2004.01.019; Brookhart MA, 2007, AM J MED, V120, P251, DOI 10.1016/j.amjmed.2006.03.029; Brown P, 2012, HEALTH-LONDON, V16, P57, DOI 10.1177/1363459309360783; Cohen D, 2001, HEALTH-LONDON, V5, P441, DOI 10.1177/136345930100500403; Hodgetts D, 2011, HEALTH PLACE, V17, P353, DOI 10.1016/j.healthplace.2010.11.015; International Osteoporosis Foundation (IOF), 2005, ADH GAP WHY OST PAT; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Marshall IJ WC, 2012, BRIT MED J, V345; Mirand AL, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-15; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R DJ, 2012, BRIT MED J, V244; Murdoch J, MISUNDERSTANDINGS CO; Murdoch J, 2013, SOCIOL HEALTH ILL, V35, P449, DOI 10.1111/j.1467-9566.2012.01499.x; Pickney CS, 2005, OSTEOPOROSIS INT, V16, P1156, DOI 10.1007/s00198-004-1818-8; Poole Kenneth ES, 2006, BMJ, V333; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Recker RR, 2005, MAYO CLIN PROC, V80, P856, DOI 10.4065/80.7.856; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rossini M BG, 2006, OSTEOPOROSIS INT, V17, P941; Salter C, 2007, BMJ-BRIT MED J, V334, P1101, DOI 10.1136/bmj.39171.577106.55; Salter CI, 2011, SOC SCI MED, V73, P808, DOI 10.1016/j.socscimed.2011.06.030; Shepstone L, 2012, OSTEOPOROSIS INT, V23, P2507, DOI 10.1007/s00198-011-1876-7; Shoemaker SJ, 2011, PATIENT EDUC COUNS, V83, P443, DOI 10.1016/j.pec.2011.02.007; (SIGN) SIGN, 2003, MAN OST RISK; Solomon DH, 2005, ARCH INTERN MED, V165, P2414, DOI 10.1001/archinte.165.20.2414; Verdijk NA, 2009, BRIT J GEN PRACT, V59, P256, DOI 10.3399/bjgp09X420338; Williams SJ CM, 2008, SOCIOL HLTH ILL, V16; World Health Organization, 2003, PREV MAN OST	30	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83552	10.1371/journal.pone.0083552	http://dx.doi.org/10.1371/journal.pone.0083552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	286ID	24392086	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000329460100010
J	Stein, GY; Herscovici, G; Korenfeld, R; Matetzky, S; Gottlieb, S; Alon, D; Gevrielov-Yusim, N; Iakobishvili, Z; Fuchs, S				Stein, Gideon Y.; Herscovici, Gabriel; Korenfeld, Roman; Matetzky, Shlomi; Gottlieb, Shmuel; Alon, Danny; Gevrielov-Yusim, Natalie; Iakobishvili, Zaza; Fuchs, Shmuel			Type-II Myocardial Infarction - Patient Characteristics, Management and Outcomes	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; OPTIMIZING PLATELET INHIBITION; UNIVERSAL DEFINITION; PRASUGREL-THROMBOLYSIS; CLASSIFICATION-SYSTEM; THERAPEUTIC OUTCOMES; ASSESS IMPROVEMENT; GLOBAL REGISTRY; RISK; INTERVENTION	Background: Type-II MI is defined as myocardial infarction (MI) secondary to ischemia due to either increased oxygen demand or decreased supply. This categorization has been used for the last five years, yet, little is known about patient characteristics and clinical outcomes. In the current work we assessed the epidemiology, causes, management and outcomes of type II MI patients. Methods: A comparative analysis was performed between patients with type-I and type-II MI who participated in two prospective national Acute Coronary Syndrome Israeli Surveys (ACSIS) performed in 2008 and 2010. Results: The surveys included 2818 patients with acute MI of whom 127 (4.5%) had type-II MI. The main causes of type-II MI were anemia (31%), sepsis (24%), and arrhythmia (17%). Patients with type-II MI tended to be older (75.6 +/- 12 vs. 63.8 +/- 13, p<0.0001), female majority (43.3% vs. 22.3%, p<0.0001), had more frequently impaired functional level (45.7% vs. 17%, p<0.0001) and a higher GRACE risk score (150 +/- 32 vs. 110 +/- 35, p<0.0001). Patients with type-II MI were significantly less often referred for coronary interventions (36% vs. 89%, p<0.0001) and less frequently prescribed guideline-directed medical therapy. Mortality rates were substantially higher among patients with type-II MI both at thirty-day (13.6% vs. 4.9%, p<0.0001) and at one-year (23.9% vs. 8.6%, p<0.0001) follow-ups. Conclusions: Patients with type-II compared to type-I MI have distinct demographics, increased prevalence of multiple comorbidities, a high-risk cardiovascular profile and an overall worse outcome. The complex medical condition of this cohort imposes a great therapeutic challenge and specific guidelines with recommended medical treatment and invasive strategies are warranted.	[Stein, Gideon Y.; Herscovici, Gabriel; Korenfeld, Roman; Alon, Danny; Fuchs, Shmuel] Tel Aviv Univ, Sackler Sch Med, Rabin Med Ctr, Beilinson Hosp, IL-69978 Tel Aviv, Israel; [Matetzky, Shlomi; Gevrielov-Yusim, Natalie] Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Cardiol Inst, IL-69978 Tel Aviv, Israel; [Gottlieb, Shmuel] Tel Aviv Univ, Sackler Sch Med, Chaim Sheba Med Ctr, Neufeld Heart Res Inst, IL-69978 Tel Aviv, Israel; [Gottlieb, Shmuel] Bikur Cholim Hosp, Cardio Dept, Jerusalem, Israel; [Iakobishvili, Zaza] Tel Aviv Univ, Sackler Sch Med, Dept Cardiol, Beilinson Hosp,Rabin Med Ctr, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Fuchs, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, Rabin Med Ctr, Beilinson Hosp, IL-69978 Tel Aviv, Israel.	shmuelf@clalit.org.il						Agewall S, 2011, EUR HEART J, V32, P404, DOI 10.1093/eurheartj/ehq456; Bahrmann P, 2012, AGING CLIN EXP RES, V24, P290, DOI 10.3275/7927; Banihashemi B, 2009, AM HEART J, V158, P917, DOI 10.1016/j.ahj.2009.09.016; Behar S, 2003, ISR MED ASSOC J, V5, P249; Bonaca MP, 2012, CIRCULATION, V125, P577, DOI 10.1161/CIRCULATIONAHA.111.041160; De Gennaro L, 2008, J INTERV CARDIOL, V21, P129, DOI 10.1111/j.1540-8183.2007.00336.x; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fox KAA, 2007, HEART, V93, P177, DOI 10.1136/hrt.2005.084830; Goncalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Gupta PK, 2011, CIRCULATION, V124, P381, DOI 10.1161/CIRCULATIONAHA.110.015701; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Jedrzkiewicz S, 2009, CAN J CARDIOL, V25, pE370, DOI 10.1016/S0828-282X(09)70163-1; Kelley WE, 2009, CLIN CHEM, V55, P2098, DOI 10.1373/clinchem.2009.130799; Morrow DA, 2009, CIRCULATION, V119, P2758, DOI 10.1161/CIRCULATIONAHA.108.833665; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; White HD, 2012, AM HEART J, V163, P563, DOI 10.1016/j.ahj.2012.01.016	20	99	106	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84285	10.1371/journal.pone.0084285	http://dx.doi.org/10.1371/journal.pone.0084285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392121	Green Published, Green Submitted, gold			2022-12-27	WOS:000329460100044
J	Urbschat, A; Zacharowski, K; Obermuller, N; Rupprecht, K; Penzkofer, D; Jennewein, C; Tran, N; Scheller, B; Dimmeler, S; Paulus, P				Urbschat, Anja; Zacharowski, Kai; Obermueller, Nicholas; Rupprecht, Katrin; Penzkofer, Daniela; Jennewein, Carla; Nguyen Tran; Scheller, Bertram; Dimmeler, Stefanie; Paulus, Patrick			The Small Fibrinopeptide B beta(15-42) as Renoprotective Agent Preserving the Endothelial and Vascular Integrity in Early Ischemia Reperfusion Injury in the Mouse Kidney	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; GELATINASE-ASSOCIATED LIPOCALIN; VE-CADHERIN; PEPTIDE B-BETA(15-42); MYOCARDIAL-INFARCTION; PIG MODEL; PERMEABILITY; JUNCTIONS; FIBRIN; SEPSIS	Disruption of the renal endothelial integrity is pivotal for the development of a vascular leak, tissue edema and consequently acute kidney injury. Kidney ischemia amplifies endothelial activation and up-regulation of pro-inflammatory mechanisms. After restoring a sufficient blood flow, the kidney is damaged through complex pathomechanisms that are classically referred to as ischemia and reperfusion injury, where the disruption of the inter-endothelial connections seems to be a crucial step in this pathomechanism. Focusing on the molecular cell-cell interaction, the fibrinopeptide B beta(15-42) prevents vascular leakage by stabilizing these inter-endothelial junctions. The peptide associates with vascular endothelial-cadherin, thus preventing early kidney dysfunction by preserving blood perfusion efficacy, edema formation and thus organ dysfunction. We intended to demonstrate the early therapeutic benefit of intravenously administered B beta(15-42) in a mouse model of renal ischemia and reperfusion. After 30 minutes of ischemia, the fibrinopeptide B beta(15-42) was administered intravenously before reperfusion was commenced for 1 and 3 hours. We show that B beta(15-42) alleviates early functional and morphological kidney damage as soon as 1 h and 3 h after ischemia and reperfusion. Mice treated with B beta(15-42) displayed a significantly reduced loss of VE-cadherin, indicating a conserved endothelial barrier leading to less neutrophil infiltration which in turn resulted in significantly reduced structural renal damage. The significant reduction in tissue and serum neutrophil gelatinase-associated lipocalin levels reinforced our findings. Moreover, renal perfusion analysis by color duplex sonography revealed that B beta(15-42) treatment preserved resistive indices and even improved blood velocity. Our data demonstrate the efficacy of early therapeutic intervention using the fibrinopeptide B beta(15-42) in the treatment of acute kidney injury resulting from ischemia and reperfusion. In this context B beta(15-42) may act as a potent renoprotective agent by preserving the endothelial and vascular integrity.	[Urbschat, Anja] Goethe Univ Hosp, Fac Med, Frankfurt, Germany; [Zacharowski, Kai; Rupprecht, Katrin; Jennewein, Carla; Nguyen Tran; Scheller, Bertram; Paulus, Patrick] Goethe Univ Hosp, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Obermueller, Nicholas] Goethe Univ Hosp, Div Nephrol, Clin Internal Med 3, Frankfurt, Germany; [Penzkofer, Daniela; Dimmeler, Stefanie] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Urbschat, A (corresponding author), Goethe Univ Hosp, Fac Med, Frankfurt, Germany.	urbschat@med.uni-frankfurt.de	Jennewein, Carla/C-2199-2013	Dimmeler, Stefanie/0000-0002-1045-2436	Deutsche Forschungsgesellschaft [SFB 834-B4]	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	This research project received funding from Deutsche Forschungsgesellschaft SFB 834-B4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atar D, 2009, J AM COLL CARDIOL, V53, P720, DOI 10.1016/j.jacc.2008.12.017; Bach TL, 1998, J BIOL CHEM, V273, P30719, DOI 10.1074/jbc.273.46.30719; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bonventre JV, 2010, CONTRIB NEPHROL, V165, P9, DOI 10.1159/000313738; Broman MT, 2007, TRENDS CARDIOVAS MED, V17, P151, DOI 10.1016/j.tcm.2007.03.004; Dejana E, 2001, THROMB HAEMOSTASIS, V86, P308; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Gorlatov S, 2002, BIOCHEMISTRY-US, V41, P4107, DOI 10.1021/bi0160314; Groger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005391; Haller H, 1996, KIDNEY INT, V50, P473, DOI 10.1038/ki.1996.338; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; KLAUSNER JM, 1989, AM J PHYSIOL, V256, pF794, DOI 10.1152/ajprenal.1989.256.5.F794; Krishnamoorthy A, 2011, BLOOD, V118, P1934, DOI 10.1182/blood-2011-02-338061; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Lote CJ, 1996, BRIT J ANAESTH, V77, P82, DOI 10.1093/bja/77.1.82; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Molitoris BA, 2002, CRIT CARE MED, V30, pS235, DOI 10.1097/00003246-200205001-00011; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Nguyen MT, 2008, PEDIATR NEPHROL, V23, P2151, DOI 10.1007/s00467-007-0470-x; Obermuller N, 2013, INT UROL NEPHROL; Paulus P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073298; Paulus P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039265; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Roesner JP, 2007, CRIT CARE MED, V35, P1730, DOI 10.1097/01.CCM.0000269035.30231.76; Roesner JP, 2009, CRIT CARE MED, V37, P598, DOI 10.1097/CCM.0b013e3181959a12; Sahni A, 2009, INT J CANCER, V125, P577, DOI 10.1002/ijc.24340; Schnell D, 2012, INTENS CARE MED, V38, P1751, DOI 10.1007/s00134-012-2692-z; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Singbartl K, 2001, FASEB J, V15, P2337, DOI 10.1096/fj.01-0199com; Sorensen I, 2011, J AM SOC NEPHROL, V22, P1887, DOI 10.1681/ASN.2011010031; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Zacharowski K, 2006, J MOL MED, V84, P469, DOI 10.1007/s00109-006-0051-7	38	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84432	10.1371/journal.pone.0084432	http://dx.doi.org/10.1371/journal.pone.0084432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392138	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100061
J	von Terzi, B; Turnbull, PCB; Bellan, SE; Beyer, W				von Terzi, Britta; Turnbull, Peter C. B.; Bellan, Steve E.; Beyer, Wolfgang			Failure of Sterne- and Pasteur-Like Strains of Bacillus anthracis to Replicate and Survive in the Urban Bluebottle Blow Fly Calliphora vicina under Laboratory Conditions	PLOS ONE			English	Article							TRANSMISSION	This study aimed to elucidate the bacteriological events occurring within the gut of Calliphora vicina, selected as the European representative of blow flies held responsible for the spread of anthrax during epidemics in certain parts of the world. Green-fluorescent-protein-carrying derivatives of Bacillus anthracis were used. These lacked either one of the virulence plasmids pXO1 and pXO2 and were infected, or not infected, with a worm intestine phage (Wip4) known to influence the phenotype and survival of the pathogen. Blood meals were prepared for the flies by inoculation of sheep blood with germinated and, in case of pXO2+ strains, encapsulated cells of the four B. anthracis strains. After being fed for 4 h an initial 10 flies were externally disinfected with peracetic acid to ensure subsequent quantitation representing ingested B. anthracis only. Following neutralization, they were crushed in sterile saline. Over each of the ensuing 7 to 10 days, 10 flies were removed and processed the same way. In the absence of Wip4, strains showed steady declines to undetectable in the total B. anthracis counts, within 7-9 days. With the phage infected strains, the falls in viable counts were significantly more rapid than in their uninfected counterparts. Spores were detectable in flies for longer periods than vegetative bacteria. In line with the findings in both biting and non-biting flies of early workers our results indicate that B. anthracis does not multiply in the guts of blow flies and survival is limited to a matter of days.	[von Terzi, Britta; Turnbull, Peter C. B.; Beyer, Wolfgang] Univ Hohenheim, Inst Environm & Anim Hyg, Stuttgart, Germany; [Bellan, Steve E.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA	University Hohenheim; University of Texas System; University of Texas Austin	Beyer, W (corresponding author), Univ Hohenheim, Inst Environm & Anim Hyg, Stuttgart, Germany.	wolfgang.beyer@uni-hohenheim.de	Bellan, Steven/D-6368-2013	Bellan, Steven/0000-0002-4110-272X	German Research Foundation (DFG) [BE 2157/3-1]; United States National Institute of General Medical Sciences MIDAS grant [U01GM087719]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); United States National Institute of General Medical Sciences MIDAS grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant BE 2157/3-1 of the German Research Foundation (DFG). SEB was funded by a United States National Institute of General Medical Sciences MIDAS grant U01GM087719 to Lauren A. Meyers and Alison P. Galvani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn JK, 2010, J WILDLIFE DIS, V46, P918, DOI 10.7589/0090-3558-46.3.918; BRAACK LEO, 1990, ONDERSTEPOORT J VET, V57, P141; Buchanan RM, 1907, LANCET, V2, P216; Carr KA, 2010, MOL MICROBIOL, V75, P365, DOI 10.1111/j.1365-2958.2009.06972.x; DAVIES JCA, 1982, CENT AFR J MED, V28, P291; DEVOS V, 2004, INFECT DIS LIVESTOCK, pCH153; Fasanella A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012219; Graham-Smith GS, 1913, CAMBRIDGE PUBLIC HLT; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Hugh-Jones ME, 2002, REV SCI TECH OIE, V21, P359, DOI 10.20506/rst.21.2.1336; Kraneveld F.C., 1940, OVERGEDRUKT UIT NED, V52, P339; Kraneveld FC, 1939, WIED NED IND BL DIER, V51, P62; MINETT FC, 1950, J COMP PATHOL THERAP, V60, P161, DOI 10.1016/S0368-1742(50)80016-4; Morris H, 1918, B LOUISIANA STATE U, V163, P3; Nalisa M, 2012, THESIS U NAMIBIA; Schuch R, 2010, APPL ENVIRON MICROB, V76, P2286, DOI 10.1128/AEM.02518-09; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; TURELL MJ, 1987, INFECT IMMUN, V55, P1859, DOI 10.1128/IAI.55.8.1859-1861.1987; Welkos S, 2011, ANTIMICROB AGENTS CH, V55, P4238, DOI 10.1128/AAC.00267-11; WHO, 2008, ANTHRAX HUMANS ANIMA; Zuur Alain F., 2009, P1	21	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83860	10.1371/journal.pone.0083860	http://dx.doi.org/10.1371/journal.pone.0083860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392098	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100022
J	Wibawa, H; Bingham, J; Nuradji, H; Lowther, S; Payne, J; Harper, J; Junaidi, A; Middleton, D; Meers, J				Wibawa, Hendra; Bingham, John; Nuradji, Harimurti; Lowther, Sue; Payne, Jean; Harper, Jenni; Junaidi, Akhmad; Middleton, Deborah; Meers, Joanne			Experimentally Infected Domestic Ducks Show Efficient Transmission of Indonesian H5N1 Highly Pathogenic Avian Influenza Virus, but Lack Persistent Viral Shedding	PLOS ONE			English	Article							ANAS-PLATYRHYNCHOS; ASIA; EVOLUTION; DISEASE; EPIDEMIOLOGY; PATHOBIOLOGY; SUBLINEAGES; ANTIBODIES; WATERFOWL; CHICKENS	Ducks are important maintenance hosts for avian influenza, including H5N1 highly pathogenic avian influenza viruses. A previous study indicated that persistence of H5N1 viruses in ducks after the development of humoral immunity may drive viral evolution following immune selection. As H5N1 HPAI is endemic in Indonesia, this mechanism may be important in understanding H5N1 evolution in that region. To determine the capability of domestic ducks to maintain prolonged shedding of Indonesian clade 2.1 H5N1 virus, two groups of Pekin ducks were inoculated through the eyes, nostrils and oropharynx and viral shedding and transmission investigated. Inoculated ducks (n = 15), which were mostly asymptomatic, shed infectious virus from the oral route from 1 to 8 days post inoculation, and from the cloacal route from 2-8 dpi. Viral ribonucleic acid was detected from 1-15 days post inoculation from the oral route and 1-24 days post inoculation from the cloacal route (cycle threshold <40). Most ducks seroconverted in a range of serological tests by 15 days post inoculation. Virus was efficiently transmitted during acute infection (5 inoculation-infected to all 5 contact ducks). However, no evidence for transmission, as determined by seroconversion and viral shedding, was found between an inoculation-infected group (n = 10) and contact ducks (n = 9) when the two groups only had contact after 10 days post inoculation. Clinical disease was more frequent and more severe in contact-infected (2 of 5) than inoculation-infected ducks (1 of 15). We conclude that Indonesian clade 2.1 H5N1 highly pathogenic avian influenza virus does not persist in individual ducks after acute infection.	[Wibawa, Hendra; Bingham, John; Nuradji, Harimurti; Lowther, Sue; Payne, Jean; Harper, Jenni; Middleton, Deborah] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Wibawa, Hendra; Nuradji, Harimurti; Meers, Joanne] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Wibawa, Hendra; Junaidi, Akhmad] Dis Invest Ctr Reg IV Wates, Yogyakarta, Indonesia; [Nuradji, Harimurti] Indonesian Res Ctr Vet Sci, Bogor, West Java, Indonesia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Bingham, J (corresponding author), CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia.	John.Bingham@csiro.au	Bingham, John/H-8591-2013; Wibawa, Hendra/AAP-5558-2020; Meers, Joanne/B-4141-2011	Bingham, John/0000-0003-2360-3827; Meers, Joanne/0000-0001-9305-0469; Nuradji, Harimurti/0000-0002-7302-5933	CSIRO [AH/2004/040]; Australian Centre for International Agriculture Research (ACIAR) [AH/2004/040]; ACIAR John Allwright Fellowship	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Centre for International Agriculture Research (ACIAR)(Australian Ctr Intl Agr Res); ACIAR John Allwright Fellowship(Australian Ctr Intl Agr Res)	The study was jointly funded by CSIRO and the Australian Centre for International Agriculture Research (ACIAR) grant number AH/2004/040. Hendra Wibawa was supported by an ACIAR John Allwright Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Alexander DJ, 2009, REV SCI TECH OIE, V28, P19, DOI 10.20506/rst.28.1.1856; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; [Anonymous], 2011, APPR CONTR PREV EL H; Bingham J, 2009, AVIAN PATHOL, V38, P267, DOI 10.1080/03079450903055371; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; CIVAS, 2006, REV FREE RANG DUCK F; FAO, 2011, H5N1 HPAI GLOB OV OC; Forrest Heather L., 2010, Animal Health Research Reviews, V11, P3, DOI 10.1017/S1466252310000071; Guan Y, 2009, REV SCI TECH OIE, V28, P39, DOI 10.20506/rst.28.1.1868; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Henning J., 2012, EPIDEMIOLOGY INFECT, P1, DOI 10.1017/S0950268812001100; Henning J, 2010, EMERG INFECT DIS, V16, P1244, DOI 10.3201/eid1608.091540; HIGGINS DA, 1987, IMMUNOLOGY, V62, P499; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1980, COMP IMMUNOL MICROB, V3, P155, DOI 10.1016/0147-9571(80)90051-X; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Jeong OM, 2009, J VET SCI, V10, P53, DOI 10.4142/jvs.2009.10.1.53; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; OIE, 2012, DIAGNOSTIC TESTS VAC, V1, P721; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P250, DOI 10.1637/7710-090606R.1; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Perkins LEL, 2002, AVIAN DIS, V46, P53, DOI 10.1637/0005-2086(2002)046[0053:POAHKO]2.0.CO;2; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sims LD, 2005, VET REC, V157, P159, DOI 10.1136/vr.157.6.159; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Tumpey TM, 2002, J VIROL, V76, P6344, DOI 10.1128/JVI.76.12.6344-6355.2002; Vijaykrishna D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000161; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WHO, 2013, CUM NUMB CONF HUM CA; Wibawa H, 2013, COMP IMMUNOL MICROB, V36, P175, DOI 10.1016/j.cimid.2012.12.001; Wibawa H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-117	36	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e83417	10.1371/journal.pone.0083417	http://dx.doi.org/10.1371/journal.pone.0083417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392085	Green Submitted, gold, Green Published			2022-12-27	WOS:000329460100009
J	Cormack, DM; Harris, RB; Stanley, J				Cormack, Donna M.; Harris, Ricci B.; Stanley, James			Investigating the Relationship between Socially-Assigned Ethnicity, Racial Discrimination and Health Advantage in New Zealand	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; DISPARITIES; WHITENESS; RACE	Background: While evidence of the contribution of racial discrimination to ethnic health disparities has increased significantly, there has been less research examining relationships between ascribed racial/ethnic categories and health. It has been hypothesized that in racially-stratified societies being assigned as belonging to the dominant racial/ethnic group may be associated with health advantage. This study aimed to investigate associations between socially-assigned ethnicity, self-identified ethnicity, and health, and to consider the role of self-reported experience of racial discrimination in any relationships between socially-assigned ethnicity and health. Methods: The study used data from the 2006/07 New Zealand Health Survey (n = 12,488), a nationally representative cross-sectional survey of adults 15 years and over. Racial discrimination was measured as reported individual-level experiences across five domains. Health outcome measures examined were self-reported general health and psychological distress. Results: The study identified varying levels of agreement between participants' self-identified and socially-assigned ethnicities. Individuals who reported both self-identifying and being socially-assigned as always belonging to the dominant European grouping tended to have more socioeconomic advantage and experience less racial discrimination. This group also had the highest odds of reporting optimal self-rated health and lower mean levels of psychological distress. These differences were attenuated in models adjusting for socioeconomic measures and individual-level racial discrimination. Conclusions: The results suggest health advantage accrues to individuals who self-identify and are socially-assigned as belonging to the dominant European ethnic grouping in New Zealand, operating in part through socioeconomic advantage and lower exposure to individual-level racial discrimination. This is consistent with the broader evidence of the negative impacts of racism on health and ethnic inequalities that result from the inequitable distribution of health determinants, the harm and chronic stress linked to experiences of racial discrimination, and via the processes and consequences of racialization at a societal level.	[Cormack, Donna M.; Harris, Ricci B.] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Stanley, James] Univ Otago, Deans Dept, Wellington, New Zealand	University of Otago; University of Otago	Cormack, DM (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	donna.cormack@otago.ac.nz			Health Research Council of New Zealand [10/416]	Health Research Council of New Zealand(Health Research Council of New Zealand)	The Crown is the owner of the copyright of the data and the Ministry of Health is the funder of the data collection. This current study was funded by the Health Research Council of New Zealand as a 3-year project grant. The project number is 10/416. The funder's website is: www.hrc.govt.nz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The results presented in this paper are the work of the authors.	Abdulrahim S, 2012, SOC SCI MED, V75, P2116, DOI 10.1016/j.socscimed.2012.07.030; Ahmed P, 2007, SOC FORCES, V86, P231, DOI 10.1353/sof.2007.0087; Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204; Browne MAO, 2010, AUST NZ J PSYCHIAT, V44, P314, DOI 10.3109/00048670903279820; Campbell ME, 2007, AM SOCIOL REV, V72, P750, DOI 10.1177/000312240707200505; Cormack D, 2010, POLITICS PRACTICE CO; Daniels J, 2006, GENDER RACE CLASS HL, P89, DOI [10.1016/S1567-5688(14)70002-9, DOI 10.1016/S1567-5688(14)70002-9]; Freeman JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025107; Garner S., 2007, WHITENESS INTRO; Garner S., 2010, RACISMS INTRO; Harawa NT, 2009, ETHNIC DIS, V19, P209; Harris R, 2012, SOC SCI MED, V74, P408, DOI 10.1016/j.socscimed.2011.11.004; Jay P., 2008, DU BOIS REV, V5, P27, DOI [DOI 10.1017/S1742058X0808003X, 10.1017/S1742058X0808003X]; Jenkins R., 2008, RETHINKING ETHNICITY, DOI DOI 10.4135/9781446214855; Jensen J., 2005, ELSI SHORT FORM USER; Jones CP, 2008, ETHNIC DIS, V18, P496; Jones CP, 2001, AM J EPIDEMIOL, V154, P299, DOI 10.1093/aje/154.4.299; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; MacIntosh T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064522; Malat J, 2010, ETHNIC RACIAL STUD, V33, P1431, DOI 10.1080/01419870903501970; Mawani R, 2002, RACE SPACE LAW UNMAP; Ministry of Health, 2015, TAT KAH MAOR HLTH CH; Ministry of Health, 2008, METH REP 2006 07 NZ; Ministry of Health, 2007, MEAS HLTH STAT WHO L; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Ridings C, 2010, REACTIONS RACE ANAL; Ridolfo H, 2011, FIELD METHOD, V23, P420, DOI 10.1177/1525822X11414835; Roth W, 2010, SOCIAL SCI Q, V91, P1287; Salmond C, 2005, NZIDEP NZ INDEX SOCI; Salmond C., 2007, NZDEP2006 INDEX DEPR; Saperstein A, 2006, SOC FORCES, V85, P57, DOI 10.1353/sof.2006.0141; Schulz A.J., 2006, GENDER RACE CLASS HL; Statistics New Zealand, 2012, WORK RAC DISCR NZ; Statistics New Zealand, 2005, STAT STAND ETHN 2005; Van Dijk T.A., 1993, ELITE DISCOURSE RACI, V6; Veenstra G, 2011, SOC SCI MED, V73, P1152, DOI 10.1016/j.socscimed.2011.07.030; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0	39	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84039	10.1371/journal.pone.0084039	http://dx.doi.org/10.1371/journal.pone.0084039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284MV	24391876	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900019
J	Hoffmann, C; Zimmermann, A; Hinney, A; Volckmar, AL; Jarrett, HW; Fromme, T; Klingenspor, M				Hoffmann, Christoph; Zimmermann, Anika; Hinney, Anke; Volckmar, Anna-Lena; Jarrett, Harry W.; Fromme, Tobias; Klingenspor, Martin			A Novel SP1/SP3 Dependent Intronic Enhancer Governing Transcription of the UCP3 Gene in Brown Adipocytes	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; FREE FATTY-ACIDS; UNCOUPLING PROTEIN-3; SKELETAL-MUSCLE; ADIPOSE-TISSUE; PPAR-DELTA; EXPRESSION; METABOLISM; PATHWAYS; EXERCISE	Uncoupling protein (UCP) 3 is a mitochondrial inner membrane protein implicated in lipid handling and metabolism of reactive oxygen species. Its transcription is mainly regulated by peroxisome proliferator-activated receptors (PPAR), a family of nuclear hormone receptors. Employing bandshift assays, RNA interference and reporter gene assays we examine an intronic region in the UCP3 gene harboring a cis-element essential for expression in brown adipocytes. We demonstrate binding of SP1 and SP3 to this element which is adjacent to a direct repeat 1 element mediating activation of UCP3 expression by PPAR gamma agonists. Transactivation mediated by these elements is interdependent and indispensable for UCP3 expression. Systematic deletion uncovered a third binding element, a putative NF1 site, in close proximity to the SP1/3 and PPAR gamma binding elements. Data mining demonstrated binding of MyoD and Myogenin to this third element in C2C12 cells, and, furthermore, revealed recruitment of p300. Taken together, this intronic region is the main enhancer driving UCP3 expression with SP1/3 and PPAR gamma as the core factors required for expression.	[Hoffmann, Christoph; Zimmermann, Anika; Fromme, Tobias; Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Hoffmann, Christoph; Zimmermann, Anika; Fromme, Tobias; Klingenspor, Martin] Tech Univ Munich, Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [Hinney, Anke; Volckmar, Anna-Lena] Univ Duisburg Essen, Univ Klinikum Essen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Essen, Germany; [Jarrett, Harry W.] Univ Texas San Antonio, Dept Chem, San Antonio, TX USA	Technical University of Munich; Technical University of Munich; University of Duisburg Essen; University of Texas System; University of Texas at San Antonio (UTSA)	Klingenspor, M (corresponding author), Tech Univ Munich, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany.	mk@tum.de	Fromme, Tobias/AAU-8982-2020; Klingenspor, Martin/K-5033-2019; Klingenspor, Martin/D-6930-2011; Hinney, Anke/D-6953-2011; Volckmar, Anna-Lena/ABE-3676-2021	Fromme, Tobias/0000-0001-9150-2513; Klingenspor, Martin/0000-0002-4502-6664; Hinney, Anke/0000-0001-5659-0706; 	German Research Foundation [DFG - KL 973/8-1]; Else Kroner-Fresenius Foundation (EKFS); Federal Ministry for Education and Research [BMBF 01KU0903, NGFNplus 01GS0822, 01GS0820]; EU FP7 project DIABAT [HEALTH-F2-2011-278373]; National Institutes of Health (NIH) [5R01GM043609]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043609] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007591] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Else Kroner-Fresenius Foundation (EKFS); Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); EU FP7 project DIABAT; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grants from the German Research Foundation (DFG - KL 973/8-1), the Else Kroner-Fresenius Foundation (EKFS), the Federal Ministry for Education and Research (BMBF 01KU0903, NGFNplus 01GS0822, 01GS0820) and the EU FP7 project DIABAT (HEALTH-F2-2011-278373). HWJ was supported by National Institutes of Health (NIH) (5R01GM043609). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Bugge A, 2010, J BIOL CHEM, V285, P17310, DOI 10.1074/jbc.M110.120584; Cadenas S, 1999, FEBS LETT, V462, P257, DOI 10.1016/S0014-5793(99)01540-9; Chou CJ, 2001, OBES RES, V9, P313, DOI 10.1038/oby.2001.39; Criscuolo F, 2006, BBA-BIOENERGETICS, V1757, P1284, DOI 10.1016/j.bbabio.2006.06.002; CUNNINGHAM S, 1985, CLIN SCI, V69, P343, DOI 10.1042/cs0690343; dos Santos RS, 2013, BIOL OPEN, V2, P82, DOI 10.1242/bio.20122295; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656; Fromme T, 2009, PHYSIOL GENOMICS, V38, P54, DOI 10.1152/physiolgenomics.00249.2007; Fromme T, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-1; Giacobino JP, 1999, INT J OBESITY, V23, pS60, DOI 10.1038/sj.ijo.0800949; Girousse A, 2009, DIABETOLOGIA, V52, P1638, DOI 10.1007/s00125-009-1385-9; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hwang CS, 1999, BIOCHEM BIOPH RES CO, V258, P464, DOI 10.1006/bbrc.1999.0662; Jucker BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1256, DOI 10.1152/ajpendo.00218.2007; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; KLAUS S, 1994, J CELL SCI, V107, P313; Liebig M, 2004, PHYSIOL BIOCHEM ZOOL, V77, P116, DOI 10.1086/381464; Matsuda J, 1997, FEBS LETT, V418, P200, DOI 10.1016/S0014-5793(97)01381-1; Millet L, 1997, J CLIN INVEST, V100, P2665, DOI 10.1172/JCI119811; Nau K, 2008, J COMP PHYSIOL B, V178, P269, DOI 10.1007/s00360-007-0219-7; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Schrauwen P, 2004, P NUTR SOC, V63, P287, DOI 10.1079/PNS2003336; Solanes G, 2003, MOL ENDOCRINOL, V17, P1944, DOI 10.1210/me.2002-0395; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Teruel T, 2000, BIOCHEM BIOPH RES CO, V273, P560, DOI 10.1006/bbrc.2000.2982; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; von Praun C, 2001, PHYSIOL BIOCHEM ZOOL, V74, P203, DOI 10.1086/319665; Weigle DS, 1998, DIABETES, V47, P298, DOI 10.2337/diabetes.47.2.298	36	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83426	10.1371/journal.pone.0083426	http://dx.doi.org/10.1371/journal.pone.0083426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391766	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200063
J	Hoyo-Becerra, C; Huebener, A; Trippler, M; Lutterbeck, M; Liu, ZJJ; Truebner, K; Bajanowski, T; Gerken, G; Hermann, DM; Schlaak, JF				Hoyo-Becerra, Carolina; Huebener, Anastasia; Trippler, Martin; Lutterbeck, Melanie; Liu, Zijian J.; Truebner, Kurt; Bajanowski, Thomas; Gerken, Guido; Hermann, Dirk M.; Schlaak, Joerg F.			Concomitant Interferon Alpha Stimulation and TLR3 Activation Induces Neuronal Expression of Depression-Related Genes That Are Elevated in the Brain of Suicidal Persons	PLOS ONE			English	Article							HEPATITIS-C VIRUS; TOLL-LIKE RECEPTOR-3; PLUS RIBAVIRIN; HIPPOCAMPAL NEUROGENESIS; PEGINTERFERON ALPHA-2A; MAJOR DEPRESSION; PLASMA-LEVELS; INFLAMMATION; STRESS; CELLS	We have previously identified 15 genes that are associated with the development of severe depressive side effects during the standard therapy with interferon alpha and ribavirin in the peripheral blood of hepatitis C virus infected patients. An enhanced expression of these genes was also found in the blood of psychiatric patients suffering severe depressive episode. Herein, we demonstrate that the same depression-related interferon-inducible genes (DRIIs) are also upregulated in postmortem brains of suicidal individuals. Using cultured mouse hippocampal and prefrontal neurons we show that costimulation with murine IFN (mIFN) and the TLR3 agonist poly(I: C) promotes the expression of the described DRIIs, at the same time inducing pro-inflammatory cytokine expression through Stat1 and Stat3 activation, promoting neuronal apoptosis. Consequently, the upregulation of selective DRIIs, production of inflammatory cytokines and inhibition of neuronal plasticity may be involved in the pathogenesis of IFN-associated depression.	[Hoyo-Becerra, Carolina; Huebener, Anastasia; Trippler, Martin; Lutterbeck, Melanie; Gerken, Guido; Schlaak, Joerg F.] Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany; [Truebner, Kurt; Bajanowski, Thomas] Univ Hosp Essen, Inst Forens Med, Essen, Germany; [Hermann, Dirk M.] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Liu, Zijian J.] Huazhong Univ Sci & Technol, Tongji Med Coll Huazhong, Dept Anat, Wuhan 430074, Peoples R China	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Huazhong University of Science & Technology	Schlaak, JF (corresponding author), Univ Hosp Essen, Dept Gastroenterol & Hepatol, Essen, Germany.	joerg.schlaak@uni-due.de	Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk/GZB-9350-2022	Hermann, Dirk M./0000-0003-0198-3152; 	Deutsche Forschungsgemeinschaft [SCHL377/2-2, SCHL377/6-2, TRR60]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Jorg F Schlaak was supported by the Deutsche Forschungsgemeinschaft (SCHL377/2-2 & 6-2, TRR60). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 2003, J NEUROSCI, V23, P5295; Basterzi AD, 2005, HUM PSYCHOPHARM CLIN, V20, P473, DOI 10.1002/hup.717; Blugeot A, 2011, J NEUROSCI, V31, P12889, DOI 10.1523/JNEUROSCI.1309-11.2011; Broering R, 2008, J HEPATOL, V48, P914, DOI 10.1016/j.jhep.2008.01.028; Chuang JH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-65; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Felger JC, 2007, BIOL PSYCHIAT, V62, P1324, DOI 10.1016/j.biopsych.2007.05.026; Feng PF, 2003, BRAIN RES, V991, P195, DOI 10.1016/j.brainres.2003.08.018; Fishman SL, 2008, J INFECT DIS, V197, P597, DOI 10.1086/526519; Fossati P, 2004, EUR NEUROPSYCHOPHARM, V14, pS503, DOI 10.1016/j.euroneuro.2004.09.001; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Girotti M, 2011, PSYCHONEUROENDOCRINO, V36, P1164, DOI 10.1016/j.psyneuen.2011.02.008; Grassi-Oliveira R, 2009, PSYCHIAT CLIN NEUROS, V63, P202, DOI 10.1111/j.1440-1819.2008.01918.x; Harwood D, 2001, INT J GERIATR PSYCH, V16, P155, DOI 10.1002/1099-1166(200102)16:2<155::AID-GPS289>3.0.CO;2-0; Hayley S, 2005, NEUROSCIENCE, V135, P659, DOI 10.1016/j.neuroscience.2005.03.051; HENRIKSSON MM, 1993, AM J PSYCHIAT, V150, P935; Hiles SA, 2012, BRAIN BEHAV IMMUN, V26, P1180, DOI 10.1016/j.bbi.2012.06.001; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Huang CC, 2006, PHYSIOL GENOMICS, V26, P125, DOI 10.1152/physiolgenomics.00002.2006; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; HUBER C, 1983, J IMMUNOL, V130, P1047; Jun HC, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/854285; Kamata M, 2000, EUR NEUROPSYCHOPHARM, V10, P129, DOI 10.1016/S0924-977X(99)00067-X; Keefe Brian, 2007, Curr Psychiatry Rep, V9, P255, DOI 10.1007/s11920-007-0028-4; Kim H, 2008, IMMUNOLOGY, V124, P480, DOI 10.1111/j.1365-2567.2007.02799.x; Kitagami T, 2003, BRAIN RES, V978, P104, DOI 10.1016/S0006-8993(03)02776-8; Kubera M, 2000, POL J PHARMACOL, V52, P237; Kumar M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-73; Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Loftis JM, 2008, NEUROSCI LETT, V430, P264, DOI 10.1016/j.neulet.2007.11.001; Lorenzl S, 2008, INT PSYCHOGERIATR, V20, P67, DOI 10.1017/S1041610207005790; Lotrich Francis E, 2005, Neuropsychiatr Dis Treat, V1, P17, DOI 10.2147/nedt.1.1.17.52301; Lucassen Paul J., 2006, CNS & Neurological Disorders-Drug Targets, V5, P531, DOI 10.2174/187152706778559273; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006; Monaco S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/236148; Monje FJ, 2011, J NEUROSCI, V31, P9075, DOI 10.1523/JNEUROSCI.1537-11.2011; Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008; Morikawa O, 1998, EUR J PHARMACOL, V349, P317, DOI 10.1016/S0014-2999(98)00187-3; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; O'Donovan A, 2013, DEPRESS ANXIETY, V30, P307, DOI 10.1002/da.22087; Okulski P, 2007, BIOL PSYCHIAT, V62, P359, DOI 10.1016/j.biopsych.2006.09.012; Orsal AS, 2008, NEUROPSYCHOBIOLOGY, V58, P211, DOI 10.1159/000201718; Oxenkrug G, 2011, AGING DIS, V2, P474; Ping FF, 2012, NEUROSCI LETT, V514, P173, DOI 10.1016/j.neulet.2012.02.087; Radkowski M, 2002, J VIROL, V76, P600, DOI 10.1128/JVI.76.2.600-608.2002; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raison CL, 2005, J CLIN PSYCHIAT, V66, P41, DOI 10.4088/JCP.v66n0106; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; RONDEAU E, 1990, CLIN NEPHROL, V33, P55; Schlaak JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038668; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; TALLEY R, 1983, AM J CLIN ONCOL-CANC, V6, P369, DOI 10.1097/00000421-198306000-00019; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009.0959; Thirumangalakudi L, 2006, J ALZHEIMERS DIS, V10, P111; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Todorovic C, 2009, NEUROPSYCHOPHARMACOL, V34, P1416, DOI 10.1038/npp.2008.178; Turbic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025406; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; Wichers MC, 2007, J PSYCHOSOM RES, V62, P207, DOI 10.1016/j.jpsychores.2006.09.007; Wilkinson J, 2010, GUT, V59, P1394, DOI 10.1136/gut.2009.199356; Wilkinson J, 2009, J VIROL, V83, P1312, DOI 10.1128/JVI.01890-08; Yang EV, 2002, J NEUROIMMUNOL, V133, P144, DOI 10.1016/S0165-5728(02)00270-9; Yu ML, 2006, ANTIVIR THER, V11, P1015; Zhao LJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-157; Zhao SH, 2010, CLIN THER, V32, P1565, DOI 10.1016/j.clinthera.2010.08.009	73	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83149	10.1371/journal.pone.0083149	http://dx.doi.org/10.1371/journal.pone.0083149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391741	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200038
J	Jeong, J; Park, YU; Kim, DK; Lee, S; Kwak, Y; Lee, SA; Lee, H; Suh, YH; Gho, YS; Hwang, D; Park, SK				Jeong, Jaehoon; Park, Young-Un; Kim, Dae-Kyum; Lee, Saebom; Kwak, Yongdo; Lee, Seol-Ae; Lee, Haeryun; Suh, Yoo-Hun; Gho, Yong Song; Hwang, Daehee; Park, Sang Ki			Cdk5 Phosphorylates Dopamine D2 Receptor and Attenuates Downstream Signaling	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; NUCLEUS-ACCUMBENS; CORTICAL-NEURONS; DENDRITIC SPINES; COCAINE REWARD; NMDA RECEPTORS; BETA-CATENIN; BINDING; MORPHOLOGY; BRAIN	The dopamine D2 receptor (DRD2) is a key receptor that mediates dopamine-associated brain functions such as mood, reward, and emotion. Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase whose function has been implicated in the brain reward circuit. In this study, we revealed that the serine 321 residue (S321) in the third intracellular loop of DRD2 (D2i3) is a novel regulatory site of Cdk5. Cdk5-dependent phosphorylation of S321 in the D2i3 was observed in in vitro and cell culture systems. We further observed that the phosphorylation of S321 impaired the agonist-stimulated surface expression of DRD2 and decreased G protein coupling to DRD2. Moreover, the downstream cAMP pathway was affected in the heterologous system and in primary neuronal cultures from p35 knockout embryos likely due to the reduced inhibitory activity of DRD2. These results indicate that Cdk5-mediated phosphorylation of S321 inhibits DRD2 function, providing a novel regulatory mechanism for dopamine signaling.	[Jeong, Jaehoon; Park, Young-Un; Kim, Dae-Kyum; Lee, Saebom; Kwak, Yongdo; Lee, Seol-Ae; Gho, Yong Song; Park, Sang Ki] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Hwang, Daehee] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Lee, Haeryun] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Suh, Yoo-Hun] Korea Brain Res Inst, Taegu, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Korea Brain Research Institute (KBRI)	Park, SK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea.	skpark@postech.ac.kr		Kim, Dae-Kyum/0000-0003-4568-8278	Korean government (MSIP) [NRF-2012R1A2A2A01012923, NRF-2012R1A4A1028200]; framework of international cooperation program [2012K2A1A2033117]; Korea Brain Research Institute (KBRI) Basic Research Program of MSIP [2031-415]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Awards	Korean government (MSIP); framework of international cooperation program; Korea Brain Research Institute (KBRI) Basic Research Program of MSIP; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Awards	This work was supported by the grants (NRF-2012R1A2A2A01012923 and NRF-2012R1A4A1028200) from the Korean government (MSIP) and also supported under the framework of international cooperation program managed by NRF of Korea (2012K2A1A2033117) and the Korea Brain Research Institute (KBRI) Basic Research Program of MSIP (2031-415). SKP was a recipient of the 2004 and 2006 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2008, INT J NEUROPSYCHOPH, V11, P197, DOI 10.1017/S1461145707007948; Benavides DR, 2007, J NEUROSCI, V27, P12967, DOI 10.1523/JNEUROSCI.4061-07.2007; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; Cho D, 2010, MOL ENDOCRINOL, V24, P574, DOI 10.1210/me.2009-0369; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Fu AKY, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4617; Gardner B, 1998, BRIT J PHARMACOL, V124, P978, DOI 10.1038/sj.bjp.0701926; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Kesavapany S, 2001, EUR J NEUROSCI, V13, P241, DOI 10.1046/j.1460-9568.2001.01376.x; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045618; Li M, 2000, MOL PHARMACOL, V57, P446, DOI 10.1124/mol.57.3.446; LIST SJ, 1981, P NATL ACAD SCI-BIOL, V78, P2620, DOI 10.1073/pnas.78.4.2620; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Meyer DA, 2008, P NATL ACAD SCI USA, V105, P18561, DOI 10.1073/pnas.0806078105; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; NG GYK, 1994, J NEUROCHEM, V63, P1589; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohshima T, 2001, P NATL ACAD SCI USA, V98, P2764, DOI 10.1073/pnas.051628498; Park SK, 2005, CELL, V122, P275, DOI 10.1016/j.cell.2005.05.031; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; READER TA, 1992, NEUROCHEM RES, V17, P749, DOI 10.1007/BF00969008; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 1997, J NEUROSCI, V17, P8491; Seeman P, 2003, SYNAPSE, V49, P209, DOI 10.1002/syn.10232; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; VOLKOW ND, 1990, AM J PSYCHIAT, V147, P719; Waldhoer M, 1998, MOL PHARMACOL, V53, P808; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wong ASL, 2011, NAT CELL BIOL, V13, P568, DOI 10.1038/ncb2217; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008	49	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84482	10.1371/journal.pone.0084482	http://dx.doi.org/10.1371/journal.pone.0084482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391960	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900103
J	Jo, YH; Patnaik, BB; Kang, SW; Chae, SH; Oh, S; Kim, DH; Noh, MY; Seo, GW; Jeong, HC; Noh, JY; Jeong, JE; Hwang, HJ; Ko, K; Han, YS; Lee, YS				Jo, Yong Hun; Patnaik, Bharat Bhusan; Kang, Se Won; Chae, Sung-Hwa; Oh, Seunghan; Kim, Dong Hyun; Noh, Mi Young; Seo, Gi Won; Jeong, Heon Cheon; Noh, Ju Young; Jeong, Ji Eun; Hwang, Hee Ju; Ko, Kisung; Han, Yeon Soo; Lee, Yong Seok			Analysis of the Genome of a Korean Isolate of the Pieris rapae Granulovirus Enabled by Its Separation from Total Host Genomic DNA by Pulse-Field Electrophoresis	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; ENVELOPE FUSION PROTEIN; LATE GENE-EXPRESSION; SINGLE NUCLEOCAPSID NUCLEOPOLYHEDROVIRUS; BOMBYX-MORI NUCLEOPOLYHEDROVIRUS; OPEN READING FRAMES; SEQUENCE-ANALYSIS; FOSMID LIBRARY; HELICOVERPA-ARMIGERA; MOLECULAR-IDENTIFICATION	Background: Most traditional genome sequencing projects involving viruses include the culture and purification of the virus particles. However, purification of virions may yield insufficient material for traditional sequencing. The electrophoretic method described here provides a strategy whereby the genomic DNA of the Korean isolate of Pieris rapae granulovirus (PiraGV-K) could be recovered in sufficient amounts for sequencing by purifying it directly from total host DNA by pulse-field gel electrophoresis (PFGE). Methodology/Principal Findings: The total genomic DNA of infected P. rapae was embedded in agarose plugs, treated with restriction nuclease and methylase, and then PFGE was used to separate PiraGV-K DNA from the DNA of P. rapae, followed by mapping of fosmid clones of the purified viral DNA. The double-stranded circular genome of PiraGV-K was found to encode 120 open reading frames (ORFs), which covered 92% of the sequence. BLAST and ORF arrangement showed the presence of 78 homologs to other genes in the database. The mean overall amino acid identity of PiraGV-K ORFs was highest with the Chinese isolate of PiraGV (similar to 99%), followed up with Choristoneura occidentalis ORFs at 58%. PiraGV-K ORFs were grouped, according to function, into 10 genes involved in transcription, 11 involved in replication, 25 structural protein genes, and 15 auxiliary genes. Genes for Chitinase (ORF 10) and cathepsin (ORF 11), involved in the liquefaction of the host, were found in the genome. Conclusions/Significance: The recovery of PiraGV-K DNA genome by pulse-field electrophoretic separation from host genomic DNA had several advantages, compared with its isolation from particles harvested as virions or inclusions from the P. rapae host. We have sequenced and analyzed the 108,658 bp PiraGV-K genome purified by the electrophoretic method. The method appears to be generally applicable to the analysis of genomes of large viruses.	[Kang, Se Won; Jeong, Ji Eun; Hwang, Hee Ju; Lee, Yong Seok] Soonchunhyang Univ, Coll Nat Sci, Dept Life Sci & Biotechnol, Asan, South Korea; [Jo, Yong Hun; Patnaik, Bharat Bhusan; Oh, Seunghan; Kim, Dong Hyun; Noh, Mi Young; Seo, Gi Won; Han, Yeon Soo] Chonnam Natl Univ, Coll Agr & Life Sci, Div Plant Biotechnol, Kwangju, South Korea; [Jeong, Heon Cheon; Noh, Ju Young] Hampyeong Cty Agr Technol Ctr, Hampyeong Cty Insect Inst, Hampyeong, South Korea; [Ko, Kisung] Chung Ang Univ, Coll Med, Med Res Inst, Dept Med, Seoul 156756, South Korea; [Chae, Sung-Hwa] GnC Bio Co Ltd, Taejon, South Korea	Soonchunhyang University; Chonnam National University; Chung Ang University; Chung Ang University Hospital	Lee, YS (corresponding author), Soonchunhyang Univ, Coll Nat Sci, Dept Life Sci & Biotechnol, Asan, South Korea.	yslee@sch.ac.kr	LEE, YONGSEOK/AAF-3965-2020; Patnaik, Bharat Bhusan/CAG-0338-2022; Patnaik, Bharat Bhusan/H-2973-2019	Patnaik, Bharat Bhusan/0000-0003-1383-6758; Patnaik, Bharat Bhusan/0000-0003-1383-6758; Lee, Yongseok/0000-0002-8687-589X	NRF; MEST [2010-0027694]	NRF; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by Mid-career researcher program through NRF grant funded by the MEST (No. 2010-0027694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2001, J VIROL, V75, P11157, DOI 10.1128/JVI.75.22.11157-11165.2001; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Ariyadasa R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/184854; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Bocs S, 2003, NUCLEIC ACIDS RES, V31, P3723, DOI 10.1093/nar/gkg590; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Chen XW, 2001, J GEN VIROL, V82, P241, DOI 10.1099/0022-1317-82-1-241; Coupland P, 2012, BIOTECHNIQUES, V53, P365, DOI 10.2144/000113962; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Dall D, 2001, BIOESSAYS, V23, P184, DOI 10.1002/1521-1878(200102)23:2&lt;184::AID-BIES1026&gt;3.0.CO;2-H; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DONOFRIO G, 1991, J MOL EVOL, V32, P504, DOI 10.1007/BF02102652; Escasa SR, 2006, J GEN VIROL, V87, P1917, DOI 10.1099/vir.0.81792-0; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005; Friesen PD, 1997, BACULOVIRUSES, P141; Garcia-Maruniak A, 2004, J VIROL, V78, P7036, DOI 10.1128/JVI.78.13.7036-7051.2004; Gomi S, 1997, VIROLOGY, V230, P35, DOI 10.1006/viro.1997.8457; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Harrison RL, 2008, VIRUS GENES, V36, P565, DOI 10.1007/s11262-008-0218-0; Hashimoto Y, 2000, VIROLOGY, V275, P358, DOI 10.1006/viro.2000.0530; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Hayakawa T, 2000, VIROLOGY, V278, P1, DOI 10.1006/viro.2000.0668; Hilton S, 2008, J GEN VIROL, V89, P2898, DOI 10.1099/vir.0.2008/002881-0; Huang SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-242; Hyink O, 2002, J GEN VIROL, V83, P957, DOI 10.1099/0022-1317-83-4-957; IJkel WFJ, 2000, VIROLOGY, V275, P30, DOI 10.1006/viro.2000.0483; Jehle JA, 2006, VIROLOGY, V346, P180, DOI 10.1016/j.virol.2005.10.032; Jiang HB, 2009, INSECT BIOCHEM MOLEC, V39, P646, DOI 10.1016/j.ibmb.2009.07.002; JUKES TH, 1986, J MOL EVOL, V24, P39, DOI 10.1007/BF02099949; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; Kim CG, 2003, GENOMICS, V82, P571, DOI 10.1016/S0888-7543(03)00174-5; Ko R, 2000, J VIROL, V74, P11240, DOI 10.1128/JVI.74.23.11240-11246.2000; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lange M, 2004, VIROLOGY, V325, P36, DOI 10.1016/j.virol.2004.04.023; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Lauzon HAM, 2006, J GEN VIROL, V87, P1477, DOI 10.1099/vir.0.81727-0; LEISY DJ, 1995, VIROLOGY, V208, P742, DOI 10.1006/viro.1995.1206; Li LL, 2002, VIROLOGY, V297, P226, DOI 10.1006/viro.2002.1411; Li QJ, 2002, VIROLOGY, V294, P106, DOI 10.1006/viro.2001.1313; Lu A, 1997, BACULOVIRUSES, P193; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Meyer JDF, 2008, MOL GENET GENOMICS, V279, P473, DOI 10.1007/s00438-008-0326-5; Mizutani T, 2007, EMERG INFECT DIS, V13, P322, DOI 10.3201/eid1302.061032; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; MORRIS TD, 1994, VIROLOGY, V200, P360; Moser BA, 2001, J GEN VIROL, V82, P283, DOI 10.1099/0022-1317-82-2-283; Mount DW, 2001, BIOINFORMATICS SEQUE, P308; Ninomiya M, 2012, J CLIN MICROBIOL, V50, P857, DOI 10.1128/JCM.05715-11; Oh S, 2013, ARCH VIROL, V158, P1701, DOI 10.1007/s00705-013-1649-z; Oh S, 2013, J INVERTEBR PATHOL, V113, P7, DOI 10.1016/j.jip.2012.12.003; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; Park TH, 2011, J GENET GENOMICS, V38, P47, DOI 10.1016/j.jcg.2010.12.002; Pearson MN, 2000, J VIROL, V74, P6126, DOI 10.1128/JVI.74.13.6126-6131.2000; Pearson MN, 1998, J VIROL, V72, P9142, DOI 10.1128/JVI.72.11.9142-9149.1998; Rapp JC, 1998, J VIROL, V72, P10197, DOI 10.1128/JVI.72.12.10197-10206.1998; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Song JJ, 2008, J GEN VIROL, V89, P2331, DOI 10.1099/vir.0.2008/002352-0; TOMALSKI MD, 1991, VIROLOGY, V184, P149, DOI 10.1016/0042-6822(91)90831-U; VanOers MM, 1997, J INVERTEBR PATHOL, V70, P1, DOI 10.1006/jipa.1997.4675; Vucic D, 1997, P NATL ACAD SCI USA, V94, P10183, DOI 10.1073/pnas.94.19.10183; Wan HH, 2000, COMPUT CHEM, V24, P71, DOI 10.1016/S0097-8485(99)00048-0; Wang P, 1998, J INVERTEBR PATHOL, V72, P57, DOI 10.1006/jipa.1998.4759; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wang XF, 2011, J PROTEOME RES, V10, P2817, DOI 10.1021/pr2000804; Wang Y, 2011, NEURAL REGEN RES, V6, P6, DOI 10.3969/j.issn.1673-5374.2011.01.001; WINSTANLEY D, 1993, J GEN VIROL, V74, P1599, DOI 10.1099/0022-1317-74-8-1599; WOLGAMOT GM, 1993, J GEN VIROL, V74, P103, DOI 10.1099/0022-1317-74-1-103; Wormleaton S, 2003, VIROLOGY, V311, P350, DOI 10.1016/S0042-6822(03)00149-1; Xiang XW, 2011, VIRUS RES, V155, P69, DOI 10.1016/j.virusres.2010.08.024; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang BQ, 2012, J VIROL, V86, P9544, DOI 10.1128/JVI.01431-12	77	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84183	10.1371/journal.pone.0084183	http://dx.doi.org/10.1371/journal.pone.0084183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391907	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900050
J	Li, WY; Sun, S; Chen, Y; Yu, HQ; Chen, ZY; Li, HW				Li, Wenyan; Sun, Shan; Chen, Yan; Yu, Huiqian; Chen, Zheng-Yi; Li, Huawei			Disrupting the Interaction between Retinoblastoma Protein and Raf-1 Leads to Defects in Progenitor Cell Proliferation and Survival during Early Inner Ear Development	PLOS ONE			English	Article							RB-RAF-1 INTERACTION; SENSORY EPITHELIA; POCKET PROTEINS; CYCLE CONTROL; HAIR-CELLS; STEM-CELLS; IN-VIVO; CANCER; ANGIOGENESIS; INACTIVATION	The retinoblastoma protein (pRb) is required for cell-cycle exit of embryonic mammalian hair cells but is not required for hair cell fate determination and early differentiation, and this provides a strategy for hair cell regeneration by manipulating the pRb pathway. To reveal the mechanism of pRb functional modification in the inner ear, we compared the effects of attenuated pRb phosphorylation by an inhibitor of the Mitogen-Activated Protein (MAP) kinase pathway and an inhibitor of the Rb-Raf-1 interaction on cultured chicken otocysts. We demonstrated that the activity of pRb is correlated with its phosphorylation state, which is regulated by a newly established cell cycle-independent pathway mediated by the physical interaction between Raf-1 and pRb. The phosphorylation of pRb plays an important role during the early stage of inner ear development, and attenuated phosphorylation in progenitor cells leads to cell cycle arrest and increased apoptosis along with a global down-regulation of the genes involved in cell cycle progression. Our study provides novel routes to modulate pRb function for hair cell regeneration.	[Li, Wenyan; Yu, Huiqian] Fudan Univ, Dept Otorhinolaryngol, Affiliated Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Sun, Shan; Chen, Yan] Fudan Univ, Res Ctr, Affiliated Eye & ENT Hosp, Shanghai 200433, Peoples R China; [Li, Huawei] Fudan Univ, Inst Stem Cell & Regenerat Med, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Li, Huawei] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Li, Wenyan; Chen, Zheng-Yi] Harvard Univ, Sch Med, Dept Otolaryngol, Boston, MA 02115 USA; [Li, Wenyan; Chen, Zheng-Yi] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Li, Wenyan; Chen, Zheng-Yi] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA	Fudan University; Fudan University; Fudan University; Fudan University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Li, HW (corresponding author), Fudan Univ, Inst Stem Cell & Regenerat Med, Inst Biomed Sci, Shanghai 200433, Peoples R China.	lihuawei63@gmail.com	Sun, Shan/GLR-2365-2022	Sun, Shan/0000-0003-2142-4307; Li, Wenyan/0000-0001-9575-7812	Major State Basic Research Development Program of China (973 Program) [2011CB504506, 2010CB945503]; National Natural Science Foundation of China [81230019, 81070793, 30901668]; Program for Changjiang Scholars and Innovative Research Team in Universities [IRT1010]; Medical Guiding Fund of the Science and Technology Commission of Shanghai Municipality [10411962100]; Program of Outstanding Shanghai Academic Leaders [11XD1401300]; Specialized Research Fund for the Doctor Program of Higher Education [20120071110077]; Shanghai Rising-Star Program [12QA1400500]; Program of Leading Medical Personnel in Shanghai; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006908] Funding Source: NIH RePORTER	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Medical Guiding Fund of the Science and Technology Commission of Shanghai Municipality; Program of Outstanding Shanghai Academic Leaders; Specialized Research Fund for the Doctor Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Rising-Star Program; Program of Leading Medical Personnel in Shanghai; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program) (2011CB504506, 2010CB945503), the National Natural Science Foundation of China (No. 81230019, 81070793, 30901668), the Program for Changjiang Scholars and Innovative Research Team in Universities (IRT1010), the Medical Guiding Fund of the Science and Technology Commission of Shanghai Municipality (10411962100), the Program of Outstanding Shanghai Academic Leaders (11XD1401300), the Specialized Research Fund for the Doctor Program of Higher Education (20120071110077), the Shanghai Rising-Star Program (12QA1400500) and the Program of Leading Medical Personnel in Shanghai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Dasgupta P, 2004, MOL CELL BIOL, V24, P9527, DOI 10.1128/MCB.24.21.9527-9541.2004; Davis RK, 2008, DRUG NEWS PERSPECT, V21, P331, DOI 10.1358/dnp.2008.21.6.1246832; Di Fiore R, 2013, J CELL PHYSIOL, V228, P1676, DOI 10.1002/jcp.24329; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Hamburger V, 1992, SERIES NORMAL STAGES; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kinkade R, 2008, CANCER RES, V68, P3810, DOI 10.1158/0008-5472.CAN-07-6672; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; Lang HN, 2000, J COMP NEUROL, V417, P205, DOI 10.1002/(SICI)1096-9861(20000207)417:2<205::AID-CNE6>3.0.CO;2-Y; Li HW, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-16; Li HW, 2004, J NEUROBIOL, V60, P61, DOI 10.1002/neu.20013; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Lin Q, 2013, NEUROREPORT, V24, P190, DOI 10.1097/WNR.0b013e32835e3279; Loponen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027360; Lu N, 2013, BIOCHEM BIOPH RES CO, V430, P700, DOI 10.1016/j.bbrc.2012.11.088; Magarinos M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014435; Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616; Sage C, 2005, SCIENCE, V307, P1114, DOI 10.1126/science.1106642; Sage C, 2006, P NATL ACAD SCI USA, V103, P7345, DOI 10.1073/pnas.0510631103; Shukla S, 2007, CELL CYCLE, V6, P1102, DOI 10.4161/cc.6.9.4146; Singh S, 2010, MOL CANCER THER, V9, P3330, DOI 10.1158/1535-7163.MCT-10-0442; Stengel KR, 2009, J BIOL CHEM, V284, P19265, DOI 10.1074/jbc.M808740200; SWANSON GJ, 1990, DEV BIOL, V137, P243, DOI 10.1016/0012-1606(90)90251-D; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; Weber T, 2008, P NATL ACAD SCI USA, V105, P781, DOI 10.1073/pnas.0708061105; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yu YL, 2010, J NEUROSCI, V30, P5927, DOI 10.1523/JNEUROSCI.5989-09.2010	29	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83726	10.1371/journal.pone.0083726	http://dx.doi.org/10.1371/journal.pone.0083726			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391814	Green Published, gold, Green Submitted			2022-12-27	WOS:000329325200112
J	Li, XB; Luo, J; Yan, TL; Xiang, L; Jin, F; Qin, DH; Sun, CB; Xie, M				Li, Xiaobai; Luo, Jie; Yan, Tianlian; Xiang, Lin; Jin, Feng; Qin, Dehui; Sun, Chongbo; Xie, Ming			Deep Sequencing-Based Analysis of the Cymbidium ensifolium Floral Transcriptome	PLOS ONE			English	Article							EST-SSR MARKERS; GENIC MICROSATELLITE MARKERS; MADS-BOX GENES; HEVEA-BRASILIENSIS; FLOWERING TIME; SNP DISCOVERY; GIBBERELLIN 3-BETA-HYDROXYLASE; FUNCTIONAL-ANALYSIS; EXPRESSED GENES; ORCHID	Cymbidium ensifolium is a Chinese Cymbidium with an elegant shape, beautiful appearance, and a fragrant aroma. C. ensifolium has a long history of cultivation in China and it has excellent commercial value as a potted plant and cut flower. The development of C. ensifolium genomic resources has been delayed because of its large genome size. Taking advantage of technical and cost improvement of RNA-Seq, we extracted total mRNA from flower buds and mature flowers and obtained a total of 9.52 Gb of filtered nucleotides comprising 98,819,349 filtered reads. The filtered reads were assembled into 101,423 isotigs, representing 51,696 genes. Of the 101,423 isotigs, 41,873 were putative homologs of annotated sequences in the public databases, of which 158 were associated with floral development and 119 were associated with flowering. The isotigs were categorized according to their putative functions. In total, 10,212 of the isotigs were assigned into 25 eukaryotic orthologous groups (KOGs), 41,690 into 58 gene ontology (GO) terms, and 9,830 into 126 Arabidopsis Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, and 9,539 isotigs into 123 rice pathways. Comparison of the isotigs with those of the two related orchid species P. equestris and C. sinense showed that 17,906 isotigs are unique to C. ensifolium. In addition, a total of 7,936 SSRs and 16,676 putative SNPs were identified. To our knowledge, this transcriptome database is the first major genomic resource for C. ensifolium and the most comprehensive transcriptomic resource for genus Cymbidium. These sequences provide valuable information for understanding the molecular mechanisms of floral development and flowering. Sequences predicted to be unique to C. ensifolium would provide more insights into C. ensifolium gene diversity. The numerous SNPs and SSRs identified in the present study will contribute to marker development for C. ensifolium.	[Li, Xiaobai; Luo, Jie; Xiang, Lin; Qin, Dehui; Sun, Chongbo; Xie, Ming] Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China; [Yan, Tianlian] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Feng] Hubei Univ, Coll Life Sci, Wuhan, Peoples R China	Zhejiang Academy of Agricultural Sciences; Zhejiang University; Hubei University	Xie, M (corresponding author), Zhejiang Acad Agr Sci, Inst Hort, Hangzhou, Zhejiang, Peoples R China.	Xieming1957@yahoo.com.cn	Li, Xiaobai/AAB-7604-2021	Li, Xiaobai/0000-0001-9615-3543	National Basic Research Program; Nature Science Foundation of China [31201648]; Postdoctoral Science Foundation of China [2012M521203]; Special Postdoctoral Science Foundation of China [2013T60607]; Foundation for Selected Postdoctoral project of Zhejiang [Bsh1201032]; Qianjiang talents project [2013R10081]; Scientific and technical innovation promotion project of ZAAS [2012R05Y01E04]; New Variety of Flowers Breeding Group Project of Zhejiang Province [2012C12909-10]	National Basic Research Program(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Special Postdoctoral Science Foundation of China; Foundation for Selected Postdoctoral project of Zhejiang; Qianjiang talents project; Scientific and technical innovation promotion project of ZAAS; New Variety of Flowers Breeding Group Project of Zhejiang Province	This research was supported by the National Basic Research Program funded by the Nature Science Foundation of China (No. 31201648), the Postdoctoral Science Foundation of China (No. 2012M521203), the Special Postdoctoral Science Foundation of China (No. 2013T60607), and the Foundation for Selected Postdoctoral project of Zhejiang (Bsh1201032), the Qianjiang talents project (No. 2013R10081), Scientific and technical innovation promotion project of ZAAS (2012R05Y01E04) and the New Variety of Flowers Breeding Group Project of Zhejiang Province (No. 2012C12909-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; An Ze-Wei, 2009, Yichuan, V31, P311, DOI 10.3724/SP.J.1005.2009.00311; Andersen JR, 2005, THEOR APPL GENET, V111, P206, DOI 10.1007/s00122-005-1996-6; Bao JS, 2002, THEOR APPL GENET, V105, P898, DOI 10.1007/s00122-002-1049-3; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Bus VGM, 2005, MOL BREEDING, V15, P103, DOI 10.1007/s11032-004-3609-5; Chagne D, 2008, GENOMICS, V92, P353, DOI 10.1016/j.ygeno.2008.07.008; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Chen MK, 2011, PLANT J, V68, P168, DOI 10.1111/j.1365-313X.2011.04677.x; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cloutier S, 2009, THEOR APPL GENET, V119, P53, DOI 10.1007/s00122-009-1016-3; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa F, 2005, EUPHYTICA, V141, P181, DOI 10.1007/s10681-005-6805-4; Dresselhaus T, 1999, MOL GEN GENET, V261, P416, DOI 10.1007/s004380050983; DUPUY D, 2007, GENUS CYMBIDIUM KEW; EMRICH SJ, 2006, GENOME RES, V16, P1; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fan SH, 2003, PROG BIOCHEM BIOPHYS, V30, P221; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Fukai S, 2002, HORTSCIENCE, V37, P1088, DOI 10.21273/HORTSCI.37.7.1088; Gao LF, 2004, THEOR APPL GENET, V108, P1392, DOI 10.1007/s00122-003-1554-z; Gao ZS, 2005, THEOR APPL GENET, V111, P171, DOI 10.1007/s00122-005-2018-4; Glover B.J., 2007, UNDERSTANDING FLOWER; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Gorniak M, 2010, MOL PHYLOGENET EVOL, V56, P784, DOI 10.1016/j.ympev.2010.03.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gur-Arie R, 2000, GENOME RES, V10, P62; Hsiao YY, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-14; Hsiao YY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-360; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Itoh H, 1999, PLANT J, V20, P15, DOI 10.1046/j.1365-313X.1999.00568.x; Itoh H, 2001, P NATL ACAD SCI USA, V98, P8909, DOI 10.1073/pnas.141239398; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Komeda Y, 2004, ANNU REV PLANT BIOL, V55, P521, DOI 10.1146/annurev.arplant.55.031903.141644; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Leitch IJ, 2009, ANN BOT-LONDON, V104, P469, DOI 10.1093/aob/mcp003; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li F, 2009, DNA RES, V16, P311, DOI 10.1093/dnares/dsp020; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SS, 2007, MOL BREEDING, V20, P167, DOI 10.1007/s11032-007-9080-3; Li XiaoBai, 2006, Biodiversity Science, V14, P541, DOI 10.1360/biodiv.060148; LIU L, 2012, J BIOMED BIOTECHNOL, V11, P251; LIU ZJ, 2006, CHINESE CYMBIDIUM PL; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Martin C, 2002, PHILOS T ROY SOC B, V357, P809, DOI 10.1098/rstb.2002.1089; Metzger James D., 1995, P617; Mondragon-Palomino M, 2008, TRENDS PLANT SCI, V13, P51, DOI 10.1016/j.tplants.2007.11.007; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Mondragon-Palomino M, 2009, ANN BOT-LONDON, V104, P583, DOI 10.1093/aob/mcn258; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; NASH, 1996, ORCHIDS, V9, P972; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Peng JR, 2009, J INTEGR PLANT BIOL, V51, P1064, DOI 10.1111/j.1744-7909.2009.00881.x; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Ramchiary N, 2011, DNA RES, V18, P305, DOI 10.1093/dnares/dsr017; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rozen S, 2000, BIOINFORMATICS METHO; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sedeek KEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064621; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; SOOK J, 2005, FUNCT INTEGR GENOMIC, V5, P136, DOI DOI 10.1007/S10142-005-0139-0; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Tan J, 2005, BIOTECHNOL LETT, V27, P1517, DOI 10.1007/s10529-005-1468-8; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Teh SL, 2011, MOL BIOL REP, V38, P3903, DOI 10.1007/s11033-010-0506-3; Triwitayakorn K, 2011, DNA RES, V18, P471, DOI 10.1093/dnares/dsr034; Tsai WC, 2006, PLANT SCI, V170, P426, DOI 10.1016/j.plantsci.2005.08.029; Tsai WC, 2013, PLANT CELL PHYSIOL, V54, pE7, DOI 10.1093/pcp/pcs187; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang SY, 2011, PLANT CELL PHYSIOL, V52, P563, DOI 10.1093/pcp/pcr015; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; WU M, 2010, J COTTON SCI, V22, P387; XIANG I, 2011, ACTA HORTICULTURAE S, V38, P143; Xiang L, 2012, PLANT PHYSIOL BIOCH, V58, P98, DOI 10.1016/j.plaphy.2012.06.011; Xiang Lin, 2011, Acta Agriculturae Zhejiangensis, V23, P517; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90	96	41	43	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85480	10.1371/journal.pone.0085480	http://dx.doi.org/10.1371/journal.pone.0085480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24392013	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900157
J	Mi, JJ; Shaw, AE; Pak, CW; Walsh, KP; Minamide, LS; Bernstein, BW; Kuhn, TB; Bamburg, JR				Mi, Jianjie; Shaw, Alisa E.; Pak, Chi W.; Walsh, Keifer P.; Minamide, Laurie S.; Bernstein, Barbara W.; Kuhn, Thomas B.; Bamburg, James R.			A Genetically Encoded Reporter for Real-Time Imaging of Cofilin-Actin Rods in Living Neurons	PLOS ONE			English	Article							HIPPOCAMPAL-NEURONS; AMYLOID-BETA; DEPOLYMERIZING FACTOR; TRANSGENE EXPRESSION; ADF/COFILIN; PROTEIN; TRAFFICKING; OLIGOMERS; DEPENDS; DISEASE	Filament bundles (rods) of cofilin and actin (1:1) form in neurites of stressed neurons where they inhibit synaptic function. Live-cell imaging of rod formation is hampered by the fact that overexpression of a chimera of wild type cofilin with a fluorescent protein causes formation of spontaneous and persistent rods, which is exacerbated by the photostress of imaging. The study of rod induction in living cells calls for a rod reporter that does not cause spontaneous rods. From a study in which single cofilin surface residues were mutated, we identified a mutant, cofilinR21Q, which when fused with monomeric Red Fluorescent Protein (mRFP) and expressed several fold above endogenous cofilin, does not induce spontaneous rods even during the photostress of imaging. CofilinR21Q- mRFP only incorporates into rods when they form from endogenous proteins in stressed cells. In neurons, cofilinR21Q-mRFP reports on rods formed from endogenous cofilin and induced by all modes tested thus far. Rods have a half-life of 30-60 min upon removal of the inducer. Vesicle transport in neurites is arrested upon treatments that form rods and recovers as rods disappear. CofilinR21Q- mRFP is a genetically encoded rod reporter that is useful in live cell imaging studies of induced rod formation, including rod dynamics, and kinetics of rod elimination.	[Mi, Jianjie; Shaw, Alisa E.; Pak, Chi W.; Walsh, Keifer P.; Minamide, Laurie S.; Bernstein, Barbara W.; Kuhn, Thomas B.; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Mi, Jianjie; Shaw, Alisa E.; Pak, Chi W.; Walsh, Keifer P.; Minamide, Laurie S.; Bernstein, Barbara W.; Kuhn, Thomas B.; Bamburg, James R.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA; [Kuhn, Thomas B.] Univ Alaska, Dept Chem & Biochem, Fairbanks, AK 99701 USA	Colorado State University; Colorado State University; University of Alaska System; University of Alaska Fairbanks	Bamburg, JR (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	James.Bamburg@colostate.edu			Colorado State University Core Infrastructure Grant; National Institutes of Health [NS040371, AG044812]; National Science Foundation [DGE-0234615]; Colorado State University Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044812] Funding Source: NIH RePORTER	Colorado State University Core Infrastructure Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Colorado State University Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided in part from a Colorado State University Core Infrastructure Grant for supporting the Microscope Imaging Network (JRB), National Institutes of Health grants NS040371 and AG044812 (JRB), National Science Foundation predoctoral fellowship DGE-0234615 (CWP), and generous donations in support of research through the Colorado State University Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	ADAMS ME, 1990, BIOCHEMISTRY-US, V29, P7414, DOI 10.1021/bi00484a009; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Ashworth SL, 2003, AM J PHYSIOL-RENAL, V284, pF852, DOI 10.1152/ajprenal.00210.2002; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Bernstein BW, 2012, J NEUROSCI, V32, P6670, DOI 10.1523/JNEUROSCI.6020-11.2012; Bernstein BW, 2011, ADV NEUROBIOL, V5, P201, DOI 10.1007/978-1-4419-7368-9_11; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fan J, 2013, J MOL BIOL, V425, P1225, DOI 10.1016/j.jmb.2013.01.020; Fath T, 2011, EUR J CELL BIOL, V90, P291, DOI 10.1016/j.ejcb.2010.10.014; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Homma K, 2008, MOL CELL NEUROSCI, V37, P261, DOI 10.1016/j.mcn.2007.10.001; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Jang DH, 2005, P NATL ACAD SCI USA, V102, P16072, DOI 10.1073/pnas.0507675102; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Klejnot M, 2013, ACTA CRYSTALLOGR D, V69, P1780, DOI 10.1107/S0907444913014418; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; MATTSON MP, 1988, INT J DEV NEUROSCI, V6, P439, DOI 10.1016/0736-5748(88)90050-0; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Minamide LS, 2003, METHOD CELL BIOL, V71, P387, DOI 10.1016/S0091-679X(03)01019-7; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; Munsie LN, 2012, J CELL SCI, V125, P3977, DOI 10.1242/jcs.097667; Pal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063989; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; Wiggan ON, 2006, CELL SIGNAL, V18, P1501, DOI 10.1016/j.cellsig.2005.12.002; Wiggan O, 2012, DEV CELL, V22, P530, DOI 10.1016/j.devcel.2011.12.026	45	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83609	10.1371/journal.pone.0083609	http://dx.doi.org/10.1371/journal.pone.0083609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391794	Green Published, Green Submitted, gold			2022-12-27	WOS:000329325200091
J	Morina, N; Ehring, T; Priebe, S				Morina, Nexhmedin; Ehring, Thomas; Priebe, Stefan			Diagnostic Utility of the Impact of Event Scale-Revised in Two Samples of Survivors of War	PLOS ONE			English	Article							MENTAL-DISORDERS; PSYCHOMETRIC PROPERTIES; TESTS; INSTRUMENTS	The study aimed at examining the diagnostic utility of the Impact of Event Scale-Revised (IES-R) as a screening tool for post-traumatic stress disorder (PTSD) in survivors of war. The IES-R was completed by two independent samples that had survived the war in the Balkans: a sample of randomly selected people who had stayed in the area of former conflict (n = 3,313) and a sample of refugees to Western European countries (n = 854). PTSD was diagnosed using the MINI International Neuropsychiatric Interview. Prevalence of PTSD was 20.1% in the Balkan sample and 33.1% in the refugee sample. Results revealed that when considering a minimum value of specificity of 0.80, the optimally sensitive cut-off score for screening for PTSD in the Balkan sample was 34. In both the Balkan sample and the refugee sample, this cut-off score provided good values on sensitivity (0.86 and 0.89, respectively) and overall efficiency (0.81 and 0.79, respectively). Further, the kappa coefficients for sensitivity for the cut-off of 34 were 0.80 in both samples. Findings of this study support the clinical utility of the IES-R as a screening tool for PTSD in large-scale research studies and intervention studies if structured diagnostic interviews are regarded as too labor-intensive and too costly.	[Morina, Nexhmedin] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Ehring, Thomas] Univ Munster, Inst Psychol, Munster, Germany; [Priebe, Stefan] Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England	University of Amsterdam; University of Munster; University of London; Queen Mary University London	Priebe, S (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Unit Social & Community Psychiat, London, England.	s.priebe@qmul.ac.uk	Ehring, Thomas/C-9168-2009; Morina, Nexhmedin/D-4976-2012; Morina, Nexhmedin/AAK-7071-2021	Ehring, Thomas/0000-0001-9502-6868; Morina, Nexhmedin/0000-0002-2331-9140; Priebe, Stefan/0000-0001-9864-3394	European Commission [INCO-CT-2004-509175]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by a grant from the European Commission, contract number INCO-CT-2004-509175. The views expressed are those of the authors and not necessarily those of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogic M, 2012, BRIT J PSYCHIAT, V200, P216, DOI 10.1192/bjp.bp.110.084764; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Brown CD, 2006, CHEMOMETR INTELL LAB, V80, P24, DOI 10.1016/j.chemolab.2005.05.004; Coyne JC, 2000, APPL PREV PSYCHOL, V9, P101, DOI 10.1016/S0962-1849(00)80009-8; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Kagee A, 2013, INT HEALTH, V5, P11, DOI 10.1093/inthealth/ihs004; KRAEMER HC, 1987, PSYCHONEUROENDOCRINO, V12, P411, DOI 10.1016/0306-4530(87)90076-X; KRAEMER HC, 1992, EVALUATING MED TESTS; Ljubotina D., 2003, REV PSYCHOL, V10, P11; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Morina N, 2003, EUROPEAN SOC TRAUMAT, P7; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Priebe S, 2010, SOC SCI MED, V71, P2170, DOI 10.1016/j.socscimed.2010.09.029; Priebe S, 2010, ARCH GEN PSYCHIAT, V67, P518, DOI 10.1001/archgenpsychiatry.2010.37; Rash CJ, 2008, ADDICT BEHAV, V33, P1039, DOI 10.1016/j.addbeh.2008.04.006; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sveen J, 2010, J ANXIETY DISORD, V24, P618, DOI 10.1016/j.janxdis.2010.03.021; Weiss Daniel S., 1997, P399; Wolfe Jessica, 1997, P192	27	57	58	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83916	10.1371/journal.pone.0083916	http://dx.doi.org/10.1371/journal.pone.0083916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	284NF	24391844	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200142
J	Navarra, J; Fernandez-Prieto, I; Garcia-Morera, J				Navarra, Jordi; Fernandez-Prieto, Irune; Garcia-Morera, Joel			Realigning Thunder and Lightning: Temporal Adaptation to Spatiotemporally Distant Events	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; UNITY ASSUMPTION; VISUAL SPEECH; PERCEPTION; RECALIBRATION; EXPOSURE; ORDER; DETERMINANTS; SYNCHRONY; WINDOW	The brain is able to realign asynchronous signals that approximately coincide in both space and time. Given that many experience-based links between visual and auditory stimuli are established in the absence of spatiotemporal proximity, we investigated whether or not temporal realignment arises in these conditions. Participants received a 3-min exposure to visual and auditory stimuli that were separated by 706 ms and appeared either from the same (Experiment 1) or from different spatial positions (Experiment 2). A simultaneity judgment task (SJ) was administered right afterwards. Temporal realignment between vision and audition was observed, in both Experiment 1 and 2, when comparing the participants' SJs after this exposure phase with those obtained after a baseline exposure to audiovisual synchrony. However, this effect was present only when the visual stimuli preceded the auditory stimuli during the exposure to asynchrony. A similar pattern of results (temporal realignment after exposure to visual-leading asynchrony but not after exposure to auditory-leading asynchrony) was obtained using temporal order judgments (TOJs) instead of SJs (Experiment 3). Taken together, these results suggest that temporal recalibration still occurs for visual and auditory stimuli that fall clearly outside the so-called temporal window for multisensory integration and appear from different spatial positions. This temporal realignment may be modulated by long-term experience with the kind of asynchrony (vision-leading) that we most frequently encounter in the outside world (e. g., while perceiving distant events).	[Navarra, Jordi; Fernandez-Prieto, Irune; Garcia-Morera, Joel] Fundacio St Joan de Deu, Barcelona, Catalonia, Spain; [Navarra, Jordi; Fernandez-Prieto, Irune; Garcia-Morera, Joel] Fundacio St Joan de Deu, CIBERSAM, Barcelona, Catalonia, Spain; [Fernandez-Prieto, Irune] Univ Barcelona, IR3C, Barcelona, Catalonia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; University of Barcelona	Navarra, J (corresponding author), Fundacio St Joan de Deu, Parc Sanitari St Joan de Deu, Barcelona, Catalonia, Spain.	jnavarrao@fsjd.org	Fernandez Prieto, Irune/V-4251-2017; Navarra, Jordi/AAB-1649-2019	Fernandez Prieto, Irune/0000-0002-1669-5842; Navarra, Jordi/0000-0003-0779-4117	Ministerio de Economia y Competitividad (Spanish Government) [PSI2009-12859, PSI2012-39149, RYC-2008-03672]; European COST action [TD0904]	Ministerio de Economia y Competitividad (Spanish Government); European COST action	This research was supported by grants PSI2009-12859, PSI2012-39149 and RYC-2008-03672 from Ministerio de Economia y Competitividad (Spanish Government), and the European COST action TD0904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Hanson JVM, 2008, EXP BRAIN RES, V185, P347, DOI 10.1007/s00221-008-1282-3; Harrar V, 2008, EXP BRAIN RES, V186, P517, DOI 10.1007/s00221-007-1253-0; Heron J, 2012, EXP BRAIN RES, V218, P477, DOI 10.1007/s00221-012-3038-3; Heron J, 2007, J VISION, V7, DOI 10.1167/7.13.5; Keetels M, 2007, EXP BRAIN RES, V182, P559, DOI 10.1007/s00221-007-1012-2; Lavond DG, 2010, HDB CLASSICAL CONDIT; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; Munhall KG, 1996, PERCEPT PSYCHOPHYS, V58, P351, DOI 10.3758/BF03206811; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Navarra J, 2010, BRAIN RES, V1323, P84, DOI 10.1016/j.brainres.2010.01.059; Navarra J, 2009, P NATL ACAD SCI USA, V106, P9169, DOI 10.1073/pnas.0810486106; Roach NW, 2011, P ROY SOC B-BIOL SCI, V278, P1314, DOI 10.1098/rspb.2010.1737; Roseboom W, 2011, PSYCHOL SCI, V22, P872, DOI 10.1177/0956797611413293; Sanabria D, 2005, NEUROSCI LETT, V377, P59, DOI 10.1016/j.neulet.2004.11.069; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Spence C., 2004, HDB MULTISENSORY PRO, P3; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vatakis A, 2008, ACTA PSYCHOL, V127, P12, DOI 10.1016/j.actpsy.2006.12.002; Vatakis A, 2008, EXP BRAIN RES, V185, P521, DOI 10.1007/s00221-007-1168-9; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; Vatakis A, 2007, EXP BRAIN RES, V181, P173, DOI 10.1007/s00221-007-0918-z; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Yarrow K, 2011, CONSCIOUS COGN, V20, P1518, DOI 10.1016/j.concog.2011.07.003; Yarrow K, 2011, J EXP PSYCHOL HUMAN, V37, P1657, DOI 10.1037/a0024235	30	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84278	10.1371/journal.pone.0084278	http://dx.doi.org/10.1371/journal.pone.0084278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391928	Green Published, gold, Green Submitted			2022-12-27	WOS:000329323900071
J	Schumann, M; Armen, RS				Schumann, Marcel; Armen, Roger S.			Identification of Distant Drug Off-Targets by Direct Superposition of Binding Pocket Surfaces	PLOS ONE			English	Article							PHOSPHOLIPASE A(2) INHIBITORS; PROTEIN-LIGAND BINDING; TOPOISOMERASE-I; PPAR-GAMMA; CDC2-LIKE KINASES; POTENT INHIBITORS; DUAL-SPECIFICITY; SITE SIMILARITY; RECEPTOR; DATABASE	Correctly predicting off-targets for a given molecular structure, which would have the ability to bind a large range of ligands, is both particularly difficult and important if they share no significant sequence or fold similarity with the respective molecular target ("distant off-targets"). A novel approach for identification of off-targets by direct superposition of protein binding pocket surfaces is presented and applied to a set of well-studied and highly relevant drug targets, including representative kinases and nuclear hormone receptors. The entire Protein Data Bank is searched for similar binding pockets and convincing distant off-target candidates were identified that share no significant sequence or fold similarity with the respective target structure. These putative target off-target pairs are further supported by the existence of compounds that bind strongly to both with high topological similarity, and in some cases, literature examples of individual compounds that bind to both. Also, our results clearly show that it is possible for binding pockets to exhibit a striking surface similarity, while the respective off-target shares neither significant sequence nor significant fold similarity with the respective molecular target ("distant off-target").	[Schumann, Marcel; Armen, Roger S.] Thomas Jefferson Univ, Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA	Jefferson University	Schumann, M (corresponding author), Thomas Jefferson Univ, Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA.	marcel.schumann@jefferson.edu; roger.armen@jefferson.edu		Schumann, Marcel/0000-0002-9473-0156	Thomas Jefferson University School of Pharmacy	Thomas Jefferson University School of Pharmacy	This work was supported by funding from the Thomas Jefferson University School of Pharmacy start-up. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano Y, 2012, HYPERTENS RES, V35, P715, DOI 10.1038/hr.2012.17; Andersson CD, 2010, PROTEINS, V78, P1408, DOI 10.1002/prot.22655; Binkowski TA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-45; Chikhi R, 2010, PROTEINS, V78, P2007, DOI 10.1002/prot.22715; Cho MC, 2003, J BIOCHEM MOL BIOL, V36, P207; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Davis MI, 2011, NAT BIOTECHNOL, V29; Debdab M, 2011, J MED CHEM, V54, P4172, DOI 10.1021/jm200274d; Dorsey BD, 2000, J MED CHEM, V43, P3386, DOI 10.1021/jm9903848; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; Edling CE, 2007, INT J BIOCHEM CELL B, V39, P1995, DOI 10.1016/j.biocel.2006.12.005; Eisenreich A, 2009, CIRC RES, V104, P589, DOI 10.1161/CIRCRESAHA.108.183905; Erbe DV, 2005, MOL PHARMACOL, V67, P69, DOI 10.1124/mol.104.005553; FABRE S, 1992, BIOORG MED CHEM LETT, V2, P449, DOI 10.1016/S0960-894X(00)80167-5; Gangjee A, 2009, BIOORGAN MED CHEM, V17, P7324, DOI 10.1016/j.bmc.2009.08.044; GRATAROLI R, 1993, BIOCHEM PHARMACOL, V46, P349, DOI 10.1016/0006-2952(93)90509-U; Hagishita S, 1996, J MED CHEM, V39, P3636, DOI 10.1021/jm960395q; Hoffmann B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-99; Innocenti A, 2010, BIOORG MED CHEM LETT, V20, P5050, DOI 10.1016/j.bmcl.2010.07.038; Ito JI, 2012, NUCLEIC ACIDS RES, V40, pD541, DOI 10.1093/nar/gkr1130; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Kuhn D, 2006, J MOL BIOL, V359, P1023, DOI 10.1016/j.jmb.2006.04.024; Kurz M, 2003, PROTEINS, V50, P312, DOI 10.1002/prot.10289; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Loughney K, 1998, GENE, V216, P139, DOI 10.1016/S0378-1119(98)00303-5; Magrioti V, 2010, EXPERT OPIN THER PAT, V20, P1, DOI 10.1517/13543770903463905; Makela A, 1997, SCAND J CLIN LAB INV, V57, P401, DOI 10.3109/00365519709084587; Milletti F, 2010, J CHEM INF MODEL, V50, P1418, DOI 10.1021/ci1001263; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Mukherjee R, 1997, J BIOL CHEM, V272, P8071, DOI 10.1074/jbc.272.12.8071; Myo S, 2004, EUR RESPIR J, V23, P511, DOI 10.1183/09031936.04.00065904; Najmanovich R, 2008, BIOINFORMATICS, V24, pI105, DOI 10.1093/bioinformatics/btn263; Norman BH, 2007, BIOORG MED CHEM LETT, V17, P5082, DOI 10.1016/j.bmcl.2007.07.009; Onnis V, 2010, J MED CHEM, V53, P3065, DOI 10.1021/jm901452y; Otake K, 2012, BIOORGAN MED CHEM, V20, P1060, DOI 10.1016/j.bmc.2011.11.035; Papoulis A, 1962, FOURIER INTEGRAL ITS; Rosenson RS, 2010, EXPERT OPIN INV DRUG, V19, P1245, DOI 10.1517/13543784.2010.517193; Sael L, 2012, PROTEINS, V80, P1177, DOI 10.1002/prot.24018; Sanchez-Mejia RO, 2010, BBA-MOL CELL BIOL L, V1801, P784, DOI 10.1016/j.bbalip.2010.05.013; Sano A, 1999, AM J RESP CRIT CARE, V159, P1903, DOI 10.1164/ajrccm.159.6.9810005; Sayed M, 2001, ONCOGENE, V20, P6994, DOI 10.1038/sj.onc.1204894; Scarsi M, 2007, MOL PHARMACOL, V71, P398, DOI 10.1124/mol.106.024596; Schumann M, 2013, J COMPUT CHEM, V34, P1258, DOI 10.1002/jcc.23251; Shrestha S, 2007, BIOORG MED CHEM LETT, V17, P2728, DOI 10.1016/j.bmcl.2007.03.001; Singh B, 2013, J RENIN-ANGIO-ALDO S, V14, P124, DOI 10.1177/1470320312459977; Singh N, 2006, ACTA CRYSTALLOGR D, V62, P410, DOI 10.1107/S0907444906003660; Spitzer R, 2011, PROTEINS, V79, P2746, DOI 10.1002/prot.23103; St-Denis NA, 2009, MOL CELL BIOL, V29, P2068, DOI 10.1128/MCB.01563-08; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Storka A, 2008, EUR J CLIN INVEST, V38, P820, DOI 10.1111/j.1365-2362.2008.02025.x; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Tseng YY, 2009, NUCL ACIDS RES, V38; Ukita T, 2001, J MED CHEM, V44, P2204, DOI 10.1021/jm000558h; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; White M. C., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P91; Wickens P, 2007, BIOORG MED CHEM LETT, V17, P4369, DOI 10.1016/j.bmcl.2007.03.057; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Xie L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002037; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Zembower DE, 1999, BIOORG MED CHEM LETT, V9, P145, DOI 10.1016/S0960-894X(98)00710-0	64	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e83533	10.1371/journal.pone.0083533	http://dx.doi.org/10.1371/journal.pone.0083533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284NF	24391782	Green Submitted, Green Published, gold			2022-12-27	WOS:000329325200079
J	To, MJ; Jones, J; Emara, M; Jadad, AR				To, Matthew J.; Jones, Jennifer; Emara, Mohamed; Jadad, Alejandro R.			Are Reports of Randomized Controlled Trials Improving over Time? A Systematic Review of 284 Articles Published in High-Impact General and Specialized Medical Journals	PLOS ONE			English	Review							ALLOCATION CONCEALMENT; CONSORT STATEMENT; QUALITY	Backg round: Inadequate reporting undermines findings of randomized controlled trials (RCTs). This study assessed and compared articles published in high-impact general medical and specialized journals. Methods: Reports of RCTs published in high-impact general and specialized medical journals were identified through a search of MEDLINE from January to March of 1995, 2000, 2005, and 2010. Articles that provided original data on adult patients diagnosed with chronic conditions were included in the study. Data on trial characteristics, reporting of allocation concealment, quality score, and the presence of a trial flow diagram were extracted independently by two reviewers, and discrepancies were resolved by consensus or independent adjudication. Descriptive statistics were used for quantitative variables. Comparisons between general medical and specialized journals, and trends over time were performed using Chisquare tests. Results: Reports of 284 trials were analyzed. There was a significantly higher proportion of RCTs published with adequate reporting of allocation concealment (p = 0.003), presentation of a trial flow diagram (p, 0.0001) and high quality scores (p = 0.038) over time. Trials published in general medical journals had higher quality scores than those in specialized journals (p = 0.001), reported adequate allocation concealment more often (p = 0.013), and presented a trial flow diagram more often (p, 0.001). Interpretation: We found significant improvements in reporting quality of RCTs published in high-impact factor journals over the last fifteen years. These improvements are likely attributed to concerted international efforts to improve reporting quality such as CONSORT. There is still much room for improvement, especially among specialized journals.	[To, Matthew J.; Jones, Jennifer; Emara, Mohamed; Jadad, Alejandro R.] Univ Hlth Network, Princess Margaret Hosp, Elect Living Lab Interdisciplinary Canc Survivors, Toronto, ON, Canada; [Jadad, Alejandro R.] Univ Hlth Network, Princess Margaret Hosp, Ctr Global eHlth Innovat, Toronto, ON, Canada; [Jadad, Alejandro R.] Univ Hlth Network, Princess Margaret Hosp, Radiat Med Program, Toronto, ON, Canada; [Jadad, Alejandro R.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Jadad, Alejandro R.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Jadad, Alejandro R.] Univ Toronto, Dept Management & Evaluat, Toronto, ON, Canada; [Jones, Jennifer] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Jadad, AR (corresponding author), Univ Hlth Network, Princess Margaret Hosp, Elect Living Lab Interdisciplinary Canc Survivors, Toronto, ON, Canada.	ajadad@ehealthinnovation.org			University of Toronto; Canada Research Chair in eHealth Innovation, University of Toronto; University Health Network	University of Toronto(University of Toronto); Canada Research Chair in eHealth Innovation, University of Toronto; University Health Network	MJT received research funding from the University of Toronto. ARJ was supported by funds from the Canada Research Chair in eHealth Innovation, University of Toronto, and the University Health Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Cavadas V, 2011, INT UROGYNECOL J, V22, P1117, DOI 10.1007/s00192-011-1426-z; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Hewitt C, 2005, BMJ-BRIT MED J, V330, P1057, DOI 10.1136/bmj.38413.576713.AE; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Jadad AR, 2011, JAMA-J AM MED ASSOC, V306, P2670, DOI 10.1001/jama.2011.1886; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JADAD AR, 2007, RANDOMIZED CONTROLLE; King DL, 2011, CLIN PSYCHOL REV, V31, P1110, DOI 10.1016/j.cpr.2011.06.009; Marshman Z, 2010, COMMUNITY DENT HLTH, V27, P253, DOI 10.1922/CDH_2497Marshman04; Mills E, 2005, J CLIN EPIDEMIOL, V58, P662, DOI 10.1016/j.jclinepi.2005.01.004; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Strech D, 2011, J CLIN PSYCHIAT, V72, P1214, DOI 10.4088/JCP.10r06166yel; Turner L, 2011, TRIALS S1, V12, pA47, DOI DOI 10.1186/1745-6215-12-S1-A47	20	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84779	10.1371/journal.pone.0084779	http://dx.doi.org/10.1371/journal.pone.0084779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391973	gold, Green Published, Green Submitted			2022-12-27	WOS:000329323900116
J	Tovo-Rodrigues, L; Rohde, LA; Menezes, AMB; Polanczyk, GV; Kieling, C; Genro, JP; Anselmi, L; Hutz, MH				Tovo-Rodrigues, Luciana; Rohde, Luis A.; Menezes, Ana M. B.; Polanczyk, Guilherme V.; Kieling, Christian; Genro, Julia P.; Anselmi, Luciana; Hutz, Mara H.			DRD4 Rare Variants in Attention-Deficit/Hyperactivity Disorder (ADHD): Further Evidence from a Birth Cohort Study	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; RECEPTOR; GENE; POPULATION; STRENGTHS; CHILDREN; BRAZIL; SUSCEPTIBILITY; PREVALENCE; PREDICTION	The dopamine receptor D4 (DRD4) is one of the most studied candidate genes for Attention-Deficit/Hyperactivity Disorder (ADHD). An excess of rare variants and non-synonymous mutations in the VNTR region of 7R allele in ADHD subjects was observed in previous studies with clinical samples. We hypothesize that genetic heterogeneity in the VNTR is an important factor in the pathophysiology of ADHD. The subjects included in the present study are members of the 1993 Pelotas Birth Cohort Study (N=5,249). We conducted an association study with the 4,101 subjects who had DNA samples collected. The hyperactivity-inattention scores were assessed through the parent version of the Strengths and Difficulties Questionnaire at 11 and 15 years of age. The contribution of allele's length and rare variants to high hyperactivity/inattention scores predisposition was evaluated by multivariate logistic regression. No effect of allele length was observed on high scores of hyperactivity-inattention. By contrast, when resequencing/haplotyping was conducted in a subsample, all 7R rare variants as well as non-synonymous 7R rare variants were associated with high hyperactivity/inattention scores (OR=2.561; P=0.024 and OR=3.216; P=0.008 respectively). A trend for association was observed with 4R rare variants. New coding mutations covered 10 novel motifs and many of them are previously unreported deletions leading to different stop codons. Our findings suggest a contribution of DRD4 7R rare variants to high hyperactivity-inattention scores in a population-based sample from a large birth cohort. These findings provide further evidence for an effect of DRD4 7R rare variants and allelic heterogeneity in ADHD genetic susceptibility.	[Tovo-Rodrigues, Luciana; Genro, Julia P.; Hutz, Mara H.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Rohde, Luis A.; Kieling, Christian; Anselmi, Luciana] Univ Fed Rio Grande do Sul, Child & Adolescent Psychiat Div, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Menezes, Ana M. B.] Univ Fed Pelotas, Grad Program Epidemiol, Pelotas, RS, Brazil; [Polanczyk, Guilherme V.] Univ Sao Paulo, Dept Psychiat, Sch Med, Sao Paulo, Brazil; [Polanczyk, Guilherme V.] Univ Sao Paulo, Res Support Ctr Neurodev & Mental Hlth, Sao Paulo, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal de Pelotas; Universidade de Sao Paulo; Universidade de Sao Paulo	Hutz, MH (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	mara.hutz@ufrgs.br	Genro, Julia/J-4795-2015; Polanczyk, Guilherme V./AAF-6142-2021; Hutz, Mara H/I-4070-2012; Tovo-Rodrigues, Luciana/D-4256-2018; Kieling, Christian/U-3905-2019; Polanczyk, Guilherme V/C-2345-2012; Rohde, Luis Augusto P/A-6426-2008; Menezes, Ana MB/G-7266-2012	Polanczyk, Guilherme V./0000-0003-2311-3289; Kieling, Christian/0000-0001-7691-4149; Polanczyk, Guilherme V/0000-0003-2311-3289; Rohde, Luis Augusto P/0000-0002-4552-4188; Menezes, Ana MB/0000-0002-2996-9427; Hutz, Mara/0000-0002-9146-1229	Wellcome Trust; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) [470937/2010-6]	Wellcome Trust(Wellcome TrustEuropean Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The cohort study follow up is supported by the Wellcome Trust. Financial support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Grant no470937/2010-6 Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi L, 2010, CAD SAUDE PUBLICA, V26, P1954, DOI 10.1590/S0102-311X2010001000012; Becker A, 2006, EUR CHILD ADOLES PSY, V15, P56, DOI 10.1007/s00787-006-1008-7; Bidwell LC, 2011, BEHAV GENET, V41, P165, DOI 10.1007/s10519-010-9437-y; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Ciruela F, 2004, ANAL CHEM, V76, P5354, DOI 10.1021/ac049295f; Dalgarno DC, 1997, BIOPOLYMERS, V43, P383; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Goodman R, 2003, INT REV PSYCHIATR, V15, P166, DOI 10.1080/0954026021000046128; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman SH, 1997, J ABNORM PSYCHOL, V106, P3, DOI 10.1037/0021-843X.106.1.3; Grady DL, 2005, AM J MED GENET B, V136B, P33, DOI 10.1002/ajmg.b.30182; Grady DL, 2003, MOL PSYCHIATR, V8, P536, DOI 10.1038/sj.mp.4001350; Hu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S2; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; King RA, 1997, J AM ACAD CHILD PSY, V36, pS4, DOI 10.1097/00004583-199710001-00002; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Manolio TA, 2009, NAT GENET, V41, P5, DOI 10.1038/ng0109-5; NOTHEN MM, 1994, HUM MOL GENET, V3, P2207, DOI 10.1093/hmg/3.12.2207; Oldenhof J, 1998, BIOCHEMISTRY-US, V37, P15726, DOI 10.1021/bi981634+; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rohde LA, 1999, J ATTEN DISORD, V3, P91, DOI [DOI 10.1177/108705479900300203, 10.1177/108705479900300203]; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tovo-Rodrigues L, 2012, MOL PSYCHIATR, V17, P520, DOI 10.1038/mp.2011.12; Vacic V, 2012, MOL BIOSYST, V8, P27, DOI 10.1039/c1mb05251a; Victora CG, 2008, INT J EPIDEMIOL, V37, P704, DOI 10.1093/ije/dym177; Victora CG, 1996, REV SAUDE PUBL, V30, P34, DOI 10.1590/S0034-89101996000100005; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; Woods AS, 2010, J RECEPT SIG TRANSD, V30, P331, DOI 10.3109/10799893.2010.513842	40	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85164	10.1371/journal.pone.0085164	http://dx.doi.org/10.1371/journal.pone.0085164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391992	Green Published, Green Submitted, gold			2022-12-27	WOS:000329323900135
J	Zhang, XM; Chen, QS; Han, XG				Zhang, Ximei; Chen, Quansheng; Han, Xingguo			Soil Bacterial Communities Respond to Mowing and Nutrient Addition in a Steppe Ecosystem	PLOS ONE			English	Article							MICROBIAL COMMUNITY; NITROGEN ADDITION; SP-NOV; DEPOSITION; DIVERSITY; STABILITY; DYNAMICS; RESOURCE	In many grassland ecosystems, nitrogen (N) and phosphorus (P) are added to improve plant productivity, and the aboveground plant biomass is mowed and stored as hay for the bullamacow. Nutrient addition and mowing affect the biodiversity and ecosystem functioning, and most of the previous studies have primarily focused on their effects on macro-organisms, neglecting the responses of soil microbial communities. In this study, we examined the changes in three community attributes (abundance, richness, and composition) of the entire bacterial kingdom and 16 dominant bacterial phyla/classes in response to mowing, N addition, P addition, and their combinations, by conducting a 5-year experiment in a steppe ecosystem in Inner Mongolia, China. Overall, N addition had a greater effect than mowing and P addition on most of these bacterial groups, as indicated by changes in the abundance, richness and composition in response to these treatments. N addition affected these soil bacterial groups primarily through reducing soil pH and increasing available N content. Meanwhile, the 16 bacterial phyla/classes responded differentially to these experimental treatments, with Acidobacteria, Acidimicrobidae, Deltaproteobacteria, and Gammaproteobacteria being the most sensitive. The changes in the abundance, richness, and composition of various bacterial groups could imply some potential shift in their ecosystem functions. Furthermore, the important role of decreased soil pH caused by N addition in affecting soil bacterial communities suggests the importance of restoring acidified soil to maintain soil bacterial diversity.	[Zhang, Ximei; Han, Xingguo] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [Chen, Quansheng; Han, Xingguo] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Institute of Botany, CAS	Han, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	xghan@ibcas.ac.cn	Han, Xingguo/K-7552-2016; Chen, Quansheng/AGH-8083-2022	Han, Xingguo/0000-0002-1836-975X; Chen, Quansheng/0000-0003-2498-3278	National Natural Science Foundation [30830026]; Postdoctoral Science Foundation of China [2012T50158, 2011M500440]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation (30830026) and Postdoctoral Science Foundation (2012T50158, 2011M500440) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, PERMANOVA FORTRAN CO; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Cease AJ, 2012, SCIENCE, V335, P467, DOI 10.1126/science.1214433; Chen Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016909; Chrzanowski TH, 1996, AQUAT MICROB ECOL, V11, P119, DOI 10.3354/ame011119; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Deiglmayr K, 2006, SOIL BIOL BIOCHEM, V38, P2980, DOI 10.1016/j.soilbio.2006.04.034; EHRICH S, 1995, ARCH MICROBIOL, V164, P16; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HANADA S, 1995, INT J SYST BACTERIOL, V45, P676, DOI 10.1099/00207713-45-4-676; Hogenhout SA, 2008, CURR OPIN PLANT BIOL, V11, P449, DOI 10.1016/j.pbi.2008.05.007; Kandeler E, 2009, FEMS MICROBIOL ECOL, V67, P444, DOI 10.1111/j.1574-6941.2008.00632.x; Klappenbach JA, 2004, ARCH MICROBIOL, V181, P17, DOI 10.1007/s00203-003-0615-7; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Liu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057599; Lovett GM, 2011, ECOSYSTEMS, V14, P615, DOI 10.1007/s10021-011-9432-z; Makino W, 2003, FUNCT ECOL, V17, P121, DOI 10.1046/j.1365-2435.2003.00712.x; PIERSON BK, 1974, ARCH MICROBIOL, V100, P5, DOI 10.1007/BF00446302; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schonbach P, 2011, PLANT SOIL, V340, P103, DOI 10.1007/s11104-010-0366-6; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Wang J. W., 1988, Research on Grassland Ecosystem, P23; Watson SW, 1994, ARCH MICROBIOL, V144, P62; Wei CZ, 2013, GLOBAL CHANGE BIOL, V19, P3688, DOI 10.1111/gcb.12348; Xu HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062025; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x; Zhang LX, 2004, ACTA BOT SIN, V46, P259; Zhang XM, 2012, J ENVIRON SCI-CHINA, V24, P1483, DOI 10.1016/S1001-0742(11)60900-5; Zhang XM, 2011, MOL ECOL, V20, P429, DOI 10.1111/j.1365-294X.2010.04933.x; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331	43	29	33	1	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84210	10.1371/journal.pone.0084210	http://dx.doi.org/10.1371/journal.pone.0084210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391915	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900058
J	Zhang, YQ; Li, ZW; Yang, M; Wang, DH; Yu, LX; Guo, CN; Guo, XD; Lin, N				Zhang, Yanqiong; Li, Zhiwei; Yang, Mei; Wang, Danhua; Yu, Lingxiang; Guo, Chaonan; Guo, Xiaodong; Lin, Na			Identification of GRB2 and GAB1 Coexpression as an Unfavorable Prognostic Factor for Hepatocellular Carcinoma by a Combination of Expression Profile and Network Analysis	PLOS ONE			English	Article							INTERACTION DATABASE; SIGNAL-TRANSDUCTION; TUMOR PROGRESSION; POOR-PROGNOSIS; GROWTH; INHIBITION; DIAGNOSIS; CONTEXT; GENES	Aim: To screen novel markers for hepatocellular carcinoma (HCC) by a combination of expression profile, interaction network analysis and clinical validation. Methods: HCC significant molecules which are differentially expressed or had genetic variations in HCC tissues were obtained from five existing HCC related databases (OncoDB. HCC, HCC. net, dbHCCvar, EHCO and Liverome). Then, the protein-protein interaction (PPI) network of these molecules was constructed. Three topological features of the network ('Degree', 'Betweenness', and 'Closeness') and the k-core algorithm were used to screen candidate HCC markers which play crucial roles in tumorigenesis of HCC. Furthermore, the clinical significance of two candidate HCC markers growth factor receptor-bound 2 (GRB2) and GRB2-associated-binding protein 1 (GAB1) was validated. Results: In total, 6179 HCC significant genes and 977 HCC significant proteins were collected from existing HCC related databases. After network analysis, 331 candidate HCC markers were identified. Especially, GAB1 has the highest k-coreness suggesting its central localization in HCC related network, and the interaction between GRB2 and GAB1 has the largest edge-betweenness implying it may be biologically important to the function of HCC related network. As the results of clinical validation, the expression levels of both GRB2 and GAB1 proteins were significantly higher in HCC tissues than those in their adjacent nonneoplastic tissues. More importantly, the combined GRB2 and GAB1 protein expression was significantly associated with aggressive tumor progression and poor prognosis in patients with HCC. Conclusion: This study provided an integrative analysis by combining expression profile and interaction network analysis to identify a list of biologically significant HCC related markers and pathways. Further experimental validation indicated that the aberrant expression of GRB2 and GAB1 proteins may be strongly related to tumor progression and prognosis in patients with HCC. The overexpression of GRB2 in combination with upregulation of GAB1 may be an unfavorable prognostic factor for HCC.	[Zhang, Yanqiong; Wang, Danhua; Lin, Na] China Acad Chinese Med Sci, Inst Chinese Mat Med, Res Ctr Tradit Chinese Med Theory, Beijing, Peoples R China; [Li, Zhiwei; Yang, Mei; Yu, Lingxiang; Guo, Chaonan; Guo, Xiaodong] Beijing 302 Hosp, Dept Pathol & Hepatol, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Fifth Medical Center of Chinese PLA General Hospital	Guo, XD (corresponding author), Beijing 302 Hosp, Dept Pathol & Hepatol, Beijing, Peoples R China.	guoxd_1981@163.com; linna888@163.com			National Natural Science Foundation of China [81303153]; National Basic Research Program of China (973 Program) [2011CB505300, 2011CB505305]; Beijing Joint Project Specific Funds	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Beijing Joint Project Specific Funds	This study was supported by the National Natural Science Foundation of China (no. 81303153), the National Basic Research Program of China (973 Program) (2011CB505300, 2011CB505305) & Beijing Joint Project Specific Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Chen JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S16; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dharmawardana PG, 2006, ANTI-CANCER DRUG, V17, P13, DOI 10.1097/01.cad.0000185180.72604.ac; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Garbay C, 2000, BIOCHEM PHARMACOL, V60, P1165, DOI 10.1016/S0006-2952(00)00428-7; Giubellino A, 2007, CANCER RES, V67, P6012, DOI 10.1158/0008-5472.CAN-07-0022; Guo XD, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-96; Guo XD, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-44; Guo XD, 2012, PATHOL ONCOL RES, V18, P635, DOI 10.1007/s12253-011-9488-2; He B, 2010, CELL RES, V20, P732, DOI 10.1038/cr.2010.67; Hoeben A, 2013, INT J CANCER, V132, P1042, DOI 10.1002/ijc.27763; Hsu CN, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-66; Ikoma J, 2002, HEPATO-GASTROENTEROL, V49, P235; Jiang FN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063941; Kondo A, 2008, J BIOL CHEM, V283, P1428, DOI 10.1074/jbc.M704999200; Lee EK, 2011, CANCER RES, V71, P6827, DOI 10.1158/0008-5472.CAN-10-4356; Lee L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S3; Lehne Benjamin, 2009, Human Genomics, V3, P291; Li S, 2007, IET SYST BIOL, V1, P51, DOI 10.1049/iet-syb:20060032; Lim HY, 2013, ANN SURG ONCOL, V20, P3747, DOI 10.1245/s10434-013-3070-y; Liu Y, 2002, FEBS LETT, V515, P1, DOI 10.1016/S0014-5793(02)02425-0; Marshall A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059459; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; McDonald CB, 2012, FEBS J, V279, P2156, DOI 10.1111/j.1742-4658.2012.08600.x; McKillop IH, 1997, HEPATOLOGY, V26, P1484; Narayanan T, 2011, BMC RES NOTES, V4, P569, DOI DOI 10.1186/1756-0500-4-569; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reimers M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000786; Sakamoto M, 2008, INTERVIROLOGY, V51, P42, DOI 10.1159/000122603; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Su WH, 2007, NUCLEIC ACIDS RES, V35, pD727, DOI 10.1093/nar/gkl845; Takeishi K, 2012, J HEPATOL, V57, P77, DOI 10.1016/j.jhep.2012.02.026; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Valente TW, 2010, SOC NETWORKS, V32, P212, DOI 10.1016/j.socnet.2010.03.003; Wang LS, 2013, TUMOR BIOL, V34, P1679, DOI 10.1007/s13277-013-0702-6; Wang SH, 2011, HEPATOLOGY, V53, P1932, DOI 10.1002/hep.24291; Wang Z, 2007, HEPATOLOGY, V46, P2003, DOI 10.1002/hep.21900; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Wuchty S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-24; Yoon SY, 2002, J CELL BIOCHEM, V84, P150, DOI 10.1002/jcb.1275; Yu XJ, 2011, HUM MUTAT, V32, pE2308, DOI 10.1002/humu.21595; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022426	50	29	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e85170	10.1371/journal.pone.0085170	http://dx.doi.org/10.1371/journal.pone.0085170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391994	gold, Green Submitted, Green Published			2022-12-27	WOS:000329323900137
J	Vieira, LD; Faoro, H; Fraga, HPD; Rogalski, M; de Souza, EM; Pedrosa, FD; Nodari, RO; Guerra, MP				Vieira, Leila do Nascimento; Faoro, Helisson; de Freitas Fraga, Hugo Pacheco; Rogalski, Marcelo; de Souza, Emanuel Maltempi; Pedrosa, Fabio de Oliveira; Nodari, Rubens Onofre; Guerra, Miguel Pedro			An Improved Protocol for Intact Chloroplasts and cpDNA Isolation in Conifers	PLOS ONE			English	Article							INVERTED REPEAT COPIES; PLASTID GENOME; DNA EXTRACTION; EVOLUTION; NUCLEAR; GENES; SEQUENCE; PROTEIN; BIOTECHNOLOGY; PINACEAE	Background: Performing chloroplast DNA (cpDNA) isolation is considered a major challenge among different plant groups, especially conifers. Isolating chloroplasts in conifers by such conventional methods as sucrose gradient and high salt has not been successful. So far, plastid genome sequencing protocols for conifer species have been based mainly on long-range PCR, which is known to be time-consuming and difficult to implement. Methodology/Principal Findings: We developed a protocol for cpDNA isolation using three different conifer families: Araucaria angustifolia and Araucaria bidwilli (Araucariaceae), Podocarpus lambertii (Podocarpaceae) and Pinus patula (Pinaceae). The present protocol is based on high salt isolation buffer followed by saline Percoll gradient. Combining these two strategies allowed enhanced chloroplast isolation, along with decreased contamination caused by polysaccharides, polyphenols, proteins, and nuclear DNA in cpDNA. Microscopy images confirmed the presence of intact chloroplasts in high abundance. This method was applied to cpDNA isolation and subsequent sequencing by Illumina MiSeq (2x250 bp), using only 50 ng of cpDNA. Reference-guided chloroplast genome mapping showed that high average coverage was achieved for all evaluated species: 24.63 for A. angustifolia, 135.97 for A. bidwilli, 1196.10 for P. lambertii, and 64.68 for P. patula. Conclusion: Results show that this improved protocol is suitable for enhanced quality and yield of chloroplasts and cpDNA isolation from conifers, providing a useful tool for studies that require isolated chloroplasts and/or whole cpDNA sequences.	[Vieira, Leila do Nascimento; de Freitas Fraga, Hugo Pacheco; Nodari, Rubens Onofre; Guerra, Miguel Pedro] Univ Fed Santa Catarina, Programa Pos Grad Recursos Genet Vegetais, Dept Fitotecnia, Florianopolis, SC, Brazil; [Faoro, Helisson; de Souza, Emanuel Maltempi; Pedrosa, Fabio de Oliveira] Univ Fed Parana, Nucleo Fixacao Biol Nitrogenio, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil; [Rogalski, Marcelo] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal do Parana; Universidade Federal de Vicosa	Guerra, MP (corresponding author), Univ Fed Santa Catarina, Programa Pos Grad Recursos Genet Vegetais, Dept Fitotecnia, Florianopolis, SC, Brazil.	miguel.guerra@ufsc.br	Faoro, Helisson/F-7163-2012; Pedrosa, Fabio 0/C-1938-2013; Vieira, Leila N/F-9934-2012; ROGALSKI, MARCELO/ABA-3940-2020; Rogalski, Marcelo/AAA-5192-2020; Nodari, Rubens O/B-7006-2014; Fraga, Hugo PF/F-9049-2012; Fraga, Hugo/L-7275-2019	Faoro, Helisson/0000-0002-0146-8639; ROGALSKI, MARCELO/0000-0002-1990-5243; Nodari, Rubens O/0000-0002-8884-2426; Fraga, Hugo PF/0000-0002-7363-5213; Guerra, Miguel/0000-0002-5319-3446; do Nascimento Vieira, Leila/0000-0001-8413-2155	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) [14848/2011-2, 3770/2012, 2780/2012-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC)(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPq) with fellowships, and by Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) under project number 14848/2011-2, 3770/2012, and 2780/2012-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkatib S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003076; Arif IA, 2010, INT J MOL SCI, V11, P3149, DOI 10.3390/ijms11093149; Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; AYLIFFE MA, 1992, THEOR APPL GENET, V85, P229, DOI 10.1007/BF00222864; Ayliffe MA, 1998, MOL BIOL EVOL, V15, P738, DOI 10.1093/oxfordjournals.molbev.a025977; Bock R, 2013, PLANT MOL BIOL, V83, P21, DOI 10.1007/s11103-013-0045-0; BOOKJANS G, 1984, ANAL BIOCHEM, V141, P244, DOI 10.1016/0003-2697(84)90452-4; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Clarke JL, 2011, PLANT MOL BIOL, V76, P207, DOI 10.1007/s11103-011-9792-y; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; Gargano D, 2013, PLANT MOL BIOL, V81, P235, DOI 10.1007/s11103-012-9994-y; Goremykin VV, 2009, MOL BIOL EVOL, V26, P99, DOI 10.1093/molbev/msn226; Greiner S, 2013, BIOESSAYS, V35, P354, DOI 10.1002/bies.201200137; He ZH, 2013, J PLANT PHYSIOL, V170, P1139, DOI 10.1016/j.jplph.2013.03.016; Hirao T, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-70; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Kaneko T, 1996, DNA Res, V3, P109; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Kubis Sybille E., 2008, V425, P171, DOI 10.1007/978-1-60327-210-0_16; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Maliga P, 2011, PLANT PHYSIOL, V155, P1501, DOI 10.1104/pp.110.170969; Mastroberti Alexandra A., 2003, Braz. J. Bot., V26, P343, DOI 10.1590/S0100-84042003000300007; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; PALMER JD, 1986, CURR GENET, V10, P823, DOI 10.1007/BF00418529; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Rogalski M, 2011, PLANT BIOTECHNOL J, V9, P554, DOI 10.1111/j.1467-7652.2011.00621.x; Rousseau-Gueutin M, 2011, PLANT PHYSIOL, V157, P2181, DOI 10.1104/pp.111.185074; Shi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031468; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; WALKER DA, 1987, METHOD ENZYMOL, V148, P145; Werner O, 2009, BRYOLOGIST, V112, P315, DOI 10.1639/0007-2745-112.2.315; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wu CS, 2007, MOL BIOL EVOL, V24, P1366, DOI 10.1093/molbev/msm059; Wu CS, 2011, GENOME BIOL EVOL, V3, P1284, DOI 10.1093/gbe/evr095; Yamamoto S, 2004, J MASS SPECTROM, V39, P1337, DOI 10.1002/jms.726; Yi X, 2013, GENOME BIOL EVOL, V5, P688, DOI 10.1093/gbe/evt042	41	71	74	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84792	10.1371/journal.pone.0084792	http://dx.doi.org/10.1371/journal.pone.0084792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	24392157	gold, Green Published, Green Submitted			2022-12-27	WOS:000329460100080
J	Huang, WT; Yang, HW; Liao, TL; Wu, WJ; Yang, SE; Chih, YC; Chuang, JH				Huang, Wan-Ting; Yang, Hsu-Wen; Liao, Tzu-Lin; Wu, Wan-Jen; Yang, Shu-Er; Chih, Yi-Chien; Chuang, Jen-Hsiang			Safety of Pandemic (H1N1) 2009 Monovalent Vaccines in Taiwan: A Self-Controlled Case Series Study	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; INFLUENZA-A H1N1; EVENT REPORTING SYSTEM; ADVERSE EVENTS; DATALINK PROJECT; UNITED-STATES; BELLS-PALSY; VACCINATION; RISK; SURVEILLANCE	In Taiwan, new H1N1 monovalent vaccines without adjuvant and with MF59 (R) adjuvant were used in the nationwide vaccination campaign beginning on November 1, 2009. From November 2009 through February 2010, the authors identified recipients of H1N1 vaccines who were diagnosed with adverse events of special interest (AESIs) in a large-linked safety database, and used the self-controlled case series (SCCS) method to examine the risk of each AESI in the 0-42 days after H1N1 vaccination. Of the 3.5 million doses of H1N1 vaccines administered and captured in the linked database, the SCCS analysis of Guillain-Barre syndrome (GBS) found an incidence rate ratio of 3.81 (95% confidence interval 0.43-33.85) within 0-42 days after nonadjuvanted H1N1 vaccination and no cases after MF59 (R)-adjuvanted H1N1 vaccination. The risks of other AESIs were, in general, not increased in any of the predefined postvaccination risk periods and age groups. The databases and infrastructure created for H1N1 vaccine safety evaluation may serve as a model for safety, effectiveness and coverage studies of licensed vaccines in Taiwan.	[Huang, Wan-Ting; Yang, Hsu-Wen; Liao, Tzu-Lin; Wu, Wan-Jen; Chuang, Jen-Hsiang] Taiwan Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan; [Yang, Shu-Er; Chih, Yi-Chien] Taiwan Ctr Dis Control, Div 4, Taipei, Taiwan		Huang, WT (corresponding author), Taiwan Ctr Dis Control, Epidem Intelligence Ctr, Taipei, Taiwan.	muagi@cdc.gov.tw	Huang, Wan-Ting/E-3497-2010; Chuang, Jen-Hsiang/G-4356-2010; Huang, Wei-Chien/D-1740-2012	Huang, Wan-Ting/0000-0002-4344-9567; Chuang, Jen-Hsiang/0000-0002-7114-3418; Chen, Chia-Hung/0000-0003-1158-9722; Huang, Wei-Chien/0000-0001-6467-8716	Taiwan Centers for Disease Control [DOH99-DC-2038]	Taiwan Centers for Disease Control	This study was supported by a grant (DOH99-DC-2038) from the Taiwan Centers for Disease Control (http://www.cdc.gov.tw). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P249; [Anonymous], NAT HLTH INS TAIW 20; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Campbell KE, 2002, AM J EPIDEMIOL, V156, P32, DOI 10.1093/aje/kwf009; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; De Wals P, 2012, JAMA-J AM MED ASSOC, V308, P175, DOI 10.1001/jama.2012.7342; Dieleman Jeanne, 2011, BMJ, V343, pd3908, DOI 10.1136/bmj.d3908; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; Glanz JM, 2006, J CLIN EPIDEMIOL, V59, P808, DOI 10.1016/j.jclinepi.2005.11.012; Glaser CA, 2012, CLIN INFECT DIS, V55, P514, DOI 10.1093/cid/cis454; Greene SK, 2012, AM J EPIDEMIOL, V175, P1100, DOI 10.1093/aje/kws195; Greene SK, 2010, AM J EPIDEMIOL, V171, P177, DOI 10.1093/aje/kwp345; Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072; Hambidge SJ, 2006, JAMA-J AM MED ASSOC, V296, P1990, DOI 10.1001/jama.296.16.1990; Huang WT, 2012, VACCINE, V30, P2168, DOI 10.1016/j.vaccine.2012.01.013; Huang WT, 2010, VACCINE, V28, P7161, DOI 10.1016/j.vaccine.2010.08.069; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Kung HC, 2010, VACCINE, V28, P7337, DOI 10.1016/j.vaccine.2010.08.073; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Lee GM, 2011, AM J PREV MED, V41, P121, DOI 10.1016/j.amepre.2011.04.004; Lu CY, 2010, VACCINE, V28, P5864, DOI 10.1016/j.vaccine.2010.06.059; McMahon AW, 2005, PEDIATRICS, V115, P453, DOI 10.1542/peds.2004-1519; Rowhani-Rahbar A, 2012, VACCINE, V31, P271, DOI 10.1016/j.vaccine.2012.07.024; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Tokars JI, 2012, PHARMACOEPIDEM DR S, V21, P546, DOI 10.1002/pds.3220; Tse A, 2012, VACCINE, V30, P2024, DOI 10.1016/j.vaccine.2012.01.027; Vellozzi C, 2009, VACCINE, V27, P2114, DOI 10.1016/j.vaccine.2009.01.125; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Wise ME, 2012, AM J EPIDEMIOL, V175, P1110, DOI 10.1093/aje/kws196; Yih WK, 2012, AM J EPIDEMIOL, V175, P1120, DOI 10.1093/aje/kws197; Zhou WG, 2004, PHARMACOEPIDEM DR S, V13, P505, DOI 10.1002/pds.998	36	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58827	10.1371/journal.pone.0058827	http://dx.doi.org/10.1371/journal.pone.0058827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23536827	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100092
J	Wu, MS; Sutton, RM; Yan, XD; Zhou, C; Chen, YW; Zhu, ZH; Han, BX				Wu, Michael Shengtao; Sutton, Robbie M.; Yan, Xiaodan; Zhou, Chan; Chen, Yiwen; Zhu, Zhuohong; Han, Buxin			Time Frame and Justice Motive: Future Perspective Moderates the Adaptive Function of General Belief in a Just World	PLOS ONE			English	Article							CONNOR-DAVIDSON RESILIENCE; SYSTEM JUSTIFICATION; SOCIAL AXIOMS; SELF; SUPPORT; LOOKING; SCALE	Background: The human ability to envision the future, that is, to take a future perspective (FP), plays a key role in the justice motive and its function in transcending disadvantages and misfortunes. The present research investigated whether individual (Study 1) and situational (Study 2) differences in FP moderated the association of general belief in a just world (GBJW) with psychological resilience. Methodology/Principal Findings: We investigated FP, GBJW, and resilience in sample of adolescents (n = 223) and disaster survivors (n = 218) in China. In Study 1, adolescents revealed stronger GBJW than PBJW, and GBJW uniquely predicted resilience in the daily lives of those with high FP (but not those with low FP). In Study 2, natural priming of FP (vs. no FP) facilitated the association of GBJW with resilience after disaster. Conclusions/Significance: Supporting predictions, participants endorsed GBJW more strongly than PBJW. Further, GBJW interacted with FP in both studies, such that there was an association between GBJW and resilience at high but not low levels of FP. The results corroborate recent findings suggesting that GBJW may be more psychologically adaptive than PBJW among some populations. They also confirm that focusing on the future is an important aspect of the adaptive function of just-world beliefs.	[Wu, Michael Shengtao] Xiamen Univ, Sch Journalism & Commun, Xiamen, Peoples R China; [Wu, Michael Shengtao; Chen, Yiwen; Zhu, Zhuohong; Han, Buxin] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Sutton, Robbie M.] Univ Kent, Sch Psychol, Canterbury, Kent, England; [Yan, Xiaodan] NYU, Dept Psychiat, New York, NY 10016 USA; [Zhou, Chan] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China	Xiamen University; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Kent; New York University; Beijing Normal University	Wu, MS (corresponding author), Xiamen Univ, Sch Journalism & Commun, Xiamen, Peoples R China.	michaelstwu@gmail.com; chenyw@psych.ac.cn; hanbx@psych.ac.cn	Sutton, Robbie/B-4943-2008	Sutton, Robbie/0000-0003-1542-1716	Knowledge Innovation Project of Chinese Academy of Sciences [KSCX2-YW-R-130]; Knowledge Innovation Project of Institute of Psychology, Chinese Academy of Sciences [08CX103010]	Knowledge Innovation Project of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Knowledge Innovation Project of Institute of Psychology, Chinese Academy of Sciences	The study was supported by The Knowledge Innovation Project of Chinese Academy of Sciences (No. KSCX2-YW-R-130) and The Knowledge Innovation Project of Institute of Psychology, Chinese Academy of Sciences (No. 08CX103010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Anderson JE, 2010, PSYCHOL SCI, V21, P1599, DOI 10.1177/0956797610386620; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Bal M, 2012, PERS SOC PSYCHOL B, V38, P835, DOI 10.1177/0146167212442970; Begue L, 2003, J PERS, V71, P435, DOI 10.1111/1467-6494.7103007; Bonanno GA, 2005, J PERS SOC PSYCHOL, V88, P984, DOI 10.1037/0022-3514.88.6.984; Bond MH, 2004, J CROSS CULT PSYCHOL, V35, P548, DOI 10.1177/0022022104268388; Bond MH, 2004, EUR J PERSONALITY, V18, P177, DOI 10.1002/per.509; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cubela Adoric Vera., 2004, JUSTICE MOTIVE ADOLE, P189, DOI DOI 10.4324/9780203575802; Dalbert C, 1998, CRIT IS SOC, P87; Dalbert C., 1999, SOC JUSTICE RES, V12, P79, DOI [10.1023/A:1022091609047, DOI 10.1023/A:1022091609047]; Dzuka J, 2006, AGING MENT HEALTH, V10, P439, DOI 10.1080/13607860600637778; Dzuka J, 2007, EUR PSYCHOL, V12, P253, DOI 10.1027/1016-9040.12.4.253; Fincher CL, 2008, P ROY SOC B-BIOL SCI, V275, P1279, DOI 10.1098/rspb.2008.0094; Fung Y.-L., 1985, SHORT HIST CHINESE P; FURNHAM A, 1993, J SOC PSYCHOL, V133, P317, DOI 10.1080/00224545.1993.9712149; Furnham A, 2003, PERS INDIV DIFFER, V34, P795, DOI 10.1016/S0191-8869(02)00072-7; Gaucher D, 2010, PERS SOC PSYCHOL B, V36, P109, DOI 10.1177/0146167209351701; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Gilbert DT, 2000, J PERS SOC PSYCHOL, V79, P690, DOI 10.1037/0022-3514.79.5.690; Hafer C., 2005, SOC JUSTICE RES, V18, P429, DOI [10.1007/s11211-005-8569-3, DOI 10.1007/S11211-005-8569-3]; Hafer C.L., 1999, SOC JUSTICE RES, V12, P189, DOI DOI 10.1023/A:1022144317302; Hafer CL, 1998, CRIT IS SOC, P65; Hafer CL, 2000, PERS SOC PSYCHOL B, V26, P1059, DOI 10.1177/01461672002611004; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Inglehart R., 2005, MODERNIZATION CULTUR; Jost J., 2003, EUROPEAN REV SOCIAL, V13, P111, DOI [DOI 10.1080/10463280240000046, 10.1080/10463280240000046]; Jost JT, 2005, CURR DIR PSYCHOL SCI, V14, P260, DOI 10.1111/j.0963-7214.2005.00377.x; Jost JT, 2004, POLIT PSYCHOL, V25, P881, DOI 10.1111/j.1467-9221.2004.00402.x; Jost JT, 2003, EUR J SOC PSYCHOL, V33, P13, DOI 10.1002/ejsp.127; Kay AC, 2008, J PERS SOC PSYCHOL, V95, P18, DOI 10.1037/0022-3514.95.1.18; Kay AC, 2007, ADV EXP SOC PSYCHOL, V39, P305, DOI 10.1016/S0065-2601(06)39006-5; Kay AC, 2009, CURR DIR PSYCHOL SCI, V18, P264, DOI 10.1111/j.1467-8721.2009.01649.x; Kay AC, 2003, J PERS SOC PSYCHOL, V85, P823, DOI 10.1037/0022-3514.85.5.823; Kay AC, 2002, PERS SOC PSYCHOL B, V28, P1300, DOI 10.1177/01461672022812014; Laurin K, 2011, J PERS SOC PSYCHOL, V100, P149, DOI 10.1037/a0021343; Lerner M., 1980, BELIEF JUST WORLD FU, DOI DOI 10.1007/978-1-4899-0448-5; LERNER MJ, 1978, PSYCHOL BULL, V85, P1030, DOI 10.1037/0033-2909.85.5.1030; Lipkus IM, 1996, PERS SOC PSYCHOL B, V22, P666, DOI 10.1177/0146167296227002; Lucas T, 2010, INT SOC SOC JUST RES; McParland JL, 2010, EUR J PAIN, V14, P71, DOI 10.1016/j.ejpain.2008.11.016; Nudelman G, 2013, SOC JUSTICE RES, V26, P105, DOI 10.1007/s11211-013-0178-y; Otto K, 2005, J RES PERS, V39, P559, DOI 10.1016/j.jrp.2005.01.004; Sutton RM, 2005, PERS INDIV DIFFER, V39, P637, DOI 10.1016/j.paid.2005.02.010; Sutton RM, 2008, PERS SOC PSYCHOL B, V34, P528, DOI 10.1177/0146167207312526; Sutton RM, 2007, BRIT J SOC PSYCHOL, V46, P649, DOI 10.1348/014466606X166220; TOMAKA J, 1994, J PERS SOC PSYCHOL, V67, P732, DOI 10.1037/0022-3514.67.4.732; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Wu MS, 2011, EUR J PERSONALITY, V25, P431, DOI 10.1002/per.807; Wu MS, 2012, 14 BIENN C INT SOC J; [吴胜涛 WU Sheng-Tao], 2009, [心理科学进展, Advances in Psychological Science], V17, P579; Yu S-H, 2010, FORMOSA J MENTAL HLT, V23, P347; Zhang G, 2008, J HAPPINESS STUD, V9, P1; [祝卓宏 ZHU Zhuo-hong], 2010, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V18, P79	56	66	67	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e80668	10.1371/journal.pone.0080668	http://dx.doi.org/10.1371/journal.pone.0080668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	261IJ	24391763	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000327657900013
J	Kang, HS; Liao, G; DeGraff, LM; Gerrish, K; Bortner, CD; Garantziotis, S; Jetten, AM				Kang, Hong Soon; Liao, Grace; DeGraff, Laura M.; Gerrish, Kevin; Bortner, Carl D.; Garantziotis, Stavros; Jetten, Anton M.			CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance	PLOS ONE			English	Article							GENE-EXPRESSION; MACROPHAGE ACCUMULATION; PROFILING REVEALS; LIVER STEATOSIS; ROR-ALPHA; OBESITY; OSTEOPONTIN; TISSUE; RECRUITMENT; HYALURONAN	CD44 is a multifunctional membrane receptor implicated in the regulation of several biological processes, including inflammation. CD44 expression is elevated in liver and white adipose tissue (WAT) during obesity suggesting a possible regulatory role for CD44 in metabolic syndrome. To study this hypothesis, we examined the effect of the loss of CD44 expression on the development of various features of metabolic syndrome using CD44 null mice. Our study demonstrates that CD44-deficient mice (CD44KO) exhibit a significantly reduced susceptibility to the development of high fat-diet (HFD)-induced hepatic steatosis, WAT-associated inflammation, and insulin resistance. The decreased expression of genes involved in fatty acid synthesis and transport (Fasn and Cd36), de novo triglyceride synthesis (Mogat1), and triglyceride accumulation (Cidea, Cidec) appears in part responsible for the reduced hepatic lipid accumulation in CD44KO(HFD) mice. In addition, the expression of various inflammatory and cell matrix genes, including several chemokines and its receptors, osteopontin, and several matrix metalloproteinases and collagen genes was greatly diminished in CD44KO(HFD) liver consistent with reduced inflammation and fibrogenesis. In contrast, lipid accumulation was significantly increased in CD44KO(HFD) WAT, whereas inflammation as indicated by the reduced infiltration of macrophages and expression of macrophage marker genes, was significantly diminished in WAT of CD44KO(HFD) mice compared to WT(HFD) mice. CD44KO(HFD) mice remained considerably more insulin sensitive and glucose tolerant than WT(HFD) mice and exhibited lower blood insulin levels. Our study indicates that CD44 plays a critical role in regulating several aspects of metabolic syndrome and may provide a new therapeutic target in the management of insulin resistance.	[Kang, Hong Soon; Liao, Grace; DeGraff, Laura M.; Jetten, Anton M.] NIH, Cell Biol Sect, Res Triangle Pk, NC USA; [Gerrish, Kevin] NIH, Microarray Grp, Res Triangle Pk, NC USA; [Bortner, Carl D.] NIEHS, Lab Signal Transduct, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Garantziotis, Stavros] NIH, Matrix Biol Sect, LRB, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA	Jetten, AM (corresponding author), NIH, Cell Biol Sect, Res Triangle Pk, NC USA.	jetten@niehs.nih.gov	yu, qing/HGC-4611-2022; Jetten, Anton/C-3736-2019; Yu, Qinghua/T-3261-2019; Garantziotis, Stavros/A-6903-2009	Jetten, Anton/0000-0003-0954-4445; Garantziotis, Stavros/0000-0003-4007-375X	Intramural Research Program of the NIEHS, NIH [Z01-ES-101586]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586, ZICES102445, ZIAES102605, ZICES102486, Z01ES101586] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the NIEHS, NIH (Z01-ES-101586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; Consolo M, 2009, INT J MOL MED, V24, P143, DOI 10.3892/ijmm_00000217; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guillen N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kitade H, 2012, DIABETES; Kodama K, 2012, P NATL ACAD SCI US; Li L, 2012, VITAM HORM, V90, P375, DOI 10.1016/B978-0-12-398313-8.00014-2; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Morimoto J, 2010, CURR DRUG TARGETS, V11, P494, DOI 10.2174/138945010790980321; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nakamachi T, 2007, DIABETES, V56, P1662, DOI 10.2337/db06-1177; Nicholls HT, 2011, DIABETES, V60, P1100, DOI 10.2337/db10-1353; Nio Y, 2012, DIABETOLOGIA; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nystrom T, 2007, EXP CELL RES, V313, P1149, DOI 10.1016/j.yexcr.2006.12.026; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pivetta E, 2011, J CELL PHYSIOL, V226, P769, DOI 10.1002/jcp.22398; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Solis MA, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/346972; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Wan ZX, 2012, OBESITY, V20, P453, DOI 10.1038/oby.2011.252; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zhu BQ, 2004, J CELL PHYSIOL, V198, P155, DOI 10.1002/jcp.10394; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	61	75	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58417	10.1371/journal.pone.0058417	http://dx.doi.org/10.1371/journal.pone.0058417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	24391892	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500081
J	Kang, HH; Yan, MF; Yu, QH; Yang, Q				Kang, Haihong; Yan, Mengfei; Yu, Qinghua; Yang, Qian			Characteristics of Nasal-Associated Lymphoid Tissue (NALT) and Nasal Absorption Capacity in Chicken	PLOS ONE			English	Article							OVIDUCTAL EPITHELIAL-CELLS; IMMUNE-SYSTEM; MUCOSAL IMMUNITY; INFLUENZA-VIRUS; FALLOPIAN-TUBE; PARTICLES; ANTIGENS; ORGAN; SITE	As the main mucosal immune inductive site of nasal cavity, nasal-associated lymphoid tissue (NALT) plays an important role in both antigen recognition and immune activation after intranasal immunization. However, the efficiency of intranasal vaccines is commonly restricted by the insufficient intake of antigen by the nasal mucosa, resulting from the nasal mucosal barrier and the nasal mucociliary clearance. The distribution of NALT and the characteristic of nasal cavity have already been described in humans and many laboratory rodents, while data about poultry are scarce. For this purpose, histological sections of the chicken nasal cavities were used to examine the anatomical structure and histological characteristics of nasal cavity. Besides, the absorptive capacity of chicken nasal mucosa was also studied using the materials with different particle size. Results showed that the NALT of chicken was located on the bottom of nasal septum and both sides of choanal cleft, which mainly consisted of second lymphoid follicle. A large number of lymphocytes were distributed under the mucosal epithelium of inferior nasal meatus. In addition, there were also diffuse lymphoid tissues located under the epithelium of the concha nasalis media and the walls of nasal cavity. The results of absorption experiment showed that the chicken nasal mucosa was capable to absorb trypan blue, OVA, and fluorescent latex particles. Inactivated avian influenza virus (IAIV) could be taken up by chicken nasal mucosa except for the stratified squamous epithelium sites located on the forepart of nasal cavity. The intake of IAIV by NALT was greater than that of the nasal mucosa covering on non-lymphoid tissue, which could be further enhanced after intranasal inoculation combined with sodium cholate or CpG DNA. The study on NALT and nasal absorptive capacity will be benefit for further understanding of immune mechanisms after nasal vaccination and development of nasal vaccines for poultry.	[Kang, Haihong; Yan, Mengfei; Yu, Qinghua; Yang, Qian] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	zxbyq@njau.edu.cn	yu, qing/HGC-4611-2022; Jetten, Anton/C-3736-2019; Yu, Qinghua/T-3261-2019; Garantziotis, Stavros/A-6903-2009	Jetten, Anton/0000-0003-0954-4445; Garantziotis, Stavros/0000-0003-4007-375X	National Science Grant of China [31172302]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586, ZICES102445, ZIAES102605, ZICES102486, Z01ES101586] Funding Source: NIH RePORTER	National Science Grant of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Science Grant of China (31172302, http://www.nsfc.gov.cn/), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://www.ec.js.edu.cn/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI N, 1988, JPN J VET SCI, V50, P183; BANG BG, 1968, AM J PATHOL, V53, P735; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Brayden DJ, 2001, EUR J PHARM SCI, V14, P183, DOI 10.1016/S0928-0987(01)00175-0; Casteleyn C, 2010, VET IMMUNOL IMMUNOP, V133, P212, DOI 10.1016/j.vetimm.2009.08.011; FAGERLAND JA, 1993, AVIAN DIS, V37, P10, DOI 10.2307/1591451; FAGERLAND JA, 1990, AM J ANAT, V189, P24, DOI 10.1002/aja.1001890104; Fagerland Jane A., 1993, Regional Immunology, V5, P28; Fujimura Y, 2000, VIRCHOWS ARCH, V436, P560, DOI 10.1007/s004289900177; Golias J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037156; HAMELEERS DMH, 1989, CELL TISSUE RES, V256, P431, DOI 10.1007/BF00218901; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Hiller AS, 1998, SCAND J IMMUNOL, V47, P159; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Itoh H, 2006, AM J REPROD IMMUNOL, V56, P91, DOI 10.1111/j.1600-0897.2006.00389.x; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; KUPER CF, 1992, IMMUNOL TODAY, V13, P219; Lathers DMR, 1998, INVEST OPHTH VIS SCI, V39, P1005; Lee HJ, 2005, EXP MOL MED, V37, P297, DOI 10.1038/emm.2005.40; Liu GY, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-36; Liu HS, 2005, INVEST OPHTH VIS SCI, V46, P4217, DOI 10.1167/iovs.05-0280; LOO SK, 1974, J ANAT, V117, P249; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; MAIR TS, 1987, J COMP PATHOL, V97, P575, DOI 10.1016/0021-9975(87)90008-9; MAIR TS, 1988, J COMP PATHOL, V99, P159, DOI 10.1016/0021-9975(88)90069-2; Maldonado-Contreras AL, 2011, CELL TISSUE RES, V343, P5, DOI 10.1007/s00441-010-1082-5; Nasu K, 2007, HUM REPROD, V22, P356, DOI 10.1093/humrep/del385; Ohshima K, 2000, HISTOL HISTOPATHOL, V15, P713, DOI 10.14670/HH-15.713; PAPPO J, 1989, CLIN EXP IMMUNOL, V76, P144; Pawar D, 2010, AAPS J, V12, P130, DOI 10.1208/s12248-009-9169-1; Qian L, 2002, ACTA BIOCH BIOPH SIN, V34, P719; Quinteiro P, 2005, ANATOMIA HISTOLOGIA, V34, P41; Reese S, 2006, VET RES, V37, P311, DOI 10.1051/vetres:2006003; Sato S, 2012, CURR OPIN VIROL, V2, P225, DOI 10.1016/j.coviro.2012.03.009; Smialek M, 2011, POL J VET SCI, V14, P291, DOI 10.2478/v10181-011-0047-2; SPIT BJ, 1989, CELL TISSUE RES, V255, P193; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Tamura S, 1998, J GEN VIROL, V79, P291, DOI 10.1099/0022-1317-79-2-291; TlaskalovaHogenova H, 1995, FOLIA MICROBIOL, V40, P385, DOI 10.1007/BF02814746; Yuanji G, 1997, INFLUENZA VIRUS EXPT; Zhang XW, 2009, VACCINE, V27, P5628, DOI 10.1016/j.vaccine.2009.07.023; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053314; Zuercher AW, 2002, J IMMUNOL, V168, P1796, DOI 10.4049/jimmunol.168.4.1796	46	75	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84097	10.1371/journal.pone.0084097	http://dx.doi.org/10.1371/journal.pone.0084097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391892	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900035
J	Zhao, ZJ; Chi, QS; Liu, QS; Zheng, WH; Liu, JS; Wang, DH				Zhao, Zhi-Jun; Chi, Qing-Sheng; Liu, Quan-Sheng; Zheng, Wei-Hong; Liu, Jin-Song; Wang, De-Hua			The Shift of Thermoneutral Zone in Striped Hamster Acclimated to Different Temperatures	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; BASAL METABOLIC-RATE; CYTOCHROME-C-OXIDASE; DJUNGARIAN HAMSTER; ENERGY-METABOLISM; BODY-TEMPERATURE; NONSHIVERING THERMOGENESIS; THERMAL CONDUCTANCE; UNCOUPLING PROTEIN; PHODOPUS-SUNGORUS	Temperature affects all biological functions and will therefore modulate ecologically significant interactions between animals and their environment. Here, we examined the effect of ambient temperature (T-a) on the thermal biology and energy budget in striped hamsters acclimated to cold (5 degrees C), warm (21 degrees C) and hot temperatures (31 degrees C). Thermoneutral zone (TNZ) was 22.5-32.5 degrees C, 25-32.5 degrees C and 30-32.5 degrees C in the cold-, warm- and hot-acclimated hamsters, respectively. The cold acclimation decreased the lower critical temperature and made the TNZ wider, and hot exposure elevated the lower critical temperature, resulting in a narrow TNZ. Within the TNZ, cold-acclimated hamsters showed a significantly higher rate of metabolism and thermogenesis than those acclimated to hot temperature. Digestive enzymes activities, including intestinal sucrase, maltase, L-alanine aminopeptidase-N and leucine aminopeptidase were higher in the cold than in the hot. The changes in metabolic rate and thermogenesis at different temperatures were in parallel with cytochrome c oxidase activity and uncoupling protein 1 gene expression of brown adipose tissue. This suggests that the shift of the lower critical temperature of TNZ is possibly associated with the rate of metabolism and thermogenesis, as well as with the digestive capacity of the gastrointestinal tract at different T-a. The upper critical temperature of TNZ may be independent of the changes in T-a. The changes of lower critical temperature of TNZ are an important strategy in adaption to variations of T-a.	[Zhao, Zhi-Jun; Zheng, Wei-Hong; Liu, Jin-Song] Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China; [Zhao, Zhi-Jun; Chi, Qing-Sheng; Wang, De-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Liu, Quan-Sheng] Guangdong Entomol Inst, Guangdong Key Lab Integrated Pest Management Agr, Guangzhou, Guangdong, Peoples R China	Wenzhou University; Chinese Academy of Sciences; Institute of Zoology, CAS; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Zhao, ZJ (corresponding author), Wenzhou Univ, Coll Life & Environm Sci, Wenzhou, Zhejiang, Peoples R China.	zhao73@foxmail.com	Liu, Quan-Sheng/A-2041-2013	Liu, Quan-Sheng/0000-0002-3001-9170; ji, li li/0000-0001-8483-1554	State Key Laboratory of Integrated Management of Pest Insects and Rodents [ChineseIPM1209]; National Natural Science Foundation of China [31270458, 31070367]	State Key Laboratory of Integrated Management of Pest Insects and Rodents; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded the State Key Laboratory of Integrated Management of Pest Insects and Rodents (no. ChineseIPM1209) and also partly supported by grants (no. 31270458 and 31070367) from the National Natural Science Foundation of China to ZJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P282, DOI 10.1086/499990; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; BLIGH J, 1973, Journal of Applied Physiology, V35, P941; BRADLEY SR, 1980, COMP BIOCHEM PHYS A, V65, P465, DOI 10.1016/0300-9629(80)90060-2; Broekman M, 2006, PHYSIOL BEHAV, V89, P750, DOI 10.1016/j.physbeh.2006.08.023; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brzek P, 2009, J EXP BIOL, V212, P1284, DOI 10.1242/jeb.023911; Burness GP, 1998, PHYSIOL ZOOL, V71, P247, DOI 10.1086/515917; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chi QS, 2011, J COMP PHYSIOL B, V181, P91, DOI 10.1007/s00360-010-0506-6; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; DELRIO CM, 1990, PHYSIOL ZOOL, V63, P987, DOI 10.1086/physzool.63.5.30152625; Glanville EJ, 2010, COMP BIOCHEM PHYS A, V155, P383, DOI 10.1016/j.cbpa.2009.12.008; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; Grodzinski W., 1975, International biol Progm, V5, P173; HAMMOND KA, 1991, PHYSIOL ZOOL, V64, P541, DOI 10.1086/physzool.64.2.30158190; Hammond KA, 2001, J EXP BIOL, V204, P1991; HAMMOND KA, 1995, J MAMMAL, V76, P232, DOI 10.2307/1382331; HELDMAIER G, 1989, J BIOL RHYTHM, V4, P251, DOI 10.1177/074873048900400211; HELDMAIER G, 1971, Z VERGL PHYSIOL, V73, P222, DOI 10.1007/BF00304134; HELDMAIER G, 1981, J COMP PHYSIOL, V142, P429, DOI 10.1007/BF00688972; HIMMSHAGEN J, 1985, ANNU REV NUTR, V5, P69, DOI 10.1146/annurev.nu.05.070185.000441; HIMMSHAGEN J, 1984, NEW ENGL J MED, V311, P1549, DOI 10.1056/NEJM198412133112407; IUPS Thermal Commission, 2001, JPN J PHYSIOL, V51, P245; Jefimow M, 2004, COMP BIOCHEM PHYS A, V139, P379, DOI 10.1016/j.cbpb.2004.10.007; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kauffman AS, 2003, PHYSIOL BEHAV, V79, P247, DOI 10.1016/S0031-9384(03)00115-X; Klingenberg M, 1999, BBA-BIOMEMBRANES, V1415, P271, DOI 10.1016/S0005-2736(98)00232-6; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Klingenspor M, 1996, BIOCHEM J, V316, P607, DOI 10.1042/bj3160607; Konarzewski M, 1995, EVOLUTION, V49, P1239, DOI 10.2307/2410448; Kronfeld-Schor N, 2000, PHYSIOL BIOCHEM ZOOL, V73, P37, DOI 10.1086/316718; Liu Jin-Song, 2003, Acta Zoologica Sinica, V49, P451; Liu QS, 2007, J COMP PHYSIOL B, V177, P509, DOI 10.1007/s00360-007-0149-4; Lovegrove BG, 2005, J COMP PHYSIOL B, V175, P231, DOI 10.1007/s00360-005-0477-1; Lovegrove BG, 2003, J COMP PHYSIOL B, V173, P87, DOI 10.1007/s00360-002-0309-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUDA A, 1988, J EXP ZOOL, V248, P133, DOI 10.1002/jez.1402480202; MCDEVITT RM, 1994, PHYSIOL ZOOL, V67, P1117, DOI 10.1086/physzool.67.5.30163885; McNab, 1974, OHIO J SCI, V74, P370; MCNAB BK, 1980, PHYSIOL ZOOL, V53, P145, DOI 10.1086/physzool.53.2.30152577; Naya DE, 2005, J COMP PHYSIOL B, V175, P31, DOI 10.1007/s00360-004-0459-8; Nespolo RF, 2002, J EXP BIOL, V205, P2697; Romanovsky AA, 2002, J APPL PHYSIOL, V92, P2667, DOI 10.1152/japplphysiol.01173.2001; Schleucher E, 2001, COMP BIOCHEM PHYS A, V129, P821, DOI 10.1016/S1095-6433(01)00356-7; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; Song ZG, 2003, J THERM BIOL, V28, P509, DOI 10.1016/S0306-4565(03)00051-2; Song ZG, 2002, ACTA THERIOL, V47, P417, DOI 10.1007/BF03192466; Speakman JR, 1996, PHYSIOL ZOOL, V69, P746, DOI 10.1086/physzool.69.4.30164228; Sundin U, 1978, AM J PHYSIOL, V252R, P822; Terblanche SE, 2000, COMP BIOCHEM PHYS B, V127, P319, DOI 10.1016/S0305-0491(00)00269-8; TOLOZA EM, 1991, AM J PHYSIOL, V261, pG608, DOI 10.1152/ajpgi.1991.261.4.G608; Wang D, 1999, J COMP PHYSIOL B, V169, P77, DOI 10.1007/s003600050196; Wang D.-H, 2003, Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology, V134A, pS96; WIESINGER H, 1990, CAN J PHYSIOL PHARM, V68, P195, DOI 10.1139/y90-030; WIESINGER H, 1989, PFLUG ARCH EUR J PHY, V413, P667, DOI 10.1007/BF00581818; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; Wooden KM, 2002, J EXP BIOL, V205, P2099; Zhang XY, 2006, HORM BEHAV, V50, P61, DOI 10.1016/j.yhbeh.2006.01.005; Zhang Z., 1998, ECOLOGY MANAGEMENT R; Zhao Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052044, 10.1371/journal.pone.0061814, 10.1371/journal.pone.0080574]; Zhao ZJ, 2011, PHYSIOL BIOCHEM ZOOL, V84, P560, DOI 10.1086/662553; Zhao ZJ, 2010, J THERM BIOL, V35, P401, DOI 10.1016/j.jtherbio.2010.08.005; Zhao ZJ, 2010, J EXP BIOL, V213, P3988, DOI 10.1242/jeb.046821; Zhao ZJ, 2010, J THERM BIOL, V35, P52, DOI 10.1016/j.jtherbio.2009.10.008; Zhao ZJ, 2005, PHYSIOL BEHAV, V85, P143, DOI 10.1016/j.physbeh.2005.03.014	68	30	34	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2014	9	1							e84396	10.1371/journal.pone.0084396	http://dx.doi.org/10.1371/journal.pone.0084396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286IW	24400087	gold, Green Submitted, Green Published			2022-12-27	WOS:000329462700021
J	Liu, MX; Chen, X; Chen, G; Cui, QH; Yan, GY				Liu, Ming-Xi; Chen, Xing; Chen, Geng; Cui, Qing-Hua; Yan, Gui-Ying			A Computational Framework to Infer Human Disease-Associated Long Noncoding RNAs	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; DATABASE; GENOME; PROTEIN; INHIBITOR; MOUSE; OVEREXPRESSION; SUSCEPTIBILITY; IDENTIFICATION	As a major class of noncoding RNAs, long noncoding RNAs (lncRNAs) have been implicated in various critical biological processes. Accumulating researches have linked dysregulations and mutations of lncRNAs to a variety of human disorders and diseases. However, to date, only a few human lncRNAs have been associated with diseases. Therefore, it is very important to develop a computational method to globally predict potential associated diseases for human lncRNAs. In this paper, we developed a computational framework to accomplish this by combining human lncRNA expression profiles, gene expression profiles, and human disease-associated gene data. Applying this framework to available human long intergenic noncoding RNAs (lincRNAs) expression data, we showed that the framework has reliable accuracy. As a result, for non-tissue-specific lincRNAs, the AUC of our algorithm is 0.7645, and the prediction accuracy is about 89%. This study will be helpful for identifying novel lncRNAs for human diseases, which will help in understanding the roles of lncRNAs in human diseases and facilitate treatment. The corresponding codes for our method and the predicted results are all available at http://asdcd.amss.ac.cn/MingXiLiu/lncRNA-disease.html.	[Liu, Ming-Xi; Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Acad Math & Syst Sci, Beijing, Peoples R China; [Liu, Ming-Xi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Xing; Yan, Gui-Ying] Chinese Acad Sci, Ctr Math & Interdisciplinary Sci, Beijing, Peoples R China; [Chen, Geng; Cui, Qing-Hua] Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Peking University	Cui, QH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Biomed Informat, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn; yangy@amss.ac.cn	Chen, Xing/G-6844-2016	Chen, Xing/0000-0001-9028-5342; Wang, Yunsheng/0000-0001-5003-4434	National Natural Science Foundation of China [10531070, 10721101, 11301517, 11371355, KJCX-YW-S7]; National Center for Mathematics and Interdisciplinary Sciences, CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Mathematics and Interdisciplinary Sciences, CAS(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China under Grant Nos. 10531070, 10721101, 11301517, 11371355, KJCX-YW-S7 and National Center for Mathematics and Interdisciplinary Sciences, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Gatti DM, 2010, PHYSIOL GENOMICS, V42, P456, DOI 10.1152/physiolgenomics.00110.2009; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haruta N, 2011, P JPN ACAD B-PHYS, V87, P641, DOI 10.2183/pjab.87.641; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Iwasaki M, 2012, J DENT RES, V91, P167, DOI 10.1177/0022034511431702; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li P, 2011, NAT PROD COMMUN, V6, P1801; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Masutani H, 2012, J CLIN BIOCHEM NUTR, V50, P23, DOI 10.3164/jcbn.11-36SR; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mattingly CJ, 2006, J EXP ZOOL PART A, V305A, P689, DOI 10.1002/jez.a.307; Mitsui Sachiko, 2011, Neural Syst Circuits, V1, P5, DOI 10.1186/2042-1001-1-5; Pibouin L, 2002, CANCER GENET CYTOGEN, V133, P55, DOI 10.1016/S0165-4608(01)00634-3; Sakuma Y, 2012, LAB INVEST, V92, P371, DOI 10.1038/labinvest.2011.187; Saviozzi S, 2009, CANCER RES, V69, P3390, DOI 10.1158/0008-5472.CAN-08-2981; Sawaki M, 2012, ONCOL LETT, V3, P61, DOI 10.3892/ol.2011.449; Sonkoly E, 2005, J BIOL CHEM, V280, P24159, DOI 10.1074/jbc.M501704200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yoshihara C, 2012, ONCOL LETT, V3, P387, DOI 10.3892/ol.2011.467; Yoshihara C, 2012, GEN COMP ENDOCR, V175, P495, DOI 10.1016/j.ygcen.2011.12.009; Yoshihara Eiji, 2011, Japanese Journal of Alcohol Studies & Drug Dependence, V46, P570; Yoshihara K, 2011, GENE CHROMOSOME CANC, V50, P167, DOI 10.1002/gcc.20841; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	51	195	205	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2014	9	1							e84408	10.1371/journal.pone.0084408	http://dx.doi.org/10.1371/journal.pone.0084408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286ID	25244184	Green Published, gold, Green Submitted			2022-12-27	WOS:000329460100056
